PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Brody, DL				Brody, David L.			Chief Concern: "I'm Worried I Have Chronic Traumatic Encephalopathy"	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Brody, David L.] NINDS, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA; [Brody, David L.] Uniformed Serv Univ Hlth Sci, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Uniformed Services University of the Health Sciences - USA	Brody, DL (corresponding author), NINDS, Mol Contrast MR Imaging Unit, Bldg 10,5n240,10 Ctr Dr, Bethesda, MD 20892 USA.	David.brody@nih.gov						Bieniek KF, 2015, ACTA NEUROPATHOL, V130, P877, DOI 10.1007/s00401-015-1502-4; Blennow K, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.84; Brody DL, 2014, CONCUSSION CARE MANU; Eisenberg MA, 2013, PEDIATRICS, V132, P8, DOI 10.1542/peds.2013-0432; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; Stern RA, 2013, NEUROLOGY, V81, P1122, DOI 10.1212/WNL.0b013e3182a55f7f	9	2	2	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 20	2018	168	4					285	+		10.7326/M17-2707	http://dx.doi.org/10.7326/M17-2707			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FW6NB	29310134				2022-12-28	WOS:000425434000017
J	Carrelha, J; Meng, YR; Kettyle, LM; Luis, TC; Norfo, R; Alcolea, V; Boukarabila, H; Grasso, F; Gambardella, A; Grover, A; Hogstrand, K; Lord, AM; Sanjuan-Pla, A; Woll, PS; Nerlov, C; Jacobsen, SEW				Carrelha, Joana; Meng, Yiran; Kettyle, Laura M.; Luis, Tiago C.; Norfo, Ruggiero; Alcolea, Veronica; Boukarabila, Hanane; Grasso, Francesca; Gambardella, Adriana; Grover, Amit; Hogstrand, Kari; Lord, Allegra M.; Sanjuan-Pla, Alejandra; Woll, Petter S.; Nerlov, Claus; Jacobsen, Sten Eirik W.			Hierarchically related lineage-restricted fates of multipotent haematopoietic stem cells	NATURE			English	Article							SLAM FAMILY MARKERS; SELF-RENEWAL; RECONSTITUTION; TRANSPLANTATION; NICHES; LIFE	Rare multipotent haematopoietic stem cells (HSCs) in adult bone marrow with extensive self-renewal potential can efficiently replenish all myeloid and lymphoid blood cells(1), securing long-term multilineage reconstitution after physiological and clinical challenges such as chemotherapy and haematopoietic transplantations(2-4). HSC transplantation remains the only curative treatment for many haematological malignancies, but inefficient blood-lineage replenishment remains a major cause of morbidity and mortality(5,6). Single-cell transplantation has uncovered considerable heterogeneity among reconstituting HSCs7-11, a finding that is supported by studies of unperturbed haematopoiesis(2-4,12) and may reflect different propensities for lineage-fate decisions by distinct myeloid-, lymphoid-and platelet-biased HSCs7-10,13. Other studies suggested that such lineage bias might reflect generation of unipotent or oligopotent self-renewing progenitors within the phenotypic HSC compartment, and implicated uncoupling of the defining HSC properties of self-renewal and multipotency(11,14). Here we use highly sensitive tracking of progenitors and mature cells of the megakaryocyte/platelet, erythroid, myeloid and B and T cell lineages, produced from singly transplanted HSCs, to reveal a highly organized, predictable and stable framework for lineage-restricted fates of long-term self-renewing HSCs. Most notably, a distinct class of HSCs adopts a fate towards effective and stable replenishment of a megakaryocyte/platelet-lineage tree but not of other blood cell lineages, despite sustained multipotency. No HSCs contribute exclusively to any other single blood-cell lineage. Single multipotent HSCs can also fully restrict towards simultaneous replenishment of megakaryocyte, erythroid and myeloid lineages without executing their sustained lymphoid lineage potential. Genetic lineage-tracing analysis also provides evidence for an important role of plateletbiased HSCs in unperturbed adult haematopoiesis. These findings uncover a limited repertoire of distinct HSC subsets, defined by a predictable and hierarchical propensity to adopt a fate towards replenishment of a restricted set of blood lineages, before loss of self-renewal and multipotency.				claus.nerlov@imm.ox.ac.uk; sten.eirik.jacobsen@ki.se	Sanjuan-Pla, Alejandra/GRX-9588-2022; Alcolea, Veronica/L-8709-2019; Jacobsen, Sten Eirik W/D-3974-2018	Sanjuan-Pla, Alejandra/0000-0002-0170-5542; Alcolea, Veronica/0000-0002-1892-9139; Jacobsen, Sten Eirik W/0000-0002-1362-3659; Cunha Luis, Tiago/0000-0002-6305-1257; Meng, Yiran/0000-0002-9333-2383; Carrelha, Joana/0000-0002-0324-2617; Norfo, Ruggiero/0000-0002-9485-6285; Woll, Petter S./0000-0002-2340-2526	Medical Research Council (MRC) MHU [MC_UU_12009]; Oxford Single Cell Biology Consortium [MR/M00919X/1]; WT-ISSF [097813/Z/11/B]; WIMM Strategic Alliance awards [G0902418, MC_UU_12025]; MRC HIU; MRC MHU [MC_UU_12009]; NIHR Oxford BRC; John Fell Fund [131/030, 101/517]; EPA fund [CF182, CF170]; Marie Curie Early Stage Researcher Fellowship; MRC UK [G0801073, MC_UU_12009/5, G0701761, G0900892, MC_UU_12009/7]; Swedish Research Council; Knut och Alice Wallenberg Foundation (WIRM); Tobias Foundation; StratRegen KI; Bloodwise [15006]; BBSRC Project Grant [BB/M024350/1]; BBSRC [BB/M024350/1] Funding Source: UKRI; MRC [G0501838, MC_UU_00016/7, G0801073, G0900892, G0701761, MR/M00919X/1, MC_UU_00016/5, MC_UU_12009/5, MC_UU_12009/7] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/M024350/1] Funding Source: researchfish; Medical Research Council [G0501838, MC_UU_12009/7, G0801073, MC_UU_12009/5, MC_UU_00016/5, G0900892, G0701761, MC_UU_00016/7] Funding Source: researchfish	Medical Research Council (MRC) MHU(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Oxford Single Cell Biology Consortium; WT-ISSF; WIMM Strategic Alliance awards; MRC HIU(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC MHU(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIHR Oxford BRC; John Fell Fund; EPA fund; Marie Curie Early Stage Researcher Fellowship; MRC UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Swedish Research Council(Swedish Research CouncilEuropean Commission); Knut och Alice Wallenberg Foundation (WIRM); Tobias Foundation; StratRegen KI; Bloodwise; BBSRC Project Grant(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank A. J. Mead, D. Atkinson, A. Giustacchini and N. Ashley for expert assistance with the Fluidigm array platform (WIMM Single Cell Core Facility is supported by the Medical Research Council (MRC) MHU (MC_UU_12009), the Oxford Single Cell Biology Consortium (MR/M00919X/1), the WT-ISSF (097813/Z/11/B#) and the WIMM Strategic Alliance awards G0902418 and MC_UU_12025); P. Sopp and S. A. Clark for expert flow cytometry technical support and cell-sorting services (WIMM FACS Core Facility is supported by the MRC HIU, MRC MHU (MC_UU_12009), NIHR Oxford BRC and the John Fell Fund (131/030 and 101/517), the EPA fund (CF182 and CF170) and by WIMM Strategic Alliance awards (G0902418 and MC_UU_12025)); the Biomedical Services at University of Oxford for animal technical support; the EMBL Monterotondo Gene Expression Service and Transgenic Core Facility for generating the Vwf-tdTomato BAC and the corresponding transgenic mouse line; N. Iscove for Kit<SUP>W41/W41</SUP> mice; A. Cumano for OP9-DL1 stromal cells; R. Drissen and S. Duarte for discussions and assistance with the preliminary phase of the studies; A. Hillen, B. Wu and T. Bouriez-Jones for technical assistance. This work was supported by Marie Curie Early Stage Researcher Fellowship (J.C.), the MRC UK (G0801073 and MC_UU_12009/5 to S.E.W.J. and G0701761, G0900892 and MC_UU_12009/7 to C.N.), the Swedish Research Council (S.E.W.J.), the Knut och Alice Wallenberg Foundation (WIRM; S.E.W.J.), the Tobias Foundation (S.E.W.J.), StratRegen KI (S.E.W.J.), Bloodwise (project grant 15006 to C.N.) and a BBSRC Project Grant (BB/M024350/1 to C.N.).	Adolfsson J, 2005, CELL, V121, P295, DOI 10.1016/j.cell.2005.02.013; Benveniste P, 2010, CELL STEM CELL, V6, P48, DOI 10.1016/j.stem.2009.11.014; Bhandoola A, 2007, IMMUNITY, V26, P678, DOI 10.1016/j.immuni.2007.05.009; Boiers C, 2013, CELL STEM CELL, V13, P535, DOI 10.1016/j.stem.2013.08.012; Busch K, 2015, NATURE, V518, P542, DOI 10.1038/nature14242; Challen GA, 2010, CELL STEM CELL, V6, P265, DOI 10.1016/j.stem.2010.02.002; Drissen R, 2016, NAT IMMUNOL, V17, P666, DOI 10.1038/ni.3412; Dykstra B, 2007, CELL STEM CELL, V1, P218, DOI 10.1016/j.stem.2007.05.015; Eaves CJ, 2015, BLOOD, V125, P2605, DOI 10.1182/blood-2014-12-570200; Haas S, 2015, CELL STEM CELL, V17, P422, DOI 10.1016/j.stem.2015.07.007; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Luis TC, 2016, NAT IMMUNOL, V17, P1424, DOI 10.1038/ni.3576; Mansson R, 2007, IMMUNITY, V26, P407, DOI 10.1016/j.immuni.2007.02.013; Marx A, 2016, GENOM PROTEOM BIOINF, V14, P55, DOI 10.1016/j.gpb.2015.11.004; Muller-Sieburg CE, 2002, BLOOD, V100, P1302, DOI 10.1182/blood.V100.4.1302.h81602001302_1302_1309; Nagasawa T, 2006, NAT REV IMMUNOL, V6, P107, DOI 10.1038/nri1780; Oguro H, 2013, CELL STEM CELL, V13, P102, DOI 10.1016/j.stem.2013.05.014; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; Pei WK, 2017, NATURE, V548, P456, DOI 10.1038/nature23653; Pietras EM, 2015, CELL STEM CELL, V17, P35, DOI 10.1016/j.stem.2015.05.003; Pineault N, 2011, TRANSFUSION, V51, p72S, DOI 10.1111/j.1537-2995.2011.03369.x; Pronk CJH, 2007, CELL STEM CELL, V1, P428, DOI 10.1016/j.stem.2007.07.005; Sanjuan-Pla A, 2013, NATURE, V502, P232, DOI 10.1038/nature12495; Sawai CM, 2016, IMMUNITY, V45, P597, DOI 10.1016/j.immuni.2016.08.007; Seggewiss R, 2010, BLOOD, V115, P3861, DOI 10.1182/blood-2009-12-234096; SPRENT J, 1994, SCIENCE, V265, P1395, DOI 10.1126/science.8073282; Sun JL, 2014, NATURE, V514, P322, DOI 10.1038/nature13824; Tehranchi R, 2010, NEW ENGL J MED, V363, P1025, DOI 10.1056/NEJMoa0912228; Vellenga E, 2001, BRIT J HAEMATOL, V114, P319, DOI 10.1046/j.1365-2141.2001.02926.x; Wang JW, 2016, NAT CELL BIOL, V18, P480, DOI 10.1038/ncb3342; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Wilson NK, 2015, CELL STEM CELL, V16, P712, DOI 10.1016/j.stem.2015.04.004; Yamamoto R, 2013, CELL, V154, P1112, DOI 10.1016/j.cell.2013.08.007; Yilmaz OH, 2006, BLOOD, V107, P924, DOI 10.1182/blood-2005-05-2140	34	169	174	5	81	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 1	2018	554	7690					106	+		10.1038/nature25455	http://dx.doi.org/10.1038/nature25455			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU7QX	29298288				2022-12-28	WOS:000424048900040
J	Kennedy, KR; Wang, AL				Kennedy, Kelsey R.; Wang, Apphia L.			Poland Syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Kennedy, Kelsey R.; Wang, Apphia L.] Univ Alabama Birmingham, Birmingham, AL 35487 USA	University of Alabama System; University of Alabama Birmingham	Kennedy, KR (corresponding author), Univ Alabama Birmingham, Birmingham, AL 35487 USA.	kcreal@uab.edu							0	4	4	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 4	2018	378	1					72	72		10.1056/NEJMicm1709713	http://dx.doi.org/10.1056/NEJMicm1709713			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FR7BE	29298145				2022-12-28	WOS:000419220500018
J	Oliver, D				Oliver, David			David Oliver: Supporting care assistants when clients become ill at home	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												davidoliver372@googlemail.com						Brindle D, 2016, GUARDIAN; East Midlands Ambulance Service NHS Trust, 2014, CRIS RESP FALLS TEAM; NHS Benchmarking Network, 2017, NAT AUD INT CAR SUMM; NHS England, 2017, NEW AMB SERV STAND A; NHS England, AMB QUAL IND; Oliver D, 2017, BMJ-BRIT MED J, V357, DOI 10.1136/bmj.j1523; Osborne H, 2016, GUARDIAN; Parry SW, 2014, CREATIVELY PREVENTIN; Slawson N., 2017, GUARDIAN; Tracey S, FALLS RESPONSE SERVI; Walker M, NORFOLK COMMUNITY HL; Weir A, 2015, GUARDIAN	12	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 2	2018	360								j5110	10.1136/bmj.j5110	http://dx.doi.org/10.1136/bmj.j5110			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FS3UL	29295812	Bronze, Green Published			2022-12-28	WOS:000419708800002
J	Xu, GF; Strathearn, L; Liu, BY; Bao, W				Xu, Guifeng; Strathearn, Lane; Liu, Buyun; Bao, Wei			Prevalence of Autism Spectrum Disorder Among US Children and Adolescents, 2014-2016	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Xu, Guifeng; Liu, Buyun; Bao, Wei] Univ Iowa, Coll Publ Hlth, Dept Epidemiol, 145 N Riverside Dr,Room S431 CPHB, Iowa City, IA 52242 USA; [Strathearn, Lane] Univ Iowa, Stead Family Childrens Hosp, Ctr Disabil & Dev, Iowa City, IA 52242 USA	University of Iowa; University of Iowa	Bao, W (corresponding author), Univ Iowa, Coll Publ Hlth, Dept Epidemiol, 145 N Riverside Dr,Room S431 CPHB, Iowa City, IA 52242 USA.	wei-bao@uiowa.edu	Strathearn, Lane/B-1740-2013; Romanova, Raisa/O-5724-2018; Bao, Wei/AAG-2431-2019	Strathearn, Lane/0000-0001-5870-8843; Bao, Wei/0000-0002-7301-5786				Blumberg Stephen J, 2013, Natl Health Stat Report, P1; Christensen DL, 2016, MMWR SURVEILL SUMM, V65, P1; Hansen SN, 2015, JAMA PEDIATR, V169, P56, DOI 10.1001/jamapediatrics.2014.1893; Lyall K, 2017, ANNU REV PUBL HEALTH, V38, P81, DOI 10.1146/annurev-publhealth-031816-044318; Parsons Van L, 2014, Vital Health Stat 2, P1; Zablotsky Benjamin, 2015, Natl Health Stat Report, P1	6	188	190	10	39	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 2	2018	319	1					81	82		10.1001/jama.2017.17812	http://dx.doi.org/10.1001/jama.2017.17812			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FR5ON	29297068	Bronze, Green Published			2022-12-28	WOS:000419116000019
J	Yip, L; Carty, SE				Yip, Linwah; Carty, Sally E.			Expanding the Options for Patient-Guided Decision Making in Papillary Thyroid Cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material								IMPORTANCE Active surveillance of low-risk papillary thyroid cancer (PTC) is now an accepted alternative to immediate surgery, but experience with this approach outside of Japan is limited. The kinetics (probability, rate, and magnitude) of PTC tumor growth under active surveillance have not been well defined. OBJECTIVE To describe the kinetics of PTC tumor growth during active surveillance. DESIGN, SETTING, AND PARTICIPANTS Cohort study of 291 patients undergoing active surveillance for low-risk PTC (intrathyroidal tumors <= 1.5 cm) with serial tumor measurements via ultrasonography at a tertiary referral center in the United States. INTERVENTION Active surveillance. MAIN OUTCOMES AND MEASURES The cumulative incidence, rate, and magnitude of the change in tumor diameter or volume, as well as associations with patient and tumor characteristics. RESULTS Of the 291 patients, 219 (75.3%) were women; mean (SD) age was 52 (15) years. During a median (range) active surveillance of 25 (6-166) months, growth in tumor diameter of 3 mm or more was observed in 11 of 291 (3.8%) patients, with a cumulative incidence of 2.5%(2 years) and 12.1% (5 years). No regional or distant metastases developed during active surveillance. In all cases, 3-dimensional measurements of tumor volume allowed for earlier identification of growth (median, 8.2 months; range, 3-46 months before increase in tumor diameter). In multivariable analysis, both younger age at diagnosis (hazard ratio per year, 0.92; 95% CI, 0.87-0.98; P = .006) and risk category at presentation (hazard ratio for inappropriate, 55.17; 95% CI, 9.4-323.19; P < .001) were independently associated with the likelihood of tumor growth. Of the tumors experiencing volume growth, kinetics demonstrated a classic exponential growth pattern, with a median doubling time of 2.2 years (range, 0.5-4.8 years; median r(2) = 0.75; range, 0.42-0.99). CONCLUSIONS AND RELEVANCE The rates of tumor growth during active surveillance in a US cohort with PTCs measuring 1.5 cmor less were low. Serial measurement of tumor volumes may facilitate early identification of tumors that will continue to grow and thereby inform the timing of surveillance imaging and therapeutic interventions.	[Yip, Linwah; Carty, Sally E.] Univ Pittsburgh, Dept Surg, Div Endocrine Surg, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Carty, SE (corresponding author), Univ Pittsburgh, 3471 Fifth Ave,Ste 101, Pittsburgh, PA 15213 USA.	cartyse@upmc.edu						Aschebrook-Kilfoy B, 2015, THYROID, V25, P1313, DOI 10.1089/thy.2015.0098; Haugen BR, 2016, THYROID, V26, P1, DOI 10.1089/thy.2015.0020; Howlader N., 2021, SEER CANC STAT REV, P1975; Ito Y, 2017, EUR J SURG ONCOL; Lim H, 2017, JAMA-J AM MED ASSOC, V317, P1338, DOI 10.1001/jama.2017.2719; Sugitani I, 2010, WORLD J SURG, V34, P1222, DOI 10.1007/s00268-009-0359-x; Tuttle RM, 2017, JAMA OTOLARYNGOL, V143, P1015, DOI 10.1001/jamaoto.2017.1442; Yip L, 2015, ANN SURG, V262, P519, DOI 10.1097/SLA.0000000000001420	8	0	0	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 2	2018	319	1					76	77		10.1001/jama.2017.18608	http://dx.doi.org/10.1001/jama.2017.18608			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FR5ON	29297064				2022-12-28	WOS:000419116000017
J	Zeiser, R; Blazar, BR				Zeiser, Robert; Blazar, Bruce R.			Pathophysiology of Chronic Graft-versus-Host Disease and Therapeutic Targets	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							CONSENSUS DEVELOPMENT PROJECT; CD4(+) T-CELLS; MURINE CHRONIC GVHD; MINOR HISTOCOMPATIBILITY ANTIGENS; PATIENT-REPORTED OUTCOMES; FOLLICULAR HELPER-CELLS; DONOR B-CELLS; CLINICAL-TRIALS; ADOPTIVE TRANSFER; RISK SCORE		[Zeiser, Robert] Freiburg Univ, Dept Hematol Oncol & Stem Cell Transplantat, Freiburg, Germany; [Blazar, Bruce R.] Univ Minnesota, Dept Pediat, Div Blood & Marrow Transplantat, Minneapolis, MN 55455 USA	University of Freiburg; University of Minnesota System; University of Minnesota Twin Cities	Blazar, BR (corresponding author), Dept Pediat, Div Blood & Marrow Transplantat, MMC 366,420 Delaware St, Minneapolis, MN 55455 USA.	blaza001@umn.edu		Zeiser, Robert/0000-0001-6565-3393	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL056067, R01HL118979] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL056067, R01 HL118979] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Ahmed SS, 2015, BONE MARROW TRANSPL, V50, P1563, DOI 10.1038/bmt.2015.191; Alho AC, 2016, BLOOD, V127, P646, DOI 10.1182/blood-2015-10-672345; Allen JL, 2014, BLOOD, V123, P2108, DOI 10.1182/blood-2013-10-533562; Anderson BE, 2003, J CLIN INVEST, V112, P101, DOI 10.1172/JCI200317601; Arai S, 2011, BLOOD, V118, P4242, DOI 10.1182/blood-2011-03-344390; Arora M, 2015, BIOL BLOOD MARROW TR, V21, P640, DOI 10.1016/j.bbmt.2014.10.022; Baron F, 2012, LEUKEMIA, V26, P2462, DOI 10.1038/leu.2012.135; Biedermann BC, 2002, LANCET, V359, P2078, DOI 10.1016/S0140-6736(02)08907-9; Blazar BR, 1998, TRANSPLANTATION, V66, P1220, DOI 10.1097/00007890-199811150-00018; Bleakley M, 2015, J CLIN INVEST, V125, P2677, DOI 10.1172/JCI81229; Boyiadzis M, 2015, CLIN CANCER RES, V21, P2020, DOI 10.1158/1078-0432.CCR-14-0586; Bruggen MC, 2014, BLOOD, V123, P290, DOI 10.1182/blood-2013-07-514372; Chen X, 2007, BLOOD, V110, P3804, DOI 10.1182/blood-2007-05-091074; Cooke KR, 2017, BIOL BLOOD MARROW TR, V23, P211, DOI 10.1016/j.bbmt.2016.09.023; Cutler C, 2006, BLOOD, V108, P756, DOI 10.1182/blood-2006-01-0233; Cutler C, 2013, BLOOD, V122, P1510, DOI 10.1182/blood-2013-04-495895; Cutler CS, 2017, BLOOD, V129, P22, DOI 10.1182/blood-2016-08-686659; Dander E, 2009, TRANSPLANTATION, V88, P1261, DOI 10.1097/TP.0b013e3181bc267e; Dertschnig S, 2015, BLOOD, V125, P2720, DOI 10.1182/blood-2014-08-597245; Huu DL, 2014, J DERMATOL SCI, V74, P214, DOI 10.1016/j.jdermsci.2014.02.008; Huu DL, 2013, BLOOD, V121, P3274, DOI 10.1182/blood-2012-11-465658; Du J, 2017, BLOOD, V129, P71, DOI 10.1182/blood-2016-02-700773; Du J, 2017, BLOOD, V129, P3121, DOI 10.1182/blood-2016-11-752444; Dubovsky JA, 2014, J CLIN INVEST, V124, P4867, DOI 10.1172/JCI75328; Filipovich AH, 2005, BIOL BLOOD MARROW TR, V11, P945, DOI 10.1016/j.bbmt.2005.09.004; Finke J, 2009, LANCET ONCOL, V10, P855, DOI 10.1016/S1470-2045(09)70225-6; Flowers MED, 2011, BLOOD, V117, P3214, DOI 10.1182/blood-2010-08-302109; Flynn R, 2016, BLOOD, V127, P2144, DOI 10.1182/blood-2015-10-678706; Flynn R, 2015, BLOOD, V125, P4085, DOI 10.1182/blood-2014-08-595470; Flynn R, 2014, BLOOD, V123, P3988, DOI 10.1182/blood-2014-03-562231; Forcade E, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.92111; Forcade E, 2016, BLOOD, V127, P2489, DOI 10.1182/blood-2015-12-688895; Fraser CJ, 2006, BLOOD, V108, P2867, DOI 10.1182/blood-2006-02-003954; Fujii H, 2008, BLOOD, V111, P3276, DOI 10.1182/blood-2007-08-106286; Fujiwara H, 2014, J IMMUNOL, V193, P2565, DOI 10.4049/jimmunol.1400954; Gilman AL, 2000, BIOL BLOOD MARROW TR, V6, P327, DOI 10.1016/S1083-8791(00)70058-9; Greinix HT, 2014, TRANSFUS APHER SCI, V50, P349, DOI 10.1016/j.transci.2014.04.005; Hechinger AK, 2015, BLOOD, V125, P570, DOI 10.1182/blood-2014-06-581793; Ip WKE, 2017, SCIENCE, V356, P513, DOI 10.1126/science.aal3535; Jagasia MH, 2015, BIOL BLOOD MARROW TR, V21, P389, DOI 10.1016/j.bbmt.2014.12.001; JENKINS MK, 1988, SCIENCE, V241, P1655, DOI 10.1126/science.3262237; Jin H, 2016, BLOOD, V127, P2249, DOI 10.1182/blood-2015-09-668145; Johnston HF, 2014, BIOL BLOOD MARROW TR, V20, P1089, DOI 10.1016/j.bbmt.2014.04.028; Jourdan M, 2014, LEUKEMIA, V28, P1647, DOI 10.1038/leu.2014.61; Kanakry CG, 2014, BLOOD, V124, P3817, DOI 10.1182/blood-2014-07-587477; Kariminia A, 2016, BLOOD, V127, P3082, DOI 10.1182/blood-2015-09-668251; Kawano Y, 2011, BLOOD, V118, P5021, DOI 10.1182/blood-2011-06-362137; Kennedy GA, 2014, LANCET ONCOL, V15, P1451, DOI 10.1016/S1470-2045(14)71017-4; Khoder A, 2014, BLOOD, V124, P2034, DOI 10.1182/blood-2014-04-571125; Kim DH, 2007, TRANSPLANTATION, V84, P917, DOI 10.1097/01.tp.0000284583.15810.6e; Kitko CL, 2014, BLOOD, V123, P786, DOI 10.1182/blood-2013-08-520072; Koreth J, 2011, NEW ENGL J MED, V365, P2055, DOI 10.1056/NEJMoa1108188; Lee SJ, 2017, BLOOD, V129, P30, DOI 10.1182/blood-2016-07-686642; Lee SJ, 2015, BIOL BLOOD MARROW TR, V21, P984, DOI 10.1016/j.bbmt.2015.02.025; MacDonald KPA, 2017, BLOOD, V129, P13, DOI 10.1182/blood-2016-06-686618; Malard F, 2014, BONE MARROW TRANSPL, V49, P539, DOI 10.1038/bmt.2013.215; Martin PJ, 2016, BLOOD, V128, P2450, DOI 10.1182/blood-2016-07-728063; Martin PJ, 2015, BIOL BLOOD MARROW TR, V21, P1343, DOI 10.1016/j.bbmt.2015.05.004; Martires KJ, 2011, ARCH DERMATOL, V147, P1081, DOI 10.1001/archdermatol.2011.226; Matsuoka K, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005265; Matsuoka K, 2010, J CLIN INVEST, V120, P1479, DOI 10.1172/JCI41072; McDonald-Hyman C, 2016, BLOOD, V128, P1013, DOI 10.1182/blood-2016-05-715896; Miklos D, 2017, BLOOD, V130, P2243, DOI 10.1182/blood-2017-07-793786; Miklos DB, 2005, BLOOD, V105, P2973, DOI 10.1182/blood-2004-09-3660; Moon JH, 2017, ANN HEMATOL, V96, P805, DOI 10.1007/s00277-017-2939-4; Okamoto S, 2015, J IMMUNOL, V194, P1357, DOI 10.4049/jimmunol.1400973; Paczesny S, 2015, BIOL BLOOD MARROW TR, V21, P780, DOI 10.1016/j.bbmt.2015.01.003; Palmer J, 2014, BIOL BLOOD MARROW TR, V20, P337, DOI 10.1016/j.bbmt.2013.11.025; Pavletic SZ, 2006, BIOL BLOOD MARROW TR, V12, P252, DOI 10.1016/j.bbmt.2006.01.008; Pidala J, 2012, HAEMATOL-HEMATOL J, V97, P451, DOI 10.3324/haematol.2011.055186; Pidala J, 2011, BLOOD, V117, P4651, DOI 10.1182/blood-2010-11-319509; Rozmus J, 2011, BIOL BLOOD MARROW TR, V17, P1804, DOI 10.1016/j.bbmt.2011.05.011; Sakoda Y, 2007, BLOOD, V109, P1756, DOI 10.1182/blood-2006-08-042853; Sarantopoulos S, 2007, CLIN CANCER RES, V13, P6107, DOI 10.1158/1078-0432.CCR-07-1290; SCHULTZ KR, 1995, BLOOD, V86, P4344, DOI 10.1182/blood.V86.11.4344.bloodjournal86114344; Schutt SD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137641; Schwab L, 2014, NAT MED, V20, P648, DOI 10.1038/nm.3517; She K, 2007, BIOL BLOOD MARROW TR, V13, P386, DOI 10.1016/j.bbmt.2006.12.441; SHULMAN HM, 1980, AM J MED, V69, P204, DOI 10.1016/0002-9343(80)90380-0; Srinivasan M, 2012, BLOOD, V119, P1570, DOI 10.1182/blood-2011-07-364414; Theil A, 2015, CYTOTHERAPY, V17, P473, DOI 10.1016/j.jcyt.2014.11.005; Tivol E, 2005, BLOOD, V105, P4885, DOI 10.1182/blood-2004-12-4980; Weinberg K, 2001, BLOOD, V97, P1458, DOI 10.1182/blood.V97.5.1458; Weiss JM, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aad8953; Westekemper H, 2010, BONE MARROW TRANSPL, V45, P1340, DOI 10.1038/bmt.2009.346; Wilhelm K, 2010, NAT MED, V16, P1434, DOI 10.1038/nm.2242; Wolff D, 2011, BIOL BLOOD MARROW TR, V17, P1, DOI 10.1016/j.bbmt.2010.05.011; Wu T, 2013, J IMMUNOL, V191, P488, DOI 10.4049/jimmunol.1300657; Wynn TA, 2012, NAT MED, V18, P1028, DOI 10.1038/nm.2807; Yamano T, 2015, IMMUNITY, V42, P1048, DOI 10.1016/j.immuni.2015.05.013; Young JS, 2012, J IMMUNOL, V189, P222, DOI 10.4049/jimmunol.1200677; Yu J, 2016, J CLIN ONCOL, V34, P2583, DOI 10.1200/JCO.2015.65.9615; Zeiser R, 2015, LEUKEMIA, V29, P2062, DOI 10.1038/leu.2015.212; Zeiser R, 2006, BLOOD, V108, P390, DOI 10.1182/blood-2006-01-0329; Zeiser R, 2016, BLOOD, V127, P3117, DOI 10.1182/blood-2016-02-699082; Zhang CY, 2006, BLOOD, V107, P2993, DOI 10.1182/blood-2005-09-3623; Zhang Y, 2007, J IMMUNOL, V179, P3305, DOI 10.4049/jimmunol.179.5.3305; Zhao DC, 2011, J IMMUNOL, V186, P856, DOI 10.4049/jimmunol.1002195; Zorn E, 2005, BLOOD, V106, P2903, DOI 10.1182/blood-2005-03-1257	99	283	289	5	46	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 28	2017	377	26					2565	2579		10.1056/NEJMra1703472	http://dx.doi.org/10.1056/NEJMra1703472			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FR0TX	29281578				2022-12-28	WOS:000418777700008
J	Voelker, R				Voelker, Rebecca			Blood Test Results-Pronto	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 19	2017	318	23					2288	2288		10.1001/jama.2017.18869	http://dx.doi.org/10.1001/jama.2017.18869			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FQ3RJ	29260207				2022-12-28	WOS:000418274000007
J	Blendon, RJ; Benson, JM				Blendon, Robert J.; Benson, John M.			The Public and the Opioid-Abuse Epidemic	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Blendon, Robert J.; Benson, John M.] Harvard TH Chan Sch Publ Hlth, Boston, MA 02115 USA; [Blendon, Robert J.] John F Kennedy Sch Govt, Cambridge, MA 02138 USA	Harvard University; Harvard T.H. Chan School of Public Health	Blendon, RJ (corresponding author), Harvard TH Chan Sch Publ Hlth, Boston, MA 02115 USA.; Blendon, RJ (corresponding author), John F Kennedy Sch Govt, Cambridge, MA 02138 USA.							[Anonymous], 2017, OP OV UND EP; Murphy Kelly., 2016, FINDING SOLUTIONS PR	2	97	97	0	21	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 1	2018	378	5					407	411		10.1056/NEJMp1714529	http://dx.doi.org/10.1056/NEJMp1714529			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FU3WP	29298128	Bronze			2022-12-28	WOS:000423783200003
J	Casasent, AK; Schalck, A; Gao, RL; Sei, E; Long, A; Pangburn, W; Casasent, T; Meric-Bernstam, F; Edgerton, ME; Navin, NE				Casasent, Anna K.; Schalck, Aislyn; Gao, Ruli; Sei, Emi; Long, Annalyssa; Pangburn, William; Casasent, Tod; Meric-Bernstam, Funda; Edgerton, Mary E.; Navin, Nicholas E.			Multiclonal Invasion in Breast Tumors Identified by Topographic Single Cell Sequencing	CELL			English	Article							CARCINOMA IN-SITU; LASER CAPTURE MICRODISSECTION; DUCTAL CARCINOMA; GENOME EVOLUTION; CANCER EVOLUTION; RNA-SEQ; NUMBER; PROGRESSION; SAMPLES; HETEROGENEITY	Ductal carcinoma in situ (DCIS) is an early-stage breast cancer that infrequently progresses to invasive ductal carcinoma (IDC). Genomic evolution has been difficult to delineate during invasion due to intratumor heterogeneity and the low number of tumor cells in the ducts. To overcome these challenges, we developed Topographic Single Cell Sequencing (TSCS) to measure genomic copy number profiles of single tumor cells while preserving their spatial context in tissue sections. We applied TSCS to 1,293 single cells from 10 synchronous patients with both DCIS and IDC regions in addition to exome sequencing. Our data reveal a direct genomic lineage between in situ and invasive tumor subpopulations and further show that most mutations and copy number aberrations evolved within the ducts prior to invasion. These results support a multiclonal invasion model, in which one or more clones escape the ducts and migrate into the adjacent tissues to establish the invasive carcinomas.	[Casasent, Anna K.; Schalck, Aislyn; Gao, Ruli; Sei, Emi; Long, Annalyssa; Pangburn, William; Navin, Nicholas E.] Univ Texas MD Anderson Canc Ctr, Dept Genet, Houston, TX 77030 USA; [Casasent, Anna K.; Schalck, Aislyn; Navin, Nicholas E.] Univ Texas MD Anderson Canc Ctr, Grad Sch Biomed Sci, Houston, TX 77030 USA; [Casasent, Tod; Navin, Nicholas E.] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA; [Meric-Bernstam, Funda] Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, Houston, TX 77030 USA; [Edgerton, Mary E.] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Navin, NE (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Genet, Houston, TX 77030 USA.; Navin, NE (corresponding author), Univ Texas MD Anderson Canc Ctr, Grad Sch Biomed Sci, Houston, TX 77030 USA.; Navin, NE (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA.; Edgerton, ME (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA.	medgerton@mdanderson.org; nnavin@mdanderson.org		Schalck, Aislyn/0000-0002-4020-1822; Gao, Ruli/0000-0002-1137-4564; Casasent, Anna/0000-0002-7857-179X	Lefkofsky Family Foundation; NCI [CA169244]; American Cancer Society [129098-RSG-16-092-01-TBG]; Chan-Zuckerberg Initiative [HCA-A-1704-01668]; Rosalie B. Hite Fellowship in Cancer Research; Cancer Prevention and Research Institute of Texas [RP140103]; MD Anderson Sequencing and Microarray Core Facility [CA016672]; NATIONAL CANCER INSTITUTE [P30CA016672, R01CA169244] Funding Source: NIH RePORTER	Lefkofsky Family Foundation; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society(American Cancer Society); Chan-Zuckerberg Initiative; Rosalie B. Hite Fellowship in Cancer Research; Cancer Prevention and Research Institute of Texas; MD Anderson Sequencing and Microarray Core Facility; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants to N.E.N. from the Lefkofsky Family Foundation, NCI (CA169244), American Cancer Society (129098-RSG-16-092-01-TBG), and Chan-Zuckerberg Initiative (HCA-A-1704-01668). N.E.N. is a T.C. Hsu Endowed Scholar, AAAS Wachtel Scholar, Andrew Sabin Family Fellow, and Jack & Beverly Randall Innovator. A.K.C. is supported by a Rosalie B. Hite Fellowship in Cancer Research. A.L. and W.P. were supported by Cancer Prevention and Research Institute of Texas (RP140103). This work was also supported by the MD Anderson Sequencing and Microarray Core Facility (CA016672). We thank Hank Adams, Louis Ramagli, Erika Thompson, Hongli Tang, Alexander Davis, and Jake Leighton for their help. We are also grateful to Sohrab Shah and his group for support using the TimeScape software.	Aceto N, 2014, CELL, V158, P1110, DOI 10.1016/j.cell.2014.07.013; Allred DC, 2008, CLIN CANCER RES, V14, P370, DOI 10.1158/1078-0432.CCR-07-1127; Allred D. Craig, 2010, Journal of the National Cancer Institute Monographs, P134, DOI 10.1093/jncimonographs/lgq035; Andl CD, 2004, AM J PHYSIOL-GASTR L, V287, pG1227, DOI 10.1152/ajpgi.00253.2004; [Anonymous], 2012, CLUSTER CLUSTER ANAL; Baslan T, 2015, GENOME RES, V25, P714, DOI 10.1101/gr.188060.114; Baslan T, 2012, NAT PROTOC, V7, P1024, DOI 10.1038/nprot.2012.039; Chin K, 2004, NAT GENET, V36, P984, DOI 10.1038/ng1409; Cowell CF, 2013, MOL ONCOL, V7, P859, DOI 10.1016/j.molonc.2013.07.005; Datta S, 2015, HISTOL HISTOPATHOL, V30, P1255, DOI 10.14670/HH-11-622; Dudik JM, 2015, COMPUT BIOL MED, V59, P10, DOI 10.1016/j.compbiomed.2015.01.007; Ester M., 1996, P KDD 96, P1; Foschini MP, 2013, HUM PATHOL, V44, P1310, DOI 10.1016/j.humpath.2012.09.022; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Galili T, 2015, BIOINFORMATICS, V31, P3718, DOI 10.1093/bioinformatics/btv428; Gao RL, 2016, NAT GENET, V48, P1119, DOI 10.1038/ng.3641; Gerlinger M, 2014, NAT GENET, V46, P225, DOI 10.1038/ng.2891; Gerstung M, 2014, BIOINFORMATICS, V30, P1198, DOI 10.1093/bioinformatics/btt750; Gerstung M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1814; Grindberg RV, 2013, P NATL ACAD SCI USA, V110, P19802, DOI 10.1073/pnas.1319700110; Hernandez L, 2012, J PATHOL, V227, P42, DOI 10.1002/path.3990; Heselmeyer-Haddad K, 2012, AM J PATHOL, V181, P1807, DOI 10.1016/j.ajpath.2012.07.012; Hu M, 2008, CANCER CELL, V13, P394, DOI 10.1016/j.ccr.2008.03.007; Johnson CE, 2012, BREAST CANCER RES TR, V133, P889, DOI 10.1007/s10549-011-1835-1; Kim SY, 2015, ONCOTARGET, V6, P7597, DOI 10.18632/oncotarget.3162; Kroigard AB, 2015, ONCOTARGET, V6, P5634, DOI 10.18632/oncotarget.3111; Leung ML, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0616-2; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Lohr JG, 2014, NAT BIOTECHNOL, V32, P479, DOI 10.1038/nbt.2892; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; Malikic S, 2015, BIOINFORMATICS, V31, P1349, DOI 10.1093/bioinformatics/btv003; Martelotto LG, 2017, NAT MED, V23, P376, DOI 10.1038/nm.4279; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; McPherson A, 2016, NAT GENET, V48, P758, DOI 10.1038/ng.3573; Miron A, 2010, CANCER RES, V70, P5674, DOI 10.1158/0008-5472.CAN-08-2660; Murtagh F, 2014, J CLASSIF, V31, P274, DOI 10.1007/s00357-014-9161-z; Navin N, 2011, NATURE, V472, P90, DOI 10.1038/nature09807; Navin N, 2010, GENOME RES, V20, P68, DOI 10.1101/gr.099622.109; Newburger DE, 2013, GENOME RES, V23, P1097, DOI 10.1101/gr.151670.112; Patel AP, 2014, SCIENCE, V344, P1396, DOI 10.1126/science.1254257; Piekenbrock M. H. a. M., 2017, DBSCAN DENSITY BASED; Roth A, 2014, NAT METHODS, V11, P396, DOI [10.1038/nmeth.2883, 10.1038/NMETH.2883]; Sakr RA, 2014, CLIN CANCER RES, V20, P2326, DOI 10.1158/1078-0432.CCR-13-2267; Sarper M, 2017, BREAST CANCER RES, V19, DOI 10.1186/s13058-017-0822-9; Scornavacca C, 2011, BIOINFORMATICS, V27, pI248, DOI 10.1093/bioinformatics/btr210; Shah SP, 2006, BIOINFORMATICS, V22, pE431, DOI 10.1093/bioinformatics/btl238; Shah SP, 2012, NATURE, V486, P395, DOI 10.1038/nature10933; Sharma M, 2010, BREAST CANCER RES TR, V123, P397, DOI 10.1007/s10549-009-0654-0; Smith MA, 2017, NAT METHODS, V14, P549, DOI 10.1038/nmeth.4303; Sontag L, 2005, J THEOR BIOL, V232, P179, DOI 10.1016/j.jtbi.2004.08.002; Suh SS, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004652; Tibshirani R, 2001, J ROY STAT SOC B, V63, P411, DOI 10.1111/1467-9868.00293; Tirosh I, 2016, SCIENCE, V352, P189, DOI 10.1126/science.aad0501; Vandewoestyne M, 2013, ANAL BIOCHEM, V439, P88, DOI 10.1016/j.ab.2013.04.023; Vehvilainen P, 2003, J BIOL CHEM, V278, P24705, DOI 10.1074/jbc.M212953200; Virnig BA, 2010, J NATL CANCER I, V102, P170, DOI 10.1093/jnci/djp482; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wang Y, 2014, NATURE, V512, P155, DOI 10.1038/nature13600; Xu X, 2012, CELL, V148, P886, DOI 10.1016/j.cell.2012.02.025; Yates LR, 2015, NAT MED, V21, P751, DOI 10.1038/nm.3886; Yue Shi-hong, 2004, J Zhejiang Univ Sci, V5, P1405, DOI 10.1631/jzus.2004.1405; Zong CH, 2012, SCIENCE, V338, P1622, DOI 10.1126/science.1229164	62	206	216	1	68	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 11	2018	172	1-2					205	+		10.1016/j.cell.2017.12.007	http://dx.doi.org/10.1016/j.cell.2017.12.007			25	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FS5MI	29307488	Bronze, Green Accepted			2022-12-28	WOS:000419840100020
J	Mead, PS				Mead, Paul S.			Plague in Madagascar - A Tragic Opportunity for Improving Public Health	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							PNEUMONIC PLAGUE		[Mead, Paul S.] Ctr Dis Control & Prevent, Natl Ctr Emerging & Zoonot Dis, Div Vector Borne Dis, Ft Collins, CO 80521 USA	Centers for Disease Control & Prevention - USA	Mead, PS (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Emerging & Zoonot Dis, Div Vector Borne Dis, Ft Collins, CO 80521 USA.							[Anonymous], 2017, SYNTH RES BIOL PEST; Chanteau S, 2003, LANCET, V361, P211, DOI 10.1016/S0140-6736(03)12270-2; Mavalankar DV, 1995, J ROY SOC MED, V88, P547; Nishiura H, 2006, J EPIDEMIOL COMMUN H, V60, P640, DOI 10.1136/jech.2005.042424; World Health Organization, 2017, PLAG OUTBR MAD EXT S	5	31	32	0	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 11	2018	378	2					106	108		10.1056/NEJMp1713881	http://dx.doi.org/10.1056/NEJMp1713881			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FS7IR	29261403	Bronze			2022-12-28	WOS:000419971600003
J	Zepeda, L				Zepeda, Lydia			The harassment tax	SCIENCE			English	Editorial Material								A senior faculty member asked me into his office. I assumed it was to talk about agricultural data. It was the fall of 1991 and I was untenured, 32 years old, and 7 months pregnant. He was in his 60s and one of many men who were going to vote on my tenure. He showed me the recent issue of Vanity Fair with Demi Moore on the cover, pregnant and nude. "She reminds me of you," he said as he tried to catch my eye. I looked at the floor, stunned. I mumbled something and backed out of his office, wondering whether I would ever feel clean again.	[Zepeda, Lydia] Univ Wisconsin, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Zepeda, L (corresponding author), Univ Wisconsin, Madison, WI 53706 USA.	SciCareerEditor@aaas.org							0	6	6	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 5	2018	359	6371					126	126		10.1126/science.359.6371.126	http://dx.doi.org/10.1126/science.359.6371.126			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FR8KW	29302016				2022-12-28	WOS:000419324700079
J	Powell, DE; Carraccio, C				Powell, Deborah E.; Carraccio, Carol			Toward Competency-Based Medical Education	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Powell, Deborah E.] Univ Minnesota, Sch Med, Minneapolis, MN 55455 USA; [Carraccio, Carol] Amer Board Pediat Inc, Chapel Hill, NC USA	University of Minnesota System; University of Minnesota Twin Cities	Powell, DE (corresponding author), Univ Minnesota, Sch Med, Minneapolis, MN 55455 USA.							Andrews JS, 2017, ACAD MED; Englander R, 2017, MED TEACH, V39, P582, DOI 10.1080/0142159X.2017.1315066; Ferguson PC, 2013, J BONE JOINT SURG AM, V95, DOI 10.2106/JBJS.M.00314; McGaghie WC., 1978, COMPETENCY BASED CUR; ten Cate O, 2007, ACAD MED, V82, P542, DOI 10.1097/ACM.0b013e31805559c7	5	56	60	2	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 4	2018	378	1					3	5		10.1056/NEJMp1712900	http://dx.doi.org/10.1056/NEJMp1712900			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FR7BE	29298154				2022-12-28	WOS:000419220500010
J	Vangipuram, R; Haley, C; Tyring, SK				Vangipuram, Ramya; Haley, Christopher; Tyring, Stephen K.			A Woman With a Large Ulcerated Nodule on the Finger	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							MERKEL CELL-CARCINOMA; POLYOMAVIRUS		[Vangipuram, Ramya; Tyring, Stephen K.] Univ Texas Hlth Sci Ctr Houston, Dept Dermatol, Houston, TX 77030 USA; [Tyring, Stephen K.] Ctr Clin Studies, 451 N Texas Ave, Webster, TX 77598 USA	University of Texas System; University of Texas Health Science Center Houston	Tyring, SK (corresponding author), Ctr Clin Studies, 451 N Texas Ave, Webster, TX 77598 USA.	styring@ccstexas.com						Feng HC, 2008, SCIENCE, V319, P1096, DOI 10.1126/science.1152586; Fitzgerald TL, 2015, AM SURGEON, V81, P802; Foulongne V, 2011, J MED VIROL, V83, P1435, DOI 10.1002/jmv.22110; Grabowski J, 2008, CLIN MED INSIGHTS-ON, V2, P327; Heath M, 2008, J AM ACAD DERMATOL, V58, P375, DOI 10.1016/j.jaad.2007.11.020; Kaufman HL, 2016, LANCET ONCOL, V17, P1374, DOI 10.1016/S1470-2045(16)30364-3; National Comprehensive Cancer Network (NCCN), NCCN CLIN PRACTICE G; Paulson KG, 2018, J AM ACAD DERMATOL, V78, P457, DOI 10.1016/j.jaad.2017.10.028; Paulson KG, 2017, CANCER-AM CANCER SOC, V123, P1464, DOI 10.1002/cncr.30475; Wang TS, 2011, SEMIN CUTAN MED SURG, V30, P48, DOI 10.1016/j.sder.2011.02.001	10	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 2	2018	319	1					78	79		10.1001/jama.2017.19282	http://dx.doi.org/10.1001/jama.2017.19282			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FR5ON	29297059				2022-12-28	WOS:000419116000018
J	Backes, M; Dingemans, SA; Dijkgraaf, MGW; van den Berg, HR; van Dijkman, B; Hoogendoorn, JM; Joosse, P; Ritchie, ED; Roerdink, WH; Schots, JPM; Sosef, NL; Spijkerman, IJB; Twigt, BA; van der Veen, AH; van Veen, RN; Vermeulen, J; Vos, DI; Winkelhagen, J; Goslings, JC; Schepers, T				Backes, Manouk; Dingemans, Siem A.; Dijkgraaf, Marcel G. W.; van den Berg, H. Rogier; van Dijkman, Bart; Hoogendoorn, Jochem M.; Joosse, Pieter; Ritchie, Ewan D.; Roerdink, W. Herbert; Schots, Judith P. M.; Sosef, Nico L.; Spijkerman, Ingrid J. B.; Twigt, Bas A.; van der Veen, Alexander H.; van Veen, Ruben N.; Vermeulen, Jefrey; Vos, Dagmar I.; Winkelhagen, Jasper; Goslings, J. Carel; Schepers, Tim		WIFI Collaboration Grp	Effect of Antibiotic Prophylaxis on Surgical Site Infections Following Removal of Orthopedic Implants Used for Treatment of Foot, Ankle, and Lower Leg Fractures A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RISK-FACTORS; COMPLICATIONS; SURGERY; PREVENTION; GUIDELINE; LIFE	IMPORTANCE Following clean (class I, not contaminated) surgical procedures, the rate of surgical site infection (SSI) should be less than approximately 2%. However, an infection rate of 12.2% has been reported following removal of orthopedic implants used for treatment of fractures below the knee. OBJECTIVE To evaluate the effect of a single dose of preoperative antibiotic prophylaxis on the incidence of SSIs following removal of orthopedic implants used for treatment of fractures below the knee. DESIGN, SETTING, AND PARTICIPANTS Multicenter, double-blind, randomized clinical trial including 500 patients aged 18 to 75 years with previous surgical treatment for fractures below the knee who were undergoing removal of orthopedic implants from 19 hospitals (17 teaching and 2 academic) in the Netherlands (November 2014-September 2016), with a follow-up of 6 months (final follow-up, March 28, 2017). Exclusion criteria were an active infection or fistula, antibiotic treatment, reimplantation of osteosynthesis material in the same session, allergy for cephalosporins, known kidney disease, immunosuppressant use, or pregnancy. INTERVENTIONS A single preoperative intravenous dose of 1000 mg of cefazolin (cefazolin group, n = 228) or sodium chloride (0.9%; saline group, n = 242). MAIN OUTCOMES AND MEASURES Primary outcome was SSI within 30 days as measured by the criteria from the US Centers for Disease Control and Prevention. Secondary outcome measures were functional outcome, health-related quality of life, and patient satisfaction. RESULTS Among 477 randomized patients (mean age, 44 years [SD, 15]; women, 274 [57%]; median time from orthopedic implant placement, 11 months [interquartile range, 7-16]), 470 patients completed the study. Sixty-six patients developed an SSI (14.0%): 30 patients (13.2%) in the cefazolin group vs 36 in the saline group (14.9%) (absolute risk difference, -1.7 [95% CI, -8.0 to 4.6], P = .60). CONCLUSIONS AND RELEVANCE Among patients undergoing surgery for removal of orthopedic implants used for treatment of fractures below the knee, a single preoperative dose of intravenous cefazolin compared with saline did not reduce the risk of surgical site infection within 30 days following implant removal.	[Backes, Manouk; Dingemans, Siem A.; Goslings, J. Carel; Schepers, Tim] Acad Med Ctr, Trauma Unit, Dept Surg, Meibergdreef 9,POB 22660, NL-1100 DD Amsterdam, Netherlands; [Dijkgraaf, Marcel G. W.] Acad Med Ctr, Clin Res Unit, Amsterdam, Netherlands; [van den Berg, H. Rogier] Onze Lieve Vrouwe Gasthuis East Amsterdam, Dept Surg, Amsterdam, Netherlands; [van Dijkman, Bart] Flevo Hosp, Dept Surg, Almere, Netherlands; [Hoogendoorn, Jochem M.] Haaglanden Med Ctr, Dept Surg, The Hague, Netherlands; [Joosse, Pieter] Med Ctr Alkmaar, Dept Surg, Alkmaar, Netherlands; [Ritchie, Ewan D.] Alrijne Hosp, Dept Surg, Leiderdorp, Netherlands; [Roerdink, W. Herbert] Deventer Hosp, Dept Surg, Deventer, Netherlands; [Schots, Judith P. M.; van der Veen, Alexander H.] Catharina Hosp, Dept Surg, Eindhoven, Netherlands; [Sosef, Nico L.] Spaarne Gasthuis Hoofddorp, Dept Surg, Hoofddorp, Netherlands; [Spijkerman, Ingrid J. B.] Acad Med Ctr, Dept Microbiol, Amsterdam, Netherlands; [Twigt, Bas A.] BovenIJ Hosp, Dept Surg, Amsterdam, Netherlands; [van Veen, Ruben N.] Onze Lieve Vrouwe Gasthuis West, Dept Surg, Amsterdam, Netherlands; [Vermeulen, Jefrey] Spaarne Gasthuis Haarlem, Dept Surg, Haarlem, Netherlands; [Vos, Dagmar I.] Amphia Hosp Breda, Dept Surg, Breda, Netherlands; [Winkelhagen, Jasper] Westfries Gasthuis Hoorn, Dept Surg, Hoorn, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Haaglanden Medical Center; Medical Center Of Alkmaar; Deventer Hospital; Catharina Hospital; Spaarne Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Spaarne Hospital; Amphia Hospital	Schepers, T (corresponding author), Acad Med Ctr, Trauma Unit, Dept Surg, Meibergdreef 9,POB 22660, NL-1100 DD Amsterdam, Netherlands.	t.schepers@amc.nl		Schepers, Tim/0000-0003-1172-4939	Netherlands Organization for Health Research and Development (ZonMw) [836031005]	Netherlands Organization for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development)	This work was supported by grant 836031005 from the Netherlands Organization for Health Research and Development (ZonMw).	Abramson Joseph H, 2011, Epidemiol Perspect Innov, V8, P1, DOI 10.1186/1742-5573-8-1; Andersen MR, 2015, INJURY, V46, P2283, DOI 10.1016/j.injury.2015.08.021; World Medical Association, 2013, JAMA, V310, P2191, DOI 10.1001/jama.2013.281053; Backes M, 2015, Open Orthop J, V9, P418, DOI 10.2174/1874325001509010418; Backes M, 2015, BMC SURG, V15, DOI 10.1186/1471-2482-15-12; Backes M, 2013, FOOT ANKLE INT, V34, P1521, DOI 10.1177/1071100713502466; Berrios SI, 2017, JAMA SURG, V152, P784, DOI 10.1001/jamasurg.2017.0904; Binkley JM, 1999, PHYS THER, V79, P371; Boxma H, 1996, LANCET, V347, P1133, DOI 10.1016/S0140-6736(96)90606-6; Bryson DJ, 2016, BONE JOINT J, V98B, P1014, DOI 10.1302/0301-620X.98B8.37359; Campbell I, 2007, STAT MED, V26, P3661, DOI 10.1002/sim.2832; de Jonge SW, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000006903; Dingemans SA, 2017, ACTA ORTHOP, V88, P422, DOI 10.1080/17453674.2017.1309886; Gans I, 2017, PATIENT SAF SURG, V11, DOI 10.1186/s13037-016-0118-5; Gillespie WJ, 2001, COCHRANE DB SYST REV; Hoiby N, 2010, INT J ANTIMICROB AG, V35, P322, DOI 10.1016/j.ijantimicag.2009.12.011; Lamers LM, 2005, NED TIJDSCHR GENEES, V149, P1574; LEAPER DJ, 1995, J HOSP INFECT, V30, P127, DOI 10.1016/0195-6701(95)90013-6; Mangram AJ, 1999, INFECT CONT HOSP EP, V20, P250, DOI 10.1086/501620; Minkowitz RB, 2007, J BONE JOINT SURG AM, V89A, P1906, DOI 10.2106/JBJS.F.01536; Moher D, 2010, BMJ-BRIT MED J, V2010, P340, DOI DOI 10.1136/BMJ.C869; National Institute for Public Health and the Environment, INC HOSP INF 2007 20; Olsen LL, 2017, BONE JOINT J, V99B, P225, DOI 10.1302/0301-620X.99B2.BJJ-2016-0344.R1; Pocock SJ, 2016, NEW ENGL J MED, V375, P861, DOI 10.1056/NEJMra1510064; Pot J, 2011, FOOT ANKLE J, V4, P1; Prokuski L, 2008, J AM ACAD ORTHOP SUR, V16, P283, DOI 10.5435/00124635-200805000-00007; RAAHAVE D, 1976, ACTA ORTHOP SCAND, V47, P28, DOI 10.3109/17453677608998968; RICHARDS RH, 1992, INJURY, V23, P25, DOI 10.1016/0020-1383(92)90120-H; Rubin DB, 1987, MULTIPLE IMPUTATION; SANDERSON PL, 1992, INJURY, V23, P29, DOI 10.1016/0020-1383(92)90121-8; Schepers T, 2011, FOOT ANKLE INT, V32, P1040, DOI 10.3113/FAI.2011.1040; Stratford PW, 2005, PHYSIOTHER CAN, V57, P154, DOI [DOI 10.2310/6640.2005.00023, DOI 10.2522/PTJ.20080290]; SWAB, SWAB GUID PER PROF; Szende A, 2014, SELF REPORTED POPULA, DOI DOI 10.1007/978-94-007-7596-1; Visser A, 2014, WORLD J SURG, V38, P1019, DOI 10.1007/s00268-013-2376-z; Vos Dagmar, 2012, J Trauma Manag Outcomes, V6, P6, DOI 10.1186/1752-2897-6-6; Wukich DK, 2010, J BONE JOINT SURG AM, V92A, P287, DOI 10.2106/JBJS.I.00080	37	26	26	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 26	2017	318	24					2438	2445		10.1001/jama.2017.19343	http://dx.doi.org/10.1001/jama.2017.19343			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FQ9ZO	29279933	Green Published, Bronze			2022-12-28	WOS:000418720700021
J	Belknap, SM				Belknap, Steven M.			In adults, benzodiazepines were not linked to increased risk for mortality at 6 mo but were linked at 12 and 48 mo	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Belknap, Steven M.] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Belknap, SM (corresponding author), Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA.							Belknap SM, 2014, ANN INTERN MED, V161, DOI 10.7326/0003-4819-161-2-201407150-02011; Kripke DF, 2016, DRUG SAFETY, V39, P93, DOI 10.1007/s40264-015-0362-0; Kripke DF, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-000850; Weich S, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1996	4	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 19	2017	167	12					JC71	JC71		10.7326/ACPJC-2017-167-12-071	http://dx.doi.org/10.7326/ACPJC-2017-167-12-071			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FQ3SD	29255861				2022-12-28	WOS:000418276000011
J	Voelker, R				Voelker, Rebecca			FDA Pursues Unproven Cancer Claims	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 19	2017	318	23					2288	2288		10.1001/jama.2017.19150	http://dx.doi.org/10.1001/jama.2017.19150			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FQ3RJ	29260209				2022-12-28	WOS:000418274000009
J	Underwood, E				Underwood, Emily			Why fossil scientists are suing Trump over monuments move	SCIENCE			English	News Item																			0	0	0	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 15	2017	358	6369					1368	1368		10.1126/science.358.6369.1368	http://dx.doi.org/10.1126/science.358.6369.1368			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FP8TH	29242325				2022-12-28	WOS:000417918500013
J	Franck, LS				Franck, Linda S.			Know-do-itis and no-do encephalopathy	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Franck, Linda S.] Univ Calif San Francisco, Dept Family Hlth Care Nursing, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Franck, LS (corresponding author), Univ Calif San Francisco, Dept Family Hlth Care Nursing, San Francisco, CA 94143 USA.	linda.franck@ucsf.edu		Franck, Linda/0000-0003-4291-9181					0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 13	2017	359								j5749	10.1136/bmj.j5749	http://dx.doi.org/10.1136/bmj.j5749			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FQ4KY	29237597				2022-12-28	WOS:000418327500013
J	Cauley, JA				Cauley, Jane A.			A two-step screening process reduces hip fractures	LANCET			English	Editorial Material							OSTEOPOROTIC FRACTURES; OLDER WOMEN; RISK		[Cauley, Jane A.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Cauley, JA (corresponding author), Univ Pittsburgh, Grad Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA 15261 USA.	jcauley@edc.pitt.edu						Amarnath ALD, 2015, J GEN INTERN MED, V30, P1733, DOI 10.1007/s11606-015-3349-8; Calonge N, 2011, ANN INTERN MED, V154, P356, DOI 10.7326/0003-4819-154-5-201103010-00307; Cauley JA, 2013, J GERONTOL A-BIOL, V68, P1243, DOI 10.1093/gerona/glt093; Compston J, 2017, ARCH OSTEOPOROS, V12, DOI 10.1007/s11657-017-0324-5; Diem SJ, 2017, J GEN INTERN MED, V32, P1235, DOI 10.1007/s11606-017-4153-4; Emmett CL, 2012, FAM PRACT, V29, P235, DOI 10.1093/fampra/cmr069; Khosla S, 2016, J BONE MINER RES, V31, P1485, DOI 10.1002/jbmr.2888; Lewiecki EM, 2016, J BONE MINER RES S, V31, pS26; Rubin KH, 2013, J BONE MINER RES, V28, P1701, DOI 10.1002/jbmr.1956; Shepstone L, 2017, LANCET; Solomon DH, 2014, J BONE MINER RES, V29, P1929, DOI 10.1002/jbmr.2202; Stone KL, 2003, J BONE MINER RES, V18, P1947, DOI 10.1359/jbmr.2003.18.11.1947; Vogt MT, 2002, J AM GERIATR SOC, V50, P97, DOI 10.1046/j.1532-5415.2002.50014.x	13	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 24	2018	391	10122					715	716		10.1016/S0140-6736(17)33295-6	http://dx.doi.org/10.1016/S0140-6736(17)33295-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FX4ND	29254857				2022-12-28	WOS:000426054000004
J	Richman, I; Krumholz, HM				Richman, Ilana; Krumholz, Harlan M.			Lessons From the Opioid Epidemic to Reinvigorate Tobacco Control Initiatives	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Richman, Ilana] Yale Univ, Sch Med, Gen Internal Med Sect, 367 Cedar St,Harkness Hall A,Room 301a, New Haven, CT 06511 USA; [Richman, Ilana; Krumholz, Harlan M.] Yale New Haven Med Ctr, Ctr Outcomes Res & Evaluat, 20 York St, New Haven, CT 06504 USA; [Krumholz, Harlan M.] Yale Univ, Sch Med, Sect Cardiovasc Med, New Haven, CT USA	Yale University; Yale University	Richman, I (corresponding author), Yale Univ, Sch Med, Gen Internal Med Sect, 367 Cedar St,Harkness Hall A,Room 301a, New Haven, CT 06511 USA.	ilana.richman@yale.edu	, Harlan/AAI-2875-2020		National Institutes of Health [NIH KL2 TR001862]; FDA; Medtronic through Yale University; United Health; IBM Watson; Element Science; Aetna; Johnson & Johnson (Janssen); Medtronic; Hugo; Centers for Medicare & Medicaid Services	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FDA(United States Department of Health & Human Services); Medtronic through Yale University; United Health; IBM Watson(International Business Machines (IBM)); Element Science; Aetna; Johnson & Johnson (Janssen); Medtronic(Medtronic); Hugo; Centers for Medicare & Medicaid Services	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Richman reported receiving grant support (NIH KL2 TR001862) from the National Institutes of Health during the writing of this article. Dr Krumholz reported receiving grant support from the FDA and Medtronic through Yale University; personal fees from United Health, IBM Watson, Element Science, and Aetna; and other support from Johnson & Johnson (Janssen) and Medtronic, Hugo, and the Centers for Medicare & Medicaid Services. No other disclosures were reported.	Bureau of Vital Statistics; Missouri Department of Health and Senior Services; WONDER Centers for Disease Control and Prevention, YEARS POT LIF LOST Y; Centers for Disease Control and Prevention, SMOK ATTR MORT YEARS; Centers for Disease Control and Prevention Office on Smoking and Health and National Center for Chronic Disease Prevention and Health Promotion, SMOK TOB US FAST FAC; Donny EC, 2015, NEW ENGL J MED, V373, P1340, DOI 10.1056/NEJMsa1502403; Gottlieb S, 2017, JAMA-J AM MED ASSOC, V318, P421, DOI 10.1001/jama.2017.9205; Jamal A, 2016, MMWR-MORBID MORTAL W, V65, P1205, DOI 10.15585/mmwr.mm6544a2; NIDA, OV DEATH RAT; Warner KE, 2017, JAMA-J AM MED ASSOC, V318, P1755, DOI 10.1001/jama.2017.14336	8	3	3	1	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 23	2018	319	4					339	340		10.1001/jama.2017.19739	http://dx.doi.org/10.1001/jama.2017.19739			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FT8LW	29309495				2022-12-28	WOS:000423405300015
J	Spong, CY; Bianchi, DW				Spong, Catherine Y.; Bianchi, Diana W.			Improving Public Health Requires Inclusion of Underrepresented Populations in Research	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CLINICAL-TRIALS; PREGNANT-WOMEN; PHARMACOKINETICS		[Spong, Catherine Y.; Bianchi, Diana W.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, NIH, 31 Ctr Dr,2A03, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Spong, CY (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, NIH, 31 Ctr Dr,2A03, Bethesda, MD 20892 USA.	spongc@mail.nih.gov						Andrew MA, 2007, CLIN PHARMACOL THER, V81, P547, DOI 10.1038/sj.clpt.6100126; Berry-Kravis E, 2013, J DEV BEHAV PEDIATR, V34, P508, DOI 10.1097/DBP.0b013e31829d1f20; Brussee JM, 2016, EXPERT REV CLIN PHAR, V9, P1235, DOI 10.1080/17512433.2016.1198256; Coverdale JH, 2008, OBSTET GYNECOL, V112, P1361, DOI 10.1097/AOG.0b013e31818c2a27; Cutter Gary R, 2012, Neurol Clin Pract, V2, P343; Feldman MA, 2014, J INTELL DISABIL RES, V58, P800, DOI 10.1111/jir.12091; Hart SJ, 2017, AM J MED GENET A, V173, P3029, DOI 10.1002/ajmg.a.38465; Jensen KB, 2017, NEUROLOGY, V88, P1912, DOI 10.1212/WNL.0000000000003934; Mestre H, 2011, SPINAL CORD, V49, P955, DOI 10.1038/sc.2011.58	9	59	59	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 23	2018	319	4					337	338		10.1001/jama.2017.19138	http://dx.doi.org/10.1001/jama.2017.19138			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FT8LW	29285540				2022-12-28	WOS:000423405300014
J	Leung, DT; LaRocque, RC; Ryan, ET				Leung, Daniel T.; LaRocque, Regina C.; Ryan, Edward T.			Travel Medicine	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							UNITED-STATES; GEOSENTINEL SURVEILLANCE; MALARIA SURVEILLANCE; RETURNED TRAVELERS; PREVENTION; DIARRHEA; RISK; METAANALYSIS; GUIDELINES; ACETAZOLAMIDE		[Leung, Daniel T.] Univ Utah, Sch Med, Salt Lake City, UT 84112 USA; Harvard Med Sch, Boston, MA USA	Utah System of Higher Education; University of Utah; Harvard University; Harvard Medical School	Leung, DT (corresponding author), Univ Utah, Sch Med, Salt Lake City, UT 84112 USA.			Leung, Daniel/0000-0001-8401-0801	American College of Physicians	American College of Physicians	American College of Physicians.	Anwar E, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001261.pub3; Arcilla MS, 2017, LANCET INFECT DIS, V17, P78, DOI 10.1016/S1473-3099(16)30319-X; Cesarone MR, 2002, ANGIOLOGY, V53, P1, DOI 10.1177/000331970205300101; Chandra D, 2009, ANN INTERN MED, V151, P180, DOI 10.7326/0003-4819-151-3-200908040-00129; Chen WH, 2016, CLIN INFECT DIS, V62, P1329, DOI 10.1093/cid/ciw145; Clemmon NS, 2015, MMWR-MORBID MORTAL W, V64, P373; Cullen KA, 2016, MMWR SURVEILL SUMM, V65, P1, DOI 10.15585/mmwr.ss6502a1; Daniels Danni, 2009, Morbidity and Mortality Weekly Report, V58, P1; Date KA, 2016, CLIN INFECT DIS, V63, P322, DOI 10.1093/cid/ciw232; DUPONT HL, 1987, JAMA-J AM MED ASSOC, V257, P1347, DOI 10.1001/jama.257.10.1347; Frances SP, 2004, J MED ENTOMOL, V41, P414, DOI 10.1603/0022-2585-41.3.414; Freeland AL, 2016, MMWR-MORBID MORTAL W, V65, DOI 10.15585/mmwr.mm6501a1; Gahlinger PM, 2000, J TRAVEL MED, V7, P120; Gautret P, 2007, VACCINE, V25, P2656, DOI 10.1016/j.vaccine.2006.12.034; Gautret P, 2015, EMERG INFECT DIS, V21, P569, DOI 10.3201/eid2104.141479; Hyle EP, 2017, ANN INTERN MED, V167, P77, DOI 10.7326/M16-2249; Kahn SR, 2012, CHEST, V141, pE195S, DOI 10.1378/chest.11-2296; Kantele A, 2016, EMERG INFECT DIS, V22, P117, DOI 10.3201/eid2201.151272; Kantele A, 2015, CLIN INFECT DIS, V60, P837, DOI 10.1093/cid/ciu957; Laaveri T, 2016, TRAVEL MED INFECT DI, V14, P299, DOI 10.1016/j.tmaid.2016.06.006; LaRocque RC, 2013, AM J TROP MED HYG, V88, P376, DOI 10.4269/ajtmh.2012.12-0460; LaRocque RC, 2010, J TRAVEL MED, V17, P387, DOI 10.1111/j.1708-8305.2010.00457.x; LaRocque RL, 2016, ANN INTERN MED, V165, P589, DOI 10.7326/M16-1397; Leder K, 2013, ANN INTERN MED, V158, P456, DOI 10.7326/0003-4819-158-6-201303190-00005; Lucey DR, 2017, ANN INTERN MED, V167, P664, DOI 10.7326/M17-1337; Luks AM, 2014, WILD ENVIRON MED, V25, pS4, DOI 10.1016/j.wem.2014.06.017; Ly KN, 2015, J INFECT DIS, V212, P176, DOI 10.1093/infdis/jiu834; Mace KE, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6612a1; Marshall CA, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2991-3; Michal Stevens A, 2017, J TRAVEL MED, P24; Mouchtouri VA, 2015, J TRAVEL MED, V22, P325, DOI 10.1111/jtm.12225; Riddle MS, 2017, J TRAVEL MED, V24, pS63, DOI 10.1093/jtm/tax026; Ritchie ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034938; Ritchie ND, 2012, J TRAVEL MED, V19, P298, DOI 10.1111/j.1708-8305.2012.00629.x; Ruppe E, 2015, CLIN INFECT DIS, V61, P593, DOI 10.1093/cid/civ333; Sazawal S, 2006, LANCET INFECT DIS, V6, P374, DOI 10.1016/S1473-3099(06)70495-9; Schwille-Kiuntke J, 2015, Aliment Pharmacol Ther, V41, P1029, DOI 10.1111/apt.13199; SHEFFIELD PJ, 1990, AVIAT SPACE ENVIR MD, V61, P1130; Sherry MK, 2015, INJURY PREV, V21, pE10, DOI 10.1136/injuryprev-2013-040923; Steffen R, 2015, JAMA-J AM MED ASSOC, V313, P71, DOI 10.1001/jama.2014.17006; Stienlauf S, 2014, TRAVEL MED INFECT DI, V12, P499, DOI 10.1016/j.tmaid.2014.04.008; van Patot MCT, 2008, HIGH ALT MED BIOL, V9, P289, DOI 10.1089/ham.2008.1029; Watson HG, 2011, BRIT J HAEMATOL, V152, P31, DOI 10.1111/j.1365-2141.2010.08408.x; Wong KK, 2017, MMWR-MORBID MORTAL W, V66, P482, DOI 10.15585/mmwr.mm6618a6	45	3	3	2	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 2	2018	168	1					ITC1	ITC15		10.7326/AITC201801020	http://dx.doi.org/10.7326/AITC201801020			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FR5SO	29297035				2022-12-28	WOS:000419126700001
J	Hey, SP; London, AJ; Weijer, C; Rid, A; Miller, F				Hey, Spencer Phillips; London, Alex John; Weijer, Charles; Rid, Annette; Miller, Franklin			Is the concept of clinical equipoise still relevant to research?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CONTROLLED-TRIALS; ETHICS; CRITIQUE; RISKS		[Hey, Spencer Phillips] Harvard Ctr Bioeth, Boston, MA 02115 USA; [Hey, Spencer Phillips] Brigham & Womens Hosp, Program Regulat Therapeut & Law, 75 Francis St, Boston, MA 02115 USA; [Hey, Spencer Phillips] Harvard Med Sch, Boston, MA 02115 USA; [London, Alex John] Carnegie Mellon Univ, Ctr Eth & Policy, Eth & Philosophy, Pittsburgh, PA 15213 USA; [Weijer, Charles] Univ Western Ontario, Dept Philosophy, Bioeth, London, ON, Canada; [Weijer, Charles] Univ Western Ontario, Dept Med, Bioeth, London, ON, Canada; [Rid, Annette] Kings Coll London, Dept Global Hlth & Social Med, Bioeth & Soc, London, England; [Miller, Franklin] Weill Cornell Med Coll, Med Eth Med, New York, NY USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Carnegie Mellon University; Western University (University of Western Ontario); Western University (University of Western Ontario); University of London; King's College London; Cornell University	Hey, SP (corresponding author), Harvard Ctr Bioeth, Boston, MA 02115 USA.; Hey, SP (corresponding author), Brigham & Womens Hosp, Program Regulat Therapeut & Law, 75 Francis St, Boston, MA 02115 USA.; Hey, SP (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.; Rid, A (corresponding author), Kings Coll London, Dept Global Hlth & Social Med, Bioeth & Soc, London, England.	shey@bwh.harvard.edu; annette.rid@kcl.ac.uk	Weijer, Charles/ABC-5433-2020; Demchuk, Andrew M/E-1103-2012	Weijer, Charles/0000-0002-5510-1074; Demchuk, Andrew M/0000-0002-4930-7789; London, Alex/0000-0002-6450-0309				Buchanan D, 2005, KENNEDY INST ETHIC J, V15, P161, DOI 10.1353/ken.2005.0010; Chaitman BR, 2004, J AM COLL CARDIOL, V43, P1375, DOI 10.1016/j.jacc.2003.11.045; Emanuel EJ, 2001, NEW ENGL J MED, V345, P915, DOI 10.1056/NEJM200109203451211; Fergusson D, 2005, CLIN TRIALS, V2, P218, DOI 10.1191/1740774505cn085oa; FREEDMAN B, 1987, NEW ENGL J MED, V317, P141, DOI 10.1056/NEJM198707163170304; Hausleiter J, 2004, CIRCULATION, V110, P790, DOI 10.1161/01.CIR.0000138935.17503.35; Hey SP, 2016, MONASH BIOETH REV, V34, P23, DOI 10.1007/s40592-016-0057-z; London AJ, 2017, J MED ETHICS, DOI [10.1136/medethics-2017-10454929175968, DOI 10.1136/MEDETHICS-2017-10454929175968]; London AJ, 2007, J MED PHILOS, V32, P99, DOI 10.1080/03605310701255727; London AJ, 2006, STAT MED, V25, P2869, DOI 10.1002/sim.2634; Miller FG, 2003, HASTINGS CENT REP, V33, P19, DOI 10.2307/3528434; Miller PB, 2006, J MED ETHICS, V32, P542, DOI 10.1136/jme.2005.014670; Rid A, 2014, MONASH BIOETH REV, V32, P63, DOI 10.1007/s40592-014-0007-6; Rid A, 2011, KENNEDY INST ETHIC J, V21, P141; Weijer C, 2015, ROUTLEDGE COMPANION, P200; Wendler D, 2007, J MED ETHICS, V33, DOI 10.1136/jme.2005.014043	16	25	25	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 28	2017	359								j5787	10.1136/bmj.j5787	http://dx.doi.org/10.1136/bmj.j5787			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FR6IO	29284666	Green Published			2022-12-28	WOS:000419169200002
J	Si, ZX; Qiao, JJ				Si, Zixiang; Qiao, Jianjun			Talaromyces marneffei Infection	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Si, Zixiang] Beilun Peoples Hosp, Ningbo, Zhejiang, Peoples R China; [Qiao, Jianjun] Zhejiang Univ, Affiliated Hosp 1, Hangzhou, Zhejiang, Peoples R China	Zhejiang University	Qiao, JJ (corresponding author), Zhejiang Univ, Affiliated Hosp 1, Hangzhou, Zhejiang, Peoples R China.	qiaojianjun@zju.edu.cn	Qiao, Jianjun/AAE-7199-2022						0	3	5	1	25	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 28	2017	377	26					2580	2580		10.1056/NEJMicm1704164	http://dx.doi.org/10.1056/NEJMicm1704164			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FR0TX	29281582				2022-12-28	WOS:000418777700009
J	Di, Q; Dai, LZ; Wang, Y; Zanobetti, A; Choirat, C; Schwartz, JD; Dominici, F				Di, Qian; Dai, Lingzhen; Wang, Yun; Zanobetti, Antonella; Choirat, Christine; Schwartz, Joel D.; Dominici, Francesca			Association of Short-term Exposure to Air Pollution With Mortality in Older Adults	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CASE-CROSSOVER; PARTICULATE MATTER; OZONE; PM2.5; PARTICLES; INFLAMMATION; RISK	IMPORTANCE The US Environmental Protection Agency is required to reexamine its National Ambient Air Quality Standards (NAAQS) every 5 years, but evidence of mortality risk is lacking at air pollution levels below the current daily NAAQS in unmonitored areas and for sensitive subgroups. OBJECTIVE To estimate the association between short-term exposures to ambient fine particulate matter (PM2.5) and ozone, and at levels below the current daily NAAQS, and mortality in the continental United States. DESIGN, SETTING, AND PARTICIPANTS Case-crossover design and conditional logistic regression to estimate the association between short-term exposures to PM2.5 and ozone (mean of daily exposure on the same day of death and 1 day prior) and mortality in 2-pollutant models. The study included the entire Medicare population from January 1, 2000, to December 31, 2012, residing in 39 182 zip codes. EXPOSURES Daily PM2.5 and ozone levels in a 1-km x 1-km grid were estimated using published and validated air pollution prediction models based on land use, chemical transport modeling, and satellite remote sensing data. From these gridded exposures, daily exposures were calculated for every zip code in the United States. Warm-season ozone was defined as ozone levels for the months April to September of each year. MAIN OUTCOMES AND MEASURES All-cause mortality in the entire Medicare population from 2000 to 2012. RESULTS During the study period, there were 22 433 862 million case days and 76 143 209 control days. Of all case and control days, 93.6% had PM2.5 levels below 25 mu g/m(3), during which 95.2% of deaths occurred (21 353 817 of 22 433 862), and 91.1% of days had ozone levels below 60 parts per billion, during which 93.4% of deaths occurred (20 955 387 of 22 433 862). The baseline daily mortality rates were 137.33 and 129.44 (per 1 million persons at risk per day) for the entire year and for the warm season, respectively. Each short-term increase of 10 mu g/m(3) in PM2.5 (adjusted by ozone) and 10 parts per billion (10(-9)) in warm-season ozone (adjusted by PM2.5) were statistically significantly associated with a relative increase of 1.05%(95% CI, 0.95%-1.15%) and 0.51%(95% CI, 0.41%-0.61%) in daily mortality rate, respectively. Absolute risk differences in daily mortality rate were 1.42 (95% CI, 1.29-1.56) and 0.66 (95% CI, 0.53-0.78) per 1 million persons at risk per day. There was no evidence of a threshold in the exposure-response relationship. CONCLUSIONS AND RELEVANCE In the US Medicare population from 2000 to 2012, short-term exposures to PM2.5 and warm-season ozone were significantly associated with increased risk of mortality. This risk occurred at levels below current national air quality standards, suggesting that these standards may need to be reevaluated.	[Di, Qian; Dai, Lingzhen; Zanobetti, Antonella; Schwartz, Joel D.] Harvard TH Chan Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02215 USA; [Wang, Yun; Choirat, Christine; Dominici, Francesca] Harvard TH Chan Sch Publ Hlth, Dept Biostat, Boston, MA USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Schwartz, JD (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Environm Hlth, Landmark Ctr West 404H, Boston, MA 02215 USA.	jschwrtz@hsph.harvard.edu		Di, Qian/0000-0002-1584-4770; Choirat, Christine/0000-0002-3745-9718	NIH [R01 ES024332-01A1, ES-000002, ES024012, R01ES026217, 4953-RFA14-3/16-4]; HEI [4953-RFA14-3/16-4]; EPA [83587201-0, RD-83479801]; NATIONAL CANCER INSTITUTE [R35CA197449] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES026217, R21ES024012, R01ES024332, P30ES000002] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HEI; EPA(United States Environmental Protection Agency); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study was supported by grants R01 ES024332-01A1, ES-000002, ES024012, R01ES026217, and 4953-RFA14-3/16-4 from the NIH; grant 4953-RFA14-3/16-4 from the HEI; and grants 83587201-0 and RD-83479801 from the EPA.	Alessandrini ER, 2016, AM J EPIDEMIOL, V184, P744, DOI 10.1093/aje/kww078; Bartoli CR, 2009, ENVIRON HEALTH PERSP, V117, P333, DOI 10.1289/ehp.11380; Bateson TF, 1999, EPIDEMIOLOGY, V10, P539, DOI 10.1097/00001648-199909000-00013; Bell ML, 2006, ENVIRON HEALTH PERSP, V114, P532, DOI 10.1289/ehp.8816; Bell ML, 2004, JAMA-J AM MED ASSOC, V292, P2372, DOI 10.1001/jama.292.19.2372; Brauner EV, 2008, AM J RESP CRIT CARE, V177, P419, DOI 10.1164/rccm.200704-632OC; Chuang KJ, 2007, AM J RESP CRIT CARE, V176, P370, DOI 10.1164/rccm.200611-1627OC; Dai LZ, 2014, ENVIRON HEALTH PERSP, V122, P837, DOI 10.1289/ehp.1307568; Di Q, 2017, NEW ENGL J MED, V376, P2513, DOI 10.1056/NEJMoa1702747; Di Q, 2017, J AIR WASTE MANAGE, V67, P39, DOI 10.1080/10962247.2016.1200159; Di Q, 2016, ENVIRON SCI TECHNOL, V50, P4712, DOI 10.1021/acs.est.5b06121; Dominici F, 2006, JAMA-J AM MED ASSOC, V295, P1127, DOI 10.1001/jama.295.10.1127; Franklin M, 2008, EPIDEMIOLOGY, V19, P680, DOI 10.1097/EDE.0b013e3181812bb7; Franklin M, 2007, J EXPO SCI ENV EPID, V17, P279, DOI 10.1038/sj.jes.7500530; Hemmingsen JG, 2015, PART FIBRE TOXICOL, V12, DOI 10.1186/s12989-015-0081-9; Hoek G, 1997, ARCH ENVIRON HEALTH, V52, P455, DOI 10.1080/00039899709602224; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; Krall JR, 2013, ENVIRON HEALTH PERSP, V121, P1148, DOI 10.1289/ehp.1206185; Langrish JP, 2009, PART FIBRE TOXICOL, V6, DOI 10.1186/1743-8977-6-8; Levy D, 2001, EPIDEMIOLOGY, V12, P186, DOI 10.1097/00001648-200103000-00010; Levy JI, 2005, EPIDEMIOLOGY, V16, P458, DOI 10.1097/01.ede.0000165820.08301.b3; Maclure M, 2000, ANNU REV PUBL HEALTH, V21, P193, DOI 10.1146/annurev.publhealth.21.1.193; MACLURE M, 1991, AM J EPIDEMIOL, V133, P144, DOI 10.1093/oxfordjournals.aje.a115853; Mills NL, 2007, NEW ENGL J MED, V357, P1075, DOI 10.1056/NEJMoa066314; Nemmar A, 2004, CIRCULATION, V110, P1670, DOI 10.1161/01.CIR.0000142053.13921.21; Ostro B, 2006, ENVIRON HEALTH PERSP, V114, P29, DOI 10.1289/ehp.8335; Peng RD, 2013, AIR QUAL ATMOS HLTH, V6, P445, DOI 10.1007/s11869-012-0180-9; Samoli E, 2005, ENVIRON HEALTH PERSP, V113, P88, DOI 10.1289/ehp.7387; Schwartz J, 1996, J AIR WASTE MANAGE, V46, P927, DOI 10.1080/10473289.1996.10467528; Schwartz J, 2002, ENVIRON HEALTH PERSP, V110, P1025, DOI 10.1289/ehp.021101025; Tamagawa E, 2008, AM J PHYSIOL-LUNG C, V295, pL79, DOI 10.1152/ajplung.00048.2007; United States Environment Protection Agency, NAAQS TABL; US Environmental Protection Agency, CRIT AIR POLL; US Environmental Protection Agency, PROC REV NAT AMB AIR; US Environmental Protection Agency, INT REV PLAN NAT AMB; Watkinson WP, 2001, ENVIRON HEALTH PERSP, V109, P539, DOI 10.2307/3454666; Zanobetti A, 2009, ENVIRON HEALTH PERSP, V117, P898, DOI 10.1289/ehp.0800108; Zanobetti A, 2008, ENVIRON HEALTH-GLOB, V7, DOI 10.1186/1476-069X-7-22	39	315	322	10	115	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 26	2017	318	24					2446	2456		10.1001/jama.2017.17923	http://dx.doi.org/10.1001/jama.2017.17923			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FQ9ZO	29279932	Bronze, Green Accepted			2022-12-28	WOS:000418720700022
J	Slomski, A				Slomski, Anita			Stenting Does Not Relieve Stable Angina Symptoms	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 26	2017	318	24					2419	2419		10.1001/jama.2017.19023	http://dx.doi.org/10.1001/jama.2017.19023			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FQ9ZO	29279927				2022-12-28	WOS:000418720700007
J	Stegmann, M; Zipfel, C				Stegmann, Martin; Zipfel, Cyril			Complex regulation of plant sex by peptides	SCIENCE			English	Editorial Material							POLLEN-TUBE; FERONIA; MECHANISMS		[Stegmann, Martin; Zipfel, Cyril] Sainsbury Lab, Norwich Res Pk, Norwich NR4 7UH, Norfolk, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Zipfel, C (corresponding author), Sainsbury Lab, Norwich Res Pk, Norwich NR4 7UH, Norfolk, England.	cyril.zipfel@tsl.ac.uk	ZIPFEL, CYRIL/ABD-5076-2021; ZIPFEL, CYRIL B/D-7103-2011	ZIPFEL, CYRIL/0000-0003-4935-8583; ZIPFEL, CYRIL B/0000-0003-4935-8583	Gatsby Charitable Foundation; European Research Council (grant "PHOSPHinnATE"); Deutsche Forschungsgemeinschaft [STE 2448/1]; BBSRC [BBS/E/J/000PR9795, BBS/E/J/000PR9796] Funding Source: UKRI	Gatsby Charitable Foundation; European Research Council (grant "PHOSPHinnATE"); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Our research is supported by the Gatsby Charitable Foundation and the European Research Council (grant "PHOSPHinnATE"). M.S. is supported by the Deutsche Forschungsgemeinschaft (STE 2448/1).	Boisson-Dernier A, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001719; Boisson-Dernier A, 2009, DEVELOPMENT, V136, P3279, DOI 10.1242/dev.040071; Dresselhaus T, 2016, CURR BIOL, V26, pR125, DOI 10.1016/j.cub.2015.12.032; Escobar-Restrepo JM, 2007, SCIENCE, V317, P656, DOI 10.1126/science.1143562; Ge ZX, 2017, SCIENCE, V358, P1596, DOI 10.1126/science.aao3642; Haruta M, 2014, SCIENCE, V343, P408, DOI 10.1126/science.1244454; Lee JS, 2016, TRENDS PLANT SCI, V21, P991, DOI 10.1016/j.tplants.2016.10.003; Li C, 2016, PLANT PHYSIOL, V171, P2379, DOI 10.1104/pp.16.00667; Mang HG, 2017, PLANT CELL, V29, P3140, DOI 10.1105/tpc.17.00464; Mecchia MA, 2017, SCIENCE, V358, P1600, DOI 10.1126/science.aao5467; Miyazaki S, 2009, CURR BIOL, V19, P1327, DOI 10.1016/j.cub.2009.06.064; Murphy E, 2016, J EXP BOT, V67, P4863, DOI 10.1093/jxb/erw281; Muschietti JP, 2018, CURR OPIN PLANT BIOL, V41, P73, DOI 10.1016/j.pbi.2017.09.008; Stegmann M, 2017, SCIENCE, V355, P287, DOI 10.1126/science.aal2541; Vogler H, 2013, PLANT J, V73, P617, DOI 10.1111/tpj.12061	15	9	9	1	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 22	2017	358	6370					1544	1545		10.1126/science.aar4190	http://dx.doi.org/10.1126/science.aar4190			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FQ6BO	29269466				2022-12-28	WOS:000418448000040
J	Friedrich, MJ				Friedrich, M. J.			Latest Report on Health Effects of Climate Change	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 19	2017	318	23					2287	2287		10.1001/jama.2017.19366	http://dx.doi.org/10.1001/jama.2017.19366			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FQ3RJ	29260232				2022-12-28	WOS:000418274000005
J	Palmer, AC; Sorger, PK				Palmer, Adam C.; Sorger, Peter K.			Combination Cancer Therapy Can Confer Benefit via Patient-to-Patient Variability without Drug Additivity or Synergy	CELL			English	Article							PHASE-III TRIAL; METASTATIC BREAST-CANCER; RECURRENT EPITHELIAL OVARIAN; 1ST-LINE TREATMENT; PRIMARY PERITONEAL; COLORECTAL-CANCER; ACUTE LEUKEMIA; SINGLE-AGENT; CHEMOTHERAPY; BEVACIZUMAB	Combination cancer therapies aim to improve the probability and magnitude of therapeutic responses and reduce the likelihood of acquired resistance in an individual patient. However, drugs are tested in clinical trials on genetically diverse patient populations. We show here that patient-to-patient variability and independent drug action are sufficient to explain the superiority of many FDA-approved drug combinations in the absence of drug synergy or additivity. This is also true for combinations tested in patient-derived tumor xenografts. In a combination exhibiting independent drug action, each patient benefits solely from the drug to which his or her tumor is most sensitive, with no added benefit from other drugs. Even when drug combinations exhibit additivity or synergy in pre-clinical models, patient-to-patient variability and low cross-resistance make independent action the dominant mechanism in clinical populations. This insight represents a different way to interpret trial data and a different way to design combination therapies.	[Palmer, Adam C.; Sorger, Peter K.] Harvard Med Sch, Lab Syst Pharmacol, Program Therapeut Sci, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Sorger, PK (corresponding author), Harvard Med Sch, Lab Syst Pharmacol, Program Therapeut Sci, Boston, MA 02115 USA.	peter_sorger@hms.harvard.edu	Palmer, Adam C/J-3589-2012; Palmer, Adam/N-5495-2019	Palmer, Adam C/0000-0001-5028-7028; Palmer, Adam/0000-0001-5028-7028; Sorger, Peter/0000-0002-3364-1838	NHMRC [1072965]; NIH [GM107618]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM107618] Funding Source: NIH RePORTER	NHMRC(National Health and Medical Research Council (NHMRC) of Australia); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Hafner, S. Goel, M. Cokol, S. Chopra, E. Sober, T. Mitchison, and B. Chabner for discussions. This work was supported by NHMRC Early Career Fellowship 1072965 (to A.C.P.) and NIH grant GM107618.	Aghajanian C, 2012, J CLIN ONCOL, V30, P2039, DOI 10.1200/JCO.2012.42.0505; Bokemeyer C, 2012, EUR J CANCER, V48, P1466, DOI 10.1016/j.ejca.2012.02.057; Bookman MA, 2009, J CLIN ONCOL, V27, P1419, DOI 10.1200/JCO.2008.19.1684; Bozic I, 2013, ELIFE, V2, DOI 10.7554/eLife.00747; Brugarolas J, 2003, LANCET, V361, P1758, DOI 10.1016/S0140-6736(03)13446-0; Burger RA, 2007, J CLIN ONCOL, V25, P5165, DOI 10.1200/JCO.2007.11.5345; Cardoso F, 2009, JNCI-J NATL CANCER I, V101, P1174, DOI 10.1093/jnci/djp235; DeRose YS, 2011, NAT MED, V17, P1514, DOI 10.1038/nm.2454; Ducreux M, 2004, ANN ONCOL, V15, P467, DOI 10.1093/annonc/mdh098; Eder J.P., 2010, HOLLAND FREI CANC ME, V8; FISHER RI, 1993, NEW ENGL J MED, V328, P1002, DOI 10.1056/NEJM199304083281404; FREI E, 1961, BLOOD, V18, P431, DOI 10.1182/blood.V18.4.431.431; FREI E, 1985, CANCER RES, V45, P6523; FREI E, 1965, BLOOD-J HEMATOL, V26, P642, DOI 10.1182/blood.V26.5.642.642; FREIREICH EJ, 1963, BLOOD, V21, P699; Fuentes G, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2888; Gaddum J.H., 1940, PHARMACOLOGY, V1st; Gandhi L, 2013, J THORAC ONCOL, V8, pE3, DOI 10.1097/JTO.0b013e3182762d20; Gao H, 2015, NAT MED, V21, P1318, DOI 10.1038/nm.3954; Giantonio BJ, 2007, J CLIN ONCOL, V25, P1539, DOI 10.1200/JCO.2006.09.6305; Goel S, 2011, PHYSIOL REV, V91, P1071, DOI 10.1152/physrev.00038.2010; Hafner M, 2016, NAT METHODS, V13, P521, DOI [10.1038/NMETH.3853, 10.1038/nmeth.3853]; Hamid O, 2013, NEW ENGL J MED, V369, P134, DOI 10.1056/NEJMoa1305133; Hidalgo M, 2014, CANCER DISCOV, V4, P998, DOI 10.1158/2159-8290.CD-14-0001; Jonas O, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010564; Karapetis CS, 2008, NEW ENGL J MED, V359, P1757, DOI 10.1056/NEJMoa0804385; Kim KB, 2013, J CLIN ONCOL, V31, P482, DOI 10.1200/JCO.2012.43.5966; Klinghoffer RA, 2015, SCI TRANSL MED, V7; Kummar S, 2010, NAT REV DRUG DISCOV, V9, P843, DOI 10.1038/nrd3216; Larkin J, 2015, NEW ENGL J MED, V373, P23, DOI [10.1056/NEJMoa1504030, 10.1056/NEJMc1509660]; LAW LW, 1952, CANCER RES, V12, P871; Liu JF, 2014, LANCET ONCOL, V15, P1207, DOI 10.1016/S1470-2045(14)70391-2; Long GV, 2014, NEW ENGL J MED, V371, P1877, DOI 10.1056/NEJMoa1406037; Malaney P, 2014, CANCER LETT, V344, P1, DOI 10.1016/j.canlet.2013.10.010; Moore MJ, 2007, J CLIN ONCOL, V25, P1960, DOI 10.1200/JCO.2006.07.9525; Oza AM, 2015, LANCET ONCOL, V16, P87, DOI 10.1016/S1470-2045(14)71135-0; Perez EA, 2017, JNCI-J NATL CANCER I, V109, DOI 10.1093/jnci/djw207; Polyzos A, 2000, CLIN DRUG INVEST, V19, P349, DOI 10.2165/00044011-200019050-00005; Pritchard JR, 2013, P NATL ACAD SCI USA, V110, pE170, DOI 10.1073/pnas.1210419110; Renouf DJ, 2014, EUR J CANCER, V50, P1909, DOI 10.1016/j.ejca.2014.04.008; Shaw AT, 2013, NEW ENGL J MED, V368, P2385, DOI 10.1056/NEJMoa1214886; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Sledge GW, 2003, J CLIN ONCOL, V21, P588, DOI 10.1200/JCO.2003.08.013; STEEL G. G., 1967, EUR J CANCER, V3, P381, DOI 10.1016/0014-2964(67)90022-9; Swain SM, 2015, NEW ENGL J MED, V372, P724, DOI 10.1056/NEJMoa1413513; TUBIANA M, 1989, ACTA ONCOL, V28, P113, DOI 10.3109/02841868909111193; Undevia SD, 2005, NAT REV CANCER, V5, P447, DOI 10.1038/nrc1629; Vogel CL, 2002, J CLIN ONCOL, V20, P719, DOI 10.1200/JCO.20.3.719	48	306	309	4	47	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 14	2017	171	7					1678	+		10.1016/j.cell.2017.11.009	http://dx.doi.org/10.1016/j.cell.2017.11.009			27	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FQ0KF	29245013	Green Accepted, Bronze			2022-12-28	WOS:000418044000022
J	Farquhar, C				Farquhar, Cynthia			Taking a long view on fertility treatments	LANCET			English	Editorial Material							INTRAUTERINE INSEMINATION; SUBFERTILITY; COUPLES		[Farquhar, Cynthia] Univ Auckland, Dept Obstet & Gynaecol, Fac Med & Hlth Sci, Auckland 1142, New Zealand	University of Auckland	Farquhar, C (corresponding author), Univ Auckland, Dept Obstet & Gynaecol, Fac Med & Hlth Sci, Auckland 1142, New Zealand.	c.farquhar@auckland.ac.nz						Bensdorp AJ, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.g7771; Brown J, 2016, COCHRANE DB SYST REV, V12, DOI DOI 10.1002/14651858.CD002249.PUB5; Dancet EAF, 2014, FERTIL STERIL, V101, P924, DOI 10.1016/j.fertnstert.2013.12.045; Farquhar CM, 2017, LANCET; Franik S, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010287.pub2; National Institute for Health and Care Excellence, 2013, FERT PEOPL FERT PROB; Steures P, 2006, LANCET, V368, P216, DOI 10.1016/S0140-6736(06)69042-9; Tarlatzis BC, 2008, HUM REPROD, V23, P462, DOI 10.1093/humrep/dem426; Weiss NS, 2014, HUM REPROD, V29, P2482, DOI 10.1093/humrep/deu215; Weiss NS, 2017, LANCET; Weiss NS, 2017, HUM REPROD OPEN	11	0	0	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 24	2018	391	10122					718	719		10.1016/S0140-6736(17)33310-X	http://dx.doi.org/10.1016/S0140-6736(17)33310-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FX4ND	29273247				2022-12-28	WOS:000426054000006
J	Bay, RA; Harrigan, RJ; Le Underwood, V; Gibbs, HL; Smith, TB; Ruegg, K				Bay, Rachael A.; Harrigan, Ryan J.; Le Underwood, Vinh; Gibbs, H. Lisle; Smith, Thomas B.; Ruegg, Kristen			Genomic signals of selection predict climate-driven population declines in a migratory bird	SCIENCE			English	Article							ADAPTATION; ASSOCIATIONS; GRADIENTS	The ongoing loss of biodiversity caused by rapid climatic shifts requires accurate models for predicting species' responses. Despite evidence that evolutionary adaptation could mitigate climate change impacts, evolution is rarely integrated into predictive models. Integrating population genomics and environmental data, we identified genomic variation associated with climate across the breeding range of the migratory songbird, yellow warbler (Setophaga petechia). Populations requiring the greatest shifts in allele frequencies to keep pace with future climate change have experienced the largest population declines, suggesting that failure to adapt may have already negatively affected populations. Broadly, our study suggests that the integration of genomic adaptation can increase the accuracy of future species distribution models and ultimately guide more effective mitigation efforts.	[Bay, Rachael A.; Harrigan, Ryan J.; Le Underwood, Vinh; Smith, Thomas B.; Ruegg, Kristen] Univ Calif Los Angeles, Ctr Trop Res, Inst Environm & Sustainabil, Los Angeles, CA 90095 USA; [Bay, Rachael A.] Univ Calif Davis, Dept Evolut & Ecol, Davis, CA 95616 USA; [Gibbs, H. Lisle] Ohio State Univ, Dept Evolut Ecol & Organismal Biol, Columbus, OH 43210 USA; [Gibbs, H. Lisle] Ohio State Univ, Ohio Biodivers Conservat Partnership, Columbus, OH 43210 USA; [Smith, Thomas B.] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, 621 Charles E Young Dr South, Los Angeles, CA 90095 USA; [Ruegg, Kristen] Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA	University of California System; University of California Los Angeles; University of California System; University of California Davis; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University of California System; University of California Los Angeles; University of California System; University of California Santa Cruz	Bay, RA (corresponding author), Univ Calif Los Angeles, Ctr Trop Res, Inst Environm & Sustainabil, Los Angeles, CA 90095 USA.; Bay, RA (corresponding author), Univ Calif Davis, Dept Evolut & Ecol, Davis, CA 95616 USA.	rachaelbay@gmail.com		Ruegg, Kristen/0000-0001-5579-941X; Underwood, Vinh/0000-0002-2526-1851	National Science Foundation [ACI-1548562]; NSF Postdoctoral Fellowship; NSF grant [PD-08-1269]; NSF grant IIA PIRE [1243524]; California Energy Commission [EPC-15-043]; First Solar Incorporated	National Science Foundation(National Science Foundation (NSF)); NSF Postdoctoral Fellowship(National Science Foundation (NSF)); NSF grant(National Science Foundation (NSF)); NSF grant IIA PIRE; California Energy Commission; First Solar Incorporated	The yellow warbler genome and annotations are available through DRYAD (doi:10.5061/dryad.dm540) and population-level RAD-Seq data are available through the National Center for Biotechnology Information's Sequence Read Archive. We thank many people who assisted in sample collection, especially M. Boulet, R. Dawson, E. Milot, K. Hobson, B. Keith, the University of Washington Burke Museum, S. Albert, and T. Kita, and many Institute for Bird Populations and MAPS (Monitoring Avian Productivity and Survivorship) volunteers for providing or assisting with collection of samples. We thank L. Frishkoff for advice on statistical analysis and N. Rose and D. Karp for helpful comments on the manuscript. This work used the Extreme Science and Engineering Discovery Environment (XSEDE), which is supported by National Science Foundation grant ACI-1548562. This work was made possible by a generous gift from J. Ellis as well as funding from an NSF Postdoctoral Fellowship (to R.A.B.), NSF grant PD-08-1269 (to R.J.H.), and NSF grant IIA PIRE 1243524 (to T.B.S.), and support from M. Nicholson, the California Energy Commission grant EPC-15-043, and First Solar Incorporated.	Aitken SN, 2008, EVOL APPL, V1, P95, DOI 10.1111/j.1752-4571.2007.00013.x; Barrett RDH, 2008, TRENDS ECOL EVOL, V23, P38, DOI 10.1016/j.tree.2007.09.008; Bay RA, 2017, AM NAT, V189, P463, DOI 10.1086/691233; Bay RA, 2014, CURR BIOL, V24, DOI 10.1016/j.cub.2014.10.044; Both C, 2006, NATURE, V441, P81, DOI 10.1038/nature04539; Ellis N, 2012, ECOLOGY, V93, P156, DOI 10.1890/11-0252.1; Fidler A, 2011, PRIMATOL MONOGR, P275, DOI 10.1007/978-4-431-53892-9_13; Fitzpatrick MC, 2015, ECOL LETT, V18, P1, DOI 10.1111/ele.12376; Frichot E, 2013, MOL BIOL EVOL, V30, P1687, DOI 10.1093/molbev/mst063; Garamszegi LZ, 2014, ECOL EVOL, V4, P1466, DOI 10.1002/ece3.1041; Gibbs HL, 2000, MOL ECOL, V9, P2137, DOI 10.1046/j.1365-294X.2000.01136.x; Hancock AM, 2011, SCIENCE, V334, P83, DOI 10.1126/science.1209244; Hitch AT, 2007, CONSERV BIOL, V21, P534, DOI 10.1111/j.1523-1739.2006.00609.x; Jonzen N, 2006, SCIENCE, V312, P1959, DOI 10.1126/science.1126119; Kunreuther H, 2014, CLIMATE CHANGE 2014: MITIGATION OF CLIMATE CHANGE, P151; Lasky JR, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1400218; Liedvogel M, 2011, TRENDS ECOL EVOL, V26, P561, DOI 10.1016/j.tree.2011.07.009; Mueller JC, 2013, MOL ECOL, V22, P2797, DOI 10.1111/mec.12282; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Pinsky ML, 2013, SCIENCE, V341, P1239, DOI 10.1126/science.1239352; Sauer J. R., 2014, N AM BREEDING BIRD S, P3; Scheffers BR, 2016, SCIENCE, V354, DOI 10.1126/science.aaf7671; Shuford W. D., 2008, CALIFORNIA BIRD SPEC, P332; Somero GN, 2010, J EXP BIOL, V213, P912, DOI 10.1242/jeb.037473; Urban MC, 2015, SCIENCE, V348, P571, DOI 10.1126/science.aaa4984; Visser ME, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002120	27	197	201	28	236	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 5	2018	359	6371					83	+		10.1126/science.aan4380	http://dx.doi.org/10.1126/science.aan4380			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FR8KW	29302012				2022-12-28	WOS:000419324700072
J	Gruszczyk, J; Kanjee, U; Chan, LJ; Menant, S; Malleret, B; Lim, NTY; Schmidt, CQ; Mok, YF; Lin, KM; Pearson, RD; Rangel, G; Smith, BJ; Call, MJ; Weekes, MP; Griffin, MDW; Murphy, JM; Abraham, J; Sriprawat, K; Menezes, MJ; Ferreira, MU; Russell, B; Renia, L; Duraisingh, MT; Tham, WH				Gruszczyk, Jakub; Kanjee, Usheer; Chan, Li-Jin; Menant, Sebastien; Malleret, Benoit; Lim, Nicholas T. Y.; Schmidt, Christoph Q.; Mok, Yee-Foong; Lin, Kai-Min; Pearson, Richard D.; Rangel, Gabriel; Smith, Brian J.; Call, Melissa J.; Weekes, Michael P.; Griffin, Michael D. W.; Murphy, James M.; Abraham, Jonathan; Sriprawat, Kanlaya; Menezes, Maria J.; Ferreira, Marcelo U.; Russell, Bruce; Renia, Laurent; Duraisingh, Manoj T.; Tham, Wai-Hong			Transferrin receptor 1 is a reticulocyte-specific receptor for Plasmodium vivax	SCIENCE			English	Article							HEMORRHAGIC-FEVER ARENAVIRUSES; HUMAN MALARIA PARASITE; ERYTHROCYTE INVASION; CRYSTAL-STRUCTURE; IN-VITRO; FALCIPARUM; DETERMINANTS; MEROZOITES; KNOWLESI; COMPLEX	Plasmodium vivax shows a strict host tropism for reticulocytes. We identified transferrin receptor 1 (TfR1) as the receptor for P. vivax reticulocyte-binding protein 2b (PvRBP2b). We determined the structure of the N-terminal domain of PvRBP2b involved in red blood cell binding, elucidating the molecular basis for TfR1 recognition. We validated TfR1 as the biological target of PvRBP2b engagement by means of TfR1 expression knockdown analysis. TfR1 mutant cells deficient in PvRBP2b binding were refractory to invasion of P. vivax but not to invasion of P. falciparum. Using Brazilian and Thai clinical isolates, we show that PvRBP2b monoclonal antibodies that inhibit reticulocyte binding also block P. vivax entry into reticulocytes. These data show that TfR1-PvRBP2b invasion pathway is critical for the recognition of reticulocytes during P. vivax invasion.	[Gruszczyk, Jakub; Chan, Li-Jin; Menant, Sebastien; Lim, Nicholas T. Y.; Call, Melissa J.; Murphy, James M.; Tham, Wai-Hong] Walter & Eliza Hall Inst Med Res, Parkville, Vic 3052, Australia; [Kanjee, Usheer; Rangel, Gabriel; Duraisingh, Manoj T.] Harvard TH Chan Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Chan, Li-Jin; Call, Melissa J.; Murphy, James M.; Tham, Wai-Hong] Univ Melbourne, Dept Med Biol, Melbourne, Vic 3010, Australia; [Malleret, Benoit] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Microbiol & Immunol, Singapore 117597, Singapore; [Malleret, Benoit; Renia, Laurent] ASTAR, Singapore Immunol Network, Singapore 138648, Singapore; [Schmidt, Christoph Q.] Ulm Univ, Inst Pharmacol Nat Prod & Clin Pharmacol, Ulm, Germany; [Mok, Yee-Foong; Griffin, Michael D. W.] Univ Melbourne, Dept Biochem & Mol Biol, Mol Sci & Biotechnol Inst Bio21, Melbourne, Vic 3010, Australia; [Lin, Kai-Min; Weekes, Michael P.] Cambridge Inst Med Res, Cambridge CB2 OXY, England; [Pearson, Richard D.] Wellcome Trust Sanger Inst, Cambridge, England; [Pearson, Richard D.] Li Ka Shing Ctr Hlth Informat & Discovery, Big Data Inst, Oxford, England; [Smith, Brian J.] La Trobe Univ, La Trobe Inst Mol Sci, Melbourne, Vic 3086, Australia; [Abraham, Jonathan] Harvard Med Sch, Dept Microbiol & Immunobiol, Boston, MA 02115 USA; [Sriprawat, Kanlaya] Mahidol Univ, Shoklo Malaria Res Unit, Mahidol Oxford Trop Med Res Unit, Fac Trop Med, Mae Sot, Thailand; [Menezes, Maria J.; Ferreira, Marcelo U.] Univ Sao Paulo, Inst Biomed Sci, Dept Parasitol, Sao Paulo, Brazil; [Russell, Bruce] Univ Otago, Dept Microbiol & Immunol, Dunedin 9054, New Zealand	Walter & Eliza Hall Institute; Harvard University; Harvard T.H. Chan School of Public Health; University of Melbourne; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); Ulm University; University of Melbourne; Wellcome Trust Sanger Institute; La Trobe University; Harvard University; Harvard Medical School; Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University; Universidade de Sao Paulo; University of Otago	Tham, WH (corresponding author), Walter & Eliza Hall Inst Med Res, Parkville, Vic 3052, Australia.; Tham, WH (corresponding author), Univ Melbourne, Dept Med Biol, Melbourne, Vic 3010, Australia.	tham@wehi.edu.au	Call, Melissa/HHZ-6671-2022; Murphy, James/B-4863-2017; Tham, Wai-Hong/L-3173-2018; Russell, Bruce/A-9240-2011; Lin, Kai-Min/R-5480-2017; Smith, Brian J/F-8282-2011; Malleret, Benoit/E-9159-2011; Rangel, Gabriel/AAZ-6762-2021; Renia, Laurent/E-2117-2011; Tham, Wai-Hong/P-6474-2019; Lin, Kai-Min/GQQ-7027-2022; Ferreira, Marcelo U/G-8289-2011	Call, Melissa/0000-0001-7684-5841; Murphy, James/0000-0003-0195-3949; Tham, Wai-Hong/0000-0001-7950-8699; Russell, Bruce/0000-0003-2333-4348; Lin, Kai-Min/0000-0003-2109-1530; Smith, Brian J/0000-0003-0498-1910; Malleret, Benoit/0000-0001-9658-7528; Rangel, Gabriel/0000-0002-8208-2817; Renia, Laurent/0000-0003-0349-1557; Tham, Wai-Hong/0000-0001-7950-8699; Ferreira, Marcelo U/0000-0002-5293-9090; Chan, Li Jin/0000-0002-9439-3487; Gruszczyk, Jakub/0000-0003-4536-2964; Griffin, Michael/0000-0001-9845-7735; Weekes, Michael/0000-0003-3196-5545; Pearson, Richard/0000-0002-7386-3566	Howard Hughes Medical Institute-Wellcome Trust International Research Scholar [208693/Z/17/Z]; Australian Research Council Future Fellowships; Speedy Innovation Grant; National Health and Medical Research Council fellowship [1105754]; Canadian Institutes of Health Research Postdoctoral Fellowship; Wellcome Trust [090770]; Wellcome Trust Senior Clinical Research Fellowship [108070/Z/15/Z]; Singapore National Medical Research Council (NMRC) [NMRC/CBRG/0047/2013]; Agency for Science, Technology and Research (A*STAR, Singapore); Wellcome Trust of Great Britain as part of the Oxford Tropical Medicine Research Programme of Wellcome Trust-Mahidol University; National Institutes of Health [1R01HL139337]; Marsden Fund [17-UOO-241]; Wellcome Trust Sanger Institute [Wellcome Trust 206194, 098051]	Howard Hughes Medical Institute-Wellcome Trust International Research Scholar; Australian Research Council Future Fellowships(Australian Research Council); Speedy Innovation Grant; National Health and Medical Research Council fellowship(National Health and Medical Research Council (NHMRC) of Australia); Canadian Institutes of Health Research Postdoctoral Fellowship(Canadian Institutes of Health Research (CIHR)); Wellcome Trust(Wellcome Trust); Wellcome Trust Senior Clinical Research Fellowship(Wellcome Trust); Singapore National Medical Research Council (NMRC)(National Medical Research Council, Singapore); Agency for Science, Technology and Research (A*STAR, Singapore)(Agency for Science Technology & Research (A*STAR)); Wellcome Trust of Great Britain as part of the Oxford Tropical Medicine Research Programme of Wellcome Trust-Mahidol University; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Marsden Fund(Royal Society of New ZealandMarsden Fund (NZ)); Wellcome Trust Sanger Institute(Wellcome Trust)	We thank J. Newman from the Commonwealth Scientific and Industrial Research Organization Collaborative Crystallization Centre for assistance with setting up the crystallization screens, the Walter and Eliza Hall Institute's Monoclonal Antibody Facility for production of antibodies, J. Williamson for assistance with mass spectrometry, and MX and SAXS beamline staff at the Australian Synchrotron for their assistance during data collection. We thank F. Nosten, the staff and patients attending the Mae Sot Malaria Clinic in Thailand, and clinics associated with the Shoklo Malaria Research Unit (SMRU), Tak Province, Thailand. We also thank Y. Colin and O. S. Bertrand (INSERM/University Paris 7) for the generous gift of the antibodies to DARC. W.-H.T. is a Howard Hughes Medical Institute-Wellcome Trust International Research Scholar (208693/Z/17/Z). This work was supported in part by the Australian Research Council Future Fellowships to W.-H.T. and M.D.W.G., a Speedy Innovation Grant to W.-H.T., and a National Health and Medical Research Council fellowship (1105754) to J.M.M. U.K. was supported by a Canadian Institutes of Health Research Postdoctoral Fellowship. R.D.P. is funded by Wellcome Trust 090770. M.P.W. was supported by a Wellcome Trust Senior Clinical Research Fellowship (108070/Z/15/Z). This study received funding from Singapore National Medical Research Council (NMRC) (NMRC/CBRG/0047/2013) and the Agency for Science, Technology and Research (A*STAR, Singapore). SMRU is sponsored by The Wellcome Trust of Great Britain as part of the Oxford Tropical Medicine Research Programme of Wellcome Trust-Mahidol University. Work in the M.T.D. laboratory was supported by National Institutes of Health grant 1R01HL139337. We also acknowledge the support of the B.R. laboratory from the Marsden Fund 17-UOO-241. The authors acknowledge the Victorian State Government Operational Infrastructure Support and Australian Government National Health and Medical Research Council Independent Research Institute Infrastructure Support Scheme. All data and code to understand and assess the conclusions of this research are available in the main text, supplementary materials, and via the following repositories: The atomic coordinates and structure factors for PvRBP2b have been deposited in PDB with accession number 5W53. Genotypes were derived from sequence data generated at the Wellcome Trust Sanger Institute (Wellcome Trust 206194 and 098051).	Abraham J, 2010, NAT STRUCT MOL BIOL, V17, P438, DOI 10.1038/nsmb.1772; Abraham J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000358; ADAMS JH, 1990, CELL, V63, P141, DOI 10.1016/0092-8674(90)90295-P; Bei AK, 2010, J INFECT DIS, V202, P1722, DOI 10.1086/657157; Bennett MJ, 2000, NATURE, V403, P46, DOI 10.1038/47417; Bozdech Z, 2008, P NATL ACAD SCI USA, V105, P16290, DOI 10.1073/pnas.0807404105; Carlton JM, 2008, NATURE, V455, P757, DOI 10.1038/nature07327; Chen L, 2014, ELIFE, V3, DOI 10.7554/eLife.04187; Cheng Y, 2004, CELL, V116, P565, DOI 10.1016/S0092-8674(04)00130-8; Cho JS, 2016, INT J PARASITOL, V46, P31, DOI 10.1016/j.ijpara.2015.08.003; Cowman AF, 2006, CELL, V124, P755, DOI 10.1016/j.cell.2006.02.006; Crosnier C, 2011, NATURE, V480, P534, DOI 10.1038/nature10606; Franca CT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005014; GALINSKI MR, 1992, CELL, V69, P1213, DOI 10.1016/0092-8674(92)90642-P; Grimberg BT, 2007, PLOS MED, V4, P1940, DOI 10.1371/journal.pmed.0040337; Gruszczyk J, 2016, P NATL ACAD SCI USA, V113, pE191, DOI 10.1073/pnas.1516512113; HARDING C, 1983, J CELL BIOL, V97, P329, DOI 10.1083/jcb.97.2.329; Helguera G, 2012, J VIROL, V86, P4024, DOI 10.1128/JVI.06397-11; HORUK R, 1993, SCIENCE, V261, P1182, DOI 10.1126/science.7689250; Lawrence CM, 1999, SCIENCE, V286, P779, DOI 10.1126/science.286.5440.779; Levy JE, 1999, NAT GENET, V21, P396, DOI 10.1038/7727; Maier AG, 2003, NAT MED, V9, P87, DOI 10.1038/nm807; Malleret B, 2015, BLOOD, V125, P1314, DOI 10.1182/blood-2014-08-596015; Malleret B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076062; Menard D, 2010, P NATL ACAD SCI USA, V107, P5967, DOI 10.1073/pnas.0912496107; Mendes C, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001192; MILLER LH, 1975, SCIENCE, V189, P561, DOI 10.1126/science.1145213; MILLER LH, 1976, NEW ENGL J MED, V295, P302, DOI 10.1056/NEJM197608052950602; Mueller I, 2009, LANCET INFECT DIS, V9, P555, DOI 10.1016/S1473-3099(09)70177-X; PAN BT, 1983, CELL, V33, P967, DOI 10.1016/0092-8674(83)90040-5; Pearson RD, 2016, NAT GENET, V48, P959, DOI 10.1038/ng.3599; Radoshitzky SR, 2008, P NATL ACAD SCI USA, V105, P2664, DOI 10.1073/pnas.0709254105; Radoshitzky SR, 2007, NATURE, V446, P92, DOI 10.1038/nature05539; SIM BKL, 1994, SCIENCE, V264, P1941, DOI 10.1126/science.8009226; Smolarek D, 2010, CELL MOL LIFE SCI, V67, P3371, DOI 10.1007/s00018-010-0387-6; Tham WH, 2011, BLOOD, V118, P1923, DOI 10.1182/blood-2011-03-341305; Tham WH, 2010, P NATL ACAD SCI USA, V107, P17327, DOI 10.1073/pnas.1008151107; Weiss GE, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004670; Woldearegai TG, 2013, T ROY SOC TROP MED H, V107, P328, DOI 10.1093/trstmh/trt016; Wright KE, 2014, NATURE, V515, P427, DOI 10.1038/nature13715	40	103	104	0	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 5	2018	359	6371					48	+		10.1126/science.aan1078	http://dx.doi.org/10.1126/science.aan1078			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FR8KW	29302006	Green Submitted, Green Accepted			2022-12-28	WOS:000419324700064
J	Hunt, BJ; Levi, M				Hunt, Beverley J.; Levi, Marcel			THERAPEUTICS Urgent reversal of vitamin K antagonists	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PROTHROMBIN COMPLEX CONCENTRATE; WARFARIN; ANTICOAGULATION; PLASMA; GUIDELINES; EFFICACY		[Hunt, Beverley J.] Kings Coll London, London, England; [Hunt, Beverley J.] Guys & St Thomas NHS Fdn Trust, Dept Haematol, London, England; [Hunt, Beverley J.] Guys & St Thomas NHS Fdn Trust, Dept Pathol, London, England; [Hunt, Beverley J.] Viapath, London, England; [Levi, Marcel] Univ Coll London Hosp NHS Fdn Trust, London, England; [Levi, Marcel] Univ Amsterdam, Acad Med Ctr, Amsterdam, Netherlands	University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; Guy's & St Thomas' NHS Foundation Trust; University College London Hospitals NHS Foundation Trust; University of London; University College London; University of Amsterdam; Academic Medical Center Amsterdam	Hunt, BJ (corresponding author), St Thomas Hosp, Thrombosis & Haemophilia Ctr, London SE1 7EH, England.	Beverley.hunt@gstt.nhs.uk	Levi, Marcel/AAZ-8559-2020					Brekelmans MPA, 2017, J THROMB THROMBOLYS, V44, P118, DOI 10.1007/s11239-017-1506-0; Britt RB, 2016, CLIN APPL THROMB HEM; Dentali F, 2006, J THROMB HAEMOST, V4, P1853, DOI 10.1111/j.1538-7836.2006.01986.x; DeZee KJ, 2006, ARCH INTERN MED, V166, P391; Dowlatshahi D, 2012, STROKE, V43, P1812, DOI 10.1161/STROKEAHA.112.652065; Fang MC, 2007, AM J MED, V120, P700, DOI 10.1016/j.amjmed.2006.07.034; Flaherty ML, 2008, NEUROLOGY, V71, P1084, DOI 10.1212/01.wnl.0000326895.58992.27; Goldstein JN, 2015, LANCET, V385, P2077, DOI 10.1016/S0140-6736(14)61685-8; Guest JF, 2010, CLIN THER, V32, P2478, DOI 10.1016/j.clinthera.2011.01.011; Guyatt GH, 2012, CHEST, V141, p7S, DOI 10.1378/chest.1412S3; Keeling D, 2011, BRIT J HAEMATOL, V154, P311, DOI 10.1111/j.1365-2141.2011.08753.x; Levi M, 2011, J THROMB HAEMOST, V9, P1705, DOI 10.1111/j.1538-7836.2011.04432.x; National Institute for Health and Care Excellence, 2014, ATR FIBR MAN CLIN GU; Pandey S, 2012, TRANSFUSION, V52, p65S, DOI 10.1111/j.1537-2995.2012.03663.x; Sarode R, 2013, CIRCULATION, V128, P1234, DOI 10.1161/CIRCULATIONAHA.113.002283; Sin JH, 2016, J CRIT CARE, V36, P166, DOI 10.1016/j.jcrc.2016.06.024; Thrombosis Canada, ANT REL BLEED MAN OR; Tran HA, 2013, MED J AUSTRALIA, V198, P198, DOI 10.5694/mja12.10614; Watson HG, 2001, BRIT J HAEMATOL, V115, P145, DOI 10.1046/j.1365-2141.2001.03070.x	19	13	14	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 4	2018	360								j5424	10.1136/bmj.j5424	http://dx.doi.org/10.1136/bmj.j5424			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FS3UX	29301740	Green Submitted			2022-12-28	WOS:000419710400006
J	Verghese, A; Shah, NH; Harrington, R				Verghese, Abraham; Shah, Nigam H.; Harrington, RobertA.			What This Computer Needs Is a Physician Humanism and Artificial Intelligence	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Verghese, Abraham; Shah, Nigam H.; Harrington, RobertA.] Stanford Univ, Sch Med, Dept Med, 300 Pasteur Dr,S102, Stanford, CA 94305 USA	Stanford University	Verghese, A (corresponding author), Stanford Univ, Sch Med, Dept Med, 300 Pasteur Dr,S102, Stanford, CA 94305 USA.	abrahamv@stanford.edu			Leigh Bureau; Gilead Global Access Advisory Board	Leigh Bureau; Gilead Global Access Advisory Board	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Verghese repoted receiving royalties from Random House and Scribner; receiving speakers fees from Leigh Bureau; and receiving fees for serving on the Gilead Global Access Advisory Board. Dr Harrington reported receiving research grants outside the topic area from Merck, CSL Behring, GlaxoSmithKline, Regado, Sanofi-Aventis, AstraZeneca, Portola, Janssen, Bristol Myers Squibb, Novartis, and The Medicines Company; serving as a consultant for Amgen, Adverse Events, Bayer, Element Science, Gilead, MyoKardia, Merck, The Medicines Company, and WebMD; and serving on the boards of directors of Signal Path, Scanadu, the American Heart Association, and Stanford Healthcare. Dr Shah reported no disclosures.	Angwin J., 2016, MACHINE BIAS; Avati A, 2017, 2017 IEEE INT C BIOI; Breiman L, 2001, STAT SCI, V16, P199, DOI 10.1214/ss/1009213726; Cabitza F, 2017, JAMA-J AM MED ASSOC, V318, P517, DOI 10.1001/jama.2017.7797; CALIFF RM, 1981, WESTERN J MED, V135, P321; Caruana R, 2015, KDD'15: PROCEEDINGS OF THE 21ST ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P1721, DOI 10.1145/2783258.2788613; Halpern Y, 2016, J AM MED INFORM ASSN, V23, P731, DOI 10.1093/jamia/ocw011; Hill RG, 2013, AM J EMERG MED, V31, P1591, DOI 10.1016/j.ajem.2013.06.028; Verghese A, 2008, NEW ENGL J MED, V359, P2748, DOI 10.1056/NEJMp0807461	9	170	174	2	65	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 2	2018	319	1					19	20		10.1001/jama.2017.19198	http://dx.doi.org/10.1001/jama.2017.19198			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FR5ON	29261830				2022-12-28	WOS:000419116000009
J	O'Grady, NP				O'Grady, Naomi P.			Inpatient Notes: Trends in Rates of Catheter-Associated Bloodstream Infection-Zeroing In on Zero or Just Fake News?	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							INTENSIVE-CARE; DEFINITION		[O'Grady, Naomi P.] NIH, Clin Ctr, Bldg 10, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Clinical Center (CC)	O'Grady, NP (corresponding author), NIH, Dept Crit Care Med, Clin Ctr, Bethesda, MD 20815 USA.	NOGrady@cc.nih.gov			National Institutes of Health Clinical Center, Bethesda, Maryland	National Institutes of Health Clinical Center, Bethesda, Maryland(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institutes of Health Clinical Center, Bethesda, Maryland.	Gaur AH, 2013, INFECT CONT HOSP EP, V34, P663, DOI 10.1086/671005; O'Grady NP, 2011, CLIN INFECT DIS, V52, pE162, DOI 10.1093/cid/cir257; Pronovost PJ, 2016, AM J MED QUAL, V31, P197, DOI 10.1177/1062860614568647; Srinivasan A., 2011, Morbidity and Mortality Weekly Report, V60, P243; Torres D, 2016, AM J INFECT CONTROL, V44, P432, DOI 10.1016/j.ajic.2015.11.007	5	1	1	1	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 19	2017	167	12					HO2	HO3		10.7326/M17-3049	http://dx.doi.org/10.7326/M17-3049			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FQ3SD	29255873				2022-12-28	WOS:000418276000001
J	Saccone, G; Maruotti, GM; Giudicepietro, A; Martinelli, P				Saccone, Gabriele; Maruotti, Giuseppe Maria; Giudicepietro, Antonia; Martinelli, Pasquale		Italian Preterm Birth Prevention	Effect of Cervical Pessary on Spontaneous Preterm Birth in Women With Singleton Pregnancies and Short Cervical Length A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							VAGINAL PROGESTERONE; 17-ALPHA-HYDROXYPROGESTERONE CAPROATE; MAINTENANCE TOCOLYSIS; METAANALYSIS; CERCLAGE; RISK; SUPPLEMENTATION; GESTATIONS; PREVENTION; EXERCISE	IMPORTANCE Spontaneous preterm birth is a major cause of perinatal morbidity and mortality. It is unclear if a cervical pessary can reduce the risk of spontaneous preterm delivery. OBJECTIVE To test whether in asymptomatic women with singleton pregnancies and no prior spontaneous preterm birth but with short cervical length on transvaginal ultrasound, use of a cervical pessary would reduce the rate of spontaneous preterm birth at less than 34 weeks of gestation. DESIGN, SETTING, AND PARTICIPANTS Parallel-group, nonblinded, randomized clinical trial conducted from March 1, 2016, to May 25, 2017, at a single center in Italy. Asymptomatic women with singleton gestations, no previous spontaneous preterm births, and cervical lengths of 25 mm or less at 18 weeks 0 days to 23 weeks 6 days of gestation were eligible. INTERVENTIONS Patients were randomized 1: 1 to receive either cervical pessary (n = 150) or no pessary (n = 150). The pessary was removed between 37 weeks 0 days and 37 weeks 6 days of gestation or earlier if clinically indicated. The control group received standard care. For cervical length of 20 mm or shorter, women in both groups were prescribed vaginal progesterone, 200 mg/d, until 36 weeks 6 days of gestation. No bed rest or activity restriction was recommended. MAIN OUTCOMES AND MEASURES The primary end point was spontaneous preterm birth at less than 34 weeks of gestation. Secondary outcomes were adverse events. RESULTS Among 300 women who were randomized (mean age, 29 [SD, 6.3] years; mean gestational age, 22 [SD, 1.3] weeks), 100% completed the trial. The primary end point occurred in significantly fewer women in the pessary group. During follow-up, the pessary group had a higher rate of increased or new vaginal discharge. CONCLUSIONS AND RELEVANCE Among women without prior spontaneous preterm birth who had asymptomatic singleton pregnancies and short transvaginal cervical length, use of a cervical pessary, compared with no pessary use, resulted in a lower rate of spontaneous preterm birth at less than 34 weeks of gestation. The results of this single-center, nonblinded study among selected pregnant women require confirmation in multicenter clinical trials.	[Saccone, Gabriele; Maruotti, Giuseppe Maria; Giudicepietro, Antonia; Martinelli, Pasquale; Italian Preterm Birth Prevention] Univ Naples Federico II, Sch Med, Dept Neurosci Reprod Sci & Dent, Girolamo Santacroce 19F-80129, Naples, Italy	University of Naples Federico II	Saccone, G (corresponding author), Univ Naples Federico II, Sch Med, Dept Neurosci Reprod Sci & Dent, Girolamo Santacroce 19F-80129, Naples, Italy.	gabriele.saccone.1990@gmail.com	Maruotti, Giuseppe M/K-8763-2018; Saccone, Gabriele/K-2792-2018	Maruotti, Giuseppe M/0000-0002-9666-6338; Saccone, Gabriele/0000-0003-0078-2113; Ghi, Tullio/0000-0003-1823-1096				[Anonymous], 2014, Obstet Gynecol, V123, P372, DOI 10.1097/01.AOG.0000443276.68274.cc; Arabin B, 2003, J PERINAT MED, V31, P122, DOI 10.1515/JPM.2003.017; Berghella V, 2017, ULTRASOUND OBST GYN, V50, P569, DOI 10.1002/uog.17457; Berghella V, 2013, AM J OBSTET GYNECOL, V209, P181, DOI 10.1016/j.ajog.2013.02.020; Berghella V, 2012, AM J OBSTET GYNECOL, V206, P376, DOI 10.1016/j.ajog.2012.03.010; Berghella V, 2011, OBSTET GYNECOL, V117, P663, DOI 10.1097/AOG.0b013e31820ca847; Chamberlain C, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001055.pub4; De-Regil LM, 2016, COCHRANE DB SYST REV, DOI [10.1590/1516-3180.20161343T2, 10.1002/14651858.CD008873.pub3]; Di Mascio D, 2016, AM J OBSTET GYNECOL, V215, P561, DOI 10.1016/j.ajog.2016.06.014; Ehsanipoor RM, 2015, OBSTET GYNECOL, V126, P125, DOI 10.1097/AOG.0000000000000850; Goya M, 2012, LANCET, V379, P1800, DOI 10.1016/S0140-6736(12)60030-0; Hui SYA, 2013, AM J PERINAT, V30, P283, DOI 10.1055/s-0032-1322550; Iams JD, 1996, NEW ENGL J MED, V334, P567, DOI 10.1056/NEJM199602293340904; Jones G, 1998, BRIT J OBSTET GYNAEC, V105, P1214; Karbasian N, 2016, J OBSTET GYNAECOL RE, V42, P1673, DOI 10.1111/jog.13138; Magro-Malosso ER, 2017, ACTA OBSTET GYN SCAN, V96, P263, DOI 10.1111/aogs.13087; Martin Joyce A, 2017, Natl Vital Stat Rep, V66, P1; Nicolaides KH, 2016, NEW ENGL J MED, V374, P1044, DOI 10.1056/NEJMoa1511014; Ota E, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000032.pub3; Patel RM, 2015, NEW ENGL J MED, V372, P331, DOI 10.1056/NEJMoa1403489; Rysavy MA, 2015, NEW ENGL J MED, V372, P1801, DOI 10.1056/NEJMoa1410689; Saccone G, 2017, ULTRASOUND OBST GYN, V49, P315, DOI 10.1002/uog.17245; Saccone G, 2016, BJOG-INT J OBSTET GY, V123, P16, DOI 10.1111/1471-0528.13724; Saccone G, 2017, J MATERN-FETAL NEO M, V30, P2918, DOI 10.1080/14767058.2016.1268595; Saccone G, 2017, J ULTRAS MED, V36, P1535, DOI 10.7863/ultra.16.08054; Saccone G, 2016, J MATERN-FETAL NEO M, V29, P2389, DOI 10.3109/14767058.2015.1086742; Saccone G, 2016, EUR J OBSTET GYN R B, V199, P76, DOI 10.1016/j.ejogrb.2016.01.042; Saccone G, 2015, AM J OBSTET GYNECOL, V213, P135, DOI 10.1016/j.ajog.2015.03.013; Saccone G, 2015, AM J OBSTET GYNECOL, V213, P16, DOI 10.1016/j.ajog.2015.01.054; Saccone G, 2015, ACTA OBSTET GYN SCAN, V94, P352, DOI 10.1111/aogs.12600; Saccone G, 2015, OBSTET GYNECOL, V125, P663, DOI 10.1097/AOG.0000000000000668; Suhag A, 2015, OBSTET GYNECOL, V126, P962, DOI 10.1097/AOG.0000000000001086; Suhag A, 2015, AM J OBSTET GYNECOL, V213, P479, DOI 10.1016/j.ajog.2015.03.031; VITSKY M, 1961, AM J OBSTET GYNECOL, V81, P1194, DOI 10.1016/S0002-9378(15)33352-4	34	63	65	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 19	2017	318	23					2317	2324		10.1001/jama.2017.18956	http://dx.doi.org/10.1001/jama.2017.18956			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FQ3RJ	29260226	Green Published, Bronze			2022-12-28	WOS:000418274000019
J	Voelker, R				Voelker, Rebecca			First Treatment Approved for Rare Blood Cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 19	2017	318	23					2288	2288		10.1001/jama.2017.18871	http://dx.doi.org/10.1001/jama.2017.18871			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FQ3RJ	29260208				2022-12-28	WOS:000418274000008
J	Horton, R				Horton, Richard			Offline: The unspoken dangers facing UK medical science	LANCET			English	Editorial Material												richard.horton@lancet.com							0	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 16	2017	390	10113					2616	2616		10.1016/S0140-6736(17)33299-3	http://dx.doi.org/10.1016/S0140-6736(17)33299-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FQ1FF	29256398	Bronze			2022-12-28	WOS:000418101000012
J	Van den Ackerveken, G				Van den Ackerveken, Guido			How plants differ in toxin-sensitivity	SCIENCE			English	Editorial Material							FUNCTIONAL-ANALYSIS; NECROSIS; PROTEIN		[Van den Ackerveken, Guido] Univ Utrecht, Dept Biol, Utrecht, Netherlands	Utrecht University	Van den Ackerveken, G (corresponding author), Univ Utrecht, Dept Biol, Utrecht, Netherlands.	g.vandenackervehen@uu.nl	Van den Ackerveken, Guido/B-8568-2011	Van den Ackerveken, Guido/0000-0002-0183-8978				Bailey Bryan A., 1995, Phytopathology, V85, P1250, DOI 10.1094/Phyto-85-1250; Cabral A, 2012, MOL PLANT MICROBE IN, V25, P697, DOI 10.1094/MPMI-10-11-0269; Cacas JL, 2016, PLANT PHYSIOL, V170, P367, DOI 10.1104/pp.15.00564; Cacas JL, 2013, PHYTOCHEMISTRY, V96, P191, DOI 10.1016/j.phytochem.2013.08.002; Fang YL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04430-0; Haas BJ, 2009, NATURE, V461, P393, DOI 10.1038/nature08358; Lenarcic T, 2017, SCIENCE, V358, P1431, DOI 10.1126/science.aan6874; Mattinen L, 2004, MOL PLANT MICROBE IN, V17, P1366, DOI 10.1094/MPMI.2004.17.12.1366; Motteram J, 2009, MOL PLANT MICROBE IN, V22, P790, DOI 10.1094/MPMI-22-7-0790; Oome S, 2014, MOL PLANT MICROBE IN, V27, P1081, DOI 10.1094/MPMI-04-14-0118-R; Ottmann C, 2009, P NATL ACAD SCI USA, V106, P10359, DOI 10.1073/pnas.0902362106; Rojko N, 2016, BBA-BIOMEMBRANES, V1858, P446, DOI 10.1016/j.bbamem.2015.09.007	12	10	10	1	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 15	2017	358	6369					1383	1384		10.1126/science.aar4188	http://dx.doi.org/10.1126/science.aar4188			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FP8TH	29242331				2022-12-28	WOS:000417918500019
J	Scaringi, S; Maccarone, TJ; D'Angelo, C; Knigge, C; Groot, PJ				Scaringi, S.; Maccarone, T. J.; D'Angelo, C.; Knigge, C.; Groot, P. J.			Magnetically gated accretion in an accreting 'non-magnetic' white dwarf	NATURE			English	Article							VY SCULPTORIS STARS; SHORT CADENCE DATA; RMS-FLUX RELATION; MV-LYRAE; LOW STATE; CATACLYSMIC VARIABLES; RAPID BURSTER; BLACK-HOLES; EX-LUPI; VARIABILITY	White dwarfs are often found in binary systems with orbital periods ranging from tens of minutes to hours in which they can accrete gas from their companion stars. In about 15 per cent of these binaries, the magnetic field of the white dwarf is strong enough (at 106 gauss or more) to channel the accreted matter along field lines onto the magnetic poles(1,2). The remaining systems are referred to as 'non-magnetic', because until now there has been no evidence that they have a magnetic field that is strong enough to affect the accretion dynamics. Here we report an analysis of archival optical observations of the 'non-magnetic' accreting white dwarf in the binary system MV Lyrae, whose light curve displays quasi-periodic bursts of about 30 minutes duration roughly every 2 hours. The timescale and amplitude of these bursts indicate the presence of an unstable, magnetically regulated accretion mode, which in turn implies the existence of magnetically gated accretion(3-5), in which disk material builds up around the magnetospheric boundary (at the co-rotation radius) and then accretes onto the white dwarf, producing bursts powered by the release of gravitational potential energy. We infer a surface magnetic field strength for the white dwarf in MV Lyrae of between 2 x 10(4) gauss and 1 x 105 gauss, too low to be detectable by other current methods. Our discovery provides a new way of studying the strength and evolution of magnetic fields in accreting white dwarfs and extends the connections between accretion onto white dwarfs, young stellar objects and neutron stars, for which similar magnetically gated accretion cycles have been identified(6-9).	[Scaringi, S.] Univ Canterbury, Sch Phys & Chem Sci, Christchurch 8041, New Zealand; [Maccarone, T. J.] Texas Tech Univ, Dept Phys & Astron, Lubbock, TX 79409 USA; [D'Angelo, C.] Leiden Univ, Leiden Observ, NL-2300 RA Leiden, Netherlands; [Knigge, C.] Univ Southampton, Sch Phys & Astron, Southampton SO17 1BJ, Hants, England; [Groot, P. J.] Radboud Univ Nijmegen, Dept Astrophys IMAPP, POB 9010, NL-6500 GL Nijmegen, Netherlands	University of Canterbury; Texas Tech University System; Texas Tech University; Leiden University; Leiden University - Excl LUMC; University of Southampton; Radboud University Nijmegen	Scaringi, S (corresponding author), Univ Canterbury, Sch Phys & Chem Sci, Christchurch 8041, New Zealand.	simone.scaringi@canterbury.ac.nz	Groot, Paul/K-4391-2016; Scaringi, Simone/AAL-9854-2021	Groot, Paul/0000-0002-4488-726X; Scaringi, Simone/0000-0001-5387-7189; Knigge, Christian/0000-0002-1116-2553	NASA Science Mission directorate; NASA [NAS5-26555]; NASA Office of Space Science [NNX09AF08G]; Erskine programme run by the University of Canterbury	NASA Science Mission directorate(National Aeronautics & Space Administration (NASA)); NASA(National Aeronautics & Space Administration (NASA)); NASA Office of Space Science(National Aeronautics & Space Administration (NASA)); Erskine programme run by the University of Canterbury	This paper includes data collected by the Kepler mission. Funding for the Kepler mission is provided by the NASA Science Mission directorate. We acknowledge with thanks the variable star observations from the AAVSO International Database contributed by observers worldwide and used in this research. Some of the data were obtained from the Barbara A. Mikulski Archive for Space Telescopes (MAST). STScI is operated by the Association of Universities for Research in Astronomy, Inc., under NASA contract NAS5-26555. Support for MAST for non-Hubble Space Telescope data is provided by the NASA Office of Space Science via grant NNX09AF08G and by other grants and contracts. P.J.G. acknowledges support from the Erskine programme run by the University of Canterbury.	Aspin C, 2010, ASTROPHYS J LETT, V719, pL50, DOI 10.1088/2041-8205/719/1/L50; Bagnoli T, 2015, MON NOT R ASTRON SOC, V449, P268, DOI 10.1093/mnras/stv330; Banzatti A, 2015, ASTROPHYS J LETT, V798, DOI 10.1088/2041-8205/798/1/L16; Baptista R, 2004, ASTRON J, V128, P411, DOI 10.1086/421852; Baran AS, 2013, ACTA ASTRONOM, V63, P203; CROPPER M, 1990, SPACE SCI REV, V54, P195, DOI 10.1007/BF00177799; D'Angelo CR, 2012, MON NOT R ASTRON SOC, V420, P416, DOI 10.1111/j.1365-2966.2011.20046.x; D'Angelo CR, 2010, MON NOT R ASTRON SOC, V406, P1208, DOI 10.1111/j.1365-2966.2010.16749.x; DHILLON VS, 1994, MON NOT R ASTRON SOC, V266, P859, DOI 10.1093/mnras/266.4.859; Dobrotka A, 2017, MON NOT R ASTRON SOC, V468, P1183, DOI 10.1093/mnras/stx513; Dobrotka A, 2015, MON NOT R ASTRON SOC, V447, P3162, DOI 10.1093/mnras/stu2631; Frank J., 2002, ACCRETION POWER ASTR, V3rd; Gansicke BT, 1999, ASTRON ASTROPHYS, V347, P178; Gilliland RL, 2010, ASTROPHYS J LETT, V713, pL160, DOI 10.1088/2041-8205/713/2/L160; Godon P, 2017, ASTROPHYS J, V846, DOI 10.3847/1538-4357/aa7f71; Godon P, 2012, ASTROPHYS J SUPPL S, V203, DOI 10.1088/0067-0049/203/2/29; Groot PJ, 2001, ASTRON ASTROPHYS, V368, P183, DOI 10.1051/0004-6361:20000483; Hameury JM, 2002, ASTRON ASTROPHYS, V394, P231, DOI 10.1051/0004-6361:20021136; Herbig GH, 2007, ASTRON J, V133, P2679, DOI 10.1086/517494; Hertfelder M, 2015, ASTRON ASTROPHYS, V579, DOI 10.1051/0004-6361/201526005; Hoard DW, 2004, ASTROPHYS J, V604, P346, DOI 10.1086/381777; Honeycutt RK, 2004, ASTRON J, V128, P1279, DOI 10.1086/422737; Jenkins JM, 2010, ASTROPHYS J LETT, V713, pL87, DOI 10.1088/2041-8205/713/2/L87; Kluzniak W., 1987, THESIS; Knevitt G, 2014, MON NOT R ASTRON SOC, V437, P3087, DOI 10.1093/mnras/stt2008; KUIJPERS J, 1994, ASTRON ASTROPHYS, V286, P491; Lasota JP, 2001, NEW ASTRON REV, V45, P449, DOI 10.1016/S1387-6473(01)00112-9; Leach R, 1999, MON NOT R ASTRON SOC, V305, P225, DOI 10.1046/j.1365-8711.1999.02450.x; Linnell AP, 2005, ASTROPHYS J, V624, P923, DOI 10.1086/429143; MEYER F, 1994, ASTRON ASTROPHYS, V288, P175; Panei JA, 2000, ASTRON ASTROPHYS, V353, P970; Patruno A, 2013, ASTROPHYS J, V771, DOI 10.1088/0004-637X/771/2/94; Patruno A, 2009, ASTROPHYS J, V707, P1296, DOI 10.1088/0004-637X/707/2/1296; PATTERSON J, 1994, PUBL ASTRON SOC PAC, V106, P209, DOI 10.1086/133375; Pavklenko E. P., 1996, ODESSA ASTRON PUBL, V9, P38; ROSINO L, 1993, PUBL ASTRON SOC PAC, V105, P51, DOI 10.1086/133126; Scaringi S, 2012, MON NOT R ASTRON SOC, V427, P3396, DOI 10.1111/j.1365-2966.2012.22022.x; Scaringi S, 2012, MON NOT R ASTRON SOC, V421, P2854, DOI 10.1111/j.1365-2966.2012.20512.x; Scaringi S, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500686; Scaringi S, 2014, MON NOT R ASTRON SOC, V438, P1233, DOI 10.1093/mnras/stt2270; SHAKURA NI, 1973, ASTRON ASTROPHYS, V24, P337; SKILLMAN DR, 1995, PUBL ASTRON SOC PAC, V107, P545, DOI 10.1086/133590; SPRUIT HC, 1993, ASTROPHYS J, V402, P593, DOI 10.1086/172162; Syunyaev R. A., 1977, SOV ASTRON LETT, V3, P138; THORSTENSEN JR, 1991, ASTRON J, V102, P272, DOI 10.1086/115874; Wynn GA, 1997, MON NOT R ASTRON SOC, V286, P436, DOI 10.1093/mnras/286.2.436	46	26	26	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 14	2017	552	7684					210	+		10.1038/nature24653	http://dx.doi.org/10.1038/nature24653			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ0FK	29239355	Green Accepted, Green Submitted			2022-12-28	WOS:000418029500038
J	Forner, A; Reig, M; Bruix, J				Forner, Alejandro; Reig, Maria; Bruix, Jordi			Hepatocellular carcinoma	LANCET			English	Review							RANDOMIZED CONTROLLED-TRIAL; CLINICAL-PRACTICE GUIDELINES; DOXORUBICIN-ELUTING BEADS; NODULES 20 MM; RADIOFREQUENCY ABLATION; LIVER-TRANSPLANTATION; PHASE-III; ALPHA-FETOPROTEIN; DOUBLE-BLIND; TRANSARTERIAL CHEMOEMBOLIZATION	Hepatocellular carcinoma appears frequently in patients with cirrhosis. Surveillance by biannual ultrasound is recommended for such patients because it allows diagnosis at an early stage, when effective therapies are feasible. The best candidates for resection are patients with a solitary tumour and preserved liver function. Liver transplantation benefits patients who are not good candidates for surgical resection, and the best candidates are those within Milan criteria (solitary tumour <= 5 cm or up to three nodules <= 3 cm). Image-guided ablation is the most frequently used therapeutic strategy, but its efficacy is limited by the size of the tumour and its localisation. Chemoembolisation has survival benefit in asymptomatic patients with multifocal disease without vascular invasion or extrahepatic spread. Finally, sorafenib, lenvatinib, which is non-inferior to sorafenib, and regorafenib increase survival and are the standard treatments in advanced hepatocellular carcinoma. This Seminar summarises the scientific evidence that supports the current recommendations for clinical practice, and discusses the areas in which more research is needed.	[Forner, Alejandro; Reig, Maria; Bruix, Jordi] Univ Barcelona, Hosp Clin, Liver Unit, Barcelona Clin Liver Canc Grp,IDIBAPS, Barcelona, Spain; [Forner, Alejandro; Reig, Maria; Bruix, Jordi] Ctr Invest Biomed Red Enfermedades Hepat & Digest, Madrid, Spain	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD	Forner, A (corresponding author), Hosp Clin Barcelona, Liver Unit, IDIBAPS, Barcelona Clin Liver Canc Grp, E-08036 Barcelona, Spain.	aforner@clinic.ub.es	Llovet, Josep M/D-4340-2014; Reig, Maria/ABB-5414-2021; Forner, Alejandro/C-8884-2016	Llovet, Josep M/0000-0003-0547-2667; Reig, Maria/0000-0002-5711-9534; Bruix, Jordi/0000-0002-9826-0753; Forner, Alejandro/0000-0002-9014-4950	Instituto de Salud Carlos III [PI13/01229, PI15/00145, PI14/00962]; AECC [PI044031]; Secretaria d'Universitats i Recerca del Departament d'Economia i Coneixement [2014 SGR 605]; WCR (AICR) [16-0026]; Spanish Health Ministry (Plan Estrategico Nacional contra la Hepatitis C); Instituto de Salud Carlos III	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); AECC; Secretaria d'Universitats i Recerca del Departament d'Economia i Coneixement; WCR (AICR); Spanish Health Ministry (Plan Estrategico Nacional contra la Hepatitis C)(Spanish Government); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission)	AF has received grant support from Instituto de Salud Carlos III (PI13/01229). MR has received grant support from Instituto de Salud Carlos III (PI15/00145). JB has received grant support from Instituto de Salud Carlos III (PI14/00962), AECC (PI044031), Secretaria d'Universitats i Recerca del Departament d'Economia i Coneixement (2014 SGR 605), and WCR (AICR) 16-0026. JB has also received support from the Spanish Health Ministry (Plan Estrategico Nacional contra la Hepatitis C). Centro de Investigacion Biomedica en Red de Enfermedades Hepaticas y Digestivas is funded by the Instituto de Salud Carlos III.	Abou-Alfa GK, 2016, J CLIN ONCOL, V34, DOI 10.1200/jco.2016.34.4_suppl.192; American College of Radiology, LIV IM REP DAT SYST; [Anonymous], 2017, EXELIXIS PHASE 3 CEL; Arguedas MR, 2003, AM J GASTROENTEROL, V98, P679, DOI [10.1016/S0002-9270(02)06049-5, 10.1111/j.1572-0241.2003.07327.x]; Berhane S, 2016, CLIN GASTROENTEROL H, V14, P875, DOI 10.1016/j.cgh.2015.12.042; Bertuccio P, 2017, J HEPATOL, V67, P302, DOI 10.1016/j.jhep.2017.03.011; Berzigotti A, 2015, HEPATOLOGY, V61, P526, DOI 10.1002/hep.27431; Boleslawski E, 2012, BRIT J SURG, V99, P855, DOI 10.1002/bjs.8753; Bravi F, 2017, EUR J CANCER PREV, V26, P368, DOI [10.1097/cej.0000000000000252, 10.1097/CEJ.0000000000000252]; Breen DJ, 2015, NAT REV CLIN ONCOL, V12, P175, DOI 10.1038/nrclinonc.2014.237; Brown KT, 2016, J CLIN ONCOL, V34, P2046, DOI 10.1200/JCO.2015.64.0821; Bruix J, 2017, J HEPATOL, V67, P999, DOI 10.1016/j.jhep.2017.06.026; Bruix J, 2017, LANCET, V389, P56, DOI 10.1016/S0140-6736(16)32453-9; Bruix J, 2016, GASTROENTEROLOGY, V150, P835, DOI 10.1053/j.gastro.2015.12.041; Bruix J, 2015, LANCET ONCOL, V16, P1344, DOI 10.1016/S1470-2045(15)00198-9; Bruix J, 2011, HEPATOLOGY, V54, P2238, DOI 10.1002/hep.24670; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Burrel M, 2012, J HEPATOL, V56, P1330, DOI 10.1016/j.jhep.2012.01.008; Cainap C, 2015, J CLIN ONCOL, V33, P172, DOI 10.1200/JCO.2013.54.3298; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Capurro M, 2003, GASTROENTEROLOGY, V125, P89, DOI 10.1016/S0016-5085(03)00689-9; Cescon M, 2012, ANN SURG, V256, P706, DOI 10.1097/SLA.0b013e3182724ce8; Chang MH, 2016, GASTROENTEROLOGY, V151, P472, DOI 10.1053/j.gastro.2016.05.048; Chen CJ, 2006, JAMA-J AM MED ASSOC, V295, P65, DOI 10.1001/jama.295.1.65; Chen HP, 2013, GUT, V62, P606, DOI 10.1136/gutjnl-2011-301708; Chen JD, 2010, GASTROENTEROLOGY, V138, P1747, DOI 10.1053/j.gastro.2010.01.042; Chen MS, 2006, ANN SURG, V243, P321, DOI 10.1097/01.sla.0000201480.65519.b8; Cheng AL, 2013, J CLIN ONCOL, V31, P4067, DOI 10.1200/JCO.2012.45.8372; Cheng AL, 2009, LANCET ONCOL, V10, P25, DOI 10.1016/S1470-2045(08)70285-7; Chow P, 2017, P AN M AM SOC CLIN, V35, P4002, DOI DOI 10.1200/JC0.201735.15.3UPPL.4002; Croswell JM, 2010, SEMIN ONCOL, V37, P202, DOI 10.1053/j.seminoncol.2010.05.006; Cucchetti A, 2013, J HEPATOL, V59, P300, DOI 10.1016/j.jhep.2013.04.009; Darnell A, 2015, RADIOLOGY, V275, P698, DOI 10.1148/radiol.15141132; Degasperi E, 2016, LANCET GASTROENTEROL, V1, P156, DOI 10.1016/S2468-1253(16)30018-8; Duvoux C, 2012, GASTROENTEROLOGY, V143, P986, DOI 10.1053/j.gastro.2012.05.052; Dyson J, 2014, J HEPATOL, V60, P110, DOI 10.1016/j.jhep.2013.08.011; EASL, 2016, DIABETOLOGIA, V59, P1121, DOI 10.1007/s00125-016-3902-y; El-Khoueiry AB, 2017, LANCET, V389, P2492, DOI 10.1016/S0140-6736(17)31046-2; El-Serag HB, 2012, GASTROENTEROLOGY, V142, P1264, DOI 10.1053/j.gastro.2011.12.061; European Assoc Study Liver, 2012, EUR J CANCER, V48, P599, DOI 10.1016/j.ejca.2011.12.021; Feng K, 2012, J HEPATOL, V57, P794, DOI 10.1016/j.jhep.2012.05.007; Ferrer-Fabrega J, 2016, HEPATOLOGY, V63, P839, DOI 10.1002/hep.28339; Fomer A, 2014, NAT REV CLIN ONCOL, V11, P525, DOI 10.1038/nrclinonc.2014.122; Forner A, 2008, HEPATOLOGY, V47, P97, DOI 10.1002/hep.21966; Forner A, 2014, BEST PRACT RES CL GA, V28, P855, DOI 10.1016/j.bpg.2014.08.002; Forner A, 2012, LANCET, V379, P1245, DOI 10.1016/S0140-6736(11)61347-0; Fuks D, 2012, HEPATOLOGY, V55, P132, DOI 10.1002/hep.24680; Galassi M, 2013, LIVER INT, V33, P771, DOI 10.1111/liv.12124; Germani G, 2010, J HEPATOL, V52, P380, DOI 10.1016/j.jhep.2009.12.004; Golfieri R, 2014, BRIT J CANCER, V111, P255, DOI 10.1038/bjc.2014.199; Han HS, 2015, J HEPATOL, V63, P643, DOI 10.1016/j.jhep.2015.04.005; Hasegawa K, 2013, J HEPATOL, V58, P724, DOI 10.1016/j.jhep.2012.11.009; Herrero JI, 2008, LIVER TRANSPLANT, V14, P272, DOI 10.1002/lt.21368; Huang JW, 2010, ANN SURG, V252, P903, DOI 10.1097/SLA.0b013e3181efc656; IARC, FACT SHEETS POP GLOB; Iavarone M, 2011, HEPATOLOGY, V54, P2055, DOI 10.1002/hep.24644; Ioannou GN, 2013, HEPATOLOGY, V57, P249, DOI 10.1002/hep.25800; Ishizawa T, 2008, GASTROENTEROLOGY, V134, P1908, DOI 10.1053/j.gastro.2008.02.091; Johnson PJ, 2015, J CLIN ONCOL, V33, P550, DOI 10.1200/JCO.2014.57.9151; Johnson PJ, 2013, J CLIN ONCOL, V31, P3517, DOI 10.1200/JCO.2012.48.4410; Kalogeridi MA, 2015, WORLD J HEPATOL, V7, P101, DOI 10.4254/wjh.v7.i1.101; Kanwal F, 2016, CLIN GASTROENTEROL H, V14, P301, DOI 10.1016/j.cgh.2015.08.010; Khalili K, 2011, J HEPATOL, V54, P723, DOI 10.1016/j.jhep.2010.07.025; Kokudo N, 2015, HEPATOL RES, V45, DOI 10.1111/hepr.12464; Kudo M, LANCET IN PRESS; Kudo M, 2014, HEPATOLOGY, V60, P1697, DOI 10.1002/hep.27290; Lammer Johannes, 2010, Cardiovasc Intervent Radiol, V33, P41, DOI 10.1007/s00270-009-9711-7; Lee JH, 2015, GASTROENTEROLOGY, V148, P1383, DOI 10.1053/j.gastro.2015.02.055; Lencioni R, 2014, INT J CLIN PRACT, V68, P609, DOI 10.1111/ijcp.12352; Lencioni R, 2016, J HEPATOL, V64, P1090, DOI 10.1016/j.jhep.2016.01.012; Lencioni R, 2010, SEMIN LIVER DIS, V30, P52, DOI 10.1055/s-0030-1247132; Leoni S, 2010, AM J GASTROENTEROL, V105, P599, DOI 10.1038/ajg.2009.654; Li WQ, 2014, HEPATOLOGY, V60, P588, DOI 10.1002/hep.27160; Llop E, 2012, J HEPATOL, V56, P103, DOI 10.1016/j.jhep.2011.06.027; Llovet JM, 2003, HEPATOLOGY, V37, P429, DOI 10.1053/jhep.2003.50047; Llovet JM, 2002, LANCET, V359, P1734, DOI 10.1016/S0140-6736(02)08649-X; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Llovet JM, 2013, J CLIN ONCOL, V31, P3509, DOI 10.1200/JCO.2012.47.3009; Llovet JM, 2012, CLIN CANCER RES, V18, P2290, DOI 10.1158/1078-0432.CCR-11-2175; Lo CM, 2002, HEPATOLOGY, V35, P1164, DOI 10.1053/jhep.2002.33156; Lok AS, 2010, GASTROENTEROLOGY, V138, P493, DOI 10.1053/j.gastro.2009.10.031; Lok AS, 2009, GASTROENTEROLOGY, V136, P138, DOI 10.1053/j.gastro.2008.09.014; Lu LC, 2014, SEMIN LIVER DIS, V34, P427, DOI 10.1055/s-0034-1394141; Malagari K, 2012, CARDIOVASC INTER RAD, V35, P1119, DOI 10.1007/s00270-012-0394-0; Marrero JA, 2005, J HEPATOL, V42, P218, DOI 10.1016/j.jhep.2004.10.005; Marrero JA, 2009, GASTROENTEROLOGY, V137, P110, DOI 10.1053/j.gastro.2009.04.005; Mazzaferro V, 1996, NEW ENGL J MED, V334, P693, DOI 10.1056/NEJM199603143341104; Mazzaferro V, 2016, HEPATOLOGY, V63, P1707, DOI 10.1002/hep.28420; Mazzaferro V, 2013, HEPATOLOGY, V57, P1826, DOI 10.1002/hep.26014; Mazzaferro V, 2009, LANCET ONCOL, V10, P35, DOI 10.1016/S1470-2045(08)70284-5; Meyer T, 2017, LANCET GASTROENTEROL, V2, P565, DOI 10.1016/S2468-1253(17)30156-5; Morgan RL, 2013, ANN INTERN MED, V158, P329, DOI 10.7326/0003-4819-158-5-201303050-00005; Morgan TR, 2004, GASTROENTEROLOGY, V127, pS87, DOI 10.1053/j.gastro.2004.09.020; Nkontchou G, 2012, CANCER PREV RES, V5, P1007, DOI 10.1158/1940-6207.CAPR-11-0450; Papatheodoridis GV, 2015, J HEPATOL, V62, P956, DOI 10.1016/j.jhep.2015.01.002; Piana G, 2011, J HEPATOL, V55, P126, DOI 10.1016/j.jhep.2010.10.023; Pinato DJ, 2017, J HEPATOL, V66, P338, DOI 10.1016/j.jhep.2016.09.008; Pinyol R, 2017, J HEPATOL, V66, pS12, DOI 10.1016/S0168-8278(17)30287-8; Poustchi H, 2011, HEPATOLOGY, V54, P1998, DOI 10.1002/hep.24581; Prieto J, 2015, NAT REV GASTRO HEPAT, V12, P681, DOI 10.1038/nrgastro.2015.173; Qiu D, 2009, INT J CANCER, V124, P443, DOI 10.1002/ijc.23911; Reig M, 2017, SEMIN LIVER DIS, V37, P109, DOI 10.1055/s-0037-1601349; Reig M, 2014, J HEPATOL, V61, P318, DOI 10.1016/j.jhep.2014.03.030; Reig M, 2013, HEPATOLOGY, V58, P2023, DOI 10.1002/hep.26586; Rimassa L, 2017, J CLIN ONCOL, V35, DOI 10.1200/JCO.2017.35.15_suppl.4000; Rimola J, 2012, J HEPATOL, V56, P1317, DOI 10.1016/j.jhep.2012.01.004; Roayaie S, 2015, HEPATOLOGY, V62, P440, DOI 10.1002/hep.27745; Salem R, 2016, GASTROENTEROLOGY, V151, P1155, DOI 10.1053/j.gastro.2016.08.029; Sangiovanni A, 2010, GUT, V59, P638, DOI 10.1136/gut.2009.187286; Sangro B, 2011, HEPATOLOGY, V54, P868, DOI 10.1002/hep.24451; Santi V, 2010, J HEPATOL, V53, P291, DOI 10.1016/j.jhep.2010.03.010; Sapisochin G, 2017, NAT REV GASTRO HEPAT, V14, P203, DOI 10.1038/nrgastro.2016.193; Sarasin FP, 1996, AM J MED, V101, P422, DOI 10.1016/S0002-9343(96)00197-0; Schlesinger S, 2013, ANN ONCOL, V24, P2449, DOI 10.1093/annonc/mdt204; Schulze K, 2016, J HEPATOL, V65, P1031, DOI 10.1016/j.jhep.2016.05.035; Shen QJ, 2012, LANCET ONCOL, V13, P817, DOI 10.1016/S1470-2045(12)70233-4; Sherman M, 2014, BEST PRACT RES CL GA, V28, P783, DOI 10.1016/j.bpg.2014.08.008; Shiina S, 2012, AM J GASTROENTEROL, V107, P569, DOI 10.1038/ajg.2011.425; Simon TG, 2016, HEPATOLOGY, V64, P47, DOI 10.1002/hep.28506; Singal A, 2009, ALIMENT PHARM THER, V30, P37, DOI 10.1111/j.1365-2036.2009.04014.x; Singal AG, 2017, GASTROENTEROLOGY, V152, P608, DOI 10.1053/j.gastro.2016.10.042; Singal AG, 2013, AM J GASTROENTEROL, V108, P425, DOI 10.1038/ajg.2012.449; Singal AK, 2010, CLIN GASTROENTEROL H, V8, P192, DOI 10.1016/j.cgh.2009.10.026; Takayasu K, 2012, J HEPATOL, V56, P886, DOI 10.1016/j.jhep.2011.10.021; Toso C, 2015, HEPATOLOGY, V62, P158, DOI 10.1002/hep.27787; Tremosini S, 2012, GUT, V61, P1481, DOI 10.1136/gutjnl-2011-301862; Trinchet JC, 2011, HEPATOLOGY, V54, P1987, DOI 10.1002/hep.24545; Tsilidis KK, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.g7607; Tsochatzis EA, 2014, LANCET, V383, P1749, DOI 10.1016/S0140-6736(14)60121-5; Varela M, 2007, J HEPATOL, V46, P474, DOI 10.1016/j.jhep.2006.10.020; Vilana R, 2010, HEPATOLOGY, V51, P2020, DOI 10.1002/hep.23600; Vilgrain V, 2017, LANCET ONCOL, V18, P1624, DOI 10.1016/S1470-2045(17)30683-6; Wang JH, 2012, J HEPATOL, V56, P412, DOI 10.1016/j.jhep.2011.05.020; Waziry R, 2017, J HEPATOL, V67, P1204, DOI 10.1016/j.jhep.2017.07.025; Welch HG, 2010, J NATL CANCER I, V102, P605, DOI 10.1093/jnci/djq099; Yao FY, 2001, HEPATOLOGY, V33, P1394, DOI 10.1053/jhep.2001.24563; Yau T, 2014, GASTROENTEROLOGY, V146, P1691, DOI 10.1053/j.gastro.2014.02.032; Yu J, 2017, GUT, V66, P1172, DOI 10.1136/gutjnl-2016-312629; Zhang BH, 2004, J CANCER RES CLIN, V130, P417, DOI 10.1007/s00432-004-0552-0; Zhang BH, 1999, J MED SCREEN, V6, P108, DOI 10.1136/jms.6.2.108; Zhu AX, 2015, LANCET ONCOL, V16, P859, DOI 10.1016/S1470-2045(15)00050-9; Zhu AX, 2015, J CLIN ONCOL, V33, P559, DOI 10.1200/JCO.2013.53.7746; Zhu AX, 2014, JAMA-J AM MED ASSOC, V312, P57, DOI 10.1001/jama.2014.7189	143	1977	2054	58	585	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 31	2018	391	10127					1301	1314		10.1016/S0140-6736(18)30010-2	http://dx.doi.org/10.1016/S0140-6736(18)30010-2			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GB1DR	29307467				2022-12-28	WOS:000428791600028
J	Shah, R; Nayyar, M; Jovin, IS; Rashid, A; Bondy, BR; Fan, THM; Flaherty, MP; Rao, SV				Shah, Rahman; Nayyar, Mannu; Jovin, Ion S.; Rashid, Abdul; Bondy, Beatrix R.; Fan, Tai-Hwang M.; Flaherty, Michael P.; Rao, Sunil V.			Device Closure Versus Medical Therapy Alone for Patent Foramen Ovale in Patients With Cryptogenic Stroke A Systematic Review and Meta-analysis	ANNALS OF INTERNAL MEDICINE			English	Review							PERCUTANEOUS CLOSURE; TRANSCATHETER CLOSURE; ISCHEMIC-STROKE; PREVENTION; RISK	Background: The optimal strategy for preventing recurrent stroke in patients with cryptogenic stroke and patent foramen ovale (PFO) is unknown. Purpose: To compare transcatheter PFO closure with medical therapy alone for prevention of recurrent stroke in patients with PFO and cryptogenic stroke. Data Sources: PubMed and the Cochrane Library (without language restrictions) from inception to October 2017, reference lists, and abstracts from cardiology meetings. Study Selection: Randomized trials enrolling adults with PFO and cryptogenic stroke that compared stroke outcomes (main outcome) and potential harms in those receiving transcatheter device closure versus medical therapy alone. Data Extraction: Two investigators independently extracted study data and rated risk of bias. Data Synthesis: Of 5 trials, 1 was excluded because it used a device that is no longer available due to high rates of complications and failure. Four high-quality trials enrolling 2892 patients showed that PFO closure decreased the absolute risk for recurrent stroke by 3.2% (risk difference, -0.032 [95% CI, -0.050 to -0.014]) compared with medical therapy. The treatment strategies did not differ in rates of transient ischemic attack or major bleeding. Closure of PFOs was associated with higher rates of new-onset atrial fibrillation (AF) than medical therapy alone in all trials, but this outcome had marked between-trial heterogeneity (I-2 = 82.5%), and high event rates in some groups resulted in extreme values for CIs. Limitation: Heterogeneity of device type and antithrombotic therapy across trials, small numbers for some outcomes, and heterogeneous and inconclusive AF results. Conclusion: In patients with PFO and cryptogenic stroke, transcatheter device closure decreases risk for recurrent stroke compared with medical therapy alone. Because recurrent stroke rates are low even with medical therapy alone and PFO closure might affect AF risk, shared decision making is crucial for this treatment.	Univ Tennessee, Memphis, TN USA; Vet Affairs Med Ctr, Memphis, TN USA; Virginia Commonwealth Univ, Richmond, VA USA; Jackson Clin, Jackson, TN USA; Univ Tennessee, Jackson, TN USA; [Flaherty, Michael P.] Univ Louisville, Rudd Heart & Lung Bldg,201 Abraham Flexner Way, Louisville, KY 40292 USA; [Rao, Sunil V.] Duke Clin Res Inst, 2400 Pratt St, Durham, NC 27705 USA; [Shah, Rahman; Nayyar, Mannu; Bondy, Beatrix R.; Fan, Tai-Hwang M.] Univ Tennessee, Div Cardiovasc Dis, Coleman Coll Med Bldg,956 Court Ave,Suite A312, Memphis, TN 38163 USA; [Jovin, Ion S.] Virginia Commonwealth Univ, Dept Internal Med, POB 980509, Richmond, VA 23298 USA; [Rashid, Abdul] Univ Tennessee, Jackson Clin, 700 West Forest Ave, Jackson, TN 38301 USA	University of Tennessee System; University of Tennessee Health Science Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Memphis VA Medical Center; Virginia Commonwealth University; University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture; University of Louisville; Duke University; University of Tennessee System; University of Tennessee Health Science Center; Virginia Commonwealth University; University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture	Shah, R (corresponding author), Univ Tennessee, Sch Med, Div Cardiovasc Dis, Coleman Coll Med Bldg,956 Court Ave,Suite A312, Memphis, TN 38163 USA.	Shahcardiology@yahoo.com	shah, Rahman/AAR-3354-2020					Agarwal S, 2012, JACC-CARDIOVASC INTE, V5, P777, DOI 10.1016/j.jcin.2012.02.021; Carroll JD, 2013, NEW ENGL J MED, V368, P1092, DOI 10.1056/NEJMoa1301440; Cornell JE, 2014, ANN INTERN MED, V160, P267, DOI 10.7326/M13-2886; Di Tullio MR, 2007, J AM COLL CARDIOL, V49, P797, DOI 10.1016/j.jacc.2006.08.063; Farb A, 2017, NEW ENGL J MED, V377, P1006, DOI 10.1056/NEJMp1700218; Furlan AJ, 2012, NEW ENGL J MED, V366, P991, DOI 10.1056/NEJMoa1009639; Gakidou E, 2010, LANCET, V376, P959, DOI 10.1016/S0140-6736(10)61257-3; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Kent DM, 2016, J AM COLL CARDIOL, V67, P907, DOI 10.1016/j.jacc.2015.12.023; Khairy P, 2003, ANN INTERN MED, V139, P753, DOI 10.7326/0003-4819-139-9-200311040-00010; Khan AR, 2013, JACC-CARDIOVASC INTE, V6, P1316, DOI 10.1016/j.jcin.2013.08.001; Kitsios GD, 2013, STROKE, V44, P2640, DOI 10.1161/STROKEAHA.113.001773; Knapp G, 2003, STAT MED, V22, P2693, DOI 10.1002/sim.1482; Li LX, 2015, LANCET NEUROL, V14, P903, DOI 10.1016/S1474-4422(15)00132-5; Mas JL, 2017, NEW ENGL J MED, V377, P1011, DOI 10.1056/NEJMoa1705915; Meier B, 2013, NEW ENGL J MED, V368, P1083, DOI 10.1056/NEJMoa1211716; Messe SR, 2016, NEUROLOGY, V87, P815, DOI 10.1212/WNL.0000000000002961; Moher D., 2015, STATEMENT SYSTEMATIC, V4, DOI [10.1186/2046-4053-4-1, DOI 10.1186/2046-4053-4-12-S2.0-84920780781, DOI 10.14306/RENHYD.20.2.223]; Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI 10.1161/CIR.0000000000000152; Overell JR, 2000, NEUROLOGY, V55, P1172, DOI 10.1212/WNL.55.8.1172; Pickett CA, 2014, TEX HEART I J, V41, P357, DOI 10.14503/THIJ-13-3879; Rao G, 2017, CIRCULATION, V136, pE172, DOI 10.1161/CIR.0000000000000523; Rengifo-Moreno P, 2013, EUR HEART J, V34, P3342, DOI 10.1093/eurheartj/eht285; Saver JL, 2017, NEW ENGL J MED, V377, P1022, DOI 10.1056/NEJMoa1610057; Sondergaard L, 2017, NEW ENGL J MED, V377, P1033, DOI 10.1056/NEJMoa1707404; Sterne JAC, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4002; Stortecky S, 2015, EUR HEART J, V36, P120, DOI 10.1093/eurheartj/ehu292; Sutton A.J., 2000, METHODS METAANALYSIS; Sweeting MJ, 2004, STAT MED, V23, P1351, DOI 10.1002/sim.1761; Taaffe M, 2008, AM J CARDIOL, V101, P1353, DOI 10.1016/j.amjcard.2007.12.040; Thaler DE, 2012, STROKE, V43, P3147, DOI 10.1161/STROKEAHA.112.659599	32	50	53	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 6	2018	168	5					335	+		10.7326/M17-2679	http://dx.doi.org/10.7326/M17-2679			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FY2GD	29310136				2022-12-28	WOS:000426632600006
J	Bath, PM; Woodhouse, LJ; Appleton, JP; Beridze, M; Christensen, H; Dineen, RA; Duley, L; England, TJ; Flaherty, K; Havard, D; Heptinstall, S; James, M; Krishnan, K; Markus, HS; Montgomery, AA; Pocock, SJ; Randall, M; Ranta, A; Robinson, TG; Scutt, P; Venables, GS; Sprigg, N				Bath, Philip M.; Woodhouse, Lisa J.; Appleton, Jason P.; Beridze, Maia; Christensen, Hanne; Dineen, Robert A.; Duley, Lelia; England, Timothy J.; Flaherty, Katie; Havard, Diane; Heptinstall, Stan; James, Marilyn; Krishnan, Kailash; Markus, Hugh S.; Montgomery, Alan A.; Pocock, Stuart J.; Randall, Marc; Ranta, Annemarei; Robinson, Thompson G.; Scutt, Polly; Venables, Graham S.; Sprigg, Nikola		TARDIS Investigators	Antiplatelet therapy with aspirin, clopidogrel, and dipyridamole versus clopidogrel alone or aspirin and dipyridamole in patients with acute cerebral ischaemia (TARDIS): a randomised, open-label, phase 3 superiority trial	LANCET			English	Article							ACUTE STROKE; NORMAL VOLUNTEERS; MINOR STROKE; ATTACK; PREVENTION; TICAGRELOR; EFFICACY; RISK	Background Intensive antiplatelet therapy with three agents might be more effective than guideline treatment for preventing recurrent events in patients with acute cerebral ischaemia. We aimed to compare the safety and efficacy of intensive antiplatelet therapy (combined aspirin, clopidogrel, and dipyridamole) with that of guideline-based antiplatelet therapy. Methods We did an international, prospective, randomised, open-label, blinded-endpoint trial in adult participants with ischaemic stroke or transient ischaemic attack (TIA) within 48 h of onset. Participants were assigned in a 1: 1 ratio using computer randomisation to receive loading doses and then 30 days of intensive antiplatelet therapy (combined aspirin 75 mg, clopidogrel 75 mg, and dipyridamole 200 mg twice daily) or guideline-based therapy (comprising either clopidogrel alone or combined aspirin and dipyridamole). Randomisation was stratified by country and index event, and minimised with prognostic baseline factors, medication use, time to randomisation, stroke-related factors, and thrombolysis. The ordinal primary outcome was the combined incidence and severity of any recurrent stroke (ischaemic or haemorrhagic; assessed using the modified Rankin Scale) or TIA within 90 days, as assessed by central telephone follow-up with masking to treatment assignment, and analysed by intention to treat. This trial is registered with the ISRCTN registry, number ISRCTN47823388. Findings 3096 participants (1556 in the intensive antiplatelet therapy group, 1540 in the guideline antiplatelet therapy group) were recruited from 106 hospitals in four countries between April 7, 2009, and March 18, 2016. The trial was stopped early on the recommendation of the data monitoring committee. The incidence and severity of recurrent stroke or TIA did not differ between intensive and guideline therapy (93 [6%] partici-pants vs 105 [7%]; adjusted common odds ratio [cOR] 0.90, 95% CI 0.67-1.20, p= 0 . 47). By contrast, intensive antiplatelet therapy was associated with more, and more severe, bleeding (adjusted cOR 2 . 54, 95% CI 2.05-3.16, p<0.0001). Interpretation Among patients with recent cerebral ischaemia, intensive antiplatelet therapy did not reduce the incidence and severity of recurrent stroke or TIA, but did significantly increase the risk of major bleeding. Triple antiplatelet therapy should not be used in routine clinical practice. (c) The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license.	[Bath, Philip M.; Woodhouse, Lisa J.; Appleton, Jason P.; Flaherty, Katie; Havard, Diane; Heptinstall, Stan; Krishnan, Kailash; Scutt, Polly; Sprigg, Nikola] Univ Nottingham, Div Clin Neurosci, Stroke Trials Unit, City Hosp Campus, Nottingham NG5 1PB, England; [Dineen, Robert A.] Univ Nottingham, Div Clin Neurosci, Radiol Sci, Nottingham, England; [Duley, Lelia; Montgomery, Alan A.] Univ Nottingham, Nottingham Clin Trials Unit, Nottingham, England; [England, Timothy J.] Univ Nottingham, Div Med Sci & GEM, Vasc Med, Nottingham, England; [James, Marilyn] Univ Nottingham, Div Rehabil & Ageing, Hlth Econ, Nottingham, England; [Bath, Philip M.; Appleton, Jason P.; Krishnan, Kailash; Sprigg, Nikola] Nottingham Univ Hosp NHS, Stroke, City Hosp Campus, Nottingham, England; [Beridze, Maia] Hosp War Vet, Tbilisi, Georgia; [Christensen, Hanne] Univ Copenhagen, Dept Neurol, Bispebjerg & Frederiksberg Hosp, Copenhagen, Denmark; [Markus, Hugh S.] Univ Cambridge, Dept Clin Neurosci, Stroke Res Grp, Cambridge Biomed Campus, Cambridge, England; [Pocock, Stuart J.] London Sch Hyg & Trop Med, Dept Med Stat, London, England; [Randall, Marc] Leeds Teaching Hosp NHS Trust, Leeds Gen Infirm, Dept Neurol, Leeds, W Yorkshire, England; [Ranta, Annemarei] Wellington Hosp, Dept Neurol, Wellington, New Zealand; [Ranta, Annemarei] Univ Otago, Wellington, New Zealand; [Robinson, Thompson G.] Univ Leicester, Dept Cardiovasc Sci, Leicester, Leics, England; [Robinson, Thompson G.] Univ Leicester, NIHR Leicester Cardiovasc Res Ctr, Leicester, Leics, England; [Venables, Graham S.] Royal Hallamshire Hosp, Sheffield Teaching Hosp NHS Fdn Trust, Dept Neurol, Sheffield, S Yorkshire, England	Nottingham University Hospital NHS Trust; Nottingham City Hospital; University of Nottingham; University of Nottingham; University of Nottingham; University of Nottingham; University of Nottingham; Nottingham University Hospital NHS Trust; Nottingham City Hospital; University of Copenhagen; Bispebjerg Hospital; University of Cambridge; University of London; London School of Hygiene & Tropical Medicine; Leeds General Infirmary; University of Leeds; University of Otago; University of Leicester; University of Leicester; University of Sheffield	Bath, PM (corresponding author), Univ Nottingham, Div Clin Neurosci, Stroke Trials Unit, City Hosp Campus, Nottingham NG5 1PB, England.	philip.bath@nottingham.ac.uk	James, Marilyn/N-8129-2017; Dineen, Robert/S-7192-2019; England, Timothy J/AAD-3100-2021; Duley, Lelia/E-8107-2015; Macleod, Malcolm Robert/B-2052-2010; Bath, Philip/F-9020-2011	England, Timothy J/0000-0001-5330-8584; Duley, Lelia/0000-0001-6721-5178; Macleod, Malcolm Robert/0000-0001-9187-9839; Ranta, Annemarei/0000-0002-3223-3330; Robinson, Thompson/0000-0003-2144-2468; Randall, Marc/0000-0002-3196-182X; Brigden, Amberly/0000-0002-7958-7881; Havard, Diane/0000-0002-3257-1137; Tittle, Ashana/0000-0003-0216-7106; Woodhouse, Lisa/0000-0002-4472-1999; Krishnan, Kailash/0000-0002-6486-3783; Price, Christopher/0000-0003-3566-3157; Bath, Philip/0000-0003-2734-5132; Christensen, Hanne/0000-0002-7472-3194; Montgomery, Alan/0000-0003-0450-1606; Kruuse, Christina/0000-0002-4210-0523; Chatterjee, Kausik/0000-0002-3093-1469; Emsley, Hedley/0000-0003-0129-4488; Dineen, Robert/0000-0002-9523-2546; Sprigg, Nikola/0000-0002-5871-8168; Appleton, Jason/0000-0002-2604-4410	National Institutes of Health Research Health Technology Assessment Programme; British Heart Foundation; British Heart Foundation [PG/08/083/25779] Funding Source: researchfish; National Institute for Health Research [NF-SI-0515-10044, 10/104/24, NF-SI-0515-10054] Funding Source: researchfish	National Institutes of Health Research Health Technology Assessment Programme; British Heart Foundation(British Heart Foundation); British Heart Foundation(British Heart Foundation); National Institute for Health Research(National Institute for Health Research (NIHR))	National Institutes of Health Research Health Technology Assessment Programme, British Heart Foundation.	Amarenco P, 2017, LANCET NEUROL, V16, P301, DOI 10.1016/S1474-4422(17)30038-8; Ankolekar S, 2014, J STROKE CEREBROVASC, V23, P1821, DOI 10.1016/j.jstrokecerebrovasdis.2014.04.022; BAMFORD J, 1991, LANCET, V337, P1521, DOI 10.1016/0140-6736(91)93206-O; Bath P, 2015, INT J STROKE, V10, P1159, DOI 10.1111/ijs.12538; Bath PMW, 2008, STROKE, V39, P2817, DOI 10.1161/STROKEAHA.107.509893; Bath PMW, 2017, INT J STROKE, V12, P524, DOI 10.1177/1747493016677988; Bath PMW, 2015, INT J STROKE, V10, P449, DOI 10.1111/ijs.12445; Bath PMW, 2015, LANCET, V385, P617, DOI 10.1016/S0140-6736(14)61121-1; Benavente OR, 2012, NEW ENGL J MED, V367, P817, DOI 10.1056/NEJMoa1204133; Chen ZM, 1997, LANCET, V349, P1641, DOI 10.1016/S0140-6736(97)04010-5; Diener HC, 1996, J NEUROL SCI, V143, P1, DOI 10.1016/S0022-510X(96)00308-5; Dienert HC, 2008, LANCET NEUROL, V7, P875, DOI 10.1016/S1474-4422(08)70198-4; Geeganage CM, 2012, STROKE, V43, P1058, DOI 10.1161/STROKEAHA.111.637686; Gent M, 1996, LANCET, V348, P1329, DOI 10.1016/s0140-6736(96)09457-3; Halkes PHA, 2006, LANCET, V367, P1665; Johnston SC, 2007, LANCET, V369, P283, DOI 10.1016/S0140-6736(07)60150-0; Johnston SC, 2016, NEW ENGL J MED, V375, P35, DOI 10.1056/NEJMoa1603060; Lees KR, 2012, STROKE, V43, P1163, DOI 10.1161/STROKEAHA.111.641423; Optimising Anal Stroke Trials OAST, 2008, INT J STROKE, V3, P78, DOI 10.1111/j.1747-4949.2008.00184.x; Rothwell PM, 2007, LANCET, V370, P1432, DOI 10.1016/S0140-6736(07)61448-2; Sandercock P, 1997, LANCET, V349, P1569; Schulman S, 2005, J THROMB HAEMOST, V3, P692, DOI 10.1111/j.1538-7836.2005.01204.x; Sprigg N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002852; Wang YJ, 2013, NEW ENGL J MED, V369, P11, DOI 10.1056/NEJMoa1215340; Weir CJ, 2003, STAT MED, V22, P705, DOI 10.1002/sim.1366; Willmot Mark, 2004, J Stroke Cerebrovasc Dis, V13, P138, DOI 10.1016/j.jstrokecerebrovasdis.2004.03.001; Wong KSL, 2013, CIRCULATION, V128, P1656, DOI 10.1161/CIRCULATIONAHA.113.003187; Zhao L, 2006, PLATELETS, V17, P100, DOI 10.1080/09537100500235966; Zhao L, 2005, THROMB HAEMOSTASIS, V93, P527, DOI 10.1160/TH04-09-0559; Zhao L, 2001, BRIT J PHARMACOL, V134, P353, DOI 10.1038/sj.bjp.0704248	30	87	89	0	12	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 3	2018	391	10123					850	859		10.1016/S0140-6736(17)32849-0	http://dx.doi.org/10.1016/S0140-6736(17)32849-0			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FX9XF	29274727	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000426463500022
J	Frakt, AB; Chernew, ME				Frakt, Austin B.; Chernew, Michael E.			The Importance of Relative Prices in Health Care Spending	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Frakt, Austin B.] Boston Univ, Sch Publ Hlth, VA Boston Healthcare Syst, Boston, MA USA; [Frakt, Austin B.] Harvard TH Chan Sch Publ Hlth, Boston, MA USA; [Chernew, Michael E.] Harvard Med Sch, Boston, MA USA	Boston University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School	Frakt, AB (corresponding author), VA Boston Healthcare Syst, 150 S Huntington Ave,Mail Stop 152H, Boston, MA 02130 USA.	frakt@bu.edu		Frakt, Austin/0000-0002-0795-5462	American Hospital Association; Anthem Health Insurance; Janssen Pharmaceuticals; Madalena Consulting; Merck Co; Milliman; Pfizer; PhRMA; Precision Health Economics; state of North Carolina; Takeda Pharmaceuticals; University of Michigan; White Case; Elsevier; Intellisphere; Laura and John Arnold Foundation; Commonwealth Fund; CareFirst; MedPAC	American Hospital Association; Anthem Health Insurance; Janssen Pharmaceuticals(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Madalena Consulting; Merck Co(Merck & Company); Milliman; Pfizer(Pfizer); PhRMA; Precision Health Economics; state of North Carolina; Takeda Pharmaceuticals(Takeda Pharmaceutical Company Ltd); University of Michigan(University of Michigan System); White Case; Elsevier; Intellisphere; Laura and John Arnold Foundation; Commonwealth Fund; CareFirst; MedPAC	Both authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Chernew reported having equity in V-BID Health, Virta Health, and Paladin Healthcare Capital. He sits on the board of advisors for The Commonwealth Fund, Paladin Healthcare Capital, the National Institute for Health Care Management, and Archway Health. He has received payment for consultancy from the American Hospital Association, Anthem Health Insurance, Janssen Pharmaceuticals, Madalena Consulting, Merck & Co, Milliman, Pfizer, PhRMA, Precision Health Economics, the state of North Carolina, Takeda Pharmaceuticals, the University of Michigan, and White & Case. He has received speaking honoraria from AcademyHealth, America's Health Insurance Plans, AmerisourceBergen, the California Association of Health Plans, DuPage Medical Group, Health Information and Management Systems Society, Madinah Institute for Leadership and Entrepreneurship, Milliman, Nielsen Holdings, Q1 Productions, RetNet Forum, and Teva Pharmaceuticals. He has also received payment for editorial services from Elsevier and Intellisphere and has research funding from the Laura and John Arnold Foundation, The Commonwealth Fund, CareFirst, and MedPAC. Dr Frakt reported no disclosure.	Anderson GF, 2003, HEALTH AFFAIR, V22, P89, DOI 10.1377/hlthaff.22.3.89; Brot-Goldberg ZC, 2017, Q J ECON, V132, P1261, DOI 10.1093/qje/qjx013; Chen C, 2014, JAMA-J AM MED ASSOC, V311, P673, DOI 10.1001/jama.2014.11; Cooper Z., 2017, POLITICS HOSP BEHAV; Elshaug AG, 2017, LANCET, V390, P191, DOI 10.1016/S0140-6736(16)32586-7; Hayek FA, 1945, AM ECON REV, V35, P519; Medicare Payment Advisory Commission, 2013, C MED PAYM POL; Medicare Payment Advisory Committee, 2015, JUNE 2015 REPORT; Sinsky CA, 2013, JAMA INTERN MED, V173, P1733, DOI 10.1001/jamainternmed.2013.9257	9	13	14	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 6	2018	319	5					441	442		10.1001/jama.2017.20047	http://dx.doi.org/10.1001/jama.2017.20047			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FV0CW	29302693				2022-12-28	WOS:000424224500009
J	Gee, MH; Han, A; Lofgren, SM; Beausang, JF; Mendoza, JL; Birnbaum, ME; Bethune, MT; Fischer, S; Yang, XB; Gomez-Eerland, R; Bingham, DB; Sibener, LV; Fernandes, RA; Velasco, A; Baltimore, D; Schumacher, TN; Khatri, P; Quake, SR; Davis, MM; Garcia, KC				Gee, Marvin H.; Han, Arnold; Lofgren, Shane M.; Beausang, John F.; Mendoza, Juan L.; Birnbaum, Michael E.; Bethune, Michael T.; Fischer, Suzanne; Yang, Xinbo; Gomez-Eerland, Raquel; Bingham, David B.; Sibener, Leah V.; Fernandes, Ricardo A.; Velasco, Andrew; Baltimore, David; Schumacher, Ton N.; Khatri, Purvesh; Quake, Stephen R.; Davis, Mark M.; Garcia, K. Christopher			Antigen Identification for Orphan T Cell Receptors Expressed on Tumor-Infiltrating Lymphocytes	CELL			English	Article							PEPTIDE-MHC; GENE-THERAPY; CANCER; SPECIFICITY; RECOGNITION; LIGANDS; LIBRARY; NEOANTIGENS; REPERTOIRE; MUTATIONS	The immune system can mount T cell responses against tumors; however, the antigen specificities of tumor-infiltrating lymphocytes (TILs) are not well understood. We used yeast-display libraries of peptide-human leukocyte antigen (pHLA) to screen for antigens of "orphan" T cell receptors (TCRs) expressed on TILs from human colorectal adenocarcinoma. Four TIL-derived TCRs exhibited strong selection for peptides presented in a highly diverse pHLA-A*02:01 library. Three of the TIL TCRs were specific for non-mutated self-antigens, two of which were present in separate patient tumors, and shared specificity for a non-mutated self-antigen derived from U2AF2. These results show that the exposed recognition surface of MHC-bound peptides accessible to the TCR contains sufficient structural information to enable the reconstruction of sequences of peptide targets for pathogenic TCRs of unknown specificity. This finding underscores the surprising specificity of TCRs for their cognate antigens and enables the facile indentification of tumor antigens through unbiased screening.	[Gee, Marvin H.; Birnbaum, Michael E.; Sibener, Leah V.] Stanford Univ, Sch Med, Program Immunol, Stanford, CA 94305 USA; [Gee, Marvin H.; Mendoza, Juan L.; Birnbaum, Michael E.; Fischer, Suzanne; Yang, Xinbo; Sibener, Leah V.; Fernandes, Ricardo A.; Velasco, Andrew; Garcia, K. Christopher] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Gee, Marvin H.; Mendoza, Juan L.; Birnbaum, Michael E.; Fischer, Suzanne; Yang, Xinbo; Sibener, Leah V.; Fernandes, Ricardo A.; Velasco, Andrew; Garcia, K. Christopher] Stanford Univ, Sch Med, Dept Struct Biol, Stanford, CA 94305 USA; [Han, Arnold; Lofgren, Shane M.; Khatri, Purvesh; Davis, Mark M.] Stanford Univ, Sch Med, Inst Immun Transplantat & Infect, Stanford, CA 94305 USA; [Han, Arnold; Davis, Mark M.] Stanford Univ, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA; [Lofgren, Shane M.; Bingham, David B.; Khatri, Purvesh] Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA; [Beausang, John F.; Quake, Stephen R.] Stanford Univ, Sch Med, Dept Bioengn, Stanford, CA 94305 USA; [Bethune, Michael T.; Baltimore, David] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA; [Gomez-Eerland, Raquel; Schumacher, Ton N.] Netherlands Canc Inst, Div Immunol, Amsterdam, Netherlands; [Quake, Stephen R.] Chan Zuckerberg Biohub, San Francisco, CA 94158 USA; [Davis, Mark M.; Garcia, K. Christopher] Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; California Institute of Technology; Netherlands Cancer Institute; Howard Hughes Medical Institute; Stanford University	Garcia, KC (corresponding author), Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA.; Garcia, KC (corresponding author), Stanford Univ, Sch Med, Dept Struct Biol, Stanford, CA 94305 USA.; Garcia, KC (corresponding author), Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA.	kcgarcia@stanford.edu	Fernandes, Ricardo/AAB-8165-2019; Schumacher, Ton/Y-2432-2019	Fernandes, Ricardo/0000-0001-5343-3334; Schumacher, Ton/0000-0003-0517-8804; Birnbaum, Michael/0000-0002-2281-3518; Khatri, Purvesh/0000-0002-4143-4708; Davis, Mark/0000-0001-6868-657X; Mendoza, Juan/0000-0001-6972-7476	Stanford Graduate Research Fellowship; NIH [CA216926-01]; Jane Coffin Childs Postdoctoral Fellowship; NIH award [CA175127]; NIH grants [DK100739, AI103867, 32681-05]; Bill and Melinda Gates Foundation; National Institute for Allergy and Infectious Diseases [1U19AI109662, U19AI057229, U54I117925, 1R01AI125197]; Dutch Cancer Society Queen Wilhelmina [2013-6122]; K.G. Jebsen Foundation; Howard Hughes Medical Institute; Parker Institute for Cancer Immunotherapy; NATIONAL CANCER INSTITUTE [K01CA175127, P01CA132681, P30CA124435, F31CA216926] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI109662, U19AI057229, R01AI125197, R01AI048540, T32AI007290, R01AI103867] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK100739] Funding Source: NIH RePORTER	Stanford Graduate Research Fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jane Coffin Childs Postdoctoral Fellowship; NIH award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); National Institute for Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Dutch Cancer Society Queen Wilhelmina; K.G. Jebsen Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Parker Institute for Cancer Immunotherapy; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Trevor Hinshaw and Chris Bolen for technical assistance; Jonathan Sockolosky, Naresha Saligrama, Fan Zhao, and Francesco Vallania for helpful discussions; Luke Lee for providing cell lines; and Molly Uyeda and Eric Smith for graphical designs. M.H.G. was supported by a Stanford Graduate Research Fellowship and an NIH grant (CA216926-01). M.T.B. was supported by a Jane Coffin Childs Postdoctoral Fellowship. J.L.M. was supported by an NIH award (CA175127). This work was supported by NIH grants (DK100739 to A.H.; AI103867 to K.C.G.; 32681-05 to D.B.), the Bill and Melinda Gates Foundation, the National Institute for Allergy and Infectious Diseases (1U19AI109662, U19AI057229, U54I117925, and 1R01AI125197 to P.K.), Dutch Cancer Society Queen Wilhelmina (2013-6122), and the K.G. Jebsen Foundation (to T.N.S.), the Howard Hughes Medical Institute (to K.C.G. and M.M.D.), and Parker Institute for Cancer Immunotherapy (to K.C.G. and M.M.D.).	Aakre CD, 2015, CELL, V163, P594, DOI 10.1016/j.cell.2015.09.055; Abelin JG, 2017, IMMUNITY, V46, P315, DOI 10.1016/j.immuni.2017.02.007; Adams JJ, 2016, NAT IMMUNOL, V17, P87, DOI 10.1038/ni.3310; Adams JJ, 2011, IMMUNITY, V35, P681, DOI 10.1016/j.immuni.2011.09.013; Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Beringer DX, 2015, NAT IMMUNOL, V16, P1153, DOI 10.1038/ni.3271; Bethune MT, 2017, BIOTECHNIQUES, V62, P123, DOI 10.2144/000114525; Birnbaum ME, 2014, CELL, V157, P1073, DOI 10.1016/j.cell.2014.03.047; Birnbaum ME, 2012, IMMUNOL REV, V250, P82, DOI 10.1111/imr.12006; Boder ET, 2000, METHOD ENZYMOL, V328, P430, DOI 10.1016/S0076-6879(00)28410-3; Borbulevych OY, 2011, J IMMUNOL, V187, P2453, DOI 10.4049/jimmunol.1101268; Boulter JM, 2003, PROTEIN ENG, V16, P707, DOI 10.1093/protein/gzg087; Brim H., 2016, NEXT GENER SEQ APPL, V3, P3; Buhrman JD, 2013, IMMUNOL RES, V55, P34, DOI 10.1007/s12026-012-8348-9; Chung IF, 2016, NUCLEIC ACIDS RES, V44, pD975, DOI 10.1093/nar/gkv1314; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Cole DK, 2010, J IMMUNOL, V185, P2600, DOI 10.4049/jimmunol.1000629; DAVIS MM, 1988, NATURE, V334, P395, DOI 10.1038/334395a0; FALK K, 1991, NATURE, V351, P290, DOI 10.1038/351290a0; Garraway LA, 2013, CELL, V153, P17, DOI 10.1016/j.cell.2013.03.002; Gibbs GM, 2008, ENDOCR REV, V29, P865, DOI 10.1210/er.2008-0032; Glanville J, 2017, NATURE, V547, P94, DOI 10.1038/nature22976; Glanville J, 2009, P NATL ACAD SCI USA, V106, P20216, DOI 10.1073/pnas.0909775106; Gonzalez-Galarza FF, 2015, NUCLEIC ACIDS RES, V43, pD784, DOI 10.1093/nar/gku1166; Graubert TA, 2012, NAT GENET, V44, P53, DOI 10.1038/ng.1031; Gros A, 2016, NAT MED, V22, P433, DOI 10.1038/nm.4051; Gros A, 2014, J CLIN INVEST, V124, P2246, DOI [10.1172/JC173639, 10.1172/JCI73639]; Guda K, 2015, P NATL ACAD SCI USA, V112, P1149, DOI 10.1073/pnas.1417064112; Han A, 2014, NAT BIOTECHNOL, V32, P684, DOI 10.1038/nbt.2938; Hansen Ted, 2009, Curr Protoc Immunol, VChapter 17, DOI 10.1002/0471142735.im1705s87; Hassan C, 2015, J BIOL CHEM, V290, P2593, DOI 10.1074/jbc.M114.607028; Hassan C, 2013, MOL CELL PROTEOMICS, V12, P1829, DOI 10.1074/mcp.M112.024810; Hiemstra HS, 1997, P NATL ACAD SCI USA, V94, P10313, DOI 10.1073/pnas.94.19.10313; Johnson LA, 2009, BLOOD, V114, P535, DOI 10.1182/blood-2009-03-211714; Kreiter S, 2015, NATURE, V520, P692, DOI 10.1038/nature14426; LeCun Y, 2015, NATURE, V521, P436, DOI 10.1038/nature14539; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liepe J, 2016, SCIENCE, V354, P354, DOI 10.1126/science.aaf4384; Linnemann C, 2013, NAT MED, V19, P1534, DOI 10.1038/nm.3359; Martin M., 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Masella AP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-31; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Munson DJ, 2016, P NATL ACAD SCI USA, V113, P8272, DOI 10.1073/pnas.1606994113; Newell EW, 2013, NAT BIOTECHNOL, V31, P623, DOI 10.1038/nbt.2593; O'Callaghan CA, 1999, ANAL BIOCHEM, V266, P9, DOI 10.1006/abio.1998.2930; OSHEA EK, 1993, CURR BIOL, V3, P658, DOI 10.1016/0960-9822(93)90063-T; Ott PA, 2017, NATURE, V547, P217, DOI 10.1038/nature22991; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rajasagi M, 2014, BLOOD, V124, P453, DOI 10.1182/blood-2014-04-567933; Raman MCC, 2016, SCI REP-UK, V6, DOI 10.1038/srep18851; Rammensee HG, 1999, IMMUNOGENETICS, V50, P213, DOI 10.1007/s002510050595; ROCK EP, 1994, J EXP MED, V179, P323, DOI 10.1084/jem.179.1.323; Rossjohn J, 2015, ANNU REV IMMUNOL, V33, P169, DOI 10.1146/annurev-immunol-032414-112334; Rubio-Godoy V, 2002, EUR J IMMUNOL, V32, P2292, DOI 10.1002/1521-4141(200208)32:8<2292::AID-IMMU2292>3.0.CO;2-K; Stronen E, 2016, SCIENCE, V352, P1337, DOI 10.1126/science.aaf2288; SUDO T, 1995, J IMMUNOL, V155, P4749; Tran E, 2014, SCIENCE, V344, P641, DOI 10.1126/science.1251102; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; van Buuren MM, 2014, J IMMUNOL, V192, P641, DOI 10.4049/jimmunol.1301770; Stormo Gary D, 2013, Curr Protoc Bioinformatics, V43, DOI [10.1002/0471250953.bi1110s43, 10.1002/0471250953.bi1201s43]; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; van Rooij N, 2013, J CLIN ONCOL, V31, pE439, DOI 10.1200/JCO.2012.47.7521; Wang YB, 2005, P NATL ACAD SCI USA, V102, P2476, DOI 10.1073/pnas.0409798102; Zhang P, 2016, ONCOGENE, V35, P5056, DOI 10.1038/onc.2016.67	64	153	158	5	64	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 25	2018	172	3					549	+		10.1016/j.cell.2017.11.043	http://dx.doi.org/10.1016/j.cell.2017.11.043			31	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FT9BS	29275860	Bronze, Green Accepted			2022-12-28	WOS:000423447600014
J	Wells, PS; Ihaddadene, R; Reilly, A; Forgie, MA				Wells, Philip S.; Ihaddadene, Ryma; Reilly, Aoife; Forgie, Melissa Anne			Diagnosis of Venous Thromboembolism: 20 Years of Progress	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							DEEP-VEIN THROMBOSIS; SUSPECTED PULMONARY-EMBOLISM; D-DIMER TEST; COMPUTED-TOMOGRAPHY; PRETEST PROBABILITY; RISK-FACTORS; EMERGENCY-DEPARTMENT; CLINICAL PROBABILITY; RULE; ULTRASONOGRAPHY	Many guidelines suggest incorporating clinical assessment, imaging, and D-dimer testing into diagnostic algorithms in patients with suspected deep venous thrombosis (DVT) and pulmonary embolism (PE). This special article reviews the evidence supporting the use of algorithms and their individual components for diagnosis of upper- and lower-extremity DVT and PE in adults, including pregnant women. The authors identified evidence through several electronic database searches to April 2017, evaluated the robustness of selected evidence, assessed whether diagnostic approaches that do not use algorithms are acceptable, and identified knowledge gaps that require further research.	[Wells, Philip S.; Ihaddadene, Ryma; Reilly, Aoife; Forgie, Melissa Anne] Ottawa Hosp, Dept Med, Gen Campus,501 Smyth Rd,Box 206, Ottawa, ON K1H 8L6, Canada	University of Ottawa; Ottawa Hospital Research Institute	Wells, PS (corresponding author), Ottawa Hosp, Dept Med, Gen Campus,501 Smyth Rd,Box 206, Ottawa, ON K1H 8L6, Canada.	pwells@toh.ca						Abdalla G, 2015, CLIN RADIOL, V70, P858, DOI 10.1016/j.crad.2015.04.007; Ageno W, 2013, J THROMB HAEMOST, V11, P1597, DOI 10.1111/jth.12301; Ambid-Lacombe C, 2009, J MAL VASCUL, V34, P211, DOI 10.1016/j.jmv.2009.02.004; Anderson DR, 2007, JAMA-J AM MED ASSOC, V298, P2743, DOI 10.1001/jama.298.23.2743; Bates SM, 2012, CHEST, V141, pE351S, DOI 10.1378/chest.11-2299; Bauld DL, 1999, AM J EMERG MED, V17, P11, DOI 10.1016/S0735-6757(99)90004-9; BAYES T, 1991, M D COMPUT, V8, P157; Bernardi E, 1998, BRIT MED J, V317, P1037; Bernardi E, 2008, JAMA-J AM MED ASSOC, V300, P1653, DOI 10.1001/jama.300.14.1653; BUIler HR, 2009, ANN INTERN MED, V150, P229; Carrier M, 2010, J THROMB HAEMOST, V8, P1716, DOI 10.1111/j.1538-7836.2010.03938.x; Ceriani E, 2010, J THROMB HAEMOST, V8, P957, DOI 10.1111/j.1538-7836.2010.03801.x; Chunilal SD, 2003, JAMA-J AM MED ASSOC, V290, P2849, DOI 10.1001/jama.290.21.2849; Di Marca S, 2015, J AM GERIATR SOC, V63, P1091, DOI 10.1111/jgs.13459; Di Nisio M, 2007, J THROMB HAEMOST, V5, P296, DOI 10.1111/j.1538-7836.2007.02328.x; Douma RA, 2010, THROMB RES, V126, pE271, DOI 10.1016/j.thromres.2010.07.008; Valls MJF, 2015, THROMB HAEMOSTASIS, V113, P406, DOI 10.1160/TH14-06-0488; Geersing GJ, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2990; Gibson NS, 2009, J THROMB HAEMOST, V7, P2035, DOI 10.1111/j.1538-7836.2009.03635.x; Gibson NS, 2008, THROMB HAEMOSTASIS, V99, P229, DOI 10.1160/TH07-05-0321; Goodacre S, 2005, ANN INTERN MED, V143, P129, DOI 10.7326/0003-4819-143-2-200507190-00012; Goodacre S, 2005, BMC EMERG MED, V5, DOI 10.1186/1471-227X-5-6; Hamadah A, 2011, J THROMB HAEMOST, V9, P2406, DOI 10.1111/j.1538-7836.2011.04533.x; Hayashino Y, 2005, RADIOLOGY, V234, P740, DOI 10.1148/radiol.2343031009; Heit JA, 2000, ARCH INTERN MED, V160, P761, DOI 10.1001/archinte.160.6.761; HENRY JW, 1995, CHEST, V107, P1375, DOI 10.1378/chest.107.5.1375; HULL R, 1981, ANN INTERN MED, V94, P12, DOI 10.7326/0003-4819-94-1-12; Jiang LB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129909; Johnson SA, 2010, JAMA-J AM MED ASSOC, V303, P438, DOI 10.1001/jama.2010.43; Karande GY, 2016, CARDIOVASC DIAGN THE, V6, P493, DOI 10.21037/cdt.2016.12.06; Kleinjan A, 2014, ANN INTERN MED, V160, P451, DOI 10.7326/M13-2056; Kline JA, 2004, J THROMB HAEMOST, V2, P1247, DOI 10.1111/j.1538-7836.2004.00790.x; Kucher N, 2011, NEW ENGL J MED, V364, P861, DOI 10.1056/NEJMcp1008740; Le Roux PY, 2012, NUCL MED COMMUN, V33, P695, DOI 10.1097/MNM.0b013e328352c7d2; Linkins LA, 2013, ANN INTERN MED, V158, P93, DOI 10.7326/0003-4819-158-2-201301150-00003; Lucassen W, 2011, ANN INTERN MED, V155, P448, DOI 10.7326/0003-4819-155-7-201110040-00007; Luxembourg B, 2012, THROMB HAEMOSTASIS, V107, P369, DOI 10.1160/TH11-07-0511; Mos ICM, 2009, J THROMB HAEMOST, V7, P1491, DOI 10.1111/j.1538-7836.2009.03518.x; Nijkeuter M, 2006, J THROMB HAEMOST, V4, P496, DOI 10.1111/j.1538-7836.2005.01779.x; Oudega R, 2005, THROMB HAEMOSTASIS, V94, P200, DOI 10.1160/TH04-12-0829; Pasha SM, 2010, THROMB RES, V125, pE123, DOI 10.1016/j.thromres.2009.11.009; Pena E, 2012, J THROMB HAEMOST, V10, P496, DOI 10.1111/j.1538-7836.2011.04612.x; Penaloza A, 2007, THROMB RES, V120, P173, DOI 10.1016/j.thromres.2006.09.001; Penaloza A, 2011, THROMB RES, V127, P81, DOI 10.1016/j.thromres.2010.10.026; Phillips JJ, 2015, EUR J RADIOL, V84, P1392, DOI 10.1016/j.ejrad.2015.03.013; Pomero F, 2013, THROMB HAEMOSTASIS, V109, P137, DOI 10.1160/TH12-07-0473; Prandoni P, 1997, ARCH INTERN MED, V157, P57, DOI 10.1001/archinte.157.1.57; Ray J G, 1999, Obstet Gynecol Surv, V54, P265, DOI 10.1097/00006254-199904000-00023; Raymakers AJN, 2014, J THORAC IMAG, V29, P209, DOI 10.1097/RTI.0b013e3182999e41; Righini M, 2008, LANCET, V371, P1343, DOI 10.1016/S0140-6736(08)60594-2; Righini M, 2014, JAMA-J AM MED ASSOC, V311, P1117, DOI 10.1001/jama.2014.2135; Rodger MA, 2005, THROMB RES, V116, P101, DOI 10.1016/j.thromres.2004.10.011; Rodrigues JD, 2016, J THROMB HAEMOST, V14, P1765, DOI 10.1111/jth.13407; Roy PM, 2006, ANN INTERN MED, V144, P157, DOI 10.7326/0003-4819-144-3-200602070-00003; Runyon MS, 2005, ACAD EMERG MED, V12, P587, DOI 10.1197/j.aem.2005.02.010; Schouten HJ, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2492; Scottish Intercollegiate Guidelines Network, 1995, CLIN GUID CRIT APPR; Shea BJ, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-10; Siccama RN, 2011, AGEING RES REV, V10, P304, DOI 10.1016/j.arr.2010.10.005; Silveira PC, 2015, JAMA INTERN MED, V175, P1112, DOI 10.1001/jamainternmed.2015.1687; Simpson EL, 2001, BRIT J OBSTET GYNAEC, V108, P56, DOI 10.1111/j.1471-0528.2001.00004.x; Singh B, 2013, EMERG MED J, V30, P701, DOI 10.1136/emermed-2012-201730; Sostman HD, 2008, RADIOLOGY, V246, P941, DOI 10.1148/radiol.2463070270; Squizzato A, 2017, THROMB RES, V154, P64, DOI 10.1016/j.thromres.2017.03.027; Stein PD, 2006, NEW ENGL J MED, V354, P2317, DOI 10.1056/NEJMoa052367; Stein PD, 2010, CLIN CHEST MED, V31, P611, DOI 10.1016/j.ccm.2010.07.001; Szucs-Farkas Z, 2014, INVEST RADIOL, V49, P201, DOI 10.1097/RLI.0000000000000016; Tan M, 2011, THROMB RES, V127, pS13, DOI 10.1016/S0049-3848(11)70005-6; Thomas SM, 2008, CLIN RADIOL, V63, P299, DOI 10.1016/j.crad.2007.09.010; van Es N, 2017, J THROMB HAEMOST, V15, P678, DOI 10.1111/jth.13630; Wells PS, 2003, NEW ENGL J MED, V349, P1227, DOI 10.1056/NEJMoa023153; Wells PS, 2006, JAMA-J AM MED ASSOC, V295, P199, DOI 10.1001/jama.295.2.199; WELLS PS, 1995, LANCET, V345, P1326, DOI 10.1016/S0140-6736(95)92535-X; Wells PS, 1997, LANCET, V350, P1795, DOI 10.1016/S0140-6736(97)08140-3; Wells PS, 2001, ANN INTERN MED, V135, P98, DOI 10.7326/0003-4819-135-2-200107170-00010; Wiener RS, 2011, ARCH INTERN MED, V171, P831, DOI 10.1001/archinternmed.2011.178; Wolf SJ, 2004, ANN EMERG MED, V44, P503, DOI 10.1016/j.annemergmed.2004.04.002; 1990, JAMA, V263, P2753	78	21	25	1	9	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 16	2018	168	2					131	+		10.7326/M17-0291	http://dx.doi.org/10.7326/M17-0291			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FU8IN	29310137				2022-12-28	WOS:000424096600017
J	Imamovic, L; Ellabaan, MMH; Machado, AMD; Citterio, L; Wulff, T; Molin, S; Johansen, HK; Sommer, MOA				Imamovic, Lejla; Ellabaan, Mostafa Mostafa Hashim; Machado, Ana Manuel Dantas; Citterio, Linda; Wulff, Tune; Molin, Soren; Johansen, Helle Krogh; Sommer, Morten Otto Alexander			Drug-Driven Phenotypic Convergence Supports Rational Treatment Strategies of Chronic Infections	CELL			English	Article							GRAM-NEGATIVE BACTERIA; HIGH-LEVEL RESISTANCE; PSEUDOMONAS-AERUGINOSA; CYSTIC-FIBROSIS; COLLATERAL SENSITIVITY; EVOLUTION; ADAPTATION; PROTEOMICS; PEPTIDES; STRAINS	Chronic Pseudomonas aeruginosa infections evade antibiotic therapy and are associated with mortality in cystic fibrosis (CF) patients. We find that in vitro resistance evolution of P. aeruginosa toward clinically relevant antibiotics leads to phenotypic convergence toward distinct states. These states are associated with collateral sensitivity toward several antibiotic classes and encoded by mutations in antibiotic resistance genes, including transcriptional regulator nfxB. Longitudinal analysis of isolates from CF patients reveals similar and defined phenotypic states, which are associated with extinction of specific sub-lineages in patients. In-depth investigation of chronic P. aeruginosa populations in a CF patient during antibiotic therapy revealed dramatic genotypic and phenotypic convergence. Notably, fluoroquinolone-resistant subpopulations harboring nfxB mutations were eradicated by antibiotic therapy as predicted by our in vitro data. This study supports the hypothesis that antibiotic treatment of chronic infections can be optimized by targeting phenotypic states associated with specific mutations to improve treatment success in chronic infections.	[Imamovic, Lejla; Ellabaan, Mostafa Mostafa Hashim; Machado, Ana Manuel Dantas; Wulff, Tune; Molin, Soren; Sommer, Morten Otto Alexander] Tech Univ Denmark, Ctr Biosustainabil, Novo Nordisk Fdn, DK-2800 Lyngby, Denmark; [Citterio, Linda] Tech Univ Denmark, Dept Bioengn, DK-2800 Lyngby, Denmark; [Johansen, Helle Krogh] Rigshosp, Dept Clin Microbiol, DK-2100 Copenhagen O, Denmark	Novo Nordisk Foundation; Technical University of Denmark; Technical University of Denmark; Rigshospitalet	Imamovic, L; Sommer, MOA (corresponding author), Tech Univ Denmark, Ctr Biosustainabil, Novo Nordisk Fdn, DK-2800 Lyngby, Denmark.	lejim@bio.dtu.dk; msom@bio.dtu.dk	Imamovic, Lejla/ABB-7301-2021	Sommer, Morten Otto Alexander/0000-0003-4005-5674; Molin, Soren/0000-0002-7973-2639	EU [638902]; Danish Council for Independent Research Sapere Aude Program DFF [4004-00213]; Novo Nordisk Foundation; Rigshospitalet Rammebevilling; RegionH rammebevilling [R144-A5287]; Lundbeck Foundation; Lundbeck Foundation [R140-2013-13496] Funding Source: researchfish; Novo Nordisk Fonden [NNF12OC1015920, NNF10CC1016517, NNF14OC0011335, NNF17OC0028232] Funding Source: researchfish; NNF Center for Biosustainability [iLoop, Bacterial Synthetic Biology, Infection Microbiology] Funding Source: researchfish	EU(European Commission); Danish Council for Independent Research Sapere Aude Program DFF; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Rigshospitalet Rammebevilling; RegionH rammebevilling; Lundbeck Foundation(Lundbeckfonden); Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Fonden(Novo Nordisk Foundation); NNF Center for Biosustainability	We thank Rasmus Lykke Marvig, Lars Jelsbak, Mari Cristina Rodriguez de Evgrafov, and Eugene Flecher for discussion and suggestions; Daniel Simon, Ulla Rydahl Johansen, and Elio Rossi for help with the storage of sputum samples; and Anna Koza for work on library preparations for population sequencing. We acknowledge the use of Pseudomonas Genome Database web resource (http://www.pseudomonas.com/). This research was funded by the EU H2020 ERC-20104-STG LimitMDR (638902) and the Danish Council for Independent Research Sapere Aude Program DFF 4004-00213. H.K.J. was funded by a clinical research stipend from The Novo Nordisk Foundation, Rigshospitalet Rammebevilling 2015-17, and RegionH rammebevilling R144-A5287. M.O.A.S. acknowledges additional funding from the Novo Nordisk Foundation and The Lundbeck Foundation.	Bantscheff M, 2007, ANAL BIOANAL CHEM, V389, P1017, DOI 10.1007/s00216-007-1486-6; Baym M, 2016, SCIENCE, V351, DOI 10.1126/science.aad3292; Bonde MT, 2016, NAT METHODS, V13, P233, DOI [10.1038/NMETH.3727, 10.1038/nmeth.3727]; Boucher HW, 2013, CLIN INFECT DIS, V56, P1685, DOI 10.1093/cid/cit152; Cabot G, 2012, ANTIMICROB AGENTS CH, V56, P6349, DOI 10.1128/AAC.01388-12; de Evgrafov MR, 2015, MOL BIOL EVOL, V32, P1175, DOI 10.1093/molbev/msv006; Esterly JS, 2012, ANTIMICROB AGENTS CH, V56, P4885, DOI 10.1128/AAC.06365-11; EUCAST, 2016, MIC CLIN BREAKP VERS; Falagas ME, 2012, ANTIMICROB AGENTS CH, V56, P4214, DOI 10.1128/AAC.00663-12; Fodor AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045001; Folkesson A, 2012, NAT REV MICROBIOL, V10, P841, DOI 10.1038/nrmicro2907; Foweraker JE, 2009, ANTIMICROB AGENTS CH, V53, P4809, DOI 10.1128/AAC.00269-09; Gibson RL, 2003, AM J RESP CRIT CARE, V168, P918, DOI 10.1164/rccm.200304-505SO; Gutu AD, 2015, ANTIMICROB AGENTS CH, V59, P5377, DOI 10.1128/AAC.00904-15; Hall MD, 2009, TRENDS PHARMACOL SCI, V30, P546, DOI 10.1016/j.tips.2009.07.003; Hauser AR, 2011, CLIN MICROBIOL REV, V24, P29, DOI 10.1128/CMR.00036-10; Imamovic L, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006609; Jansen G, 2016, EVOL MED PUBLIC HLTH, P182, DOI 10.1093/emph/eow016; Johansen HK, 2004, PEDIATR PULM, V37, P427, DOI 10.1002/ppul.10457; Lazar V, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.57; Li XZ, 2015, CLIN MICROBIOL REV, V28, P337, DOI 10.1128/CMR.00117-14; Lister PD, 2009, CLIN MICROBIOL REV, V22, P582, DOI 10.1128/CMR.00040-09; Marvig RL, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0563-9; Marvig RL, 2015, NAT GENET, V47, P57, DOI 10.1038/ng.3148; May M, 2014, NATURE, V509, pS4, DOI 10.1038/509S4a; Munck C, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009940; ONeill J, 2016, REV ANTIMICROBIAL RE; Palmer KL, 2007, J BACTERIOL, V189, P8079, DOI 10.1128/JB.01138-07; Parkins MD, 2015, J CYST FIBROS, V14, P293, DOI 10.1016/j.jcf.2015.03.012; Pittman JE, 2011, PEDIATR PULM, V46, P497, DOI 10.1002/ppul.21397; Poole K, 1996, MOL MICROBIOL, V21, P713, DOI 10.1046/j.1365-2958.1996.281397.x; Poole K, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00065; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sole M, 2015, J ANTIMICROB CHEMOTH, V70, P3004, DOI 10.1093/jac/dkv228; Taylor-Robinson D, 2012, THORAX, V67, P860, DOI 10.1136/thoraxjnl-2011-200953; Willner D, 2012, ISME J, V6, P471, DOI 10.1038/ismej.2011.104; Wong A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002928; Yang L, 2011, P NATL ACAD SCI USA, V108, P7481, DOI 10.1073/pnas.1018249108; Zhao BY, 2016, CELL, V165, P234, DOI 10.1016/j.cell.2016.01.045	40	76	78	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 11	2018	172	1-2					121	+		10.1016/j.cell.2017.12.012	http://dx.doi.org/10.1016/j.cell.2017.12.012			28	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FS5MI	29307490	Green Published, hybrid			2022-12-28	WOS:000419840100014
J	Huang, YF; Mao, K; Chen, X; Sun, MA; Kawabe, T; Li, WZ; Usher, N; Zhu, J; Urban, JF; Paul, WE; Germain, RN				Huang, Yuefeng; Mao, Kairui; Chen, Xi; Sun, Ming-an; Kawabe, Takeshi; Li, Weizhe; Usher, Nicholas; Zhu, Jinfang; Urban, Joseph F., Jr.; Paul, William E.; Germain, Ronald N.			S1P-dependent interorgan trafficking of group 2 innate lymphoid cells supports host defense	SCIENCE			English	Article							T-CELLS; TYPE-2 IMMUNITY; TUFT CELLS; INFLAMMATION; RECEPTOR; EGRESS; S1P(1)	Innate lymphoid cells (ILCs) are innate counterparts of adaptive T lymphocytes, contributing to host defense, tissue repair, metabolic homeostasis, and inflammatory diseases. ILCs have been considered to be tissue-resident cells, but whether ILCs move between tissue sites during infection has been unclear. We show here that interleukin-25- or helminth-induced inflammatory ILC2s are circulating cells that arise from resting ILC2s residing in intestinal lamina propria. They migrate to diverse tissues based on sphingosine 1-phosphate (S1P)-mediated chemotaxis that promotes lymphatic entry, blood circulation, and accumulation in peripheral sites, including the lung, where they contribute to anti-helminth defense and tissue repair. This ILC2 expansion and migration is a behavioral parallel to the antigen-driven proliferation and migration of adaptive lymphocytes to effector sites and indicates that ILCs complement adaptive immunity by providing both local and distant tissue protection during infection.	[Huang, Yuefeng; Chen, Xi; Kawabe, Takeshi; Usher, Nicholas; Zhu, Jinfang; Paul, William E.; Germain, Ronald N.] NIAID, Lab Immunol, NIH, Bethesda, MD 20892 USA; [Mao, Kairui; Li, Weizhe; Germain, Ronald N.] NIAID, Lab Syst Biol, NIH, Bethesda, MD 20892 USA; [Sun, Ming-an] Eunice Kennedy Shriver Natl Inst Child Hlth & Hu, NIH, Bethesda, MD 20892 USA; [Usher, Nicholas] Cornell Univ, Dept Undergrad Biol, Ithaca, NY 14853 USA; [Urban, Joseph F., Jr.] ARS, Diet Gen & Immunol Lab, Beltsville Human Nutr Res Ctr, USDA, Beltsville, MD 20705 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Cornell University; United States Department of Agriculture (USDA)	Huang, YF; Germain, RN (corresponding author), NIAID, Lab Immunol, NIH, Bethesda, MD 20892 USA.; Germain, RN (corresponding author), NIAID, Lab Syst Biol, NIH, Bethesda, MD 20892 USA.	yuefeng.huang@nih.gov; rgermain@niaid.nih.gov	Zhu, Jinfang/B-7574-2012; Sun, Mingan/D-7141-2019; Germain, Ronald/ABE-7090-2020; Germain, Ronald N./Z-1945-2019	Zhu, Jinfang/0000-0002-0117-4745; Sun, Mingan/0000-0002-4661-3027; Usher, Nicholas/0000-0001-8779-519X; Urban, Joseph/0000-0002-1590-8869	Intramural Research Program of NIAID, NIH; USDA [8040-51000-058-00D]; NIAID K99 award [1K99AI123350-01A1]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001034, ZIAAI001169, R00AI123350] Funding Source: NIH RePORTER	Intramural Research Program of NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); USDA(United States Department of Agriculture (USDA)); NIAID K99 award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank K. Weng, T. Moyer, and C. Henry for cell sorting; A. Moseman for technical assistance with parabiosis surgery; M. Wong for assistance with library preparation; J. M. Ward for analyzing histological sections; and the staff of the NIAID animal facility for the postoperative care of parabiotic mice. We thank E. Shevach and members of the Laboratories of Immunology and Systems Biology, NIAID, for discussions. This work was supported by the Intramural Research Program of NIAID, NIH, and by the USDA (8040-51000-058-00D). Y. Huang was also supported by a NIAID K99 award (1K99AI123350-01A1). RNA-seq data are available in the Gene Expression Omnibus database (accession number GSE104708). Y.F. designed, performed, and interpreted the majority of the experiments and drafted the manuscript. K.M. designed, performed, and interpreted confocal imaging experiments. X.C., T.K., and N.U. assisted with experiments. M.S. performed RNA-seq data analysis. W.L. assisted with image data analysis. J.Z. helped to design and interpret the experiments. J.F.U. provided N. brasiliensis and helped to design and interpret worm experiments. W.E.P. designed the experiments. R.N.G. designed the experiments, interpreted the data, and finalized the manuscript. All authors (with exception of W.E.P.) contributed to the discussion of experimental findings and preparation of the manuscript.	Allende ML, 2004, J BIOL CHEM, V279, P15396, DOI 10.1074/jbc.M314291200; Artis D, 2015, NATURE, V517, P293, DOI 10.1038/nature14189; Bal SM, 2016, NAT IMMUNOL, V17, P636, DOI 10.1038/ni.3444; Banerji S, 1999, J CELL BIOL, V144, P789, DOI 10.1083/jcb.144.4.789; Brestoff JR, 2015, NATURE, V519, P242, DOI 10.1038/nature14115; Dadi S, 2016, CELL, V164, P365, DOI 10.1016/j.cell.2016.01.002; Eberl G, 2015, SCIENCE, V348, DOI 10.1126/science.aaa6566; Gasteiger G, 2015, SCIENCE, V350, P981, DOI 10.1126/science.aac9593; Gerbe F, 2016, NATURE, V529, P226, DOI 10.1038/nature16527; HAMANN A, 1994, J IMMUNOL, V152, P3282; Howitt MR, 2016, SCIENCE, V351, P1329, DOI 10.1126/science.aaf1648; Huang YF, 2016, INT IMMUNOL, V28, P23, DOI 10.1093/intimm/dxv044; Huang YF, 2015, NAT IMMUNOL, V16, P161, DOI 10.1038/ni.3078; Klose CSN, 2016, NAT IMMUNOL, V17, P765, DOI 10.1038/ni.3489; Lee MW, 2015, CELL, V160, P74, DOI 10.1016/j.cell.2014.12.011; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Mirchandani AS, 2014, J IMMUNOL, V192, P2442, DOI 10.4049/jimmunol.1300974; Monticelli LA, 2011, NAT IMMUNOL, V12, P1045, DOI [10.1038/ni.2131, 10.1031/ni.2131]; Moro K, 2016, NAT IMMUNOL, V17, P76, DOI 10.1038/ni.3309; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Ohne Y, 2016, NAT IMMUNOL, V17, P646, DOI 10.1038/ni.3447; Oliphant CJ, 2014, IMMUNITY, V41, P283, DOI 10.1016/j.immuni.2014.06.016; Park CO, 2015, NAT MED, V21, P688, DOI 10.1038/nm.3883; Price AE, 2010, P NATL ACAD SCI USA, V107, P11489, DOI 10.1073/pnas.1003988107; Shiow LR, 2006, NATURE, V440, P540, DOI 10.1038/nature04606; Silver JS, 2016, NAT IMMUNOL, V17, P626, DOI 10.1038/ni.3443; Sonnenberg GF, 2015, NAT MED, V21, P698, DOI 10.1038/nm.3892; Svensson M, 2002, J CLIN INVEST, V110, P1113, DOI 10.1172/JCI200215988; von Moltke J, 2016, NATURE, V529, P221, DOI 10.1038/nature16161; Walzer T, 2007, NAT IMMUNOL, V8, P1337, DOI 10.1038/ni1523; Yu Y, 2016, NATURE, V539, P102, DOI 10.1038/nature20105; Zook EC, 2016, NAT IMMUNOL, V17, P775, DOI 10.1038/ni.3481	33	271	291	4	62	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 5	2018	359	6371					114	119		10.1126/science.aam5809	http://dx.doi.org/10.1126/science.aam5809			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FR8KW	29302015	Green Accepted			2022-12-28	WOS:000419324700078
J	Wu, SF; Fatemi, V; Gibson, QD; Watanabe, K; Taniguchi, T; Cava, RJ; Jarillo-Herrero, P				Wu, Sanfeng; Fatemi, Valla; Gibson, Quinn D.; Watanabe, Kenji; Taniguchi, Takashi; Cava, Robert J.; Jarillo-Herrero, Pablo			Observation of the quantum spin Hall effect up to 100 kelvin in a monolayer crystal	SCIENCE			English	Article							INSULATOR; STATE; GAP	A variety of monolayer crystals have been proposed to be two-dimensional topological insulators exhibiting the quantum spin Hall effect (QSHE), possibly even at high temperatures. Here we report the observation of the QSHE in monolayer tungsten ditelluride (WTe2) at temperatures up to 100 kelvin. In the short-edge limit, the monolayer exhibits the hallmark transport conductance, similar to e(2)/h per edge, where e is the electron charge and h is Planck's constant. Moreover, a magnetic field suppresses the conductance, and the observed Zeeman-type gap indicates the existence of a Kramers degenerate point and the importance of time-reversal symmetry for protection from elastic backscattering. Our results establish the QSHE at temperatures much higher than in semiconductor heterostructures and allow for exploring topological phases in atomically thin crystals.	[Wu, Sanfeng; Fatemi, Valla; Jarillo-Herrero, Pablo] MIT, Dept Phys, Cambridge, MA 02139 USA; [Gibson, Quinn D.; Cava, Robert J.] Princeton Univ, Dept Chem, Princeton, NJ 08544 USA; [Watanabe, Kenji; Taniguchi, Takashi] Natl Inst Mat Sci, Adv Mat Lab, 1-1 Namiki, Tsukuba, Ibaraki 3050044, Japan	Massachusetts Institute of Technology (MIT); Princeton University; National Institute for Materials Science	Wu, SF; Fatemi, V; Jarillo-Herrero, P (corresponding author), MIT, Dept Phys, Cambridge, MA 02139 USA.	swu02@mit.edu; vfatemi@mit.edu; pjarillo@mit.edu	Watanabe, Kenji/ABB-2135-2021; Jarillo-Herrero, Pablo/E-3755-2013	Watanabe, Kenji/0000-0003-3701-8119; Jarillo-Herrero, Pablo/0000-0001-8217-8213; /0000-0003-3648-7706	Air Force Research Laboratory [FA9550-16-1-0382]; Gordon and Betty Moore Foundation's Emergent Phenomena in Quantum Systems (EPiQS) Initiative [GBMF4541]; Center for Excitonics, an Energy Frontier Research Center - the U.S. Department of Energy, Basic Energy Sciences Office [DE-SC0001088]; NSF [DMR-0819762, ECS-0335765]; MIT Pappalardo Fellowship in Physics; NSF Materials Research Science and Engineering Center (MRSEC) grant [DMR-1420541]; Japan Society for the Promotion of Science (JSPS) [JP15K21722, JP25106006]	Air Force Research Laboratory; Gordon and Betty Moore Foundation's Emergent Phenomena in Quantum Systems (EPiQS) Initiative; Center for Excitonics, an Energy Frontier Research Center - the U.S. Department of Energy, Basic Energy Sciences Office(United States Department of Energy (DOE)); NSF(National Science Foundation (NSF)); MIT Pappalardo Fellowship in Physics; NSF Materials Research Science and Engineering Center (MRSEC) grant(National Science Foundation (NSF)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	We thank L. Fu and X. Qian for helpful discussions. This work was partly supported through Air Force Research Laboratory grant no. FA9550-16-1-0382 as well as the Gordon and Betty Moore Foundation's Emergent Phenomena in Quantum Systems (EPiQS) Initiative through grant no. GBMF4541 to P.J.-H. Device nanofabrication was partly supported by the Center for Excitonics, an Energy Frontier Research Center funded by the U.S. Department of Energy, Basic Energy Sciences Office, under award no. DE-SC0001088. This work made use of the Materials Research Science and Engineering Center's shared experimental facilities supported by the NSF under award no. DMR-0819762. Sample fabrication was performed in part at the Harvard Center for Nanoscale Science supported by the NSF under grant no. ECS-0335765. S.W. acknowledges the support of the MIT Pappalardo Fellowship in Physics. The WTe<INF>2</INF> crystal growth performed at Princeton University was supported by the NSF Materials Research Science and Engineering Center (MRSEC) grant DMR-1420541. Growth of hexagonal boron nitride crystals was supported by the Elemental Strategy Initiative conducted by the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan; and the Japan Society for the Promotion of Science (JSPS) Grants-in-Aid for Scientific Research (KAKENHI) through grant nos. JP15K21722 and JP25106006. The data presented in this paper are available from the corresponding authors upon reasonable request.	Bernevig BA, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.106802; Cao Y, 2015, NANO LETT, V15, P4914, DOI 10.1021/acs.nanolett.5b00648; Drozdov IK, 2014, NAT PHYS, V10, P664, DOI [10.1038/NPHYS3048, 10.1038/nphys3048]; Du LJ, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.096802; Essert S, 2015, 2D MATER, V2, DOI 10.1088/2053-1583/2/2/024005; Fatemi V, 2017, PHYS REV B, V95, DOI 10.1103/PhysRevB.95.041410; Fei ZY, 2017, NAT PHYS, V13, P677, DOI [10.1038/NPHYS4091, 10.1038/nphys4091]; Hasan MZ, 2010, REV MOD PHYS, V82, P3045, DOI 10.1103/RevModPhys.82.3045; Jia ZY, 2017, PHYS REV B, V96, DOI 10.1103/PhysRevB.96.041108; Kane CL, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.226801; Knez I, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.136603; Konig M, 2007, SCIENCE, V318, P766, DOI 10.1126/science.1148047; Konig M, 2008, J PHYS SOC JPN, V77, DOI 10.1143/JPSJ.77.031007; Li SS, 2016, SCI REP-UK, V6, DOI 10.1038/srep23242; Li TX, 2015, PHYS REV LETT, V115, DOI 10.1103/PhysRevLett.115.136804; MA EY, 2015, NAT COMMUN, V6; Maciejko J, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.155310; Maciejko J, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.256803; Murakami S, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.236805; Nichele F, 2016, NEW J PHYS, V18, DOI 10.1088/1367-2630/18/8/083005; Qi XL, 2011, REV MOD PHYS, V83, DOI 10.1103/RevModPhys.83.1057; Qian XF, 2014, SCIENCE, V346, P1344, DOI 10.1126/science.1256815; Roth A, 2009, SCIENCE, V325, P294, DOI 10.1126/science.1174736; Sabater C, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.176802; Tang SJ, 2017, NAT PHYS, V13, P683, DOI [10.1038/NPHYS4174, 10.1038/nphys4174]; Vayrynen JI, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.115309; Wang L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9892; Xu Y, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.136804; Ye F, 2016, SMALL, V12, P5802, DOI 10.1002/smll.201601207; Zheng FP, 2016, ADV MATER, V28, P4845, DOI 10.1002/adma.201600100; Zhou JJ, 2014, NANO LETT, V14, P4767, DOI 10.1021/nl501907g	31	472	481	33	370	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 5	2018	359	6371					76	79		10.1126/science.aan6003	http://dx.doi.org/10.1126/science.aan6003			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FR8KW	29302010	Green Submitted			2022-12-28	WOS:000419324700070
J	Voelker, R				Voelker, Rebecca			Opioid Withdrawal Symptoms Subside With Cranial Nerve Stimulation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	3	3	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 2	2018	319	1					14	14		10.1001/jama.2017.19313	http://dx.doi.org/10.1001/jama.2017.19313			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FR5ON	29297062				2022-12-28	WOS:000419116000005
J	Leonard, J; Morales, A; Zupancic, P; Donner, T; Esslinger, T				Leonard, Julian; Morales, Andrea; Zupancic, Philip; Donner, Tobias; Esslinger, Tihnan			Monitoring and manipulating Higgs and Goldstone modes in a supersolid quantum gas	SCIENCE			English	Article							BOSE-EINSTEIN CONDENSATE; LONG-RANGE INTERACTIONS; CHARGE-DENSITY WAVES; OPTICAL CAVITY; EXCITATIONS; TRANSITION; SCATTERING; SYMMETRY; BREAKING; LATTICE	Higgs and Goldstone modes are collective excitations of the amplitude and phase of an order parameter that is related to the breaking of a continuous symmetry. We directly studied these modes in a supersolid quantum gas created by coupling a Bose-Einstein condensate to two optical cavities, whose field amplitudes form the real and imaginary parts of a U(1)-symmetric order parameter. Monitoring the cavity fields in real time allowed us to observe the dynamics of the associated Higgs and Goldstone modes and revealed their amplitude and phase nature. We used a spectroscopic method to measure their frequencies, and we gave a tunable mass to the Goldstone mode by exploring the crossover between continuous and discrete symmetry. Our experiments link spectroscopic measurements to the theoretical concept of Higgs and Goldstone modes.	[Leonard, Julian; Morales, Andrea; Zupancic, Philip; Donner, Tobias; Esslinger, Tihnan] ETH, Inst Quantum Elect, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Donner, T (corresponding author), ETH, Inst Quantum Elect, CH-8093 Zurich, Switzerland.	donner@phys.ethz.ch	Esslinger, Tilman/M-9022-2016; Donner, Tobias/A-2845-2011	Esslinger, Tilman/0000-0002-8333-107X; Donner, Tobias/0000-0001-7016-587X; Leonard, Julian/0000-0003-3696-6870; Zupancic, Philip/0000-0002-4698-2818; Morales, Andrea/0000-0003-1222-6333	Synthetic Quantum Many-Body Systems (European Research Council advanced grant); European Union Collaborative Project TherMiQ [618074]; SBFI (Swiss State Secretariat for Education, Research and Innovation) [641122]; SNF (Swiss National Science Foundation); DACH (Deutschland, Austria, and Confoederatio Helvetica) project "Quantum Crystals of Matter and Light"	Synthetic Quantum Many-Body Systems (European Research Council advanced grant); European Union Collaborative Project TherMiQ; SBFI (Swiss State Secretariat for Education, Research and Innovation); SNF (Swiss National Science Foundation)(Swiss National Science Foundation (SNSF)); DACH (Deutschland, Austria, and Confoederatio Helvetica) project "Quantum Crystals of Matter and Light"	We thank J. Larson R. Mottl F. Piazza, and B. P. Venkatesh for fruitful discussions, and we are most grateful to W. Zwerger for his insighits and a careful reading of the manuscript. We acknowledge funding from Synthetic Quantum Many-Body Systems (European Research Council advanced grant) and the European Union Collaborative Project TherMiQ (grant agreement 618074); we also acknowledge SBFI (Swiss State Secretariat for Education, Research and Innovation) support for the Horizon2020 project QUIC (Quantum Simulations of Insulators and Conductors; grant agreement 641122) and SNF (Swiss National Science Foundation) support for the NCCR QSIT (National Centre of Competence in Research - Quantum Science and Technology) and DACH (Deutschland, Austria, and Confoederatio Helvetica) project "Quantum Crystals of Matter and Light". The data presented in this paper are available upon request to T.D.	Arkani-Hamed N, 1998, PHYS LETT B, V429, P263, DOI 10.1016/S0370-2693(98)00466-3; Asboth JK, 2004, PHYS REV A, V70, DOI 10.1103/PhysRevA.70.013414; Baksic A, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.173601; BERNSTEIN J, 1974, REV MOD PHYS, V46, P7, DOI 10.1103/RevModPhys.46.7; Endres M, 2012, NATURE, V487, P454, DOI 10.1038/nature11255; Fan JT, 2014, PHYS REV A, V89, DOI 10.1103/PhysRevA.89.023812; GOLDSTONE J, 1961, NUOVO CIMENTO, V19, P154, DOI 10.1007/BF02812722; Klinder J, 2015, PHYS REV LETT, V115, DOI 10.1103/PhysRevLett.115.230403; Landig R, 2016, NATURE, V532, P476, DOI 10.1038/nature17409; Lemoine M., 2008, INFLATIONARY COSMOLO; Leonard J, 2017, NATURE, V543, P87, DOI 10.1038/nature21067; LITTLEWOOD PB, 1981, PHYS REV LETT, V47, P811, DOI 10.1103/PhysRevLett.47.811; LIU KS, 1973, J LOW TEMP PHYS, V10, P655, DOI 10.1007/BF00655458; Measson MA, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.060503; Morrison S, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.040403; Mottl R, 2012, SCIENCE, V336, P1570, DOI 10.1126/science.1220314; Nagy D, 2008, EUR PHYS J D, V48, P127, DOI 10.1140/epjd/e2008-00074-6; Pekker D, 2015, ANNU REV CONDEN MA P, V6, P269, DOI 10.1146/annurev-conmatphys-031214-014350; Peskin M., 1995, INTRO QUANTUM FIELD; Piazza F, 2015, PHYS REV LETT, V115, DOI 10.1103/PhysRevLett.115.163601; Piazza F, 2013, ANN PHYS-NEW YORK, V339, P135, DOI 10.1016/j.aop.2013.08.015; Pino JM, 2011, PHYS REV A, V83, DOI 10.1103/PhysRevA.83.033615; Podolsky D, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.174522; Ritsch H, 2013, REV MOD PHYS, V85, P553, DOI 10.1103/RevModPhys.85.553; Ruegg C, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.205701; Sachdev S., 2011, QUANTUM PHASE TRANSI; SOORYAKUMAR R, 1980, PHYS REV LETT, V45, P660, DOI 10.1103/PhysRevLett.45.660; Stamper-Kurn DM, 1999, PHYS REV LETT, V83, P2876, DOI 10.1103/PhysRevLett.83.2876; Stenger J, 1999, PHYS REV LETT, V82, P4569, DOI 10.1103/PhysRevLett.82.4569; Varma CM, 2002, J LOW TEMP PHYS, V126, P901, DOI 10.1023/A:1013890507658; YARNELL JL, 1958, PHYS REV LETT, V1, P9, DOI 10.1103/PhysRevLett.1.9	33	86	86	3	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 15	2017	358	6369					1415	1418		10.1126/science.aan2608	http://dx.doi.org/10.1126/science.aan2608			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP8TH	29242343	Green Submitted			2022-12-28	WOS:000417918500037
J	Darrow, JJ; Brown, ECF; Kesselheim, AS				Darrow, Jonathan J.; Brown, Erin C. Fuse; Kesselheim, Aaron S.			The Regulatory Accountability Act of 2017-Implications for FDA Regulation and Public Health	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Darrow, Jonathan J.; Kesselheim, Aaron S.] Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, Program Regulat Therapeut & Law PORTAL, 75 Francis St, Boston, MA 02115 USA; [Darrow, Jonathan J.; Kesselheim, Aaron S.] Harvard Med Sch, Boston, MA 02115 USA; [Brown, Erin C. Fuse] Georgia State Univ, Coll Law, Atlanta, GA 30303 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University System of Georgia; Georgia State University	Darrow, JJ (corresponding author), Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, Program Regulat Therapeut & Law PORTAL, 75 Francis St, Boston, MA 02115 USA.; Darrow, JJ (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.		Darrow, J J/R-8365-2019	Darrow, J J/0000-0002-7351-4243; Fuse Brown, Erin/0000-0002-6821-5345				[Anonymous], 1973, FED REGISTER, V38, P19782; Leslie Kux, 2011, COMMUNICATION	2	3	3	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 1	2018	378	5					412	414		10.1056/NEJMp1711643	http://dx.doi.org/10.1056/NEJMp1711643			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FU3WP	29261363				2022-12-28	WOS:000423783200004
J	Cabrera, CR; Tanzi, L; Sanz, J; Naylor, B; Thomas, P; Cheiney, P; Tarruell, L				Cabrera, C. R.; Tanzi, L.; Sanz, J.; Naylor, B.; Thomas, P.; Cheiney, P.; Tarruell, L.			Quantum liquid droplets in a mixture of Bose-Einstein condensates	SCIENCE			English	Article							HELIUM NANODROPLETS; DYNAMICS	Quantum droplets are small clusters of atoms self-bound by the balance of attractive and repulsive forces. Here, we report on the observation of droplets solely stabilized by contact interactions in a mixture of two Bose-Einstein condensates. We demonstrate that they are several orders of magnitude more dilute than liquid helium by directly measuring their size and density via in situ imaging. We show that the droplets are stablized against collapse by quantum fluctuations and that they require a minimum atom number to be stable. Below that number, quantum pressure drives a liquid-to-gas transition that we map out as a function of interaction strength. These ultradilute isotropic liquids remain weakly interacting and constitute an ideal platform to benchmark quantum many-body theories.	[Cabrera, C. R.; Tanzi, L.; Sanz, J.; Naylor, B.; Thomas, P.; Cheiney, P.; Tarruell, L.] Barcelona Inst Sci & Technol, ICFO Inst Ciencies Foton, Castelldefels 08860, Barcelona, Spain	Barcelona Institute of Science & Technology; Universitat Politecnica de Catalunya; Institut de Ciencies Fotoniques (ICFO)	Tarruell, L (corresponding author), Barcelona Inst Sci & Technol, ICFO Inst Ciencies Foton, Castelldefels 08860, Barcelona, Spain.	leticia.tarruell@icfo.eu	Tarruell, Leticia/I-8152-2012; Tanzi, Luca/M-1809-2014; Sanz, Julio/AAF-6008-2021; Naylor, Bruno/J-9457-2017	Tarruell, Leticia/0000-0002-0564-1435; Tanzi, Luca/0000-0002-1933-5092; Sanz, Julio/0000-0002-4083-5171; Cabrera Cordova, Cesar Raymundo/0000-0003-3867-9074; Thomas, Philip/0000-0002-3378-7976; Naylor, Bruno/0000-0002-6945-9683	Fundacio Privada Cellex; European Union [MagQUPT-631633, QUIC-641122]; Spanish Ministerio de Economia y Competitividad (StrongQSIM) [FIS2014-59546-P]; Spanish Ministerio de Economia y Competitividad (Severo Ochoa) [SEV-2015-0522]; Deutsche Forschungsgemeinschaft [FOR2414]; Generalitat de Catalunya [SGR874]; Fundacion BBVA; Mexican Consejo Nacional de Ciencia y Tecnologia [402242/384738]; Spanish Ministerio de Economia y Competitividad [BES-2015-072186]; Marie Sklodowska-Curie actions [TOPDOL-657439]; Ramon y Cajal program [RYC-2015-17890]; Fundacio Privada Cellex; European Union [MagQUPT-631633, QUIC-641122]; Spanish Ministerio de Economia y Competitividad (StrongQSIM) [FIS2014-59546-P]; Spanish Ministerio de Economia y Competitividad (Severo Ochoa) [SEV-2015-0522]; Deutsche Forschungsgemeinschaft [FOR2414]; Generalitat de Catalunya [SGR874]; Fundacion BBVA; Mexican Consejo Nacional de Ciencia y Tecnologia [402242/384738]; Spanish Ministerio de Economia y Competitividad [BES-2015-072186]; Marie Sklodowska-Curie actions [TOPDOL-657439]; Ramon y Cajal program [RYC-2015-17890]	Fundacio Privada Cellex(Foundation CELLEX); European Union(European Commission); Spanish Ministerio de Economia y Competitividad (StrongQSIM); Spanish Ministerio de Economia y Competitividad (Severo Ochoa); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Generalitat de Catalunya(Generalitat de Catalunya); Fundacion BBVA(BBVA Foundation); Mexican Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Spanish Ministerio de Economia y Competitividad(Spanish Government); Marie Sklodowska-Curie actions; Ramon y Cajal program(Spanish Government); Fundacio Privada Cellex(Foundation CELLEX); European Union(European Commission); Spanish Ministerio de Economia y Competitividad (StrongQSIM); Spanish Ministerio de Economia y Competitividad (Severo Ochoa); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Generalitat de Catalunya(Generalitat de Catalunya); Fundacion BBVA(BBVA Foundation); Mexican Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Spanish Ministerio de Economia y Competitividad(Spanish Government); Marie Sklodowska-Curie actions; Ramon y Cajal program(Spanish Government)	We acknowledge insightful discussions with G. Astrakharchik, J. Boronat, A. Celi, I. Ferrier-Barbut, M. A. Garcia-March, M. Lewenstein, P. Massignan, D. Petrov, and A. Recati. We thank A. Simoni and M. Tomza for calculations of the potassium scattering lengths. We are grateful to M. Bosch, V. Brunaud, V. Lienhard, A. Munoz, L. Saemisch, J. Sastre, and I. Urtiaga for experimental assistance during the construction of the apparatus. We acknowledge funding from Fundacio Privada Cellex, European Union (MagQUPT-631633 and QUIC-641122), Spanish Ministerio de Economia y Competitividad (StrongQSIM FIS2014-59546-P and Severo Ochoa SEV-2015-0522), Deutsche Forschungsgemeinschaft (FOR2414), Generalitat de Catalunya (SGR874 and CERCA program), and Fundacion BBVA. C.R.C. acknowledges support from the Mexican Consejo Nacional de Ciencia y Tecnologia (402242/384738), J.S. from the Spanish Ministerio de Economia y Competitividad (BES-2015-072186), P.C. from the Marie Sklodowska-Curie actions (TOPDOL-657439), and L. Tarruell from the Ramon y Cajal program (RYC-2015-17890). The experimental data presented in the figures are available at http://upcommons.upc.edu/handle/2117/111148. Other materials may be requested from the corresponding author.	Baillie D, 2017, PHYS REV LETT, V119, DOI 10.1103/PhysRevLett.119.255302; Baillie D, 2016, PHYS REV A, V94, DOI 10.1103/PhysRevA.94.021602; Barranco M, 2006, J LOW TEMP PHYS, V142, P1, DOI 10.1007/s10702-005-0267-x; Bisset RN, 2016, PHYS REV A, V94, DOI 10.1103/PhysRevA.94.033619; Bradley CC, 1997, PHYS REV LETT, V78, P985, DOI 10.1103/PhysRevLett.78.985; Bulgac A, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.050402; Cappellaro A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13647-y; Chevy F, 2016, J PHYS B-AT MOL OPT, V49, DOI 10.1088/0953-4075/49/19/192001; Chomaz L, 2016, PHYS REV X, V6, DOI 10.1103/PhysRevX.6.041039; Cikojevic V, 2018, PHYS REV B, V97, DOI 10.1103/PhysRevB.97.140502; D'Errico C, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/7/223; Dalfovo F, 2001, J CHEM PHYS, V115, P10078, DOI 10.1063/1.1424926; Donley EA, 2001, NATURE, V412, P295, DOI 10.1038/35085500; Falke S, 2008, PHYS REV A, V78, DOI 10.1103/PhysRevA.78.012503; Ferrier-Barbut I, 2016, J PHYS B-AT MOL OPT, V49, DOI 10.1088/0953-4075/49/21/214004; Ferrier-Barbut I, 2016, PHYS REV LETT, V116, DOI 10.1103/PhysRevLett.116.215301; Gerton JM, 2000, NATURE, V408, P692, DOI 10.1038/35047030; Hall DS, 1998, PHYS REV LETT, V81, P1539, DOI 10.1103/PhysRevLett.81.1539; Kadau H, 2016, NATURE, V530, P194, DOI 10.1038/nature16485; LEE TD, 1957, PHYS REV, V106, P1135, DOI 10.1103/PhysRev.106.1135; Matthews MR, 1999, PHYS REV LETT, V83, P3358, DOI 10.1103/PhysRevLett.83.3358; Petrov DS, 2016, PHYS REV LETT, V117, DOI 10.1103/PhysRevLett.117.100401; Petrov DS, 2015, PHYS REV LETT, V115, DOI 10.1103/PhysRevLett.115.155302; Petrov DS, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.103201; Roy S, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.053202; Schmitt M, 2016, NATURE, V539, P259, DOI 10.1038/nature20126; Semeghini G., 2017, ARXIVORGABS171010890; Wachtler F, 2016, PHYS REV A, V94, DOI 10.1103/PhysRevA.94.043618; Wachtler F, 2016, PHYS REV A, V93, DOI 10.1103/PhysRevA.93.061603; Wenzel M, 2017, PHYS REV A, V96, DOI 10.1103/PhysRevA.96.053630	30	335	337	10	73	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 19	2018	359	6373					301	+		10.1126/science.aao5686	http://dx.doi.org/10.1126/science.aao5686			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT6BB	29242233	Green Published, Green Submitted			2022-12-28	WOS:000423236700033
J	Fink, HA; Jutkowitz, E; McCarten, JR; Hemmy, LS; Butler, M; Davila, H; Ratner, E; Calvert, C; Barclay, TR; Brasure, M; Nelson, VA; Kane, RL				Fink, Howard A.; Jutkowitz, Eric; McCarten, J. Riley; Hemmy, Laura S.; Butler, Mary; Davila, Heather; Ratner, Edward; Calvert, Collin; Barclay, Terry R.; Brasure, Michelle; Nelson, Victoria A.; Kane, Robert L.			Pharmacologic Interventions to Prevent Cognitive Decline, Mild Cognitive Impairment, and Clinical Alzheimer-Type Dementia A Systematic Review	ANNALS OF INTERNAL MEDICINE			English	Review							QUALITY-OF-LIFE; POSTMENOPAUSAL HORMONE-THERAPY; ESTROGEN PLUS PROGESTIN; CONJUGATED EQUINE ESTROGENS; ISOLATED SYSTOLIC HYPERTENSION; HEALTH INITIATIVE MEMORY; PLACEBO-CONTROLLED TRIAL; WOMENS HEALTH; DOUBLE-BLIND; RANDOMIZED-TRIAL	Background: Optimal treatment to prevent or delay cognitive decline, mild cognitive impairment (MCI), or dementia is uncertain. Purpose: To summarize current evidence on the efficacy and harms of pharmacologic interventions to prevent or delay cognitive decline, MCI, or dementia in adults with normal cognition or MCI. Data Sources: Several electronic databases from January 2009 to July 2017, bibliographies, and expert recommendations. Study Selection: English-language trials of at least 6 months' duration enrolling adults without dementia and comparing pharmacologic interventions with placebo, usual care, or active control on cognitive outcomes. Data Extraction: Two reviewers independently rated risk of bias and strength of evidence; 1 extracted data, and a second checked accuracy. Data Synthesis: Fifty-one unique trials were rated as having low to moderate risk of bias (including 3 that studied dementia medications, 16 antihypertensives, 4 diabetes medications, 2 nonsteroidal anti-inflammatory drugs [NSAIDs] or aspirin, 17 hormones, and 7 lipid-lowering agents). In persons with normal cognition, estrogen and estrogen-progestin increased risk for dementia or a combined outcome of MCI or dementia (1 trial, low strength of evidence); high-dose raloxifene decreased risk for MCI but not for dementia (1 trial, low strength of evidence); and antihypertensives (4 trials), NSAIDs (1 trial), and statins (1 trial) did not alter dementia risk (low to insufficient strength of evidence). In persons with MCI, cholinesterase inhibitors did not reduce dementia risk (1 trial, low strength of evidence). In persons with normal cognition and those with MCI, these pharmacologic treatments neither improved nor slowed decline in cognitive test performance (low to insufficient strength of evidence). Adverse events were inconsistently reported but were increased for estrogen (stroke), estrogen-progestin (stroke, coronary heart disease, invasive breast cancer, and pulmonary embolism), and raloxifene (venous thromboembolism). Limitation: High attrition, short follow-up, inconsistent cognitive outcomes, and possible selective reporting and publication. Conclusion: Evidence does not support use of the studied pharmacologic treatments for cognitive protection in persons with normal cognition or MCI.	Minneapolis VA Hlth Care Syst, Minneapolis, MN USA; [Butler, Mary; Davila, Heather; Brasure, Michelle; Nelson, Victoria A.] Univ Minnesota, Div Hlth Policy & Management, 420 Delaware St Southeast,Mayo Mem Bldg D351, Minneapolis, MN 55455 USA; [Calvert, Collin] Univ Minnesota, Div Epidemiol, 1300 South 2nd St,Room 300,West Bank Off Bldg, Minneapolis, MN 55455 USA; [Jutkowitz, Eric] Brown Univ, Sch Publ Hlth, Box G S121-6,121 South Main St,6th Floor, Providence, RI 02912 USA; HealthPartners, Minneapolis, MN USA; [Fink, Howard A.; McCarten, J. Riley; Hemmy, Laura S.; Ratner, Edward] VA Hlth Care Syst, Geriatr Res Educ & Clin Ctr, One Vet Dr,11-G, Minneapolis, MN 55417 USA; [Barclay, Terry R.] Univ Minnesota, Dept Neurol, 295 Phalen Blvd,Mailstop 41203C, St Paul, MN 55130 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Brown University; Geriatric Research Education & Clinical Center; University of Minnesota System; University of Minnesota Twin Cities	Fink, HA (corresponding author), VA Hlth Care Syst, One Vet Dr,11-G, Minneapolis, MN 55417 USA.	Howard.fink@va.gov		Davila, Heather/0000-0003-1832-7901; , Collin/0000-0003-1834-5245	AHRQ [290-2015-00008-I]	AHRQ(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	This manuscript is based on research conducted by the Minnesota Evidence-based Practice Center under AHRQ contract 290-2015-00008-I.	Agency for Healthcare Research and Quality, 2016, INT PREV COGN DECL M; Albert MS, 2011, ALZHEIMERS DEMENT, V7, P270, DOI 10.1016/j.jalz.2011.03.008; Alhola P, 2010, J OBSTET GYNAECOL RE, V36, P796, DOI 10.1111/j.1447-0756.2010.01214.x; Anderson C, 2011, LANCET NEUROL, V10, P43, DOI 10.1016/S1474-4422(10)70250-7; Anderson GL, 2004, JAMA-J AM MED ASSOC, V291, P1701, DOI 10.1001/jama.291.14.1701; APPLEGATE WB, 1994, ARCH INTERN MED, V154, P2154, DOI 10.1001/archinte.154.19.2154; Binder EF, 2001, MATURITAS, V38, P137, DOI 10.1016/S0378-5122(00)00214-0; BIRD AS, 1990, J HYPERTENS, V8, P147, DOI 10.1097/00004872-199002000-00008; Bokde ALW, 2016, PSYCHIAT RES-NEUROIM, V249, P84, DOI 10.1016/j.pscychresns.2016.01.018; Breitner J, 2015, ALZHEIMERS DEMENT, V11, P216, DOI 10.1016/j.jalz.2014.03.009; Breitner J, 2013, ALZHEIMERS DEMENT, V9, P714, DOI 10.1016/j.jalz.2012.11.012; Breitner JC, 2011, ALZHEIMERS DEMENT, V7, P402, DOI 10.1016/j.jalz.2010.12.014; Breitner JCS, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010041; Carlsson CM, 2002, DRUG AGING, V19, P793, DOI 10.2165/00002512-200219100-00008; Cheatham RA, 2009, PHYSIOL BEHAV, V98, P374, DOI 10.1016/j.physbeh.2009.06.015; Cherrier MM, 2015, AM J ALZHEIMERS DIS, V30, P421, DOI 10.1177/1533317514556874; Coker LH, 2009, NEUROLOGY, V72, P125, DOI 10.1212/01.wnl.0000339036.88842.9e; Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3; Cooper C, 2015, AM J PSYCHIAT, V172, P323, DOI 10.1176/appi.ajp.2014.14070878; Cooper C, 2013, BRIT J PSYCHIAT, V203, P255, DOI 10.1192/bjp.bp.113.127811; Cukierman-Yaffe T, 2014, LANCET DIABETES ENDO, V2, P562, DOI 10.1016/S2213-8587(14)70062-2; Daviglus ML, 2011, ARCH NEUROL-CHICAGO, V68, P1185, DOI 10.1001/archneurol.2011.100; Daviglus ML, 2010, ANN INTERN MED, V153, P176, DOI 10.7326/0003-4819-153-3-201008030-00260; Davison SL, 2013, MENOPAUSE, V20, P1020, DOI [10.1097/GME.0b013e318287474f, 10.1097/gme.0b013e318287474f]; Devi G, 2007, GENDER MED, V4, P352, DOI 10.1016/S1550-8579(07)80064-7; Doody RS, 2009, NEUROLOGY, V72, P1555, DOI 10.1212/01.wnl.0000344650.95823.03; Espeland MA, 2004, JAMA-J AM MED ASSOC, V291, P2959, DOI 10.1001/jama.291.24.2959; Espeland MA, 2013, JAMA INTERN MED, V173, P1429, DOI 10.1001/jamainternmed.2013.7727; Espeland MA, 2010, J AM GERIATR SOC, V58, P1263, DOI 10.1111/j.1532-5415.2010.02953.x; Ettinger B, 1999, JAMA-J AM MED ASSOC, V282, P637, DOI 10.1001/jama.282.7.637; Feldman HH, 2007, LANCET NEUROL, V6, P501, DOI 10.1016/S1474-4422(07)70109-6; Fogari R, 2006, J HUM HYPERTENS, V20, P177, DOI 10.1038/sj.jhh.1001964; Fogari R, 2003, J HUM HYPERTENS, V17, P781, DOI 10.1038/sj.jhh.1001613; Forette F, 1998, LANCET, V352, P1347, DOI 10.1016/S0140-6736(98)03086-4; Forette F, 2002, ARCH INTERN MED, V162, P2046, DOI 10.1001/archinte.162.18.2046; Gavrilova SIK, 2011, NEUROSCI BEHAV PHYSI, V41, P391; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Gleason CE, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001833; GOLDSTEIN G, 1990, HYPERTENSION, V15, P361, DOI 10.1161/01.HYP.15.4.361; Gorenstein C, 2011, ARCH WOMEN MENT HLTH, V14, P367, DOI 10.1007/s00737-011-0230-6; Grady D, 2002, AM J MED, V113, P543, DOI 10.1016/S0002-9343(02)01270-6; GURLAND BJ, 1988, J AM GERIATR SOC, V36, P1015, DOI 10.1111/j.1532-5415.1988.tb04369.x; Hajar I, 2013, J AM GERIATR SOC, V61, P194, DOI 10.1111/jgs.12100; Henderson VW, 2016, NEUROLOGY, V87, P699, DOI 10.1212/WNL.0000000000002980; Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928; Hildreth KL, 2015, DEMENT GER COGN D EX, V5, P51, DOI 10.1159/000371509; Iadecola C, 2016, HYPERTENSION, V68, pE67, DOI 10.1161/HYP.0000000000000053; Jack CR, 2008, NEUROBIOL AGING, V29, P1285, DOI 10.1016/j.neurobiolaging.2007.03.004; Kane R, 2017, AHRQ PUBLICATION; Kang JH, 2007, BMJ-BRIT MED J, V334, P987, DOI 10.1136/bmj.39166.597836.BE; Kantarci K, 2016, J ALZHEIMERS DIS, V53, P547, DOI 10.3233/JAD-160258; Kelley AS, 2015, ANN INTERN MED, V163, P729, DOI 10.7326/M15-0381; Koekkoek PS, 2012, J NEUROL SCI, V314, P71, DOI 10.1016/j.jns.2011.10.028; Launer LJ, 2011, LANCET NEUROL, V10, P969, DOI 10.1016/S1474-4422(11)70188-0; Ligthart SA, 2010, VASC HEALTH RISK MAN, V6, P775, DOI 10.2147/VHRM.S7343; Lithell H, 2003, J HYPERTENS, V21, P875, DOI 10.1097/00004872-200305000-00011; Luchsinger JA, 2011, J NUTR HEALTH AGING, V15, P445, DOI 10.1007/s12603-011-0057-x; Luchsinger JA, 2016, J ALZHEIMERS DIS, V51, P501, DOI 10.3233/JAD-150493; Lyketsos CG, 2007, NEUROLOGY, V68, P1800; Maki PM, 2009, MENOPAUSE, V16, P1167, DOI 10.1097/gme.0b013e3181ace484; Martin BK, 2008, ARCH NEUROL-CHICAGO, V65, P896, DOI 10.1001/archneur.2008.65.7.nct70006; Martin BK, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010033; McGuinness B, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003160.pub3; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Meng XF, 2014, J ALZHEIMERS DIS, V42, P1295, DOI 10.3233/JAD-140954; Muldoon MF, 2000, AM J MED, V108, P538, DOI 10.1016/S0002-9343(00)00353-3; Muldoon MF, 2004, AM J MED, V117, P823, DOI 10.1016/j.amjmed.2004.07.041; Nickelsen T, 1999, PSYCHONEUROENDOCRINO, V24, P115, DOI 10.1016/S0306-4530(98)00041-9; Norton S, 2014, LANCET NEUROL, V13, P788, DOI 10.1016/S1474-4422(14)70136-X; O'Brien J, 2014, EPIDEMIOL REV, V36, P83, DOI 10.1093/epirev/mxt008; Owens DK, 2010, J CLIN EPIDEMIOL, V63, P513, DOI 10.1016/j.jclinepi.2009.03.009; Parale GP, 2006, EUR J CLIN PHARMACOL, V62, P259, DOI 10.1007/s00228-005-0073-z; Patel A, 2007, LANCET, V370, P829, DOI 10.1016/S0140-6736(07)61303-8; Pefanco MA, 2007, J AM GERIATR SOC, V55, P426, DOI 10.1111/j.1532-5415.2007.01085.x; Perez-Stable EJ, 2000, AM J MED, V108, P359, DOI 10.1016/S0002-9343(00)00304-1; Peters O, 2012, J NUTR HEALTH AGING, V16, P544, DOI 10.1007/s12603-012-0062-8; Peters R, 2008, LANCET NEUROL, V7, P683, DOI 10.1016/S1474-4422(08)70143-1; Petersen RC, 2005, NEW ENGL J MED, V352, P2379, DOI 10.1056/NEJMoa050151; Petersen RC, 2004, J INTERN MED, V256, P183, DOI 10.1111/j.1365-2796.2004.01388.x; Petrella JR, 2009, AM J NEURORADIOL, V30, P411, DOI 10.3174/ajnr.A1359; Prince MJ, 1996, BMJ-BRIT MED J, V312, P801; Prins ND, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt275; Rapp SR, 2003, JAMA-J AM MED ASSOC, V289, P2663, DOI 10.1001/jama.289.20.2663; Rasgon NL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089095; Resnick SM, 2009, NEUROLOGY, V72, P135, DOI 10.1212/01.wnl.0000339037.76336.cf; Resnick SM, 2017, JAMA-J AM MED ASSOC, V317, P717, DOI 10.1001/jama.2016.21044; Resnick SM, 2009, J CLIN ENDOCR METAB, V94, P4152, DOI 10.1210/jc.2009-1340; Reynolds CF, 2011, ARCH GEN PSYCHIAT, V68, P51, DOI 10.1001/archgenpsychiatry.2010.184; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Rozzini L, 2007, INT J GERIATR PSYCH, V22, P356, DOI 10.1002/gps.1681; Salloway S, 2004, NEUROLOGY, V63, P651, DOI 10.1212/01.WNL.0000134664.80320.92; Santanello NC, 1997, J AM GERIATR SOC, V45, P8, DOI 10.1111/j.1532-5415.1997.tb00971.x; Sato N, 2013, J HYPERTENS, V31, P1245, DOI 10.1097/HJH.0b013e32835fdf60; Saxby BK, 2008, NEUROLOGY, V70, P1858, DOI 10.1212/01.wnl.0000311447.85948.78; Schuff N, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.04.005; Seaquist ER, 2013, J DIABETES COMPLICAT, V27, P485, DOI 10.1016/j.jdiacomp.2013.03.005; Shepherd J, 2002, LANCET, V360, P1623, DOI 10.1016/S0140-6736(02)11600-X; Shumaker SA, 2004, JAMA-J AM MED ASSOC, V291, P2947, DOI 10.1001/jama.291.24.2947; Shumaker SA, 2003, JAMA-J AM MED ASSOC, V289, P2651, DOI 10.1001/jama.289.20.2651; Skoog I, 2005, AM J HYPERTENS, V18, P1052, DOI 10.1016/j.amjhyper.2005.02.013; Small GW, 2008, AM J GERIAT PSYCHIAT, V16, P999, DOI 10.1097/JGP.0b013e31818cd3a4; Song Y, 2013, GERIATR GERONTOL INT, V13, P817, DOI 10.1111/ggi.12044; Starr JM, 1996, J AM GERIATR SOC, V44, P411, DOI 10.1111/j.1532-5415.1996.tb06412.x; Starr JM, 2005, J NEUROL SCI, V229, P103, DOI 10.1016/j.jns.2004.11.005; Tedesco MA, 1999, AM J HYPERTENS, V12, P1130, DOI 10.1016/S0895-7061(99)00156-9; Tendolkar I, 2012, INT J GERIATR PSYCH, V27, P49, DOI 10.1002/gps.2688; Thal LJ, 2005, NEUROPSYCHOPHARMACOL, V30, P1204, DOI 10.1038/sj.npp.1300690; Tierney MC, 2009, PSYCHONEUROENDOCRINO, V34, P1065, DOI 10.1016/j.psyneuen.2009.02.009; Trompet S, 2010, J NEUROL, V257, P85, DOI 10.1007/s00415-009-5271-7; Viswanathan M., 2012, SYSTEMATIC REV HLTH; Wahjoepramono EJ, 2016, CNS NEUROL DISORD-DR, V15, P337, DOI 10.2174/1871527315666151110125704; Wang J, 2015, J ALZHEIMERS DIS, V44, P385, DOI 10.3233/JAD-141506; Williams John W, 2010, Evid Rep Technol Assess (Full Rep), P1; Williamson JD, 2014, JAMA INTERN MED, V174, P324, DOI 10.1001/jamainternmed.2013.13656; Winblad B, 2008, NEUROLOGY, V70, P2024, DOI 10.1212/01.wnl.0000303815.69777.26; Wong WB, 2013, PHARMACOEPIDEM DR S, V22, P345, DOI 10.1002/pds.3381; Wroolie TE, 2015, AM J GERIAT PSYCHIAT, V23, P1117, DOI 10.1016/j.jagp.2015.05.009; Yaffe K, 2005, AM J PSYCHIAT, V162, P683, DOI 10.1176/appi.ajp.162.4.683; Yaffe K, 2001, NEW ENGL J MED, V344, P1207, DOI 10.1056/NEJM200104193441604; Yaffe K, 2006, ARCH NEUROL-CHICAGO, V63, P945, DOI 10.1001/archneur.63.7.945; Yodfat Y, 1996, J HUM HYPERTENS, V10, P117	121	93	99	4	52	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 2	2018	168	1					39	+		10.7326/M17-1529	http://dx.doi.org/10.7326/M17-1529			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FR5SO	29255847				2022-12-28	WOS:000419126700006
J	Koh, HK; Restuccia, R				Koh, Howard K.; Restuccia, Robert			Housing as Health	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									[Koh, Howard K.] Harvard TH Chan Sch Publ Hlth, Practice Publ Hlth Leadership, Boston, MA 02115 USA; [Koh, Howard K.] Harvard Kennedy Sch, Cambridge, MA 02138 USA; [Restuccia, Robert] Community Catalyst, Boston, MA USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University	Koh, HK (corresponding author), Harvard TH Chan Sch Publ Hlth, Practice Publ Hlth Leadership, Boston, MA 02115 USA.; Koh, HK (corresponding author), Harvard Kennedy Sch, Cambridge, MA 02138 USA.	hkoh@hsph.harvard.edu							0	13	13	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 2	2018	319	1					12	13		10.1001/jama.2017.20081	http://dx.doi.org/10.1001/jama.2017.20081			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FR5ON	29297066	Bronze			2022-12-28	WOS:000419116000003
J	Lucas, T				Lucas, Tamara			Irene Agyepong: building capacity in Ghana's public health system	LANCET			English	Biographical-Item																			0	0	0	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 23	2017	390	10114					E62	E62		10.1016/S0140-6736(17)32288-2	http://dx.doi.org/10.1016/S0140-6736(17)32288-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FQ9GF	29303725				2022-12-28	WOS:000418669800002
J	Givnish, TJ				Givnish, Thomas J.			A New World of plants	SCIENCE			English	Editorial Material									[Givnish, Thomas J.] Univ Wisconsin, Dept Bot, Madison, WI 53705 USA	University of Wisconsin System; University of Wisconsin Madison	Givnish, TJ (corresponding author), Univ Wisconsin, Dept Bot, Madison, WI 53705 USA.	givnish@wisc.edu						Ash JD, 2017, GLOBAL CHANGE BIOL, V23, P1305, DOI 10.1111/gcb.13429; Forzza RC, 2012, BIOSCIENCE, V62, P39, DOI 10.1525/bio.2012.62.1.8; Freitas L, 2016, PHYTOKEYS, P65, DOI 10.3897/phytokeys.58.5643; Givnish TJ, 2015, P ROY SOC B-BIOL SCI, V282, P171, DOI 10.1098/rspb.2015.1553; Givnish TJ, 2014, MOL PHYLOGENET EVOL, V71, P55, DOI 10.1016/j.ympev.2013.10.010; Joppa LN, 2013, SCIENCE, V341, P1100, DOI 10.1126/science.1241706; Thornhill AH, 2017, BMC BIOL, V15, DOI 10.1186/s12915-017-0435-x; Ulloa CU, 2017, SCIENCE, V358, P1614, DOI 10.1126/science.aao0398	8	6	6	1	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 22	2017	358	6370					1535	1536		10.1126/science.aar4191	http://dx.doi.org/10.1126/science.aar4191			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FQ6BO	29269460				2022-12-28	WOS:000418448000034
J	Moscou, MJ; van Esse, HP				Moscou, Matthew J.; van Esse, H. Peter			The quest for durable resistance	SCIENCE			English	Editorial Material							STEM RUST		[Moscou, Matthew J.; van Esse, H. Peter] Sainsbury Lab, Norwich Res Pk, Norwich NR4 7UH, Norfolk, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Moscou, MJ (corresponding author), Sainsbury Lab, Norwich Res Pk, Norwich NR4 7UH, Norfolk, England.	matthew.moscou@sainsbury-laboratory.ac.uk	Moscou, Matthew/D-5266-2011; van Esse, Peter/U-5304-2018	Moscou, Matthew/0000-0003-2098-6818; van Esse, Peter/0000-0002-3667-060X	BBSRC [BBS/E/J/000PR9795] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/J/000PR9795] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Chen JP, 2017, SCIENCE, V358, P1607, DOI 10.1126/science.aao4810; Dodds PN, 2010, NAT REV GENET, V11, P539, DOI 10.1038/nrg2812; Hodson DP, 2011, EUPHYTICA, V179, P93, DOI 10.1007/s10681-010-0335-4; KISLEV ME, 1982, SCIENCE, V216, P993, DOI 10.1126/science.216.4549.993; Le Mouel C, 2017, EUR REV AGRIC ECON, V44, P541, DOI 10.1093/erae/jbx006; Mago R, 2015, NAT PLANTS, V1, DOI [10.1038/nplants.2015.186, 10.1038/NPLANTS.2015.186]; McDonald BA, 2002, ANNU REV PHYTOPATHOL, V40, P349, DOI 10.1146/annurev.phyto.40.120501.101443; Meyer M, 2017, NAT PLANTS, V3, P780, DOI 10.1038/s41477-017-0017-5; Petre Benjamin, 2014, Front Plant Sci, V5, P416, DOI 10.3389/fpls.2014.00416; Raffaele S, 2012, NAT REV MICROBIOL, V10, P417, DOI 10.1038/nrmicro2790; Saintenac C, 2013, SCIENCE, V341, P783, DOI 10.1126/science.1239022; Salcedo A, 2017, SCIENCE, V358, P1604, DOI 10.1126/science.aao7294; Singh RP, 2015, PHYTOPATHOLOGY, V105, P872, DOI 10.1094/PHYTO-01-15-0030-FI; Worthington RJ, 2013, TRENDS BIOTECHNOL, V31, P177, DOI 10.1016/j.tibtech.2012.12.006; You L., 2014, SPTIAL PRODUCTION AL	15	9	10	0	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 22	2017	358	6370					1541	1542		10.1126/science.aar4797	http://dx.doi.org/10.1126/science.aar4797			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FQ6BO	29269464				2022-12-28	WOS:000418448000038
J	Maguid, E; Yannai, M; Faerman, A; Yulevich, I; Kleiner, V; Hasman, E				Maguid, Elhanan; Yannai, Michael; Faerman, Arkady; Yulevich, Igor; Kleiner, Vladimir; Hasman, Erez			Disorder-induced optical transition from spin Hall to random Rashba effect	SCIENCE			English	Article							LIGHT; SEMICONDUCTORS; PHOTONICS; ELEMENTS	Disordered structures give rise to intriguing phenomena owing to the complex nature of their interaction with light. We report on photonic spin-symmetry breaking and unexpected spin-optical transport phenomena arising from subwavelength-scale disordered geometric phase structure. Weak disorder induces a photonic spin Hall effect, observed via quantum weak measurements, whereas strong disorder leads to spin-split modes in momentum space, a random optical Rashba effect. Study of the momentum space entropy reveals an optical transition upon reaching a critical point where the structure's anisotropy axis vanishes. Incorporation of singular topology into the disordered structure demonstrates repulsive vortex interaction depending on the disorder strength. The photonic disordered geometric phase can serve as a platform for the study of different phenomena emerging from complex media involving spin-orbit coupling.	[Hasman, Erez] Technion Israel Inst Technol, Fac Mech Engn, Micro & Nanoopt Lab, IL-3200003 Haifa, Israel; Technion Israel Inst Technol, Fac Mech Engn, Russell Berrie Nanotechnol Inst, IL-3200003 Haifa, Israel	Technion Israel Institute of Technology; Technion Israel Institute of Technology	Hasman, E (corresponding author), Technion Israel Inst Technol, Fac Mech Engn, Micro & Nanoopt Lab, IL-3200003 Haifa, Israel.	mehasman@technion.ac.il		Yannai, Michael/0000-0002-8482-1871	Israel Science Foundation (ISF)	Israel Science Foundation (ISF)(Israel Science Foundation)	This research was supported, by the Israel Science Foundation (ISF). The fabrication was performed at the Micro-Nano Fabrication and Printing Unit (MNF&PU), Technion. All results are reported in the main paper and supplementary materials.	Abrahams E., 2010, 50 YEARS ANDERSON LO; AHARONOV Y, 1988, PHYS REV LETT, V60, P1351, DOI 10.1103/PhysRevLett.60.1351; Apostol A, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.093901; Berry M. V., 2000, EUR J PHYS, V1, P154; BERRY MV, 1984, PROC R SOC LON SER-A, V392, P45, DOI 10.1098/rspa.1984.0023; Bliokh KY, 2015, NAT PHOTONICS, V9, P796, DOI 10.1038/nphoton.2015.201; Bliokh KY, 2015, PHYS REP, V592, P1, DOI 10.1016/j.physrep.2015.06.003; Bliokh KY, 2015, SCIENCE, V348, P1448, DOI 10.1126/science.aaa9519; Bomzon Z, 2002, OPT LETT, V27, P1141, DOI 10.1364/OL.27.001141; Dahan N, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.136402; Ducci S, 1999, PHYS REV LETT, V83, P5210, DOI 10.1103/PhysRevLett.83.5210; DYAKONOV MI, 1971, PHYS LETT A, VA 35, P459, DOI 10.1016/0375-9601(71)90196-4; Hosten O, 2008, SCIENCE, V319, P787, DOI 10.1126/science.1152697; Ishizaka K, 2011, NAT MATER, V10, P521, DOI [10.1038/NMAT3051, 10.1038/nmat3051]; Lin DM, 2014, SCIENCE, V345, P298, DOI 10.1126/science.1253213; Pors A, 2016, SCI REP-UK, V6, DOI 10.1038/srep28448; RASHBA EI, 1960, SOV PHYS-SOL STATE, V2, P1109; Riek C, 2015, SCIENCE, V350, P420, DOI 10.1126/science.aac9788; Rogers ETF, 2012, NAT MATER, V11, P432, DOI [10.1038/NMAT3280, 10.1038/nmat3280]; Segev M, 2013, NAT PHOTONICS, V7, P197, DOI [10.1038/NPHOTON.2013.30, 10.1038/nphoton.2013.30]; Shalaev VM, 2007, NAT PHOTONICS, V1, P41, DOI 10.1038/nphoton.2006.49; Sheinfux HH, 2017, SCIENCE, V356, P953, DOI 10.1126/science.aah6822; Shitrit N, 2013, SCIENCE, V340, P724, DOI 10.1126/science.1234892; Sinova J, 2015, REV MOD PHYS, V87, P1213, DOI 10.1103/RevModPhys.87.1213; Wiersma DS, 2013, NAT PHOTONICS, V7, P188, DOI [10.1038/nphoton.2013.29, 10.1038/NPHOTON.2013.29]; Yin XB, 2013, SCIENCE, V339, P1405, DOI 10.1126/science.1231758	26	42	43	5	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 15	2017	358	6369					1411	+		10.1126/science.aap8640	http://dx.doi.org/10.1126/science.aap8640			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP8TH	29242342				2022-12-28	WOS:000417918500036
J	Pain, E				Pain, Elisabeth			France nabs foreign climate science talent	SCIENCE			English	News Item																			0	0	0	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 15	2017	358	6369					1365	1366		10.1126/science.358.6369.1365	http://dx.doi.org/10.1126/science.358.6369.1365			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP8TH	29242322				2022-12-28	WOS:000417918500010
J	Frakt, AB; Garthwaite, C				Frakt, Austin B.; Garthwaite, Craig			The CVS-Aetna Merger: Another Large Bet on the Changing US Health Care Landscape	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Boston Univ, Sch Publ Hlth, VA Boston Healthcare Syst, Boston, MA 02215 USA; Harvard TH Chan Sch Publ Hlth, Boston, MA USA; [Garthwaite, Craig] Northwestern Univ, Kellogg Sch Management, 2001 Sheridan Rd, Evanston, IL 60618 USA; [Frakt, Austin B.] VA Boston Healthcare Syst, 150 South Huntington Ave,152H, Boston, MA 02130 USA	Boston University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Harvard University; Harvard T.H. Chan School of Public Health; Northwestern University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System	Frakt, AB (corresponding author), VA Boston Healthcare Syst, 150 South Huntington Ave,152H, Boston, MA 02130 USA.	frakt@bu.edu		Frakt, Austin/0000-0002-0795-5462				[Anonymous], 22338 NAT BUR EC RES; Ashwood JS, 2016, HEALTH AFFAIR, V35, P449, DOI 10.1377/hlthaff.2015.0995; Dranove D, 2017, 23956 NAT BUR EC RES; Garthwaite C, 2017, PROMARKET BLOG  1101; Gaynor M., 2011, 17208 NAT BUR EC RES; Johnson G, 2017, HEALTH AFFAIR, V36, P539, DOI 10.1377/hlthaff.2016.0722; Starc A, 2015, 21783 NAT BUR EC RES	7	5	5	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 3	2018	168	7					511	+		10.7326/M17-3319	http://dx.doi.org/10.7326/M17-3319			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GB4AB	29310130				2022-12-28	WOS:000429000900011
J	De Rosa, S; Sievert, H; Sabatino, J; Polimeni, A; Sorrentino, S; Indolfi, C				De Rosa, Salvatore; Sievert, Horst; Sabatino, Jolanda; Polimeni, Alberto; Sorrentino, Sabato; Indolfi, Ciro			Percutaneous Closure Versus Medical Treatment in Stroke Patients With Patent Foramen Ovale A Systematic Review and Meta-analysis	ANNALS OF INTERNAL MEDICINE			English	Review							TRANSIENT ISCHEMIC ATTACK; CRYPTOGENIC STROKE; RECURRENT STROKE; CLINICAL-TRIALS; THERAPY; GUIDELINE; SIZE; ADD	Background: New evidence emerged recently regarding the percutaneous closure of patent foramen ovale (PFO) to prevent recurrent stroke in patients with cryptogenic stroke. Purpose: To compare risks for recurrent cerebrovascular events in adults with PFO and cryptogenic stroke who underwent PFO closure versus those who received medical therapy alone. Data Sources: PubMed, Scopus, and Google Scholar from 1 December 2004 through 14 September 2017; references of eligible studies; relevant scientific session abstracts; and cardiology Web sites. Study Selection: Randomized controlled trials, published in English, that compared PFO closure using a currently available device with medical treatment alone and that reported, at minimum, the rates of stroke or transient ischemic attack (TIA) or of new-onset atrial fibrillation (AF) or atrial flutter (AFL). Data Extraction: 2 investigators independently extracted study data and assessed study quality. Data Synthesis: 4 of 5 trials comparing PFO closure with medical therapy used commercially available devices. These 4 trials, involving 2531 patients, found that PFO closure reduced the risk for the main outcome of stroke or TIA (risk difference [RD], -0.029 [95% CI, -0.050 to -0.007]) and increased the risk for new-onset AF or AFL (RD, 0.033 [CI, 0.012 to 0.054]). The beneficial effect of PFO closure was associated with larger interatrial shunts (P = 0.034). Limitation: Trials were not double-blind, and inclusion criteria were heterogeneous. Conclusion: Compared with medical treatment, PFO closure prevents recurrent stroke and TIA but increases the incidence of AF or AFL in PFO carriers with cryptogenic stroke.	Magna Graecia Univ Catanzaro, Catanzaro, Italy; Cardiovasc Ctr Frankfurt, Frankfurt, Germany; Anglia Ruskin Univ, Cambridge, England; Anglia Ruskin Univ, Chelmsford, Essex, England; CNR, Catanzaro, Italy; [De Rosa, Salvatore; Sabatino, Jolanda; Polimeni, Alberto; Sorrentino, Sabato; Indolfi, Ciro] Magna Graecia Univ Catanzaro, Dept Med & Surg Sci, Div Cardiol, Viale Europa S-N, I-88100 Catanzaro, CZ, Italy; [Sievert, Horst] Cardiovasc Ctr Frankfurt CVC, Seckbacher Landstr 65, D-60389 Frankfurt, Germany	Magna Graecia University of Catanzaro; Cardiovascular Center (CVC) Frankfurt; Anglia Ruskin University; Anglia Ruskin University; Consiglio Nazionale delle Ricerche (CNR); Magna Graecia University of Catanzaro; Cardiovascular Center (CVC) Frankfurt	Indolfi, C (corresponding author), Magna Graecia Univ Catanzaro, Dept Med & Surg Sci, Viale Europa S-N, I-88100 Catanzaro, CZ, Italy.	saderosa@unicz.it; indolfi@unicz.it	De Rosa, Salvatore/J-6350-2012; Sabatino, Jolanda/M-2506-2017; Sorrentino, Sabato/D-3297-2019; Sabatino, Jolanda/AAO-5173-2020; Polimeni, Alberto AP/K-4731-2018; Polimeni, Alberto/M-9243-2019	De Rosa, Salvatore/0000-0001-5388-942X; Sorrentino, Sabato/0000-0002-8316-7134; Sabatino, Jolanda/0000-0002-1661-5419; Polimeni, Alberto AP/0000-0002-9166-3031; Polimeni, Alberto/0000-0002-9166-3031	Italian Ministry of Education, University and Research (MIUR) [OPTIMA CARDIOPATHS PON03PE_00009_4]	Italian Ministry of Education, University and Research (MIUR)(Ministry of Education, Universities and Research (MIUR))	This work was partly supported by a grant (OPTIMA CARDIOPATHS PON03PE_00009_4) from the Italian Ministry of Education, University and Research (MIUR).	Agmon Y, 1999, CIRCULATION, V99, P1942, DOI 10.1161/01.CIR.99.15.1942; Capodanno D, 2014, EUROINTERVENTION, V9, P1342, DOI 10.4244/EIJV9I11A225; Carroll JD, 2013, NEW ENGL J MED, V368, P1092, DOI 10.1056/NEJMoa1301440; Cornell JE, 2014, ANN INTERN MED, V160, P267, DOI 10.7326/M13-2886; DerSimonian R, 2007, CONTEMP CLIN TRIALS, V28, P105, DOI 10.1016/j.cct.2006.04.004; FISHER DC, 1995, CHEST, V107, P1504, DOI 10.1378/chest.107.6.1504; Furie KL, 2011, STROKE, V42, P227, DOI 10.1161/STR.0b013e3181f7d043; Furlan AJ, 2012, NEW ENGL J MED, V366, P991, DOI 10.1056/NEJMoa1009639; Goel SS, 2009, AM J CARDIOL, V103, P124, DOI 10.1016/j.amjcard.2008.08.036; Goldstein LB, 2011, STROKE, V42, P517, DOI 10.1161/STR.0b013e3181fcb238; Guolo A, 2017, STAT METHODS MED RES, V26, P1500, DOI 10.1177/0962280215583568; HAGEN PT, 1984, MAYO CLIN PROC, V59, P17, DOI 10.1016/S0025-6196(12)60336-X; Hedges LV, 2016, PSYCHOL METHODS, V21, P61, DOI 10.1037/met0000042; HICKIE JB, 1956, BRIT HEART J, V18, P320; HOMMA S, 1994, STROKE, V25, P582, DOI 10.1161/01.STR.25.3.582; IntHout J, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-25; Jarral OA, 2011, INT J CARDIOL, V153, P4, DOI 10.1016/j.ijcard.2011.02.027; Jung JM, 2013, J STROKE CEREBROVASC, V22, P1399, DOI 10.1016/j.jstrokecerebrovasdis.2013.04.034; Kent DM, 2013, NEUROLOGY, V81, P619, DOI 10.1212/WNL.0b013e3182a08d59; Kent DM, 2010, STROKE, V41, pS26, DOI 10.1161/STROKEAHA.110.595140; Kizer JR, 2005, NEW ENGL J MED, V353, P2361, DOI 10.1056/NEJMcp043981; Kwong JSW, 2013, INT J CARDIOL, V168, P4132, DOI 10.1016/j.ijcard.2013.07.077; MANTEL N, 1959, J NATL CANCER I, V22, P719; Mas JL, 2017, NEW ENGL J MED, V377, P1011, DOI 10.1056/NEJMoa1705915; Mattioli AV, 2001, EUR HEART J, V22, P261, DOI 10.1053/euhj.2001.2293; Meier B, 2013, NEW ENGL J MED, V368, P1083, DOI 10.1056/NEJMoa1211716; Messe SR, 2016, NEUROLOGY, V87, P815, DOI 10.1212/WNL.0000000000002961; Mojadidi MK, 2017, JACC-CARDIOVASC INTE, V10, P2228, DOI 10.1016/j.jcin.2017.09.002; MORISHITA Y, 1985, ANN THORAC SURG, V40, P614, DOI 10.1016/S0003-4975(10)60359-1; Nagaraja V, 2013, HEART LUNG CIRC, V22, P903, DOI 10.1016/j.hlc.2013.07.022; Pandit A, 2014, HEART LUNG CIRC, V23, P303, DOI 10.1016/j.hlc.2013.12.003; Prefasi D, 2016, INT J STROKE, V11, pNP7, DOI 10.1177/1747493015607505; Rucker G, 2009, STAT MED, V28, P721, DOI 10.1002/sim.3511; Saver JL, 2017, NEW ENGL J MED, V377, P1022, DOI 10.1056/NEJMoa1610057; Shuster JJ, 2016, STAT MED, V35, P2467, DOI 10.1002/sim.6844; Smith SC, 2011, CIRCULATION, V124, P2458, DOI 10.1161/CIR.0b013e318235eb4d; Sondergaard L, 2017, NEW ENGL J MED, V377, P1033, DOI 10.1056/NEJMoa1707404; Sun YP, 2016, CIRC J, V80, P1665, DOI 10.1253/circj.CJ-16-0534; Sweeting MJ, 2004, STAT MED, V23, P1351, DOI 10.1002/sim.1761; Villareal RP, 2004, J AM COLL CARDIOL, V43, P742, DOI 10.1016/j.jacc.2003.11.023; Zier LS, 2016, EXPERT REV CARDIOVAS, V14, P1235, DOI 10.1080/14779072.2016.1224178	41	44	44	0	10	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 6	2018	168	5					343	+		10.7326/M17-3033	http://dx.doi.org/10.7326/M17-3033			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FY2GD	29310133				2022-12-28	WOS:000426632600007
J	Plesa, C; Sidore, AM; Lubock, NB; Zhang, D; Kosuri, S				Plesa, Calin; Sidore, Angus M.; Lubock, Nathan B.; Zhang, Di; Kosuri, Sriram			Multiplexed gene synthesis in emulsions for exploring protein functional landscapes	SCIENCE			English	Article							DNA-SYNTHESIS; ADENYLYLTRANSFERASE; ENZYMES	Improving our ability to construct and functionally characterize DNA sequences would broadly accelerate progress in biology. Here, we introduce DropSynth, a scalable, low-cost method to build thousands of defined gene-length constructs in a pooled (multiplexed) manner. DropSynth uses a library of barcoded beads that pull down the oligonucleotides necessary for a gene's assembly, which are then processed and assembled in water-in-oil emulsions. We used DropSynth to successfully build more than 7000 synthetic genes that encode phylogenetically diverse homologs of two essential genes in Escherichia coli. We tested the ability of phosphopantetheine adenylyltransferase homologs to complement a knockout E. coli strain in multiplex, revealing core functional motifs and reasons underlying homolog incompatibility. DropSynth coupled with multiplexed functional assays allows us to rationally explore sequence-function relationships at an unprecedented scale.	[Plesa, Calin; Lubock, Nathan B.; Kosuri, Sriram] Univ Calif Los Angeles, Dept Chem & Biochem, 405 Hilgard Ave, Los Angeles, CA 90024 USA; [Sidore, Angus M.] UCLA, Dept Chem & Biomol Engn, Los Angeles, CA USA; [Zhang, Di] Univ Penn, Genom & Computat Biol Grad Grp, Perelman Sch Med, Philadelphia, PA 19104 USA; [Kosuri, Sriram] UCLA, US DOE, Inst Genom & Prote,Jonsson Comprehens Canc Ctr, Mol Biol Inst,Quantitat & Computat Biol Inst,Eli, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of Pennsylvania; Pennsylvania Medicine; UCLA Jonsson Comprehensive Cancer Center; United States Department of Energy (DOE); University of California System; University of California Los Angeles	Kosuri, S (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, 405 Hilgard Ave, Los Angeles, CA 90024 USA.; Kosuri, S (corresponding author), UCLA, US DOE, Inst Genom & Prote,Jonsson Comprehens Canc Ctr, Mol Biol Inst,Quantitat & Computat Biol Inst,Eli, Los Angeles, CA 90024 USA.	sri@ucla.edu	Plesa, Calin/X-2775-2019; Zhang, Di/AAN-3312-2021	Plesa, Calin/0000-0002-8121-3344; Zhang, Di/0000-0002-9007-4665; Kosuri, Sriram/0000-0002-4661-0600; Lubock, Nathan/0000-0001-8064-2465	Human Frontier Science Program [LT000068/2016]; Netherlands Organisation for Scientific Research Rubicon fellowship; National Science Foundation Graduate Research Fellowship [2016211460]; Ruth L. Kirschstein National Research Service Award [GM007185]; National Institutes of Health New Innovator Award [DP2GM114829]; Searle Scholars Program; U.S. Department of Energy [DE-FC02-02ER63421]; UCLA; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [DP2GM114829, T32GM007185] Funding Source: NIH RePORTER	Human Frontier Science Program(Human Frontier Science Program); Netherlands Organisation for Scientific Research Rubicon fellowship; National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health New Innovator Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Searle Scholars Program; U.S. Department of Energy(United States Department of Energy (DOE)); UCLA(University of California System); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the funds from the Human Frontier Science Program (LT000068/2016 to C.P.), Netherlands Organisation for Scientific Research Rubicon fellowship (to C.P.), National Science Foundation Graduate Research Fellowship under grant 2016211460 (to A.M.S.), a Ruth L. Kirschstein National Research Service Award (GM007185 to N.L.), National Institutes of Health New Innovator Award (DP2GM114829 to S.K.), Searle Scholars Program (to S.K.), U.S. Department of Energy (DE-FC02-02ER63421 to S.K.), UCLA, and L. Wudl and F. Wudl. We thank J. Sampson and P. Anderson at Agilent Technologies for oligo pools and critical advice. We thank G. Church and R. Terry for guidance during the early developments and S. Feng, the UCLA Broad Stem Cell Research Center Sequencing Core, and the Technology Center for Genomics and Bioinformatics for providing next-generation sequencing (NGS) services. S.K. and D.Z. are named inventors on a patent application on the DropSynth method (US14460496). The scripts required to generate DropSynth oligos are available at https://github.com/kosurilab/DropSynth. Sequencing data are available from the sequencing read archive (SRA) with the accession no. SRP126669.	Bhattacharyya S, 2016, ELIFE, V5, DOI 10.7554/eLife.20309; Borovkov AY, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq677; de Jonge BLM, 2013, ANTIMICROB AGENTS CH, V57, P6005, DOI 10.1128/AAC.01661-13; Fowler DM, 2014, NAT METHODS, V11, P801, DOI [10.1038/NMETH.3027, 10.1038/nmeth.3027]; Gasperini M, 2016, NAT PROTOC, V11, P1782, DOI 10.1038/nprot.2016.135; Halabi N, 2009, CELL, V138, P774, DOI 10.1016/j.cell.2009.07.038; Hopf TA, 2017, NAT BIOTECHNOL, V35, P128, DOI 10.1038/nbt.3769; Hsiau THC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119927; Hughes RA, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a023812; Inoue F, 2015, GENOMICS, V106, P159, DOI 10.1016/j.ygeno.2015.06.005; Izard T, 1999, EMBO J, V18, P2021, DOI 10.1093/emboj/18.8.2021; Izard T, 2002, J MOL BIOL, V315, P487, DOI 10.1006/jmbi.2001.5272; Kim H, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks546; Klein JC, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkv1177; Kosuri S, 2014, NAT METHODS, V11, P499, DOI [10.1038/NMETH.2918, 10.1038/nmeth.2918]; Kosuri S, 2010, NAT BIOTECHNOL, V28, P1295, DOI 10.1038/nbt.1716; Lubock NB, 2017, NUCLEIC ACIDS RES, V45, P9206, DOI 10.1093/nar/gkx691; Ma SY, 2012, CURR OPIN CHEM BIOL, V16, P260, DOI 10.1016/j.cbpa.2012.05.001; Marks DS, 2012, NAT BIOTECHNOL, V30, P1072, DOI 10.1038/nbt.2419; Quan JY, 2011, NAT BIOTECHNOL, V29, P449, DOI 10.1038/nbt.1847; Rocklin GJ, 2017, SCIENCE, V357, P168, DOI 10.1126/science.aan0693; Sarkisyan KS, 2016, NATURE, V533, P397, DOI 10.1038/nature17995; Schwartz JJ, 2012, NAT METHODS, V9, P913, DOI 10.1038/nmeth.2137	23	58	77	2	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 19	2018	359	6373					343	347		10.1126/science.aao5167	http://dx.doi.org/10.1126/science.aao5167			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT6BB	29301959	Green Accepted, Green Submitted			2022-12-28	WOS:000423236700042
J	Bindman, AB; Pronovost, PJ; Asch, DA				Bindman, Andrew B.; Pronovost, Peter J.; Asch, David A.			Funding Innovation in a Learning Health Care System	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Bindman, Andrew B.] Univ Calif San Francisco, Philip R Lee Inst Hlth Policy Studies, 3333 Calif St,Ste 265, San Francisco, CA 94118 USA; [Bindman, Andrew B.] Univ Calif San Francisco, Dept Med, 3333 Calif St,Ste 265, San Francisco, CA 94118 USA; [Pronovost, Peter J.] Johns Hopkins Univ, Sch Med, Armstrong Inst, Baltimore, MD USA; [Asch, David A.] Univ Penn, Wharton Sch, Perelman Sch Med, Philadelphia, PA 19104 USA; [Asch, David A.] Corporal Michael J Crescenz VA Med Ctr, Philadelphia, PA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Johns Hopkins University; University of Pennsylvania; Pennsylvania Medicine	Bindman, AB (corresponding author), Univ Calif San Francisco, Philip R Lee Inst Hlth Policy Studies, 3333 Calif St,Ste 265, San Francisco, CA 94118 USA.; Bindman, AB (corresponding author), Univ Calif San Francisco, Dept Med, 3333 Calif St,Ste 265, San Francisco, CA 94118 USA.	andrew.bindman@ucsf.edu		Asch, David/0000-0002-7970-286X	AHRQ; Patient-Centered Outcomes Research Institute	AHRQ(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); Patient-Centered Outcomes Research Institute(Patient-Centered Outcomes Research Institute - PCORI)	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Bindman served as director of the Agency for Healthcare Research and Quality (AHRQ) from May 2016 to January 2017 and is not permitted to apply for AHRQ grant funding until 2019. Dr Pronovost reported receiving grants from AHRQ and the Patient-Centered Outcomes Research Institute. No other disclosures were reported.	Forrest CB, 2018, HEALTH SERV RES, V53, P2615, DOI 10.1111/1475-6773.12751; Goldman LR, 2016, JAMA-J AM MED ASSOC, V316, P1649, DOI 10.1001/jama.2016.14800; Grannemann TW, HLTH AFFAIRS; Krumholz HM, 2016, JAMA-J AM MED ASSOC, V316, P1669, DOI 10.1001/jama.2016.12537; Smith M., 2013, BUSINESS MODELS RESP	5	22	22	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 9	2018	319	2					119	120		10.1001/jama.2017.18205	http://dx.doi.org/10.1001/jama.2017.18205			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FS4PR	29270611	Green Published			2022-12-28	WOS:000419775500008
J	Boyle, A				Boyle, Adrian			This emergency department crisis was predictable-and partly preventable The solutions are not complicated, but they require recognition that there is a problem	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Boyle, Adrian] Royal Coll Emergency Med, London, England		Boyle, A (corresponding author), Royal Coll Emergency Med, London, England.	adrian.boyle@addenbrookes.nhs.uk		Boyle, Adrian/0000-0002-9009-5423					0	3	3	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 8	2018	360								k64	10.1136/bmj.k64	http://dx.doi.org/10.1136/bmj.k64			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FS9MB	29311156				2022-12-28	WOS:000422741200002
J	Carpick, RW				Carpick, Robert W.			The contact sport of rough surfaces	SCIENCE			English	Editorial Material							FRICTION		[Carpick, Robert W.] Univ Penn, Dept Mech Engn & Appl Mech, Philadelphia, PA 19104 USA	University of Pennsylvania	Carpick, RW (corresponding author), Univ Penn, Dept Mech Engn & Appl Mech, Philadelphia, PA 19104 USA.	carpick@seas.upenn.edu						ARCHARD JF, 1957, PROC R SOC LON SER-A, V243, P190, DOI 10.1098/rspa.1957.0214; Bennett AI, 2017, TRIBOL LETT, V65, DOI 10.1007/s11249-017-0901-1; Campana C, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.075420; Dowson D., 1998, HIST TRIBOLOGY; GREENWOOD JA, 1966, PROC R SOC LON SER-A, V295, P300, DOI 10.1098/rspa.1966.0242; Johnson KL., 1985, CONTACT MECH, DOI [10.1017/CBO9781139171731, DOI 10.1201/B17588-12]; Mate CMathew, 2008, HINDU; Muser MH, 2017, TRIBOL LETT, V65, DOI 10.1007/s11249-017-0900-2; Persson BNJ, 2001, J CHEM PHYS, V115, P3840, DOI 10.1063/1.1388626; Tysoe WT, 2015, TRIBOL LUBR TECHNOL, V71, P96	10	32	35	2	62	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 5	2018	359	6371					38	38		10.1126/science.aaq1814	http://dx.doi.org/10.1126/science.aaq1814			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FR8KW	29302004				2022-12-28	WOS:000419324700058
J	Hughes, TP; Anderson, KD; Connolly, SR; Heron, SF; Kerry, JT; Lough, JM; Baird, AH; Baum, JK; Berumen, ML; Bridge, TC; Claar, DC; Eakin, CM; Gilmour, JP; Graham, NAJ; Harrison, H; Hobbs, JPA; Hoey, AS; Hoogenboom, M; Lowe, RJ; McCulloch, MT; Pandolfi, JM; Pratchett, M; Schoepf, V; Torda, G; Wilson, SK				Hughes, Terry P.; Anderson, Kristen D.; Connolly, Sean R.; Heron, Scott F.; Kerry, James T.; Lough, Janice M.; Baird, Andrew H.; Baum, Julia K.; Berumen, Michael L.; Bridge, Tom C.; Claar, Danielle C.; Eakin, C. Mark; Gilmour, James P.; Graham, Nicholas A. J.; Harrison, Hugo; Hobbs, Jean-Paul A.; Hoey, Andrew S.; Hoogenboom, Mia; Lowe, Ryan J.; McCulloch, Malcolm T.; Pandolfi, John M.; Pratchett, Morgan; Schoepf, Verena; Torda, Gergely; Wilson, Shaun K.			Spatial and temporal patterns of mass bleaching of corals in the Anthropocene	SCIENCE			English	Article							CLIMATE-CHANGE; REEF; RECOVERY; IMPACTS; STRESS; GROWTH; TRENDS	Tropical reef systems are transitioning to a new era in which the interval between recurrent bouts of coral bleaching is too short for a full recovery of mature assemblages. We analyzed bleaching records at 100 globally distributed reef locations from 1980 to 2016. The median return time between pairs of severe bleaching events has diminished steadily since 1980 and is now only 6 years. As global warming has progressed, tropical sea surface temperatures are warmer now during current La Nina conditions than they were during El Nino events three decades ago. Consequently, as we transition to the Anthropocene, coral bleaching is occurring more frequently in all El Nino-Southern Oscillation phases, increasing the likelihood of annual bleaching in the coming decades.	[Hughes, Terry P.; Anderson, Kristen D.; Connolly, Sean R.; Kerry, James T.; Lough, Janice M.; Baird, Andrew H.; Bridge, Tom C.; Graham, Nicholas A. J.; Harrison, Hugo; Hoey, Andrew S.; Hoogenboom, Mia; Pratchett, Morgan; Torda, Gergely] James Cook Univ, ARC, Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia; [Connolly, Sean R.; Hoogenboom, Mia] James Cook Univ, Coll Marine & Environm Sci, Townsville, Qld 4811, Australia; [Heron, Scott F.; Eakin, C. Mark] US Natl Ocean & Atmospher Adm, Coral Reef Watch, College Pk, MD 20740 USA; [Heron, Scott F.] James Cook Univ, Marine Geophys Lab, Dept Phys, Coll Sci Technol & Engn, Townsville, Qld 4811, Australia; [Lough, Janice M.; Torda, Gergely] Australian Inst Marine Sci, PMB 3, Townsville, Qld 4810, Australia; [Baum, Julia K.; Claar, Danielle C.] Univ Victoria, Dept Biol, Victoria, BC V8W 2Y2, Canada; [Berumen, Michael L.] King Abdullah Univ Sci & Technol, Red Sea Res Ctr, Thuwal 235996900, Saudi Arabia; [Bridge, Tom C.] Queensland Museum, 70-102 Flinders St, Townsville, Qld 4810, Australia; [Gilmour, James P.] Univ Western Australia, Australian Inst Marine Sci, Indian Ocean Marine Sci Ctr, Perth, WA 6009, Australia; [Graham, Nicholas A. J.] Univ Lancaster, Lancaster Environm Ctr, Lancaster LA1 4YQ, England; [Hobbs, Jean-Paul A.] Curtin Univ, Dept Environm & Agr, Perth, WA 6845, Australia; [Lowe, Ryan J.; McCulloch, Malcolm T.; Schoepf, Verena] Univ Western Australia, ARC Ctr Excellence Coral Reef Studies, UWA Oceans Inst, Crawley, WA 6009, Australia; [Lowe, Ryan J.; McCulloch, Malcolm T.; Schoepf, Verena] Univ Western Australia, Sch Earth Sci, Crawley, WA 6009, Australia; [Pandolfi, John M.] Univ Queensland, ARC Ctr Excellence Coral Reef Studies, Sch Biol Sci, Brisbane, Qld 4072, Australia; [Wilson, Shaun K.] Dept Biodivers Conservat & Attract, Perth, WA 6151, Australia	James Cook University; James Cook University; National Oceanic Atmospheric Admin (NOAA) - USA; James Cook University; Australian Institute of Marine Science; University of Victoria; King Abdullah University of Science & Technology; Queensland Museum; Australian Institute of Marine Science; University of Western Australia; Lancaster University; Curtin University; University of Western Australia; University of Western Australia; University of Queensland	Hughes, TP (corresponding author), James Cook Univ, ARC, Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia.	terry.hughes@jcu.edu.au	Harrison, Hugo/F-6830-2012; Wilson, Shaun/K-8597-2019; Baird, Andrew Hamilton/C-8449-2009; Torda, Gergely/ABE-6388-2020; Heron, Scott F/E-7928-2011; Hoey, Andrew S/B-5457-2015; Graham, Nicholas AJ/C-8360-2014; Hoogenboom, Mia O/D-3664-2012; Schoepf, Verena/H-5786-2014; Lough, Janice M/L-1682-2013; Torda, Gergely/ABE-6400-2020; Claar, Danielle/AAP-9348-2020; Pratchett, Morgan/AAW-5179-2020; Pandolfi, John M/A-3121-2009; Berumen, Michael/F-7745-2011; Eakin, C. Mark/F-5585-2010; McCulloch, Malcolm Thomas/C-3651-2009; Lowe, Ryan/A-5032-2012; Hughes, Terry/L-4721-2013; Bridge, Tom/J-2693-2014; Connolly, Sean/E-7773-2011	Harrison, Hugo/0000-0001-8831-0086; Wilson, Shaun/0000-0002-4590-0948; Baird, Andrew Hamilton/0000-0001-8504-4077; Graham, Nicholas AJ/0000-0002-0304-7467; Hoogenboom, Mia O/0000-0003-3709-6344; Schoepf, Verena/0000-0002-9467-1088; Lough, Janice M/0000-0002-3789-1009; Torda, Gergely/0000-0002-4585-3045; Claar, Danielle/0000-0003-2389-111X; Pratchett, Morgan/0000-0002-1862-8459; Pandolfi, John M/0000-0003-3047-6694; Berumen, Michael/0000-0003-2463-2742; Eakin, C. Mark/0000-0002-5987-0858; McCulloch, Malcolm Thomas/0000-0003-1538-1558; Lowe, Ryan/0000-0002-7080-8406; Hoey, Andrew/0000-0002-4261-5594; Anderson, Kristen/0000-0002-1576-6979; Heron, Scott/0000-0001-5262-6978; Hughes, Terry/0000-0002-5257-5063; Bridge, Tom/0000-0003-3951-284X; Connolly, Sean/0000-0003-1537-0859; Baum, Julia/0000-0002-9827-1612	Australian Research Council's Centre of Excellence Program [CE140100020]	Australian Research Council's Centre of Excellence Program(Australian Research Council)	Major funding for this research was provided by the Australian Research Council's Centre of Excellence Program (CE140100020). The contents of this manuscript are solely the opinions of the authors and do not constitute a statement of policy, decision, or position on behalf of the National Oceanic and Atmospheric Administration or the U.S. government. Data reported in this paper are tabulated in the supplementary materials.	Baird AH, 2002, MAR ECOL PROG SER, V237, P133, DOI 10.3354/meps237133; Baker AC, 2008, ESTUAR COAST SHELF S, V80, P435, DOI 10.1016/j.ecss.2008.09.003; Carilli JE, 2010, GLOBAL CHANGE BIOL, V16, P1247, DOI 10.1111/j.1365-2486.2009.02043.x; Crutzen P. J., 2006, EARTH SYSTEM SCI ANT; Donner SD, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175490; Gilmour JP, 2013, SCIENCE, V340, P69, DOI 10.1126/science.1232310; Glynn PW, 2015, CORAL REEFS, V34, P421, DOI 10.1007/s00338-015-1280-4; GLYNN PW, 1993, CORAL REEFS, V12, P1, DOI 10.1007/BF00303779; Hartmann DL, 2013, CONTRIBUTION WORKING; Heron SF, 2016, SCI REP-UK, V6, DOI 10.1038/srep38402; Hoegh-Guldberg O., 2013, CLIMATE CHANGE 2014; Hughes TP, 2017, NATURE, V546, P82, DOI 10.1038/nature22901; Hughes TP, 2017, NATURE, V543, P373, DOI 10.1038/nature21707; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Kayanne H, 2002, MAR ECOL PROG SER, V239, P93, DOI 10.3354/meps239093; Kleypas JA, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032257; Lough JM, 2000, GEOPHYS RES LETT, V27, P3901, DOI 10.1029/2000GL011715; McClanahan TR, 2014, CORAL REEFS, V33, P939, DOI 10.1007/s00338-014-1178-6; National Aeronautics and Space Administration (NASA), 2016, GLOB AN 2016 YEAR TO; Oliver J. K., 2009, ECOLOGICAL STUDIES A; Rockstrom J, 2009, NATURE, V461, P472, DOI 10.1038/461472a; Spalding MD, 2015, SCIENCE, V350, P769, DOI 10.1126/science.aad0349; van Hooidonk R, 2013, NAT CLIM CHANGE, V3, P508, DOI [10.1038/NCLIMATE1829, 10.1038/nclimate1829]; Wellington G. M., 2007, GEOLOGICAL APPROACHE	24	1016	1036	52	732	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 5	2018	359	6371					80	+		10.1126/science.aan8048	http://dx.doi.org/10.1126/science.aan8048			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FR8KW	29302011	Green Submitted, Green Accepted			2022-12-28	WOS:000419324700071
J	Atri, D; Furfaro, D; Dhaliwal, G; Feingold, KR; Manesh, R				Atri, Deepak; Furfaro, David; Dhaliwal, Gurpreet; Feingold, Kenneth R.; Manesh, Reza			Going from A to Z	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							ZOLLINGER-ELLISON-SYNDROME; CHRONIC DIARRHEA; MANAGEMENT; CONTROVERSIES		[Atri, Deepak; Furfaro, David; Manesh, Reza] Johns Hopkins Univ Hosp, Dept Med, Baltimore, MD 21287 USA; [Atri, Deepak; Furfaro, David; Manesh, Reza] Johns Hopkins Univ, Sch Med, Baltimore, MD USA; [Dhaliwal, Gurpreet; Feingold, Kenneth R.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Dhaliwal, Gurpreet; Feingold, Kenneth R.] San Francisco VA Med Ctr, Med Serv, San Francisco, CA USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center	Manesh, R (corresponding author), Johns Hopkins Univ Hosp, Div Gen Internal Med, 600 N Wolfe St,Meyer 8-34D, Baltimore, MD 21287 USA.	rsedigh1@jhmi.edu	Atri, Deepak/ADL-5644-2022	Atri, Deepak/0000-0001-8139-5419				Berna MJ, 2006, MEDICINE, V85, P295, DOI 10.1097/01.md.0000236956.74128.76; Camilleri M, 2004, CLIN GASTROENTEROL H, V2, P198, DOI 10.1016/S1542-3565(04)00003-5; Epelboym I, 2014, ONCOLOGIST, V19, P44, DOI 10.1634/theoncologist.2013-0369; Feliberti E, 2017, ENDOTEXT; Gibril F, 1999, J NUCL MED, V40, P539; Ito T, 2013, CURR OPIN GASTROEN, V29, P650, DOI 10.1097/MOG.0b013e328365efb1; Jensen RT, 2006, NEUROENDOCRINOLOGY, V84, P173, DOI 10.1159/000098009; Krampitz Geoffrey W, 2013, Adv Surg, V47, P59; MEKO JB, 1995, ANNU REV MED, V46, P395; Morrow EH, 2009, SURG CLIN N AM, V89, P1091, DOI 10.1016/j.suc.2009.06.018; Norton JA, 1999, NEW ENGL J MED, V341, P635, DOI 10.1056/NEJM199908263410902; Roy PK, 2000, MEDICINE, V79, P379, DOI 10.1097/00005792-200011000-00004; Schiller LR, 2017, CLIN GASTROENTEROL H, V15, P182, DOI 10.1016/j.cgh.2016.07.028; Skoura E, 2016, J NUCL MED, V57, P34, DOI 10.2967/jnumed.115.166017; Tomassetti P, 2005, WORLD J GASTROENTERO, V11, P5423, DOI 10.3748/wjg.v11.i35.5423	15	0	0	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 4	2018	378	1					73	79		10.1056/NEJMcps1701264	http://dx.doi.org/10.1056/NEJMcps1701264			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FR7BE	29298151				2022-12-28	WOS:000419220500019
J	Taubes, G				Taubes, Gary			ESSAY What if sugar is worse than just empty calories? An essay by Gary Taubes	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							FRUCTOSE		[Taubes, Gary] Nutr Sci Initiat, San Diego, CA 92130 USA		Taubes, G (corresponding author), Nutr Sci Initiat, San Diego, CA 92130 USA.	gataubes@gmail.com						Amer Diabet Assoc, 2013, DIABETES CARE, V36, P1033, DOI 10.2337/dc12-2625; Chan M., 2016, 47 M NAT AC MED; Dyck R, 2010, CAN MED ASSOC J, V182, P249, DOI 10.1503/cmaj.090846; Emerson H, 1924, ARCH INTERN MED, V34, P585, DOI 10.1001/archinte.1924.00120050002001; Feynman R.P., 1967, CHARACTER PHYS LAW; Finkelstein EA, 2009, HEALTH AFFAIR, V28, pW822, DOI 10.1377/hlthaff.28.5.w822; Fitz RH, 1898, JAMA-J AM MED ASSOC, V31, P165, DOI [10.1001/jama.1898.92450040015001a, DOI 10.1001/JAMA.1898.92450040015001A]; Himsworth HP, 1935, CLIN SCI, V2, P117; Joslin EP, 1921, J AMER MED ASSOC, V76, P79; Kearns CE, 2016, JAMA INTERN MED, V176, P1680, DOI 10.1001/jamainternmed.2016.5394; KEYS A, 1971, ATHEROSCLEROSIS, V14, P193, DOI 10.1016/0021-9150(71)90049-9; Khan TA, 2016, OBESITY, V24, P549, DOI 10.1002/oby.21431; McKenzie Amy L, 2017, JMIR Diabetes, V2, pe5, DOI 10.2196/diabetes.6981; Scientific Advisory Committee on Nutrition, 2015, CARB HLTH; Shafrir E., 1991, Sugars and sweeteners., P63; TAPPY L, 1993, AM J CLIN NUTR, V58, P766; White P, 1959, TREATMENT DIABETES M, P47; Yudkin J, 1972, PURE WHITE DEADLY	18	2	3	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 4	2018	360								j5808	10.1136/bmj.j5808	http://dx.doi.org/10.1136/bmj.j5808			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FS3UX	29298751				2022-12-28	WOS:000419710400009
J	Colantuoni, E; Scharfstein, DO; Wang, C; Hashem, MD; Leroux, A; Needham, DM; Girard, TD				Colantuoni, Elizabeth; Scharfstein, Daniel O.; Wang, Chenguang; Hashem, Mohamed D.; Leroux, Andrew; Needham, Dale M.; Girard, Timothy D.			Statistical methods to compare functional outcomes in - randomized controlled trials with high mortality	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PRINCIPAL STRATIFICATION; CAUSAL INFERENCE; CLINICAL-TRIALS; EFFICACY	Mortality is a common primary endpoint in randomized controlled trials of patients with a high severity of illness, such as critically ill patients. However, researchers are increasingly evaluating functional outcomes, such as quality of life. Importantly, in such trials some patients may die before the assessment of a functional outcome, resulting in the functional outcome being "truncated due to death." As described in this paper, defining and testing treatment effects on functional outcomes in this setting requires careful consideration. Data from a completed trial of critically ill patients are used to highlight key differences among three statistical approaches used when analyzing such trials.	[Colantuoni, Elizabeth; Scharfstein, Daniel O.; Hashem, Mohamed D.; Needham, Dale M.] Johns Hopkins Univ, Outcomes Crit Illness & Surg OACIS Grp, Baltimore, MD 21218 USA; [Colantuoni, Elizabeth; Scharfstein, Daniel O.; Leroux, Andrew] Johns Hopkins Univ, Dept Biostat, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA; [Wang, Chenguang] Johns Hopkins Univ, Sch Med, Div Biostat & Bioinformat, Baltimore, MD USA; [Hashem, Mohamed D.; Needham, Dale M.] Johns Hopkins Univ, Sch Med, Div Pulm & Crit Care Med, Baltimore, MD USA; [Needham, Dale M.] Johns Hopkins Univ, Sch Med, Dept Phys Med & Rehabil, Baltimore, MD USA; [Girard, Timothy D.] Univ Pittsburgh, Sch Med, Dept Crit Care Med, Clin Res Invest & Syst Modeling Acute Illness CRI, Pittsburgh, PA USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Colantuoni, E (corresponding author), Johns Hopkins Univ, Outcomes Crit Illness & Surg OACIS Grp, Baltimore, MD 21218 USA.; Colantuoni, E (corresponding author), Johns Hopkins Univ, Dept Biostat, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA.	ejohnso2@jhmi.edu	Girard, Timothy/I-3008-2019	Girard, Timothy/0000-0002-9833-4871	National Heart, Lung and Blood Institute [R24HL111895]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R24HL111895] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG000247] Funding Source: NIH RePORTER	National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf and declare: EC, AL, DOS, and DMN have support from National Heart, Lung and Blood Institute (R24HL111895) for the submitted work; CW and DOS were compensated for consultation services that motivated the composite outcome methods discussed in this paper, CW and DS were not paid for preparation of this manuscript.	Akach M, 2017, STAT MED, V36, P5, DOI 10.1002/sim.7033; Chiba Y, 2011, AM J EPIDEMIOL, V173, P745, DOI 10.1093/aje/kwq418; Egleston BL, 2007, BIOSTATISTICS, V8, P526, DOI 10.1093/biostatistics/kxl027; Ferguson ND, 2013, AM J RESP CRIT CARE, V187, P256, DOI 10.1164/rccm.201206-1057OC; Frangakis CE, 2002, BIOMETRICS, V58, P21, DOI 10.1111/j.0006-341X.2002.00021.x; Fried TR, 2002, NEW ENGL J MED, V346, P1061, DOI 10.1056/NEJMsa012528; Girard TD, 2008, LANCET, V371, P126, DOI 10.1016/S0140-6736(08)60105-1; Hayden D, 2005, BIOMETRICS, V61, P305, DOI 10.1111/j.0006-341X.2005.030227.x; Hebert PC, 1999, NEW ENGL J MED, V340, P409, DOI 10.1056/NEJM199902113400601; Lachin JM, 1999, CONTROL CLIN TRIALS, V20, P408, DOI 10.1016/S0197-2456(99)00022-7; McMillan T, 2016, NAT REV NEUROL, V12, P477, DOI 10.1038/nrneurol.2016.89; McMurray JJV, 2014, NEW ENGL J MED, V371, P993, DOI 10.1056/NEJMoa1409077; Motzer RJ, 2015, NEW ENGL J MED, V373, P1803, DOI 10.1056/NEJMoa1510665; ROSENBAUM PR, 1984, J ROY STAT SOC A STA, V147, P656, DOI 10.2307/2981697; RUBIN DB, 1974, J EDUC PSYCHOL, V66, P688, DOI 10.1037/h0037350; Rubin DB, 2000, J AM STAT ASSOC, V95, P435, DOI 10.2307/2669382; Rubin DB, 2006, STAT SCI, V21, P299, DOI 10.1214/088342306000000114; Schoenfeld DA, 2002, CRIT CARE MED, V30, P1772, DOI 10.1097/00003246-200208000-00016; Tchetgen EJT, 2014, STAT MED, V33, P3601, DOI 10.1002/sim.6181; Turnbull AE, 2016, CRIT CARE MED, V44, P1267, DOI 10.1097/CCM.0000000000001651; Zhang JNL, 2003, J EDUC BEHAV STAT, V28, P353, DOI 10.3102/10769986028004353	21	41	41	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 3	2018	360								j5748	10.1136/bmj.j5748	http://dx.doi.org/10.1136/bmj.j5748			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FS3UP	29298779	hybrid, Green Submitted, Green Published			2022-12-28	WOS:000419709400005
J	Horton, R				Horton, Richard			Offline: Are China's global ambitions good for global health?	LANCET			English	Editorial Material												richard.horton@lancet.com							0	0	0	1	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 23	2017	390	10114					2752	2752		10.1016/S0140-6736(17)33355-X	http://dx.doi.org/10.1016/S0140-6736(17)33355-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FQ9GF	29303716				2022-12-28	WOS:000418669800013
J	Kenrick, P				Kenrick, Paul			How land plant life cycles first evolved	SCIENCE			English	Editorial Material							EVOLUTION; ORIGIN; MECHANISM		[Kenrick, Paul] Nat Hist Museum, Dept Earth Sci, London SW7 5BD, England	Natural History Museum London	Kenrick, P (corresponding author), Nat Hist Museum, Dept Earth Sci, London SW7 5BD, England.	p.kenrick@nhm.ac.uk		Kenrick, Paul/0000-0002-3626-5460	Royal Society of London	Royal Society of London(Royal Society of London)	I am indebted to D. Edwards, L. Dolan, and The Royal Society of London for funding an interdisciplinary discussion meeting on "Rhynie Chert-Our earliest terrestrial ecosystem revisited," held in March 2017.	Bennett TA, 2014, CURR BIOL, V24, P2776, DOI 10.1016/j.cub.2014.09.054; Bowman JL, 2016, ANNU REV GENET, V50, P133, DOI 10.1146/annurev-genet-120215-035227; Delwiche CF, 2015, CURR BIOL, V25, pR899, DOI 10.1016/j.cub.2015.08.029; Duckett JG, 2009, NEW PHYTOL, V183, P1053, DOI 10.1111/j.1469-8137.2009.02905.x; Edwards D., 2017, PHILOS T R SOC LON B, DOI [10.1098/rstb.2017.0489, DOI 10.1098/RSTB.2017.0489]; Edwards D, 2014, NEW PHYTOL, V202, P50, DOI 10.1111/nph.12645; Haig D, 2008, BOT REV, V74, P395, DOI 10.1007/s12229-008-9012-x; Kenrick P, 2018, PHILOS T R SOC B, V373, DOI 10.1098/rstb.2017.0149; Ligrone R, 2012, ANN BOT-LONDON, V109, P851, DOI 10.1093/aob/mcs017; Pires ND, 2013, P NATL ACAD SCI USA, V110, P9571, DOI 10.1073/pnas.1305457110; Qiu YL, 2012, J SYST EVOL, V50, P171, DOI 10.1111/j.1759-6831.2012.00188.x; Tam THY, 2015, P NATL ACAD SCI USA, V112, pE3959, DOI 10.1073/pnas.1416324112; Viaene T, 2014, CURR BIOL, V24, P2786, DOI 10.1016/j.cub.2014.09.056; Wickett NJ, 2014, P NATL ACAD SCI USA, V111, pE4859, DOI 10.1073/pnas.1323926111; Xu B, 2014, SCIENCE, V343, P1505, DOI 10.1126/science.1248417	15	13	14	1	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 22	2017	358	6370					1538	1539		10.1126/science.aan2923	http://dx.doi.org/10.1126/science.aan2923			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FQ6BO	29269462				2022-12-28	WOS:000418448000036
J	Kim, KH; Spah, A; Pathak, H; Perakis, F; Mariedahl, D; Amann-Winkel, K; Sellberg, JA; Lee, JH; Kim, S; Park, J; Nam, KH; Katayama, T; Nilsson, A				Kim, Kyung Hwan; Spah, Alexander; Pathak, Harshad; Perakis, Fivos; Mariedahl, Daniel; Amann-Winkel, Katrin; Sellberg, Jonas A.; Lee, Jae Hyuk; Kim, Sangsoo; Park, Jaehyun; Nam, Ki Hyun; Katayama, Tetsuo; Nilsson, Anders			Maxima in the thermodynamic response and correlation functions of deeply supercooled water	SCIENCE			English	Article							LIQUID-LIQUID TRANSITION; X-RAY; MOLECULAR-MODEL; GLASSY WATER; WIDOM LINE; ICE; SINGULARITY; SCATTERING; BEHAVIOR; SYSTEMS	Femtosecond x-ray laser pulses were used to probe micrometer-sized water droplets that were cooled down to 227 kelvin in vacuum. Isothermal compressibility and correlation length were extracted from x-ray scattering at the low-momentum transfer region. The temperature dependence of these thermodynamic response and correlation functions shows maxima at 229 kelvin for water and 233 kelvin for heavy water. In addition, we observed that the liquids undergo the fastest growth of tetrahedral structures at similar temperatures. These observations point to the existence of a Widom line, defined as the locus of maximum correlation length emanating from a critical point at positive pressures in the deeply supercooled regime. The difference in the maximum value of the isothermal compressibility between the two isotopes shows the importance of nuclear quantum effects.	[Kim, Kyung Hwan; Spah, Alexander; Pathak, Harshad; Perakis, Fivos; Mariedahl, Daniel; Amann-Winkel, Katrin; Nilsson, Anders] Stockholm Univ, AlbaNova Univ Ctr, Dept Phys, SE-10691 Stockholm, Sweden; [Sellberg, Jonas A.] KTH Royal Inst Technol, AlbaNova Univ Ctr, Dept Appl Phys, Biomed & Xray Phys, SE-10691 Stockholm, Sweden; [Lee, Jae Hyuk; Kim, Sangsoo; Park, Jaehyun; Nam, Ki Hyun] Pohang Accelerator Lab, Pohang 37673, Gyeongbuk, South Korea; [Katayama, Tetsuo] Japan Synchrotron Radiat Res Inst, Kouto 1-1-1, Sayo, Hyogo 6795198, Japan	Stockholm University; Royal Institute of Technology; Pohang University of Science & Technology (POSTECH); Japan Synchrotron Radiation Research Institute	Nilsson, A (corresponding author), Stockholm Univ, AlbaNova Univ Ctr, Dept Phys, SE-10691 Stockholm, Sweden.	andersn@fysik.su.se	Perakis, Fivos/AAG-3317-2020; Sellberg, Jonas A/C-6506-2009; Nilsson, Anders/E-1943-2011; Nam, Ki Hyun/N-6812-2019; Amann-Winkel, Katrin/AFR-7504-2022	Perakis, Fivos/0000-0001-9863-9811; Sellberg, Jonas A/0000-0003-2793-5052; Nilsson, Anders/0000-0003-1968-8696; Nam, Ki Hyun/0000-0003-3268-354X; Amann-Winkel, Katrin/0000-0002-7319-7807; Kim, Sangsoo/0000-0003-4005-5404; Mariedahl, Daniel/0000-0002-7440-6789; Kim, Kyung Hwan/0000-0002-0482-9786	European Research Council [667205]; Swedish National Research Council; Ministry of Science and ICT of Korea [2017-1st-CXI-006]	European Research Council(European Research Council (ERC)European Commission); Swedish National Research Council; Ministry of Science and ICT of Korea	This work has been supported by a European Research Council Advanced Grant under project no. 667205 and the Swedish National Research Council. The experiments were performed at beamline NCI of PAL-XFEL (proposal no. 2017-1st-CXI-006) funded by the Ministry of Science and ICT of Korea and at beamline BL3 of SACLA, with the approval of the Japan Synchrotron Radiation Research Institute (proposal no. 2015A8038). We thank L.-P. Wang for providing iAMOEBA compressibility data. The experimental data are available in the supplementary materials.	Amann-Winkel K, 2016, CHEM REV, V116, P7570, DOI 10.1021/acs.chemrev.5b00663; Angell CA, 2008, SCIENCE, V319, P582, DOI 10.1126/science.1131939; Ceriotti M, 2016, CHEM REV, V116, P7529, DOI 10.1021/acs.chemrev.5b00674; Debenedetti PG, 2003, J PHYS-CONDENS MAT, V15, pR1669, DOI 10.1088/0953-8984/15/45/R01; Gallo P, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6806; HENDRICKS RW, 1974, J CHEM PHYS, V61, P319, DOI 10.1063/1.1681639; Holten V, 2012, SCI REP-UK, V2, DOI 10.1038/srep00713; Huang C, 2009, P NATL ACAD SCI USA, V106, P15214, DOI 10.1073/pnas.0904743106; Huang CC, 2010, J CHEM PHYS, V133, DOI 10.1063/1.3495974; KANNO H, 1979, J CHEM PHYS, V70, P4008, DOI 10.1063/1.438021; Kim KH, 2017, PHYS REV LETT, V119, DOI 10.1103/PhysRevLett.119.075502; Li YP, 2013, P NATL ACAD SCI USA, V110, P12209, DOI 10.1073/pnas.1309042110; Limmer DT, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3643333; Mallamace F, 2013, P NATL ACAD SCI USA, V110, P4899, DOI 10.1073/pnas.1221805110; Mallamace F, 2009, P NATL ACAD SCI USA, V106, P15097, DOI 10.1073/pnas.0908198106; Mishima O, 1998, NATURE, V396, P329, DOI 10.1038/24540; Moore EB, 2011, NATURE, V479, P506, DOI 10.1038/nature10586; Ni YC, 2016, J CHEM PHYS, V144, DOI 10.1063/1.4952991; Nilsson A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9998; Palmer JC, 2014, NATURE, V510, P385, DOI 10.1038/nature13405; Pathak H, 2016, J CHEM PHYS, V145, DOI 10.1063/1.4963913; Perakis F, 2017, P NATL ACAD SCI USA, V114, P8193, DOI 10.1073/pnas.1705303114; POOLE PH, 1992, NATURE, V360, P324, DOI 10.1038/360324a0; Reddy SK, 2016, J CHEM PHYS, V145, DOI 10.1063/1.4967719; Russo J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4556; Sastry S, 1996, PHYS REV E, V53, P6144, DOI 10.1103/PhysRevE.53.6144; Schlesinger D, 2016, J CHEM PHYS, V144, DOI 10.1063/1.4944387; Sellberg JA, 2014, NATURE, V510, P381, DOI 10.1038/nature13266; Singh RS, 2016, J CHEM PHYS, V144, DOI 10.1063/1.4944986; Skinner LB, 2014, J CHEM PHYS, V141, DOI 10.1063/1.4902412; SPEEDY RJ, 1976, J CHEM PHYS, V65, P851, DOI 10.1063/1.433153; Stanley HE., 1971, PHASE TRANSITIONS CR; Stokely K, 2010, P NATL ACAD SCI USA, V107, P1301, DOI 10.1073/pnas.0912756107; Wang LP, 2013, J PHYS CHEM B, V117, P9956, DOI 10.1021/jp403802c; Wikfeldt KT, 2011, PHYS CHEM CHEM PHYS, V13, P19918, DOI 10.1039/c1cp22076d; Xu LM, 2005, P NATL ACAD SCI USA, V102, P16558, DOI 10.1073/pnas.0507870102; Xu YT, 2016, P NATL ACAD SCI USA, V113, P14921, DOI 10.1073/pnas.1611395114	37	182	184	9	121	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 22	2017	358	6370					1589	+		10.1126/science.aap8269	http://dx.doi.org/10.1126/science.aap8269			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ6BO	29269472	Green Submitted			2022-12-28	WOS:000418448000058
J	Yang, WH; Heithoff, DM; Aziz, PV; Sperandio, M; Nizet, V; Mahan, MJ; Marth, JD				Yang, Won Ho; Heithoff, Douglas M.; Aziz, Peter V.; Sperandio, Markus; Nizet, Victor; Mahan, Michael J.; Marth, Jamey D.			Recurrent infection progressively disables host protection against intestinal inflammation	SCIENCE			English	Article							ALKALINE-PHOSPHATASE; SIALIDASE NEU3; BOWEL-DISEASE; RECEPTOR 4; ROLES; GENE; GLYCOSYLATION; PATHOGENESIS; GANGLIOSIDE; ACTIVATION	Intestinal inflammation is the central pathological feature of colitis and the inflammatory bowel diseases. These syndromes arise from unidentified environmental factors. We found that recurrent nonlethal gastric infections of Gram-negative Salmonella enterica Typhimurium (ST), a major source of human food poisoning, caused inflammation of murine intestinal tissue, predominantly the colon, which persisted after pathogen clearance and irreversibly escalated in severity with repeated infections. ST progressively disabled a host mechanism of protection by inducing endogenous neuraminidase activity, which accelerated the molecular aging and clearance of intestinal alkaline phosphatase (IAP). Disease was linked to a Toll-like receptor 4 (TLR4)-dependent mechanism of IAP desialylation with accumulation of the IAP substrate and TLR4 ligand, lipopolysaccharide-phosphate. The administration of IAP or the antiviral neuraminidase inhibitor zanamivir was therapeutic by maintaining IAP abundance and function.	[Yang, Won Ho; Heithoff, Douglas M.; Aziz, Peter V.; Mahan, Michael J.; Marth, Jamey D.] Univ Calif Santa Barbara, Ctr Nanomed, Santa Barbara, CA 93106 USA; [Yang, Won Ho; Aziz, Peter V.; Marth, Jamey D.] Univ Calif Santa Barbara, Sanford Burnham Prebys Med Discovery Inst, Santa Barbara, CA 93106 USA; [Yang, Won Ho; Heithoff, Douglas M.; Aziz, Peter V.; Mahan, Michael J.; Marth, Jamey D.] Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA; [Sperandio, Markus] Ludwig Maximilians Univ Munchen, Walter Brendel Ctr Expt Med, Munich, Germany; [Nizet, Victor] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Nizet, Victor] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA	University of California System; University of California Santa Barbara; Sanford Burnham Prebys Medical Discovery Institute; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; University of Munich; University of California System; University of California San Diego; University of California System; University of California San Diego	Marth, JD (corresponding author), Univ Calif Santa Barbara, Ctr Nanomed, Santa Barbara, CA 93106 USA.; Marth, JD (corresponding author), Univ Calif Santa Barbara, Sanford Burnham Prebys Med Discovery Inst, Santa Barbara, CA 93106 USA.; Marth, JD (corresponding author), Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA.	jmarth@sbpdiscovery.com	Nizet, Victor/AAF-3190-2019	Marth, Jamey/0000-0001-9323-1649; Heithoff, Douglas/0000-0001-8954-2516; Aziz, Peter/0000-0001-8957-100X; Nizet, Victor/0000-0003-3847-0422; Sperandio, Markus/0000-0002-7689-3613	NIH [HL125352, HL131474]; Wille Family Foundation; German Research Foundation [SFB914]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL131474, R01HL125352] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wille Family Foundation; German Research Foundation(German Research Foundation (DFG)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was funded by NIH grants HL125352 (J.D.M. and V.N.) and HL131474 (J.D.M., M.J.M., and V.N.). Additional support was provided by the Wille Family Foundation (J.D.M.) and by SFB914 from the German Research Foundation (M.S.). The data presented in this study are in the main text and in the Supplementary Materials. W.H.Y., D.M.H., P.V.A., M.J.M., and J.D.M. designed the experimental strategies. J.D.M. and M.J.M. supervised the project. W.H.Y., D.M.H., and P.V.A. performed the experiments and acquired data. All authors contributed to data analysis and manuscript preparation. The authors declare that they have no competing interests.	Abreu MT, 2010, NAT REV IMMUNOL, V10, P131, DOI 10.1038/nri2707; Alam SN, 2014, ANN SURG, V259, P715, DOI 10.1097/SLA.0b013e31828fae14; Bates JM, 2007, CELL HOST MICROBE, V2, P371, DOI 10.1016/j.chom.2007.10.010; Beutler B, 2000, CURR OPIN MICROBIOL, V3, P23, DOI 10.1016/S1369-5274(99)00046-6; Carl VS, 2004, J LEUKOCYTE BIOL, V76, P735, DOI 10.1189/jlb.1003526; Crocker PR, 2007, NAT REV IMMUNOL, V7, P255, DOI 10.1038/nri2056; Davis MR, 2012, JOVE-J VIS EXP, DOI 10.3791/3916; de Jong HK, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002933; Dheer R, 2016, INFECT IMMUN, V84, P798, DOI 10.1128/IAI.01374-15; Dolowschiak T, 2016, CELL HOST MICROBE, V20, P238, DOI 10.1016/j.chom.2016.06.008; Eckmann L, 2006, ANN NY ACAD SCI, V1072, P28, DOI 10.1196/annals.1326.008; Ellies LG, 2002, BLOOD, V100, P3618, DOI 10.1182/blood-2002-04-1007; Ellies LG, 2002, P NATL ACAD SCI USA, V99, P10042, DOI 10.1073/pnas.142005099; Feasey NA, 2012, LANCET, V379, P2489, DOI 10.1016/S0140-6736(11)61752-2; Figueroa-Bossi N, 2001, MOL MICROBIOL, V39, P260, DOI 10.1046/j.1365-2958.2001.02234.x; Foot NJ, 2011, BLOOD, V117, P638, DOI 10.1182/blood-2010-07-295287; Foster SL, 2009, CLIN IMMUNOL, V130, P7, DOI 10.1016/j.clim.2008.08.015; Fu JX, 2011, J CLIN INVEST, V121, P1657, DOI 10.1172/JCI45538; Fuhrer A, 2010, J EXP MED, V207, P2843, DOI 10.1084/jem.20101098; Gilliss Debra, 2011, Morbidity and Mortality Weekly Report, V60, P749; Goldberg RF, 2008, P NATL ACAD SCI USA, V105, P3551, DOI 10.1073/pnas.0712140105; Grewal PK, 2006, MOL CELL BIOL, V26, P4970, DOI 10.1128/MCB.00308-06; Halfvarson J, 2011, INFLAMM BOWEL DIS, V17, P6, DOI 10.1002/ibd.21295; Hata K, 2008, ANTIMICROB AGENTS CH, V52, P3484, DOI 10.1128/AAC.00344-08; Heithoff DM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002647; Hinnebusch BF, 2004, AM J PHYSIOL-GASTR L, V286, pG23, DOI 10.1152/ajpgi.00203.2003; Huang Y.-L., 2015, NAT COMMUN, V6; Huhta H, 2016, J HISTOCHEM CYTOCHEM, V64, P470, DOI 10.1369/0022155416656154; Kakugawa Y, 2002, P NATL ACAD SCI USA, V99, P10718, DOI 10.1073/pnas.152597199; Kamada N, 2013, NAT REV IMMUNOL, V13, P321, DOI 10.1038/nri3430; Kamdar K, 2016, CELL HOST MICROBE, V19, P21, DOI 10.1016/j.chom.2015.12.006; Kaser A, 2010, ANNU REV IMMUNOL, V28, P573, DOI 10.1146/annurev-immunol-030409-101225; Kawamura S, 2012, CELL DEATH DIFFER, V19, P170, DOI 10.1038/cdd.2011.83; Khor B, 2011, NATURE, V474, P307, DOI 10.1038/nature10209; Knights D, 2013, GUT, V62, P1505, DOI 10.1136/gutjnl-2012-303954; Koyama I, 2002, CLIN BIOCHEM, V35, P455, DOI 10.1016/S0009-9120(02)00330-2; Leaphart CL, 2007, J IMMUNOL, V179, P4808, DOI 10.4049/jimmunol.179.7.4808; Lee CH, 1999, ANAL BIOCHEM, V267, P161, DOI 10.1006/abio.1998.2961; Liu FT, 2010, ANN NY ACAD SCI, V1183, P158, DOI 10.1111/j.1749-6632.2009.05131.x; Lukas M, 2010, INFLAMM BOWEL DIS, V16, P1180, DOI 10.1002/ibd.21161; Ma W, 2001, J BIOL CHEM, V276, P13664, DOI 10.1074/jbc.M011157200; Majowicz SE, 2010, CLIN INFECT DIS, V50, P882, DOI 10.1086/650733; Manco S, 2006, INFECT IMMUN, V74, P4014, DOI 10.1128/IAI.01237-05; Miklavcic JJ, 2015, WORLD J GASTROENTERO, V21, P10080, DOI 10.3748/wjg.v21.i35.10080; Molnar K, 2012, WORLD J GASTROENTERO, V18, P3254, DOI 10.3748/wjg.v18.i25.3254; Monti E, 2010, ADV CARBOHYD CHEM BI, V64, P403, DOI 10.1016/S0065-2318(10)64007-3; Moscona A, 2005, NEW ENGL J MED, V353, P1363, DOI 10.1056/NEJMra050740; Mozzi A, 2015, GLYCOBIOLOGY, V25, P855, DOI 10.1093/glycob/cwv026; Nagalingam NA, 2012, INFLAMM BOWEL DIS, V18, P968, DOI 10.1002/ibd.21866; Narisawa S, 2003, MOL CELL BIOL, V23, P7525, DOI 10.1128/MCB.23.21.7525-7530.2003; Ohtsubo K, 2005, CELL, V123, P1307, DOI 10.1016/j.cell.2005.09.041; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; Ohtsubo K, 2011, NAT MED, V17, P1067, DOI 10.1038/nm.2414; Poelstra K, 1997, LAB INVEST, V76, P319; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Ramasamy S, 2011, INFLAMM BOWEL DIS, V17, P532, DOI 10.1002/ibd.21377; Sansonetti PJ, 2004, NAT REV IMMUNOL, V4, P953, DOI 10.1038/nri1499; Scallan E, 2011, EMERG INFECT DIS, V17, P16, DOI [10.3201/eid1701.P21101, 10.3201/eid1701.091101p2]; Schwerdtfeger SM, 2010, PHARMAZIE, V65, P551, DOI 10.1691/ph.2010.0546; Sonnenberg A, 2008, INFLAMM BOWEL DIS, V14, P955, DOI 10.1002/ibd.20408; Stamatos NM, 2010, J LEUKOCYTE BIOL, V88, P1227, DOI 10.1189/jlb.1209776; SUSSMAN NL, 1989, AM J PHYSIOL, V257, pG14, DOI 10.1152/ajpgi.1989.257.1.G14; Tuin A, 2009, GUT, V58, P379, DOI 10.1136/gut.2007.128868; Varki A, 2012, ANN NY ACAD SCI, V1253, P16, DOI 10.1111/j.1749-6632.2012.06517.x; Wada T, 1999, BIOCHEM BIOPH RES CO, V261, P21, DOI 10.1006/bbrc.1999.0973; Weinhold B, 2005, J BIOL CHEM, V280, P42971, DOI 10.1074/jbc.M511097200; Yamaguchi K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041132; Yamaguchi K, 2010, BIOCHEM J, V430, P107, DOI 10.1042/BJ20100350; Yang WH, 2015, P NATL ACAD SCI USA, V112, P13657, DOI 10.1073/pnas.1515464112; Yang WH, 2012, BLOOD, V120, P1015, DOI 10.1182/blood-2012-04-424366; Zaki MH, 2010, IMMUNITY, V32, P379, DOI 10.1016/j.immuni.2010.03.003	71	47	48	1	62	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 22	2017	358	6370							eaao5610	10.1126/science.aao5610	http://dx.doi.org/10.1126/science.aao5610			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FQ6BO	29269445	Green Accepted			2022-12-28	WOS:000418448000057
J	Baicker, K; Chandra, A				Baicker, Katherine; Chandra, Amitabh			Evidence-Based Health Policy	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							EMERGENCY-DEPARTMENT USE; INSURANCE	A clear framework for defining evidence-based health policy (EBHP) is a prerequisite for a rational approach to making policy choices. EBHP requires well-specified policies, distinguishing between policies and goals, and empirical evidence of the magnitude of effects.	[Baicker, Katherine] Univ Chicago, Chicago, IL 60637 USA; [Baicker, Katherine; Chandra, Amitabh] Natl Bur Econ Res, Cambridge, MA 02138 USA; [Chandra, Amitabh] Harvard Univ, Cambridge, MA 02138 USA	University of Chicago; National Bureau of Economic Research; Harvard University	Baicker, K (corresponding author), Univ Chicago, Chicago, IL 60637 USA.; Baicker, K (corresponding author), Natl Bur Econ Res, Cambridge, MA 02138 USA.							Asch DA, 2016, NEW ENGL J MED, V374, P606, DOI 10.1056/NEJMp1512297; Ioannidis JPA, 2016, J CLIN EPIDEMIOL, V73, P82, DOI 10.1016/j.jclinepi.2016.02.012; McWilliams JM, 2016, NEW ENGL J MED, V375, P2218, DOI 10.1056/NEJMp1610821; Sommers BD, 2017, NEW ENGL J MED, V376, P1708, DOI 10.1056/NEJMp1614378; Taubman SL, 2014, SCIENCE, V343, P263, DOI 10.1126/science.1246183	5	38	39	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 21	2017	377	25					2413	2415		10.1056/NEJMp1709816	http://dx.doi.org/10.1056/NEJMp1709816			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FQ5RZ	29262287				2022-12-28	WOS:000418420000004
J	Bergmark, RW; Pynnonen, M				Bergmark, Regan W.; Pynnonen, Melissa			Diagnosis and First-Line Treatment of Chronic Sinusitis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							UPDATE ADULT SINUSITIS; CHRONIC RHINOSINUSITIS; CANADIAN GUIDELINES	IMPORTANCE Practice guidelines have provided a strong recommendation for the daily use of topical intranasal steroid therapy for patients with chronic rhinosinusitis (CRS). Deficiencies in utilization of intranasal steroid therapy may represent a gap in quality of care. OBJECTIVE To evaluate the utilization patterns of topical intranasal steroid therapy for CRS in the Canadian population. DESIGN, SETTING, AND PARTICIPANTS Retrospective review of a Canadian population-based health care administrative database. A validated case definition for CRS was applied, and the utilization of topical intranasal steroid therapy within this cohort was quantified during the 2014-2015 fiscal year. INTERVENTIONS Intranasal steroid spray for CRS. MAIN OUTCOMES AND MEASURES Primary outcome was the rate ( per 100 patients) and quantity ( per patient) of intranasal steroid spray utilization in patients with CRS. Secondary outcome was the geographic variation in the rate and quantity of intranasal steroid spray utilization for CRS. RESULTS A total of 19 057 adult patients with CRS were evaluated. The overall rate of intranasal steroid spray utilization was 20.1 per 100 patients with CRS ( 3821 of 19 057). In the 3821 patients with CRS who used an intranasal steroid spray during 2014 to 2015, the mean quantity of utilization was 2.4 U ( 1 U = 1 bottle per month) per patient ( 9314 U divided by 3821 patients with CRS). There was large geographic variation in both the rate and quantity of intranasal steroid spray utilization (P < .001 for both comparisons). CONCLUSIONS AND RELEVANCE Topical intranasal steroid therapy continues to be underutilized for patients with CRS. Given the negative impact of low-quality medical care, outcomes from this study indicate a need to further evaluate factors leading to the underutilization of a recommended treatment in patients with CRS to improve overall health system performance.	[Bergmark, Regan W.] Harvard Med Sch, Dept Otolaryngol, Boston, MA USA; [Bergmark, Regan W.] Massachusetts Eye & Ear Infirm, Dept Otolaryngol, 243 Charles St, Boston, MA 02114 USA; [Pynnonen, Melissa] Univ Michigan, Dept Otolaryngol Head & Neck Surg, 1500 E Med Ctr Dr,SPC 5312, Ann Arbor, MI 48109 USA	Harvard University; Harvard Medical School; Harvard University; Massachusetts Eye & Ear Infirmary; University of Michigan System; University of Michigan	Pynnonen, M (corresponding author), Univ Michigan, Dept Otolaryngol Head & Neck Surg, 1500 E Med Ctr Dr,SPC 5312, Ann Arbor, MI 48109 USA.	pynnonen@med.umich.edu		Bergmark, Regan/0000-0003-3249-4343				Fokkens WJ, 2012, RHINOLOGY, V50, P1, DOI 10.4193/Rhin20.600; Goodman Denise M, 2013, JAMA, V309, P837, DOI 10.1001/jama.2013.1137; Kaplan A, 2013, CAN FAM PHYSICIAN, V59, pE528; Kaplan A, 2013, CAN FAM PHYSICIAN, V59, P1275; Novis SJ, 2016, INT FORUM ALLERGY RH, V6, P486, DOI 10.1002/alr.21691; Perry BF, 2004, OTOLARYNG HEAD NECK, V130, P449, DOI 10.1016/j.otohns.2004.01.005; Rosenfeld RM, 2015, OTOLARYNG HEAD NECK, V152, P598, DOI 10.1177/0194599815574247; Rosenfeld RM, 2015, OTOLARYNG HEAD NECK, V152, pS1, DOI 10.1177/0194599815572097; Rudmik L, 2016, JAMA OTOLARYNGOL, V142, P1056, DOI 10.1001/jamaoto.2016.1110; Rudmik L, 2015, JAMA-J AM MED ASSOC, V314, P926, DOI 10.1001/jama.2015.7544	10	2	2	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 19	2017	318	23					2344	2345		10.1001/jama.2017.18196	http://dx.doi.org/10.1001/jama.2017.18196			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FQ3RJ	29260210				2022-12-28	WOS:000418274000022
J	Fletcher, RH				Fletcher, Robert H.			Colonoscopy outreach increased CRC screening more than FIT outreach; both were better than usual care	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							BLOOD-TEST		[Fletcher, Robert H.] Harvard Med Sch, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Fletcher, RH (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.							Chubak J, 2016, CANCER EPIDEM BIOMAR, V25, P344, DOI 10.1158/1055-9965.EPI-15-0470; Fenton JJ, 2010, ANN FAM MED, V8, P397, DOI 10.1370/afm.1133	2	1	1	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 19	2017	167	12					JC65	JC65		10.7326/ACPJC-2017-167-12-065	http://dx.doi.org/10.7326/ACPJC-2017-167-12-065			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FQ3SD	29255855				2022-12-28	WOS:000418276000005
J	Llinas, M				Llinas, Manuel			Less Lipid, More Commitment	CELL			English	Editorial Material							HUMAN MALARIA PARASITE; PLASMODIUM-FALCIPARUM; SEXUAL DEVELOPMENT; TRANSMISSION	Sexual differentiation of the malaria parasite is a pre-requisite for transmission from humans to the mosquito vector and has emerged as a target for intervention in eradication efforts. In this issue of Cell, a study from Marti, Clardy, and colleagues (Brancucci et al., 2017) describes a host-derived lipid lysophosphatidylcholine (LysoPC) that regulates sexual commitment.	[Llinas, Manuel] Penn State Univ, Dept Chem, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; [Llinas, Manuel] Penn State Univ, Huck Ctr Malaria Res, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Llinas, M (corresponding author), Penn State Univ, Dept Chem, Dept Biochem & Mol Biol, University Pk, PA 16802 USA.; Llinas, M (corresponding author), Penn State Univ, Huck Ctr Malaria Res, University Pk, PA 16802 USA.	manuel@psu.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI125565] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI125565] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bobenchik AM, 2013, P NATL ACAD SCI USA, V110, P18262, DOI 10.1073/pnas.1313965110; Brancucci N. M. B., 2017, CELL; Brancucci NMB, 2015, NAT PROTOC, V10, P1131, DOI 10.1038/nprot.2015.072; Josling GA, 2015, NAT REV MICROBIOL, V13, P573, DOI 10.1038/nrmicro3519; Kafsack BFC, 2014, NATURE, V507, P248, DOI 10.1038/nature12920; Pessi G, 2004, P NATL ACAD SCI USA, V101, P6206, DOI 10.1073/pnas.0307742101; Poran A, 2017, NATURE, V551, P95, DOI 10.1038/nature24280; Silvestrini F, 2000, PARASITOLOGY, V121, P465, DOI 10.1017/S0031182099006691; Sinha A, 2014, NATURE, V507, P253, DOI 10.1038/nature12970; Smith TG, 2000, PARASITOLOGY, V121, P127, DOI 10.1017/S0031182099006265	10	6	6	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 14	2017	171	7					1474	1476		10.1016/j.cell.2017.11.044	http://dx.doi.org/10.1016/j.cell.2017.11.044			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FQ0KF	29245007	Green Accepted, Bronze			2022-12-28	WOS:000418044000004
J	Cantuti-Castelvetri, L; Fitzner, D; Bosch-Queralt, M; Weil, MT; Su, MH; Sen, P; Ruhwedel, T; Mitkovski, M; Trendelenburg, G; Lutjohann, D; Mobius, W; Simons, M				Cantuti-Castelvetri, Ludovico; Fitzner, Dirk; Bosch-Queralt, Mar; Weil, Marie-Theres; Su, Minhui; Sen, Paromita; Ruhwedel, Torben; Mitkovski, Miso; Trendelenburg, George; Luetjohann, Dieter; Moebius, Wiebke; Simons, Mikael			Defective cholesterol clearance limits remyelination in the aged central nervous system	SCIENCE			English	Article							LIVER X RECEPTORS; MULTIPLE-SCLEROSIS; CNS REMYELINATION; APOLIPOPROTEIN-E; DIFFERENTIATION; MACROPHAGES; MICROGLIA; CELLS	Age-associated decline in regeneration capacity limits the restoration of nervous system functionality after injury. In a model for demyelination, we found that old mice fail to resolve the inflammatory response initiated after myelin damage. Aged phagocytes accumulated excessive amounts of myelin debris, which triggered cholesterol crystal formation and phagolysosomal membrane rupture and stimulated inflammasomes. Myelin debris clearance required cholesterol transporters, including apolipoprotein E. Stimulation of reverse cholesterol transport was sufficient to restore the capacity of old mice to remyelinate lesioned tissue. Thus, cholesterol-rich myelin debris can overwhelm the efflux capacity of phagocytes, resulting in a phase transition of cholesterol into crystals and thereby inducing a maladaptive immune response that impedes tissue regeneration.	[Cantuti-Castelvetri, Ludovico; Fitzner, Dirk; Bosch-Queralt, Mar; Weil, Marie-Theres; Su, Minhui; Sen, Paromita; Simons, Mikael] Max Planck Inst Expt Med, D-37075 Gottingen, Germany; [Cantuti-Castelvetri, Ludovico; Bosch-Queralt, Mar; Su, Minhui; Simons, Mikael] Munich Cluster Syst Neurol SyNergy, D-81377 Munich, Germany; [Cantuti-Castelvetri, Ludovico; Bosch-Queralt, Mar; Su, Minhui; Simons, Mikael] Tech Univ Munich, Inst Neuronal Cell Biol, D-80805 Munich, Germany; [Cantuti-Castelvetri, Ludovico; Bosch-Queralt, Mar; Su, Minhui; Simons, Mikael] German Ctr Neurodegenerat Dis DZNE, D-81377 Munich, Germany; [Fitzner, Dirk; Trendelenburg, George] Univ Gottingen, Dept Neurol, Med Ctr, D-37075 Gottingen, Germany; [Weil, Marie-Theres; Moebius, Wiebke] Ctr Nanoscale Microscopy & Mol Physiol Brain CNMP, D-37075 Gottingen, Germany; [Ruhwedel, Torben; Moebius, Wiebke] Max Planck Inst Expt Med, Dept Neurogenet, D-37075 Gottingen, Germany; [Mitkovski, Miso] Max Planck Inst Expt Med, Light Microscopy Facil, D-37075 Gottingen, Germany; [Luetjohann, Dieter] Univ Bonn, Inst Clin Chem & Clin Pharmacol, D-53127 Bonn, Germany	Max Planck Society; University of Munich; Technical University of Munich; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Gottingen; Max Planck Society; Max Planck Society; University of Bonn	Simons, M (corresponding author), Max Planck Inst Expt Med, D-37075 Gottingen, Germany.; Simons, M (corresponding author), Munich Cluster Syst Neurol SyNergy, D-81377 Munich, Germany.; Simons, M (corresponding author), Tech Univ Munich, Inst Neuronal Cell Biol, D-80805 Munich, Germany.; Simons, M (corresponding author), German Ctr Neurodegenerat Dis DZNE, D-81377 Munich, Germany.	msimons@gwdg.de	Cantuti-Castelvetri, Ludovico/AAH-8208-2019; Cantuti-castelvetri, Ludovico/AAF-9990-2020	Cantuti-Castelvetri, Ludovico/0000-0002-0642-1610; Trendelenburg, George/0000-0001-9277-6241; Mitkovski, Miso/0000-0001-9195-2434; Sen, Paromita/0000-0001-9862-6914; Simons, Mikael/0000-0001-5329-192X; Ruhwedel, Torben/0000-0002-9535-9395; /0000-0002-2902-7165	European Research Council (ERC) Consolidator Grant; German Research Foundation (DFG) [SI 746/9-1, SI 746/10-1, SPP1757, TRR128, TRR43]; Klaus Tschira Stiftung; Adelson Foundation; Excellence Cluster for Systems Neurology (SyNergy); Excellence Cluster for Nanoscale Microscopy and Molecular Physiology of the Brain (CNMPB); ERC grant; Boehringer Ingelheim stipend	European Research Council (ERC) Consolidator Grant(European Research Council (ERC)); German Research Foundation (DFG)(German Research Foundation (DFG)); Klaus Tschira Stiftung; Adelson Foundation; Excellence Cluster for Systems Neurology (SyNergy); Excellence Cluster for Nanoscale Microscopy and Molecular Physiology of the Brain (CNMPB); ERC grant; Boehringer Ingelheim stipend	We thank L. Vaculciakova for help with the calculations of three-dimensional reconstructions and A. Kerksiek for technical assistance. This work was supported by a European Research Council (ERC) Consolidator Grant (M.S.) and grants from the German Research Foundation (DFG) (SI 746/9-1,10-1, SPP1757, TRR128, and TRR43), the Klaus Tschira Stiftung, the Adelson Foundation, Excellence Cluster for Systems Neurology (SyNergy), and Excellence Cluster for Nanoscale Microscopy and Molecular Physiology of the Brain (CNMPB). W.M. is supported by an ERC grant to K.-A. Nave. M.B.-Q. is supported by a Boehringer Ingelheim stipend. All data are presented in the main text and supplementary materials.	Aguzzi A, 2013, SCIENCE, V339, P156, DOI 10.1126/science.1227901; Bei FF, 2016, CELL, V164, P219, DOI 10.1016/j.cell.2015.11.036; Deshmukh VA, 2013, NATURE, V502, P327, DOI 10.1038/nature12647; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Fu X, 2001, J BIOL CHEM, V276, P38378, DOI 10.1074/jbc.M105805200; Hafiane A, 2014, BBA-MOL CELL BIOL L, V1841, P1498, DOI 10.1016/j.bbalip.2014.07.018; Hong C, 2014, NAT REV DRUG DISCOV, V13, P433, DOI 10.1038/nrd4280; Huang JK, 2011, NAT NEUROSCI, V14, P45, DOI 10.1038/nn.2702; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; Meffre D, 2015, P NATL ACAD SCI USA, V112, P7587, DOI 10.1073/pnas.1424951112; Mei F, 2014, NAT MED, V20, P954, DOI 10.1038/nm.3618; Miron VE, 2013, NAT NEUROSCI, V16, P1211, DOI 10.1038/nn.3469; Moore KJ, 2011, CELL, V145, P341, DOI 10.1016/j.cell.2011.04.005; Najm FJ, 2015, NATURE, V522, P216, DOI 10.1038/nature14335; Patrikios P, 2006, BRAIN, V129, P3165, DOI 10.1093/brain/awl217; Rajamaki K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011765; Ruckh JM, 2012, CELL STEM CELL, V10, P96, DOI 10.1016/j.stem.2011.11.019; Shen SM, 2008, NAT NEUROSCI, V11, P1024, DOI 10.1038/nn.2172; Zimmer S, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad6100	19	206	209	14	68	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 9	2018	359	6376					684	688		10.1126/science.aan4183	http://dx.doi.org/10.1126/science.aan4183			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW2FH	29301957	Green Submitted			2022-12-28	WOS:000425117700040
J	Cheung, LC; Katki, HA; Chaturvedi, AK; Jemal, A; Berg, CD				Cheung, Li C.; Katki, Hormuzd A.; Chaturvedi, Anil K.; Jemal, Ahmedin; Berg, Christine D.			Preventing Lung Cancer Mortality by Computed Tomography Screening: The Effect of Risk-Based Versus US Preventive Services Task Force Eligibility Criteria, 2005-2015	ANNALS OF INTERNAL MEDICINE			English	Letter									[Cheung, Li C.; Katki, Hormuzd A.; Chaturvedi, Anil K.; Berg, Christine D.] NCI, NIH, US Dept HHS, Bethesda, MD 20892 USA; [Jemal, Ahmedin] Amer Canc Soc, Atlanta, GA 30329 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); American Cancer Society	Cheung, LC (corresponding author), NCI, NIH, US Dept HHS, Bethesda, MD 20892 USA.	li.cheung@nih.gov	Cheung, Li/AAY-3594-2020	Cheung, Li/0000-0003-1625-4331	Intramural Research Program of the U.S. National Institutes of Health/National Cancer Institute; NATIONAL CANCER INSTITUTE [ZIACP010181] Funding Source: NIH RePORTER	Intramural Research Program of the U.S. National Institutes of Health/National Cancer Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	By the Intramural Research Program of the U.S. National Institutes of Health/National Cancer Institute.	Jemal A, 2017, JAMA ONCOL, V3, P1278, DOI 10.1001/jamaoncol.2016.6416; Katki HA, 2016, JAMA-J AM MED ASSOC, V315, P2300, DOI 10.1001/jama.2016.6255; Lumley T., 2004, J STAT SOFTW, V9, P1, DOI [10.18637/jss.v009.i08, DOI 10.18637/JSS.V009.I08]; Moyer VA, 2014, ANN INTERN MED, V160, P330, DOI 10.7326/M13-2771; Pinsky PF, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv226	5	37	37	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 6	2018	168	3					229	232		10.7326/M17-2067	http://dx.doi.org/10.7326/M17-2067			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FV0CU	29297008	Green Accepted			2022-12-28	WOS:000424224300015
J	Nikolaev, SI; Vetiska, S; Bonilla, X; Boudreau, E; Jauhiainen, S; Jahromi, BR; Khyzha, N; DiStefano, PV; Suutarinen, S; Kiehl, TR; Pereira, VM; Herman, AM; Krings, T; Andrade-Barazarte, H; Tung, T; Valiante, T; Zadeh, G; Tymianski, M; Rauramaa, T; Yla-Herttuala, S; Wythe, JD; Antonarakis, SE; Frosen, J; Fish, JE; Radovanovic, I				Nikolaev, S. I.; Vetiska, S.; Bonilla, X.; Boudreau, E.; Jauhiainen, S.; Jahromi, B. Rezai; Khyzha, N.; DiStefano, P. V.; Suutarinen, S.; Kiehl, T. -R.; Pereira, V. Mendes; Herman, A. M.; Krings, T.; Andrade-Barazarte, H.; Tung, T.; Valiante, T.; Zadeh, G.; Tymianski, M.; Rauramaa, T.; Yla-Herttuala, S.; Wythe, J. D.; Antonarakis, S. E.; Frosen, J.; Fish, J. E.; Radovanovic, I.			Somatic Activating KRAS Mutations in Arteriovenous Malformations of the Brain	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							VENOUS MALFORMATION; ENDOTHELIAL-CELLS; SIGNALING PATHWAY; GENE; NOTCH; ANGIOGENESIS; PREVALENCE; RECEPTORS; DISEASE; PROTEIN	BACKGROUND Sporadic arteriovenous malformations of the brain, which are morphologically abnormal connections between arteries and veins in the brain vasculature, are a leading cause of hemorrhagic stroke in young adults and children. The genetic cause of this rare focal disorder is unknown. METHODS We analyzed tissue and blood samples from patients with arteriovenous malformations of the brain to detect somatic mutations. We performed exome DNA sequencing of tissue samples of arteriovenous malformations of the brain from 26 patients in the main study group and of paired blood samples from 17 of those patients. To confirm our findings, we performed droplet digital polymerase-chain-reaction (PCR) analysis of tissue samples from 39 patients in the main study group (21 with matching blood samples) and from 33 patients in an independent validation group. We interrogated the downstream signaling pathways, changes in gene expression, and cellular phenotype that were induced by activating KRAS mutations, which we had discovered in tissue samples. RESULTS We detected somatic activating KRAS mutations in tissue samples from 45 of the 72 patients and in none of the 21 paired blood samples. In endothelial cell-enriched cultures derived from arteriovenous malformations of the brain, we detected KRAS mutations and observed that expression of mutant KRAS (KRAS(G12V)) in endothelial cells in vitro induced increased ERK (extracellular signal-regulated kinase) activity, increased expression of genes related to angiogenesis and Notch signaling, and enhanced migratory behavior. These processes were reversed by inhibition of MAPK (mitogen-activated protein kinase)-ERK signaling. CONCLUSIONS We identified activating KRAS mutations in the majority of tissue samples of arteriovenous malformations of the brain that we analyzed. We propose that these malformations develop as a result of KRAS-induced activation of the MAPK-ERK signaling pathway in brain endothelial cells.	[Nikolaev, S. I.; Bonilla, X.; Antonarakis, S. E.] Univ Geneva, Dept Genet Med & Dev, Med Sch, Geneva, Switzerland; [Nikolaev, S. I.; Antonarakis, S. E.] Univ Hosp Geneva, Serv Genet Med, Geneva, Switzerland; [Antonarakis, S. E.] Inst Genet & Genom Geneva, iGE3, Geneva, Switzerland; [Vetiska, S.; Tymianski, M.; Radovanovic, I.] Krembil Res Inst, Dept Fundamental Neurobiol, Toronto, ON, Canada; [Boudreau, E.; Khyzha, N.; DiStefano, P. V.; Fish, J. E.] Toronto Gen Hosp, Res Inst, Toronto, ON, Canada; [Kiehl, T. -R.] Univ Hlth Network, Toronto Western Hosp, Dept Pathol, Toronto, ON, Canada; [Pereira, V. Mendes; Krings, T.; Andrade-Barazarte, H.; Tung, T.; Valiante, T.; Zadeh, G.; Tymianski, M.; Radovanovic, I.] Univ Hlth Network, Toronto Western Hosp, Div Neurosurg, Dept Surg, Toronto, ON, Canada; [Pereira, V. Mendes; Krings, T.] Univ Hlth Network, Toronto Western Hosp, Joint Div Med Imaging, Dept Med Imaging, Toronto, ON, Canada; [Boudreau, E.; Khyzha, N.; DiStefano, P. V.; Kiehl, T. -R.; Fish, J. E.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Boudreau, E.; Khyzha, N.; DiStefano, P. V.; Fish, J. E.] Heart & Stroke Richard Lewar Ctr Excellence Cardi, Toronto, ON, Canada; [Jauhiainen, S.; Jahromi, B. Rezai; Suutarinen, S.; Yla-Herttuala, S.; Frosen, J.] Univ Eastern Finland, Dept Mol Med, AIV Inst, Kuopio, Finland; [Jauhiainen, S.; Jahromi, B. Rezai; Suutarinen, S.; Rauramaa, T.; Frosen, J.] Kuopio Univ Hosp, Hemorrhag Brain Pathol Res Grp, Dept Neurosurg, Kuopio, Finland; [Jauhiainen, S.; Jahromi, B. Rezai; Suutarinen, S.; Rauramaa, T.; Frosen, J.] Kuopio Univ Hosp, NeuroCtr, Kuopio, Finland; [Rauramaa, T.] Kuopio Univ Hosp, Dept Pathol, Kuopio, Finland; [Herman, A. M.; Wythe, J. D.] Baylor Coll Med, Cardiovasc Res Inst, Houston, TX 77030 USA; [Herman, A. M.; Wythe, J. D.] Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA	University of Geneva; University of Geneva; Krembil Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; Finland National Institute for Health & Welfare; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; Baylor College of Medicine; Baylor College of Medicine	Nikolaev, SI (corresponding author), Univ Geneva, Dept Genet Med & Dev, Med Sch, Geneva, Switzerland.; Radovanovic, I (corresponding author), Krembil Res Inst, Dept Fundamental Neurobiol, Toronto, ON, Canada.; Fish, JE (corresponding author), Toronto Gen Hosp, Res Inst, Toronto, ON, Canada.; Radovanovic, I (corresponding author), Univ Hlth Network, Toronto Western Hosp, Div Neurosurg, Dept Surg, Toronto, ON, Canada.; Fish, JE (corresponding author), Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada.; Fish, JE (corresponding author), Heart & Stroke Richard Lewar Ctr Excellence Cardi, Toronto, ON, Canada.; Frosen, J (corresponding author), Univ Eastern Finland, Dept Mol Med, AIV Inst, Kuopio, Finland.; Frosen, J (corresponding author), Kuopio Univ Hosp, Hemorrhag Brain Pathol Res Grp, Dept Neurosurg, Kuopio, Finland.; Frosen, J (corresponding author), Kuopio Univ Hosp, NeuroCtr, Kuopio, Finland.	sergey.nikolaev@unige.ch; juhana.frosen@kuh.fi; jason.fish@utoronto.ca; ivan.radovanovic@uhn.ca	Bonilla, Ximena/AAI-7910-2021; Valiante, Taufik A/C-3285-2015; Antonarakis, Stylianos E/N-8866-2014; Jahromi, Behnam Rezai/ABD-3299-2020; Andrade-Barazarte, Hugo/AAK-3971-2020	Valiante, Taufik A/0000-0002-3443-3790; Antonarakis, Stylianos E/0000-0001-8907-5823; Jahromi, Behnam Rezai/0000-0003-3937-2816; Andrade-Barazarte, Hugo/0000-0001-6673-6369; Fish, Jason/0000-0003-0640-7277; Wythe, Joshua/0000-0002-3225-2937; Jauhiainen, Suvi/0000-0002-0630-8175; Bonilla, Ximena/0000-0002-4950-6825; Khyzha, Nadiya/0000-0001-8804-0039; Tymianski, Mike/0000-0002-6311-9565	Swiss Cancer League; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007676] Funding Source: NIH RePORTER	Swiss Cancer League; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funded by the Swiss Cancer League and others.	Al-Shahi R, 2002, J NEUROL NEUROSUR PS, V73, P547, DOI 10.1136/jnnp.73.5.547; Al-Shahi R, 2001, BRAIN, V124, P1900, DOI 10.1093/brain/124.10.1900; Amyere M, 2017, CIRCULATION, V136, P1037, DOI 10.1161/CIRCULATIONAHA.116.026886; Anglesio MS, 2017, NEW ENGL J MED, V376, P1835, DOI 10.1056/NEJMoa1614814; Ayturk UM, 2016, AM J HUM GENET, V98, P789, DOI 10.1016/j.ajhg.2016.03.009; Benedito R, 2013, EXP CELL RES, V319, P1281, DOI 10.1016/j.yexcr.2013.01.010; Berman MF, 2000, NEUROSURGERY, V47, P389, DOI 10.1097/00006123-200008000-00023; Boscolo E, 2006, INT J MOL MED, V18, P813; Brown RD, 1996, NEUROLOGY, V46, P949, DOI 10.1212/WNL.46.4.949; Cagnol S, 2013, ONCOGENE, V32, P564, DOI 10.1038/onc.2012.88; Couto JA, 2017, AM J HUM GENET, V100, P546, DOI 10.1016/j.ajhg.2017.01.018; Couto JA, 2016, PLAST RECONSTR SURG, V137, p77E, DOI 10.1097/PRS.0000000000001868; Couto JA, 2015, AM J HUM GENET, V96, P480, DOI 10.1016/j.ajhg.2015.01.007; Cuadrado A, 2010, BIOCHEM J, V429, P403, DOI 10.1042/BJ20100323; Do HD, 2012, ONCOTARGET, V3, P546; FINBY N, 1965, N Y State J Med, V65, P554; Fish JE, 2015, DEV DYNAM, V244, P391, DOI 10.1002/dvdy.24252; Gallione CJ, 2004, LANCET, V363, P852, DOI 10.1016/S0140-6736(04)15732-2; Hashimoto T, 2004, NEUROSURGERY, V54, P410, DOI 10.1227/01.NEU.0000103421.35266.71; Johnson DW, 1996, NAT GENET, V13, P189, DOI 10.1038/ng0696-189; Kouhara H, 1997, CELL, V89, P693, DOI 10.1016/S0092-8674(00)80252-4; Li S, 2014, MOL MED REP, V9, P2233, DOI 10.3892/mmr.2014.2061; Limaye N, 2015, AM J HUM GENET, V97, P914, DOI 10.1016/j.ajhg.2015.11.011; Limaye N, 2009, NAT GENET, V41, P118, DOI 10.1038/ng.272; Maddaluno L, 2013, NATURE, V498, P492, DOI 10.1038/nature12207; MCALLISTER KA, 1994, NAT GENET, V8, P345, DOI 10.1038/ng1294-345; Meadows KN, 2001, J BIOL CHEM, V276, P49289, DOI 10.1074/jbc.M108069200; Murphy PA, 2008, P NATL ACAD SCI USA, V105, P10901, DOI 10.1073/pnas.0802743105; Murphy PA, 2014, P NATL ACAD SCI USA, V111, P18007, DOI 10.1073/pnas.1415316111; Murphy PA, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3002670; Murphy PA, 2009, LAB INVEST, V89, P971, DOI 10.1038/labinvest.2009.62; Park JT, 2015, ONCOGENE, V34, P2801, DOI 10.1038/onc.2014.223; Revencu N, 2008, HUM MUTAT, V29, P959, DOI 10.1002/humu.20746; Simanshu DK, 2017, CELL, V170, P17, DOI 10.1016/j.cell.2017.06.009; Uranishi R, 2001, NEUROSURGERY, V48, P359, DOI 10.1097/00006123-200102000-00024; Zhang B, 2013, GENOME RES, V23, P917, DOI 10.1101/gr.149674.112; Zhao YJ, 2014, NAT REV CLIN ONCOL, V11, P385, DOI 10.1038/nrclinonc.2014.83; ZhuGe QC, 2009, BRAIN, V132, P3231, DOI 10.1093/brain/awp246	38	216	220	3	34	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 18	2018	378	3					250	261		10.1056/NEJMoa1709449	http://dx.doi.org/10.1056/NEJMoa1709449			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FT1IJ	29298116	Green Accepted, Bronze			2022-12-28	WOS:000422888400009
J	Acome, E; Mitchell, SK; Morrissey, TG; Emmett, MB; Benjamin, C; King, M; Radakovitz, M; Keplinger, C				Acome, E.; Mitchell, S. K.; Morrissey, T. G.; Emmett, M. B.; Benjamin, C.; King, M.; Radakovitz, M.; Keplinger, C.			Hydraulically amplified self-healing electrostatic actuators with muscle-like performance	SCIENCE			English	Article							DIELECTRIC ELASTOMER ACTUATORS; ARTIFICIAL MUSCLES; PART I; ROBOTS; SKIN	Existing soft actuators have persistent challenges that restrain the potential of soft robotics, highlighting a need for soft transducers that are powerful, high-speed, efficient, and robust. We describe a class of soft actuators, termed hydraulically amplified self-healing electrostatic (HASEL) actuators, which harness a mechanism that couples electrostatic and hydraulic forces to achieve a variety of actuation modes. We introduce prototypical designs of HASEL actuators and demonstrate their robust, muscle-like performance as well as their ability to repeatedly self-heal after dielectric breakdown-all using widely available materials and common fabrication techniques. A soft gripper handling delicate objects and a self-sensing artificial muscle powering a robotic arm illustrate the wide potential of HASEL actuators for next-generation soft robotic devices.	[Acome, E.; Mitchell, S. K.; Morrissey, T. G.; Emmett, M. B.; Benjamin, C.; King, M.; Radakovitz, M.; Keplinger, C.] Univ Colorado, Dept Mech Engn, Boulder, CO 80309 USA; [Keplinger, C.] Univ Colorado, Mat Sci & Engn Program, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	Keplinger, C (corresponding author), Univ Colorado, Dept Mech Engn, Boulder, CO 80309 USA.; Keplinger, C (corresponding author), Univ Colorado, Mat Sci & Engn Program, Boulder, CO 80309 USA.	christoph.keplinger@colorado.edu	Keplinger, Christoph/E-5553-2011	Keplinger, Christoph/0000-0001-9151-4100; King, Madeline/0000-0002-7126-3188	startup funds from the University of Colorado, Boulder; Undergraduate Research Opportunities Program at the University of Colorado, Boulder	startup funds from the University of Colorado, Boulder; Undergraduate Research Opportunities Program at the University of Colorado, Boulder	This work was supported by startup funds from the University of Colorado, Boulder. M.B.E, M.K., and M.R. received financial support from the Undergraduate Research Opportunities Program at the University of Colorado, Boulder. E.A., S.K.M., M.B.E., and C.K. are listed as inventors on a provisional patent application (U.S. 62/474,814) submitted by the University of Colorado, Boulder, that covers fundamental principles and various designs of HASEL transducers.	Bauer S, 2014, ADV MATER, V26, P149, DOI 10.1002/adma.201303349; Brochu P, 2010, MACROMOL RAPID COMM, V31, P10, DOI 10.1002/marc.200900425; Carpi F, 2003, SENSOR ACTUAT A-PHYS, V107, P85, DOI 10.1016/S0924-4247(03)00257-7; Carpi F, 2010, IEEE-ASME T MECH, V15, P308, DOI 10.1109/TMECH.2009.2021651; Dunki SJ, 2015, ADV FUNCT MATER, V25, P2467, DOI 10.1002/adfm.201500077; Haines CS, 2014, SCIENCE, V343, P868, DOI 10.1126/science.1246906; Hunt S, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4869294; Ilievski F, 2011, ANGEW CHEM INT EDIT, V50, P1890, DOI 10.1002/anie.201006464; Keplinger C, 2012, SOFT MATTER, V8, P285, DOI 10.1039/c1sm06736b; Keplinger C, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2929383; Kim S, 2013, TRENDS BIOTECHNOL, V31, P23, DOI 10.1016/j.tibtech.2013.03.002; Koh SJA, 2017, J MECH PHYS SOLIDS, V105, P81, DOI 10.1016/j.jmps.2017.04.015; Kovacs G, 2009, SENSOR ACTUAT A-PHYS, V155, P299, DOI 10.1016/j.sna.2009.08.027; Madden JDW, 2004, IEEE J OCEANIC ENG, V29, P706, DOI 10.1109/JOE.2004.833135; Mazzolai B, 2012, BIOINSPIR BIOMIM, V7, DOI 10.1088/1748-3182/7/2/025005; Overvelde JTB, 2015, P NATL ACAD SCI USA, V112, P10863, DOI 10.1073/pnas.1504947112; Pelrine R, 2000, SCIENCE, V287, P836, DOI 10.1126/science.287.5454.836; Plante JS, 2007, SENSOR ACTUAT A-PHYS, V137, P96, DOI 10.1016/j.sna.2007.01.017; Polygerinos P, 2017, ADV ENG MATER, V19, DOI 10.1002/adem.201700016; Rosset S, 2013, SMART MATER STRUCT, V22, DOI 10.1088/0964-1726/22/10/104018; Rus D, 2015, NATURE, V521, P467, DOI 10.1038/nature14543; Sadeghi MM, 2016, J MICROELECTROMECH S, V25, P557, DOI 10.1109/JMEMS.2016.2552141; Shepherd RF, 2011, P NATL ACAD SCI USA, V108, P20400, DOI 10.1073/pnas.1116564108; Song S, 2017, P NATL ACAD SCI USA, V114, pE4344, DOI 10.1073/pnas.1620344114; Sun JY, 2014, ADV MATER, V26, P7608, DOI 10.1002/adma.201403441; Suo ZG, 2010, ACTA MECH SOLIDA SIN, V23, P549, DOI 10.1016/s0894-9166(11)60004-9; Trimmer B, 2017, SOFT ROBOT, V4, P1, DOI 10.1089/soro.2017.29011.bat; Trivedi Deepak, 2008, Applied Bionics and Biomechanics, V5, P99, DOI 10.1080/11762320802557865; Wu EY, 2002, IEEE T ELECTRON DEV, V49, P2131, DOI 10.1109/TED.2002.805612; Yuan W, 2008, ADV MATER, V20, P621, DOI 10.1002/adma.200701018; Zhao XH, 2014, APPL PHYS REV, V1, DOI 10.1063/1.4871696; Zimmermann K., 2009, MECH TERRESTRIAL LOC, P125	32	457	474	112	842	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 5	2018	359	6371					61	65		10.1126/science.aao6139	http://dx.doi.org/10.1126/science.aao6139			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FR8KW	29302008				2022-12-28	WOS:000419324700066
J	Mjosberg, J; Rao, A				Mjosberg, Jenny; Rao, Anna			Lung inflammation originating in the gut	SCIENCE			English	Editorial Material							INNATE LYMPHOID-CELLS		[Mjosberg, Jenny; Rao, Anna] Karolinska Inst, Dept Med, Ctr Infect Med, Stockholm, Sweden; [Mjosberg, Jenny] Linkoping Univ, Dept Clin & Expt Med, Linkoping, Sweden	Karolinska Institutet; Linkoping University	Mjosberg, J (corresponding author), Karolinska Inst, Dept Med, Ctr Infect Med, Stockholm, Sweden.; Mjosberg, J (corresponding author), Linkoping Univ, Dept Clin & Expt Med, Linkoping, Sweden.	jenny.mjosberg@ki.se						Bal SM, 2016, NAT IMMUNOL, V17, P636, DOI 10.1038/ni.3444; Budden KF, 2017, NAT REV MICROBIOL, V15, P55, DOI 10.1038/nrmicro.2016.142; Ebbo M, 2017, NAT REV IMMUNOL, V17, P665, DOI 10.1038/nri.2017.86; Gasteiger G, 2015, SCIENCE, V350, P981, DOI 10.1126/science.aac9593; Huang YF, 2018, SCIENCE, V359, P114, DOI 10.1126/science.aam5809; Huang YF, 2015, NAT IMMUNOL, V16, P161, DOI 10.1038/ni.3078; Lim AI, 2017, CELL, V168, P1086, DOI 10.1016/j.cell.2017.02.021; Mandala S, 2002, SCIENCE, V296, P346, DOI 10.1126/science.1070238; Martinez-Gonzalez I, 2016, IMMUNITY, V45, P198, DOI 10.1016/j.immuni.2016.06.017; Silver JS, 2016, NAT IMMUNOL, V17, P626, DOI 10.1038/ni.3443; Skon CN, 2013, NAT IMMUNOL, V14, P1285, DOI 10.1038/ni.2745; Vetter M, 2017, THER ADV GASTROENTER, V10, P773, DOI 10.1177/1756283X17727388	12	37	53	7	103	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 5	2018	359	6371					36	37		10.1126/science.aar4301	http://dx.doi.org/10.1126/science.aar4301			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FR8KW	29302003				2022-12-28	WOS:000419324700057
J	Milanovic, M; Fan, DNY; Belenki, D; Dabritz, JHM; Zhao, Z; Yu, Y; Dorr, JR; Dimitrova, L; Lenze, D; Barbosa, IAM; Mendoza-Parra, MA; Kanashova, T; Metzner, M; Pardon, K; Reimann, M; Trumpp, A; Dorken, B; Zuber, J; Gronemeyer, H; Hummel, M; Dittmar, G; Lee, S; Schmitt, CA				Milanovic, Maja; Fan, Dorothy N. Y.; Belenki, Dimitri; Dabritz, J. Henry M.; Zhao, Zhen; Yu, Yong; Doerr, Jan R.; Dimitrova, Lora; Lenze, Dido; Barbosa, Ines A. Monteiro; Mendoza-Parra, Marco A.; Kanashova, Tamara; Metzner, Marlen; Pardon, Katharina; Reimann, Maurice; Trumpp, Andreas; Doerken, Bernd; Zuber, Johannes; Gronemeyer, Hinrich; Hummel, Michael; Dittmar, Gunnar; Lee, Soyoung; Schmitt, Clemens A.			Senescence-associated reprogramming promotes cancer stemness	NATURE			English	Article							ACUTE MYELOID-LEUKEMIA; CELLULAR SENESCENCE; SELF-RENEWAL; IN-VIVO; SECRETORY PHENOTYPE; TUMOR SUPPRESSION; DAMAGE RESPONSE; CELLS; P53; EXPRESSION	Cellular senescence is a stress-responsive cell-cycle arrest program that terminates the further expansion of (pre-) malignant cells(1,2). Key signalling components of the senescence machinery, such as p16(INK4a), p21(CIP1) and p53, as well as trimethylation of lysine 9 at histone H3 (H3K9me3), also operate as critical regulators of stem-cell functions (which are collectively termed 'stemness')(3). In cancer cells, a gain of stemness may have profound implications for tumour aggressiveness and clinical outcome. Here we investigated whether chemotherapy-induced senescence could change stem-cell-related properties of malignant cells. Gene expression and functional analyses comparing senescent and non-senescent B-cell lymphomas from E mu-Myc transgenic mice revealed substantial upregulation of an adult tissue stem-cell signature, activated Wnt signalling, and distinct stem-cell markers in senescence. Using genetically switchable models of senescence targeting H3K9me3 or p53 to mimic spontaneous escape from the arrested condition, we found that cells released from senescence re-entered the cell cycle with strongly enhanced and Wnt-dependent clonogenic growth potential compared to virtually identical populations that had been equally exposed to chemotherapy but had never been senescent. In vivo, these previously senescent cells presented with a much higher tumour initiation potential. Notably, the temporary enforcement of senescence in p53-regulatable models of acute lymphoblastic leukaemia and acute myeloid leukaemia was found to reprogram non-stem bulk leukaemia cells into self-renewing, leukaemia-initiating stem cells. Our data, which are further supported by consistent results in human cancer cell lines and primary samples of human haematological malignancies, reveal that senescence-associated stemness is an unexpected, cell-autonomous feature that exerts its detrimental, highly aggressive growth potential upon escape from cell-cycle blockade, and is enriched in relapse tumours. These findings have profound implications for cancer therapy, and provide new mechanistic insights into the plasticity of cancer cells.	[Milanovic, Maja; Fan, Dorothy N. Y.; Belenki, Dimitri; Dabritz, J. Henry M.; Doerr, Jan R.; Metzner, Marlen; Pardon, Katharina; Reimann, Maurice; Doerken, Bernd; Lee, Soyoung; Schmitt, Clemens A.] Charite, Med Dept Hematol Oncol & Tumor Immunol, D-13353 Berlin, Germany; [Milanovic, Maja; Fan, Dorothy N. Y.; Belenki, Dimitri; Dabritz, J. Henry M.; Doerr, Jan R.; Metzner, Marlen; Pardon, Katharina; Reimann, Maurice; Doerken, Bernd; Lee, Soyoung; Schmitt, Clemens A.] Charite, Mol Krebsforschungszentrum MKFZ, Virchow Campus, D-13353 Berlin, Germany; [Fan, Dorothy N. Y.; Trumpp, Andreas; Doerken, Bernd; Hummel, Michael; Lee, Soyoung; Schmitt, Clemens A.] German Canc Consortium, Deutsch Konsortium Translat Krebsforsch, D-69120 Heidelberg, Germany; [Fan, Dorothy N. Y.; Trumpp, Andreas] Deutsch Krebsforschungszentrum DKFZ, German Canc Res Ctr, Neuenheimer Feld 280, D-69120 Heidelberg, Germany; [Fan, Dorothy N. Y.; Trumpp, Andreas; Doerken, Bernd; Hummel, Michael; Lee, Soyoung; Schmitt, Clemens A.] German Canc Consortium, Deutsch Konsortium Translat Krebsforsch, Partner Site Berlin, Berlin, Germany; [Zhao, Zhen] Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, 1275 York Ave, New York, NY 10065 USA; [Yu, Yong; Kanashova, Tamara; Doerken, Bernd; Dittmar, Gunnar; Lee, Soyoung; Schmitt, Clemens A.] Helmholtz Assoc, Max Delbruck Ctr Mol Med, Robert Rossle Str 10, D-13125 Berlin, Germany; [Dimitrova, Lora; Lenze, Dido] Charite, Dept Pathol, Berlin, Germany; [Barbosa, Ines A. Monteiro; Zuber, Johannes] Vienna Bioctr, IMP, Dr Bohr Gasse 7, A-1030 Vienna, Austria; [Mendoza-Parra, Marco A.; Gronemeyer, Hinrich] Univ Strasbourg, Equipe Labellisee Ligue Canc, Dept Funct Genom & Canc,INSERM,U964, Inst Genet & Biol Mol & Cellulaire,CNRS,UMR7104, F-67400 Illkirch Graffenstaden, France; [Trumpp, Andreas] Heidelberg Inst Stem Cell Technol & Expt Med HI S, Neuenheimer Feld 280, D-69120 Heidelberg, Germany; [Doerken, Bernd; Hummel, Michael; Schmitt, Clemens A.] Berlin Inst Hlth, Anna Louisa Karsch Str 2, D-10178 Berlin, Germany; [Dittmar, Gunnar] Luxembourg Inst Hlth, 1A-B Rue Thomas Edison, L-1455 Strassen, Luxembourg	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Memorial Sloan Kettering Cancer Center; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Berlin Institute of Health; Luxembourg Institute of Health	Schmitt, CA (corresponding author), Charite, Med Dept Hematol Oncol & Tumor Immunol, D-13353 Berlin, Germany.; Schmitt, CA (corresponding author), Charite, Mol Krebsforschungszentrum MKFZ, Virchow Campus, D-13353 Berlin, Germany.	clemens.schmitt@charite.de	Dittmar, Gunnar/C-6333-2019; Gronemeyer, Hinrich/H-7002-2016; Fan, Dorothy Ngo-yin/AAQ-2998-2020; Trumpp, Andreas/Z-2141-2019; Gronemeyer, Hinrich/G-6240-2011; Lee, Soyoung/T-6669-2019; Schmitt, Clemens A/S-9479-2017; Lee, Soyoung/AHC-5032-2022; Zuber, Johannes/E-7517-2011; Gronemeyer, Hinrich/AAH-5575-2019	Dittmar, Gunnar/0000-0003-3647-8623; Gronemeyer, Hinrich/0000-0001-9454-2449; Trumpp, Andreas/0000-0002-6212-3466; Gronemeyer, Hinrich/0000-0001-9454-2449; Schmitt, Clemens A/0000-0002-4731-2226; Lee, Soyoung/0000-0002-4614-2931; Zuber, Johannes/0000-0001-8810-6835; Gronemeyer, Hinrich/0000-0001-9454-2449; Dorr, Jan Rafael/0000-0002-4927-6548; Milanovic, Maja/0000-0003-1860-6003; Zhao, Zhen/0000-0001-5271-4759; Belenki, Dimitri/0000-0002-9004-9849; Mendoza-Parra, Marco Antonio/0000-0002-1809-1727; Barbosa, Ines/0000-0001-8977-0930; Dabritz, Jan Henry Matthias/0000-0002-7184-9656; Yu, Yong/0000-0003-1928-2514; Hummel, Michael/0000-0001-6717-605X	Boehringer Ingelheim Foundation; Deutsche Forschungsgemeinschaft [SFB/TRR 54, SFB 873]; Helmholtz Alliance 'Preclinical Comprehensive Cancer Center' grant from the Helmholtz Association [HA-305]; Dietmar Hopp Foundation; Deutsche Krebshilfe [110678]; German Excellence Initiative; German Cancer Consortium (GCC)	Boehringer Ingelheim Foundation(Boehringer Ingelheim); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Helmholtz Alliance 'Preclinical Comprehensive Cancer Center' grant from the Helmholtz Association; Dietmar Hopp Foundation; Deutsche Krebshilfe(Deutsche Krebshilfe); German Excellence Initiative; German Cancer Consortium (GCC)	We thank G. Evan, the late A. Harris, T. Jacks and T. Jenuwein for mice, cells and materials; E. Berg, N. Burbach, A. Herrmann, H. Lammert, S. Mende, B. Teichmann and the Berlin-Brandenburg Center for Regenerative Therapies (BCRT) flow cytometry laboratory for technical assistance; and members of the Schmitt laboratory for discussions and editorial advice. This work was supported by a Ph.D. fellowship to J.R.D. from the Boehringer Ingelheim Foundation; by grants from the Deutsche Forschungsgemeinschaft to B.D., M.H. and C.A.S. (SFB/TRR 54) and to A. T. (SFB 873); by the Helmholtz Alliance 'Preclinical Comprehensive Cancer Center' grant (HA-305) from the Helmholtz Association to A. T. and C.A.S.; by the Dietmar Hopp Foundation to A. T.; and by the Deutsche Krebshilfe (grant 110678) to C. A. S. This interdisciplinary work was further made possible by the Berlin School of Integrative Oncology (BSIO) graduate program funded within the German Excellence Initiative, and the German Cancer Consortium (GCC).	Acosta JC, 2013, NAT CELL BIOL, V15, P978, DOI 10.1038/ncb2784; ADAMS JM, 1985, NATURE, V318, P533, DOI 10.1038/318533a0; Baar MP, 2017, CELL, V169, P132, DOI 10.1016/j.cell.2017.02.031; Baker DJ, 2016, NATURE, V530, P184, DOI 10.1038/nature16932; BANCHEREAU J, 1991, SCIENCE, V251, P70, DOI 10.1126/science.1702555; Boersema PJ, 2009, NAT PROTOC, V4, P484, DOI 10.1038/nprot.2009.21; Braig M, 2005, NATURE, V436, P660, DOI 10.1038/nature03841; Chaffer CL, 2011, P NATL ACAD SCI USA, V108, P7950, DOI 10.1073/pnas.1102454108; Chambers Stuart M, 2007, Cell Stem Cell, V1, P578, DOI 10.1016/j.stem.2007.10.003; Chen JK, 2013, NAT GENET, V45, P34, DOI 10.1038/ng.2491; Coppe JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Dickins RA, 2005, NAT GENET, V37, P1289, DOI 10.1038/ng1651; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Dorr JR, 2013, NATURE, V501, P421, DOI 10.1038/nature12437; Feil R, 1997, BIOCHEM BIOPH RES CO, V237, P752, DOI 10.1006/bbrc.1997.7124; Godar S, 2008, CELL, V134, P62, DOI 10.1016/j.cell.2008.06.006; Greve B, 2012, CYTOM PART A, V81A, P284, DOI 10.1002/cyto.a.22022; Gupta PB, 2009, CELL, V138, P645, DOI 10.1016/j.cell.2009.06.034; Haugstetter AM, 2010, BRIT J CANCER, V103, P505, DOI 10.1038/sj.bjc.6605784; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Hu ZY, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-96; Ivanova NB, 2002, SCIENCE, V298, P601, DOI 10.1126/science.1073823; Jing H, 2011, GENE DEV, V25, P2137, DOI 10.1101/gad.17620611; Kelly PN, 2007, SCIENCE, V317, P337, DOI 10.1126/science.1142596; Kim J, 2010, CELL, V143, P313, DOI 10.1016/j.cell.2010.09.010; Krizhanovsky V, 2008, COLD SH Q B, V73, P513, DOI 10.1101/sqb.2008.73.048; Krizhanovsky V, 2009, NATURE, V460, P1085, DOI 10.1038/4601085a; Lee TI, 2006, NAT PROTOC, V1, P729, DOI 10.1038/nprot.2006.98; Lin AW, 1998, GENE DEV, V12, P3008, DOI 10.1101/gad.12.19.3008; Lu DS, 2011, P NATL ACAD SCI USA, V108, P13253, DOI 10.1073/pnas.1110431108; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; Mosteiro L, 2016, SCIENCE, V354, DOI 10.1126/science.aaf4445; Munoz-Espin D, 2014, NAT REV MOL CELL BIO, V15, P482, DOI 10.1038/nrm3823; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; Onder TT, 2012, NATURE, V483, P598, DOI 10.1038/nature10953; Pawlikowski JS, 2013, P NATL ACAD SCI USA, V110, P16009, DOI 10.1073/pnas.1303491110; Perez-Mancera PA, 2014, NAT REV CANCER, V14, P547, DOI 10.1038/nrc3773; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Premsrirut PK, 2011, CELL, V145, P145, DOI 10.1016/j.cell.2011.03.012; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Reimann M, 2007, BLOOD, V110, P2996, DOI 10.1182/blood-2007-02-075614; Reimann M, 2010, CANCER CELL, V17, P262, DOI 10.1016/j.ccr.2009.12.043; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Ritschka B, 2017, GENE DEV, V31, P172, DOI 10.1101/gad.290635.116; Schmitt CA, 1999, GENE DEV, V13, P2670, DOI 10.1101/gad.13.20.2670; Schmitt CA, 2002, CANCER CELL, V1, P289, DOI 10.1016/S1535-6108(02)00047-8; Schmitt CA, 2002, CELL, V109, P335, DOI 10.1016/S0092-8674(02)00734-1; Schmitt CA, 2000, NAT MED, V6, P1029, DOI 10.1038/79542; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Wang YZ, 2010, SCIENCE, V327, P1650, DOI 10.1126/science.1186624; Whitfield ML, 2002, MOL BIOL CELL, V13, P1977, DOI 10.1091/mbc.02-02-0030; Wong DJ, 2008, CELL STEM CELL, V2, P333, DOI 10.1016/j.stem.2008.02.009; Yang DH, 2009, CIRC RES, V104, P372, DOI 10.1161/CIRCRESAHA.108.185405; Zhao Z, 2010, GENE DEV, V24, P1389, DOI 10.1101/gad.1940710; Zon LI, 2008, NATURE, V453, P306, DOI 10.1038/nature07038; Zuber J, 2011, NATURE, V478, P524, DOI 10.1038/nature10334	59	455	465	14	177	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 4	2018	553	7686					96	+		10.1038/nature25167	http://dx.doi.org/10.1038/nature25167			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS4NI	29258294	Green Accepted			2022-12-28	WOS:000419769300037
J	Moberly, T				Moberly, Tom			INVESTIGATION The pharma deals that CCGs fail to declare	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Moberly, Tom] BMJ, London, England		Moberly, T (corresponding author), BMJ, London, England.	tmoberly@bmj.com						Iacobucci G, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h6000; Iacobucci G, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1569; NHS England, 2017, MAN CONFL INT REV ST	3	4	4	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 4	2018	360								j5915	10.1136/bmj.j5915	http://dx.doi.org/10.1136/bmj.j5915			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FS3UX	29298768				2022-12-28	WOS:000419710400011
J	Murphy, WJ				Murphy, William J.			Making a Better Hematopoietic Stem Cell - Timing Is Everything	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							TRANSPLANTATION; DONOR		[Murphy, William J.] Univ Calif Davis, Sch Med, Div Hematol Oncol, Dept Dermatol, Sacramento, CA 95817 USA; [Murphy, William J.] Univ Calif Davis, Sch Med, Div Hematol Oncol, Dept Internal Med, Sacramento, CA 95817 USA	University of California System; University of California Davis; University of California System; University of California Davis	Murphy, WJ (corresponding author), Univ Calif Davis, Sch Med, Div Hematol Oncol, Dept Dermatol, Sacramento, CA 95817 USA.; Murphy, WJ (corresponding author), Univ Calif Davis, Sch Med, Div Hematol Oncol, Dept Internal Med, Sacramento, CA 95817 USA.							Bird GA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105525; Kekre N, 2014, BLOOD, V124, P334, DOI 10.1182/blood-2014-02-514760; Kollek M, 2017, J EXP MED, V214, P2967, DOI 10.1084/jem.20161721; Labi V, 2014, BLOOD, V123, P2652, DOI 10.1182/blood-2013-11-537217; Wagner JE, 2002, BLOOD, V100, P1611, DOI 10.1182/blood-2002-01-0294	5	1	1	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 4	2018	378	1					89	91		10.1056/NEJMcibr1713508	http://dx.doi.org/10.1056/NEJMcibr1713508			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FR7BE	29298159				2022-12-28	WOS:000419220500023
J	Sullivan, KM; Goldmuntz, EA; Keyes-Elstein, L; McSweeney, PA; Pinckney, A; Welch, B; Mayes, MD; Nash, RA; Crofford, LJ; Eggleston, B; Castina, S; Griffith, LM; Goldstein, JS; Wallace, D; Craciunescu, O; Khanna, D; Folz, RJ; Goldin, J; Clair, EWS; Seibold, JR; Phillips, K; Mineishi, S; Simms, RW; Ballen, K; Wener, MH; Georges, GE; Heimfeld, S; Hosing, C; Forman, S; Kafaja, S; Silver, RM; Griffing, L; Storek, J; LeClercq, S; Brasington, R; Csuka, ME; Bredeson, C; Keever-Taylor, C; Domsic, RT; Kahaleh, MB; Medsger, T; Furst, DE				Sullivan, K. M.; Goldmuntz, E. A.; Keyes-Elstein, L.; McSweeney, P. A.; Pinckney, A.; Welch, B.; Mayes, M. D.; Nash, R. A.; Crofford, L. J.; Eggleston, B.; Castina, S.; Griffith, L. M.; Goldstein, J. S.; Wallace, D.; Craciunescu, O.; Khanna, D.; Folz, R. J.; Goldin, J.; Clair, E. W. St.; Seibold, J. R.; Phillips, K.; Mineishi, S.; Simms, R. W.; Ballen, K.; Wener, M. H.; Georges, G. E.; Heimfeld, S.; Hosing, C.; Forman, S.; Kafaja, S.; Silver, R. M.; Griffing, L.; Storek, J.; LeClercq, S.; Brasington, R.; Csuka, M. E.; Bredeson, C.; Keever-Taylor, C.; Domsic, R. T.; Kahaleh, M. B.; Medsger, T.; Furst, D. E.		SCOT Study Investigators	Myeloablative Autologous Stem-Cell Transplantation for Severe Scleroderma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SEVERE SYSTEMIC-SCLEROSIS; DOSE IMMUNOSUPPRESSIVE THERAPY; AUTOIMMUNE-DISEASES; CLINICAL-TRIALS; DOUBLE-BLIND; MARROW-TRANSPLANTATION; PULSE CYCLOPHOSPHAMIDE; HEART-FAILURE; LUNG-DISEASE; END-POINT	BACKGROUND Despite current therapies, diffuse cutaneous systemic sclerosis (scleroderma) often has a devastating outcome. We compared myeloablative CD34+ selected autologous hematopoietic stem-cell transplantation with immunosuppression by means of 12 monthly infusions of cyclophosphamide in patients with scleroderma. METHODS We randomly assigned adults (18 to 69 years of age) with severe scleroderma to undergo myeloablative autologous stem-cell transplantation (36 participants) or to receive cyclophosphamide (39 participants). The primary end point was a global rank composite score comparing participants with each other on the basis of a hierarchy of disease features assessed at 54 months: death, event-free survival (survival without respiratory, renal, or cardiac failure), forced vital capacity, the score on the Disability Index of the Health Assessment Questionnaire, and the modified Rodnan skin score. RESULTS In the intention-to-treat population, global rank composite scores at 54 months showed the superiority of transplantation (67% of 1404 pairwise comparisons favored transplantation and 33% favored cyclophosphamide, P = 0.01). In the per-protocol population (participants who received a transplant or completed >= 9 doses of cyclophosphamide), the rate of event-free survival at 54 months was 79% in the transplantation group and 50% in the cyclophosphamide group (P = 0.02). At 72 months, Kaplan-Meier estimates of event-free survival (74% vs. 47%) and overall survival (86% vs. 51%) also favored transplantation (P = 0.03 and 0.02, respectively). A total of 9% of the participants in the transplantation group had initiated disease-modifying antirheumatic drugs (DMARDs) by 54 months, as compared with 44% of those in the cyclophosphamide group (P = 0.001). Treatment-related mortality in the transplantation group was 3% at 54 months and 6% at 72 months, as compared with 0% in the cyclophosphamide group. CONCLUSIONS Myeloablative autologous hematopoietic stem-cell transplantation achieved long-term benefits in patients with scleroderma, including improved event-free and overall survival, at a cost of increased expected toxicity. Rates of treatment-related death and post-transplantation use of DMARDs were lower than those in previous reports of nonmyeloablative transplantation. (Funded by the National Institute of Allergy and Infectious Diseases and the National Institutes of Health; ClinicalTrials. gov number, NCT00114530.)	[Sullivan, K. M.; Craciunescu, O.; Clair, E. W. St.] Duke Univ, Med Ctr, Durham, NC USA; [Wallace, D.] RTI Int, Chapel Hill, NC USA; [Keyes-Elstein, L.; Pinckney, A.; Eggleston, B.; Castina, S.] Rho Fed Syst Div, Chapel Hill, NC USA; [Goldmuntz, E. A.; Welch, B.; Griffith, L. M.; Goldstein, J. S.] Natl Inst Allergy & Infect Dis, Bethesda, MD USA; [McSweeney, P. A.; Nash, R. A.] Colorado Blood Canc Inst, Denver, CO USA; [Mayes, M. D.] Univ Texas Houston, McGovern Med Sch, Houston, TX USA; [Hosing, C.] MD Anderson Canc Ctr, Houston, TX USA; [Crofford, L. J.; Phillips, K.] Vanderbilt Univ, 221 Kirkland Hall, Nashville, TN 37235 USA; [Khanna, D.; Seibold, J. R.] Univ Michigan, Ann Arbor, MI 48109 USA; [Folz, R. J.] Case Western Reserve Univ, Cleveland, OH 44106 USA; [Folz, R. J.] Univ Hosp, Cleveland, OH USA; [Mineishi, S.] Univ Alabama Birmingham, Birmingham, AL USA; [Simms, R. W.] Boston Univ, Boston, MA 02215 USA; [Ballen, K.] Univ Virginia, Charlottesville, VA USA; [Wener, M. H.; Furst, D. E.] Univ Washington, Seattle, WA 98195 USA; [Georges, G. E.; Heimfeld, S.] Fred Hutchinson Canc Res Ctr, 1124 Columbia St, Seattle, WA 98104 USA; [Goldin, J.; Kafaja, S.; Furst, D. E.] Univ Calif Los Angeles, Los Angeles, CA USA; [Forman, S.] City Hope Natl Med Ctr, 1500 E Duarte Rd, Duarte, CA 91010 USA; [Silver, R. M.] Med Univ South Carolina, Charleston, SC USA; [Griffing, L.] Mayo Clin, Scottsdale, AZ USA; [Storek, J.; LeClercq, S.] Univ Calgary, Calgary, AB, Canada; [Brasington, R.] Washington Univ, St Louis, MO USA; [Csuka, M. E.; Keever-Taylor, C.] Med Coll Wisconsin, Milwaukee, WI 53226 USA; [Bredeson, C.] Ottawa Hosp, Res Inst, Ottawa, ON, Canada; [Domsic, R. T.; Medsger, T.] Univ Pittsburgh, Pittsburgh, PA USA; [Kahaleh, M. B.] Univ Toledo, Med Ctr, Toledo, OH USA	Duke University; Research Triangle Institute; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Texas System; University of Texas Health Science Center Houston; University of Texas System; UTMD Anderson Cancer Center; Vanderbilt University; University of Michigan System; University of Michigan; Case Western Reserve University; University Hospitals of Cleveland; University of Alabama System; University of Alabama Birmingham; Boston University; University of Virginia; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; University of California System; University of California Los Angeles; City of Hope; Medical University of South Carolina; Mayo Clinic; Mayo Clinic Phoenix; University of Calgary; Washington University (WUSTL); Medical College of Wisconsin; University of Ottawa; Ottawa Hospital Research Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University System of Ohio; University of Toledo	Sullivan, KM (corresponding author), Duke Univ, Med Ctr, Dr Sullivan Cellular Therapy Program, Dept Med, Box 3961, Durham, NC 27710 USA.	keith.sullivan@duke.edu	Wener, Mark/ABE-4491-2021; Wallace, Dennis/AAR-7005-2021; Braun, Aaron/E-4198-2018	Braun, Aaron/0000-0002-7310-6661; Keever-Taylor, Carolyn/0000-0002-3085-6876; Eggleston, Barry/0000-0003-0472-9707; Goldin, Jonathan/0000-0003-3007-9947	National Institute of Allergy and Infectious Diseases; National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI005419] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funded by the National Institute of Allergy and Infectious Diseases and the National Institutes of Health; ClinicalTrials.gov number, NCT00114530.	Bartunek J, 2017, EUR HEART J, V38, P648, DOI 10.1093/eurheartj/ehw543; Berger VW, 2003, STAT MED, V22, P3017, DOI 10.1002/sim.1538; Berry JD, 2013, AMYOTROPH LAT SCL FR, V14, P162, DOI 10.3109/21678421.2012.762930; Binks M, 2001, ANN RHEUM DIS, V60, P577, DOI 10.1136/ard.60.6.577; Burt RK, 2013, LANCET, V381, P1116, DOI 10.1016/S0140-6736(12)62114-X; Burt RK, 2011, LANCET, V378, P498, DOI 10.1016/S0140-6736(11)60982-3; CLEMENTS PJ, 1993, J RHEUMATOL, V20, P1892; Craciunescu OI, 2011, INT J RADIAT ONCOL, V79, P1248, DOI 10.1016/j.ijrobp.2010.05.036; Cudkowicz ME, 2013, LANCET NEUROL, V12, P1059, DOI 10.1016/S1474-4422(13)70221-7; Daikeler T, 2012, PEDIATR RES, V71, P439, DOI 10.1038/pr.2011.57; de Kleer I, 2006, BLOOD, V107, P1696, DOI 10.1182/blood-2005-07-2800; Delemarre EM, 2016, BLOOD, V127, P91, DOI 10.1182/blood-2015-06-649145; Elhai M, 2012, RHEUMATOLOGY, V51, P1017, DOI 10.1093/rheumatology/ker269; Farge D, 2010, HAEMATOL-HEMATOL J, V95, P284, DOI 10.3324/haematol.2009.013458; Finkelstein DM, 1999, STAT MED, V18, P1341, DOI 10.1002/(SICI)1097-0258(19990615)18:11&lt;1341::AID-SIM129&gt;3.0.CO;2-7; Hosing C, 2011, BIOL BLOOD MARROW TR, V17, P674, DOI 10.1016/j.bbmt.2010.08.003; Hung EW, 2013, J RHEUMATOL, V40, P455, DOI 10.3899/jrheum.121087; Keever-Taylor CA, 2017, BIOL BLOOD MARROW TR, V23, P1463, DOI 10.1016/j.bbmt.2017.05.018; Khanna D, 2006, ANN RHEUM DIS, V65, P1325, DOI 10.1136/ard.2005.050187; Khanna D, 2016, LANCET, V387, P2630, DOI 10.1016/S0140-6736(16)00232-4; Mayes MD, 2003, ARTHRITIS RHEUM, V48, P2246, DOI 10.1002/art.11073; McSweeney PA, 2002, BLOOD, V100, P1602, DOI 10.1182/blood.V100.5.1602.h81702001602_1602_1610; Muraro PA, 2014, J CLIN INVEST, V124, P1168, DOI 10.1172/JCI71691; Nash RA, 2007, BLOOD, V110, P1388, DOI 10.1182/blood-2007-02-072389; Nihtyanova SI, 2014, ARTHRITIS RHEUMATOL, V66, P1625, DOI 10.1002/art.38390; Onishi A, 2013, ARTHRITIS RHEUM-US, V65, P1913, DOI 10.1002/art.37969; Packer M, 2016, CIRCULATION, V134, P1664, DOI 10.1161/CIRCULATIONAHA.116.023538; Snowden JA, 2016, BLOOD, V127, P8, DOI 10.1182/blood-2015-11-678607; Stokes ME, 2009, CATEGORICAL DATA ANA; Storek J, 2004, CLIN IMMUNOL, V113, P285, DOI 10.1016/j.clim.2004.07.006; Sullivan KM, 2006, NEW ENGL J MED, V355, P1173; Sullivan KM, 2016, ARTHRITIS RHEUMATOL, V68, P2361, DOI 10.1002/art.39748; Sullivan KM, 2010, BIOL BLOOD MARROW TR, V16, pS48, DOI 10.1016/j.bbmt.2009.10.034; Tashkin DP, 2007, AM J RESP CRIT CARE, V176, P1026, DOI 10.1164/rccm.200702-326OC; Tashkin DP, 2016, LANCET RESP MED, V4, P708, DOI 10.1016/S2213-2600(16)30152-7; Tyndall A, 1997, LANCET, V349, P254, DOI 10.1016/S0140-6736(05)64864-7; van Bekkum DW, 2000, BONE MARROW TRANSPL, V25, P357, DOI 10.1038/sj.bmt.1702153; van Laar JM, 2014, JAMA-J AM MED ASSOC, V311, P2490, DOI 10.1001/jama.2014.6368; Vaxman I, 2015, BONE MARROW TRANSPL, V50, P706, DOI 10.1038/bmt.2014.325; Wittkop L, 2010, CLIN TRIALS, V7, P19, DOI 10.1177/1740774509356117	40	288	301	0	36	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 4	2018	378	1					35	47		10.1056/NEJMoa1703327	http://dx.doi.org/10.1056/NEJMoa1703327			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FR7BE	29298160	Green Accepted, Bronze			2022-12-28	WOS:000419220500015
J	Feldman, TE; Reardon, MJ; Rajagopal, V; Makkar, RR; Bajwa, TK; Kleiman, NS; Linke, A; Kereiakes, DJ; Waksman, R; Thourani, VH; Stoler, RC; Mishkel, GJ; Rizik, DG; Iyer, VS; Gleason, TG; Tchetche, D; Rovin, JD; Buchbinder, M; Meredith, IT; Gotberg, M; Bjursten, H; Meduri, C; Salinger, MH; Allocco, DJ; Dawkins, KD				Feldman, Ted E.; Reardon, Michael J.; Rajagopal, Vivek; Makkar, Raj R.; Bajwa, Tanvir K.; Kleiman, Neal S.; Linke, Axel; Kereiakes, Dean J.; Waksman, Ron; Thourani, Vinod H.; Stoler, Robert C.; Mishkel, Gregory J.; Rizik, David G.; Iyer, Vijay S.; Gleason, Thomas G.; Tchetche, Didier; Rovin, Joshua D.; Buchbinder, Maurice; Meredith, Ian T.; Gotberg, Matthias; Bjursten, Henrik; Meduri, Christopher; Salinger, Michael H.; Allocco, Dominic J.; Dawkins, Keith D.			Effect of Mechanically Expanded vs Self-Expanding Transcatheter Aortic Valve Replacement on Mortality and Major Adverse Clinical Events in High-Risk Patients With Aortic Stenosis The REPRISE III Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PERMANENT PACEMAKER IMPLANTATION; END-POINT DEFINITIONS; IMPACT; REGURGITATION; OUTCOMES; INSIGHTS; BIOPROSTHESIS; PREDICTORS	IMPORTANCE Transcatheter aortic valve replacement (TAVR) is established for selected patients with severe aortic stenosis. However, limitations such as suboptimal deployment, conduction disturbances, and paravalvular leak occur. OBJECTIVE To evaluate if a mechanically expanded valve (MEV) is noninferior to an approved self-expanding valve (SEV) in high-risk patients with aortic stenosis undergoing TAVR. DESIGN, SETTING, AND PARTICIPANTS The REPRISE III trialwas conducted in 912 patients with high or extreme risk and severe, symptomatic aortic stenosis at 55 centers in North America, Europe, and Australia between September 22, 2014, and December 24, 2015, with final follow-up on March 8, 2017. INTERVENTIONS Participants were randomized in a 2: 1 ratio to receive either an MEV(n = 607) or an SEV (n = 305). MAIN OUTCOMES AND MEASURES The primary safety end point was the 30-day composite of all-cause mortality, stroke, life-threatening or major bleeding, stage 2/3 acute kidney injury, and major vascular complications tested for noninferiority (margin, 10.5%). The primary effectiveness end point was the 1-year composite of all-cause mortality, disabling stroke, and moderate or greater paravalvular leak tested for noninferiority (margin, 9.5%). If noninferiority criteria were met, the secondary end point of 1-year moderate or greater paravalvular leak was tested for superiority in the full analysis data set. RESULTS Among 912 randomized patients (mean age, 82.8 [SD, 7.3] years; 463 [51%] women; predicted risk of mortality, 6.8%), 874 (96%) were evaluable at 1 year. The primary safety composite end point at 30 days occurred in 20.3% of MEV patients and 17.2% of SEV patients (difference, 3.1%; Farrington-Manning 97.5% CI, -infinity to 8.3%; P = .003 for noninferiority). At 1 year, the primary effectiveness composite end point occurred in 15.4% with the MEV and 25.5% with the SEV (difference, -10.1%; Farrington-Manning 97.5% CI, -infinity to -4.4%; P<.001 for noninferiority). The 1-year rates of moderate or severe paravalvular leak were 0.9% for the MEV and 6.8% for the SEV (difference, -6.1%; 95% CI, -9.6% to -2.6%; P<.001). The superiority analysis for primary effectivenesswas statistically significant (difference, -10.2%; 95% CI, -16.3% to -4.0%; P<.001). The MEV had higher rates of new pacemaker implants (35.5% vs 19.6%; P<.001) and valve thrombosis (1.5% vs 0%) but lower rates of repeat procedures (0.2% vs 2.0%), valve-in-valve deployments (0% vs 3.7%), and valve malpositioning (0% vs 2.7%). CONCLUSIONS AND RELEVANCE Among high-risk patients with aortic stenosis, use of the MEV compared with the SEV did not result in inferior outcomes for the primary safety end point or the primary effectiveness end point. These findings suggest that the MEV may be a useful addition for TAVR in high-risk patients.	[Feldman, Ted E.; Salinger, Michael H.] Northshore Univ Hlth Syst, Evanston Hosp, Div Cardiol, Evanston, IL USA; [Reardon, Michael J.] Houston Methodist DeBakey Heart & Vasc Ctr, Dept Cardiovasc Surg, Houston, TX USA; [Rajagopal, Vivek; Meduri, Christopher] Piedmont Heart Inst, Atlanta, GA USA; [Makkar, Raj R.] Cedars Sinai Heart Inst, Los Angeles, CA USA; [Bajwa, Tanvir K.] Aurora St Lukes Med Ctr, Milwaukee, WI USA; [Kleiman, Neal S.] Houston Methodist DeBakey Heart & Vasc Ctr, Dept Cardiol, Houston, TX USA; [Linke, Axel] Univ Leipzig, Heart Ctr, Leipzig, Germany; [Linke, Axel] Leipzig Heart Inst, Leipzig, Germany; [Kereiakes, Dean J.] Christ Hosp, Heart & Vasc Ctr, Lindner Res Ctr, Cincinnati, OH 45219 USA; [Waksman, Ron; Thourani, Vinod H.] Washington Hosp Ctr, Washington, DC 20010 USA; [Stoler, Robert C.] Baylor Heart & Vasc Hosp, Dallas, TX USA; [Mishkel, Gregory J.] St Johns Hosp, Springfield, IL USA; [Rizik, David G.] HonorHealth, Scottsdale, AZ USA; [Rizik, David G.] Scottsdale Lincoln Hlth Network, Scottsdale, AZ USA; [Iyer, Vijay S.] Univ Buffalo, Gates Vasc Inst, Buffalo, NY USA; [Gleason, Thomas G.] Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA; [Tchetche, Didier] Clin Pasteur, Toulouse, France; [Rovin, Joshua D.] Morton Plant Mease Healthcare Syst, Clearwater, FL USA; [Buchbinder, Maurice] Stanford Univ, Fdn Cardiovasc Med, Stanford, CA 94305 USA; [Meredith, Ian T.; Allocco, Dominic J.; Dawkins, Keith D.] Boston Sci Corp, Marlborough, MA USA; [Gotberg, Matthias] Lund Univ, Skane Univ Hosp, Dept Cardiol, Clin Sci, Lund, Sweden; [Bjursten, Henrik] Lund Univ, Skane Univ Univ Hosp, Dept Cardiothorac Surg, Clin Sci, Lund, Sweden	NorthShore University Health System; The Methodist Hospital System; The Methodist Hospital - Houston; Methodist DeBakey Heart & Vascular Center; Piedmont Heart Institute; Cedars Sinai Medical Center; The Methodist Hospital System; The Methodist Hospital - Houston; Methodist DeBakey Heart & Vascular Center; Heart Center Leipzig GMBH; Leipzig University; Heart Center Leipzig GMBH; Christ Hospital - Ohio; MedStar Washington Hospital Center; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Stanford University; Boston Scientific; Lund University; Skane University Hospital; Lund University	Feldman, TE (corresponding author), Evanston Hosp Corp, Div Cardiol, Walgreen Bldg,Third Floor,2650 Ridge Ave, Evanston, IL 60201 USA.	tfeldman@tfeldman.org	Reardon, Michael/ABF-8880-2021; thourani, vinod/AAP-5968-2020	Gotberg, Matthias/0000-0002-0912-7927; Bjursten, Henrik/0000-0001-5428-7455	Boston Scientific Corp	Boston Scientific Corp(Boston Scientific)	Boston Scientific Corp funded the trial.	Abdelghani M, 2016, EUR HEART J, V37, P2627, DOI 10.1093/eurheartj/ehw115; Adams DH, 2014, NEW ENGL J MED, V370, P1790, DOI 10.1056/NEJMoa1400590; Athappan G, 2013, J AM COLL CARDIOL, V61, P1585, DOI 10.1016/j.jacc.2013.01.047; Bellomo R, 2004, CRIT CARE, V8, pR204, DOI 10.1186/cc2872; Biner S, 2014, AM J CARDIOL, V113, P132, DOI 10.1016/j.amjcard.2013.09.030; Buellesfeld L, 2012, J AM COLL CARDIOL, V60, P493, DOI 10.1016/j.jacc.2012.03.054; Cesari M, 2005, J AM GERIATR SOC, V53, P1675, DOI 10.1111/j.1532-5415.2005.53501.x; Chakravarty T, 2017, LANCET, V389, P2383, DOI 10.1016/S0140-6736(17)30757-2; Child CG, 1964, LIVER PORTAL HYPERTE, P50; Dolgin M, 1994, NOMENCLATURE CRITERI; Dumonteil N, 2017, EUROINTERVENTION, V13, P796, DOI 10.4244/EIJ-D-16-01025; Escarcega RO, 2014, INT J CARDIOL, V174, P207, DOI 10.1016/j.ijcard.2014.03.200; Falk V, 2017, EUR HEART J; Grover FL, 2017, J AM COLL CARDIOL, V69, P1215, DOI 10.1016/j.jacc.2016.11.033; Hayashida K, 2012, JACC-CARDIOVASC INTE, V5, P1247, DOI 10.1016/j.jcin.2012.09.003; Kappetein AP, 2012, J AM COLL CARDIOL, V60, P1438, DOI [10.1093/ejcts/ezs533, 10.1016/j.jacc.2012.09.001]; Kodali S, 2015, EUR HEART J, V36, P449, DOI 10.1093/eurheartj/ehu384; Leon MB, 2011, J AM COLL CARDIOL, V57, P253, DOI 10.1016/j.jacc.2010.12.005; Leon MB, 2010, NEW ENGL J MED, V363, P1597, DOI 10.1056/NEJMoa1008232; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; Meredith IT, 2016, JACC-CARDIOVASC INTE, V9, P376, DOI 10.1016/j.jcin.2015.10.024; Meredith IT, 2014, J AM COLL CARDIOL, V64, P1339, DOI 10.1016/j.jacc.2014.05.067; Meredith IT, 2012, EUROINTERVENTION, V8, pQ70, DOI 10.4244/EIJV8SQA12; Nishimura RA, 2017, CIRCULATION, V135, pE1159, DOI 10.1161/CIR.0000000000000503; Popma JJ, 2017, JACC-CARDIOVASC INTE, V10, P268, DOI 10.1016/j.jcin.2016.08.050; Popma JJ, 2014, J AM COLL CARDIOL, V63, P1972, DOI 10.1016/j.jacc.2014.02.556; PUGH RNH, 1973, BRIT J SURG, V60, P646, DOI 10.1002/bjs.1800600817; Reardon MJ, 2017, NEW ENGL J MED, V376, P1321, DOI 10.1056/NEJMoa1700456; Smith CR, 2011, NEW ENGL J MED, V364, P2187, DOI 10.1056/NEJMoa1103510; Thourani VH, 2016, LANCET, V387, P2218, DOI 10.1016/S0140-6736(16)30073-3; Toggweiler S, 2012, JACC-CARDIOVASC INTE, V5, P571, DOI 10.1016/j.jcin.2012.03.008; Urena M, 2014, CIRCULATION, V129, P1233, DOI 10.1161/CIRCULATIONAHA.113.005479; Van Belle E, 2014, CIRCULATION, V129, P1415, DOI 10.1161/CIRCULATIONAHA.113.002677; Windecker S, 2017, AM HEART J, V184, DOI 10.1016/j.ahj.2016.10.017; Witkowski A, 2014, J INTERV CARDIOL, V27, P300, DOI 10.1111/joic.12120; Zoghbi WA, 2011, J AM SOC ECHOCARDIOG, V24, P132, DOI 10.1016/j.echo.2010.12.014	36	110	111	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 2	2018	319	1					27	37		10.1001/jama.2017.19132	http://dx.doi.org/10.1001/jama.2017.19132			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FR5ON	29297076	Green Published, Bronze			2022-12-28	WOS:000419116000013
J	Knip, M; Akerblom, HK; Al Taji, E; Becker, D; Bruining, J; Castano, L; Danne, T; de Beaufort, C; Dosch, HM; Dupre, J; Fraser, WD; Howard, N; Ilonen, J; Konrad, D; Kordonouri, O; Krischer, JP; Lawson, ML; Ludvigsson, J; Madacsy, L; Mahon, JL; Ormisson, A; Palmer, JP; Pozzilli, P; Savilahti, E; Serrano-Rios, M; Songini, M; Taback, S; Vaarala, O; White, NH; Virtanen, SM; Wasikowa, R				Knip, Mikael; Akerblom, Hans K.; Al Taji, Eva; Becker, Dorothy; Bruining, Jan; Castano, Luis; Danne, Thomas; de Beaufort, Carine; Dosch, Hans-Michael; Dupre, John; Fraser, William D.; Howard, Neville; Ilonen, Jorma; Konrad, Daniel; Kordonouri, Olga; Krischer, Jeffrey P.; Lawson, Margaret L.; Ludvigsson, Johnny; Madacsy, Laszlo; Mahon, Jeffrey L.; Ormisson, Anne; Palmer, Jerry P.; Pozzilli, Paolo; Savilahti, Erkki; Serrano-Rios, Manuel; Songini, Marco; Taback, Shayne; Vaarala, Outi; White, Neil H.; Virtanen, Suvi M.; Wasikowa, Renata		TRIGR Study Group	Effect of Hydrolyzed Infant Formula vs Conventional Formula on Risk of Type 1 Diabetes The TRIGR Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BETA-CELL AUTOIMMUNITY; CHILDHOOD; CHILDREN; SUSCEPTIBILITY; PROGRESSION; MELLITUS; INSULIN; MOTHERS; TRENDS; SIGNS	IMPORTANCE Early exposure to complex dietary proteins may increase the risk of type 1 diabetes in children with genetic disease susceptibility. There are no intact proteins in extensively hydrolyzed formulas. OBJECTIVE To test the hypothesis that weaning to an extensively hydrolyzed formula decreases the cumulative incidence of type 1 diabetes in young children. DESIGN, SETTING, AND PARTICIPANTS An international double-blind randomized clinical trial of 2159 infants with human leukocyte antigen-conferred disease susceptibility and a first-degree relative with type 1 diabetes recruited from May 2002 to January 2007 in 78 study centers in 15 countries; 1081 were randomized to be weaned to the extensively hydrolyzed casein formula and 1078 to a conventional formula. The follow-up of the participants ended on February 28, 2017. INTERVENTIONS The participants received either a casein hydrolysate or a conventional adapted cow's milk formula supplemented with 20% of the casein hydrolysate. The minimum duration of study formula exposure was 60 days by 6 to 8 months of age. MAIN OUTCOMES AND MEASURES Primary outcome was type 1 diabetes diagnosed according to World Health Organization criteria. Secondary outcomes included age at diabetes diagnosis and safety (adverse events). RESULTS Among 2159 newborn infants (1021 female [47.3%]) who were randomized, 1744 (80.8%) completed the trial. The participants were observed for a median of 11.5 years (quartile [Q] 1-Q3, 10.2-12.8). The absolute risk of type 1 diabetes was 8.4% among those randomized to the casein hydrolysate (n = 91) vs 7.6% among those randomized to the conventional formula (n = 82) (difference, 0.8%[95% CI, -1.6% to 3.2%]). The hazard ratio for type 1 diabetes adjusted for human leukocyte antigen risk group, duration of breastfeeding, duration of study formula consumption, sex, and region while treating study center as a random effect was 1.1 (95% CI, 0.8 to 1.5; P = .46). The median age at diagnosis of type 1 diabetes was similar in the 2 groups (6.0 years [Q1-Q3, 3.1-8.9] vs 5.8 years [Q1-Q3, 2.6-9.1]; difference, 0.2 years [95% CI, -0.9 to 1.2]). Upper respiratory infections were the most common adverse event reported (frequency, 0.48 events/year in the hydrolysate group and 0.50 events/year in the control group). CONCLUSIONS AND RELEVANCE Among infants at risk for type 1 diabetes, weaning to a hydrolyzed formula compared with a conventional formula did not reduce the cumulative incidence of type 1 diabetes after median follow-up for 11.5 years. These findings do not support a need to revise the dietary recommendations for infants at risk for type 1 diabetes.	[Knip, Mikael; Akerblom, Hans K.; Savilahti, Erkki; Vaarala, Outi] Univ Helsinki, Helsinki, Finland; [Knip, Mikael] Helsinki Univ Hosp, Helsinki, Finland; [Al Taji, Eva] Charles Univ Prague, Fac Med 3, Prague, Czech Republic; [Becker, Dorothy] Univ Pittsburgh, Pittsburgh, PA USA; [Bruining, Jan] Sophia Childrens Univ Hosp, Rotterdam, Netherlands; [Castano, Luis] Univ Basque Country, Cruces Univ Hosp, CIBERDEM CIBERER, Baracaldo, Spain; [Konrad, Daniel; Kordonouri, Olga] Kinder & Jugendkrankenhaus Auf Der Bult, Hannover, Germany; [de Beaufort, Carine] Ctr Hosp Luxembourg, Luxembourg, Luxembourg; [Dosch, Hans-Michael] Univ Toronto, Toronto, ON, Canada; [Dupre, John] Univ Western Ontario, London, ON, Canada; [Fraser, William D.] Univ Sherbrooke, Sherbrooke, PQ, Canada; [Howard, Neville] Childrens Hosp Westmead, Sydney, NSW, Australia; [Ilonen, Jorma] Univ Turku, Turku, Finland; [Ilonen, Jorma] Turku Univ Hosp, Turku, Finland; [Konrad, Daniel] Univ Childrens Hosp Zurich, Zurich, Switzerland; [Krischer, Jeffrey P.] Univ S Florida, Tampa, FL USA; [Lawson, Margaret L.] Childrens Hosp Eastern Ontario, Ottawa, ON, Canada; [Ludvigsson, Johnny] Linkoping Univ, Linkoping, Sweden; [Madacsy, Laszlo] Semmelweis Univ, Budapest, Hungary; [Mahon, Jeffrey L.] Univ Western Ontario, London, ON, Canada; [Ormisson, Anne] Tartu Univ, Tartu, Estonia; [Palmer, Jerry P.] Univ Washington, Seattle, WA USA; [Pozzilli, Paolo] Univ Campus Biomed Rome, Rome, Italy; [Serrano-Rios, Manuel] CIBERDEM, Spanish Biomed Res Ctr Diabet & Associated Metab, Madrid, Spain; [Songini, Marco] St Michelle Hosp, Azienda Ospedaliera Brotzu Diab Unit, Cagliari, Italy; [Taback, Shayne] Univ Manitoba, Winnipeg, MB, Canada; [Vaarala, Outi] AstraZeneca, Respiratory Inflammat & Autoimmun Innovat Med, Gothenburg, Sweden; [White, Neil H.] Washington Univ, Sch Med, St Louis, MO USA; [Virtanen, Suvi M.] Natl Inst Hlth & Welf, Helsinki, Finland; [Wasikowa, Renata] Med Univ Wroclaw, Wroclaw, Poland	University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Charles University Prague; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Erasmus University Rotterdam; Erasmus MC - Sophia Children's Hospital; CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; CIBERER; Hospital Universitario Cruces; University of Basque Country; Luxembourg Hospital Center; University of Toronto; Western University (University of Western Ontario); University of Sherbrooke; University of Sydney; University of Turku; University of Turku; University Children's Hospital Zurich; State University System of Florida; University of South Florida; University of Ottawa; Children's Hospital of Eastern Ontario; Linkoping University; Semmelweis University; Western University (University of Western Ontario); University of Tartu; University of Washington; University of Washington Seattle; University Campus Bio-Medico - Rome Italy; CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; University of Manitoba; AstraZeneca; Washington University (WUSTL); Finland National Institute for Health & Welfare; Wroclaw Medical University	Knip, M (corresponding author), Univ Helsinki, Childrens Hosp, POB 22 Stenbackinkatu 11, FI-00014 Helsinki, Finland.	mikael.knip@helsinki.fi	Serrano Ríos, Manuel/E-4625-2019; Tillmann, Vallo/G-8118-2012; Ludvigsson, Johnny/AAI-2051-2020; de Beaufort, Carine/AAJ-8063-2021; Virtanen, Suvi/AAP-1922-2021; Mahon, Jeff/G-3324-2011; Bilbao, Jose Ramon/A-9177-2008; Tabacco, Gaia/AAA-6526-2022; Knip, Mikael/AAL-3773-2020; Khazrai, Yeganeh Manon/ABD-5854-2020; Zlatohlavkova, Blanka/K-5821-2017; Lawson, Margaret/M-6969-2015	Serrano Ríos, Manuel/0000-0002-3214-1444; Tillmann, Vallo/0000-0002-5279-4493; Ludvigsson, Johnny/0000-0003-1695-5234; de Beaufort, Carine/0000-0003-4310-6799; Bilbao, Jose Ramon/0000-0002-3176-501X; Tabacco, Gaia/0000-0002-6808-0700; Khazrai, Yeganeh Manon/0000-0002-4729-3125; Huidobro Fernandez, Belen/0000-0001-6682-4393; Cieslak, Agnieszka/0000-0002-9853-6959; Cummings, Elizabeth/0000-0002-1196-7191; Szadkowska, Agnieszka/0000-0002-8281-4408; Konrad, Daniel/0000-0001-9067-4356; Ilonen, Jorma/0000-0002-9973-2062; Virtanen, Suvi/0000-0001-8928-0878; Chanoine, Jean-Pierre/0000-0002-5167-2064; Castano, Luis/0000-0003-0437-9401; Knip, Mikael/0000-0003-0474-0033; Wikiera, Beata/0000-0001-8797-6636; Mannu, Carla/0000-0002-5421-9193; Zlatohlavkova, Blanka/0000-0002-2131-1786; Luopajarvi, Kristiina/0000-0002-9428-1282; Biester, Torben/0000-0001-8051-5562; Metzger, Daniel/0000-0002-1715-4319; Songini, Marco/0000-0003-3524-645X; Craig, Maria E/0000-0001-6004-576X; Lawson, Margaret/0000-0002-2370-9552; Jarosz-Chobot, Przemyslawa/0000-0002-1120-0994; Basiak, Aleksander/0000-0001-9779-6575; Maxwell, Cynthia/0000-0003-4734-1251; Pitocco, Dario/0000-0002-6220-686X; Hyytinen, Mila Maarit/0000-0001-5361-6421	Eunice Kennedy Shriver National Institute of Child Health and Development (NICHD); National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health [HD040364, HD042444, HD051997]; Canadian Institutes of Health Research; Commission of the European Communities [QLK1-2002-00372]; European Foundation for the Study of Diabates/JDRF/Novo Nordisk; Academy of Finland (Centre of Excellence in Molecular Systems Immunology and Physiology Research) [250114]; Dutch Diabetes Research Foundation; Finnish Diabetes Research Foundation; JDRF; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U01HD040364, U01HD042444, R01HD051997, U01HD051997] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK017047] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Commission of the European Communities(European Commission); European Foundation for the Study of Diabates/JDRF/Novo Nordisk; Academy of Finland (Centre of Excellence in Molecular Systems Immunology and Physiology Research)(Academy of Finland); Dutch Diabetes Research Foundation; Finnish Diabetes Research Foundation; JDRF(Juvenile Diabetes Research Foundation); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Eunice Kennedy Shriver National Institute of Child Health and Development (NICHD) and National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health (grants HD040364, HD042444, and HD051997), Canadian Institutes of Health Research, JDRF, and the Commission of the European Communities (specific RTD programme Quality of Life and Management of Living Resources, contract QLK1-2002-00372 Diabetes Prevention). Other funding came from the European Foundation for the Study of Diabates/JDRF/Novo Nordisk Focused Research Grant, Academy of Finland (Centre of Excellence in Molecular Systems Immunology and Physiology Research 2012-2017, Decision No. 250114), Dutch Diabetes Research Foundation, and Finnish Diabetes Research Foundation. Mead Johnson Nutrition provided the blinded color-coded study formulas.	Akerblom HK, 2011, DIABETOLOGIA, V54, P627, DOI 10.1007/s00125-010-1964-9; Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Goggins WB, 2000, BIOMETRICS, V56, P940, DOI 10.1111/j.0006-341X.2000.00940.x; Green A, 1998, DIABETOLOGIA, V41, P1151; Ilonen J, 2016, PEDIATR DIABETES, V17, P8, DOI 10.1111/pedi.12327; Kimpimaki T, 2001, J CLIN ENDOCR METAB, V86, P4782, DOI 10.1210/jc.86.10.4782; Knip M, 2002, DIABETES CARE, V25, P623, DOI 10.2337/diacare.25.3.623; Knip M, 2016, PEDIATR DIABETES, V17, P17, DOI 10.1111/pedi.12386; Knip M, 2014, JAMA-J AM MED ASSOC, V311, P2279, DOI 10.1001/jama.2014.5610; Knip M, 2010, NEW ENGL J MED, V363, P1900, DOI 10.1056/NEJMoa1004809; Knip M, 2010, AM J CLIN NUTR, V91, p1506S, DOI 10.3945/ajcn.2010.28701C; Kostic AD, 2015, CELL HOST MICROBE, V17, P260, DOI 10.1016/j.chom.2015.01.001; LAN KKG, 1989, BIOMETRICS, V45, P1017, DOI 10.2307/2531701; Libman IM, 2005, PEDIATR DIABETES, V6, P119, DOI 10.1111/j.1399-543X.2005.00119.x; Lund-Blix NA, 2017, DIABETES CARE, V40, P920, DOI 10.2337/dc17-0016; Norris JM, 2003, JAMA-J AM MED ASSOC, V290, P1713, DOI 10.1001/jama.290.13.1713; Parkkola A, 2013, DIABETES CARE, V36, P348, DOI 10.2337/dc12-0445; Patterson CC, 2009, LANCET, V373, P2027, DOI 10.1016/S0140-6736(09)60568-7; Sorkio S, 2010, DIABETES-METAB RES, V26, P206, DOI 10.1002/dmrr.1074; Vaarala O, 1999, DIABETES, V48, P1389, DOI 10.2337/diabetes.48.7.1389; Vaarala O, 2012, ARCH PEDIAT ADOL MED, V166, P608, DOI 10.1001/archpediatrics.2011.1559; Virtanen SM, 2006, DIABETOLOGIA, V49, P1512, DOI 10.1007/s00125-006-0236-1; VIRTANEN SM, 1991, DIABETES CARE, V14, P415, DOI 10.2337/diacare.14.5.415; WARRAM JH, 1984, NEW ENGL J MED, V311, P149, DOI 10.1056/NEJM198407193110304; Ziegler AG, 2003, JAMA-J AM MED ASSOC, V290, P1721, DOI 10.1001/jama.290.13.1721; Ziegler AG, 1999, DIABETES, V48, P460, DOI 10.2337/diabetes.48.3.460; Ziegler AG, 2013, JAMA-J AM MED ASSOC, V309, P2473, DOI 10.1001/jama.2013.6285	27	74	74	1	27	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 2	2018	319	1					38	48		10.1001/jama.2017.19826	http://dx.doi.org/10.1001/jama.2017.19826			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FR5ON	29297078	Green Accepted, Green Published, Bronze			2022-12-28	WOS:000419116000014
J	Purnell, TS; Luo, X; Cooper, LA; Massie, AB; Kucirka, LM; Henderson, ML; Gordon, EJ; Crews, DC; Boulware, LE; Segev, DL				Purnell, Tanjala S.; Luo, Xun; Cooper, Lisa A.; Massie, Allan B.; Kucirka, Lauren M.; Henderson, Macey L.; Gordon, Elisa J.; Crews, Deidra C.; Boulware, L. Ebony; Segev, Dorry L.			Association of Race and Ethnicity With Live Donor Kidney Transplantation in the United States From 1995 to 2014	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							STAGE RENAL-DISEASE; RACIAL DISPARITIES; DONATION; PREVALENCE; EDUCATION; RATES; KNOWLEDGE; PROGRAM; PATIENT; POINTS	IMPORTANCE Over the past 2 decades, there has been increased attention and effort to reduce disparities in live donor kidney transplantation (LDKT) for black, Hispanic, and Asian patients with end-stage kidney disease. The goal of this study was to investigate whether these efforts have been successful. OBJECTIVE To estimate changes over time in racial/ethnic disparities in LDKT in the United States, accounting for differences in death and deceased donor kidney transplantation. DESIGN, SETTING, AND PARTICIPANTS A secondary analysis of a prospectively maintained cohort study conducted in the United States of 453 162 adult first-time kidney transplantation candidates included in the Scientific Registry of Transplant Recipients between January 1, 1995, and December 31, 2014, with follow-up through December 31, 2016. EXPOSURES Race/ethnicity. MAIN OUTCOMES AND MEASURES The primary study outcome was time to LDKT. Multivariable Cox proportional hazards and competing risk models were constructed to assess changes in racial/ethnic disparities in LDKT among adults on the deceased donor kidney transplantation waiting list and interaction terms were used to test the statistical significance of temporal changes in racial/ethnic differences in receipt of LDKT. The adjusted subhazard ratios are estimates derived from the multivariable competing risk models. Data were categorized into 5-year increments (1995-1999, 2000-2004, 2005-2009, 2010-2014) to allow for an adequate sample size in each analytical cell. RESULTS Among 453 162 adult kidney transplantation candidates (mean [SD] age, 50.9 [13.1] years; 39% were women; 48% were white; 30%, black; 16%, Hispanic; and 6%, Asian), 59 516 (13.1%) received LDKT. Overall, there were 39 509 LDKTs among white patients, 8926 among black patients, 8357 among Hispanic patients, and 2724 among Asian patients. In 1995, the cumulative incidence of LDKT at 2 years after appearing on the waiting list was 7.0% among white patients, 3.4% among black patients, 6.8% among Hispanic patients, and 5.1% among Asian patients. In 2014, the cumulative incidence of LDKT was 11.4% among white patients, 2.9% among black patients, 5.9% among Hispanic patients, and 5.6% among Asian patients. From 1995-1999 to 2010-2014, racial/ethnic disparities in the receipt of LDKT increased (P < .001 for all statistical interaction terms in adjusted models comparing white patients vs black, Hispanic, and Asian patients). In 1995-1999, compared with receipt of LDKT among white patients, the adjusted subhazard ratio was 0.45 (95% CI, 0.42-0.48) among black patients, 0.83 (95% CI, 0.77-0.88) among Hispanic patients, and 0.56 (95% CI, 0.50-0.63) among Asian patients. In 2010-2014, compared with receipt of LDKT among white patients, the adjusted subhazard ratio was 0.27 (95% CI, 0.26-0.28) among black patients, 0.52 (95% CI, 0.50-0.54) among Hispanic patients, and 0.42 (95% CI, 0.39-0.45) among Asian patients. CONCLUSIONS AND RELEVANCE Among adult first-time kidney transplantation candidates in the United States who were added to the deceased donor kidney transplantation waiting list between 1995 and 2014, disparities in the receipt of live donor kidney transplantation increased from 1995-1999 to 2010-2014. These findings suggest that national strategies for addressing disparities in receipt of live donor kidney transplantation should be revisited.	[Purnell, Tanjala S.; Luo, Xun; Massie, Allan B.; Kucirka, Lauren M.; Henderson, Macey L.; Segev, Dorry L.] Johns Hopkins Sch Med, Div Transplantat, Dept Surg, Baltimore, MD USA; [Purnell, Tanjala S.; Cooper, Lisa A.; Massie, Allan B.; Kucirka, Lauren M.; Segev, Dorry L.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Purnell, Tanjala S.; Cooper, Lisa A.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Behav & Soc, Baltimore, MD USA; [Purnell, Tanjala S.; Cooper, Lisa A.; Crews, Deidra C.] Johns Hopkins Univ, Johns Hopkins Ctr Hlth Equ, Baltimore, MD USA; [Cooper, Lisa A.] Johns Hopkins Sch Med, Div Gen Internal Med, Baltimore, MD USA; [Gordon, Elisa J.] Northwestern Univ, Feinberg Sch Med, Dept Surg, Chicago, IL 60611 USA; [Crews, Deidra C.] Johns Hopkins Sch Med, Div Nephrol, Dept Med, Baltimore, MD USA; [Boulware, L. Ebony] Duke Univ, Sch Med, Div Gen Internal Med, Durham, NC USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; Northwestern University; Feinberg School of Medicine; Johns Hopkins University; Johns Hopkins Medicine; Duke University	Segev, DL (corresponding author), Johns Hopkins Med Inst, 2000 E Monument St, Baltimore, MD 21205 USA.	tpurnell@jhmi.edu; dorry@jhmi.edu		Boulware, Ebony/0000-0002-8650-4212	Agency for Healthcare Research and Quality [K01HS024600]; National Heart, Lung, and Blood Institute [K24HL083113]; National Institute of Diabetes and Digestive and Kidney Diseases [K24DK101828, K01DK101677, F30DK095545, K01DK114388-01, R01DK104876, R03AI126090, K23DK097184, R01DK098759]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K01HS024600] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K24HL083113] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R03AI126090] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK101677, K24DK101828, F30DK095545, K01DK114388, R01DK098759, R01DK104876, K23DK097184] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grant K01HS024600 (awarded to Dr Purnell) from the Agency for Healthcare Research and Quality and grant K24HL083113 (awarded to Dr Cooper) from the National Heart, Lung, and Blood Institute. It was also supported by the following grants from the National Institute of Diabetes and Digestive and Kidney Diseases: K24DK101828 (awarded to Dr Segev), K01DK101677 (awarded to Dr Massie), F30DK095545 (awarded to Dr Kucirka), K01DK114388-01 (awarded to Dr Henderson), R01DK104876 and R03AI126090 (awarded to Dr Gordon), K23DK097184 (awarded to Dr Crews), and R01DK098759 (awarded to Dr Boulware).	Alvaro EM, 2010, J HEALTH COMMUN, V15, P374, DOI 10.1080/10810731003753133; Arriola KRJ, 2014, PROG TRANSPLANT, V24, P362, DOI 10.7182/pit2014830; Ashby VB, 2011, AM J TRANSPLANT, V11, P1712, DOI 10.1111/j.1600-6143.2011.03606.x; Boulware LE, 2008, AM J TRANSPLANT, V8, P1451, DOI 10.1111/j.1600-6143.2008.02266.x; Boulware LE, 2013, AM J KIDNEY DIS, V61, P476, DOI 10.1053/j.ajkd.2012.08.039; Boulware LE, 2005, AM J TRANSPLANT, V5, P1503, DOI 10.1111/j.1600-6143.2005.00860.x; Egan BM, 2010, JAMA-J AM MED ASSOC, V303, P2043, DOI 10.1001/jama.2010.650; Ephraim PL, 2012, BMC NEPHROL, V13, DOI 10.1186/1471-2369-13-135; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; FREEDMAN BI, 1993, AM J KIDNEY DIS, V21, P387, DOI 10.1016/S0272-6386(12)80266-6; Garonzik-Wang JM, 2012, TRANSPLANTATION, V93, P1147, DOI 10.1097/TP.0b013e31824e75a5; Gordon EJ, 2010, AM J TRANSPLANT, V10, P2701, DOI 10.1111/j.1600-6143.2010.03304.x; Gordon EJ., 2017, CURR TRANSPLANT REP, V4, P32; Gordon EJ, 2014, PROG TRANSPLANT, V24, P56, DOI 10.7182/pit2014378; Gore JL, 2009, AM J TRANSPLANT, V9, P1124, DOI 10.1111/j.1600-6143.2009.02620.x; Grams ME, 2013, AM J KIDNEY DIS, V62, P245, DOI 10.1053/j.ajkd.2013.03.009; Hall EC, 2012, AM J KIDNEY DIS, V59, P849, DOI 10.1053/j.ajkd.2011.12.021; Hall EC, 2011, AM J KIDNEY DIS, V58, P813, DOI 10.1053/j.ajkd.2011.05.023; Johansen KL, 2012, CLIN J AM SOC NEPHRO, V7, P1490, DOI 10.2215/CJN.13151211; Moore DR, 2013, AM J TRANSPLANT, V13, P450, DOI 10.1111/j.1600-6143.2012.04340.x; Ogden CL, 2014, JAMA-J AM MED ASSOC, V311, P806, DOI 10.1001/jama.2014.732; Patzer RE, 2012, NAT REV NEPHROL, V8, P533, DOI 10.1038/nrneph.2012.117; Purnell TS, 2013, AM J TRANSPLANT, V13, P1557, DOI 10.1111/ajt.12258; Purnell TS, 2012, ADV CHRONIC KIDNEY D, V19, P244, DOI 10.1053/j.ackd.2012.01.008; Rodrigue JR, 2008, AM J KIDNEY DIS, V51, P663, DOI 10.1053/j.ajkd.2007.11.027; Rodrigue JR, 2015, CLIN J AM SOC NEPHRO, V10, P1687, DOI 10.2215/CJN.00700115; Rodrigue JR, 2013, TRANSPLANTATION, V96, P767, DOI 10.1097/TP.0b013e318298fa61; Schweitzer EJ, 1997, AM J KIDNEY DIS, V29, P739, DOI 10.1016/S0272-6386(97)90128-1; Scientific Registry of Transplant Recipients, 2015 SRTR ANN DAT RE; Selvin E, 2014, ANN INTERN MED, V160, P517, DOI 10.7326/M13-2411; US Renal Data System, 2016, 2016 USRDS ANN DAT R; Waterman AD, 2015, BMC NEPHROL, V16, DOI 10.1186/s12882-015-0143-0	32	146	146	1	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 2	2018	319	1					49	61		10.1001/jama.2017.19152	http://dx.doi.org/10.1001/jama.2017.19152			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FR5ON	29297077	Bronze, Green Published			2022-12-28	WOS:000419116000015
J	Stokstad, E				Stokstad, Erik			A new great ape species	SCIENCE			English	Editorial Material																			0	3	3	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 22	2017	358	6370					1522	1522		10.1126/science.358.6370.1522	http://dx.doi.org/10.1126/science.358.6370.1522			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FQ6BO	29269457				2022-12-28	WOS:000418448000021
J	Turner, NC				Turner, Nicholas C.			Signatures of DNA-Repair Deficiencies in Breast Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Turner, Nicholas C.] Inst Canc Res, Breast Canc Now Res Ctr, London, England; [Turner, Nicholas C.] Royal Marsden Hosp, Breast Unit, London, England	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust	Turner, NC (corresponding author), Inst Canc Res, Breast Canc Now Res Ctr, London, England.; Turner, NC (corresponding author), Royal Marsden Hosp, Breast Unit, London, England.			Turner, Nicholas/0000-0001-8937-0873				Committee on Obstetric Practice American College of Obstetricians and Gynecologists, 2012, Obstet Gynecol, V120, P1522, DOI 10.1097/01.AOG.0000423817.47165.48; Kattwinkel J, 1987, TXB NEONATAL RESUSCI; Kluckow M, 2015, SEMIN FETAL NEONAT M, V20, P225, DOI 10.1016/j.siny.2015.03.002; McDonald SJ, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004074.pub3; O'Donnell CPF, 2010, J PEDIATR-US, V156, P846, DOI 10.1016/j.jpeds.2010.01.007; Rabe H, 2012, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD003248.pub4, 10.1002/14651858.CD003248.pub3]; Rojas-Reyes MX, 2012, COCHRANE DB SYST REV; Tarnow-Mordi W, 2017, NEW ENGL J MED, V377, P2445, DOI 10.1056/NEJMoa1711281; World Health Organization, 2017, PRET BIRTH FACT SHEE; Wyckoff MH, 2015, PEDIATRICS, V136, pS196, DOI 10.1542/peds.2015-3373G	10	12	12	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 21	2017	377	25					2490	2492		10.1056/NEJMcibr1710161	http://dx.doi.org/10.1056/NEJMcibr1710161			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FQ5RZ	29262283				2022-12-28	WOS:000418420000015
J	Nordling, L				Nordling, Linda			Sudan seeks a science revival	SCIENCE			English	News Item																			0	1	1	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 15	2017	358	6369					1369	1369		10.1126/science.358.6369.1369	http://dx.doi.org/10.1126/science.358.6369.1369			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP8TH	29242326				2022-12-28	WOS:000417918500014
J	Amarenco, P				Amarenco, Pierre			Learning from TARDIS: time for more focused trials in stroke prevention	LANCET			English	Editorial Material							TRANSIENT ISCHEMIC ATTACK; MINOR STROKE; ASPIRIN; RISK; CLOPIDOGREL; TICAGRELOR; EFFICACY		[Amarenco, Pierre] Sorbonne Paris Cite Univ, Bichat Hosp, Dept Neurol, Paris Diderot, F-75018 Paris, France; [Amarenco, Pierre] Sorbonne Paris Cite Univ, Bichat Hosp, Stroke Ctr, Paris Diderot, F-75018 Paris, France		Amarenco, P (corresponding author), Sorbonne Paris Cite Univ, Bichat Hosp, Dept Neurol, Paris Diderot, F-75018 Paris, France.; Amarenco, P (corresponding author), Sorbonne Paris Cite Univ, Bichat Hosp, Stroke Ctr, Paris Diderot, F-75018 Paris, France.	pierre.amarenco@aphp.fr			Pfizer; Sanofi; Bristol-Myers Squibb; Merck; AstraZeneca; Boston Scientific; Boehringer Ingelheim; Bayer; Daiichi-Sankyo; Lundbeck; Edwards; Kowa; GlaxoSmithKline; Fibrogen; St-Jude Medical; French Government	Pfizer(Pfizer); Sanofi(Sanofi-Aventis); Bristol-Myers Squibb(Bristol-Myers Squibb); Merck(Merck & Company); AstraZeneca(AstraZeneca); Boston Scientific(Boston Scientific); Boehringer Ingelheim(Boehringer Ingelheim); Bayer(Bayer AG); Daiichi-Sankyo(Daiichi Sankyo Company Limited); Lundbeck(Lundbeck Corporation); Edwards; Kowa; GlaxoSmithKline(GlaxoSmithKline); Fibrogen; St-Jude Medical(St. Jude Medical); French Government	I am part of the RIGHT-2 steering committee led by Philip Bath (main author of the TARDIS trial), and I am co-Chair of the Executive Committee of the SOCRATES and THALES trials, both testing ticagrelor in secondary prevention of stroke. I also report research grant support and lecture fees from Pfizer, Sanofi (antithrombotic treatment), Bristol-Myers Squibb (antithrombotic treatment), Merck, AstraZeneca (antithrombotic treatment), and Boston Scientific; consultancy fees from Pfizer, Bristol-Myers Squibb, Merck, Boehringer Ingelheim (antithrombotic treatment), AstraZeneca (antithrombotic treatment), Bayer (antithrombotic treatment), Daiichi-Sankyo (antithrombotic treatment), Lundbeck, Edwards, Boston Scientific, Kowa, GlaxoSmithKline, and Fibrogen; lecture fees from Bayer, Boston Scientific, and St-Jude Medical; and research grants from the French Government.	Amarenco P, 2017, LANCET NEUROL, V16, P301, DOI 10.1016/S1474-4422(17)30038-8; Amarenco P, 2016, NEW ENGL J MED, V374, P1533, DOI 10.1056/NEJMoa1412981; Bath PM, 2017, LANCET; Halkes PHA, 2007, LANCET NEUROL, V6, P115, DOI 10.1016/S1474-4422(06)70685-8; Johnston SC, 2016, NEW ENGL J MED, V375, P35, DOI 10.1056/NEJMoa1603060; Rothwell PM, 2016, LANCET, V388, P365, DOI 10.1016/S0140-6736(16)30468-8; Royal College of Physicians, 2016, NAT CLIN GUID STROK; Sirimarco G, 2013, STROKE, V44, P2427, DOI 10.1161/STROKEAHA.113.001363; Wang YL, 2016, JAMA-J AM MED ASSOC, V316, P70, DOI 10.1001/jama.2016.8662; Wang YJ, 2013, NEW ENGL J MED, V369, P11, DOI 10.1056/NEJMoa1215340	10	1	1	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 3	2018	391	10123					819	821		10.1016/S0140-6736(17)33309-3	http://dx.doi.org/10.1016/S0140-6736(17)33309-3			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FX9XF	29274728	hybrid			2022-12-28	WOS:000426463500006
J	Papi, A; Brightling, C; Pedersen, SE; Reddel, HK				Papi, Alberto; Brightling, Christopher; Pedersen, Soren E.; Reddel, Helen K.			Asthma	LANCET			English	Review							AIRWAY SMOOTH-MUSCLE; UNCONTROLLED PERSISTENT ASTHMA; DOSE INHALED CORTICOSTEROIDS; DOUBLE-BLIND; LUNG-FUNCTION; RISK-FACTORS; BRONCHIAL THERMOPLASTY; SEVERE EXACERBATIONS; EOSINOPHILIC ASTHMA; RELIEVER THERAPY	Asthma-one of the most common chronic, non-communicable diseases in children and adults-is characterised by variable respiratory symptoms and variable airflow limitation. Asthma is a consequence of complex gene-environment interactions, with heterogeneity in clinical presentation and the type and intensity of airway inflammation and remodelling. The goal of asthma treatment is to achieve good asthma control-ie, to minimise symptom burden and risk of exacerbations. Anti-inflammatory and bronchodilator treatments are the mainstay of asthma therapy and are used in a stepwise approach. Pharmacological treatment is based on a cycle of assessment and re-evaluation of symptom control, risk factors, comorbidities, side-effects, and patient satisfaction by means of shared decisions. Asthma is classed as severe when requiring high-intensity treatment to keep it under control, or if it remains uncontrolled despite treatment. New biological therapies for treatment of severe asthma, together with developments in biomarkers, present opportunities for phenotype-specific interventions and realisation of more personalised treatment. In this Seminar, we provide a clinically focused overview of asthma, including epidemiology, pathophysiology, clinical diagnosis, asthma phenotypes, severe asthma, acute exacerbations, and clinical management of disease in adults and children older than 5 years. Emerging therapies, controversies, and uncertainties in asthma management are also discussed.	[Papi, Alberto] Univ Ferrara, Dept Med Sci, Res Ctr Asthma & COPD, I-44121 Ferrara, Italy; [Brightling, Christopher] Univ Leicester, Dept Infect Immun & Inflammat, Inst Lung Hlth, Leicester Natl Inst Hlth Res,Biomed Res Ctr, Leicester, Leics, England; [Brightling, Christopher] Univ Hosp Leicester NHS Trust, Leicester, Leics, England; [Pedersen, Soren E.] Univ Southern Denmark, Kolding Hosp, Dept Paediat, Kolding, Denmark; [Reddel, Helen K.] Univ Sydney, Clin Management Grp, Woolcock Inst Med Res, Sydney, NSW, Australia; [Reddel, Helen K.] Univ Sydney, NHMRC Ctr Res Excellence Severe Asthma, Woolcock Inst Med Res, Sydney, NSW, Australia	University of Ferrara; University of Leicester; University Hospitals of Leicester NHS Trust; University of Leicester; Kolding Hospital; University of Southern Denmark; University of Sydney; Woolcock Institute of Medical Research; University of Sydney; Woolcock Institute of Medical Research	Papi, A (corresponding author), Univ Ferrara, Dept Med Sci, Res Ctr Asthma & COPD, I-44121 Ferrara, Italy.	ppa@unife.it	Reddel, Helen/ABD-6338-2021; Reddel, Helen/AAC-3394-2020; Papi, alberto/AAC-1888-2019	Reddel, Helen/0000-0002-6695-6350; brightling, chris/0000-0002-9345-4903				Agbetile J, 2014, J ALLERGY CLIN IMMUN, V134, P33, DOI 10.1016/j.jaci.2013.09.050; Anagnostou K, 2012, PRIM CARE RESP J, V21, P71, DOI 10.4104/pcrj.2011.00097; Andersson M, 2013, PEDIATRICS, V132, pE435, DOI 10.1542/peds.2013-0741; [Anonymous], 2016, SIGN 153 BRIT GUID M; Asher MI, 2006, LANCET, V368, P733, DOI 10.1016/S0140-6736(06)69283-0; Basheti IA, 2008, PATIENT EDUC COUNS, V72, P26, DOI 10.1016/j.pec.2008.01.014; Bateman ED, 2015, LANCET RESP MED, V3, P719, DOI 10.1016/S2213-2600(15)00254-4; Baur X, 2012, EUR RESPIR J, V39, P529, DOI 10.1183/09031936.00096111; Beasley R, 2016, EUR RESPIR J, V47, P981, DOI 10.1183/13993003.01692-2015; Bel EH, 2014, NEW ENGL J MED, V371, P1189, DOI 10.1056/NEJMoa1403291; Bisgaard H, 2006, CHEST, V130, P1733, DOI 10.1378/chest.130.6.1733; Bjermer L, 2016, CHEST, V150, P789, DOI 10.1016/j.chest.2016.03.032; Bleecker ER, 2016, LANCET, V388, P2115, DOI 10.1016/S0140-6736(16)31324-1; Boulet LP, 2009, EUR RESPIR J, V33, P897, DOI 10.1183/09031936.00121308; Boulet LP, 2012, CLIN CHEST MED, V33, P405, DOI 10.1016/j.ccm.2012.06.002; Boyd M, 2009, COCHRANE DB SYST REV, V2; Boyle RJ, 2012, THORAX, V67, P215, DOI 10.1136/thoraxjnl-2011-200665; Brightling CE, 2012, CLIN EXP ALLERGY, V42, P638, DOI 10.1111/j.1365-2222.2011.03917.x; Brightling CE, 2006, CHEST, V129, p116S, DOI 10.1378/chest.129.1_suppl.116S; Brightling CE, 2003, CLIN EXP ALLERGY, V33, P1711, DOI 10.1111/j.1365-2222.2003.01827.x; Brightling CE, 2002, NEW ENGL J MED, V346, P1699, DOI 10.1056/NEJMoa012705; Brightling C, 2008, J ALLERGY CLIN IMMUN, V121, P5, DOI 10.1016/j.jaci.2007.10.028; Brightling CE, 2017, LANCET RESP MED, V5, P92, DOI 10.1016/S2213-2600(17)30011-5; Brouwer AFJ, 2008, EUR RESPIR J, V32, P1262, DOI 10.1183/09031936.00148107; Brusselle GG, 2013, THORAX, V68, P322, DOI 10.1136/thoraxjnl-2012-202698; Bush A, 2011, EUR RESPIR J, V38, P947, DOI 10.1183/09031936.00030711; Busse WW, 2011, NEW ENGL J MED, V364, P1005, DOI 10.1056/NEJMoa1009705; Cabieses B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105347; Castro M, 2015, LANCET RESP MED, V3, P355, DOI [10.1016/S2213-2600(15)00042-9, 10.1016/S2213-2600(15)00119-8]; Castro M, 2010, AM J RESP CRIT CARE, V181, P116, DOI 10.1164/rccm.200903-0354OC; Cates CJ, 2013, COCHRANE DB SYST REV, V4; Choy DF, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aab3142; Chung KF, 2014, EUR RESPIR J, V43, P343, DOI 10.1183/09031936.00202013; Contoli M, 2010, J ALLERGY CLIN IMMUN, V125, P830, DOI 10.1016/j.jaci.2010.01.003; Corren J, 2017, NEW ENGL J MED, V377, P936, DOI 10.1056/NEJMoa1704064; Corren J, 2016, CHEST, V150, P799, DOI 10.1016/j.chest.2016.03.018; Covar RA, 2005, IMMUNOL ALLERGY CLIN, V25, P169, DOI 10.1016/j.iac.2004.09.009; Crane J, 2012, PEDIAT ALLERG IMM-UK, V23, P59, DOI 10.1111/j.1399-3038.2011.01227.x; de Nijs SB, 2013, EUR RESPIR REV, V22, P44, DOI 10.1183/09059180.00007112; Del Giacco SR, 2017, ALLERGY, V72, P207, DOI 10.1111/all.13072; Dixon AE, 2006, CHEST, V130, P429, DOI 10.1378/chest.130.2.429; Djukanovic R, 2014, AM J RESP CRIT CARE, V190, P145, DOI 10.1164/rccm.201312-2235OC; Doe C, 2010, CHEST, V138, P1140, DOI 10.1378/chest.09-3058; Ducharme FM, 2014, LANCET, V383, P1593, DOI 10.1016/S0140-6736(14)60615-2; Dunican E. M., 2015, ANN AM THORAC SOC S, V12, P144; Dusser D, 2007, ALLERGY, V62, P591, DOI 10.1111/j.1398-9995.2007.01394.x; Elliot JG, 2009, RESPIROLOGY, V14, P808, DOI 10.1111/j.1440-1843.2009.01551.x; Fabbri L, 1998, THORAX, V53, P803, DOI 10.1136/thx.53.9.803; Fergeson JE, 2017, J ALLERGY CLIN IMMUN, V139, P438, DOI 10.1016/j.jaci.2016.06.054; Fitzpatrick AM, 2011, J ALLERGY CLIN IMMUN, V127, P382, DOI 10.1016/j.jaci.2010.11.015; Gakidou E, 2010, LANCET, V376, P959, DOI 10.1016/S0140-6736(10)61257-3; Gauvreau GM, 2014, NEW ENGL J MED, V370, P2102, DOI 10.1056/NEJMoa1402895; Gibeon D, 2015, CHEST, V148, P870, DOI 10.1378/chest.14-3056; Gibson PG, 2017, LANCET, V390, P659, DOI 10.1016/S0140-6736(17)31281-3; Gibson PG, 2004, THORAX, V59, P94, DOI 10.1136/thorax.2003.011858; Global initiative for asthma, DIAGN IN TREATM ASTH; Gonem S, 2016, LANCET RESP MED, V4, P699, DOI 10.1016/S2213-2600(16)30179-5; Green RH, 2002, LANCET, V360, P1715, DOI 10.1016/S0140-6736(02)11679-5; Green RH, 2002, THORAX, V57, P875, DOI 10.1136/thorax.57.10.875; Gupta S, 2009, CHEST, V136, P1521, DOI 10.1378/chest.09-0174; Haldar P, 2008, AM J RESP CRIT CARE, V178, P218, DOI 10.1164/rccm.200711-1754OC; Hanania NA, 2016, LANCET RESP MED, V4, P781, DOI 10.1016/S2213-2600(16)30265-X; Hanania NA, 2013, AM J RESP CRIT CARE, V187, P804, DOI 10.1164/rccm.201208-1414OC; Hartley RA, 2016, J ALLERGY CLIN IMMUN, V137, P1413, DOI 10.1016/j.jaci.2016.02.001; Jayaram L, 2006, EUR RESPIR J, V27, P483, DOI 10.1183/09031936.06.00137704; Jenkins C, 2004, BMJ-BRIT MED J, V328, P434, DOI 10.1136/bmj.328.7437.434; JOHNSTON SL, 1995, BRIT MED J, V310, P1225, DOI 10.1136/bmj.310.6989.1225; Joos GF, 2003, EUR RESPIR J, V21, P1050, DOI 10.1183/09031936.03.00008403; Kelly HW, 2012, NEW ENGL J MED, V367, P904, DOI 10.1056/NEJMoa1203229; Kerstjens HAM, 2012, NEW ENGL J MED, V367, P1198, DOI 10.1056/NEJMoa1208606; Kew KM, 2016, COCHRANE DB SYST REV, V1; Kulkarni NS, 2010, J ALLERGY CLIN IMMUN, V126, P61, DOI 10.1016/j.jaci.2010.03.026; Kuo CHS, 2017, AM J RESP CRIT CARE, V195, P443, DOI 10.1164/rccm.201512-2452OC; Lambrecht BN, 2015, NAT IMMUNOL, V16, P45, DOI 10.1038/ni.3049; Lefebvre P, 2015, J ALLERGY CLIN IMMUN, V136, P1488, DOI 10.1016/j.jaci.2015.07.046; Lemanske RF, 2010, NEW ENGL J MED, V362, P975, DOI 10.1056/NEJMoa1001278; Lemay KS, 2014, PRIM CARE RESP J, V23, P79, DOI 10.4104/pcrj.2014.00011; Leynaert B, 2012, THORAX, V67, P625, DOI 10.1136/thoraxjnl-2011-201249; Lindsay JT, 2013, EXPERT REV RESP MED, V7, P607, DOI 10.1586/17476348.2013.842129; Liu AH, 2007, J ALLERGY CLIN IMMUN, V119, P817, DOI 10.1016/j.jaci.2006.12.662; Lohne A., 2020, BENSOLVE VLP SOLVER; Loymans RJB, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3009; Mancinelli L, 1997, WESTERN J MED, V167, P322; Marks GB, 2001, THORAX, V56, P468, DOI 10.1136/thorax.56.6.468; Martinez FD, 2011, LANCET, V377, P650, DOI 10.1016/S0140-6736(10)62145-9; McGeachie MJ, 2016, NEW ENGL J MED, V374, P1842, DOI 10.1056/NEJMoa1513737; Melani AS, 2011, RESP MED, V105, P930, DOI 10.1016/j.rmed.2011.01.005; Moffatt MF, 2007, NATURE, V448, P470, DOI 10.1038/nature06014; Moffatt MF, 2010, NEW ENGL J MED, V363, P1211, DOI 10.1056/NEJMoa0906312; Mokhallati N, 2016, CURR OPIN PEDIATR, V28, P331, DOI 10.1097/MOP.0000000000000361; Moore WC, 2010, AM J RESP CRIT CARE, V181, P315, DOI 10.1164/rccm.200906-0896OC; Nair P, 2017, NEW ENGL J MED, V376, P2448, DOI 10.1056/NEJMoa1703501; NICHOLSON KG, 1993, BRIT MED J, V307, P982, DOI 10.1136/bmj.307.6910.982; Normansell R, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011293.pub2; Normansell R, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003559.pub4; Nowak RM, 2015, AM J EMERG MED, V33, P14, DOI 10.1016/j.ajem.2014.09.036; O'Byrne PM, 2017, TRIALS, V18, DOI 10.1186/s13063-016-1731-4; O'Byrne PM, 2016, LANCET RESP MED, V4, P797, DOI 10.1016/S2213-2600(16)30227-2; O'Byrne PM, 2013, CHEST, V143, P511, DOI 10.1378/chest.12-0412; O'Byrne PM, 2009, AM J RESP CRIT CARE, V179, P19, DOI 10.1164/rccm.200807-1126OC; O'Reilly R, 2013, J ALLERGY CLIN IMMUN, V131, P1024, DOI 10.1016/j.jaci.2012.08.044; Ortega HG, 2016, LANCET RESP MED, V4, P549, DOI 10.1016/S2213-2600(16)30031-5; Ortega HG, 2014, NEW ENGL J MED, V371, P1198, DOI 10.1056/NEJMoa1403290; Papi A, 2007, NEW ENGL J MED, V356, P2040, DOI 10.1056/NEJMoa063861; Papi A, 2013, LANCET RESP MED, V1, P23, DOI 10.1016/S2213-2600(13)70012-2; Park JA, 2012, J ALLERGY CLIN IMMUN, V130, P1375, DOI 10.1016/j.jaci.2012.05.031; Parsons JP, 2013, AM J RESP CRIT CARE, V187, P1016, DOI 10.1164/rccm.201303-0437ST; Parsons JR, 2010, CURR OPIN PULM MED, V16, P60, DOI 10.1097/MCP.0b013e328332ca2f; Patel M, 2013, LANCET RESP MED, V1, P32, DOI 10.1016/S2213-2600(13)70007-9; Pearce N, 1999, THORAX, V54, P268, DOI 10.1136/thx.54.3.268; Pedersen S, 2001, AM J RESP CRIT CARE, V164, P521, DOI 10.1164/ajrccm.164.4.2101050; Pellegrino R, 2005, EUR RESPIR J, V26, P948, DOI 10.1183/09031936.05.00035205; Pinnock H, 2017, BMC MED, V15, DOI 10.1186/s12916-017-0823-7; Portelli MA, 2015, CLIN EXP ALLERGY, V45, P21, DOI 10.1111/cea.12327; Raghavan D, 2016, RESPIROLOGY, V21, P449, DOI 10.1111/resp.12702; Rajan JP, 2015, J ALLERGY CLIN IMMUN, V135, P676, DOI 10.1016/j.jaci.2014.08.020; Reddel HK, 2017, LANCET, V389, P157, DOI 10.1016/S0140-6736(16)31399-X; Report G., 1996, REV FRANCAISE ALLERG, V36, P685; Russell RJ, 2017, CLIN SCI, V131, P1723, DOI 10.1042/CS20160253; Schatz M, 2006, J ALLERGY CLIN IMMUN, V117, P549, DOI 10.1016/j.jaci.2006.01.011; Schatz M, 2014, J ALLERGY CLIN IMMUN, V133, P1549, DOI 10.1016/j.jaci.2013.10.006; Shay LA, 2015, MED DECIS MAKING, V35, P114, DOI 10.1177/0272989X14551638; Simpson JL, 2006, RESPIROLOGY, V11, P54, DOI 10.1111/j.1440-1843.2006.00784.x; Smoliga JM, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.h6951; Stein Renato T, 2004, Paediatr Respir Rev, V5, P155, DOI 10.1016/j.prrv.2004.01.007; Stinson SE, 2015, J ALLERGY CLIN IMMUN, V135, P395, DOI 10.1016/j.jaci.2014.08.027; Suissa S, 2002, THORAX, V57, P880, DOI 10.1136/thorax.57.10.880; Suissa S, 2000, NEW ENGL J MED, V343, P332, DOI 10.1056/NEJM200008033430504; Sweeney J, 2012, THORAX, V67, P754, DOI 10.1136/thoraxjnl-2012-201869; Teach SJ, 2015, J ALLERGY CLIN IMMUN, V136, P1476, DOI 10.1016/j.jaci.2015.09.008; ten Brinke A, 2004, AM J RESP CRIT CARE, V170, P601, DOI 10.1164/rccm.200404-440OC; ten Brinke A, 2001, J PSYCHOSOM RES, V50, P7, DOI 10.1016/S0022-3999(00)00203-8; To T, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-204; van Maanen A, 2013, EUR RESPIR J, V41, P832, DOI 10.1183/09031936.00019412; Vonk JM, 2003, THORAX, V58, P322, DOI 10.1136/thorax.58.4.322; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Wark PAB, 2006, THORAX, V61, P909, DOI 10.1136/thx.2005.045187; Wechsler ME, 2013, J ALLERGY CLIN IMMUN, V132, P1295, DOI 10.1016/j.jaci.2013.08.009; Wenzel S, 2016, LANCET, V388, P31, DOI 10.1016/S0140-6736(16)30307-5; Wenzel SE, 2012, NAT MED, V18, P716, DOI 10.1038/nm.2678; Wilson SJ, 2016, EUR RESPIR J, V48, P1307, DOI 10.1183/13993003.01129-2016; Woodruff PG, 2009, AM J RESP CRIT CARE, V180, P388, DOI 10.1164/rccm.200903-0392OC	142	935	1008	48	538	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 24	2018	391	10122					783	800		10.1016/S0140-6736(17)33311-1	http://dx.doi.org/10.1016/S0140-6736(17)33311-1			18	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FX4ND	29273246				2022-12-28	WOS:000426054000029
J	Shepstone, L; Lenaghan, E; Cooper, C; Clarke, S; Fong-Soe-Khioe, R; Fordham, R; Gittoes, N; Harvey, I; Harvey, N; Heawood, A; Holland, R; Howe, A; Kanis, J; Marshall, T; O'Neill, T; Peters, T; Redmond, N; Torgerson, D; Turner, D; McCloskey, E				Shepstone, Lee; Lenaghan, Elizabeth; Cooper, Cyrus; Clarke, Shane; Fong-Soe-Khioe, Rebekah; Fordham, Richard; Gittoes, Neil; Harvey, Ian; Harvey, Nick; Heawood, Alison; Holland, Richard; Howe, Amanda; Kanis, John; Marshall, Tarnya; O'Neill, Terence; Peters, Tim; Redmond, Niamh; Torgerson, David; Turner, David; McCloskey, Eugene		SCOOP Study Team	Screening in the community to reduce fractures in older women (SCOOP): a randomised controlled trial	LANCET			English	Article							OSTEOPOROTIC FRACTURES; HIP FRACTURE; MEN; UK; PREVENTION	Background Despite effective assessment methods and medications targeting osteoporosis and related fractures, screening for fracture risk is not currently advocated in the UK. We tested whether a community-based screening intervention could reduce fractures in older women. Methods We did a two-arm randomised controlled trial in women aged 70-85 years to compare a screening programme using the Fracture Risk Assessment Tool (FRAX) with usual management. Women were recruited from 100 general practitioner (GP) practices in seven regions of the UK: Birmingham, Bristol, Manchester, Norwich, Sheffield, Southampton, and York. We excluded women who were currently on prescription anti-osteoporotic drugs and any individuals deemed to be unsuitable to enter a research study (eg, known dementia, terminally ill, or recently bereaved). The primary outcome was the proportion of individuals who had one or more osteoporosis-related fractures over a 5-year period. In the screening group, treatment was recommended in women identified to be at high risk of hip fracture, according to the FRAX 10-year hip fracture probability. Prespecified secondary outcomes were the proportions of participants who had at least one hip fracture, any clinical fracture, or mortality; and the effect of screening on anxiety and health-related quality of life. This trial is registered with the International Standard Randomised Controlled Trial registry, number ISRCTN 55814835. Findings 12 483 eligible women were identified and participated in the trial, and 6233 women randomly assigned to the screening group between April 15, 2008, and July 2, 2009. Treatment was recommended in 898 (14%) of 6233 women. Use of osteoporosis medication was higher at the end of year 1 in the screening group compared with controls (15% vs 4%), with uptake particularly high (78% at 6 months) in the screening high-risk subgroup. Screening did not reduce the primary outcome of incidence of all osteoporosis-related fractures (hazard ratio [HR] 0.94, 95% CI 0.85-1.03, p=0.178), nor the overall incidence of all clinical fractures (0.94, 0.86-1.03, p=0.183), but screening reduced the incidence of hip fractures (0.72, 0.59-0.89, p=0.002). There was no evidence of differences in mortality, anxiety levels, or quality of life. Interpretation Systematic, community-based screening programme of fracture risk in older women in the UK is feasible, and could be effective in reducing hip fractures.	[Shepstone, Lee; Lenaghan, Elizabeth; Fong-Soe-Khioe, Rebekah; Fordham, Richard; Harvey, Ian; Howe, Amanda; Turner, David] Univ East Anglia, Sch Med, Norwich NR4 7TJ, Norfolk, England; [Marshall, Tarnya] Norfolk & Norwich Univ Hosp, Norwich, Norfolk, England; [Heawood, Alison; Peters, Tim; Redmond, Niamh] Univ Bristol, Bristol Med Sch, Bristol, Avon, England; [Clarke, Shane] Univ Hosp Bristol, Dept Rheumatol, Bristol, Avon, England; [Cooper, Cyrus; Harvey, Nick] Univ Southampton, Southampton Gen Hosp, Med Res Council, Lifecourse Epidemiol Unit, Southampton, Hants, England; [Gittoes, Neil] Queen Elizabeth Hosp, Ctr Endocrinol Diabet & Metab, Birmingham, W Midlands, England; [Holland, Richard] Univ Leicester, Leicester Med Sch, Ctr Med, Leicester, Leics, England; [O'Neill, Terence] Univ Manchester, Natl Inst Hlth Res, Manchester Musculoskeletal BRU, Cent Manchester Univ Hosp NHS Fdn Trust, Manchester, Lancs, England; [O'Neill, Terence] Univ Manchester, Arthrit Res UK Ctr Epidemiol, Manchester, Lancs, England; [Torgerson, David] Univ York, Dept Hlth Sci, York, N Yorkshire, England; [Kanis, John] Univ Sheffield, Ctr Metab Bone Dis, Sheffield, S Yorkshire, England; [Kanis, John] Univ Sheffield, Mellanby Ctr Bone Res, Ctr Integrated Res Musculoskeletal Ageing, Sheffield, S Yorkshire, England; [Kanis, John] Australian Catholic Univ, Melbourne, Vic, Australia	University of East Anglia; Norfolk & Norwich University Hospitals NHS Foundation Trust; Norfolk & Norwich University Hospital; University of Bristol; University of Bristol; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Southampton; University of Birmingham; University of Leicester; University of Manchester; University of Manchester; University of York - UK; University of Sheffield; University of Sheffield; Australian Catholic University	Shepstone, L (corresponding author), Univ East Anglia, Sch Med, Norwich NR4 7TJ, Norfolk, England.	l.shepstone@uea.ac.uk	Torgerson, David/L-4566-2019; McCloskey, Eugene/T-5197-2019; Turner, David A/E-1847-2013	Torgerson, David/0000-0002-1667-4275; Turner, David A/0000-0002-1689-4147; O'Neill, Terence/0000-0002-8896-4677; Redmond, Niamh M/0000-0001-8814-3396; Harvey, Nicholas/0000-0002-8194-2512; Fordham, Richard/0000-0002-5520-6255; Peters, Tim/0000-0003-2881-4180; Cooper, Cyrus/0000-0003-3510-0709; Holland, Richard/0000-0002-4663-6923; Heawood (nee Shaw), Alison/0000-0002-5907-4608; Bell, Kerry Jane/0000-0001-5124-138X	Arthritis Research UK; Medical Research Council; EPSRC [EP/J008192/1] Funding Source: UKRI; MRC [G0601019, G0400491, MC_U147585819, MR/K025643/1, MR/P020941/1, MC_U147585827] Funding Source: UKRI; Medical Research Council [MC_U147585824, G0601019, MR/P020941/1, MC_UP_A620_1014, MC_U147585819, MC_UU_12011/1, U1475000001, MC_U147585827, MR/K025643/1, G0400491] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10026, NF-SI-0508-10082, NF-SI-0513-10085] Funding Source: researchfish	Arthritis Research UK(Versus Arthritis); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	Arthritis Research UK and Medical Research Council.	Barr RJ, 2010, OSTEOPOROSIS INT, V21, P561, DOI 10.1007/s00198-009-1007-x; Centre for Metabolic Bone Diseases, FRAX FRACT RISK ASS; Clark EM, 2012, J BONE MINER RES, V27, P664, DOI 10.1002/jbmr.1478; Compston J, 2009, MATURITAS, V62, P105, DOI 10.1016/j.maturitas.2008.11.022; Emmett CL, 2012, FAM PRACT, V29, P235, DOI 10.1093/fampra/cmr069; Hernlund E, 2013, ARCH OSTEOPOROS, V8, DOI 10.1007/s11657-013-0136-1; Johnell O, 2006, OSTEOPOROSIS INT, V17, P1726, DOI 10.1007/s00198-006-0172-4; Kanis JA, 2008, OSTEOPOROSIS INT, V19, P385, DOI 10.1007/s00198-007-0543-5; Kanis JA, 2007, OSTEOPOROSIS INT, V18, P1033, DOI 10.1007/s00198-007-0343-y; Kanis JA, 2005, BONE, V36, P22, DOI 10.1016/j.bone.2004.08.018; LAKATOS E, 1992, STAT MED, V11, P179, DOI 10.1002/sim.4780110205; Office for National Statistics, 2015, DEATHS REG ENGL WAL; Schuit SCE, 2004, BONE, V34, P195, DOI 10.1016/j.bone.2003.10.001; SERNBO I, 1993, OSTEOPOROSIS INT, V3, P148, DOI 10.1007/BF01623276; Shepstone L, 2012, OSTEOPOROSIS INT, V23, P2507, DOI 10.1007/s00198-011-1876-7; Silva RB, 2013, J AM MED DIR ASSOC, V14, P685, DOI 10.1016/j.jamda.2013.05.015; Spielberger C. D., 1973, MANUAL STATE TRAIT I; UK National Screening Committee, 2013, SCREEN OST POSTM WOM; Wainwright SA, 2005, J CLIN ENDOCR METAB, V90, P2787, DOI 10.1210/jc.2004-1568	20	136	143	2	53	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 24	2018	391	10122					741	747		10.1016/S0140-6736(17)32640-5	http://dx.doi.org/10.1016/S0140-6736(17)32640-5			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FX4ND	29254858	Green Published, Green Accepted, Green Submitted, Bronze			2022-12-28	WOS:000426054000025
J	Cheng, ML; Solit, DB				Cheng, Michael L.; Solit, David B.			Opportunities and Challenges in Genomic Sequencing for Precision Cancer Care	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							TUMOR; DNA		[Cheng, Michael L.] Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave,Box 8, New York, NY 10065 USA; [Solit, David B.] Mem Sloan Kettering Canc Ctr, Kravis Ctr Mol Oncol, 1275 York Ave, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Solit, DB (corresponding author), Mem Sloan Kettering Canc Ctr, Kravis Ctr Mol Oncol, 1275 York Ave, New York, NY 10065 USA.	solitd@mskcc.org	Solit, David B./AAC-5309-2019	Solit, David/0000-0002-6614-802X	NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA008748] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Chakravarty D, 2017, JCO PRECIS ONCOL, V1; Chang MT, 2016, NAT BIOTECHNOL, V34, P155, DOI 10.1038/nbt.3391; Garofalo A, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0333-9; Hyman DM, 2015, NEW ENGL J MED, V373, P726, DOI 10.1056/NEJMoa1502309; Hyman DM, 2017, J CLIN ONCOL, V35, P2501, DOI [10.1200/JCO.2017.35.18_suppl.LBA2501, DOI 10.1200/JCO.2017.35.18_SUPPL.LBA2501]; Le DT, 2015, NEW ENGL J MED, V372, P2509, DOI 10.1056/NEJMoa1500596; Mandelker D, 2017, JAMA-J AM MED ASSOC, V318, P825, DOI 10.1001/jama.2017.11137; Middha S, 2017, JCO PRECIS ONCOL, V1, DOI 10.1200/PO.17.00084; Quigley D, 2017, CANCER DISCOV, V7, P999, DOI 10.1158/2159-8290.CD-17-0146; Zehir A, 2017, NAT MED, V23, P703, DOI 10.1038/nm.4333	10	6	6	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 6	2018	168	3					221	+		10.7326/M17-2940	http://dx.doi.org/10.7326/M17-2940			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FV0CU	29310131	Green Accepted			2022-12-28	WOS:000424224300011
J	Wild, R; Kowal, J; Eyring, J; Ngwa, EM; Aebi, M; Locher, KP				Wild, Rebekka; Kowal, Julia; Eyring, Jillianne; Ngwa, Elsy M.; Aebi, Markus; Locher, Kaspar P.			Structure of the yeast oligosaccharyltransferase complex gives insight into eukaryotic N-glycosylation	SCIENCE			English	Article							LIPID-LINKED OLIGOSACCHARIDE; X-RAY-STRUCTURE; ENDOPLASMIC-RETICULUM; CRYSTAL-STRUCTURE; OXIDOREDUCTASE ACTIVITY; MOLECULAR-BASIS; VENOM FACTOR; ACTIVE-SITE; PROTEIN; TRANSFERASE	Oligosaccharyltransferase (OST) is an essential membrane protein complex in the endoplasmic reticulum, where it transfers an oligosaccharide from a dolichol-pyrophosphate-activated donor to glycosylation sites of secretory proteins. Here we describe the atomic structure of yeast OST determined by cryo-electron microscopy, revealing a conserved subunit arrangement. The active site of the catalytic STT3 subunit points away from the center of the complex, allowing unhindered access to substrates. The dolichol-pyrophosphate moiety binds to a lipid-exposed groove of STT3, whereas two noncatalytic subunits and an ordered N-glycan form a membrane-proximal pocket for the oligosaccharide. The acceptor polypeptide site faces an oxidoreductase domain in stand-alone OST complexes or is immediately adjacent to the translocon, suggesting how eukaryotic OSTs efficiently glycosylate a large number of polypeptides before their folding.	[Wild, Rebekka; Kowal, Julia; Locher, Kaspar P.] ETH, Dept Biol, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland; [Eyring, Jillianne; Ngwa, Elsy M.; Aebi, Markus] ETH, Dept Biol, Inst Microbiol, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Locher, KP (corresponding author), ETH, Dept Biol, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland.; Aebi, M (corresponding author), ETH, Dept Biol, Inst Microbiol, CH-8093 Zurich, Switzerland.	markus.aebi@micro.biol.ethz.ch; locher@mol.biol.ethz.ch		Eyring, Jillianne/0000-0001-6120-9834; Kowal, Julia/0000-0003-4694-1896	Swiss National Science Foundation Sinergia program TransGlyco [CRSII3_147632]; Swiss National Science Foundation Sinergia program GlycoStart [CRSII5_173709]; ETH postdoctoral fellowship program;  [310030_162636]	Swiss National Science Foundation Sinergia program TransGlyco; Swiss National Science Foundation Sinergia program GlycoStart; ETH postdoctoral fellowship program; 	This work was supported by the Swiss National Science Foundation Sinergia programs TransGlyco (CRSII3_147632) and GlycoStart (CRSII5_173709) and grant 310030_162636 to M.A. R.W. acknowledges support from the ETH postdoctoral fellowship program.	Burda P, 1998, GLYCOBIOLOGY, V8, P455, DOI 10.1093/glycob/8.5.455; Chavan M, 2006, TRENDS BIOCHEM SCI, V31, P17, DOI 10.1016/j.tibs.2005.11.010; Chavan M, 2005, J BIOL CHEM, V280, P22917, DOI 10.1074/jbc.M502858200; Cherepanova NA, 2016, SCI REP-UK, V6, DOI 10.1038/srep20946; Cherepanova NA, 2014, J CELL BIOL, V206, P525, DOI 10.1083/jcb.201404083; Dell A., 2010, INT J MICROBIOL, V2010, DOI [10.1074/jbc.RA117.001068, DOI 10.1155/2010/148178]; Dumax-Vorzet A, 2013, J CELL SCI, V126, P2595, DOI 10.1242/jcs.115410; Gahmberg CG, 1996, TRENDS BIOCHEM SCI, V21, P308, DOI 10.1016/0968-0004(96)10034-7; Gerber S, 2013, J BIOL CHEM, V288, P8849, DOI 10.1074/jbc.M112.445940; Grigorian A, 2012, ANN NY ACAD SCI, V1253, P49, DOI 10.1111/j.1749-6632.2011.06391.x; Harada Y, 2009, P NATL ACAD SCI USA, V106, P6945, DOI 10.1073/pnas.0812489106; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Igura M, 2008, EMBO J, V27, P234, DOI 10.1038/sj.emboj.7601940; Kelleher DJ, 2006, GLYCOBIOLOGY, V16, p47R, DOI 10.1093/glycob/cwj066; Kim H, 2005, J BIOL CHEM, V280, P20261, DOI 10.1074/jbc.M412213200; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; Korolev S, 2002, PROTEINS, V49, P420, DOI 10.1002/prot.10161; Kowarik M, 2002, MOL CELL, V10, P769, DOI 10.1016/S1097-2765(02)00685-8; Kowarik M, 2006, EMBO J, V25, P1957, DOI 10.1038/sj.emboj.7601087; Krishnan V, 2009, STRUCTURE, V17, P611, DOI 10.1016/j.str.2009.01.015; Lara P, 2017, J BIOL CHEM, V292, P11349, DOI 10.1074/jbc.M117.779421; Laursen NS, 2011, EMBO J, V30, P606, DOI 10.1038/emboj.2010.341; Li GT, 2005, J BIOL CHEM, V280, P1864, DOI 10.1074/jbc.M410969200; Li H, 2008, STRUCTURE, V16, P432, DOI 10.1016/j.str.2007.12.013; Lizak C, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3627; Lizak C, 2011, NATURE, V474, P350, DOI 10.1038/nature10151; MARSHALL RD, 1972, ANNU REV BIOCHEM, V41, P673, DOI 10.1146/annurev.bi.41.070172.003325; Matsumoto S, 2013, P NATL ACAD SCI USA, V110, P17868, DOI 10.1073/pnas.1309777110; Mohorko E, 2014, STRUCTURE, V22, P590, DOI 10.1016/j.str.2014.02.013; Mpakali A, 2017, J MED CHEM, V60, P2963, DOI 10.1021/acs.jmedchem.6b01890; Mueller S, 2015, MOL BIOL CELL, V26, P2596, DOI 10.1091/mbc.E15-03-0168; Murray AN, 2015, CHEM BIOL, V22, P1052, DOI 10.1016/j.chembiol.2015.06.017; Napiorkowska M, 2017, NAT STRUCT MOL BIOL, V24, P1100, DOI 10.1038/nsmb.3491; Nasab FP, 2008, MOL BIOL CELL, V19, P3758, DOI 10.1091/mbc.E08-05-0467; NILSSON I, 1993, J BIOL CHEM, V268, P5798; PATHAK R, 1995, BIOCHEMISTRY-US, V34, P4179, DOI 10.1021/bi00013a005; Pfeffer S, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14516; Pfeffer S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9403; Poljak K., 2017, MOL CELL PROTEOMICS, V17, P18; Qin SY, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.394288; Ramirez AS, 2017, GLYCOBIOLOGY, V27, P525, DOI 10.1093/glycob/cwx017; Rapoport TA, 2017, ANNU REV CELL DEV BI, V33, P369, DOI 10.1146/annurev-cellbio-100616-060439; Schallus T, 2008, MOL BIOL CELL, V19, P3404, DOI 10.1091/mbc.E08-04-0354; Schulz BL, 2009, P NATL ACAD SCI USA, V106, P11061, DOI 10.1073/pnas.0812515106; Schwarz F, 2011, CURR OPIN STRUC BIOL, V21, P576, DOI 10.1016/j.sbi.2011.08.005; Shibatani T, 2005, BIOCHEMISTRY-US, V44, P5982, DOI 10.1021/bi047328f; Shrimal S, 2017, J CELL BIOL, V216, P3625, DOI 10.1083/jcb.201702159; Taschner M, 2016, EMBO J, V35, P773, DOI 10.15252/embj.201593164; Thunnissen MMGM, 2001, NAT STRUCT BIOL, V8, P131, DOI 10.1038/84117; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; Wilson CM, 2005, J BIOL CHEM, V280, P4195, DOI 10.1074/jbc.M410329200; Yan G, 2002, J BIOL CHEM, V277, P47692, DOI 10.1074/jbc.M208136200; Yan Q, 1999, J BIOL CHEM, V274, P5021, DOI 10.1074/jbc.274.8.5021; Zacchi LF, 2016, MOL CELL PROTEOMICS, V15, P2435, DOI 10.1074/mcp.M115.056366; Zielinska DF, 2010, CELL, V141, P897, DOI 10.1016/j.cell.2010.04.012	55	104	105	6	70	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 2	2018	359	6375					545	549		10.1126/science.aar5140	http://dx.doi.org/10.1126/science.aar5140			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU4AS	29301962	Green Accepted			2022-12-28	WOS:000423795800035
J	Chen, HW; Xue, J; Churikov, D; Hass, EP; Shi, SH; Lemon, LD; Luciano, P; Bertuch, AA; Zappulla, DC; Geli, V; Wu, J; Lei, M				Chen, Hongwen; Xue, Jing; Churikov, Dmitri; Hass, Evan P.; Shi, Shaohua; Lemon, Laramie D.; Luciano, Pierre; Bertuch, Alison A.; Zappulla, David C.; Geli, Vincent; Wu, Jian; Lei, Ming			Structural Insights into Yeast Telomerase Recruitment to Telomeres	CELL			English	Article							SACCHAROMYCES-CEREVISIAE; DNA-REPAIR; RNA; KU; PROTEIN; EST1; SUBUNIT; BINDING; CDC13; PHOSPHORYLATION	Telomerase maintains chromosome ends from humans to yeasts. Recruitment of yeast telomerase to telomeres occurs through its Ku and Est1 subunits via independent interactions with telomerase RNA (TLC1) and telomeric proteins Sir4 and Cdc13, respectively. However, the structures of the molecules comprising these telomerase-recruiting pathways remain unknown. Here, we report crystal structures of the Ku heterodimer and Est1 complexed with their key binding partners. Two major findings are as follows: (1) Ku specifically binds to telomeraseRNA in a distinct, yet related, manner to how it binds DNA; and (2) Est1 employs two separate pockets to bind distinct motifs of Cdc13. The N-terminal Cdc13-binding site of Est1 cooperates with the TLC1-Ku-Sir4 pathway for telomerase recruitment, whereas the C-terminal interface is dispensable for binding Est1 in vitro yet is nevertheless essential for telomere maintenance in vivo. Overall, our results integrate previous models and provide fundamentally valuable structural information regarding telomere biology.	[Chen, Hongwen; Xue, Jing; Shi, Shaohua; Wu, Jian] Univ Chinese Acad Sci, Shanghai Inst Biochem & Cell Biol, CAS Ctr Excellence Mol Cell Sci, State Key Lab Mol Biol,Chinese Acad Sci, Shanghai 201210, Peoples R China; [Churikov, Dmitri; Luciano, Pierre; Geli, Vincent] Aix Marseille Univ, CNRS UMR7258, INSERM U1068, CRCM,Inst Paoli Calmettes,Equipe Labellisee Ligue, F-13009 Marseille, France; [Hass, Evan P.; Zappulla, David C.] Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA; [Lemon, Laramie D.; Bertuch, Alison A.] Baylor Coll Med, Dept Pediat, One Baylor Plaza,BCM225, Houston, TX 77030 USA; [Lei, Ming] Shanghai Jiao Tong Univ, Sch Med, Shanghai Inst Precis Med, Peoples Hosp 9, Shanghai 200125, Peoples R China; [Lei, Ming] Shanghai Jiao Tong Univ, Sch Med, Key Lab Cell Differentiat & Apoptosis, Chinese Minist Educ, Shanghai 200025, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of Chinese Academy of Sciences, CAS; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC); Johns Hopkins University; Baylor College of Medicine; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Wu, J (corresponding author), Univ Chinese Acad Sci, Shanghai Inst Biochem & Cell Biol, CAS Ctr Excellence Mol Cell Sci, State Key Lab Mol Biol,Chinese Acad Sci, Shanghai 201210, Peoples R China.; Lei, M (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Inst Precis Med, Peoples Hosp 9, Shanghai 200125, Peoples R China.; Lei, M (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Key Lab Cell Differentiat & Apoptosis, Chinese Minist Educ, Shanghai 200025, Peoples R China.	wujian@shsmu.edu.cn; leim@shsmu.edu.cn	Chen, Hongwen/AAT-4530-2020	Chen, Hongwen/0000-0002-1065-9808; Luciano, Pierre/0000-0002-1394-4129; Lemon, Laramie/0000-0003-1933-8645; Zappulla, David/0000-0001-8242-3493; Xue, Jing/0000-0002-7331-1382	Ministry of Science and Technology of China [2013CB910402]; National Natural Science Foundation of China [31330040, 31525007, 31500625, U1732124]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDB08010201]; Youth Innovation Promotion Association of the Chinese Academy of Sciences; National Institute of General Medical Sciences of the NIH (USA) [RO1GM118757, RO1GM077509]; "Ligue contre le Cancer'' (Equipe Labellisee); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077509, R01GM118757] Funding Source: NIH RePORTER	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); Youth Innovation Promotion Association of the Chinese Academy of Sciences; National Institute of General Medical Sciences of the NIH (USA); "Ligue contre le Cancer'' (Equipe Labellisee); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr. Jin-Qiu Zhou for the plasmids and yeast strains. We thank L. Wu, D. Yao, and R. Zhang from BL18U1 and BL19U1 beamlines at NCPSS for help with crystal data collection, and thank protein production team at NCPSS for technical assistance. This work was supported by grants from the Ministry of Science and Technology of China (2013CB910402 to M.L.), the National Natural Science Foundation of China (31330040 and 31525007 to M.L. and 31500625 and U1732124 to J.W.), the Strategic Priority Research Program of the Chinese Academy of Sciences (XDB08010201 to M.L.), and the Youth Innovation Promotion Association of the Chinese Academy of Sciences (to J.W.). Research was also supported in part by the National Institute of General Medical Sciences of the NIH (USA) (RO1GM118757 to D.C.Z. and RO1GM077509 to A.A.B.). Work in the V.G. laboratory is supported by the "Ligue contre le Cancer'' (Equipe Labellisee).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bianchi A, 2007, CELL, V128, P1051, DOI 10.1016/j.cell.2007.01.041; Chan A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000236; Dalby AB, 2013, RNA, V19, P841, DOI 10.1261/rna.038703.113; Egan ED, 2012, RNA, V18, P1747, DOI 10.1261/rna.034629.112; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans SK, 2002, GENETICS, V162, P1101; Fell VL, 2015, MUTAT RES-REV MUTAT, V763, P15, DOI 10.1016/j.mrrev.2014.06.002; Fisher TS, 2004, NAT STRUCT MOL BIOL, V11, P1198, DOI 10.1038/nsmb854; Gallardo F, 2008, EMBO J, V27, P748, DOI 10.1038/emboj.2008.21; Gallardo F, 2011, MOL CELL, V44, P819, DOI 10.1016/j.molcel.2011.09.020; Gao H, 2010, GENETICS, V186, P1147, DOI 10.1534/genetics.110.122044; Hass EP, 2015, ELIFE, V4, DOI 10.7554/eLife.07750; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Lee SE, 1998, CELL, V94, P399, DOI 10.1016/S0092-8674(00)81482-8; Lemieux B, 2016, CELL, V165, P1171, DOI 10.1016/j.cell.2016.04.018; Lendvay TS, 1996, GENETICS, V144, P1399; Leontis NB, 2001, RNA, V7, P499, DOI 10.1017/S1355838201002515; Li S, 2009, CELL, V136, P50, DOI 10.1016/j.cell.2008.11.027; Lopez CR, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002233; Luciano P, 2012, EMBO J, V31, P2034, DOI 10.1038/emboj.2012.40; LUNDBLAD V, 1993, CELL, V73, P347, DOI 10.1016/0092-8674(93)90234-H; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Mozdy AD, 2006, RNA, V12, P1721, DOI 10.1261/rna.134706; Nugent CI, 1996, SCIENCE, V274, P249, DOI 10.1126/science.274.5285.249; O'Sullivan RJ, 2010, NAT REV MOL CELL BIO, V11, P171, DOI 10.1038/nrm2848; Osterhage JL, 2006, NAT STRUCT MOL BIOL, V13, P720, DOI 10.1038/nsmb1125; Peterson SE, 2001, NAT GENET, V27, P64, DOI 10.1038/83778; Pfingsten JS, 2012, CELL, V148, P922, DOI 10.1016/j.cell.2012.01.033; Ribes-Zamora A, 2007, NAT STRUCT MOL BIOL, V14, P301, DOI 10.1038/nsmb1214; Roy R, 2004, J BIOL CHEM, V279, P86, DOI 10.1074/jbc.M306841200; Sabourin M, 2007, MOL CELL, V27, P550, DOI 10.1016/j.molcel.2007.07.016; Schramke V, 2004, NAT GENET, V36, P46, DOI 10.1038/ng1284; Shi T, 2013, CELL, V153, P1340, DOI 10.1016/j.cell.2013.05.007; SINGER MS, 1994, SCIENCE, V266, P404, DOI 10.1126/science.7545955; Stellwagen AE, 2003, GENE DEV, V17, P2384, DOI 10.1101/gad.1125903; Sun J, 2011, CELL RES, V21, P258, DOI 10.1038/cr.2010.138; Taddei A, 2012, GENETICS, V192, P107, DOI 10.1534/genetics.112.140608; Walker JR, 2001, NATURE, V412, P607, DOI 10.1038/35088000; Wang F, 2007, NATURE, V445, P506, DOI 10.1038/nature05454; WELLINGER RJ, 1993, CELL, V72, P51, DOI 10.1016/0092-8674(93)90049-V; Williams JM, 2014, GENETICS, V197, P1123, DOI 10.1534/genetics.114.164707; Wu Y, 2011, P NATL ACAD SCI USA, V108, P20362, DOI 10.1073/pnas.1100281108; Xue B, 2010, BBA-PROTEINS PROTEOM, V1804, P996, DOI 10.1016/j.bbapap.2010.01.011; Zappulla DC, 2004, P NATL ACAD SCI USA, V101, P10024, DOI 10.1073/pnas.0403641101	45	50	50	3	37	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 11	2018	172	1-2					331	+		10.1016/j.cell.2017.12.008	http://dx.doi.org/10.1016/j.cell.2017.12.008			26	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FS5MI	29290466	Green Accepted, Bronze			2022-12-28	WOS:000419840100029
J	McGoldrick, LL; Singh, AK; Saotome, K; Yelshanskaya, MV; Twomey, EC; Grassucci, RA; Sobolevsky, AI				McGoldrick, Luke L.; Singh, Appu K.; Saotome, Kei; Yelshanskaya, Maria V.; Twomey, Edward C.; Grassucci, Robert A.; Sobolevsky, Alexander I.			Opening of the human epithelial calcium channel TRPV6	NATURE			English	Article							CRYSTAL-STRUCTURE; EXPRESSION; MICROSCOPY; MECHANISM; FAMILY	Calcium-selective transient receptor potential vanilloid subfamily member 6 (TRPV6) channels play a critical role in calcium uptake in epithelial tissues(1-4). Altered TRPV6 expression is associated with a variety of human diseases(5), including cancers(6). TRPV6 channels are constitutively active(1,7,8) and their open probability depends on the lipidic composition of the membrane in which they reside; it increases substantially in the presence of phosphatidylinositol 4,5-bisphosphate(7,9). Crystal structures of detergent-solubilized rat TRPV6 in the closed state have previously been solved(10,11). Corroborating electrophysiological results(3), these structures demonstrated that the Ca2+ selectivity of TRPV6 arises from a ring of aspartate side chains in the selectivity filter that binds Ca2+ tightly. However, how TRPV6 channels open and close their pores for ion permeation has remained unclear. Here we present cryo-electron microscopy structures of human TRPV6 in the open and closed states. The channel selectivity filter adopts similar conformations in both states, consistent with its explicit role in ion permeation. The iris-like channel opening is accompanied by an alpha-to-pi-helical transition in the pore-lining transmembrane helix S6 at an alanine hinge just below the selectivity filter. As a result of this transition, the S6 helices bend and rotate, exposing different residues to the ion channel pore in the open and closed states. This gating mechanism, which defines the constitutive activity of TRPV6, is, to our knowledge, unique among tetrameric ion channels and provides structural insights for understanding their diverse roles in physiology and disease.	[McGoldrick, Luke L.; Singh, Appu K.; Saotome, Kei; Yelshanskaya, Maria V.; Twomey, Edward C.; Grassucci, Robert A.; Sobolevsky, Alexander I.] Columbia Univ, Dept Biochem & Mol Biophys, 650 West 168th St, New York, NY 10032 USA; [McGoldrick, Luke L.; Twomey, Edward C.] Columbia Univ, Integrated Program Cellular Mol & Biomed Studies, 650 West 168th St, New York, NY 10032 USA	Columbia University; Columbia University	Sobolevsky, AI (corresponding author), Columbia Univ, Dept Biochem & Mol Biophys, 650 West 168th St, New York, NY 10032 USA.	as4005@cumc.columbia.edu		Saotome, Kei/0000-0002-4135-5356; Twomey, Edward/0000-0002-1855-1586	NIH [T32 GM008224, F31 NS093838, R01 CA206573, R01 NS083660, GM103310]; Amgen Young Investigator award; Simons Foundation [349247]; NYSTAR; Irma T. Hirschl Career Scientist award; NATIONAL CANCER INSTITUTE [R01CA206573] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103310, T32GM008224] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS083660, F31NS093838] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Amgen Young Investigator award(Amgen); Simons Foundation; NYSTAR; Irma T. Hirschl Career Scientist award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank T. Rohacs for advice on electrophysiological recordings, J. Frank for comments on the manuscript, H. Kao for computational support and members of the E.C. Greene laboratory for assistance with their fluorimeter. L.L.M. and E.C.T. are supported by the NIH (T32 GM008224 and F31 NS093838, respectively). A.I.S. is supported by the NIH (R01 CA206573, R01 NS083660), and Amgen Young Investigator and Irma T. Hirschl Career Scientist awards. Data were collected at the Columbia University Medical Center cryo-EM facility and at the Simons Electron Microscopy Center and National Resource for Automated Molecular Microscopy located at the New York Structural Biology Center, supported by grants from the Simons Foundation (349247), NYSTAR, and the NIH (GM103310).	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Bodding M, 2004, J BIOL CHEM, V279, P36546, DOI 10.1074/jbc.M404679200; Boukalova S, 2010, J BIOL CHEM, V285, P41455, DOI 10.1074/jbc.M110.145466; Chen SX, 2013, ULTRAMICROSCOPY, V135, P24, DOI 10.1016/j.ultramic.2013.06.004; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; den Dekker E, 2003, CELL CALCIUM, V33, P497, DOI 10.1016/S0143-4160(03)00065-4; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fecher-Trost C, 2014, HANDB EXP PHARMACOL, V222, P359, DOI 10.1007/978-3-642-54215-2_14; Fecher-Trost C, 2013, J BIOL CHEM, V288, P16629, DOI 10.1074/jbc.M113.469726; Gao Y, 2016, NATURE, V534, P347, DOI 10.1038/nature17964; Goehring A, 2014, NAT PROTOC, V9, P2574, DOI 10.1038/nprot.2014.173; Hoenderop JGJ, 2005, PHYSIOL REV, V85, P373, DOI 10.1152/physrev.00003.2004; Hoenderop JGJ, 2001, J PHYSIOL-LONDON, V537, P747; Hofmann L, 2017, CELL CALCIUM, V63, P24, DOI 10.1016/j.ceca.2016.10.003; Huynh KW, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11130; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; Kimanius D, 2016, ELIFE, V5, DOI 10.7554/eLife.18722; Kovacs G, 2012, CELL CALCIUM, V52, P468, DOI 10.1016/j.ceca.2012.08.005; Kucukelbir A, 2014, NAT METHODS, V11, P63, DOI [10.1038/nmeth.2727, 10.1038/NMETH.2727]; Lehen'kyi V, 2012, J PHYSIOL-LONDON, V590, P1369, DOI 10.1113/jphysiol.2011.225862; Liao MF, 2013, NATURE, V504, P107, DOI 10.1038/nature12822; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Nasr ML, 2017, NAT METHODS, V14, P49, DOI [10.1038/NMETH.4079, 10.1038/nmeth.4079]; Owsianik G, 2006, ANNU REV PHYSIOL, V68, P685, DOI 10.1146/annurev.physiol.68.040204.101406; Paulsen CE, 2015, NATURE, V520, P511, DOI 10.1038/nature14367; Peng JB, 1999, J BIOL CHEM, V274, P22739, DOI 10.1074/jbc.274.32.22739; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rohou A, 2015, J STRUCT BIOL, V192, P216, DOI 10.1016/j.jsb.2015.08.008; Russo CJ, 2014, SCIENCE, V346, P1377, DOI 10.1126/science.1259530; Saotome K, 2016, NATURE, V534, P506, DOI 10.1038/nature17975; Scheres SHW, 2012, NAT METHODS, V9, P853, DOI 10.1038/nmeth.2115; Shen PS, 2016, CELL, V167, P763, DOI 10.1016/j.cell.2016.09.048; Singh AK, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10993-9; Smart OS, 1996, J MOL GRAPH MODEL, V14, P354, DOI 10.1016/S0263-7855(97)00009-X; Suloway C, 2005, J STRUCT BIOL, V151, P41, DOI 10.1016/j.jsb.2005.03.010; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Twomey EC, 2017, NATURE, V549, P60, DOI 10.1038/nature23479; van der Wijst J, 2017, SCI REP-UK, V7, DOI 10.1038/srep45489; Velisetty P, 2016, SCI REP-UK, V6, DOI 10.1038/srep27652; Voets T, 2003, J GEN PHYSIOL, V121, P245, DOI 10.1085/jgp.20028752; WL D, 2002, PYMOL MOL GRAPHICS S; Woudenberg-Vrenken TE, 2012, AM J PHYSIOL-GASTR L, V303, pG879, DOI 10.1152/ajpgi.00089.2012; Yue LX, 2001, NATURE, V410, P705, DOI 10.1038/35070596; Zakharian E, 2011, FASEB J, V25, P3915, DOI 10.1096/fj.11-184630; Zhang K, 2016, J STRUCT BIOL, V193, P1, DOI 10.1016/j.jsb.2015.11.003; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193; Zubcevic L, 2016, NAT STRUCT MOL BIOL, V23, P180, DOI 10.1038/nsmb.3159	50	120	123	3	71	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 11	2018	553	7687					233	+		10.1038/nature25182	http://dx.doi.org/10.1038/nature25182			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS4WL	29258289	Green Accepted			2022-12-28	WOS:000419794800042
J	Hand, E				Hand, Eric			PLANETARY SCIENCE Mars methane rises and falls with the seasons	SCIENCE			English	News Item																			0	4	4	1	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 5	2018	359	6371					16	17		10.1126/science.359.6371.16	http://dx.doi.org/10.1126/science.359.6371.16			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FR8KW	29301992				2022-12-28	WOS:000419324700020
J	Johnson, JR; Russo, TA				Johnson, James R.; Russo, Thomas A.			Acute Pyelonephritis in Adults	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							URINARY-TRACT-INFECTIONS; ACUTE UNCOMPLICATED PYELONEPHRITIS; DOUBLE-BLIND; TRIMETHOPRIM-SULFAMETHOXAZOLE; ANTIBIOTIC-TREATMENT; PRACTICE GUIDELINES; RANDOMIZED-TRIAL; BLOOD CULTURES; UNITED-STATES; CIPROFLOXACIN	An otherwise healthy 35-year-old woman presents with urinary urgency, dysuria, fever, malaise, nausea, and flank pain. During a recent trip to India, she took a fluoroquinolone for diarrhea. On examination, the temperature is 38.6 degrees C, the pulse 110 beats per minute, and the blood pressure 105/50 mm Hg; she has suprapubic and flank tenderness, without abdominal tenderness. The white-cell count is 16,500 per cubic millimeter, and the serum creatinine concentration 1.4 mg per deciliter (124 mu mol per liter) (most recent measurement before presentation, 0.8 mg per deciliter [71 mu mol per liter]). Urinalysis is positive for leukocyte esterase and nitrites. How would you evaluate and manage this case?	[Johnson, James R.] Minneapolis Vet Affairs VA Hlth Care Syst, Minneapolis, MN USA; [Johnson, James R.] Univ Minnesota, Minneapolis, MN USA; [Russo, Thomas A.] Univ Buffalo State Univ New York, Buffalo, NY USA; [Russo, Thomas A.] VA Western New York Hlth Care Syst, Buffalo, NY USA	University of Minnesota System; University of Minnesota Twin Cities; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Johnson, JR (corresponding author), Minneapolis VA Hlth Care Syst, 1 Vet Dr,Infect Dis 111F, Minneapolis, MN 55417 USA.	johns007@umn.edu	Russo, Thomas/ABE-9633-2020		Actavis; Merck; Tetraphase; Medicines Company; Syntiron; Crucell/Janssen; National Institutes of Health	Actavis; Merck(Merck & Company); Tetraphase; Medicines Company; Syntiron; Crucell/Janssen; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Dr. Johnson reports receiving grant support from Actavis, Merck, Tetraphase, the Medicines Company, and Syntiron and consulting fees from Crucell/Janssen, being named on pending patents on high-resolution two-locus clonal typing of extraintestinal pathogenic Escherichia coli (61/749,144) and on primers, assays, and methods for detecting an E. coli subtype (61/667,402), and serving as coinvestigator on a project that received support from a grant from the National Institutes of Health to IDGenomics; and Dr. Russo, holding a patent (6,410,703) on "Identification of a vaccine candidate from an extraintestinal isolate of E. coli." No other potential conflict of interest relevant to this article was reported.	Brown P, 2005, PHARMACOECONOMICS, V23, P1123, DOI 10.2165/00019053-200523110-00005; CARDENAS DD, 1995, ARCH PHYS MED REHAB, V76, P272, DOI 10.1016/S0003-9993(95)80615-6; Craig WD, 2008, RADIOGRAPHICS, V28, P255, DOI 10.1148/rg.281075171; Cronberg S, 2001, SCAND J INFECT DIS, V33, P339, DOI 10.1080/003655401750173922; Czaja CA, 2007, CLIN INFECT DIS, V45, P273, DOI 10.1086/519268; Eliakim-Raz N, 2013, J ANTIMICROB CHEMOTH, V68, P2183, DOI 10.1093/jac/dkt177; Godaly G, 2015, CURR OPIN INFECT DIS, V28, P88, DOI 10.1097/QCO.0000000000000127; Gupta K, 2011, CLIN INFECT DIS, V52, pE103, DOI [10.1093/cid/ciq257, 10.1093/cid/cir102]; Ikaheimo R, 1996, CLIN INFECT DIS, V22, P91, DOI 10.1093/clinids/22.1.91; JACKSON GG, 1958, JAMA-J AM MED ASSOC, V166, P14, DOI 10.1001/jama.1958.02990010016004; JERNELIUS H, 1988, ACTA MED SCAND, V223, P469; Johnson JR, 2017, OPEN FORUM INFECT DI, V4, DOI 10.1093/ofid/ofx089; JOHNSON JR, 1991, J INFECT DIS, V163, P325, DOI 10.1093/infdis/163.2.325; Jolley JA, 2010, DRUGS, V70, P1643, DOI 10.2165/11538050-000000000-00000; Ki M, 2004, AM J EPIDEMIOL, V160, P985, DOI 10.1093/aje/kwh308; Kim Y, 2017, INFECT CHEMOTHER, V49, P22, DOI 10.3947/ic.2017.49.1.22; Kochanek Kenneth D, 2016, Natl Vital Stat Rep, V65, P1; Kyriakidou KG, 2008, CLIN THER, V30, P1859, DOI 10.1016/j.clinthera.2008.10.007; Lagu T, 2012, CRIT CARE MED, V40, P754, DOI 10.1097/CCM.0b013e318232db65; Long B, 2016, J EMERG MED, V51, P529, DOI 10.1016/j.jemermed.2016.07.003; Monmaturapoj T, 2012, INT J INFECT DIS, V16, pE843, DOI 10.1016/j.ijid.2012.07.009; Naber KG, 2004, INT J ANTIMICROB AG, V23, pS41, DOI 10.1016/j.ijantimicag.2003.09.002; Owens RC, 2011, J CLIN MICROBIOL, V49, P3406, DOI 10.1128/JCM.00993-11; Peterson J, 2008, UROLOGY, V71, P17, DOI 10.1016/j.urology.2007.09.002; Piccoli GB, 2006, INT J ANTIMICROB AG, V28, pS49, DOI 10.1016/j.ijantimicag.2006.05.017; PLATT R, 1983, AM J MED, V75, P44, DOI 10.1016/0002-9343(83)90072-4; Rhodes A, 2017, CRIT CARE MED, V45, P486, DOI 10.1097/CCM.0000000000002255; Rubenstein JN, 2003, INFECT DIS CLIN N AM, V17, P333, DOI 10.1016/S0891-5520(03)00012-6; Sanchez M, 2002, EMERG MED J, V19, P19, DOI 10.1136/emj.19.1.19; Sandberg T, 2012, LANCET, V380, P484, DOI 10.1016/S0140-6736(12)60608-4; Scholes D, 2005, ANN INTERN MED, V142, P20, DOI 10.7326/0003-4819-142-1-200501040-00008; Schrock JW, 2010, AM J EMERG MED, V28, P682, DOI 10.1016/j.ajem.2009.03.003; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Singh R, 2015, CURR OPIN INFECT DIS, V28, P112, DOI 10.1097/QCO.0000000000000120; Smaill FM, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000490.pub3; STAMM WE, 1989, J INFECT DIS, V159, P400, DOI 10.1093/infdis/159.3.400; Talan DA, 2000, JAMA-J AM MED ASSOC, V283, P1583, DOI 10.1001/jama.283.12.1583; Talan DA, 2004, J UROLOGY, V171, P734, DOI 10.1097/01.ju.0000106191.11936.64; Talan DA, 2016, EMERG INFECT DIS, V22, P1594, DOI 10.3201/eid2209.160148; Tchesnokova V, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174132; Tice AD, 2004, CLIN INFECT DIS, V38, P1651, DOI 10.1086/420939; Ubee SS, 2011, BJU INT, V107, P1474, DOI 10.1111/j.1464-410X.2010.09660.x; Ulleryd P, 2003, SCAND J INFECT DIS, V35, P34, DOI 10.1080/0036554021000026988; van Nieuwkoop C, 2010, CLIN INFECT DIS, V51, P1266, DOI 10.1086/657071; van Nieuwkoop C, 2017, BMC MED, V15, DOI 10.1186/s12916-017-0835-3; Velasco M, 2003, CLIN INFECT DIS, V37, P1127, DOI 10.1086/378291; Warren JW, 1999, CLIN INFECT DIS, V29, P745, DOI 10.1086/520427	47	58	60	1	24	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 4	2018	378	1					48	59		10.1056/NEJMcp1702758	http://dx.doi.org/10.1056/NEJMcp1702758			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FR7BE	29298155				2022-12-28	WOS:000419220500016
J	Hewitt, DB; Barnard, C; Bilimoria, KY				Hewitt, D. Brock; Barnard, Cynthia; Bilimoria, Karl Y.			Insulin Dosing Error in a Patient With Severe Hyperkalemia	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Hewitt, D. Brock; Barnard, Cynthia] Northwestern Univ, Chicago, IL 60611 USA; [Bilimoria, Karl Y.] Northwestern Univ, Feinberg Sch Med, Dept Surg, SOQIC, 633 N St Clair St,20th Floor, Chicago, IL 60611 USA	Northwestern University; Northwestern University; Feinberg School of Medicine	Bilimoria, KY (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Surg, SOQIC, 633 N St Clair St,20th Floor, Chicago, IL 60611 USA.	k-bilimoria@northwestern.edu			American College of Surgeons; American Board of Surgeons; Accreditation Council for Graduate Medical Education	American College of Surgeons; American Board of Surgeons; Accreditation Council for Graduate Medical Education	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Bilimoria reports receipt of grants from the American College of Surgeons, the American Board of Surgeons, and the Accreditation Council for Graduate Medical Education and personal fees from the American College of Surgeons. No other disclosures were reported.	[Anonymous], 2008, PATIENT SAFETY QUALI; Gundgurthi Abhay, 2012, Indian J Endocrinol Metab, V16 Suppl 1, pS120, DOI 10.4103/2230-8210.94254; Iglesias P, 2008, DIABETES OBES METAB, V10, P811, DOI 10.1111/j.1463-1326.2007.00802.x; Institute for Safe Medication Practices, 2014, ISMP LIST HIGH AL ME; Kim HJ, 2002, NEPHRON, V92, P33, DOI 10.1159/000065375; Martinez-Vea A, 1999, J ELECTROCARDIOL, V32, P45, DOI 10.1016/S0022-0736(99)90020-1; The Joint Commission, 2017, ESS ROL LEAD DEV SAF	7	2	2	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 26	2017	318	24					2485	2486		10.1001/jama.2017.7964	http://dx.doi.org/10.1001/jama.2017.7964			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FQ9ZO	29279937				2022-12-28	WOS:000418720700026
J	Cooper, KM; Till, CB; Kent, AJR; Costa, F; Rubin, AE; Gravley, D; Deering, C; Cole, J; Bose, M				Cooper, Kari M.; Till, Christy B.; Kent, Adam J. R.; Costa, Fidel; Rubin, Allison E.; Gravley, Darren; Deering, Chad; Cole, Jim; Bose, Maitrayee			Response to Comment on "Rapid cooling and cold storage in a silicic magma reservoir recorded in individual crystals"	SCIENCE			English	Editorial Material							LI DIFFUSION; ZIRCON; GROWTH; CRYSTALLIZATION; SURVIVAL; ROCKS; MELTS	In a recent paper, we used Li concentration profiles and U-Th ages to constrain the thermal conditions of magma storage. Wilson and co-authors argue that the data instead reflect control of Li behavior by charge balance during partitioning and not by experimentally determined diffusion rates. Their arguments are based on (i) a coupled diffusion mechanism for Li, which has been postulated but has not been documented to occur, and (ii) poorly constrained zircon growth rates combined with the assumption of continuous zircon crystallization.	[Cooper, Kari M.; Rubin, Allison E.] Univ Calif Davis, Dept Earth & Planetary Sci, Davis, CA 95616 USA; [Till, Christy B.; Bose, Maitrayee] Arizona State Univ, Sch Earth & Space Explorat, Tempe, AZ USA; [Kent, Adam J. R.] Oregon State Univ, Coll Earth Ocean & Atmospher Sci, Corvallis, OR 97331 USA; [Costa, Fidel] Nanyang Technol Univ, Earth Observ Singapore, Singapore, Singapore; [Costa, Fidel] Nanyang Technol Univ, Asian Sch Environm, Singapore, Singapore; [Gravley, Darren; Cole, Jim] Univ Canterbury, Dept Geol Sci, Christchurch, New Zealand; [Deering, Chad] Michigan Technol Univ, Geol & Min Engn Sci, Houghton, MI 49931 USA	University of California System; University of California Davis; Arizona State University; Arizona State University-Tempe; Oregon State University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; University of Canterbury; Michigan Technological University	Cooper, KM (corresponding author), Univ Calif Davis, Dept Earth & Planetary Sci, Davis, CA 95616 USA.	kmcooper@ucdavis.edu	Till, Christy/Y-1173-2019; Kent, Adam/ABC-1641-2021; Costa, Fidel/B-7035-2011; Cooper, Kari M/G-8261-2012	Till, Christy/0000-0001-8924-2206; Kent, Adam/0000-0003-3564-6285; Costa, Fidel/0000-0002-1409-5325; Deering, Chad/0000-0002-3768-2258	Directorate For Geosciences [1425491] Funding Source: National Science Foundation	Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))		BAKER DR, 1988, J NON-CRYST SOLIDS, V102, P62, DOI 10.1016/0022-3093(88)90113-5; Bergantz GW, 2017, J GEOPHYS RES-SOL EA, V122, P6131, DOI 10.1002/2017JB014218; Bindeman IN, 2016, J PETROL, V57, P437, DOI 10.1093/petrology/egw013; Cherniak DJ, 2010, CONTRIB MINERAL PETR, V160, P383, DOI 10.1007/s00410-009-0483-5; Cooper GF, 2014, CONTRIB MINERAL PETR, V167, DOI 10.1007/s00410-014-1018-2; Dufek J., 2017, IAVCEI SCI ASSEMBLY, P286; Harrison TM, 2007, GEOLOGY, V35, P635, DOI 10.1130/G23505A.1; Rubin AE, 2017, SCIENCE, V356, P1154, DOI 10.1126/science.aam8720; Schmitt AK, 2011, CONTRIB MINERAL PETR, V162, P1215, DOI 10.1007/s00410-011-0648-x; Schmitt AK, 2011, ANNU REV EARTH PL SC, V39, P321, DOI 10.1146/annurev-earth-040610-133330; Storm S, 2012, CONTRIB MINERAL PETR, V163, P505, DOI 10.1007/s00410-011-0682-8; Tang M, 2017, EARTH PLANET SC LETT, V474, P110, DOI 10.1016/j.epsl.2017.06.034; Trail D, 2016, CONTRIB MINERAL PETR, V171, DOI 10.1007/s00410-016-1238-8; Watson EB, 1996, T ROY SOC EDIN-EARTH, V87, P43, DOI 10.1017/S0263593300006465; Watson EB, 1995, AM MINERAL, V80, P1179; Wilson CJN, 2017, SCIENCE, V358, DOI 10.1126/science.aap8429; Zhang YX, 2016, AM MINERAL, V101, P1252, DOI 10.2138/am-2016-5462	17	5	5	1	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 22	2017	358	6370							eaap9145	10.1126/science.aap9145	http://dx.doi.org/10.1126/science.aap9145			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FQ6BO	29269447				2022-12-28	WOS:000418448000002
J	Dalton, CA				Dalton, Colleen A.			How seismic waves lose energy	SCIENCE			English	Editorial Material							LITHOSPHERE; RHEOLOGY		[Dalton, Colleen A.] Brown Univ, Dept Earth Environm & Planetary Sci, Providence, RI 02912 USA	Brown University	Dalton, CA (corresponding author), Brown Univ, Dept Earth Environm & Planetary Sci, Providence, RI 02912 USA.	colleen_dalton@brown.edu						Dalton CA, 2008, J GEOPHYS RES-SOL EA, V113, DOI 10.1029/2007JB005429; Faul U, 2015, ANNU REV EARTH PL SC, V43, P541, DOI 10.1146/annurev-earth-060313-054732; Gribb TT, 1998, J GEOPHYS RES-SOL EA, V103, P27267, DOI 10.1029/98JB02786; Hirth G, 1996, EARTH PLANET SC LETT, V144, P93, DOI 10.1016/0012-821X(96)00154-9; Kawakatsu H, 2009, SCIENCE, V324, P499, DOI 10.1126/science.1169499; Takeuchi N, 2017, SCIENCE, V358, P1593, DOI 10.1126/science.aao3508; Yamauchi H, 2016, J GEOPHYS RES-SOL EA, V121, P7790, DOI 10.1002/2016JB013316	7	1	1	2	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 22	2017	358	6370					1536	1537		10.1126/science.aar2748	http://dx.doi.org/10.1126/science.aar2748			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FQ6BO	29269461				2022-12-28	WOS:000418448000035
J	Mecchia, MA; Santos-Fernandez, G; Duss, NN; Somoza, SC; Boisson-Dernier, A; Gagliardini, V; Martinez-Bernardini, A; Fabrice, TN; Ringli, C; Muschietti, JP; Grossniklaus, U				Mecchia, Martin A.; Santos-Fernandez, Gorka; Duss, Nadine N.; Somoza, Sofia C.; Boisson-Dernier, Aurelien; Gagliardini, Valeria; Martinez-Bernardini, Andrea; Fabrice, Tohnyui Ndinyanka; Ringli, Christoph; Muschietti, Jorge P.; Grossniklaus, Ueli			RALF4/19 peptides interact with LRX proteins to control pollen tube growth in Arabidopsis	SCIENCE			English	Article							CELL-WALL; RECEPTOR KINASE; HORMONE; TIP; FAMILY	The communication of changes in the extracellular matrix to the interior of the cell is crucial for a cell's function. The extracellular peptides of the RAPID ALKALINIZATION FACTOR (RALF) family have been identified as ligands of receptor-like kinases of the CrRLK1L subclass, but the exact mechanism of their perception is unclear. We found that Arabidopsis RALF4 and RALF19 redundantly regulate pollen tube integrity and growth, and that their function depends on pollen-expressed proteins of the LEUCINE-RICH REPEAT EXTENSIN (LRX) family, which play a role in cell wall development but whose mode of action is not understood. The LRX proteins interact with RALFs, monitoring cell wall changes, which are communicated to the interior of the pollen tube via the CrRLK1L pathway to sustain normal growth.	[Mecchia, Martin A.; Santos-Fernandez, Gorka; Duss, Nadine N.; Gagliardini, Valeria; Martinez-Bernardini, Andrea; Fabrice, Tohnyui Ndinyanka; Ringli, Christoph; Grossniklaus, Ueli] Univ Zurich, Dept Plant & Microbial Biol, CH-8008 Zurich, Switzerland; [Mecchia, Martin A.; Santos-Fernandez, Gorka; Duss, Nadine N.; Gagliardini, Valeria; Martinez-Bernardini, Andrea; Fabrice, Tohnyui Ndinyanka; Ringli, Christoph; Grossniklaus, Ueli] Univ Zurich, Zurich Basel Plant Sci Ctr, CH-8008 Zurich, Switzerland; [Mecchia, Martin A.; Somoza, Sofia C.; Muschietti, Jorge P.] Dr Hector Torres INGEBI CONICET, Inst Invest Ingn Genet & Biol Mol, Vuelta Obligado 2490,C1428ADN, Buenos Aires, DF, Argentina; [Mecchia, Martin A.] IIBBA CONICET, Fdn Inst Leloir, Buenos Aires, DF, Argentina; [Boisson-Dernier, Aurelien] Univ Cologne, Bot Inst, Bioctr, D-50674 Cologne, Germany; [Muschietti, Jorge P.] Univ Buenos Aires, Dept Biodiversidad & Biol Expt, Fac Ciencias Exactas & Nat, Int Guiraldes 2160,Ciudad Univ,Pabellon 2, Buenos Aires, DF, Argentina; [Fabrice, Tohnyui Ndinyanka] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland	University of Zurich; University of Zurich; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Leloir Institute; University of Cologne; University of Buenos Aires; University of Basel	Grossniklaus, U (corresponding author), Univ Zurich, Dept Plant & Microbial Biol, CH-8008 Zurich, Switzerland.; Grossniklaus, U (corresponding author), Univ Zurich, Zurich Basel Plant Sci Ctr, CH-8008 Zurich, Switzerland.; Muschietti, JP (corresponding author), Dr Hector Torres INGEBI CONICET, Inst Invest Ingn Genet & Biol Mol, Vuelta Obligado 2490,C1428ADN, Buenos Aires, DF, Argentina.; Muschietti, JP (corresponding author), Univ Buenos Aires, Dept Biodiversidad & Biol Expt, Fac Ciencias Exactas & Nat, Int Guiraldes 2160,Ciudad Univ,Pabellon 2, Buenos Aires, DF, Argentina.	prometeo@dna.uba.ar; grossnik@botinst.uzh.ch	Grossniklaus, Ueli/E-9995-2016	Grossniklaus, Ueli/0000-0002-0522-8974; Mecchia, Martin/0000-0002-3444-3294; Boisson-Dernier, Aurelien/0000-0002-9790-3710; Muschietti, Jorge/0000-0002-5719-4833; Ringli, Christoph/0000-0002-5533-2235; Somoza, Sofia Cristina/0000-0002-0270-2220; Gagliardini, Valeria/0000-0001-9471-0764	University of Zurich; Research and Technology Project MecanX - SystemsX.ch [145676]; Swiss National Science Foundation [310030B_160336, CR32I3_156724]; Deutsche Forschungsgemeinschaft [BO 4470/1-1]; Agencia Nacional de Promocion Cientifica y Tecnologica [PICT2014, PICT2015]; EMBO Short-Term Fellowship; Company of Biologists	University of Zurich; Research and Technology Project MecanX - SystemsX.ch; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); EMBO Short-Term Fellowship(European Molecular Biology Organization (EMBO)); Company of Biologists	We thank H. Vogler and M. Jaciubek for advice on pollen tube assays and cloning strategies, respectively; A. Sede for help with genotyping; K. Locher and T. Pfluger for access to Monolith technology; T. Hander for help with the BLItz system; and C. Eichenberger, A. Bolanos, D. Guthorl, P. Kopf, and A. Frey for general laboratory support. Supported by the University of Zurich; Research and Technology Project MecanX (grant 145676 to U.G. and C.R.) funded by SystemsX.ch; Swiss National Science Foundation grants 310030B_160336 and CR32I3_156724 (U.G.); Deutsche Forschungsgemeinschaft grant BO 4470/1-1 (A.B.-D.), and Agencia Nacional de Promocion Cientifica y Tecnologica grants PICT2014 (J.P.M. and M.A.M.) and PICT2015 (J.P.M.). The stay of M.A.M. in U.G.'s laboratory was supported by an EMBO Short-Term Fellowship and the Company of Biologists. Supplement contains additional data.	Baumberger N, 2003, PLANT PHYSIOL, V131, P1313, DOI 10.1104/pp.102.014928; Baumberger N, 2001, GENE DEV, V15, P1128, DOI 10.1101/gad.200201; Boisson-Dernier A, 2015, P NATL ACAD SCI USA, V112, P12211, DOI 10.1073/pnas.1512375112; Boisson-Dernier A, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001719; Boisson-Dernier A, 2011, J EXP BOT, V62, P1581, DOI 10.1093/jxb/erq445; Boisson-Dernier A, 2009, DEVELOPMENT, V136, P3279, DOI 10.1242/dev.040071; Chebli Y, 2012, PLANT PHYSIOL, V160, P1940, DOI 10.1104/pp.112.199729; Chen J, 2016, P NATL ACAD SCI USA, V113, pE5519, DOI 10.1073/pnas.1608449113; Covey PA, 2010, PLANT PHYSIOL, V153, P703, DOI 10.1104/pp.110.155457; do Canto AM, 2014, PLANT PHYSIOL BIOCH, V75, P45, DOI 10.1016/j.plaphy.2013.12.005; Fabrice T. Ndinyanka, 2017, BIORXIV, DOI [10.1101/223008, DOI 10.1101/223008]; Haruta M, 2014, SCIENCE, V343, P408, DOI 10.1126/science.1244454; Hepler PK, 2013, MOL PLANT, V6, P998, DOI 10.1093/mp/sst103; Hofte H, 2015, PLANT CELL PHYSIOL, V56, P224, DOI 10.1093/pcp/pcu182; Li C, 2015, ELIFE, V4, DOI [10.7554/eLife.06587, 10.1155/2015/757269]; Liao HD, 2017, PLANT CELL PHYSIOL, V58, P1143, DOI 10.1093/pcp/pcx048; Marton ML, 2012, CURR BIOL, V22, P1194, DOI 10.1016/j.cub.2012.04.061; Miyazaki S, 2009, CURR BIOL, V19, P1327, DOI 10.1016/j.cub.2009.06.064; Murphy E, 2014, TRENDS PLANT SCI, V19, P664, DOI 10.1016/j.tplants.2014.06.005; Okuda S, 2013, MOL PLANT, V6, P1074, DOI 10.1093/mp/sst050; Pearce G, 2001, P NATL ACAD SCI USA, V98, P12843, DOI 10.1073/pnas.201416998; Schallus T, 2008, MOL BIOL CELL, V19, P3404, DOI 10.1091/mbc.E08-04-0354; Schiott M, 2004, P NATL ACAD SCI USA, V101, P9502, DOI 10.1073/pnas.0401542101; Srivastava R, 2009, PLANT J, V59, P930, DOI 10.1111/j.1365-313X.2009.03926.x; Stegmann M, 2017, SCIENCE, V355, P287, DOI 10.1126/science.aal2541; Vogler Hannes, 2015, Plants-Basel, V4, P167, DOI 10.3390/plants4020167; Wu JS, 2007, PLANT J, V52, P877, DOI 10.1111/j.1365-313X.2007.03289.x; Zhang GY, 2010, MOL BIOL REP, V37, P3273, DOI 10.1007/s11033-009-9912-9	28	142	152	3	66	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 22	2017	358	6370					1600	1603		10.1126/science.aao5467	http://dx.doi.org/10.1126/science.aao5467			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ6BO	29242232				2022-12-28	WOS:000418448000061
J	Normile, D				Normile, Dennis			Safety concerns derail dengue vaccination program	SCIENCE			English	News Item																			0	24	24	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 22	2017	358	6370					1514	1515		10.1126/science.358.6370.1514	http://dx.doi.org/10.1126/science.358.6370.1514			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ6BO	29269451				2022-12-28	WOS:000418448000015
J	Greene, JA; Loscalzo, J				Greene, Jeremy A.; Loscalzo, Joseph			Putting the Patient Back Together - Social Medicine, Network Medicine, and the Limits of Reductionism	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							MUTATIONAL SIGNATURES; BREAST-CANCER		[Greene, Jeremy A.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21218 USA; [Greene, Jeremy A.] Johns Hopkins Univ, Sch Med, Dept Hist Med, Baltimore, MD 21218 USA; [Greene, Jeremy A.] Johns Hopkins Univ, Sch Med, Ctr Med Humanities & Social Med, Baltimore, MD 21218 USA; [Loscalzo, Joseph] Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA; [Loscalzo, Joseph] Harvard Med Sch, Boston, MA USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Greene, JA (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21218 USA.; Greene, JA (corresponding author), Johns Hopkins Univ, Sch Med, Dept Hist Med, Baltimore, MD 21218 USA.; Greene, JA (corresponding author), Johns Hopkins Univ, Sch Med, Ctr Med Humanities & Social Med, Baltimore, MD 21218 USA.		Loscalzo, Joseph/ABD-8980-2021					Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Davies H, 2017, NAT MED, V23, P517, DOI 10.1038/nm.4292; Drost J, 2017, SCIENCE, V358, P234, DOI 10.1126/science.aao3130; Polak P, 2017, NAT GENET, V49, P1476, DOI 10.1038/ng.3934; Riaz N, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00921-w; Robson M, 2017, NEW ENGL J MED, V377, P523, DOI 10.1056/NEJMoa1706450	6	92	95	3	15	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 21	2017	377	25					2493	2499		10.1056/NEJMms1706744	http://dx.doi.org/10.1056/NEJMms1706744			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FQ5RZ	29262277				2022-12-28	WOS:000418420000016
J	Venegas, C; Kumar, S; Franklin, BS; Dierkes, T; Brinkschulte, R; Tejera, D; Vieira-Saecker, A; Schwartz, S; Santarelli, F; Kummer, MP; Griep, A; Gelpi, E; Beilharz, M; Riedel, D; Golenbock, DT; Geyer, M; Walter, J; Latz, E; Heneka, MT				Venegas, Carmen; Kumar, Sathish; Franklin, Bernardo S.; Dierkes, Tobias; Brinkschulte, Rebecca; Tejera, Dario; Vieira-Saecker, Ana; Schwartz, Stephanie; Santarelli, Francesco; Kummer, Markus P.; Griep, Angelika; Gelpi, Ellen; Beilharz, Michael; Riedel, Dietmar; Golenbock, Douglas T.; Geyer, Matthias; Walter, Jochen; Latz, Eicke; Heneka, Michael T.			Microglia-derived ASC specks cross-seed amyloid-beta in Alzheimer's disease	NATURE			English	Article							NLRP3 INFLAMMASOME; IN-VIVO; ACTIVATION; PROTEIN; SIGNAL; MICE; PRESENILIN-1; PYROPTOSOME; MECHANISM; PEPTIDE	The spreading of pathology within and between brain areas is a hallmark of neurodegenerative disorders. In patients with Alzheimer's disease, deposition of amyloid-beta is accompanied by activation of the innate immune system and involves inflammasome-dependent formation of ASC specks in microglia. ASC specks released by microglia bind rapidly to amyloid-beta and increase the formation of amyloid-beta oligomers and aggregates, acting as an inflammation-driven cross-seed for amyloid-beta pathology. Here we show that intrahippocampal injection of ASC specks resulted in spreading of amyloid-beta pathology in transgenic double-mutant APP(Swe)PSEN1(dE9) mice. By contrast, homogenates from brains of APP(Swe)PSEN1(dE9) mice failed to induce seeding and spreading of amyloid-beta pathology in ASC-deficient APP(Swe)PSEN1(dE9) mice. Moreover, co-application of an anti-ASC antibody blocked the increase in amyloid-beta pathology in APP(Swe)PSEN1(dE9) mice. These findings support the concept that inflammasome activation is connected to seeding and spreading of amyloid-beta pathology in patients with Alzheimer's disease.	[Venegas, Carmen; Dierkes, Tobias; Tejera, Dario; Vieira-Saecker, Ana; Schwartz, Stephanie; Santarelli, Francesco; Kummer, Markus P.; Griep, Angelika; Heneka, Michael T.] Univ Bonn, Dept Neurodegenerat Dis & Gerontopsychiat, Sigmund Freud Str 25, D-53127 Bonn, Germany; [Kumar, Sathish; Walter, Jochen] Univ Bonn, Dept Neurol, D-53127 Bonn, Germany; [Franklin, Bernardo S.; Dierkes, Tobias; Brinkschulte, Rebecca; Beilharz, Michael; Geyer, Matthias; Latz, Eicke] Univ Bonn, Inst Innate Immun, D-53127 Bonn, Germany; [Gelpi, Ellen] Univ Barcelona, Hosp Clin, IDIBAPS, Neurol Tissue Bank, E-08036 Barcelona, Spain; [Riedel, Dietmar] Max Planck Inst Biophys Chem, Electron Microscopy Grp, D-37077 Gottingen, Germany; [Golenbock, Douglas T.; Latz, Eicke; Heneka, Michael T.] Univ Massachusetts, Sch Med, Dept Infect Dis & Immunol, Worcester, MA 01655 USA; [Latz, Eicke; Heneka, Michael T.] DZNE, D-53127 Bonn, Germany	University of Bonn; University of Bonn; University of Bonn; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Max Planck Society; University of Massachusetts System; University of Massachusetts Worcester; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE)	Heneka, MT (corresponding author), Univ Bonn, Dept Neurodegenerat Dis & Gerontopsychiat, Sigmund Freud Str 25, D-53127 Bonn, Germany.; Heneka, MT (corresponding author), Univ Massachusetts, Sch Med, Dept Infect Dis & Immunol, Worcester, MA 01655 USA.; Heneka, MT (corresponding author), DZNE, D-53127 Bonn, Germany.	michael.heneka@ukbonn.de	Heneka, Michael/AAE-8011-2019; Walter, Jochen/B-3677-2014; Venegas, Carmen/HIK-2268-2022; Wang, Caihong/T-5837-2019; Tejera, Dario/AAA-5997-2022; Franklin, Bernardo S/G-8186-2012; Latz, Eicke/H-3951-2014; Kumar, Sathish/L-1367-2019; Heneka, Michael/E-8072-2015	Venegas, Carmen/0000-0002-8902-4986; Wang, Caihong/0000-0002-6808-3709; Franklin, Bernardo S/0000-0003-2591-9833; Latz, Eicke/0000-0003-1488-5666; Walter, Jochen/0000-0002-4678-2912; Kumar, Sathish/0000-0002-2792-7047; Heneka, Michael/0000-0003-4996-1630; Geyer, Matthias/0000-0002-7718-5002	Deutsche Forschungsgemeinschaft through Cluster of Excellence "Immunosensation"; Clinical Research Group [KFO177]; ERC InflammAct; ERC PLAT-IL-1; ERA-NET consortium TracInflam; JPND consortium InCure;  [SFB670];  [WA1477/6]	Deutsche Forschungsgemeinschaft through Cluster of Excellence "Immunosensation"; Clinical Research Group; ERC InflammAct; ERC PLAT-IL-1; ERA-NET consortium TracInflam; JPND consortium InCure; ; 	This work was funded by the Deutsche Forschungsgemeinschaft through the Cluster of Excellence "Immunosensation" (to M.T.H., E.L., M.G. and B.S.F.), the Clinical Research Group (KFO177; to M.T.H., E.L. and J.W.), the SFB670 (E.L.), grant WA1477/6 (J.W.), ERC InflammAct (E.L.), ERC PLAT-IL-1 (B.S.F.), the ERA-NET consortium TracInflam (M.T.H.) and JPND consortium InCure (M.T.H.).	Baroja-Mazo A, 2014, NAT IMMUNOL, V15, P738, DOI 10.1038/ni.2919; Borchelt DR, 1996, NEURON, V17, P1005, DOI 10.1016/S0896-6273(00)80230-5; Cai X, 2014, CELL, V156, P1207, DOI 10.1016/j.cell.2014.01.063; Dick MS, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11929; Elinav E, 2011, CELL, V145, P745, DOI 10.1016/j.cell.2011.04.022; Fernandes-Alnemri T, 2007, CELL DEATH DIFFER, V14, P1590, DOI 10.1038/sj.cdd.4402194; Fernandes-Alnemri T, 2008, METHOD ENZYMOL, V442, P251, DOI [10.1016/S0076-6S79(08)01413-4, 10.1016/S0076-6879(08)01413-4]; Franklin BS, 2014, NAT IMMUNOL, V15, P727, DOI 10.1038/ni.2913; Fritschi SK, 2014, ACTA NEUROPATHOL, V128, P477, DOI 10.1007/s00401-014-1339-2; Gjoneska E, 2015, NATURE, V518, P365, DOI 10.1038/nature14252; Heneka MT, 2015, NAT IMMUNOL, V16, P229, DOI 10.1038/ni.3102; Heneka MT, 2014, NAT REV IMMUNOL, V14, P463, DOI 10.1038/nri3705; Heneka MT, 2013, NATURE, V493, P674, DOI 10.1038/nature11729; Jack CR, 2013, LANCET NEUROL, V12, P207, DOI 10.1016/S1474-4422(12)70291-0; Jager S, 2009, J NEUROCHEM, V111, P1369, DOI 10.1111/j.1471-4159.2009.06420.x; Jucker M, 2013, NATURE, V501, P45, DOI 10.1038/nature12481; Karch CM, 2014, NEURON, V83, P11, DOI 10.1016/j.neuron.2014.05.041; Kumar S, 2011, EMBO J, V30, P2255, DOI 10.1038/emboj.2011.138; Lambert JC, 2013, NAT GENET, V45, P1452, DOI 10.1038/ng.2802; Lu A, 2014, CELL, V156, P1193, DOI 10.1016/j.cell.2014.02.008; Masumoto J, 1999, J BIOL CHEM, V274, P33835, DOI 10.1074/jbc.274.48.33835; Meyer-Luehmann M, 2006, SCIENCE, V313, P1781, DOI 10.1126/science.1131864; Musiek ES, 2015, NAT NEUROSCI, V18, P800, DOI 10.1038/nn.4018; Nuvolone M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117208; Raj T, 2014, SCIENCE, V344, P519, DOI 10.1126/science.1249547; Rostagno Agueda, 2009, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0333s44; Scheuner D, 1996, NAT MED, V2, P864, DOI 10.1038/nm0896-864; Tomiyama T, 2008, ANN NEUROL, V63, P377, DOI 10.1002/ana.21321; Wahle T, 2006, J NEUROSCI, V26, P12838, DOI 10.1523/JNEUROSCI.1982-06.2006; Yokoyama JS, 2016, JAMA NEUROL, V73, P691, DOI 10.1001/jamaneurol.2016.0150; Youm YH, 2013, CELL METAB, V18, P519, DOI 10.1016/j.cmet.2013.09.010; Zhang B, 2013, CELL, V153, P707, DOI 10.1016/j.cell.2013.03.030	33	436	450	8	157	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 21	2017	552	7685					355	+		10.1038/nature25158	http://dx.doi.org/10.1038/nature25158			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ7RI	29293211				2022-12-28	WOS:000418559800049
J	Hauser, F; Li, ZX; Waadt, R; Schroeder, JI				Hauser, Felix; Li, Zixing; Waadt, Rainer; Schroeder, Julian I.			SnapShot: Abscisic Acid Signaling	CELL			English	Editorial Material							PLANTS; ABA		[Hauser, Felix; Li, Zixing; Schroeder, Julian I.] Univ Calif San Diego, Div Biol Sci, Cell & Dev Biol Sect, La Jolla, CA 92093 USA; [Waadt, Rainer] Heidelberg Univ, Ctr Organismal Studies, Plant Dev Biol, Heidelberg, Germany	University of California System; University of California San Diego; Ruprecht Karls University Heidelberg	Hauser, F (corresponding author), Univ Calif San Diego, Div Biol Sci, Cell & Dev Biol Sect, La Jolla, CA 92093 USA.		, None/H-5163-2019; Hauser, Felix/K-1030-2015	, None/0000-0001-6725-9760; Hauser, Felix/0000-0001-6725-9760; Waadt, Rainer/0000-0002-6772-3006	NIH [GM060396]; NSF [MCB1616236]; DFG [WA 3768/1-1]; Direct For Biological Sciences [1616236] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060396] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); DFG(German Research Foundation (DFG)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Research in the authors' laboratories was supported by NIH (GM060396) and NSF (MCB1616236) grants to J.I.S. R.W. was supported by the DFG (WA 3768/1-1).	Boursiac Y, 2013, TRENDS PLANT SCI, V18, P325, DOI 10.1016/j.tplants.2013.01.007; Hartung W, 2010, FUNCT PLANT BIOL, V37, P806, DOI 10.1071/FP10058; Ma Y, 2009, SCIENCE, V324, P1064, DOI 10.1126/science.1172408; Munemasa S, 2015, CURR OPIN PLANT BIOL, V28, P154, DOI 10.1016/j.pbi.2015.10.010; Nakashima K, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00170; Park SY, 2009, SCIENCE, V324, P1068, DOI 10.1126/science.1173041; Zhu JK, 2016, CELL, V167, P313, DOI 10.1016/j.cell.2016.08.029	7	76	82	8	58	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 14	2017	171	7					1708	+		10.1016/j.cell.2017.11.045	http://dx.doi.org/10.1016/j.cell.2017.11.045			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FQ0KF	29245015	Green Accepted, Bronze			2022-12-28	WOS:000418044000025
J	Miao, D; Margolis, CA; Gao, WH; Voss, MH; Li, W; Martini, DJ; Norton, C; Bosse, D; Wankowicz, SM; Cullen, D; Horak, C; Wind-Rotolo, M; Tracy, A; Giannakis, M; Hodi, FS; Drake, CG; Ball, MW; Allaf, ME; Snyder, A; Hellmann, MD; Ho, T; Motzer, RJ; Signoretti, S; Kaelin, WG; Choueiri, TK; Van Allen, EM				Miao, Diana; Margolis, Claire A.; Gao, Wenhua; Voss, Martin H.; Li, Wei; Martini, Dylan J.; Norton, Craig; Bosse, Dominick; Wankowicz, Stephanie M.; Cullen, Dana; Horak, Christine; Wind-Rotolo, Megan; Tracy, Adam; Giannakis, Marios; Hodi, Frank Stephen; Drake, Charles G.; Ball, Mark W.; Allaf, Mohamad E.; Snyder, Alexandra; Hellmann, Matthew D.; Ho, Thai; Motzer, Robert J.; Signoretti, Sabina; Kaelin, William G., Jr.; Choueiri, Toni K.; Van Allen, Eliezer M.			Genomic correlates of response to immune checkpoint therapies in clear cell renal cell carcinoma	SCIENCE			English	Article							CTLA-4 BLOCKADE; PD-1 BLOCKADE; PBRM1; TUMORS; MUTATIONS; EXPRESSION; EVEROLIMUS; RESISTANCE; SUNITINIB; NIVOLUMAB	Immune checkpoint inhibitors targeting the programmed cell death 1 receptor (PD-1) improve survival in a subset of patients with clear cell renal cell carcinoma (ccRCC). To identify genomic alterations in ccRCC that correlate with response to anti-PD-1 monotherapy, we performed whole-exome sequencing of metastatic ccRCC from 35 patients. We found that clinical benefit was associated with loss-of-function mutations in the PBRM1 gene (P = 0.012), which encodes a subunit of the PBAF switch-sucrose nonfermentable (SWI/SNF) chromatin remodeling complex. We confirmed this finding in an independent validation cohort of 63 ccRCC patients treated with PD-1 or PD-L1 (PD-1 ligand) blockade therapy alone or in combination with anti-CTLA-4 (cytotoxic T lymphocyte-associated protein 4) therapies (P = 0.0071). Gene-expression analysis of PBAF-deficient ccRCC cell lines and PBRM1-deficient tumors revealed altered transcriptional output in JAK-STAT (Janus kinase-signal transducers and activators of transcription), hypoxia, and immune signaling pathways. PBRM1 loss in ccRCC may alter global tumor-cell expression profiles to influence responsiveness to immune checkpoint therapy.	[Miao, Diana; Margolis, Claire A.; Gao, Wenhua; Martini, Dylan J.; Norton, Craig; Bosse, Dominick; Wankowicz, Stephanie M.; Giannakis, Marios; Hodi, Frank Stephen; Signoretti, Sabina; Kaelin, William G., Jr.; Choueiri, Toni K.; Van Allen, Eliezer M.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA; [Miao, Diana; Margolis, Claire A.; Wankowicz, Stephanie M.; Tracy, Adam; Giannakis, Marios; Van Allen, Eliezer M.] MIT, Broad Inst, Cambridge, MA 02142 USA; [Miao, Diana; Margolis, Claire A.; Wankowicz, Stephanie M.; Tracy, Adam; Giannakis, Marios; Van Allen, Eliezer M.] Harvard, Cambridge, MA 02142 USA; [Voss, Martin H.; Snyder, Alexandra; Hellmann, Matthew D.; Motzer, Robert J.] Mem Sloan Kettering Canc Ctr, New York, NY 10065 USA; [Voss, Martin H.; Hellmann, Matthew D.; Motzer, Robert J.] Weill Cornell Med Coll, New York, NY 10065 USA; [Li, Wei] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02215 USA; [Cullen, Dana; Horak, Christine; Wind-Rotolo, Megan] Bristol Myers Squibb, New York, NY 10154 USA; [Drake, Charles G.] Columbia Univ, Med Ctr, New York, NY 10032 USA; [Ball, Mark W.; Allaf, Mohamad E.] Johns Hopkins Univ, Sch Med, James Buchanan Brady Urol Inst, Baltimore, MD 21287 USA; [Ball, Mark W.; Allaf, Mohamad E.] Johns Hopkins Univ, Sch Med, Dept Urol, Baltimore, MD 21287 USA; [Ho, Thai] Mayo Clin, Scottsdale, AZ 85259 USA; [Kaelin, William G., Jr.] Dana Farber Canc Inst, Howard Hughes Med Inst, Boston, MA 02215 USA; [Snyder, Alexandra] Adapt Biotechnol, Seattle, WA 98102 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Memorial Sloan Kettering Cancer Center; Cornell University; Harvard University; Dana-Farber Cancer Institute; Bristol-Myers Squibb; Columbia University; Johns Hopkins University; Johns Hopkins University; Mayo Clinic; Mayo Clinic Phoenix; Harvard University; Dana-Farber Cancer Institute; Howard Hughes Medical Institute	Choueiri, TK; Van Allen, EM (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA.; Van Allen, EM (corresponding author), MIT, Broad Inst, Cambridge, MA 02142 USA.; Van Allen, EM (corresponding author), Harvard, Cambridge, MA 02142 USA.	toni_choueiri@dfci.harvard.edu; eliezerm_vanallen@dfci.harvard.edu	Ball, Mark/H-3915-2019; Choueiri, Toni/K-5238-2019; Giannakis, Marios/Z-4908-2019	Ball, Mark/0000-0003-1780-2627; Choueiri, Toni/0000-0002-9201-3217; Bosse, Dominick/0000-0003-2992-5632; Voss, Martin/0000-0003-0551-5807; Margolis, Claire/0000-0002-1019-2419; Ho, Thai/0000-0003-0023-2939; Martini, Dylan/0000-0002-0843-1222; Wankowicz, Stephanie/0000-0002-4225-7459; Li, Wei/0000-0002-2163-7903	Bristol-Myers Squibb II-ON consortium; American Association for Cancer Research KureIt Grant for Kidney Cancer Research; Cancer Immunologic Data Commons [NIH U24CA224316]; Dana-Farber/Harvard Cancer Center Kidney Specialized Program of Research Excellence (SPORE); Kohlberg chair at Harvard Medical School; Trust Family; Michael Brigham, and Loker Pinard Funds for Kidney Cancer Research at the Dana-Farber Cancer Institute; Gerstner Family Career Development Award; National Cancer Institute [K12CA90628]; U.S. Department of Defense [W81XWH-17-1-0546]; NATIONAL CANCER INSTITUTE [U24CA224316, P30CA008748, K08CA188615, K12CA090628] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR001100] Funding Source: NIH RePORTER	Bristol-Myers Squibb II-ON consortium(Bristol-Myers Squibb); American Association for Cancer Research KureIt Grant for Kidney Cancer Research; Cancer Immunologic Data Commons; Dana-Farber/Harvard Cancer Center Kidney Specialized Program of Research Excellence (SPORE); Kohlberg chair at Harvard Medical School; Trust Family; Michael Brigham, and Loker Pinard Funds for Kidney Cancer Research at the Dana-Farber Cancer Institute; Gerstner Family Career Development Award; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); U.S. Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This project was supported by the Bristol-Myers Squibb II-ON consortium, the American Association for Cancer Research KureIt Grant for Kidney Cancer Research (E.M.V. and T.K.C.), and the Cancer Immunologic Data Commons (NIH U24CA224316). D.M. is a Howard Hughes Medical Institute Medical Research Fellow. T.K.C. is supported in part by the Dana-Farber/Harvard Cancer Center Kidney Specialized Program of Research Excellence (SPORE); the Kohlberg chair at Harvard Medical School; and the Trust Family, Michael Brigham, and Loker Pinard Funds for Kidney Cancer Research at the Dana-Farber Cancer Institute. T.H. is supported by the Gerstner Family Career Development Award, the National Cancer Institute (K12CA90628), and the U.S. Department of Defense (W81XWH-17-1-0546). Opinions, interpretations, conclusions, and recommendations are those of the author and are not necessarily endorsed by the U.S. Department of Defense.	Beuselinck B, 2015, CLIN CANCER RES, V21, P1329, DOI 10.1158/1078-0432.CCR-14-1128; Carlo MI, 2017, KIDNEY CANCER, V1, P49, DOI 10.3233/KCA-160003; Carter SL, 2012, NAT BIOTECHNOL, V30, P413, DOI 10.1038/nbt.2203; Choueiri TK, 2016, CLIN CANCER RES, V22, P5461, DOI 10.1158/1078-0432.CCR-15-2839; Creighton CJ, 2013, NATURE, V499, P43, DOI 10.1038/nature12222; de Velasco G, 2016, CANCER IMMUNOL RES, V4, P820, DOI 10.1158/2326-6066.CIR-16-0110; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Fay AP, 2016, J NATL COMPR CANC NE, V14, P820, DOI 10.6004/jnccn.2016.0086; Gao WH, 2017, P NATL ACAD SCI USA, V114, P1027, DOI 10.1073/pnas.1619726114; Gerlinger M, 2014, NAT GENET, V46, P225, DOI 10.1038/ng.2891; Gofrit ON, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-1385-9; Hakimi AA, 2013, CLIN CANCER RES, V19, P3259, DOI 10.1158/1078-0432.CCR-12-3886; Hsieh JJ, 2017, EUR UROL, V71, P405, DOI 10.1016/j.eururo.2016.10.007; Kadoch C, 2013, NAT GENET, V45, P592, DOI 10.1038/ng.2628; Kapur P, 2013, LANCET ONCOL, V14, P159, DOI 10.1016/S1470-2045(12)70584-3; Kwiatkowski DJ, 2016, CLIN CANCER RES, V22, P2445, DOI 10.1158/1078-0432.CCR-15-2631; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Le DT, 2015, NEW ENGL J MED, V372, P2509, DOI 10.1056/NEJMoa1500596; Motzer RJ, 2015, NEW ENGL J MED, V373, P1803, DOI 10.1056/NEJMoa1510665; Nam S. J., 2015, UROL ONCOL, V33; Nargund AM, 2017, CELL REP, V18, P2893, DOI 10.1016/j.celrep.2017.02.074; Pan D, 2018, SCIENCE, V359, P770, DOI 10.1126/science.aao1710; Pawlowski R, 2013, INT J CANCER, V132, pE11, DOI 10.1002/ijc.27822; Ramsay AG, 2013, BRIT J HAEMATOL, V162, P313, DOI 10.1111/bjh.12380; Rizvi NA, 2015, SCIENCE, V348, P124, DOI 10.1126/science.aaa1348; Rooney MS, 2015, CELL, V160, P48, DOI 10.1016/j.cell.2014.12.033; Rosenberg JE, 2016, LANCET, V387, P1909, DOI 10.1016/S0140-6736(16)00561-4; Sato Y, 2013, NAT GENET, V45, P860, DOI 10.1038/ng.2699; Senbabaoglu Y, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1092-z; Sharma P, 2017, CELL, V168, P707, DOI 10.1016/j.cell.2017.01.017; Snyder A, 2014, NEW ENGL J MED, V371, P2189, DOI 10.1056/NEJMoa1406498; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Uhlen M, 2017, SCIENCE, V357, P660, DOI 10.1126/science.aan2507; Van Allen EM, 2015, SCIENCE, V350, P207, DOI 10.1126/science.aad0095; Varela I, 2011, NATURE, V469, P539, DOI 10.1038/nature09639; Wolchok JD, 2009, CLIN CANCER RES, V15, P7412, DOI 10.1158/1078-0432.CCR-09-1624	37	613	630	9	134	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 16	2018	359	6377					801	805	aan5951	10.1126/science.aan5951	http://dx.doi.org/10.1126/science.aan5951			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW2ET	29301960	Green Accepted			2022-12-28	WOS:000425116200047
J	Kim, J; Yang, D; Oh, SH; An, K				Kim, Junki; Yang, Daeho; Oh, Seung-hoon; An, Kyungwon			Coherent single-atom superradiance	SCIENCE			English	Article							CAVITY; SUPER; LIGHT; LASER	Superradiance is a quantum phenomenon emerging in macroscopic systems whereby correlated single atoms cooperatively emit photons. Demonstration of controlled collective atom-field interactions has resulted from the ability to directly imprint correlations with an atomic ensemble. Here we report cavity-mediated coherent single-atom superradiance: Single atoms with predefined correlation traverse a high-quality factor cavity one by one, emitting photons cooperatively with the N atoms that have already gone through the cavity (N represents the number of atoms). Enhanced collective photoemission of N-squared dependence was observed even when the intracavity atom number was less than unity. The correlation among single atoms was achieved by nanometer-precision position control and phase-aligned state manipulation of atoms by using a nanohole-array aperture. Our results demonstrate a platform for phase-controlled atom-field interactions.	[An, Kyungwon] Seoul Natl Univ, Dept Phys & Astron, Seoul 08826, South Korea; Seoul Natl Univ, Inst Appl Phys, Seoul 08826, South Korea	Seoul National University (SNU); Seoul National University (SNU)	An, K (corresponding author), Seoul Natl Univ, Dept Phys & Astron, Seoul 08826, South Korea.	kwan@phya.snu.ac.kr	An, Kyungwon/AAP-9792-2020	An, Kyungwon/0000-0003-4142-6297; Kim, Junki/0000-0001-8133-4819; Yang, Daeho/0000-0002-4575-037X	Samsung Science and Technology Foundation [SSTF-BA1502-05]	Samsung Science and Technology Foundation(Samsung)	We thank M. Lee and H.-G. Hong for helpful comments. This work was supported by a grant from the Samsung Science and Technology Foundation under project SSTF-BA1502-05. We declare no competing financial interests. All data needed to evaluate the conclusions in the paper are present in the paper and/or the supplementary materials.	An K, 1997, OPT LETT, V22, P1500, DOI 10.1364/OL.22.001500; Baumann K, 2010, NATURE, V464, P1301, DOI 10.1038/nature09009; BJORK G, 1994, PHYS REV A, V50, P1675, DOI 10.1103/PhysRevA.50.1675; Bohnet JG, 2012, NATURE, V484, P78, DOI 10.1038/nature10920; Casabone B, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.023602; Choi WS, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.093603; Deleglise S, 2008, NATURE, V455, P510, DOI 10.1038/nature07288; DICKE RH, 1954, PHYS REV, V93, P99, DOI 10.1103/PhysRev.93.99; Douglas JS, 2015, NAT PHOTONICS, V9, P326, DOI 10.1038/NPHOTON.2015.57; Fang-Yen C, 2006, PHYS REV A, V73, DOI 10.1103/PhysRevA.73.041802; GROSS M, 1982, PHYS REP, V93, P301, DOI 10.1016/0370-1573(82)90102-8; Hammerer K, 2010, REV MOD PHYS, V82, P1041, DOI 10.1103/RevModPhys.82.1041; Higgins KDB, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5705; Hong HG, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.243601; Inouye S, 1999, SCIENCE, V285, P571, DOI 10.1126/science.285.5427.571; Khajavikhan M, 2012, NATURE, V482, P204, DOI 10.1038/nature10840; Le Kien F., 1993, F PHYS, V23, P177; Lee M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4441; Lodahl P, 2017, NATURE, V541, P473, DOI 10.1038/nature21037; Meir Z, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.193002; Mlynek JA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6186; Neuzner A, 2016, NAT PHOTONICS, V10, P303, DOI [10.1038/NPHOTON.2016.19, 10.1038/nphoton.2016.19]; Norcia MA, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1601231; Reimann R, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.023601; Rohlsberger R, 2010, SCIENCE, V328, P1248, DOI 10.1126/science.1187770; Roof SJ, 2016, PHYS REV LETT, V117, DOI 10.1103/PhysRevLett.117.073003; Scheibner M, 2007, NAT PHYS, V3, P106, DOI 10.1038/nphys494; Scully MO, 2009, SCIENCE, V325, P1510, DOI 10.1126/science.1176695; SKRIBANO.N, 1973, PHYS REV LETT, V30, P309, DOI 10.1103/PhysRevLett.30.309	30	32	32	3	45	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 9	2018	359	6376					662	665		10.1126/science.aar2179	http://dx.doi.org/10.1126/science.aar2179			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW2FH	29269423	Green Submitted			2022-12-28	WOS:000425117700034
J	Mooley, KP; Nakar, E; Hotokezaka, K; Hallinan, G; Corsi, A; Frail, DA; Horesh, A; Murphy, T; Lenc, E; Kaplan, DL; De, K; Dobie, D; Chandra, P; Deller, A; Gottlieb, O; Kasliwal, MM; Kulkarni, SR; Myers, ST; Nissanke, S; Piran, T; Lynch, C; Bhalerao, V; Bourke, S; Bannister, KW; Singer, LP				Mooley, K. P.; Nakar, E.; Hotokezaka, K.; Hallinan, G.; Corsi, A.; Frail, D. A.; Horesh, A.; Murphy, T.; Lenc, E.; Kaplan, D. L.; De, K.; Dobie, D.; Chandra, P.; Deller, A.; Gottlieb, O.; Kasliwal, M. M.; Kulkarni, S. R.; Myers, S. T.; Nissanke, S.; Piran, T.; Lynch, C.; Bhalerao, V.; Bourke, S.; Bannister, K. W.; Singer, L. P.			A mildly relativistic wide-angle outflow in the neutron-star merger event GW170817	NATURE			English	Article							GAMMA-RAY BURSTS; ELECTROMAGNETIC COUNTERPART; EMISSION; DETECTABILITY; AFTERGLOWS	GW170817 was the first gravitational-wave detection of a binary neutron-star merger(1). It was accompanied by radiation across the electromagnetic spectrum and localized(2) to the galaxy NGC 4993 at a distance of 40 megaparsecs. It has been proposed that the observed gamma-ray, X-ray and radio emission is due to an ultra-relativistic jet being launched during the merger (and successfully breaking out of the surrounding material), directed away from our line of sight (off-axis)(3-6). The presence of such a jet is predicted from models that posit neutron-star mergers as the drivers of short hard-gamma-ray bursts(7,8). Here we report that the radio light curve of GW170817 has no direct signature of the afterglow of an off-axis jet. Although we cannot completely rule out the existence of a jet directed away from the line of sight, the observed gamma-ray emission could not have originated from such a jet. Instead, the radio data require the existence of a mildly relativistic wide-angle outflow moving towards us. This outflow could be the high-velocity tail of the neutron-rich material that was ejected dynamically during the merger, or a cocoon of material that breaks out when a jet launched during the merger transfers its energy to the dynamical ejecta. Because the cocoon model explains the radio light curve of GW170817, as well as the gamma-ray and X-ray emission (and possibly also the ultraviolet and optical emission)(9-15), it is the model that is most consistent with the observational data. Cocoons may be a ubiquitous phenomenon produced in neutron-star mergers, giving rise to a hitherto unidentified population of radio, ultraviolet, X-ray and gamma-ray transients in the local Universe.	[Mooley, K. P.] Denys Wilkinson Bldg,Keble Rd, Oxford OX1 3RH, England; [Mooley, K. P.; Frail, D. A.; Myers, S. T.] Natl Radio Astron Observ, Socorro, NM 87801 USA; [Mooley, K. P.; Hallinan, G.; De, K.; Kasliwal, M. M.; Kulkarni, S. R.] CALTECH, 1200 East Calif Blvd,MC 249-17, Pasadena, CA 91125 USA; [Nakar, E.; Gottlieb, O.] Tel Aviv Univ, Raymond & Beverly Sackler Sch Phys & Astron, IL-69978 Tel Aviv, Israel; [Hotokezaka, K.] Princeton Univ, Dept Astrophys Sci, Peyton Hall, Princeton, NJ 08544 USA; [Corsi, A.] Texas Tech Univ, Dept Phys & Astron, Box 41051, Lubbock, TX 79409 USA; [Horesh, A.] Hebrew Univ Jerusalem, Racah Inst Phys, IL-91904 Jerusalem, Israel; [Murphy, T.; Lenc, E.; Dobie, D.; Lynch, C.] Univ Sydney, Sydney Inst Astron, Sch Phys, Sydney, NSW 2006, Australia; [Murphy, T.; Lenc, E.; Dobie, D.; Lynch, C.] ARC Ctr Excellence All Sky Astrophys CAASTRO, Sydney, NSW, Australia; [Kaplan, D. L.] Univ Wisconsin, Dept Phys, Milwaukee, WI 53201 USA; [Dobie, D.; Bannister, K. W.] CSIRO Astron & Space Sci, ATNF, POB 76, Epping, NSW 1710, Australia; [Chandra, P.] Tata Inst Fundamental Res, Natl Ctr Radio Astrophys, Pune Univ Campus, Ganeshkhind Pune 411007, India; [Chandra, P.] Stockholm Univ, AlbaNova, Dept Astron, SE-10691 Stockholm, Sweden; [Deller, A.] Swinburne Univ Technol, Ctr Astrophys & Supercomp, John St, Hawthorn, Vic 3122, Australia; [Deller, A.] ARC Ctr Excellence Gravitat Wave Discovery OzGrav, Hawthorn, Vic, Australia; [Nissanke, S.] Radboud Univ Nijmegen, Inst Math Astrophys & Particle Phys, Heyendaalseweg 135, NL-6525 AJ Nijmegen, Netherlands; [Bhalerao, V.] Indian Inst Technol, Dept Phys, Bombay 400076, Maharashtra, India; [Bourke, S.] Chalmers Univ Technol, Dept Space Earth & Environm, Onsala Space Observ, S-43992 Onsala, Sweden; [Singer, L. P.] NASA, Astroparticle Phys Lab, Goddard Space Flight Ctr, Mail Code 661, Greenbelt, MD 20771 USA	National Radio Astronomy Observatory (NRAO); California Institute of Technology; Tel Aviv University; Princeton University; Texas Tech University System; Texas Tech University; Hebrew University of Jerusalem; University of Sydney; University of Wisconsin System; University of Wisconsin Milwaukee; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Tata Institute of Fundamental Research (TIFR); National Centre for Radio Astrophysics (NCRA), Pune; Stockholm University; Swinburne University of Technology; Radboud University Nijmegen; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Bombay; Chalmers University of Technology; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center	Mooley, KP (corresponding author), Denys Wilkinson Bldg,Keble Rd, Oxford OX1 3RH, England.; Mooley, KP (corresponding author), Natl Radio Astron Observ, Socorro, NM 87801 USA.; Mooley, KP (corresponding author), CALTECH, 1200 East Calif Blvd,MC 249-17, Pasadena, CA 91125 USA.	kunal@astro.caltech.edu	Lynch, Christene/O-2062-2018; Bhalerao, Varun/AAC-1467-2022; Hotokezaka, Kenta/AAA-3890-2022; Horesh, Assaf/O-9873-2016	Lynch, Christene/0000-0002-0494-192X; Bhalerao, Varun/0000-0002-6112-7609; Gottlieb, Ore/0000-0003-3115-2456; Kasliwal, Tamay/0000-0001-5634-7167; Deller, Adam/0000-0001-9434-3837; Horesh, Assaf/0000-0002-5936-1156; Nakar, Ehud/0000-0002-4534-7089; Bannister, Keith/0000-0003-2149-0363; Dobie, Dougal/0000-0003-0699-7019; Lenc, Emil/0000-0002-9994-1593; Chandra, Poonam/0000-0002-0844-6563	Australian Government; Hintze Centre for Astrophysical Surveys; Hintze Family Charitable Foundation; ERC starting grant (GRB/SN); ISF [1277/13]; NSF [AST-1654815, AST-1412421]; National Science Foundation CAREER award [1455090]; I-Core Program of the Planning and Budgeting Committee; Israel Science Foundation; Australian Research Council [FT150100099]; Australian Research Council Centre of Excellence for All-sky Astrophysics (CAASTRO) [CE110001020]; GROWTH (Global Relay of Observatories Watching Transients Happen) project - NSF under PIRE grant [1545949]; Netherlands Organization for Scientific Research through NWO VIDI grant [639.042.612-Nissanke]; NWO TOP grant [62002444-Nissanke]; Department of Science and Technology via SwarnaJayanti Fellowship [DST/SJF/PSA-01/2014-15]; Advanced ERC grant TReX; Science and Engineering Research Board, Department of Science and Technology, India; Direct For Mathematical & Physical Scien [1412421] Funding Source: National Science Foundation; Division Of Astronomical Sciences [1455090] Funding Source: National Science Foundation	Australian Government(Australian GovernmentCGIAR); Hintze Centre for Astrophysical Surveys; Hintze Family Charitable Foundation; ERC starting grant (GRB/SN); ISF(Israel Science Foundation); NSF(National Science Foundation (NSF)); National Science Foundation CAREER award(National Science Foundation (NSF)); I-Core Program of the Planning and Budgeting Committee; Israel Science Foundation(Israel Science Foundation); Australian Research Council(Australian Research Council); Australian Research Council Centre of Excellence for All-sky Astrophysics (CAASTRO)(Australian Research Council); GROWTH (Global Relay of Observatories Watching Transients Happen) project - NSF under PIRE grant; Netherlands Organization for Scientific Research through NWO VIDI grant; NWO TOP grant; Department of Science and Technology via SwarnaJayanti Fellowship; Advanced ERC grant TReX; Science and Engineering Research Board, Department of Science and Technology, India; Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); Division Of Astronomical Sciences(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We acknowledge the support and dedication of the staff of the National Radio Astronomy Observatory and particularly thank the VLA Director, M. McKinnon, as well as A. Mioduszewski and H. Medlin, for making the VLA campaign possible. We thank B. Griswold (NASA/GSFC) for beautiful graphic arts (Fig. 2). S.R.K. thanks M. Shull for discussions. The National Radio Astronomy Observatory is a facility of the National Science Foundation operated under cooperative agreement by Associated Universities, Inc. We thank the GMRT staff for scheduling our observations. The GMRT is run by the National Centre for Radio Astrophysics of the Tata Institute of Fundamental Research. The Australia Telescope Compact Array is part of the Australia Telescope National Facility, which is funded by the Australian Government for operation as a National Facility managed by CSIRO. K.P.M. is a Hintze Fellow and so is supported by the Hintze Centre for Astrophysical Surveys, which is funded through the Hintze Family Charitable Foundation. E.N. acknowledges the support of an ERC starting grant (GRB/SN) and an ISF grant (1277/13). G.H. acknowledges the support of NSF award AST-1654815. A.C. acknowledges support from the National Science Foundation CAREER award number 1455090 titled 'CAREER: Radio and gravitational-wave emission from the largest explosions since the Big Bang'. A. H. acknowledges support by the I-Core Program of the Planning and Budgeting Committee and the Israel Science Foundation. T.M. acknowledges the support of the Australian Research Council through grant FT150100099. Parts of this research were conducted by the Australian Research Council Centre of Excellence for All-sky Astrophysics (CAASTRO), through project number CE110001020. D.L.K. was supported by NSF grant AST-1412421. M.M.K.'s work was supported by the GROWTH (Global Relay of Observatories Watching Transients Happen) project funded by the NSF under PIRE grant number 1545949. This work is part of the research programme Innovational Research Incentives Scheme (Vernieuwingsimpuls), which is financed by the Netherlands Organization for Scientific Research through NWO VIDI grant number 639.042.612-Nissanke and NWO TOP grant number 62002444-Nissanke. P.C. acknowledges support from the Department of Science and Technology via SwarnaJayanti Fellowship awards (DST/SJF/PSA-01/2014-15). T.P. acknowledges the support of the Advanced ERC grant TReX. V.B. acknowledges the support of the Science and Engineering Research Board, Department of Science and Technology, India, for the GROWTH-India project.	Abbott BP, 2017, PHYS REV LETT, V119, DOI 10.1103/PhysRevLett.119.161101; Abbott BP, 2017, ASTROPHYS J LETT, V848, DOI 10.3847/2041-8213/aa91c9; Abbott BP, 2017, ASTROPHYS J LETT, V848, DOI 10.3847/2041-8213/aa920c; Ade PAR, 2016, ASTRON ASTROPHYS, V594, DOI 10.1051/0004-6361/201525830; Alexander KD, 2017, ASTROPHYS J LETT, V848, DOI 10.3847/2041-8213/aa905d; Bauswein A, 2013, ASTROPHYS J, V773, DOI 10.1088/0004-637X/773/1/78; Blagorodnova N, 2017, GCN CIRC, P21816; Cooke RJ, 2016, ASTROPHYS J, V830, DOI 10.3847/0004-637X/830/2/148; EICHLER D, 1989, NATURE, V340, P126, DOI 10.1038/340126a0; Evans PA, 2017, SCIENCE, V358, P1565, DOI 10.1126/science.aap9580; Fong W, 2015, ASTROPHYS J, V815, DOI 10.1088/0004-637X/815/2/102; Gottlieb O., 2017, COCOON SHOCK BREAKOU; Gottlieb O, 2018, MON NOT R ASTRON SOC, V473, P576, DOI 10.1093/mnras/stx2357; Granot J, 2002, ASTROPHYS J, V570, pL61, DOI 10.1086/340991; Haggard D, 2017, ASTROPHYS J LETT, V848, DOI 10.3847/2041-8213/aa8ede; Hallinan G, 2017, SCIENCE, V358, P1579, DOI 10.1126/science.aap9855; Hogbom J. A., 1974, Astronomy and Astrophysics Supplement Series, V15, P417; Hotokezaka K, 2015, MON NOT R ASTRON SOC, V450, P1430, DOI 10.1093/mnras/stv620; Hotokezaka K, 2013, PHYS REV D, V87, DOI 10.1103/PhysRevD.87.024001; Kasliwal MM, 2017, SCIENCE, V358, P1559, DOI 10.1126/science.aap9455; Kyutoku K, 2014, MON NOT R ASTRON SOC, V437, pL6, DOI 10.1093/mnrasl/slt128; Lazzati D, 2017, ASTROPHYS J LETT, V848, DOI 10.3847/2041-8213/aa8f3d; Lazzati D, 2017, MON NOT R ASTRON SOC, V471, P1652, DOI 10.1093/mnras/stx1683; Margutti R, 2017, ASTROPHYS J LETT, V848, DOI 10.3847/2041-8213/aa9057; McMullin JP, 2007, ASTR SOC P, V376, P127; Moharana R, 2017, MON NOT R ASTRON SOC, V472, pL55, DOI 10.1093/mnrasl/slx131; Nakar E, 2002, ASTROPHYS J, V579, P699, DOI 10.1086/342791; Nakar E, 2007, PHYS REP, V442, P166, DOI 10.1016/j.physrep.2007.02.005; Nakar E, 2017, ASTROPHYS J, V834, DOI 10.3847/1538-4357/834/1/28; Nissanke S, 2013, ASTROPHYS J, V767, DOI 10.1088/0004-637X/767/2/124; Piro A. L., 2017, EVIDENCE COCOON EMIS; Reddy SH, 2017, J ASTRON INSTRUM, V6, DOI 10.1142/S2251171716410117; Sari R, 1998, ASTROPHYS J, V497, pL17, DOI 10.1086/311269; Sault RJ, 1995, ASTR SOC P, V77, P433; Shepherd MC, 1997, ASTR SOC P, V125, P77; Shull JM, 2012, ASTROPHYS J, V759, DOI 10.1088/0004-637X/759/1/23; Soderberg AM, 2006, ASTROPHYS J, V638, P930, DOI 10.1086/499121; Troja E, 2017, NATURE, V551, P71, DOI 10.1038/nature24290; Tumlinson J, 2017, ANNU REV ASTRON ASTR, V55, P389, DOI 10.1146/annurev-astro-091916-055240; van Eerten HJ, 2012, ASTROPHYS J, V751, DOI 10.1088/0004-637X/751/2/155; Villar VA, 2017, ASTROPHYS J LETT, V851, DOI 10.3847/2041-8213/aa9c84	42	246	247	1	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 8	2018	554	7691					207	+		10.1038/nature25452	http://dx.doi.org/10.1038/nature25452			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1OE	29261643	Green Accepted, Green Submitted			2022-12-28	WOS:000424332600032
J	Fitzpatrick, MJ; Edelsparre, AH				Fitzpatrick, Mark J.; Edelsparre, Allan H.			The genomics of climate change	SCIENCE			English	Editorial Material							DISPERSAL; BEHAVIOR		[Fitzpatrick, Mark J.; Edelsparre, Allan H.] Univ Toronto Scarborough, Dept Biol Sci, Integrat Behav & Neurosci Grp, Toronto, ON M1C 1A4, Canada	University of Toronto; University Toronto Scarborough	Fitzpatrick, MJ (corresponding author), Univ Toronto Scarborough, Dept Biol Sci, Integrat Behav & Neurosci Grp, Toronto, ON M1C 1A4, Canada.	mark.fitzpatrick@utoronto.ca	Fitzpatrick, Mark J/A-3414-2008	Fitzpatrick, Mark/0000-0003-3484-4327				Anreiter I, 2017, P NATL ACAD SCI USA, V114, P12518, DOI 10.1073/pnas.1710770114; Bay RA, 2018, SCIENCE, V359, P83, DOI 10.1126/science.aan4380; Edelsparre AH, 2014, ECOL LETT, V17, P333, DOI 10.1111/ele.12234; Funk J, 2014, ROCKY MOUNTAIN FORES; Gloria-Soria A, 2008, CURR BIOL, V18, P1694, DOI 10.1016/j.cub.2008.09.043; Haag CR, 2005, P ROY SOC B-BIOL SCI, V272, P2449, DOI 10.1098/rspb.2005.3235; Marvel K, 2013, P NATL ACAD SCI USA, V110, P19301, DOI 10.1073/pnas.1314382110; Matthews LJ, 2011, AM J PHYS ANTHROPOL, V145, P382, DOI 10.1002/ajpa.21507; Mueller JC, 2013, MOL ECOL, V22, P2797, DOI 10.1111/mec.12282; Nadeau CP, 2017, TRENDS ECOL EVOL, V32, P786, DOI 10.1016/j.tree.2017.07.012; Sauer J. R., 2014, N AM BREEDING BIRD S, P3; Shuford W. D., 2008, CALIFORNIA BIRD SPEC, P332; Verhulst EC, 2016, MOL ECOL, V25, P1801, DOI 10.1111/mec.13519	13	10	10	9	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 5	2018	359	6371					29	30		10.1126/science.aar3920	http://dx.doi.org/10.1126/science.aar3920			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FR8KW	29301999				2022-12-28	WOS:000419324700053
J	Bereiter, B; Shackleton, S; Baggenstos, D; Kawamura, K; Severinghaus, J				Bereiter, Bernhard; Shackleton, Sarah; Baggenstos, Daniel; Kawamura, Kenji; Severinghaus, Jeff			Mean global ocean temperatures during the last glacial transition	NATURE			English	Article							ABRUPT CLIMATE-CHANGE; SOUTHERN-OCEAN; SEA-LEVEL; ICE-CORE; ATMOSPHERIC CO2; TRAPPED AIR; NOBLE-GASES; POLAR ICE; WATER; CIRCULATION	Little is known about the ocean temperature's long-term response to climate perturbations owing to limited observations and a lack of robust reconstructions. Although most of the anthropogenic heat added to the climate system has been taken up by the ocean up until now, its role in a century and beyond is uncertain. Here, using noble gases trapped in ice cores, we show that the mean global ocean temperature increased by 2.57 +/- 0.24 degrees Celsius over the last glacial transition (20,000 to 10,000 years ago). Our reconstruction provides unprecedented precision and temporal resolution for the integrated global ocean, in contrast to the depth-, region-, organism-and season-specific estimates provided by other methods. We find that the mean global ocean temperature is closely correlated with Antarctic temperature and has no lead or lag with atmospheric CO2, thereby confirming the important role of Southern Hemisphere climate in global climate trends. We also reveal an enigmatic 700-year warming during the early Younger Dryas period (about 12,000 years ago) that surpasses estimates of modern ocean heat uptake.	[Bereiter, Bernhard; Shackleton, Sarah; Baggenstos, Daniel; Severinghaus, Jeff] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92037 USA; [Bereiter, Bernhard; Baggenstos, Daniel] Univ Bern, Climate & Environm Phys, Phys Inst, CH-3012 Bern, Switzerland; [Bereiter, Bernhard; Baggenstos, Daniel] Univ Bern, Oeschger Ctr Climate Res, CH-3012 Bern, Switzerland; [Bereiter, Bernhard] Empa, Lab Air Pollut Environm Technol, CH-8600 Dubendorf, Switzerland; [Kawamura, Kenji] Natl Inst Polar Res, Res Org Informat & Syst, 10-3 Midori Cho, Tachikawa, Tokyo 1908518, Japan; [Kawamura, Kenji] Grad Univ Adv Studies SOKENDAI, Dept Polar Sci, 10-3 Midori Cho, Tachikawa, Tokyo 1908518, Japan; [Kawamura, Kenji] Japan Agcy Marine Earth Sci & Technol, Inst Biogeosci, 2-15 Natsushima Cho, Yokosuka, Kanagawa 2370061, Japan	University of California System; University of California San Diego; Scripps Institution of Oceanography; University of Bern; University of Bern; Swiss Federal Institutes of Technology Domain; Swiss Federal Laboratories for Materials Science & Technology (EMPA); Research Organization of Information & Systems (ROIS); National Institute of Polar Research (NIPR) - Japan; Graduate University for Advanced Studies - Japan; Japan Agency for Marine-Earth Science & Technology (JAMSTEC)	Bereiter, B (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92037 USA.; Bereiter, B (corresponding author), Univ Bern, Climate & Environm Phys, Phys Inst, CH-3012 Bern, Switzerland.; Bereiter, B (corresponding author), Univ Bern, Oeschger Ctr Climate Res, CH-3012 Bern, Switzerland.; Bereiter, B (corresponding author), Empa, Lab Air Pollut Environm Technol, CH-8600 Dubendorf, Switzerland.	bereiter@climate.unibe.ch	Baggenstos, Daniel/AAK-5751-2021; Kawamura, Kenji/C-7660-2011	Baggenstos, Daniel/0000-0001-9756-6884; Kawamura, Kenji/0000-0003-1163-700X	Swiss National Science Foundation [P2BEP2_152071]; US National Science Foundation [05-38630, 09-44343]; JSPS KAKENHI [21671001, 26241011, 15KK0027, 17H06320]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); US National Science Foundation(National Science Foundation (NSF)); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Swiss National Science Foundation (scholarship P2BEP2_152071), by the US National Science Foundation (grants 05-38630 and 09-44343 to J.S.) and by the JSPS KAKENHI (grants 21671001, 26241011, 15KK0027 and 17H06320 to K.K.). We thank C. Buizert for providing the WAIS divide past firn temperature modelling results and P. Pfister for providing the Bern3D model results. We are deeply indebted to many participants in the WAIS Divide project and especially thank K. Taylor, M. Twickler, the National Ice Core Laboratory, the Ice Drilling Design and Operations (IDDO) for ice drilling, the New York Air National Guard for airlift, and the Office of Polar Programs of the US National Science Foundation. R. Keeling first provided the idea for the noble-gas-based determination of mean ocean temperature.	Abraham JP, 2013, REV GEOPHYS, V51, P450, DOI 10.1002/rog.20022; Alduchov OA, 1996, J APPL METEOROL, V35, P601, DOI 10.1175/1520-0450(1996)035<0601:IMFAOS>2.0.CO;2; Allan R, 2006, J CLIMATE, V19, P5816, DOI 10.1175/JCLI3937.1; Alley R. B., 2008, WAIS DIVIDE ICE CORE; Anderson RF, 2009, SCIENCE, V323, P1443, DOI 10.1126/science.1167441; Annan JD, 2013, CLIM PAST, V9, P367, DOI 10.5194/cp-9-367-2013; [Anonymous], 2007, DEEP-SEA RES PT 1, V54, P940; Bereiter B., RAPID COMMU IN PRESS; Bereiter B, 2012, P NATL ACAD SCI USA, V109, P9755, DOI 10.1073/pnas.1204069109; Bereiter B, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL036737; Berger A, 2017, EARTHS FUTURE, V5, P811, DOI 10.1002/2017EF000554; Bindoff NL, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P867; Buizert C, 2015, CLIM PAST, V11, P153, DOI 10.5194/cp-11-153-2015; Buizert C, 2016, CRYOSPHERE, V10, P2099, DOI 10.5194/tc-10-2099-20160; Buizert C, 2015, PALEOCEANOGRAPHY, V30, P1595, DOI 10.1002/2015PA002795; Cuffey KM, 2016, P NATL ACAD SCI USA, V113, P14249, DOI 10.1073/pnas.1609132113; Elderfield H, 2012, SCIENCE, V337, P704, DOI 10.1126/science.1221294; Elderfield H, 2010, QUATERNARY SCI REV, V29, P160, DOI 10.1016/j.quascirev.2009.07.013; Ferrari R, 2014, P NATL ACAD SCI USA, V111, P8753, DOI 10.1073/pnas.1323922111; Fudge TJ, 2013, NATURE, V500, P440, DOI 10.1038/nature12376; Galbraith ED, 2016, GEOPHYS RES LETT, V43, P8214, DOI 10.1002/2016GL069846; Gebbie G, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL046769; Gleckler PJ, 2016, NAT CLIM CHANGE, V6, P394, DOI [10.1038/NCLIMATE2915, 10.1038/nclimate2915]; Hamme RC, 2004, DEEP-SEA RES PT I, V51, P1517, DOI 10.1016/j.dsr.2004.06.009; He F, 2014, GEOPHYS RES LETT, V41, P623, DOI 10.1002/2013GL058085; Headly M. A., 2008, THESIS; Headly MA, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD008317; Huybers P, 2006, SCIENCE, V313, P508, DOI 10.1126/science.1125249; IPCC, 2013, CLIMATE CHANGE 2022; Jiang DB, 2010, J CLIMATE, V23, P5030, DOI 10.1175/2010JCLI3526.1; Johnson GC, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004477; Joos F, 2008, P NATL ACAD SCI USA, V105, P1425, DOI 10.1073/pnas.0707386105; Kawamura K., 2013, ATMOS CHEM PHYS DISC, V13, P7021; Keeling RF, 2004, TELLUS B, V56, P322, DOI 10.1111/j.1600-0889.2004.00117.x; Knutti R, 2008, NAT GEOSCI, V1, P735, DOI 10.1038/ngeo337; Kobashi T, 2008, GEOCHIM COSMOCHIM AC, V72, P4675, DOI 10.1016/j.gca.2008.07.006; Lambeck K, 2014, P NATL ACAD SCI USA, V111, P15296, DOI 10.1073/pnas.1411762111; Levermann A, 2013, P NATL ACAD SCI USA, V110, P13745, DOI 10.1073/pnas.1219414110; Loose B, 2016, J GEOPHYS RES-OCEANS, V121, P5959, DOI 10.1002/2016JC011809; Luthi D, 2010, EARTH PLANET SC LETT, V297, P226, DOI 10.1016/j.epsl.2010.06.023; Marcott SA, 2014, NATURE, V514, P616, DOI 10.1038/nature13799; McManus JF, 2004, NATURE, V428, P834, DOI 10.1038/nature02494; Neff PD, 2014, ANN GLACIOL, V55, P72, DOI 10.3189/2014AoG68A023; Parrenin F, 2013, SCIENCE, V339, P1060, DOI 10.1126/science.1226368; Piotrowski AM, 2008, EARTH PLANET SC LETT, V272, P394, DOI 10.1016/j.epsl.2008.05.011; Reimer PJ, 2013, RADIOCARBON, V55, P1869, DOI 10.2458/azu_js_rc.55.16947; Renssen H, 2015, NAT GEOSCI, V8, P946, DOI [10.1038/NGEO2557, 10.1038/ngeo2557]; Rhodes RH, 2015, SCIENCE, V348, P1016, DOI 10.1126/science.1262005; Ritz SP, 2011, QUATERNARY SCI REV, V30, P3728, DOI 10.1016/j.quascirev.2011.09.021; Sarmiento J. L., 2006, OCEAN BIOGEOCHEMICAL, pxii; Schlatter T. W., 2009, ATMOSPHERIC COMPOSIT; Schmidt GA, 2014, CLIM PAST, V10, P221, DOI 10.5194/cp-10-221-2014; Schmitt J, 2012, SCIENCE, V336, P711, DOI 10.1126/science.1217161; Schmittner A, 2011, SCIENCE, V334, P1385, DOI 10.1126/science.1203513; Schwander J., 1996, NATO ASI SERIES, V43; Severinghaus JP, 2009, SCIENCE, V324, P1431, DOI 10.1126/science.1169473; Severinghaus JP, 1998, NATURE, V391, P141, DOI 10.1038/34346; Severinghaus JP, 2003, GEOCHIM COSMOCHIM AC, V67, P325, DOI 10.1016/S0016-7037(02)00965-1; Shakun JD, 2015, EARTH PLANET SC LETT, V426, P58, DOI 10.1016/j.epsl.2015.05.042; Shakun JD, 2012, NATURE, V484, P49, DOI 10.1038/nature10915; Sigman DM, 2010, NATURE, V466, P47, DOI 10.1038/nature09149; Snow K, 2016, GEOPHYS RES LETT, V43, P7089, DOI 10.1002/2016GL069479; Snyder C. W., 2016, NATURE; Souney JM, 2014, ANN GLACIOL, V55, P15, DOI 10.3189/2014AoG68A008; Spahni R, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017093; Stocker TF, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2003PA000920; Taylor K. C., 2009, WAIS DIVIDE ICE CORE; Viglione GA, 2016, J GEOPHYS RES-OCEANS, V121, P6295, DOI 10.1002/2016JC011773; Wanninkhof R, 2014, LIMNOL OCEANOGR-METH, V12, P351, DOI 10.4319/lom.2014.12.351; WEISS RF, 1978, J CHEM ENG DATA, V23, P69, DOI 10.1021/je60076a014; Wood D., 1966, SOLUBILITIES KR XE F, P1, DOI [10.21236/AD0631557, DOI 10.21236/AD0631557]	71	88	88	6	161	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 4	2018	553	7686					39	+		10.1038/nature25152	http://dx.doi.org/10.1038/nature25152			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS4NI	29300008	Green Accepted, Green Published			2022-12-28	WOS:000419769300025
J	Luzzatto, L; Arese, P				Luzzatto, Lucio; Arese, Paolo			Favism and Glucose-6-Phosphate Dehydrogenase Deficiency	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							SEVERE HEMOLYTIC-ANEMIA; RED-BLOOD-CELLS; VICIA-FABA L.; G6PD DEFICIENCY; ENZYME DEFICIENCY; MOLECULAR HETEROGENEITY; HUMAN-ERYTHROCYTES; CONVICINE CONTENTS; HYDROGEN-PEROXIDE; POINT MUTATIONS		[Luzzatto, Lucio] Muhimbili Univ Hlth & Allied Sci, Dept Hematol, Dar Es Salaam, Tanzania; [Arese, Paolo] Univ Turin, Dept Oncol, Biochem Unit, Turin, Italy	Muhimbili University of Health & Allied Sciences; University of Turin	Luzzatto, L (corresponding author), Muhimbili Univ Hlth & Allied Sci, United Nations Rd,POB 65001, Dar Es Salaam, Tanzania.	lluzzatto@blood.ac.tz						ALBANO E, 1984, BIOCHEM PHARMACOL, V33, P1701, DOI 10.1016/0006-2952(84)90299-5; ALLISON AC, 1960, NATURE, V186, P531, DOI 10.1038/186531a0; Arese P, 2005, CELL PHYSIOL BIOCHEM, V16, P133, DOI 10.1159/000089839; ARESE P, 1990, SEMIN HEMATOL, V27, P1; Baird K, 2015, PATHOG GLOB HEALTH, V109, P93, DOI 10.1179/2047773215Y.0000000016; BELSEY MA, 1973, B WORLD HEALTH ORGAN, V48, P1; Benmansour I, 2013, BLOOD CELL MOL DIS, V50, P110, DOI 10.1016/j.bcmd.2012.08.005; BEUTLER E, 1989, BLOOD, V74, P2550; BEUTLER E, 1962, P NATL ACAD SCI USA, V48, P9, DOI 10.1073/pnas.48.1.9; BEUTLER E, 1991, NEW ENGL J MED, V324, P169; Bhutani VK, 2015, PEDIATRICS, V136, pE1268, DOI 10.1542/peds.2015-2122; Bicakci Z, 2009, SAUDI MED J, V30, P292; BREWER GJ, 1962, JAMA-J AM MED ASSOC, V180, P386, DOI 10.1001/jama.1962.03050180032008; BRODRIBB HS, 1966, BRIT MED J, V2, P642, DOI 10.1136/bmj.2.5514.642-a; Bunn HF, 2013, BLOOD, V121, P20, DOI 10.1182/blood-2012-08-449397; CALABRO V, 1989, HAEMATOLOGICA, V74, P71; CALABRO V, 1993, AM J HUM GENET, V52, P527; Cardador-Martinez A, 2012, J FOOD QUALITY, V35, P419, DOI 10.1111/jfq.12006; CARSON PE, 1956, SCIENCE, V124, P484, DOI 10.1126/science.124.3220.484-a; CHAN TK, 1982, BRIT J HAEMATOL, V50, P575, DOI 10.1111/j.1365-2141.1982.tb01957.x; CHEVION M, 1982, EUR J BIOCHEM, V127, P405, DOI 10.1111/j.1432-1033.1982.tb06886.x; Chu CS, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002224; Darbandi B, 2014, IRAN J PEDIATR HEMAT, V4, P53; DESROCHES P, 1995, J STORED PROD RES, V31, P83, DOI 10.1016/0022-474X(94)00028-R; Farran MT, 2002, INT J TOXICOL, V21, P201, DOI 10.1080/10915810290096333; FERMI C, 1905, ANN IGIENE SPERIMENT, V15, P76; FERRALI M, 1992, BIOCHEM J, V285, P295, DOI 10.1042/bj2850295; FISCHER TM, 1985, BRIT J HAEMATOL, V59, P159, DOI 10.1111/j.1365-2141.1985.tb02976.x; GAETANI GF, 1989, BLOOD, V73, P334; GAETANI GF, 1979, BRIT J HAEMATOL, V43, P39, DOI 10.1111/j.1365-2141.1979.tb03717.x; GALIANO S, 1990, BRIT MED J, V300, P236, DOI 10.1136/bmj.300.6719.236; GALL JC, 1965, AM J HUM GENET, V17, P359; Goncalves P., 1994, British Journal of Haematology, V87, P146; Griffiths DW, 1996, J SCI FOOD AGR, V72, P469, DOI [10.1002/(SICI)1097-0010(199612)72:4&lt;469::AID-JSFA681&gt;3.0.CO;2-P, 10.1002/(SICI)1097-0010(199612)72:4<469::AID-JSFA681>3.3.CO;2-G]; GRIFFITHS DW, 1992, J SCI FOOD AGR, V59, P463, DOI 10.1002/jsfa.2740590406; Gutierrez N, 2006, THEOR APPL GENET, V114, P59, DOI 10.1007/s00122-006-0410-3; Hendawey M. H., 2013, Annals of Agricultural Science (Cairo), V58, P183, DOI 10.1016/j.aoas.2013.07.010; Iolascon A, 1999, EUR J HAEMATOL, V62, P307; Jablonska-Skwiecinska E, 1999, HUM MUTAT, V14, P477, DOI 10.1002/(SICI)1098-1004(199912)14:6<477::AID-HUMU6>3.0.CO;2-X; John GK, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-280; Kalfa TA, 2016, HEMATOL-AM SOC HEMAT, P690, DOI 10.1182/asheducation-2016.1.690; Kamerbeek NM, 2007, BLOOD, V109, P3560, DOI 10.1182/blood-2006-08-042531; Kaplan M, 1998, CLIN PERINATOL, V25, P575, DOI 10.1016/S0095-5108(18)30098-8; Khamassi K, 2013, PLANT GENET RESOUR-C, V11, P250, DOI 10.1017/S1479262113000105; KISLEV ME, 1988, CURR ANTHROPOL, V29, P175, DOI 10.1086/203623; LACHMANN PJ, 1984, SPRINGER SEMIN IMMUN, V7, P143, DOI 10.1007/BF01893018; Laosombat V, 2006, INT J HEMATOL, V83, P139, DOI 10.1532/IJH97.A20513; Laosombat V, 2005, BLOOD CELL MOL DIS, V34, P191, DOI 10.1016/j.bcmd.2004.11.001; Longo L, 2002, EMBO J, V21, P4229, DOI 10.1093/emboj/cdf426; Louicharoen C, 2009, SCIENCE, V326, P1546, DOI 10.1126/science.1178849; Luisada A, 1941, MEDICINE, V20, P229, DOI 10.1097/00005792-194105000-00003; LUZZATTO L, 1979, BLOOD, V54, P961; Luzzatto L, 2012, HEREDITY, V108, P456, DOI 10.1038/hdy.2011.90; LUZZATTO L, 1969, SCIENCE, V164, P839, DOI 10.1126/science.164.3881.839; Luzzatto L, 2015, NATHAN OSKIS HEMATOL, P609; Luzzatto L, 2016, HEMATOL ONCOL CLIN N, V30, P373, DOI 10.1016/j.hoc.2015.11.006; Luzzatto L, 2015, LANCET HAEMATOL, V2, pE400, DOI 10.1016/S2352-3026(15)00191-X; Maiga B, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-270; MARTINI G, 1986, EMBO J, V5, P1849, DOI 10.1002/j.1460-2075.1986.tb04436.x; Mason PJ, 2007, BLOOD REV, V21, P267, DOI 10.1016/j.blre.2007.05.002; McMillan DC, 2001, TOXICOL SCI, V62, P353, DOI 10.1093/toxsci/62.2.353; Meletis J., 2004, HAEMA, V7, P17; MELONI T, 1983, ACTA HAEMATOL-BASEL, V70, P83, DOI 10.1159/000206700; MELONI T, 1992, ACTA HAEMATOL-BASEL, V87, P29; Minucci A, 2012, BLOOD CELL MOL DIS, V48, P154, DOI 10.1016/j.bcmd.2012.01.001; Monteiro WM, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-70; MORELLI A, 1978, P NATL ACAD SCI USA, V75, P1979, DOI 10.1073/pnas.75.4.1979; Motulsky AG, 1961, P C GENETIC POLYMORP, P159; MOTULSKY ARNO G., 1960, HUMAN BIOL, V32, P28; Multari S, 2015, COMPR REV FOOD SCI F, V14, P511, DOI 10.1111/1541-4337.12146; NAFA K, 1993, HUM MOL GENET, V2, P81, DOI 10.1093/hmg/2.1.81; Noori-Daloii MR, 2004, J PHYSIOL BIOCHEM, V60, P273, DOI 10.1007/BF03167073; Odievre MH, 2011, INT J HEMATOL, V93, P664, DOI 10.1007/s12185-011-0827-6; Pamba A, 2012, BLOOD, V120, P4123, DOI 10.1182/blood-2012-03-416032; Pavlik M, 2002, ROST VYROBA, V48, P543; PIOMELLI S, 1968, J CLIN INVEST, V47, P940, DOI 10.1172/JCI105786; PITZ WJ, 1980, CAN I FOOD SC TECH J, V13, P35, DOI 10.1016/S0315-5463(80)73300-X; Pulkkinen M, 2016, FOOD CHEM, V212, P10, DOI 10.1016/j.foodchem.2016.05.077; Reading NS, 2016, BLOOD CELL MOL DIS, V60, P58, DOI 10.1016/j.bcmd.2016.07.001; RINALDI A, 1976, AM J HUM GENET, V28, P496; Rockett KA, 2014, NAT GENET, V46, P1197, DOI 10.1038/ng.3107; Rother RP, 2005, JAMA-J AM MED ASSOC, V293, P1653, DOI 10.1001/jama.293.13.1653; ROVIRA A, 1995, BRIT J HAEMATOL, V91, P66, DOI 10.1111/j.1365-2141.1995.tb05246.x; ROVIRA A, 1994, HUM MOL GENET, V3, P833; Rueangweerayut R, 2017, AM J TROP MED HYG, V97, P702, DOI 10.4269/ajtmh.16-0779; Shah SS, 2012, SCI REP-UK, V2, DOI 10.1038/srep00299; Simoons, 1998, PLANTS LIFE PLANTS D; Sirugo G, 2013, AM J HEMATOL, V88, P436, DOI 10.1002/ajh.23424; Skorokhod A, 2007, REDOX REP, V12, P73, DOI 10.1179/135100007X162284; TARLOV AR, 1962, ARCH INTERN MED, V109, P209, DOI 10.1001/archinte.1962.03620140081013; TURRINI F, 1985, BLOOD, V66, P302; Uyoga S, 2015, LANCET HAEMATOL, V2, pE437, DOI 10.1016/S2352-3026(15)00152-0; van Wijk R, 2004, BLOOD CELL MOL DIS, V32, P112, DOI 10.1016/j.bcmd.2003.10.006; VOGELS IMC, 1986, BRIT J HAEMATOL, V63, P402; von Fricken ME, 2014, ACTA TROP, V135, P62, DOI 10.1016/j.actatropica.2014.03.011; VULLIAMY TJ, 1988, P NATL ACAD SCI USA, V85, P5171, DOI 10.1073/pnas.85.14.5171; White NJ, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-418; WINTERBOURN CC, 1986, BIOCHEM PHARMACOL, V35, P2009, DOI 10.1016/0006-2952(86)90734-3; YOSHIDA A, 1971, B WORLD HEALTH ORGAN, V45, P243; ZOHARY D, 1973, SCIENCE, V182, P887, DOI 10.1126/science.182.4115.887; Zuccotti GV, 2014, ITAL J PEDIATR, V40, DOI 10.1186/1824-7288-40-71	102	103	105	1	47	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 4	2018	378	1					60	71		10.1056/NEJMra1708111	http://dx.doi.org/10.1056/NEJMra1708111			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FR7BE	29298156				2022-12-28	WOS:000419220500017
J	Markovitz, AA; Mack, JA; Nallamothu, BK; Ayanian, JZ; Ryan, AM				Markovitz, Adam A.; Mack, Jacob A.; Nallamothu, Brahmajee K.; Ayanian, John Z.; Ryan, Andrew M.			Incremental effects of antihypertensive drugs: instrumental variable analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							NUTRITION EXAMINATION SURVEY; SYSTOLIC BLOOD-PRESSURE; RISK-FACTOR CONTROL; COMBINATION THERAPY; HYPERTENSION PREVALENCE; CARDIOVASCULAR RISK; NATIONAL-HEALTH; OLDER-ADULTS; MANAGEMENT; SPRINT	OBJECTIVES To assess the incremental effects of adding extra antihypertensive drugs from a new class to a patient's regimen. DESIGN Instrumental variable analysis of data from SPRINT (Systolic Blood Pressure Intervention Trial). To account for confounding by indication-when treatments seem less effective if they are administered to sicker patients-randomization status was used as the instrumental variable. Patients' randomization status was either intensive (systolic blood pressure target < 120 mm Hg) or standard (systolic blood pressure target < 140 mm Hg) treatment. Results from instrumental variable models were compared with those from standard multivariable models. SETTING Secondary data analysis of a randomized clinical trial conducted at 102 sites in 2010-15. PARTICIPANTS 9092 SPRINT participants with hypertension and increased cardiovascular risk but no history of diabetes or stroke. MAIN OUTCOMES MEASURES Systolic blood pressure, major cardiovascular events, and serious adverse events. RESULTS In standard multivariable models not adjusted for confounding by indication, addition of an antihypertensive drug from a new class was associated with modestly lower systolic blood pressure (-1.3 mm Hg, 95% confidence interval -1.6 to -1.0) and no change in major cardiovascular events (absolute risk of events per 1000 patient years, 0.5, 95% confidence interval -1.5 to 2.3). In instrumental variable models, the addition of an antihypertensive drug from a new class led to clinically important reductions in systolic blood pressure (-14.4 mm Hg, -15.6 to -13.3) and fewer major cardiovascular events (absolute risk -6.2, -10.9 to -1.3). Incremental reductions in systolic blood pressure remained large and similar in magnitude for patients already taking drugs from zero, one, two, or three or more drug classes. This finding was consistent across all subgroups of patients. The addition of another antihypertensive drug class was not associated with adverse events in either standard or instrumental variable models. CONCLUSIONS After adjustment for confounding by indication, the addition of a new antihypertensive drug class led to large reductions in systolic blood pressure and major cardiovascular events among patients at high risk for cardiovascular events but without diabetes. Effects on systolic blood pressure persisted across all levels of baseline drug use and all subgroups of patients.	[Markovitz, Adam A.; Ayanian, John Z.; Ryan, Andrew M.] Univ Michigan, Sch Publ Hlth, Dept Hlth Management & Policy, Ann Arbor, MI 48109 USA; [Markovitz, Adam A.] Univ Michigan, Sch Med, Ann Arbor, MI USA; [Markovitz, Adam A.; Ryan, Andrew M.] Univ Michigan, Ctr Evaluating Hlth Reform, Ann Arbor, MI 48109 USA; [Markovitz, Adam A.; Nallamothu, Brahmajee K.] VA Ctr Clin Management Res, Ann Arbor, MI USA; [Mack, Jacob A.] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI USA; [Nallamothu, Brahmajee K.; Ayanian, John Z.; Ryan, Andrew M.] Univ Michigan, Inst Healthcare Policy & Innovat, Ann Arbor, MI 48109 USA; [Nallamothu, Brahmajee K.] MiCHAMP, Ann Arbor, MI USA; [Nallamothu, Brahmajee K.] Univ Michigan, Sch Med, Dept Internal Med, Div Cardiovasc Med, Ann Arbor, MI 48104 USA; [Ayanian, John Z.] Univ Michigan, Sch Med, Dept Internal Med, Div Gen Med, Ann Arbor, MI 48104 USA; [Ayanian, John Z.] Gerald R Ford Sch Publ Policy, Ann Arbor, MI USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Ryan, AM (corresponding author), Univ Michigan, Sch Publ Hlth, Dept Hlth Management & Policy, Ann Arbor, MI 48109 USA.; Ryan, AM (corresponding author), Univ Michigan, Ctr Evaluating Hlth Reform, Ann Arbor, MI 48109 USA.; Ryan, AM (corresponding author), Univ Michigan, Inst Healthcare Policy & Innovat, Ann Arbor, MI 48109 USA.	amryan@umich.edu		Mack, Jacob/0000-0002-8571-3880	NHLBI; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK092926] Funding Source: NIH RePORTER	NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	No funding organization was involved in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication. SPRINT was funded by the NHLBI.	AALEN OO, 1989, STAT MED, V8, P907, DOI 10.1002/sim.4780080803; [Anonymous], 2017, NEW ENGLAND J MED; Aronow WS, 2011, CIRCULATION, V123, pE616, DOI [10.1161/CIR.0b013e318222d03f, 10.1161/CIR.0b013e31821daaf6]; Baum CF, 2003, STATA J, V3, P1, DOI 10.1177/1536867X0300300101; Beddhu S, 2017, ANN INTERN MED, V167, P375, DOI 10.7326/M16-2966; Bress AP, 2016, J AM COLL CARDIOL, V67, P463, DOI 10.1016/j.jacc.2015.10.037; Bromfield SG, 2014, J CLIN HYPERTENS, V16, P270, DOI 10.1111/jch.12281; Burns NS, 2017, NEW ENGL J MED, V376, P2205, DOI 10.1056/NEJMp1705323; Calhoun DA, 2008, HYPERTENSION, V51, P1403, DOI 10.1161/HYPERTENSIONAHA.108.189141; Calhoun DA, 2009, HYPERTENSION, V54, P32, DOI 10.1161/HYPERTENSIONAHA.109.131300; Clarke KA, 2005, CONFLICT MANAG PEACE, V22, P341, DOI 10.1080/07388940500339183; Coady SA, 2017, NEW ENGL J MED, V376, P1849, DOI 10.1056/NEJMsa1603542; CRUICKSHANK JM, 1987, LANCET, V1, P581; Cushman WC, 2016, HYPERTENSION, V67, P263, DOI 10.1161/HYPERTENSIONAHA.115.06722; Egan BM, 2014, CIRCULATION, V129, P2052, DOI 10.1161/CIRCULATIONAHA.113.007699; Ferdinand KC, 2011, J AM SOC HYPERTENS, V5, P102, DOI 10.1016/j.jash.2011.01.006; Flack JM, 2010, HYPERTENSION, V56, P780, DOI 10.1161/HYPERTENSIONAHA.110.152892; Forouzanfar MH, 2017, JAMA-J AM MED ASSOC, V317, P165, DOI 10.1001/jama.2016.19043; Gaziano TA, 2009, J HYPERTENS, V27, P1472, DOI 10.1097/HJH.0b013e32832a9ba3; Gradman AH, 2011, J CLIN HYPERTENS, V13, P146, DOI 10.1111/j.1751-7176.2010.00397.x; Gradman AH, 2010, J CLIN HYPERTENS, V12, P869, DOI 10.1111/j.1751-7176.2010.00360.x; Gu QP, 2012, CIRCULATION, V126, P2105, DOI 10.1161/CIRCULATIONAHA.112.096156; James PA, 2014, JAMA-J AM MED ASSOC, V311, P1809, DOI 10.1001/jama.2013.284427; Law MR, 2003, BRIT MED J, V326, P1427, DOI 10.1136/bmj.326.7404.1427; Lip GYH, 1998, J HUM HYPERTENS, V12, P761, DOI 10.1038/sj.jhh.1000688; Maher RL, 2014, EXPERT OPIN DRUG SAF, V13, P57, DOI 10.1517/14740338.2013.827660; Mancia G, 2013, J HYPERTENS, V31, P1925, DOI 10.1097/HJH.0b013e328364ca4c; Markovitz A, 2017, INCREMENTAL EFFECTS, DOI DOI 10.5281/ZENODO.1042177; Mold JW, 2010, J AM BOARD FAM MED, V23, P371, DOI 10.3122/jabfm.2010.03.090178; Moran AE, 2015, NEW ENGL J MED, V372, P447, DOI 10.1056/NEJMsa1406751; Mukete BN, 2016, J CLIN HYPERTENS, V18, P10, DOI 10.1111/jch.12624; Murphy CM, 2016, J PUBLIC HEALTH-UK, V38, P450, DOI 10.1093/pubmed/fdv057; Nallamothu BK, 2008, CIRCULATION, V118, P1294, DOI 10.1161/CIRCULATIONAHA.107.703579; Navar AM, 2016, JAMA CARDIOL, V1, P864, DOI 10.1001/jamacardio.2016.2861; Oparil S, 2010, CLIN THER, V32, P1252, DOI 10.1016/j.clinthera.2010.07.008; Rana BK, 2014, AM J HYPERTENS, V27, P828, DOI 10.1093/ajh/hpt271; SPRINT Research Group, 2015, N Engl J Med, V373, P2103, DOI 10.1056/NEJMoa1511939; Staiger D, 1997, ECONOMETRICA, V65, P557, DOI 10.2307/2171753; Tchetgen EJT, 2015, EPIDEMIOLOGY, V26, P402, DOI 10.1097/EDE.0000000000000262; Therneau T., 2015, PACKAGE SURVIVAL ANA; Timbie JW, 2010, ARCH INTERN MED, V170, P1037, DOI 10.1001/archinternmed.2010.150; Timbie JW, 2010, HEALTH SERV RES, V45, P437, DOI 10.1111/j.1475-6773.2009.01075.x; Touyz RM, 2016, HYPERTENSION, V67, P268, DOI 10.1161/HYPERTENSIONAHA.115.06725; Wald DS, 2009, AM J MED, V122, P290, DOI 10.1016/j.amjmed.2008.09.038; Williamson JD, 2016, JAMA-J AM MED ASSOC, V315, P2673, DOI 10.1001/jama.2016.7050; Wu J, 2005, AM J HYPERTENS, V18, P935, DOI 10.1016/j.amjhyper.2005.01.011; Zanchetti A, 2010, EUR HEART J, V31, P2837, DOI 10.1093/eurheartj/ehq281	47	8	8	1	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 22	2017	359								j5542	10.1136/bmj.j5542	http://dx.doi.org/10.1136/bmj.j5542			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FS0AK	29273586	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000419436100001
J	Semsarian, C; Moynihan, R				Semsarian, Christopher; Moynihan, Ray			CHRISTMAS 2017 The Christmas gift of genetic uncertainty	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Semsarian, Christopher] Centenary Inst, Agnes Ginges Ctr Mol Cardiol, Sydney, NSW 2042, Australia; [Semsarian, Christopher] Univ Sydney, Sydney Med Sch, Cent Clin Sch, Sydney, NSW, Australia; [Semsarian, Christopher] Royal Prince Alfred Hosp, Dept Cardiol, Sydney, NSW, Australia; [Moynihan, Ray] Bond Univ, Ctr Res Evidence Based Practice, Southport, Qld, Australia; [Moynihan, Ray] Univ Sydney, Sydney Med Sch Publ Hlth, Sydney, NSW, Australia	University of Sydney; Centenary Institute; University of Sydney; University of Sydney; Bond University; University of Sydney	Semsarian, C (corresponding author), Centenary Inst, Agnes Ginges Ctr Mol Cardiol, Sydney, NSW 2042, Australia.; Semsarian, C (corresponding author), Univ Sydney, Sydney Med Sch, Cent Clin Sch, Sydney, NSW, Australia.; Semsarian, C (corresponding author), Royal Prince Alfred Hosp, Dept Cardiol, Sydney, NSW, Australia.	c.semsarian@centenary.org.au	Moynihan, Ray/ABC-3010-2020		National Health and Medical Research Council (NHMRC) [1059156]; NHMRC Early Career Fellowship [1124207]	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Early Career Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	CS is the recipient of a National Health and Medical Research Council (NHMRC) Practitioner Fellowship (#1059156). RM is the recipient of an NHMRC Early Career Fellowship. (#1124207)	Dewey FE, 2014, JAMA-J AM MED ASSOC, V311, P1035, DOI 10.1001/jama.2014.1717; Ingles J, 2014, TRENDS CARDIOVAS MED, V24, P217, DOI 10.1016/j.tcm.2014.05.009; Ormond KE, 2010, LANCET, V375, P1749, DOI 10.1016/S0140-6736(10)60599-5; Wilson BJ, 2017, J CLIN EPIDEMIOL, V92, P4, DOI 10.1016/j.jclinepi.2017.08.018	4	1	1	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 22	2017	359								j5762	10.1136/bmj.j5762	http://dx.doi.org/10.1136/bmj.j5762			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FS0AK	29273693				2022-12-28	WOS:000419436100002
J	Ulloa, CU; Acevedo-Rodriguez, P; Beck, S; Belgrano, MJ; Bernal, R; Berry, PE; Brako, L; Celis, M; Davidse, G; Forzza, RC; Gradstein, SR; Hokche, O; Leon, B; Leon-Yanez, S; Magill, RE; Neill, DA; Nee, M; Raven, PH; Stimmel, H; Strong, MT; Villasenor, JL; Zarucchi, JL; Zuloaga, FO; Jorgensen, PM				Ulloa, Carmen Ulloa; Acevedo-Rodriguez, Pedro; Beck, Stephan; Belgrano, Manuel J.; Bernal, Rodrigo; Berry, Paul E.; Brako, Lois; Celis, Marcela; Davidse, Gerrit; Forzza, Rafaela C.; Gradstein, S. Robbert; Hokche, Omaira; Leon, Blanca; Leon-Yanez, Susana; Magill, Robert E.; Neill, David A.; Nee, Michael; Raven, Peter H.; Stimmel, Heather; Strong, Mark T.; Villasenor, Jose L.; Zarucchi, James L.; Zuloaga, Fernando O.; Jorgensen, Peter M.			An integrated assessment of the vascular plant species of the Americas	SCIENCE			English	Article								The cataloging of the vascular plants of the Americas has a centuries-long history, but it is only in recent decades that an overview of the entire flora has become possible. We present an integrated assessment of all known native species of vascular plants in the Americas. Twelve regional and national checklists, prepared over the past 25 years and including two large ongoing flora projects, were merged into a single list. Our publicly searchable checklist includes 124,993 species, 6227 genera, and 355 families, which correspond to 33% of the 383,671 vascular plant species known worldwide. In the past 25 years, the rate at which new species descriptions are added has averaged 744 annually for the Americas, and we can expect the total to reach about 150,000.	[Ulloa, Carmen Ulloa; Davidse, Gerrit; Magill, Robert E.; Nee, Michael; Raven, Peter H.; Stimmel, Heather; Zarucchi, James L.; Jorgensen, Peter M.] Missouri Bot Garden, St Louis, MO 63166 USA; [Acevedo-Rodriguez, Pedro; Strong, Mark T.] Smithsonian Inst, US Natl Herbarium, Washington, DC 20560 USA; [Beck, Stephan] Univ Mayor San Andres, Herbario Nacl Bolivia, La Paz, Bolivia; [Belgrano, Manuel J.; Zuloaga, Fernando O.] Inst Bot Darwinion, Buenos Aires, DF, Argentina; [Bernal, Rodrigo] Jardin Bot Quindio, Calarca, Quindio, Colombia; [Berry, Paul E.] Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA; [Brako, Lois] Univ Michigan, Off Res, Ann Arbor, MI 48109 USA; [Celis, Marcela] Univ Norte, Dept Quim & Biol, Fac Ciencias Basicas, Barranquilla, Colombia; [Celis, Marcela] Univ Nacl Colombia, Inst Ciencias Nat, Bogota, Colombia; [Forzza, Rafaela C.] Inst Pesquisas Jardim Bot Rio de Janeiro, Rio De Janeiro, Brazil; [Gradstein, S. Robbert] Museum Natl Hist Nat, Herbier Natl Inst Systemat Evolut Biodiversite, Paris, France; [Hokche, Omaira] Univ Cent Venezuela, Inst Expt Jardin Bot Dr Tobias Lasser, Herbario Nacl Venezuela, Caracas, Venezuela; [Leon, Blanca] Univ Texas Austin, Dept Geog & Environm, Austin, TX 78712 USA; [Leon, Blanca] Museo Hist Nat, Lima, Peru; [Leon-Yanez, Susana] Pontificia Univ Catolica Ecuador, Herbario QCA, Quito, Ecuador; [Neill, David A.] Univ Estatal Amazon, Puyo, Ecuador; [Villasenor, Jose L.] Univ Nacl Autonoma Mexico, Inst Biol, Dept Bot, Mexico City, DF, Mexico	Missouri Botanical Gardens; Smithsonian Institution; Smithsonian National Museum of Natural History; Universidad Mayor de San Andres; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Universidad del Norte; Universidad Nacional de Colombia; Jardim Botanico do Rio de Janeiro; Museum National d'Histoire Naturelle (MNHN); University of Central Venezuela; University of Texas System; University of Texas Austin; Universidad Nacional Mayor de San Marcos; Pontificia Universidad Catolica del Ecuador; Universidad Nacional Autonoma de Mexico	Ulloa, CU (corresponding author), Missouri Bot Garden, St Louis, MO 63166 USA.	carmen.ulloa@mobot.org	León, Blanca/V-4592-2019; Forzza, Rafaela C/N-9274-2015; Villasenor, Jose Luis/R-9719-2019; Celis Pacheco, Yolanda Marcela/S-5401-2017	León, Blanca/0000-0001-6307-8639; Strong, Mark/0000-0002-0582-0863; Neill, David Alan/0000-0002-5143-9430; Acevdo-Rodriguez, Pedro/0000-0002-0946-8668; Berry, Paul/0000-0002-3307-2954; Campostrini Forzza, Rafaela/0000-0002-7035-9313; Belgrano, Manuel/0000-0002-0232-3204; Celis Pacheco, Yolanda Marcela/0000-0002-4298-2052	National Council for Scientific and Technological Development of Brazil (CNPq)	National Council for Scientific and Technological Development of Brazil (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Our gratitude goes to the hundreds of contributors to the various projects, collectors, volunteers, and botanical institutions; governmental and funding agencies; and individuals that have supported these endeavors. We thank L. Jost for permitting use of his photograph and S. Tello for preparing Fig. 3. This project was conceived by C.U.U., P.M.J., and P.H.R. The checklist data were compiled by C.U.U. and P.M.J., data was contributed by C.U.U., P.A.-R., S.B., M.J.B., R.B., P.E.B., L.B., M.C., G.D., R.C.F., S.R.G., O.H., B.L., S.L.-Y., D.A.N., M.N., P.H.R., M.T.S., J.L.V., J.L.Z., F.O.Z., and P.M.J. The structure of the Tropicos database was developed by R.E.M. All queries in Microsoft SQL Server and multiple data reports were conducted by H.S. The project website was designed by P.M.J. and C.U.U. and populated by H.S. All data analyses were conducted by and figures and tables prepared by C.U.U. and P.M.J. The checklist data were formatted by P.M.J. The original manuscript was drafted by C.U.U., and all coauthors contributed to subsequent versions. R.C.F. received a Research Productivity Fellowship from the National Council for Scientific and Technological Development of Brazil (CNPq). The Checklist of the Vascular Plants of the Americas is available as a text document in the supplemental materials, and all of the information is publicly available on a website on the Missouri Botanical Garden database Tropicos at http://tropicos.org/Project/VPA.	ACEVEDORODRIGUE.P, 2012, CATALOGUE SEED PLANT; Barboza GE, 2016, CATALOGO PLANTAS LIQ, V2, P2404; Botting D., 1973, HUMBOLDT COSMOS, P76; Brako L, 1993, MONOGRAPHS SYSTEMATI, P45; Cardoso D, 2017, P NATL ACAD SCI USA, V114, P10695, DOI 10.1073/pnas.1706756114; Christenhusz MJM, 2016, PHYTOTAXA, V261, P201, DOI 10.11646/phytotaxa.261.3.1; Davidse G., 1994, FLORA MESOAMERICANA; de Oviedo Gonzalo Fernandez, 1526, NATURAL HYSTORIA IND; Flora of North America Editorial Committee, 1993, FLORA N AM N MEXICO, V1-20; FORZZA R. C., 2010, CATALOGO PLANTAS FUN, V1, P21; Funk V.A., 2007, CONTRIB U S NATL HER, V55, P1; Hokche O.P, 2008, NUEVO CATALOGO FLORA; Ibisch PL, 2016, SCIENCE, V354, P1423, DOI 10.1126/science.aaf7166; Jorgensen P.M., 1999, MONOGRAPHS SYSTEMATI, V75, P1; JORGENSEN PM, 2014, MONOGRAPHS SYSTEMATI, V127, P1; Len-Yanez S., 2011, LIBRO ROJO PLANTAS E; Lughadha EN, 2016, PHYTOTAXA, V272, P82, DOI 10.11646/phytotaxa.272.1.5; Villasenor JL, 2016, REV MEX BIODIVERS, V87, P559, DOI 10.1016/j.rmb.2016.06.017; MAE, 2016, ESTR NAC BIOD 2015 2; Neill D. A., 2011, ADICIONES FLORA ECUA; Pimm SL, 2015, ANN MO BOT GARD, V100, P170, DOI 10.3417/2012018; Pitman NCA, 2002, SCIENCE, V298, P989, DOI 10.1126/science.298.5595.989; Prado Jefferson, 2015, Rodriguésia, V66, P1073, DOI 10.1590/2175-7860201566410; PRANCE GT, 1977, EXTINCTION IS FOREVE; Ulloa C., 2004, DIEZ ANOS ADICIONES, V2004, P1, DOI DOI 10.5962/BHL.TITLE.63538; Zappi Daniela C., 2015, Rodriguésia, V66, P1085, DOI 10.1590/2175-7860201566411; Zhengyi W., 2013, FLORA CHINA INTRO, V1; Zuloaga F., 2008, ANN MO BOT GARD, V107, P1	28	240	300	2	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 22	2017	358	6370					1614	+		10.1126/science.aao0398	http://dx.doi.org/10.1126/science.aao0398			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ6BO	29269477				2022-12-28	WOS:000418448000065
J	Wade, J; Dyck, B; Palin, RM; Moore, JDP; Smye, AJ				Wade, Jon; Dyck, Brendan; Palin, Richard M.; Moore, James D. P.; Smye, Andrew J.			The divergent fates of primitive hydrospheric water on Earth and Mars	NATURE			English	Article							MINERAL EQUILIBRIA CALCULATIONS; SYSTEM K2O-FEO-MGO-AL2O3-SIO2-H2O-TIO2-FE2O3; CONTINENTAL LITHOSPHERE; GLOBAL DISTRIBUTION; THERMAL STRUCTURE; PHASE-DIAGRAMS; GUSEV CRATER; UPPER-MANTLE; OXIDATION; CRUST	Despite active transport into Earth's mantle, water has been present on our planet's surface for most of geological time(1,2). Yet water disappeared from the Martian surface soon after its formation. Although some of the water on Mars was lost to space via photolysis following the collapse of the planet's magnetic field(3-5), the widespread serpentinization of Martian crust(6,7) suggests that metamorphic hydration reactions played a critical part in the sequestration of the crust. Here we quantify the relative volumes of water that could be removed from each planet's surface via the burial and metamorphism of hydrated mafic crusts, and calculate mineral transition-induced bulk-density changes at conditions of elevated pressure and temperature for each. The metamorphic mineral assemblages in relatively FeO-rich Martian lavas can hold about 25 per cent more structurally bound water than those in metamorphosed terrestrial basalts, and can retain it at greater depths within Mars. Our calculations suggest that in excess of 9 per cent by volume of the Martian mantle may contain hydrous mineral species as a consequence of surface reactions, compared to about 4 per cent by volume of Earth's mantle. Furthermore, neither primitive nor evolved hydrated Martian crust show noticeably different bulk densities compared to their anhydrous equivalents, in contrast to hydrous mafic terrestrial crust, which transforms to denser eclogite upon dehydration. This would have allowed efficient overplating and burial of early Martian crust in a stagnant-lid tectonic regime, in which the lithosphere comprised a single tectonic plate, with only the warmer, lower crust involved in mantle convection. This provided an important sink for hydrospheric water and a mechanism for oxidizing the Martian mantle. Conversely, relatively buoyant mafic crust and hotter geothermal gradients on Earth reduced the potential for upper-mantle hydration early in its geological history, leading to water being retained close to its surface, and thus creating conditions conducive for the evolution of complex multicellular life.	[Wade, Jon] Univ Oxford, Dept Earth Sci, South Parks Rd, Oxford OX1 3AN, England; [Dyck, Brendan] Univ Cambridge, Dept Earth Sci, Cambridge CB2 3EQ, England; [Dyck, Brendan] Simon Fraser Univ, Dept Earth Sci, Burnaby, BC V5A 1S6, Canada; [Palin, Richard M.] Colorado Sch Mines, Dept Geol & Geol Engn, Golden, CO 80401 USA; [Moore, James D. P.] Nanyang Technol Univ, Earth Observ Singapore, Singapore, Singapore; [Smye, Andrew J.] Penn State Univ, Dept Geosci, University Pk, PA 16801 USA	University of Oxford; University of Cambridge; Simon Fraser University; Colorado School of Mines; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Wade, J (corresponding author), Univ Oxford, Dept Earth Sci, South Parks Rd, Oxford OX1 3AN, England.	jon.wade@earth.ox.ac.uk	Moore, James/AAV-2044-2020; Wade, Jon/H-7012-2012	Wade, Jon/0000-0002-6998-236X; Moore, James Daniel Paul/0000-0001-8912-2730	NERC [NE/K009540/1]; National Research Foundation (NRF) of Singapore [NRF-NRFF2013-04]; Earth Observatory of Singapore; NRF; Singapore Ministry of Education under the Research Centres of Excellence initiative; Natural Environment Research Council [NE/K009540/1] Funding Source: researchfish	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); National Research Foundation (NRF) of Singapore(National Research Foundation, Singapore); Earth Observatory of Singapore; NRF; Singapore Ministry of Education under the Research Centres of Excellence initiative(Ministry of Education, Singapore); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	J.W. acknowledges receipt of an NERC Independent Research Fellowship NE/K009540/1. J.D.P.M. was supported by the National Research Foundation (NRF) of Singapore under the NRF Fellowship scheme (National Research Fellow award NRF-NRFF2013-04) and by the Earth Observatory of Singapore, the NRF, and the Singapore Ministry of Education under the Research Centres of Excellence initiative.	Acuna MH, 1999, SCIENCE, V284, P790, DOI 10.1126/science.284.5415.790; Berry AJ, 2008, NATURE, V455, P960, DOI 10.1038/nature07377; Carr MH, 2015, GEOPHYS RES LETT, V42, P726, DOI 10.1002/2014GL062464; Carr MH, 2010, EARTH PLANET SC LETT, V294, P185, DOI 10.1016/j.epsl.2009.06.042; Carson CJ, 1999, J METAMORPH GEOL, V17, P9; Carter J, 2013, J GEOPHYS RES-PLANET, V118, P831, DOI 10.1029/2012JE004145; Chassefiere E, 2013, J GEOPHYS RES-PLANET, V118, P1123, DOI 10.1002/jgre.20089; CHRISTIE DM, 1986, EARTH PLANET SC LETT, V79, P397, DOI 10.1016/0012-821X(86)90195-0; Connolly JAD, 2005, EARTH PLANET SC LETT, V236, P524, DOI 10.1016/j.epsl.2005.04.033; CONNOLLY JAD, 1990, AM J SCI, V290, P666, DOI 10.2475/ajs.290.6.666; Di Achille G, 2010, NAT GEOSCI, V3, P459, DOI 10.1038/NGEO891; DREIBUS G, 1985, METEORITICS, V20, P367; Driscoll P, 2014, PHYS EARTH PLANET IN, V236, P36, DOI 10.1016/j.pepi.2014.08.004; Dubinin E, 2017, J GEOPHYS RES-SPACE, V122, P7142, DOI 10.1002/2017JA024126; Ehlmann BL, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL042596; Filiberto J, 2015, J GEOPHYS RES-PLANET, V120, P109, DOI 10.1002/2014JE004745; Fischer R, 2016, J GEODYN, V100, P198, DOI 10.1016/j.jog.2016.03.004; Francois C, 2014, EARTH PLANET SC LETT, V396, P235, DOI 10.1016/j.epsl.2014.04.025; Gale A, 2013, GEOCHEM GEOPHY GEOSY, V14, P489, DOI 10.1029/2012GC004334; GILBERT MC, 1966, AM J SCI, V264, P698, DOI 10.2475/ajs.264.9.698; Green ECR, 2016, J METAMORPH GEOL, V34, P845, DOI 10.1111/jmg.12211; Guiraud M, 2001, J METAMORPH GEOL, V19, P445, DOI 10.1046/j.0263-4929.2001.00320.x; Hartel THD, 1996, J METAMORPH GEOL, V14, P591, DOI 10.1046/j.1525-1314.1996.00404.x; Hauck SA, 2002, J GEOPHYS RES-PLANET, V107, DOI 10.1029/2001JE001801; Herzberg C, 2010, EARTH PLANET SC LETT, V292, P79, DOI 10.1016/j.epsl.2010.01.022; Holland T, 2003, CONTRIB MINERAL PETR, V145, P492, DOI 10.1007/s00410-003-0464-z; Holland TJB, 2011, J METAMORPH GEOL, V29, P333, DOI 10.1111/j.1525-1314.2010.00923.x; Kato Y, 2003, PRECAMBRIAN RES, V125, P191, DOI 10.1016/S0301-9268(03)00043-3; Khorzhinskii D.S., 1959, PHYSICOCHEMICAL BASI; Korenaga J, 2011, J GEOPHYS RES-SOL EA, V116, DOI 10.1029/2011JB008410; KRETZ R, 1983, AM MINERAL, V68, P277; Lammer H, 2013, SPACE SCI REV, V174, P113, DOI 10.1007/s11214-012-9943-8; Lessel J, 2015, AM MINERAL, V100, P2163, DOI 10.2138/am-2015-4732; Lillis RJ, 2008, ICARUS, V194, P575, DOI 10.1016/j.icarus.2007.09.032; MCDONOUGH WF, 1995, CHEM GEOL, V120, P223, DOI 10.1016/0009-2541(94)00140-4; McKenzie D, 2005, EARTH PLANET SC LETT, V233, P337, DOI 10.1016/j.epsl.2005.02.005; McSween HY, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2006JE002698; Michaut C, 2007, EARTH PLANET SC LETT, V257, P83, DOI 10.1016/j.epsl.2007.02.019; Mouginot J, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2011GL050286; Palin RM, 2016, J METAMORPH GEOL, V34, P871, DOI 10.1111/jmg.12212; Palin RM, 2016, GEOSCI FRONT, V7, P591, DOI 10.1016/j.gsf.2015.08.005; Palin RM, 2016, NAT GEOSCI, V9, P60, DOI [10.1038/ngeo2605, 10.1038/NGEO2605]; PARSONS B, 1977, J GEOPHYS RES, V82, P803, DOI 10.1029/JB082i005p00803; Peck WH, 2001, GEOCHIM COSMOCHIM AC, V65, P4215, DOI 10.1016/S0016-7037(01)00711-6; Poli S, 2002, ANNU REV EARTH PL SC, V30, P207, DOI 10.1146/annurev.earth.30.091201.140550; Powell R, 2008, J METAMORPH GEOL, V26, P155, DOI 10.1111/j.1525-1314.2007.00756.x; POWELL R, 1988, J METAMORPH GEOL, V6, P173, DOI 10.1111/j.1525-1314.1988.tb00415.x; Powell R, 1998, J METAMORPH GEOL, V16, P577, DOI 10.1111/j.1525-1314.1998.00157.x; Rosenberg CL, 2005, J METAMORPH GEOL, V23, P19, DOI 10.1111/j.1525-1314.2005.00555.x; Squyres SW, 2007, SCIENCE, V316, P738, DOI 10.1126/science.1139045; Thompson J.B., 1959, RES GEOCHEMISTRY, P427; Tuff J, 2013, NATURE, V498, P342, DOI 10.1038/nature12225; Usui T, 2015, EARTH PLANET SC LETT, V410, P140, DOI 10.1016/j.epsl.2014.11.022; Vigneresse JL, 1996, J PETROL, V37, P1579, DOI 10.1093/petrology/37.6.1579; Viviano CE, 2013, J GEOPHYS RES-PLANET, V118, P1858, DOI 10.1002/jgre.20141; Wadhwa M, 2001, SCIENCE, V291, P1527, DOI 10.1126/science.1057594; WATSON LL, 1994, SCIENCE, V265, P86, DOI 10.1126/science.265.5168.86; White R, 2010, TUTORIAL USING READB; White RW, 2014, J METAMORPH GEOL, V32, P261, DOI 10.1111/jmg.12071; White RW, 2000, J METAMORPH GEOL, V18, P497, DOI 10.1046/j.1525-1314.2000.00269.x; White RW, 2002, J METAMORPH GEOL, V20, P41, DOI 10.1046/j.0263-4929.2001.00349.x; White WM, 2014, TREATISE GEOCHEMISTR, V4, P457, DOI [Oxford, DOI 10.1016/B978-0-08-095975-7.00315-6]; Williams Q, 2001, ANNU REV EARTH PL SC, V29, P365, DOI 10.1146/annurev.earth.29.1.365; Wordsworth RD, 2016, ANNU REV EARTH PL SC, V44, P381, DOI 10.1146/annurev-earth-060115-012355; Yin A, 2012, LITHOSPHERE-US, V4, P286, DOI 10.1130/L192.1	65	41	42	3	65	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 21	2017	552	7685					391	+		10.1038/nature25031	http://dx.doi.org/10.1038/nature25031			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ7RI	29293210	Green Submitted, Green Accepted			2022-12-28	WOS:000418559800056
J	Gamble, C; Krishan, A; Stocken, D; Lewis, S; Juszczak, E; Dore, C; Williamson, PR; Altman, DG; Montgomery, A; Lim, P; Berlin, J; Senn, S; Day, S; Barbachano, Y; Loder, E				Gamble, Carrol; Krishan, Ashma; Stocken, Deborah; Lewis, Steff; Juszczak, Edmund; Dore, Caroline; Williamson, Paula R.; Altman, Douglas G.; Montgomery, Alan; Lim, Pilar; Berlin, Jesse; Senn, Stephen; Day, Simon; Barbachano, Yolanda; Loder, Elizabeth			Guidelines for the Content of Statistical Analysis Plans in Clinical Trials	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article								IMPORTANCE While guidance on statistical principles for clinical trials exists, there is an absence of guidance covering the required content of statistical analysis plans (SAPs) to support transparency and reproducibility. OBJECTIVE To develop recommendations for a minimum set of items that should be addressed in SAPs for clinical trials, developed with input from statisticians, previous guideline authors, journal editors, regulators, and funders. DESIGN Funders and regulators (n = 39) of randomized trials were contacted and the literature was searched to identify existing guidance; a survey of current practice was conducted across the network of UK Clinical Research Collaboration-registered trial units (n = 46, 1 unit had 2 responders) and a Delphi survey (n = 73 invited participants) was conducted to establish consensus on SAPs. The Delphi survey was sent to statisticians in trial units who completed the survey of current practice (n = 46), CONSORT (Consolidated Standards of Reporting Trials) and SPIRIT (Standard Protocol Items: Recommendations for Interventional Trials) guideline authors (n = 16), pharmaceutical industry statisticians (n = 3), journal editors (n = 9), and regulators (n = 2) (3 participants were included in 2 groups each), culminating in a consensus meeting attended by experts (N = 12) with representatives from each group. The guidance subsequently underwent critical review by statisticians from the surveyed trial units and members of the expert panel of the consensus meeting (N = 51), followed by piloting of the guidance document in the SAPs of 5 trials. FINDINGS No existing guidance was identified. The registered trials unit survey (46 responses) highlighted diversity in current practice and confirmed support for developing guidance. The Delphi survey (54 of 73, 74% participants completing both rounds) reached consensus on 42%(n = 46) of 110 items. The expert panel (N = 12) agreed that 63 items should be included in the guidance, with an additional 17 items identified as important but may be referenced elsewhere. Following critical review and piloting, some overlapping items were combined, leaving 55 items. CONCLUSIONS AND RELEVANCE Recommendations are provided for a minimum set of items that should be addressed and included in SAPs for clinical trials. Trial registration, protocols, and statistical analysis plans are critically important in ensuring appropriate reporting of clinical trials.	[Gamble, Carrol; Williamson, Paula R.] Univ Liverpool, Biostat Dept, Block F Waterhouse Bldg,1-5 Brownlow St, Liverpool L69 3GL, Merseyside, England; [Krishan, Ashma] Univ Liverpool, Clin Trials Res Ctr, Liverpool, Merseyside, England; [Stocken, Deborah] Newcastle Univ, Newcastle, England; [Stocken, Deborah] Univ Leeds, Leeds Inst Clin Trials Res, Leeds, W Yorkshire, England; [Lewis, Steff] Univ Edinburgh, Edinburgh, Midlothian, Scotland; [Juszczak, Edmund] Univ Oxford, Oxford, England; [Dore, Caroline] UCL Comprehens Clin Trials Unit, London, England; [Altman, Douglas G.] Univ Oxford, Ctr Stat Med, Oxford, England; [Montgomery, Alan] Univ Nottingham, Nottingham, England; [Lim, Pilar] Janssen Res & Dev LLC, Raritan, NJ USA; [Berlin, Jesse] Johnson & Johnson, Titusville, NJ USA; [Senn, Stephen] Luxembourg Inst Hlth, Strassen, Luxembourg; [Day, Simon] Clin Trials Consulting & Training Ltd, Buckingham, England; [Barbachano, Yolanda] Med & Healthcare Prod Regulatory Agcy, London, England; [Loder, Elizabeth] BMJ, London, England	University of Liverpool; University of Liverpool; Newcastle University - UK; University of Leeds; University of Edinburgh; University of Oxford; University of London; University College London; University of Oxford; University of Nottingham; Johnson & Johnson; Johnson & Johnson USA; Janssen Biotech Inc; Johnson & Johnson; Johnson & Johnson USA; Luxembourg Institute of Health; The Medicines & Healthcare Products Regulatory Agency	Gamble, C (corresponding author), Univ Liverpool, Biostat Dept, Block F Waterhouse Bldg,1-5 Brownlow St, Liverpool L69 3GL, Merseyside, England.	c.gamble@liverpool.ac.uk	Dore, Caroline J/J-4716-2012; Senn, Stephen/B-2903-2013; Gamble, Carrol/AAE-9895-2019; Williamson, Paula R/B-6425-2016	Dore, Caroline J/0000-0001-9796-4970; Senn, Stephen/0000-0002-7558-8473; Gamble, Carrol/0000-0002-3021-1955; Williamson, Paula R/0000-0001-9802-6636; Montgomery, Alan/0000-0003-0450-1606; Lewis, Steff/0000-0003-1210-2314; Stocken, Deborah/0000-0001-8031-1738	UK Medical Research Council Network of Hubs for Trials Methodology Research [MR/L004933/1-R44]; Cancer Research UK [16895] Funding Source: researchfish; Medical Research Council [MC_UU_12023/21, MR/K025635/1, MR/L004933/1, MR/L004933/2] Funding Source: researchfish; MRC [MC_UU_12023/21, MR/L004933/2, MR/K025635/1, MR/L004933/1] Funding Source: UKRI	UK Medical Research Council Network of Hubs for Trials Methodology Research(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by grant MR/L004933/1-R44 from the UK Medical Research Council Network of Hubs for Trials Methodology Research and supported and endorsed by the UK Clinical Research Collaboration Registered Clinical Trials Unit Network.	[Anonymous], 1998, ICH HARM TRIP GUID S; Baker M, 2016, NATURE, V533, P452, DOI 10.1038/533452a; Bonini S, 2014, NEW ENGL J MED, V371, P2452, DOI 10.1056/NEJMp1409464; Chan A-W, 2013, BMJ-BRIT MED J, V2013, P346, DOI DOI 10.1136/BMJ.E7586; Conroy EJ, 2015, CLIN TRIALS, V12, P664, DOI 10.1177/1740774515589959; Dunn G, 2005, STAT METHODS MED RES, V14, P369, DOI 10.1191/0962280205sm403oa; Dwan K, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001666; Finfer S, 2009, CRIT CARE RESUSC, V11, P5; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1311, DOI [10.1016/j.jclinepi.2011.06.004, 10.1016/j.jclinepi.2011.03.017]; Herson J, 2016, INT J CLIN ONCOL, V21, P22, DOI 10.1007/s10147-015-0876-6; International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use, 2016, ICH HARM GUID INT AD; Kirkham JJ, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c365; Moher David, 2010, BMJ, V340, pc869, DOI [10.1016/j.jclinepi.2010.03.004, 10.1136/bmj.c869]; Smith CT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0532-z; Taichman DB, 2017, DATA SHARING STATEME; Thomas L, 2012, JAMA-J AM MED ASSOC, V308, P773, DOI 10.1001/jama.2012.9502	16	180	184	3	28	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 19	2017	318	23					2337	2343		10.1001/jama.2017.18556	http://dx.doi.org/10.1001/jama.2017.18556			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FQ3RJ	29260229	Bronze, Green Published			2022-12-28	WOS:000418274000021
J	Kirkland, KB				Kirkland, Kathryn B.			Walking the Shoreline Erosion, Regrowth, and Professional Formation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							EMPATHY; STUDENTS		[Kirkland, Kathryn B.] Geisel Sch Med Dartmouth, Sect Palliat Med, Dept Med, Hanover, NH USA; [Kirkland, Kathryn B.] Dartmouth Hitchcock Med Ctr, Lebanon, NH 03756 USA	Dartmouth College; Dartmouth College	Kirkland, KB (corresponding author), Dartmouth Hitchcock Med Ctr, Palliat Med Sect, One Med Ctr Dr, Lebanon, NH 03756 USA.	kathryn.kirkland@dartmouth.edu						FEUDTNER C, 1994, ACAD MED, V69, P670, DOI 10.1097/00001888-199408000-00017; Hojat M, 2009, ACAD MED, V84, P1182, DOI 10.1097/ACM.0b013e3181b17e55; Holmes CL, 2017, MED EDUC, V51, P732, DOI 10.1111/medu.13344; Neumann M, 2011, ACAD MED, V86, P996, DOI 10.1097/ACM.0b013e318221e615	4	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 19	2017	318	23					2297	2298		10.1001/jama.2017.18040	http://dx.doi.org/10.1001/jama.2017.18040			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FQ3RJ	29260228				2022-12-28	WOS:000418274000014
J	Loxterkamp, D				Loxterkamp, David			No country for old men: on mentoring in medicine, by David Loxterkamp	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PHYSICIAN		[Loxterkamp, David] Seaport Community Hlth Ctr, 53 Schood Dr, Belfast, ME 04915 USA		Loxterkamp, D (corresponding author), Seaport Community Hlth Ctr, 53 Schood Dr, Belfast, ME 04915 USA.	dloxterkamp@pchc.com						Bodenheimer TS, 2013, HEALTH AFFAIR, V32, P1881, DOI 10.1377/hlthaff.2013.0234; Coles R, 1989, CALL STORIES TEACHIN; Dellinger EP, 2017, JAMA SURG, V152, P967, DOI 10.1001/jamasurg.2017.2342; Lehrer J, 2010, NEW YORKER, V13; Yeats WB, SAILING BYZANTIUM	5	0	0	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 18	2017	359								j5756	10.1136/bmj.j5756	http://dx.doi.org/10.1136/bmj.j5756			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FR9ZY	29254941				2022-12-28	WOS:000419434900001
J	Fusco, G; Chen, SW; Williamson, PTF; Cascella, R; Perni, M; Jarvis, JA; Cecchi, C; Vendruscolo, M; Chiti, F; Cremades, N; Ying, LM; Dobson, CM; De Simone, A				Fusco, Giuliana; Chen, Serene W.; Williamson, Philip T. F.; Cascella, Roberta; Perni, Michele; Jarvis, James A.; Cecchi, Cristina; Vendruscolo, Michele; Chiti, Fabrizio; Cremades, Nunilo; Ying, Liming; Dobson, Christopher M.; De Simone, Alfonso			Structural basis of membrane disruption and cellular toxicity by alpha-synuclein oligomers	SCIENCE			English	Article							PARKINSONS-DISEASE; NMR-SPECTROSCOPY; AGGREGATION; BINDING; FIBRIL; STATES	Oligomeric species populated during the aggregation process of alpha-synuclein have been linked to neuronal impairment in Parkinson's disease and related neurodegenerative disorders. By using solution and solid-state nuclear magnetic resonance techniques in conjunction with other structural methods, we identified the fundamental characteristics that enable toxic alpha-synuclein oligomers to perturb biological membranes and disrupt cellular function; these include a highly lipophilic element that promotes strong membrane interactions and a structured region that inserts into lipid bilayers and disrupts their integrity. In support of these conclusions, mutations that target the region that promotes strong membrane interactions by alpha-synuclein oligomers suppressed their toxicity in neuroblastoma cells and primary cortical neurons.	[Fusco, Giuliana; Chen, Serene W.; Perni, Michele; Vendruscolo, Michele; Dobson, Christopher M.] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England; [Fusco, Giuliana; Chen, Serene W.; Jarvis, James A.; De Simone, Alfonso] Imperial Coll London, Dept Life Sci, London SW7 2AZ, England; [Williamson, Philip T. F.] Univ Southampton, Ctr Biol Sci, Southampton S017 1BJ, Hants, England; [Williamson, Philip T. F.] Univ Southampton, Inst Life Sci, Southampton S017 1BJ, Hants, England; [Cascella, Roberta; Chiti, Fabrizio] Univ Florence, Sect Biochem, Dept Expt & Clin Biomed Sci, I-50134 Florence, Italy; [Cremades, Nunilo] Univ Zaragoza, Biocomputat & Complex Syst Phys Inst BIFI, Joint Unit, BIFI Inst Quim Fis Rocasolano,CONICET, Zaragoza 50018, Spain; [Ying, Liming] Imperial Coll London, Natl Heart & Lung Inst, Mol Med, London SW7 2AZ, England	University of Cambridge; Imperial College London; University of Southampton; University of Southampton; University of Florence; University of Zaragoza; Imperial College London	Dobson, CM (corresponding author), Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England.; De Simone, A (corresponding author), Imperial Coll London, Dept Life Sci, London SW7 2AZ, England.	cmd44@cam.ac.uk; adesimon@imperial.ac.uk	Williamson, Philip T.F./A-3362-2008; Vendruscolo, Michele/F-5901-2012; Ying, Liming/G-7999-2011; Cremades, Nunilo/F-9634-2015	Williamson, Philip T.F./0000-0002-0231-8640; Vendruscolo, Michele/0000-0002-3616-1610; Ying, Liming/0000-0001-9752-6292; perni, michele/0000-0001-7593-8376; Fusco, Giuliana/0000-0002-3644-9809; Cecchi, Cristina/0000-0001-8387-7737; Chiti, Fabrizio/0000-0002-1330-1289; Chen, Serene W/0000-0001-7084-5621; Cremades, Nunilo/0000-0002-9138-6687	Parkinson's UK [G-1508]; UK Medical Research Council [MR/N000676/1]; Wellcome Trust [104933/2/14E]; Leverhulme Trust [RPG-2015-350, RPG-2015-345]; British Heart Foundation [PG/14/93/31237, PG/11/81/29130]; UK Biotechnology and Biological Sciences Research Council [BB/M023923/1, BB/G00594X/1]; Agency of Science, Technology and Research of Singapore; Ministry of Economy, Industry, and Competitiveness of Spain [MINECO RYC-2012-12068, MINECO/FEDER EU BEU2015-64119-P]; Regione Toscana (SUPREMAL); University of Florence (Eondi di Ateneo); Centre for Misfolding Diseases of the University of Cambridge; BBSRC [BB/M023923/1, BB/G00594X/1] Funding Source: UKRI; MRC [MR/N000676/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G00594X/1, BB/M023923/1] Funding Source: researchfish; Medical Research Council [MR/N000676/1] Funding Source: researchfish; Parkinson&quot;s UK [G-1508, H-1103] Funding Source: researchfish	Parkinson's UK(Parkinson's UK); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Leverhulme Trust(Leverhulme Trust); British Heart Foundation(British Heart Foundation); UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Agency of Science, Technology and Research of Singapore(Agency for Science Technology & Research (A*STAR)); Ministry of Economy, Industry, and Competitiveness of Spain(Spanish Government); Regione Toscana (SUPREMAL)(Regione Toscana); University of Florence (Eondi di Ateneo); Centre for Misfolding Diseases of the University of Cambridge; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Parkinson&quot;s UK(Parkinson&apos;s UK)	This research was supported by Parkinson's UK (G-1508 to G.F., M.V., C.M.D., and A.D.); the UK Medical Research Council (MR/N000676/1 to G.F., M.V. C.M.D., and A.D.); the Wellcome Trust (104933/2/14E to kD.): the Leverhulme Trust (RPG-2015-350 to A.D. and RPG-2015-345 to L.Y.); the British Heart Foundation (PG/14/93/31237 to A.D. and PG/11/81/29130 to L.Y.); the UK Biotechnology and Biological Sciences Research Council (BB/M023923/1 to A.D. and BB/G00594X/1 to L.Y.); the Agency of Science, Technology and Research of Singapore (to S.W.C.); the Ministry of Economy, Industry, and Competitiveness of Spain (MINECO RYC-2012-12068 and MINECO/FEDER EU BEU2015-64119-P to N.C.); the Regione Toscana (SUPREMAL to E.C., C.C., and R.C); the University of Florence (Eondi di Ateneo to E.C. and. C.C); and the Centre for Misfolding Diseases of the University of Cambridge. The data supporting the findings of this study are available within the article and supplementary materials.	Angelova PR, 2016, J CELL SCI, V129, P1792, DOI 10.1242/jcs.180737; Auluck PK, 2010, ANNU REV CELL DEV BI, V26, P211, DOI 10.1146/annurev.cellbio.042308.113313; Bodner CR, 2009, J MOL BIOL, V390, P775, DOI 10.1016/j.jmb.2009.05.066; Bousset L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3575; Campioni S, 2010, NAT CHEM BIOL, V6, P140, DOI [10.1038/NCHEMBIO.283, 10.1038/nchembio.283]; Chen SW, 2015, P NATL ACAD SCI USA, V112, pE1994, DOI 10.1073/pnas.1421204112; Chiti F, 2017, ANNU REV BIOCHEM, V86, P27, DOI 10.1146/annurev-biochem-061516-045115; Comellas G, 2012, J AM CHEM SOC, V134, P5090, DOI 10.1021/ja209019s; Cremades N, 2012, CELL, V149, P1048, DOI 10.1016/j.cell.2012.03.037; Danzer KM, 2007, J NEUROSCI, V27, P9220, DOI 10.1523/JNEUROSCI.2617-07.2007; Deas E, 2016, ANTIOXID REDOX SIGN, V24, P376, DOI 10.1089/ars.2015.6343; Devine MJ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1453; Ehrnhoefer DE, 2008, NAT STRUCT MOL BIOL, V15, P558, DOI 10.1038/nsmb.1437; Fusco G, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12563; Fusco G, 2016, SCI REP-UK, V6, DOI 10.1038/srep27125; Fusco G, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4827; Grey M, 2011, J PARKINSON DIS, V1, P359, DOI 10.3233/JPD-2011-11067; Lashuel HA, 2013, NAT REV NEUROSCI, V14, P38, DOI 10.1038/nrn3406; Lorenzen N, 2014, FEBS LETT, V588, P497, DOI 10.1016/j.febslet.2013.12.015; Luth ES, 2014, J BIOL CHEM, V289, P21490, DOI 10.1074/jbc.M113.545749; Milojevic J, 2007, J AM CHEM SOC, V129, P4282, DOI 10.1021/ja067367+; Rodriguez JA, 2015, NATURE, V525, P486, DOI 10.1038/nature15368; Soper JH, 2011, J MOL NEUROSCI, V43, P391, DOI 10.1007/s12031-010-9455-5; Tuttle MD, 2016, NAT STRUCT MOL BIOL, V23, P409, DOI 10.1038/nsmb.3194; Uversky VN, 2009, CURR PROTEIN PEPT SC, V10, P483, DOI 10.2174/138920309789351921; Vallurupalli P, 2012, J AM CHEM SOC, V134, P8148, DOI 10.1021/ja3001419; Vamvaca K, 2009, J MOL BIOL, V389, P413, DOI 10.1016/j.jmb.2009.03.021; Vilar M, 2008, P NATL ACAD SCI USA, V105, P8637, DOI 10.1073/pnas.0712179105; Winner B, 2011, P NATL ACAD SCI USA, V108, P4194, DOI 10.1073/pnas.1100976108	29	329	333	14	163	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 15	2017	358	6369					1440	+		10.1126/science.aan6160	http://dx.doi.org/10.1126/science.aan6160			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP8TH	29242346	Green Submitted, Green Accepted, Green Published			2022-12-28	WOS:000417918500043
J	Han, DR; Qi, XD; Myhrvold, C; Wang, B; Dai, MJ; Jiang, SX; Bates, M; Liu, Y; An, B; Zhang, F; Yan, H; Yin, P				Han, Dongran; Qi, Xiaodong; Myhrvold, Cameron; Wang, Bei; Dai, Mingjie; Jiang, Shuoxing; Bates, Maxwell; Liu, Yan; An, Byoungkwon; Zhang, Fei; Yan, Hao; Yin, Peng			Single-stranded DNA and RNA origami	SCIENCE			English	Article							CROSSOVER DNA; FOLDING DNA; NANOSTRUCTURES; DESIGN; ASSEMBLIES; MOLECULE; SHAPES; KNOTS	Self-folding of an information-carrying polymer into a defined structure is foundational to biology and offers attractive potential as a synthetic strategy. Although multicomponent self-assembly has produced complex synthetic nanostructures, unimolecular folding has seen limited progress. We describe a framework to design and synthesize a single DNA or RNA strand to self-fold into a complex yet unknotted structure that approximates an arbitrary user-prescribed shape. We experimentally construct diverse multikilobase single-stranded structures, including a similar to 10,000-nucleotide (nt) DNA structure and a similar to 6000-nt RNA structure. We demonstrate facile replication of the strand in vitro and in living cells. The work here thus establishes unimolecular folding as a general strategy for constructing complex and replicable nucleic acid nanostructures, and expands the design space and material scalability for bottom-up nanotechnology.	[Han, Dongran; Myhrvold, Cameron; Dai, Mingjie; Yin, Peng] Harvard Med Sch, Dept Syst Biol, Boston, MA 02115 USA; [Han, Dongran; Myhrvold, Cameron; Wang, Bei; Dai, Mingjie; Yin, Peng] Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA; [Qi, Xiaodong; Jiang, Shuoxing; Liu, Yan; Zhang, Fei; Yan, Hao] Biodesign Ctr Mol Design & Biomimet Biodesign Ins, Tempe, AZ 85287 USA; [Qi, Xiaodong; Jiang, Shuoxing; Liu, Yan; Zhang, Fei; Yan, Hao] Arizona State Univ, Sch Mol Sci, Tempe, AZ 85287 USA; [Wang, Bei] Univ Sci & Technol China, Dept Polymer Sci & Engn, Hefei 230026, Anhui, Peoples R China; [Bates, Maxwell; An, Byoungkwon] BioNlano Res Grp, Autodesk Life Sci, Pier 9, San Francisco, CA 94111 USA	Harvard University; Harvard Medical School; Harvard University; Arizona State University; Arizona State University-Tempe; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Autodesk, Inc.	Yan, H; Yin, P (corresponding author), Harvard Med Sch, Dept Syst Biol, Boston, MA 02115 USA.; Yin, P (corresponding author), Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA.; Zhang, F; Yan, H (corresponding author), Biodesign Ctr Mol Design & Biomimet Biodesign Ins, Tempe, AZ 85287 USA.; Zhang, F; Yan, H (corresponding author), Arizona State Univ, Sch Mol Sci, Tempe, AZ 85287 USA.; An, B (corresponding author), BioNlano Res Grp, Autodesk Life Sci, Pier 9, San Francisco, CA 94111 USA.	dran@csail.mit.edu; fei.zhang@asu.edu; hao.yan@asu.edu; py@hms.harvard.edu	Liu, Yan/K-1999-2014; Liu, Yan/AAD-6038-2022	Liu, Yan/0000-0003-0906-2606; Liu, Yan/0000-0003-0906-2606; Dai, Mingjie/0000-0002-8665-4966; Qi, Xiaodong/0000-0001-8200-6630	Office of Naval Research [N000141010827, N000141310593, N000141410610, N000141612182, N000141612410, N000141512689]; Army Research Office [W911NF1210238]; National Science Foundation [CCF1054898, CMMI1333215, CMMI1334109, CMMI1344915, CCF1317291]; National Institutes of Health [1R01EB01865901]; NSF [1360635, 1563799, 1334109]; Autodesk Life Sciences; China Scholarship Council [201506340048]; Fannie and John Hertz Foundation; Direct For Computer & Info Scie & Enginr [1564025] Funding Source: National Science Foundation; Division of Computing and Communication Foundations [1563799] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB018659] Funding Source: NIH RePORTER	Office of Naval Research(Office of Naval Research); Army Research Office; National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Autodesk Life Sciences; China Scholarship Council(China Scholarship Council); Fannie and John Hertz Foundation; Direct For Computer & Info Scie & Enginr(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE)); Division of Computing and Communication Foundations(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	The authors thank W. Shin and P. Rothemund for helpful discussions. B.A. thanks A. Berliner, E. Groban; J. Schaeffer, F. Mazzoldi, A. Kinnoto, L. Peck, and M. Tinnus for help with software tool development. The work was funded by Office of Naval Research grants N000141010827, N000141310593, N000141410610, N000141612182, and N000141612410; Army Research Office grant W911NF1210238; National Science Foundation grants CCF1054898, CMMI1333215, CMMI1334109, CMMI1344915, and CCF1317291; and National Institutes of Health grant 1R01EB01865901 to P.Y.; Office of Naval Research grant N000141512689 and NSF grants 1360635, 1563799 and 1334109 to H.Y.; and internal support from Autodesk Life Sciences. B.W. thanks the China Scholarship Council (No.201506340048) for fellowship support. C.M. was funded by the Fannie and John Hertz Foundation. All data are reported in the main text and in the Supplementary Materials. A provisional U.S. patent has been filed based on this work. P.Y. is cofounder of Ultivue Inc. and NuProbe Global.	Acuna GP, 2012, SCIENCE, V338, P506, DOI 10.1126/science.1228638; Alexander JW, 1928, T AM MATH SOC, V30, P275, DOI 10.2307/1989123; Alexander J. W., 1926, ANN MATH, V28, P562, DOI 10.2307/1968399; Andersen ES, 2009, NATURE, V459, P73, DOI 10.1038/nature07971; Avakyan N, 2016, NAT CHEM, V8, P368, DOI [10.1038/nchem.2451, 10.1038/NCHEM.2451]; Bell NAW, 2016, NAT NANOTECHNOL, V11, P645, DOI [10.1038/nnano.2016.50, 10.1038/NNANO.2016.50]; Benson E, 2015, NATURE, V523, P441, DOI 10.1038/nature14586; CHEN JH, 1991, NATURE, V350, P631, DOI 10.1038/350631a0; Chworos A, 2004, SCIENCE, V306, P2068, DOI 10.1126/science.1104686; Delebecque CJ, 2011, SCIENCE, V333, P470, DOI 10.1126/science.1206938; Dietz H, 2009, SCIENCE, V325, P725, DOI 10.1126/science.1174251; Douglas SM, 2007, P NATL ACAD SCI USA, V104, P6644, DOI 10.1073/pnas.0700930104; Douglas SM, 2012, SCIENCE, V335, P831, DOI 10.1126/science.1214081; Douglas SM, 2009, NATURE, V459, P414, DOI 10.1038/nature08016; Ducani C, 2013, NAT METHODS, V10, P647, DOI [10.1038/NMETH.2503, 10.1038/nmeth.2503]; Dunn KE, 2015, NATURE, V525, P82, DOI 10.1038/nature14860; Fu JL, 2014, NAT NANOTECHNOL, V9, P531, DOI [10.1038/nnano.2014.100, 10.1038/NNANO.2014.100]; Geary C, 2014, SCIENCE, V345, P799, DOI 10.1126/science.1253920; Gerling T, 2015, SCIENCE, V347, P1446, DOI 10.1126/science.aaa5372; Gopinath A, 2016, NATURE, V535, P401, DOI 10.1038/nature18287; Gu HZ, 2009, NAT NANOTECHNOL, V4, P245, DOI [10.1038/NNANO.2009.5, 10.1038/nnano.2009.5]; Han DR, 2013, ANGEW CHEM INT EDIT, V52, P9031, DOI 10.1002/anie.201302177; Han DR, 2013, SCIENCE, V339, P1412, DOI 10.1126/science.1232252; Han DR, 2011, SCIENCE, V332, P342, DOI 10.1126/science.1202998; He Y, 2008, NATURE, V452, P198, DOI 10.1038/nature06597; Horiya S, 2003, CHEM BIOL, V10, P645, DOI 10.1016/S1074-5521(03)00146-7; Iinuma R, 2014, SCIENCE, V344, P65, DOI 10.1126/science.1250944; Jaeger L, 2000, ANGEW CHEM INT EDIT, V39, P2521, DOI 10.1002/1521-3773(20000717)39:14<2521::AID-ANIE2521>3.0.CO;2-P; Jaeger L, 2006, CURR OPIN STRUC BIOL, V16, P531, DOI 10.1016/j.sbi.2006.07.001; Jin Z, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2690; Ke YG, 2014, NAT CHEM, V6, P994, DOI [10.1038/NCHEM.2083, 10.1038/nchem.2083]; Ke YG, 2012, SCIENCE, V338, P1177, DOI 10.1126/science.1227268; Kilchherr F, 2016, SCIENCE, V353, DOI 10.1126/science.aaf5508; Knudsen JB, 2015, NAT NANOTECHNOL, V10, P892, DOI [10.1038/NNANO.2015.190, 10.1038/nnano.2015.190]; Kuzyk A, 2012, NATURE, V483, P311, DOI 10.1038/nature10889; Lee H, 2012, P NATL ACAD SCI USA, V109, pE2774, DOI 10.1073/pnas.1210309109; Li Z, 2009, J AM CHEM SOC, V131, P13093, DOI 10.1021/ja903768f; Lin CX, 2007, J AM CHEM SOC, V129, P14475, DOI 10.1021/ja0760980; Lin CX, 2006, ANGEW CHEM INT EDIT, V45, P7537, DOI 10.1002/anie.200602113; Lin CX, 2008, P NATL ACAD SCI USA, V105, P17626, DOI 10.1073/pnas.0805416105; Liu D, 2016, NAT CHEM, V8, P907, DOI [10.1038/NCHEM.2564, 10.1038/nchem.2564]; MANSFIELD ML, 1994, NAT STRUCT BIOL, V1, P213, DOI 10.1038/nsb0494-213; Martin TG, 2016, P NATL ACAD SCI USA, V113, pE7456, DOI 10.1073/pnas.1612720113; Murasugi K., 2007, KNOT THEORY ITS APPL; Nickels PC, 2016, SCIENCE, V354, P305, DOI 10.1126/science.aah5974; Rajendran A, 2011, ACS NANO, V5, P665, DOI 10.1021/nn1031627; Rothemund PWK, 2006, NATURE, V440, P297, DOI 10.1038/nature04586; Seeman NC, 1996, CURR OPIN STRUC BIOL, V6, P519, DOI 10.1016/S0959-440X(96)80118-7; Shen ZY, 2004, J AM CHEM SOC, V126, P1666, DOI 10.1021/ja038381e; Shih WM, 2004, NATURE, V427, P618, DOI 10.1038/nature02307; Sparvath S. L., 2011, METHOD MOL BIOL, V1500, P51, DOI [10.1007/978-1-4939-6454-3, DOI 10.1007/978-1-4939-6454-3]; Sun W, 2014, SCIENCE, V346, P717, DOI 10.1126/science.1258361; Takusagawa F, 1996, J AM CHEM SOC, V118, P8945; Taylor WR, 2000, NATURE, V406, P916, DOI 10.1038/35022623; Tikhomirov G, 2017, NAT NANOTECHNOL, V12, P251, DOI [10.1038/NNANO.2016.256, 10.1038/nnano.2016.256]; Veneziano R, 2016, SCIENCE, V352, DOI 10.1126/science.aaf4388; Wagner JR, 2005, NATURE, V438, P325, DOI 10.1038/nature04118; Wang M., 2017, AUTODESK MOL VIEWER; Wei B, 2012, NATURE, V485, P623, DOI 10.1038/nature11075; Williams S, 2009, LECT NOTES COMPUT SC, V5347, P90, DOI 10.1007/978-3-642-03076-5_8; Winfree E, 1998, NATURE, V394, P539, DOI 10.1038/28998; Woo S, 2011, NAT CHEM, V3, P620, DOI [10.1038/NCHEM.1070, 10.1038/nchem.1070]; Zhang F, 2015, NAT NANOTECHNOL, V10, P779, DOI [10.1038/NNANO.2015.162, 10.1038/nnano.2015.162]; Zhang XP, 2002, J AM CHEM SOC, V124, P12940, DOI 10.1021/ja026973b; Zheng JP, 2009, NATURE, V461, P74, DOI 10.1038/nature08274	65	137	144	15	239	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 15	2017	358	6369							eaao2648	10.1126/science.aao2648	http://dx.doi.org/10.1126/science.aao2648			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP8TH	29242318	Green Accepted			2022-12-28	WOS:000417918500033
J	Gao, X; Tao, Y; Lamas, V; Huang, MQ; Yeh, WH; Pan, BF; Hu, YJ; Hu, JH; Thompson, DB; Shu, YL; Li, YM; Wang, HY; Yang, SM; Xu, QB; Polley, DB; Liberman, MC; Kong, WJ; Holt, JR; Chen, ZY; Liu, DR				Gao, Xue; Tao, Yong; Lamas, Veronica; Huang, Mingqian; Yeh, Wei-Hsi; Pan, Bifeng; Hu, Yu-Juan; Hu, Johnny H.; Thompson, David B.; Shu, Yilai; Li, Yamin; Wang, Hongyang; Yang, Shiming; Xu, Qiaobing; Polley, Daniel B.; Liberman, M. Charles; Kong, Wei-Jia; Holt, Jeffrey R.; Chen, Zheng-Yi; Liu, David R.			Treatment of autosomal dominant hearing loss by in vivo delivery of genome editing agents	NATURE			English	Article							MOUSE MODEL; NUCLEASE SPECIFICITY; VESTIBULAR FUNCTION; DEAFNESS; SYSTEM; EXPRESSION; COMPONENTS; CLEAVAGE; CHANNEL; ENABLES	Although genetic factors contribute to almost half of all cases of deafness, treatment options for genetic deafness are limited(1-5). We developed a genome-editing approach to target a dominantly inherited form of genetic deafness. Here we show that cationic lipid-mediated in vivo delivery of Cas9-guide RNA complexes can ameliorate hearing loss in a mouse model of human genetic deafness. We designed and validated, both in vitro and in primary fibroblasts, genome editing agents that preferentially disrupt the dominant deafness-associated allele in the Tmc1 (transmembrane channel-like gene family 1) Beethoven (Bth) mouse model, even though the mutant Tmc1(Bth) allele differs from the wild-type allele at only a single base pair. Injection of Cas9-guide RNA-lipid complexes targeting the Tmc1(Bth) allele into the cochlea of neonatal Tmc1(Bth/+) mice substantially reduced progressive hearing loss. We observed higher hair cell survival rates and lower auditory brainstem response thresholds in injected ears than in uninjected ears or ears injected with control complexes that targeted an unrelated gene. Enhanced acoustic startle responses were observed among injected compared to uninjected Tmc1(Bth/+) mice. These findings suggest that protein-RNA complex delivery of target gene-disrupting agents in vivo is a potential strategy for the treatment of some types of autosomal-dominant hearing loss.	[Gao, Xue; Yeh, Wei-Hsi; Hu, Johnny H.; Thompson, David B.; Liu, David R.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Gao, Xue; Yeh, Wei-Hsi; Hu, Johnny H.; Thompson, David B.; Liu, David R.] Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA; [Gao, Xue; Yeh, Wei-Hsi; Hu, Johnny H.; Liu, David R.] Broad Inst MIT & Harvard, Cambridge, MA 02141 USA; [Tao, Yong; Lamas, Veronica; Huang, Mingqian; Hu, Yu-Juan; Shu, Yilai; Wang, Hongyang; Polley, Daniel B.; Liberman, M. Charles; Chen, Zheng-Yi] Harvard Med Sch, Dept Otolaryngol & Program Neurosci, Boston, MA 02114 USA; [Tao, Yong; Lamas, Veronica; Huang, Mingqian; Hu, Yu-Juan; Shu, Yilai; Wang, Hongyang; Polley, Daniel B.; Liberman, M. Charles; Chen, Zheng-Yi] Massachusetts Eye & Ear Infirm, Eaton Peabody Lab, Boston, MA 02114 USA; [Tao, Yong; Hu, Yu-Juan; Kong, Wei-Jia] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Otorhinolaryngol, Wuhan 430022, Hubei, Peoples R China; [Yeh, Wei-Hsi] Harvard Univ, Program Speech & Hearing Biosci & Technol, Cambridge, MA 02138 USA; [Pan, Bifeng; Holt, Jeffrey R.] Boston Childrens Hosp, FM Kirby Neurobiol Ctr, Dept Otolaryngol, Boston, MA 02115 USA; [Pan, Bifeng; Holt, Jeffrey R.] Boston Childrens Hosp, FM Kirby Neurobiol Ctr, Dept Neurol, Boston, MA 02115 USA; [Pan, Bifeng; Holt, Jeffrey R.] Harvard Med Sch, Boston, MA 02115 USA; [Shu, Yilai] Fudan Univ, Shanghai Med Coll, Eye & ENT Hosp, Dept Otolaryngol Head & Neck Surg, Shanghai, Peoples R China; [Li, Yamin; Xu, Qiaobing] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA; [Wang, Hongyang; Yang, Shiming] Chinese PLA Med Sch, Key Lab Hearing Impairment Prevent & Treatment Be, Minist Educ, Dept Otolaryngol & Head Neck Surg,Key Lab Hearing, Beijing, Peoples R China; [Gao, Xue] Rice Univ, Dept Chem & Biomol Engn, Houston, TX 77005 USA; [Tao, Yong] Shanghai Jiao Tong Univ, Sch Med, Peoples Hosp 9, Dept Otolaryngol Head & Neck Surg, Shanghai 200011, Peoples R China; [Tao, Yong] Shanghai Jiao Tong Univ, Sch Med, Ear Inst, Shanghai 200011, Peoples R China	Harvard University; Harvard University; Howard Hughes Medical Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; Harvard University; Massachusetts Eye & Ear Infirmary; Huazhong University of Science & Technology; Harvard University; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Fudan University; Tufts University; Rice University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Liu, DR (corresponding author), Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA.; Liu, DR (corresponding author), Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA.; Liu, DR (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02141 USA.; Chen, ZY (corresponding author), Harvard Med Sch, Dept Otolaryngol & Program Neurosci, Boston, MA 02114 USA.; Chen, ZY (corresponding author), Massachusetts Eye & Ear Infirm, Eaton Peabody Lab, Boston, MA 02114 USA.	Zheng-Yi_Chen@meei.harvard.edu; drliu@fas.harvard.edu	hu, yujuan/GNQ-9970-2022; Liu, David R./HCH-3132-2022	gao, xue/0000-0003-3213-9704; Kong, Wei-Jia/0000-0001-5410-2297; Shu, Yilai/0000-0001-8893-434X; Polley, Daniel/0000-0002-5120-2409	DARPA [HR0011-17-2-0049]; US NIH [R01 EB022376, R35 GM118062, R01 DC006908, P30 DC05209, R01 DC00138, R01 DC013521]; David-Shulsky Foundation; Frederick and Ines Yeatts Hair Cell Regeneration grant; Bertarelli Foundation; Jeff and Kimberly Barber Fund; Broad Institute; HHMI; Direct For Mathematical & Physical Scien [1452122] Funding Source: National Science Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD090255] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB022376] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM118062] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [P30DC005209, R01DC006908, F32DC000138, R01DC009836, R01DC013521, R01DC000188] Funding Source: NIH RePORTER	DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); David-Shulsky Foundation; Frederick and Ines Yeatts Hair Cell Regeneration grant; Bertarelli Foundation; Jeff and Kimberly Barber Fund; Broad Institute; HHMI(Howard Hughes Medical Institute); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by DARPA HR0011-17-2-0049 (to D.R.L.), US NIH R01 EB022376 (to D.R.L.), R35 GM118062 (to D.R.L.), R01 DC006908 (to Z.-Y.C), P30 DC05209 (to M.C.L.), R01 DC00138 (to M.C.L.), and R01 DC013521 (to J.R.H.). We are grateful for support from the David-Shulsky Foundation (to Z.-Y.C.), a Frederick and Ines Yeatts Hair Cell Regeneration grant (to Y.T., V.L., M.H., and Y.S.), the Bertarelli Foundation and the Jeff and Kimberly Barber Fund (to J.R.H.), the Broad Institute (to D.R.L and Z.-Y.C.), and the HHMI (to D.R.L.). We thank H. Rees, S. Tsai, M. Packer, K. Zhao and D. Usanov for assistance.	Ahmed H, 2017, JARO-J ASSOC RES OTO, V18, P649, DOI 10.1007/s10162-017-0634-8; Angeli S, 2012, ANAT REC, V295, P1812, DOI 10.1002/ar.22579; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Geleoc GSG, 2014, SCIENCE, V344, P596, DOI 10.1126/science.1241062; Huang MQ, 2013, J NEUROSCI, V33, P15086, DOI 10.1523/JNEUROSCI.1489-13.2013; Kawashima Y, 2015, PFLUG ARCH EUR J PHY, V467, P85, DOI 10.1007/s00424-014-1582-3; Kim S, 2014, GENOME RES, V24, P1012, DOI 10.1101/gr.171322.113; Komor AC, 2017, CELL, V168, P20, DOI 10.1016/j.cell.2016.10.044; Kurima K, 2002, NAT GENET, V30, P277, DOI 10.1038/ng842; Lentz JJ, 2013, NAT MED, V19, P345, DOI 10.1038/nm.3106; Long CZ, 2016, SCIENCE, V351, P400, DOI 10.1126/science.aad5725; Lumpkin EA, 2003, GENE EXPR PATTERNS, V3, P389, DOI 10.1016/S1567-133X(03)00089-9; MARAZITA ML, 1993, AM J MED GENET, V46, P486, DOI 10.1002/ajmg.1320460504; Morton CC, 2006, NEW ENGL J MED, V354, P2151, DOI 10.1056/NEJMra050700; Muller U, 2015, NAT REV DRUG DISCOV, V14, P346, DOI 10.1038/nrd4533; Pan B, 2017, NAT BIOTECHNOL, V35, P264, DOI 10.1038/nbt.3801; Pan BF, 2013, NEURON, V79, P504, DOI 10.1016/j.neuron.2013.06.019; Pattanayak V, 2013, NAT BIOTECHNOL, V31, P839, DOI 10.1038/nbt.2673; Sacheli R, 2013, GENE THER, V20, P237, DOI 10.1038/gt.2012.51; Shibata SB, 2016, AM J HUM GENET, V98, P1101, DOI 10.1016/j.ajhg.2016.03.028; Tsai SQ, 2015, NAT BIOTECHNOL, V33, P187, DOI 10.1038/nbt.3117; Vreugde S, 2002, NAT GENET, V30, P257, DOI 10.1038/ng848; Wang M, 2016, P NATL ACAD SCI USA, V113, P2868, DOI 10.1073/pnas.1520244113; Yang Y, 2016, NAT BIOTECHNOL, V34, P334, DOI 10.1038/nbt.3469; Yin H, 2016, NAT BIOTECHNOL, V34, P328, DOI 10.1038/nbt.3471; Zhang F. Z., 2015, CRISPR DESIGN; Zhao Y, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0090836, 10.1371/journal.pone.0104330]; Zuris JA, 2015, NAT BIOTECHNOL, V33, P73, DOI 10.1038/nbt.3081	28	264	285	15	266	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 11	2018	553	7687					217	+		10.1038/nature25164	http://dx.doi.org/10.1038/nature25164			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS4WL	29258297	Green Accepted, Green Submitted			2022-12-28	WOS:000419794800039
J	Hauser, AS; Chavali, S; Masuho, I; Jahn, LJ; Martemyanov, KA; Gloriam, DE; Babu, MM				Hauser, Alexander S.; Chavali, Sreenivas; Masuho, Ikuo; Jahn, Leonie J.; Martemyanov, Kirill A.; Gloriam, David E.; Babu, M. Madan			Pharmacogenomics of GPCR Drug Targets	CELL			English	Article							CRYO-EM STRUCTURE; CRYSTAL-STRUCTURE; GENETIC-VARIATION; PROTEIN; RECEPTOR; COMPLEX; POLYMORPHISM; SELECTIVITY; ACTIVATION	Natural genetic variation in the human genome is a cause of individual differences in responses to medications and is an underappreciated burden on public health. Although 108 G-protein-coupled receptors (GPCRs) are the targets of 475 (similar to 34%) Food and Drug Administration (FDA)-approved drugs and account for a global sales volume of over 180 billion US dollars annually, the prevalence of genetic variation among GPCRs targeted by drugs is unknown. By analyzing data from 68,496 individuals, we find that GPCRs targeted by drugs show genetic variation within functional regions such as drug-and effector-binding sites in the human population. We experimentally show that certain variants of m-opioid and Cholecystokinin-A receptors could lead to altered or adverse drug response. By analyzing UK National Health Service drug prescription and sales data, we suggest that characterizing GPCR variants could increase prescription precision, improving patients' quality of life, and relieve the economic and societal burden due to variable drug responsiveness.	[Hauser, Alexander S.; Chavali, Sreenivas; Babu, M. Madan] MRC Lab Mol Biol, Francis Crick Ave, Cambridge CB2 0QH, England; [Hauser, Alexander S.; Gloriam, David E.] Univ Copenhagen, Dept Drug Design & Pharmacol, Univ Pk 2, DK-2100 Copenhagen, Denmark; [Masuho, Ikuo; Martemyanov, Kirill A.] Scripps Res Inst Florida, Dept Neurosci, Jupiter, FL 33458 USA; [Jahn, Leonie J.] Tech Univ Denmark, Novo Nordisk Fdn, Ctr Biosustainabil, DK-2800 Lyngby, Denmark	MRC Laboratory Molecular Biology; University of Copenhagen; Scripps Research Institute; Novo Nordisk Foundation; Technical University of Denmark	Hauser, AS; Babu, MM (corresponding author), MRC Lab Mol Biol, Francis Crick Ave, Cambridge CB2 0QH, England.; Hauser, AS (corresponding author), Univ Copenhagen, Dept Drug Design & Pharmacol, Univ Pk 2, DK-2100 Copenhagen, Denmark.	alexander.hauser@sund.ku.dk; madanm@mrc-lmb.cam.ac.uk	Gloriam, David E./A-1904-2011; Mohan, Babu P./I-7362-2019; Hauser, Alexander/AAV-3436-2020	Gloriam, David E./0000-0002-4299-7561; Hauser, Alexander/0000-0003-1098-6419	Medical Research Council [MC_U105185859]; European Research Council [DE-ORPHAN 639125]; NIH [DA036596, DA026405]; Lundbeck Foundation [R163-2013-16327]; European Union's Horizon research innovation programme (Marie Sklodowska-Curie grant) [642738]; Lundbeck Foundation [R77-2010-6772, R140-2013-13496] Funding Source: researchfish; Novo Nordisk Fonden [NNF13SA0009311, NNF10CC1016517, NNF14OC0011335, NNF17OC0028232, NNF13SA0006019] Funding Source: researchfish; NNF Center for Biosustainability [Bacterial Synthetic Biology] Funding Source: researchfish; NATIONAL INSTITUTE ON DRUG ABUSE [K02DA026405, R01DA036596] Funding Source: NIH RePORTER; MRC [MC_U105185859] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Research Council(European Research Council (ERC)European Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lundbeck Foundation(Lundbeckfonden); European Union's Horizon research innovation programme (Marie Sklodowska-Curie grant); Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Fonden(Novo Nordisk Foundation); NNF Center for Biosustainability; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank J. Gough, R. Henderson, M. Andersen, S. Foster, T. Flock, and H. Harbrecht for comments on the manuscript and S. Bird specifically for her constructive comments on the economic burden estimates. We thank H. Schioth, M. Attwood, and M. Rask-Andersen for their input on the drug-GPCR dataset and N. Skamangas for assistance with experiments. We thank the various consortia members and the National Health Service for making the data publicly available. This work was supported by the Medical Research Council (MC_U105185859; M.M.B. and S.C.), the European Research Council (DE-ORPHAN 639125; D.E.G. and A.S.H.), NIH grants DA036596 and DA026405 (K.A.M.), and the Lundbeck Foundation (R163-2013-16327; D.E.G. and A.S.H.). L.J.J. is supported by the European Union's Horizon 2020 research innovation programme (Marie Sklodowska-Curie grant agreement no. 642738, MetaRNA). M.M.B. is a Research Prize Fellow of the Lister Institute of Preventive Medicine.	Adzhubei Ivan, 2013, Curr Protoc Hum Genet, VChapter 7, DOI 10.1002/0471142905.hg0720s76; Allen JA, 2011, ANNU REV PHARMACOL, V51, P117, DOI 10.1146/annurev-pharmtox-010510-100553; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Boucrot E, 2015, NATURE, V517, P460, DOI 10.1038/nature14067; Chen BY, 2014, CELL, V156, P195, DOI 10.1016/j.cell.2013.11.048; Costa-Neto CM, 2016, MOL PHARMACOL, V90, P587, DOI 10.1124/mol.116.105940; Dolfin E, 2011, J ASSIST REPROD GEN, V28, P925, DOI 10.1007/s10815-011-9619-4; Dufresne M, 2006, PHYSIOL REV, V86, P805, DOI 10.1152/physrev.00014.2005; Evans WE, 2003, NEW ENGL J MED, V348, P538, DOI 10.1056/NEJMra020526; FDA, 2014, DRUGS TABL PHARM BIO; Flock T, 2017, NATURE, V545, P317, DOI 10.1038/nature22070; Flock T, 2015, NATURE, V524, P173, DOI 10.1038/nature14663; Gahbauer S, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00494; Gallion J, 2017, HUM MUTAT, V38, P569, DOI 10.1002/humu.23193; Giacomini KM, 2007, NATURE, V446, P975, DOI 10.1038/446975a; Hauser AS, 2017, NAT REV DRUG DISCOV, V16, P829, DOI 10.1038/nrd.2017.178; Hollins B, 2009, CELL SIGNAL, V21, P1015, DOI 10.1016/j.cellsig.2009.02.017; Hornbeck PV, 2015, NUCLEIC ACIDS RES, V43, pD512, DOI 10.1093/nar/gku1267; Huang KY, 2016, NUCLEIC ACIDS RES, V44, pD435, DOI 10.1093/nar/gkv1240; Isberg V, 2015, TRENDS PHARMACOL SCI, V36, P22, DOI 10.1016/j.tips.2014.11.001; Johnson JA, 2008, CIRCULATION, V118, P1383, DOI 10.1161/CIRCULATIONAHA.107.704023; Jubb HC, 2017, J MOL BIOL, V429, P365, DOI 10.1016/j.jmb.2016.12.004; Kang YY, 2015, NATURE, V523, P561, DOI 10.1038/nature14656; Katritch V, 2014, TRENDS BIOCHEM SCI, V39, P233, DOI 10.1016/j.tibs.2014.03.002; Koscielny G, 2017, NUCLEIC ACIDS RES, V45, pD985, DOI 10.1093/nar/gkw1055; Kukurba KR, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004304; Lauschke V. M., 2017, PHARMACOGENOMIC BIOM; Law V, 2014, NUCLEIC ACIDS RES, V42, pD1091, DOI 10.1093/nar/gkt1068; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Liang YL, 2017, NATURE, V546, P118, DOI 10.1038/nature22327; Liggett SB, 2006, P NATL ACAD SCI USA, V103, P11288, DOI 10.1073/pnas.0509937103; Masuho I, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aab4068; Masuho Ikuo, 2015, Methods Mol Biol, V1335, P107, DOI 10.1007/978-1-4939-2914-6_8; Miosge LA, 2015, P NATL ACAD SCI USA, V112, pE5189, DOI 10.1073/pnas.1511585112; Munk C, 2016, BRIT J PHARMACOL, V173, P2195, DOI 10.1111/bph.13509; Munk C, 2016, CURR OPIN PHARMACOL, V30, P51, DOI 10.1016/j.coph.2016.07.003; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Orman JS, 2009, CNS DRUGS, V23, P899, DOI 10.2165/11203740-000000000-00000; Pandy-Szekeres G., 2017, NUCL ACIDS RES; Perez JM, 2003, NAT MED, V9, P1300, DOI 10.1038/nm930; Raimondi F, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12971-7; Rask-Andersen M, 2014, ANNU REV PHARMACOL, V54, P9, DOI 10.1146/annurev-pharmtox-011613-135943; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Raveh A, 2010, CELL, V143, P750, DOI 10.1016/j.cell.2010.10.018; Relling MV, 2015, NATURE, V526, P343, DOI 10.1038/nature15817; Rieck M., 2016, PHARMACOGENOMICS J; Roden DM, 2002, NAT REV DRUG DISCOV, V1, P37, DOI 10.1038/nrd705; Ruderfer DM, 2016, NAT GENET, V48, P1107, DOI 10.1038/ng.3638; Santos R, 2017, NAT REV DRUG DISCOV, V16, P19, DOI 10.1038/nrd.2016.230; Savova V, 2016, NAT GENET, V48, P231, DOI 10.1038/ng.3493; Sim SC, 2011, TRENDS PHARMACOL SCI, V32, P72, DOI 10.1016/j.tips.2010.11.008; Smedley D, 2015, NUCLEIC ACIDS RES, V43, pW589, DOI 10.1093/nar/gkv350; Southan C, 2016, NUCLEIC ACIDS RES, V44, pD1054, DOI 10.1093/nar/gkv1037; Sultana J, 2013, J PHARMACOL PHARMACO, V4, pS73, DOI 10.4103/0976-500X.120957; Thompson MD, 2014, METHODS MOL BIOL, V1175, P189, DOI 10.1007/978-1-4939-0956-8_9; Trzaskowski B, 2012, CURR MED CHEM, V19, P1090, DOI 10.2174/092986712799320556; Turner TN, 2017, NUCLEIC ACIDS RES, V45, pD804, DOI 10.1093/nar/gkw865; US Food and Drug Administration, 2013, CLIN PHARM PREM EV E; van der Lee R, 2014, CHEM REV, V114, P6589, DOI 10.1021/cr400525m; Venkatakrishnan AJ, 2016, NATURE, V536, P484, DOI 10.1038/nature19107; Venkatakrishnan AJ, 2014, CURR OPIN STRUC BIOL, V27, P129, DOI 10.1016/j.sbi.2014.08.002; Venkatakrishnan AJ, 2013, NATURE, V494, P185, DOI 10.1038/nature11896; Wacker D, 2017, CELL, V170, P414, DOI 10.1016/j.cell.2017.07.009; Wacker D, 2013, SCIENCE, V340, P615, DOI 10.1126/science.1232808; Ward LD, 2012, NAT BIOTECHNOL, V30, P1095, DOI 10.1038/nbt.2422; Zhang Y, 2017, NATURE, V546, P248, DOI 10.1038/nature22394	66	296	302	10	103	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 11	2018	172	1-2					41	+		10.1016/j.cell.2017.11.033	http://dx.doi.org/10.1016/j.cell.2017.11.033			33	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FS5MI	29249361	Green Published, hybrid			2022-12-28	WOS:000419840100008
J	Johnson, ZL; Chen, J				Johnson, Zachary Lee; Chen, Jue			ATP Binding Enables Substrate Release from Multidrug Resistance Protein 1	CELL			English	Article							MALTOSE TRANSPORTER; CRYSTAL-STRUCTURE; ALTERNATING ACCESS; CATALYTIC CYCLE; P-GLYCOPROTEIN; MRP1; EXPRESSION; ABCC1; MODEL; VISUALIZATION	The multidrug resistance protein MRP1 is an ATP-driven pump that confers resistance to chemotherapy. Previously, we have shown that intracellular substrates are recruited to a bipartite binding site when the transporter rests in an inward-facing conformation. A key question remains: how are high-affinity substrates transferred across the membrane and released outside the cell? Using electron cryomicroscopy, we show here that ATP binding opens the transport pathway to the extracellular space and reconfigures the substrate-binding site such that it relinquishes its affinity for substrate. Thus, substrate is released prior to ATP hydrolysis. With this result, we now have a complete description of the conformational cycle that enables substrate transfer in a eukaryotic ABC exporter.	[Johnson, Zachary Lee; Chen, Jue] Rockefeller Univ, Lab Membrane Biol & Biophys, New York, NY 10065 USA; [Johnson, Zachary Lee; Chen, Jue] Howard Hughes Med Inst, New York, NY 10065 USA	Rockefeller University; Howard Hughes Medical Institute	Chen, J (corresponding author), Rockefeller Univ, Lab Membrane Biol & Biophys, New York, NY 10065 USA.; Chen, J (corresponding author), Howard Hughes Med Inst, New York, NY 10065 USA.	juechen@rockefeller.edu			Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bakos E, 2000, J CELL SCI, V113, P4451; Bakos E, 1998, J BIOL CHEM, V273, P32167, DOI 10.1074/jbc.273.48.32167; Brown A, 2015, ACTA CRYSTALLOGR D, V71, P136, DOI 10.1107/S1399004714021683; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; COLE SPC, 1992, SCIENCE, V258, P1650, DOI 10.1126/science.1360704; Cole SPC, 2014, J BIOL CHEM, V289, P30880, DOI 10.1074/jbc.R114.609248; Cole SPC, 2014, ANNU REV PHARMACOL, V54, P95, DOI 10.1146/annurev-pharmtox-011613-135959; Dawson RJP, 2007, FEBS LETT, V581, P935, DOI 10.1016/j.febslet.2007.01.073; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; Deeley RG, 2006, FEBS LETT, V580, P1103, DOI 10.1016/j.febslet.2005.12.036; Deeley RG, 2006, PHYSIOL REV, V86, P849, DOI 10.1152/physrev.00035.2005; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Filipits M, 2005, J CLIN ONCOL, V23, P1161, DOI 10.1200/JCO.2005.03.033; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Gao M, 2000, J BIOL CHEM, V275, P13098, DOI 10.1074/jbc.275.17.13098; Grant T, 2015, ELIFE, V4, DOI 10.7554/eLife.06980; Grigorieff N, 2016, METHOD ENZYMOL, V579, P191, DOI 10.1016/bs.mie.2016.04.013; Haber M, 2006, J CLIN ONCOL, V24, P1546, DOI 10.1200/JCO.2005.01.6196; Heymann JB, 2007, J STRUCT BIOL, V157, P3, DOI 10.1016/j.jsb.2006.06.006; Hou YX, 2000, J BIOL CHEM, V275, P20280, DOI 10.1074/jbc.M001109200; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; Johnson ZL, 2017, CELL, V168, P1075, DOI 10.1016/j.cell.2017.01.041; Khare D, 2009, MOL CELL, V33, P528, DOI 10.1016/j.molcel.2009.01.035; Leslie EM, 2005, TOXICOL APPL PHARM, V204, P216, DOI 10.1016/j.taap.2004.10.012; Loe DW, 1996, J BIOL CHEM, V271, P9675, DOI 10.1074/jbc.271.16.9675; Lu JF, 2015, DRUG METAB REV, V47, P406, DOI 10.3109/03602532.2015.1105253; Mao QC, 2000, J BIOL CHEM, V275, P34166, DOI 10.1074/jbc.M004584200; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nicholls RA, 2014, ACTA CRYSTALLOGR D, V70, P2487, DOI 10.1107/S1399004714016241; Oldham ML, 2007, NATURE, V450, P515, DOI 10.1038/nature06264; Oldham ML, 2011, P NATL ACAD SCI USA, V108, P15152, DOI 10.1073/pnas.1108858108; Oldham ML, 2011, SCIENCE, V332, P1202, DOI 10.1126/science.1200767; Payen LF, 2003, J BIOL CHEM, V278, P38537, DOI 10.1074/jbc.M305786200; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Punjani A, 2017, NAT METHODS, V14, P290, DOI [10.1038/nmeth.4169, 10.1038/NMETH.4169]; Ramaen O, 2006, J MOL BIOL, V359, P940, DOI 10.1016/j.jmb.2006.04.005; Rohou A, 2015, J STRUCT BIOL, V192, P216, DOI 10.1016/j.jsb.2015.08.008; Rubinstein JL, 2015, J STRUCT BIOL, V192, P188, DOI 10.1016/j.jsb.2015.08.007; SCHARSCHMIDT BF, 1979, J LAB CLIN MED, V93, P790; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Senior AE, 1995, FEBS LETT, V377, P285, DOI 10.1016/0014-5793(95)01345-8; Siarheyeva A, 2010, J BIOL CHEM, V285, P7575, DOI 10.1074/jbc.M109.047290; Sindelar CV, 2012, J STRUCT BIOL, V180, P26, DOI 10.1016/j.jsb.2012.05.005; STEIN PE, 1994, STRUCTURE, V2, P45, DOI 10.1016/S0969-2126(00)00007-1; TENEYCK LF, 1977, ACTA CRYSTALLOGR A, V33, P486, DOI 10.1107/S0567739477001211; Ward A, 2007, P NATL ACAD SCI USA, V104, P19005, DOI 10.1073/pnas.0709388104; Westlake CJ, 2003, BIOCHEMISTRY-US, V42, P14099, DOI 10.1021/bi035333y; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Winter S. S., 2013, HEALTH IRVINE CALIF, V5, p5A; Zalcberg J, 2000, PROSTATE CANCER P D, V3, P66, DOI 10.1038/sj.pcan.4500394	52	103	105	3	59	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 11	2018	172	1-2					81	+		10.1016/j.cell.2017.12.005	http://dx.doi.org/10.1016/j.cell.2017.12.005			19	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FS5MI	29290467	Bronze			2022-12-28	WOS:000419840100011
J	Robertson, N; Rappas, M; Dore, AS; Brown, J; Bottegoni, G; Koglin, M; Cansfield, J; Jazayeri, A; Cooke, RM; Marshall, FH				Robertson, Nathan; Rappas, Mathieu; Dore, Andrew S.; Brown, Jason; Bottegoni, Giovanni; Koglin, Markus; Cansfield, Julie; Jazayeri, Ali; Cooke, Robert M.; Marshall, Fiona H.			Structure of the complement C5a receptor bound to the extra-helical antagonist NDT9513727	NATURE			English	Article							CRYSTAL-STRUCTURE; SMALL-MOLECULE; OPIOID RECEPTOR; OLIGOMERIZATION; IDENTIFICATION; ACID; GPCR	The complement system is a crucial component of the host response to infection and tissue damage. Activation of the complement cascade generates anaphylatoxins including C5a and C3a. C5a exerts a pro-inflammatory effect via the G-protein-coupled receptor C5a anaphylatoxin chemotactic receptor 1 (C5aR1, also known as CD88) that is expressed on cells of myeloid origin(1,2). Inhibitors of the complement system have long been of interest as potential drugs for the treatment of diseases such as sepsis, rheumatoid arthritis, Crohn's disease and ischaemia-reperfusion injuries(1). More recently, a role of C5a in neurodegenerative conditions such as Alzheimer's disease has been identified(3). Peptide antagonists based on the C5a ligand have progressed to phase 2 trials in psoriasis and rheumatoid arthritis; however, these compounds exhibited problems with off-target activity, production costs, potential immunogenicity and poor oral bioavailability. Several small-molecule competitive antagonists for C5aR1, such as W-54011(5) and NDT9513727(6), have been identified by C5a radioligand-binding assays(4). NDT9513727 is a non-peptide inverse agonist of C5aR1, and is highly selective for the primate and gerbil receptors over those of other species. Here, to study the mechanism of action of C5a antagonists, we determine the structure of a thermostabilized C5aR1 (known as C5aR1 StaR) in complex with NDT9513727. We found that the small molecule bound between transmembrane helices 3, 4 and 5, outside the helical bundle. One key interaction between the small molecule and residue Trp213(5.49) seems to determine the species selectivity of the compound. The structure demonstrates that NDT9513727 exerts its inverse-agonist activity through an extra-helical mode of action.	[Robertson, Nathan; Rappas, Mathieu; Dore, Andrew S.; Brown, Jason; Bottegoni, Giovanni; Koglin, Markus; Cansfield, Julie; Jazayeri, Ali; Cooke, Robert M.; Marshall, Fiona H.] Heptares Therapeut Ltd, BioPk,Broadwater Rd, Welwyn Garden City AL7 3AX, Herts, England	Heptares Therapeutics Ltd.	Marshall, FH (corresponding author), Heptares Therapeut Ltd, BioPk,Broadwater Rd, Welwyn Garden City AL7 3AX, Herts, England.	fiona.marshall@heptares.com	Marshall, Fiona/AAZ-9626-2020	Bottegoni, Giovanni/0000-0003-1251-583X; Robertson, Nathan/0000-0002-5449-2501				Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brodbeck RM, 2008, J PHARMACOL EXP THER, V327, P898, DOI 10.1124/jpet.108.141572; Caffrey M, 2009, NAT PROTOC, V4, P706, DOI 10.1038/nprot.2009.31; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cheng RKY, 2017, NATURE, V545, P112, DOI 10.1038/nature22309; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Floyd DH, 2003, J BIOL CHEM, V278, P35354, DOI 10.1074/jbc.M305607200; Harder E, 2016, J CHEM THEORY COMPUT, V12, P281, DOI 10.1021/acs.jctc.5b00864; Hebert TE, 1996, J BIOL CHEM, V271, P16384, DOI 10.1074/jbc.271.27.16384; Higginbottom A, 2005, J BIOL CHEM, V280, P17831, DOI 10.1074/jbc.M410797200; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hutchison AJ, 2004, ANNU REP MED CHEM, V39, P139, DOI 10.1016/S0065-7743(04)39011-1; Jazayeri A, 2016, NATURE, V533, P274, DOI 10.1038/nature17414; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Klco JM, 2003, J BIOL CHEM, V278, P35345, DOI 10.1074/jbc.M305606200; Klos A, 2013, PHARMACOL REV, V65, P500, DOI 10.1124/pr.111.005223; Krautler V, 2001, J COMPUT CHEM, V22, P501, DOI 10.1002/1096-987X(20010415)22:5<501::AID-JCC1021>3.0.CO;2-V; Landlinger C, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0369-6; Lu J, 2017, NAT STRUCT MOL BIOL, V24, P570, DOI 10.1038/nsmb.3417; Manglik A, 2012, NATURE, V485, P321, DOI 10.1038/nature10954; MARTYNA GJ, 1992, J CHEM PHYS, V97, P2635, DOI 10.1063/1.463940; MARTYNA GJ, 1994, J CHEM PHYS, V101, P4177, DOI 10.1063/1.467468; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Oswald C, 2016, NATURE, V540, P462, DOI 10.1038/nature20606; Rabiet MJ, 2008, J BIOL CHEM, V283, P31038, DOI 10.1074/jbc.M805260200; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Robertson N, 2011, NEUROPHARMACOLOGY, V60, P36, DOI 10.1016/j.neuropharm.2010.07.001; Serrano-Vega MJ, 2008, P NATL ACAD SCI USA, V105, P877, DOI 10.1073/pnas.0711253105; Sumichika H, 2002, J BIOL CHEM, V277, P49403, DOI 10.1074/jbc.M209672200; Tehan BG, 2014, PHARMACOL THERAPEUT, V143, P51, DOI 10.1016/j.pharmthera.2014.02.004; TUCKERMAN M, 1992, J CHEM PHYS, V97, P1990, DOI 10.1063/1.463137; Wang C, 2013, NATURE, V497, P338, DOI 10.1038/nature12167; Waters SM, 2005, J BIOL CHEM, V280, P40617, DOI 10.1074/jbc.M509245200; White JF, 2012, NATURE, V490, P508, DOI 10.1038/nature11558; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Woodruff TM, 2011, MOL IMMUNOL, V48, P1631, DOI 10.1016/j.molimm.2011.04.014; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Wu HX, 2012, NATURE, V485, P327, DOI 10.1038/nature10939; Zhang DD, 2015, NATURE, V520, P317, DOI 10.1038/nature14287	44	71	72	2	58	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 4	2018	553	7686					111	+		10.1038/nature25025	http://dx.doi.org/10.1038/nature25025			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS4NI	29300009				2022-12-28	WOS:000419769300040
J	Melamed, A; Fink, G; Wright, AA; Keating, NL; Gockley, AA; del Carmen, MG; Schorge, JO; Rauh-Hain, JA				Melamed, Alexander; Fink, Gunther; Wright, Alexi A.; Keating, Nancy L.; Gockley, Allison A.; del Carmen, Marcela G.; Schorge, John O.; Rauh-Hain, J. Alejandro			Effect of adoption of neoadjuvant chemotherapy for advanced ovarian cancer on all cause mortality: quasi-experimental study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							REGRESSION DISCONTINUITY DESIGNS; PRIMARY CYTOREDUCTIVE SURGERY; ADVANCED-STAGE OVARIAN; DEBULKING SURGERY; SURVIVAL; TRIAL; WOMEN	OBJECTIVE To estimate the causal effect of increased use of neoadjuvant chemotherapy (NACT) on all cause mortality in advanced epithelial ovarian cancer. DESIGN Quasi-experimental fuzzy regression discontinuity design and cross sectional analysis. SETTING Cancer programs throughout the United States accredited by the Commission on Cancer. PARTICIPANTS 6034 women with a diagnosis of stage 3C or 4 epithelial ovarian cancer from regions that rapidly adopted use of NACT from 2011 to 2012 (27% increase in the New England and east south central regions) or remained unchanged (control regions, south Atlantic, west north central, and east north central regions). MAIN OUTCOME MEASURE All cause mortality within three years of diagnosis. Kaplan-Meier curves and proportional hazard models were estimated to compare mortality differences between rapidly adopting regions and controls. RESULTS 1156 women were treated for advanced epithelial ovarian cancer during 2011 and 2012 in the two rapidly adopting regions and 4878 women in the three control regions. In the rapidly adopting regions, patients treated in 2012 compared with 2011 had a mortality hazard ratio of 0.81 (95% confidence interval 0.71 to 0.94) after adjusting for mortality time trends, whereas no difference was observed in control regions (1.02, 0.93 to 1.12). Compared with control regions, larger declines in 90 day surgical mortality (7.0% to 4.0% v 5.0% to 4.3%, P=0.01) and in the proportion of women not receiving surgery and chemotherapy (20.0% to 17.4% v 19.0 to 19.5%, P=0.04) were observed in rapidly adopting regions. Cross sectional analysis confirmed that treatment in regions with greater use of NACT was associated was lower mortality (P=0.001). CONCLUSIONS Adoption of NACT for advanced epithelial ovarian cancer in New England and east south central regions led to a sizable reduction in mortality within three years after diagnosis.	[Melamed, Alexander; del Carmen, Marcela G.; Schorge, John O.] Massachusetts Gen Hosp, Div Gynecol Oncol, Vincent Dept Obstet & Gynecol, Boston, MA 02114 USA; [Fink, Gunther] Harvard TH Chan Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA USA; [Wright, Alexi A.] Dana Farber Canc Inst, Div Populat Sci, Boston, MA 02115 USA; [Keating, Nancy L.] Harvard Med Sch, Dept Hlth Care Policy, Boston, MA USA; [Gockley, Allison A.] Brigham & Womens Hosp, Dept Obstet & Gynecol, Div Gynecol Oncol, 75 Francis St, Boston, MA 02115 USA; [Rauh-Hain, J. Alejandro] Univ Texas MD Anderson Canc Ctr, Div Surg, Dept Gynecol Oncol & Reprod Med, Houston, TX 77030 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; University of Texas System; UTMD Anderson Cancer Center	Melamed, A (corresponding author), Massachusetts Gen Hosp, Div Gynecol Oncol, Vincent Dept Obstet & Gynecol, Boston, MA 02114 USA.	alexander.melamed@mgh.harvard.edu	Melamed, Alexander/R-8299-2019; Keating, Nancy L/I-9968-2019; Wright, Alexi/T-5793-2019	Melamed, Alexander/0000-0002-0654-0863; Keating, Nancy L/0000-0002-8274-4681; 	National Cancer Institute at the National Institutes of Health [R25CA092203, K24CA181510, K07CA166210]; Deborah Kelly Center for Outcome Research at Massachusetts General Hospital; NATIONAL CANCER INSTITUTE [K07CA166210, R25CA092203, K24CA181510] Funding Source: NIH RePORTER	National Cancer Institute at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Deborah Kelly Center for Outcome Research at Massachusetts General Hospital; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Cancer Institute at the National Institutes of Health (R25CA092203 JAR-H, K24CA181510 NLK, and K07CA166210 AAW), and the Deborah Kelly Center for Outcome Research at Massachusetts General Hospital. The funders had no role in the design and execution of this study.	Bor J, 2014, EPIDEMIOLOGY, V25, P729, DOI 10.1097/EDE.0000000000000138; Cannistra SA, 2004, NEW ENGL J MED, V351, P2519, DOI 10.1056/NEJMra041842; Chi DS, 2012, GYNECOL ONCOL, V124, P10, DOI 10.1016/j.ygyno.2011.08.014; Chi DS, 2011, J CLIN ONCOL, V29, P4073, DOI 10.1200/JCO.2011.35.9935; Fagotti A, 2016, EUR J CANCER, V59, P22, DOI 10.1016/j.ejca.2016.01.017; Hausman C, 2017, NBER WORKING PAPER S; Imbens GW, 2008, J ECONOMETRICS, V142, P615, DOI 10.1016/j.jeconom.2007.05.001; Kehoe S, 2015, LANCET, V386, P249, DOI 10.1016/S0140-6736(14)62223-6; Lee DS, 2010, J ECON LIT, V48, P281, DOI 10.1257/jel.48.2.281; Melamed A, 2016, GYNECOL ONCOL, V143, P236, DOI 10.1016/j.ygyno.2016.09.002; Meyer LA, 2016, J CLIN ONCOL, V34, P3854, DOI 10.1200/JCO.2016.68.1239; Mueller JJ, 2016, GYNECOL ONCOL, V140, P436, DOI 10.1016/j.ygyno.2016.01.008; O'Keeffe AG, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5293; Rauh-Hain JA, 2017, JAMA ONCOL, V3, P76, DOI 10.1001/jamaoncol.2016.4411; Raval MV, 2009, J SURG ONCOL, V99, P488, DOI 10.1002/jso.21173; Rosen B, 2014, GYNECOL ONCOL, V134, P462, DOI 10.1016/j.ygyno.2014.07.004; Terza JV, 2008, J HEALTH ECON, V27, P531, DOI 10.1016/j.jhealeco.2007.09.009; Thrall MM, 2011, OBSTET GYNECOL, V118, P537, DOI 10.1097/AOG.0b013e31822a6d56; Vergote I, 2011, J CLIN ONCOL, V29, P4076, DOI 10.1200/JCO.2011.36.9785; Vergote I, 2010, NEW ENGL J MED, V363, P943, DOI 10.1056/NEJMoa0908806; Vergote IB, 2016, J CLIN ONCOL, V34, P3827, DOI 10.1200/JCO.2016.69.7458; Wright AA, 2016, GYNECOL ONCOL, V143, P3, DOI 10.1016/j.ygyno.2016.05.022; Wright JD, 2014, CANCER-AM CANCER SOC, V120, P1246, DOI 10.1002/cncr.28508	23	20	20	1	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 3	2018	360								j5463	10.1136/bmj.j5463	http://dx.doi.org/10.1136/bmj.j5463			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FS3UP	29298771	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000419709400004
J	Voelker, R				Voelker, Rebecca			Treatment for Rare Enzyme Disorder	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 2	2018	319	1					14	14		10.1001/jama.2017.20058	http://dx.doi.org/10.1001/jama.2017.20058			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FR5ON	29297063				2022-12-28	WOS:000419116000006
J	Cunningham, LL; Tucci, DL				Cunningham, Lisa L.; Tucci, Debara L.			Hearing Loss in Adults	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							ENDOSCOPIC 3RD VENTRICULOSTOMY; CHOROID-PLEXUS CAUTERIZATION; CHILDREN CLINICAL ARTICLE; VOLUMETRIC BRAIN ANALYSIS; HYDROCEPHALIC CHILDREN; COGNITIVE-DEVELOPMENT; INFANT HYDROCEPHALUS; AFRICAN CHILDREN; UGANDA; SHUNT		[Cunningham, Lisa L.] Natl Inst Deafness & Other Commun Disorders, Sect Sensory Cell Biol, Bethesda, MD USA; [Tucci, Debara L.] Duke Univ, Med Ctr, Div Head & Neck Surg & Commun Sci, Box 3805, Durham, NC 27710 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); Duke University	Tucci, DL (corresponding author), Duke Univ, Med Ctr, Div Head & Neck Surg & Commun Sci, Box 3805, Durham, NC 27710 USA.	debara.tucci@duke.edu	Cunningham, Lisa/AAH-9051-2020	Cunningham, Lisa/0000-0001-5320-964X	Roche Pharmaceuticals; Otic Pharma; Otonomy; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [ZIADC000079] Funding Source: NIH RePORTER	Roche Pharmaceuticals(Roche Holding); Otic Pharma; Otonomy; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	Dr. Tucci reports receiving consulting fees and travel support from Roche Pharmaceuticals, consulting fees from Otic Pharma, and consulting fees from Otonomy and serving as chair of a data and safety monitoring board for Otonomy. No other potential conflict of interest relevant to this article was reported.	Azab WA, 2016, CHILD NERV SYST, V32, P775, DOI 10.1007/s00381-016-3032-3; Bankole OB, 2015, J NEUROSURG-PEDIATR, V15, P524, DOI 10.3171/2014.10.PEDS14228; FLETCHER JM, 1992, ARCH NEUROL-CHICAGO, V49, P818, DOI 10.1001/archneur.1992.00530320042010; Fletcher JM, 1996, CHILD NERV SYST, V12, P192, DOI 10.1007/BF00301250; Fletcher JM, 1996, ARCH NEUROL-CHICAGO, V53, P549, DOI 10.1001/archneur.1996.00550060093022; Kahle KT, 2016, LANCET, V387, P788, DOI 10.1016/S0140-6736(15)60694-8; Kulkarni AV, 2015, J NEUROSURG-PEDIATR, V16, P267, DOI 10.3171/2015.1.PEDS14597; Kulkarni AV, 2010, NEUROSURGERY, V67, P588, DOI 10.1227/01.NEU.0000373199.79462.21; Kulkarni AV, 2010, CHILD NERV SYST, V26, P75, DOI 10.1007/s00381-009-0983-7; Lane JD, 2014, J NEUROSURG-PEDIATR, V13, P140, DOI 10.3171/2013.11.PEDS13394; Larysz P, 2014, CHILD NERV SYST, V30, P99, DOI 10.1007/s00381-013-2200-y; Mandell JG, 2015, J NEUROSURG-PEDIATR, V15, P113, DOI 10.3171/2014.9.PEDS12426; Mandell JG, 2015, J NEUROSURG-PEDIATR, V15, P125, DOI 10.3171/2014.9.PEDS12427; Marano PJ, 2015, J NEUROSURG-PEDIATR, V15, P399, DOI 10.3171/2014.10.PEDS14250; Mweshi MM, 2010, MED J ZAMBIA, V37, P246; Warf BC, 2005, J NEUROSURG, V102, P1, DOI 10.3171/ped.2005.102.1.0001; Warf BC, 2005, J NEUROSURG, V103, P475, DOI 10.3171/ped.2005.103.6.0475; Warf BC, 2005, J NEUROSURG, V102, P358, DOI 10.3171/ped.2005.102.4.0358; Warf BC, 2015, COMBINED ENDOSCOPIC, V2nd; Warf BC, 2013, WORLD NEUROSURG S, V79, P2; Warf B, 2009, J NEUROS-PEDIATR, V4, P564, DOI 10.3171/2009.7.PEDS09136; Warf BC, 2008, J NEUROSURG-PEDIATR, V2, P310, DOI 10.3171/PED.2008.2.11.310; Warf BC, 2011, J NEUROSURG-PEDIATR, V7, P88, DOI 10.3171/2010.9.PEDS10326; Warf BC, 2013, CHILD NERV SYST, V29, P935, DOI 10.1007/s00381-013-2072-1; Warf BC, 2012, J NEUROSURG-PEDIATR, V10, P108, DOI 10.3171/2012.4.PEDS1253; Warf BC, 2011, J NEUROSURG-PEDIATR, V8, P502, DOI 10.3171/2011.8.PEDS11221; Warf BC, 2011, J NEUROSURG-PEDIATR, V8, P509, DOI 10.3171/2011.8.PEDS11163; Warf BC, 2011, J NEUROSURG-PEDIATR, V8, P377, DOI 10.3171/2011.7.PEDS1198; Warf BC, 2011, J NEUROSURG-PEDIATR, V7, P127, DOI 10.3171/2010.11.PEDS10428; Warf BC, 2010, J NEUROSURG-PEDIATR, V5, P204, DOI 10.3171/2009.9.PEDS09304	30	176	186	5	34	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 21	2017	377	25					2465	2473		10.1056/NEJMra1616601	http://dx.doi.org/10.1056/NEJMra1616601			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FQ5RZ	29262274	Green Accepted			2022-12-28	WOS:000418420000010
J	Lawler, A				Lawler, Andrew			Satellites trace Afghanistan's lost empires	SCIENCE			English	News Item																			0	1	1	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 15	2017	358	6369					1364	1365		10.1126/science.358.6369.1364	http://dx.doi.org/10.1126/science.358.6369.1364			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP8TH	29242321				2022-12-28	WOS:000417918500009
J	Reese, A				Reese, April			Ice-shrouded life sees daylight	SCIENCE			English	News Item																			0	0	0	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 15	2017	358	6369					1366	1366		10.1126/science.358.6369.1366	http://dx.doi.org/10.1126/science.358.6369.1366			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP8TH	29242323				2022-12-28	WOS:000417918500011
J	Andrew, E; Nehme, Z; Bernard, S; Abramson, MJ; Newbigin, E; Piper, B; Dunlop, J; Holman, P; Smith, K				Andrew, Emily; Nehme, Ziad; Bernard, Stephen; Abramson, Michael J.; Newbigin, Ed; Piper, Ben; Dunlop, Justin; Holman, Paul; Smith, Karen			Stormy weather: a retrospective analysis of demand for emergency medical services during epidemic thunderstorm asthma	BMJ-BRITISH MEDICAL JOURNAL			English	Article							GRASS-POLLEN; CARDIAC-ARREST; AIR-POLLUTION; OUTBREAK; ASSOCIATION; MELBOURNE; REGISTRY; CARE	OBJECTIVES To describe the demand for emergency medical assistance during the largest outbreak of thunderstorm asthma reported globally, which occurred on 21 November 2016. DESIGN A time series analysis was conducted of emergency medical service caseload between 1 January 2015 and 31 December 2016. Demand during the thunderstorm asthma event was compared to historical trends for the overall population and across specific subgroups. SETTING Victoria, Australia. MAIN OUTCOME MEASURES Number of overall cases attended by emergency medical services, and within patient subgroups. RESULTS On 21 November 2016, the emergency medical service received calls for 2954 cases, which was 1014 more cases than the average over the historical period. Between 6 pm and midnight, calls for 1326 cases were received, which was 2.5 times higher than expected. A total of 332 patients were assessed by paramedics as having acute respiratory distress on 21 November, compared with a daily average of 52 during the historical period. After adjustment for temporal trends, thunderstorm asthma was associated with a 42% (95% confidence interval 40% to 44%) increase in overall caseload for the emergency medical service and a 432% increase in emergency medical attendances for acute respiratory distress symptoms. Emergency transports to hospital increased by 17% (16% to 19%) and time critical referrals from general practitioners increased by 47% (21% to 80%). Large increases in demand were seen among patients with a history of asthma and bronchodilator use. The incidence of out-of-hospital cardiac arrest increased by 82% (67% to 99%) and pre-hospital deaths by 41% (29% to 55%). CONCLUSIONS An unprecedented outbreak of thunderstorm asthma was associated with substantial increase in demand for emergency medical services and pre-hospital cardiac arrest. The health impact of future events may be minimised through use of preventive measures by patients and predictive early warning systems.	[Andrew, Emily; Nehme, Ziad; Bernard, Stephen; Smith, Karen] Ambulance Victoria, Ctr Res & Evaluat, Doncaster, Vic 3108, Australia; [Andrew, Emily; Nehme, Ziad; Bernard, Stephen; Abramson, Michael J.; Smith, Karen] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia; [Nehme, Ziad; Smith, Karen] Dept Community Emergency Hlth & Paramed Practice, Frankston, Vic 3199, Australia; [Bernard, Stephen] Alfred Hosp, Intens Care Unit, Melbourne, Vic 3004, Australia; [Newbigin, Ed] Univ Melbourne, Sch BioSci, Melbourne, Vic 3052, Australia; [Piper, Ben] Emergency Serv Telecommun Author, Burwood East, Vic 3151, Australia; [Dunlop, Justin; Holman, Paul] Ambulance Victoria, Emergency Management Unit, Melbourne, Vic 3000, Australia	Monash University; Florey Institute of Neuroscience & Mental Health; University of Melbourne	Andrew, E (corresponding author), Ambulance Victoria, Ctr Res & Evaluat, Doncaster, Vic 3108, Australia.; Andrew, E (corresponding author), Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia.	emily.andrew@ambulance.vic.gov.au	Abramson, Michael/AAQ-2671-2020	Abramson, Michael/0000-0002-9954-0538; Smith, Karen/0000-0002-9057-0685; Nehme, Ziad/0000-0003-2432-1645				Al-Rubaish AM, 2007, J FAM COMMUNITY MED, V14, P47; Alderman P M, 1986, Arch Emerg Med, V3, P260; BELLOMO R, 1992, MED J AUSTRALIA, V156, P834, DOI 10.5694/j.1326-5377.1992.tb136994.x; D'Amato G, 2008, J ALLERGY CLIN IMMUN, V121, P537, DOI 10.1016/j.jaci.2007.10.046; Dabrera G, 2013, QJM-INT J MED, V106, P207, DOI 10.1093/qjmed/hcs234; Davidson AC, 1996, BRIT MED J, V312, P601; de Morton J, 2011, INT J BIOMETEOROL, V55, P613, DOI 10.1007/s00484-010-0361-x; Dennekamp M, 2010, EPIDEMIOLOGY, V21, P494, DOI 10.1097/EDE.0b013e3181e093db; Department of Health and Human Services, 2017, NOV 2016 VICT EP THU; Eastwood K, 2016, AUST HEALTH REV, V40, P378, DOI 10.1071/AH15134; EGAN P, 1985, MED J AUSTRALIA, V142, P330, DOI 10.5694/j.1326-5377.1985.tb113389.x; Elliot AJ, 2014, EMERG MED J, V31, P675, DOI 10.1136/emermed-2013-203122; Erbas B, 2012, CLIN EXP ALLERGY, V42, P799, DOI 10.1111/j.1365-2222.2012.03995.x; Fdez-Arroyabe P, 2017, INT J BIOMETEOROL, V61, pS115, DOI 10.1007/s00484-017-1413-2; Forouzan A, 2014, J ENVIRON PUBLIC HEA, V2014, DOI 10.1155/2014/504017; Girgis ST, 2000, EUR RESPIR J, V16, P3, DOI 10.1034/j.1399-3003.2000.16a02.x; Gold DR, 2013, CIRCULATION, V127, P1903, DOI 10.1161/CIRCULATIONAHA.111.064337; Hajat S, 1997, BRIT J GEN PRACT, V47, P639; Higham J, 1997, J EPIDEMIOL COMMUN H, V51, P233, DOI 10.1136/jech.51.3.233; Howden ML, 2011, MED J AUSTRALIA, V195, P512, DOI 10.5694/mja11.11044; Inspector-General for Emergency Management, 2017, REV RESPONSE THUNDER; Kaufman JD, 2016, LANCET, V388, P696, DOI 10.1016/S0140-6736(16)00378-0; Levy ML, 2007, BRIT J PRIMARY CARE, V1, P69; Lindstrom SJ, 2017, MED J AUSTRALIA, V207, P235, DOI 10.5694/mja17.00285; Losappio L, 2011, ALLERGY, V66, P1510, DOI 10.1111/j.1398-9995.2011.02699.x; Marks GB, 2001, THORAX, V56, P468, DOI 10.1136/thorax.56.6.468; National Asthma Council Australia, 2017, AUSTR ASTHM HDB CLAS; Nehme Z, 2015, CIRC-CARDIOVASC QUAL, V8, P56, DOI 10.1161/CIRCOUTCOMES.114.001185; PACKE GE, 1985, LANCET, V2, P199; Perkins GD, 2015, CIRCULATION, V132, P1286, DOI 10.1161/CIR.0000000000000144; Pulimood TB, 2007, J ALLERGY CLIN IMMUN, V120, P610, DOI 10.1016/j.jaci.2007.04.045; Schappi GF, 1998, AEROBIOLOGIA, V14, P29, DOI DOI 10.1007/BF02694592; SUPHIOGLU C, 1992, LANCET, V339, P569, DOI 10.1016/0140-6736(92)90864-Y; Taylor PE, 2004, CURR ALLERGY ASTHM R, V4, P409, DOI 10.1007/s11882-004-0092-3; Taylor PE, 2002, J ALLERGY CLIN IMMUN, V109, P51, DOI 10.1067/mai.2002.120759; Victorian Government, 2013, STAT HLTH EM RESP PL; Wardman A E Dennis, 2002, Can Respir J, V9, P267; Wark PAB, 2002, CLIN EXP ALLERGY, V32, P1750, DOI 10.1046/j.1365-2222.2002.01556.x; Waters J, 1993, N S W PUBLIC HLTH B, V4, P100, DOI [10.1071/NB93049, DOI 10.1071/NB93049]; Weichenthal S, 2016, AM J EPIDEMIOL, V183, P613, DOI 10.1093/aje/kwv252	40	38	38	2	19	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 13	2017	359								j5636	10.1136/bmj.j5636	http://dx.doi.org/10.1136/bmj.j5636			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FQ4KY	29237604	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000418327500009
J	Llibre, JM; Hung, CC; Brinson, C; Castelli, F; Girard, PM; Kahl, LP; Blair, EA; Angelis, K; Wynne, B; Vandermeulen, K; Underwood, M; Smith, K; Gartland, M; Aboud, M				Llibre, Josep M.; Hung, Chien-Ching; Brinson, Cynthia; Castelli, Francesco; Girard, Pierre-Marie; Kahl, Lesley P.; Blair, Elizabeth A.; Angelis, Kostas; Wynne, Brian; Vandermeulen, Kati; Underwood, Mark; Smith, Kim; Gartland, Martin; Aboud, Michael			Efficacy, safety, and tolerability of dolutegravir-rilpivirine for the maintenance of virological suppression in adults with HIV-1: phase 3, randomised, non-inferiority SWORD-1 and SWORD-2 studies	LANCET			English	Article							HIV-1-INFECTED PATIENTS; DOUBLE-BLIND; OPEN-LABEL; PLUS LAMIVUDINE; TRIAL; SIMPLIFICATION; INFECTION; MULTICENTER; RITONAVIR; ABACAVIR	Background Lifelong HIV antiretroviral therapy (ART) has prompted an interest in two-drug regimens to minimise cumulative drug exposure and toxicities. The safety, tolerability, and efficacy of dolutegravir and rilpivirine suggest potential compatibility and effectiveness as a two-drug regimen. We aimed to investigate this two-drug regimen in a phase 3 study. Methods We identically designed SWORD-1 and SWORD-2, which were open-label, parallel-group, multicentre, phase 3, randomised, non-inferiority studies in 12 countries evaluating efficacy and safety of once-daily dolutegravir 50 mg plus rilpivirine 25 mg versus current ART regimen (CAR). We included participants aged 18 years or older who were on first or second ART with stable plasma HIV-1 RNA (viral load <50 copies per mL) for 6 months or longer at screening. We randomly assigned participants (1: 1) with stratification by third-agent class, age, and planned participation in a bone mineral density substudy. The primary endpoint was proportion of participants with viral load lower than 50 copies per mL at week 48 among those individuals who received one or more doses of study medication. Investigators monitored adverse events to assess safety. These trials are registered with ClinicalTrials.gov, numbers NCT02429791 (SWORD-1) and NCT02422797 (SWORD-2). Findings We screened for participants from April 14, 2015, to Oct 15, 2015, for SWORD-1 and from April 21, 2015, to Sept 25, 2015, for SWORD-2. We randomly assigned 516 participants to dolutegravir-rilpivirine and 512 to continue with CAR. At week 48 (last patient visit was Nov 22, 2016), in the pooled analysis of the intention-to-treat population, 95% of participants had viral loads lower than 50 copies per mL in each group (486 of 513 in the dolutegravir-rilpivirine group vs 485 of 511 in the CAR group), with an adjusted treatment difference of -0 . 2% (95% CI -3 . 0 to 2 . 5) and showed non-inferiority with a predefined margin of -8%. 395 (77%) of 513 participants in the dolutegravir-rilpivirine group and 364 (71%) of 511 participants in the CAR group reported adverse events. The most common adverse events were nasopharyngitis (49 [10%] for dolutegravir-rilpivirine vs 50 [10%] for CAR) and headache (41 [8%] vs 23 [5%]). More participants taking dolutegravir-rilpivirine (17 [3%]) reported adverse events leading to withdrawal than did participants taking CAR (three [< 1%]). Interpretation Dolutegravir-rilpivirine was non-inferior to CAR over 48 weeks in participants with HIV suppression and showed a safety profile consistent with its components. Results support the use of this two-drug regimen to maintain HIV suppression.	[Llibre, Josep M.] Univ Hosp Germans Trias, Infect Dis, Barcelona, Spain; [Llibre, Josep M.] Fight AIDS Fdn, Barcelona, Spain; [Hung, Chien-Ching] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei, Taiwan; [Hung, Chien-Ching] Natl Taiwan Univ, Coll Med, Taipei, Taiwan; [Brinson, Cynthia] Cent Texas Clin Res, Austin, TX USA; [Castelli, Francesco] Univ Brescia, Univ Dept Infect & Trop, Brescia, Italy; [Castelli, Francesco] Azienda Socio Sanitaria Terr Spedali Civili Bresc, Brescia, Italy; [Girard, Pierre-Marie] St Antoine Hosp, AP HP, Paris, France; [Kahl, Lesley P.; Aboud, Michael] ViiV Healthcare, 980 Great West Rd, Brentford TW8 9GS, England; [Blair, Elizabeth A.; Underwood, Mark; Smith, Kim; Gartland, Martin] ViiV Healthcare, Res Triangle Pk, NC USA; [Angelis, Kostas] GlaxoSmithKline, Uxbridge, Middx, England; [Wynne, Brian] ViiV Healthcare, Collegeville, PA USA; [Vandermeulen, Kati] Janssen Pharmaceut NV, Beerse, Belgium	National Taiwan University; National Taiwan University Hospital; National Taiwan University; University of Brescia; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; Johnson & Johnson; Janssen Pharmaceuticals	Kahl, LP (corresponding author), ViiV Healthcare, 980 Great West Rd, Brentford TW8 9GS, England.	lesley.p.kahl@viivhealthcare.com		Underwood, Mark/0000-0002-6803-2346; Castelli, Francesco/0000-0001-9161-7804	ViiV Healthcare; Janssen Pharmaceutica NV	ViiV Healthcare; Janssen Pharmaceutica NV(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc)	ViiV Healthcare and Janssen Pharmaceutica NV.	Achhra AC, 2016, LANCET HIV, V3, pE351, DOI 10.1016/S2352-3018(16)30015-7; Baril JG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148231; Castagna A, 2014, J INFECT DIS, V210, P354, DOI 10.1093/infdis/jiu051; Ciaffi L, 2017, LANCET HIV, V4, pE384, DOI 10.1016/S2352-3018(17)30069-3; Clotet B, 2014, LANCET, V383, P2222, DOI 10.1016/S0140-6736(14)60084-2; Cohen CJ, 2012, JAIDS-J ACQ IMM DEF, V60, P33, DOI 10.1097/QAI.0b013e31824d006e; Cottrell ML, 2013, CLIN PHARMACOKINET, V52, P981, DOI 10.1007/s40262-013-0093-2; de Mendoza C, 2016, AIDS REV, V18, P223; Di Giambenedetto S, 2017, J ANTIMICROB CHEMOTH, V72, P1163, DOI 10.1093/jac/dkw557; Fettiplace A, 2017, JAIDS-J ACQ IMM DEF, V74, P423, DOI 10.1097/qai.0000000000001269; Gallant J, 2017, LANCET, V390, P2063, DOI [10.1016/S0140-6736(17)32299-7, 10.1016/s0140-6736(17)32299-7]; Gantner P, 2017, HIV MED, V18, P704, DOI 10.1111/hiv.12506; Goebel F, 2006, AIDS, V20, P1721, DOI 10.1097/01.aids.0000242818.65215.bd; Kelly SG, 2016, DRUGS, V76, P523, DOI 10.1007/s40265-016-0553-8; Kobayashi M, 2011, ANTIMICROB AGENTS CH, V55, P813, DOI 10.1128/AAC.01209-10; Lv ZT, 2015, HIV AIDS-RES PALLIAT, V7, P95, DOI 10.2147/HIV.S79956; Min S, 2010, ANTIMICROB AGENTS CH, V54, P254, DOI 10.1128/AAC.00842-09; Mulligan K, 2015, CLIN INFECT DIS, V61, P572, DOI 10.1093/cid/civ324; Palella FJ, 2014, AIDS, V28, P335, DOI 10.1097/QAD.0000000000000087; Trottier B, 2017, ANTIVIR THER, V22, P295, DOI 10.3851/IMP3166; U.S. Food and Drug Administration (FDA) Guidance, 2015, HUM IMM VIR 1 INF DE; Vingerhoets J, 2013, ANTIVIR THER, V18, P253, DOI 10.3851/IMP2358; Walmsley SL, 2013, NEW ENGL J MED, V369, P1807, DOI 10.1056/NEJMoa1215541; Wensing Annemarie M, 2015, Top Antivir Med, V23, P132	24	237	241	2	42	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 3	2018	391	10123					839	849		10.1016/S0140-6736(17)33095-7	http://dx.doi.org/10.1016/S0140-6736(17)33095-7			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FX9XF	29310899				2022-12-28	WOS:000426463500021
J	Welch, HG; Brawley, OW				Welch, H. Gilbert; Brawley, Otis W.			Scrutiny-Dependent Cancer and Self-fulfilling Risk Factors	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							PROSTATE-CANCER; BREAST-CANCER; OVERDIAGNOSIS		[Welch, H. Gilbert] Dartmouth Coll, Tuck 203B, Hanover, NH 03755 USA; [Brawley, Otis W.] Amer Canc Soc, 250 Williams St,Suite 600, Atlanta, GA 30303 USA	Dartmouth College; American Cancer Society	Welch, HG (corresponding author), Dartmouth Coll, Tuck 203B, Hanover, NH 03755 USA.	h.gilbert.welch@dartmouth.edu						Albertsen PC, 2016, J CLIN ONCOL, V34, P4310, DOI 10.1200/JCO.2016.70.4742; Berwick M, 2005, J NATL CANCER I, V97, P195, DOI 10.1093/jnci/dji019; Conroy SM, 2017, CANCER EPIDEM BIOMAR, V26, P541, DOI 10.1158/1055-9965.EPI-16-0935; Hayse B, 2016, SURGERY, V160, P454, DOI 10.1016/j.surg.2016.03.031; Tangen CM, 2016, J CLIN ONCOL, V34, P4338, DOI 10.1200/JCO.2016.68.1965; Welch HG, 2010, J NATL CANCER I, V102, P605, DOI 10.1093/jnci/djq099	6	24	24	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 16	2018	168	2					143	+		10.7326/M17-2792	http://dx.doi.org/10.7326/M17-2792			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FU8IN	29297002				2022-12-28	WOS:000424096600019
J	Perry, RJ; Wang, YL; Cline, GW; Rabin-Court, A; Song, JYD; Dufour, S; Zhang, XM; Petersen, KF; Shulman, GI				Perry, Rachel J.; Wang, Yongliang; Cline, Gary W.; Rabin-Court, Aviva; Song, Joongyu D.; Dufour, Sylvie; Zhang, Xian Man; Petersen, Kitt Falk; Shulman, Gerald I.			Leptin Mediates a Glucose-Fatty Acid Cycle to Maintain Glucose Homeostasis in Starvation	CELL			English	Article							HEPATIC INSULIN-RESISTANCE; ADIPOSE-TISSUE INFLAMMATION; MALONYL-COA; BODY-WEIGHT; ACTIVATION; MECHANISM; GLUCONEOGENESIS; RESTRICTION; SUPPRESSION; METABOLISM	The transition from the fed to the fasted state necessitates a shift from carbohydrate to fat metabolism that is thought to be mostly orchestrated by reductions in plasma insulin concentrations. Here, we show in awake rats that insulinopenia per se does not cause this transition but that both hypoleptinemia and insulinopenia are necessary. Furthermore, we show that hypoleptinemia mediates a glucosefatty acid cycle through activation of the hypothalamic- pituitary-adrenal axis, resulting in increased white adipose tissue (WAT) lipolysis rates and increased hepatic acetyl-coenzyme A (CoA) content, which are essential to maintain gluconeogenesis during starvation. We also show that in prolonged starvation, substrate limitation due to reduced rates of glucose-alanine cycling lowers rates of hepatic mitochondrial anaplerosis, oxidation, and gluconeogenesis. Taken together, these data identify a leptin-mediated glucose-fatty acid cycle that integrates responses of the muscle, WAT, and liver to promote a shift from carbohydrate to fat oxidation and maintain glucose homeostasis during starvation.	[Perry, Rachel J.; Wang, Yongliang; Cline, Gary W.; Rabin-Court, Aviva; Song, Joongyu D.; Zhang, Xian Man; Petersen, Kitt Falk; Shulman, Gerald I.] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06520 USA; [Shulman, Gerald I.] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06520 USA; [Dufour, Sylvie; Shulman, Gerald I.] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06520 USA	Yale University; Yale University; Howard Hughes Medical Institute; Yale University	Shulman, GI (corresponding author), Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06520 USA.; Shulman, GI (corresponding author), Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06520 USA.; Shulman, GI (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06520 USA.	gerald.shulman@yale.edu	Shulman, Gerald I./P-7176-2019	Shulman, Gerald I./0000-0003-1529-5668; Wang, Yongliang/0000-0002-1494-0496; Perry, Rachel/0000-0003-0748-8064; Song, Joongyu/0000-0001-5475-5589	United States Public Health Service [R01 DK113984, R01 DK40936, P30 DK059635, R01 AG23686, T32 DK101019, K99 CA215315, R01 NS087568, UL1TR000142]; NATIONAL CANCER INSTITUTE [K99CA215315] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000142, UL1TR001863] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK101019, R01DK113984, U24DK059635, P30DK045735, R01DK040936] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS087568] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG023686] Funding Source: NIH RePORTER	United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors thank Jianying Dong, Mario Kahn, Dongyan Zhang, Gina Butrico, Irina Smolgovsky, Maria Batsu, and Codruta Todeasa for their valuable technical contributions. This study was funded by grants from the United States Public Health Service (R01 DK113984, R01 DK40936, P30 DK059635, R01 AG23686, T32 DK101019, K99 CA215315, R01 NS087568, UL1TR000142).	Ahima RS, 2008, MOL ENDOCRINOL, V22, P1023, DOI 10.1210/me.2007-0529; [Anonymous], CURR OBES REP, V6, P334; Benedict F.G., 1915, STUDY PROLONGED FAST; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Cahill G F Jr, 1970, N Engl J Med, V282, P668, DOI 10.1056/NEJM197003052821026; Chan JL, 2003, J CLIN INVEST, V111, P1409, DOI 10.1172/JCI200317490; Denroche HC, 2015, DIABETOLOGIA, V58, P1100, DOI 10.1007/s00125-015-3529-4; Denroche HC, 2011, DIABETES, V60, P1414, DOI 10.2337/db10-0958; FELIG P, 1969, ARCH INTERN MED, V123, P293, DOI 10.1001/archinte.123.3.293; Flier JS, 2000, J CLIN INVEST, V105, P859, DOI 10.1172/JCI9725; JENSEN MD, 1989, DIABETES, V38, P1595, DOI 10.2337/diabetes.38.12.1595; Jurczak MJ, 2012, J BIOL CHEM, V287, P2558, DOI 10.1074/jbc.M111.316760; Jurczak MJ, 2011, DIABETES, V60, P890, DOI 10.2337/db10-1328; Karl JP, 2016, METABOLISM, V65, P416, DOI 10.1016/j.metabol.2015.11.001; Kim KH, 2014, DIABETES METAB J, V38, P245, DOI 10.4093/dmj.2014.38.4.245; Kliewer SA, 2010, AM J CLIN NUTR, V91, p254S, DOI 10.3945/ajcn.2009.28449B; LEIMER KR, 1977, J CHROMATOGR, V141, P121, DOI 10.1016/S0021-9673(00)99131-3; Levin N, 1996, P NATL ACAD SCI USA, V93, P1726, DOI 10.1073/pnas.93.4.1726; Luan B, 2014, CELL METAB, V19, P1058, DOI 10.1016/j.cmet.2014.03.024; MCGARRY JD, 1978, J BIOL CHEM, V253, P8291; Morton GJ, 2015, J CLIN INVEST, V125, P4587, DOI 10.1172/JCI82723; Pasiakos SM, 2011, OBESITY, V19, P1124, DOI 10.1038/oby.2010.316; PELLEYMOUNTER MA, 1995, SCIENCE, V269, P540, DOI 10.1126/science.7624776; Perry RJ, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01143-w; Perry RJ, 2017, CELL METAB, V25, P749, DOI 10.1016/j.cmet.2016.12.017; Perry RJ, 2017, J CLIN INVEST, V127, P657, DOI 10.1172/JCI88477; Perry RJ, 2016, DIABETOLOGIA, V59, P933, DOI 10.1007/s00125-016-3909-4; Perry RJ, 2015, CELL, V160, P745, DOI 10.1016/j.cell.2015.01.012; Perry RJ, 2014, NAT MED, V20, P759, DOI 10.1038/nm.3579; Petersen MC, 2016, J CLIN INVEST, V126, P4361, DOI 10.1172/JCI86013; Ravussin Y, 2014, MOL METAB, V3, P432, DOI 10.1016/j.molmet.2014.02.003; ROTHMAN DL, 1991, SCIENCE, V254, P573, DOI 10.1126/science.1948033; SAGGERSON ED, 1981, FEBS LETT, V132, P166, DOI 10.1016/0014-5793(81)81152-0; Samuel VT, 2007, J CLIN INVEST, V117, P739, DOI 10.1172/JCI30400; Samuel VT, 2004, J BIOL CHEM, V279, P32345, DOI 10.1074/jbc.M313478200; Schorr M, 2017, NAT REV ENDOCRINOL, V13, P174, DOI 10.1038/nrendo.2016.175; Shibuya I, 2002, ANN NY ACAD SCI, V971, P522, DOI 10.1111/j.1749-6632.2002.tb04517.x; SHULMAN GI, 1987, J CLIN INVEST, V80, P387, DOI 10.1172/JCI113084; Vatner DF, 2015, P NATL ACAD SCI USA, V112, P1143, DOI 10.1073/pnas.1423952112; Villareal DT, 2016, J BONE MINER RES, V31, P40, DOI 10.1002/jbmr.2701; Yu CL, 2002, J BIOL CHEM, V277, P50230, DOI 10.1074/jbc.M200958200	41	78	83	2	42	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 11	2018	172	1-2					234	+		10.1016/j.cell.2017.12.001	http://dx.doi.org/10.1016/j.cell.2017.12.001			32	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FS5MI	29307489	Green Accepted, Bronze			2022-12-28	WOS:000419840100022
J	Ramsuran, V; Naranbhai, V; Horowitz, A; Qi, Y; Martin, MP; Yuki, Y; Gao, XJ; Walker-Sperling, V; Del Prete, GQ; Schneider, DK; Lifson, JD; Fellay, J; Deeks, SG; Martin, JN; Goedert, JJ; Wolinsky, SM; Michael, NL; Kirk, GD; Buchbinder, S; Haas, D; Ndung'u, T; Goulder, P; Parham, P; Walker, BD; Carlson, JM; Carrington, M				Ramsuran, Veron; Naranbhai, Vivek; Horowitz, Amir; Qi, Ying; Martin, Maureen P.; Yuki, Yuko; Gao, Xiaojiang; Walker-Sperling, Victoria; Del Prete, Gregory Q.; Schneider, Douglas K.; Lifson, Jeffrey D.; Fellay, Jacques; Deeks, Steven G.; Martin, Jeffrey N.; Goedert, James J.; Wolinsky, Steven M.; Michael, Nelson L.; Kirk, Gregory D.; Buchbinder, Susan; Haas, David; Ndung'u, Thumbi; Goulder, Philip; Parham, Peter; Walker, Bruce D.; Carlson, Jonathan M.; Carrington, Mary			Elevated HLA-A expression impairs HIV control through inhibition of NKG2A-expressing cells	SCIENCE			English	Article							C EXPRESSION; RECEPTOR CD94/NKG2A; DOWN-REGULATION; INFECTED CELLS; NK CELLS; TRANSPLANTATION; ASSOCIATION; VARIANTS; PROTEINS; DISEASE	The highly polymorphic human leukocyte antigen (HLA) locus encodes cell surface proteins that are critical for immunity. HLA-A expression levels vary in an allele-dependent manner, diversifying allele-specific effects beyond peptide-binding preference. Analysis of 9763 HIV-infected individuals from 21 cohorts shows that higher HLA-A levels confer poorer control of HIV. Elevated HLA-A expression provides enhanced levels of an HLA-A-derived signal peptide that specifically binds and determines expression levels of HLA-E, the ligand for the inhibitory NKG2A natural killer (NK) cell receptor. HLA-B haplotypes that favor NKG2A-mediated NK cell licensing (i.e., education) exacerbate the deleterious effect of high HLA-A on HIV control, consistent with NKG2A-mediated inhibition impairing NK cell clearance of HIV-infected targets. Therapeutic blockade of HLA-E: NKG2A interaction may yield benefit in HIV disease.	[Ramsuran, Veron; Naranbhai, Vivek; Qi, Ying; Martin, Maureen P.; Yuki, Yuko; Gao, Xiaojiang; Carrington, Mary] Leidos Biomed Res Inc, Canc & Inflammat Program, Frederick Natl Lab Canc Res, Frederick, MD 21702 USA; [Ramsuran, Veron; Naranbhai, Vivek; Ndung'u, Thumbi; Walker, Bruce D.; Carrington, Mary] Ragon Inst Massachusetts Gen Hosp Massachusetts I, Cambridge, MA 02139 USA; [Ramsuran, Veron] Univ KwaZulu Natal, Sch Lab Med & Med Sci, KwaZulu Natal Res Innovat & Sequencing Platform K, Durban, South Africa; [Ramsuran, Veron; Naranbhai, Vivek] Ctr AIDS Programme Res South Africa CAPRISA, Durban, South Africa; [Naranbhai, Vivek] Univ Oxford, Nuffield Dept Med, Wellcome Trust Ctr Human Genet, Oxford, England; [Horowitz, Amir] Icahn Sch Med Mt Sinai, Dept Oncol Sci, Precis Immunol Inst, New York, NY 10029 USA; [Walker-Sperling, Victoria] NCI, Canc & Inflammat Program, Ctr Canc Res, NIH, Frederick, MD 21702 USA; [Del Prete, Gregory Q.; Schneider, Douglas K.; Lifson, Jeffrey D.] Leidos Biomed Res Inc, AIDS & Canc Virus Program, Frederick Natl Lab Canc Res, Frederick, MD 21702 USA; [Fellay, Jacques] Ecole Polytech Fed Lausanne, Sch Life Sci, Lausanne, Switzerland; [Fellay, Jacques] Swiss Inst Bioinformat, Lausanne, Switzerland; [Deeks, Steven G.; Buchbinder, Susan] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Martin, Jeffrey N.; Buchbinder, Susan] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Goedert, James J.] NCI, Infect & Immunoepidemiol Branch, Div Canc Epidemiol & Genet, NIH, Rockville, MD 20850 USA; [Wolinsky, Steven M.] Northwestern Univ, Div Infect Dis, Feinberg Sch Med, Chicago, IL 60611 USA; [Michael, Nelson L.] Walter Reed Army Inst Res, US Mil HIV Res Program, Silver Spring, MD 20910 USA; [Kirk, Gregory D.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA; [Buchbinder, Susan] San Francisco Dept Publ Hlth, HIV Res Sect, San Francisco, CA 94102 USA; [Haas, David] Vanderbilt Univ, Sch Med, Nashville, TN 37232 USA; [Ndung'u, Thumbi; Goulder, Philip; Walker, Bruce D.] African Hlth Res Inst, Durban, South Africa; [Ndung'u, Thumbi] Univ KwaZulu Natal, HIV Pathogenesis Programme, Doris Duke Med Res Inst, Nelson R Mandela Sch Med, Durban, South Africa; [Ndung'u, Thumbi] Max Planck Inst Infect Biol, Berlin, Germany; [Goulder, Philip] Univ Oxford, Dept Paediat, Oxford, England; [Parham, Peter] Stanford Univ, Dept Struct Biol, Stanford, CA 94305 USA; [Parham, Peter] Stanford Univ, Dept Microbiol & Immunol, Stanford, CA 94305 USA; [Walker, Bruce D.] MIT, Inst Med & Engn Sci, Cambridge, MA 02139 USA; [Carlson, Jonathan M.] Microsoft Res, Redmond, WA 98052 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; University of Kwazulu Natal; University of Oxford; Wellcome Centre for Human Genetics; Icahn School of Medicine at Mount Sinai; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute of Bioinformatics; University of California System; University of California San Francisco; University of California System; University of California San Francisco; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Northwestern University; Feinberg School of Medicine; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; San Francisco Department of Public Health; Vanderbilt University; University of Kwazulu Natal; Max Planck Society; University of Oxford; Stanford University; Stanford University; Massachusetts Institute of Technology (MIT); Microsoft	Carrington, M (corresponding author), Leidos Biomed Res Inc, Canc & Inflammat Program, Frederick Natl Lab Canc Res, Frederick, MD 21702 USA.; Carrington, M (corresponding author), Ragon Inst Massachusetts Gen Hosp Massachusetts I, Cambridge, MA 02139 USA.	carringm@mail.nih.gov	Fellay, Jacques/A-6681-2009; Wolinsky, Steven/B-2893-2012	Fellay, Jacques/0000-0002-8240-939X; Ndung'u, Thumbi/0000-0003-2962-3992; Naranbhai, Vivek/0000-0003-4281-8882; Ramsuran, Veron/0000-0003-1590-9893; Deeks, Steven/0000-0001-6371-747X	National Cancer Institute, National Institutes of Health; Collaboration for AIDS Vaccine Discovery of the Bill and Melinda Gates Foundation; Howard Hughes Medical Institute; International AIDS Vaccine Initiative; South Africa National Research Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI068636, R01AI133673, U01AI035039, UM1AI069496, UM1AI068634] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Collaboration for AIDS Vaccine Discovery of the Bill and Melinda Gates Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute); International AIDS Vaccine Initiative; South Africa National Research Foundation(National Research Foundation - South Africa); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank the volunteers in the contributing cohorts, their health-care providers, and the investigators involved in data collection. This work was supported by the National Cancer Institute, National Institutes of Health, and the Collaboration for AIDS Vaccine Discovery of the Bill and Melinda Gates Foundation. Additional funding was provided by the Howard Hughes Medical Institute (T.N.), International AIDS Vaccine Initiative, and South Africa National Research Foundation. See the extended acknowledgments in the supplementary materials for full details. Data and code to understand and assess the conclusions of this research are available in the main text, supplementary materials, or upon request of the authors. Genotyping of samples was subject to materials transfer agreements and institutional review board approved protocols, full details of which have been supplied to Science. V.N., V.R., A.H., J.M.C, and M.C. conceived and designed the study. All authors contributed to the generation, acquisition, analysis, and/or interpretation of data. V.N., V.R., and M.C. drafted the manuscript. All authors critically reviewed the manuscript for important intellectual content and approved the final version of the manuscript. This work is licensed under a Creative Commons Attribution 4.0 International (CC BY 4.0) license, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. This license does not apply to figures/photos/artwork or other content included in the article that is credited to a third party; obtain authorization from the rights holder before using such material.	Apps R, 2016, CELL HOST MICROBE, V19, P686, DOI 10.1016/j.chom.2016.04.005; Apps R, 2015, J IMMUNOL, V194, P3594, DOI 10.4049/jimmunol.1403234; Apps R, 2013, SCIENCE, V340, P87, DOI 10.1126/science.1232685; Beziat V, 2011, BLOOD, V117, P4394, DOI 10.1182/blood-2010-11-319194; Braud VM, 1998, NATURE, V391, P795, DOI 10.1038/35869; Brodin P, 2009, TRENDS IMMUNOL, V30, P143, DOI 10.1016/j.it.2009.01.006; Carlson JM, 2016, NAT MED, V22, P606, DOI 10.1038/nm.4100; Cohen GB, 1999, IMMUNITY, V10, P661, DOI 10.1016/S1074-7613(00)80065-5; Davis ZB, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005421; Horowitz A, 2016, SCI IMMUNOL, V1, DOI 10.1126/sciimmunol.aag1672; Ibrahim EC, 2003, AM J PATHOL, V162, P501, DOI 10.1016/S0002-9440(10)63844-8; KAUFMAN J, 1995, IMMUNOL REV, V143, P63, DOI 10.1111/j.1600-065X.1995.tb00670.x; Kulkarni S, 2011, NATURE, V472, P495, DOI 10.1038/nature09914; Lee N, 1998, J IMMUNOL, V160, P4951; Lee N, 1998, P NATL ACAD SCI USA, V95, P5199, DOI 10.1073/pnas.95.9.5199; Manguso RT, 2017, NATURE, V547, P413, DOI 10.1038/nature23270; Merino AM, 2013, CLIN EXP IMMUNOL, V174, P414, DOI 10.1111/cei.12187; Moser JM, 2002, NAT IMMUNOL, V3, P189, DOI 10.1038/ni757; Nattermann J, 2005, ANTIVIR THER, V10, P95; Orr MT, 2010, CELL, V142, P847, DOI 10.1016/j.cell.2010.08.031; Pereyra FP, 2010, SCIENCE, V330, P1551, DOI 10.1126/science.1195271; Petersdorf EW, 2015, NEW ENGL J MED, V373, P599, DOI 10.1056/NEJMoa1500140; Petersdorf EW, 2014, BLOOD, V124, P3996, DOI 10.1182/blood-2014-09-599969; Raj P, 2016, ELIFE, V5, DOI 10.7554/eLife.12089; Ramsuran V, 2017, J IMMUNOL, V198, P2320, DOI 10.4049/jimmunol.1601679; Ramsuran V, 2015, HUM MOL GENET, V24, P4268, DOI 10.1093/hmg/ddv158; Strong RK, 2003, J BIOL CHEM, V278, P5082, DOI 10.1074/jbc.M208268200; Vince N, 2016, AM J HUM GENET, V99, P1353, DOI 10.1016/j.ajhg.2016.09.023; Wada H, 2004, EUR J IMMUNOL, V34, P81, DOI 10.1002/eji.200324432; Wieten L, 2014, TISSUE ANTIGENS, V84, P523, DOI 10.1111/tan.12478; Wissemann WT, 2013, AM J HUM GENET, V93, P984, DOI 10.1016/j.ajhg.2013.10.009	31	95	97	1	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 5	2018	359	6371					86	90		10.1126/science.aam8825	http://dx.doi.org/10.1126/science.aam8825			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FR8KW	29302013	Green Accepted, Green Submitted			2022-12-28	WOS:000419324700073
J	Schneider, FRN; Sana, H; Evans, CJ; Bestenlehner, JM; Castro, N; Fossati, L; Grafener, G; Langer, N; Ramirez-Agudelo, OH; Sabin-Sanjulian, C; Simon-Diaz, S; Tramper, F; Crowther, PA; de Koter, A; de Mink, SE; Dufton, PL; Garcia, M; Gieles, M; Henault-Brunet, V; Herrero, A; Izzard, RG; Kalari, V; Lennon, DJ; Apellaniz, JM; Markova, N; Najarro, F; Podsiadlowski, P; Puls, J; Taylor, WD; van Loon, JT; Vink, JS; Norman, C				Schneider, F. R. N.; Sana, H.; Evans, C. J.; Bestenlehner, J. M.; Castro, N.; Fossati, L.; Graefener, G.; Langer, N.; Ramirez-Agudelo, O. H.; Sabin-Sanjulian, C.; Simon-Diaz, S.; Tramper, F.; Crowther, P. A.; de Koter, A.; de Mink, S. E.; Dufton, P. L.; Garcia, M.; Gieles, M.; Henault-Brunet, V.; Herrero, A.; Izzard, R. G.; Kalari, V.; Lennon, D. J.; Apellaniz, J. Maiz; Markova, N.; Najarro, F.; Podsiadlowski, Ph.; Puls, J.; Taylor, W. D.; van Loon, J. Th.; Vink, J. S.; Norman, C.			An excess of massive stars in the local 30 Doradus starburst	SCIENCE			English	Article							LUMINOSITY FUNCTION; 1ST STARS; MILKY-WAY; STELLAR; GALAXIES; CLUSTERS; METALLICITY; UNIVERSE; DENSITY; REGIONS	The 30 Doradus star-forming region in the Large Magellanic Cloud is a nearby analog of large star-formation events in the distant universe. We determined the recent formation history and the initial mass function (IMF) of massive stars in 30 Doradus on the basis of spectroscopic observations of 247 stars more massive than 15 solar masses (M-circle dot). The main episode of massive star formation began about 8 million years (My) ago, and the star-formation rate seems to have declined in the last 1 My. The IMF is densely sampled up to 200 M-circle dot and contains 32 +/- 12% more stars above 30 M-circle dot than predicted by a standard Salpeter IMF. In the mass range of 15 to 200 M-circle dot, the IMF power-law exponent is 1.90(-0.26)(+0.37), shallower than the Salpeter value of 2.35.	[Schneider, F. R. N.; Podsiadlowski, Ph.] Univ Oxford, Dept Phys, Keble Rd, Oxford OX1 3RH, England; [Sana, H.; de Koter, A.] Katholieke Univ Leuven, Inst Astrophys, Celestijnenlaan 200D, B-3001 Leuven, Belgium; [Evans, C. J.; Ramirez-Agudelo, O. H.; Taylor, W. D.] Royal Observ Edinburgh, UK Astron Technol Ctr, Blackford Hill, Edinburgh EH9 3HJ, Midlothian, Scotland; [Bestenlehner, J. M.] Max Planck Inst Astronomie, Konigstuhl 17, D-69117 Heidelberg, Germany; [Bestenlehner, J. M.; Crowther, P. A.] Univ Sheffield, Dept Phys & Astron, Hicks Bldg,Hounsfield Rd, Sheffield S3 7RH, S Yorkshire, England; [Castro, N.] Univ Michigan, Dept Astron, 1085 South Univ Ave, Ann Arbor, MI 48109 USA; [Fossati, L.] Austrian Acad Sci, Space Res Inst, Schmiedlstr 6, A-8042 Graz, Austria; [Graefener, G.; Langer, N.; Podsiadlowski, Ph.] Univ Bonn, Argelander Inst Astron, Hugel 71, D-53121 Bonn, Germany; [Sabin-Sanjulian, C.] Univ La Serena, Dept Fis & Astron, Ave Juan Cisternas 1200 Norte, La Serena, Chile; [Simon-Diaz, S.; Herrero, A.] Inst Astrofis Canarias, E-38205 Tenerife, Spain; [Simon-Diaz, S.; Herrero, A.] Univ La Laguna, Dept Astrofis, E-38206 Tenerife, Spain; [Tramper, F.; Lennon, D. J.] European Space Astron Ctr, Miss Operat Div, POB 78, Madrid 28691, Spain; [de Koter, A.; de Mink, S. E.] Univ Amsterdam, Astron Inst Anton Pannekoek, Sci Pk 904, NL-1098 XH Amsterdam, Netherlands; [Dufton, P. L.] Queens Univ Belfast, Sch Math & Phys, Astrophys Res Ctr, Belfast BT7 1NN, Antrim, North Ireland; [Garcia, M.; Najarro, F.] INTA, CSIC, Ctr Astrobiol, Carretera Torrejon Ajalvir Km 4, E-28850 Madrid, Spain; [Gieles, M.; Izzard, R. G.] Univ Surrey, Dept Phys, Fac Engn & Phys Sci, Guildford GU2 7XH, Surrey, England; [Henault-Brunet, V.] Natl Res Council Herzberg Astron & Astrophys, 5071 West Saanich Rd, Victoria, BC V9E 2E7, Canada; [Henault-Brunet, V.] Radboud Univ Nijmegen, Dept Astrophys, Inst Math Astrophys & Particle Phys, POB 9010, NL-6500 GL Nijmegen, Netherlands; [Izzard, R. G.] The Observ, Inst Astron, Madingley Rd, Cambridge CB3 0HA, England; [Kalari, V.] Univ Chile, Dept Astron, Camino El Observ 1515,Casilla 36-D, Santiago, Chile; [Apellaniz, J. Maiz] INTA, CSIC, Ctr Astrobiol, European Space Astron Ctr Campus, E-28692 Villanueva De La Canada, Spain; [Markova, N.] Bulgarian Acad Sci, Inst Astron Natl Astron Observ, POB 136, Smoljan 4700, Bulgaria; [Puls, J.] Ludwig Maximilians Univ Munchen, Univ Sternwarte, Scheinerstr 1, D-81679 Munich, Germany; [van Loon, J. Th.] Keele Univ, Lennard Jones Labs, Keele ST5 5BG, Staffs, England; [Vink, J. S.] Armagh Observ, Coll Hill, Armagh BT61 9DG, North Ireland; [Norman, C.] Johns Hopkins Univ, Homewood Campus, Baltimore, MD 21218 USA; [Norman, C.] Space Telescope Sci Inst, 3700 San Martin Dr, Baltimore, MD 21218 USA	University of Oxford; KU Leuven; University of Edinburgh; University of Sheffield; University of Michigan System; University of Michigan; Austrian Academy of Sciences; University of Bonn; Universidad de La Serena; Instituto de Astrofisica de Canarias; Universidad de la Laguna; European Space Agency; University of Amsterdam; Queens University Belfast; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Astrobiologia (INTA); University of Surrey; National Research Council Canada; Radboud University Nijmegen; University of Cambridge; Universidad de Chile; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Astrobiologia (INTA); Bulgarian Academy of Sciences; University of Munich; Keele University; Johns Hopkins University; Space Telescope Science Institute	Schneider, FRN (corresponding author), Univ Oxford, Dept Phys, Keble Rd, Oxford OX1 3RH, England.	fabian.schneider@physics.ox.ac.uk	Langer, Norbert/ABD-7263-2021; Tramper, Frank/A-3786-2019; Najarro, Francisco/G-7288-2015; Vink, Jorick/AAR-1401-2021; Castro, Norberto/L-2852-2017; Gieles, Mark/AAP-6403-2020; Sana, Hugues/B-2664-2013; Herrero, Artemio/H-7312-2015; Simón-Díaz, Sergio/AAE-1921-2019	Tramper, Frank/0000-0001-8631-7700; Najarro, Francisco/0000-0002-9124-0039; Vink, Jorick/0000-0002-8445-4397; Castro, Norberto/0000-0003-0521-473X; Gieles, Mark/0000-0002-9716-1868; Sana, Hugues/0000-0001-6656-4130; Simón-Díaz, Sergio/0000-0003-1168-3524; Ramirez Agudelo, Oscar Hernan/0000-0002-9379-5409; de Mink, Selma/0000-0001-9336-2825; Henault-Brunet, V./0000-0003-2927-5465; Schneider, Fabian/0000-0002-5965-1022; Fossati, Luca/0000-0003-4426-9530; Izzard, Robert/0000-0003-0378-4843; Grafener, Gotz/0000-0002-5249-8547	European Southern Observatory (ESO) [182.D-0222]; Oxford Hintze Centre for Astrophysical Surveys; Hintze Family Charitable Foundation; FWO-Odysseus program [G0F8H6N]; Deutsche Forschungsgemeinschaft [GR 1717/5]; European Union's Horizon 2020 research and innovation program under a Marie Sklodowska-Curie grant [665593]; CONICYT-Chile through the FONDECYT Postdoctoral Project [3170778]; Spanish Ministry of Economy and Competitiveness (MINECO) [AYA2015-68012-C2-1, SEV2015-0548]; European Union's Horizon 2020 research and innovation program from the European Commission under a Marie Sklodowska-Curie grant [661502]; European Research Council (ERC) [715063]; Spanish MINECO [FIS2012-39162-C06-01, ESP2015-65597-C4-1-R]; Royal Society (University Research Fellowship); European Research Council (CLUSTERS) [ERC StG-335936]; STFC [ST/L003910/1]; Churchill College, Cambridge; FONDECYT-Chile fellowship [3160117]; Spanish government Ministerio de Economia y Competitividad (MINECO) [AYA2016-75931-C2-2-P]; Bulgarian National Science Fund [DN08/1/13.12.2016]; Association of Universities for Research in Astronomy under NASA [NAS5-26555]; ESO's Science Archive Facility [182.D-0222]; STFC [ST/L003910/2, ST/H001921/1] Funding Source: UKRI	European Southern Observatory (ESO); Oxford Hintze Centre for Astrophysical Surveys; Hintze Family Charitable Foundation; FWO-Odysseus program; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Union's Horizon 2020 research and innovation program under a Marie Sklodowska-Curie grant; CONICYT-Chile through the FONDECYT Postdoctoral Project; Spanish Ministry of Economy and Competitiveness (MINECO)(Spanish Government); European Union's Horizon 2020 research and innovation program from the European Commission under a Marie Sklodowska-Curie grant; European Research Council (ERC)(European Research Council (ERC)European Commission); Spanish MINECO(Spanish Government); Royal Society (University Research Fellowship)(Royal Society of London); European Research Council (CLUSTERS); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Churchill College, Cambridge; FONDECYT-Chile fellowship; Spanish government Ministerio de Economia y Competitividad (MINECO)(Spanish Government); Bulgarian National Science Fund(National Science Fund of Bulgaria); Association of Universities for Research in Astronomy under NASA; ESO's Science Archive Facility; STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	We thank the referees for constructive feedback that helped to improve this work. Our findings are based on observations collected at the European Southern Observatory (ESO) under program ID 182.D-0222. This work was supported by the Oxford Hintze Centre for Astrophysical Surveys, which is funded through generous support from the Hintze Family Charitable Foundation. H.S. acknowledges support from the FWO-Odysseus program under project G0F8H6N. G.G. acknowledges financial support from Deutsche Forschungsgemeinschaft grant GR 1717/5. O.H.R.-A. acknowledges funding from the European Union's Horizon 2020 research and innovation program under a Marie Sklodowska-Curie grant agreement (665593) awarded to the Science and Technology Facilities Council (STFC). C.S.-S. acknowledges support from CONICYT-Chile through the FONDECYT Postdoctoral Project (grant 3170778). S.S.-D. and A.H. thank the Spanish Ministry of Economy and Competitiveness (MINECO) for grants AYA2015-68012-C2-1 and SEV2015-0548. S.E.d.M. has received funding under the European Union's Horizon 2020 research and innovation program from the European Commission under a Marie Sklodowska-Curie grant agreement (661502) and the European Research Council (ERC) (grant agreement 715063). M.Ga. and F.N. acknowledge Spanish MINECO grants FIS2012-39162-C06-01 and ESP2015-65597-C4-1-R. M.Gi. acknowledges financial support from the Royal Society (University Research Fellowship) and the European Research Council (ERC StG-335936, CLUSTERS). R.G.I. thanks the STFC for funding his Rutherford fellowship under grant ST/L003910/1 and Churchill College, Cambridge, for his fellowship and access to their library. V.K. acknowledges funding from FONDECYT-Chile fellowship grant 3160117. J.M.A. acknowledges support from the Spanish government Ministerio de Economia y Competitividad (MINECO) through grant AYA2016-75931-C2-2-P. N.M. acknowledges the financial support of the Bulgarian National Science Fund under grant DN08/1/13.12.2016. The Space Telescope Science Institute is operated by the Association of Universities for Research in Astronomy under NASA contract NAS5-26555. C.J.E. is also a visiting professor at the University of Edinburgh. The raw VFTS observations are available from ESO's Science Archive Facility at http://archive.eso.org under project ID 182.D-0222. A web interface for the BONNSAI software is available at www.astro.uni-bonn.de/stars/bonnsai. Input and derived stellar parameters for all stars used in this study are provided in table S3 and in machine-readable form in data S1, the best-fitting SFH can be found in data S2, and our Python code for determining the stellar maximum birth masses is available in data S3.	Andersen M, 2009, ASTROPHYS J, V707, P1347, DOI 10.1088/0004-637X/707/2/1347; Bastian N, 2010, ANNU REV ASTRON ASTR, V48, P339, DOI 10.1146/annurev-astro-082708-101642; Baugh CM, 2005, MON NOT R ASTRON SOC, V356, P1191, DOI 10.1111/j.1365-2966.2004.08553.x; Blaauw A., 1961, BAN, V15, P265; Bromm V, 1999, ASTROPHYS J, V527, pL5, DOI 10.1086/312385; Ceverino D, 2009, ASTROPHYS J, V695, P292, DOI 10.1088/0004-637X/695/1/292; Cignoni M, 2015, ASTROPHYS J, V811, DOI 10.1088/0004-637X/811/2/76; Crowther PA, 2016, MON NOT R ASTRON SOC, V458, P624, DOI 10.1093/mnras/stw273; Crowther PA, 2010, MON NOT R ASTRON SOC, V408, P731, DOI 10.1111/j.1365-2966.2010.17167.x; Davies B, 2015, ASTROPHYS J, V806, DOI 10.1088/0004-637X/806/1/21; de Mink SE, 2014, ASTROPHYS J, V782, DOI 10.1088/0004-637X/782/1/7; Dib S, 2017, MON NOT R ASTRON SOC, V464, P1738, DOI 10.1093/mnras/stw2465; Doran EI, 2013, ASTRON ASTROPHYS, V558, DOI 10.1051/0004-6361/201321824; Figer DF, 2005, NATURE, V434, P192, DOI 10.1038/nature03293; Fujii MS, 2011, SCIENCE, V334, P1380, DOI 10.1126/science.1211927; Graham JF, 2017, ASTROPHYS J, V834, DOI 10.3847/1538-4357/834/2/170; Gunawardhana MLP, 2011, MON NOT R ASTRON SOC, V415, P1647, DOI 10.1111/j.1365-2966.2011.18800.x; HUMMER DG, 1988, ASTROPHYS J, V328, P704, DOI 10.1086/166328; Japelj J, 2016, ASTRON ASTROPHYS, V593, DOI 10.1051/0004-6361/201628603; KENNICUTT RC, 1988, ASTRON J, V95, P720, DOI 10.1086/114669; Kennicutt RC, 2012, ANNU REV ASTRON ASTR, V50, P531, DOI 10.1146/annurev-astro-081811-125610; Loeb A, 2001, ANNU REV ASTRON ASTR, V39, P19, DOI 10.1146/annurev.astro.39.1.19; Madau P, 2014, ANNU REV ASTRON ASTR, V52, P415, DOI 10.1146/annurev-astro-081811-125615; Maiz-Apellaniz J, 1998, ASTRON ASTROPHYS, V329, P409; Marks M, 2012, MON NOT R ASTRON SOC, V422, P2246, DOI 10.1111/j.1365-2966.2012.20767.x; Oey MS, 2003, ASTRON J, V126, P2317, DOI 10.1086/378163; Oh S, 2015, ASTROPHYS J, V805, DOI 10.1088/0004-637X/805/2/92; Pasquini L., 2002, MESSENGER, V110, P1; Pietrzynski G, 2013, NATURE, V495, P76, DOI 10.1038/nature11878; SALPETER EE, 1955, ASTROPHYS J, V121, P161, DOI 10.1086/145971; Schneider FRN, 2014, ASTRON ASTROPHYS, V570, DOI 10.1051/0004-6361/201424286; Schneider FRN, 2014, ASTROPHYS J, V780, DOI 10.1088/0004-637X/780/2/117; Taylor WD, 2011, ASTRON ASTROPHYS, V530, DOI 10.1051/0004-6361/201116785; Weisz DR, 2013, ASTROPHYS J, V762, DOI 10.1088/0004-637X/762/2/123	35	128	128	1	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 5	2018	359	6371					69	71		10.1126/science.aan0106	http://dx.doi.org/10.1126/science.aan0106			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FR8KW	29302009	Green Submitted, Green Accepted			2022-12-28	WOS:000419324700068
J	Kuehn, B				Kuehn, Bridget			NIH Strategy to Combat Opioid Crisis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	5	5	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 26	2017	318	24					2418	2418		10.1001/jama.2017.19920	http://dx.doi.org/10.1001/jama.2017.19920			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FQ9ZO	29279912				2022-12-28	WOS:000418720700004
J	Missirian, A; Schlenker, W				Missirian, Anouch; Schlenker, Wolfram			Asylum applications respond to temperature fluctuations	SCIENCE			English	Article							CLIMATE-CHANGE; MIGRATION; VARIABILITY; YIELDS	International negotiations on climate change, along with recent upsurges in migration across the Mediterranean Sea, have highlighted the need to better understand the possible effects of climate change on human migration-in particular, across national borders. Here we examine how, in the recent past (2000-2014), weather variations in 103 source countries translated into asylum applications to the European Union, which averaged 351,000 per year in our sample. We find that temperatures that deviated from the moderate optimum (similar to 20 degrees C) increased asylum applications in a nonlinear fashion, which implies an accelerated increase under continued future warming. Holding everything else constant, asylum applications by the end of the century are predicted to increase, on average, by 28% (98,000 additional asylum applications per year) under representative concentration pathway (RCP) scenario 4.5 and by 188% (660,000 additional applications per year) under RCP 8.5 for the 21 climate models in the NASA Earth Exchange Global Daily Downscaled Projections (NEX-GDDP).	[Missirian, Anouch; Schlenker, Wolfram] Columbia Univ, Sch Int & Publ Affairs, New York, NY 10027 USA; [Schlenker, Wolfram] Columbia Univ, Earth Inst, New York, NY 10027 USA; [Schlenker, Wolfram] Natl Bur Econ Res, 1050 Massachusetts Ave, Cambridge, MA 02138 USA	Columbia University; Columbia University; National Bureau of Economic Research	Schlenker, W (corresponding author), Columbia Univ, Sch Int & Publ Affairs, New York, NY 10027 USA.; Schlenker, W (corresponding author), Columbia Univ, Earth Inst, New York, NY 10027 USA.; Schlenker, W (corresponding author), Natl Bur Econ Res, 1050 Massachusetts Ave, Cambridge, MA 02138 USA.	wolfram.schlenker@columbia.edu		Schlenker, Wolfram/0000-0002-6231-9944; Missirian, Anouch/0000-0001-7142-1839	U.S. Department of Energy, Office of Science, Biological and Environmental Research Program; Integrated Assessment Research Program [DE-SC0005171]; Joint Research Centre of the EU	U.S. Department of Energy, Office of Science, Biological and Environmental Research Program(United States Department of Energy (DOE)); Integrated Assessment Research Program; Joint Research Centre of the EU	This work was supported by the U.S. Department of Energy, Office of Science, Biological and Environmental Research Program, Integrated Assessment Research Program, grant DE-SC0005171, as well as the Joint Research Centre of the EU. Data on asylum applications, as well as the weather data and climate projections, are all freely accessible online (see supplementary materials for links).	[Anonymous], 2016, RISK ANAL 2016; [Anonymous], 2011, PRESS C PRES OB PRES; Bazzi S, 2017, AM ECON J-APPL ECON, V9, P219, DOI 10.1257/app.20150548; Bohra-Mishra P, 2014, P NATL ACAD SCI USA, V111, P9780, DOI 10.1073/pnas.1317166111; Burke M, 2015, NATURE, V527, P235, DOI 10.1038/nature15725; Burke MB, 2009, P NATL ACAD SCI USA, V106, P20670, DOI 10.1073/pnas.0907998106; Cai RH, 2016, J ENVIRON ECON MANAG, V79, P135, DOI 10.1016/j.jeem.2016.06.005; Clemens MA, 2014, INTERNATIONAL HANDBOOK ON MIGRATION AND ECONOMIC DEVELOPMENT, P152; Clemens MA, 2011, J ECON PERSPECT, V25, P83, DOI 10.1257/jep.25.3.83; Dell M, 2012, AM ECON J-MACROECON, V4, P66, DOI 10.1257/mac.4.3.66; Gray C, 2016, CLIMATIC CHANGE, V135, P555, DOI 10.1007/s10584-015-1592-y; Hsiang SM, 2013, SCIENCE, V341, P1212, DOI 10.1126/science.1235367; Kelley CP, 2015, P NATL ACAD SCI USA, V112, P3241, DOI 10.1073/pnas.1421533112; Lobell DB, 2011, NAT CLIM CHANGE, V1, P42, DOI [10.1038/nclimate1043, 10.1038/NCLIMATE1043]; Luterbacher J, 2015, NAT GEOSCI, V8, P246, DOI 10.1038/ngeo2404; McGuirk E, 2017, 23056 NBER; Missirian A, 2017, AM ECON REV, V107, P436, DOI 10.1257/aer.p20171051; REIFMAN AS, 1991, PERS SOC PSYCHOL B, V17, P580, DOI 10.1177/0146167291175013; Schlenker W, 2010, ENVIRON RES LETT, V5, DOI 10.1088/1748-9326/5/1/014010; Schlenker W, 2009, P NATL ACAD SCI USA, V106, P15594, DOI 10.1073/pnas.0906865106; Tack J, 2015, P NATL ACAD SCI USA, V112, P6931, DOI 10.1073/pnas.1415181112	21	79	80	5	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 22	2017	358	6370					1610	1613		10.1126/science.aao0432	http://dx.doi.org/10.1126/science.aao0432			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FQ6BO	29269476				2022-12-28	WOS:000418448000064
J	Friedrich, MJ				Friedrich, M. J.			Preexisting Antibody Titer Associated With Severe Dengue	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 19	2017	318	23					2287	2287		10.1001/jama.2017.19368	http://dx.doi.org/10.1001/jama.2017.19368			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FQ3RJ	29260233				2022-12-28	WOS:000418274000006
J	Warriner, DR; Twigg, V; Flanders, LK; Gaynor, EP				Warriner, David R.; Twigg, Victoria; Flanders, Lucy K.; Gaynor, Edward P.			CHRISTMAS 2017: THE LIVES OF DOCTORS 10 Minute consultation: Mastering management language syndrome	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Warriner, David R.] Leeds Teaching Hosp, Leeds LS1 3EX, W Yorkshire, England; [Twigg, Victoria] Queens Med Ctr, Nottingham NG7 2UH, England; [Flanders, Lucy K.] Epsom Gen Hosp, Epsom KT18 7EG, Surrey, England; [Gaynor, Edward P.] Chelsea & Westminster Hosp, London SW10 9NH, England	University of Leeds; University of Nottingham; Imperial College London	Warriner, DR (corresponding author), Leeds Teaching Hosp, Leeds LS1 3EX, W Yorkshire, England.	david.warriner@nhs.net							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 13	2017	359								j5661	10.1136/bmj.j5661	http://dx.doi.org/10.1136/bmj.j5661			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FQ4KY	29237606				2022-12-28	WOS:000418327500010
J	Kussmaul, WG				Kussmaul, William G., III			Patent Foramen Ovale Closure	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							TRANSCATHETER CLOSURE; STROKE		[Kussmaul, William G., III] 5 Arrowhead Trail, Media, PA 19063 USA		Kussmaul, WG (corresponding author), 5 Arrowhead Trail, Media, PA 19063 USA.	w.kussmaul@verizon.net						BRIDGES ND, 1992, CIRCULATION, V86, P1902, DOI 10.1161/01.CIR.86.6.1902; De Rosa S, 2018, ANN INTERN MED, V168, P343, DOI 10.7326/M17-3033; HAGEN PT, 1984, MAYO CLIN PROC, V59, P17, DOI 10.1016/S0025-6196(12)60336-X; Jalal Z, 2016, CAN J CARDIOL, V32, DOI 10.1016/j.cjca.2016.02.068; Kernan WN, 2014, STROKE, V45, P2160, DOI 10.1161/STR.0000000000000024; LECHAT P, 1988, NEW ENGL J MED, V318, P1148, DOI 10.1056/NEJM198805053181802; Mas JL, 2017, NEW ENGL J MED, V377, P1011, DOI 10.1056/NEJMoa1705915; Merkler AE, 2017, STROKE, V48, P3073, DOI 10.1161/STROKEAHA.117.018501; Messe SR, 2016, NEUROLOGY, V87, P815, DOI 10.1212/WNL.0000000000002961; Shah R, 2018, ANN INTERN MED, V168, P335, DOI 10.7326/M17-2679; Sondergaard L, 2017, NEW ENGL J MED, V377, P1033, DOI 10.1056/NEJMoa1707404	11	0	0	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 6	2018	168	5					367	368		10.7326/M18-0024	http://dx.doi.org/10.7326/M18-0024			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FY2GD	29310129				2022-12-28	WOS:000426632600013
J	Pouncey, C				Pouncey, Claire			President Trump's Mental Health - Is It Morally Permissible for Psychiatrists to Comment?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Pouncey, Claire] Eudaimonia Associates, Philadelphia, PA 19103 USA		Pouncey, C (corresponding author), Eudaimonia Associates, Philadelphia, PA 19103 USA.							APA (American Psychiatric Association), 2013, PRINC MED ETH ANN ES; *COUNC ETH JUD AFF, 2001, COD MED ETH CURR OP; Lee B. X., 2017, DANGEROUS CASE D TRU; Nirappil F., 2017, WASHINGTON POST	4	6	6	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 1	2018	378	5					405	407		10.1056/NEJMp1714828	http://dx.doi.org/10.1056/NEJMp1714828			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FU3WP	29281801				2022-12-28	WOS:000423783200002
J	Tucker, AT; Leonard, SP; DuBois, CD; Knauf, GA; Cunningham, AL; Wilke, CO; Trent, MS; Davies, BW				Tucker, Ashley T.; Leonard, Sean P.; DuBois, Cory D.; Knauf, Gregory A.; Cunningham, Ashley L.; Wilke, Claus O.; Trent, M. Stephen; Davies, Bryan W.			Discovery of Next-Generation Antimicrobials through Bacterial Self-Screening of Surface-Displayed Peptide Libraries	CELL			English	Article							ESCHERICHIA-COLI; OUTER-MEMBRANE; PSEUDOMONAS-AERUGINOSA; DE-NOVO; DATABASE; SUSCEPTIBILITY; ACTIVATION; SEQUENCES; COMPONENT; APOPTOSIS	Peptides have great potential to combat antibiotic resistance. While many platforms can screen peptides for their ability to bind to target cells, there are virtually no platforms that directly assess the functionality of peptides. This limitation is exacerbated when identifying antimicrobial peptides because the phenotype, death, selects against itself and has caused a scientific bottleneck that confines research to a few naturally occurring classes of antimicrobial peptides. We have used this seeming dissonance to develop Surface Localized Antimicrobial Display (SLAY), a platform that allows screening of unlimited numbers of peptides of any length, composition, and structure in a single tube for antimicrobial activity. Using SLAY, we screened similar to 800,000 random peptide sequences for antimicrobial function and identified thousands of active sequences, dramatically increasing the number of known antimicrobial sequences. SLAY hits present with different potential mechanisms of peptide action and access to areas of antimicrobial physicochemical space beyond what nature has evolved.	[Tucker, Ashley T.; Knauf, Gregory A.; Cunningham, Ashley L.; Davies, Bryan W.] Univ Texas Austin, Dept Mol Biosci, Austin, TX 78712 USA; [Leonard, Sean P.; DuBois, Cory D.; Wilke, Claus O.] Univ Texas Austin, Dept Integrat Biol, Austin, TX 78712 USA; [Wilke, Claus O.] Univ Texas Austin, Ctr Computat Biol & Bioinformat, Austin, TX 78712 USA; [Wilke, Claus O.; Davies, Bryan W.] Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA; [Davies, Bryan W.] Univ Texas Austin, Ctr Syst & Synthet Biol, Austin, TX 78712 USA; [Davies, Bryan W.] Univ Texas Austin, John Ring LaMontagne Ctr Infect Dis, Inst Cellular & Mol Biol, Austin, TX 78712 USA; [Trent, M. Stephen] Univ Georgia, Coll Vet Med, Dept Infect Dis, Athens, GA 30602 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University System of Georgia; University of Georgia	Davies, BW (corresponding author), Univ Texas Austin, Dept Mol Biosci, Austin, TX 78712 USA.; Davies, BW (corresponding author), Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA.; Davies, BW (corresponding author), Univ Texas Austin, Ctr Syst & Synthet Biol, Austin, TX 78712 USA.; Davies, BW (corresponding author), Univ Texas Austin, John Ring LaMontagne Ctr Infect Dis, Inst Cellular & Mol Biol, Austin, TX 78712 USA.	bwdavies@austin.utexas.edu		Davies, Bryan/0000-0002-2046-0341; Leonard, Sean/0000-0001-5634-3254	NIH [AI125337, AI064184, AI076322]; Sanofi iAward; Welch Foundation [F-1870]; DARPA [HR0011-15-C-0095]; Army Research Office [W911NF-12-1-0390]; NIH NRSA Fellowship [F32 GM116523]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI125337, R01AI076322, R01AI064184, R56AI076322] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM116523] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sanofi iAward; Welch Foundation(The Welch Foundation); DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Army Research Office; NIH NRSA Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grant AI125337 to B.W.D., Sanofi iAward to B.W.D., Welch Foundation grant F-1870 to B.W.D., and DARPA HR0011-15-C-0095 to B.W.D.; NIH grants AI064184 and AI076322 to M.S.T. and Army Research Office grant W911NF-12-1-0390 to M.S.T.; and NIH NRSA Fellowship F32 GM116523 to A.T.T. We would like to thank the Genome Sequencing and Analysis Facility (GSAF) for next-generation sequencing and the Microscopy and Imaging Facility at UT Austin for flow cytometry use.	Bahar AA, 2013, PHARMACEUTICALS-BASE, V6, P1543, DOI 10.3390/ph6121543; BELLOC F, 1994, CYTOMETRY, V17, P59, DOI 10.1002/cyto.990170108; Brunetti J, 2017, CURR TOP MED CHEM, V17, P613, DOI 10.2174/1568026616666160713143017; Carmona G, 2013, PROTEIN J, V32, P456, DOI 10.1007/s10930-013-9505-2; Catchen J, 2013, MOL ECOL, V22, P3124, DOI 10.1111/mec.12354; Catchen JM, 2011, G3-GENES GENOM GENET, V1, P171, DOI 10.1534/g3.111.000240; Clatworthy AE, 2007, NAT CHEM BIOL, V3, P541, DOI 10.1038/nchembio.2007.24; Cock PJA, 2009, BIOINFORMATICS, V25, P1422, DOI 10.1093/bioinformatics/btp163; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Darzynkiewicz Z, 1997, CYTOMETRY, V27, P1; Deslouches B, 2005, ANTIMICROB AGENTS CH, V49, P3208, DOI 10.1128/AAC.49.8.3208-3216.2005; Dodt Matthias, 2012, Biology (Basel), V1, P895, DOI 10.3390/biology1030895; Dwyer DJ, 2015, ANNU REV PHARMACOL, V55, P313, DOI 10.1146/annurev-pharmtox-010814-124712; Edwards IA, 2016, ACS INFECT DIS, V2, P442, DOI 10.1021/acsinfecdis.6b00045; Fjell CD, 2012, NAT REV DRUG DISCOV, V11, P37, DOI 10.1038/nrd3591; Fox JL, 2013, NAT BIOTECHNOL, V31, P379, DOI 10.1038/nbt.2572; Friedrich C, 1999, ANTIMICROB AGENTS CH, V43, P1542, DOI 10.1128/AAC.43.7.1542; Furman JL, 2015, AAPS J, V17, P111, DOI 10.1208/s12248-014-9681-9; GAZIT E, 1995, BIOCHEMISTRY-US, V34, P11479, DOI 10.1021/bi00036a021; Georgiou G, 1996, PROTEIN ENG, V9, P239, DOI 10.1093/protein/9.2.239; Giacometti A, 2000, ANTIMICROB AGENTS CH, V44, P1694, DOI 10.1128/AAC.44.6.1694-1696.2000; Gould IM, 2013, VIRULENCE, V4, P185, DOI 10.4161/viru.22507; GRAHAM LL, 1991, TRENDS BIOCHEM SCI, V16, P328, DOI 10.1016/0968-0004(91)90135-I; Hadley EB, 2010, CURR TOP MED CHEM, V10, P1872; Hammami R, 2009, NUCLEIC ACIDS RES, V37, pD963, DOI 10.1093/nar/gkn655; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; Herrera CM, 2010, MOL MICROBIOL, V76, P1444, DOI 10.1111/j.1365-2958.2010.07150.x; Hilpert K, 2005, NAT BIOTECHNOL, V23, P1008, DOI 10.1038/nbt1113; Hilpert K, 2007, NAT PROTOC, V2, P1333, DOI 10.1038/nprot.2007.160; Huber W, 2015, NAT METHODS, V12, P115, DOI [10.1038/nmeth.3252, 10.1038/NMETH.3252]; Jacobs AC, 2014, MBIO, V5, DOI 10.1128/mBio.01076-14; Kang SJ, 2014, EXPERT REV ANTI-INFE, V12, P1477, DOI 10.1586/14787210.2014.976613; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LeBeau AM, 2009, MOL CANCER THER, V8, P1378, DOI 10.1158/1535-7163.MCT-08-1170; Lewis K, 2013, NAT REV DRUG DISCOV, V12, P371, DOI 10.1038/nrd3975; Li X, 2011, BIOCHEM SOC T, V39, P1895, DOI 10.1042/BST20110736; Liberati NT, 2006, P NATL ACAD SCI USA, V103, P2833, DOI 10.1073/pnas.0511100103; Ling LL, 2015, NATURE, V517, P455, DOI 10.1038/nature14098; Lorenz C, 2016, J BACTERIOL, V198, P3162, DOI 10.1128/JB.00502-16; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Mah TF, 2014, JOVE-J VIS EXP, DOI 10.3791/50854; Mai J, 2011, ANTIMICROB AGENTS CH, V55, P5205, DOI 10.1128/AAC.05175-11; Miller W. R., 2016, COLD SPRING HARB PER, V6; Mori N, 2012, J ANTIMICROB CHEMOTH, V67, P2173, DOI 10.1093/jac/dks174; Nelson D.L., 2004, PRINCIPLES BIOCH, V4th; Neme R., 2017, NAT ECOL EVOL, V1; Novkovic M, 2012, BIOINFORMATICS, V28, P1406, DOI 10.1093/bioinformatics/bts141; O'Neill J., 2016, Tackling drug-resistant infections globally: final report and recommendations; Payne DJ, 2007, NAT REV DRUG DISCOV, V6, P29, DOI 10.1038/nrd2201; Peschel A, 2006, NAT REV MICROBIOL, V4, P529, DOI 10.1038/nrmicro1441; Piotto SP, 2012, INT J ANTIMICROB AG, V39, P346, DOI 10.1016/j.ijantimicag.2011.12.003; Qaiyumi S., 2007, ANTIMICROBIAL SUSCEP, P75, DOI [10.1201/9781420014495.ch4, DOI 10.1201/9781420014495.CH4]; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Schwab U, 1999, ANTIMICROB AGENTS CH, V43, P1435, DOI 10.1128/AAC.43.6.1435; Shin A, 2015, BIOCHEMISTRY-US, V54, P3921, DOI 10.1021/acs.biochem.5b00392; Srinivas N, 2010, SCIENCE, V327, P1010, DOI 10.1126/science.1182749; Trent MS, 2001, J BIOL CHEM, V276, P43132, DOI 10.1074/jbc.M106962200; Trimble M. J., 2016, COLD SPRING HARB PER, V6; Varkey J, 2005, ANTIMICROB AGENTS CH, V49, P4561, DOI 10.1128/AAC.49.11.4561-4566.2005; Waghu FH, 2016, NUCLEIC ACIDS RES, V44, pD1094, DOI 10.1093/nar/gkv1051; Wang GS, 2016, NUCLEIC ACIDS RES, V44, pD1087, DOI 10.1093/nar/gkv1278; Wiegand I, 2008, NAT PROTOC, V3, P163, DOI 10.1038/nprot.2007.521; Woodruff HB, 2014, APPL ENVIRON MICROB, V80, P2, DOI 10.1128/AEM.01143-13; World Health Organization, 2017, GLOBAL PRIORITY LIST, DOI DOI 10.1016/S1473-3099(09)70222-1; Yang ST, 2006, BBA-BIOMEMBRANES, V1758, P1580, DOI 10.1016/j.bbamem.2006.06.007; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zhang SK, 2016, SCI REP-UK, V6, DOI 10.1038/srep27394; Zhao J, 2013, J CHEM INF MODEL, V53, P3280, DOI 10.1021/ci400477e; Zhao XW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066557; Zipperer A, 2016, NATURE, V535, P511, DOI 10.1038/nature18634	70	73	75	11	88	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 25	2018	172	3					618	+		10.1016/j.cell.2017.12.009	http://dx.doi.org/10.1016/j.cell.2017.12.009			24	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FT9BS	29307492	Green Accepted, Bronze			2022-12-28	WOS:000423447600019
J	Glynn, LG; McManus, RJ				Glynn, Liam G.; McManus, Richard J.			Blood Pressure Control: Missed Opportunity or Potential Holy Grail?	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							HYPERTENSION		[Glynn, Liam G.] Univ Limerick, Grad Entry Med Sch, Limerick, Ireland; [Glynn, Liam G.] Univ Limerick, Hlth Res Inst, Limerick, Ireland; [McManus, Richard J.] Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Oxford OX2 6GG, England	University of Limerick; University of Limerick; University of Oxford	Glynn, LG (corresponding author), Univ Limerick, Grad Entry Med Sch, Limerick, Ireland.; Glynn, LG (corresponding author), Univ Limerick, Hlth Res Inst, Limerick, Ireland.	liam.glynn@ul.ie		Glynn, Liam/0000-0002-6153-9363	Department of Health [NIHR-RP-02-12-015] Funding Source: Medline; National Institute for Health Research [NIHR-RP-02-12-015] Funding Source: researchfish	Department of Health; National Institute for Health Research(National Institute for Health Research (NIHR))		[Anonymous], 1979, JAMA, V242, P2562; Khanna RR, 2012, ARCH INTERN MED, V172, P1344, DOI 10.1001/archinternmed.2012.2749; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Mills KT, 2018, ANN INTERN MED, V168, P110, DOI 10.7326/M17-1805; Pickering TG, 2008, HYPERTENSION, V52, P10, DOI 10.1161/HYPERTENSIONAHA.107.189010; Tucker KL, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002389; Wang YR, 2007, ARCH INTERN MED, V167, P141, DOI 10.1001/archinte.167.2.141; Whelton PK, 2017, HYPERTENSION, V71, pe13, DOI [10.1161/HYPERTENSIONAHA.115.0710827001299, DOI 10.1161/HYP.0000000000000065]; WILBER JA, 1972, AM J MED, V52, P653, DOI 10.1016/0002-9343(72)90055-1	10	2	3	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 16	2018	168	2					147	+		10.7326/M17-3036	http://dx.doi.org/10.7326/M17-3036			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FU8IN	29277851	Green Submitted			2022-12-28	WOS:000424096600021
J	Millstein, JH				Millstein, Jeffrey H.			The Envelope	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Millstein, Jeffrey H.] Penn Med, 1006 Mantua Pike, Woodbury Hts, NJ 08097 USA	University of Pennsylvania; Pennsylvania Medicine	Millstein, JH (corresponding author), Penn Med, 1006 Mantua Pike, Woodbury Hts, NJ 08097 USA.	millstej@uphs.upenn.edu							0	2	2	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 2	2018	319	1					23	23		10.1001/jama.2017.19273	http://dx.doi.org/10.1001/jama.2017.19273			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FR5ON	29297081				2022-12-28	WOS:000419116000011
J	Slomski, A				Slomski, Anita			Surgery Improves Seizures in Children With Drug-Resistant Epilepsy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 26	2017	318	24					2419	2419		10.1001/jama.2017.19991	http://dx.doi.org/10.1001/jama.2017.19991			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FQ9ZO	29279931				2022-12-28	WOS:000418720700011
J	Bates, ER				Bates, Eric R.			Guided early deescalation of antiplatelet treatment was noninferior to usual prasugrel care in PCI-treated ACS	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Bates, Eric R.] Univ Michigan, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Bates, ER (corresponding author), Univ Michigan, Ann Arbor, MI 48109 USA.							Cuisset T, 2017, EUR HEART J, V38, P3070, DOI 10.1093/eurheartj/ehx175; Ibanez B, 2018, KARDIOL POL, V76, P229, DOI 10.5603/KP.2018.0041	2	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 19	2017	167	12					JC69	JC69		10.7326/ACPJC-2017-167-12-069	http://dx.doi.org/10.7326/ACPJC-2017-167-12-069			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FQ3SD	29255859				2022-12-28	WOS:000418276000009
J	Milman, N				Milman, Nataliya			Tocilizumab increased sustained glucocorticoid-free remission from giant cell arteritis	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Milman, Nataliya] Univ Ottawa, Ottawa, ON, Canada	University of Ottawa	Milman, N (corresponding author), Univ Ottawa, Ottawa, ON, Canada.							Mahr AD, 2007, ARTHRITIS RHEUM, V56, P2789, DOI 10.1002/art.22754	1	2	2	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 19	2017	167	12					JC63	JC63		10.7326/ACPJC-2017-167-12-063	http://dx.doi.org/10.7326/ACPJC-2017-167-12-063			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FQ3SD	29255853				2022-12-28	WOS:000418276000003
J	Zhu, CB; Usiskin, RE; Yu, Y; Maier, J				Zhu, Changbao; Usiskin, Robert E.; Yu, Yan; Maier, Joachim			The nanoscale circuitry of battery electrodes	SCIENCE			English	Review							LITHIUM ION BATTERY; IN-SITU OBSERVATION; HIGH-ENERGY; CATHODE MATERIALS; MIXED CONDUCTORS; PERFORMANCE; STORAGE; INTERCALATION; VISUALIZATION; DIFFUSION	Developing high-performance, affordable, and durable batteries is one of the decisive technological tasks of our generation. Here, we review recent progress in understanding how to optimally arrange the various necessary phases to form the nanoscale structure of a battery electrode. The discussion begins with design principles for optimizing electrode kinetics based on the transport parameters and dimensionality of the phases involved. These principles are then used to review and classify various nanostructured architectures that have been synthesized. Connections are drawn to the necessary fabrication methods, and results from in operando experiments are highlighted that give insight into how electrodes evolve during battery cycling.	[Zhu, Changbao; Usiskin, Robert E.; Yu, Yan; Maier, Joachim] Max Planck Inst Solid State Res, Heisenbergstr 1, D-70569 Stuttgart, Germany; [Yu, Yan] Univ Sci & Technol China, Key Lab Mat Energy Convers, Hefei 230026, Anhui, Peoples R China; [Zhu, Changbao] Sun Yat Sen Univ, Dept Mat Sci and Engn, Guangzhou 510275, Guangdong, Peoples R China	Max Planck Society; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Sun Yat Sen University	Maier, J (corresponding author), Max Planck Inst Solid State Res, Heisenbergstr 1, D-70569 Stuttgart, Germany.	weiglein@fkf.mpg.de	Yu, Yan/C-7031-2012; Yu, Yan/K-1288-2019; Yu, Yan/GYV-4514-2022; Zhu, Changbao/B-7605-2016	Yu, Yan/0000-0002-3685-7773; Yu, Yan/0000-0002-3685-7773; Zhu, Changbao/0000-0002-4438-8102; Maier, Joachim/0000-0003-2274-6068; Usiskin, Robert/0000-0003-0840-7246	Max Planck Society; Alexander von Humboldt Foundation	Max Planck Society(Max Planck Society); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation)	The authors thank M. Kuhne for useful comments on the manuscript. This work was financially supported by the Max Planck Society and the Alexander von Humboldt Foundation (Sofja Kovalevskaja award).	Amin R, 2008, SOLID STATE IONICS, V179, P1683, DOI 10.1016/j.ssi.2008.01.079; Amin R, 2017, J POWER SOURCES, V348, P311, DOI 10.1016/j.jpowsour.2017.02.071; Vu A, 2012, ADV ENERGY MATER, V2, P1056, DOI 10.1002/aenm.201200320; [Anonymous], 2004, PHYS CHEM IONIC MAT; ATLUNG S, 1979, J ELECTROCHEM SOC, V126, P1311, DOI 10.1149/1.2129269; Besenhard JO, 1999, J POWER SOURCES, V81, P268, DOI 10.1016/S0378-7753(99)00199-8; Bhattacharyya R, 2010, NAT MATER, V9, P504, DOI [10.1038/NMAT2764, 10.1038/nmat2764]; Bruce PG, 2008, ANGEW CHEM INT EDIT, V47, P2930, DOI 10.1002/anie.200702505; Cao FF, 2010, CHEM MATER, V22, P1908, DOI 10.1021/cm9036742; Chandrashekar S, 2012, NAT MATER, V11, P311, DOI [10.1038/nmat3246, 10.1038/NMAT3246]; Chen KF, 2015, CHEM SOC REV, V44, P6230, DOI 10.1039/c5cs00147a; Cho JP, 2000, J ELECTROCHEM SOC, V147, P15, DOI 10.1149/1.1393137; Choi NS, 2012, ANGEW CHEM INT EDIT, V51, P9994, DOI 10.1002/anie.201201429; Chueh WC, 2013, NANO LETT, V13, P866, DOI 10.1021/nl3031899; Crank J., 1975, MATH DIFFUSION; Dunn B, 2011, SCIENCE, V334, P928, DOI 10.1126/science.1212741; Ebner M, 2013, SCIENCE, V342, P716, DOI 10.1126/science.1241882; Ebner M, 2013, ADV ENERGY MATER, V3, P845, DOI 10.1002/aenm.201200932; Gaberscek M, 2007, ELECTROCHEM COMMUN, V9, P2778, DOI 10.1016/j.elecom.2007.09.020; Gaberscek M, 2006, SOLID STATE IONICS, V177, P2647, DOI 10.1016/j.ssi.2006.02.035; Gao HC, 2016, ADV ENERGY MATER, V6, DOI 10.1002/aenm.201502130; Gong YJ, 2014, ADV FUNCT MATER, V24, P125, DOI 10.1002/adfm.201300844; Grey CP, 2017, NAT MATER, V16, P45, DOI [10.1038/NMAT4777, 10.1038/nmat4777]; Gu M, 2013, NANO LETT, V13, P6106, DOI 10.1021/nl403402q; Guo YG, 2007, ADV MATER, V19, P2087, DOI 10.1002/adma.200602828; Han FD, 2015, ADV MATER, V27, P3473, DOI 10.1002/adma.201500180; Harks PPRML, 2015, J POWER SOURCES, V288, P92, DOI 10.1016/j.jpowsour.2015.04.084; Hess M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9169; HO C, 1980, J ELECTROCHEM SOC, V127, P343, DOI 10.1149/1.2129668; Hosono E, 2009, NANO LETT, V9, P1045, DOI 10.1021/nl803394v; Hu YS, 2007, ADV FUNCT MATER, V17, P1873, DOI 10.1002/adfm.200601152; Hu YS, 2007, ADV MATER, V19, P1963, DOI 10.1002/adma.200700697; Hu YS, 2006, ADV MATER, V18, P1421, DOI 10.1002/adma.200502723; HUANG CK, 1988, J ELECTROCHEM SOC, V135, P408, DOI 10.1149/1.2095628; Huang JY, 2010, SCIENCE, V330, P1515, DOI 10.1126/science.1195628; Huggins RA, 2011, HANDBOOK OF BATTERY MATERIALS, 2ND EDITION, P405; Hwang TH, 2012, NANO LETT, V12, P802, DOI 10.1021/nl203817r; Islam MS, 2014, CHEM SOC REV, V43, P185, DOI 10.1039/c3cs60199d; Jamnik J, 2001, PHYS CHEM CHEM PHYS, V3, P1668, DOI 10.1039/b100180i; Jiao F, 2008, ANGEW CHEM INT EDIT, V47, P9711, DOI 10.1002/anie.200803431; Kaskhedikar NA, 2009, ADV MATER, V21, P2664, DOI 10.1002/adma.200901079; Kuhne M, 2017, NAT NANOTECHNOL, V12, P895, DOI [10.1038/nnano.2017.108, 10.1038/NNANO.2017.108]; laberna P. L, 2006, NAT MATER, V5, P567, DOI [10.1038/nmnatl672, DOI 10.1021/JA906261C]; Lai W, 2011, J ELECTROCHEM SOC, V158, pA115, DOI 10.1149/1.3515896; Lee S, 2012, ANGEW CHEM INT EDIT, V51, P8748, DOI 10.1002/anie.201203581; Li D, 2004, ADV MATER, V16, P1151, DOI 10.1002/adma.200400719; Li N, 2014, NANO ENERGY, V5, P105, DOI 10.1016/j.nanoen.2014.02.011; Li W, 2015, NANO LETT, V15, P2186, DOI 10.1021/acs.nanolett.5b00291; Li XF, 2013, J MATER CHEM A, V1, P165, DOI 10.1039/c2ta00437b; Lim J, 2016, SCIENCE, V353, P566, DOI 10.1126/science.aaf4914; Liu B, 2012, NANO LETT, V12, P3005, DOI 10.1021/nl300794f; Liu CY, 2014, NAT NANOTECHNOL, V9, P1031, DOI [10.1038/NNANO.2014.247, 10.1038/nnano.2014.247]; Liu DX, 2014, ANGEW CHEM INT EDIT, V53, P9498, DOI 10.1002/anie.201404197; Liu H, 2014, SCIENCE, V344, DOI 10.1126/science.1252817; Liu JY, 2016, ADV MATER, V28, P7696, DOI 10.1002/adma.201600829; Liu N, 2014, NAT NANOTECHNOL, V9, P187, DOI [10.1038/nnano.2014.6, 10.1038/NNANO.2014.6]; Long JW, 2004, CHEM REV, V104, P4463, DOI 10.1021/cr020740l; Maier J, 2014, FARADAY DISCUSS, V176, P17, DOI 10.1039/c4fd00135d; Maier J, 2014, CHEM MATER, V26, P348, DOI 10.1021/cm4021657; Maier J, 2013, ANGEW CHEM INT EDIT, V52, P4998, DOI [10.1002/anie.201205569, 10.1002/anie.201302312]; Marmur A, 2008, LANGMUIR, V24, P7573, DOI 10.1021/la800304r; Mathew M, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.061407; Meng XB, 2012, ADV MATER, V24, P3589, DOI 10.1002/adma.201200397; Miller DJ, 2013, ADV ENERGY MATER, V3, P1098, DOI 10.1002/aenm.201300015; Niu JJ, 2014, NANO LETT, V14, P4005, DOI 10.1021/nl501415b; Oh P, 2014, NANO LETT, V14, P5965, DOI 10.1021/nl502980k; Ohrner N., 2015, NAT COMMUN, V6, P6045, DOI [10.1038/ncomms7045, DOI 10.1038/NCOMMS7045]; Park M, 2010, J POWER SOURCES, V195, P7904, DOI 10.1016/j.jpowsour.2010.06.060; Pecher O, 2017, CHEM MATER, V29, P213, DOI 10.1021/acs.chemmater.6b03183; Preis W, 1997, BER BUNSEN PHYS CHEM, V101, P50, DOI 10.1002/bbpc.19971010106; Preis W, 1996, J CHEM SOC FARADAY T, V92, P1197, DOI 10.1039/ft9969201197; Qi J, 2015, CHEM SOC REV, V44, P6749, DOI 10.1039/c5cs00344j; Rickert H., 1982, ELECTROCHEMISTRY SOL, P79, DOI [10.1007/978-3-642-68312-1, DOI 10.1007/978-3-642-68312-1]; Sathiya M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7276; SCHMALZRIED H, 1980, PROG SOLID STATE CH, V13, P119, DOI 10.1016/0079-6786(80)90002-3; Singh GK, 2008, ELECTROCHIM ACTA, V53, P7599, DOI 10.1016/j.electacta.2008.03.083; Strelcov E, 2015, NANOSCALE, V7, P3022, DOI 10.1039/c4nr06767c; Sun F, 2016, ACS APPL MATER INTER, V8, P7156, DOI 10.1021/acsami.6b00708; Sun J, 2015, NAT NANOTECHNOL, V10, P980, DOI [10.1038/nnano.2015.194, 10.1038/NNANO.2015.194]; Sun YK, 2012, NAT MATER, V11, P942, DOI [10.1038/NMAT3435, 10.1038/nmat3435]; Tang YX, 2015, CHEM SOC REV, V44, P5926, DOI 10.1039/c4cs00442f; Ulvestad A, 2015, SCIENCE, V348, P1344, DOI 10.1126/science.aaa1313; Wang JJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12372; Wang JJ, 2014, ANGEW CHEM INT EDIT, V53, P4460, DOI 10.1002/anie.201310402; Wen LY, 2016, ADV ENERGY MATER, V6, DOI 10.1002/aenm.201600468; Wu C, 2016, ADV MATER, V28, P7276, DOI 10.1002/adma.201600964; Wu FX, 2016, ACS NANO, V10, P1333, DOI 10.1021/acsnano.5b06716; Wu H, 2012, NAT NANOTECHNOL, V7, P309, DOI [10.1038/nnano.2012.35, 10.1038/NNANO.2012.35]; Xu N, 2017, NANO LETT, V17, P538, DOI 10.1021/acs.nanolett.6b04610; Yamamoto K, 2010, ANGEW CHEM INT EDIT, V49, P4414, DOI 10.1002/anie.200907319; Yan Y, 2014, ADV ENERGY MATER, V4, DOI 10.1002/aenm.201301584; You Y, 2016, ADV MATER, V28, P7243, DOI 10.1002/adma.201600846; Yu WJ, 2015, ACS NANO, V9, P5063, DOI 10.1021/acsnano.5b00157; Yu XY, 2015, ANGEW CHEM INT EDIT, V54, P4001, DOI 10.1002/anie.201411353; Yu Y, 2009, J AM CHEM SOC, V131, P15984, DOI 10.1021/ja906261c; Yuan CZ, 2014, ANGEW CHEM INT EDIT, V53, P1488, DOI 10.1002/anie.201303971; Zhang HG, 2011, NAT NANOTECHNOL, V6, P277, DOI [10.1038/NNANO.2011.38, 10.1038/nnano.2011.38]; Zhang WM, 2008, ADV MATER, V20, P1160, DOI 10.1002/adma.200701364; Zhang XY, 2014, NANO LETT, V14, P2279, DOI 10.1021/nl404285y; Zhao Q, 2015, NANO LETT, V15, P721, DOI 10.1021/nl504263m; Zhu CB, 2016, ADV MATER, V28, P2409, DOI 10.1002/adma.201505943; Zhu CB, 2015, ADV FUNCT MATER, V25, P2335, DOI 10.1002/adfm.201404468; Zhu CB, 2015, ADV ENERGY MATER, V5, DOI 10.1002/aenm.201401170; Zhu CB, 2014, NANO LETT, V14, P5342, DOI 10.1021/nl5024063; Zhu CB, 2014, NANO LETT, V14, P2175, DOI 10.1021/nl500548a; Zhu CB, 2014, ANGEW CHEM INT EDIT, V53, P2152, DOI 10.1002/anie.201308354	106	179	182	27	436	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 15	2017	358	6369							eaao2808	10.1126/science.aao2808	http://dx.doi.org/10.1126/science.aao2808			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP8TH	29242319				2022-12-28	WOS:000417918500031
J	Wilson, N; MacDonald, EJ; Mansoor, OD; Morgan, J				Wilson, Nick; MacDonald, E. Jane; Mansoor, Osman David; Morgan, Jane			CHRISTMAS 2017: LANGUAGE AND LITERACY In bed with Siri and Google Assistant: a comparison of sexual health advice	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							SMARTPHONE		[Wilson, Nick] Univ Otago, Dept Publ Hlth, Wellington, New Zealand; [MacDonald, E. Jane] Univ Otago, Dept Obstet & Gynaecol, Wellington, New Zealand; [Morgan, Jane] Waikato Dist Hlth Board, Hamilton, New Zealand	University of Otago; University of Otago	Wilson, N (corresponding author), Univ Otago, Dept Publ Hlth, Wellington, New Zealand.	nick.wilson@otago.ac.nz						[Anonymous], 2017, OCKHAM AWARDS EXCELL; Dalrymple T, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d1789; Dart T, 2016, GUARDIAN; Gibbs S, 2015, GUARDIAN; Ladher N, 2016, BMJ-BRIT MED J, V355, DOI 10.1136/bmj.i6679; Martin L., 12 MORE REASONS TO S; Miner AS, 2016, JAMA INTERN MED, V176, P619, DOI 10.1001/jamainternmed.2016.0400; NHS, NHS CHO LIV WELL SEX; Ofcom, 2017, ADULTS MEDIA USE AND; Sabelis I., 2001, J IMPROBABLE RES, P7; Schultz WW, 1999, BRIT MED J, V319, P1596, DOI 10.1136/bmj.319.7225.1596; South West Grid for Learning, 2015, SWGFL DIG LIT; Stevens L, 2017, DIGITAL HLTH; Strayer DL, 2017, CAN J EXP PSYCHOL, V71, P93, DOI 10.1037/cep0000104; TruthinAdvertising.Org, 2017, TINA ORG TAK GWYN PA	15	11	11	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 13	2017	359								j5635	10.1136/bmj.j5635	http://dx.doi.org/10.1136/bmj.j5635			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FQ4KY	29237603				2022-12-28	WOS:000418327500008
J	Biccard, BM; Madiba, TE; Kluyts, HL; Munlemvo, DM; Madzimbamuto, FD; Basenero, A; Gordon, CS; Youssouf, C; Rakotoarison, SR; Gobin, V; Samateh, AL; Sani, CM; Omigbodun, AO; Amanor-Boadu, SD; Tumukunde, JT; Esterhuizen, TM; Le Manach, Y; Forget, P; Elkhogia, AM; Mehyaoui, RM; Zoumeno, E; Ndayisaba, G; Ndasi, H; Ndonga, AKN; Ngumi, ZWW; Patel, UP; Ashebir, DZ; Antwi-Kusi, AAK; Mbwele, B; Sama, HD; Elfiky, M; Fawzy, MA; Pearse, RM				Biccard, Bruce M.; Madiba, Thandinkosi E.; Kluyts, Hyla-Louise; Munlemvo, Dolly M.; Madzimbamuto, Farai D.; Basenero, Apollo; Gordon, Christina S.; Youssouf, Coulibaly; Rakotoarison, Sylvia R.; Gobin, Veekash; Samateh, Ahmadou L.; Sani, Chaibou M.; Omigbodun, Akinyinka O.; Amanor-Boadu, Simbo D.; Tumukunde, Janat T.; Esterhuizen, Tonya M.; Le Manach, Yannick; Forget, Patrice; Elkhogia, Abdulaziz M.; Mehyaoui, Ryad M.; Zoumeno, Eugene; Ndayisaba, Gabriel; Ndasi, Henry; Ndonga, Andrew K. N.; Ngumi, Zipporah W. W.; Patel, Ushmah P.; Ashebir, Daniel Zemenfes; Antwi-Kusi, Akwasi A. K.; Mbwele, Bernard; Sama, Hamza Doles; Elfiky, Mahmoud; Fawzy, Maher A.; Pearse, Rupert M.		African Surg Outcomes Study ASOS	Perioperative patient outcomes in the African Surgical Outcomes Study: a 7-day prospective observational cohort study	LANCET			English	Article							GLOBAL HEALTH; COST-EFFECTIVENESS; INCOME COUNTRIES; MORTALITY; SURGERY; CARE; STATEMENT; DISEASES; FAILURE; RESCUE	Background There is a need to increase access to surgical treatments in African countries, but perioperative complications represent a major global health-care burden. There are few studies describing surgical outcomes in Africa. Methods We did a 7-day, international, prospective, observational cohort study of patients aged 18 years and older undergoing any inpatient surgery in 25 countries in Africa (the African Surgical Outcomes Study). We aimed to recruit as many hospitals as possible using a convenience sampling survey, and required data from at least ten hospitals per country (or half the surgical centres if there were fewer than ten hospitals) and data for at least 90% of eligible patients from each site. Each country selected one recruitment week between February and May, 2016. The primary outcome was in-hospital postoperative complications, assessed according to predefined criteria and graded as mild, moderate, or severe. Data were presented as median (IQR), mean (SD), or n (%), and compared using t tests. This study is registered on the South African National Health Research Database (KZ_2015RP7_22) and ClinicalTrials.gov (NCT03044899). Findings We recruited 11 422 patients (median 29 [IQR 10-70]) from 247 hospitals during the national cohort weeks. Hospitals served a median population of 810 000 people (IQR 200 000-2 000 000), with a combined number of specialist surgeons, obstetricians, and anaesthetists totalling 0.7 (0.2-1.9) per 100 000 population. Hospitals did a median of 212 (IQR 65-578) surgical procedures per 100 000 population each year. Patients were younger (mean age 38.5 years [SD 16.1]), with a lower risk profile (American Society of Anesthesiologists median score 1 [IQR 1-2]) than reported in high-income countries. 1253 (11%) patients were infected with HIV, 6504 procedures (57%) were urgent or emergent, and the most common procedure was caesarean delivery (3792 patients, 33%). Postoperative complications occurred in 1977 (18.2%, 95% CI 17.4-18.9]) of 10 885 patients. 239 (2.1%) of 11 193 patients died, 225 (94.1%) after the day of surgery. Infection was the most common complication (1156 [10.2%] of 10 970 patients), of whom 112 (9.7%) died. Interpretation Despite a low-risk profile and few postoperative complications, patients in Africa were twice as likely to die after surgery when compared with the global average for postoperative deaths. Initiatives to increase access to surgical treatments in Africa therefore should be coupled with improved surveillance for deteriorating physiology in patients who develop postoperative complications, and the resources necessary to achieve this objective.	[Biccard, Bruce M.] Univ Cape Town, Fac Hlth Sci, Groote Schuur Hosp, Dept Anaesthesia & Perioperat Med, Rondebosch, South Africa; [Madiba, Thandinkosi E.] Univ KwaZulu Natal, Dept Surg, Durban, South Africa; [Kluyts, Hyla-Louise] Sefako Makgatho Hlth Sci Univ, Dept Anaesthesiol, Pretoria, South Africa; [Munlemvo, Dolly M.] Univ Hosp Kinshasha, Anaesthesiol, Kinshasa, DEM REP CONGO; [Madzimbamuto, Farai D.] Univ Zimbabwe, Dept Anaesthesia & Crit Care Med, Coll Hlth Sci, Harare, Zimbabwe; [Basenero, Apollo; Gordon, Christina S.] Minist Hlth & Social Serv Namibia, Windhoek, Namibia; [Youssouf, Coulibaly] Fac Med Bamako, Bamako, Mali; [Rakotoarison, Sylvia R.] LOT II M 46 R, Androhibe, Tana, Madagascar; [Gobin, Veekash] Jawaharlal Nehru Hosp, Minist Hlth & Qual Life, Rose Belle, Mauritius; [Samateh, Ahmadou L.] Edward Francis Small Teaching Hosp, Dept Surg, Banjul, Gambia; [Sani, Chaibou M.] Natl Hosp Niamey, Dept Anesthesiol Intens Care & Emergency, Niamey, Niger; [Omigbodun, Akinyinka O.] Univ Ibadan, Coll Med, Obstet & Gynaecol, Ibadan, Nigeria; [Amanor-Boadu, Simbo D.] Univ Coll Hosp, Dept Anaesthesia, Ibadan, Nigeria; [Tumukunde, Janat T.] Makerere Univ, Anaesthesiol, Kampala, Uganda; [Esterhuizen, Tonya M.] Stellenbosch Univ, Ctr Evidence Based Hlth Care, Stellenbosch, South Africa; [Le Manach, Yannick] McMaster Univ, Fac Hlth Sci, Michael DeGroote Sch Med, Dept Anesthesia & Clin Epidemiol, Hamilton, ON, Canada; [Le Manach, Yannick] McMaster Univ, Fac Hlth Sci, Michael DeGroote Sch Med, Dept Biostat, Hamilton, ON, Canada; [Le Manach, Yannick] David Braley Cardiac Vasc & Stroke Res Inst, Populat Hlth Res Inst, Perioperat Med & Surg Res Unit, Hamilton, ON, Canada; [Forget, Patrice] Vrije Univ Brussel, Univ Ziekenhuis Brussel, Anesthesiol & Perioperat Med, Brussels, Belgium; [Elkhogia, Abdulaziz M.] Tripoli Med Ctr, Dept Anaesthesia, Tripoli, Libya; [Mehyaoui, Ryad M.] Univ Hosp, Hosp Cardiovasc Pathol, Algiers, Algeria; [Zoumeno, Eugene] Hop Mere & Enfant, Fac Sci Sante Cotonou, Lagune De Cotonou, Benin; [Ndayisaba, Gabriel] Kamenge Teaching Hosp, Dept Surg, Bujumbura, Burundi; [Ndasi, Henry] Baptist Hosp, Dept Orthopaed & Gen Surg, Mutengene, Cameroon; [Ndonga, Andrew K. N.] Mater Hosp, Gen & Gastrosurg, Nairobi, Kenya; [Ngumi, Zipporah W. W.] Univ Nairobi, Dept Anaesthesia, Sch Med, Nairobi, Kenya; [Patel, Ushmah P.] Univ Teaching Hosp, Anaesthesiol, Lusaka, Zambia; [Ashebir, Daniel Zemenfes] Addis Ababa Univ, Sch Med, Dept Surg, Addis Ababa, Ethiopia; [Antwi-Kusi, Akwasi A. K.] Kwame Nkrumah Univ Sci & Technol, Coll Hlth Sci, Sch Med Sci, Dept Anaesthesiol & Intens Care, Kumasi, Ghana; [Mbwele, Bernard] Christian Social Serv Commiss, HIV AIDS Care & Treatment & PMTCT, Mwanza, Tanzania; [Sama, Hamza Doles] Sylvanus Olympio Univ, Anaesthesia Intens Care Med Pain Management, Teaching Hosp, Lome, Togo; [Elfiky, Mahmoud] Cairo Univ, Dept Surg, Cairo, Egypt; [Fawzy, Maher A.] Cairo Univ, Fac Med, Dept Anesthesia, Cairo, Egypt; [Fawzy, Maher A.] Cairo Univ, Fac Med, ICU Dept, Cairo, Egypt; [Fawzy, Maher A.] Cairo Univ, Fac Med, Pain Management Dept, Cairo, Egypt; [Pearse, Rupert M.] Queen Mary Univ London, Intens Care Med, London, England	University of Cape Town; University of Kwazulu Natal; Sefako Makgatho Health Sciences University; University of Zimbabwe; University of Ibadan; University of Ibadan; University College Hospital, Ibadan; Makerere University; Stellenbosch University; McMaster University; McMaster University; Population Health Research Institute; University Hospital Brussels; Vrije Universiteit Brussel; University of Nairobi; University of Zambia; Addis Ababa University; Kwame Nkrumah University Science & Technology; Egyptian Knowledge Bank (EKB); Cairo University; Egyptian Knowledge Bank (EKB); Cairo University; Egyptian Knowledge Bank (EKB); Cairo University; Egyptian Knowledge Bank (EKB); Cairo University; University of London; Queen Mary University London	Biccard, BM (corresponding author), Groote Schuur Hosp, Dept Anaesthesia & Perioperat Med, ZA-7925 Cape Town, South Africa.; Biccard, BM (corresponding author), Univ Cape Town, ZA-7925 Cape Town, South Africa.	bruce.biccard@uct.ac.za	Kluyts, Hyla-Louise/AAD-3313-2021; Adamou, Harissou/Y-9250-2019; Elfagieh, Mohamed/AAU-4711-2020; Bhuiyan, Mirza MZU/Y-8884-2019; Pearse, Rupert/H-5426-2011; Ahmed, Muktar/AAY-6783-2020; Yakubu, Saidu Yusuf/AHC-7116-2022; Le Manach, Yannick/AAE-5700-2019; Elfiky, Mahmoud/B-1569-2015; van Dyk, Dominique/FDT-8706-2022; Mbwele, Bernard/ABB-7847-2020; Omoshoro-Jones, Jones A. O./AAV-1341-2020; attia, attia/GZL-7187-2022; Madiba, T E/ABI-8313-2020; Mukinda, Fidele K./AAD-6258-2019; Forget, Patrice/AAO-6918-2020; Alli, Ahmad/GPT-5028-2022; Paruk, Fathima/AAO-1864-2021; Mohammed, Mohammed Mustafa Hassan/AAT-8065-2020; Madiba, T E/N-6069-2013; Rodseth, Reitze/B-2471-2010	Kluyts, Hyla-Louise/0000-0002-9917-1330; Adamou, Harissou/0000-0001-8055-9426; Elfagieh, Mohamed/0000-0002-1148-9767; Bhuiyan, Mirza MZU/0000-0002-0406-6563; Pearse, Rupert/0000-0002-4373-5934; Ahmed, Muktar/0000-0002-9524-7027; Yakubu, Saidu Yusuf/0000-0002-6378-4805; Le Manach, Yannick/0000-0003-0474-8545; Elfiky, Mahmoud/0000-0003-1820-8603; van Dyk, Dominique/0000-0001-8579-007X; Mbwele, Bernard/0000-0002-3444-5505; Omoshoro-Jones, Jones A. O./0000-0002-1071-298X; attia, attia/0000-0003-2602-7263; Madiba, T E/0000-0002-0155-9143; Mukinda, Fidele K./0000-0002-0764-6213; Forget, Patrice/0000-0001-5772-8439; Alli, Ahmad/0000-0003-4879-7090; Paruk, Fathima/0000-0002-6549-0106; Mohammed, Mohammed Mustafa Hassan/0000-0003-3013-1792; Madiba, T E/0000-0002-0155-9143; Rodseth, Reitze/0000-0002-3779-7805; Spijkerman, Sandra/0000-0003-4461-3370; Omigbodun, Akinyinka/0000-0002-6377-9299; Hewitt Smith, Adam/0000-0002-6019-2441; Nabukenya, Mary T./0000-0003-3545-6086; Osinaike, Babatunde/0000-0002-5848-5018; Agaba, Peter/0000-0002-2166-5517; Reddy, K Srinath/0000-0003-3416-3548; Afolabi, Bosede/0000-0002-7511-7567; Lawal, Taiwo Akeem/0000-0002-8632-5783; CHOKWE, THOMAS/0000-0002-3378-0678; YUSUF, AYODEJI SALMAN/0000-0002-6002-8641; Adisa, Adewale/0000-0003-1927-3992; Desalu, Ibironke/0000-0002-5437-8530; NGUMI, ZIPPORAH/0000-0002-8918-7021; Hardcastle, Timothy/0000-0002-3967-0234; Sama, Hamza D./0000-0001-5365-8154	Medical Research Council of South Africa	Medical Research Council of South Africa(South African Medical Research Council)	Medical Research Council of South Africa.	Ahmad T, 2017, BRIT J ANAESTH, V119, P258, DOI 10.1093/bja/aex185; Aiken LH, 2003, JAMA-J AM MED ASSOC, V290, P1617, DOI 10.1001/jama.290.12.1617; [Anonymous], 2017, BRIT J ANAESTH, V119, P553, DOI [10.1093/bja/aew472, 10.1093/bja/aew316]; Austin PC, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-82; Bainbridge D, 2012, LANCET, V380, P1075, DOI 10.1016/S0140-6736(12)60990-8; Bhangu A, 2016, BRIT J SURG, V103, P971, DOI 10.1002/bjs.10151; Biccard B M, 2015, SAMJ, S. Afr. med. j., V105, P465, DOI 10.7196/SAMJ.9435; Chao TE, 2014, LANCET GLOB HEALTH, V2, pE334, DOI 10.1016/S2214-109X(14)70213-X; Chu KM, 2010, ARCH SURG-CHICAGO, V145, P721, DOI 10.1001/archsurg.2010.137; Dare AJ, 2014, LANCET, V384, P2245, DOI 10.1016/S0140-6736(14)60237-3; Davies JF, 2016, SURGERY, V159, P1269, DOI 10.1016/j.surg.2015.12.022; Devereaux PJ, 2012, JAMA-J AM MED ASSOC, V307, P2295, DOI 10.1001/jama.2012.5502; Flott K, 2017, LANCET, V389, P1279, DOI 10.1016/S0140-6736(17)30868-1; Funk LM, 2010, LANCET, V376, P1055, DOI 10.1016/S0140-6736(10)60392-3; Gakidou E, 2010, LANCET, V376, P959, DOI 10.1016/S0140-6736(10)61257-3; Griffiths P, 2013, INT J NURS STUD, V50, P292, DOI 10.1016/j.ijnurstu.2012.10.016; Grimes CE, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-1496-3; Grimes CE, 2014, WORLD J SURG, V38, P252, DOI 10.1007/s00268-013-2243-y; Harrell F.E., 2015, REGRESSION MODELING, DOI [10.1007/978-3-319-19425-7, DOI 10.1007/978-3-319-19425-7, 10.1007/978-1-4757-3462-1]; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Jamison DT, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P3, DOI 10.1596/978-0-8213-6179-5/Chpt-1; Jammer I, 2015, EUR J ANAESTH, V32, P88, DOI 10.1097/EJA.0000000000000118; McGinley A, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e5310; Meara JG, 2015, SURGERY, V158, P3, DOI [10.1016/j.surg.2015.04.011, 10.1016/S0140-6736(15)60160-X]; Meara JG, 2014, LANCET, V383, P12, DOI 10.1016/S0140-6736(13)62345-4; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Pearse RM, 2012, LANCET, V380, P1059, DOI 10.1016/S0140-6736(12)61148-9; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; Rickard JL, 2016, WORLD J SURG, V40, P784, DOI 10.1007/s00268-015-3308-x; Rose J, 2015, LANCET GLOB HEALTH, V3, pS13, DOI 10.1016/S2214-109X(15)70087-2; Sileshi B, 2017, ANESTHESIOLOGY, V127, P250, DOI 10.1097/ALN.0000000000001713; Sterne Jonathan A C, 2009, BMJ, V338, pb2393, DOI 10.1136/bmj.b2393; von Elm E, 2007, PLOS MED, V4, P1623, DOI [10.1371/journal.pmed.0040296, 10.1371/journal.pmed.0040297]; Weiser TG, 2015, LANCET, V385, P11, DOI 10.1016/S0140-6736(15)60806-6	34	260	264	5	36	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 21	2018	391	10130					1589	1598		10.1016/S0140-6736(18)30001-1	http://dx.doi.org/10.1016/S0140-6736(18)30001-1			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GD5JG	29306587	Green Submitted			2022-12-28	WOS:000430542700028
J	Trombetti, A; Hars, M; Hsu, FC; Reid, KF; Church, TS; Gill, TM; King, AC; Liu, CK; Manini, TM; McDermott, MM; Newman, AB; Rejeski, WJ; Guralnik, JM; Pahor, M; Fielding, RA				Trombetti, A.; Hars, M.; Hsu, F. C.; Reid, K. F.; Church, T. S.; Gill, T. M.; King, A. C.; Liu, C. K.; Manini, T. M.; McDermott, M. M.; Newman, A. B.; Rejeski, W. J.; Guralnik, J. M.; Pahor, M.; Fielding, R. A.		LIFE Study	Effect of Physical Activity on Frailty	ANNALS OF INTERNAL MEDICINE			English	Editorial Material													Hars, Mélany/AAI-1125-2021; Trombetti, Andrea/F-4575-2011	Trombetti, Andrea/0000-0002-0540-7024; HARS, MELANY/0000-0002-5108-0528; Gill, Thomas/0000-0002-6450-0368					0	0	0	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 6	2018	168	5					I22	I22		10.7326/P17-9052	http://dx.doi.org/10.7326/P17-9052			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FY2GD	29310139				2022-12-28	WOS:000426632600001
J	Boyd, MA; Cooper, DA				Boyd, Mark A.; Cooper, David A.			Combination ART: are two drugs as good as three?	LANCET			English	Editorial Material							INITIAL TREATMENT; HIV-1 INFECTION; REGIMENS; ZIDOVUDINE; TRIAL		[Boyd, Mark A.] Univ Adelaide, Fac Hlth & Med Sci, Adelaide, SA 5112, Australia; [Boyd, Mark A.; Cooper, David A.] Univ New South Wales, Kirby Inst, Sydney, NSW, Australia	University of Adelaide; University of New South Wales Sydney; Kirby Institute	Boyd, MA (corresponding author), Univ Adelaide, Fac Hlth & Med Sci, Adelaide, SA 5112, Australia.; Boyd, MA (corresponding author), Univ New South Wales, Kirby Inst, Sydney, NSW, Australia.	mark.boyd@adelaide.edu.au		Boyd, Mark/0000-0002-6848-3307				Achhra AC, 2016, LANCET HIV, V3, pE351, DOI 10.1016/S2352-3018(16)30015-7; Darbyshire JH, 1996, LANCET, V348, P1239, DOI 10.1016/S0140-6736(05)65509-2; Gulick RM, 2004, NEW ENGL J MED, V350, P1850, DOI 10.1056/NEJMoa031772; Hammer SM, 1997, NEW ENGL J MED, V337, P725, DOI 10.1056/NEJM199709113371101; Llibre JM, 2017, LANCET; Margolis DA, 2017, LANCET, V390, P1499, DOI 10.1016/S0140-6736(17)31917-7; Marschner IC, 1998, J INFECT DIS, V177, P40, DOI 10.1086/513823; Matthews RP, 2017, 9 IAS C HIV SCI PAR; Montaner JSG, 1998, JAMA-J AM MED ASSOC, V279, P930, DOI 10.1001/jama.279.12.930; PEDERSEN C, 1992, AIDS, V6, P821, DOI 10.1097/00002030-199208000-00009; Riddler SA, 2008, NEW ENGL J MED, V358, P2095, DOI 10.1056/NEJMoa074609	11	2	2	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 3	2018	391	10123					817	819		10.1016/S0140-6736(18)30008-4	http://dx.doi.org/10.1016/S0140-6736(18)30008-4			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FX9XF	29310898				2022-12-28	WOS:000426463500005
J	Wang, YZ; Small, DL; Stanimirovic, DB; Morley, P; Durkin, JP				Wang, Yizheng; Small, Daniel L.; Stanimirovic, Danica B.; Morley, Paul; Durkin, Jon P.			AMPA receptor-mediated regulation of a Gi-protein in cortical neurons (vol 389, pg 502, 1997)	NATURE			English	Correction												yzwang@ion.ac.cn						Wang YZ, 1997, NATURE, V389, P502, DOI 10.1038/39062	1	1	1	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 15	2018	554	7692					392	392		10.1038/nature25163	http://dx.doi.org/10.1038/nature25163			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW0PD	29258299	Bronze			2022-12-28	WOS:000424996300045
J	Xu, GF; Strathearn, L; Liu, BY; Bao, W				Xu, Guifeng; Strathearn, Lane; Liu, Buyun; Bao, Wei			Corrected Prevalence of Autism Spectrum Disorder Among US Children and Adolescents	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Xu, Guifeng; Liu, Buyun; Bao, Wei] Univ Iowa, Coll Publ Hlth, Dept Epidemiol, 145 N Riverside Dr,Room S431 CPHB, Iowa City, IA 52242 USA; [Strathearn, Lane] Univ Iowa, Stead Family Childrens Hosp, Ctr Disabil & Development, 145 N Riverside Dr,Room S431 CPHB, Iowa City, IA 52242 USA	University of Iowa; University of Iowa	Bao, W (corresponding author), Univ Iowa, Coll Publ Hlth, Dept Epidemiol, 145 N Riverside Dr,Room S431 CPHB, Iowa City, IA 52242 USA.	wei-bao@uiowa.edu	Bao, Wei/AAG-2431-2019; Romanova, Raisa/O-5724-2018; Strathearn, Lane/B-1740-2013	Bao, Wei/0000-0002-7301-5786; Strathearn, Lane/0000-0001-5870-8843				[Anonymous], 2018, JAMA, V319, P505, DOI 10.1001/jama.2018.0022; Xu GF, 2018, JAMA-J AM MED ASSOC, V319, P81, DOI 10.1001/jama.2017.17812	2	17	17	3	16	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 6	2018	319	5					505	505		10.1001/jama.2018.0001	http://dx.doi.org/10.1001/jama.2018.0001			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FV0CW	29305599	Green Published			2022-12-28	WOS:000424224500028
J	Ahmadi, M; Alves, BXR; Baker, CJ; Bertsche, W; Butler, E; Capra, A; Carruth, C; Cesar, CL; Charlton, M; Cohen, S; Collister, R; Eriksson, S; Evans, A; Evetts, N; Fajans, J; Friesen, T; Fujiwara, MC; Gill, DR; Gutierrez, A; Hangst, JS; Hardy, WN; Hayden, ME; Isaac, CA; Ishida, A; Ohnson, MAJ; Ones, SAJ; Onsell, SJ; Kurchaninov, L; Madsen, N; Mathers, M; Maxwell, D; McKenna, JTK; Menary, S; Michan, JM; Momose, T; Munich, JJ; Nolan, P; Olchanski, K; Olin, A; Pusa, P; Rasmussen, CO; Robicheaux, F; Sacramento, RL; Sameed, M; Sarid, E; Silveira, DM; Stracka, S; Stutter, G; So, C; Tharp, TD; Thompson, JE; Thompson, RI; van der Werf, DP; Wurtele, JS				Ahmadi, M.; Alves, B. X. R.; Baker, C. J.; Bertsche, W.; Butler, E.; Capra, A.; Carruth, C.; Cesar, C. L.; Charlton, M.; Cohen, S.; Collister, R.; Eriksson, S.; Evans, A.; Evetts, N.; Fajans, J.; Friesen, T.; Fujiwara, M. C.; Gill, D. R.; Gutierrez, A.; Hangst, J. S.; Hardy, W. N.; Hayden, M. E.; Isaac, C. A.; Ishida, A.; Ohnson, M. A. J.; Ones, S. A. J.; Onsell, S. J.; Kurchaninov, L.; Madsen, N.; Mathers, M.; Maxwell, D.; McKenna, J. T. K.; Menary, S.; Michan, J. M.; Momose, T.; Munich, J. J.; Nolan, P.; Olchanski, K.; Olin, A.; Pusa, P.; Rasmussen, C. O.; Robicheaux, F.; Sacramento, R. L.; Sameed, M.; Sarid, E.; Silveira, D. M.; Stracka, S.; Stutter, G.; So, C.; Tharp, T. D.; Thompson, J. E.; Thompson, R. I.; van der Werf, D. P.; Wurtele, J. S.			Observation of the hyperfine spectrum of antihydrogen (vol 548, pg 66, 2017)	NATURE			English	Correction													Cesar, Claudio/AAH-4612-2021; Hardy, Walter Newbold/AAN-7827-2020; Wurtele, Jonathan S/J-6278-2016	Wurtele, Jonathan S/0000-0001-8401-0297; Cesar, Claudio/0000-0003-2638-0032				Ahmadi M, 2017, NATURE, V548, P66, DOI 10.1038/nature23446	1	0	0	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 25	2018	553	7689					530	530		10.1038/nature24663	http://dx.doi.org/10.1038/nature24663			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU6OE	29258296	Bronze			2022-12-28	WOS:000423971100046
J	Wu, XF; Thi, VLD; Huang, YM; Billerbeck, E; Saha, D; Hoffmann, HH; Wang, YM; Silva, LAV; Sarbanes, S; Sun, T; Andrus, L; Yu, Y; Quirk, C; Li, M; MacDonald, MR; Schneider, WM; An, XL; Rosenberg, BR; Rice, CM				Wu, Xianfang; Viet Loan Dao Thi; Huang, Yumin; Billerbeck, Eva; Saha, Debjani; Hoffmann, Hans-Heinrich; Wang, Yaomei; Silva, Luis A. Vale; Sarbanes, Stephanie; Sun, Tony; Andrus, Linda; Yu, Yingpu; Quirk, Corrine; Li, Melody; MacDonald, Margaret R.; Schneider, William M.; An, Xiuli; Rosenberg, Brad R.; Rice, Charles M.			Intrinsic Immunity Shapes Viral Resistance of Stem Cells	CELL			English	Article							INTERFERON-STIMULATED GENES; VESICULAR STOMATITIS-VIRUS; INSULIN-PRODUCING CELLS; HEMATOPOIETIC STEM; IN-VITRO; PROGENITOR CELLS; BONE-MARROW; HUMAN CYTOMEGALOVIRUS; DIFFERENTIATION; INFECTION	Stem cells are highly resistant to viral infection compared to their differentiated progeny; however, the mechanism is mysterious. Here, we analyzed gene expression in mammalian stem cells and cells at various stages of differentiation. We find that, conserved across species, stem cells express a subset of genes previously classified as interferon (IFN) stimulated genes (ISGs) but that expression is intrinsic, as stem cells are refractory to interferon. This intrinsic ISG expression varies in a cell-type-specific manner, and many ISGs decrease upon differentiation, at which time cells become IFN responsive, allowing induction of a broad spectrum of ISGs by IFN signaling. Importantly, we show that intrinsically expressed ISGs protect stem cells against viral infection. We demonstrate the in vivo importance of intrinsic ISG expression for protecting stem cells and their differentiation potential during viral infection. These findings have intriguing implications for understanding stem cell biology and the evolution of pathogen resistance.	[Wu, Xianfang; Viet Loan Dao Thi; Billerbeck, Eva; Hoffmann, Hans-Heinrich; Sarbanes, Stephanie; Sun, Tony; Andrus, Linda; Yu, Yingpu; Quirk, Corrine; Li, Melody; MacDonald, Margaret R.; Schneider, William M.; Rice, Charles M.] Rockefeller Univ, Lab Virol & Infect Dis, New York, NY 10065 USA; [Saha, Debjani; Rosenberg, Brad R.] Rockefeller Univ, Program Immunogen, New York, NY 10065 USA; [Huang, Yumin; Wang, Yaomei; An, Xiuli] New York Blood Ctr, Lab Membrane Biol, New York, NY 10065 USA; [Huang, Yumin] Zhengzhou Univ, Affiliated Hosp 1, Dept Hematol, Zhengzhou 450001, Henan, Peoples R China; [Wang, Yaomei; An, Xiuli] Zhengzhou Univ, Sch Life Sci, Zhengzhou 450001, Henan, Peoples R China; [Silva, Luis A. Vale] NYU, Dept Biol, New York, NY 10003 USA	Rockefeller University; Rockefeller University; New York Blood Center; Zhengzhou University; Zhengzhou University; New York University	Rice, CM (corresponding author), Rockefeller Univ, Lab Virol & Infect Dis, New York, NY 10065 USA.	ricec@rockefeller.edu	Wu, Xianfang/O-5004-2019; Li, Melody/AAV-1802-2021; Wu, Xianfang/HII-9315-2022	Wu, Xianfang/0000-0002-2995-935X; Rosenberg, Brad/0000-0002-5885-1276	NIH [R01-AI091707, U19 AI111825, DK100810]; John C. Whitehead Presidential Fellowship; NSF of China [81530005]; Greenberg Medical Research Institute; Starr Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI091707, U19AI111825] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK100810] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD012142] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); John C. Whitehead Presidential Fellowship; NSF of China(National Natural Science Foundation of China (NSFC)); Greenberg Medical Research Institute; Starr Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank all Rice lab members for helpful comments on the manuscript; A. Brivanlou for RUES2, D. Huangfu for HUES8-iCas9, and S. Duncan for iPS.C3A cells. This work was supported by NIH grant R01-AI091707 (C.M.R. and B.R.R.), by NIH grant U19 AI111825 and the John C. Whitehead Presidential Fellowship (B.R.R.), in part by NIH grant DK100810 and a grant 81530005 from NSF of China (X.A.). Additional funding was provided by the Greenberg Medical Research Institute, the Starr Foundation, and anonymous donors.	Allen EK, 2017, NAT MED, V23, P975, DOI 10.1038/nm.4370; Anderson R, 2003, ADV VIRUS RES, V59, P229, DOI 10.1016/S0065-3527(03)59007-8; Bailey CC, 2014, ANNU REV VIROL, V1, P261, DOI 10.1146/annurev-virology-031413-085537; Baldridge MT, 2010, NATURE, V465, P793, DOI 10.1038/nature09135; Belzile JP, 2014, J VIROL, V88, P4021, DOI 10.1128/JVI.03492-13; Biacchesi S, 2004, VIROLOGY, V321, P247, DOI 10.1016/j.virol.2003.12.020; Bomsel M, 2003, NAT REV MOL CELL BIO, V4, P57, DOI 10.1038/nrm1005; BORDEN EC, 1982, CANCER RES, V42, P4948; BURKE DC, 1978, CELL, V13, P243, DOI 10.1016/0092-8674(78)90193-9; Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6; Carter CC, 2010, NAT MED, V16, P446, DOI 10.1038/nm.2109; CASTELLA A, 1985, AM J CLIN PATHOL, V84, P423; Couderc T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040029; Dalton KP, 2001, VIROLOGY, V279, P414, DOI 10.1006/viro.2000.0736; de Veer MJ, 2001, J LEUKOCYTE BIOL, V69, P912; del Valle JR, 2007, J VIROL, V81, P10597, DOI 10.1128/JVI.00923-07; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Douam F, 2015, ANNU REV GENET, V49, P21, DOI 10.1146/annurev-genet-112414-054823; Eisenberg E, 2013, TRENDS GENET, V29, P569, DOI 10.1016/j.tig.2013.05.010; Feuer G, 1996, J VIROL, V70, P4038, DOI 10.1128/JVI.70.6.4038-4044.1996; Finkelshtein D, 2013, P NATL ACAD SCI USA, V110, P7306, DOI 10.1073/pnas.1214441110; Garcia-Sastre A, 2017, CELL HOST MICROBE, V22, P176, DOI 10.1016/j.chom.2017.07.012; GONCZOL E, 1984, SCIENCE, V224, P159, DOI 10.1126/science.6322309; Grow EJ, 2015, NATURE, V522, P221, DOI 10.1038/nature14308; HERTZOG PJ, 1994, MOL REPROD DEV, V39, P226; Hong XX, 2013, J BIOL CHEM, V288, P16196, DOI 10.1074/jbc.M112.435461; Hu JP, 2013, BLOOD, V121, P3246, DOI 10.1182/blood-2013-01-476390; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Klattenhoff CA, 2013, CELL, V152, P570, DOI 10.1016/j.cell.2013.01.003; Kuznetsov SA, 2001, J CELL BIOL, V153, P1133, DOI 10.1083/jcb.153.5.1133; Laguette N, 2011, NATURE, V474, P654, DOI 10.1038/nature10117; Lange UC, 2008, MOL CELL BIOL, V28, P4688, DOI 10.1128/MCB.00272-08; Li HD, 2016, CELL STEM CELL, V19, P593, DOI 10.1016/j.stem.2016.08.005; Li Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114485; Lian QZ, 2010, CIRCULATION, V121, P1113, DOI 10.1161/CIRCULATIONAHA.109.898312; Maillard PV, 2013, SCIENCE, V342, P235, DOI 10.1126/science.1241930; Marchetto MCN, 2013, NATURE, V503, P525, DOI 10.1038/nature12686; Marques JT, 2007, TRENDS GENET, V23, P359, DOI 10.1016/j.tig.2007.04.004; McMahon AW, 2007, VACCINE, V25, P1727, DOI 10.1016/j.vaccine.2006.11.027; Mendelson M, 1996, J GEN VIROL, V77, P3099, DOI 10.1099/0022-1317-77-12-3099; NAEYE RL, 1965, J AMER MED ASSOC, V194, P1277, DOI 10.1001/jama.194.12.1277; Park MS, 2003, J VIROL, V77, P1501, DOI 10.1128/JVI.77.2.1501-1511.2003; Rezania A, 2014, NAT BIOTECHNOL, V32, P1121, DOI 10.1038/nbt.3033; Roson-Burgo B, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-910; Schneider WM, 2014, ANNU REV IMMUNOL, V32, P513, DOI 10.1146/annurev-immunol-032713-120231; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Shalek AK, 2014, NATURE, V510, P363, DOI 10.1038/nature13437; Shen HM, 1999, J VIROL, V73, P728, DOI 10.1128/JVI.73.1.728-737.1999; Singh K J, 2001, J Assoc Physicians India, V49, P790; SWARTZENDRUBER DE, 1975, J CELL PHYSIOL, V85, P179, DOI 10.1002/jcp.1040850204; Tan XY, 2013, STEM CELL RES, V11, P1045, DOI 10.1016/j.scr.2013.07.006; Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016; THEOFILOPOULOS AN, 1976, J IMMUNOL, V117, P953; Tsetsarkin K, 2006, VECTOR-BORNE ZOONOT, V6, P325, DOI 10.1089/vbz.2006.6.325; Villa N, 2016, CYTOTHERAPY, V18, P465, DOI 10.1016/j.jcyt.2015.12.007; Wakim LM, 2013, NAT IMMUNOL, V14, P238, DOI 10.1038/ni.2525; Weichold FF, 1998, BLOOD, V91, P907, DOI 10.1182/blood.V91.3.907.907_907_915; Weissman IL, 2000, CELL, V100, P157, DOI 10.1016/S0092-8674(00)81692-X; Wolf D, 2009, NATURE, V458, P1201, DOI 10.1038/nature07844; Wu XF, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002617; Zhang DH, 2009, CELL RES, V19, P429, DOI 10.1038/cr.2009.28; Zhang LQ, 2005, J VIROL, V79, P1113, DOI 10.1128/JVI.79.2.1113-1124.2005; Zhang Y, 2017, EVID-BASED COMPL ALT, V2017, P1, DOI DOI 10.1016/J.C0MP0SITESB.2017.01.051	63	175	178	1	46	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 25	2018	172	3					423	+		10.1016/j.cell.2017.11.018	http://dx.doi.org/10.1016/j.cell.2017.11.018			41	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FT9BS	29249360	Green Accepted, Bronze			2022-12-28	WOS:000423447600005
J	Collins, J; Robinson, C; Danhof, H; Knetsch, CW; van Leeuwen, HC; Lawley, TD; Auchtung, JM; Britton, RA				Collins, J.; Robinson, C.; Danhof, H.; Knetsch, C. W.; van Leeuwen, H. C.; Lawley, T. D.; Auchtung, J. M.; Britton, R. A.			Dietary trehalose enhances virulence of epidemic Clostridium difficile	NATURE			English	Article							EMERGENCE; INFECTION; STRAIN; SPREAD; MALABSORPTION; RESISTANCE; MORTALITY; DISEASE	Clostridium difficile disease has recently increased to become a dominant nosocomial pathogen in North America and Europe, although little is known about what has driven this emergence. Here we show that two epidemic ribotypes (RT027 and RT078) have acquired unique mechanisms to metabolize low concentrations of the disaccharide trehalose. RT027 strains contain a single point mutation in the trehalose repressor that increases the sensitivity of this ribotype to trehalose by more than 500-fold. Furthermore, dietary trehalose increases the virulence of a RT027 strain in a mouse model of infection. RT078 strains acquired a cluster of four genes involved in trehalose metabolism, including a PTS permease that is both necessary and sufficient for growth on low concentrations of trehalose. We propose that the implementation of trehalose as a food additive into the human diet, shortly before the emergence of these two epidemic lineages, helped select for their emergence and contributed to hypervirulence.	[Collins, J.; Danhof, H.; Auchtung, J. M.; Britton, R. A.] Baylor Coll Med, Dept Mol Virol & Microbiol, One Baylor Plaza, Houston, TX 77030 USA; [Robinson, C.] Univ Oregon, Inst Mol Biol, 1318 Franklin Blvd, Eugene, OR 97403 USA; [Knetsch, C. W.; van Leeuwen, H. C.] Leiden Univ, Med Ctr, Dept Med Microbiol, Albinusdreef 2, NL-2333 ZA Leiden, Netherlands; [Lawley, T. D.] Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Hinxton CB10 1SA, Cambs, England	Baylor College of Medicine; University of Oregon; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Wellcome Trust Sanger Institute	Britton, RA (corresponding author), Baylor Coll Med, Dept Mol Virol & Microbiol, One Baylor Plaza, Houston, TX 77030 USA.	robert.britton@bcm.edu	Danhof, Heather/ABD-3763-2020; Collins, James/I-4740-2019	Danhof, Heather/0000-0002-6347-0021; Collins, James/0000-0003-2479-5189; Knetsch, Wilco/0000-0001-8569-3456; Auchtung, Jennifer/0000-0003-3038-583X	National Institutes of Health [U01AI124290-01, 5U19AI09087202]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI123278, U01AI124290] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056338] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institutes of Health (U01AI124290-01 and 5U19AI09087202). We thank the members of the Ostomy Association of Greater Lansing for anonymously donating samples, and D. Lyras for the RT244 strains. We thank V. Young, D. Mills, J. Walter and M. Costa-Mattioli for comments on the manuscript.	Auchtung JM, 2016, METHODS MOL BIOL, V1476, P235, DOI 10.1007/978-1-4939-6361-4_18; BERGOZ R, 1971, GASTROENTEROLOGY, V60, P909; BERGOZ R, 1973, SCAND J GASTROENTERO, V8, P657; Bouillaut L, 2013, J BACTERIOL, V195, P844, DOI 10.1128/JB.01492-12; Collins J, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0097-2; de Kok S, 2014, ACS SYNTH BIOL, V3, P97, DOI 10.1021/sb4001992; Dingle TC, 2011, INFECT IMMUN, V79, P4061, DOI 10.1128/IAI.05305-11; Eyre DW, 2015, EUROSURVEILLANCE, V20, DOI 10.2807/1560-7917.ES2015.20.10.21059; Fagan RP, 2011, J BIOL CHEM, V286, P27483, DOI 10.1074/jbc.M111.263889; Goorhuis A, 2008, CLIN INFECT DIS, V47, P1162, DOI 10.1086/592257; Griffiths D, 2010, J CLIN MICROBIOL, V48, P770, DOI 10.1128/JCM.01796-09; Gupta A, 2014, INFECT DRUG RESIST, V7, P63, DOI 10.2147/IDR.S46780; He M, 2013, NAT GENET, V45, P109, DOI 10.1038/ng.2478; He M, 2010, P NATL ACAD SCI USA, V107, P7527, DOI 10.1073/pnas.0914322107; Higashiyama T, 2002, PURE APPL CHEM, V74, P1263, DOI 10.1351/pac200274071263; HOLM S, 1979, SCAND J STAT, V6, P65; Jhung MA, 2008, EMERG INFECT DIS, V14, P1039, DOI 10.3201/eid1407.071641; Knetsch CW, 2011, MICROBIOL-SGM, V157, P3113, DOI 10.1099/mic.0.051953-0; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Leffler DA, 2015, NEW ENGL J MED, V372, P1539, DOI 10.1056/NEJMra1403772; Lim SK, 2014, CLIN INFECT DIS, V58, P1723, DOI 10.1093/cid/ciu203; Limbago BM, 2009, J CLIN MICROBIOL, V47, P3004, DOI 10.1128/JCM.00964-09; Ng YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077575; Oku T, 2000, EUR J CLIN NUTR, V54, P783, DOI 10.1038/sj.ejcn.1601091; Pfaffl MW., 2006, REAL TIME PCR, P63; Polivkova S, 2016, ANAEROBE, V40, P35, DOI 10.1016/j.anaerobe.2016.05.002; POPOFF MR, 1988, INFECT IMMUN, V56, P2299, DOI 10.1128/IAI.56.9.2299-2306.1988; Robinson CD, 2014, INFECT IMMUN, V82, P2815, DOI 10.1128/IAI.01524-14; Roca A. I., F1000 RES, V2, P2; Rupnik M, 2016, ANAEROBE, V42, P142, DOI 10.1016/j.anaerobe.2016.10.005; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; SMITH CJ, 1981, ANTIMICROB AGENTS CH, V19, P997, DOI 10.1128/AAC.19.6.997; Spigaglia P, 2008, J MED MICROBIOL, V57, P784, DOI 10.1099/jmm.0.47738-0; Spigaglia P, 2010, J CLIN MICROBIOL, V48, P2892, DOI 10.1128/JCM.02482-09; Stabler RA, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r102; Theriot CM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4114; Walker AS, 2013, CLIN INFECT DIS, V56, P1589, DOI 10.1093/cid/cit127	37	195	200	5	118	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 18	2018	553	7688					291	+		10.1038/nature25178	http://dx.doi.org/10.1038/nature25178			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT9MB	29310122	Green Accepted, Green Submitted			2022-12-28	WOS:000423475100041
J	Stolper, DA; Keller, CB				Stolper, Daniel A.; Keller, C. Brenhin			A record of deep-ocean dissolved O-2 from the oxidation state of iron in submarine basalts	NATURE			English	Article							ATMOSPHERIC OXYGEN; PROTEROZOIC OCEAN; BILLION YEARS; NEW-MODEL; GA AGO; CRUST; RISE; CHEMISTRY; OPHIOLITE; SEAWATER	The oxygenation of the deep ocean in the geological past has been associated with a rise in the partial pressure of atmospheric molecular oxygen (O-2) to near-present levels and the emergence of modern marine biogeochemical cycles(1-5). It has also been linked to the origination and diversification of early animals(3,5-7). It is generally thought that the deep ocean was largely anoxic from about 2,500 to 800 million years ago(1-12), with estimates of the occurrence of deep-ocean oxygenation and the linked increase in the partial pressure of atmospheric oxygen to levels sufficient for this oxygenation ranging from about 800 to 400 million years ago(3,5,7,11,13). Deep-ocean dissolved oxygen concentrations over this interval are typically estimated using geochemical signatures preserved in ancient continental shelf or slope sediments, which only indirectly reflect the geochemical state of the deep ocean. Here we present a record that more directly reflects deep-ocean oxygen concentrations, based on the ratio of Fe3+ to total Fe in hydrothermally altered basalts formed in ocean basins. Our data allow for quantitative estimates of deep-ocean dissolved oxygen concentrations from 3.5 billion years ago to 14 million years ago and suggest that deep-ocean oxygenation occurred in the Phanerozoic (541 million years ago to the present) and potentially not until the late Palaeozoic (less than 420 million years ago).	[Stolper, Daniel A.; Keller, C. Brenhin] Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA; [Keller, C. Brenhin] Berkeley Geochronol Ctr, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; Berkeley Geochronolgy Center	Stolper, DA (corresponding author), Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA.	dstolper@berkeley.edu			Ann and Gordon Getty Foundation	Ann and Gordon Getty Foundation	D.A.S. acknowledges discussions with M. Bender, B. Buffett, D. DePaolo, J. Eiler, S. Finnegan, W. Fischer, J. Higgins, A. Saal and E. Stolper. We thank D. Canfield for advice on a prior draft. C.B.K. acknowledges support from the Ann and Gordon Getty Foundation.	ALT JC, 1984, CONTRIB MINERAL PETR, V87, P149, DOI 10.1007/BF00376221; Andersen MB, 2015, NATURE, V517, P356, DOI 10.1038/nature14062; Bach W, 2003, GEOCHIM COSMOCHIM AC, V67, P3871, DOI 10.1016/S0016-7037(03)00304-1; Belcher CM, 2008, SCIENCE, V321, P1197, DOI 10.1126/science.1160978; Bergman NM, 2004, AM J SCI, V304, P397, DOI 10.2475/ajs.304.5.397; Berner RA, 2009, AM J SCI, V309, P603, DOI 10.2475/07.2009.03; BICKLE MJ, 1992, EARTH PLANET SC LETT, V113, P219, DOI 10.1016/0012-821X(92)90221-G; Blamey NJF, 2016, GEOLOGY, V44, P651, DOI 10.1130/G37937.1; Canfield D. E., 2014, TREATISE GEOCHEMISTR, V2nd, P197; Canfield DE, 2005, ANNU REV EARTH PL SC, V33, P1, DOI 10.1146/annurev.earth.33.092203.122711; Canfield DE, 1998, NATURE, V396, P450, DOI 10.1038/24839; Canfield DE, 2007, SCIENCE, V315, P92, DOI 10.1126/science.1135013; Canfield DE, 2008, SCIENCE, V321, P949, DOI 10.1126/science.1154499; Dahl TW, 2010, P NATL ACAD SCI USA, V107, P17911, DOI 10.1073/pnas.1011287107; Dilek Y, 2011, GEOL SOC AM BULL, V123, P387, DOI 10.1130/B30446.1; Elderfield H, 1996, ANNU REV EARTH PL SC, V24, P191, DOI 10.1146/annurev.earth.24.1.191; Furnes H, 2015, GONDWANA RES, V27, P649, DOI 10.1016/j.gr.2013.06.004; Furnes H, 2014, GEOSCI FRONT, V5, P571, DOI 10.1016/j.gsf.2014.02.002; Gale A, 2013, GEOCHEM GEOPHY GEOSY, V14, P489, DOI 10.1029/2012GC004334; GREGORY RT, 1981, J GEOPHYS RES, V86, P2737, DOI 10.1029/JB086iB04p02737; Halevy I, 2017, SCIENCE, V355, P1069, DOI 10.1126/science.aal4151; Hofmann A, 2008, CHEM GEOL, V257, P224, DOI 10.1016/j.chemgeo.2008.09.015; JOHNSON HP, 1994, J GEOPHYS RES-SOL EA, V99, P3123, DOI 10.1029/93JB00717; Karstensen J, 2008, PROG OCEANOGR, V77, P331, DOI 10.1016/j.pocean.2007.05.009; Kasting JF, 2006, EARTH PLANET SC LETT, V252, P82, DOI 10.1016/j.epsl.2006.09.029; Keller CB, 2015, NATURE, V523, P301, DOI 10.1038/nature14584; Keller CB, 2012, NATURE, V485, P490, DOI 10.1038/nature11024; Kelley KA, 2009, SCIENCE, V325, P605, DOI 10.1126/science.1174156; KUMP L.R., 2001, GEOCHEM GEOPHY GEOSY, V2, P1025, DOI DOI 10.1029/2000GC000114; Kump LR, 2007, NATURE, V448, P1033, DOI 10.1038/nature06058; Laakso TA, 2014, EARTH PLANET SC LETT, V388, P81, DOI 10.1016/j.epsl.2013.11.049; Li ZXA, 2004, EARTH PLANET SC LETT, V228, P483, DOI 10.1016/j.epsl.2004.10.006; Lyons TW, 2014, NATURE, V506, P307, DOI 10.1038/nature13068; Muller RD, 2013, GEOLOGY, V41, P907, DOI 10.1130/G34405.1; NILSSON K, 1993, GEOCHIM COSMOCHIM AC, V57, P3807, DOI 10.1016/0016-7037(93)90158-S; PALLISTER JS, 1989, J GEOPHYS RES-SOLID, V94, P15901, DOI 10.1029/JB094iB11p15901; Planavsky NJ, 2014, SCIENCE, V346, P635, DOI 10.1126/science.1258410; R Foundation for Statistical Computing, 2015, R LANG ENV STAT COMP; Rybacki KS, 2016, PRECAMBRIAN RES, V275, P513, DOI 10.1016/j.precamres.2016.01.010; Sahoo SK, 2012, NATURE, V489, P546, DOI 10.1038/nature11445; Sarmiento J.L., 2013, OCEAN BIOGEOCHEMICAL, DOI [DOI 10.2307/J.CTT3FGXQX, 10.1515/9781400849079, DOI 10.1515/9781400849079]; Scott AC, 2006, P NATL ACAD SCI USA, V103, P10861, DOI 10.1073/pnas.0604090103; Scott C, 2008, NATURE, V452, P456, DOI 10.1038/nature06811; Slack JF, 2007, EARTH PLANET SC LETT, V255, P243, DOI 10.1016/j.epsl.2006.12.018; Sperling EA, 2015, NATURE, V523, P451, DOI 10.1038/nature14589; Staudigel H., 1996, GEOPHYS MONOGR SER, V96, P19, DOI DOI 10.1029/GM096P0019; Stolper DA, 2016, SCIENCE, V353, P1427, DOI 10.1126/science.aaf5445; WALLACE P, 1992, GEOCHIM COSMOCHIM AC, V56, P1863, DOI 10.1016/0016-7037(92)90316-B	49	87	91	4	89	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 18	2018	553	7688					323	+		10.1038/nature25009	http://dx.doi.org/10.1038/nature25009			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT9MB	29310121	Green Submitted			2022-12-28	WOS:000423475100048
J	Clemente, JC; Manasson, J; Scher, JU				Clemente, Jose C.; Manasson, Julia; Scher, Jose U.			The role of the gut microbiome in systemic inflammatory disease	BMJ-BRITISH MEDICAL JOURNAL			English	Review							EXCLUSIVE ENTERAL NUTRITION; ACTIVE ULCERATIVE-COLITIS; DEVELOPING RHEUMATOID-ARTHRITIS; FECAL MICROBIOTA; CROHNS-DISEASE; CELIAC-DISEASE; PSORIATIC-ARTHRITIS; DOUBLE-BLIND; ANKYLOSING ENTHESOPATHY; INTESTINAL MICROBIOTA	The role of the gut microbiome in models of inflammatory and autoimmune disease is now well characterized. Renewed interest in the human microbiome and its metabolites, as well as notable advances in host mucosal immunology, has opened multiple avenues of research to potentially modulate inflammatory responses. The complexity and interdependence of these diet-microbe-metabolite-host interactions are rapidly being unraveled. Importantly, most of the progress in the field comes from new knowledge about the functional properties of these microorganisms in physiology and their effect in mucosal immunity and distal inflammation. This review summarizes the preclinical and clinical evidence on how dietary, probiotic, prebiotic, and microbiome based therapeutics affect our understanding of wellness and disease, particularly in autoimmunity.	[Clemente, Jose C.] Icahn Sch Med Mt Sinai, Icahn Inst Genom & Multiscale Biol, Dept Genet & Genom Sci, New York, NY 10029 USA; [Manasson, Julia; Scher, Jose U.] NYU, Sch Med, Dept Med, Div Rheumatol, New York, NY 10003 USA; [Manasson, Julia; Scher, Jose U.] Hosp Joint Dis & Med Ctr, New York, NY 10003 USA	Icahn School of Medicine at Mount Sinai; New York University; NYU Langone Medical Center; Hospital for Joint Disease NYULMC	Scher, JU (corresponding author), NYU, Sch Med, Dept Med, Div Rheumatol, New York, NY 10003 USA.; Scher, JU (corresponding author), Hosp Joint Dis & Med Ctr, New York, NY 10003 USA.	Jose.Scher@nyumc.org	Manasson, Julia/AAZ-5391-2021	Manasson, Julia/0000-0003-3448-5520	NIH/NIAMS [K23AR064318, 1R03AR072182]; SUCCESS grant; Crohn's and Colitis Foundation of America [362048]; Judith and Stewart NYU Colton Center for Autoimmunity; Riley Family Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR069515, R03AR072182, K23AR064318] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD018522] Funding Source: NIH RePORTER	NIH/NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); SUCCESS grant; Crohn's and Colitis Foundation of America; Judith and Stewart NYU Colton Center for Autoimmunity; Riley Family Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Supported by grant No K23AR064318 and 1R03AR072182 from NIH/NIAMS to JUS, SUCCESS grant to JCC, Crohn's and Colitis Foundation of America #362048 to JCC, the Judith and Stewart NYU Colton Center for Autoimmunity, and the Riley Family Foundation.	Abdollahi-Roodsaz S, 2008, J CLIN INVEST, V118, P205, DOI 10.1172/JCI32639; Abdollahi-Roodsaz S, 2016, NAT REV RHEUMATOL, V12, P446, DOI 10.1038/nrrheum.2016.68; Aguiar-Pulido V, 2016, EVOL BIOINFORM, V12, P5, DOI 10.4137/EBO.S36436; Ahmed I, 2016, MICROORGANISMS, V4, DOI 10.3390/microorganisms4020020; Alipour B, 2014, INT J RHEUM DIS, V17, P519, DOI 10.1111/1756-185X.12333; Anstadt EJ, 2016, J IMMUNOL, V197, P2110, DOI 10.4049/jimmunol.1600876; Arpaia N, 2013, NATURE, V504, P451, DOI 10.1038/nature12726; Asquith M, 2017, ARTHRITIS RHEUMATOL, V69, P1984, DOI 10.1002/art.40183; Asquith MJ, 2016, ARTHRITIS RHEUMATOL, V68, P2151, DOI 10.1002/art.39681; Atarashi K, 2015, CELL, V163, P367, DOI 10.1016/j.cell.2015.08.058; Atarashi K, 2013, NATURE, V500, P232, DOI 10.1038/nature12331; Bejaoui M, 2015, DIGEST DIS, V33, P105, DOI 10.1159/000437104; Benito-Garcia E, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2123; Benjamin JL, 2011, GUT, V60, P923, DOI 10.1136/gut.2010.232025; Berer K, 2014, FEBS LETT, V588, P4207, DOI 10.1016/j.febslet.2014.04.007; Berer K, 2011, NATURE, V479, P538, DOI 10.1038/nature10554; Bhatia BK, 2014, J AM ACAD DERMATOL, V71, P350, DOI 10.1016/j.jaad.2014.03.017; Binger KJ, 2015, J CLIN INVEST, V125, P4223, DOI 10.1172/JCI80919; Birkenfeld S, 2009, BRIT J DERMATOL, V161, P1331, DOI 10.1111/j.1365-2133.2009.09398.x; Blander JM, 2017, NAT IMMUNOL, V18, P851, DOI 10.1038/ni.3780; Borody TJ, 2003, J CLIN GASTROENTEROL, V37, P42, DOI 10.1097/00004836-200307000-00012; Brownlee WJ, 2017, LANCET, V389, P1336, DOI 10.1016/S0140-6736(16)30959-X; Caesar R, 2015, CELL METAB, V22, P658, DOI 10.1016/j.cmet.2015.07.026; Canete JD, 2012, ANN RHEUM DIS, V71, P1265, DOI 10.1136/annrheumdis-2012-201632; Casellas F, 2007, ALIMENT PHARM THER, V25, P1061, DOI 10.1111/j.1365-2036.2007.03288.x; Clemente JC, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500183; Cohen LJ, 2017, NATURE, V549, P48, DOI 10.1038/nature23874; Cohen SA, 2014, J PEDIATR GASTR NUTR, V59, P516, DOI 10.1097/MPG.0000000000000449; Costello ME, 2015, ARTHRITIS RHEUMATOL, V67, P686, DOI 10.1002/art.38967; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; Day AS, 2013, EXPERT REV CLIN IMMU, V9, P375, DOI [10.1586/ECI.13.12, 10.1586/eci.13.12]; De Bastiani R, 2015, DERMATOLOGY, V230, P156, DOI 10.1159/000369615; De Filippis F, 2017, APPL ENVIRON MICROB, V83, DOI 10.1128/AEM.00905-17; De Filippis F, 2016, GUT, V65, P1812, DOI 10.1136/gutjnl-2015-309957; Di Giuseppe D, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4498; Di Giuseppe D, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e4230; Di Minno MND, 2014, ANN RHEUM DIS, V73, P1157, DOI 10.1136/annrheumdis-2012-202812; Dogan B, 2014, INFLAMM BOWEL DIS, V20, P1919, DOI 10.1097/MIB.0000000000000183; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Eder L, 2015, ANN RHEUM DIS, V74, P813, DOI 10.1136/annrheumdis-2013-204448; Edson-Heredia E, 2014, J INVEST DERMATOL, V134, P18, DOI 10.1038/jid.2013.326; Engin B, 2014, INT J DERMATOL, V53, P1468, DOI 10.1111/ijd.12171; Fallingborg J, 1999, DAN MED BULL, V46, P183; Farrokhi V, 2013, CLIN TRANSL IMMUNOL, V2, DOI 10.1038/cti.2013.11; Forbes JD, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01081; FORTIN PR, 1995, J CLIN EPIDEMIOL, V48, P1379, DOI 10.1016/0895-4356(95)00028-3; Frick JS, 2013, CURR TOP MICROBIOL, V358, P273, DOI 10.1007/82_2012_217; Fujimori S, 2007, J GASTROEN HEPATOL, V22, P1199, DOI 10.1111/j.1440-1746.2006.04535.x; Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721; Garber K, 2015, NAT BIOTECHNOL, V33, P228, DOI 10.1038/nbt.3161; Gensollen T, 2016, SCIENCE, V352, P539, DOI 10.1126/science.aad9378; Gevers D, 2014, CELL HOST MICROBE, V15, P382, DOI 10.1016/j.chom.2014.02.005; Gkouskou KK, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00028; GOVERMAN J, 1993, CELL, V72, P551, DOI 10.1016/0092-8674(93)90074-Z; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Grinspan AM, 2015, GASTROENTEROLOGY, V149, P15, DOI 10.1053/j.gastro.2015.05.030; Groeger D, 2013, GUT MICROBES, V4, P325, DOI 10.4161/gmic.25487; Guo CJ, 2017, CELL, V168, P517, DOI 10.1016/j.cell.2016.12.021; Gupta P, 2000, J PEDIATR GASTR NUTR, V31, P453, DOI 10.1097/00005176-200010000-00024; Hafer A, 2007, BMC GASTROENTEROL, V7, DOI 10.1186/1471-230X-7-36; Hagfors Linda, 2005, Nutr Metab (Lond), V2, P26, DOI 10.1186/1743-7075-2-26; Hagfors L, 2003, NUTR J, V2, DOI 10.1186/1475-2891-2-5; Haghikia A, 2015, IMMUNITY, V43, P817, DOI 10.1016/j.immuni.2015.09.007; Hatakka K, 2003, SCAND J RHEUMATOL, V32, P211, DOI 10.1080/03009740310003695; He ZX, 2016, GUT PATHOG, V8, DOI 10.1186/s13099-016-0146-9; HENSELER T, 1995, J AM ACAD DERMATOL, V32, P982, DOI 10.1016/0190-9622(95)91336-X; Herron MD, 2005, ARCH DERMATOL, V141, P1527, DOI 10.1001/archderm.141.12.1527; Hevia A, 2014, MBIO, V5, DOI 10.1128/mBio.01548-14; Holscher HD, 2017, GUT MICROBES, V8, P172, DOI 10.1080/19490976.2017.1290756; Hu Y, 2017, ANN RHEUM DIS, V76, P1357, DOI 10.1136/annrheumdis-2016-210431; Hu Y, 2015, ARTHRIT CARE RES, V67, P597, DOI 10.1002/acr.22481; Hudcovic T, 2001, FOLIA MICROBIOL, V46, P565, DOI 10.1007/BF02818004; Hugenholtz P, 1998, J BACTERIOL, V180, P4765, DOI 10.1128/JB.180.18.4765-4774.1998; Huse SM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000255; Iannone F, 2016, AUTOIMMUN REV, V15, P447, DOI 10.1016/j.autrev.2016.01.010; Isaac S, 2017, J ANTIMICROB CHEMOTH, V72, P128, DOI 10.1093/jac/dkw383; Jacob V, 2017, INFLAMM BOWEL DIS, V23, P903, DOI 10.1097/MIB.0000000000001132; Jacobi A, 2015, DERMATOLOGY, V231, P231, DOI 10.1159/000433528; Jenks K, 2010, J RHEUMATOL, V37, P2118, DOI 10.3899/jrheum.100193; Jin ZC, 2014, ANN RHEUM DIS, V73, P1962, DOI 10.1136/annrheumdis-2013-203323; Jowett SL, 2004, GUT, V53, P1479, DOI 10.1136/gut.2003.024828; Kato K, 2004, ALIMENT PHARM THER, V20, P1133, DOI 10.1111/j.1365-2036.2004.02268.x; Kelly CR, 2016, ANN INTERN MED, V165, P609, DOI 10.7326/M16-0271; Kernbauer E, 2014, NATURE, V516, P94, DOI 10.1038/nature13960; Kolho KL, 2015, AM J GASTROENTEROL, V110, P921, DOI 10.1038/ajg.2015.149; Korem T, 2017, CELL METAB, V25, P1243, DOI 10.1016/j.cmet.2017.05.002; Kump PK, 2013, INFLAMM BOWEL DIS, V19, P2155, DOI 10.1097/MIB.0b013e31829ea325; Langen MACLV, 2009, INFLAMM BOWEL DIS, V15, P454, DOI 10.1002/ibd.20737; Lederberg J, 2000, SCIENCE, V288, P287, DOI 10.1126/science.288.5464.287; Lee YH, 2012, ARCH MED RES, V43, P356, DOI 10.1016/j.arcmed.2012.06.011; Lee YK, 2011, P NATL ACAD SCI USA, V108, P4615, DOI 10.1073/pnas.1000082107; Levin BJ, 2017, SCIENCE, V355, DOI 10.1126/science.aai8386; Li WQ, 2012, ANN RHEUM DIS, V71, P1267, DOI 10.1136/annrheumdis-2011-201273; Lin P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105684; Linos A, 1999, AM J CLIN NUTR, V70, P1077; Liu XF, 2016, SCI REP-UK, V6, DOI 10.1038/srep30594; Lopez P, 2016, SCI REP-UK, V6, DOI 10.1038/srep24072; Love TJ, 2012, ANN RHEUM DIS, V71, P1273, DOI 10.1136/annrheumdis-2012-201299; Lu B, 2014, ARTHRITIS RHEUMATOL, V66, P1998, DOI 10.1002/art.38634; Machiels K, 2014, GUT, V63, P1275, DOI 10.1136/gutjnl-2013-304833; Maeda Y, 2016, ARTHRITIS RHEUMATOL, V68, P2646, DOI 10.1002/art.39783; Malchow HA, 1997, J CLIN GASTROENTEROL, V25, P653, DOI 10.1097/00004836-199712000-00021; Maldonado MA, 1999, J IMMUNOL, V162, P6322; Mallon P, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005573.pub2; Matsumoto I, 1999, SCIENCE, V286, P1732, DOI 10.1126/science.286.5445.1732; Mazmanian SK, 2008, NATURE, V453, P620, DOI 10.1038/nature07008; McGowan JW, 2005, ARCH DERMATOL, V141, P1601, DOI 10.1001/archderm.141.12.1601; McKellar G, 2007, ANN RHEUM DIS, V66, P1239, DOI 10.1136/ard.2006.065151; Michaelsson G, 2000, BRIT J DERMATOL, V142, P44, DOI 10.1046/j.1365-2133.2000.03240.x; Millsop JW, 2014, J AM ACAD DERMATOL, V71, P561, DOI 10.1016/j.jaad.2014.03.016; Mirza A, 2017, CLIN IMMUNOL, V183, P213, DOI 10.1016/j.clim.2017.03.001; Mizuno M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173032; Moayyedi P, 2015, GASTROENTEROLOGY, V149, P102, DOI 10.1053/j.gastro.2015.04.001; Morgan XC, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r79; Mraz M, 2014, J ENDOCRINOL, V222, pR113, DOI 10.1530/JOE-14-0283; Mudd AT, 2017, GUT MICROBES, V8, P589, DOI 10.1080/19490976.2017.1353849; Muegge BD, 2011, SCIENCE, V332, P970, DOI 10.1126/science.1198719; Norling LV, 2013, CURR OPIN PHARMACOL, V13, P476, DOI 10.1016/j.coph.2013.02.003; Ochoa-Reparaz J, 2010, J IMMUNOL, V185, P4101, DOI 10.4049/jimmunol.1001443; Ojetti V, 2003, AM J GASTROENTEROL, V98, P2574, DOI 10.1016/S0002-9270(03)01717-9; Olle B, 2013, NAT BIOTECHNOL, V31, P309, DOI 10.1038/nbt.2548; Palm NW, 2014, CELL, V158, P1000, DOI 10.1016/j.cell.2014.08.006; Paramsothy S, 2017, LANCET, V389, P1218, DOI 10.1016/S0140-6736(17)30182-4; Pattison DJ, 2004, ARTHRITIS RHEUM-US, V50, P3804, DOI 10.1002/art.20731; Pattison DJ, 2004, ANN RHEUM DIS, V63, P843, DOI 10.1136/ard.2003.016097; Peng LY, 2007, PEDIATR RES, V61, P37, DOI 10.1203/01.pdr.0000250014.92242.f3; Petersen AM, 2014, J CROHNS COLITIS, V8, P1498, DOI 10.1016/j.crohns.2014.06.001; Pineda MD, 2011, MED SCI MONITOR, V17, pCR347; Poretsky R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093827; Prinz M, 2006, J CLIN INVEST, V116, P456, DOI 10.1172/JCI26078; Proudman SM, 2015, ANN RHEUM DIS, V74, P89, DOI 10.1136/annrheumdis-2013-204145; Rahimi R, 2008, DIGEST DIS SCI, V53, P2524, DOI 10.1007/s10620-007-0171-0; Ratner M, 2016, NAT BIOTECHNOL, V34, P1004, DOI 10.1038/nbt1016-1004b; Rehakova Z, 2000, HUM IMMUNOL, V61, P555, DOI 10.1016/S0198-8859(00)00122-1; Rogier R, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0278-2; Rolfe VE, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004826; Romero-Talamas H, 2014, SURG OBES RELAT DIS, V10, P1155, DOI 10.1016/j.soard.2014.03.025; Rosell M, 2009, EPIDEMIOLOGY, V20, P896, DOI 10.1097/EDE.0b013e3181b5f0ce; Rosillo MA, 2016, EUR J NUTR, V55, P315, DOI 10.1007/s00394-015-0850-0; Rossen NG, 2015, GASTROENTEROLOGY, V149, P110, DOI 10.1053/j.gastro.2015.03.045; Rothhammer V, 2016, NAT MED, V22, P586, DOI 10.1038/nm.4106; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Sakaguchi N, 2003, NATURE, V426, P454, DOI 10.1038/nature02119; Salgado E, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000924; Scher JU, 2015, ARTHRITIS RHEUMATOL, V67, P128, DOI 10.1002/art.38892; Scher JU, 2013, ELIFE, V2, DOI 10.7554/eLife.01202; Schultz M, 2004, BMC GASTROENTEROL, V4, DOI 10.1186/1471-230X-4-5; Sellon RK, 1998, INFECT IMMUN, V66, P5224, DOI 10.1128/IAI.66.11.5224-5231.1998; Sender R, 2016, CELL, V164, P337, DOI 10.1016/j.cell.2016.01.013; Shapiro JA, 1996, EPIDEMIOLOGY, V7, P256, DOI 10.1097/00001648-199605000-00007; Siggins A, 2012, FEMS MICROBIOL ECOL, V80, P265, DOI 10.1111/j.1574-6941.2011.01284.x; Silva S, 2015, J NUTR BIOCHEM, V26, P360, DOI 10.1016/j.jnutbio.2014.11.011; Sinkorova Z, 2008, HUM IMMUNOL, V69, P845, DOI 10.1016/j.humimm.2008.08.296; Skoldstam L, 2003, ANN RHEUM DIS, V62, P208, DOI 10.1136/ard.62.3.208; Slavin J, 2013, NUTRIENTS, V5, P1417, DOI 10.3390/nu5041417; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105; Sokol H, 2010, CURR OPIN GASTROEN, V26, P327, DOI 10.1097/MOG.0b013e328339536b; Sood A, 2009, CLIN GASTROENTEROL H, V7, P1202, DOI 10.1016/j.cgh.2009.07.016; Stebbings SM, 2009, J RHEUMATOL, V36, P797, DOI 10.3899/jrheum.080964; Stoll ML, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/s13075-014-0486-0; Stoll ML, 2015, ARTHRITIS RHEUMA S10, V67; Sundstrom B, 2015, RHEUMATOLOGY, V54, P487, DOI 10.1093/rheumatology/keu330; Suskind DL, 2014, J PEDIATR GASTR NUTR, V58, P87, DOI 10.1097/MPG.0000000000000103; Tamburini S, 2016, NAT MED, V22, P713, DOI 10.1038/nm.4142; TAUROG JD, 1994, J EXP MED, V180, P2359, DOI 10.1084/jem.180.6.2359; Tjellstrom B, 2012, SCAND J GASTROENTERO, V47, P1454, DOI 10.3109/00365521.2012.703234; Tringe SG, 2005, NAT REV GENET, V6, P805, DOI 10.1038/nrg1709; Trompette A, 2014, NAT MED, V20, P159, DOI 10.1038/nm.3444; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Tyson GW, 2004, NATURE, V428, P37, DOI 10.1038/nature02340; Ungprasert P, 2017, INDIAN J DERMATOL, V62, P41, DOI 10.4103/0019-5154.198031; UNNI KK, 1975, J RHEUMATOL, V2, P36; van de Wiele T, 2007, J APPL MICROBIOL, V102, P452, DOI 10.1111/j.1365-2672.2006.03084.x; van Nood E, 2013, NEW ENGL J MED, V368, P407, DOI 10.1056/NEJMoa1205037; Viladomiu M, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aaf9655; Vilanova C, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.101, 10.1038/nmicrobiol.2016.101]; Vineis JH, 2016, MBIO, V7, DOI [10.1128/mBio.01713-16, 10.1128/mbio.01713-16]; Vrieze A, 2012, GASTROENTEROLOGY, V143, P913, DOI 10.1053/j.gastro.2012.06.031; Wall CL, 2013, WORLD J GASTROENTERO, V19, P7652, DOI 10.3748/wjg.v19.i43.7652; Watanabe Y, 2012, APPL ENVIRON MICROB, V78, P511, DOI 10.1128/AEM.06035-11; Watson D, 2013, J APPL MICROBIOL, V114, P1132, DOI 10.1111/jam.12105; Weingarden AR, 2013, J CLIN GASTROENTEROL, V47, P735, DOI 10.1097/MCG.0b013e31829004ae; WEINREICH S, 1995, HUM IMMUNOL, V42, P103, DOI 10.1016/0198-8859(94)00034-N; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; Wekerle H, 2013, CURR OPIN IMMUNOL, V25, P683, DOI 10.1016/j.coi.2013.09.009; Wu GD, 2016, GUT, V65, P63, DOI 10.1136/gutjnl-2014-308209; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Wu HJ, 2010, IMMUNITY, V32, P815, DOI 10.1016/j.immuni.2010.06.001; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Yokote H, 2008, AM J PATHOL, V173, P1714, DOI 10.2353/ajpath.2008.080622; Yoshitomi H, 2005, J EXP MED, V201, P949, DOI 10.1084/jem.20041758; Youngster I, 2014, JAMA-J AM MED ASSOC, V312, P1772, DOI 10.1001/jama.2014.13875; Zamani B, 2016, INT J RHEUM DIS, V19, P869, DOI 10.1111/1756-185X.12888; Zechner EL, 2017, CURR OPIN MICROBIOL, V35, P64, DOI 10.1016/j.mib.2017.01.011; Zhang HS, 2014, APPL ENVIRON MICROB, V80, P7551, DOI 10.1128/AEM.02676-14; Zigra PI, 2007, NETH J MED, V65, P411; Zimmer J, 2012, EUR J CLIN NUTR, V66, P53, DOI 10.1038/ejcn.2011.141	199	226	237	14	180	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 8	2018	360								j5145	10.1136/bmj.j5145	http://dx.doi.org/10.1136/bmj.j5145			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FS9MB	29311119	Green Published			2022-12-28	WOS:000422741200009
J	Bourdeau, RW; Lee-Gosselin, A; Lakshmanan, A; Farhadi, A; Kumar, SR; Nety, SP; Shapiro, MG				Bourdeau, Raymond W.; Lee-Gosselin, Audrey; Lakshmanan, Anupama; Farhadi, Arash; Kumar, Sripriya Ravindra; Nety, Suchita P.; Shapiro, Mikhail G.			Acoustic reporter genes for noninvasive imaging of microorganisms in mammalian hosts	NATURE			English	Article							ESCHERICHIA-COLI; FLUORESCENT PROTEIN; GUT MICROBIOTA; GAS VESICLES; IN-VIVO; LACTOCOCCUS-LACTIS; LIVING MICE; BACTERIA; EXPRESSION; NANOSTRUCTURES	The mammalian microbiome has many important roles in health and disease(1,2), and genetic engineering is enabling the development of microbial therapeutics and diagnostics(3-7). A key determinant of the activity of both natural and engineered microorganisms in vivo is their location within the host organism(8,9). However, existing methods for imaging cellular location and function, primarily based on optical reporter genes, have limited deep tissue performance owing to light scattering or require radioactive tracers(10-12). Here we introduce acoustic reporter genes, which are genetic constructs that allow bacterial gene expression to be visualized in vivo using ultrasound, a widely available inexpensive technique with deep tissue penetration and high spatial resolution(13-15). These constructs are based on gas vesicles, a unique class of gas-filled protein nanostructures that are expressed primarily in water-dwelling photosynthetic organisms as a means to regulate buoyancy(16,17). Heterologous expression of engineered gene clusters encoding gas vesicles allows Escherichia coli and Salmonella typhimurium to be imaged noninvasively at volumetric densities below 0.01% with a resolution of less than 100 mu m. We demonstrate the imaging of engineered cells in vivo in proof-of-concept models of gastrointestinal and tumour localization, and develop acoustically distinct reporters that enable multiplexed imaging of cellular populations. This technology equips microbial cells with a means to be visualized deep inside mammalian hosts, facilitating the study of the mammalian microbiome and the development of diagnostic and therapeutic cellular agents.	[Bourdeau, Raymond W.; Lee-Gosselin, Audrey; Nety, Suchita P.; Shapiro, Mikhail G.] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA; [Lakshmanan, Anupama; Farhadi, Arash; Kumar, Sripriya Ravindra] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA	California Institute of Technology; California Institute of Technology	Shapiro, MG (corresponding author), CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA.	mikhail@caltech.edu	Farhadi, Arash/AAY-6758-2020	Farhadi, Arash/0000-0001-9137-8559; Lakshmanan, Anupama/0000-0002-6702-837X; Nety, Suchita/0000-0002-4201-1061	National Institutes of Health [R01-EB018975]; Canadian Institute of Health Research [MOP 136842]; Pew Scholarship in the Biomedical Sciences; NSF [1144469]; Biotechnology Leaders Program; NSERC; Caltech Summer Undergraduate Research Fellowship; Heritage Medical Research Institute; Burroughs Wellcome Career Award at the Scientific Interface; David and Lucile Packard Fellowship for Science and Engineering; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB018975] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Pew Scholarship in the Biomedical Sciences; NSF(National Science Foundation (NSF)); Biotechnology Leaders Program; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Caltech Summer Undergraduate Research Fellowship; Heritage Medical Research Institute; Burroughs Wellcome Career Award at the Scientific Interface(Burroughs Wellcome Fund); David and Lucile Packard Fellowship for Science and Engineering(The David & Lucile Packard Foundation); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	We thank F. S. Foster, D. Maresca, A. Mukherjee, M. Din, T. Danino, J. Willmann and S. K. Mazmanian for discussions, and A. McDowall for assistance with electron microscopy. This research was supported by the National Institutes of Health grant R01-EB018975, the Canadian Institute of Health Research grant MOP 136842 and the Pew Scholarship in the Biomedical Sciences. A. L. is supported by the NSF graduate research fellowship (award 1144469) and the Biotechnology Leaders Program. A. F. is supported by the NSERC graduate fellowship. S. P. N. was supported by the Caltech Summer Undergraduate Research Fellowship. Research in the Shapiro laboratory is also supported by the Heritage Medical Research Institute, the Burroughs Wellcome Career Award at the Scientific Interface and the David and Lucile Packard Fellowship for Science and Engineering.	Blum-Oehler G, 2003, RES MICROBIOL, V154, P59, DOI 10.1016/S0923-2508(02)00007-4; Borkowski O, 2016, CURR OPIN MICROBIOL, V33, P123, DOI 10.1016/j.mib.2016.07.009; Chen ZY, 2014, J CLIN INVEST, V124, P3391, DOI 10.1172/JCI72517; Chu J, 2016, NAT BIOTECHNOL, V34, P760, DOI 10.1038/nbt.3550; Claesen J, 2015, ACS SYNTH BIOL, V4, P358, DOI 10.1021/sb500258b; Daniel C, 2013, APPL ENVIRON MICROB, V79, P1086, DOI 10.1128/AEM.03221-12; Daniel C, 2011, TRENDS BIOTECHNOL, V29, P499, DOI 10.1016/j.tibtech.2011.05.002; Danino T, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3519; Danino T, 2012, ACS SYNTH BIOL, V1, P465, DOI 10.1021/sb3000639; Derrien M, 2015, TRENDS MICROBIOL, V23, P354, DOI 10.1016/j.tim.2015.03.002; Din MO, 2016, NATURE, V536, P81, DOI 10.1038/nature18930; Donaldson GP, 2016, NAT REV MICROBIOL, V14, P20, DOI 10.1038/nrmicro3552; Errico C, 2015, NATURE, V527, P499, DOI 10.1038/nature16066; FOSTER FS, 1993, IEEE T ULTRASON FERR, V40, P608, DOI 10.1109/58.238115; Foucault ML, 2010, APPL ENVIRON MICROB, V76, P264, DOI 10.1128/AEM.01686-09; Francis KP, 2000, INFECT IMMUN, V68, P3594, DOI 10.1128/IAI.68.6.3594-3600.2000; Freeling JL, 2016, MOL THER-METH CLIN D, V3, DOI 10.1038/mtm.2016.70; Gorbach SL, 1996, MED MICROBIOLOGY; HAYES PK, 1992, ARCH MICROBIOL, V157, P229, DOI 10.1007/BF00245155; Klumpp S, 2014, CURR OPIN BIOTECH, V28, P96, DOI 10.1016/j.copbio.2014.01.001; Lakshmanan A, 2016, ACS NANO, V10, P7314, DOI 10.1021/acsnano.6b03364; Li N, 1998, J BACTERIOL, V180, P2450, DOI 10.1128/JB.180.9.2450-2458.1998; Pfeifer F, 2012, NAT REV MICROBIOL, V10, P705, DOI 10.1038/nrmicro2834; Riglar DT, 2017, NAT BIOTECHNOL, V35, P653, DOI 10.1038/nbt.3879; Romero PA, 2009, NAT REV MOL CELL BIO, V10, P866, DOI 10.1038/nrm2805; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Shaner NC, 2013, NAT METHODS, V10, P407, DOI [10.1038/nmeth.2413, 10.1038/NMETH.2413]; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shapiro MG, 2014, NAT NANOTECHNOL, V9, P311, DOI [10.1038/nnano.2014.32, 10.1038/NNANO.2014.32]; Sleight SC, 2013, ACS SYNTH BIOL, V2, P519, DOI 10.1021/sb400055h; Smith-Bindman R, 2012, JAMA-J AM MED ASSOC, V307, P2400, DOI 10.1001/jama.2012.5960; Sonnenborn Ulrich, 2009, Microbial Ecology in Health and Disease, V21, P122, DOI 10.3109/08910600903444267; Steidler L, 2000, SCIENCE, V289, P1352, DOI 10.1126/science.289.5483.1352; WALSBY AE, 1994, MICROBIOL REV, V58, P94, DOI 10.1128/MMBR.58.1.94-144.1994; Wang HJ, 2013, RADIOLOGY, V267, P818, DOI 10.1148/radiol.13122509; Wang Y, 2014, BRAIN BEHAV IMMUN, V38, P1, DOI 10.1016/j.bbi.2013.12.015	37	145	156	18	247	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 4	2018	553	7686					86	+		10.1038/nature25021	http://dx.doi.org/10.1038/nature25021			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS4NI	29300010	Green Accepted			2022-12-28	WOS:000419769300035
J	Dowlatshahi, EA; Diercks, GFH; van Doorn, MBA				Dowlatshahi, E. A.; Diercks, G. F. H.; van Doorn, M. B. A.			Blisters in disguise	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PEMPHIGUS-VULGARIS; MORTALITY; RITUXIMAB		[Dowlatshahi, E. A.; Diercks, G. F. H.; van Doorn, M. B. A.] Erasmus MC, Rotterdam, Netherlands; [Diercks, G. F. H.] Univ Groningen, Univ Med Ctr Groningen, Groningen, Netherlands	Erasmus University Rotterdam; Erasmus MC; University of Groningen	Dowlatshahi, EA (corresponding author), Erasmus MC, Rotterdam, Netherlands.	emmilia.dowlat@gmail.com	Diercks, Gilles/P-7413-2019	Diercks, Gilles/0000-0001-8053-216X				Feldman RJ, 2011, EXPERT REV CLIN IMMU, V7, P529, DOI [10.1586/eci.11.22, 10.1586/ECI.11.22]; Hsu DY, 2016, BRIT J DERMATOL, V174, P1290, DOI 10.1111/bjd.14463; Joly P, 2007, NEW ENGL J MED, V357, P545, DOI 10.1056/NEJMoa067752; Kridin K, 2017, ACTA DERM-VENEREOL, V97, P607, DOI 10.2340/00015555-2611; Langan SM, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a180; Ljubojevic S, 2002, J EUR ACAD DERMATOL, V16, P599, DOI 10.1046/j.1468-3083.2002.00504.x; Robinson AJ, 2017, AUSTRALAS J DERMATOL, DOI [10.1111/ajd.12571.28211049, DOI 10.1111/AJD.12571.28211049]; Uzun S, 2006, INT J DERMATOL, V45, P523, DOI 10.1111/j.1365-4632.2004.02533.x; Zaraa I, 2011, J EUR ACAD DERMATOL, V25, P1160, DOI 10.1111/j.1468-3083.2010.03939.x	9	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 4	2018	360								j5364	10.1136/bmj.j5364	http://dx.doi.org/10.1136/bmj.j5364			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FS3UX	29301743				2022-12-28	WOS:000419710400005
J	Shahid, S; Kim, G; Johnson, NR; Wafula, E; Wang, F; Coruh, C; Bernal-Galeano, V; Phifer, T; dePamphilis, CW; Westwood, JH; Axtell, MJ				Shahid, Saima; Kim, Gunjune; Johnson, Nathan R.; Wafula, Eric; Wang, Feng; Coruh, Ceyda; Bernal-Galeano, Vivian; Phifer, Tamia; dePamphilis, Claude W.; Westwood, James H.; Axtell, Michael J.			MicroRNAs from the parasitic plant Cuscuta campestris target host messenger RNAs	NATURE			English	Article							SIRNA BIOGENESIS; CYTOPLASMIC KINASE; ARABIDOPSIS; SECONDARY; INTERFERENCE; EXPRESSION; RESISTANCE; EXCHANGE; COMPLEX; BIOLOGY	Dodders (Cuscuta spp.) are obligate parasitic plants that obtain water and nutrients from the stems of host plants via specialized feeding structures called haustoria. Dodder haustoria facilitate bidirectional movement of viruses, proteins and mRNAs between host and parasite(1), but the functional effects of these movements are not known. Here we show that Cuscuta campestris haustoria accumulate high levels of many novel microRNAs (miRNAs) while parasitizing Arabidopsis thaliana. Many of these miRNAs are 22 nucleotides in length. Plant miRNAs of this length are uncommon, and are associated with amplification of target silencing through secondary short interfering RNA (siRNA) production(2). Several A. thaliana mRNAs are targeted by 22-nucleotide C. campestris miRNAs during parasitism, resulting in mRNA cleavage, secondary siRNA production, and decreased mRNA accumulation. Hosts with mutations in two of the loci that encode target mRNAs supported significantly higher growth of C. campestris. The same miRNAs that are expressed and active when C. campestris parasitizes A. thaliana are also expressed and active when it infects Nicotiana benthamiana. Homologues of target mRNAs from many other plant species also contain the predicted target sites for the induced C. campestris miRNAs. These data show that C. campestris miRNAs act as trans-species regulators of host-gene expression, and suggest that they may act as virulence factors during parasitism.	[Shahid, Saima; Johnson, Nathan R.; Wang, Feng; Coruh, Ceyda; dePamphilis, Claude W.; Axtell, Michael J.] Penn State Univ, Huck Inst Life Sci, University Pk, PA 16802 USA; [Shahid, Saima; Johnson, Nathan R.; Wafula, Eric; Wang, Feng; Coruh, Ceyda; dePamphilis, Claude W.; Axtell, Michael J.] Penn State Univ, Dept Biol, University Pk, PA 16802 USA; [Kim, Gunjune; Bernal-Galeano, Vivian; Westwood, James H.] Virginia Polytech Inst & State Univ, Dept Plant Pathol Physiol & Weed Sci, Blacksburg, VA 24061 USA; [Phifer, Tamia] Knox Coll, Galesburg, IL 61401 USA; [Wang, Feng] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA; [Coruh, Ceyda] Salk Inst Biol Studies, La Jolla, CA 92037 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Virginia Polytechnic Institute & State University; Indiana University System; Indiana University Bloomington; Salk Institute	Axtell, MJ (corresponding author), Penn State Univ, Huck Inst Life Sci, University Pk, PA 16802 USA.; Axtell, MJ (corresponding author), Penn State Univ, Dept Biol, University Pk, PA 16802 USA.	mja18@psu.edu	Johnson, Nathan/AAD-5863-2019; shahid, saima/GXV-9647-2022; Wang, Feng/AAA-7977-2020	Johnson, Nathan/0000-0002-5279-9964; Wang, Feng/0000-0002-4760-8211; Bernal-Galeano, Vivian/0000-0002-0438-2937; Shahid, Saima/0000-0001-9385-0925	US National Science Foundation [1238057, 1339207]; US National Institute of Food and Agriculture [135997]	US National Science Foundation(National Science Foundation (NSF)); US National Institute of Food and Agriculture	This research was supported in part by awards from the US National Science Foundation (1238057 to J.H.W. and C.W.D.; 1339207 to M.J.A.) and the US National Institute of Food and Agriculture (135997 to J.H.W.).	Alakonya A, 2012, PLANT CELL, V24, P3153, DOI 10.1105/tpc.112.099994; Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; Axtell MJ, 2006, CELL, V127, P565, DOI 10.1016/j.cell.2006.09.032; Baulcombe DC, 2015, CURR OPIN PLANT BIOL, V26, P141, DOI 10.1016/j.pbi.2015.06.007; Baum JA, 2007, NAT BIOTECHNOL, V25, P1322, DOI 10.1038/nbt1359; Bombarely A, 2012, MOL PLANT MICROBE IN, V25, P1523, DOI 10.1094/MPMI-06-12-0148-TA; Chen HM, 2010, P NATL ACAD SCI USA, V107, P15269, DOI 10.1073/pnas.1001738107; Cho SH, 2012, PLANT CELL, V24, P4837, DOI 10.1105/tpc.112.103176; Costea M, 2015, TAXON, V64, P1225, DOI 10.12705/646.7; Cuperus JT, 2010, NAT STRUCT MOL BIOL, V17, P997, DOI 10.1038/nsmb.1866; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; Dawson Jean H., 1994, Reviews of Weed Science, V6, P265; Dharmasiri N, 2005, DEV CELL, V9, P109, DOI 10.1016/j.devcel.2005.05.014; Elmayan T, 1998, PLANT CELL, V10, P1747, DOI 10.1105/tpc.10.10.1747; Fei QL, 2013, PLANT CELL, V25, P2400, DOI 10.1105/tpc.113.114652; Froelich DR, 2011, PLANT CELL, V23, P4428, DOI 10.1105/tpc.111.093179; Huang GZ, 2006, P NATL ACAD SCI USA, V103, P14302, DOI 10.1073/pnas.0604698103; Jekat SB, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00225; Johnson NR, 2016, G3-GENES GENOM GENET, V6, P2103, DOI 10.1534/g3.116.030452; Kim G, 2015, CURR OPIN PLANT BIOL, V26, P20, DOI 10.1016/j.pbi.2015.05.012; Kim G, 2014, SCIENCE, V345, P808, DOI 10.1126/science.1253122; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lin WW, 2013, P NATL ACAD SCI USA, V110, P12114, DOI 10.1073/pnas.1302154110; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lu DP, 2010, P NATL ACAD SCI USA, V107, P496, DOI 10.1073/pnas.0909705107; Martin M., 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Mylona P, 2002, DEVELOPMENT, V129, P4327; Nowara D, 2010, PLANT CELL, V22, P3130, DOI 10.1105/tpc.110.077040; Pall GS, 2008, NAT PROTOC, V3, P1077, DOI 10.1038/nprot.2008.67; Parry G, 2009, P NATL ACAD SCI USA, V106, P22540, DOI 10.1073/pnas.0911967106; Pernas M, 2010, CURR BIOL, V20, P818, DOI 10.1016/j.cub.2010.02.062; Robert-Seilaniantz A, 2011, PLANT J, V67, P218, DOI 10.1111/j.1365-313X.2011.04591.x; Si-Ammour A, 2011, PLANT PHYSIOL, V157, P683, DOI 10.1104/pp.111.180083; Ten Hove CA, 2010, CURR BIOL, V20, P452, DOI 10.1016/j.cub.2010.01.018; Veronese P, 2006, PLANT CELL, V18, P257, DOI 10.1105/tpc.105.035576; Wang M, 2016, NAT PLANTS, V2, DOI [10.1038/NPLANTS.2016.151, 10.1038/nplants.2016.151]; Weiberg A, 2015, CURR OPIN BIOTECH, V32, P207, DOI 10.1016/j.copbio.2014.12.025; Weiberg A, 2013, SCIENCE, V342, P118, DOI 10.1126/science.1239705; Xie ZX, 2005, P NATL ACAD SCI USA, V102, P12984, DOI 10.1073/pnas.0506426102; Zhang T, 2016, NAT PLANTS, V2, DOI [10.1038/NPLANTS.2016.153, 10.1038/nplants.2016.153]	40	173	184	13	190	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 4	2018	553	7686					82	+		10.1038/nature25027	http://dx.doi.org/10.1038/nature25027			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS4NI	29300014	Green Submitted			2022-12-28	WOS:000419769300034
J	Voelker, R				Voelker, Rebecca			Digital Pill Gains Approval	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	1	1	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 2	2018	319	1					14	14		10.1001/jama.2017.19309	http://dx.doi.org/10.1001/jama.2017.19309			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FR5ON	29297061				2022-12-28	WOS:000419116000004
J	Nazarian, S; Hansford, R; Rahsepar, AA; Weltin, V; McVeigh, D; Ipek, EG; Kwan, A; Berger, RD; Calkins, H; Lardo, AC; Kraut, MA; Kamel, IR; Zimmerman, SL; Halperin, HR				Nazarian, Saman; Hansford, Rozann; Rahsepar, Amir A.; Weltin, Valeria; McVeigh, Diana; Ipek, Esra Gucuk; Kwan, Alan; Berger, Ronald D.; Calkins, Hugh; Lardo, Albert C.; Kraut, Michael A.; Kamel, Ihab R.; Zimmerman, Stefan L.; Halperin, Henry R.			Safety of Magnetic Resonance Imaging in Patients with Cardiac Devices	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							IMPLANTABLE-CARDIOVERTER-DEFIBRILLATORS; PACEMAKER-DEPENDENT PATIENTS; 1.5 TESLA; PERMANENT PACEMAKERS; INDUSTRY VIEWPOINT; ELECTRONIC DEVICES; ABSORPTION RATE; PACING DEVICES; IN-VITRO; MRI	BACKGROUND Patients who have pacemakers or defibrillators are often denied the opportunity to undergo magnetic resonance imaging (MRI) because of safety concerns, unless the devices meet certain criteria specified by the Food and Drug Administration (termed "MRI-conditional" devices). M METHODS We performed a prospective, nonrandomized study to assess the safety of MRI at a magnetic field strength of 1.5 Tesla in 1509 patients who had a pacemaker (58%) or an implantable cardioverter-defibrillator (42%) that was not considered to be MRI-conditional (termed a "legacy" device). Overall, the patients underwent 2103 thoracic and nonthoracic MRI examinations that were deemed to be clinically necessary. The pacing mode was changed to asynchronous mode for pacing-dependent patients and to demand mode for other patients. Tachyarrhythmia functions were disabled. Outcome assessments included adverse events and changes in the variables that indicate lead and generator function and interaction with surrounding tissue (device parameters). RESULTS No long-term clinically significant adverse events were reported. In nine MRI examinations (0.4%; 95% confidence interval, 0.2 to 0.7), the patient's device reset to a backup mode. The reset was transient in eight of the nine examinations. In one case, a pacemaker with less than 1 month left of battery life reset to ventricular inhibited pacing and could not be reprogrammed; the device was subsequently replaced. The most common notable change in device parameters (>50% change from baseline) immediately after MRI was a decrease in P-wave amplitude, which occurred in 1% of the patients. At long-term follow-up (results of which were available for 63% of the patients), the most common notable changes from baseline were decreases in P-wave amplitude (in 4% of the patients), increases in atrial capture threshold (4%), increases in right ventricular capture threshold (4%), and increases in left ventricular capture threshold (3%). The observed changes in lead parameters were not clinically significant and did not require device revision or reprogramming. CONCLUSIONS We evaluated the safety of MRI, performed with the use of a prespecified safety protocol, in 1509 patients who had a legacy pacemaker or a legacy implantable cardioverterdefibrillator system. No long-term clinically significant adverse events were reported.	[Nazarian, Saman] Univ Penn, Perelman Sch Med, Dept Med Cardiol, Philadelphia, PA 19104 USA; [Nazarian, Saman; Hansford, Rozann; Rahsepar, Amir A.; Weltin, Valeria; McVeigh, Diana; Ipek, Esra Gucuk; Kwan, Alan; Berger, Ronald D.; Calkins, Hugh; Lardo, Albert C.; Halperin, Henry R.] Johns Hopkins Univ Hosp, Dept Med Cardiol, Baltimore, MD 21287 USA; [Nazarian, Saman] Johns Hopkins Univ Hosp, Dept Epidemiol, Baltimore, MD 21287 USA; [Lardo, Albert C.; Kraut, Michael A.; Kamel, Ihab R.; Zimmerman, Stefan L.; Halperin, Henry R.] Johns Hopkins Univ Hosp, Dept Radiol, Baltimore, MD 21287 USA; [Berger, Ronald D.; Lardo, Albert C.; Halperin, Henry R.] Johns Hopkins Univ Hosp, Dept Biomed Engn, Baltimore, MD 21287 USA	University of Pennsylvania; Pennsylvania Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine	Nazarian, S (corresponding author), Univ Penn, Perelman Sch Med, 3400 Spruce St,Founders 9, Philadelphia, PA 19104 USA.	saman.nazarian@uphs.upenn.edu	Zimmerman, Stefan L/U-3269-2019; Nazarian, Saman/ABC-8000-2020	Kwan, Alan/0000-0002-4393-1011; /0000-0002-6228-4673	Johns Hopkins University; National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL089333, R01HL116280, R01HL094610, R01HL064795] Funding Source: NIH RePORTER	Johns Hopkins University(Johns Hopkins University); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funded by Johns Hopkins University and the National Institutes of Health;	[Anonymous], 2011, CAG00399R3 CTR MED M; Baker KB, 2004, J MAGN RESON IMAGING, V20, P315, DOI 10.1002/jmri.20103; Bertelsen L, 2017, EUROPACE, V19, P818, DOI 10.1093/europace/euw066; Boilson BA, 2012, J INTERV CARD ELECTR, V33, P59, DOI 10.1007/s10840-011-9615-8; Buendia F, 2010, REV ESP CARDIOL, V63, P735, DOI 10.1016/S0300-8932(10)70167-6; Burke PT, 2010, J INTERV CARD ELECTR, V28, P59, DOI 10.1007/s10840-009-9463-y; CALLANS DJ, 1993, J AM COLL CARDIOL, V22, P746, DOI 10.1016/0735-1097(93)90186-5; Camacho JC, 2016, AM J ROENTGENOL, V207, P599, DOI 10.2214/AJR.16.16033; Cohen JD, 2012, AM J CARDIOL, V110, P1631, DOI 10.1016/j.amjcard.2012.07.030; Coman JA, 2004, J AM COLL CARDIOL, V43, p138A, DOI 10.1016/S0735-1097(04)90585-2; Danilovic D, 1998, PACE, V21, P1356, DOI 10.1111/j.1540-8159.1998.tb00205.x; Danilovic D, 1999, PACE, V22, P567, DOI 10.1111/j.1540-8159.1999.tb00498.x; Del Ojo JL, 2005, PACE, V28, P274, DOI 10.1111/j.1540-8159.2005.50033.x; Faris OP, 2005, PACE, V28, P268, DOI 10.1111/j.1540-8159.2005.50035.x; Faris OP, 2006, CIRCULATION, V114, P1232, DOI 10.1161/CIRCULATIONAHA.106.647800; Forleo GB, 2010, HEART RHYTHM, V7, P750, DOI 10.1016/j.hrthm.2010.02.020; FRAME R, 1992, PACE, V15, P870, DOI 10.1111/j.1540-8159.1992.tb03077.x; Gimbel JR, 2013, HEART RHYTHM, V10, P685, DOI 10.1016/j.hrthm.2013.01.022; Gimbel JR, 2004, J AM COLL CARDIOL, V43, P1325, DOI 10.1016/j.jacc.2004.02.009; Gimbel JR, 2005, PACE, V28, P270, DOI 10.1111/j.1540-8159.2005.09520.x; Gimbel JR, 2005, PACE, V28, P1041, DOI 10.1111/j.1540-8159.2005.00230.x; Gimbel JR, 1996, PACE, V19, P913, DOI 10.1111/j.1540-8159.1996.tb03387.x; Glikson M, 2000, J CARDIOVASC ELECTR, V11, P127, DOI 10.1111/j.1540-8167.2000.tb00311.x; Higgins JV, 2015, HEART RHYTHM, V12, P540, DOI 10.1016/j.hrthm.2014.10.039; Junttila MJ, 2011, HEART, V97, P1852, DOI 10.1136/heartjnl-2011-300153; Kaasalainen T, 2014, EUR J RADIOL, V83, P1387, DOI 10.1016/j.ejrad.2014.04.022; Levine PA, 2005, PACE, V28, P266, DOI 10.1111/j.1540-8159.2005.50027.x; Martin ET, 2004, J AM COLL CARDIOL, V43, P1315, DOI 10.1016/j.jacc.2003.12.016; Mollerus M, 2008, PACE, V31, P1241, DOI 10.1111/j.1540-8159.2008.01172.x; Mollerus M, 2010, EUROPACE, V12, P947, DOI 10.1093/europace/euq092; Naehle CP, 2009, J AM COLL CARDIOL, V54, P549, DOI 10.1016/j.jacc.2009.04.050; Nazarian S, 2016, J MAGN RESON IMAGING, V43, P115, DOI 10.1002/jmri.24971; Nazarian S, 2011, ANN INTERN MED, V155, P415, DOI 10.7326/0003-4819-155-7-201110040-00004; Nazarian S, 2009, HEART RHYTHM, V6, P138, DOI 10.1016/j.hrthm.2008.10.021; Nazarian S, 2006, CIRCULATION, V114, P1277, DOI 10.1161/CIRCULATIONAHA.105.607655; Roguin A, 2004, CIRCULATION, V110, P475, DOI 10.1161/01.CIR.0000137121.28722.33; Russo RJ, 2017, NEW ENGL J MED, V376, P755, DOI 10.1056/NEJMoa1603265; Sharif MN, 1998, AM J CARDIOL, V82, P600, DOI 10.1016/S0002-9149(98)00414-7; Smith JM, 2005, PACE, V28, P264, DOI 10.1111/j.1540-8159.2005.09591.x; Sommer T, 2000, RADIOLOGY, V215, P869, DOI 10.1148/radiology.215.3.r00jn08869; Sommer T, 2006, CIRCULATION, V114, P1285, DOI 10.1161/CIRCULATIONAHA.105.597013; Stanton MS, 2005, PACE, V28, P265, DOI 10.1111/j.1540-8159.2005.50025.x; Vahlhaus C, 2001, PACE, V24, P489, DOI 10.1046/j.1460-9592.2001.00489.x; Wilkoff BL, 2011, HEART RHYTHM, V8, P65, DOI 10.1016/j.hrthm.2010.10.002; Wollmann CG, 2014, J CARDIOVASC MAGN R, V16, DOI 10.1186/1532-429X-16-30	45	165	167	1	23	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 28	2017	377	26					2555	2564		10.1056/NEJMoa1604267	http://dx.doi.org/10.1056/NEJMoa1604267			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FR0TX	29281579	Green Accepted, Bronze			2022-12-28	WOS:000418777700007
J	Abramowicz, M; Zuccotti, G; Pflomm, JM				Abramowicz, Mark; Zuccotti, Gianna; Pflomm, Jean-Marie			Guselkumab (Tremfya) for Psoriasis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint							ANTI-INTERLEUKIN-23 MONOCLONAL-ANTIBODY; PHASE-III; ADALIMUMAB; EFFICACY; MODERATE; SAFETY; TRIAL						Pflomm, Jean-Marie/HDO-0765-2022					[Anonymous], 2015, MED LETT DRUGS THER, V57, P81; Blauvelt A, 2017, J AM ACAD DERMATOL, V76, P405, DOI 10.1016/j.jaad.2016.11.041; Langley RG, 2018, BRIT J DERMATOL, V178, P114, DOI 10.1111/bjd.15750; Reich K, 2017, J AM ACAD DERMATOL, V76, P418, DOI 10.1016/j.jaad.2016.11.042	4	1	1	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 26	2017	318	24					2487	2488		10.1001/jama.2017.18515	http://dx.doi.org/10.1001/jama.2017.18515			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FQ9ZO	29279926				2022-12-28	WOS:000418720700027
J	Gerber, JS; Ross, RK; Bryan, M; Localio, R; Szymczak, JE; Wasserman, R; Barkman, D; Odeniyi, F; Conaboy, K; Bell, L; Zaoutis, TE; Fiks, AG				Gerber, Jeffrey S.; Ross, Rachael K.; Bryan, Matthew; Localio, Russell; Szymczak, Julia E.; Wasserman, Richard; Barkman, Darlene; Odeniyi, Folasade; Conaboy, Kathryn; Bell, Louis; Zaoutis, Theoklis E.; Fiks, Alexander G.			Association of Broad-vs Narrow-Spectrum Antibiotics With Treatment Failure, Adverse Events, and Quality of Life in Children With Acute Respiratory Tract Infections	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CLINICAL-PRACTICE GUIDELINE; ACUTE OTITIS-MEDIA; SENSITIVITY-ANALYSIS; RELIABILITY; VALIDITY; PEDSQL(TM)-4.0; FEASIBILITY; SINUSITIS; DIAGNOSIS; HEALTHY	IMPORTANCE Acute respiratory tract infections account for the majority of antibiotic exposure in children, and broad-spectrum antibiotic prescribing for acute respiratory tract infections is increasing. It is not clear whether broad-spectrum treatment is associated with improved outcomes compared with narrow-spectrum treatment. OBJECTIVE To compare the effectiveness of broad-spectrum and narrow-spectrum antibiotic treatment for acute respiratory tract infections in children. DESIGN, SETTING, AND PARTICIPANTS A retrospective cohort study assessing clinical outcomes and a prospective cohort study assessing patient-centered outcomes of children between the ages of 6 months and 12 years diagnosed with an acute respiratory tract infection and prescribed an oral antibiotic between January 2015 and April 2016 in a network of 31 pediatric primary care practices in Pennsylvania and New Jersey. Stratified and propensity score-matched analyses to account for confounding by clinician and by patient-level characteristics, respectively, were implemented for both cohorts. EXPOSURES Broad-spectrum antibiotics vs narrow-spectrum antibiotics. MAIN OUTCOMES AND MEASURES In the retrospective cohort, the primary outcomes were treatment failure and adverse events 14 days after diagnosis. In the prospective cohort, the primary outcomes were quality of life, other patient-centered outcomes, and patient-reported adverse events. RESULTS Of 30 159 children in the retrospective cohort (19 179 with acute otitis media; 6746, group A streptococcal pharyngitis; and 4234, acute sinusitis), 4307 (14%) were prescribed broad-spectrum antibiotics including amoxicillin-clavulanate, cephalosporins, and macrolides. Broad-spectrum treatment was not associated with a lower rate of treatment failure (3.4% for broad-spectrum antibiotics vs 3.1% for narrow-spectrum antibiotics; risk difference for full matched analysis, 0.3%[95% CI, -0.4% to 0.9%]). Of 2472 children enrolled in the prospective cohort (1100 with acute otitis media; 705, group A streptococcal pharyngitis; and 667, acute sinusitis), 868 (35%) were prescribed broad-spectrum antibiotics. Broad-spectrum antibiotics were associated with a slightly worse child quality of life (score of 90.2 for broad-spectrum antibiotics vs 91.5 for narrow-spectrum antibiotics; score difference for full matched analysis, -1.4%[95% CI, -2.4% to -0.4%]) but not with other patient-centered outcomes. Broad-spectrum treatment was associated with a higher risk of adverse events documented by the clinician (3.7% for broad-spectrum antibiotics vs 2.7% for narrow-spectrum antibiotics; risk difference for full matched analysis, 1.1% [95% CI, 0.4% to 1.8%]) and reported by the patient (35.6% for broad-spectrum antibiotics vs 25.1% for narrow-spectrum antibiotics; risk difference for full matched analysis, 12.2%[95% CI, 7.3% to 17.2%]). CONCLUSIONS AND RELEVANCE Among children with acute respiratory tract infections, broad-spectrum antibiotics were not associated with better clinical or patient-centered outcomes compared with narrow-spectrum antibiotics, and were associated with higher rates of adverse events. These data support the use of narrow-spectrum antibiotics for most children with acute respiratory tract infections.	[Gerber, Jeffrey S.; Ross, Rachael K.; Odeniyi, Folasade; Bell, Louis; Zaoutis, Theoklis E.; Fiks, Alexander G.] Childrens Hosp Philadelphia, Ctr Pediat Clin Effectiveness, Philadelphia, PA 19146 USA; [Gerber, Jeffrey S.; Zaoutis, Theoklis E.] Childrens Hosp Philadelphia, Div Infect Dis, Philadelphia, PA 19104 USA; [Gerber, Jeffrey S.; Bryan, Matthew; Localio, Russell; Szymczak, Julia E.; Zaoutis, Theoklis E.; Fiks, Alexander G.] Univ Penn, Dept Biostat Epidemiol & Informat, Perelman Sch Med, Philadelphia, PA 19104 USA; [Wasserman, Richard] Univ Vermont, Larner Coll Med, Burlington, VT 05405 USA; [Barkman, Darlene; Conaboy, Kathryn] Childrens Hosp Philadelphia, Div Patient & Family Experience, Family & Patient Serv Dept, Philadelphia, PA 19146 USA; [Bell, Louis; Fiks, Alexander G.] Childrens Hosp Philadelphia, Div Gen Pediat, Philadelphia, PA 19146 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; University of Vermont; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Gerber, JS (corresponding author), Childrens Hosp Philadelphia, 2716 S St, Philadelphia, PA 19146 USA.	gerberj@email.chop.edu	Gerber, Jeffrey/GYD-3567-2022	Gerber, Jeffrey/0000-0002-3076-3186	Patient-Centered Outcomes Research Institute (PCORI) [CE-1304-7279]	Patient-Centered Outcomes Research Institute (PCORI)(Patient-Centered Outcomes Research Institute - PCORI)	The research was funded through award CE-1304-7279 from the Patient-Centered Outcomes Research Institute (PCORI).	Alison P., 2009, FIXED EFFECTS REGRES; [Anonymous], 2015, RED BOOK 2015 REPORT; Austin PC, 2015, STAT METHODS MED RES; Bishop Y. M., 2007, DISCRETE MULTIVARIAT; BRESLOW NE, 1978, AM J EPIDEMIOL, V108, P299, DOI 10.1093/oxfordjournals.aje.a112623; Casey JR, 2004, PEDIATRICS, V113, P866, DOI 10.1542/peds.113.4.866; Chai G, 2012, PEDIATRICS, V130, P23, DOI 10.1542/peds.2011-2879; Chow AW, 2012, CLIN INFECT DIS, V54, pE72, DOI [10.1093/cid/cis370, 10.1093/cid/cir1043]; Coker TR, 2010, JAMA-J AM MED ASSOC, V304, P2161, DOI 10.1001/jama.2010.1651; Ding P, 2016, EPIDEMIOLOGY, V27, P368, DOI 10.1097/EDE.0000000000000457; Feudtner C, 2000, PEDIATRICS, V106, P205; Fiks AG, 2012, J PEDIATR-US, V160, P719, DOI 10.1016/j.jpeds.2012.01.039; Fleming-Dutra KE, 2013, PEDIATR INFECT DIS J, DOI [10.1097/INF.0000000000001708, DOI 10.1097/INF.0000000000001708]; Gabriel SE, 2012, NEW ENGL J MED, V367, P787, DOI 10.1056/NEJMp1207437; Gerber JS, 2015, J PEDIAT INF DIS SOC, V4, P297, DOI 10.1093/jpids/piu086; Gerber JS, 2013, PEDIATRICS, V131, P677, DOI 10.1542/peds.2012-2500; Grijalva CG, 2009, JAMA-J AM MED ASSOC, V302, P758, DOI 10.1001/jama.2009.1163; Hansen B., OPTMATCH FUNCTIONS O; Hansen BB, 2004, J AM STAT ASSOC, V99, P609, DOI 10.1198/016214504000000647; Hersh AL, 2016, JAMA INTERN MED, V176, P1870, DOI 10.1001/jamainternmed.2016.6625; Hersh AL, 2011, PEDIATRICS, V128, P1053, DOI 10.1542/peds.2011-1337; Hoberman A, 2011, NEW ENGL J MED, V364, P105, DOI 10.1056/NEJMoa0912254; Institute of Medicine, 2001, CROSSING QUALITY CHA, DOI [10.17226/10027, DOI 10.17226/10027]; McCaig LF, 2003, EMERG INFECT DIS, V9, P432; Shehab N, 2016, JAMA-J AM MED ASSOC, V316, P2115, DOI 10.1001/jama.2016.16201; Shulman ST, 2014, CLIN INFECT DIS, V58, P1496, DOI 10.1093/cid/ciu172; Shulman ST, 2012, CLIN INFECT DIS, V55, P1279, DOI 10.1093/cid/cis847; Steinman MA, 2003, JAMA-J AM MED ASSOC, V289, P719, DOI 10.1001/jama.289.6.719; Stevens MW, 2012, ARCH PEDIAT ADOL MED, V166, P74, DOI 10.1001/archpediatrics.2011.694; Stuart EA, 2008, DEV PSYCHOL, V44, P395, DOI 10.1037/0012-1649.44.2.395; Szymczak JE, 2017, PED AC SOC ANN M MAY; Szymczak JE, 2018, J PEDIAT INF DIS SOC, V7, P303, DOI 10.1093/jpids/pix073; Tahtinen PA, 2011, NEW ENGL J MED, V364, P116, DOI 10.1056/NEJMoa1007174; VanderWeele TJ, 2017, ANN INTERN MED, V167, P268, DOI 10.7326/M16-2607; Varni JW, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-2; Varni JW, 2011, QUAL LIFE RES, V20, P45, DOI 10.1007/s11136-010-9730-5; Varni JW, 2003, AMBUL PEDIATR, V3, P329, DOI 10.1367/1539-4409(2003)003<0329:TPAAPP>2.0.CO;2; Varni JW, 2001, MED CARE, V39, P800, DOI 10.1097/00005650-200108000-00006; Varni JW, 2013, PEDSQL MEASUREMENT M; Wald ER, 2013, PEDIATRICS, V132, pE262, DOI 10.1542/peds.2013-1071	41	103	105	1	33	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 19	2017	318	23					2325	2336		10.1001/jama.2017.18715	http://dx.doi.org/10.1001/jama.2017.18715			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FQ3RJ	29260224	Green Published, Bronze			2022-12-28	WOS:000418274000020
J	Powles, T; Duran, I; van der Heijden, MS; Loriot, Y; Vogelzang, NJ; De Giorgi, U; Oudard, S; Retz, MM; Castellano, D; Bamias, A; Flechon, A; Gravis, G; Hussain, S; Takano, T; Leng, N; Kadel, EE; Banchereau, R; Hegde, PS; Mariathasan, S; Cui, N; Shen, XD; Derleth, CL; Green, MC; Ravaud, A				Powles, Thomas; Duran, Ignacio; van der Heijden, Michiel S.; Loriot, Yohann; Vogelzang, Nicholas J.; De Giorgi, Ugo; Oudard, Stephane; Retz, Margitta M.; Castellano, Daniel; Bamias, Aristotelis; Flechon, Aude; Gravis, Gwenaelle; Hussain, Syed; Takano, Toshimi; Leng, Ning; Kadel, Edward E., III; Banchereau, Romain; Hegde, Priti S.; Mariathasan, Sanjeev; Cui, Na; Shen, Xiaodong; Derleth, Christina L.; Green, Marjorie C.; Ravaud, Alain			Atezolizumab versus chemotherapy in patients with platinum-treated locally advanced or metastatic urothelial carcinoma (IMvigor211): a multicentre, open-label, phase 3 randomised controlled trial	LANCET			English	Article							TRANSITIONAL-CELL CARCINOMA; CLINICAL ACTIVITY; VINFLUNINE PLUS; CANCER-IMMUNITY; SUPPORTIVE CARE; BLADDER-CANCER; SAFETY; DOCETAXEL; CISPLATIN; THERAPY	Background Few options exist for patients with locally advanced or metastatic urothelial carcinoma after progression with platinum-based chemotherapy. We aimed to assess the safety and efficacy of atezolizumab (anti-programmed death-ligand 1 [PD-L1]) versus chemotherapy in this patient population. Methods We conducted this multicentre, open-label, phase 3 randomised controlled trial (IMvigor211) at 217 academic medical centres and community oncology practices mainly in Europe, North America, and the Asia-Pacific region. Patients (aged >= 18 years) with metastatic urothelial carcinoma who had progressed after platinum-based chemotherapy were randomly assigned (1: 1), via an interactive voice and web response system with a permuted block design (block size of four), to receive atezolizumab 1200 mg or chemotherapy (physician's choice: vinflunine 320 mg/m(2), paclitaxel 175 mg/m(2), or 75 mg/m(2) docetaxel) intravenously every 3 weeks. Randomisation was stratified by PD-L1 expression (expression on <1% [IC0] or 1% to <5% [IC1] of tumour-infiltrating immune cells vs >= 5% of tumour-infiltrating immune cells [IC2/3]), chemotherapy type (vinflunine vs taxanes), liver metastases (yes vs no), and number of prognostic factors (none vs one, two, or three). Patients and investigators were aware of group allocation. Patients, investigators, and the sponsor were masked to PD-L1 expression status. The primary endpoint of overall survival was tested hierarchically in prespecified populations: IC2/3, followed by IC1/2/3, followed by the intention-to-treat population. This study, which is ongoing but not recruiting participants, is registered with ClinicalTrials.gov, number NCT02302807. Findings Between Jan 13, 2015, and Feb 15, 2016, we randomly assigned 931 patients from 198 sites to receive atezolizumab (n=467) or chemotherapy (n=464). In the IC2/3 population (n=234), overall survival did not differ significantly between patients in the atezolizumab group and those in the chemotherapy group (median 11.1 months [95% CI 8.6-15.5; n=116] vs 10.6 months [8.4-12.2; n=118]; stratified hazard ratio [HR] 0.87, 95% CI 0.63-1.21; p=0.41), thus precluding further formal statistical analysis. Confirmed objective response rates were similar between treatment groups in the IC2/3 population: 26 (23%) of 113 evaluable patients had an objective response in the atezolizumab group compared with 25 (22%) of 116 patients in the chemotherapy group. Duration of response was numerically longer in the atezolizumab group than in the chemotherapy group (median 15.9 months [95% CI 10.4 to not estimable] vs 8.3 months [5.6-13.2]; HR 0.57, 95% CI 0.26-1.26). In the intention-to-treat population, patients receiving atezolizumab had fewer grade 3-4 treatment-related adverse events than did those receiving chemotherapy (91 [20%] of 459 vs 189 [43%] of 443 patients), and fewer adverse events leading to treatment discontinuation (34 [7%] vs 78 [18%] patients). Interpretation Atezolizumab was not associated with significantly longer overall survival than chemotherapy in patients with platinum-refractory metastatic urothelial carcinoma overexpressing PD-L1 (IC2/3). However, the safety profile for atezolizumab was favourable compared with chemotherapy, Exploratory analysis of the intention-to-treat population showed well-tolerated, durable responses in line with previous phase 2 data for atezolizumab in this setting.	[Powles, Thomas] Queen Mary Univ London, Barts Canc Inst, St Bartholomews Hosp, Expt Canc Med Ctr, London E1 4NS, England; [Duran, Ignacio] Univ Seville, CSIC, Hosp Univ Virgen del Rocio, Inst Biomed Seville IBiS, Seville, Spain; [Duran, Ignacio] Inst Biomed Seville, Seville, Spain; [van der Heijden, Michiel S.] Netherlands Canc Inst, Dept Med Oncol, Amsterdam, Netherlands; [Loriot, Yohann] Univ Paris Saclay, Dept Med Oncol, Gustave Roussy, Villejuif, France; [Vogelzang, Nicholas J.] US Oncol Res, Comprehens Canc Ctr Nevada, Las Vegas, NV USA; [De Giorgi, Ugo] Ist Sci Romagnolo Studio & Cura Tumori IRST IRCCS, Meldola, Italy; [Oudard, Stephane] Rene Descartes Univ, European Georges Pompidou Hosp, Oncol Dept, Paris, France; [Retz, Margitta M.] Tech Univ Munich, Dept Urol, Klinikum Rechts Isar, Munich, Germany; [Castellano, Daniel] Univ Hosp 12 Octubre, Med Oncol Dept, CIBER ONC, Madrid, Spain; [Bamias, Aristotelis] Univ Athens, Alexandra Hosp, Athens, Greece; [Flechon, Aude] Ctr Leon Berard, Lyon, France; [Gravis, Gwenaelle] Inst Paoli Calmette, Dept Canc Med, Marseille, France; [Hussain, Syed] Plymouth Univ, Peninsula Sch Med, Plymouth, Devon, England; [Hussain, Syed] Plymouth Univ, Peninsula Sch Dent, Plymouth Univ Hosp NHS Trust, Plymouth, Devon, England; [Takano, Toshimi] Toranomon Gen Hosp, Dept Med Oncol, Tokyo, Japan; [Leng, Ning; Kadel, Edward E., III; Banchereau, Romain; Hegde, Priti S.; Mariathasan, Sanjeev; Cui, Na; Shen, Xiaodong; Derleth, Christina L.; Green, Marjorie C.] Genentech Inc, San Francisco, CA 94080 USA; [Ravaud, Alain] Bordeaux Univ Hosp, Dept Med Oncol, Bordeaux, France	University of London; Queen Mary University London; Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital; Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Netherlands Cancer Institute; UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; Comprehensive Cancer Centers of Nevada; US Oncology Network; IRCCS Meldola (IRST); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Technical University of Munich; CIBER - Centro de Investigacion Biomedica en Red; CIBERONC; Hospital Universitario 12 de Octubre; Alexandra Hospital; National & Kapodistrian University of Athens; UNICANCER; Centre Leon Berard; UNICANCER; Institut Paoli-Calmette (IPC); University of Plymouth; University of Plymouth; Toranomon Hospital; Roche Holding; Genentech; CHU Bordeaux	Powles, T (corresponding author), Queen Mary Univ London, Barts Canc Inst, St Bartholomews Hosp, Expt Canc Med Ctr, London E1 4NS, England.	thomas.powles@bartshealth.nhs.uk	Gravis, Gwenaelle/CAG-3019-2022; Bamias, Aristotelis/AAD-5332-2019; Loriot, Yohann/W-5572-2019	Gravis, Gwenaelle/0000-0002-3127-1554; Bamias, Aristotelis/0000-0002-5996-7262; Ravaud, Alain/0000-0001-9455-6744; OUDARD, Stephane/0000-0003-0893-285X; DURAN, IGNACIO/0000-0001-8571-7163	F Hoffmann-La Roche; Genentech	F Hoffmann-La Roche(Hoffmann-La Roche); Genentech(Roche HoldingGenentech)	F Hoffmann-La Roche, Genentech.	[Anonymous], 2017, TEC AT SUMM PROD CHA; [Anonymous], 2017, TEC AT PACK INS; Balar AV, 2017, LANCET, V389, P67, DOI 10.1016/S0140-6736(16)32455-2; Bellmunt J, 2017, NEW ENGL J MED, V376, P1015, DOI 10.1056/NEJMoa1613683; Bellmunt J, 2015, ANN ONCOL, V26, P812, DOI 10.1093/annonc/mdv009; Bellmunt J, 2014, ANN ONCOL, V25, P40, DOI 10.1093/annonc/mdu223; Bellmunt J, 2009, J CLIN ONCOL, V27, P4454, DOI 10.1200/JCO.2008.20.5534; Carbone DP, 2017, NEW ENGL J MED, V376, P2415, DOI 10.1056/NEJMoa1613493; Castellano D, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-779; Chalmers ZR, 2017, GENOME MED, V9, DOI 10.1186/s13073-017-0424-2; Chen DS, 2017, NATURE, V541, P321, DOI 10.1038/nature21349; Chen DS, 2013, IMMUNITY, V39, P1, DOI 10.1016/j.immuni.2013.07.012; Choueiri TK, 2012, J CLIN ONCOL, V30, P507, DOI 10.1200/JCO.2011.37.7002; Fehrenbacher L, 2016, LANCET, V387, P1837, DOI 10.1016/S0140-6736(16)00587-0; Frampton GM, 2013, NAT BIOTECHNOL, V31, P1023, DOI 10.1038/nbt.2696; Garcia-Donas J, 2017, LANCET ONCOL, V18, P672, DOI 10.1016/S1470-2045(17)30242-5; Herbst RS, 2014, NATURE, V515, P563, DOI 10.1038/nature14011; LOEHRER PJ, 1992, J CLIN ONCOL, V10, P1066, DOI 10.1200/JCO.1992.10.7.1066; Massard C, 2016, J CLIN ONCOL, V34, P3119, DOI 10.1200/JCO.2016.67.9761; McDermott DF, 2016, J CLIN ONCOL, V34, P833, DOI 10.1200/JCO.2015.63.7421; Medioni J, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2262-9; Motzer RJ, 2015, NEW ENGL J MED, V373, P1803, DOI 10.1056/NEJMoa1510665; National Cancer Institute Surveillance E and End Results, 2016, CANC STAT FACTS BLAD; National Comprehensive Cancer Network, 2017, NCCN CLIN PRACT GUID; Pistamaltzian N, 2016, ANTI-CANCER DRUG, V27, P48, DOI 10.1097/CAD.0000000000000297; Plimack ER, 2017, LANCET ONCOL, V18, P212, DOI 10.1016/S1470-2045(17)30007-4; Powles T, 2014, NATURE, V515, P558, DOI 10.1038/nature13904; Powles T, 2017, EUR UROL, V72, P477, DOI 10.1016/j.eururo.2017.03.047; Rittmeyer A, 2017, LANCET, V389, P255, DOI 10.1016/S0140-6736(16)32517-X; Rosenberg JE, 2016, LANCET, V387, P1909, DOI 10.1016/S0140-6736(16)00561-4; Sankin A, 2018, UROL ONCOL-SEMIN ORI, V36, P459, DOI 10.1016/j.urolonc.2017.04.007; von der Maase H, 2005, J CLIN ONCOL, V23, P4602, DOI 10.1200/JCO.2005.07.757	32	804	824	5	89	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 24	2018	391	10122					748	757		10.1016/S0140-6736(17)33297-X	http://dx.doi.org/10.1016/S0140-6736(17)33297-X			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FX4ND	29268948	Green Submitted			2022-12-28	WOS:000426054000026
J	Guna, A; Volkmar, N; Christianson, JC; Hegde, RS				Guna, Alina; Volkmar, Norbert; Christianson, John C.; Hegde, Ramanujan S.			The ER membrane protein complex is a transmembrane domain insertase	SCIENCE			English	Article							TAIL-ANCHORED PROTEINS; ENDOPLASMIC-RETICULUM; TARGETING FACTOR; IDENTIFICATION; DEGRADATION; BIOGENESIS; CHAPERONE	Insertion of proteins into membranes is an essential cellular process. The extensive biophysical and topological diversity of membrane proteins necessitates multiple insertion pathways that remain incompletely defined. Here we found that known membrane insertion pathways fail to effectively engage tail-anchored membrane proteins with moderately hydrophobic transmembrane domains. These proteins are instead shielded in the cytosol by calmodulin. Dynamic release from calmodulin allowed sampling of the endoplasmic reticulum (ER), where the conserved ER membrane protein complex (EMC) was shown to be essential for efficient insertion in vitro and in cells. Purified EMC in synthetic liposomes catalyzed the insertion of its substrates in a reconstituted system. Thus, EMC is a transmembrane domain insertase, a function that may explain its widely pleiotropic membrane-associated phenotypes across organisms.	[Guna, Alina; Hegde, Ramanujan S.] Med Res Council MRC Lab Mol Biol, Francis Crick Ave,Cambridge Biomed Campus, Cambridge CB2 0QH, England; [Volkmar, Norbert; Christianson, John C.] Univ Oxford, Ludwig Inst Canc Res, Old Rd Campus,Res Bldg, Oxford OX3 7DQ, England; [Volkmar, Norbert] Cambridge Inst Med Res, Hills Rd,Cambridge Biomed Campus, Cambridge CB2 0XY, England	Ludwig Institute for Cancer Research; University of Oxford; University of Cambridge	Hegde, RS (corresponding author), Med Res Council MRC Lab Mol Biol, Francis Crick Ave,Cambridge Biomed Campus, Cambridge CB2 0QH, England.	rhegde@mrc-lmb.cam.ac.uk	Christianson, John C/Y-4567-2019	Volkmar, Norbert/0000-0003-0766-5606; Hegde, Ramanujan/0000-0001-8338-852X; Christianson, John/0000-0002-0474-1207; Guna, Alina/0000-0003-0757-1255	UK Medical Research Council [MC_UP_A022_1007, MR/L001209/1]; Ludwig Institute for Cancer Research; Gates Cambridge Scholarship from the Gates Foundation; MRC [MC_UP_A022_1007] Funding Source: UKRI; Medical Research Council [MC_UP_A022_1007] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Ludwig Institute for Cancer Research; Gates Cambridge Scholarship from the Gates Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We are grateful to M. Skehel and his team for mass spectrometry analysis; P. Chitwood and B. Phillips for discussions and help with microsome and EMC preparation; R. Voorhees and S. Shao for useful discussions; S. Juszkiewicz for help with flow cytometry analysis; M. Kivlen for help preparing the PURE translation system; and R. Keenan, E. Miller, and S. Juszkiewicz for critical reading of this manuscript. This work was supported by the UK Medical Research Council (grants MC_UP_A022_1007 to R.S.H. and MR/L001209/1 to J.C.C.) and the Ludwig Institute for Cancer Research (J.C.C.). A.G. was supported by a Gates Cambridge Scholarship from the Gates Foundation. Additional data can be found in the supplementary materials. This work is licensed under a Creative Commons Attribution 4.0 International (CC BY 4.0) license, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. This license does not apply to figures/photos/artwork or other content included in the article that is credited to a third party; obtain authorization from the rights holder before using such material.	Abell BM, 2003, J BIOL CHEM, V278, P5669, DOI 10.1074/jbc.M209968200; Anghel SA, 2017, CELL REP, V21, P3708, DOI 10.1016/j.celrep.2017.12.006; Aviram N, 2016, NATURE, V540, P134, DOI 10.1038/nature20169; Brambillasca S, 2005, EMBO J, V24, P2533, DOI 10.1038/sj.emboj.7600730; Christianson JC, 2012, NAT CELL BIOL, V14, P93, DOI 10.1038/ncb2383; Hassdenteufel S, 2017, FEBS LETT, V591, P3211, DOI 10.1002/1873-3468.12831; Hegde RS, 2011, NAT REV MOL CELL BIO, V12, P787, DOI 10.1038/nrm3226; Hessa T, 2011, NATURE, V475, P394, DOI 10.1038/nature10181; Itakura E, 2016, MOL CELL, V63, P21, DOI 10.1016/j.molcel.2016.05.020; Jonikas MC, 2009, SCIENCE, V323, P1693, DOI 10.1126/science.1167983; Kalbfleisch T, 2007, TRAFFIC, V8, P1687, DOI 10.1111/j.1600-0854.2007.00661.x; Lahiri S, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001969; Louie RJ, 2012, GENOME MED, V4, DOI 10.1186/gm404; Mariappan M, 2011, NATURE, V477, P61, DOI 10.1038/nature10362; Mariappan M, 2010, NATURE, V466, P1120, DOI 10.1038/nature09296; Mateja A, 2015, SCIENCE, V347, P1152, DOI 10.1126/science.1261671; Rao M, 2016, ELIFE, V5, DOI 10.7554/eLife.21301; Richard M, 2013, P NATL ACAD SCI USA, V110, pE1055, DOI 10.1073/pnas.1216154110; Rivera-Monroy J, 2016, SCI REP-UK, V6, DOI 10.1038/srep39464; Satoh T, 2015, ELIFE, V4, DOI 10.7554/eLife.06306; Savidis G, 2016, CELL REP, V16, P232, DOI 10.1016/j.celrep.2016.06.028; Shao SC, 2017, SCIENCE, V355, P298, DOI 10.1126/science.aah6130; Shao SC, 2011, CELL, V147, P1576, DOI 10.1016/j.cell.2011.11.048; Stefer S, 2011, SCIENCE, V333, P758, DOI 10.1126/science.1207125; Wang F, 2014, NATURE, V512, P441, DOI 10.1038/nature13471; Wang F, 2010, MOL CELL, V40, P159, DOI 10.1016/j.molcel.2010.08.038; Wideman Jeremy G, 2015, F1000Res, V4, P624, DOI 10.12688/f1000research.6944.1	27	139	139	1	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 26	2018	359	6374					470	473		10.1126/science.aao3099	http://dx.doi.org/10.1126/science.aao3099			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT6SD	29242231	Green Accepted, Green Submitted, Green Published			2022-12-28	WOS:000423283200050
J	Gaya, M; Barral, P; Burbage, M; Aggarwal, S; Montaner, B; Navia, AW; Aid, M; Tsui, C; Maldonado, P; Nair, U; Ghneim, K; Fallon, PG; Sekaly, RP; Barouch, DH; Shalek, AK; Bruckbauer, A; Strid, J; Batista, FD				Gaya, Mauro; Barral, Patricia; Burbage, Marianne; Aggarwal, Shweta; Montaner, Beatriz; Navia, Andrew Warren; Aid, Malika; Tsui, Carlson; Maldonado, Paula; Nair, Usha; Ghneim, Khader; Fallon, Padraic G.; Sekaly, Rafick-Pierre; Barouch, Dan H.; Shalek, Alex K.; Bruckbauer, Andreas; Strid, Jessica; Batista, Facundo D.			Initiation of Antiviral B Cell Immunity Relies on Innate Signals from Spatially Positioned NKT Cells	CELL			English	Article							KILLER T-CELLS; LYMPH-NODES; IN-VIVO; ANTIBODY-RESPONSES; IL-4 PRODUCTION; COGNATE HELP; ANTIGEN; ACTIVATION; MICE; INFECTION	B cells constitute an essential line of defense from pathogenic infections through the generation of class-switched antibody-secreting cells (ASCs) in germinal centers. Although this process is known to be regulated by follicular helper T(TfH) cells, the mechanism by which B cells initially seed germinal center reactions remains elusive. We found that NKT cells, a population of innate-like T lymphocytes, are critical for the induction of B cell immunity upon viral infection. The positioning of NKT cells at the interfollicular areas of lymph nodes facilitates both their direct priming by resident macrophages and the localized delivery of innate signals to antigen-experienced B cells. Indeed, NKT cells secrete an early wave of IL-4 and constitute up to 70% of the total IL-4-producing cells during the initial stages of infection. Importantly, the requirement of this innate immunity arm appears to be evolutionarily conserved because early NKT and IL-4 gene signatures also positively correlate with the levels of neutralizing antibodies in Zika-virus-infected macaques. In conclusion, our data support a model wherein a pre-TfH wave of IL-4 secreted by interfollicular NKT cells triggers the seeding of germinal center cells and serves as an innate link between viral infection and B cell immunity.	[Gaya, Mauro; Navia, Andrew Warren; Nair, Usha; Barouch, Dan H.; Shalek, Alex K.; Batista, Facundo D.] Ragon Inst MGH MIT & Harvard, Cambridge, MA 02139 USA; [Gaya, Mauro; Barral, Patricia; Burbage, Marianne; Aggarwal, Shweta; Montaner, Beatriz; Tsui, Carlson; Maldonado, Paula; Bruckbauer, Andreas; Batista, Facundo D.] Francis Crick Inst, London NW1A 1AT, England; [Barral, Patricia] Kings Coll London, Peter Gorer Dept Immunobiol, London SE1 9RT, England; [Navia, Andrew Warren; Shalek, Alex K.] MIT, Inst Med Engn & Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Navia, Andrew Warren; Shalek, Alex K.] Broad Inst, Cambridge, MA 02142 USA; [Aid, Malika; Barouch, Dan H.] Harvard Med Sch, Ctr Virol & Vaccine Res, Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Ghneim, Khader; Sekaly, Rafick-Pierre] Case Western Reserve Univ, Cleveland, OH 44106 USA; [Fallon, Padraic G.] Trinity Coll Dublin, Inst Mol Med, Dublin, Ireland; [Strid, Jessica] Imperial Coll London, Div Immunol & Inflammat, Dept Med, London W12 0NN, England; [Batista, Facundo D.] Harvard Med Sch, Dept Microbiol & Immunobiol, Boston, MA 02115 USA; [Batista, Facundo D.] Harvard Med Sch, HMS Ctr Immune Imaging, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; Francis Crick Institute; University of London; King's College London; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Case Western Reserve University; Trinity College Dublin; Imperial College London; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Gaya, M; Batista, FD (corresponding author), Ragon Inst MGH MIT & Harvard, Cambridge, MA 02139 USA.; Gaya, M; Batista, FD (corresponding author), Francis Crick Inst, London NW1A 1AT, England.; Batista, FD (corresponding author), Harvard Med Sch, Dept Microbiol & Immunobiol, Boston, MA 02115 USA.; Batista, FD (corresponding author), Harvard Med Sch, HMS Ctr Immune Imaging, Boston, MA 02115 USA.	contact@maurogaya.com; fbatista1@mgh.harvard.edu	Fallon, Padraic/Y-2711-2019; Barouch, Dan/Y-3918-2019; Burbage, Marianne/GLQ-7327-2022; Shalek, Alex/Y-2434-2019	Fallon, Padraic/0000-0002-8401-7293; Burbage, Marianne/0000-0003-0686-2608; Shalek, Alex/0000-0001-5670-8778; Montaner, Beatriz/0000-0001-9877-7317; Barral, Patricia/0000-0003-4324-8973	Francis Crick Institute from Cancer Research UK [FC001035]; United Kingdom Medical Research Council [FC001035]; Wellcome Trust [FC001035]; Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery of the NIH [UM1AI100663]; Phillip T. and Susan M. Ragon Institute Foundation; Bill and Melinda Gates Foundation Innovation Award [228966]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI100663] Funding Source: NIH RePORTER	Francis Crick Institute from Cancer Research UK; United Kingdom Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Phillip T. and Susan M. Ragon Institute Foundation; Bill and Melinda Gates Foundation Innovation Award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank the flow cytometry facility for technical support and the biological resource unit for the breeding of animals and assistance with the generation of CD1d-floxed animals (at the Francis Crick and Ragon Institutes). We thank Kathrin Kirsch for the maintenance of mouse colonies. We thank Neil Rogers and Caetano Reis e Sousa for the provision of MyD88<SUP>-/-</SUP>, TLR7<SUP>-/-</SUP>, CD11c-Cre, and Lyz2-Cre mice and for scientific discussions. We thank Michael Reth for the Mb1-Cre strain. We thank Mark Wilson for the IL-4-GFP reporter mice. We thank Andrew McKenzie for the IL-33R<SUP>-/</SUP>-bone marrow. We thank Samuel W. Kazer and Sanjay M. Prakadan for assistance with RNA-seq analysis. We thank Adolfo Garcia-Sastre for the NS1-GFP virus. We thank Paul Thomas for the PR8-OTII virus. We thank Daniel Lingwood for the HA trimer. We thank the NIH Tetramer Core Facility for the provision of labeled CD1d tetramers. We thank all members of the Lymphocyte Interaction Laboratory for critical reading of the manuscript and scientific discussions. This work was supported by the Francis Crick Institute, which receives its core funding from Cancer Research UK (FC001035), the United Kingdom Medical Research Council (FC001035), the Wellcome Trust (FC001035), the Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery of the NIH (UM1AI100663), the Phillip T. and Susan M. Ragon Institute Foundation, and Bill and Melinda Gates Foundation Innovation Award 228966 (to F.D.B.).	Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Aid M, 2017, CELL, V169, P610, DOI 10.1016/j.cell.2017.04.008; AMIGORENA S, 1994, NATURE, V369, P113, DOI 10.1038/369113a0; Artiaga BL, 2016, SCI REP-UK, V6, DOI 10.1038/srep23593; Bai L, 2013, P NATL ACAD SCI USA, V110, P16097, DOI 10.1073/pnas.1303218110; Barral P, 2008, P NATL ACAD SCI USA, V105, P8345, DOI 10.1073/pnas.0802968105; Barral P, 2010, NAT IMMUNOL, V11, P303, DOI 10.1038/ni.1853; Batista FD, 2009, NAT REV IMMUNOL, V9, P15, DOI 10.1038/nri2454; Brennan PJ, 2013, NAT REV IMMUNOL, V13, P101, DOI 10.1038/nri3369; Carrasco YR, 2007, IMMUNITY, V27, P160, DOI 10.1016/j.immuni.2007.06.007; Chang PP, 2012, NAT IMMUNOL, V13, P35, DOI 10.1038/ni.2166; De Santo C, 2008, J CLIN INVEST, V118, P4036, DOI 10.1172/JCI36264; Dufort FJ, 2007, J IMMUNOL, V179, P4953, DOI 10.4049/jimmunol.179.8.4953; Galli G, 2007, P NATL ACAD SCI USA, V104, P3984, DOI 10.1073/pnas.0700191104; Gaya M, 2015, SCIENCE, V347, P667, DOI 10.1126/science.aaa1300; Groom JR, 2012, IMMUNITY, V37, P1091, DOI 10.1016/j.immuni.2012.08.016; Hagglof T, 2016, NAT IMMUNOL, V17, P1407, DOI 10.1038/ni.3583; Heesters BA, 2013, IMMUNITY, V38, P1164, DOI 10.1016/j.immuni.2013.02.023; Huang SCC, 2016, IMMUNITY, V45, P817, DOI 10.1016/j.immuni.2016.09.016; Ishikawa H, 2010, VIROLOGY, V407, P325, DOI 10.1016/j.virol.2010.08.030; Kastenmuller W, 2012, CELL, V150, P1235, DOI 10.1016/j.cell.2012.07.021; King IL, 2012, NAT IMMUNOL, V13, P44, DOI 10.1038/ni.2172; King IL, 2009, J EXP MED, V206, P1001, DOI 10.1084/jem.20090313; Kinjo Y, 2011, NAT IMMUNOL, V12, P966, DOI 10.1038/ni.2096; Leadbetter EA, 2008, P NATL ACAD SCI USA, V105, P8339, DOI 10.1073/pnas.0801375105; Lee YJ, 2013, NAT IMMUNOL, V14, P1146, DOI 10.1038/ni.2731; Leite-De-Moraes MC, 2001, J IMMUNOL, V166, P945, DOI 10.4049/jimmunol.166.2.945; Manicassamy B, 2010, P NATL ACAD SCI USA, V107, P11531, DOI 10.1073/pnas.0914994107; Mohrs K, 2005, IMMUNITY, V23, P419, DOI 10.1016/j.immuni.2005.09.006; Mohrs M, 2001, IMMUNITY, V15, P303, DOI 10.1016/S1074-7613(01)00186-8; Nagarajan NA, 2007, J IMMUNOL, V178, P2706, DOI 10.4049/jimmunol.178.5.2706; Qi H, 2006, SCIENCE, V312, P1672, DOI 10.1126/science.1125703; Reinhardt RL, 2009, NAT IMMUNOL, V10, P385, DOI 10.1038/ni.1715; Ricardo-Gonzalez RR, 2010, P NATL ACAD SCI USA, V107, P22617, DOI 10.1073/pnas.1009152108; Sagoo P, 2016, NAT MED, V22, P64, DOI 10.1038/nm.4016; Satija R, 2015, NAT BIOTECHNOL, V33, P495, DOI 10.1038/nbt.3192; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Sung JH, 2012, CELL, V150, P1249, DOI 10.1016/j.cell.2012.08.015; Thomas PG, 2006, P NATL ACAD SCI USA, V103, P2764, DOI 10.1073/pnas.0511185103; Townsend MJ, 2000, J EXP MED, V191, P1069, DOI 10.1084/jem.191.6.1069; Turqueti-Neves A, 2014, EUR J IMMUNOL, V44, P2130, DOI 10.1002/eji.201344203; Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032; Weinstein JS, 2016, NAT IMMUNOL, V17, P1197, DOI 10.1038/ni.3554; Yusuf I, 2010, J IMMUNOL, V185, P190, DOI 10.4049/jimmunol.0903505	44	100	102	0	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 25	2018	172	3					517	+		10.1016/j.cell.2017.11.036	http://dx.doi.org/10.1016/j.cell.2017.11.036			37	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FT9BS	29249358	hybrid, Green Published			2022-12-28	WOS:000423447600012
J	Eddy, MT; Lee, MY; Gao, ZG; White, KL; Didenko, T; Horst, R; Audet, M; Stanczak, P; McClary, KM; Han, GW; Jacobson, KA; Stevens, RC; Wuthrich, K				Eddy, Matthew T.; Lee, Ming-Yue; Gao, Zhan-Guo; White, Kate L.; Didenko, Tatiana; Horst, Reto; Audet, Martin; Stanczak, Pawel; McClary, Kyle M.; Han, Gye Won; Jacobson, Kenneth A.; Stevens, Raymond C.; Wuthrich, Kurt			Allosteric Coupling of Drug Binding and Intracellular Signaling in the A(2A) Adenosine Receptor	CELL			English	Article							MAGNETIC-RESONANCE SPECTRA; G-PROTEIN; BETA(2)-ADRENERGIC RECEPTOR; CRYSTAL-STRUCTURE; CONFORMATIONAL EQUILIBRIUM; FUNCTIONAL SELECTIVITY; ASPARTATE RESIDUE; RHODOPSIN; NMR; ACTIVATION	Signaling across cellular membranes, the 826 human G protein-coupled receptors (GPCRs) govern a wide range of vital physiological processes, making GPCRs prominent drug targets. X-ray crystallography provided GPCR molecular architectures, which also revealed the need for additional structural dynamics data to support drug development. Here, nuclear magnetic resonance (NMR) spectroscopy with the wild-type-like A(2A) adenosine receptor (A(2A)AR) in solution provides a comprehensive characterization of signaling-related structural dynamics. All six tryptophan indole and eight glycine backbone N-15-H-1 NMR signals in A(2A)AR were individually assigned. These NMR probes provided insight into the role of Asp52(2.50) as an allosteric link between the orthosteric drug binding site and the intracellular signaling surface, revealing strong interactions with the toggle switch Trp 246(6.48), and delineated the structural response to variable efficacy of bound drugs across A(2A)AR. The present data support GPCR signaling based on dynamic interactions between two semi-independent subdomains connected by an allosteric switch at Asp52(2.50).	[Eddy, Matthew T.; Didenko, Tatiana; Horst, Reto; Stanczak, Pawel; Wuthrich, Kurt] Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA; [Eddy, Matthew T.; Lee, Ming-Yue; White, Kate L.; Audet, Martin; McClary, Kyle M.; Han, Gye Won; Stevens, Raymond C.] Univ Southern Calif, Dept Biol Sci, Bridge Inst, Los Angeles, CA 90089 USA; [Eddy, Matthew T.; Lee, Ming-Yue; White, Kate L.; Audet, Martin; McClary, Kyle M.; Han, Gye Won; Stevens, Raymond C.] Univ Southern Calif, Dept Chem, Bridge Inst, Los Angeles, CA 90089 USA; [Gao, Zhan-Guo; Jacobson, Kenneth A.] NIDDK, Lab Bioorgan Chem, NIH, Bethesda, MD 20892 USA; [Horst, Reto] Pfizer Worldwide Res & Dev, Eastern Point Rd, Groton, CT 06340 USA; [Wuthrich, Kurt] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA	Scripps Research Institute; University of Southern California; University of Southern California; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Pfizer; Scripps Research Institute	Wuthrich, K (corresponding author), Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA.; Wuthrich, K (corresponding author), Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA.	wuthrich@scripps.edu	Han, Gye Won/GLQ-8724-2022; Jacobson, Kenneth Alan/A-1530-2009; Horst, Reto/AAY-9812-2020; Han, Gye Won/GLT-1531-2022; Han, Gye Won/GLQ-8673-2022; Stevens, Raymond/K-7272-2015; Lee, Ming-Yue/AAW-9142-2020	Han, Gye Won/0000-0003-4107-835X; Jacobson, Kenneth Alan/0000-0001-8104-1493; Stevens, Raymond/0000-0002-4522-8725; Lee, Ming-Yue/0000-0001-7082-1216; Eddy, Matthew/0000-0002-3349-6212; Wuthrich, Kurt/0000-0001-8739-6965	NIH/NIGMS (PSI Biology grant) [U54 GM094618, R01GM115825]; NIDDK Intramural Research Program [ZIA DK031117]; American Cancer Society; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK031117] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM094618, R01GM115825] Funding Source: NIH RePORTER	NIH/NIGMS (PSI Biology grant); NIDDK Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); American Cancer Society(American Cancer Society); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Sophie Nguyen for help with the production of A2AAR biomass, Jeffrey Velasquez for help in cloning of A<INF>2A</INF>AR constructs, Yekaterina Kadyshevskaya for help with the preparation of figures, Dr. Vsevold Katritch for input on the manuscript, and Angela Walker for careful checking of the manuscript. The authors acknowledge support from the NIH/NIGMS (PSI Biology grant U54 GM094618 and R01GM115825) and the NIDDK Intramural Research Program (ZIA DK031117). M.T.E. acknowledges funding from an American Cancer Society postdoctoral fellowship. K.W. is the Cecil H. and Ida M. Green Professor of Structural Biology at The Scripps Research Institute.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Bara-Jimenez W, 2003, NEUROLOGY, V61, P293, DOI 10.1212/01.WNL.0000073136.00548.D4; BIHOREAU C, 1993, P NATL ACAD SCI USA, V90, P5133, DOI 10.1073/pnas.90.11.5133; Bocquet N, 2015, BBA-BIOMEMBRANES, V1848, P1224, DOI 10.1016/j.bbamem.2015.02.014; Bokoch MP, 2010, NATURE, V463, P108, DOI 10.1038/nature08650; Bricogne G., 2016, BUSTER VERSION 2 10; Caffrey M, 2009, NAT PROTOC, V4, P706, DOI 10.1038/nprot.2009.31; Carpenter B, 2016, NATURE, V536, P104, DOI 10.1038/nature18966; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cheng RKY, 2017, STRUCTURE, V25, P1275, DOI 10.1016/j.str.2017.06.012; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Chun E, 2012, STRUCTURE, V20, P967, DOI 10.1016/j.str.2012.04.010; Chung KY, 2012, J BIOL CHEM, V287, P36305, DOI 10.1074/jbc.M112.406371; COOPER DMF, 1982, J NEUROCHEM, V38, P1164, DOI 10.1111/j.1471-4159.1982.tb05365.x; Crocker E, 2006, J MOL BIOL, V357, P163, DOI 10.1016/j.jmb.2005.12.046; DeVree BT, 2016, NATURE, V535, P182, DOI 10.1038/nature18324; Didenko T, 2013, CURR OPIN STRUC BIOL, V23, P740, DOI 10.1016/j.sbi.2013.07.011; Dore AS, 2011, STRUCTURE, V19, P1283, DOI 10.1016/j.str.2011.06.014; Dunwiddie TV, 2001, ANNU REV NEUROSCI, V24, P31, DOI 10.1146/annurev.neuro.24.1.31; Eddy MT, 2016, STRUCTURE, V24, P2190, DOI 10.1016/j.str.2016.09.015; Elling CE, 2006, J BIOL CHEM, V281, P17337, DOI 10.1074/jbc.M512510200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; FAHMY K, 1995, BIOPHYS CHEM, V56, P171, DOI 10.1016/0301-4622(95)00030-2; Fenalti G, 2014, NATURE, V506, P191, DOI 10.1038/nature12944; FRANKE RR, 1990, SCIENCE, V250, P123, DOI 10.1126/science.2218504; Han M, 1998, BIOCHEMISTRY-US, V37, P8253, DOI 10.1021/bi980147r; Horst R, 2013, ANGEW CHEM INT EDIT, V52, P10762, DOI 10.1002/anie.201305286; Hua T, 2017, NATURE, V547, P468, DOI 10.1038/nature23272; Isogai S, 2016, NATURE, V530, P237, DOI 10.1038/nature16577; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; JOHNSON CE, 1958, J CHEM PHYS, V29, P1012, DOI 10.1063/1.1744645; Katritch V, 2012, TRENDS PHARMACOL SCI, V33, P17, DOI 10.1016/j.tips.2011.09.003; Kim TH, 2013, J AM CHEM SOC, V135, P9465, DOI 10.1021/ja404305k; Kimata N, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12683; Klein-Seetharaman J, 1999, P NATL ACAD SCI USA, V96, P13744, DOI 10.1073/pnas.96.24.13744; Kofuku Y, 2014, ANGEW CHEM INT EDIT, V53, P13376, DOI 10.1002/anie.201406603; Kofuku Y, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2046; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Lin SW, 1996, BIOCHEMISTRY-US, V35, P11149, DOI 10.1021/bi960858u; Lin SW, 2000, METHOD ENZYMOL, V315, P116; Liu DS, 2016, J BIOMOL NMR, V65, P1, DOI 10.1007/s10858-016-0022-4; Liu JJ, 2012, SCIENCE, V335, P1106, DOI 10.1126/science.1215802; Liu W, 2012, SCIENCE, V337, P232, DOI 10.1126/science.1219218; Manglik A, 2014, CURR OPIN CELL BIOL, V27, P136, DOI 10.1016/j.ceb.2014.01.008; MARKLEY JL, 1968, SCIENCE, V161, P1249, DOI 10.1126/science.161.3847.1249; Martin S, 1999, MOL PHARMACOL, V55, P210, DOI 10.1124/mol.55.2.210; Massink A, 2015, MOL PHARMACOL, V87, P305, DOI 10.1124/mol.114.095737; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MCDONALD CC, 1967, J AM CHEM SOC, V89, P6332, DOI 10.1021/ja01000a061; Munk C, 2016, BRIT J PHARMACOL, V173, P2195, DOI 10.1111/bph.13509; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nygaard R, 2013, CELL, V152, P532, DOI 10.1016/j.cell.2013.01.008; Ohta A, 2001, NATURE, V414, P916, DOI 10.1038/414916a; Okude J, 2015, ANGEW CHEM INT EDIT, V54, P15771, DOI 10.1002/anie.201508794; Palmer TM, 1997, BIOCHEMISTRY-US, V36, P832, DOI 10.1021/bi962290v; PERKINS SJ, 1979, BIOCHIM BIOPHYS ACTA, V576, P409, DOI 10.1016/0005-2795(79)90416-1; PERT CB, 1973, SCIENCE, V182, P1359, DOI 10.1126/science.182.4119.1359; Pervushin K, 1997, P NATL ACAD SCI USA, V94, P12366, DOI 10.1073/pnas.94.23.12366; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; Sakmar TP, 1995, ISRAEL J CHEM, V35, P325; Schwartz TW, 2006, ANNU REV PHARMACOL, V46, P481, DOI 10.1146/annurev.pharmtox.46.120604.141218; Segala E, 2016, J MED CHEM, V59, P6470, DOI 10.1021/acs.jmedchem.6b00653; Shi L, 2002, J BIOL CHEM, V277, P14777, DOI 10.1074/jbc.M108967200; Shieh T, 1997, J MOL BIOL, V269, P373, DOI 10.1006/jmbi.1997.1035; Sounier R, 2015, NATURE, V524, P375, DOI 10.1038/nature14680; Staus DP, 2016, NATURE, V535, P448, DOI 10.1038/nature18636; Steen A, 2013, J BIOL CHEM, V288, P12511, DOI 10.1074/jbc.M112.449587; Sun BF, 2017, P NATL ACAD SCI USA, V114, P2066, DOI 10.1073/pnas.1621423114; Tao Q, 1998, J PHARMACOL EXP THER, V285, P651; Venkatakrishnan AJ, 2016, NATURE, V536, P484, DOI 10.1038/nature19107; Wacker D, 2013, SCIENCE, V340, P615, DOI 10.1126/science.1232808; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; WUTHRICH K, 1969, P NATL ACAD SCI USA, V63, P1071, DOI 10.1073/pnas.63.4.1071; Wuthrich K, 1986, NMR PROTEINS NUCL AC; Xu F, 2011, SCIENCE, V332, P322, DOI 10.1126/science.1202793; Ye LB, 2016, NATURE, V533, P265, DOI 10.1038/nature17668; Young A, 2016, CANCER CELL, V30, P391, DOI 10.1016/j.ccell.2016.06.025	80	114	114	2	78	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 11	2018	172	1-2					68	+		10.1016/j.cell.2017.12.004	http://dx.doi.org/10.1016/j.cell.2017.12.004			25	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FS5MI	29290469	Green Accepted, Bronze			2022-12-28	WOS:000419840100010
J	Rajbhandari, P; Thomas, BJ; Feng, AC; Hong, C; Wang, JX; Vergnes, L; Sallam, T; Wang, B; Sandhu, J; Seldin, MM; Lusis, AJ; Fong, LG; Katz, M; Lee, R; Young, SG; Reue, K; Smale, ST; Tontonoz, P				Rajbhandari, Prashant; Thomas, Brandon J.; Feng, An-Chieh; Hong, Cynthia; Wang, Jiexin; Vergnes, Laurent; Sallam, Tamer; Wang, Bo; Sandhu, Jaspreet; Seldin, Marcus M.; Lusis, Aldons J.; Fong, Loren G.; Katz, Melanie; Lee, Richard; Young, Stephen G.; Reue, Karen; Smale, Stephen T.; Tontonoz, Peter			IL-10 Signaling Remodels Adipose Chromatin Architecture to Limit Thermogenesis and Energy Expenditure	CELL			English	Article							GENE-DEFICIENT MICE; INSULIN-RESISTANCE; BEIGE FAT; BROWN ADIPOCYTES; HEPATIC STEATOSIS; OBESITY; INTERLEUKIN-10; ADIPOGENESIS; INFLAMMATION; MACROPHAGES	Signaling pathways that promote adipose tissue thermogenesis are well characterized, but the limiters of energy expenditure are largely unknown. Here, we show that ablation of the anti-inflammatory cytokine IL-10 improves insulin sensitivity, protects against diet-induced obesity, and elicits the browning of white adipose tissue. Mechanistic studies define bone marrow cells as the source of the IL-10 signal and adipocytes as the target cell type mediating these effects. IL-10 receptor alpha is highly enriched in mature adipocytes and is induced in response to differentiation, obesity, and aging. Assay for transposase-accessible chromatin sequencing (ATAC-seq), ChIP-seq, and RNA-seq reveal that IL-10 represses the transcription of thermogenic genes in adipocytes by altering chromatin accessibility and inhibiting ATF and C/EBP beta recruitment to key enhancer regions. These findings expand our understanding of the relationship between inflammatory signaling pathways and adipose tissue function and provide insight into the physiological control of thermogenesis that could inform future therapy.	[Rajbhandari, Prashant; Hong, Cynthia; Wang, Jiexin; Wang, Bo; Sandhu, Jaspreet; Tontonoz, Peter] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; [Reue, Karen; Smale, Stephen T.; Tontonoz, Peter] Univ Calif Los Angeles, David Geffen Sch Med, Mol Biol Inst, Los Angeles, CA 90095 USA; [Tontonoz, Peter] Univ Calif Los Angeles, David Geffen Sch Med, Howard Hughes Med Inst, Los Angeles, CA 90095 USA; [Thomas, Brandon J.; Feng, An-Chieh; Seldin, Marcus M.; Lusis, Aldons J.; Smale, Stephen T.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; [Vergnes, Laurent; Seldin, Marcus M.; Lusis, Aldons J.; Reue, Karen] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; [Sallam, Tamer; Fong, Loren G.; Young, Stephen G.] Univ Calif Los Angeles, David Geffen Sch Med, Div Cardiol, Dept Med, Los Angeles, CA 90095 USA; [Katz, Melanie; Lee, Richard] Ionis Pharmaceut, Carlsbad, CA 92008 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Ionis Pharmaceuticals, Inc.	Tontonoz, P (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA.; Tontonoz, P (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Mol Biol Inst, Los Angeles, CA 90095 USA.; Tontonoz, P (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Howard Hughes Med Inst, Los Angeles, CA 90095 USA.	ptontonoz@mednet.ucla.edu	wang, jie/GRS-0942-2022	Wang, Bo/0000-0001-9234-035X; Rajbhandari, Prashant/0000-0002-8146-3861; Young, Stephen/0000-0001-7270-3176; vergnes, laurent/0000-0002-8804-589X	NIH [F32DK104484, T32AI007323, T32GM008042, HL128822, F32DK109601, HL090533, GM086372, DK063491]; Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan; NATIONAL CANCER INSTITUTE [P30CA016042] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL090553, K08HL128822] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007323] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK109601, F32DK104484, P30DK063491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008042, R01GM086372] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the UCLA Broad Stem Cell Research Center Core for sequencing. This work was supported by grants from the NIH (F32DK104484 to P.R.; T32AI007323 and T32GM008042 to B.J.T.; HL128822 to T.S.; F32DK109601 to B.W.; HL090533 to K.R., S.G.Y., and P.T.; GM086372 to S.T.S.; and DK063491 P.T.). A-C.F. is funded by the Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan.	Altshuler-Keylin S, 2016, CELL METAB, V24, P402, DOI 10.1016/j.cmet.2016.08.002; Asterholm IW, 2014, CELL METAB, V20, P103, DOI 10.1016/j.cmet.2014.05.005; Bapat SP, 2015, NATURE, V528, P137, DOI 10.1038/nature16151; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Buenrostro Jason D, 2015, Curr Protoc Mol Biol, V109, DOI 10.1002/0471142727.mb2129s109; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Church CD, 2014, METHOD ENZYMOL, V537, P31, DOI 10.1016/B978-0-12-411619-1.00003-3; Clementi AH, 2009, BBA-MOL BASIS DIS, V1792, P1062, DOI 10.1016/j.bbadis.2009.08.007; Couper KN, 2008, J IMMUNOL, V180, P5771, DOI 10.4049/jimmunol.180.9.5771; den Boer MAM, 2006, ENDOCRINOLOGY, V147, P4553, DOI 10.1210/en.2006-0417; Faulkner JL, 2013, FASEB J, V27; Feldmann HM, 2009, CELL METAB, V9, P203, DOI 10.1016/j.cmet.2008.12.014; Gao MM, 2013, MOL THER, V21, P1852, DOI 10.1038/mt.2013.125; Goto T, 2016, CYTOKINE, V77, P107, DOI 10.1016/j.cyto.2015.11.001; Harms M, 2013, NAT MED, V19, P1252, DOI 10.1038/nm.3361; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hoentjen F, 2003, GUT, V52, P1721, DOI 10.1136/gut.52.12.1721; Hong EG, 2009, DIABETES, V58, P2525, DOI 10.2337/db08-1261; Hummasti S, 2006, MOL ENDOCRINOL, V20, P1261, DOI 10.1210/me.2006-0025; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; Keubler LM, 2015, INFLAMM BOWEL DIS, V21, P1967, DOI 10.1097/MIB.0000000000000468; Knudsen JG, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0084910, 10.1371/journal.pone.0086457]; Kowalski GM, 2011, DIABETOLOGIA, V54, P888, DOI 10.1007/s00125-010-2020-5; Laakso M, 2017, J LIPID RES, V58, P481, DOI 10.1194/jlr.O072629; Lang R, 2002, J IMMUNOL, V169, P2253, DOI 10.4049/jimmunol.169.5.2253; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Lee MW, 2015, CELL, V160, P74, DOI 10.1016/j.cell.2014.12.011; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Long JZ, 2016, CELL, V166, P424, DOI 10.1016/j.cell.2016.05.071; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Lumeng CN, 2011, J CLIN INVEST, V121, P2111, DOI 10.1172/JCI57132; Madsen KL, 2000, GASTROENTEROLOGY, V118, P1094, DOI 10.1016/S0016-5085(00)70362-3; Mauer J, 2014, NAT IMMUNOL, V15, P423, DOI 10.1038/ni.2865; Miller AM, 2011, HEPATOLOGY, V54, P846, DOI 10.1002/hep.24517; MOLDAWER LL, 1987, CLIN PHYSIOL, V7, P263, DOI 10.1111/j.1475-097X.1987.tb00169.x; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Murray PJ, 2012, NAT IMMUNOL, V13, P916, DOI 10.1038/ni.2391; Nisoli E, 2000, P NATL ACAD SCI USA, V97, P8033, DOI 10.1073/pnas.97.14.8033; Odegaard JI, 2016, CELL, V166, P841, DOI 10.1016/j.cell.2016.06.040; Ohno H, 2012, CELL METAB, V15, P395, DOI 10.1016/j.cmet.2012.01.019; Parks BW, 2015, CELL METAB, V21, P334, DOI 10.1016/j.cmet.2015.01.002; Parks BW, 2013, CELL METAB, V17, P141, DOI 10.1016/j.cmet.2012.12.007; Petruzzelli M, 2014, CELL METAB, V20, P433, DOI 10.1016/j.cmet.2014.06.011; Qiu YF, 2014, CELL, V157, P1292, DOI 10.1016/j.cell.2014.03.066; Rao RR, 2014, CELL, V157, P1279, DOI 10.1016/j.cell.2014.03.065; Rogers GW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021746; Rosen ED, 2014, CELL, V156, P20, DOI 10.1016/j.cell.2013.12.012; Sallam T, 2016, NATURE, V534, P124, DOI 10.1038/nature17674; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; Sartipy P, 2003, P NATL ACAD SCI USA, V100, P7265, DOI 10.1073/pnas.1133870100; Seale P, 2007, CELL METAB, V6, P38, DOI 10.1016/j.cmet.2007.06.001; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Siersbaek MS, 2012, MOL CELL BIOL, V32, P3452, DOI 10.1128/MCB.00526-12; Stancakova A, 2009, DIABETES, V58, P1212, DOI 10.2337/db08-1607; Sun L, 2013, P NATL ACAD SCI USA, V110, P3387, DOI 10.1073/pnas.1222643110; Tang T, 2010, J BIOL CHEM, V285, P4637, DOI 10.1074/jbc.M109.068007; Tiraby C, 2003, TRENDS ENDOCRIN MET, V14, P439, DOI 10.1016/j.tem.2003.10.001; Villanueva CJ, 2013, CELL METAB, V17, P423, DOI 10.1016/j.cmet.2013.01.016; Villanueva CJ, 2011, CELL METAB, V13, P413, DOI 10.1016/j.cmet.2011.02.014; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Wallenius V, 2002, NAT MED, V8, P75, DOI 10.1038/nm0102-75; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Zambelli F, 2009, NUCLEIC ACIDS RES, V37, pW247, DOI 10.1093/nar/gkp464	63	83	85	5	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 11	2018	172	1-2					218	+		10.1016/j.cell.2017.11.019	http://dx.doi.org/10.1016/j.cell.2017.11.019			33	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FS5MI	29249357	Bronze, Green Accepted			2022-12-28	WOS:000419840100021
J	Sheldon, T				Sheldon, Tony			Could Dutch style sex education reduce pregnancies among UK teenagers?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												tonysheldon5@cs.com						Bennett C, 2016, THESIS; Bennett C, 2018, SEX EDUC-SEX SOC LEA, V18, P74, DOI 10.1080/14681811.2017.1390449; Bennett C, 2017, SOCIOL HEALTH ILL, V39, P1365, DOI 10.1111/1467-9566.12591; Newby KV, 2018, SEX EDUC-SEX SOC LEA, V18, P90, DOI 10.1080/14681811.2017.1392297; Sedgh G, 2015, J ADOLESCENT HEALTH, V56, P223, DOI 10.1016/j.jadohealth.2014.09.007	5	2	2	0	20	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 5	2018	360								j5930	10.1136/bmj.j5930	http://dx.doi.org/10.1136/bmj.j5930			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FS3VJ	29305374				2022-12-28	WOS:000419711800006
J	Butler, M; Nelson, VA; Davila, H; Ratner, E; Fink, HA; Hemmy, LS; McCarten, JR; Barclay, TR; Brasure, M; Kane, RL				Butler, Mary; Nelson, Victoria A.; Davila, Heather; Ratner, Edward; Fink, Howard A.; Hemmy, Laura S.; McCarten, J. Riley; Barclay, Terry R.; Brasure, Michelle; Kane, Robert L.			Over-the-Counter Supplement Interventions to Prevent Cognitive Decline, Mild Cognitive Impairment, and Clinical Alzheimer-Type Dementia A Systematic Review	ANNALS OF INTERNAL MEDICINE			English	Review							SOY ISOFLAVONE SUPPLEMENTATION; PLACEBO-CONTROLLED TRIAL; GINKGO-BILOBA EXTRACT; DOUBLE-BLIND; OLDER-ADULTS; B-VITAMINS; POSTMENOPAUSAL WOMEN; FATTY-ACIDS; FISH-OIL; PERFORMANCE	Background: Optimal interventions to prevent or delay cognitive decline, mild cognitive impairment (MCI), or dementia are uncertain. Purpose: To summarize the evidence on efficacy and harms of over-the-counter (OTC) supplements to prevent or delay cognitive decline, MCI, or clinical Alzheimer-type dementia in adults with normal cognition or MCI but no dementia diagnosis. Data Sources: Multiple electronic databases from 2009 to July 2017 and bibliographies of systematic reviews. Study Selection: English-language trials of at least 6 months' duration that enrolled adults without dementia and compared cognitive outcomes with an OTC supplement versus placebo or active controls. Data Extraction: Extraction performed by a single reviewer and confirmed by a second reviewer; dual-reviewer assessment of risk of bias; consensus determination of strength of evidence. Data Synthesis: Thirty-eight trials with low to medium risk of bias compared omega-3 fatty acids, soy, ginkgo biloba, B vitamins, vitamin D plus calcium, vitamin C or beta-carotene, multi-ingredient supplements, or other OTC interventions with placebo or other supplements. Few studies examined effects on clinical Alzheimer-type dementia or MCI, and those that did suggested no benefit. Daily folic acid plus vitamin B-12 was associated with improvements in performance on some objectively measured memory tests that were statistically significant but of questionable clinical significance. Moderate-strength evidence showed that vitamin E had no benefit on cognition. Evidence about effects of omega-3 fatty acids, soy, ginkgo biloba, folic acid alone or with other B vitamins, beta-carotene, vitamin C, vitamin D plus calcium, and multivitamins or multi-ingredient supplements was either insufficient or low-strength, suggesting that these supplements did not reduce risk for cognitive decline. Adverse events were rarely reported. Limitation: Studies had high attrition and short follow-up and used a highly variable set of cognitive outcome measures. Conclusion: Evidence is insufficient to recommend any OTC supplement for cognitive protection in adults with normal cognition or MCI.	[Butler, Mary; Nelson, Victoria A.; Davila, Heather; Brasure, Michelle] Univ Minnesota, Div Hlth Policy & Management, 420 Delaware St Southeast,Mayo Mem Bldg D351, Minneapolis, MN 55455 USA; [Ratner, Edward; Fink, Howard A.; Hemmy, Laura S.; McCarten, J. Riley] Minneapolis VA Hlth Care Syst, Geriatr Res Educ & Clin Ctr, One Vet Dr,11-G, Minneapolis, MN 55417 USA; HealthPartners, Minneapolis, MN USA; [Barclay, Terry R.] Univ Minnesota, Dept Neurol, 295 Phalen Blvd,Mailstop 41203C, St Paul, MN 55130 USA	University of Minnesota System; University of Minnesota Twin Cities; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System; University of Minnesota System; University of Minnesota Twin Cities	Butler, M (corresponding author), Univ Minnesota, Div Hlth Policy & Management, 420 Delaware St Southeast,Mayo Mem Bldg D351, Minneapolis, MN 55455 USA.	butl0092@umn.edu		Davila, Heather/0000-0003-1832-7901	Agency for Healthcare Research and Quality [290-2015-00008-I]	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	This manuscript is based on research conducted by the Minnesota Evidence-based Practice Center under AHRQ contract 290-2015-00008-I.	Abraham RP, 2015, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD011905, DOI 10.1002/14651858.CD011905]; Alzheimers Research and Prevention Foundation, 2017, PILL 1 DIETS SUPPL; Andreeva VA, 2011, AM J CLIN NUTR, V94, P278, DOI 10.3945/ajcn.110.006320; [Anonymous], 2015, NUTR BUSINESS J; Balk EM, 2015, ANN INTERN MED, V163, P437, DOI 10.7326/M15-0452; Berkman ND, 2013, METHODS GUIDE EFFECT; Birks J, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003120.pub3; Charernboon Thammanard, 2015, Journal of the Medical Association of Thailand, V98, P508; Collins R, 2002, LANCET, V360, P23, DOI 10.1016/S0140-6736(02)09328-5; Cukierman-Yaffe T, 2014, LANCET DIABETES ENDO, V2, P562, DOI 10.1016/S2213-8587(14)70062-2; Dangour AD, 2010, J ALZHEIMERS DIS, V22, P205, DOI 10.3233/JAD-2010-090940; Dangour AD, 2010, AM J CLIN NUTR, V91, P1725, DOI 10.3945/ajcn.2009.29121; de Jager CA, 2012, INT J GERIATR PSYCH, V27, P592, DOI 10.1002/gps.2758; DeKosky ST, 2008, JAMA-J AM MED ASSOC, V300, P2253, DOI 10.1001/jama.2008.683; Dodge HH, 2008, NEUROLOGY, V70, P1809, DOI 10.1212/01.wnl.0000303814.13509.db; Douaud G, 2013, P NATL ACAD SCI USA, V110, P9523, DOI 10.1073/pnas.1301816110; Durga J, 2007, LANCET, V369, P208, DOI 10.1016/S0140-6736(07)60109-3; Gavrilova SI, 2014, INT J GERIATR PSYCH, V29, P1087, DOI 10.1002/gps.4103; Geleijnse JM, 2012, ALZHEIMERS DEMENT, V8, P278, DOI 10.1016/j.jalz.2011.06.002; Gleason CE, 2009, AGE AGEING, V38, P86, DOI 10.1093/ageing/afn227; Grodstein F, 2013, ANN INTERN MED, V159, P806, DOI 10.7326/0003-4819-159-12-201312170-00006; Henderson VW, 2012, NEUROLOGY, V78, P1841, DOI 10.1212/WNL.0b013e318258f822; Howes JB, 2004, CLIMACTERIC, V7, P70, DOI 10.1080/13697130310001651490; Kane R. L., 2017, COMP EFFECTIVENESS R, V188, P86; Kang JH, 2009, CIRCULATION, V119, P2772, DOI 10.1161/CIRCULATIONAHA.108.816900; Kang JH, 2006, ARCH INTERN MED, V166, P2462, DOI 10.1001/archinte.166.22.2462; Kato-Kataoka A, 2010, J CLIN BIOCHEM NUTR, V47, P246, DOI 10.3164/jcbn.10-62; Kreijkamp-Kaspers S, 2004, JAMA-J AM MED ASSOC, V292, P65, DOI 10.1001/jama.292.1.65; Kritz-Silverstein D, 2003, MENOPAUSE, V10, P196, DOI 10.1097/00042192-200310030-00004; Kritz-Silverstein D, 2008, J AM GERIATR SOC, V56, P1292, DOI 10.1111/j.1532-5415.2008.01768.x; Kryscio RJ, 2017, JAMA NEUROL, V74, P567, DOI 10.1001/jamaneurol.2016.5778; Lee LK, 2013, PSYCHOPHARMACOLOGY, V225, P605, DOI 10.1007/s00213-012-2848-0; Malouf R, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004514.pub2; McMahon JA, 2006, NEW ENGL J MED, V354, P2764, DOI 10.1056/NEJMoa054025; McNeill G, 2007, NUTR J, V6, DOI 10.1186/1475-2891-6-10; Naeini AMA, 2014, EUR J NUTR, V53, P1255, DOI 10.1007/s00394-013-0628-1; Oulhaj A, 2016, J ALZHEIMERS DIS, V50, P547, DOI 10.3233/JAD-150777; Petersen RC, 2005, NEW ENGL J MED, V352, P2379, DOI 10.1056/NEJMoa050151; Qato DM, 2016, JAMA INTERN MED, V176, P473, DOI 10.1001/jamainternmed.2015.8581; Ro SC, 2007, MENOPAUSE, V14, P489, DOI 10.1097/gme.0b013e31802v4f4f; Rossom RC, 2012, J AM GERIATR SOC, V60, P2197, DOI 10.1111/jgs.12032; Schiepers OJG, 2009, J NUTR, V139, P1368, DOI 10.3945/jn.108.103721; Smith AD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012244; Snitz BE, 2009, JAMA-J AM MED ASSOC, V302, P2663, DOI 10.1001/jama.2009.1913; Stott DJ, 2005, AM J CLIN NUTR, V82, P1320, DOI 10.1093/ajcn/82.6.1320; Strike SC, 2016, J GERONTOL A-BIOL, V71, P236, DOI 10.1093/gerona/glv109; Sydenham E, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005379.pub3; van de Rest O, 2008, NEUROLOGY, V71, P430, DOI 10.1212/01.wnl.0000324268.45138.86; van der Zwaluw NL, 2014, NEUROLOGY, V83, P2158, DOI 10.1212/WNL.0000000000001050; Vellas B, 2012, LANCET NEUROL, V11, P851, DOI 10.1016/S1474-4422(12)70206-5; Viswanathan M., 2012, SYSTEMATIC REV HLTH; Walker JG, 2012, AM J CLIN NUTR, V95, P194, DOI 10.3945/ajcn.110.007799; Williams J. W., 2010, 2902007100661 HHSA A; Witte AV, 2014, CEREB CORTEX, V24, P3059, DOI 10.1093/cercor/bht163; Witte AV, 2014, J NEUROSCI, V34, P7862, DOI 10.1523/JNEUROSCI.0385-14.2014; Wolters M, 2005, PREV MED, V41, P253, DOI 10.1016/j.ypmed.2004.11.007; Yurko-Mauro K, 2010, ALZHEIMERS DEMENT, V6, P456, DOI 10.1016/j.jalz.2010.01.013	57	74	77	6	46	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 2	2018	168	1					52	+		10.7326/M17-1530	http://dx.doi.org/10.7326/M17-1530			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FR5SO	29255909				2022-12-28	WOS:000419126700007
J	Kuehn, B				Kuehn, Bridget			Crowdsourcing Pregnancy Data	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 26	2017	318	24					2418	2418		10.1001/jama.2017.19923	http://dx.doi.org/10.1001/jama.2017.19923			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FQ9ZO	29279913				2022-12-28	WOS:000418720700005
J	Roberts, SR				Roberts, Stewart R.			Charcot's Opinion and Criticism of German Medicine	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 26	2017	318	24					2498	2498		10.1001/jama.2017.10500	http://dx.doi.org/10.1001/jama.2017.10500			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FQ9ZO	29279916				2022-12-28	WOS:000418720700038
J	Rowland, K				Rowland, Kate			You don't know me	LANCET			English	Editorial Material									[Rowland, Kate] Rush Univ, Dept Family Med, 600 S Paulina, Chicago, IL 60612 USA	Rush University	Rowland, K (corresponding author), Rush Univ, Dept Family Med, 600 S Paulina, Chicago, IL 60612 USA.	kathleen_rowland@rush.edu	Rowland, Kate/Q-6256-2019	Rowland, Kate/0000-0002-1383-0279					0	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 23	2017	390	10114					2869	2870		10.1016/S0140-6736(17)33307-X	http://dx.doi.org/10.1016/S0140-6736(17)33307-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FQ9GF	29303723				2022-12-28	WOS:000418669800027
J	Gallo, P; Stanley, HE				Gallo, Paola; Stanley, H. Eugene			Experiments provide evidence for two liquid phases in supercooled water droplets	SCIENCE			English	Editorial Material							WIDOM LINE; TRANSITION; SILICON		[Gallo, Paola] Univ Roma Tre, Dipartimento Matemat & Fis, Via Vasca Navale 84, I-00146 Rome, Italy; [Stanley, H. Eugene] Boston Univ, Dept Phys, 590 Commonwealth Ave, Boston, MA 02215 USA; [Stanley, H. Eugene] Boston Univ, Ctr Polymer Studies, Boston, MA 02215 USA	Roma Tre University; Boston University; Boston University	Gallo, P (corresponding author), Univ Roma Tre, Dipartimento Matemat & Fis, Via Vasca Navale 84, I-00146 Rome, Italy.	gallop@fis.uniroma3.it		Stanley, H./0000-0003-2800-4495; GALLO, Paola/0000-0003-4370-9071				Abascal JLF, 2010, J CHEM PHYS, V133, DOI 10.1063/1.3506860; De Marzio M, 2017, J CHEM PHYS, V146, DOI 10.1063/1.4975387; Gallo P, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6806; Gallo P, 2016, CHEM REV, V116, P7463, DOI 10.1021/acs.chemrev.5b00750; Kim KH, 2017, SCIENCE, V358, P1589, DOI 10.1126/science.aap8269; Mishima O, 1998, NATURE, V396, P329, DOI 10.1038/24540; Palmer JC, 2014, NATURE, V510, P385, DOI 10.1038/nature13405; POOLE PH, 1992, NATURE, V360, P324, DOI 10.1038/360324a0; Saika-Voivod I, 2001, NATURE, V412, P514, DOI 10.1038/35087524; Smallenburg F, 2014, NAT PHYS, V10, P653, DOI [10.1038/nphys3030, 10.1038/NPHYS3030]; Vasisht VV, 2011, NAT PHYS, V7, P549, DOI [10.1038/NPHYS1993, 10.1038/nphys1993]; Xu LM, 2005, P NATL ACAD SCI USA, V102, P16558, DOI 10.1073/pnas.0507870102	13	46	46	4	88	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 22	2017	358	6370					1543	1544		10.1126/science.aar3575	http://dx.doi.org/10.1126/science.aar3575			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FQ6BO	29269465				2022-12-28	WOS:000418448000039
J	Obermeyer, Z; Samra, JK; Mullainathan, S				Obermeyer, Ziad; Samra, Jasmeet K.; Mullainathan, Sendhil			Individual differences in normal body temperature: longitudinal big data analysis of patient records	BMJ-BRITISH MEDICAL JOURNAL			English	Article							LONGEVITY; OLDER; RESTRICTION; BIOMARKERS; OBESITY; HEAT	OBJECTIVE To estimate individual level body temperature and to correlate it with other measures of physiology and health. DESIGN Observational cohort study. SETTING Outpatient clinics of a large academic hospital, 2009-14. PARTICIPANTS 35 488 patients who neither received a diagnosis for infections nor were prescribed antibiotics, in whom temperature was expected to be within normal limits. MAIN OUTCOME MEASURES Baseline temperatures at individual level, estimated using random effects regression and controlling for ambient conditions at the time of measurement, body site, and time factors. Baseline temperatures were correlated with demographics, medical comorbidities, vital signs, and subsequent one year mortality. RESULTS In a diverse cohort of 35 488 patients (mean age 52.9 years, 64% women, 41% non-white race) with 243 506 temperature measurements, mean temperature was 36.6 degrees C (95% range 35.7-37.3 degrees C, 99% range 35.337.7 degrees C). Several demographic factors were linked to individual level temperature, with older people the coolest (-0.021 degrees C for every decade, P<0.001) and African-American women the hottest (versus white men: 0.052 degrees C, P<0.001). Several comorbidities were linked to lower temperature (eg, hypothyroidism: -0.013 degrees C, P=0.01) or higher temperature (eg, cancer: 0.020, P<0.001), as were physiological measurements (eg, body mass index: 0.002 per m/kg(2), P<0.001). Overall, measured factors collectively explained only 8.2% of individual temperature variation. Despite this, unexplained temperature variation was a significant predictor of subsequent mortality: controlling for all measured factors, an increase of 0.149 degrees C (1 SD of individual temperature in the data) was linked to 8.4% higher one year mortality (P=0.014). CONCLUSIONS Individuals' baseline temperatures showed meaningful variation that was not due solely to measurement error or environmental factors. Baseline temperatures correlated with demographics, comorbid conditions, and physiology, but these factors explained only a small part of individual temperature variation. Unexplained variation in baseline temperature, however, strongly predicted mortality.	[Obermeyer, Ziad; Samra, Jasmeet K.] Brigham & Womens Hosp, Dept Emergency Med, 75 Francis St, Boston, MA 02115 USA; [Obermeyer, Ziad] Harvard Med Sch, Dept Emergency Med & Hlth Care Policy, Boston, MA 02115 USA; [Mullainathan, Sendhil] Harvard Univ, Dept Econ, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University	Obermeyer, Z (corresponding author), Brigham & Womens Hosp, Dept Emergency Med, 75 Francis St, Boston, MA 02115 USA.; Obermeyer, Z (corresponding author), Harvard Med Sch, Dept Emergency Med & Hlth Care Policy, Boston, MA 02115 USA.	zobermeyer@bwh.harvard.edu			office of the director of the National Institutes of Health [DP5 OD012161]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD012161] Funding Source: NIH RePORTER	office of the director of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by a grant from the office of the director of the National Institutes of Health (DP5 OD012161) to ZO. This research was independent from funders. The funder had no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the article for publication.	Agency for Healthcare Research and Quality, 2011, CLIN CLASS SOFTW CCS, P11; Bain AR, 2012, ACTA PHYSIOL, V206, P98, DOI 10.1111/j.1748-1716.2012.02452.x; BASS DE, 1955, MEDICINE, V34, P323, DOI 10.1097/00005792-195509000-00002; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BLAND JM, 1995, BRIT MED J, V310, P170, DOI 10.1136/bmj.310.6973.170; BOUCHARD C, 1990, NEW ENGL J MED, V322, P1477, DOI 10.1056/NEJM199005243222101; Burnham RS, 2006, AM J PHYS MED REHAB, V85, P553, DOI 10.1097/01.phm.0000223232.32653.7f; CASTLE SC, 1991, J AM GERIATR SOC, V39, P853, DOI 10.1111/j.1532-5415.1991.tb04450.x; Conti B, 2008, CELL MOL LIFE SCI, V65, P1626, DOI 10.1007/s00018-008-7536-1; Conti B, 2006, SCIENCE, V314, P825, DOI 10.1126/science.1132191; ERICKSON R, 1980, NURS RES, V29, P157; Faizi M, 2014, INJURY, V45, P1942, DOI 10.1016/j.injury.2014.09.024; Gagne JJ, 2011, J CLIN EPIDEMIOL, V64, P749, DOI 10.1016/j.jclinepi.2010.10.004; Gardiner JC, 2009, STAT MED, V28, P221, DOI 10.1002/sim.3478; GRASSI G, 1995, HYPERTENSION, V25, P560, DOI 10.1161/01.HYP.25.4.560; Gunes UY, 2008, J CLIN NURS, V17, P2284, DOI 10.1111/j.1365-2702.2007.02272.x; Halonen JI, 2011, OCCUP ENVIRON MED, V68, P296, DOI 10.1136/oem.2010.056507; Heilbronn LK, 2006, JAMA-J AM MED ASSOC, V295, P1539, DOI 10.1001/jama.295.13.1539; HOLM S, 1979, SCAND J STAT, V6, P65; HORVATH STEVEN M., 1950, JOUR AMER MED ASSOC, V144, P1562; KEYS ANCEL, 1950, The Biology of Human Starvation.; Landsberg L, 2009, METABOLISM, V58, P871, DOI 10.1016/j.metabol.2009.02.017; LAWSON RN, 1963, CAN MED ASSOC J, V88, P68; MACKOWIAK PA, 1992, JAMA-J AM MED ASSOC, V268, P1578, DOI 10.1001/jama.268.12.1578; MOGHISSI KS, 1972, AM J OBSTET GYNECOL, V114, P405, DOI 10.1016/0002-9378(72)90617-5; Murdoch TB, 2013, JAMA-J AM MED ASSOC, V309, P1351, DOI 10.1001/jama.2013.393; National Oceanographic and Atmospheric Administration, NCEP MET ASS DAT SYS; REFINETTI R, 1992, PHYSIOL BEHAV, V51, P613, DOI 10.1016/0031-9384(92)90188-8; Repasky EA, 2013, CANCER IMMUNOL RES, V1, P210, DOI 10.1158/2326-6066.CIR-13-0118; Roth GS, 2002, SCIENCE, V297, P811, DOI 10.1126/science.1071851; SCHERRER U, 1994, CIRCULATION, V89, P2634, DOI 10.1161/01.CIR.89.6.2634; Sund-Levander M, 2002, SCAND J CARING SCI, V16, P122, DOI 10.1046/j.1471-6712.2002.00069.x; Topol EJ, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000484; TROISI RJ, 1991, HYPERTENSION, V17, P669, DOI 10.1161/01.HYP.17.5.669; Waalen J, 2011, J GERONTOL A-BIOL, V66, P487, DOI 10.1093/gerona/glr001; Wooldridge JM, 2010, ECONOMETRIC ANALYSIS OF CROSS SECTION AND PANEL DATA, 2ND EDITION, P3; Wunderlich CA., 1871, TEMPERATURE DIS MANU	37	68	70	3	21	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 13	2017	359								j5468	10.1136/bmj.j5468	http://dx.doi.org/10.1136/bmj.j5468			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FQ4KY	29237616	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000418327500003
J	Saotome, K; Murthy, SE; Kefauver, JM; Whitwam, T; Patapoutian, A; Ward, AB				Saotome, Kei; Murthy, Swetha E.; Kefauver, Jennifer M.; Whitwam, Tess; Patapoutian, Ardem; Ward, Andrew B.			Structure of the mechanically activated ion channel Piezol	NATURE			English	Article							OF-FUNCTION MUTATIONS; CRYSTAL-STRUCTURE; TOUCH SENSATION; REVEALS; PROPRIOCEPTION; ARCHITECTURE; VALIDATION; MECHANISMS; RESOLUTION; LIPIDS	Piezol and Piezo2 are mechanically activated ion channels that mediate touch perception, proprioception and vascular development. Piezo proteins are distinct from other ion channels and their structure remains poorly defined, which impedes detailed study of their gating and ion permeation properties. Here we report a high-resolution cryo-electron microscopy structure of the mouse Piezol trimer. The detergent-solubilized complex adopts a three-bladed propeller shape with a curved transmembrane region containing at least 26 transmembrane helices per protomer. The flexible propeller blades can adopt distinct conformations, and consist of a series of four-transmembrane helical bundles that we term Piezo repeats. Carboxy-terminal domains line the central ion pore, and the channel is closed by constrictions in the cytosol. A kinked helical beam and anchor domain link the Piezo repeats to the pore, and are poised to control gating allosterically. The structure provides a foundation to dissect further how Piezo channels are regulated by mechanical force.	[Saotome, Kei; Murthy, Swetha E.; Kefauver, Jennifer M.; Whitwam, Tess; Patapoutian, Ardem] Scripps Res Inst, Dept Neurosci, Howard Hughes Med Inst, La Jolla, CA 92037 USA; [Saotome, Kei; Kefauver, Jennifer M.; Ward, Andrew B.] Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA	Howard Hughes Medical Institute; Scripps Research Institute; Scripps Research Institute	Patapoutian, A (corresponding author), Scripps Res Inst, Dept Neurosci, Howard Hughes Med Inst, La Jolla, CA 92037 USA.; Ward, AB (corresponding author), Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA.	ardem@scripps.edu; andrew@scripps.edu	Ward, Andrew B/F-9203-2014; Ward, Andrew/ABD-7728-2021	Ward, Andrew B/0000-0001-7153-3769; Ward, Andrew/0000-0001-7153-3769; Murthy, Swetha/0000-0001-9580-3380; Saotome, Kei/0000-0002-4135-5356	Ray Thomas Edwards Foundation; National Institutes of Health (NIH) [NS083174, DE022358]; NIH [1-S10OD021634]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE022358] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS083174] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD021634] Funding Source: NIH RePORTER	Ray Thomas Edwards Foundation; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank H. Turner and G. Ozorowski for assistance with electron microscopy data collection. We acknowledge early efforts to characterize Piezol using electron microscopy by E. Wilson-Kubalek and R. Milligan, and S. Kakuda for screening purification conditions. We thank A. Sobolevsky for critical reading of the manuscript, and members of the Ward and Patapoutian laboratories for discussion. This work was supported by a Ray Thomas Edwards Foundation grant to A.B.W. and National Institutes of Health (NIH) grants NS083174 and DE022358 to A.P. Computational analyses were performed using shared instrumentation funded by NIH 1-S10OD021634. A.P. is an investigator of the Howard Hughes Medical Institute. This is manuscript 29582 from The Scripps Research Institute.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Albuisson J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2899; Andolfo I, 2013, BLOOD, V121, P3925, DOI 10.1182/blood-2013-02-482489; Bae C, 2013, P NATL ACAD SCI USA, V110, pE1162, DOI 10.1073/pnas.1219777110; Bartesaghi A, 2014, P NATL ACAD SCI USA, V111, P11709, DOI 10.1073/pnas.1402809111; Bavi N, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11984; Berndsen Z, 2017, BIOINFORMATICS, V33, P3824, DOI 10.1093/bioinformatics/btx500; Brohawn SG, 2014, NATURE, V516, P126, DOI 10.1038/nature14013; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chesler AT, 2016, NEW ENGL J MED, V375, P1355, DOI 10.1056/NEJMoa1602812; Coste B, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8223; Coste B, 2013, P NATL ACAD SCI USA, V110, P4667, DOI 10.1073/pnas.1221400110; Coste B, 2012, NATURE, V483, P176, DOI 10.1038/nature10812; Coste B, 2010, SCIENCE, V330, P55, DOI 10.1126/science.1193270; Cox CD, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10366; Drin G, 2010, FEBS LETT, V584, P1840, DOI 10.1016/j.febslet.2009.10.022; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ge JP, 2015, NATURE, V527, P64, DOI 10.1038/nature15247; Glogowska E, 2017, BLOOD, V130, P1845, DOI 10.1182/blood-2017-05-786004; Haliloglu G, 2017, J HUM GENET, V62, P497, DOI 10.1038/jhg.2016.153; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Kamajaya A, 2014, STRUCTURE, V22, P1520, DOI 10.1016/j.str.2014.08.009; Kawate T, 2009, NATURE, V460, P592, DOI 10.1038/nature08198; Kim SE, 2012, NATURE, V483, P209, DOI 10.1038/nature10801; Lewis AH, 2015, ELIFE, V4, DOI 10.7554/eLife.12088; Li J, 2014, NATURE, V515, P279, DOI 10.1038/nature13701; Liao MF, 2013, NATURE, V504, P107, DOI 10.1038/nature12822; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Lukacs V, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9329; Mahmud AA, 2017, CLIN GENET, V91, P470, DOI 10.1111/cge.12850; Mansoor SE, 2016, NATURE, V538, P66, DOI 10.1038/nature19367; Nonomura K, 2017, NATURE, V541, P176, DOI 10.1038/nature20793; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Phillips R, 2009, NATURE, V459, P379, DOI 10.1038/nature08147; Pliotas C, 2015, NAT STRUCT MOL BIOL, V22, P991, DOI 10.1038/nsmb.3120; Ranade SS, 2015, NEURON, V87, P1162, DOI 10.1016/j.neuron.2015.08.032; Ranade SS, 2014, NATURE, V516, P121, DOI 10.1038/nature13980; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Schrodinger L.L.C.,, 2015, PYMOL MOL GRAPHICS S; Suloway C, 2005, J STRUCT BIOL, V151, P41, DOI 10.1016/j.jsb.2005.03.010; Syeda R, 2016, CELL REP, V17, P1739, DOI 10.1016/j.celrep.2016.10.033; Unni S, 2011, J COMPUT CHEM, V32, P1488, DOI 10.1002/jcc.21720; Ursell Tristan, 2008, V1, P37, DOI 10.1007/978-1-4020-6426-5_2; Woo SH, 2015, NAT NEUROSCI, V18, P1756, DOI 10.1038/nn.4162; Wu J, 2017, TRENDS BIOCHEM SCI, V42, P57, DOI 10.1016/j.tibs.2016.09.004; Wu J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12939; Zarychanski R, 2012, BLOOD, V120, P1908, DOI 10.1182/blood-2012-04-422253; Zhang K, 2016, J STRUCT BIOL, V193, P1, DOI 10.1016/j.jsb.2015.11.003; Zhao QC, 2016, NEURON, V89, P1248, DOI 10.1016/j.neuron.2016.01.046; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193	51	229	238	18	176	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 22	2018	554	7693					481	+		10.1038/nature25453	http://dx.doi.org/10.1038/nature25453			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW8PA	29261642	Green Accepted			2022-12-28	WOS:000425597400037
J	Mills, KT; Obst, KM; Shen, W; Molina, S; Zhang, HJ; He, H; Cooper, LA; He, J				Mills, Katherine T.; Obst, Katherine M.; Shen, Wei; Molina, Sandra; Zhang, Hui-Jie; He, Hua; Cooper, Lisa A.; He, Jiang			Comparative Effectiveness of Implementation Strategies for Blood Pressure Control in Hypertensive Patients A Systematic Review and Meta-analysis	ANNALS OF INTERNAL MEDICINE			English	Review							CLUSTER-RANDOMIZED-TRIAL; TEAM-BASED CARE; VARIANCE-ESTIMATION; PHARMACIST COLLABORATION; IMPROVE HYPERTENSION; CHRONIC DISEASES; MANAGEMENT; INTERVENTIONS; ADHERENCE; PHYSICIAN	Background: The prevalence of hypertension is high and is increasing worldwide, whereas the proportion of controlled hypertension is low. Purpose: To assess the comparative effectiveness of 8 implementation strategies for blood pressure (BP) control in adults with hypertension. Data Sources: Systematic searches of MEDLINE and Embase from inception to September 2017 with no language restrictions, supplemented with manual reference searches. Study Selection: Randomized controlled trials lasting at least 6 months comparing the effect of implementation strategies versus usual care on BP reduction in adults with hypertension. Data Extraction: Two investigators independently extracted data and assessed study quality. Data Synthesis: A total of 121 comparisons from 100 articles with 55 920 hypertensive patients were included. Multilevel, multicomponent strategies were most effective for systolic BP reduction, including team-based care with medication titration by a nonphysician (-7.1 mm Hg [95% Cl, -8.9 to -5.2 mm Hg]), team-based care with medication titration by a physician (-6.2 mm Hg [Cl, -8.1 to -4.2 mm Hg]), and multilevel strategies without team-based care (-5.0 mm Hg [Cl, -8.0 to -2.0 mm Hg]). Patient-level strategies resulted in systolic BP changes of -3.9 mm Hg (Cl, -5.4 to -2.3 mm Hg) for health coaching and -2.7 mm Hg (Cl, -3.6 to -1.7 mm Hg) for home BP monitoring. Similar trends were seen for diastolic BP reduction. Limitation: Sparse data from low-and middle-income countries; few trials of some implementation strategies, such as provider training; and possible publication bias. Conclusion: Multilevel, multicomponent strategies, followed by patient-level strategies, are most effective for BP control in patients with hypertension and should be used to improve hypertension control.	[Mills, Katherine T.; Obst, Katherine M.; He, Hua; He, Jiang] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Epidemiol, 1440 Canal St,Suite 2000, New Orleans, LA 70112 USA; [Shen, Wei] Nanjing Med Univ, Sch Publ Hlth, 818 East Tianyuan Rd, Nanjing 211166, Jiangsu, Peoples R China; [Molina, Sandra] Georgia Dept Publ Hlth, 1916 Northleg Rd, Augusta, GA 30909 USA; [Zhang, Hui-Jie] Xiamen Univ, Affiliated Hosp 1, Xiamen 361003, Peoples R China; [Cooper, Lisa A.] Johns Hopkins Univ, Sch Med, Dept Med, 2024 East Monument St,Suite 2-500, Baltimore, MD 21205 USA; [Cooper, Lisa A.] Johns Hopkins Univ, Sch Med, Dept Hlth Behav & Soc, 2024 East Monument St,Suite 2-500, Baltimore, MD 21205 USA; [Cooper, Lisa A.] Bloomberg Sch Publ Hlth, 2024 East Monument St,Suite 2-500, Baltimore, MD 21205 USA; [He, Jiang] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Epidemiol, 1440 Canal St,Suite 2042, New Orleans, LA 70112 USA	Tulane University; Xiamen University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Tulane University	He, J (corresponding author), Tulane Univ, Sch Publ Hlth & Trop Med, Dept Epidemiol, 1440 Canal St,Suite 2000, New Orleans, LA 70112 USA.	jhe@tulane.edu	Zhang, Hui/HHN-8494-2022; He, Jiang/AAF-5303-2020; zhang, hui/GXH-6098-2022	He, Jiang/0000-0002-8286-9652; 	National Institute of General Medical Sciences [P20GM109036]; National Heart, Lung, and Blood Institute [U01HL114197]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL114197] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM109036] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	By award P20GM109036 from the National Institute of General Medical Sciences and award U01HL114197 from the National Heart, Lung, and Blood Institute.	Agarwal R, 2011, HYPERTENSION, V57, P29, DOI 10.1161/HYPERTENSIONAHA.110.160911; Anchala R, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.114.001213; Baik D, 2017, NURS FORUM, V52, P313, DOI 10.1111/nuf.12194; Carter BL, 2008, J CLIN HYPERTENS, V10, P260, DOI 10.1111/j.1751-7176.2008.07434.x; Carter BL, 2015, CIRC-CARDIOVASC QUAL, V8, P235, DOI 10.1161/CIRCOUTCOMES.114.001283; Carter BL, 2012, J CLIN HYPERTENS, V14, P51, DOI 10.1111/j.1751-7176.2011.00542.x; Carter BL, 2009, ARCH INTERN MED, V169, P1996, DOI 10.1001/archinternmed.2009.358; Carter BL, 2009, ARCH INTERN MED, V169, P1748, DOI 10.1001/archinternmed.2009.316; Chan WV, 2017, CIRCULATION, V135, pE122, DOI 10.1161/CIR.0000000000000481; Clark CE, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3995; Committee on Public Health Priorities to Reduce and Control Hypertension in the US Population Institute of Medicine, 2010, POP BAS POL SYST CHA; Cooper LA, 2011, J GEN INTERN MED, V26, P1297, DOI 10.1007/s11606-011-1794-6; Dehmer SP, 2016, AM J PREV MED, V50, pS34, DOI 10.1016/j.amepre.2016.01.027; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; Edelman D, 2010, ANN INTERN MED, V152, P689, DOI 10.7326/0003-4819-152-11-201006010-00001; Ettehad D, 2016, LANCET, V387, P957, DOI 10.1016/S0140-6736(15)01225-8; Fletcher RD, 2012, CIRCULATION, V125, P2462, DOI 10.1161/CIRCULATIONAHA.111.029983; Forouzanfar MH, 2017, JAMA-J AM MED ASSOC, V317, P165, DOI 10.1001/jama.2016.19043; Gay HC, 2016, HYPERTENSION, V67, P733, DOI 10.1161/HYPERTENSIONAHA.115.06853; Glynn LG, 2010, BRIT J GEN PRACT, V60, DOI 10.3399/bjgp10X544113; He J, 2016, CIRCULATION, V134, pE712; Hebert PL, 2012, J GEN INTERN MED, V27, P630, DOI 10.1007/s11606-011-1924-1; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Hunt JS, 2008, J GEN INTERN MED, V23, P1966, DOI 10.1007/s11606-008-0791-x; Jafar TH, 2009, ANN INTERN MED, V151, P593, DOI 10.7326/0003-4819-151-9-200911030-00004; Jolles EP, 2012, J HYPERTENS, V30, P1500, DOI 10.1097/HJH.0b013e32835476e1; Kivela K, 2014, PATIENT EDUC COUNS, V97, P147, DOI 10.1016/j.pec.2014.07.026; Knapp G, 2003, STAT MED, V22, P2693, DOI 10.1002/sim.1482; Kulchaitanaroaj P, 2017, J HYPERTENS, V35, P178, DOI 10.1097/HJH.0000000000001126; Margolis KL, 2013, JAMA-J AM MED ASSOC, V310, P46, DOI 10.1001/jama.2013.6549; McManus R, 2010, LANCET, V376, P163, DOI 10.1016/S0140-6736(10)60964-6; Mills KT, 2016, CIRCULATION, V134, P441, DOI 10.1161/CIRCULATIONAHA.115.018912; Mills KT, 2014, AM J MED SCI, V348, P139, DOI 10.1097/MAJ.0000000000000298; Okamoto MP, 2001, PHARMACOTHERAPY, V21, P1337, DOI 10.1592/phco.21.17.1337.34424; Omboni S, 2011, AM J HYPERTENS, V24, P989, DOI 10.1038/ajh.2011.100; Parati G, 2009, J HYPERTENS, V27, P198, DOI 10.1097/HJH.0b013e3283163caf; Pladevall M, 2010, CIRCULATION, V122, P1183, DOI 10.1161/CIRCULATIONAHA.109.892778; Rudd P, 2004, AM J HYPERTENS, V17, P921, DOI 10.1016/j.amjhyper.2004.06.006; Santschi V, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000718; Shaw KM, 2015, PREV CHRONIC DIS, V11; Sidik K, 2005, J BIOPHARM STAT, V15, P823, DOI 10.1081/BIP-200067915; Sidik K, 2005, J R STAT SOC C-APPL, V54, P367, DOI 10.1111/j.1467-9876.2005.00489.x; Sim JJ, 2014, CAN J CARDIOL, V30, P544, DOI 10.1016/j.cjca.2014.01.003; SOGHIKIAN K, 1992, MED CARE, V30, P855, DOI 10.1097/00005650-199209000-00009; Stewart K, 2014, J CLIN PHARM THER, V39, P527, DOI 10.1111/jcpt.12185; Tao D, 2015, J TELEMED TELECARE, V21, P3, DOI 10.1177/1357633X14541041; Tipton E, 2015, PSYCHOL METHODS, V20, P375, DOI 10.1037/met0000011; Tobe SW, 2016, J CLIN HYPERTENS, V18, P600, DOI 10.1111/jch.12835; Walsh JME, 2006, MED CARE, V44, P646, DOI 10.1097/01.mlr.0000220260.30768.32; Whelton PK, 2016, HYPERTENSION, V68, P1066, DOI 10.1161/HYPERTENSIONAHA.116.07905; Wolever Ruth Q, 2013, Glob Adv Health Med, V2, P38, DOI 10.7453/gahmj.2013.042	52	106	109	2	31	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 16	2018	168	2					110	+		10.7326/M17-1805	http://dx.doi.org/10.7326/M17-1805			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FU8IN	29277852	Green Accepted			2022-12-28	WOS:000424096600015
J	Kirby, T				Kirby, Tony			Profile Tony Capon: the world's first professor of planetary health	LANCET			English	Biographical-Item																		CAPON T, PUBLICATION LISTS	1	1	1	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 6	2018	391	10115					21	21		10.1016/S0140-6736(17)33251-8	http://dx.doi.org/10.1016/S0140-6736(17)33251-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FR9ZB	29246643				2022-12-28	WOS:000419432300014
J	Brown, ECF; Sarpatwari, A				Brown, Erin C. Fuse; Sarpatwari, Ameet			Removing ERISA's Impediment to State Health Reform	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Brown, Erin C. Fuse] Georgia State Univ, Coll Law, Atlanta, GA 30303 USA; [Sarpatwari, Ameet] Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, Program Regulat Therapeut & Law, 75 Francis St, Boston, MA 02115 USA; [Sarpatwari, Ameet] Harvard Med Sch, Boston, MA USA	University System of Georgia; Georgia State University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Brown, ECF (corresponding author), Georgia State Univ, Coll Law, Atlanta, GA 30303 USA.			Fuse Brown, Erin/0000-0002-6821-5345				Cooper Z, 2016, NEW ENGL J MED, V375, P1915, DOI 10.1056/NEJMp1608571; Kaiser Family Foundation, 2016, 2016 EMPL HLTH BEN S; Kim K., 2017, THESIS U MASSACHUSET; Kyanko KA, 2013, HEALTH SERV RES, V48, P1154, DOI 10.1111/1475-6773.12007; Osborn R, 2016, HEALTH AFFAIR, V35, P2327, DOI 10.1377/hlthaff.2016.1088	5	7	7	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 4	2018	378	1					5	7		10.1056/NEJMp1709167	http://dx.doi.org/10.1056/NEJMp1709167			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FR7BE	29298152				2022-12-28	WOS:000419220500011
J	Mansbridge, CT; Inada-Kim, M				Mansbridge, Christopher T.; Inada-Kim, Matthew			Pneumomediastinum Associated with Influenza A Infection	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Mansbridge, Christopher T.; Inada-Kim, Matthew] Hampshire Hosp NHS Fdn Trust, Winchester, Hants, England		Mansbridge, CT (corresponding author), Hampshire Hosp NHS Fdn Trust, Winchester, Hants, England.	cmansbridge@doctors.org.uk		inada-kim, matthew/0000-0001-6026-2246					0	3	4	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 4	2018	378	1								10.1056/NEJMicm1702849	http://dx.doi.org/10.1056/NEJMicm1702849			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FR7BE	29298153				2022-12-28	WOS:000419220500001
J	Brasure, M; Desai, P; Davila, H; Nelson, VA; Calvert, C; Jutkowitz, E; Butler, M; Fink, HA; Ratner, E; Hemmy, LS; McCarten, JR; Barclay, TR; Kane, RL				Brasure, Michelle; Desai, Priyanka; Davila, Heather; Nelson, Victoria A.; Calvert, Collin; Jutkowitz, Eric; Butler, Mary; Fink, Howard A.; Ratner, Edward; Hemmy, Laura S.; McCarten, J. Riley; Barclay, Terry R.; Kane, Robert L.			Physical Activity Interventions in Preventing Cognitive Decline and Alzheimer-Type Dementia A Systematic Review	ANNALS OF INTERNAL MEDICINE			English	Review							OLDER-ADULTS; PROTEIN SUPPLEMENTATION; RANDOMIZED-TRIAL; DOUBLE-BLIND; EXERCISE; MEMORY; DISEASE; RISK; PERFORMANCE; PREVALENCE	Background: The prevalence of cognitive impairment and dementia is expected to increase dramatically as the population ages, creating burdens on families and health care systems. Purpose: To assess the effectiveness of physical activity interventions in slowing cognitive decline and delaying the onset of cognitive impairment and dementia in adults without diagnosed cognitive impairments. Data Sources: Several electronic databases from January 2009 to July 2017 and bibliographies of systematic reviews. Study Selection: Trials published in English that lasted 6 months or longer, enrolled adults without clinically diagnosed cognitive impairments, and compared cognitive and dementia outcomes between physical activity interventions and inactive controls. Data Extraction: Extraction by 1 reviewer and confirmed by a second; dual-reviewer assessment of risk of bias; consensus determination of strength of evidence. Data Synthesis: Of 32 eligible trials, 16 with low to moderate risk of bias compared a physical activity intervention with an inactive control. Most trials had 6-month follow-up; a few had 1-or 2-year follow-up. Evidence was insufficient to draw conclusions about the effectiveness of aerobic training, resistance training, or tai chi for improving cognition. Low-strength evidence showed that multicomponent physical activity interventions had no effect on cognitive function. Low-strength evidence showed that a multidomain intervention comprising physical activity, diet, and cognitive training improved several cognitive outcomes. Evidence regarding effects on dementia prevention was insufficient for all physical activity interventions. Limitation: Heterogeneous interventions and cognitive test measures, small and underpowered studies, and inability to assess the clinical significance of cognitive test outcomes. Conclusion: Evidence that short-term, single-component physical activity interventions promote cognitive function and prevent cognitive decline or dementia in older adults is largely insufficient. A multidomain intervention showed a delay in cognitive decline (low-strength evidence).	[Brasure, Michelle; Desai, Priyanka; Davila, Heather; Nelson, Victoria A.; Butler, Mary] Univ Minnesota, Div Hlth Policy & Management, 420 Delaware St Southeast,Mayo Mem Bldg D351, Minneapolis, MN 55455 USA; [Calvert, Collin] Univ Minnesota, Div Epidemiol, 1300 South 2nd St,Room 300 West Bank Off Bldg, Minneapolis, MN 55455 USA; [Jutkowitz, Eric] Brown Univ, Sch Publ Hlth, Box G S121-6,121 South Main St,6th Floor, Providence, RI 02912 USA; Minneapolis VA Hlth Care Syst, Minneapolis, MN USA; HealthPartners, Minneapolis, MN USA; [Fink, Howard A.; Ratner, Edward; Hemmy, Laura S.; McCarten, J. Riley] VA Hlth Care Syst, Geriatr Res Educ & Clin Ctr, One Vet Dr,11-G, Minneapolis, MN 55417 USA; [Barclay, Terry R.] Univ Minnesota, Dept Neurol, 295 Phalen Blvd,Mailstop 41203C, St Paul, MN 55130 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Brown University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System; Geriatric Research Education & Clinical Center; University of Minnesota System; University of Minnesota Twin Cities	Brasure, M (corresponding author), Univ Minnesota, Div Hlth Policy & Management, 420 Delaware St Southeast,Mayo Mem Bldg D351, Minneapolis, MN 55455 USA.	brasu001@umn.edu		, Collin/0000-0003-1834-5245; Davila, Heather/0000-0003-1832-7901	Agency for Healthcare Research and Quality [290-2015-00008-I]	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	This manuscript is based on research conducted by the Minnesota Evidence-based Practice Center under AHRQ contract 290-2015-00008-I.	Andrieu S, 2017, LANCET NEUROL, V16, P377, DOI 10.1016/S1474-4422(17)30040-6; Angevaren M, 2008, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD005381.pub3, 10.1002/14651858.CD005381.pub2]; Antunes HK, 2015, BRAZ J MED BIOL RES, V48, P805, DOI 10.1590/1414-431X20154529; Beckett MW, 2015, BMC GERIATR, V15, DOI 10.1186/s12877-015-0007-2; Bellou V, 2017, ALZHEIMERS DEMENT, V13, P406, DOI 10.1016/j.jalz.2016.07.152; Berkman ND, 2015, J CLIN EPIDEMIOL, V68, P1312, DOI 10.1016/j.jclinepi.2014.11.023; Beydoun MA, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-643; Blondell SJ, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-510; Bun S, 2015, J ALZHEIMERS DIS, V45, P15, DOI 10.3233/JAD-142232; Carlson MC, 2008, GERONTOLOGIST, V48, P793, DOI 10.1093/geront/48.6.793; Cassilhas RC, 2007, MED SCI SPORT EXER, V39, P1401, DOI 10.1249/mss.0b013e318060111f; Evers A, 2011, AGING MENT HEALTH, V15, P446, DOI 10.1080/13607863.2010.543657; Evidence-based Practice Center Systematic Review Protocol, 2015, INT PREV COGN DECL M; Hamer M, 2009, PSYCHOL MED, V39, P3, DOI 10.1017/S0033291708003681; Hars M, 2014, AGE AGEING, V43, P196, DOI 10.1093/ageing/aft163; Hotting K, 2012, HEALTH PSYCHOL, V31, P145, DOI 10.1037/a0025371; Kane R. L., 2017, COMP EFFECTIVENESS R, V188, P86; Kelley AS, 2015, ANN INTERN MED, V163, P729, DOI 10.7326/M15-0381; Klusmann V, 2010, J GERONTOL A-BIOL, V65, P680, DOI 10.1093/gerona/glq053; Komulainen P, 2010, EUR GERIATR MED, V1, P266, DOI 10.1016/j.eurger.2010.08.001; Lachman ME, 2006, J AGING PHYS ACTIV, V14, P59, DOI 10.1123/japa.14.1.59; Langa KM, 2017, JAMA INTERN MED, V177, P51, DOI 10.1001/jamainternmed.2016.6807; Lautenschlager NT, 2008, JAMA-J AM MED ASSOC, V300, P1027, DOI 10.1001/jama.300.9.1027; Lehtisalo J, 2016, J NUTR HEALTH AGING, V20, P146, DOI 10.1007/s12603-015-0565-1; Liu-Ambrose T, 2008, J AM GERIATR SOC, V56, P1821, DOI [10.1111/j.1532-5415.2008.01931.x, 10.1111/j.1532-5415.2008.01984.x]; Nguyen MH, 2012, CLIN INTERV AGING, V7, P185, DOI 10.2147/CIA.S32600; Martin CK, 2007, REJUV RES, V10, P179, DOI 10.1089/rej.2006.0502; Mortimer JA, 2012, J ALZHEIMERS DIS, V30, P757, DOI 10.3233/JAD-2012-120079; Muscari A, 2010, INT J GERIATR PSYCH, V25, P1055, DOI 10.1002/gps.2462; Napoli N, 2014, AM J CLIN NUTR, V100, P189, DOI 10.3945/ajcn.113.082883; Ngandu T, 2015, LANCET, V385, P2255, DOI 10.1016/S0140-6736(15)60461-5; Oken BS, 2006, ALTERN THER HEALTH M, V12, P40; Okumiya K, 1996, J AM GERIATR SOC, V44, P569, DOI 10.1111/j.1532-5415.1996.tb01444.x; Oswald Wolf D, 2006, Eur J Ageing, V3, P179, DOI 10.1007/s10433-006-0035-z; Plassman BL, 2008, ANN INTERN MED, V148, P427, DOI 10.7326/0003-4819-148-6-200803180-00005; Prince M, 2016, ALZHEIMERS RES THER, V8, DOI 10.1186/s13195-016-0188-8; Prince M, 2013, ALZHEIMERS DEMENT, V9, P63, DOI 10.1016/j.jalz.2012.11.007; Rosano C, 2010, J GERONTOL A-BIOL, V65, P639, DOI 10.1093/gerona/glq038; Ruscheweyh R, 2011, NEUROBIOL AGING, V32, P1304, DOI 10.1016/j.neurobiolaging.2009.08.001; Satizabal CL, 2016, NEW ENGL J MED, V374, P523, DOI 10.1056/NEJMoa1504327; Satoh M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095230; Sink KM, 2015, JAMA-J AM MED ASSOC, V314, P781, DOI 10.1001/jama.2015.9617; Smith PJ, 2010, PSYCHOSOM MED, V72, P239, DOI 10.1097/PSY.0b013e3181d14633; Taylor-Piliae RE, 2010, J AGING PHYS ACTIV, V18, P261, DOI 10.1123/japa.18.3.261; Tesky VA, 2011, GEROPSYCH, V24, P83, DOI 10.1024/1662-9647/a000035; Tieland M, 2012, J AM MED DIR ASSOC, V13, P713, DOI 10.1016/j.jamda.2012.05.020; Tieland M, 2012, EUR J NUTR, V51, P173, DOI 10.1007/s00394-011-0203-6; van de Rest O, 2014, MECH AGEING DEV, V136, P85, DOI 10.1016/j.mad.2013.12.005; Viswanathan M., 2012, ASSESS RISK BIAS IND; Williams J. W., 2010, 2902007100661 HHSA A; Williams John W, 2010, Evid Rep Technol Assess (Full Rep), P1; Williams P, 1997, AUST NZ J PUBL HEAL, V21, P45, DOI 10.1111/j.1467-842X.1997.tb01653.x; Williamson JD, 2009, J GERONTOL A-BIOL, V64, P688, DOI 10.1093/gerona/glp014	53	153	156	7	172	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 2	2018	168	1					30	+		10.7326/M17-1528	http://dx.doi.org/10.7326/M17-1528			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FR5SO	29255839				2022-12-28	WOS:000419126700005
J	Fuchs, VR				Fuchs, Victor R.			Is Single Payer the Answer for the US Health Care System?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							UNITED-STATES		[Fuchs, Victor R.] Stanford Univ, Stanford, CA 94305 USA	Stanford University	Fuchs, VR (corresponding author), Stanford Univ, Stanford Inst Econ Policy Res, 366 Galvez, Stanford, CA 94305 USA.	vfuchs@stanford.edu						Bradley E., 2013, AM HLTH CARE PARADOX; Bundorf MK, FORUM HLTH EC POLICY, V10; Chetty R, 2016, JAMA-J AM MED ASSOC, V315, P1750, DOI 10.1001/jama.2016.4226; Emanuel EJ, 2007, COMPREHENSIVE CURE U; Fuchs VR, 2013, JAMA-J AM MED ASSOC, V309, P33, DOI 10.1001/jama.2012.125458; Himmelstein DU, 2014, HEALTH AFFAIR, V33, P1586, DOI 10.1377/hlthaff.2013.1327; Obama B, 2016, JAMA-J AM MED ASSOC, V316, P525, DOI 10.1001/jama.2016.9797	7	11	12	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 2	2018	319	1					15	16		10.1001/jama.2017.18739	http://dx.doi.org/10.1001/jama.2017.18739			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FR5ON	29255843				2022-12-28	WOS:000419116000007
J	Woodcock, J; Dohm, J				Woodcock, Janet; Dohm, Julie			Toward Better-Quality Compounded Drugs - An Update from the FDA	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Woodcock, Janet; Dohm, Julie] US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD 20993 USA	US Food & Drug Administration (FDA)	Woodcock, J (corresponding author), US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD 20993 USA.							[Anonymous], 2017, FDA AL HLTH CAR PROF; [Anonymous], 2016, INS COND COMP FAC GU; FDA, 2017, FDA INV 2 SER ADV EV	3	5	5	1	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 28	2017	377	26					2509	2512		10.1056/NEJMp1712905	http://dx.doi.org/10.1056/NEJMp1712905			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FR0TX	29281577	Bronze			2022-12-28	WOS:000418777700001
J	Kuehn, B				Kuehn, Bridget			Opioid Emergency Declared	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	4	4	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 26	2017	318	24					2418	2418		10.1001/jama.2017.19014	http://dx.doi.org/10.1001/jama.2017.19014			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FQ9ZO	29279911				2022-12-28	WOS:000418720700003
J	Pieramici, DJ				Pieramici, Dante J.			Sports-Related Eye Injuries	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PROTECTIVE EYEWEAR; EPIDEMIOLOGY	IMPORTANCE Ocular trauma can lead to lifelong sequelae, and sports-related ocular injuries have been shown to disproportionately affect the young. Studies quantifying and characterizing the incidence and type of injuries seen with sports-related ocular trauma may be useful for resource utilization, training, and prevention efforts. OBJECTIVE To examine the emergency department (ED) burden of sports-related ocular trauma in the United States. DESIGN, SETTING, AND PARTICIPANTS This retrospective, cross-sectional study examined the Nationwide Emergency Department Sample, containing data from approximately 30 million ED visits annually at more than 900 hospitals nationwide, from January 1, 2010, to December 31, 2013, to determine factors associated with sports-related ocular trauma. MAIN OUTCOMES AND MEASURES Annual incidence of sports-related ocular trauma, broken down by age, sex, mechanism of injury, and related activity, as well as factors associated with short-term impaired vision. RESULTS During the study period, 120 847 individuals (mean age, 22.3 years [95% CI, 21.9-22.7]; 96 872 males, 23 963 females, and 12 with missing data) presented with sports-related ocular trauma, which was the primary diagnosis in 85 961 patients. Injuries occurred most commonly among males (69 849 [81.3%]; 95% CI, 80.6%-81.9%) and occurred most frequently as a result of playing basketball (22.6%; 95% CI, 21.7%-23.6%), playing baseball or softball (14.3%; 95% CI, 13.7%-14.9%), and shooting an air gun (11.8%; 95% CI, 10.8%-12.8%). Odds of presentation to the ED with impaired vision were greatest for paintball and air gun injuries relative to football-related injuries (odds ratio, 4.75; 95% CI, 2.21-10.19 and 3.71; 95% CI, 2.34-5.88, respectively; P < .001). CONCLUSIONS AND RELEVANCE In our study, approximately 30 000 individuals presented annually to EDs in the United States with sports-related eye injuries; in more than 70% of these cases, eye injuries were the primary diagnosis. Activities involving projectiles pose the greatest risk for visual impairment in the short term, although long-term outcomes were unavailable.	[Pieramici, Dante J.] Calif Retina Res Fdn, 525 E Micheltorena St, Santa Barbara, CA 93103 USA; [Pieramici, Dante J.] Calif Retina Consultants, Santa Barbara, CA USA		Pieramici, DJ (corresponding author), Calif Retina Res Fdn, 525 E Micheltorena St, Santa Barbara, CA 93103 USA.	dpieramici@yahoo.com						Channa R, 2016, JAMA OPHTHALMOL, V134, P312, DOI 10.1001/jamaophthalmol.2015.5778; Haring RS, 2016, JAMA OPHTHALMOL, V134, P1382, DOI 10.1001/jamaophthalmol.2016.4253; Kriz PK, 2015, PEDIATRICS, V136, P521, DOI 10.1542/peds.2015-0216; Kriz PK, 2012, PEDIATRICS, V130, P1069, DOI 10.1542/peds.2012-1492; Kuhn F, 2006, OPHTHAL EPIDEMIOL, V13, P209, DOI 10.1080/09286580600665886; Lincoln AE, 2012, AM J SPORT MED, V40, P611, DOI 10.1177/0363546511428873; McGwin G, 2005, ARCH OPHTHALMOL-CHIC, V123, P970, DOI 10.1001/archopht.123.7.970; Micieli JA, 2014, CAN J OPHTHALMOL, V49, P243, DOI 10.1016/j.jcjo.2014.03.008; Vinger PF, 2004, BRIT J OPHTHALMOL, V88, P167, DOI 10.1136/bjo.2003.026229	9	3	4	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 26	2017	318	24					2483	2484		10.1001/jama.2017.17560	http://dx.doi.org/10.1001/jama.2017.17560			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FQ9ZO	29279910				2022-12-28	WOS:000418720700025
J	Slomski, A				Slomski, Anita			Prochlorperazine Superior to Hydromorphone for Migraine	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 26	2017	318	24					2419	2419		10.1001/jama.2017.19989	http://dx.doi.org/10.1001/jama.2017.19989			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FQ9ZO	29279930				2022-12-28	WOS:000418720700010
J	Liberal, I; Engheta, N				Liberal, Inigo; Engheta, Nader			The rise of near-zero-index technologies	SCIENCE			English	Editorial Material							OXIDE		[Liberal, Inigo] Univ Publ Navarra, Dept Elect & Elect Engn, Pamplona 31006, Spain; [Engheta, Nader] Univ Penn, Dept Elect & Syst Engn, Philadelphia, PA 19104 USA	Universidad Publica de Navarra; University of Pennsylvania	Engheta, N (corresponding author), Univ Penn, Dept Elect & Syst Engn, Philadelphia, PA 19104 USA.	engheta@ee.upenn.edu			Vannevar Bush Faculty Fellowship award, Office of Naval Research grant [N00014-16-1-2029]; U.S. Air Force Office of Scientific Research Multidisciplinary University Research Initiatives grants [FA9550-14-1-0389, FA9550-17-1-0002]; Juan de la Cierva-Incorporacion Fellowship	Vannevar Bush Faculty Fellowship award, Office of Naval Research grant; U.S. Air Force Office of Scientific Research Multidisciplinary University Research Initiatives grants; Juan de la Cierva-Incorporacion Fellowship	This work is supported in part by the Vannevar Bush Faculty Fellowship award, Office of Naval Research grant N00014-16-1-2029, and the U.S. Air Force Office of Scientific Research Multidisciplinary University Research Initiatives grants FA9550-14-1-0389 and FA9550-17-1-0002. I.L. acknowledges support from a Juan de la Cierva-Incorporacion Fellowship.	Alam MZ, 2016, SCIENCE, V352, P795, DOI 10.1126/science.aae0330; Caspani L, 2016, PHYS REV LETT, V116, DOI 10.1103/PhysRevLett.116.233901; Huang YW, 2016, NANO LETT, V16, P5319, DOI 10.1021/acs.nanolett.6b00555; Kinsey N, 2015, OPTICA, V2, P616, DOI 10.1364/OPTICA.2.000616; Li Y, 2015, NAT PHOTONICS, V9, P738, DOI [10.1038/nphoton.2015.198, 10.1038/NPHOTON.2015.198]; Liberal I, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10989; Liberal I, 2017, SCIENCE, V355, DOI 10.1126/science.aal2672; Liberal I, 2017, NAT PHOTONICS, V11, P149, DOI [10.1038/NPHOTON.2017.13, 10.1038/nphoton.2017.13]; Liberal I, 2017, P NATL ACAD SCI USA, V114, P822, DOI 10.1073/pnas.1611924114; Monticone F, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.213903; Prain A, 2017, PHYS REV LETT, V118, DOI 10.1103/PhysRevLett.118.133904; Silveirinha M, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.157403; Silveirinha MG, 2014, PHYS REV A, V89, DOI 10.1103/PhysRevA.89.023813; Ziolkowski RW, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.046608	14	59	61	6	71	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 22	2017	358	6370					1540	1541		10.1126/science.aaq0459	http://dx.doi.org/10.1126/science.aaq0459			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FQ6BO	29269463				2022-12-28	WOS:000418448000037
J	Blank, R; Daniels, RJ; Gilliland, G; Gutmann, A; Hawgood, S; Hrabowski, FA; Pollack, ME; Price, V; Reif, LR; Schlissel, MS				Blank, Rebecca; Daniels, Ronald J.; Gilliland, Gary; Gutmann, Amy; Hawgood, Samuel; Hrabowski, Freeman A.; Pollack, Martha E.; Price, Vincent; Reif, L. Rafael; Schlissel, Mark S.			A new data effort to inform career choices in biomedicine	SCIENCE			English	Editorial Material									[Blank, Rebecca] Univ Wisconsin, Madison, WI 53706 USA; [Daniels, Ronald J.] Johns Hopkins Univ, Baltimore, MD 21218 USA; [Gilliland, Gary] Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA; [Gutmann, Amy] Univ Penn, Philadelphia, PA 19104 USA; [Hawgood, Samuel] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Hrabowski, Freeman A.] Univ Maryland Baltimore Cty, Baltimore, MD 21250 USA; [Pollack, Martha E.] Cornell Univ, Ithaca, NY 14850 USA; [Price, Vincent] Duke Univ, Durham, NC 27708 USA; [Reif, L. Rafael] MIT, Cambridge, MA 02139 USA; [Schlissel, Mark S.] Univ Michigan, Ann Arbor, MI 48109 USA	University of Wisconsin System; University of Wisconsin Madison; Johns Hopkins University; Fred Hutchinson Cancer Center; University of Pennsylvania; University of California System; University of California San Francisco; University System of Maryland; University of Maryland Baltimore County; Cornell University; Duke University; Massachusetts Institute of Technology (MIT); University of Michigan System; University of Michigan	Daniels, RJ (corresponding author), Johns Hopkins Univ, Baltimore, MD 21218 USA.	rdaniels@jhu.edu						Alberts B, 2014, P NATL ACAD SCI USA, V111, P5773, DOI 10.1073/pnas.1404402111; Council NR, 2011, DATA BASED ASSESSMEN; Daniels RJ, 2015, P NATL ACAD SCI USA, V112, P313, DOI 10.1073/pnas.1418761112; Federation of American Societies for Experimental Biology, 2015, SUST DISC BIOL MED S; Flaherty Colleen, 2017, INSIDE HIGHER ED; Kahn S, 2017, NAT BIOTECHNOL, V35, P90, DOI 10.1038/nbt.3766; National Academy of Sciences and National Academy of Engineering and Institute of Medicine, 2014, POSTD EXP REV; National Academy of Sciences National Academy of Engineering Institute of Medicine, 1995, RESH GRAD ED SCI ENG; National Institutes of Health, 2012, BIOM WORKF WORK GROU; National Research Council, 2005, BRIDG IND FOST IND N; Royal Society, 2010, SCI CENT SEC OUR FUT; Sauermann H, 2016, SCIENCE, V352, P663, DOI 10.1126/science.aaf2061; Sauermann H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036307; The Royal Society, 2014, DOCT STUD CAR EXP PR	14	26	26	2	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 15	2017	358	6369					1388	1389		10.1126/science.aar4638	http://dx.doi.org/10.1126/science.aar4638			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FP8TH	29242335				2022-12-28	WOS:000417918500023
J	Sadelain, M				Sadelain, Michael			CD19 CAR T Cells	CELL			English	Editorial Material									[Sadelain, Michael] Mem Sloan Kettering Canc Ctr, Ctr Cell Engn, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center	Sadelain, M (corresponding author), Mem Sloan Kettering Canc Ctr, Ctr Cell Engn, New York, NY 10065 USA.	m-sadelain@ski.mskcc.org							0	64	65	0	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 14	2017	171	7					1471	1471		10.1016/j.cell.2017.12.002	http://dx.doi.org/10.1016/j.cell.2017.12.002			1	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FQ0KF	29245005	Bronze			2022-12-28	WOS:000418044000002
J	Aronson, JK				Aronson, Jeffrey K.			Non-existent authors	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Aronson, Jeffrey K.] Nuffield Dept Primary Care Hlth Sci, Ctr Evidence Based Med, Oxford, England	University of Oxford	Aronson, JK (corresponding author), Nuffield Dept Primary Care Hlth Sci, Ctr Evidence Based Med, Oxford, England.	jeffrey.aronson@phc.ox.ac.uk						Aczel AD, 2006, ARTIST MATHEMATICIAN; [Anonymous], 1908, BIOMETRIKA, V6, P1; Aronson JK, 2017, PARODIES RESISTENTIA; Bohannon J, 2016, SCIENCE, V351, P902, DOI 10.1126/science.351.6276.902; Chen M, 2000, BRIT MED J, V321, P1565, DOI 10.1136/bmj.321.7276.1565; Flanagin A, 1998, JAMA-J AM MED ASSOC, V280, P222, DOI 10.1001/jama.280.3.222; Gilbert N, 2009, NATURE, V15; International committee of Medical Journal Editors, DEF ROL AUTH CONTR; MATZINGER P, 1978, J EXP MED, V148, P84, DOI 10.1084/jem.148.1.84; Retraction Watch, SERB SOK AUTH SPOOF; Retraction Watch, ARCH JES ANG LEM CAT; da Silva JAT, 2017, SCI ENG ETHICS, V23, P1807, DOI 10.1007/s11948-016-9825-7; Vezyraki A, 2013, BIOCH BIOPHYS RES CO; Yong A., 2014, NOT AM MATH SOC, V61, P1040, DOI DOI 10.1090/N0TI1164	14	0	0	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 13	2017	359								j5706	10.1136/bmj.j5706	http://dx.doi.org/10.1136/bmj.j5706			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FQ4KY	29237602				2022-12-28	WOS:000418327500012
J	Massari, F; Di Nunno, V				Massari, Francesco; Di Nunno, Vincenzo			Atezolizumab for platinum-treated metastatic urothelial carcinoma	LANCET			English	Editorial Material							PEMBROLIZUMAB		[Massari, Francesco; Di Nunno, Vincenzo] St Orsola Marcello Malpighi Hosp, Div Oncol, I-40138 Bologna, Italy	IRCCS Azienda Ospedaliero-Universitaria di Bologna	Massari, F (corresponding author), St Orsola Marcello Malpighi Hosp, Div Oncol, I-40138 Bologna, Italy.	fmassari79@gmail.com	Massari, Francesco/K-7239-2016; Di Nunno, Vincenzo/Q-8253-2018; DI NUNNO, VINCENZO/AAW-4446-2021	Massari, Francesco/0000-0001-6476-6871; DI NUNNO, VINCENZO/0000-0003-4441-9834				Balar AV, 2017, LANCET ONCOL, V18, P1483, DOI 10.1016/S1470-2045(17)30616-2; Balar AV, 2017, LANCET, V389, P67, DOI 10.1016/S0140-6736(16)32455-2; Bellmunt J, 2017, NEW ENGL J MED, V376, P1015, DOI 10.1056/NEJMoa1613683; Bellmunt J, 2013, ANN ONCOL, V24, P1466, DOI 10.1093/annonc/mdt007; Chen DS, 2017, NATURE, V541, P321, DOI 10.1038/nature21349; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Manson G, 2016, ANN ONCOL, V27, P1199, DOI 10.1093/annonc/mdw181; Plimack ER, 2017, LANCET ONCOL, V18, P212, DOI 10.1016/S1470-2045(17)30007-4; Powles T, 2017, LANCET; Powles T, 2017, EUR UROL, V72, P477, DOI 10.1016/j.eururo.2017.03.047; Rijnders M, 2017, EUR UROL, V72, P411, DOI 10.1016/j.eururo.2017.06.012; Rosenberg JE, 2016, LANCET, V387, P1909, DOI 10.1016/S0140-6736(16)00561-4; Smyth MJ, 2016, NAT REV CLIN ONCOL, V13, P143, DOI 10.1038/nrclinonc.2015.209	13	11	11	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 24	2018	391	10122					716	718		10.1016/S0140-6736(17)33298-1	http://dx.doi.org/10.1016/S0140-6736(17)33298-1			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FX4ND	29268949				2022-12-28	WOS:000426054000005
J	Wang, M; Rule, S; Zinzani, PL; Goy, A; Casasnovas, O; Smith, SD; Damaj, G; Doorduijn, J; Lamy, T; Morschhauser, F; Panizo, C; Shah, B; Davies, A; Eek, R; Dupuis, J; Jacobsen, E; Kater, AP; Le Gouill, S; Oberic, L; Robak, T; Covey, T; Dua, R; Hamdy, A; Huang, X; Izumi, R; Patel, P; Rothbaum, W; Slatter, JG; Jurczak, W				Wang, Michael; Rule, Simon; Zinzani, Pier Luigi; Goy, Andre; Casasnovas, Olivier; Smith, Stephen D.; Damaj, Gandhi; Doorduijn, Jeanette; Lamy, Thierry; Morschhauser, Franck; Panizo, Carlos; Shah, Bijal; Davies, Andrew; Eek, Richard; Dupuis, Jehan; Jacobsen, Eric; Kater, Arnon P.; Le Gouill, Steven; Oberic, Lucie; Robak, Taduesz; Covey, Todd; Dua, Richa; Hamdy, Ahmed; Huang, Xin; Izumi, Raquel; Patel, Priti; Rothbaum, Wayne; Slatter, J. Greg; Jurczak, Wojciech			Acalabrutinib in relapsed or refractory mantle cell lymphoma (ACE-LY-004): a single-arm, multicentre, phase 2 trial	LANCET			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; BRUTON TYROSINE KINASE; X-LINKED AGAMMAGLOBULINEMIA; IN-VIVO; BTK INHIBITOR; IBRUTINIB; RECEPTOR; ACP-196; SELECTIVITY; CLL	Background Bruton tyrosine kinase is a clinically validated target in mantle cell lymphoma. Acalabrutinib (ACP-196) is a highly selective, potent Bruton tyrosine kinase inhibitor developed to minimise off-target activity. Methods In this open-label, phase 2 study, oral acalabrutinib (100 mg twice per day) was given to patients with relapsed or refractory mantle cell lymphoma, until disease progression or unacceptable toxicity. The primary endpoint was overall response assessed according to the Lugano classification, and safety analyses were done in all participants. This trial is registered with ClinicalTrials.gov, number NCT02213926. Findings From March 12, 2015, to Jan 5, 2016, 124 patients with relapsed or refractory mantle cell lymphoma were enrolled and all patients received treatment; median age 68 years. Patients received a median of two (IQR 1-2) previous therapies. At a median follow-up of 15.2 months, 100 (81%)patients achieved an overall response and 49 (40%) patients achieved a complete response. The Kaplan-Meier estimated medians for duration of response, progression-free survival, and overall survival were not reached; the 12-month rates were 72% (95% CI 62-80), 67% (58-75), and 87% (79-92%), respectively. The most common adverse events were primarily grade 1 or 2 and were headache (47 [38%]), diarrhoea (38 [31%]), fatigue (34 [27%]), and myalgia (26 [21%]). The most common grade 3 or worse adverse events were neutropenia (13 [10%]), anaemia (11 [9%]), and pneumonia (six [5%]). There were no cases of atrial fibrillation and one case of grade 3 or worse haemorrhage. The median duration of treatment was 13.8 months. Treatment was discontinued in 54 (44%) patients, primarily due to progressive disease (39 [31%]) and adverse events (seven [6%]). Interpretation Acalabrutinib treatment provided a high rate of durable responses and a favourable safety profile in patients with relapsed or refractory mantle cell lymphoma. These findings suggest an important role for acalabrutinib in the treatment of this disease population.	[Wang, Michael] Univ Texas MD Anderson Canc Ctr, Dept Lymphoma & Myeloma, Houston, TX 77030 USA; [Wang, Michael] Univ Texas MD Anderson Canc Ctr, Dept Stem Cell Transplantat & Cellular Therapy, Houston, TX 77030 USA; [Rule, Simon] Plymouth Univ, Med Sch, Plymouth, Devon, England; [Zinzani, Pier Luigi] Univ Bologna, Inst Hematol Seragnoli, Bologna, Italy; [Goy, Andre] Hackensack Univ, Med Ctr, John Theurer Canc Ctr, Hackensack, NJ USA; [Casasnovas, Olivier] CHU Dijon, Dept Hematol, INSERM, UMR 1231, Dijon, France; [Smith, Stephen D.] Univ Washington, Fred Hutchinson Canc Res Ctr, Seattle, WA 98195 USA; [Damaj, Gandhi] Inst Hematol Basse Normandie, Caen, France; [Doorduijn, Jeanette] Erasmus MC, Rotterdam, Netherlands; [Doorduijn, Jeanette; Kater, Arnon P.] HOVON Lunenburg Lymphoma Phase I II Consortium, Amsterdam, Netherlands; [Lamy, Thierry] CHU Rennes, Rennes, France; [Morschhauser, Franck] Univ Lille, CHU Lille, EA 7365, Grp Rech Formes Injectables & Technol Associees, Lille, France; [Panizo, Carlos] Clin Univ Navarra, Pamplona, Spain; [Shah, Bijal] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA; [Davies, Andrew] Univ Southampton, Canc Sci Unit, Canc Res UK Ctr, Southampton, Hants, England; [Davies, Andrew] Southampton Gen Hosp, Fac Med, Southampton, Hants, England; [Eek, Richard] Border Med Oncol, Wodonga, Vic, Australia; [Dupuis, Jehan] Hop Henri Mondor, AP HP, Unite Hemopathies Lymphoides, Creteil, France; [Jacobsen, Eric] Dana Farber Canc Inst, Boston, MA 02115 USA; [Jacobsen, Eric] Harvard Med Sch, Boston, MA USA; [Kater, Arnon P.] Acad Med Ctr, Amsterdam, Netherlands; [Le Gouill, Steven] Hop Hotel Dieu, CHU Nantes, Nantes, France; [Le Gouill, Steven] INSERM, UMR 892, Team 10, Nantes, France; [Oberic, Lucie] Oncopole Toulouse, Inst Univ Canc, Toulouse, France; [Robak, Taduesz] Med Univ Lodz, Copernicus Mem Hosp, Lodz, Poland; [Covey, Todd; Dua, Richa; Hamdy, Ahmed; Huang, Xin; Izumi, Raquel; Patel, Priti; Rothbaum, Wayne; Slatter, J. Greg] Acerta Pharma, Redwood City, CA USA; [Jurczak, Wojciech] Jagiellonian Univ, Dept Hematol, Krakow, Poland	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Plymouth; University of Bologna; Hackensack University Medical Center; CHU Dijon Bourgogne; Institut Agro; AgroSup Dijon; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; Erasmus University Rotterdam; Erasmus MC; CHU Rennes; Universite de Lille - ISITE; CHU Lille; Universite de Lille; University of Navarra; H Lee Moffitt Cancer Center & Research Institute; Cancer Research UK; University of Southampton; University of Southampton; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; University of Amsterdam; Academic Medical Center Amsterdam; Nantes Universite; CHU de Nantes; Institut National de la Sante et de la Recherche Medicale (Inserm); Medical University Lodz; Jagiellonian University; Collegium Medicum Jagiellonian University	Wang, M (corresponding author), Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA.	miwang@mdanderson.org	Jurczak, Wojciech/AAV-7973-2020; Goy, Andre/AHC-0473-2022; Robak, Tadeusz/ABA-5496-2020; Jurczak, Wojciech/M-1625-2019; Jurczak, Wojciech/ABB-2136-2020; Goy, Andre/AAS-4464-2020; Robak, Tadeusz/AAW-7365-2021; Jurczak, Wojciech/L-7645-2019; ZINZANI, PIER LUIGI/J-9182-2016	Jurczak, Wojciech/0000-0003-1879-8084; Goy, Andre/0000-0001-5125-6522; Jurczak, Wojciech/0000-0003-1879-8084; Goy, Andre/0000-0001-5125-6522; Robak, Tadeusz/0000-0002-3411-6357; Panizo Santos, Carlos Manuel/0000-0002-3945-585X; Davies, Andrew/0000-0002-7517-6938; le gouill, steven/0000-0001-9840-2128; ZINZANI, PIER LUIGI/0000-0002-2112-2651; Casasnovas, Rene-Olivier/0000-0002-1156-8983	Acerta Pharma	Acerta Pharma	Acerta Pharma, a member of the AstraZeneca Group.	Barf T, 2017, J PHARMACOL EXP THER, V363, P240, DOI 10.1124/jpet.117.242909; Burkle A, 2007, BLOOD, V110, P3316, DOI 10.1182/blood-2007-05-089409; Buggy JJ, 2012, INT REV IMMUNOL, V31, P119, DOI 10.3109/08830185.2012.664797; Byrd JC, 2016, NEW ENGL J MED, V374, P323, DOI 10.1056/NEJMoa1509981; Chang BY, 2013, BLOOD, V122, P2412, DOI 10.1182/blood-2013-02-482125; Cheah CY, 2016, J CLIN ONCOL, V34, P1256, DOI 10.1200/JCO.2015.63.5904; Cheson BD, 2007, J CLIN ONCOL, V25, P579, DOI 10.1200/JCO.2006.09.2403; Cheson BD, 2014, J CLIN ONCOL, V32, P3059, DOI 10.1200/JCO.2013.54.8800; Cohen Jonathon B, 2017, Am Soc Clin Oncol Educ Book, V37, P512, DOI 10.14694/EDBK_175448; Covey T, 2015, CANCER RES, V75, DOI 10.1158/1538-7445.AM2015-2596; Davids Matthew S, 2012, Open J Hematol, V3; de Rooij MFM, 2012, BLOOD, V119, P2590, DOI 10.1182/blood-2011-11-390989; Dreyling M, 2016, HAEMATOLOGICA, V101, P104, DOI 10.3324/haematol.2014.119115; Jayappa KD, 2017, BLOOD ADV, V1, P933, DOI 10.1182/bloodadvances.2016004176; Kamel S, 2015, LEUKEMIA, V29, P783, DOI 10.1038/leu.2014.247; Osoba D, 1998, J CLIN ONCOL, V16, P139, DOI 10.1200/JCO.1998.16.1.139; Pharmacyclics, 2017, IMBR PACK INS; Ponader S, 2012, BLOOD, V119, P1182, DOI 10.1182/blood-2011-10-386417; SAFFRAN DC, 1994, NEW ENGL J MED, V330, P1488, DOI 10.1056/NEJM199405263302104; SIMON R, 1989, CONTROL CLIN TRIALS, V10, P1, DOI 10.1016/0197-2456(89)90015-9; Stephens DM, 2015, THER ADV HEMATOL, V6, P242, DOI 10.1177/2040620715592569; Wang ML, 2013, NEW ENGL J MED, V369, P507, DOI 10.1056/NEJMoa1306220; Wiestner A, 2015, HAEMATOLOGICA, V100, P1495, DOI 10.3324/haematol.2014.119123; ZHU QL, 1994, HUM MOL GENET, V3, P1899, DOI 10.1093/hmg/3.10.1899	24	244	252	9	50	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 17	2018	391	10121					659	667		10.1016/S0140-6736(17)33108-2	http://dx.doi.org/10.1016/S0140-6736(17)33108-2			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FW4MN	29241979	Green Accepted			2022-12-28	WOS:000425287800025
J	Abbosh, C; Birkbak, NJ; Wilson, GA; Jamal-Hanjani, M; Constantin, T; Salari, R; Le Quesne, J; Moore, DA; Veeriah, S; Rosenthal, R; Marafioti, T; Kirkizlar, E; Watkins, TBK; McGranahan, N; Ward, S; Martinson, L; Riley, J; Fraioli, F; Al Bakir, M; Gronroos, E; Zambrana, F; Endozo, R; Bi, WL; Fennessy, FM; Sponer, N; Johnson, D; Laycock, J; Shafi, S; Czyzewska-Khan, J; Rowan, A; Chambers, T; Matthews, N; Turajlic, S; Hiley, C; Lee, SM; Forster, MD; Ahmad, T; Falzon, M; Borg, E; Lawrence, D; Hayward, M; Kolvekar, S; Panagiotopoulos, N; Janes, SM; Thakrar, R; Ahmed, A; Blackhall, F; Summers, Y; Hafez, D; Naik, A; Ganguly, A; Kareht, S; Shah, R; Joseph, L; Quinn, AM; Crosbie, PA; Naidu, B; Middleton, G; Langman, G; Trotter, S; Nicolson, M; Remmen, H; Kerr, K; Chetty, M; Gomersall, L; Fennell, DA; Nakas, A; Rathinam, S; Anand, G; Khan, S; Russell, P; Ezhil, V; Ismail, B; Irvin-Sellers, M; Prakash, V; Lester, JF; Kornaszewska, M; Attanoos, R; Adams, H; Davies, H; Oukrif, D; Akarca, AU; Hartley, JA; Lowe, HL; Lock, S; Iles, N; Bell, H; Ngai, Y; Elgar, G; Szallasi, Z; Schwarz, RF; Herrero, J; Stewart, A; Quezada, SA; Peggs, KS; Van Loo, P; Dive, C; Lin, CJ; Rabinowitz, M; Aerts, HJWL; Hackshaw, A; Shaw, JA; Zimmermann, BG; Swanton, C				Abbosh, Christopher; Birkbak, Nicolai J.; Wilson, Gareth A.; Jamal-Hanjani, Mariam; Constantin, Tudor; Salari, Raheleh; Le Quesne, John; Moore, David A.; Veeriah, Selvaraju; Rosenthal, Rachel; Marafioti, Teresa; Kirkizlar, Eser; Watkins, Thomas B. K.; McGranahan, Nicholas; Ward, Sophia; Martinson, Luke; Riley, Joan; Fraioli, Francesco; Al Bakir, Maise; Gronroos, Eva; Zambrana, Francisco; Endozo, Raymondo; Bi, Wenya Linda; Fennessy, Fiona M.; Sponer, Nicole; Johnson, Diana; Laycock, Joanne; Shafi, Seema; Czyzewska-Khan, Justyna; Rowan, Andrew; Chambers, Tim; Matthews, Nik; Turajlic, Samra; Hiley, Crispin; Lee, Siow Ming; Forster, Martin D.; Ahmad, Tanya; Falzon, Mary; Borg, Elaine; Lawrence, David; Hayward, Martin; Kolvekar, Shyam; Panagiotopoulos, Nikolaos; Janes, Sam M.; Thakrar, Ricky; Ahmed, Asia; Blackhall, Fiona; Summers, Yvonne; Hafez, Dina; Naik, Ashwini; Ganguly, Apratim; Kareht, Stephanie; Shah, Rajesh; Joseph, Leena; Quinn, Anne Marie; Crosbie, Phil A.; Naidu, Babu; Middleton, Gary; Langman, Gerald; Trotter, Simon; Nicolson, Marianne; Remmen, Hardy; Kerr, Keith; Chetty, Mahendran; Gomersall, Lesley; Fennell, Dean A.; Nakas, Apostolos; Rathinam, Sridhar; Anand, Girija; Khan, Sajid; Russell, Peter; Ezhil, Veni; Ismail, Babikir; Irvin-Sellers, Melanie; Prakash, Vineet; Lester, Jason F.; Kornaszewska, Malgorzata; Attanoos, Richard; Adams, Haydn; Davies, Helen; Oukrif, Dahmane; Akarca, Ayse U.; Hartley, John A.; Lowe, Helen L.; Lock, Sara; Iles, Natasha; Bell, Harriet; Ngai, Yenting; Elgar, Greg; Szallasi, Zoltan; Schwarz, Roland F.; Herrero, Javier; Stewart, Aengus; Quezada, Sergio A.; Peggs, Karl S.; Van Loo, Peter; Dive, Caroline; Lin, C. Jimmy; Rabinowitz, Matthew; Aerts, Hugo J. W. L.; Hackshaw, Allan; Shaw, Jacqui A.; Zimmermann, Bernhard G.; Swanton, Charles		TRACERx Consortium; PEACE Consortium	Phylogenetic ctDN A analysis depicts early-stage lung cancer evolution (vol 545, pg 446, 2017)	NATURE			English	Correction													Quezada, Sergio/ABF-6466-2020; Hartley, John/GRY-6691-2022; Marafioti, Teresa/AAA-4652-2019; McGranahan, Nicholas/ABD-6561-2021; Aerts, Hugo/ABF-2821-2020; Herrero, Javier/H-6971-2019; Fraioli, Francesco/AAD-8046-2019; Blackhall, Fiona/N-2186-2015	Quezada, Sergio/0000-0002-9763-1700; Marafioti, Teresa/0000-0003-1223-6275; McGranahan, Nicholas/0000-0001-9537-4045; Aerts, Hugo/0000-0002-2122-2003; Herrero, Javier/0000-0001-7313-717X; turajlic, samra/0000-0001-8846-136X; Zimmermann, Bernhard/0000-0002-5275-4571; Janes, Sam/0000-0002-6634-5939; Lowe, Helen/0000-0001-8630-378X; naidu, babu/0000-0003-1576-230X; Thakrar, Ricky/0000-0001-9793-2223; Lee, Siow Ming/0000-0002-1741-6235; Dive, Caroline/0000-0002-1726-8850; Szallasi, Zoltan/0000-0001-5395-7509; fraioli, francesco/0000-0003-0821-6327; Crosbie, Phil/0000-0001-8941-4813; Gronroos, Eva/0000-0001-8303-5409; Blackhall, Fiona/0000-0001-8716-3395; Birkbak, Nicolai/0000-0003-1613-9587; Hiley, Crispin/0000-0002-5869-0775; Middleton, Gary/0000-0001-5695-3474; Constantin, Tudor/0000-0002-8798-1782; Oukrif, Dahmane/0000-0001-8645-158X; Shaw, Jacqui/0000-0003-4227-503X; Stewart, Aengus/0000-0001-5182-653X	Medical Research Council [MR/P014712/1, MC_UP_1203/1, G108/596] Funding Source: Medline; MRC [MR/P014712/1, G108/596, MC_UP_1203/1] Funding Source: UKRI; Cancer Research UK [18176, 20466, 17891, 17786, 19278, 20274, 20275, 19310, 22246, 20465] Funding Source: researchfish; Rosetrees Trust [M445, M35-F2, M391, M740, M640, M231-CD1, M510-CD1, M35-F1-CD1, M179] Funding Source: researchfish; Wellcome Trust [107963/Z/15/Z] Funding Source: researchfish; The Francis Crick Institute [VEG 108844, C28575/A25223, C50947/A18176, 10485, 10170, 10174, 10169, A1278, 10467, 10359, 10172, C60895/A23896] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Rosetrees Trust(Rosetrees Trust); Wellcome Trust(Wellcome TrustEuropean Commission); The Francis Crick Institute		Abbosh C, 2017, NATURE, V545, P446, DOI 10.1038/nature22364	1	16	17	2	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 8	2018	554	7691					264	264		10.1038/nature25161	http://dx.doi.org/10.1038/nature25161			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1OE	29258292	Bronze			2022-12-28	WOS:000424332600044
J	Murthy, PA; Neidig, M; Klemt, R; Bayha, L; Boettcher, I; Enss, T; Holten, M; Zurn, G; Preiss, PM; Jochim, S				Murthy, Puneet A.; Neidig, Mathias; Klemt, Ralf; Bayha, Luca; Boettcher, Igor; Enss, Tilman; Holten, Marvin; Zuern, Gerhard; Preiss, Philipp M.; Jochim, Selim			High-temperature pairing in a strongly interacting two-dimensional Fermi gas	SCIENCE			English	Article							SUPERCONDUCTIVITY; PSEUDOGAP	The nature of the normal phase of strongly correlated fermionic systems is an outstanding question in quantum many-body physics. We used spatially resolved radio-frequency spectroscopy to measure pairing energy of fermions across a wide range of temperatures and interaction strengths in a two-dimensional gas of ultracold fermionic atoms. We observed many-body pairing at temperatures far above the critical temperature for superfluidity. In the strongly interacting regime, the pairing energy in the normal phase considerably exceeds the intrinsic two-body binding energy of the system and shows a clear dependence on local density. This implies that pairing in this regime is driven by many-body correlations, rather than two-body physics. Our findings show that pairing correlations in strongly interacting two-dimensional fermionic systems are remarkably robust against thermal fluctuations.	[Murthy, Puneet A.; Neidig, Mathias; Klemt, Ralf; Bayha, Luca; Holten, Marvin; Zuern, Gerhard; Preiss, Philipp M.; Jochim, Selim] Heidelberg Univ, Inst Phys, Heidelberg, Germany; [Boettcher, Igor] Simon Fraser Univ, Dept Phys, Burnaby, BC, Canada; [Enss, Tilman] Heidelberg Univ, Inst Theoret Phys, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Simon Fraser University; Ruprecht Karls University Heidelberg	Murthy, PA (corresponding author), Heidelberg Univ, Inst Phys, Heidelberg, Germany.	murthy@physi.uni-heidelberg.de	Enss, Tilman/G-4043-2011	Enss, Tilman/0000-0002-5334-2448; Holten, Marvin/0000-0002-0652-4484; Boettcher, Igor/0000-0002-1634-4022	European Research Council consolidator grant [725636]; Heidelberg Center for Quantum Dynamics; Deutsche Forschungsgemeinschaft (DFG) Collaborative Research Centre [SFB 1225]; DFG [BO 4640/1-1]; European Union's Horizon 2020 program under the Marie Sklodowska-Curie grant [706487]	European Research Council consolidator grant(European Research Council (ERC)); Heidelberg Center for Quantum Dynamics; Deutsche Forschungsgemeinschaft (DFG) Collaborative Research Centre(German Research Foundation (DFG)); DFG(German Research Foundation (DFG)); European Union's Horizon 2020 program under the Marie Sklodowska-Curie grant	We gratefully acknowledge insightful discussions with M. Parish, J. Levinsen, N. Defenu, and W. Zwerger. We thank T. Lompe for discussions and for a critical reading of the manuscript. This work has been supported by the European Research Council consolidator grant 725636 and the Heidelberg Center for Quantum Dynamics and is part of the Deutsche Forschungsgemeinschaft (DFG) Collaborative Research Centre "SFB 1225 (ISOQUANT)." I.B. acknowledges support from DFG and grant BO 4640/1-1. P.M.P. acknowledges funding from European Union's Horizon 2020 program under the Marie Sklodowska-Curie grant agreement 706487. Supporting data can be found in the supplementary materials. Raw data are available upon request. P.A.M and G.Z. initiated the project. P.A.M., M.N., R.K., and M.H. performed the measurements and analyzed the data. I.B. and T.E. provided theory support and assistance with preparing the manuscript. P.M.P. and S.J. supervised the project. All authors contributed to the interpretation and discussion of the experimental results.	BARDEEN J, 1957, PHYS REV, V108, P1175, DOI 10.1103/PhysRev.108.1175; Barth M, 2014, PHYS REV A, V89, DOI 10.1103/PhysRevA.89.013614; Boettcher I, 2016, PHYS REV LETT, V116, DOI 10.1103/PhysRevLett.116.045303; Chen QJ, 2009, REP PROG PHYS, V72, DOI 10.1088/0034-4885/72/12/122501; DEMELO CARS, 1993, PHYS REV LETT, V71, P3202, DOI 10.1103/PhysRevLett.71.3202; Dyke P, 2016, PHYS REV A, V93, DOI 10.1103/PhysRevA.93.011603; Feld M, 2011, NATURE, V480, P75, DOI 10.1038/nature10627; Fischer AM, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.214503; Frohlich B, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.130403; Gaebler JP, 2010, NAT PHYS, V6, P569, DOI 10.1038/NPHYS1709; Kasahara S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12843; Langmack C, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.060402; Lee JJ, 2014, NATURE, V515, P245, DOI 10.1038/nature13894; Levinsen J., 2015, ANN REV COLD ATOMS M, V3, P1; Marsiglio F, 2015, PHYS REV B, V91, DOI 10.1103/PhysRevB.91.054509; Mueller EJ, 2017, REP PROG PHYS, V80, DOI 10.1088/1361-6633/aa7e53; Murthy PA, 2015, PHYS REV LETT, V115, DOI 10.1103/PhysRevLett.115.010401; Nascimbene S, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.215303; Ngampruetikorn V, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.265301; Perali A, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.060402; RANDERIA M, 1989, PHYSICA C, V162, P1457, DOI 10.1016/0921-4534(89)90770-3; RANDERIA M, 1990, PHYS REV B, V41, P327, DOI 10.1103/PhysRevB.41.327; Ries MG, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.230401; Sagi Y, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.075301; Schirotzek A, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.140403; Schunck CH, 2007, SCIENCE, V316, P867, DOI 10.1126/science.1140749; Shin Y, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.090403; Sommer AT, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.045302; Torma P, 2016, PHYS SCRIPTA, V91, DOI 10.1088/0031-8949/91/4/043006; YANG CN, 1962, REV MOD PHYS, V34, P694, DOI 10.1103/RevModPhys.34.694; Zurn G, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.135301	31	28	28	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 26	2018	359	6374					452	455		10.1126/science.aan5950	http://dx.doi.org/10.1126/science.aan5950			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT6SD	29269421	Green Submitted			2022-12-28	WOS:000423283200045
J	Bourrier, V; Lovis, C; Beust, H; Ehrenreich, D; Henry, GW; Astudillo-Defru, N; Allart, R; Bonfils, X; Segransan, D; Delfosse, X; Cegla, HM; Wyttenbach, A; Heng, K; Lavie, B; Pepe, F				Bourrier, Vincent; Lovis, Christophe; Beust, Herve; Ehrenreich, David; Henry, Gregory W.; Astudillo-Defru, Nicola; Allart, Romain; Bonfils, Xavier; Segransan, Damien; Delfosse, Xavier; Cegla, Heather M.; Wyttenbach, Aurelien; Heng, Kevin; Lavie, Baptiste; Pepe, Francesco			Orbital misalignment of the Neptune-mass exoplanet GJ 436b with the spin of its cool star	NATURE			English	Article							PLANET	The angle between the spin of a star and the orbital planes of its planets traces the history of the planetary system. Exoplanets orbiting close to cool stars are expected to be on circular, aligned orbits because of strong tidal interactions with the stellar convective envelope(1). Spin-orbit alignment can be measured when the planet transits its star, but such ground-based spectroscopic measurements are challenging for cool, slowly rotating stars(2). Here we report the three-dimensional characterization of the trajectory of an exoplanet around an M dwarf star, derived by mapping the spectrum of the stellar photosphere along the chord transited by the planet(3). We find that the eccentric orbit of the Neptune-mass exoplanet GJ 436b is nearly perpendicular to the stellar equator. Both eccentricity and misalignment, surprising around a cool star, can result from dynamical interactions ( via Kozai migration(4)) with a yet-undetected outer companion. This inward migration of GJ 436b could have triggered the atmospheric escape that now sustains its giant exosphere(5).	[Bourrier, Vincent; Lovis, Christophe; Ehrenreich, David; Astudillo-Defru, Nicola; Allart, Romain; Segransan, Damien; Cegla, Heather M.; Wyttenbach, Aurelien; Lavie, Baptiste; Pepe, Francesco] Observ Univ Geneve, 51 Chemin Maillettes, CH-1290 Versoix, Switzerland; [Beust, Herve; Bonfils, Xavier; Delfosse, Xavier] Univ Grenoble Alpes, CNRS, IPAG, F-38000 Grenoble, France; [Henry, Gregory W.] Tennessee State Univ, Ctr Excellence Informat Syst, Nashville, TN 37209 USA; [Heng, Kevin] Univ Bern, Ctr Space & Habitabil, Sidlerstr 5, CH-3012 Bern, Switzerland	University of Geneva; Centre National de la Recherche Scientifique (CNRS); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Institut de Planetologie et d'Astrophysique de Grenoble (IPAG); Tennessee State University; University of Bern	Bourrier, V (corresponding author), Observ Univ Geneve, 51 Chemin Maillettes, CH-1290 Versoix, Switzerland.	vincent.bourrier@unige.ch		Pepe, Francesco/0000-0002-9815-773X; Allart, Romain/0000-0002-1199-9759; Astudillo-Defru, Nicola/0000-0002-8462-515X; Wyttenbach, Aurelien/0000-0001-9003-7699; Cegla, Heather/0000-0001-8934-7315	ESO La Silla Observatory, Chile, under GTO program [072.C-0488]; Fundacion Galileo Galilei of the INAF (Istituto Nazionale di Astrofisica) at the Spanish Observatorio del Roque de los Muchachos of the Instituto de Astrofisica de Canarias under OPTICON program [16A/049]; European Community's Seventh Framework Programme (FP7) [312430]; European Research Council (ERC) under the European Union's Horizon Research and Innovation Programme [724427]; Swiss National Science Foundation (SNSF); SNSF; Tennessee State University; State of Tennessee through its Centers of Excellence programme; CNRS/PNP (Programme national de planetologie); European Research Council [337591-ExTrA]	ESO La Silla Observatory, Chile, under GTO program; Fundacion Galileo Galilei of the INAF (Istituto Nazionale di Astrofisica) at the Spanish Observatorio del Roque de los Muchachos of the Instituto de Astrofisica de Canarias under OPTICON program; European Community's Seventh Framework Programme (FP7)(European Commission); European Research Council (ERC) under the European Union's Horizon Research and Innovation Programme(European Research Council (ERC)); Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF)); SNSF(Swiss National Science Foundation (SNSF)); Tennessee State University; State of Tennessee through its Centers of Excellence programme; CNRS/PNP (Programme national de planetologie); European Research Council(European Research Council (ERC)European Commission)	This work is based on observations made with the HARPS spectrograph on the 3.6 m ESO telescope at the ESO La Silla Observatory, Chile, under GTO program ID 072.C-0488, and with the Italian Telescopio Nazionale Galileo operated on the island of La Palma by the Fundacion Galileo Galilei of the INAF (Istituto Nazionale di Astrofisica) at the Spanish Observatorio del Roque de los Muchachos of the Instituto de Astrofisica de Canarias under OPTICON program 16A/049, 'Sensing Planetary Atmospheres with Differential Echelle Spectroscopy' (SPADES). OPTICON has received funding from the European Community's Seventh Framework Programme (FP7/2013-2016) under grant agreement number 312430. This project has also received funding from the European Research Council (ERC) under the European Union's Horizon 2020 Research and Innovation Programme under grant agreement number 724427 (FOUR ACES). This work was carried out in the framework of the National Centre for Competence in Research 'PlanetS' supported by the Swiss National Science Foundation (SNSF). R.A., N.A.-D., V.B., D.E., C.L. and A.W. acknowledge the financial support of the SNSF. H.M.C. gratefully acknowledges support as a CHEOPS Fellow from the SNSF National Centre of Competence in Research 'PlanetS'. G.W.H. acknowledges long-term support from Tennessee State University and the State of Tennessee through its Centers of Excellence programme. X.B. and X.D. acknowledge the support of CNRS/PNP (Programme national de planetologie). X.B. acknowledges funding from the European Research Council under the ERC Grant Agreement number 337591-ExTrA. We thank C. A. Watson for calculating the convective mass of GJ 436, H. Knutson for facilitating the determination of the stellar rotation period, J.-B. Delisle for discussing the system geometry, and the Telescopio Nazionale Galileo staff for the service observation.	Albrecht S, 2012, ASTROPHYS J, V757, DOI 10.1088/0004-637X/757/1/18; Alonso R, 2008, ASTRON ASTROPHYS, V487, pL5, DOI 10.1051/0004-6361:200810007; Astudillo-Defru N, 2017, ASTRON ASTROPHYS, V600, DOI 10.1051/0004-6361/201527078; Ballard S, 2010, ASTROPHYS J, V716, P1047, DOI 10.1088/0004-637X/716/2/1047; Baraffe I, 2003, ASTRON ASTROPHYS, V402, P701, DOI 10.1051/0004-6361:20030252; Baraffe I, 2015, ASTRON ASTROPHYS, V577, DOI 10.1051/0004-6361/201425481; Barnes SA, 2016, ASTROPHYS J, V823, DOI 10.3847/0004-637X/823/1/16; Batygin K, 2009, ASTROPHYS J, V699, P23, DOI 10.1088/0004-637X/699/1/23; Bean JL, 2008, ASTRON ASTROPHYS, V486, P1039, DOI 10.1051/0004-6361:200810013; Beust H, 2012, ASTRON ASTROPHYS, V545, DOI 10.1051/0004-6361/201219183; Bourrier V, 2017, ASTRON ASTROPHYS, V599, DOI 10.1051/0004-6361/201629973; Bourrier V, 2015, ASTRON ASTROPHYS, V579, DOI 10.1051/0004-6361/201525750; Brothwell RD, 2014, MON NOT R ASTRON SOC, V440, P3392, DOI 10.1093/mnras/stu520; Butler RP, 2017, ASTRON J, V153, DOI 10.3847/1538-3881/aa66ca; Butler RP, 2004, ASTROPHYS J, V617, P580, DOI 10.1086/425173; Cameron AC, 2010, MON NOT R ASTRON SOC, V403, P151, DOI 10.1111/j.1365-2966.2009.16131.x; Cegla HM, 2016, ASTRON ASTROPHYS, V588, DOI 10.1051/0004-6361/201527794; Cosentino R, 2012, PROC SPIE, V8446, DOI 10.1117/12.925738; Ehrenreich D, 2015, NATURE, V522, P459, DOI 10.1038/nature14501; Hagelberg J, 2016, MON NOT R ASTRON SOC, V455, P2178, DOI 10.1093/mnras/stv2398; Henry GW, 1999, PUBL ASTRON SOC PAC, V111, P845, DOI 10.1086/316388; Knutson HA, 2014, NATURE, V505, P66, DOI 10.1038/nature12887; Knutson HA, 2011, ASTROPHYS J, V735, DOI 10.1088/0004-637X/735/1/27; Kreidberg L, 2015, PUBL ASTRON SOC PAC, V127, P1161, DOI 10.1086/683602; Lanotte AA, 2014, ASTRON ASTROPHYS, V572, DOI 10.1051/0004-6361/201424373; Maciejewski G, 2014, ACTA ASTRONOM, V64, P323; Mann AW, 2015, ASTROPHYS J, V804, DOI 10.1088/0004-637X/804/1/64; Mardling R. A., 2008, LONG TERM TIDAL EVOL; Mayor M., 2003, MESSENGER, V114, P20; Meibom S, 2015, NATURE, V517, P589, DOI 10.1038/nature14118; Morin J, 2008, MON NOT R ASTRON SOC, V390, P567, DOI 10.1111/j.1365-2966.2008.13809.x; Queloz D, 2010, ASTRON ASTROPHYS, V517, DOI 10.1051/0004-6361/201014768; Stevenson KB, 2012, ASTROPHYS J, V755, DOI 10.1088/0004-637X/755/1/9; Mascareno AS, 2015, MON NOT R ASTRON SOC, V452, P2745, DOI 10.1093/mnras/stv1441; Tong X, 2009, SCI CHINA SER G, V52, P640, DOI 10.1007/s11433-009-0070-9; Winn JN, 2010, ASTROPHYS J LETT, V718, pL145, DOI 10.1088/2041-8205/718/2/L145	36	66	66	0	3	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 25	2018	553	7689					477	+		10.1038/nature24677	http://dx.doi.org/10.1038/nature24677			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU6OE	29258300	Green Published, Green Submitted			2022-12-28	WOS:000423971100035
J	Martin-Navarro, I; Brodie, JP; Romanowsky, AJ; Ruiz-Lara, T; van de Ven, G				Martin-Navarro, Ignacio; Brodie, Jean P.; Romanowsky, Aaron J.; Ruiz-Lara, Tomas; van de Ven, Glenn			Black-hole-regulated star formation in massive galaxies	NATURE			English	Article							STELLAR POPULATION SYNTHESIS; RESOLUTION GALACTIC SPECTRA; DIGITAL SKY SURVEY; ILLUSTRIS SIMULATION; HOST GALAXIES; PROJECT; MODELS; DARK; COEVOLUTION; EVOLUTION	Supermassive black holes, with masses more than a million times that of the Sun, seem to inhabit the centres of all massive galaxies(1,2). Cosmologically motivated theories of galaxy formation require feedback from these supermassive black holes to regulate star formation(3). In the absence of such feedback, state-of-the-art numerical simulations fail to reproduce the number density and properties of massive galaxies in the local Universe(4-6). There is, however, no observational evidence of this strongly coupled coevolution between supermassive black holes and star formation, impeding our understanding of baryonic processes within galaxies. Here we report that the star formation histories of nearby massive galaxies, as measured from their integrated optical spectra, depend on the mass of the central supermassive black hole. Our results indicate that the black-hole mass scales with the gas cooling rate in the early Universe. The subsequent quenching of star formation takes place earlier and more efficiently in galaxies that host higher-mass central black holes. The observed relation between black-hole mass and star formation efficiency applies to all generations of stars formed throughout the life of a galaxy, revealing a continuous interplay between black-hole activity and baryon cooling.	[Martin-Navarro, Ignacio; Romanowsky, Aaron J.] Univ Calif Observ, 1156 High St, Santa Cruz, CA 95064 USA; [Martin-Navarro, Ignacio; Brodie, Jean P.; van de Ven, Glenn] Max Planck Inst Astron, Konigstuhl 17, D-69117 Heidelberg, Germany; [Romanowsky, Aaron J.] San Jose State Univ, Dept Phys & Astron, One Washington Sq, San Jose, CA 95192 USA; [Ruiz-Lara, Tomas] Inst Astrofis Canarias, E-38205 Tenerife, Spain; [Ruiz-Lara, Tomas] Univ La Laguna, Dept Astrofis, E-38200 Tenerife, Spain; [van de Ven, Glenn] European Southern Observ, Karl Schwarzschild Str 2, D-85748 Garching, Germany	University of California System; University of California Santa Cruz; Max Planck Society; California State University System; San Jose State University; Instituto de Astrofisica de Canarias; Universidad de la Laguna; European Southern Observatory	Martin-Navarro, I (corresponding author), Univ Calif Observ, 1156 High St, Santa Cruz, CA 95064 USA.; Martin-Navarro, I (corresponding author), Max Planck Inst Astron, Konigstuhl 17, D-69117 Heidelberg, Germany.	imartinn@ucsc.edu	van de Ven, Glenn/R-5189-2019; Ruiz-Lara, Tomás/AAA-5399-2020; Martin-Navarro, Ignacio/F-5882-2016	van de Ven, Glenn/0000-0003-4546-7731; Ruiz-Lara, Tomás/0000-0001-6984-4795; Martin-Navarro, Ignacio/0000-0001-8494-0080	National Science Foundation (NSF) [AST-1616598, AST-1616710]; Marie Curie Global Fellowship; German Research Foundation [SFB 881]; Spanish Ministry of Economy and Competitiveness (MINECO) [AYA2016-77237-C3-1-P, AYA2014-56795-P]; European Research Council (ERC) under European Union's Horizon 2020 research and innovation programme [724857]; Research Corporation for Science Advancement Cottrell Scholar	National Science Foundation (NSF)(National Science Foundation (NSF)); Marie Curie Global Fellowship; German Research Foundation(German Research Foundation (DFG)); Spanish Ministry of Economy and Competitiveness (MINECO); European Research Council (ERC) under European Union's Horizon 2020 research and innovation programme(European Research Council (ERC)); Research Corporation for Science Advancement Cottrell Scholar	We acknowledge support from the National Science Foundation (NSF) grants AST-1616598 and AST-1616710, from a Marie Curie Global Fellowship, from SFB 881 'The Milky Way System' (subprojects A7 and A8) funded by the German Research Foundation, and from grants AYA2016-77237-C3-1-P and AYA2014-56795-P from the Spanish Ministry of Economy and Competitiveness (MINECO). G.v.d.V. acknowledges funding from the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme under grant agreement no. 724857 (Consolidator Grant ArcheoDyn). A.J.R. was supported as a Research Corporation for Science Advancement Cottrell Scholar. I.M.-N. thanks the TRACES group and M. Mezcua for their comments, R. van den Bosch for making the HETMGS data publicly available and A. Boecker for her help.	Beifiori A, 2012, MON NOT R ASTRON SOC, V419, P2497, DOI 10.1111/j.1365-2966.2011.19903.x; Bernardi M, 2007, ASTROPHYS J, V660, P267, DOI 10.1086/512719; Bower RG, 2017, MON NOT R ASTRON SOC, V465, P32, DOI 10.1093/mnras/stw2735; Bruzual G, 2003, MON NOT R ASTRON SOC, V344, P1000, DOI 10.1046/j.1365-8711.2003.06897.x; Cappellari M, 2004, PUBL ASTRON SOC PAC, V116, P138, DOI 10.1086/381875; Cappellari M, 2011, MON NOT R ASTRON SOC, V413, P813, DOI 10.1111/j.1365-2966.2010.18174.x; Choi E, 2017, ASTROPHYS J, V844, DOI 10.3847/1538-4357/aa7849; Courteau S, 2007, ASTROPHYS J, V655, pL21, DOI 10.1086/511524; Crain RA, 2015, MON NOT R ASTRON SOC, V450, P1937, DOI 10.1093/mnras/stv725; Delgado RMG, 2005, MON NOT R ASTRON SOC, V357, P945, DOI 10.1111/j.1365-2966.2005.08692.x; Fan XH, 2001, ASTRON J, V122, P2833, DOI 10.1086/324111; Ferrarese L, 2000, ASTROPHYS J, V539, pL9, DOI 10.1086/312838; Gebhardt K, 2000, ASTROPHYS J, V539, pL13, DOI 10.1086/312840; Delgado RMG, 2010, MON NOT R ASTRON SOC, V403, P797, DOI 10.1111/j.1365-2966.2009.16152.x; Hu J, 2008, MON NOT R ASTRON SOC, V386, P2242, DOI 10.1111/j.1365-2966.2008.13195.x; Jahnke K, 2011, ASTROPHYS J, V734, DOI 10.1088/0004-637X/734/2/92; Jarrett TH, 2000, ASTRON J, V119, P2498, DOI 10.1086/301330; Kauffmann G, 2003, MON NOT R ASTRON SOC, V346, P1055, DOI 10.1111/j.1365-2966.2003.07154.x; Koleva M, 2008, MON NOT R ASTRON SOC, V385, P1998, DOI 10.1111/j.1365-2966.2008.12908.x; Kormendy J, 2013, ANNU REV ASTRON ASTR, V51, P511, DOI 10.1146/annurev-astro-082708-101811; Kormendy J, 2011, NATURE, V469, P374, DOI 10.1038/nature09694; Kuntschner H, 2010, MON NOT R ASTRON SOC, V408, P97, DOI 10.1111/j.1365-2966.2010.17161.x; Le Borgne D, 2004, ASTRON ASTROPHYS, V425, P881, DOI 10.1051/0004-6361:200400044; Leitner SN, 2012, ASTROPHYS J, V745, DOI 10.1088/0004-637X/745/2/149; Magorrian J, 1998, ASTRON J, V115, P2285, DOI 10.1086/300353; Martiin-Navarro I, 2016, ASTROPHYS J LETT, V832, DOI 10.3847/2041-8205/832/1/L11; Mullaney JR, 2012, MON NOT R ASTRON SOC, V419, P95, DOI 10.1111/j.1365-2966.2011.19675.x; Ocvirk P, 2006, MON NOT R ASTRON SOC, V365, P46, DOI 10.1111/j.1365-2966.2005.09182.x; Ocvirk P, 2006, MON NOT R ASTRON SOC, V365, P74, DOI 10.1111/j.1365-2966.2005.09323.x; Peng CY, 2007, ASTROPHYS J, V671, P1098, DOI 10.1086/522774; Pietrinferni A, 2004, ASTROPHYS J, V612, P168, DOI 10.1086/422498; Rodriguez-Gomez V, 2016, MON NOT R ASTRON SOC, V458, P2371, DOI 10.1093/mnras/stw456; Ruiz-Lara T, 2015, ASTRON ASTROPHYS, V583, DOI 10.1051/0004-6361/201526752; Ruschel-Dutra D, 2017, MON NOT R ASTRON SOC, V466, P3353, DOI 10.1093/mnras/stw3276; Saglia RP, 2016, ASTROPHYS J, V818, DOI 10.3847/0004-637X/818/1/47; Sanchez-Blazquez P, 2011, MON NOT R ASTRON SOC, V415, P709, DOI 10.1111/j.1365-2966.2011.18749.x; Schaye J, 2015, MON NOT R ASTRON SOC, V446, P521, DOI 10.1093/mnras/stu2058; Shankar F, 2016, MON NOT R ASTRON SOC, V460, P3119, DOI 10.1093/mnras/stw678; Shimasaku K, 2001, ASTRON J, V122, P1238, DOI 10.1086/322094; Sijacki D, 2015, MON NOT R ASTRON SOC, V452, P575, DOI 10.1093/mnras/stv1340; Silk J, 2012, RES ASTRON ASTROPHYS, V12, P917, DOI 10.1088/1674-4527/12/8/004; Stanley F, 2015, MON NOT R ASTRON SOC, V453, P591, DOI 10.1093/mnras/stv1678; Terrazas BA, 2016, ASTROPHYS J LETT, V830, DOI 10.3847/2041-8205/830/1/L12; Thomas D, 2005, ASTROPHYS J, V621, P673, DOI 10.1086/426932; van den Bosch RCE, 2016, ASTROPHYS J, V831, DOI 10.3847/0004-637X/831/2/134; van den Bosch RCE, 2015, ASTROPHYS J SUPPL S, V218, DOI 10.1088/0067-0049/218/1/10; Vazdekis A, 2010, MON NOT R ASTRON SOC, V404, P1639, DOI 10.1111/j.1365-2966.2010.16407.x; Vogelsberger M, 2014, MON NOT R ASTRON SOC, V444, P1518, DOI 10.1093/mnras/stu1536; Volonteri M, 2011, ASTROPHYS J, V737, DOI 10.1088/0004-637X/737/2/50	49	33	33	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 18	2018	553	7688					307	+		10.1038/nature24999	http://dx.doi.org/10.1038/nature24999			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT9MB	29291597	Green Submitted			2022-12-28	WOS:000423475100044
J	Rosenbaum, L				Rosenbaum, Lisa			Swallowing a Spy - The Potential Uses of Digital Adherence Monitoring	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		Choudhry NK, 2011, NEW ENGL J MED, V365, P2088, DOI 10.1056/NEJMsa1107913; Frias J, 2017, J MED INTERNET RES, V19, DOI 10.2196/jmir.7833; Ho PM, 2009, CIRCULATION, V119, P3028, DOI 10.1161/CIRCULATIONAHA.108.768986; Kane JM, 2013, J CLIN PSYCHIAT, V74, pE533, DOI [10.4088/JCP.12m08222, 10.4088/JCP.12045tx2c, 10.4088/JCP.12117tx1c]; Osterberg L, 2005, NEW ENGL J MED, V353, P487, DOI 10.1056/NEJMra050100	5	19	19	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 11	2018	378	2					101	103		10.1056/NEJMp1716206	http://dx.doi.org/10.1056/NEJMp1716206			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FS7IR	29281504				2022-12-28	WOS:000419971600001
J	Stone, R				Stone, Richard			How to defeat a nerve agent	SCIENCE			English	Editorial Material																			0	34	34	1	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 5	2018	359	6371					23	23		10.1126/science.359.6371.23	http://dx.doi.org/10.1126/science.359.6371.23			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FR8KW	29301996				2022-12-28	WOS:000419324700024
J	Armstrong, K; Ranganathan, R; Fishman, M				Armstrong, Katrina; Ranganathan, Rajesh; Fishman, Mark			Toward a Culture of Scientific Inquiry - The Role of Medical Teaching Services	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Armstrong, Katrina; Ranganathan, Rajesh; Fishman, Mark] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Fishman, Mark] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA	Harvard University; Massachusetts General Hospital; Harvard University	Armstrong, K (corresponding author), Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA.							Broca P., 1861, B SOCI T ANTHROPOLOG, V2, P235; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; Cushing H, 1909, J AMER MED ASSOC, V53, P249; HALL JM, 1990, SCIENCE, V250, P1684, DOI 10.1126/science.2270482; National Institute of Health, 2014, PHYS SCI WORKF WORK	5	12	12	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 4	2018	378	1					1	3		10.1056/NEJMp1712474	http://dx.doi.org/10.1056/NEJMp1712474			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FR7BE	29298148				2022-12-28	WOS:000419220500009
J	Cantrell, FL				Cantrell, F. Lee			Epinephrine Concentrations in EpiPens After the Expiration Date RESPONSE	ANNALS OF INTERNAL MEDICINE			English	Letter									[Cantrell, F. Lee] Calif Poison Control Syst, San Diego, CA 92103 USA		Cantrell, FL (corresponding author), Calif Poison Control Syst, San Diego, CA 92103 USA.							GRANT TA, 1994, AM J EMERG MED, V12, P319, DOI 10.1016/0735-6757(94)90148-1; Stepensky D, 2004, J PHARM SCI-US, V93, P969, DOI 10.1002/jps.20010	2	2	2	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 2	2018	168	1					82	82		10.7326/L17-0496	http://dx.doi.org/10.7326/L17-0496			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FR5SO	29297030				2022-12-28	WOS:000419126700018
J	Chen, JP; Upadhyaya, NM; Ortiz, D; Sperschneider, J; Li, F; Bouton, C; Breen, S; Dong, CM; Xu, B; Zhang, XX; Mago, R; Newell, K; Xia, XD; Bernoux, M; Taylor, JM; Steffenson, B; Jin, Y; Zhang, P; Kanyuka, K; Figueroa, M; Ellis, JG; Park, RF; Dodds, PN				Chen, Jiapeng; Upadhyaya, Narayana M.; Ortiz, Diana; Sperschneider, Jana; Li, Feng; Bouton, Clement; Breen, Susan; Dong, Chongmei; Xu, Bo; Zhang, Xiaoxiao; Mago, Rohit; Newell, Kim; Xia, Xiaodi; Bernoux, Maud; Taylor, Jennifer M.; Steffenson, Brian; Jin, Yue; Zhang, Peng; Kanyuka, Kostya; Figueroa, Melania; Ellis, Jeffrey G.; Park, Robert F.; Dodds, Peter N.			Loss of AvrSr50 by somatic exchange in stem rust leads to virulence for Sr50 resistance in wheat	SCIENCE			English	Article							F-SP TRITICI; PATHOGEN; HYBRIDIZATION; GRASSES	Race-specific resistance genes protect the global wheat crop from stem rust disease caused by Puccinia graminis f. sp. tritici (Pgt) but are often overcome owing to evolution of new virulent races of the pathogen. To understand virulence evolution in Pgt, we identified the protein ligand (AvrSr50) recognized by the Sr50 resistance protein. A spontaneous mutant of Pgt virulent to Sr50 contained a 2.5 mega-base pair loss-of-heterozygosity event. A haustorial secreted protein from this region triggers Sr50-dependent defense responses in planta and interacts directly with the Sr50 protein. Virulence alleles of AvrSr50 have arisen through DNA insertion and sequence divergence, and our data provide molecular evidence that in addition to sexual recombination, somatic exchange can play a role in the emergence of new virulence traits in Pgt.	[Chen, Jiapeng; Dong, Chongmei; Zhang, Peng; Park, Robert F.] Univ Sydney, Sch Life & Environm Sci, Plant Breeding Inst, Cobbitty, NSW, Australia; [Chen, Jiapeng; Upadhyaya, Narayana M.; Ortiz, Diana; Breen, Susan; Xu, Bo; Zhang, Xiaoxiao; Mago, Rohit; Newell, Kim; Xia, Xiaodi; Bernoux, Maud; Taylor, Jennifer M.; Ellis, Jeffrey G.; Dodds, Peter N.] Commonwealth Sci & Ind Res Org, Agr & Food, Canberra, ACT, Australia; [Chen, Jiapeng] Univ Sydney, Charles Perkins Ctr, Judith & David Coffey Life Lab, Sydney, NSW, Australia; [Sperschneider, Jana] Commonwealth Sci & Ind Res Org, Ctr Environm & Life Sci, Agr & Food, Perth, WA, Australia; [Li, Feng; Steffenson, Brian; Jin, Yue; Figueroa, Melania] Univ Minnesota, Dept Plant Pathol, St Paul, MN USA; [Li, Feng; Steffenson, Brian; Jin, Yue; Figueroa, Melania] Univ Minnesota, Stakman Borlaug Ctr Sustainable Plant Hlth, St Paul, MN 55108 USA; [Bouton, Clement; Kanyuka, Kostya] Rothamsted Res, Biointeract & Crop Protect, Harpenden AL5 2JQ, Herts, England; [Jin, Yue] USDA ARS, Cereal Dis Lab, St Paul, MN USA	University of Sydney; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Sydney; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research; United States Department of Agriculture (USDA)	Park, RF (corresponding author), Univ Sydney, Sch Life & Environm Sci, Plant Breeding Inst, Cobbitty, NSW, Australia.; Dodds, PN (corresponding author), Commonwealth Sci & Ind Res Org, Agr & Food, Canberra, ACT, Australia.	robert.park@sydney.edu.au; peter.dodds@csiro.au	ORTIZ VALLEJO, Diana Carolina/AAY-5552-2021; Chen, Jiapeng/AAT-5040-2020; Zhang, Peng/AAT-7660-2020; Bernoux, Maud/D-4212-2009; ORTIZ VALLEJO, Diana Carolina/AAY-3866-2021; Upadhyaya, Narayana M/A-1480-2008; Breen, Susan/AAJ-1555-2021; Mago, Rohit/D-3927-2009; LI, Feng/ABD-9629-2021; Zhang, Peng/HDN-6195-2022; Sperschneider, Jana/I-3390-2012; Figueroa, Melania/AAI-8692-2021; Bernoux, Maud/N-1360-2019; DONG, CHONG/AAT-8328-2020; Figueroa, Melania/R-7696-2017; Breen, Susan/AAD-5873-2022; Taylor, Jennifer M/A-1686-2010; Mago, Rohit/AAB-7878-2022; Zhang, Xiaoxiao/C-6002-2016; Kanyuka, Kostya/F-9156-2016; Dodds, Peter/D-1181-2009	ORTIZ VALLEJO, Diana Carolina/0000-0001-6120-5788; Chen, Jiapeng/0000-0002-9145-3018; Upadhyaya, Narayana M/0000-0002-3052-0416; Breen, Susan/0000-0001-5232-9973; Mago, Rohit/0000-0001-5286-073X; LI, Feng/0000-0001-8528-4249; Figueroa, Melania/0000-0003-2636-661X; Figueroa, Melania/0000-0003-2636-661X; Taylor, Jennifer M/0000-0003-4231-0181; Zhang, Xiaoxiao/0000-0002-5417-6963; Kanyuka, Kostya/0000-0001-6324-4123; Dodds, Peter/0000-0003-0620-5923; Bernoux, Maud/0000-0001-5416-4295; Park, Robert/0000-0002-9145-5371; Steffenson, Brian/0000-0001-7961-5363; Sperschneider, Jana/0000-0002-9385-8588; Dong, Chong/0000-0003-3205-302X; Bouton, Clement/0000-0001-9607-6533	TwoBlades foundation; Grains Research and Development Corporation [US00067, CSP00161]; University of Minnesota Lieberman-Okinow Endowment; University of Minnesota Lieberman-Stakman Endowment; Experimental Station USDA-National Institute of Food and Agriculture Hatch Funds [MIN-22-058]; Biotechnology and Biological Sciences Research Council [BB/P016855/1]; Judith and David Coffey Life Lab; Plant Breeding Institute, University of Sydney; National Center for Biotechnology Information Sequencing Read Archive [PRJNA396463, PRJNA415866]; BBSRC [BB/J019518/1, BB/R012393/1, BBS/E/C/000I0250, BBS/E/C/00005203] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/C/000I0250, BB/J019518/1, BBS/E/C/00005203, BB/R012393/1] Funding Source: researchfish	TwoBlades foundation; Grains Research and Development Corporation(Grains R&D Corp); University of Minnesota Lieberman-Okinow Endowment; University of Minnesota Lieberman-Stakman Endowment; Experimental Station USDA-National Institute of Food and Agriculture Hatch Funds; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Judith and David Coffey Life Lab; Plant Breeding Institute, University of Sydney; National Center for Biotechnology Information Sequencing Read Archive; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Work described here was supported by the TwoBlades foundation, the Grains Research and Development Corporation (grants US00067 and CSP00161), University of Minnesota Lieberman-Okinow and Stakman Endowments, Experimental Station USDA-National Institute of Food and Agriculture Hatch Funds (project MIN-22-058), and the Biotechnology and Biological Sciences Research Council (project BB/P016855/1). J.C. was supported by the Judith and David Coffey Life Lab and the Plant Breeding Institute, University of Sydney. J.G.E. has a scientific advisory role with the TwoBlades foundation. Sequence data was deposited in the National Center for Biotechnology Information Sequencing Read Archive under bioprojects PRJNA396463 and PRJNA415866. DNA of the rust isolates used in this study is available from R.F.P. under a materials transfer agreement with the University of Sydney. We thank R. East and L. Ma for excellent technical assistance. Additional data are provided in the supplementary materials.	Anderson C, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3011-9; Bernoux M, 2011, CELL HOST MICROBE, V9, P200, DOI 10.1016/j.chom.2011.02.009; Dodds PN, 2010, NAT REV GENET, V11, P539, DOI 10.1038/nrg2812; Dong SM, 2015, CURR OPIN GENET DEV, V35, P57, DOI 10.1016/j.gde.2015.09.001; Ellis JG, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00641; Lee WS, 2012, PLANT PHYSIOL, V160, P582, DOI 10.1104/pp.112.203489; Lei Y, 2017, PHYTOPATHOLOGY, V107, P329, DOI 10.1094/PHYTO-07-16-0261-R; Leonard KJ, 2005, MOL PLANT PATHOL, V6, P99, DOI 10.1111/j.1364-3703.2005.00273.x; Littlefield LJ, 1979, ULTRASTRUCTURE RUST; LUIG NH, 1972, AUST J BIOL SCI, V25, P335, DOI 10.1071/BI9720335; Mago R, 2015, NAT PLANTS, V1, DOI [10.1038/nplants.2015.186, 10.1038/NPLANTS.2015.186]; Miller M. E., 2017, BIORXIV; Olivera P, 2015, PHYTOPATHOLOGY, V105, P917, DOI 10.1094/PHYTO-11-14-0302-FI; Pardey PG, 2013, SCIENCE, V340, P147, DOI 10.1126/science.122970; Park RF, 2007, AUST J AGR RES, V58, P558, DOI 10.1071/AR07117; Park REF, 1999, MYCOL RES, V103, P715, DOI 10.1017/S0953756298007631; Park RF, 2012, ANNU REV PHYTOPATHOL, V50, P219, DOI 10.1146/annurev-phyto-072910-095405; Periyannan S, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006380; Ravensdale M, 2011, MOL PLANT PATHOL, V12, P93, DOI 10.1111/j.1364-3703.2010.00657.x; Rutter WB, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3678-6; Salcedo A, 2017, SCIENCE, V358, P1604, DOI 10.1126/science.aao7294; Schwessinger B., 2017, BIORXIV; Singh RP, 2015, PHYTOPATHOLOGY, V105, P872, DOI 10.1094/PHYTO-01-15-0030-FI; Upadhyaya NM, 2015, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00759; WILLIAMS PG, 1975, T BRIT MYCOL SOC, V64, P23, DOI 10.1016/S0007-1536(75)80072-6	25	102	112	5	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 22	2017	358	6370					1607	+		10.1126/science.aao4810	http://dx.doi.org/10.1126/science.aao4810			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ6BO	29269475	Green Submitted			2022-12-28	WOS:000418448000063
J	Beltrame, A; Staffolani, S				Beltrame, Anna; Staffolani, Silvia			Clinical Diagnosis of Hidradenitis Suppurativa	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Beltrame, Anna; Staffolani, Silvia] Sacro Cuore Don Calabria Hosp, Negrar, Italy	IRCCS Sacro Cuore Don Calabria	Beltrame, A (corresponding author), Sacro Cuore Don Calabria Hosp, Negrar, Italy.	anna.beltrame@sacrocuore.it	Beltrame, Anna/ABB-1434-2020	Beltrame, Anna/0000-0002-7499-5843; staffolani, silvia/0000-0002-3588-3638					0	1	1	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 21	2017	377	25					2474	2474		10.1056/NEJMicm1707912	http://dx.doi.org/10.1056/NEJMicm1707912			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FQ5RZ	29262280				2022-12-28	WOS:000418420000011
J	Caputi, TL; Smith, D; Ayers, JW				Caputi, Theodore L.; Smith, Davey; Ayers, John W.			Suicide Risk Behaviors Among Sexual Minority Adolescents in the United States, 2015	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							ORIENTATION; IDEATION; HEALTH		[Caputi, Theodore L.] Univ Penn, Wharton Sch, Philadelphia, PA 19104 USA; [Smith, Davey] Univ Calif San Diego, Sch Med, La Jolla, CA 92093 USA; [Ayers, John W.] San Diego State Univ, Grad Sch Publ Hlth, San Diego, CA 92182 USA	University of Pennsylvania; University of California System; University of California San Diego; California State University System; San Diego State University	Ayers, JW (corresponding author), 2967 Four Corners St, Chula Vista, CA 91914 USA.	ayers.john.w@gmail.com	Caputi, Theodore/P-8697-2019; Caputi, Theodore/ADP-8818-2022; Smith, David/GQQ-8257-2022	Caputi, Theodore/0000-0003-3498-9032; Caputi, Theodore/0000-0003-3498-9032; Smith, Davey/0000-0003-3603-1733	Joseph Wharton Scholar program; US-Ireland Alliance; University of California, San Diego [P30 AI036214]; Center for AIDS Research, a National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI118422, P30AI036214] Funding Source: NIH RePORTER	Joseph Wharton Scholar program; US-Ireland Alliance; University of California, San Diego(University of California System); Center for AIDS Research, a National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Joseph Wharton Scholar program and the George J. Mitchell scholarship program from the US-Ireland Alliance (both Mr Caputi) and by grant P30 AI036214 from the University of California, San Diego, Center for AIDS Research, a National Institutes of Health-funded program (Dr Smith).	Brener ND, 2013, MMWR RECOMM REP, V62, P1; Hatzenbuehler ML, 2017, JAMA PEDIATR, V171, P322, DOI 10.1001/jamapediatrics.2016.4732; King G, 2000, AM J POLIT SCI, V44, P347, DOI 10.2307/2669316; Mueller AS, 2015, AM J PUBLIC HEALTH, V105, P980, DOI 10.2105/AJPH.2014.302391; Silenzio VMB, 2007, AM J PUBLIC HEALTH, V97, P2017, DOI 10.2105/AJPH.2006.095943; Zaza S, 2016, JAMA-J AM MED ASSOC, V316, P2355, DOI 10.1001/jama.2016.11683	6	30	30	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 19	2017	318	23					2349	2351		10.1001/jama.2017.16908	http://dx.doi.org/10.1001/jama.2017.16908			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FQ3RJ	29260214	Green Accepted, Bronze, Green Published			2022-12-28	WOS:000418274000024
J	Friedrich, MJ				Friedrich, M. J.			Tuberculosis Update 2017	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 19	2017	318	23					2287	2287		10.1001/jama.2017.18477	http://dx.doi.org/10.1001/jama.2017.18477			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FQ3RJ	29260231				2022-12-28	WOS:000418274000004
J	Green, MJ; Squier, SM				Green, Michael J.; Squier, Susan M.			Graphic Medicine: The Best of 2017	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Green, Michael J.] Penn State Coll Med, Dept Humanities, 500 Univ Dr, Hershey, PA 17033 USA; [Green, Michael J.] Penn State Coll Med, Dept Med, Hershey, PA 17033 USA; [Squier, Susan M.] Penn State Univ, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Green, MJ (corresponding author), Penn State Coll Med, Dept Humanities, 500 Univ Dr, Hershey, PA 17033 USA.	mjg15@psu.edu	Green, Martin A/H-7567-2012	Green, Martin A/0000-0002-8860-396X; Green, Michael/0000-0002-4828-4749				Czerwiec M. K, 2017, TAKING TURNS STORIES; Moss M., 2017, LAST THINGS GRAPHIC	2	1	1	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 19	2017	318	23					2280	2281		10.1001/jama.2017.18637	http://dx.doi.org/10.1001/jama.2017.18637			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FQ3RJ	29260201				2022-12-28	WOS:000418274000001
J	Hirata, M; Ishilowa, K; Matsuno, G; Kobayashi, A; Miyagawa, K; Tamura, M; Berthier, C; Kanoda, K				Hirata, Michihiro; Ishilowa, Kyohei; Matsuno, Geoid; Kobayashi, Aldto; Miyagawa, Kazuya; Tamura, Masafumi; Berthier, Claude; Kanoda, Kazushi			Anomalous spin correlations and excitonic instability of interacting 2D Weyl fermions	SCIENCE			English	Article							ELECTRON-ELECTRON INTERACTIONS; STATE; ALPHA-(BEDT-TTF)(2)I-3; RELAXATION; PRESSURE; GRAPHENE; METALS	The Coulomb interaction in systems of quasi-relativistic massless electrons has an unscreened long-range component at variance with conventional correlated metals. We used nuclear magnetic resonance (NMR) measurements to reveal unusual spin correlations of two-dimensional Weyl fermions in an organic material, causing a divergent increase of the Korringa ratio by a factor of 1000 upon cooling, in marked contrast to conventional metallic behavior. Combined with model calculations, we show that this divergence stems from an interaction-driven velocity renormalization that almost exclusively suppresses zero-momentum spin fluctuations. At low temperatures, the NMR relaxation rate shows an unexpected increase; numerical analyses show that this increase corresponds to internode excitonic fluctuations, a precursor to a transition from massless to massive quasiparticles.	[Hirata, Michihiro] Tohoku Univ, Inst Mat Res, Aoba Ku, Sendai, Miyagi 9808577, Japan; [Hirata, Michihiro; Ishilowa, Kyohei; Miyagawa, Kazuya; Kanoda, Kazushi] Univ Tokyo, Dept Appl Phys, Bunkyo Ku, Tokyo 1138656, Japan; [Matsuno, Geoid; Kobayashi, Aldto] Nagoya Univ, Dept Phys, Chikusa Ku, Nagoya, Aichi 4648602, Japan; [Tamura, Masafumi] Tokyo Univ Sci, Fac Sci & Technol, Dept Phys, Noda, Chiba 2788510, Japan; [Berthier, Claude] UPS, UGA, EMFL, LNCMI CNRS UPR3228,Lab Natl Champs Magnet Intense, Boite Postale 166, F-38042 Grenoble 9, France; [Berthier, Claude] INSA, Boite Postale 166, F-38042 Grenoble 9, France	Tohoku University; University of Tokyo; Nagoya University; Tokyo University of Science; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Hirata, M (corresponding author), Tohoku Univ, Inst Mat Res, Aoba Ku, Sendai, Miyagi 9808577, Japan.; Hirata, M; Kanoda, K (corresponding author), Univ Tokyo, Dept Appl Phys, Bunkyo Ku, Tokyo 1138656, Japan.	michihiro_hirata@imr.tohoku.ac.jp; kanoda@ap.t.u-tokyo.ac.jp	Berthier, Claude/D-9686-2011; Kanoda, Kazushi/ABA-8572-2021; Hirata, Michihiro/H-6904-2016	Berthier, Claude/0000-0001-6796-0506; Hirata, Michihiro/0000-0003-2027-751X; Tamura, Masafumi/0000-0003-4420-0699; Kobayashi, Akito/0000-0001-9997-8532	MEXT/JSPS [20110002, 21110519, 24654101, 25220709, 15K05166, 15H02108, 17K05532, 17K14330]; JSPS [66]; MEXT Global Center of Excellence Program at the University of Tokyo [004]; Kurata Memorial Hitachi Science and Technology Foundation; Motizuki Fund of the Yukawa Memorial Foundation; Grants-in-Aid for Scientific Research [17K14330] Funding Source: KAKEN	MEXT/JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); MEXT Global Center of Excellence Program at the University of Tokyo; Kurata Memorial Hitachi Science and Technology Foundation; Motizuki Fund of the Yukawa Memorial Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank K. Nomura for critical discussions and reading of the manuscript, D. Basko for technical help with RG calculations, M. O. Goerbig for support and discussions; J. S. Kinyon for fruitful discussions; and H. Fukuyarna N. Nagaosa, H. Isobe, H. Kohn, Y. Suzurnura, M. Ogata, T. Osada., C. Hotta, H. Yasuoka, D. Liu, H. Nojiri, T. Kihara, H. Mukuda, M. Tokunaga, Y. Maeno, W. Li, M. Potemski, M.-H. Julien, H. Mayaffre, and M. Horvatic for helpful discussions and comments. Supported by MEXT/JSPS KAKENHI grants 20110002, 21110519, 24654101, 25220709, 15K05166, 15H02108, 17K05532 and 17K14330; JSPS Postdoctoral Fellowship for Reseamh Abroad grant 66, 2013; the MEXT Global Center of Excellence Program at the University of Tokyo (Physical Sciences Frontier grant 004); the Kurata Memorial Hitachi Science and Technology Foundation (G.M. and A.K.); and the Motizuki Fund of the Yukawa Memorial Foundation (M.H.). The data presented in this paper are available upon request to the first author.	Beal-Monod MT, 1972, J LOW TEMP PHYS, V9, P73, DOI 10.1007/BF00655487; BULUT N, 1990, PHYS REV LETT, V64, P2723, DOI 10.1103/PhysRevLett.64.2723; Dora B, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.197602; Elias DC, 2011, NAT PHYS, V7, P701, DOI [10.1038/nphys2049, 10.1038/NPHYS2049]; Goerbig MO, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.045415; Goldman M., 1970, SPIN TEMPERATURE NUC; Hirata M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12666; Hirata M, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.195146; Hirata M, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.125133; Ishikawa K, 2016, PHYS REV B, V94, DOI 10.1103/PhysRevB.94.085154; Isobe H, 2016, PHYS REV LETT, V116, DOI 10.1103/PhysRevLett.116.116803; Isobe H, 2012, J PHYS SOC JPN, V81, DOI 10.1143/JPSJ.81.113704; Itaya M, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.227003; Katayama S, 2006, J PHYS SOC JPN, V75, DOI 10.1143/JPSJ.75.054705; KELDYSH LV, 1965, FIZ TVERD TELA+, V6, P2219; Khveshchenko DV, 2009, J PHYS-CONDENS MAT, V21, DOI 10.1088/0953-8984/21/7/075303; Kino H, 2006, J PHYS SOC JPN, V75, DOI 10.1143/JPSJ.75.034704; Kobayashi A, 2007, J PHYS SOC JPN, V76, DOI 10.1143/JPSJ.76.034711; Kotov VN, 2012, REV MOD PHYS, V84, P1067, DOI 10.1103/RevModPhys.84.1067; Li Q, 2016, NAT PHYS, V12, P550, DOI [10.1038/NPHYS3648, 10.1038/nphys3648]; Liu D, 2016, PHYS REV LETT, V116, DOI 10.1103/PhysRevLett.116.226401; Matsuno G, 2017, J PHYS SOC JPN, V86, DOI 10.7566/JPSJ.86.014705; MORIYA T, 1963, J PHYS SOC JPN, V18, P516, DOI 10.1143/JPSJ.18.516; NARATH A, 1968, PHYS REV, V175, P373, DOI 10.1103/PhysRev.175.373; Okvatovity Z, 2016, PHYS REV B, V94, DOI 10.1103/PhysRevB.94.245141; PISARSKI RD, 1984, PHYS REV D, V29, P2423, DOI 10.1103/PhysRevD.29.2423; SCHWENK H, 1985, MOL CRYST LIQ CRYST, V119, P329, DOI 10.1080/00268948508075181; Seo H, 2000, J PHYS SOC JPN, V69, P805, DOI 10.1143/JPSJ.69.805; Tajima N, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.033401; Tajima N, 2006, J PHYS SOC JPN, V75, DOI 10.1143/JPSJ.75.051010; Takagi R, 2016, PHYS REV B, V93, DOI 10.1103/PhysRevB.93.024403; Tanaka Y, 2016, J PHYS SOC JPN, V85, DOI 10.7566/JPSJ.85.104706; Wehling TO, 2014, ADV PHYS, V63, P1, DOI 10.1080/00018732.2014.927109; Wei HZ, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.196403; Yasuoka H, 2017, PHYS REV LETT, V118, DOI 10.1103/PhysRevLett.118.236403	35	50	50	1	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 15	2017	358	6369					1403	1406		10.1126/science.aan5351	http://dx.doi.org/10.1126/science.aan5351			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP8TH	29242340	Green Submitted			2022-12-28	WOS:000417918500034
J	Holsteen, AL; Raza, S; Fan, PY; Kik, PG; Brongersma, ML				Holsteen, Aaron L.; Raza, Soren; Fan, Pengyu; Kik, Pieter G.; Brongersma, Mark L.			Purcell effect for active tuning of light scattering from semiconductor optical antennas	SCIENCE			English	Article							PLANE-WAVE SCATTERING; CIRCULAR-CYLINDER; SURFACE	Subwavelength, high refractive index semiconductor nanostructures support optical resonances that endow them with valuable antenna functions. Control over the intrinsic properties, including their complex refractive index, size, and geometry, has been used to manipulate fundamental light absorption, scattering, and emission processes in nanostructured optoelectronic devices. In this study, we harness the electric and magnetic resonances of such antennas to achieve a very strong dependence of the optical properties on the external environment. Specifically, we illustrate how the resonant scattering wavelength of single silicon nanowires is tunable across the entire visible spectrum by simply moving the height of the nanowires above a metallic mirror. We apply this concept by using a nanoelectromechanical platform to demonstrate active tuning.	[Holsteen, Aaron L.; Raza, Soren; Fan, Pengyu; Kik, Pieter G.; Brongersma, Mark L.] Stanford Univ, Geballe Lab Adv Mat, Stanford, CA 94305 USA; [Kik, Pieter G.] Univ Cent Florida, Coll Opt & Photon, CREOL, Orlando, FL 32816 USA	Stanford University; State University System of Florida; University of Central Florida	Brongersma, ML (corresponding author), Stanford Univ, Geballe Lab Adv Mat, Stanford, CA 94305 USA.	hrongersma@stanford.edu	Raza, Søren/P-7431-2019; Raza, Søren/E-9211-2011; Brongersma, Mark L/R-6099-2016	Raza, Søren/0000-0002-0296-7202; Raza, Søren/0000-0002-0296-7202; Brongersma, Mark L/0000-0003-1777-8970	U.S. Air Force Office of Scientific Research [FA9550-14-1-0389]; Samsung corporation; National Defense Science and Engineering Graduate Fellowship; VILLUM FONDEN [VKR023371]	U.S. Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Samsung corporation(Samsung); National Defense Science and Engineering Graduate Fellowship; VILLUM FONDEN(Villum Fonden)	This research was supported by the U.S. Air Force Office of Scientific Research (grant FA9550-14-1-0389) and the Samsung corporation. A.L.H. acknowledges a National Defense Science and Engineering Graduate Fellowship. S.R. acknowledges support by a grant (VKR023371) from VILLUM FONDEN. We thank R. Zia for valuable discussions. M.L.B. and A.L.H. are inventors on as application 62/486742 held and submitted by Stanford University that covers NEMS actuated high-index optical antennas for light manipulation and control.	Bohren C., 2008, ABSORPTION SCATTERIN; Borghi R, 1997, J OPT SOC AM A, V14, P1500, DOI 10.1364/JOSAA.14.001500; Borghi R, 1996, J OPT SOC AM A, V13, P483, DOI 10.1364/JOSAA.13.000483; Cao LY, 2011, NANO LETT, V11, P1463, DOI 10.1021/nl1040429; Cao LY, 2009, NAT MATER, V8, P643, DOI [10.1038/NMAT2477, 10.1038/nmat2477]; CHANCE RR, 1978, ADV CHEM PHYS, V37, P1, DOI DOI 10.1002/9780470142561.CH1; Evlyukhin AB, 2013, J OPT SOC AM B, V30, P2589, DOI 10.1364/JOSAB.30.002589; FORD GW, 1984, PHYS REP, V113, P195, DOI 10.1016/0370-1573(84)90098-X; Karaveli S, 2013, NANO LETT, V13, P2264, DOI 10.1021/nl400883r; Kinoshita S, 2005, CHEMPHYSCHEM, V6, P1442, DOI 10.1002/cphc.200500007; Kuznetsov AI, 2016, SCIENCE, V354, DOI 10.1126/science.aag2472; MOSKOVITS M, 1982, J CHEM PHYS, V77, P4408, DOI 10.1063/1.444442; MOSKOVITS M, 1985, REV MOD PHYS, V57, P783, DOI 10.1103/RevModPhys.57.783; Motsch M, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/6/063022; Novotny L., 2012, PRINCIPLES NANOOPTIC; Zneludev N. I., 2016, NAT NANOTECHNOL, V11, P16	16	80	80	4	60	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 15	2017	358	6369					1407	1410		10.1126/science.aao5371	http://dx.doi.org/10.1126/science.aao5371			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP8TH	29242341				2022-12-28	WOS:000417918500035
J	Mervis, J				Mervis, Jeffrey			NOT SO FAST	SCIENCE			English	Editorial Material																			0	9	9	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 15	2017	358	6369					1370	1374		10.1126/science.358.6369.1370	http://dx.doi.org/10.1126/science.358.6369.1370			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FP8TH	29242327				2022-12-28	WOS:000417918500015
J	Doroshow, JH; Simon, RM				Doroshow, James H.; Simon, Richard M.			On the Design of Combination Cancer Therapy	CELL			English	Editorial Material							AGENTS	Combination therapy programs are the hallmark of the successful treatment of all forms of human malignancies. In this issue of Cell, Palmer and Sorger present data suggesting that cell culture results indicative of synergistic anticancer drug interactions rarely translate clinically and that the results of combination therapies in mouse models or human clinical trials, even if successful, are best explained by the independent activities of the individually administered drugs.	[Doroshow, James H.; Simon, Richard M.] NCI, Div Canc Treatment & Diag, NIH, Bethesda, MD 20892 USA; [Doroshow, James H.] NCI, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Doroshow, JH (corresponding author), NCI, Div Canc Treatment & Diag, NIH, Bethesda, MD 20892 USA.; Doroshow, JH (corresponding author), NCI, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	doroshoj@mail.nih.gov			Intramural NIH HHS [ZIA BC011078] Funding Source: Medline	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		DEVITA VT, 1973, NEW ENGL J MED, V288, P998, DOI 10.1056/NEJM197305102881905; FREI E, 1965, BLOOD-J HEMATOL, V26, P642, DOI 10.1182/blood.V26.5.642.642; HEWLETT PS, 1950, ANN APPL BIOL, V37, P527, DOI 10.1111/j.1744-7348.1950.tb00973.x; Kummar S, 2010, NAT REV DRUG DISCOV, V9, P843, DOI 10.1038/nrd3216; Kwak EL, 2007, CLIN CANCER RES, V13, P5232, DOI 10.1158/1078-0432.CCR-07-1385; LEICHMAN CG, 1995, J CLIN ONCOL, V13, P1303, DOI 10.1200/JCO.1995.13.6.1303; Palmer AC, 2017, CELL, V171, P1678, DOI 10.1016/j.cell.2017.11.009; Parchment RE, 2016, SEMIN ONCOL, V43, P514, DOI 10.1053/j.seminoncol.2016.07.002; SARTORELLI AC, 1969, CANCER RES, V29, P2292	9	42	43	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 14	2017	171	7					1476	1478		10.1016/j.cell.2017.11.035	http://dx.doi.org/10.1016/j.cell.2017.11.035			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FQ0KF	29245008	Bronze, Green Accepted			2022-12-28	WOS:000418044000005
J	Hosono, Y; Niknafs, YS; Prensner, JR; Iyer, MK; Dhanasekaran, SM; Mehra, R; Pitchiaya, S; Tien, J; Escara-Wilke, J; Poliakov, A; Chu, SC; Saleh, S; Sankar, K; Su, FY; Guo, SL; Qiao, YY; Freier, SM; Bui, HH; Cao, XH; Malik, R; Johnson, TM; Beer, DG; Feng, FY; Zhou, WB; Chinnaiyan, AM				Hosono, Yasuyuki; Niknafs, Yashar S.; Prensner, John R.; Iyer, Matthew K.; Dhanasekaran, Saravana M.; Mehra, Rohit; Pitchiaya, Sethuramasundaram; Tien, Jean; Escara-Wilke, June; Poliakov, Anton; Chu, Shih-Chun; Saleh, Sahal; Sankar, Keerthana; Su, Fengyun; Guo, Shuling; Qiao, Yuanyuan; Freier, Susan M.; Bui, Huynh-Hoa; Cao, Xuhong; Malik, Rohit; Johnson, Timothy M.; Beer, David G.; Feng, Felix Y.; Zhou, Weibin; Chinnaiyan, Arul M.			Oncogenic Role of THOR, a Conserved Cancer/Testis Long Non-coding RNA	CELL			English	Article							ZINC-FINGER TARGETER; BINDING PROTEINS; CANCER; EXPRESSION; PATHWAYS; LOCALIZATION; ANNOTATION; LANDSCAPE; MELANOMA; LINCRNAS	Large-scale transcriptome sequencing efforts have vastly expanded the catalog of long non-coding RNAs (lncRNAs) with varying evolutionary conservation, lineage expression, and cancer specificity. Here, we functionally characterize a novel ultra-conserved lncRNA, THOR (ENSG00000226856), which exhibits expression exclusively in testis and a broad range of human cancers. THOR knockdown and overexpression in multiple cell lines and animal models alters cell or tumor growth supporting an oncogenic role. We discovered a conserved interaction of THOR with IGF2BP1 and show that THOR contributes to the mRNA stabilization activities of IGF2BP1. Notably, transgenic THOR knockout produced fertilization defects in zebrafish and also conferred a resistance to melanoma onset. Likewise, ectopic expression of human THOR in zebrafish accelerated the onset of melanoma. THOR represents a novel class of functionally important cancer/testis lncRNAs whose structure and function have undergone positive evolutionary selection.	[Hosono, Yasuyuki; Niknafs, Yashar S.; Prensner, John R.; Iyer, Matthew K.; Dhanasekaran, Saravana M.; Mehra, Rohit; Pitchiaya, Sethuramasundaram; Tien, Jean; Poliakov, Anton; Chu, Shih-Chun; Saleh, Sahal; Sankar, Keerthana; Su, Fengyun; Qiao, Yuanyuan; Cao, Xuhong; Malik, Rohit; Feng, Felix Y.; Chinnaiyan, Arul M.] Univ Michigan, Michigan Ctr Translat Pathol, Ann Arbor, MI 48109 USA; [Niknafs, Yashar S.; Chinnaiyan, Arul M.] Univ Michigan, Dept Cellular & Mol Biol, Ann Arbor, MI 48109 USA; [Prensner, John R.] Boston Childrens Hosp, Dept Pediat, Boston, MA USA; [Iyer, Matthew K.] Univ Michigan, Dept Computat Med & Bioinformat, Ann Arbor, MI 48109 USA; [Dhanasekaran, Saravana M.; Mehra, Rohit; Malik, Rohit; Chinnaiyan, Arul M.] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Guo, Shuling; Freier, Susan M.; Bui, Huynh-Hoa] Ionis Pharmaceut, Carlsbad, CA USA; [Johnson, Timothy M.] Univ Michigan, Sch Med, Dept Dermatol, Ann Arbor, MI USA; [Johnson, Timothy M.; Beer, David G.; Feng, Felix Y.; Chinnaiyan, Arul M.] Univ Michigan, Comprehens Canc Ctr, Ann Arbor, MI 48109 USA; [Beer, David G.] Univ Michigan, Dept Surg, Sect Thorac Surg, Ann Arbor, MI 48109 USA; [Feng, Felix Y.] Univ Michigan, Dept Radiat Oncol, Ann Arbor, MI 48109 USA; [Zhou, Weibin] Univ Michigan, Dept Pediat & Communicable Dis, Ann Arbor, MI 48109 USA; [Chinnaiyan, Arul M.] Univ Michigan, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA; [Chinnaiyan, Arul M.] Univ Michigan, Dept Urol, Ann Arbor, MI 48109 USA; [Zhou, Weibin] Duke Univ, Ctr Human Dis Modeling, 300 N Duke St, Durham, NC 27701 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Harvard University; Boston Children's Hospital; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Ionis Pharmaceuticals, Inc.; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Howard Hughes Medical Institute; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Duke University	Chinnaiyan, AM (corresponding author), Univ Michigan, Michigan Ctr Translat Pathol, Ann Arbor, MI 48109 USA.; Chinnaiyan, AM (corresponding author), Univ Michigan, Dept Cellular & Mol Biol, Ann Arbor, MI 48109 USA.; Chinnaiyan, AM (corresponding author), Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA.; Chinnaiyan, AM (corresponding author), Univ Michigan, Comprehens Canc Ctr, Ann Arbor, MI 48109 USA.; Chinnaiyan, AM (corresponding author), Univ Michigan, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA.; Chinnaiyan, AM (corresponding author), Univ Michigan, Dept Urol, Ann Arbor, MI 48109 USA.	arul@med.umich.edu	Hosono, Yasuyuki/J-4295-2019; Hosono, Yasuyuki/GOP-1342-2022	Qiao, Yuanyuan/0000-0002-1178-3480; Dhanasekaran, saravana mohan/0000-0002-0489-2224	National Cancer Institute Early Detection Research Network [U01CA214170]; U.S. National Institutes of Health (NIH) [RO1 CA154365]; Genentech Fellowship; Prostate Cancer Foundation; U.S. Department of Defense [W81XWH-13-1-0284]; University of Michigan Cellular and Molecular Biology National Research Service Award Institutional Predoctoral Training Grant; NIH [DK091405, DK081943, F30-CA-200328]; Janette Ferrantino Investigator Award; American Society of Nephrology Carl W. Gottschalk Scholar Research Grant; NATIONAL CANCER INSTITUTE [F30CA200328, R01CA154365, P30CA046592, U01CA214170] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R00DK091405, K99DK091405, P30DK081943] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007315, T32GM007863] Funding Source: NIH RePORTER	National Cancer Institute Early Detection Research Network(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Genentech Fellowship; Prostate Cancer Foundation; U.S. Department of Defense(United States Department of Defense); University of Michigan Cellular and Molecular Biology National Research Service Award Institutional Predoctoral Training Grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Janette Ferrantino Investigator Award; American Society of Nephrology Carl W. Gottschalk Scholar Research Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Shukla, L. Xiao, A. Delekta, and Y. Zhang for technical assistance; J. Shavit and S. Kregel for discussion; and T. Saunders for mice embryos. This work was supported in part by the National Cancer Institute Early Detection Research Network (U01CA214170) and U.S. National Institutes of Health (NIH) grant RO1 CA154365 (D.G.B. and A.M.C.). A.M.C. is an American Cancer Society Research Professor, a Howard Hughes Medical Institute Investigator, and a Taubman Scholar of the University of Michigan. Y.H. was supported by a Genentech Fellowship. R. Malik is supported by a Prostate Cancer Foundation Young Investigator Award and by U.S. Department of Defense Postdoctoral Fellowship W81XWH-13-1-0284. Y.S.N. was supported by a University of Michigan Cellular and Molecular Biology National Research Service Award Institutional Predoctoral Training Grant and by a Prostate Cancer Foundation Young Investigator Award. W.Z. was supported by grants from the NIH (DK091405, DK081943 sub), the Janette Ferrantino Investigator Award, and the American Society of Nephrology Carl W. Gottschalk Scholar Research Grant. Y.S.N. is supported by an NIH F30 grant (F30-CA-200328). S.G., S.M.F., and H.-H.B. are employees of Ionis Pharmaceuticals, which may develop therapeutic ASO compounds against THOR. The University of Michigan will file a patent on THOR as a target and has filed a related technology disclosure around lncRNAs diagnostics in cancer. A.M.C., Y.H., and Y.S.N. will be named co-inventors.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Bell JL, 2013, CELL MOL LIFE SCI, V70, P2657, DOI 10.1007/s00018-012-1186-z; Berghmans S, 2005, P NATL ACAD SCI USA, V102, P407, DOI 10.1073/pnas.0406252102; Bray NL, 2016, NAT BIOTECHNOL, V34, P525, DOI 10.1038/nbt.3519; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Calin GA, 2007, CANCER CELL, V12, P215, DOI 10.1016/j.ccr.2007.07.027; Decker CJ, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a012286; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dovey M, 2009, ZEBRAFISH, V6, P397, DOI 10.1089/zeb.2009.0606; Fratta E, 2011, MOL ONCOL, V5, P164, DOI 10.1016/j.molonc.2011.02.001; Gaysinskaya V, 2014, CYTOM PART A, V85A, P556, DOI 10.1002/cyto.a.22463; Glisovic T, 2008, FEBS LETT, V582, P1977, DOI 10.1016/j.febslet.2008.03.004; Hammerle M, 2013, HEPATOLOGY, V58, P1703, DOI 10.1002/hep.26537; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Hasegawa Y, 2010, DEV CELL, V19, P469, DOI 10.1016/j.devcel.2010.08.006; Holman Jerry D, 2014, Curr Protoc Bioinformatics, V46, DOI 10.1002/0471250953.bi1324s46; Hudson RS, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-13; Huppertz I, 2014, METHODS, V65, P274, DOI 10.1016/j.ymeth.2013.10.011; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Iyer MK, 2015, NAT GENET, V47, P199, DOI 10.1038/ng.3192; Karolchik D, 2014, NUCLEIC ACIDS RES, V42, pD764, DOI 10.1093/nar/gkt1168; Kauffmann A, 2008, ONCOGENE, V27, P565, DOI 10.1038/sj.onc.1210700; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; KhosraviFar R, 1996, MOL CELL BIOL, V16, P3923; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Kong L, 2007, NUCLEIC ACIDS RES, V35, pW345, DOI 10.1093/nar/gkm391; Kwan KM, 2007, DEV DYNAM, V236, P3088, DOI 10.1002/dvdy.21343; Langenau DM, 2008, ONCOGENE, V27, P4242, DOI 10.1038/onc.2008.56; Lee S, 2016, CELL, V164, P69, DOI 10.1016/j.cell.2015.12.017; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li JH, 2015, FRONT BIOENG BIOTECH, V2, DOI 10.3389/fbioe.2014.00088; Liberzon A, 2011, BIOINFORMATICS, V27, P1739, DOI 10.1093/bioinformatics/btr260; Lieschke GJ, 2007, NAT REV GENET, V8, P353, DOI 10.1038/nrg2091; Lin MF, 2011, BIOINFORMATICS, V27, pI275, DOI 10.1093/bioinformatics/btr209; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mehra R, 2014, NEOPLASIA, V16, P1121, DOI 10.1016/j.neo.2014.11.006; Mele M, 2015, SCIENCE, V348, P660, DOI 10.1126/science.aaa0355; Nielsen J, 2004, NUCLEIC ACIDS RES, V32, P4368, DOI 10.1093/nar/gkh754; Palanichamy JK, 2016, J CLIN INVEST, V126, P1495, DOI 10.1172/JCI80046; Pitchiaya S, 2012, EMBO REP, V13, P709, DOI 10.1038/embor.2012.85; Poliakov A, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.007039; Raj A, 2008, NAT METHODS, V5, P877, DOI 10.1038/NMETH.1253; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Sahu A, 2015, TRENDS CANCER, V1, P93, DOI 10.1016/j.trecan.2015.08.010; Sanchez-Rivera FJ, 2015, NAT REV CANCER, V15, P387, DOI 10.1038/nrc3950; Sander JD, 2007, NUCLEIC ACIDS RES, V35, pW599, DOI 10.1093/nar/gkm349; Sander JD, 2010, NUCLEIC ACIDS RES, V38, pW462, DOI 10.1093/nar/gkq319; Sauvageau M, 2013, ELIFE, V2, DOI 10.7554/eLife.01749; Scanlan MJ, 2002, IMMUNOL REV, V188, P22, DOI 10.1034/j.1600-065X.2002.18803.x; Simpson AJG, 2005, NAT REV CANCER, V5, P615, DOI 10.1038/nrc1669; St Laurent G, 2015, TRENDS GENET, V31, P239, DOI 10.1016/j.tig.2015.03.007; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Suster Maximiliano L, 2009, Methods Mol Biol, V561, P41, DOI 10.1007/978-1-60327-019-9_3; Tapparel C, 2003, GENE, V323, P189, DOI 10.1016/j.gene.2003.09.038; Ulitsky I, 2013, CELL, V154, P26, DOI 10.1016/j.cell.2013.06.020; Ulitsky I, 2011, CELL, V147, P1537, DOI 10.1016/j.cell.2011.11.055; Uren PJ, 2012, BIOINFORMATICS, V28, P3013, DOI 10.1093/bioinformatics/bts569; Wang L, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt006; Weidensdorfer D, 2009, RNA, V15, P104, DOI 10.1261/rna.1175909; Westerfield M., 2007, ZEBRAFISH BOOK GUIDE; White R, 2013, NAT REV CANCER, V13, P624, DOI 10.1038/nrc3589; Winnepenninckx VR, 2006, JNCI-J NATL CANCER I, V98, P472, DOI 10.1093/jnci/djj103; Zarnegar BJ, 2016, NAT METHODS, V13, P489, DOI [10.1038/NMETH.3840, 10.1038/nmeth.3840]	65	156	165	3	50	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 14	2017	171	7					1559	+		10.1016/j.cell.2017.11.040	http://dx.doi.org/10.1016/j.cell.2017.11.040			34	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FQ0KF	29245011	Green Accepted, Bronze			2022-12-28	WOS:000418044000013
J	Kotloff, KL; Riddle, MS; Platts-Mills, JA; Pavlinac, P; Zaidi, AKM				Kotloff, Karen L.; Riddle, Mark S.; Platts-Mills, James A.; Pavlinac, Patricia; Zaidi, Anita K. M.			Shigellosis	LANCET			English	Review							FLEXNERI 2A VACCINE; GLOBAL ENTERIC MULTICENTER; HEMOLYTIC-UREMIC SYNDROME; IRRITABLE-BOWEL-SYNDROME; UNITED-STATES; DOUBLE-BLIND; ANTIMICROBIAL-RESISTANCE; CHILDHOOD SHIGELLOSIS; RISK-FACTORS; BACILLARY DYSENTERY	Shigellosis is a clinical syndrome caused by invasion of the epithelium lining the terminal ileum, colon, and rectum by Shigella species. Although infections occur globally, and in people of all ages, endemic infections among children aged 1-4 years living in low-income and middle-income settings constitute most of the disease burden. The versatile manifestations of these highly contagious organisms range from acute watery diarrhoea to fulminant dysentery characterised by frequent scant bloody stools with fever, prostration, and abdominal cramps. A broad array of uncommon, but often severe, intestinal and extraintestinal complications can occur. Despite marked reductions in mortality during the past three decades, there are roughly 164 000 annual deaths attributable to shigellosis. Intercontinental dissemination of multiresistant shigella strains, facilitated by travellers and men who have sex with men, has prompted new recommendations for antibiotic therapy. Awareness of disease burden and the emerging threats posed by shigella have accelerated interest in development of shigella vaccines, many of which are being tested in clinical trials.	[Kotloff, Karen L.] Univ Maryland, Sch Med, Ctr Vaccine Dev, Inst Global Hlth,Dept Pediat, Baltimore, MD 21201 USA; [Kotloff, Karen L.] Univ Maryland, Sch Med, Ctr Vaccine Dev, Dept Med,Inst Global Hlth, Baltimore, MD 21201 USA; [Riddle, Mark S.] Naval Med Res Ctr, Silver Spring, MD USA; [Riddle, Mark S.] Uniformed Serv Univ Hlth Sci, Dept Prevent Med & Biostat, Bethesda, MD 20814 USA; [Platts-Mills, James A.] Univ Virginia, Div Infect Dis & Int Hlth, Charlottesville, VA USA; [Pavlinac, Patricia] Univ Washington, Dept Global Hlth, Global Ctr Integrated Hlth Women Adolescents & Ch, Seattle, WA 98195 USA; [Zaidi, Anita K. M.] Bill & Melinda Gates Fdn, Enter & Diarrheal Dis Programme, Seattle, WA USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Naval Medical Research Center (NMRC); Uniformed Services University of the Health Sciences - USA; University of Virginia; University of Washington; University of Washington Seattle; Bill & Melinda Gates Foundation	Kotloff, KL (corresponding author), Univ Maryland, Sch Med, Ctr Vaccine Dev, Inst Global Hlth,Dept Pediat, Baltimore, MD 21201 USA.; Kotloff, KL (corresponding author), Univ Maryland, Sch Med, Ctr Vaccine Dev, Dept Med,Inst Global Hlth, Baltimore, MD 21201 USA.	kkotloff@medicine.umaryland.edu	kotloff, karen l/E-7768-2012; Riddle, Mark/R-8788-2019	kotloff, karen l/0000-0003-1808-6431; Riddle, Mark/0000-0002-0607-7880				Anderson M, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00045; Ashida H, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00219; AVITAL A, 1982, CLIN PEDIATR, V21, P645, DOI 10.1177/000992288202101101; Baker KS, 2015, LANCET INFECT DIS, V15, P913, DOI 10.1016/S1473-3099(15)00002-X; Barry EM, 2013, NAT REV GASTRO HEPAT, V10, P245, DOI 10.1038/nrgastro.2013.12; Bennish ML, 2006, CLIN INFECT DIS, V42, P356, DOI 10.1086/499236; BENNISH ML, 1991, REV INFECT DIS, V13, pS319; BENNISH ML, 1993, AM J GASTROENTEROL, V88, P53; Bhattacharya S, 2013, LANCET INFECT DIS, V13, P1050, DOI 10.1016/S1473-3099(13)70273-1; Bingrui W, 1984, Arch Roum Pathol Exp Microbiol, V43, P285; BLACK RE, 1982, AM J EPIDEMIOL, V115, P315, DOI 10.1093/oxfordjournals.aje.a113308; BLACK RE, 1978, AM J EPIDEMIOL, V108, P47; Boumghar-Bourtchai L, 2008, EMERG INFECT DIS, V14, P1297, DOI 10.3201/eid1408.080147; Bovee L, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-347; Bowen A, 2015, MMWR-MORBID MORTAL W, V64, P318; CDC, 2013, ANTIBIOTIC RESISTANC; CDC, 2017, CDC REC DIAGN MAN SH; Chakraborty S, 2016, CLIN VACCINE IMMUNOL, V23, P315, DOI 10.1128/CVI.00608-15; Chang ZR, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1977-1; Christopher PRH, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006784.pub4; CLEMENS JD, 1986, AM J EPIDEMIOL, V123, P710, DOI 10.1093/oxfordjournals.aje.a114291; CLSI, 2020, PERF STAND ANT SUSC, V40; COHEN D, 1991, J CLIN MICROBIOL, V29, P386, DOI 10.1128/JCM.29.2.386-389.1991; Cohen D, 1997, LANCET, V349, P155, DOI 10.1016/S0140-6736(96)06255-1; COHEN D, 1991, LANCET, V337, P993, DOI 10.1016/0140-6736(91)92657-N; COHEN D, 1992, J INFECT DIS, V165, P785, DOI 10.1093/infdis/165.4.785; Connor TR, 2015, ELIFE, V4, DOI 10.7554/eLife.07335; Coster TS, 1999, INFECT IMMUN, V67, P3437, DOI 10.1128/IAI.67.7.3437-3443.1999; DUPONT HL, 1972, J INFECT DIS, V125, P12, DOI 10.1093/infdis/125.1.12; DUPONT HL, 1989, J INFECT DIS, V159, P1126, DOI 10.1093/infdis/159.6.1126; DUPONT HL, 1973, JAMA-J AM MED ASSOC, V226, P1525, DOI 10.1001/jama.226.13.1525; Faherty C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049980; Farag TH, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002280; FERRECCIO C, 1991, AM J EPIDEMIOL, V134, P614, DOI 10.1093/oxfordjournals.aje.a116134; Fischler GE, 2007, J FOOD PROTECT, V70, P2873, DOI 10.4315/0362-028X-70.12.2873; FORMAL SB, 1991, J INFECT DIS, V164, P533, DOI 10.1093/infdis/164.3.533; Freedman SB, 2016, CLIN INFECT DIS, V62, P1251, DOI 10.1093/cid/ciw099; Gaudreau C, 2011, EMERG INFECT DIS, V17, P1747, DOI 10.3201/eid1709.102034; Gerke C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134478; Gilbart VL, 2015, SEX TRANSM INFECT, V91, P598, DOI 10.1136/sextrans-2015-052014; Goodridge Lawrence D, 2013, Bacteriophage, V3, pe25098; Gray MD, 2015, OPEN FORUM INFECT DI, V2, DOI 10.1093/ofid/ofv134; HALTALIN KC, 1968, J PEDIATR-US, V73, P617, DOI 10.1016/S0022-3476(68)80282-3; Halvorson HA, 2006, AM J GASTROENTEROL, V101, P1894, DOI 10.1111/j.1572-0241.2006.00654.x; The HC, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002055; Havelaar AH, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001923; HENRY FJ, 1987, HUM NUTR-CLIN NUTR, V41C, P243; HERRINGTON DA, 1990, VACCINE, V8, P353, DOI 10.1016/0264-410X(90)90094-3; Holt KE, 2012, NAT GENET, V44, P1056, DOI 10.1038/ng.2369; Hossain MU, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01817; HYAMS KC, 1991, NEW ENGL J MED, V325, P1423, DOI 10.1056/NEJM199111143252006; ISLAM MR, 1994, J TROP PEDIATRICS, V40, P320, DOI 10.1093/tropej/40.6.320; Jehl SP, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002809; Jeong HJ, 2007, EXP PARASITOL, V115, P181, DOI 10.1016/j.exppara.2006.08.002; Jung IS, 2009, J CLIN GASTROENTEROL, V43, P534, DOI 10.1097/MCG.0b013e31818c87d7; Kahsay Atsebaha Gebrekidan, 2016, BMC Res Notes, V9, P422, DOI 10.1186/s13104-016-2236-7; Keddy KH, 2012, CLIN INFECT DIS, V54, P1448, DOI 10.1093/cid/cis224; KHAN MU, 1982, T ROY SOC TROP MED H, V76, P164, DOI 10.1016/0035-9203(82)90266-8; Khan WA, 1999, PEDIATRICS, V103, part. no., DOI 10.1542/peds.103.2.e18; Khan WA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054024; Kotloff KL, 2007, HUM VACCINES, V3, P268, DOI 10.4161/hv.4746; Kotloff KL, 2013, LANCET, V382, P209, DOI 10.1016/S0140-6736(13)60844-2; Kotloff KL, 2002, INFECT IMMUN, V70, P2016, DOI 10.1128/IAI.70.4.2016-2021.2002; KOTLOFF KL, 1995, VACCINE, V13, P495, DOI 10.1016/0264-410X(94)00011-B; KOTLOFF KL, 1995, VACCINE, V13, P1488, DOI 10.1016/0264-410X(95)00102-7; Kotloff KL, 2004, J INFECT DIS, V190, P1745, DOI 10.1086/424680; Kotloff KL, 1999, B WORLD HEALTH ORGAN, V77, P651; Lamba K, 2016, EMERG INFECT DIS, V22, P679, DOI 10.3201/eid2204.151825; Lane CR, 2016, CLIN INFECT DIS, V62, P722, DOI 10.1093/cid/civ1018; Launay O, 2017, EBIOMEDICINE, V22, P164, DOI 10.1016/j.ebiom.2017.07.013; LEE LA, 1991, AM J EPIDEMIOL, V133, P608, DOI 10.1093/oxfordjournals.aje.a115933; LEVINE MM, 1973, J INFECT DIS, V127, P261, DOI 10.1093/infdis/127.3.261; Levine MM, 2007, NAT REV MICROBIOL, V5, P540, DOI 10.1038/nrmicro1662; Li STT, 2007, PLOS MED, V4, P495, DOI 10.1371/journal.pmed.0040098; Liu J, 2016, LANCET, V388, P1291, DOI 10.1016/S0140-6736(16)31529-X; Livio S, 2014, CLIN INFECT DIS, V59, P933, DOI 10.1093/cid/ciu468; Mani S, 2016, VACCINE, V34, P2887, DOI 10.1016/j.vaccine.2016.02.075; Marder EP, 2017, MMWR-MORBID MORTAL W, V66, P397, DOI 10.15585/mmwr.mm6615a1; Matkowskyj KA, 2000, NAT MED, V6, P1048, DOI 10.1038/79563; Mattock E, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00064; McKenzie R, 2008, VACCINE, V26, P3291, DOI 10.1016/j.vaccine.2008.03.079; Meitert T, 1982, Arch Roum Pathol Exp Microbiol, V41, P357; MEL DM, 1965, B WORLD HEALTH ORGAN, V32, P647; Miron D, 2000, PEDIATR INFECT DIS J, V19, P898, DOI 10.1097/00006454-200009000-00022; MOHLEBOETANI JC, 1995, AM J PUBLIC HEALTH, V85, P812, DOI 10.2105/AJPH.85.6.812; Mook P, 2016, EMERG INFECT DIS, V22, P1948, DOI 10.3201/eid2211.160653; MURPHY GS, 1993, ANN INTERN MED, V118, P582, DOI 10.7326/0003-4819-118-8-199304150-00002; MURPHY TV, 1979, PEDIATRICS, V63, P511; Murray K, 2017, EMERG INFECT DIS, V23, P332, DOI 10.3201/eid2302.161203; NELSON JD, 1982, REV INFECT DIS, V4, P546; NELSON JD, 1974, J INFECT DIS, V129, pS222, DOI 10.1093/infdis/129.Supplement_2.S222; Noriega FR, 1999, INFECT IMMUN, V67, P782, DOI 10.1128/IAI.67.2.782-788.1999; Nyholm O, 2015, EMERG INFECT DIS, V21, P891, DOI 10.3201/eid2105.140621; Oaks EV, 2006, VACCINE, V24, P2290, DOI 10.1016/j.vaccine.2005.11.040; Orr N, 2005, INFECT IMMUN, V73, P8027, DOI 10.1128/IAI.73.12.8027-8032.2005; Osler W, 1892, PRINCIPLES PRACTICE; Parisot M, 2016, AM J TROP MED HYG, V95, P26, DOI 10.4269/ajtmh.15-0669; Passwell JH, 2010, VACCINE, V28, P2231, DOI 10.1016/j.vaccine.2009.12.050; Phalipon A, 2009, J IMMUNOL, V182, P2241, DOI 10.4049/jimmunol.0803141; Pourakbari B, 2012, J MICROBIOL IMMUNOL, V45, P147, DOI 10.1016/j.jmii.2011.09.005; Qiu S, 2015, CLIN MICROBIOL INFEC, V21, DOI 10.1016/j.cmi.2014.10.019; Rabbani GH, 2009, PEDIATR INFECT DIS J, V28, P420, DOI 10.1097/INF.0b013e31819510b5; Rahman KM, 2011, VACCINE, V29, P1347, DOI 10.1016/j.vaccine.2010.10.035; Ram PK, 2008, EPIDEMIOL INFECT, V136, P577, DOI 10.1017/S0950268807009351; Raqib R, 1996, GUT, V38, P328, DOI 10.1136/gut.38.3.328; Raqib R, 2006, P NATL ACAD SCI USA, V103, P9178, DOI 10.1073/pnas.0602888103; Raqib R, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-111; Riddle MS, 2016, CLIN VACCINE IMMUNOL, V23, P908, DOI 10.1128/CVI.00224-16; Riddle MS, 2016, AM J GASTROENTEROL, V111, P602, DOI 10.1038/ajg.2016.126; Riddle MS, 2011, VACCINE, V29, P7009, DOI 10.1016/j.vaccine.2011.07.033; ROBBINS JB, 1995, J INFECT DIS, V171, P1387, DOI 10.1093/infdis/171.6.1387; Rohmer L, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-355; Roy SK, 2008, EUR J CLIN NUTR, V62, P849, DOI 10.1038/sj.ejcn.1602795; SACK DA, 1994, LANCET, V343, P1413, DOI 10.1016/S0140-6736(94)92531-3; Salam MA, 1999, BRIT MED J, V318, P939, DOI 10.1136/bmj.318.7188.939; Saps M, 2008, J PEDIATR-US, V152, P812, DOI 10.1016/j.jpeds.2007.11.042; Scallan E, 2011, EMERG INFECT DIS, V17, P16, DOI [10.3201/eid1701.P21101, 10.3201/eid1701.091101p2]; Schaffner DW, 2014, J FOOD PROTECT, V77, P574, DOI 10.4315/0362-028X.JFP-13-366; Shah N, 2009, AM J TROP MED HYG, V80, P609, DOI 10.4269/ajtmh.2009.80.609; Shepherd JG, 2000, INFECT IMMUN, V68, P6056, DOI 10.1128/IAI.68.10.6056-6061.2000; Shiga K., 1906, PHILIPP J SCI, V1, P485; Shimanovich AA, 2017, CLIN VACCINE IMMUNOL, V24, P1, DOI 10.1128/CVI.00412-16; SIMON DG, 1981, J RHEUMATOL, V8, P969; Simon JK, 2011, CLIN IMMUNOL, V139, P185, DOI 10.1016/j.clim.2011.02.003; Sivapalasingam S, 2006, ANTIMICROB AGENTS CH, V50, P49, DOI 10.1128/AAC.50.1.49-54.2006; Soffer N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175256; STRUELENS MJ, 1985, J INFECT DIS, V152, P784, DOI 10.1093/infdis/152.4.784; TACKET CO, 1992, AM J TROP MED HYG, V47, P276, DOI 10.4269/ajtmh.1992.47.276; Talukder KA, 2004, J ANTIMICROB CHEMOTH, V54, P730, DOI 10.1093/jac/dkh425; TAUXE RV, 1986, AM J PUBLIC HEALTH, V76, P627, DOI 10.2105/AJPH.76.6.627; Taylor DN, 2008, ANTIMICROB AGENTS CH, V52, P1179, DOI 10.1128/AAC.01108-07; Thabane M, 2009, AM J GASTROENTEROL, V104, P2267, DOI 10.1038/ajg.2009.302; Thompson CN, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003708; Troeger C, 2017, LANCET INFECT DIS, V17, P909, DOI 10.1016/S1473-3099(17)30276-1; Verdu EF, 2012, AM J GASTROENTEROL, V107, P981, DOI 10.1038/ajg.2012.65; Victora CG, 2000, B WORLD HEALTH ORGAN, V78, P1246; Wahid R, 2013, CLIN IMMUNOL, V148, P35, DOI 10.1016/j.clim.2013.03.009; WHO, 2017, GLOB PRIOR LIST ANT, DOI DOI 10.1016/S1473-3099(17)30753-3; World Health Organization, 2017, SEL US ESS MED	139	226	237	12	50	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 24	2018	391	10122					801	812		10.1016/S0140-6736(17)33296-8	http://dx.doi.org/10.1016/S0140-6736(17)33296-8			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FX4ND	29254859				2022-12-28	WOS:000426054000030
J	Amano, T; Szekely, T; Sandel, B; Nagy, S; Mundkur, T; Langendoen, T; Blanco, D; Soykan, CU; Sutherland, WJ				Amano, Tatsuya; Szekely, Tamas; Sandel, Brody; Nagy, Szabolcs; Mundkur, Taej; Langendoen, Tom; Blanco, Daniel; Soykan, Candan U.; Sutherland, William J.			Successful conservation of global waterbird populations depends on effective governance	NATURE			English	Article							EXTINCTION RISK; CLIMATE-CHANGE; COUNT DATA; DECLINES; BIRDS; BIODIVERSITY; CORRUPTION; FRAMEWORK; ABUNDANCE; PATTERNS	Understanding global patterns of biodiversity change is crucial for conservation research, policies and practices. However, for most ecosystems, the lack of systematically collected data at a global level limits our understanding of biodiversity changes and their localscale drivers. Here we address this challenge by focusing on wetlands, which are among the most biodiverse and productive of any environments(1,2) and which provide essential ecosystem services(3,4), but are also amongst the most seriously threatened ecosystems(3,5). Using birds as an indicator taxon of wetland biodiversity, we model time-series abundance data for 461 waterbird species at 25,769 survey sites across the globe. We show that the strongest predictor of changes in waterbird abundance, and of conservation efforts having beneficial effects, is the effective governance of a country. In areas in which governance is on average less effective, such as western and central Asia, sub-Saharan Africa and South America, waterbird declines are particularly pronounced; a higher protected area coverage of wetland environments facilitates waterbird increases, but only in countries with more effective governance. Our findings highlight that sociopolitical instability can lead to biodiversity loss and undermine the benefit of existing conservation efforts, such as the expansion of protected area coverage. Furthermore, data deficiencies in areas with less effective governance could lead to underestimations of the extent of the current biodiversity crisis.	[Amano, Tatsuya; Sutherland, William J.] Univ Cambridge, Dept Zool, Conservat Sci Grp, David Attenborough Bldg,Pembroke St, Cambridge CB2 3QZ, England; [Amano, Tatsuya] Univ Cambridge, Ctr Study Existential Risk, 16 Mill Lane, Cambridge CB2 1SG, England; [Szekely, Tamas] Univ Bath, Dept Biol & Biochem, Milner Ctr Evolut, Bath BA2 7AY, Avon, England; [Szekely, Tamas] Univ Debrecen, Dept Evolutionary Zool, H-4010 Debrecen, Hungary; [Sandel, Brody] Santa Clara Univ, Dept Biol, 500 El Camino Real, Santa Clara, CA 95053 USA; [Nagy, Szabolcs; Mundkur, Taej; Langendoen, Tom] Wetlands Int Head Off, Horapk 9, NL-6717 LZ Ede, Netherlands; [Blanco, Daniel] Wetlands Int LAC Argentina Off, Capitan Gen Ramon Freire 1512, RA-1426 Buenos Aires, DF, Argentina; [Soykan, Candan U.] Natl Audubon Soc, Conservat Sci, 220 Montgomery St,Suite 1000, San Francisco, CA 94104 USA	University of Cambridge; University of Cambridge; University of Bath; University of Debrecen; Santa Clara University	Amano, T (corresponding author), Univ Cambridge, Dept Zool, Conservat Sci Grp, David Attenborough Bldg,Pembroke St, Cambridge CB2 3QZ, England.; Amano, T (corresponding author), Univ Cambridge, Ctr Study Existential Risk, 16 Mill Lane, Cambridge CB2 1SG, England.	amatatsu830@gmail.com	Bagher, Saeed/U-1068-2019; Amano, Tatsuya/E-7367-2010; Szekely, Tamas/I-7089-2016	Amano, Tatsuya/0000-0001-6576-3410; Szekely, Tamas/0000-0003-2093-0056				Abadi F, 2014, ECOL MODEL, V273, P236, DOI 10.1016/j.ecolmodel.2013.11.017; Amano T, 2012, ECOL INDIC, V13, P243, DOI 10.1016/j.ecolind.2011.06.008; Amano T, 2010, BIOL CONSERV, V143, P2238, DOI 10.1016/j.biocon.2010.06.010; [Anonymous], 2005, EC HUM WELL BEING WE; [Anonymous], 2016, LIV PLAN REP 2016 RI; Balmford A, 2003, TRENDS ECOL EVOL, V18, P326, DOI 10.1016/S0169-5347(03)00067-3; Bare M, 2015, ENVIRON RES LETT, V10, DOI 10.1088/1748-9326/10/12/125010; Barnes MD, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12747; BirdLife International NatureServe, 2014, BIRD SPEC DISTR MAPS; Boere GC, 2006, WATERBIRDS WORLD; Bowler DE, 2017, NAT ECOL EVOL, V1, DOI 10.1038/s41559-016-0067; Brandolin PG, 2016, WETL ECOL MANAG, V24, P93, DOI 10.1007/s11273-015-9454-y; Brochet AL, 2016, BIRD CONSERV INT, V26, P1, DOI 10.1017/S0959270915000416; Cardillo M, 2004, PLOS BIOL, V2, P909, DOI 10.1371/journal.pbio.0020197; Ceddia MG, 2014, P NATL ACAD SCI USA, V111, P7242, DOI 10.1073/pnas.1317967111; Center for International Earth Science Information Network (CIESIN) Food and Agriculture Organization of the United Nations (FAO) and Centro Internacional de Agricultura Tropical (CIAT), 2005, GRIDD POP WORLD VERS; de Villemereuil P, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-102; Delany S., 2010, GUIDANCE WATERBIRD M; Donoghue MJ, 1996, PHILOS T R SOC B, V351, P1241, DOI 10.1098/rstb.1996.0107; Dudgeon D, 2006, BIOL REV, V81, P163, DOI 10.1017/S1464793105006950; Dunn EH, 2005, AUK, V122, P338, DOI 10.1642/0004-8038(2005)122[0338:ETSVOT]2.0.CO;2; Freckleton RP, 2002, AM NAT, V160, P712, DOI 10.1086/343873; Friedl MA, 2010, REMOTE SENS ENVIRON, V114, P168, DOI 10.1016/j.rse.2009.08.016; Gelman A., 2003, BAYESIAN DATA ANAL; Gill F., 2015, IOC WORLD BIRD LIST; Green RE, 2005, SCIENCE, V307, P550, DOI 10.1126/science.1106049; GROSSMAN GM, 1995, Q J ECON, V110, P353, DOI 10.2307/2118443; Harring N, 2013, SOC SCI QUART, V94, P660, DOI 10.1111/j.1540-6237.2012.00904.x; Harris I, 2014, INT J CLIMATOL, V34, P623, DOI 10.1002/joc.3711; Hsu A, 2016, ENV PERFORMANCE INDE; Intergovernmental Platform on Biodiversity and Ecosystem Services, 2015, GEN SCOP REP REG SUB; Jetz W, 2012, NATURE, V491, P444, DOI 10.1038/nature11631; Kaufmann Daniel., 2010, WORLDWIDE GOVERNANCE, DOI 10.1017/S1876404511200046; Kirby JS, 2008, BIRD CONSERV INT, V18, pS49, DOI 10.1017/S0959270908000439; Kleijn D, 2014, J APPL ECOL, V51, P289, DOI 10.1111/1365-2664.12193; LeBaron G. S., 2015, 115 CHRISTMAS BIRD C; Link WA, 2006, CONDOR, V108, P13, DOI 10.1650/0010-5422(2006)108[0013:AHMFRA]2.0.CO;2; Link WA, 2007, ECOLOGY, V88, P49, DOI 10.1890/0012-9658(2007)88[49:SCOAPC]2.0.CO;2; Lockwood M, 2010, J ENVIRON MANAGE, V91, P754, DOI 10.1016/j.jenvman.2009.10.005; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; Mace GM, 2008, CONSERV BIOL, V22, P1424, DOI 10.1111/j.1523-1739.2008.01044.x; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; McKee J, 2013, HUM ECOL, V41, P773, DOI 10.1007/s10745-013-9586-8; Miller DC, 2013, CONSERV LETT, V6, P12, DOI 10.1111/j.1755-263X.2012.00270.x; Morrison RIG, 2012, WATERBIRDS, V35, P120, DOI 10.1675/063.035.0112; Nourani E, 2015, BIRD CONSERV INT, V25, P242, DOI 10.1017/S0959270914000264; Owens IPF, 2000, P NATL ACAD SCI USA, V97, P12144, DOI 10.1073/pnas.200223397; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Pavon-Jordan D, 2015, DIVERS DISTRIB, V21, P571, DOI 10.1111/ddi.12300; Pearce-Higgins JW, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.1561; Pekel JF, 2016, NATURE, V540, P418, DOI 10.1038/nature20584; Pimm SL, 2014, SCIENCE, V344, P987, DOI 10.1126/science.1246752; Pocock MJO, 2011, P ROY SOC B-BIOL SCI, V278, P1532, DOI 10.1098/rspb.2010.1971; R Core Team, 2015, R LANGUAGE ENV STAT; ROBBINS CS, 1989, P NATL ACAD SCI USA, V86, P7658, DOI 10.1073/pnas.86.19.7658; Sanderson FJ, 2006, BIOL CONSERV, V131, P93, DOI 10.1016/j.biocon.2006.02.008; Smith RJ, 2003, NATURE, V426, P67, DOI 10.1038/nature02025; Stephens PA, 2016, SCIENCE, V352, P84, DOI 10.1126/science.aac4858; Sturtz S, 2005, J STAT SOFTW, V12, P1, DOI 10.18637/jss.v012.i03; Sundstrom A, 2015, GLOBAL ENVIRON CHANG, V31, P253, DOI 10.1016/j.gloenvcha.2015.02.002; Thomas A., 2004, GEOBUGS USER MANUAL; Umemiya C, 2010, ENVIRON SCI POLICY, V13, P695, DOI 10.1016/j.envsci.2010.07.002; UNEP- WCMC and IUCN, 2015, PROT PLAN WOLRD DAT; United Nations, 2015, SUST DEV KNOWL PLATF; van de Pol MV, 2009, ANIM BEHAV, V77, P753, DOI 10.1016/j.anbehav.2008.11.006; van Roomen M., 2014, WATERBIRD SITE MONIT; van Roomen M., 2011, ANAL POPULATION TREN; Wilman H, 2014, ECOLOGY, V95, P2027, DOI DOI 10.1890/13-1917.1; Young HS, 2016, ANNU REV ECOL EVOL S, V47, P333, DOI 10.1146/annurev-ecolsys-112414-054142	69	112	123	14	162	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 11	2018	553	7687					199	+		10.1038/nature25139	http://dx.doi.org/10.1038/nature25139			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FS4WL	29258291	Green Submitted			2022-12-28	WOS:000419794800035
J	Yin, D; Schwarz, EM; Thomas, CG; Felde, RL; Korf, IF; Cutter, AD; Schartner, CM; Ralston, EJ; Meyer, BJ; Haag, ES				Yin, Da; Schwarz, Erich M.; Thomas, Cristel G.; Felde, Rebecca L.; Korf, Ian F.; Cutter, Asher D.; Schartner, Caitlin M.; Ralston, Edward J.; Meyer, Barbara J.; Haag, Eric S.			Rapid genome shrinkage in a self-fertile nematode reveals sperm competition proteins	SCIENCE			English	Article							CAENORHABDITIS-ELEGANS; SELECTION; EVOLUTION; SIZE; HERMAPHRODITISM; ARABIDOPSIS; BEHAVIOR; GENES; MALES; WILD	To reveal impacts of sexual mode on genome content, we compared chromosome-scale assemblies of the outcrossing nematode Caenorhabditis nigoni to its self-fertile sibling species, C. briggsae. C. nigoni's genome resembles that of outcrossing relatives but encodes 31% more protein-coding genes than C. briggsae. C. nigoni genes lacking C. briggsae orthologs were disproportionately small and male-biased in expression. These include the male secreted short (mss) gene family, which encodes sperm surface glycoproteins conserved only in outcrossing species. Sperm from mss-nullmales of outcrossing C. remanei failed to compete with wild-type sperm, despite normal fertility in noncompetitive mating. Restoring mss to C. briggsae males was sufficient to enhance sperm competitiveness. Thus, sex has a pervasive influence on genome content that can be used to identify sperm competition factors.	[Yin, Da; Thomas, Cristel G.; Felde, Rebecca L.; Haag, Eric S.] Univ Maryland, Dept Biol, College Pk, MD 20742 USA; [Schwarz, Erich M.] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA; [Thomas, Cristel G.; Cutter, Asher D.] Univ Toronto, Dept Ecol & Evolutionary Biol, Toronto, ON M5S 3B2, Canada; [Korf, Ian F.] Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA; [Korf, Ian F.] Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA; [Schartner, Caitlin M.; Ralston, Edward J.; Meyer, Barbara J.] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Schartner, Caitlin M.; Ralston, Edward J.; Meyer, Barbara J.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	University System of Maryland; University of Maryland College Park; Cornell University; University of Toronto; University of California System; University of California Davis; University of California System; University of California Davis; Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Haag, ES (corresponding author), Univ Maryland, Dept Biol, College Pk, MD 20742 USA.; Schwarz, EM (corresponding author), Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA.	ems394@cornell.edu; ehaag@umd.edu	Yin, Da/AAM-1339-2021; Cutter, Asher/A-5647-2009; Cutter, Asher/ABA-9539-2020	Yin, Da/0000-0002-5336-2772; Cutter, Asher/0000-0001-7141-0013; Meyer, Barbara/0000-0002-6530-4588; Schwarz, Erich/0000-0003-3151-4381; Thomas, Cristel/0000-0001-8310-9666; Korf, Ian/0000-0001-5259-6182	USDA [2010-65205-20361]; NIFA-NSF [S-0923812]; NSF [IOS-1355119]; NIH [GM079414]; NIH grant [AI111173, GM030702]; Moore Foundation [4551]; Cornell University start-up funds; NIH Office of Research Infrastructure Programs [P40 OD010440]; NCBI BioProject [PRJNA384657, PRJNA384658];  [NIHS10RR029668]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR029668] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI111173] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079414, R37GM030702, R01GM030702] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	USDA(United States Department of Agriculture (USDA)); NIFA-NSF; NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Moore Foundation(Gordon and Betty Moore Foundation); Cornell University start-up funds; NIH Office of Research Infrastructure Programs; NCBI BioProject; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank E. Antoniou, P. W. Sternberg, C. T. Brown, the Michigan State University High-Performance Computing Center (supported by USDA grant 2010-65205-20361 and NIFA-NSF grant IOS-0923812), and the UC Berkeley V. J. Coates Genomics Sequencing Laboratory (supported by NIHS10RR029668) for sequencing and computational support. We thank G. Williams and R. H. Waterston for transcriptome data, the Caenorhabditis Genomes Project for prepublication access to the genomes of C. afra and C. sp. 34, Z. Zhao and M. A. Felix for nematode and plasmid reagents, and S. Mount for helpful discussions. Supported by NSF award IOS-1355119 and NIH grant GM079414 (E.S.H.); NIH grant AI111173, Moore Foundation grant 4551, and Cornell University start-up funds (E.M.S.); and NIH grant GM030702 (B.J.M.). B.J.M. is an investigator of the Howard Hughes Medical Institute. Some strains were provided by the CGC, which is funded by the NIH Office of Research Infrastructure Programs (P40 OD010440). Data availability and accession codes: C. nigoni genomic and transcriptomic data have been archived as NCBI BioProject accessions PRJNA384657 and PRJNA384658, and the C. nigoni genome assembly as DDBJ/ENA/GenBank accession PDUG00000000. Genome assembly, gene prediction, and gene expression data for C. nigoni, with supplementary data sets for other species, have been archived at the OSF (C. nigoni, https://osf.io/dkbwt and doi:10.17605/osf.io/dkbwt; other species, https://osf.io/b47r8 and doi:10.17605/osf.io/b47r8).	Barriere A, 2009, GENOME RES, V19, P470, DOI 10.1101/gr.081851.108; BELL G, 1982, MASTERPIECE NATURE E; Bi Y, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004993; Bundus JD, 2015, EVOLUTION, V69, P2005, DOI 10.1111/evo.12708; Cassone BJ, 2017, G3-GENES GENOM GENET, V7, P1127, DOI 10.1534/g3.117.040089; CHARNOV E L, 1982; Chasnov JR, 2010, J EVOLUTION BIOL, V23, P539, DOI 10.1111/j.1420-9101.2009.01919.x; Chasnov JR, 2002, GENETICS, V160, P983; Coghlan A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-549; Cutter AD, 2015, BIOESSAYS, V37, P1169, DOI 10.1002/bies.201500083; Cutter AD, 2015, BIOESSAYS, V37, P983, DOI 10.1002/bies.201500053; Denver DR, 2004, NATURE, V430, P679, DOI 10.1038/nature02697; Dolgin ES, 2007, EVOLUTION, V61, P1339, DOI 10.1111/j.1558-5646.2007.00118.x; Emms DM, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0721-2; Felix MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094723; Fierst JL, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005323; Garcia LR, 2007, GENETICS, V175, P1761, DOI 10.1534/genetics.106.068304; Glemin S, 2013, EVOLUTION, V67, P225, DOI 10.1111/j.1558-5646.2012.01778.x; HAMILTON WD, 1967, SCIENCE, V156, P477, DOI 10.1126/science.156.3774.477; Hansen JM, 2015, ELIFE, V4, DOI 10.7554/eLife.05423; Hu TT, 2011, NAT GENET, V43, P476, DOI 10.1038/ng.807; Kiontke K, 2004, P NATL ACAD SCI USA, V101, P9003, DOI 10.1073/pnas.0403094101; Kiontke KC, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-339; Le TS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13215-4; Li RS, 2016, GENOME RES, V26, P1219, DOI 10.1101/gr.204479.116; LIVELY CM, 1990, AM NAT, V135, P489, DOI 10.1086/285058; Noble LM, 2015, CURR BIOL, V25, P2730, DOI 10.1016/j.cub.2015.09.019; Olson MV, 1999, AM J HUM GENET, V64, P18, DOI 10.1086/302219; Palopoli MF, 2008, NATURE, V454, P1019, DOI 10.1038/nature07171; Parra G, 2009, NUCLEIC ACIDS RES, V37, P289, DOI 10.1093/nar/gkn916; Schurko AM, 2009, TRENDS ECOL EVOL, V24, P208, DOI 10.1016/j.tree.2008.11.010; Shi C, 2017, ELIFE, V6, DOI 10.7554/eLife.23493; Sicard A, 2011, ANN BOT-LONDON, V107, P1433, DOI 10.1093/aob/mcr023; Stewart AD, 2002, GENETICS, V160, P975; Tecle E, 2015, MOL REPROD DEV, V82, P635, DOI 10.1002/mrd.22500; Thomas CG, 2015, GENOME RES, V25, P667, DOI 10.1101/gr.187237.114; Thomas CG, 2012, CURR BIOL, V22, P2167, DOI 10.1016/j.cub.2012.09.038; Ting JJ, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001915; Wang J, 2010, SCIENCE, V329, P293, DOI 10.1126/science.1190130; WARD S, 1983, DEV BIOL, V98, P70, DOI 10.1016/0012-1606(83)90336-6; WARD S, 1981, J CELL BIOL, V91, P26, DOI 10.1083/jcb.91.1.26; Wilson LD, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-10; Woodruff GC, 2010, GENETICS, V186, P997, DOI 10.1534/genetics.110.120550; Wright SI, 2008, GENET RES, V90, P119, DOI 10.1017/S0016672307008920	44	49	49	0	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 5	2018	359	6371					55	+		10.1126/science.aao0827	http://dx.doi.org/10.1126/science.aao0827			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FR8KW	29302007	Green Accepted			2022-12-28	WOS:000419324700065
J	Feinmann, J				Feinmann, Jane			The BMJ charity appeal Christmas 2017: help Medecins Sans Frontieres' volunteer doctors help the Rohingya people	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												jane@janefeinmann.com						Cross I., 2017, 2 LITTLE GIRLS	1	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 29	2017	359								j5926	10.1136/bmj.j5926	http://dx.doi.org/10.1136/bmj.j5926			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FR6IV	29288150				2022-12-28	WOS:000419170000002
J	Rubin, R				Rubin, Rita			Most Drinking Water-Associated Disease Outbreaks Linked to Legionella	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item													Rubin, Rita/AAD-1259-2020						0	0	0	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 26	2017	318	24					2420	2420		10.1001/jama.2017.19202	http://dx.doi.org/10.1001/jama.2017.19202			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FQ9ZO	29279942				2022-12-28	WOS:000418720700012
J	Rubin, R				Rubin, Rita			Lyme Disease Spreading Beyond States With Historically High Incidence	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item													Rubin, Rita/AAD-1259-2020						0	0	0	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 26	2017	318	24					2420	2420		10.1001/jama.2017.19129	http://dx.doi.org/10.1001/jama.2017.19129			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FQ9ZO	29279941				2022-12-28	WOS:000418720700013
J	Jaffe, S				Jaffe, Susan			US Children's Health Insurance Program in jeopardy	LANCET			English	Editorial Material																			0	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 23	2017	390	10114					E60	E61		10.1016/S0140-6736(17)33359-7	http://dx.doi.org/10.1016/S0140-6736(17)33359-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FQ9GF	29303724				2022-12-28	WOS:000418669800001
J	Chandra, S				Chandra, Shekhar			My second-chance Ph.D	SCIENCE			English	Editorial Material								I thought that attending a top-ranked university in the West, and especially the United States, would be a guaranteed ticket to success. I was also eager to help the world by studying the impact of pollution on the global environment. As a child growing up in a remote village in India, I had seen some of these effects myself, such as how indoor air pollution from cooking leads to health problems and how changing weather patterns affect farmers' crops. I hoped that the atmospheric science research I planned to pursue could help improve the lives of my family and friends back home and the many others in similar situations. So, when I arrived in the United States in 2007 to start my Ph.D., I was ready to put my head down and get to work.	[Chandra, Shekhar] MIT, Environm Policy, Cambridge, MA 02139 USA; [Chandra, Shekhar] MIT, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Chandra, S (corresponding author), MIT, Environm Policy, Cambridge, MA 02139 USA.; Chandra, S (corresponding author), MIT, Cambridge, MA 02139 USA.	SciCareerEditor@aaas.org							0	0	0	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 22	2017	358	6370					1658	1658		10.1126/science.358.6370.1658	http://dx.doi.org/10.1126/science.358.6370.1658			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FQ6BO	29269478				2022-12-28	WOS:000418448000068
J	Kaiser, J				Kaiser, Jocelyn			Blockade harms Qatari science	SCIENCE			English	News Item																			0	0	0	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 22	2017	358	6370					1519	1519		10.1126/science.358.6370.1519	http://dx.doi.org/10.1126/science.358.6370.1519			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ6BO	29269455				2022-12-28	WOS:000418448000019
J	Akola, J; Jones, RO				Akola, J.; Jones, R. O.			Speeding up crystallization	SCIENCE			English	Editorial Material									[Akola, J.] Norwegian Univ Sci & Technol, Dept Phys, NO-7491 Trondheim, Norway; [Akola, J.] Tampere Univ Technol, Fac Nat Sci, Lab Phys, FI-33101 Tampere, Finland; [Jones, R. O.] Forschungszentrum Julich, PGI 1, D-52425 Julich, Germany; [Jones, R. O.] Forschungszentrum Julich, Julich Aachen Res Alliance HPC, D-52425 Julich, Germany	Norwegian University of Science & Technology (NTNU); Tampere University; Helmholtz Association; Research Center Julich; Helmholtz Association; Research Center Julich	Akola, J (corresponding author), Norwegian Univ Sci & Technol, Dept Phys, NO-7491 Trondheim, Norway.; Akola, J (corresponding author), Tampere Univ Technol, Fac Nat Sci, Lab Phys, FI-33101 Tampere, Finland.	jaakko.akola@ntnu.no; r.jones@fz-juelich.de	Akola, Jaakko/L-6076-2013; Jones, Robert O./B-3235-2014	Akola, Jaakko/0000-0001-9037-7095; Jones, Robert O./0000-0003-1167-4812				Akola J, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.235201; Caravati S, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2801626; Hegedus J, 2008, NAT MATER, V7, P399, DOI 10.1038/nmat2157; Kalikka J, 2016, PHYS REV B, V94, DOI 10.1103/PhysRevB.94.134105; Kalikka J, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.184109; Lee TH, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.145702; Loke D, 2012, SCIENCE, V336, P1566, DOI 10.1126/science.1221561; Rao F, 2017, SCIENCE, V358, P1423, DOI 10.1126/science.aao3212	8	14	14	2	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 15	2017	358	6369					1386	1386		10.1126/science.aaq0476	http://dx.doi.org/10.1126/science.aaq0476			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FP8TH	29242333				2022-12-28	WOS:000417918500021
J	Grover, S				Grover, Samantha			My children help my science	SCIENCE			English	Editorial Material									[Grover, Samantha] La Trobe Univ, Melbourne, Vic, Australia	La Trobe University	Grover, S (corresponding author), La Trobe Univ, Melbourne, Vic, Australia.	SciCareerEditor@aaas.org		Grover, Samantha/0000-0002-8836-4815					0	0	1	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 15	2017	358	6369					1486	1486		10.1126/science.358.6369.1486	http://dx.doi.org/10.1126/science.358.6369.1486			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FP8TH	29242348				2022-12-28	WOS:000417918500049
J	Nie, L; Mei, DH; Xiong, HF; Peng, B; Ren, ZB; Hernandez, XIP; DeLariva, A; Wang, M; Engelhard, MH; Kovarik, L; Datye, AK; Wang, Y				Nie, Lei; Mei, Donghai; Xiong, Haifeng; Peng, Bo; Ren, Zhibo; Hernandez, Xavier Isidro Pereira; DeLariva, Andrew; Wang, Meng; Engelhard, Mark H.; Kovarik, Libor; Datye, Abhaya K.; Wang, Yong			Activation of surface lattice oxygen in single-atom Pt/Ce0(2) for low-temperature CO oxidation	SCIENCE			English	Article							METAL-SUPPORT INTERACTION; CERIA CATALYSTS; REDUCED SURFACES; WATER; PLATINUM; PT/CEO2; ADSORPTION; CEO2(111); INTERFACE; STABILITY	To improve fuel efficiency, advanced combustion engines are being designed to minimize the amount of heat wasted in the exhaust. Hence, future generations of catalysts must perform at temperatures that are 100 degrees C lower than current exhaust-treatment catalysts. Achieving low-temperature activity, while surviving the harsh conditions encountered at high engine loads, remains a formidable challenge. In this study, we demonstrate how atomically dispersed ionic platinum (Pt2+) on ceria (Ce0(2)), which is already thermally stable, can be activated via steam treatment (at 750 degrees C) to simultaneously achieve the goals of low-temperature carbon monoxide (CO) oxidation activity while providing outstanding hydrothermal stability. A new type of active site is created on Ce0(2) in the vicinity of Pt2+, which provides the improved reactivity. These active sites are stable up to 800 degrees C in oxidizing environments.	[Nie, Lei; Mei, Donghai; Peng, Bo; Ren, Zhibo; Wang, Meng; Engelhard, Mark H.; Kovarik, Libor; Wang, Yong] Pacific Northwest Natl Lab, Inst Integrated Catalysis & Environm Mol Sci Lab, POB 999, Richland, WA 99352 USA; [Xiong, Haifeng; DeLariva, Andrew; Datye, Abhaya K.] Univ New Mexico, Dept Chem & Biol Engn, Albuquerque, NM 87131 USA; [Xiong, Haifeng; DeLariva, Andrew; Datye, Abhaya K.] Univ New Mexico, Ctr Microengn Mat, Albuquerque, NM 87131 USA; [Ren, Zhibo] Beijing Univ Chem Technol, State Key Lab Chem Resources Engn, Beijing 100029, Peoples R China; [Hernandez, Xavier Isidro Pereira; Wang, Yong] Washington State Univ, Gene & Linda Voiland Sch Chem Engn & Bioengn, Pullman, WA 99184 USA	United States Department of Energy (DOE); Pacific Northwest National Laboratory; University of New Mexico; University of New Mexico; Beijing University of Chemical Technology; Washington State University	Wang, Y (corresponding author), Pacific Northwest Natl Lab, Inst Integrated Catalysis & Environm Mol Sci Lab, POB 999, Richland, WA 99352 USA.; Datye, AK (corresponding author), Univ New Mexico, Ctr Microengn Mat, Albuquerque, NM 87131 USA.; Wang, Y (corresponding author), Washington State Univ, Gene & Linda Voiland Sch Chem Engn & Bioengn, Pullman, WA 99184 USA.	datye@unm.edu; yong.wang@pnnl.gov	Mei, Donghai/D-3251-2011; Engelhard, Mark/F-1317-2010; Mei, Donghai/A-2115-2012; Datye, Abhaya/AAC-7449-2020; Wang, Meng/K-2132-2014; Hernandez, Xavier Isidro Pereira/S-8790-2019; Datye, Abhaya K/B-2253-2019	Mei, Donghai/0000-0002-0286-4182; Engelhard, Mark/0000-0002-5543-0812; Mei, Donghai/0000-0002-0286-4182; Datye, Abhaya/0000-0002-7126-8659; Wang, Meng/0000-0002-3380-3534; Hernandez, Xavier Isidro Pereira/0000-0002-7020-0011; Datye, Abhaya K/0000-0002-7126-8659; Ren, Zhibo/0000-0001-8034-9752; Nie, Lei/0000-0003-4359-3451; Kovarik, Libor/0000-0002-2418-6925; Peng, Bo/0000-0003-1098-5897; DeLaRiva, Andrew/0000-0001-8755-1013	U.S. Department of Energy (DOE), Office of Science, Basic Energy Sciences (BES) and Division of Chemical Sciences [DE-FG02-05ER15712]; DOE, Office of Energy Efficiency and. Renewable Energy, Vehicle Technology Office; Pacific Northwest National Laboratory (PNNL) Laboratory Directed Research and Development Materials Synthesis and Simulation Across Scales Initiatives; DOE Office of Science BES [DE-AC05-RL01830, FWP-47319]; Office of Biological and Environmental Research, located at PNNL; DOE [DE-AC02-06CH11357]; U.S. Department of Energy (DOE), Office of Science, Basic Energy Sciences (BES) and Division of Chemical Sciences [DE-FG02-05ER15712]; DOE, Office of Energy Efficiency and. Renewable Energy, Vehicle Technology Office; Pacific Northwest National Laboratory (PNNL) Laboratory Directed Research and Development Materials Synthesis and Simulation Across Scales Initiatives; DOE Office of Science BES [DE-AC05-RL01830, FWP-47319]; Office of Biological and Environmental Research, located at PNNL; DOE [DE-AC02-06CH11357]	U.S. Department of Energy (DOE), Office of Science, Basic Energy Sciences (BES) and Division of Chemical Sciences; DOE, Office of Energy Efficiency and. Renewable Energy, Vehicle Technology Office; Pacific Northwest National Laboratory (PNNL) Laboratory Directed Research and Development Materials Synthesis and Simulation Across Scales Initiatives; DOE Office of Science BES(United States Department of Energy (DOE)); Office of Biological and Environmental Research, located at PNNL; DOE(United States Department of Energy (DOE)); U.S. Department of Energy (DOE), Office of Science, Basic Energy Sciences (BES) and Division of Chemical Sciences; DOE, Office of Energy Efficiency and. Renewable Energy, Vehicle Technology Office; Pacific Northwest National Laboratory (PNNL) Laboratory Directed Research and Development Materials Synthesis and Simulation Across Scales Initiatives; DOE Office of Science BES(United States Department of Energy (DOE)); Office of Biological and Environmental Research, located at PNNL; DOE(United States Department of Energy (DOE))	This work was primarily supported by the U.S. Department of Energy (DOE), Office of Science, Basic Energy Sciences (BES) and Division of Chemical Sciences (grant DE-FG02-05ER15712). Additional support from the DOE, Office of Energy Efficiency and. Renewable Energy, Vehicle Technology Office, and the Pacific Northwest National Laboratory (PNNL) Laboratory Directed Research and Development Materials Synthesis and Simulation Across Scales Initiatives (L.N.); and DOE Office of Science BES under DE-AC05-RL01830 and FWP-47319 (Z.R. and D.M.) is acknowledged. Catalyst characterization was primarily performed at the Environmental Molecular Sciences Laboratory, a DOE Office of Science User Facility sponsored by the Office of Biological and Environmental Research, located at PNNL. PNNL is operated for DOE by Battelle. Use of the Advanced Photon Source an Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory, was supported by the DOE under contract no. DE-AC02-06CH11357. We also thank H. Shi for discussions and comments on the manuscript. At data are reported in the main text and supplementary materials. Certain aspects of the per are described in U.S. patent application 62/579,959.	Allian AD, 2011, J AM CHEM SOC, V133, P4498, DOI 10.1021/ja110073u; [Anonymous], [No title captured]; Artiglia L, 2017, J PHYS CHEM LETT, V8, P102, DOI 10.1021/acs.jpclett.6b02314; Balcon S, 2000, APPL CATAL A-GEN, V196, P179, DOI 10.1016/S0926-860X(99)00469-X; Bazin P, 2005, PHYS CHEM CHEM PHYS, V7, P187, DOI 10.1039/b414159h; Binder AJ, 2015, ANGEW CHEM INT EDIT, V54, P13263, DOI 10.1002/anie.201506093; Bruix A, 2014, ANGEW CHEM INT EDIT, V53, P10525, DOI 10.1002/anie.201402342; Bruix A, 2012, J AM CHEM SOC, V134, P8968, DOI 10.1021/ja302070k; Cargnello M, 2013, SCIENCE, V341, P771, DOI 10.1126/science.1240148; Chang HL, 2014, SAE INT J FUELS LUBR, V7, P480, DOI 10.4271/2014-01-1509; Chen MS, 2007, SURF SCI, V601, P5326, DOI 10.1016/j.susc.2007.08.019; Ding K, 2015, SCIENCE, V350, P189, DOI 10.1126/science.aac6368; Dvorak F, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10801; Gatla S, 2016, ACS CATAL, V6, P6151, DOI 10.1021/acscatal.6b00677; Henderson MA, 2003, SURF SCI, V526, P1, DOI 10.1016/S0039-6028(02)02657-2; Jones J, 2016, SCIENCE, V353, P150, DOI 10.1126/science.aaf8800; Ke J, 2015, ACS CATAL, V5, P5164, DOI 10.1021/acscatal.5b00832; Lee J, 2016, J PHYS CHEM C, V120, P25870, DOI 10.1021/acs.jpcc.6b08656; Liu HH, 2014, APPL SURF SCI, V314, P725, DOI 10.1016/j.apsusc.2014.06.196; Lykhach Y, 2012, J PHYS CHEM C, V116, P12103, DOI 10.1021/jp302229x; Molinari M, 2012, J PHYS CHEM C, V116, P7073, DOI 10.1021/jp300576b; Mullins DR, 2012, J PHYS CHEM C, V116, P19419, DOI 10.1021/jp306444h; National Archives and Records Administration, 2016, FED REGISTER, V8, P73478; Nishihata Y, 2002, NATURE, V418, P164, DOI 10.1038/nature00893; NUNAN JG, 1992, J CATAL, V133, P309, DOI 10.1016/0021-9517(92)90242-A; Peterson EJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5885; Schmieg S. J., APPL CATAL B, V6, P127; Szlachetko, 2015, ANGEW CHEM, V127, P8852, DOI DOI 10.1002/ANGE.201503022; Wang CL, 2017, ACS CATAL, V7, P887, DOI 10.1021/acscatal.6b02685; Yang XF, 2013, ACCOUNTS CHEM RES, V46, P1740, DOI 10.1021/ar300361m; Zammit M., 2013, FUTURE AUTOMOTIVE AF	31	814	832	103	1335	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 15	2017	358	6369					1419	+		10.1126/science.aao2109	http://dx.doi.org/10.1126/science.aao2109			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP8TH	29242344				2022-12-28	WOS:000417918500038
J	Poelma, J; Rolland, J				Poelma, Justin; Rolland, Jason			Rethinking digital manufacturing with polymers	SCIENCE			English	Editorial Material							LIQUID INTERFACE PRODUCTION		[Poelma, Justin; Rolland, Jason] Carbon Inc, 1089 Mills Way, Redwood City, CA 94063 USA		Rolland, J (corresponding author), Carbon Inc, 1089 Mills Way, Redwood City, CA 94063 USA.	jason@carbon3d.com						Ahn SH, 2002, RAPID PROTOTYPING J, V8, P248, DOI 10.1108/13552540210441166; Caulfield B, 2007, J MATER PROCESS TECH, V182, P477, DOI 10.1016/j.jmatprotec.2006.09.007; Hegde M, 2017, ADV MATER, V29, DOI 10.1002/adma.201701240; Janusziewicz R, 2016, P NATL ACAD SCI USA, V113, P11703, DOI 10.1073/pnas.1605271113; Ligon SC, 2017, CHEM REV, V117, P10212, DOI 10.1021/acs.chemrev.7b00074; Rogers JA, 2016, P NATL ACAD SCI USA, V113, P11667, DOI 10.1073/pnas.1614927113; Shaffer S, 2014, POLYMER, V55, P5969, DOI 10.1016/j.polymer.2014.07.054; Tumbleston JR, 2015, SCIENCE, V347, P1349, DOI 10.1126/science.aaa2397; Wohlers Associates, 2017, WOHL REP 2017 3D PRI	9	23	33	0	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 15	2017	358	6369					1384	1385		10.1126/science.aaq1351	http://dx.doi.org/10.1126/science.aaq1351			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FP8TH	29242332				2022-12-28	WOS:000417918500020
J	Douglas, AE				Douglas, Angela E.			Big Role for a Tiny Genome	CELL			English	Editorial Material							EVOLUTION; INSECTS	In this issue of Cell, Salem et al. demonstrate a remarkable instance of herbivory dependent on a co-evolved mutualism with specialized bacteria. Despite having a tiny genome and limited metabolic repertoire, the bacteria in Cassida beetles produce pectinases predicted to mediate degradation of plant cell walls in the insect diet.	[Douglas, Angela E.] Cornell Univ, Dept Entomol, Ithaca, NY 14850 USA; [Douglas, Angela E.] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14850 USA	Cornell University; Cornell University	Douglas, AE (corresponding author), Cornell Univ, Dept Entomol, Ithaca, NY 14850 USA.; Douglas, AE (corresponding author), Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14850 USA.	aes326@cornell.edu						Brune A, 2014, NAT REV MICROBIOL, V12, P168, DOI 10.1038/nrmicro3182; Douglas AE, 2015, ANNU REV ENTOMOL, V60, P17, DOI 10.1146/annurev-ento-010814-020822; Kirsch R, 2014, INSECT BIOCHEM MOLEC, V52, P33, DOI 10.1016/j.ibmb.2014.06.008; Moran NA, 1996, P NATL ACAD SCI USA, V93, P2873, DOI 10.1073/pnas.93.7.2873; Moran NA, 2014, ANNU REV MICROBIOL, V68, P195, DOI 10.1146/annurev-micro-091213-112901; Salem H, 2017, CELL, V171, P1520, DOI 10.1016/j.cell.2017.10.029; Voragen AGJ, 2009, STRUCT CHEM, V20, P263, DOI 10.1007/s11224-009-9442-z; Watanabe H, 2010, ANNU REV ENTOMOL, V55, P609, DOI 10.1146/annurev-ento-112408-085319	8	0	0	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 14	2017	171	7					1472	1473		10.1016/j.cell.2017.11.038	http://dx.doi.org/10.1016/j.cell.2017.11.038			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FQ0KF	29245006	Bronze			2022-12-28	WOS:000418044000003
J	Dare, AJ; Onajin-Obembe, B; Makasa, EM				Dare, Anna J.; Onajin-Obembe, Bisola; Makasa, Emmanuel M.			A snapshot of surgical outcomes and needs in Africa	LANCET			English	Editorial Material							SAFE SURGERY; ANESTHESIA; ACCESS		[Dare, Anna J.] Univ Toronto, Dept Surg, Toronto, ON M5B 1T8, Canada; [Dare, Anna J.] Univ Toronto, Ctr Global Heath Res, Toronto, ON M5B 1T8, Canada; [Onajin-Obembe, Bisola] Univ Port Harcourt, Anesthesiol Dept, Port Harcourt, Nigeria; [Makasa, Emmanuel M.] Minist Foreign Affairs Zambia, Lusaka, Zambia; [Makasa, Emmanuel M.] Univ Witwatersrand, Dept Surg, Johannesburg, South Africa	University of Toronto; University of Toronto; University of Port Harcourt; University of Witwatersrand	Dare, AJ (corresponding author), Univ Toronto, Dept Surg, Toronto, ON M5B 1T8, Canada.; Dare, AJ (corresponding author), Univ Toronto, Ctr Global Heath Res, Toronto, ON M5B 1T8, Canada.	anna.dare@mail.utoronto.ca	Onajin-Obembe, Bisola O.I/N-2719-2018	Onajin-Obembe, Bisola O.I/0000-0001-5611-7011				Ahmad T, 2016, BRIT J ANAESTH, V117, P601, DOI 10.1093/bja/aew316; Alkire BC, 2015, LANCET GLOB HEALTH, V3, pE316, DOI 10.1016/S2214-109X(15)70115-4; Biccard BM, 2018, LANCET, V391, P1589, DOI [10.1016/S0140-6736(18)30001-1, 10.1016/s0140-6736(18)30001-1]; Burssa D, 2017, WORLD J SURG, V41, P3038, DOI 10.1007/s00268-017-4271-5; Grimes CE, 2011, WORLD J SURG, V35, P941, DOI 10.1007/s00268-011-1010-1; Haider A, 2017, WORLD J SURG, V41, P2426, DOI 10.1007/s00268-017-4028-1; Kim J., 2014, LANCET BOSTON MA US; LeBrun DG, 2014, SURGERY, V155, P365, DOI 10.1016/j.surg.2013.10.008; Meara JG, 2015, LANCET, V386, P569, DOI 10.1016/S0140-6736(15)60160-X; Rayne S, 2017, BMJ GLOB HEALTH, V2, DOI 10.1136/bmjgh-2016-000170; Shrime MG, 2015, LANCET GLOB HEALTH, V3, pS8, DOI 10.1016/S2214-109X(14)70384-5; Watters DA, 2015, WORLD J SURG, V39, P856, DOI 10.1007/s00268-014-2638-4; Weiser TG, 2009, LANCET, V374, P1113, DOI 10.1016/S0140-6736(09)61161-2	13	10	10	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 21	2018	391	10130					1553	1554		10.1016/S0140-6736(18)30002-3	http://dx.doi.org/10.1016/S0140-6736(18)30002-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GD5JG	29306588				2022-12-28	WOS:000430542700005
J	Gostin, LO				Gostin, Lawrence O.			Language, Science, and Politics The Politicization of Public Health	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Gostin, Lawrence O.] Georgetown Univ, Law Ctr, ONeill Inst Natl & Global Hlth Law, 600 New Jersey Ave NW, Washington, DC 20001 USA	Georgetown University	Gostin, LO (corresponding author), Georgetown Univ, Law Ctr, ONeill Inst Natl & Global Hlth Law, 600 New Jersey Ave NW, Washington, DC 20001 USA.	gostin@law.georgetown.edu		Gostin, Lawrence/0000-0001-5286-4044				Cohen J., SCIENCE; Gostin LO, 2013, JAMA-J AM MED ASSOC, V310, P1127, DOI 10.1001/jama.2013.276527; Lewis Tanya, 2017, SCI AM; McNutt M, STATEMENT NAS NAE NA; Mooney C., WASHINGTON POST; National Academy of Sciences, EINST MEM; Sun L., WASHINGTON POST	7	11	11	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 13	2018	319	6					541	542		10.1001/jama.2017.21763	http://dx.doi.org/10.1001/jama.2017.21763			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FV9LD	29285536				2022-12-28	WOS:000424908400008
J	Barrow, AD; Edeling, MA; Trifonov, V; Luo, JQ; Goyal, P; Bohl, B; Bando, JK; Kim, AH; Walker, J; Andahazy, M; Bugatti, M; Melocchi, L; Vermi, W; Fremont, DH; Cox, S; Cella, M; Schmedt, C; Colonna, M				Barrow, Alexander D.; Edeling, Melissa A.; Trifonov, Vladimir; Luo, Jingqin; Goyal, Piyush; Bohl, Benjamin; Bando, Jennifer K.; Kim, Albert H.; Walker, John; Andahazy, Mary; Bugatti, Mattia; Melocchi, Laura; Vermi, William; Fremont, Daved H.; Cox, Sarah; Cella, Marina; Schmedt, Christian; Colonna, Marco			Natural Killer Cells Control Tumor Growth by Sensing a Growth Factor	CELL			English	Article							CYTOTOXICITY RECEPTOR NKP44; INNATE LYMPHOID-CELLS; PDGF-D; ACTIVATING RECEPTOR; NK-CELL; MELANOMA-CELLS; CANCER; EXPRESSION; CARCINOMA; MICE	Many tumors produce platelet-derived growth factor (PDGF)-DD, which promotes cellular proliferation, epithelial-mesenchymal transition, stromal reaction, and angiogenesis through autocrine and paracrine PDGFR beta signaling. By screening a secretome library, we found that the human immunoreceptor NKp44, encoded by NCR2 and expressed on natural killer (NK) cells and innate lymphoid cells, recognizes PDGF-DD. PDGF-DD engagement of NKp44 triggered NK cell secretion of interferon gamma (IFN)-gamma and tumor necrosis factor alpha (TNF-alpha) that induced tumor cell growth arrest. A distinctive transcriptional signature of PDGF-DD-induced cytokines and the downregulation of tumor cell-cycle genes correlated with NCR2 expression and greater survival in glioblastoma. NKp44 expression in mouse NK cells controlled the dissemination of tumors expressing PDGF-DD more effectively than control mice, an effect enhanced by blockade of the inhibitory receptor CD96 or CpG-oligonucleotide treatment. Thus, while cancer cell production of PDGF-DD supports tumor growth and stromal reaction, it concomitantly activates innate immune responses to tumor expansion.	[Barrow, Alexander D.; Edeling, Melissa A.; Bando, Jennifer K.; Vermi, William; Fremont, Daved H.; Cella, Marina; Colonna, Marco] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Trifonov, Vladimir; Goyal, Piyush; Bohl, Benjamin; Walker, John; Andahazy, Mary; Cox, Sarah; Schmedt, Christian] Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA; [Luo, Jingqin] Washington Univ, Sch Med, Siteman Canc Ctr, Div Publ Hlth Sci,Biostat Core, St Louis, MO 63110 USA; [Kim, Albert H.] Washington Univ, Dept Neurol Surg, Sch Med, St Louis, MO 63110 USA; [Bugatti, Mattia; Melocchi, Laura; Vermi, William] Univ Brescia, Dept Pathol, I-25123 Brescia, Italy	Washington University (WUSTL); Novartis; Siteman Cancer Center; Washington University (WUSTL); Washington University (WUSTL); University of Brescia	Colonna, M (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.	mcolonna@wustl.edu	Cella, Marina/ABA-8564-2020; Kim, Albert H./HGF-0057-2022	Cella, Marina/0000-0003-1230-1313; Barrow, Alexander/0000-0001-5833-0537; Melocchi, Laura/0000-0001-5161-6305; Bando, Jennifer/0000-0002-1331-7424; luo, jingqin/0000-0003-2759-3072; Fremont, Daved/0000-0002-8544-2689	Marie Curie International Outgoing Fellowship; Fondazione Beretta (Brescia, Italy); AIRC [IG 2014/15378]; Ministero della Salute [Ricerca Finalizzata RF-2010-2315888]; NIH [RO1 CA176695]; NCI Cancer Center Support Grant [P30 CA091842]; NATIONAL CANCER INSTITUTE [P30CA091842] Funding Source: NIH RePORTER	Marie Curie International Outgoing Fellowship(European Commission); Fondazione Beretta (Brescia, Italy); AIRC(Fondazione AIRC per la ricerca sul cancro); Ministero della Salute(Ministry of Health, Italy); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI Cancer Center Support Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We would like to thank Susan Gilfillan, Bob Schreiber, Gavin Dunn, Sheila Stewart, Fabio Luna, Whitney Barnes, Todd Fehniger, and Maximilian Rosario for helpful experimental advice and comments. A.D.B. was awarded a Marie Curie International Outgoing Fellowship. M.B. is supported by Fondazione Beretta (Brescia, Italy). W.V. is supported by AIRC (IG 2014/15378) and Ministero della Salute (Ricerca Finalizzata RF-2010-2315888). M. Cella is supported by the NIH (RO1 CA176695). J.L. is supported in part by NCI Cancer Center Support Grant (P30 CA091842).	Ahola-Olli AV, 2017, AM J HUM GENET, V100, P40, DOI 10.1016/j.ajhg.2016.11.007; Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708; Arase H, 2002, SCIENCE, V296, P1323, DOI 10.1126/science.1070884; Barrow AD, 2015, J IMMUNOL, V194, P3317, DOI 10.4049/jimmunol.1402289; Barrow AD, 2011, J CLIN INVEST, V121, P3505, DOI 10.1172/JCI45913; BAST RC, 1981, J CLIN INVEST, V68, P1331, DOI 10.1172/JCI110380; Baychelier F, 2013, BLOOD, V122, P2935, DOI 10.1182/blood-2013-03-489054; Bergsten E, 2001, NAT CELL BIOL, V3, P512, DOI 10.1038/35074588; Bezbradica JS, 2012, CURR OPIN IMMUNOL, V24, P58, DOI 10.1016/j.coi.2011.12.010; Blake SJ, 2016, CLIN CANCER RES, V22, P5183, DOI 10.1158/1078-0432.CCR-16-0933; Boles KS, 2005, BLOOD, V106, P779, DOI 10.1182/blood-2005-02-0817; Braumuller H, 2013, NATURE, V494, P361, DOI 10.1038/nature11824; Cantoni C, 1999, J EXP MED, V189, P787, DOI 10.1084/jem.189.5.787; Carrega P, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9280; Cella M, 2009, NATURE, V457, P722, DOI 10.1038/nature07537; Chang CC, 2005, J IMMUNOL, V174, P1462, DOI 10.4049/jimmunol.174.3.1462; Chen JZ, 2005, BIOCHEM BIOPH RES CO, V329, P976, DOI 10.1016/j.bbrc.2005.02.062; DESCHODTLANCKMAN M, 1990, INT J CANCER, V46, P1124, DOI 10.1002/ijc.2910460629; DEUEL TF, 1983, SCIENCE, V221, P1348, DOI 10.1126/science.6310754; Dolcetti R, 2013, SEMIN CANCER BIOL, V23, P441, DOI 10.1016/j.semcancer.2013.07.005; Fuchs A, 2013, IMMUNITY, V38, P769, DOI 10.1016/j.immuni.2013.02.010; Gajewski TF, 2013, NAT IMMUNOL, V14, P1014, DOI 10.1038/ni.2703; Glatzer T, 2013, IMMUNITY, V38, P1223, DOI 10.1016/j.immuni.2013.05.013; GONG JH, 1994, LEUKEMIA, V8, P652; Gonzalez R, 2010, P NATL ACAD SCI USA, V107, P3552, DOI 10.1073/pnas.0914019107; GORER PA, 1950, BRIT J CANCER, V4, P372, DOI 10.1038/bjc.1950.36; Groh V, 2002, NATURE, V419, P734, DOI 10.1038/nature01112; Ho JW, 2008, J VIROL, V82, P2028, DOI 10.1128/JVI.02065-07; Huang W, 2015, J BIOL CHEM, V290, P9162, DOI 10.1074/jbc.M114.610865; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; Kline J, 2010, CURR OPIN INVEST DR, V11, P1354; LaRochelle WJ, 2002, CANCER RES, V62, P2468; Lefrancois L, 2001, Curr Protoc Immunol, VChapter 3, DOI 10.1002/0471142735.im0319s17; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li SS, 2013, CELL HOST MICROBE, V14, P387, DOI 10.1016/j.chom.2013.09.007; Li XR, 2003, CYTOKINE GROWTH F R, V14, P91, DOI 10.1016/S1359-6101(02)00090-4; Lin YC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5767; Liu CW, 2008, J CLIN INVEST, V118, P1165, DOI 10.1172/JCI33583; Lokker NA, 2002, CANCER RES, V62, P3729; Nakamura K, 2002, LIFE SCI, V70, P791, DOI 10.1016/S0024-3205(01)01454-0; Nazarenko I, 2012, UPSALA J MED SCI, V117, P99, DOI 10.3109/03009734.2012.665097; Nikpay M, 2015, NAT GENET, V47, P1121, DOI 10.1038/ng.3396; Nirschl CJ, 2017, CELL, V170, P127, DOI 10.1016/j.cell.2017.06.016; OI VT, 1983, P NATL ACAD SCI-BIOL, V80, P825, DOI 10.1073/pnas.80.3.825; Raulet DH, 2013, ANNU REV IMMUNOL, V31, P413, DOI 10.1146/annurev-immunol-032712-095951; Reigstad LJ, 2005, FEBS J, V272, P5723, DOI 10.1111/j.1742-4658.2005.04989.x; Robinette ML, 2015, NAT IMMUNOL, V16, P306, DOI 10.1038/ni.3094; Rosental B, 2011, J IMMUNOL, V187, P5693, DOI 10.4049/jimmunol.1102267; SCHNEIDER U, 1977, INT J CANCER, V19, P621, DOI 10.1002/ijc.2910190505; Shim AHR, 2010, P NATL ACAD SCI USA, V107, P11307, DOI 10.1073/pnas.1000806107; Sivori S, 2000, J NEUROIMMUNOL, V107, P220, DOI 10.1016/S0165-5728(00)00221-6; SOULE HD, 1973, J NATL CANCER I, V51, P1409, DOI 10.1093/jnci/51.5.1409; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Takeda K, 2011, J LEUKOCYTE BIOL, V90, P777, DOI 10.1189/jlb.0411208; Ustach CV, 2010, CANCER RES, V70, P9631, DOI 10.1158/0008-5472.CAN-10-0511; Ustach CV, 2005, MOL CELL BIOL, V25, P6279, DOI 10.1128/MCB.25.14.6279-6288.2005; Vitale M, 1998, J EXP MED, V187, P2065, DOI 10.1084/jem.187.12.2065; Wu Q, 2013, CANCER TREAT REV, V39, P640, DOI 10.1016/j.ctrv.2012.11.006; Xu L, 2005, CANCER RES, V65, P5711, DOI 10.1158/0008-5472.CAN-04-4313	59	140	147	3	83	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 25	2018	172	3					534	+		10.1016/j.cell.2017.11.037	http://dx.doi.org/10.1016/j.cell.2017.11.037			34	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FT9BS	29275861	Green Accepted, Bronze			2022-12-28	WOS:000423447600013
J	Abdel-Wahab, N; Shah, M; Lopez-Olivo, MA; Suarez-Almazor, ME				Abdel-Wahab, Noha; Shah, Mohsin; Lopez-Olivo, Maria A.; Suarez-Almazor, Maria E.			Use of Immune Checkpoint Inhibitors in the Treatment of Patients With Cancer and Preexisting Autoimmune Disease A Systematic Review	ANNALS OF INTERNAL MEDICINE			English	Review							ADVANCED MELANOMA; METASTATIC MELANOMA; ADVERSE EVENTS; RHEUMATOID-ARTHRITIS; MUSCULAR SARCOIDOSIS; LUPUS-ERYTHEMATOSUS; MALIGNANT-MELANOMA; MYASTHENIA-GRAVIS; IPILIMUMAB; NIVOLUMAB	Background: Cancer immunotherapy with checkpoint inhibitors (CPIs) is associated with frequent immune-related adverse events (irAEs) and is often not recommended for patients with concomitant autoimmune disease. Purpose: To summarize the evidence on adverse events associated with CPIs in patients with cancer and preexisting autoimmune disease. Data Sources: MEDLINE, EMBASE, Web of Science, PubMed ePubs, and the Cochrane Central Register of Controlled Trials through September 2017 with no language restrictions. Study Selection: Original case reports, case series, and observational studies describing patients with cancer and autoimmune disease who were receiving CPIs. Data Extraction: 2 reviewers independently extracted data and assessed the quality of reporting. Data Synthesis: 123 patients in 49 publications were identified; 92 (75%) had exacerbation of preexisting autoimmune disease, irAEs, or both. No differences in adverse events were observed in patients with active versus inactive disease. Patients receiving immunosuppressive therapy at initiation of CPI therapy seemed to have fewer adverse events than those not receiving treatment. Most flares and irAEs were managed with corticosteroids; 16% required other immunosuppressive therapies. Adverse events improved in more than half of patients without discontinuation of CPI therapy. Three patients died of adverse events. Limitations: The quality and quantity of data were limited. Case reports typically describe unique manifestations and are not generalizable to the population at large. Because there were no prospective observational studies, incidence could not be determined. Conclusion: Flares and irAEs in patients with autoimmune disease who are receiving CPIs can often be managed without discontinuing therapy, although some events may be severe and fatal. Prospective longitudinal studies are needed to establish incidence of adverse events and evaluate risk-benefit ratios and patient preferences in this population.	[Abdel-Wahab, Noha; Shah, Mohsin; Lopez-Olivo, Maria A.; Suarez-Almazor, Maria E.] Univ Texas MD Anderson Canc Ctr, Dept Gen Internal Med, Sect Rheumatol & Clin Immunol, Unit 1465, 1515 Holcombe Blvd, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Suarez-Almazor, ME (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Gen Internal Med, Sect Rheumatol & Clin Immunol, Unit 1465, 1515 Holcombe Blvd, Houston, TX 77030 USA.	msalmazor@mdanderson.org	Shah, Mohsin/H-3025-2019; Lopez-Olivo, Maria/AAD-6510-2019	Shah, Mohsin/0000-0002-3450-4843; Lopez-Olivo, Maria/0000-0002-5165-8393	National Institute of Arthritis and Musculoskeletal and Skin Diseases [AR053593]	National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Dr. Suarez-Almazor had a K24 career award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases while the study was conducted (grant AR053593).	Abdel-Wahab N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160221; Audemard A, 2013, DERMATOLOGY, V227, P146, DOI 10.1159/000353408; Aya F, 2017, ANN ONCOL, V28, P433, DOI 10.1093/annonc/mdw613; Bagley SJ., 2016, CANC TREAT COMMUN, V6, P20, DOI [10.1016/j.ctrc.2016.02.009, DOI 10.1016/J.CTRC.2016.02.009]; Barreto M, 2004, EUR J HUM GENET, V12, P620, DOI 10.1038/sj.ejhg.5201214; Batacchi Z, 2015, THYROID, V25, pA215; Benn Bryan S, 2017, J Thorac Oncol, V12, pe100, DOI 10.1016/j.jtho.2017.03.006; Bergqvist V, 2017, CANCER IMMUNOL IMMUN, V66, P581, DOI 10.1007/s00262-017-1962-6; Bertrand A, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0455-8; Bonigen J, 2017, J EUR ACAD DERMATOL, V31, pe254, DOI 10.1111/jdv.14011; Bostwick A Doran, 2015, J Immunother Cancer, V3, P19, DOI 10.1186/s40425-015-0064-2; Boutros C, 2016, NAT REV CLIN ONCOL, V13, P473, DOI 10.1038/nrclinonc.2016.58; Calabrese C, 2017, RMD OPEN, V3, DOI 10.1136/rmdopen-2016-000412; Calabrese L, 2017, ANN RHEUM DIS, V76, P1, DOI 10.1136/annrheumdis-2016-209782; Cappelli LC, 2017, ARTHRIT CARE RES, V69, P1751, DOI 10.1002/acr.23177; Chia PL, 2016, J IMMUNOTHER, V39, P202, DOI 10.1097/CJI.0000000000000121; Chou S, 2017, J CUTAN PATHOL, V44, P851, DOI 10.1111/cup.13013; Cusnir I, 2017, J RHEUMATOL, V44, P950; Dulos J, 2012, J IMMUNOTHER, V35, P169, DOI 10.1097/CJI.0b013e318247a4e7; Esfahani K, 2017, NEW ENGL J MED, V376, P1989, DOI 10.1056/NEJMc1703047; Gerdes LA, 2016, ANN NEUROL, V80, P294, DOI 10.1002/ana.24715; Gettings EJ, 2015, MULT SCLER J, V21, P670, DOI 10.1177/1352458514549403; Gielisse EAR, 2014, J CROHNS COLITIS, V8, P1742, DOI 10.1016/j.crohns.2014.08.002; Gutzmer R, 2017, EUR J CANCER, V75, P24, DOI 10.1016/j.ejca.2016.12.038; Hegde U, 2017, NEUROLOGY SP6, V88, P1526; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Hughes J, 2015, DIABETES CARE, V38, pe55, DOI 10.2337/dc14-2349; Izzedine H, 2014, INVEST NEW DRUG, V32, P769, DOI 10.1007/s10637-014-0092-7; Johnson DB, 2016, JAMA ONCOL, V2, P234, DOI 10.1001/jamaoncol.2015.4368; Johnson DB, 2015, CANCER IMMUNOL RES, V3, P464, DOI 10.1158/2326-6066.CIR-14-0217; Kageyama SI, 2016, INT CANCER CONF J, V5, P192, DOI 10.1007/s13691-016-0256-8; Kamil F, 2013, AM J GASTROENTEROL, V108, pS404, DOI 10.14309/00000434-201310001-01361; Kato Y, 2016, J EUR ACAD DERMATOL, V30, pE89, DOI 10.1111/jdv.13336; Kaufman HL, 2016, LANCET ONCOL, V17, P1374, DOI 10.1016/S1470-2045(16)30364-3; Kelly WN, 2007, DRUG SAFETY, V30, P367, DOI 10.2165/00002018-200730050-00001; Kwatra Vineet, 2017, J Med Case Rep, V11, P73, DOI 10.1186/s13256-017-1229-z; Kyi C, 2014, J IMMUNOTHER CANCER, V2, DOI 10.1186/s40425-014-0035-z; Larkin J, 2015, NEW ENGL J MED, V373, P23, DOI [10.1056/NEJMoa1504030, 10.1056/NEJMc1509660]; Lau KHV, 2016, MUSCLE NERVE, V54, P157, DOI 10.1002/mus.25141; Lau KHV, 2016, NEUROLOGY SP3, V86; Le Burel S, 2018, ANN RHEUM DIS, V77, P468, DOI 10.1136/annrheumdis-2016-210820; Le Burel S, 2017, EUR J CANCER, V82, P34, DOI 10.1016/j.ejca.2017.05.032; Lee B, 2016, ANN ONCOL, V27, P1174, DOI 10.1093/annonc/mdw056; Lee YH, 2015, Z RHEUMATOL, V74, P230, DOI 10.1007/s00393-014-1415-y; Lee YH, 2009, LUPUS, V18, P9, DOI 10.1177/0961203308093923; Lee YH, 2014, HUM IMMUNOL, V75, P414, DOI 10.1016/j.humimm.2014.02.020; Li G, 2014, DIAGN PATHOL, V9, DOI 10.1186/s13000-014-0157-0; Liu JL, 2009, J EUR ACAD DERMATOL, V23, P425, DOI 10.1111/j.1468-3083.2009.03087.x; Maeda O, 2016, NAGOYA J MED SCI, V78, P119; Massard C, 2016, J CLIN ONCOL, V34, P3119, DOI 10.1200/JCO.2016.67.9761; Matsumura N, 2016, ACTA DERM-VENEREOL, V96, P259, DOI 10.2340/00015555-2212; Maul LV, 2016, J IMMUNOTHER, V39, P188, DOI 10.1097/CJI.0000000000000118; Menzies AM, 2017, ANN ONCOL, V28, P368, DOI 10.1093/annonc/mdw443; Narita T, 2016, J DERMATOL, V43, P210, DOI 10.1111/1346-8138.13028; Ong M, 2016, J IMMUNOTHER CANCER, V4, DOI 10.1186/s40425-016-0171-8; Page DB, 2014, ANNU REV MED, V65, P185, DOI 10.1146/annurev-med-092012-112807; Pedersen M, 2014, CANCER IMMUNOL IMMUN, V63, P1341, DOI 10.1007/s00262-014-1607-y; Phadke Sneha D, 2016, J Investig Med High Impact Case Rep, V4, p2324709616674316; Plachouri KM, 2012, J DTSCH DERMATOL GES, V10, P861; Puri A, 2017, MELANOMA RES, V27, P519, DOI 10.1097/CMR.0000000000000387; Ribas A, 2014, J CLIN ONCOL, V32, DOI 10.1200/jco.2014.32.18_suppl.lba9000; Robert C, 2015, NEW ENGL J MED, V372, P320, DOI 10.1056/NEJMoa1412082; Robert C, 2014, LANCET, V384, P1109, DOI 10.1016/S0140-6736(14)60958-2; Roberts P, 2016, JAMA OPHTHALMOL, V134, P1184, DOI 10.1001/jamaophthalmol.2016.2944; Roche L, 2017, BRIT J DERMATOL, V177, P143; Rosenberg JE, 2016, LANCET, V387, P1909, DOI 10.1016/S0140-6736(16)00561-4; Sahuquillo-Torralba A, 2016, ACTAS DERMO-SIFILOGR, V107, P264, DOI 10.1016/j.ad.2015.07.012; Scalapino KJ, 2008, IMMUNOL REV, V223, P143, DOI 10.1111/j.1600-065X.2008.00639.x; Sharma P, 2015, SCIENCE, V348, P56, DOI 10.1126/science.aaa8172; Shreders A, 2015, J CLIN ONCOL, V33; Spain L, 2016, ANN ONCOL, V27, P1135, DOI 10.1093/annonc/mdw130; Uemura M, 2016, J HEMATOL ONCOL, V9, DOI 10.1186/s13045-016-0309-7; von Euw E, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-35; Weber JS, 2013, J CLIN ONCOL, V31, P4311, DOI 10.1200/JCO.2013.51.4802; Weishaupt C, 2012, J DTSCH DERMATOL GES, V10, P683; Wu J, 2016, INT J RHEUM DIS, V19, P1237, DOI 10.1111/1756-185X.12705; Zhu J, 2016, MUSCLE NERVE, V54, P506, DOI 10.1002/mus.25055; Zmeili O, 2013, ENDOCR REV, P1	78	236	244	7	37	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 16	2018	168	2					121	+		10.7326/M17-2073	http://dx.doi.org/10.7326/M17-2073			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FU8IN	29297009				2022-12-28	WOS:000424096600016
J	Jobin, C				Jobin, Christian			Precision medicine using microbiota	SCIENCE			English	Editorial Material							BACTERIA		[Jobin, Christian] Univ Florida, Dept Med, Dept Infect Dis & Immunol, Gainesville, FL 32611 USA; [Jobin, Christian] Univ Florida, Dept Anat & Cell Biol, Gainesville, FL 32611 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Jobin, C (corresponding author), Univ Florida, Dept Med, Dept Infect Dis & Immunol, Gainesville, FL 32611 USA.; Jobin, C (corresponding author), Univ Florida, Dept Anat & Cell Biol, Gainesville, FL 32611 USA.	christian.jobin@medicine.ufl.edu			National Institutes of Health [R01 DK73338]; University of Florida, Department of Medicine Gatorade Fund; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK073338] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Florida, Department of Medicine Gatorade Fund; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	C.J. is supported by National Institutes of Health grant R01 DK73338 and by the University of Florida, Department of Medicine Gatorade Fund.	Cani PD, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01765; Daillere R, 2016, IMMUNITY, V45, P931, DOI 10.1016/j.immuni.2016.09.009; Geller LT, 2017, SCIENCE, V357, P1156, DOI 10.1126/science.aah5043; Gopalakrishnan V, 2018, SCIENCE, V359, P97, DOI 10.1126/science.aan4236; Iida N, 2013, SCIENCE, V342, P967, DOI 10.1126/science.1240527; Kelly CR, 2015, GASTROENTEROLOGY, V149, P223, DOI 10.1053/j.gastro.2015.05.008; Koppel N, 2017, SCIENCE, V356, DOI 10.1126/science.aag2770; Matson V, 2018, SCIENCE, V359, P104, DOI 10.1126/science.aao3290; Miquel S, 2015, MBIO, V6, DOI 10.1128/mBio.00300-15; Pasolli E, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004977; Plovier H, 2017, NAT MED, V23, P107, DOI 10.1038/nm.4236; Routy B, 2018, SCIENCE, V359, P91, DOI 10.1126/science.aan3706; Sivan A, 2015, SCIENCE, V350, P1084, DOI 10.1126/science.aac4255; Vetizou M, 2015, SCIENCE, V350, P1079, DOI 10.1126/science.aad1329; Viaud S, 2013, SCIENCE, V342, P971, DOI 10.1126/science.1240537	15	66	70	1	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 5	2018	359	6371					32	34		10.1126/science.aar2946	http://dx.doi.org/10.1126/science.aar2946			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FR8KW	29302001				2022-12-28	WOS:000419324700055
J	Palmer, J; Boyce, N; Hall, P; Howe, R				Palmer, Joanna; Boyce, Niall; Hall, Phoebe; Howe, Rhiannon			2017 Wakley Prize Essay	LANCET			English	Editorial Material									[Palmer, Joanna; Hall, Phoebe; Howe, Rhiannon] The Lancet, London EC2Y 5AS, England; [Boyce, Niall] The Lancet Psychiat, London, England		Palmer, J (corresponding author), The Lancet, London EC2Y 5AS, England.								0	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 23	2017	390	10114					2751	2751		10.1016/S0140-6736(17)33361-5	http://dx.doi.org/10.1016/S0140-6736(17)33361-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FQ9GF	29303715				2022-12-28	WOS:000418669800012
J	Lipscombe, LL				Lipscombe, Lorraine L.			Liraglutide reduced a composite renal outcome at a median 4 y in patients with type 2 diabetes and high CV risk	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							CARDIOVASCULAR OUTCOMES		[Lipscombe, Lorraine L.] Womens Coll Hosp, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Womens College Hospital	Lipscombe, LL (corresponding author), Womens Coll Hosp, Toronto, ON, Canada.			Lipscombe, Lorraine/0000-0001-7412-7993				American Diabetes Association, 2017, Diabetes Care, V40, pS75; Marso SP, 2016, NEW ENGL J MED, V375, P311, DOI 10.1056/NEJMoa1603827; Xie XF, 2016, LANCET, V387, P435, DOI 10.1016/S0140-6736(15)00805-3; Zinman B, 2015, NEW ENGL J MED, V373, P2117, DOI 10.1056/NEJMoa1504720; Zoungas S, 2017, LANCET DIABETES ENDO, V5, P431, DOI 10.1016/S2213-8587(17)30104-3	5	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 19	2017	167	12					JC66	JC66		10.7326/ACPJC-2017-167-12-066	http://dx.doi.org/10.7326/ACPJC-2017-167-12-066			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FQ3SD	29255856				2022-12-28	WOS:000418276000006
J	Genova, D; Kolzenburg, S; Wiesmaier, S; Dallanave, E; Neuville, DR; Hess, KU; Dingwell, DB				Di Genova, D.; Kolzenburg, S.; Wiesmaier, S.; Dallanave, E.; Neuville, D. R.; Hess, K. U.; Dingwell, D. B.			A compositional tipping point governing the mobilization and eruption style of rhyolitic magma	NATURE			English	Article							PUYEHUE-CORDON CAULLE; YELLOWSTONE CALDERA; MELT INCLUSIONS; LARGE-VOLUME; EXPLOSIVE VOLCANISM; SILICATE-GLASSES; MEMBER RHYOLITES; HIGH-TEMPERATURE; CHAITEN VOLCANO; AEOLIAN ISLANDS	The most viscous volcanic melts and the largest explosive eruptions(1) on our planet consist of calcalkaline rhyolites(2,3). These eruptions have the potential to influence global climate(4). The eruptive products are commonly very crystal-poor and highly degassed, yet the magma is mostly stored as crystal mushes containing small amounts of interstitial melt with elevated water content(5). It is unclear how magma mushes are mobilized to create large batches of eruptible crystal-free magma. Further, rhyolitic eruptions(6-8) can switch repeatedly between effusive and explosive eruption styles and this transition is difficult to attribute to the rheological effects of water content or crystallinity(9,10). Here we measure the viscosity of a series of melts spanning the compositional range of the Yellowstone volcanic system and find that in a narrow compositional zone, melt viscosity increases by up to two orders of magnitude. These viscosity variations are not predicted by current viscosity models(11,12) and result from melt structure reorganization, as confirmed by Raman spectroscopy. We identify a critical compositional tipping point, independently documented in the global geochemical record of rhyolites, at which rhyolitic melts fluidize or stiffen and that clearly separates effusive from explosive deposits worldwide. This correlation between melt structure, viscosity and eruptive behaviour holds despite the variable water content and other parameters, such as temperature, that are inherent in natural eruptions. Thermodynamic modelling demonstrates how the observed subtle compositional changes that result in fluidization or stiffening of the melt can be induced by crystal growth from the melt or variation in oxygen fugacity. However, the rheological effects of water and crystal content alone cannot explain the correlation between composition and eruptive style. We conclude that the composition of calcalkaline rhyolites is decisive in determining the mobilization and eruption dynamics of Earth's largest volcanic systems, resulting in a better understanding of how the melt structure controls volcanic processes.	[Di Genova, D.] Univ Bristol, Sch Earth Sci, Wills Mem Bldg,Queens Rd, Bristol BS8 1RJ, Avon, England; [Di Genova, D.; Kolzenburg, S.; Wiesmaier, S.; Dallanave, E.; Hess, K. U.; Dingwell, D. B.] Ludwig Maximilians Univ Munchen, Dept Earth & Environm Sci, Theresienstr 41-3, D-80333 Munich, Germany; [Neuville, D. R.] Univ Paris Diderot, Paris Sorbonne Cite, CNRS IPGP UMR 7154, Geomat, Paris, France	University of Bristol; University of Munich; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Universite Paris Cite	Genova, D (corresponding author), Univ Bristol, Sch Earth Sci, Wills Mem Bldg,Queens Rd, Bristol BS8 1RJ, Avon, England.; Genova, D (corresponding author), Ludwig Maximilians Univ Munchen, Dept Earth & Environm Sci, Theresienstr 41-3, D-80333 Munich, Germany.	danilo.digenova@bristol.ac.uk	Di Genova, Danilo/I-3512-2019; Dingwell, Donald B/A-4724-2011; Dallanave, Edoardo/AAS-6344-2020; Kolzenburg, Stephan/AAJ-8260-2020; Hess, Kai-Uwe/C-8211-2009; Neuville, Daniel R./E-7074-2017	Di Genova, Danilo/0000-0002-7370-6739; Dingwell, Donald B/0000-0002-3332-789X; Dallanave, Edoardo/0000-0003-4673-1792; Hess, Kai-Uwe/0000-0003-1860-8543; Neuville, Daniel R./0000-0002-8487-5001; Kolzenburg, Stephan/0000-0002-1364-007X	European Research Council [247076]; DFG [ED 1757/1-1]	European Research Council(European Research Council (ERC)European Commission); DFG(German Research Foundation (DFG))	This study was supported by a European Research Council Advanced Grant to D.B.D. on 'Explosive volcanism in the Earth system: experimental insights' (EVOKES, grant number 247076). E.D. was supported by DFG grant ED 1757/1-1. We thank M. Kaliwoda and R. Hochleitner for Raman measurements at the Mineralogical State Collection Munich (SNSB). In addition, we thank H. W. Lohringer, D. Mueller, and A. Wimmer for assistance during the sample preparation, microprobe analyses and iron titration. Scientific discussions with M. Diez, D. Morgavi and C. M. P. De Campos were greatly appreciated. D. D. G. thanks C. Chelle-Michou and J. Lourenco for their assistance with R programming and H. Mader for comments and suggestions.	Albert PG, 2012, J VOLCANOL GEOTH RES, V229, P74, DOI 10.1016/j.jvolgeores.2012.03.009; Alloway BV, 2015, SCI REP-UK, V5, DOI 10.1038/srep17589; Arce JL, 2005, J VOLCANOL GEOTH RES, V147, P125, DOI 10.1016/j.jvolgeores.2005.03.010; Bachmann O, 2004, J PETROL, V45, P1565, DOI 10.1093/petrology/egh019; Bachmann O, 2014, CONTRIB MINERAL PETR, V167, DOI 10.1007/s00410-014-1025-3; BAKER PE, 1974, CONTRIB MINERAL PETR, V44, P85, DOI 10.1007/BF00385783; Barone G, 2016, GEOCHIM COSMOCHIM AC, V174, P70, DOI 10.1016/j.gca.2015.11.011; Befus KS, 2016, CONTRIB MINERAL PETR, V171, DOI 10.1007/s00410-016-1244-x; Befus KS, 2014, B VOLCANOL, V76, DOI 10.1007/s00445-014-0808-8; Bindeman IN, 2001, J PETROL, V42, P1491, DOI 10.1093/petrology/42.8.1491; Bolte T, 2015, CONTRIB MINERAL PETR, V169, DOI 10.1007/s00410-015-1112-0; Bouhifd MA, 2013, CHEM GEOL, V346, P125, DOI 10.1016/j.chemgeo.2012.10.026; Bryan SE, 2010, EARTH-SCI REV, V102, P207, DOI 10.1016/j.earscirev.2010.07.001; BUTLER RF, 1975, J GEOPHYS RES, V80, P4049, DOI 10.1029/JB080i029p04049; Cabrera A, 2015, J VOLCANOL GEOTH RES, V298, P71, DOI 10.1016/j.jvolgeores.2014.12.014; Carn S.A., 2009, EOS, V90, P205, DOI [10.1029/2009EO240001, DOI 10.1029/2009E0240001]; Castro J, 2002, EARTH PLANET SC LETT, V199, P211, DOI 10.1016/S0012-821X(02)00559-9; Castro JM, 2013, B VOLCANOL, V75, DOI 10.1007/s00445-013-0702-9; Castro JM, 2009, NATURE, V461, P780, DOI 10.1038/nature08458; Cathey HE, 2004, J PETROL, V45, P27, DOI 10.1093/petrology/egg081; Chamberlain KJ, 2014, CONTRIB MINERAL PETR, V168, DOI 10.1007/s00410-014-1034-2; Chevrel MO, 2014, GEOCHIM COSMOCHIM AC, V124, P348, DOI 10.1016/j.gca.2013.08.026; Christiansen R.L., 2001, 729G US GEOL SURV, V729-G, P145, DOI DOI 10.1007/S00445-007-0138-1; Clay PL, 2013, CONTRIB MINERAL PETR, V165, P373, DOI 10.1007/s00410-012-0813-x; De Rosa R, 2003, B VOLCANOL, V65, P530, DOI 10.1007/s00445-003-0281-2; DEROSA R, 1983, J VOLCANOL GEOTH RES, V17, P313, DOI 10.1016/0377-0273(83)90074-4; Di Genova D, 2014, GEOCHIM COSMOCHIM AC, V142, P314, DOI 10.1016/j.gca.2014.07.012; Di Genova D, 2013, J VOLCANOL GEOTH RES, V249, P201, DOI 10.1016/j.jvolgeores.2012.10.017; Di Genova D, 2016, J GEOPHYS RES-PLANET, V121, P740, DOI 10.1002/2016JE005010; Di Genova D, 2016, AM MINERAL, V101, P943, DOI 10.2138/am-2016-5534CCBYNCND; Di Genova D, 2015, J RAMAN SPECTROSC, V46, P1235, DOI 10.1002/jrs.4751; DINGWELL DB, 1991, AM MINERAL, V76, P1560; DINGWELL DB, 1989, AM MINERAL, V74, P1038; DINGWELL DB, 1986, GEOCHIM COSMOCHIM AC, V50, P1261, DOI 10.1016/0016-7037(86)90409-6; DINGWELL DB, 1988, GEOCHIM COSMOCHIM AC, V52, P395, DOI 10.1016/0016-7037(88)90095-6; DINGWELL DB, 1987, GEOCHIM COSMOCHIM AC, V51, P195, DOI 10.1016/0016-7037(87)90231-6; DUNBAR NW, 1989, B VOLCANOL, V51, P177, DOI 10.1007/BF01067954; DUNLOP DJ, 1973, J GEOPHYS RES, V78, P1780, DOI 10.1029/JB078i011p01780; Dunlop DJ, 2002, J GEOPHYS RES-SOL EA, V107, DOI 10.1029/2001JB000487; Edmonds M, 2001, EARTH PLANET SC LETT, V186, P159, DOI 10.1016/S0012-821X(01)00242-4; EICHELBERGER JC, 1986, NATURE, V323, P598, DOI 10.1038/323598a0; EICHELBERGER JC, 1975, GEOL SOC AM BULL, V86, P1381, DOI 10.1130/0016-7606(1975)86<1381:OOAADE>2.0.CO;2; Ellis BS, 2015, B VOLCANOL, V77, DOI 10.1007/s00445-015-0972-5; Ellis BS, 2014, GEOLOGY, V42, P431, DOI 10.1130/G35399.1; Ellis BS, 2010, LITHOS, V120, P475, DOI 10.1016/j.lithos.2010.09.008; Folkes CB, 2011, B VOLCANOL, V73, P1455, DOI 10.1007/s00445-011-0511-y; FRIEDMAN I, 1963, J GEOPHYS RES, V68, P6523, DOI 10.1029/JZ068i024p06523; FYTIKAS M, 1986, J VOLCANOL GEOTH RES, V28, P297, DOI 10.1016/0377-0273(86)90028-4; Gaillard F, 2002, AM MINERAL, V87, P829; Gardner JE, 2017, EARTH PLANET SC LETT, V459, P252, DOI 10.1016/j.epsl.2016.11.037; Gertisser R, 2009, J VOLCANOL GEOTH RES, V186, P387, DOI 10.1016/j.jvolgeores.2009.07.015; Giordano D, 2008, EARTH PLANET SC LETT, V271, P123, DOI 10.1016/j.epsl.2008.03.038; Girard G, 2010, CONTRIB MINERAL PETR, V160, P441, DOI 10.1007/s00410-009-0487-1; Girard G, 2009, J PETROL, V50, P2095, DOI 10.1093/petrology/egp070; Giuli G, 2011, AM MINERAL, V96, P631, DOI 10.2138/am.2011.3464; Gonnermann HM, 2003, NATURE, V426, P432, DOI 10.1038/nature02138; Gualda GAR, 2012, J PETROL, V53, P875, DOI 10.1093/petrology/egr080; Gunnarsson B, 1998, J VOLCANOL GEOTH RES, V83, P1, DOI 10.1016/S0377-0273(98)00017-1; Hammer JE, 1999, B VOLCANOL, V60, P355, DOI 10.1007/s004450050238; HEIKEN G, 1978, J VOLCANOL GEOTH RES, V4, P375, DOI 10.1016/0377-0273(78)90023-9; HIGGINS MW, 1973, GEOL SOC AM BULL, V84, P455, DOI 10.1130/0016-7606(1973)84<455:PONVCO>2.0.CO;2; Hildreth W, 2007, J PETROL, V48, P951, DOI 10.1093/petrology/egm007; Hui HJ, 2007, GEOCHIM COSMOCHIM AC, V71, P403, DOI 10.1016/j.gca.2006.09.003; Kolzenburg S, 2016, GEOCHIM COSMOCHIM AC, V195, P244, DOI 10.1016/j.gca.2016.09.022; Kolzenburg S, 2014, J GEOPHYS RES-SOL EA, V119, P5305, DOI 10.1002/2013JB010931; Kolzenburg S, 2013, GEOCHEM GEOPHY GEOSY, V14, P4936, DOI 10.1002/2013GC004819; Kolzenburg S, 2017, B VOLCANOL, V79, DOI 10.1007/s00445-017-1128-6; Kremers S, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL053312; Kuehn S. C., 2000, WHATS NEW NEWBERRY V, P135; Lafuente B., 2015, HIGHLIGHTS MINERALOG, P1, DOI DOI 10.1515/9783110417104-003; Le Losq C, 2013, CHEM GEOL, V346, P57, DOI 10.1016/j.chemgeo.2012.09.009; Leonard GS, 2002, J VOLCANOL GEOTH RES, V115, P461, DOI 10.1016/S0377-0273(01)00326-2; Liebske C, 2003, GEOCHIM COSMOCHIM AC, V67, P473, DOI 10.1016/S0016-7037(02)01139-0; MACDONALD R, 1987, MINERAL MAG, V51, P183, DOI 10.1180/minmag.1987.051.360.01; Macias JL, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2003JB002551; Manley CR, 1996, AM MINERAL, V81, P158; Martin FF, 2017, ARCHAEOMETRY, V59, P435, DOI 10.1111/arcm.12270; Michaud V, 2000, J VOLCANOL GEOTH RES, V99, P195, DOI 10.1016/S0377-0273(00)00173-6; Morgavi D, 2016, LITHOS, V260, P457, DOI 10.1016/j.lithos.2016.03.026; Mujin M, 2014, GEOLOGY, V42, P611, DOI 10.1130/G35553.1; Mysen BO, 2007, AM MINERAL, V92, P933, DOI 10.2138/am.2007.2334; MYSEN BO, 1978, AM J SCI, V278, P1307, DOI 10.2475/ajs.278.9.1307; Nash BP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044205; Palais J. M., 1989, UNDERSTANDING CLIMAT, V52, P31, DOI [10.1029/GM052p0031., DOI 10.1029/GM052P0031]; Pallister JS, 2013, ANDEAN GEOL, V40, P277, DOI 10.5027/andgeoV40n2-a06; Pe-Piper G, 2008, LITHOS, V106, P110, DOI 10.1016/j.lithos.2008.07.002; Perkins ME, 2002, GEOL SOC AM BULL, V114, P367, DOI 10.1130/0016-7606(2002)114<0367:ESVOTY>2.0.CO;2; PERKINS ME, 1995, GEOL SOC AM BULL, V107, P1484, DOI 10.1130/0016-7606(1995)107<1484:FTOTCI>2.3.CO;2; Philpotts A. R, 2009, PRINCIPLES IGNEOUS M; Piochi M, 2009, GEOCHEM GEOPHY GEOSY, V10, DOI 10.1029/2008GC002176; Pocklington HC, 1940, P CAMB PHILOS SOC, V36, P507; POUCHOU JL, 1991, ELECTRON PROBE QUANTITATION, P31; PULLAIAH G, 1975, EARTH PLANET SC LETT, V28, P133, DOI 10.1016/0012-821X(75)90221-6; Rango T, 2010, WATER AIR SOIL POLL, V208, P221, DOI 10.1007/s11270-009-0161-2; Robock A, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2008JD011652; Rosen SA, 2005, J ARCHAEOL SCI, V32, P775, DOI 10.1016/j.jas.2005.01.001; Rowe MC, 2012, AM MINERAL, V97, P1685, DOI 10.2138/am.2012.4006; Scaillet B, 1999, J PETROL, V40, P381, DOI 10.1093/petrology/40.3.381; Scarfe CM, 1977, CAN MINERAL, V15, P185; Schipper CI, 2015, B VOLCANOL, V77, DOI 10.1007/s00445-015-0925-z; Selbekk RS, 2007, J VOLCANOL GEOTH RES, V160, P42, DOI 10.1016/j.jvolgeores.2006.08.005; SHACKLEY MS, 2016, N M GEOL, V38, P52; Shapiro L. M., 1956, GEOLOGICAL SURVEY C, V1036, P295; Sharma K, 2008, J VOLCANOL GEOTH RES, V178, P719, DOI 10.1016/j.jvolgeores.2008.08.003; SHAW HR, 1972, AM J SCI, V272, P870, DOI 10.2475/ajs.272.9.870; Singer BS, 2008, GEOL SOC AM BULL, V120, P599, DOI 10.1130/B26276.1; SPARKS RSJ, 1981, PHILOS T R SOC A, V299, P241, DOI 10.1098/rsta.1981.0023; Stelten ME, 2015, J PETROL, V56, P1607, DOI 10.1093/petrology/egv047; Stevenson RJ, 1998, B VOLCANOL, V60, P89, DOI 10.1007/s004450050218; STEVENSON RJ, 1995, J VOLCANOL GEOTH RES, V68, P297, DOI 10.1016/0377-0273(95)00015-1; STEVENSON RJ, 1994, NEW ZEAL J GEOL GEOP, V37, P211, DOI 10.1080/00288306.1994.9514616; Stokes S., 1992, QUATERNARY RES, V30, P270; Tauxe L, 2002, GEOCHEM GEOPHY GEOSY, V3, DOI 10.1029/2001GC000241; Tauxe L, 1996, J GEOPHYS RES-SOL EA, V101, P571, DOI 10.1029/95JB03041; Tauxe L, 2010, ESSENTIALS OF PALEOMAGNETISM, P33; TOBOLSKY AV, 1963, J PHYS CHEM-US, V67, P2439, DOI 10.1021/j100805a044; Tuffen H, 2009, J VOLCANOL GEOTH RES, V185, P352, DOI 10.1016/j.jvolgeores.2008.10.021; Ulrich T, 2013, GEOSTAND GEOANAL RES, V37, P169, DOI 10.1111/j.1751-908X.2012.00189.x; Vazquez JA, 2009, J VOLCANOL GEOTH RES, V188, P186, DOI 10.1016/j.jvolgeores.2008.11.030; WALTER RC, 1987, CONTRIB MINERAL PETR, V95, P462, DOI 10.1007/BF00402206; Watt SFL, 2013, ANDEAN GEOL, V40, P216, DOI 10.5027/andgeoV40n2-a02; Watt SFL, 2009, J GEOPHYS RES-SOL EA, V114, DOI 10.1029/2008JB006219; Wiesmaier S, 2012, J PETROL, V53, P2465, DOI 10.1093/petrology/egs056; Wolff JA, 2015, LITHOS, V236, P275, DOI 10.1016/j.lithos.2015.09.002	124	55	56	2	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 14	2017	552	7684					235	+		10.1038/nature24488	http://dx.doi.org/10.1038/nature24488			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ0FK	29239352				2022-12-28	WOS:000418029500043
J	Jena, AB; Olenski, AR; Molitor, D; Miller, N				Jena, Anupam B.; Olenski, Andrew R.; Molitor, David; Miller, Nolan			Association between rainfall and diagnoses of joint or back pain: retrospective claims analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							WEATHER CONDITIONS; OSTEOARTHRITIS; SYMPTOMS; MATTER	OBJECTIVE To study the relation between rainfall and outpatient visits for joint or back pain in a large patient population. DESIGN Observational study. SETTING US Medicare insurance claims data linked to rainfall data from US weather stations. PARTICIPANTS 1 552 842 adults aged >= 65 years attending a total of 11 673 392 outpatient visits with a general internist during 2008-12. MAIN OUTCOME MEASURES The proportion of outpatient visits for joint or back pain related conditions (rheumatoid arthritis, osteoarthritis, spondylosis, intervertebral disc disorders, and other non-traumatic joint disorders) was compared between rainy days and non-rainy days, adjusting for patient characteristics, chronic conditions, and geographic fixed effects (thereby comparing rates of joint or back pain related outpatient visits on rainy days versus non-rainy days within the same area). RESULTS Of the 11 673 392 outpatient visits by Medicare beneficiaries, 2 095 761 (18.0%) occurred on rainy days. In unadjusted and adjusted analyses, the difference in the proportion of patients with joint or back pain between rainy days and non-rainy days was significant (unadjusted, 6.23% v 6.42% of visits, P<0.001; adjusted, 6.35% v 6.39%, P=0.05), but the difference was in the opposite anticipated direction and was so small that it is unlikely to be clinically meaningful. No statistically significant relation was found between the proportion of claims for joint or back pain and the number of rainy days in the week of the outpatient visit. No relation was found among a subgroup of patients with rheumatoid arthritis. CONCLUSION In a large analysis of older Americans insured by Medicare, no relation was found between rainfall and outpatient visits for joint or back pain. A relation may still exist, and therefore larger, more detailed data on disease severity and pain would be useful to support the validity of this commonly held belief.	[Jena, Anupam B.] Harvard Med Sch, Dept Hlth Care Policy, Boston, MA 02115 USA; [Jena, Anupam B.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Jena, Anupam B.] Natl Bur Econ Res, Cambridge, MA 02138 USA; [Olenski, Andrew R.] Columbia Univ, Dept Econ, New York, NY 10027 USA; [Molitor, David; Miller, Nolan] Univ Illinois, Dept Finance, Champaign, IL USA	Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; National Bureau of Economic Research; Columbia University; University of Illinois System; University of Illinois Urbana-Champaign	Jena, AB (corresponding author), Harvard Med Sch, Dept Hlth Care Policy, Boston, MA 02115 USA.; Jena, AB (corresponding author), Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA.; Jena, AB (corresponding author), Natl Bur Econ Res, Cambridge, MA 02138 USA.	jena@hcp.med.harvard.edu		Olenski, Andrew/0000-0002-7461-0536	Office of the Director, National Institutes of Health (NIH) [1DP5OD017897-01]; National Institute on Aging [R01AG053350]; NATIONAL INSTITUTE ON AGING [P01AG005842, R01AG053350] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD017897] Funding Source: NIH RePORTER	Office of the Director, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	All authors have completed the ICMJE uniform disclosure form at (available on request from the corresponding author) and declare: support provided by grants from the Office of the Director, National Institutes of Health (ABJ, NIH early independence award, grant 1DP5OD017897-01) and National Institute on Aging (NM and DM, grant R01AG053350); no financial relationships with any organizations that might have an interest in the submitted work in the previous 3 years; and no other relationships or activities that could appear to have influenced the submitted work.	Abasolo L, 2013, REUMATOL CLIN, V9, P226, DOI 10.1016/j.reuma.2012.09.006; Beilken K, 2017, PAIN MED, V18, P1139, DOI 10.1093/pm/pnw126; Dorleijn DMJ, 2014, PAIN, V155, P808, DOI 10.1016/j.pain.2014.01.018; Drane D, 1997, J RHEUMATOL, V24, P1309; Duong V, 2016, RHEUMATOL INT, V36, P679, DOI 10.1007/s00296-015-3419-6; Madestam A, 2013, Q J ECON, V128, P1633, DOI 10.1093/qje/qjt021; McAlindon T, 2007, AM J MED, V120, P429, DOI 10.1016/j.amjmed.2006.07.036; Menne MJ, 2012, J ATMOS OCEAN TECH, V29, P897, DOI 10.1175/JTECH-D-11-00103.1; Redelmeier DA, 1996, P NATL ACAD SCI USA, V93, P2895, DOI 10.1073/pnas.93.7.2895; Smedslund G, 2011, EUR J PAIN, V15, P5, DOI 10.1016/j.ejpain.2010.05.003; Smedslund G, 2009, ARTHRIT RHEUM-ARTHR, V61, P1243, DOI 10.1002/art.24729; Steffens D, 2014, ARTHRIT CARE RES, V66, P1867, DOI 10.1002/acr.22378; Timmermans EJ, 2015, J RHEUMATOL, V42, P1885, DOI 10.3899/jrheum.141594	13	8	8	2	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 13	2017	359								j5326	10.1136/bmj.j5326	http://dx.doi.org/10.1136/bmj.j5326			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FQ4KY	29237605	hybrid, Green Submitted, Green Published			2022-12-28	WOS:000418327500001
J	Weiser, J; Perez, A; Bradley, H; King, H; Shouse, RL				Weiser, John; Perez, Alejandro; Bradley, Heather; King, Hope; Shouse, R. Luke			Low Prevalence of Hepatitis B Vaccination Among Patients Receiving Medical Care for HIV Infection in the United States, 2009 to 2012	ANNALS OF INTERNAL MEDICINE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ANTIRETROVIRAL THERAPY; NATURAL-HISTORY; MORTALITY; COHORT; ADULTS; RECOMMENDATIONS; IMMUNIZATION; INDIVIDUALS; PROGRESSION	Background: Persons with HIV infection are at increased risk for hepatitis B virus infection. In 2016, the World Health Organization resolved to eliminate hepatitis B as a public health threat by 2030. Objective: To estimate the prevalence of hepatitis B vaccination among U.S. patients receiving medical care for HIV infection ("HIV patients"). Design: Nationally representative cross-sectional survey. Setting: United States. Participants: 18 089 adults receiving HIV medical care who participated in the Medical Monitoring Project during 2009 to 2012. Measurements: Primary outcomes were prevalence of 1) no documentation of hepatitis B vaccination or laboratory evidence of immunity or infection (candidates to initiate vaccination), and 2) initiation of vaccination among candidates, defined as documentation of at least 1 vaccine dose in a 1-year surveillance period during which patients received ongoing HIV medical care. Results: At the beginning of the surveillance period, 44.2% (95% CI, 42.2% to 46.2%) of U.S. HIV patients were candidates to initiate vaccination. By the end of the surveillance period, 9.6% CI, 8.4% to 10.8%) of candidates were vaccinated, 7.5% (CI, 6.4% to 8.6%) had no documented vaccination but had documented infection or immunity, and 82.9% (CI, 81.1% to 84.7%) remained candidates. Among patients at facilities funded by the Ryan White HIV/ AIDS Program (RWHAP), 12.5% (CI, 11.1% to 13.9%) were vaccinated during the surveillance period versus 3.7% (CI, 2.6% to 4.7%) at facilities not funded by RWHAP. At the end of surveillance, 36.7% (CI, 34.4% to 38.9%) of HIV patients were candidates to initiate vaccination. Limitation: The study was not designed to describe vaccine series completion or actual prevalence of immunity. Conclusion: More than one third of U.S. HIV patients had missed opportunities to initiate hepatitis B vaccination. Meeting goals for hepatitis B elimination will require increased vaccination of HIV patients in all practice settings, particularly at facilities not funded by RWHAP.	[Weiser, John; Perez, Alejandro; Bradley, Heather; Shouse, R. Luke] Ctr Dis Control & Prevent, Div HIV AIDS Prevent, 1600 Clifton Rd NE,MS E46, Atlanta, GA 30329 USA; [King, Hope] Ctr Dis Control & Prevent, 1600 Clifton Rd NE,MS G37, Atlanta, GA 30303 USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Weiser, J (corresponding author), Ctr Dis Control & Prevent, Div HIV AIDS Prevent, 1600 Clifton Rd NE,MS E46, Atlanta, GA 30329 USA.	jweiser@cdc.gov		Weiser, John/0000-0003-2310-5641	Centers for Disease Control and Prevention	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	Funding for the Medical Monitoring Project is provided by the Centers for Disease Control and Prevention.	[Anonymous], 1995, MMWR Recomm Rep, V44, P1; Bailey CL, 2008, INT J INFECT DIS, V12, pE77, DOI 10.1016/j.ijid.2008.05.1226; Blanco NB, 2011, JAIDS-J ACQ IMM DEF, V58, P472, DOI 10.1097/QAI.0b013e318237915e; Buchacz Kate, 2015, Open AIDS J, V9, P123, DOI 10.2174/1874613601509010123; Centers for Disease Control and Prevention, 2010, DIST PUBL HLTH RES P; Centers for Disease Control and Prevention, 2017, US 2014 SURV DAT VIR; Centers for Disease Control and Prevention, 2017, HEP B FAQS HLTH PROF; Centers for Disease Control and Prevention US, 2015, 2015 SEX TRANSM DIS; Centers for Disease Control (CDC), 1982, MMWR Morb Mortal Wkly Rep, V31, P317; Chaiklang K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080409; Chun HM, 2010, CLIN INFECT DIS, V50, P426, DOI 10.1086/649885; Fonseca MO, 2005, VACCINE, V23, P2902, DOI 10.1016/j.vaccine.2004.11.057; Frankel Martin R, 2012, Open AIDS J, V6, P67, DOI 10.2174/1874613601206010067; Galant JE, 2012, HIV GUIDE MANAGEMENT, P65; Goldschmidt RH, 2016, AM FAM PHYSICIAN, V94, P708; Groves RM, 2006, PUBLIC OPIN QUART, V70, P646, DOI 10.1093/poq/nfl033; Health Resources and Services Administration, 2017, EXPL NAT AND STAT LE; Heeringa SG, 2017, APPL SURVEY DATA ANA, VSecond, DOI DOI 10.1201/9781315153278; Hoover KW, 2012, SEX TRANSM DIS, V39, P349, DOI 10.1097/OLQ.0b013e318244a923; Hughes AJ, 2018, CLIN INFECT DIS, V66, P485, DOI 10.1093/cid/cix795; Immunization Action Coalition, 2015, STAND ORD ADM HEP B; Institute of Medicine Committee on Immunization Finance Policies and Practices, 2000, CALL SHOTS IMM FIN P; Kellerman SE, 2003, J INFECT DIS, V188, P571, DOI 10.1086/377135; Klein MB, 2016, CLIN INFECT DIS, V63, P1160, DOI 10.1093/cid/ciw531; Konopnicki D, 2005, AIDS, V19, P593, DOI 10.1097/01.aids.0000163936.99401.fe; KROGSGAARD K, 1987, HEPATOLOGY, V7, P37, DOI 10.1002/hep.1840070109; Launay O, 2011, JAMA-J AM MED ASSOC, V305, P1432, DOI 10.1001/jama.2011.351; Mast Eric E., 2006, Morbidity and Mortality Weekly Report, V55, P1; McKibben LJ, 2000, MMWR RECOMM REP, V49, P15; McNaghten AD, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000550; Mena G, 2015, HUM VACC IMMUNOTHER, V11, P2582, DOI 10.1080/21645515.2015.1055424; National Academies of Sciences Engineering and Medicine, 2017, NAT STRAT EL HEP B C; Nikolopoulos GK, 2009, CLIN INFECT DIS, V48, P1763, DOI 10.1086/599110; Osborn MK, 2007, HIV MED, V8, P271, DOI 10.1111/j.1468-1293.2007.00469.x; Overton ET, 2005, CLIN INFECT DIS, V41, P1045, DOI 10.1086/433180; Panel on Opportunistic Infections in HIV-Infected Adults and Adolescents, 2017, GUID PREV TREATM OPP; Price H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049314; Puoti M, 2006, J HEPATOL, V44, pS65, DOI 10.1016/j.jhep.2005.11.015; Roberts H, 2016, HEPATOLOGY, V63, P388, DOI 10.1002/hep.28109; Sarndal CE, 2005, WILEY SER SURV METH, P1; Selik RM, 2014, MMWR RECOMM REP, V63; Shilaih M, 2016, J INFECT DIS, V214, P599, DOI 10.1093/infdis/jiw195; Smith Bryce D., 2012, Morbidity and Mortality Weekly Report, V61, P1; Spradling PR, 2010, J VIRAL HEPATITIS, V17, P879, DOI 10.1111/j.1365-2893.2009.01249.x; Thio CL, 2002, LANCET, V360, P1921, DOI 10.1016/S0140-6736(02)11913-1; U. S. Department of Health and Human Services, 2017, NAT VIR HEP ACT PLAN; Valour F, 2014, VACCINE, V32, P4558, DOI 10.1016/j.vaccine.2014.06.015; Weber R, 2006, ARCH INTERN MED, V166, P1632, DOI 10.1001/archinte.166.15.1632; Weiser J, 2015, JAMA INTERN MED, V175, P1650, DOI 10.1001/jamainternmed.2015.4095; Whitaker JA, 2012, LANCET INFECT DIS, V12, P966, DOI 10.1016/S1473-3099(12)70243-8; Williams H, 2011, INT J STD AIDS, V22, P405, DOI 10.1258/ijsa.2011.010503; World Health Organization, 2016, GLOB HLTH SECT STRAT; World Health Organization, 2017, IMM PEOPL LIV HIV PE	53	11	11	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 20	2018	168	4					245	+		10.7326/M17-1689	http://dx.doi.org/10.7326/M17-1689			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FW6NB	29277848	Green Accepted			2022-12-28	WOS:000425434000013
J	Kumar, V; Cohen, JT; van Klaveren, D; Soeteman, DI; Wong, JB; Neumann, PJ; Kent, DM				Kumar, Vaibhav; Cohen, Joshua T.; van Klaveren, David; Soeteman, Djora I.; Wong, John B.; Neumann, Peter J.; Kent, David M.			Risk-Targeted Lung Cancer Screening A Cost-Effectiveness Analysis	ANNALS OF INTERNAL MEDICINE			English	Article							INDIVIDUAL PATIENTS; SELECTION CRITERIA; MORTALITY; TRIAL; IMPLEMENTATION; TUTORIAL; SURVIVAL; HEALTH	Background: Targeting low-dose computed tomography (LDCT) for lung cancer screening to persons at highest risk for lung cancer mortality has been suggested to improve screening efficiency. Objective: To quantify the value of risk-targeted selection for lung cancer screening compared with National Lung Screening Trial (NLST) eligibility criteria. Design: Cost-effectiveness analysis using a multistate prediction model. Data Sources: NLST. Target Population: Current and former smokers eligible for lung cancer screening. Time Horizon: Lifetime. Perspective: Health care sector. Intervention: Risk-targeted versus NLST-based screening. Outcome Measures: Incremental 7-year mortality, life expectancy, quality-adjusted life-years (QALYs), costs, and cost-effectiveness of screening with LDCT versus chest radiography at each decile of lung cancer mortality risk. Results of Base-Case Analysis: Participants at greater risk for lung cancer mortality were older and had more comorbid conditions and higher screening-related costs. The incremental lung cancer mortality benefits during the first 7 years ranged from 1.2 to 9.5 lung cancer deaths prevented per 10 000 person-years for the lowest to highest risk deciles, respectively (extreme decile ratio, 7.9). The gradient of benefits across risk groups, however, was attenuated in terms of life-years (extreme decile ratio, 3.6) and QALYs (extreme decile ratio, 2.4). The incremental cost-effectiveness ratios (ICERs) were similar across risk deciles ($ 75 000 per QALY in the lowest risk decile to $ 53 000 per QALY in the highest risk decile). Payers willing to pay $ 100 000 per QALY would pay for LDCT screening for all decile groups. Results of Sensitivity Analysis: Alternative assumptions did not substantially alter our findings. Limitation: Our model did not account for all correlated differences between lung cancer mortality risk and quality of life. Conclusions: Although risk targeting may improve screening efficiency in terms of early lung cancer mortality per person screened, the gains in efficiency are attenuated and modest in terms of life-years, QALYs, and cost-effectiveness.	[Kumar, Vaibhav; Cohen, Joshua T.; Neumann, Peter J.; Kent, David M.] Tufts Med Ctr, Inst Clin Res & Hlth Policy Studies, 800 Washington St,Box 063, Boston, MA 02111 USA; [van Klaveren, David] Leiden Univ, Med Ctr, Dept Med Stat, POB 9600, NL-2300 RC Leiden, Netherlands; Harvard Sch Publ Hlth, Boston, MA USA; [Soeteman, Djora I.] Harvard TH Chan Sch Publ Hlth, Ctr Hlth Decis Sci, 718 Huntington Ave,2nd Floor, Boston, MA 02115 USA; [Wong, John B.] Tufts Med Ctr, 800 Washington St,302, Boston, MA 02111 USA	Tufts Medical Center; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Tufts Medical Center	Kent, DM (corresponding author), Tufts Med Ctr, Predict Analyt & Comparat Effectiveness PACE Ctr, Inst Clin Res & Hlth Policy Studies, 800 Washington St,Box 063, Boston, MA 02111 USA.	dkent1@tuftsmedicalcenter.org	Kumar, Vaibhav/ABG-5515-2020; van Klaveren, David/ABF-3020-2021	Kumar, Vaibhav/0000-0002-5594-9497; van Klaveren, David/0000-0002-2096-606X; Wong, John/0000-0003-4203-9010	National Institutes of Health [U01NS086294]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS086294] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	National Institutes of Health (U01NS086294).	Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; Black WC, 2014, NEW ENGL J MED, V371, P1793, DOI 10.1056/NEJMoa1312547; Centers for Medicare & Medicaid Services, PHYS FEE SCHED LOOK; de Wreede LC, 2010, COMPUT METH PROG BIO, V99, P261, DOI 10.1016/j.cmpb.2010.01.001; Goffin JR, 2015, JAMA ONCOL, V1, P807, DOI 10.1001/jamaoncol.2015.2472; Goulart BHL, 2013, ONCOLOGIST, V18, P941, DOI 10.1634/theoncologist.2013-0007; Guessous I, 2015, PUBLIC HEALTH REV, V36, DOI 10.1186/s40985-015-0010-3; Hayward Rodney A, 2006, BMC Med Res Methodol, V6, P18, DOI 10.1186/1471-2288-6-18; Jaklitsch MT, 2012, J THORAC CARDIOV SUR, V144, P33, DOI 10.1016/j.jtcvs.2012.05.060; Katki HA, 2016, JAMA-J AM MED ASSOC, V315, P2300, DOI 10.1001/jama.2016.6255; Kent DM, 2007, JAMA-J AM MED ASSOC, V298, P1209, DOI 10.1001/jama.298.10.1209; Kent DM, 2016, INT J EPIDEMIOL, V45, P2075, DOI 10.1093/ije/dyw118; Kent DM, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-85; Kim DD, 2016, COST EFFECTIVENESS H, P385; Kim JJ, 2015, ANN INTERN MED, V163, P589, DOI 10.7326/M15-0420; Kinsinger LS, 2017, JAMA INTERN MED, V177, P399, DOI 10.1001/jamainternmed.2016.9022; Kovalchik SA, 2013, NEW ENGL J MED, V369, P245, DOI 10.1056/NEJMoa1301851; Moyer VA, 2014, ANN INTERN MED, V160, P330, DOI 10.7326/M13-2771; Neumann PJ, 2014, NEW ENGL J MED, V371, P796, DOI 10.1056/NEJMp1405158; Oken MM, 2011, JAMA-J AM MED ASSOC, V306, P1865, DOI 10.1001/jama.2011.1591; Pope CA, 2011, ENVIRON HEALTH PERSP, V119, P1616, DOI 10.1289/ehp.1103639; Putter H, 2007, STAT MED, V26, P2389, DOI 10.1002/sim.2712; Rothwell PM, 1999, LANCET, V353, P2105, DOI 10.1016/S0140-6736(98)11415-0; Sanchez-Salcedo P, 2015, AM J RESP CRIT CARE, V191, P924, DOI 10.1164/rccm.201410-1848OC; Sanders GD, 2016, JAMA-J AM MED ASSOC, V316, P1093, DOI 10.1001/jama.2016.12195; Sturza J, 2010, MED DECIS MAKING, V30, P685, DOI 10.1177/0272989X10369004; Tammemagi MC, 2013, NEW ENGL J MED, V368, P728, DOI 10.1056/NEJMoa1211776; ten Haaf K, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002277; van der Aalst CM, 2016, LANCET RESP MED, V4, P749, DOI 10.; van Klaveren D, 2017, MED DECIS MAKING, V37, P770, DOI 10.1177/0272989X17696994; Wender R, 2013, CA-CANCER J CLIN, V63, P107, DOI 10.3322/caac.21172; Williams C, 2017, MED DECIS MAKING, V37, P427, DOI 10.1177/0272989X16670617; Williams C, 2017, MED DECIS MAKING, V37, P340, DOI 10.1177/0272989X16651869	33	60	63	1	28	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 6	2018	168	3					161	+		10.7326/M17-1401	http://dx.doi.org/10.7326/M17-1401			18	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FV0CU	29297005	Green Accepted			2022-12-28	WOS:000424224300004
J	Thion, MS; Low, D; Silvin, A; Chen, JM; Grisel, P; Schulte-Schrepping, J; Blecher, R; Ulas, T; Squarzoni, P; Hoeffel, G; Coulpier, F; Siopi, E; David, FS; Scholz, C; Shihui, F; Lum, J; Amoyo, AA; Larbi, A; Poidinger, M; Buttgereit, A; Lledo, PM; Greter, M; Chan, JKY; Amit, I; Beyer, M; Schultze, JL; Schlitzer, A; Pettersson, S; Ginhoux, F; Garel, S				Thion, Morgane Sonia; Low, Donovan; Silvin, Aymeric; Chen, Jinmiao; Grisel, Pauline; Schulte-Schrepping, Jonas; Blecher, Ronnie; Ulas, Thomas; Squarzoni, Paola; Hoeffel, Guillaume; Coulpier, Fanny; Siopi, Eleni; David, Friederike Sophie; Scholz, Claus; Shihui, Foo; Lum, Josephine; Amoyo, Arlaine Anne; Larbi, Anis; Poidinger, Michael; Buttgereit, Anne; Lledo, Pierre-Marie; Greter, Melanie; Chan, Jerry Kok Yen; Amit, Ido; Beyer, Marc; Schultze, Joachim Ludwig; Schlitzer, Andreas; Pettersson, Sven; Ginhoux, Florent; Garel, Sonia			Microbiome Influences Prenatal and Adult Microglia in a Sex-Specific Manner	CELL			English	Article							CENTRAL-NERVOUS-SYSTEM; GUT MICROBIOTA; GENDER-DIFFERENCES; BRAIN-DEVELOPMENT; RNA-SEQ; EXPRESSION; MACROPHAGE; DYNAMICS; REVEALS; ABNORMALITIES	Microglia are embryonically seeded macrophages that contribute to brain development, homeostasis, and pathologies. It is thus essential to decipher how microglial properties are temporally regulated by intrinsic and extrinsic factors, such as sexual identity and the microbiome. Here, we found that microglia undergo differentiation phases, discernable by transcriptomic signatures and chromatin accessibility landscapes, which can diverge in adult males and females. Remarkably, the absence of microbiome in germ-free mice had a time and sexually dimorphic impact both prenatally and postnatally: microglia were more profoundly perturbed in male embryos and female adults. Antibiotic treatment of adult mice triggered sexually biased microglial responses revealing both acute and long-term effects of microbiota depletion. Finally, human fetal microglia exhibited significant overlap with the murine transcriptomic signature. Our study shows that microglia respond to environmental challenges in a sex- and time-dependent manner from prenatal stages, with major implications for our understanding of microglial contributions to health and disease.	[Thion, Morgane Sonia; Grisel, Pauline; Squarzoni, Paola; Coulpier, Fanny; Garel, Sonia] PSL Res Univ, Ecole Normale Super, CNRS, IBENS,INSERM, F-75005 Paris, France; [Low, Donovan; Silvin, Aymeric; Chen, Jinmiao; Hoeffel, Guillaume; Shihui, Foo; Lum, Josephine; Larbi, Anis; Poidinger, Michael; Schlitzer, Andreas; Ginhoux, Florent] ASTAR, Singapore Immunol Network SIgN, Singapore 138648, Singapore; [Schulte-Schrepping, Jonas; Ulas, Thomas; David, Friederike Sophie; Scholz, Claus; Beyer, Marc; Schultze, Joachim Ludwig] Univ Bonn, Life & Med Sci LIMES Inst, Genom & Immunoregulat, D-53115 Bonn, Germany; [Blecher, Ronnie; Amit, Ido] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel; [Hoeffel, Guillaume] Aix Marseille Univ, CNRS, CIML, INSERM, F-13288 Marseille, France; [Siopi, Eleni; Lledo, Pierre-Marie] CNRS, Inst Pasteur, Unite Percept & Memoire, UMR 3571, F-75015 Paris, France; [Amoyo, Arlaine Anne] Natl Canc Ctr, Singapore 169610, Singapore; [Buttgereit, Anne; Greter, Melanie] Univ Zurich, Inst Expt Immunol, CH-8057 Zurich, Switzerland; [Chan, Jerry Kok Yen] KK Womens & Childrens Hosp, Dept Reprod Med, Singapore 229899, Singapore; [Chan, Jerry Kok Yen] KK Womens & Childrens Hosp, KK Res Ctr, 100 Bukit Timah Rd, Singapore 229899, Singapore; [Beyer, Marc] German Ctr Neurodegenerat Dis DZNE, Mol Immunol Neurodegenerat, D-53127 Bonn, Germany; [Schultze, Joachim Ludwig] German Ctr Neurodegenerat Dis, Platform Single Cell Genom & Epigen, D-53175 Bonn, Germany; [Schultze, Joachim Ludwig] Univ Bonn, D-53175 Bonn, Germany; [Schlitzer, Andreas] Univ Bonn, LIMES Inst, Myeloid Cell Biol, D-53115 Bonn, Germany; [Pettersson, Sven] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore 639798, Singapore; [Pettersson, Sven] Nanyang Technol Univ, Sch Biol Sci, Singapore 639798, Singapore; [Pettersson, Sven] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, S-17165 Stockholm, Sweden	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); University of Bonn; Weizmann Institute of Science; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; National Cancer Centre Singapore (NCCS); University of Zurich; KK Women's & Children's Hospital; KK Women's & Children's Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Bonn; University of Bonn; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Karolinska Institutet	Garel, S (corresponding author), PSL Res Univ, Ecole Normale Super, CNRS, IBENS,INSERM, F-75005 Paris, France.; Ginhoux, F (corresponding author), ASTAR, Singapore Immunol Network SIgN, Singapore 138648, Singapore.	florent_ginhoux@immunol.a-star.edu.sg; garel@biologie.ens.fr	Scholz, Claus Jürgen/H-3202-2019; Pettersson, Sven/F-9511-2015; Larbi, Anis/ABE-5868-2020; Garel, Sonia/P-4538-2017; Beyer, Marc/ABE-1408-2021; Schultze, Joachim L./ABA-8176-2020; Hoeffel, Guillaume/ABG-4881-2021; Chen, Jinmiao/ABE-5601-2021; Thion, Morgane Sonia/GRJ-4332-2022	Scholz, Claus Jürgen/0000-0002-6406-7859; Garel, Sonia/0000-0003-2984-3645; Beyer, Marc/0000-0001-9704-148X; Schultze, Joachim L./0000-0003-2812-9853; Hoeffel, Guillaume/0000-0002-2534-4972; Thion, Morgane/0000-0003-2364-8451; Siopi, Eleni/0000-0002-2731-8540; Poidinger, Michael/0000-0002-1047-2277; David, Friederike/0000-0001-9521-5669; Greter, Melanie/0000-0002-7220-5369; Blecher, Ronnie/0000-0003-2847-1149	PSL* Reseach University, "Investments for the future" [ANR-10-INBS-04, ANR-10-LABX-54 MEMO LIFE, ANR-11-IDEX-000-02]; "Investissements d'Avenir'' program [ANR-10-INBS-09]; LKC School of Medicine; SCELSE; MOE (Tier1 grant); NIMBLE grant NTU; NTU GUTME grant; Swedish Medical Council (VR); DFG [SFB704, SCHL 2116/1-1]; Federal Ministry for Economic Affairs and Energy (BMWi Project FASTGENOMICS); European Union's Horizon 2020 [733100-SYSCID]; INSERM; CNRS; ERC Consolidator [NImO 616080]; Merlion Program; EMBO YIP	PSL* Reseach University, "Investments for the future"; "Investissements d'Avenir'' program(French National Research Agency (ANR)); LKC School of Medicine; SCELSE; MOE (Tier1 grant)(Ministry of Education, Singapore); NIMBLE grant NTU; NTU GUTME grant; Swedish Medical Council (VR); DFG(German Research Foundation (DFG)); Federal Ministry for Economic Affairs and Energy (BMWi Project FASTGENOMICS); European Union's Horizon 2020; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); ERC Consolidator; Merlion Program; EMBO YIP(European Molecular Biology Organization (EMBO))	We are grateful to the Garel and Ginhoux lab for discussions and critical comments on the manuscript. We thank Lucy Robinson for editing the manuscript, Esther Klingler and Samuel Collombet for scientific discussions, the IBENS Imaging Facility (France BioImaging, supported by ANR-10-INBS-04, ANR-10-LABX-54 MEMO LIFE and ANR-11-IDEX-000-02 PSL* Reseach University, "Investments for the future"), the cytometry core facility of Institut Curie for cell sorting, the IBENS transcriptomic facility (by the France Genomique national infrastructure, funded as part of the "Investissements d'Avenir'' program [contract ANR-10-INBS-09]). We are grateful to C. Auger, A. Delecourt, E. Touzalin, D. Valera and C. Le Moal for excellent technical assistance. This work was supported by grants from the LKC School of Medicine, SCELSE, MOE (Tier1 grant), NIMBLE grant NTU, NTU GUTME grant, Swedish Medical Council (VR to S.P.), the DFG (SFB704 to J.L.S., M.B., and T.U. and SCHL 2116/1-1 to A.S.), the Federal Ministry for Economic Affairs and Energy (BMWi Project FASTGENOMICS to J.L.S.), the European Union's Horizon 2020 (733100-SYSCID to M.B., J.S.S., and J.L.S.), INSERM, CNRS, the ERC Consolidator (NImO 616080 to S.G.), and from the Merlion Program (to S.G and F.G.). M.B., A.S., and J.L.S. are members of the Excellence Cluster ImmunoSensation. F.G. and S.G. are EMBO YIP awardees.	Arno B, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6611; Beaume M, 2011, J MICROBIOL METH, V84, P327, DOI 10.1016/j.mimet.2010.12.025; Bibikova M, 2011, GENOMICS, V98, P288, DOI 10.1016/j.ygeno.2011.07.007; Braniste V, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009759; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Buttgereit A, 2016, NAT IMMUNOL, V17, P1397, DOI 10.1038/ni.3585; Casano AM, 2015, DEV CELL, V32, P469, DOI 10.1016/j.devcel.2015.01.018; Colonna M, 2017, ANNU REV IMMUNOL, V35, P441, DOI 10.1146/annurev-immunol-051116-052358; Derecki NC, 2014, ACTA NEUROPATHOL, V128, P333, DOI 10.1007/s00401-014-1321-z; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Erny D, 2015, NAT NEUROSCI, V18, P965, DOI 10.1038/nn.4030; Ginhoux F, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020537; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Gosselin D, 2017, SCIENCE, V356, DOI 10.1126/science.aal3222; Gosselin D, 2014, CELL, V159, P1327, DOI 10.1016/j.cell.2014.11.023; Grabert K, 2016, NAT NEUROSCI, V19, P504, DOI 10.1038/nn.4222; Hahne F, 2016, METHODS MOL BIOL, V1418, P335, DOI 10.1007/978-1-4939-3578-9_16; Halladay AK, 2015, MOL AUTISM, V6, DOI 10.1186/s13229-015-0019-y; Heijtza RD, 2011, P NATL ACAD SCI USA, V108, P3047, DOI 10.1073/pnas.1010529108; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hickman SE, 2013, NAT NEUROSCI, V16, P1896, DOI 10.1038/nn.3554; Honda K, 2016, NATURE, V535, P75, DOI 10.1038/nature18848; Hong S, 2016, CURR OPIN NEUROBIOL, V36, P128, DOI 10.1016/j.conb.2015.12.004; Hsiao EY, 2013, CELL, V155, P1451, DOI 10.1016/j.cell.2013.11.024; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kierdorf K, 2013, NAT NEUROSCI, V16, P273, DOI 10.1038/nn.3318; Klein SL, 2016, NAT REV IMMUNOL, V16, P626, DOI 10.1038/nri.2016.90; Kramer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lara-Astiaso D, 2014, SCIENCE, V345, P943, DOI 10.1126/science.1256271; Lavin Y, 2014, CELL, V159, P1312, DOI 10.1016/j.cell.2014.11.018; Lawrence M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003118; Lenz KM, 2015, NEUROSCIENTIST, V21, P306, DOI 10.1177/1073858414536468; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lu MF, 2008, CELL HOST MICROBE, V4, P293, DOI 10.1016/j.chom.2008.06.009; Mapplebeck JCS, 2016, PAIN, V157, pS2, DOI 10.1097/j.pain.0000000000000389; Marin O, 2013, EUR J NEUROSCI, V38, P2019, DOI 10.1111/ejn.12225; Markle JGM, 2013, SCIENCE, V339, P1084, DOI 10.1126/science.1233521; Masuda T, 2012, CELL REP, V1, P334, DOI 10.1016/j.celrep.2012.02.014; Matcovitch-Natan O, 2016, SCIENCE, V353, DOI 10.1126/science.aad8670; McCarthy MM, 2017, BIOL PSYCHIAT, V81, P402, DOI 10.1016/j.biopsych.2016.10.004; Mildner A, 2017, GLIA, V65, P375, DOI 10.1002/glia.23097; Nagai Y, 2002, BLOOD, V99, P1699, DOI 10.1182/blood.V99.5.1699; Nelson LH, 2017, J NEUROSCI RES, V95, P447, DOI 10.1002/jnr.23821; Newman AM, 2015, NAT METHODS, V12, P453, DOI [10.1038/NMETH.3337, 10.1038/nmeth.3337]; Ngo ST, 2014, FRONT NEUROENDOCRIN, V35, P347, DOI 10.1016/j.yfrne.2014.04.004; Ochoa S, 2012, SCHIZOPHR RES TREAT, V2012, DOI 10.1155/2012/916198; Picelli S, 2014, NAT PROTOC, V9, P171, DOI 10.1038/nprot.2014.006; Prinz M, 2017, NAT IMMUNOL, V18, P385, DOI 10.1038/ni.3703; Ransohoff RM, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a020560; Reemst K, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00566; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rosshart SP, 2017, CELL, V171, P1015, DOI 10.1016/j.cell.2017.09.016; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; Sampson TR, 2016, CELL, V167, P1469, DOI 10.1016/j.cell.2016.11.018; Schafer DP, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020545; Schwarz JM, 2012, J NEUROCHEM, V120, P948, DOI 10.1111/j.1471-4159.2011.07630.x; Semenkovich NP, 2016, P NATL ACAD SCI USA, V113, P14805, DOI 10.1073/pnas.1617793113; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sharon G, 2016, CELL, V167, P915, DOI 10.1016/j.cell.2016.10.027; Shemer A, 2015, SEMIN IMMUNOPATHOL, V37, P613, DOI 10.1007/s00281-015-0519-z; Squarzoni P, 2014, CELL REP, V8, P1271, DOI 10.1016/j.celrep.2014.07.042; Swinnen N, 2013, GLIA, V61, P150, DOI 10.1002/glia.22421; Takasato M, 2004, MECH DEVELOP, V121, P547, DOI 10.1016/j.mod.2004.04.007; Tay TL, 2017, NAT NEUROSCI, V20, P793, DOI 10.1038/nn.4547; Theocharidis A, 2009, NAT PROTOC, V4, P1535, DOI 10.1038/nprot.2009.177; Thion MS, 2017, CURR OPIN NEUROBIOL, V47, P121, DOI 10.1016/j.conb.2017.10.004; Tay TL, 2017, J PHYSIOL-LONDON, V595, P1929, DOI 10.1113/JP272134; Ueno M, 2013, NAT NEUROSCI, V16, P543, DOI 10.1038/nn.3358; Ulas T, 2017, NAT IMMUNOL, V18, P622, DOI 10.1038/ni.3745; Volk DW, 2017, NEUROBIOL DIS, V99, P58, DOI 10.1016/j.nbd.2016.12.019; Wolf SA, 2017, ANNU REV PHYSIOL, V79, P619, DOI 10.1146/annurev-physiol-022516-034406; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; Yurkovetskiy L, 2013, IMMUNITY, V39, P400, DOI 10.1016/j.immuni.2013.08.013; Zagni Emanuela, 2016, Neurosci J, V2016, P2827090, DOI 10.1155/2016/2827090; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	80	364	369	15	109	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 25	2018	172	3					500	+		10.1016/j.cell.2017.11.042	http://dx.doi.org/10.1016/j.cell.2017.11.042			33	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FT9BS	29275859	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000423447600011
J	Clery, D				Clery, Daniel			ASTRONOMY Earth-based planet finders power up	SCIENCE			English	News Item														Clery, Daniel/0000-0002-8742-3596					0	0	0	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 5	2018	359	6371					18	19		10.1126/science.359.6371.18	http://dx.doi.org/10.1126/science.359.6371.18			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FR8KW	29301994				2022-12-28	WOS:000419324700022
J	Sahoo, PK; Memaran, S; Xin, Y; Balicas, L; Gutierrez, HR				Sahoo, Prasana K.; Memaran, Shahriar; Xin, Yan; Balicas, Luis; Gutierrez, Humberto R.			One-pot growth of two-dimensional lateral heterostructures via sequential edge-epitaxy	NATURE			English	Article							TUNGSTEN; MOLYBDENUM; REDUCTION; VOLATILIZATION; DIODES	Two-dimensional heterojunctions of transition-metal dichalcogenides(1-15) have great potential for application in low-power, high-performance and flexible electro-optical devices, such as tunnelling transistors(5,6), light-emitting diodes(2,3), photodetectors(2,4) and photovoltaic cells(7,8). Although complex heterostructures have been fabricated via the van der Waals stacking of different two-dimensional materials(2-4,14), the in situ fabrication of high-quality lateral heterostructures(9-13,15) with multiple junctions remains a challenge. Transition-metal-dichalcogenide lateral heterostructures have been synthesized via single-step(9,11,12), two-step(10,13) or multi-step growth processes(15). However, these methods lack the flexibility to control, in situ, the growth of individual domains. In situ synthesis of multi-junction lateral heterostructures does not require multiple exchanges of sources or reactors, a limitation in previous approaches(9-13,15) as it exposes the edges to ambient contamination, compromises the homogeneity of domain size in periodic structures, and results in long processing times. Here we report a one-pot synthetic approach, using a single heterogeneous solid source, for the continuous fabrication of lateral multi-junction heterostructures consisting of monolayers of transition-metal dichalcogenides. The sequential formation of heterojunctions is achieved solely by changing the composition of the reactive gas environment in the presence of water vapour. This enables selective control of the water-induced oxidation(16) and volatilization(17) of each transition-metal precursor, as well as its nucleation on the substrate, leading to sequential edge-epitaxy of distinct transition-metal dichalcogenides. Photoluminescence maps confirm the sequential spatial modulation of the bandgap, and atomic-resolution images reveal defect-free lateral connectivity between the different transition-metal-dichalcogenide domains within a single crystal structure. Electrical transport measurements revealed diode-like responses across the junctions. Our new approach offers greater flexibility and control than previous methods for continuous growth of transition-metal-dichalcogenide-based multi-junction lateral heterostructures. These findings could be extended to other families of two-dimensional materials, and establish a foundation for the development of complex and atomically thin in-plane superlattices, devices and integrated circuits(18).	[Sahoo, Prasana K.; Gutierrez, Humberto R.] Univ S Florida, Dept Phys, Tampa, FL 33620 USA; [Memaran, Shahriar; Xin, Yan; Balicas, Luis] Florida State Univ, Natl High Magnet Field Lab, Tallahassee, FL 32310 USA; [Memaran, Shahriar; Balicas, Luis] Florida State Univ, Dept Phys, Tallahassee, FL 32306 USA	State University System of Florida; University of South Florida; State University System of Florida; Florida State University; State University System of Florida; Florida State University	Sahoo, PK; Gutierrez, HR (corresponding author), Univ S Florida, Dept Phys, Tampa, FL 33620 USA.	prasanasahoo@gmail.com; humberto3@usf.edu	Sahoo, Prasana K/E-9577-2012; Balicas, Luis/A-3110-2008	Sahoo, Prasana K/0000-0001-6316-7842; Rodriguez Gutierrez, Humberto/0000-0001-8997-5274	National Science Foundation (NSF) [DMR-1557434]; US Army Research Office MURI [W911NF-11-1-0362]; Office Naval Research DURIP Grant [11997003]; NSF [DMR-1157490]; State of Florida; Direct For Mathematical & Physical Scien [1557434] Funding Source: National Science Foundation	National Science Foundation (NSF)(National Science Foundation (NSF)); US Army Research Office MURI(MURI); Office Naval Research DURIP Grant; NSF(National Science Foundation (NSF)); State of Florida; Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported by the National Science Foundation (NSF) grant DMR-1557434 (CAREER: Two-Dimensional Heterostructures Based on Transition Metal Dichalcogenides). L.B acknowledges the US Army Research Office MURI grant W911NF-11-1-0362 (Synthesis and Physical Characterization of Two-Dimensional Materials and Their Heterostructures) and the Office Naval Research DURIP Grant 11997003 (Stacking Under Inert Conditions). TEM work was performed at the National High Magnetic Field Laboratory, which is supported by the NSF Cooperative Agreement DMR-1157490 and the State of Florida. P.K.S. and H.R.G. thank M.A. Cotta for comments.	BELTON GR, 1964, J PHYS CHEM-US, V68, P1852, DOI 10.1021/j100789a030; BELTON GR, 1965, J PHYS CHEM-US, V69, P2065, DOI 10.1021/j100890a043; Berkdemir A, 2013, SCI REP-UK, V3, DOI 10.1038/srep01755; BLACKBURN PE, 1958, J PHYS CHEM-US, V62, P769, DOI 10.1021/j150565a001; Blanco E, 2007, METALL MATER TRANS B, V38, P689, DOI 10.1007/s11663-006-9001-6; CANNON P, 1964, NATURE, V203, P750, DOI 10.1038/203750a0; Chen J, 2008, J PHYS D APPL PHYS, V41, DOI 10.1088/0022-3727/41/11/115305; Duan XD, 2016, NANO LETT, V16, P264, DOI 10.1021/acs.nanolett.5b03662; Duan XD, 2014, NAT NANOTECHNOL, V9, P1024, DOI [10.1038/NNANO.2014.222, 10.1038/nnano.2014.222]; Feng QL, 2015, ACS NANO, V9, P7450, DOI 10.1021/acsnano.5b02506; Feng QL, 2014, ADV MATER, V26, P2648, DOI 10.1002/adma.201306095; Frey GL, 2001, J SOLID STATE CHEM, V162, P300, DOI 10.1006/jssc.2001.9319; Geim AK, 2013, NATURE, V499, P419, DOI 10.1038/nature12385; Gong YJ, 2015, NANO LETT, V15, P6135, DOI 10.1021/acs.nanolett.5b02423; Gong YJ, 2014, NAT MATER, V13, P1135, DOI [10.1038/NMAT4091, 10.1038/nmat4091]; Huang CM, 2014, NAT MATER, V13, P1096, DOI [10.1038/nmat4064, 10.1038/NMAT4064]; Jadczak J, 2014, J APPL PHYS, V116, DOI 10.1063/1.4901994; Kadiev KM, 2010, PETROL CHEM+, V50, P312, DOI 10.1134/S0965544110040092; Kang J, 2013, J APPL PHYS, V113, DOI 10.1063/1.4799126; Kang K, 2017, NATURE, V550, P229, DOI 10.1038/nature23905; KILPATRI.M, 1966, J ELECTROCHEM SOC, V113, P17, DOI 10.1149/1.2423850; Lalik E, 2001, J PHYS CHEM B, V105, P9153, DOI 10.1021/jp011622p; Lee C, 2010, ACS NANO, V4, P2695, DOI 10.1021/nn1003937; Lee CH, 2014, NAT NANOTECHNOL, V9, P676, DOI [10.1038/NNANO.2014.150, 10.1038/nnano.2014.150]; Li MY, 2015, SCIENCE, V349, P524, DOI 10.1126/science.aab4097; Lin YC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8311; Lu DY, 2008, J MATER RES, V23, P402, DOI [10.1557/jmr.2008.0056, 10.1557/JMR.2008.0056]; MILLNER T, 1949, NATURE, V163, P601, DOI 10.1038/163601b0; Nam D, 2015, SCI REP-UK, V5, DOI 10.1038/srep17113; Pospischil A, 2014, NAT NANOTECHNOL, V9, P257, DOI [10.1038/nnano.2014.14, 10.1038/NNANO.2014.14]; Pradhan NR, 2015, SCI REP-UK, V5, DOI 10.1038/srep08979; Rajan AG, 2016, ACS NANO, V10, P4330, DOI 10.1021/acsnano.5b07916; Rothschild A, 1999, MATER RES INNOV, V3, P145, DOI 10.1007/s100190050140; SARIN VK, 1975, J MATER SCI, V10, P593, DOI 10.1007/BF00566566; Sarkar D, 2015, NATURE, V526, P91, DOI 10.1038/nature15387; Smolik G.R., 2000, INEELEXT9901353; SPEVACK PA, 1992, J PHYS CHEM-US, V96, P9029, DOI 10.1021/j100201a062; TASKINEN P, 1977, SCAND J METALL, V6, P228; Walter TN, 2017, J VAC SCI TECHNOL B, V35, DOI 10.1116/1.4975144; Wang H, 2012, NANO LETT, V12, P4674, DOI 10.1021/nl302015v; Wang SS, 2014, CHEM MATER, V26, P6371, DOI 10.1021/cm5025662; Withers F, 2015, NAT MATER, V14, P301, DOI 10.1038/nmat4205; Xu WG, 2017, NATURE, V541, P62, DOI 10.1038/nature20601; Yu WJ, 2013, NAT NANOTECHNOL, V8, P952, DOI [10.1038/nnano.2013.219, 10.1038/NNANO.2013.219]; Zhang ZW, 2017, SCIENCE, V357, P788, DOI 10.1126/science.aan6814	45	300	304	36	748	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 4	2018	553	7686					63	+		10.1038/nature25155	http://dx.doi.org/10.1038/nature25155			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS4NI	29300012	Green Submitted			2022-12-28	WOS:000419769300030
J	Coulehan, J				Coulehan, Jack			Negative Capability and the Art of Medicine	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Coulehan, Jack] SUNY Stony Brook, Ctr Med Humanities Compassionate Care & Bioeth, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Coulehan, J (corresponding author), SUNY Stony Brook, Ctr Med Humanities Compassionate Care & Bioeth, Stony Brook, NY 11794 USA.	john.coulehan@stonybrookmedicine.edu						Cioffi J, 1997, J ADV NURS, V26, P203, DOI 10.1046/j.1365-2648.1997.1997026203.x; Coulehan Jack, 2005, J Palliat Med, V8, P382, DOI 10.1089/jpm.2005.8.382; De Bono E., 1967, USE LATERAL THINKING; Feinstein AR., 1967, CLIN JUDGMENT; Keats John, 1899, COMPLETE POETICAL WO, P277; Osler W., 2001, OSLERS WAY LIFE OTHE, P305	6	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 26	2017	318	24					2429	2430		10.1001/jama.2017.19333	http://dx.doi.org/10.1001/jama.2017.19333			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FQ9ZO	29279939				2022-12-28	WOS:000418720700018
J	Slomski, A				Slomski, Anita			Recumbent Delivery With Epidural and Spontaneous Vaginal Births	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 26	2017	318	24					2419	2419		10.1001/jama.2017.19985	http://dx.doi.org/10.1001/jama.2017.19985			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FQ9ZO	29279928				2022-12-28	WOS:000418720700008
J	Nordstrom, A				Nordstrom, Anders			Is WHO ready to improve its country work?	LANCET			English	Editorial Material									[Nordstrom, Anders] Govt Sweden, Minist Foreign Affairs, UN Policy Dept, S-10333 Stockholm, Sweden		Nordstrom, A (corresponding author), Govt Sweden, Minist Foreign Affairs, UN Policy Dept, S-10333 Stockholm, Sweden.	anders.nordstrom@gov.se							0	3	3	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 23	2017	390	10114					2749	2751		10.1016/S0140-6736(17)33360-3	http://dx.doi.org/10.1016/S0140-6736(17)33360-3			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FQ9GF	29303714				2022-12-28	WOS:000418669800011
J	Cho, A				Cho, Adrian			COSMIC CONVERGENCE	SCIENCE			English	Editorial Material																			0	0	0	1	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 22	2017	358	6370					1520	1521		10.1126/science.358.6370.1520	http://dx.doi.org/10.1126/science.358.6370.1520			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FQ6BO	29269456				2022-12-28	WOS:000418448000020
J	Voosen, P				Voosen, Paul			Deep Pacific cooled by 'little ice age' waters	SCIENCE			English	News Item																			0	0	0	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 22	2017	358	6370					1515	1516		10.1126/science.358.6370.1515	http://dx.doi.org/10.1126/science.358.6370.1515			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ6BO	29269452				2022-12-28	WOS:000418448000016
J	Lipscombe, LL				Lipscombe, Lorraine L.			Exenatide did not reduce major cardiovascular outcomes in type 2 diabetes	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							LIRAGLUTIDE		[Lipscombe, Lorraine L.] Womens Coll Hosp, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Womens College Hospital	Lipscombe, LL (corresponding author), Womens Coll Hosp, Toronto, ON, Canada.			Lipscombe, Lorraine/0000-0001-7412-7993				Buse JB, 2013, LANCET, V381, P117, DOI 10.1016/S0140-6736(12)61267-7; Marso SP, 2016, NEW ENGL J MED, V375, P311, DOI 10.1056/NEJMoa1603827; Pfeffer MA, 2015, NEW ENGL J MED, V373, P2247, DOI 10.1056/NEJMoa1509225	3	1	1	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 19	2017	167	12					JC67	JC67		10.7326/ACPJC-2017-167-12-067	http://dx.doi.org/10.7326/ACPJC-2017-167-12-067			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FQ3SD	29255857				2022-12-28	WOS:000418276000007
J	Van Spall, HGC				Van Spall, Harriette G. C.			Review: In HF with preserved EF, beta-blockers reduced mortality; drug treatment overall did not	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							HEART-FAILURE		[Van Spall, Harriette G. C.] McMaster Univ, Hamilton, ON, Canada	McMaster University	Van Spall, HGC (corresponding author), McMaster Univ, Hamilton, ON, Canada.			Van Spall, Harriette Gillian Christine/0000-0002-8370-4569				Desai AS, 2012, CIRCULATION, V126, P501, DOI 10.1161/CIRCULATIONAHA.112.125435; Owan TE, 2006, NEW ENGL J MED, V355, P251, DOI 10.1056/NEJMoa052256; Ponikowski P, 2016, EUR HEART J, V37, P2129, DOI 10.1093/eurheartj/ehw128; Roger VL, 2013, CIRC RES, V113, P646, DOI 10.1161/CIRCRESAHA.113.300268	4	1	1	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 19	2017	167	12					JC68	JC68		10.7326/ACPJC-2017-167-12-068	http://dx.doi.org/10.7326/ACPJC-2017-167-12-068			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FQ3SD	29255858				2022-12-28	WOS:000418276000008
J	Kundu, P; Blacher, E; Elinav, E; Pettersson, S				Kundu, Parag; Blacher, Eran; Elinav, Eran; Pettersson, Sven			Our Gut Microbiome: The Evolving Inner Self	CELL			English	Review							INTESTINAL MICROBIOTA; COMPARATIVE METAGENOMICS; BACTERIAL DIVERSITY; PARKINSONS-DISEASE; COMMENSAL BACTERIA; AMNIOTIC-FLUID; LACTIC-ACID; C. ELEGANS; HUMAN-MILK; LIFE-SPAN	The "holobiont'' concept, defined as the collective contribution of the eukaryotic and prokaryotic counterparts to the multicellular organism, introduces a complex definition of individuality enabling a new comprehensive view of human evolution and personalized characteristics. Here, we provide snapshots of the evolving microbial-host associations and relations during distinct milestones across the lifespan of a human being. We discuss the current knowledge of biological symbiosis between the microbiome and its host and portray the challenges in understanding these interactions and their potential effects on human physiology, including microbiome-nervous system inter-relationship and its relevance to human variation and individuality.	[Kundu, Parag; Pettersson, Sven] Singapore Ctr Environm Life Sci Engn, 60 Nanyang Dr, Singapore 637551, Singapore; [Kundu, Parag; Pettersson, Sven] Nanyang Technol Univ, Lee Kong Chian Sch Med, 60 Nanyang Dr, Singapore 637551, Singapore; [Blacher, Eran; Elinav, Eran] Weizmann Inst Sci, Dept Immunol, IL-7610001 Rehovot, Israel; [Pettersson, Sven] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, SE-17177 Stockholm, Sweden	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Weizmann Institute of Science; Karolinska Institutet	Kundu, P; Pettersson, S (corresponding author), Singapore Ctr Environm Life Sci Engn, 60 Nanyang Dr, Singapore 637551, Singapore.; Kundu, P; Pettersson, S (corresponding author), Nanyang Technol Univ, Lee Kong Chian Sch Med, 60 Nanyang Dr, Singapore 637551, Singapore.; Elinav, E (corresponding author), Weizmann Inst Sci, Dept Immunol, IL-7610001 Rehovot, Israel.; Pettersson, S (corresponding author), Karolinska Inst, Dept Microbiol Tumor & Cell Biol, SE-17177 Stockholm, Sweden.	pkundu@ntu.edu.sg; eran.elinav@weizmann.ac.il; sven.pettersson@ki.se	Blacher, Eran/X-3010-2019; Pettersson, Sven/F-9511-2015; Blacher, Eran/AAV-7462-2020; Elinav, Eran/ABE-8881-2020	Blacher, Eran/0000-0003-3207-0153; Elinav, Eran/0000-0002-5775-2110; Kundu, Parag/0000-0002-8684-7530	Gurwin Family Fund for Scientific Research; Leona M. and Harry B. Helmsley Charitable Trust; Crown Endowment Fund for Immunological Research; estate of J. Gitlitz; estate of L. Hershkovich; Benoziyo Endowment Fund for the Advancement of Science; Adelis Foundation; European Research Council, a Marie Curie Integration grant; German-Israeli Foundation for Scientific Research and Development; Israel Science Foundation; Minerva Foundation; Rising Tide Foundation; Helmholtz Foundation; European Foundation for the Study of Diabetes; Lee Kong Chian School of Medicine [SUG 2017-001]; Singapore Centre on Environmental Life Sciences Engineering; NTU Integrated, Medical and Biological and Environmental Life Sciences (NIMBELS) [50025000]; NTU Food Technology Center (NAFTEC) at Nanyang Technological University; Ministry Of Education [2016-T1-002-070]; CIFAR; The V.R. Schwartz Research Fellow Chair; French National Center for Scientific Research (CNRS)	Gurwin Family Fund for Scientific Research; Leona M. and Harry B. Helmsley Charitable Trust; Crown Endowment Fund for Immunological Research; estate of J. Gitlitz; estate of L. Hershkovich; Benoziyo Endowment Fund for the Advancement of Science; Adelis Foundation; European Research Council, a Marie Curie Integration grant; German-Israeli Foundation for Scientific Research and Development(German-Israeli Foundation for Scientific Research and Development); Israel Science Foundation(Israel Science Foundation); Minerva Foundation; Rising Tide Foundation; Helmholtz Foundation(Helmholtz Association); European Foundation for the Study of Diabetes; Lee Kong Chian School of Medicine; Singapore Centre on Environmental Life Sciences Engineering; NTU Integrated, Medical and Biological and Environmental Life Sciences (NIMBELS); NTU Food Technology Center (NAFTEC) at Nanyang Technological University; Ministry Of Education; CIFAR(Canadian Institute for Advanced Research (CIFAR)); The V.R. Schwartz Research Fellow Chair; French National Center for Scientific Research (CNRS)(Centre National de la Recherche Scientifique (CNRS))	We thank the members of the Elinav and Pettersson laboratories for discussions and apologize to authors whose work was not included in this review due to space constraints. E.E. is supported by Y. and R. Ungar, the Abisch Frenkel Foundation for the Promotion of Life Sciences, the Gurwin Family Fund for Scientific Research, the Leona M. and Harry B. Helmsley Charitable Trust, the Crown Endowment Fund for Immunological Research, the estate of J. Gitlitz, the estate of L. Hershkovich, the Benoziyo Endowment Fund for the Advancement of Science, the Adelis Foundation, J.L. and V. Schwartz, A. and G. Markovitz, A. and C. Adelson, the French National Center for Scientific Research (CNRS), D.L. Schwarz; The V.R. Schwartz Research Fellow Chair, L. Steinberg, J.N. Halpern, and A. Edelheit, as well as by grants funded by the European Research Council, a Marie Curie Integration grant, the German-Israeli Foundation for Scientific Research and Development, the Israel Science Foundation, the Minerva Foundation, the Rising Tide Foundation, the Helmholtz Foundation, and the European Foundation for the Study of Diabetes. E.E. is an international scholar of Howard Hughes Medical Institute (HHMI). S.P. is supported by Lee Kong Chian School of Medicine (SUG 2017-001); Singapore Centre on Environmental Life Sciences Engineering; NTU Integrated, Medical and Biological and Environmental Life Sciences (NIMBELS) (50025000), and NTU Food Technology Center (NAFTEC) at Nanyang Technological University; and TIER 1 grant Ministry Of Education (2016-T1-002-070). E.E. and S.P. are senior fellows of Canadian Institute of Advanced Research (CIFAR). E.E. and S.P. are grateful for the continuous support from CIFAR and valuable input from CIFAR colleagues.	Aagaard K, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008599; Agans R, 2011, FEMS MICROBIOL ECOL, V77, P404, DOI 10.1111/j.1574-6941.2011.01120.x; Albesharat R, 2011, SYST APPL MICROBIOL, V34, P148, DOI 10.1016/j.syapm.2010.12.001; Assie A., 2016, ENV MICROBIOL REP; Bearfield C, 2002, BJOG-INT J OBSTET GY, V109, P527, DOI 10.1016/S1470-0328(02)01349-6; Beasley SS, 2004, APPL ENVIRON MICROB, V70, P5051, DOI 10.1128/AEM.70.8.5051-5053.2004; Bezirtzoglou E, 2011, ANAEROBE, V17, P478, DOI 10.1016/j.anaerobe.2011.03.009; Biagi E, 2016, CURR BIOL, V26, P1480, DOI 10.1016/j.cub.2016.04.016; Biagi E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010667; Bonder MJ, 2016, NAT GENET, V48, P1407, DOI 10.1038/ng.3663; Braniste V, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009759; Brubaker L, 2017, ANN TRANSL MED, V5, DOI 10.21037/atm.2016.11.62; Cabreiro F, 2013, CELL, V153, P228, DOI 10.1016/j.cell.2013.02.035; Collado MC, 2016, SCI REP-UK, V6, DOI 10.1038/srep23129; Chang JY, 2011, J PEDIATR GASTR NUTR, V53, P512, DOI 10.1097/MPG.0b013e318227e518; Chen H, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01427-7; Chevalier C, 2015, CELL, V163, P1360, DOI 10.1016/j.cell.2015.11.004; Claesson MJ, 2011, P NATL ACAD SCI USA, V108, P4586, DOI 10.1073/pnas.1000097107; Collado MC, 2008, AM J CLIN NUTR, V88, P894, DOI 10.1093/ajcn/88.4.894; Collins J, 2014, NEUROGASTROENT MOTIL, V26, P98, DOI 10.1111/nmo.12236; Collins SM, 2012, NAT REV MICROBIOL, V10, P735, DOI 10.1038/nrmicro2876; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; DiGiulio DB, 2015, P NATL ACAD SCI USA, V112, P11060, DOI 10.1073/pnas.1502875112; Dominguez-Bello MG, 2010, P NATL ACAD SCI USA, V107, P11971, DOI 10.1073/pnas.1002601107; Fair DA, 2008, P NATL ACAD SCI USA, V105, P4028, DOI 10.1073/pnas.0800376105; Fasano A, 2015, LANCET NEUROL, V14, P625, DOI 10.1016/S1474-4422(15)00007-1; Favier CF, 2002, APPL ENVIRON MICROB, V68, P219, DOI 10.1128/AEM.68.1.219-226.2002; Fernandez L, 2013, PHARMACOL RES, V69, P1, DOI 10.1016/j.phrs.2012.09.001; Ferretti P, 2017, EXP DERMATOL, V26, P211, DOI 10.1111/exd.13210; Goodrich JK, 2016, CELL HOST MICROBE, V19, P731, DOI 10.1016/j.chom.2016.04.017; Gosalbes MJ, 2013, CLIN EXP ALLERGY, V43, P198, DOI 10.1111/cea.12063; Griffin JL, 2015, CIRC-CARDIOVASC GENE, V8, P187, DOI 10.1161/CIRCGENETICS.114.000219; Guo LL, 2014, CELL, V156, P109, DOI 10.1016/j.cell.2013.12.018; Gusarov I, 2013, CELL, V152, P818, DOI 10.1016/j.cell.2012.12.043; Han B, 2017, CELL, V169, P1249, DOI 10.1016/j.cell.2017.05.036; Harach T, 2017, SCI REP-UK, V7, DOI 10.1038/srep41802; Hardoff R, 2001, MOVEMENT DISORD, V16, P1041, DOI 10.1002/mds.1203; Heijtza RD, 2011, P NATL ACAD SCI USA, V108, P3047, DOI 10.1073/pnas.1010529108; Heikkila MP, 2003, J APPL MICROBIOL, V95, P471, DOI 10.1046/j.1365-2672.2003.02002.x; Hollister EB, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0101-x; Holtmaat A, 2009, NAT REV NEUROSCI, V10, P647, DOI 10.1038/nrn2699; Hou DS, 2013, FERTIL STERIL, V100, P1261, DOI 10.1016/j.fertnstert.2013.07.1991; Hsiao EY, 2013, CELL, V155, P1451, DOI 10.1016/j.cell.2013.11.024; Jimenez E, 2005, CURR MICROBIOL, V51, P270, DOI 10.1007/s00284-005-0020-3; Jimenez E, 2008, RES MICROBIOL, V159, P595, DOI 10.1016/j.resmic.2008.09.001; Jimenez E, 2008, RES MICROBIOL, V159, P187, DOI 10.1016/j.resmic.2007.12.007; Jimenez E, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-143; Jost WH, 1997, DRUG AGING, V10, P249, DOI 10.2165/00002512-199710040-00002; Kabouridis PS, 2015, NEURON, V85, P289, DOI 10.1016/j.neuron.2014.12.037; Kao A. C. C., 2016, INFLUENCE PREBIOTICS; Kelly LP, 2014, MOVEMENT DISORD, V29, P999, DOI 10.1002/mds.25736; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Koenig JE, 2011, P NATL ACAD SCI USA, V108, P4578, DOI 10.1073/pnas.1000081107; Korem T, 2017, CELL METAB, V25, P1243, DOI 10.1016/j.cmet.2017.05.002; Koren O, 2012, CELL, V150, P470, DOI 10.1016/j.cell.2012.07.008; Kurokawa K, 2007, DNA RES, V14, P169, DOI 10.1093/dnares/dsm018; Langille MG, 2014, MICROBIOME, V2, DOI 10.1186/s40168-014-0050-9; Le Huerou-Luron I, 2010, NUTR RES REV, V23, P23, DOI 10.1017/S0954422410000065; Lee HU, 2017, J MOL MED, V95, P29, DOI 10.1007/s00109-016-1486-0; MacNeil LT, 2013, CELL, V153, P240, DOI 10.1016/j.cell.2013.02.049; Mandar R, 2015, RES MICROBIOL, V166, P440, DOI 10.1016/j.resmic.2015.03.009; Makino H, 2011, APPL ENVIRON MICROB, V77, P6788, DOI 10.1128/AEM.05346-11; Maltais ML, 2009, J MUSCULOSKEL NEURON, V9, P186; Maqsood R, 2016, NEUROCHEM RES, V41, P2819, DOI 10.1007/s11064-016-2039-1; Mariat D, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-123; Markenson GR, 2003, J REPROD MED, V48, P775; Martin R, 2005, J HUM LACT, V21, P8, DOI 10.1177/0890334404272393; Martin R, 2003, J PEDIATR-US, V143, P754, DOI 10.1016/j.jpeds.2003.09.028; Martin R, 2005, J HUM LACT, V21, P18; Martin R, 2007, RES MICROBIOL, V158, P31, DOI 10.1016/j.resmic.2006.11.004; Martin R, 2009, APPL ENVIRON MICROB, V75, P965, DOI 10.1128/AEM.02063-08; Matsumiya Yoshiko, 2002, Journal of Infection and Chemotherapy, V8, P43; Maurice CF, 2015, ISME J, V9, P2423, DOI 10.1038/ismej.2015.53; Moles L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066986; Moore AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078822; O'Mahony SM, 2011, PSYCHOPHARMACOLOGY, V214, P71, DOI 10.1007/s00213-010-2010-9; Obata Y, 2016, GASTROENTEROLOGY, V151, P836, DOI 10.1053/j.gastro.2016.07.044; Ottaviani E, 2011, BIOGERONTOLOGY, V12, P599, DOI 10.1007/s10522-011-9352-5; Palmer C, 2007, PLOS BIOL, V5, P1556, DOI 10.1371/journal.pbio.0050177; Paus T, 2008, NAT REV NEUROSCI, V9, P947, DOI 10.1038/nrn2513; Perez-Munoz ME, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0268-4; Pettker CM, 2007, OBSTET GYNECOL, V109, P739, DOI 10.1097/01.AOG.0000255663.47512.23; Rajilic-Stojanovic M, 2013, ENVIRON MICROBIOL, V15, P1146, DOI 10.1111/1462-2920.12023; Rautava S, 2012, NEONATOLOGY, V102, P178, DOI 10.1159/000339182; Ren C, 2007, CELL METAB, V6, P144, DOI 10.1016/j.cmet.2007.06.006; Rhee SH, 2009, NAT REV GASTRO HEPAT, V6, P306, DOI 10.1038/nrgastro.2009.35; Ringel-Kulka T., 2013, PLOS ONE, V8; Saffrey MJ, 2014, AGE, V36, P1019, DOI 10.1007/s11357-013-9603-2; Sampson TR, 2016, CELL, V167, P1469, DOI 10.1016/j.cell.2016.11.018; Sarkar A, 2016, TRENDS NEUROSCI, V39, P763, DOI 10.1016/j.tins.2016.09.002; Satokari R, 2009, LETT APPL MICROBIOL, V48, P8, DOI 10.1111/j.1472-765X.2008.02475.x; Scheperjans F, 2015, MOVEMENT DISORD, V30, P350, DOI 10.1002/mds.26069; Schieber AMP, 2015, SCIENCE, V350, P558, DOI 10.1126/science.aac6468; Sela DA, 2008, P NATL ACAD SCI USA, V105, P18964, DOI 10.1073/pnas.0809584105; Sharon G, 2016, CELL, V167, P915, DOI 10.1016/j.cell.2016.10.027; Shoemark DK, 2015, J ALZHEIMERS DIS, V43, P725, DOI 10.3233/JAD-141170; Smith MI, 2013, SCIENCE, V339, P548, DOI 10.1126/science.1229000; Smith P, 2017, ELIFE, V6, DOI 10.7554/eLife.27014; Stappenbeck TS, 2016, NATURE, V534, P191, DOI 10.1038/nature18285; Stinson LF, 2017, CRIT REV MICROBIOL, V43, P352, DOI 10.1080/1040841X.2016.1211088; Storelli G, 2011, CELL METAB, V14, P403, DOI 10.1016/j.cmet.2011.07.012; Stout MJ, 2013, AM J OBSTET GYNECOL, V208, DOI 10.1016/j.ajog.2013.01.018; Suez J, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.75; Suez J, 2014, NATURE, V514, P181, DOI 10.1038/nature13793; Thaiss CA, 2016, NATURE, V540, P544, DOI 10.1038/nature20796; Thevaranjan N, 2017, CELL HOST MICROBE, V21, P455, DOI 10.1016/j.chom.2017.03.002; Tissier H., 1900, RECHERCHES FLORE INT; Turnbaugh PJ, 2009, J PHYSIOL-LONDON, V587, P4153, DOI 10.1113/jphysiol.2009.174136; Vaishampayan PA, 2010, GENOME BIOL EVOL, V2, P53, DOI 10.1093/gbe/evp057; Verdier J, 2015, VISZERALMEDIZIN, V31, P156, DOI 10.1159/000431071; Verstraelen H, 2016, PEERJ, V4, DOI 10.7717/peerj.1602; Virk B, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-67; Wang J, 2016, NAT GENET, V48, P1396, DOI 10.1038/ng.3695; Watson E, 2013, CELL, V153, P253, DOI 10.1016/j.cell.2013.02.050; WEAVER LT, 1991, GUT, V32, P1321, DOI 10.1136/gut.32.11.1321; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Zeevi D, 2015, CELL, V163, P1079, DOI 10.1016/j.cell.2015.11.001; Zhang CH, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3163; Zhang L, 2012, CELL RES, V22, P107, DOI 10.1038/cr.2011.158; Zhang R., 2013, ISRN MICROBIOL, V2013; Zhang ZG, 2016, CURR BIOL, V26, P1873, DOI 10.1016/j.cub.2016.05.012; Zheng J, 2015, NUTRIENTS, V7, P6924, DOI 10.3390/nu7085315	122	297	320	27	207	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 14	2017	171	7					1481	1493		10.1016/j.cell.2017.11.024	http://dx.doi.org/10.1016/j.cell.2017.11.024			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FQ0KF	29245010	Green Accepted, Bronze			2022-12-28	WOS:000418044000007
J	Wigley, C; Bucknall, V; Fleming, S				Wigley, Catrin; Bucknall, Victoria; Fleming, Simon			CHRISTMAS 2017: LANGUAGE AND LITERACY Santa's little helpers: a novel approach to developing patient information leaflets	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							READABILITY ASSESSMENT; CONSENT FORMS		[Wigley, Catrin] Univ Hosp Coventry & Warwickshire NHS Trust, Coventry CV2 2DX, W Midlands, England; [Bucknall, Victoria] Victoria Hosp, Kirkcaldy KY2 5AH, Scotland; [Fleming, Simon] Barts Hlth Whitechapel, London E1 1BB, England	University of Warwick; Barts Health NHS Trust	Wigley, C (corresponding author), Univ Hosp Coventry & Warwickshire NHS Trust, Coventry CV2 2DX, W Midlands, England.	catrin.h.wigley@gmail.com	Fleming, Simon/AAA-6328-2021	Fleming, Simon/0000-0002-6428-6242				Abdul-Sater L, 2011, OTOLARYNG HEAD NECK, V144, P685, DOI 10.1177/0194599811399556; BURSCH B, 1993, ANN EMERG MED, V22, P586, DOI 10.1016/S0196-0644(05)81947-X; Central Connecticut State University, WORLDS MOST LIT NAT; Chan SW, 2017, BMJ-BRIT MED J, V357, DOI 10.1136/bmj.j2224; Cherla DV, 2012, LARYNGOSCOPE, V122, P1649, DOI 10.1002/lary.23309; Department of Health, 2014, REF GUID CONS EX TRE; Edmunds MR, 2013, JAMA OPHTHALMOL, V131, P1610, DOI 10.1001/jamaophthalmol.2013.5521; Fitzsimmons PR, 2010, J ROY COLL PHYS EDIN, V40, P292, DOI 10.4997/JRCPE.2010.401; Flood A., 2016, GUARDIAN; MDU Journal, INF CONS YEAR MONT; Paasche-Orlow MK, 2003, NEW ENGL J MED, V348, P721, DOI 10.1056/NEJMsa021212; Patel CR, 2013, HEAD NECK-J SCI SPEC, V35, P1421, DOI 10.1002/hed.23157; Robbins J A, 1993, Fam Med, V25, P17; Walsh TM, 2008, RESP CARE, V53, P1310; Williamson JML, 2010, INT J CLIN PRACT, V64, P322, DOI 10.1111/j.1742-1241.2009.02245.x	15	5	5	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 13	2017	359								j5565	10.1136/bmj.j5565	http://dx.doi.org/10.1136/bmj.j5565			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FQ4KY	29237600				2022-12-28	WOS:000418327500006
J	Paladini, C; Baron, F; Jorissen, A; Le Bouquin, JB; Freytag, B; Van Eck, S; Wittkowski, M; Hron, J; Chiavassa, A; Berger, JP; Siopis, C; Mayer, A; Sadowski, G; Kravchenko, K; Shetye, S; Kerschbaum, F; Kluska, J; Ramstedt, S				Paladini, C.; Baron, F.; Jorissen, A.; Le Bouquin, J. -B.; Freytag, B.; Van Eck, S.; Wittkowski, M.; Hron, J.; Chiavassa, A.; Berger, J. -P.; Siopis, C.; Mayer, A.; Sadowski, G.; Kravchenko, K.; Shetye, S.; Kerschbaum, F.; Kluska, J.; Ramstedt, S.			Large granulation cells on the surface of the giant star pi(1) Gruis	NATURE			English	Article								Convection plays a major part in many astrophysical processes, including energy transport, pulsation, dynamos and winds on evolved stars, in dust clouds and on brown dwarfs(1,2). Most of our knowledge about stellar convection has come from studying the Sun: about two million convective cells with typical sizes of around 2,000 kilometres across are present on the surface of the Sun(3)-a phenomenon known as granulation. But on the surfaces of giant and supergiant stars there should be only a few large (several tens of thousands of times larger than those on the Sun) convective cells(3), owing to low surface gravity. Deriving the characteristic properties of convection (such as granule size and contrast) for the most evolved giant and supergiant stars is challenging because their photospheres are obscured by dust, which partially masks the convective patterns(4). These properties can be inferred from geometric model fitting(5-7), but this indirect method does not provide information about the physical origin of the convective cells(5-7). Here we report interferometric images of the surface of the evolved giant star pi(1) Gruis, of spectral type(8,9) S5,7. Our images show a nearly circular, dust-free atmosphere, which is very compact and only weakly affected by molecular opacity. We find that the stellar surface has a complex convective pattern with an average intensity contrast of 12 per cent, which increases towards shorter wavelengths. We derive a characteristic horizontal granule size of about 1.2 x 10(11) metres, which corresponds to 27 per cent of the diameter of the star. Our measurements fall along the scaling relations between granule size, effective temperature and surface gravity that are predicted by simulations of stellar surface convection(10-12).	[Paladini, C.; Jorissen, A.; Van Eck, S.; Siopis, C.; Sadowski, G.; Kravchenko, K.; Shetye, S.] Univ Libre Bruxelles, Inst Astron & Astrophys, CP 226, B-1050 Brussels, Belgium; [Paladini, C.] European Southern Observ, Alonso de Cordova 3107, Santiago, Chile; [Baron, F.] Georgia State Univ, Dept Phys & Astron, POB 5060, Atlanta, GA 30302 USA; [Le Bouquin, J. -B.; Berger, J. -P.] Univ Grenoble Alpes, CNRS, IPAG, F-38000 Grenoble, France; [Freytag, B.; Ramstedt, S.] Uppsala Univ, Dept Phys & Astron, Box 516, S-75120 Uppsala, Sweden; [Wittkowski, M.] European Southern Observ, Karl Schwarzschild Str 2, D-85748 Garching, Germany; [Hron, J.; Mayer, A.; Kerschbaum, F.] Univ Vienna, Dept Astrophys, Turkenschanzstr 17, A-1180 Vienna, Austria; [Chiavassa, A.] Univ Nice Sophia Antipolis, Lab Lagrange, Observ Cote Azur, UMR 7293,CNRS, BP 4229, F-06304 Nice 4, France; [Kluska, J.] Univ Exeter, Dept Phys & Astron, Stocker Rd, Exeter EX4 4QL, Devon, England	Universite Libre de Bruxelles; European Southern Observatory; University System of Georgia; Georgia State University; Centre National de la Recherche Scientifique (CNRS); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Institut de Planetologie et d'Astrophysique de Grenoble (IPAG); Uppsala University; European Southern Observatory; University of Vienna; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Universite Cote d'Azur; Observatoire de la Cote d'Azur; University of Exeter	Paladini, C (corresponding author), Univ Libre Bruxelles, Inst Astron & Astrophys, CP 226, B-1050 Brussels, Belgium.; Paladini, C (corresponding author), European Southern Observ, Alonso de Cordova 3107, Santiago, Chile.	cpaladin@eso.org	Kerschbaum, Franz/AAB-1523-2019; Kluska, Jacques/ABI-1624-2020	Kerschbaum, Franz/0000-0001-6320-0980; Kluska, Jacques/0000-0002-9491-393X; Paladini, Claudia/0000-0003-4974-7239	Fonds National de la Recherche Scientifique (F.R.S.-FNRS), Belgium; PRODEX office, Belgium; Belgian Science Policy Office [BR/143/A2/STARLAB]; FRIA grant (Belgium); National Science Foundation, NSF-AST [1445935, 1616483]; Fondation ULB; European Union's Horizon 2020 research and innovation programme [730890]; Austrian Science Fund (FWF) [AP23006-N16]	Fonds National de la Recherche Scientifique (F.R.S.-FNRS), Belgium(Fonds de la Recherche Scientifique - FNRS); PRODEX office, Belgium; Belgian Science Policy Office(Belgian Federal Science Policy Office); FRIA grant (Belgium)(Fonds de la Recherche Scientifique - FNRS); National Science Foundation, NSF-AST(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); Fondation ULB; European Union's Horizon 2020 research and innovation programme; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	C.P. acknowledges the support of the Fonds National de la Recherche Scientifique (F.R.S.-FNRS), Belgium. C.S., G.S. are supported by the PRODEX office, Belgium. This research has been funded by the Belgian Science Policy Office under contract BR/143/A2/STARLAB (S.S., A.J., S.V.E.). K.K. is supported by a FRIA grant (Belgium). F.B. acknowledges funding by the National Science Foundation, NSF-AST numbers 1445935 and 1616483. J.K. acknowledges the Philip Leverhulme Prize (PLP-2013-110). S.V.E. thanks the Fondation ULB for its support. The research leading to these results has received funding from the European Union's Horizon 2020 research and innovation programme under Grant Agreement 730890 (OPTICON) and from the Austrian Science Fund (FWF) under project AP23006-N16. We thank all the ESO/VLTI staff for supporting our observations.	Baron F, 2014, ASTR SOC P, V487, P229; Baron F, 2010, PROC SPIE, V7734, DOI 10.1117/12.857364; Borde P, 2002, ASTRON ASTROPHYS, V393, P183, DOI 10.1051/0004-6361:20021020; Freytag B, 2008, ASTRON ASTROPHYS, V483, P571, DOI 10.1051/0004-6361:20078096; Freytag B, 2017, ASTRON ASTROPHYS, V600, DOI 10.1051/0004-6361/201629594; Freytag B., 1997, SCI VLT INTERFEROMET, P316; Gimenez A., 1999, ASP C SER, V173; Haubois X, 2009, ASTRON ASTROPHYS, V508, P923, DOI 10.1051/0004-6361/200912927; KEENAN PC, 1954, ASTROPHYS J, V120, P484, DOI 10.1086/145937; Kervella P, 2011, ASTRON ASTROPHYS, V531, DOI 10.1051/0004-6361/201116962; Kupka F., 2004, P INT ASTR UN S, V224, P119; Lafrasse S., 2010, P SOC PHOTO-OPT INS, V7013; Ludwig H.-G., 2009, MEM SOC ASTRON IT, V80, P711; Mayer A, 2014, ASTRON ASTROPHYS, V570, DOI 10.1051/0004-6361/201424465; Montarges M, 2016, ASTRON ASTROPHYS, V588, DOI 10.1051/0004-6361/201527028; Paladini C, 2017, ASTRON ASTROPHYS, V600, DOI 10.1051/0004-6361/201527210; Renard S, 2011, ASTRON ASTROPHYS, V533, DOI 10.1051/0004-6361/201016263; SCHWARZSCHILD M, 1975, ASTROPHYS J, V195, P137, DOI 10.1086/153313; Thiebaut E, 2008, PROC SPIE, V7013; Trampedach R, 2013, ASTROPHYS J, V769, DOI 10.1088/0004-637X/769/1/18; Tremblay PE, 2013, ASTRON ASTROPHYS, V557, DOI 10.1051/0004-6361/201321878; ULRICH RK, 1970, ASTROPHYS SPACE SCI, V7, P71; Van Eck S, 2017, ASTRON ASTROPHYS, V601, DOI 10.1051/0004-6361/201525886; van Leeuwen F, 2007, ASTRON ASTROPHYS, V474, P653, DOI 10.1051/0004-6361:20078357; Wedemeyer-Bohm S, 2009, ASTRON ASTROPHYS, V503, P225, DOI 10.1051/0004-6361/200911983; Wittkowski M, 2017, ASTRON ASTROPHYS, V601, DOI 10.1051/0004-6361/201630214; Young JS, 2000, MON NOT R ASTRON SOC, V315, P635, DOI 10.1046/j.1365-8711.2000.03438.x	28	29	29	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 18	2018	553	7688					310	+		10.1038/nature25001	http://dx.doi.org/10.1038/nature25001			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT9MB	29258298				2022-12-28	WOS:000423475100045
J	Che, T; Majumdar, S; Zaidi, SA; Ondachi, P; McCorvy, JD; Wang, S; Mosier, PD; Uprety, R; Vardy, E; Krumm, BE; Han, GW; Lee, MY; Pardon, E; Steyaert, J; Huang, XP; Strachan, RT; Tribo, AR; Pasternak, GW; Carroll, FI; Stevens, RC; Cherezov, V; Katritch, V; Wacker, D; Roth, BL				Che, Tao; Majumdar, Susruta; Zaidi, Saheem A.; Ondachi, Pauline; McCorvy, John D.; Wang, Sheng; Mosier, Philip D.; Uprety, Rajendra; Vardy, Eyal; Krumm, Brian E.; Han, Gye Won; Lee, Ming-Yue; Pardon, Els; Steyaert, Jan; Huang, Xi-Ping; Strachan, Ryan T.; Tribo, Alexandra R.; Pasternak, Gavril W.; Carroll, F. Ivy; Stevens, Raymond C.; Cherezov, Vadim; Katritch, Vsevolod; Wacker, Daniel; Roth, Bryan L.			Structure of the Nanobody-Stabilized Active State of the Kappa Opioid Receptor	CELL			English	Article							PROTEIN-COUPLED RECEPTORS; STRUCTURE-BASED DISCOVERY; CRYSTAL-STRUCTURE; FORCE-FIELD; POTENT ANTINOCICEPTION; FUNCTIONAL SELECTIVITY; AGONIST; MU; COMPLEX; BINDING	The kappa-opioid receptor (KOP) mediates the actions of opioids with hallucinogenic, dysphoric, and analgesic activities. The design of KOP analgesics devoid of hallucinatory and dysphoric effects has been hindered by an incomplete structural and mechanistic understanding of KOP agonist actions. Here, we provide a crystal structure of human KOP in complex with the potent epoxymorphinan opioid agonist MP1104 and an active-state-stabilizing nanobody. Comparisons between inactive-and active-state opioid receptor structures reveal substantial conformational changes in the binding pocket and intracellular and extracellular regions. Extensive structural analysis and experimental validation illuminate key residues that propagate larger-scale structural rearrangements and transducer binding that, collectively, elucidate the structural determinants of KOP pharmacology, function, and biased signaling. These molecular insights promise to accelerate the structure-guided design of safer and more effective k-opioid receptor therapeutics.	[Che, Tao; McCorvy, John D.; Wang, Sheng; Vardy, Eyal; Krumm, Brian E.; Strachan, Ryan T.; Tribo, Alexandra R.; Wacker, Daniel; Roth, Bryan L.] Univ North Carolina Chapel Hill, Sch Med, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Majumdar, Susruta; Uprety, Rajendra; Pasternak, Gavril W.] Mem Sloan Kettering Canc Ctr, Mol Pharmacol Program, New York, NY 10065 USA; [Majumdar, Susruta; Uprety, Rajendra; Pasternak, Gavril W.] Mem Sloan Kettering Canc Ctr, Dept Neurol, New York, NY 10065 USA; [Zaidi, Saheem A.; Stevens, Raymond C.; Katritch, Vsevolod] Univ Southern Calif, Dept Biol Sci, Bridge Inst, Los Angeles, CA 90089 USA; [Ondachi, Pauline; Carroll, F. Ivy] Res Triangle Inst, Ctr Organ & Med Chem, POB 12194, Res Triangle Pk, NC 27709 USA; [Mosier, Philip D.] Virginia Commonweath Univ, Dept Med Chem, Richmond, VA 23298 USA; [Mosier, Philip D.] Virginia Commonweath Univ, Inst Struct Biol Drug Discovery & Dev, Richmond, VA 23298 USA; [Han, Gye Won; Lee, Ming-Yue; Stevens, Raymond C.; Cherezov, Vadim; Katritch, Vsevolod] Univ Southern Calif, Dept Chem, Bridge Inst, Los Angeles, CA 90089 USA; [Lee, Ming-Yue] Arizona State Univ, Sch Mol Sci, Biodesign Ctr Appl Struct Discovery, Biodesign Inst, Tempe, AZ 85287 USA; [Lee, Ming-Yue] Nanjing Audit Univ, Inst Nat Resources & Environm Audits, Nanjing, Jiangsu, Peoples R China; [Pardon, Els; Steyaert, Jan] Vrije Univ Brussel, Struct Biol Brussels, B-1050 Brussels, Belgium; [Pardon, Els; Steyaert, Jan] VIB, VIB VUB Ctr Struct Biol, B-1050 Brussels, Belgium; [Huang, Xi-Ping; Roth, Bryan L.] Univ North Carolina Chapel Hill, Sch Med, NIMH PDSP, Chapel Hill, NC 27599 USA; [Roth, Bryan L.] Univ North Carolina Chapel Hill, Eshelman Sch Pharm, Div Chem Biol & Med Chem, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; University of Southern California; Research Triangle Institute; University of Southern California; Arizona State University; Arizona State University-Tempe; Nanjing Audit University; Vrije Universiteit Brussel; Flanders Institute for Biotechnology (VIB); National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Wacker, D; Roth, BL (corresponding author), Univ North Carolina Chapel Hill, Sch Med, Dept Pharmacol, Chapel Hill, NC 27599 USA.; Roth, BL (corresponding author), Univ North Carolina Chapel Hill, Sch Med, NIMH PDSP, Chapel Hill, NC 27599 USA.; Roth, BL (corresponding author), Univ North Carolina Chapel Hill, Eshelman Sch Pharm, Div Chem Biol & Med Chem, Chapel Hill, NC 27599 USA.	dwacker@email.unc.edu; bryan_roth@med.unc.edu	steyaert, jan/GQP-7811-2022; Roth, Bryan L/F-3928-2010; Han, Gye Won/GLQ-8724-2022; Katritch, Vsevolod/Y-2721-2019; , PEP-MX Core/AGV-4051-2022; Zaidi, Saheem/J-8199-2019; Katritch, Vsevolod/Q-8357-2016; Roth, Bryan/ABE-7032-2020; Han, Gye Won/GLQ-8673-2022; Stevens, Raymond/K-7272-2015; Cherezov, Vadim/L-9812-2013; Han, Gye Won/GLT-1531-2022; Lee, Ming-Yue/AAW-9142-2020; Steyaert, Jan/H-4662-2011	Han, Gye Won/0000-0003-4107-835X; Katritch, Vsevolod/0000-0003-3883-4505; Roth, Bryan/0000-0002-0561-6520; Stevens, Raymond/0000-0002-4522-8725; Cherezov, Vadim/0000-0002-5265-3914; Lee, Ming-Yue/0000-0001-7082-1216; Steyaert, Jan/0000-0002-3825-874X; Zaidi, Saheem/0000-0001-7531-3587; Uprety, Rajendra/0000-0003-1190-5318; Pardon, Els/0000-0002-2466-0172	NIH [RO1MH61887, U19MH82441]; NIMH Psychoactive Drug Screening Program Contract; Michael Hooker Distinguished Chair of Pharmacology; National Institute on Drug Abuse [DA035764, DA038858, DA0624, DA034106]; Mayday Foundation; Peter F. McManus Trust [DA034106]; NIH/NCI Cancer Center support grant [P30 CA008748]; National Cancer Institute [P30CA016086]; Federal funds from the National Cancer Institute [ACB-12002]; National Institute of General Medical Sciences [AGM-12006]; DOE Office of Science [DE-AC02-06CH11357]; NATIONAL CANCER INSTITUTE [P30CA016086, P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U19MH082441, R01MH061887] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R33DA034106, R01DA017204, R33DA038858, R21DA038858, R01DA006241, R21DA034106, R01DA027170, P01DA035764] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIMH Psychoactive Drug Screening Program Contract; Michael Hooker Distinguished Chair of Pharmacology; National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Mayday Foundation; Peter F. McManus Trust; NIH/NCI Cancer Center support grant; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Federal funds from the National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); DOE Office of Science(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by NIH grants (RO1MH61887 and U19MH82441), the NIMH Psychoactive Drug Screening Program Contract, and the Michael Hooker Distinguished Chair of Pharmacology (to B.L.R.), as well as grants from the National Institute on Drug Abuse to B.L.R., R.C.S., V.C., and V.K. (DA035764), to V.K. (DA038858), to G.W.P. (DA0624), and to S.M. (DA034106). This research was also funded by the Mayday Foundation and the Peter F. McManus Trust (to G.W.P.), (DA034106) (S.M.), and an NIH/NCI Cancer Center support grant (P30 CA008748) (to Memorial Sloan Kettering Cancer Center). We thank INSTRUCT, part of the European Strategy Forum on Research Infrastructures (ESFRI), and the Research Foundation - Flanders (FWO) for their support to the nanobody discovery and thank Nele Buys and Katleen Willibal for the technical assistance. We also thank R.H.J. Olsen for providing the KOP-G alpha i1 and MOP-G alpha i1 constructs. We gratefully acknowledge M.J. Miley and the UNC Macromolecular Crystallization Core for advice and use of their equipment for crystal harvesting and transport, which is supported by the National Cancer Institute (award number P30CA016086). We thank J. Smith and R. Fischetti and the staff of GM/CA@APS, which has been funded with Federal funds from the National Cancer Institute (ACB-12002) and the National Institute of General Medical Sciences (AGM-12006). This research used resources of the Advanced Photon Source, a U.S. Department of Energy (DOE) Office of Science User Facility, operated for the DOE Office of Science by Argonne National Laboratory (contract no. DE-AC02-06CH11357).	ABAGYAN R, 1994, J COMPUT CHEM, V15, P488, DOI 10.1002/jcc.540150503; Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x; BLACK JW, 1983, PROC R SOC SER B-BIO, V220, P141, DOI 10.1098/rspb.1983.0093; Bruchas MR, 2010, BRAIN RES, V1314, P44, DOI 10.1016/j.brainres.2009.08.062; Bruchas MR, 2016, TRENDS PHARMACOL SCI, V37, P279, DOI 10.1016/j.tips.2016.01.001; Brust TF, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aai8441; Caffrey M, 2009, NAT PROTOC, V4, P706, DOI 10.1038/nprot.2009.31; Carpenter B, 2016, NATURE, V536, P104, DOI 10.1038/nature18966; CHAVKIN C, 1982, SCIENCE, V215, P413, DOI 10.1126/science.6120570; Chun E, 2012, STRUCTURE, V20, P967, DOI 10.1016/j.str.2012.04.010; Cunningham CW, 2011, PHARMACOL REV, V63, P316, DOI 10.1124/pr.110.003244; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Endoh T, 2001, JPN J PHARMACOL, V85, P282, DOI 10.1254/jjp.85.282; Fenalti G, 2015, NAT STRUCT MOL BIOL, V22, P265, DOI 10.1038/nsmb.2965; Fenalti G, 2014, NATURE, V506, P191, DOI 10.1038/nature12944; Granier S, 2012, NATURE, V485, P400, DOI 10.1038/nature11111; Holst B, 2010, J BIOL CHEM, V285, P3973, DOI 10.1074/jbc.M109.064725; Huang WJ, 2015, NATURE, V524, P315, DOI 10.1038/nature14886; Kang YY, 2015, NATURE, V523, P561, DOI 10.1038/nature14656; Katritch V, 2014, TRENDS BIOCHEM SCI, V39, P233, DOI 10.1016/j.tibs.2014.03.002; Katritch V, 2013, ANNU REV PHARMACOL, V53, P531, DOI 10.1146/annurev-pharmtox-032112-135923; Kellogg GE, 2000, EUR J MED CHEM, V35, P651, DOI 10.1016/S0223-5234(00)00167-7; Kenakin T, 2013, NAT REV DRUG DISCOV, V12, P205, DOI 10.1038/nrd3954; Kenakin T, 2012, ACS CHEM NEUROSCI, V3, P193, DOI 10.1021/cn200111m; Kim S, 2017, J COMPUT CHEM, V38, P1879, DOI 10.1002/jcc.24829; Krivov GG, 2009, PROTEINS, V77, P778, DOI 10.1002/prot.22488; Kroeze WK, 2015, NAT STRUCT MOL BIOL, V22, P362, DOI 10.1038/nsmb.3014; Kruse AC, 2013, NATURE, V504, P101, DOI 10.1038/nature12735; Larson DL, 2000, J MED CHEM, V43, P1573, DOI 10.1021/jm000059g; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee J, 2016, J CHEM THEORY COMPUT, V12, P405, DOI 10.1021/acs.jctc.5b00935; Liu W, 2013, SCIENCE, V342, P1521, DOI 10.1126/science.1244142; Lomize MA, 2006, BIOINFORMATICS, V22, P623, DOI 10.1093/bioinformatics/btk023; Majumdar S, 2012, J MED CHEM, V55, P6352, DOI 10.1021/jm300305c; Manglik A, 2016, NATURE, V537, P185, DOI 10.1038/nature19112; Manglik A, 2012, NATURE, V485, P321, DOI 10.1038/nature10954; MARTIN WR, 1976, J PHARMACOL EXP THER, V197, P517; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nagase H, 2012, CHEM PHARM BULL, V60, P945, DOI 10.1248/cpb.c12-00336; Pardon E, 2014, NAT PROTOC, V9, P674, DOI 10.1038/nprot.2014.039; PASTERNAK GW, 1975, MOL PHARMACOL, V11, P735; PERT CB, 1973, SCIENCE, V182, P1359, DOI 10.1126/science.182.4119.1359; PFEIFFER A, 1986, SCIENCE, V233, P774, DOI 10.1126/science.3016896; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Roth BL, 2002, P NATL ACAD SCI USA, V99, P11934, DOI 10.1073/pnas.182234399; SAMAMA P, 1993, J BIOL CHEM, V268, P4625; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Shi L, 2002, J BIOL CHEM, V277, P14777, DOI 10.1074/jbc.M108967200; Smart OS, 2012, ACTA CRYSTALLOGR D, V68, P368, DOI 10.1107/S0907444911056058; Spahn V, 2017, SCIENCE, V355, P966, DOI 10.1126/science.aai8636; Spetea M, 2017, BRIT J PHARMACOL, V174, P2444, DOI 10.1111/bph.13854; Thomas JB, 1998, J MED CHEM, V41, P1980, DOI 10.1021/jm980063g; Thompson AA, 2012, NATURE, V485, P395, DOI 10.1038/nature11085; Urbano M, 2014, BIOORG MED CHEM LETT, V24, P2021, DOI 10.1016/j.bmcl.2014.03.040; Valentin-Hansen L, 2012, J BIOL CHEM, V287, P43516, DOI 10.1074/jbc.M112.395137; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Varadi A, 2015, ACS CHEM NEUROSCI, V6, P1813, DOI 10.1021/acschemneuro.5b00153; Vardy E, 2015, NEURON, V86, P936, DOI 10.1016/j.neuron.2015.03.065; Vardy E, 2013, J BIOL CHEM, V288, P34470, DOI 10.1074/jbc.M113.515668; Venkatakrishnan AJ, 2013, NATURE, V494, P185, DOI 10.1038/nature11896; Wacker D, 2017, CELL, V170, P414, DOI 10.1016/j.cell.2017.07.009; Wacker D, 2017, CELL, V168, P377, DOI 10.1016/j.cell.2016.12.033; Wacker D, 2013, SCIENCE, V340, P615, DOI 10.1126/science.1232808; Wang S, 2017, SCIENCE, V358, P381, DOI 10.1126/science.aan5468; White KL, 2015, J PHARMACOL EXP THER, V352, P98, DOI 10.1124/jpet.114.216820; Wu HX, 2012, NATURE, V485, P327, DOI 10.1038/nature10939; Yan F, 2009, BIOCHEMISTRY-US, V48, P6898, DOI 10.1021/bi900605n; Zheng Z, 2017, J MED CHEM, V60, P3070, DOI 10.1021/acs.jmedchem.7b00109	71	210	212	3	93	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 11	2018	172	1-2					55	+		10.1016/j.cell.2017.12.011	http://dx.doi.org/10.1016/j.cell.2017.12.011			28	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FS5MI	29307491	Bronze, Green Accepted, Green Published			2022-12-28	WOS:000419840100009
J	Matson, V; Fessler, J; Bao, R; Chongsuwat, T; Zha, YY; Alegre, ML; Luke, JJ; Gajewski, TF				Matson, Vyara; Fessler, Jessica; Bao, Riyue; Chongsuwat, Tara; Zha, Yuanyuan; Alegre, Maria-Luisa; Luke, Jason J.; Gajewski, Thomas F.			The commensal microbiome is associated with anti-PD-1 efficacy in metastatic melanoma patients	SCIENCE			English	Article								Anti-PD-1-based immunotherapy has had a major impact on cancer treatment but has only benefited a subset of patients. Among the variables that could contribute to interpatient heterogeneity is differential composition of the patients' microbiome, which has been shown to affect antitumor immunity and immunotherapy efficacy in preclinical mouse models. We analyzed baseline stool samples from metastatic melanoma patients before immunotherapy treatment, through an integration of 16S ribosomal RNA gene sequencing, metagenomic shotgun sequencing, and quantitative polymerase chain reaction for selected bacteria. A significant association was observed between commensal microbial composition and clinical response. Bacterial species more abundant in responders included Bifidobacterium longum, Collinsella aerofaciens, and Enterococcus faecium. Reconstitution of germ-free mice with fecal material from responding patients could lead to improved tumor control, augmented T cell responses, and greater efficacy of anti-PD-L1 therapy. Our results suggest that the commensal microbiome may have a mechanistic impact on antitumor immunity in human cancer patients.	[Matson, Vyara; Fessler, Jessica; Gajewski, Thomas F.] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA; [Bao, Riyue] Univ Chicago, Ctr Res Informat, Chicago, IL 60637 USA; [Bao, Riyue] Univ Chicago, Dept Pediat, Chicago, IL 60637 USA; [Chongsuwat, Tara; Zha, Yuanyuan; Alegre, Maria-Luisa; Luke, Jason J.; Gajewski, Thomas F.] Univ Chicago, Dept Med, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago; University of Chicago	Gajewski, TF (corresponding author), Univ Chicago, Dept Pathol, Chicago, IL 60637 USA.; Gajewski, TF (corresponding author), Univ Chicago, Dept Med, Chicago, IL 60637 USA.	tgajewsk@medicine.bsd.uchicago.edu	Luke, Jason John/AAB-9724-2022; Zha, Yuanyuan/I-2890-2015	Luke, Jason John/0000-0002-1182-4908; Zha, Yuanyuan/0000-0003-4323-0730; Gajewski, Thomas/0000-0001-5727-3972	NIH grant [R35 CA210098]; Team Science Award from the Melanoma Research Alliance; American Cancer Society-Jules L. Plangere Jr. Family Foundation Professorship in Cancer Immunotherapy; University of Chicago Medicine Comprehensive Cancer Center; University of Chicago Cancer Biology Training program [T32 CA009594]; Center for Research Informatics of The University of Chicago Biological Science Division; Roche-Genentech; BMS; Merck; Incyte; Seattle Genetics; Ono; Bristol-Myers Squibb; NATIONAL CANCER INSTITUTE [R35CA210098, T32CA009594, F99CA234946] Funding Source: NIH RePORTER	NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Team Science Award from the Melanoma Research Alliance; American Cancer Society-Jules L. Plangere Jr. Family Foundation Professorship in Cancer Immunotherapy; University of Chicago Medicine Comprehensive Cancer Center; University of Chicago Cancer Biology Training program; Center for Research Informatics of The University of Chicago Biological Science Division; Roche-Genentech(Roche HoldingGenentech); BMS(Bristol-Myers Squibb); Merck(Merck & Company); Incyte; Seattle Genetics; Ono; Bristol-Myers Squibb(Bristol-Myers Squibb); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank E. Chang, A. Sivan, C. Nagler, L. Huang, P. Bleda-Ferre, N. Hubert, Z. Early, and B. Theriault for helpful discussions and M. Jarsulic, B. Choy, N. Martinec, S. Owens, S. Greenwald, H. Morrison, and J. Polinski for technical assistance. This work was supported by NIH grant R35 CA210098, a Team Science Award from the Melanoma Research Alliance, the American Cancer Society-Jules L. Plangere Jr. Family Foundation Professorship in Cancer Immunotherapy, funds from the University of Chicago Medicine Comprehensive Cancer Center, the University of Chicago Cancer Biology Training program (T32 CA009594), and The Center for Research Informatics of The University of Chicago Biological Science Division. The bioinformatics analysis was performed on Gardner High-Performance Computing clusters at Center for Research Informatics, Biological Sciences Division. Data reported in this study are tabulated in the main text and supplementary materials. The 16S and shotgun sequencing were performed at the Argonne National Laboratory and the University of Chicago-affiliated Marine Biological Laboratory, respectively; data files were deposited into The NCBI Sequence Read Archive (SRA) and are available under the accession no. SRP116709. Custom code and additional processed data used in this study are publicly available on GitHub at https://github.com/cribioinfo/sci2017_analysis. T.F.G. is an advisory board member for Roche-Genentech, Merck, Abbvie, Bayer, Aduro, and Fog Pharma. T.F.G. receives research support from Roche-Genentech, BMS, Merck, Incyte, Seattle Genetics, and Ono. T.F.G. is a shareholder/cofounder of Jounce Therapeutics. The University of Chicago holds a licensing arrangement with Evelo. T.F.G is an inventor on U.S. patent US20160354416 A1 submitted by the University of Chicago that covers the use the microbiota to improve cancer immunotherapy. J.J.L. is a consultant to and receives research funding from Bristol-Myers Squibb and Merck.	Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Ayers M, 2017, J CLIN INVEST, V127, P2930, DOI 10.1172/JCI91190; Corrales L, 2017, CELL RES, V27, P96, DOI 10.1038/cr.2016.149; Daillere R, 2016, IMMUNITY, V45, P931, DOI 10.1016/j.immuni.2016.09.009; Geva-Zatorsky N, 2017, CELL, V168, P928, DOI 10.1016/j.cell.2017.01.022; Gopalakrishnan V., 2017, SCIENCE; Iida N, 2013, SCIENCE, V342, P967, DOI 10.1126/science.1240527; Peng WY, 2016, CANCER DISCOV, V6, P202, DOI 10.1158/2159-8290.CD-15-0283; Robert C, 2015, NEW ENGL J MED, V372, P2521, DOI 10.1056/NEJMoa1503093; Round JL, 2010, P NATL ACAD SCI USA, V107, P12204, DOI 10.1073/pnas.0909122107; Routy B, 2018, SCIENCE, V359, P91, DOI 10.1126/science.aan3706; Sivan A, 2015, SCIENCE, V350, P1084, DOI 10.1126/science.aac4255; Spranger S, 2015, NATURE, V523, P231, DOI 10.1038/nature14404; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Tumeh PC, 2014, NATURE, V515, P568, DOI 10.1038/nature13954; Ugurel S, 2008, CANCER IMMUNOL IMMUN, V57, P685, DOI 10.1007/s00262-007-0407-z; Vetizou M, 2015, SCIENCE, V350, P1079, DOI 10.1126/science.aad1329	17	1327	1402	28	326	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 5	2018	359	6371					104	+		10.1126/science.aao3290	http://dx.doi.org/10.1126/science.aao3290			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FR8KW	29302014	Green Accepted			2022-12-28	WOS:000419324700076
J	Stone, R				Stone, Richard			Weapons in waiting	SCIENCE			English	Editorial Material																			0	5	5	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 5	2018	359	6371					24	24		10.1126/science.359.6371.24	http://dx.doi.org/10.1126/science.359.6371.24			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FR8KW	29301997				2022-12-28	WOS:000419324700025
J	Wipond, R				Wipond, Rob			Reporting flu vaccine science	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												rob@robwipond.com						Branswell H., 2017, STUDY SHOWS MISCARRI; Centers for Disease Control and Prevention, FLU VACC POSS SAF SI; Donahue JG, 2017, VACCINE, V35, P5314, DOI 10.1016/j.vaccine.2017.06.069; Fox Maggie, 2017, NBC NEWS; Lardieri A, 2017, US NEWS WORLD REPORT; McCullough M., 2017, INQUIRER DAILY  0913; Mukherjee S, 2017, FORTUNE         0913; Sandman P., 2017, FLU VACCINATION DISH; Stobbe M., 2017, STUDY PROMPTS CALL E; Sun L, 2017, WASHINGTON POST	10	0	0	1	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 5	2018	360								k15	10.1136/bmj.k15	http://dx.doi.org/10.1136/bmj.k15			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FS3VJ	29305418				2022-12-28	WOS:000419711800001
J	Weng, J; Zhou, ZG; Guo, LX; Zhu, DL; Ji, LN; Luo, XP; Mu, YM; Jia, WP; Yang, WY				Weng, Jianping; Zhou, Zhiguang; Guo, Lixin; Zhu, Dalong; Ji, Linong; Luo, Xiaoping; Mu, Yiming; Jia, Weiping; Yang, Wenying		T1D China Study Grp	Incidence of type 1 diabetes in China, 2010-13: population based study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							INCIDENCE TRENDS; YOUNG-ADULTS; CHILDHOOD; MELLITUS; DIAGNOSIS; CLASSIFICATION; KETOACIDOSIS; PREVALENCE; ETIOLOGY; DISEASE	OBJECTIVE To estimate the incidence of type 1 diabetes in all age groups in China during 2010-13. DESIGN Population based, registry study using data from multiple independent sources. SETTING National registration system in all 505 hospitals providing diabetes care, and communities of patients with diabetes in 13 areas across China, covering more than 133 million person years at risk, approximately 10% of the whole population. PARTICIPANTS 5018 people of all ages with newly diagnosed type 1 diabetes and resident in the study areas from 1 January 2010 to 31 December 2013. MAIN OUTCOME MEASURES Incidence of type 1 diabetes per 100 000 person years by age, sex, and study area. Type 1 diabetes was doctor diagnosed and further validated by onsite follow-up. Completeness of case ascertainment was assessed using the capture mark recapture method. RESULTS 5018 cases of newly diagnosed type 1 diabetes were ascertained: 1239 participants were aged <15 years, 1799 were aged 15-29 years, and 1980 were aged >= 30 years. The proportion of new onset cases in participants aged >= 20 years was 65.3%. The estimated incidence of type 1 diabetes per 100 000 persons years for all ages in China was 1.01 (95% confidence interval 0.18 to 1.84). Incidence per 100 000 persons years by age group was 1.93 (0.83 to 3.03) for 0-14 years, 1.28 (0.45 to 2.11) for 15-29 years, and 0.69 (0.00 to 1.51) for >= 30 years, with a peak in age group 10-14 years. The incidence in under 15s was positively correlated with latitude (r=0.88, P<0.001), although this association was not observed in age groups 15-29 years or >= 30 years. CONCLUSION Most cases of new onset type 1 diabetes in China occurred among adults. The incidence of type 1 diabetes in Chinese children was among the lowest reported in the study.	[Weng, Jianping; Zhou, Zhiguang; Guo, Lixin; Zhu, Dalong; Ji, Linong; Luo, Xiaoping; Mu, Yiming; Jia, Weiping; Yang, Wenying; T1D China Study Grp] Sun Yat Sen Univ, Dept Endocrinol & Metab Dis, Affiliated Hosp 3, Guangzhou 510630, Guangdong, Peoples R China; [Weng, Jianping] Sun Yat Sen Univ, Dept Endocrinol & Metab, Hosp 3, Guangdong Prov Key Lab Diabetol, Guangzhou, Guangdong, Peoples R China; [Zhou, Zhiguang] Cent South Univ, Inst Endocrinol & Metab, Xiangya Hosp 2, Endocrinol Dept, Changsha, Hunan, Peoples R China; [Guo, Lixin] Beijing Hosp, Endocrinol Dept, Beijing, Peoples R China; [Zhu, Dalong] Nanjing Univ, Internal Med & Endocrinol Dept, Med Sch, Affiliated Nanjing Drum Tower Hosp, Nanjing, Jiangsu, Peoples R China; [Ji, Linong] Peking Univ, Peoples Hosp, Dept Endocrinol & Metab, Endocrinol Dept, Beijing, Peoples R China; [Luo, Xiaoping] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Pediat Dept, Wuhan, Hubei, Peoples R China; [Mu, Yiming] Peoples Liberat Army Gen Hosp, Endocrinol Dept, Beijing, Peoples R China; [Jia, Weiping] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Endocrinol Dept, Shanghai, Peoples R China; [Yang, Wenying] China Japan Friendship Hosp, Endocrinol & Metab Dis Ctr, Endocrinol, Beijing, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Central South University; Beijing Hospital; Nanjing University; Peking University; Huazhong University of Science & Technology; Chinese People's Liberation Army General Hospital; Shanghai Jiao Tong University; China-Japan Friendship Hospital	Weng, J (corresponding author), Sun Yat Sen Univ, Dept Endocrinol & Metab Dis, Affiliated Hosp 3, Guangzhou 510630, Guangdong, Peoples R China.; Weng, J (corresponding author), Sun Yat Sen Univ, Dept Endocrinol & Metab, Hosp 3, Guangdong Prov Key Lab Diabetol, Guangzhou, Guangdong, Peoples R China.	wjianp@mail.sysu.edu.cn	Linong, Ji/AAB-6543-2020	Zhou, Zhiguang/0000-0002-0374-1838; Weng, Jianping/0000-0002-7889-1697	national key R&D programme of China [2017YFC1309603, 1309602]; National Natural Science Foundation of China [81530025]; China International Medical Foundation	national key R&D programme of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China International Medical Foundation	This study was funded by the China International Medical Foundation, national key R&D programme of China (2017YFC1309603, 1309602), and National Natural Science Foundation of China (key programme 81530025).	Agresti A, 1998, AM STAT, V52, P119, DOI 10.2307/2685469; Akerblom HK, 2002, AM J MED GENET, V115, P18, DOI 10.1002/ajmg.10340; Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS67, DOI [10.2337/dc10-S062, 10.2337/dc13-S067, 10.2337/dc12-s064, 10.2337/dc11-S062]; Atkinson MA, 2014, LANCET, V383, P69, DOI 10.1016/S0140-6736(13)60591-7; Bessaoud K, 2006, DIABETIC MED, V23, P857, DOI 10.1111/j.1464-5491.2006.01925.x; Beyerlein A, 2015, EPIDEMIOLOGY, V26, pE31, DOI 10.1097/EDE.0000000000000254; BLOHME G, 1992, DIABETOLOGIA, V35, P56, DOI 10.1007/BF00400852; Chen JM, 2009, AM J HUM GENET, V85, P775, DOI 10.1016/j.ajhg.2009.10.016; Chiang JL, 2014, DIABETES CARE, V37, P2034, DOI 10.2337/dc14-1140; Craig ME, 2013, PEDIATR DIABETES, V14, P149, DOI 10.1111/pedi.12033; Dabelea D, 2007, JAMA-J AM MED ASSOC, V297, P2716; Dabelea D, 2014, PEDIATRICS, V133, pE938, DOI 10.1542/peds.2013-2795; Gavin JR, 1997, DIABETES CARE, V20, P1183; Harjutsalo V, 2013, JAMA-J AM MED ASSOC, V310, P427, DOI 10.1001/jama.2013.8399; International Diabetes Federation, 2015, INT DIAB FED DIAB AT; Joint British Diabetes Societies Inpatient Care Group, 2013, MAN DIAB KET DKA AD, DOI [10.1111/pedi.12152, DOI 10.1111/PEDI.12152]; KARJALAINEN J, 1989, NEW ENGL J MED, V320, P881, DOI 10.1056/NEJM198904063201401; Karvonen M, 2000, DIABETES CARE, V23, P1516, DOI 10.2337/diacare.23.10.1516; KROLEWSKI AS, 1987, NEW ENGL J MED, V317, P1390; Kyvik KO, 2004, DIABETOLOGIA, V47, P377, DOI 10.1007/s00125-004-1331-9; Mayer-Davis EJ, 2017, NEW ENGL J MED, V376, P1419, DOI 10.1056/NEJMoa1610187; Onda Y, 2017, DIABETIC MED, V34, P909, DOI 10.1111/dme.13295; Park Y, 2017, DIABETES-METAB RES, V33, DOI 10.1002/dmrr.2907; Patterson CC, 2012, DIABETOLOGIA, V55, P2142, DOI 10.1007/s00125-012-2571-8; Patterson CC, 2001, DIABETOLOGIA, V44, pB9, DOI 10.1007/PL00002961; Patterson CC, 2009, LANCET, V373, P2027, DOI 10.1016/S0140-6736(09)60568-7; Pishdad GR, 2005, DIABETES CARE, V28, P927, DOI 10.2337/diacare.28.4.927; Population Census Office under the State Council Department of Population and Employment Statistics National Bureau of Statistics of China, TAB 2010 POP CENS PE; Pundziute-Lycka A, 2002, DIABETOLOGIA, V45, P783, DOI 10.1007/s00125-002-0845-2; Staples JA, 2003, ENVIRON HEALTH PERSP, V111, P518, DOI 10.1289/ehp.5941; Thunander M, 2008, DIABETES RES CLIN PR, V82, P247, DOI 10.1016/j.diabres.2008.07.022; Vehik K, 2008, DIABETES CARE, V31, P1392, DOI 10.2337/dc07-2210; Wolfsdorf JI, 2014, PEDIATR DIABETES, V15, P154, DOI 10.1111/pedi.12165; Yang DZ, 2016, J DIABETES, V8, P847, DOI 10.1111/1753-0407.12366; Yang Z, 1998, DIABETES CARE, V21, P525, DOI 10.2337/diacare.21.4.525; YIP PSF, 1995, AM J EPIDEMIOL, V142, P1047; Zhong VW, 2014, PEDIATR DIABETES, V15, P573, DOI 10.1111/pedi.12152	38	144	193	12	83	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 4	2018	360								j5295	10.1136/bmj.j5295	http://dx.doi.org/10.1136/bmj.j5295			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FS3UX	29298776	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000419710400004
J	Zhang, HN; Qiao, AN; Yang, LL; Van Eps, N; Frederiksen, KS; Yang, DH; Dai, AT; Cai, XQ; Zhang, H; Yi, CY; Cao, C; He, LL; Yang, HY; Lau, J; Ernst, OP; Hanson, MA; Stevens, RC; Wang, MW; Reedtz-Runge, S; Jiang, HL; Zhao, Q; Wu, BL				Zhang, Haonan; Qiao, Anna; Yang, Linlin; Van Eps, Ned; Frederiksen, Klaus S.; Yang, Dehua; Dai, Antao; Cai, Xiaoqing; Zhang, Hui; Yi, Cuiying; Cao, Can; He, Lingli; Yang, Huaiyu; Lau, Jesper; Ernst, Oliver P.; Hanson, Michael A.; Stevens, Raymond C.; Wang, Ming-Wei; Reedtz-Runge, Steffen; Jiang, Hualiang; Zhao, Qiang; Wu, Beili			Structure of the glucagon receptor in complex with a glucagon analogue	NATURE			English	Article							CRYO-EM STRUCTURE; GLP-1 RECEPTOR; PEPTIDE-1 RECEPTOR; LIGAND-BINDING; REFINEMENT; ACTIVATION; ORIGIN; FAMILY	Class B G-protein-coupled receptors (GPCRs), which consist of an extracellular domain (ECD) and a transmembrane domain (TMD), respond to secretin peptides to play a key part in hormonal homeostasis, and are important therapeutic targets for a variety of diseases(1-8). Previous work(9-11) has suggested that peptide ligands bind to class B GPCRs according to a two-domain binding model, in which the C-terminal region of the peptide targets the ECD and the N-terminal region of the peptide binds to the TMD binding pocket. Recently, three structures of class B GPCRs in complex with peptide ligands have been solved(12-14). These structures provide essential insights into peptide ligand recognition by class B GPCRs. However, owing to resolution limitations, the specific molecular interactions for peptide binding to class B GPCRs remain ambiguous. Moreover, these previously solved structures have different ECD conformations relative to the TMD, which introduces questions regarding inter-domain conformational flexibility and the changes required for receptor activation. Here we report the 3.0 angstrom-resolution crystal structure of the full-length human glucagon receptor (GCGR) in complex with a glucagon analogue and partial agonist, NNC1702. This structure provides molecular details of the interactions between GCGR and the peptide ligand. It reveals a marked change in the relative orientation between the ECD and TMD of GCGR compared to the previously solved structure of the inactive GCGR-NNC0640-mAb1 complex. Notably, the stalk region and the first extracellular loop undergo major conformational changes in secondary structure during peptide binding, forming key interactions with the peptide. We further propose a dual-binding-site trigger model for GCGR activation-which requires conformational changes of the stalk, first extracellular loop and TMD-that extends our understanding of the previously established two-domain peptide-binding model of class B GPCRs.	[Zhang, Haonan; Qiao, Anna; Yang, Dehua; Dai, Antao; Cai, Xiaoqing; Zhang, Hui; Yi, Cuiying; Wang, Ming-Wei; Jiang, Hualiang; Zhao, Qiang; Wu, Beili] Chinese Acad Sci, Shanghai Inst Mat Med, CAS Key Lab Receptor Res, 555 Zuchongzhi Rd, Shanghai 201203, Peoples R China; [Zhang, Haonan; Qiao, Anna; Jiang, Hualiang; Zhao, Qiang] Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, 555 Zuchongzhi Rd, Shanghai 201203, Peoples R China; [Zhang, Haonan; Qiao, Anna; Zhang, Hui; Cao, Can; Wang, Ming-Wei; Zhao, Qiang; Wu, Beili] Univ Chinese Acad Sci, 19A Yuquan Rd, Beijing 100049, Peoples R China; [Yang, Linlin] Zhengzhou Univ, Sch Basic Med Sci, Dept Pharmacol, 100 Sci Ave, Zhengzhou 450001, Henan, Peoples R China; [Van Eps, Ned; Ernst, Oliver P.] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada; [Frederiksen, Klaus S.; Lau, Jesper; Reedtz-Runge, Steffen] Novo Nordisk AS, Novo Nordisk Pk, DK-2760 Malov, Denmark; [Yang, Dehua; Dai, Antao; Cai, Xiaoqing; Wang, Ming-Wei] Chinese Acad Sci, Shanghai Inst Mat Med, Natl Ctr Drug Screening, 189 Guo Shou Jing Rd, Shanghai 201203, Peoples R China; [Cao, Can; He, Lingli] Chinese Acad Sci, Inst Biophys, CAS Ctr Excellence Biomacromol, Natl Ctr Prot Sci,Natl Lab Biomacromol, Beijing 100101, Peoples R China; [Yang, Huaiyu] East China Normal Univ, Inst Biomed Sci, Shanghai Key Lab Regulatory Biol, 500 Dongchuan Rd, Shanghai 200241, Peoples R China; [Yang, Huaiyu] East China Normal Univ, Sch Life Sci, 500 Dongchuan Rd, Shanghai 200241, Peoples R China; [Ernst, Oliver P.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Hanson, Michael A.] GPCR Consortium, San Marcos, CA 92078 USA; [Stevens, Raymond C.] ShanghaiTech Univ, iHuman Inst, 393 Hua Xia Zhong Rd, Shanghai 201210, Peoples R China; [Stevens, Raymond C.; Wang, Ming-Wei; Wu, Beili] ShanghaiTech Univ, Sch Life Sci & Technol, 393 Hua Xia Zhong Rd, Shanghai 201210, Peoples R China; [Wang, Ming-Wei] Fudan Univ, Sch Pharm, 826 Zhangheng Rd, Shanghai 201203, Peoples R China; [Jiang, Hualiang] Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Drug Discovery & Design Ctr, 555 Zuchongzhi Rd, Shanghai 201203, Peoples R China; [Zhao, Qiang; Wu, Beili] Chinese Acad Sci, CAS Ctr Excellence Biomacromol, Beijing 100101, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Zhengzhou University; University of Toronto; Novo Nordisk; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Chinese Academy of Sciences; Institute of Biophysics, CAS; East China Normal University; East China Normal University; University of Toronto; ShanghaiTech University; ShanghaiTech University; Fudan University; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Chinese Academy of Sciences	Zhao, Q; Wu, BL (corresponding author), Chinese Acad Sci, Shanghai Inst Mat Med, CAS Key Lab Receptor Res, 555 Zuchongzhi Rd, Shanghai 201203, Peoples R China.; Zhao, Q (corresponding author), Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, 555 Zuchongzhi Rd, Shanghai 201203, Peoples R China.; Zhao, Q; Wu, BL (corresponding author), Univ Chinese Acad Sci, 19A Yuquan Rd, Beijing 100049, Peoples R China.; Wu, BL (corresponding author), ShanghaiTech Univ, Sch Life Sci & Technol, 393 Hua Xia Zhong Rd, Shanghai 201210, Peoples R China.; Zhao, Q; Wu, BL (corresponding author), Chinese Acad Sci, CAS Ctr Excellence Biomacromol, Beijing 100101, Peoples R China.	zhaoq@simm.ac.cn; beiliwu@simm.ac.cn	Yang, Dehua/M-5789-2019; Stevens, Raymond/K-7272-2015; Lau, Jesper/G-3834-2011	Stevens, Raymond/0000-0002-4522-8725; Van Eps, Ned/0000-0001-9178-1436	CAS Strategic Priority Research Program [XDB08020000]; CAS [QYZDB-SSW-SMC024, QYZDB-SSW-SMC054]; National Science Foundation of China [31422017, 81525024]; Shanghai Science and Technology Development Fund [15DZ2291600]; E-Institutes of Shanghai Municipal Education Commission [E09013]; Special Program for Applied Research on Super Computation of the NSFC-Guangdong Joint Fund [U1501501]; Canada Excellence Research Chairs program; Canadian Institute for Advanced Research	CAS Strategic Priority Research Program; CAS(Chinese Academy of Sciences); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Science and Technology Development Fund; E-Institutes of Shanghai Municipal Education Commission; Special Program for Applied Research on Super Computation of the NSFC-Guangdong Joint Fund; Canada Excellence Research Chairs program(Canada Research Chairs); Canadian Institute for Advanced Research(Canadian Institute for Advanced Research (CIFAR))	This work was supported by CAS Strategic Priority Research Program XDB08020000, CAS grants QYZDB-SSW-SMC024 (B.W.) and QYZDB-SSW-SMC054 (Q.Z.), the National Science Foundation of China grants 31422017 (B.W.) and 81525024 (Q.Z.), the Shanghai Science and Technology Development Fund 15DZ2291600 (M.-W.W.), the E-Institutes of Shanghai Municipal Education Commission (E09013), the Special Program for Applied Research on Super Computation of the NSFC-Guangdong Joint Fund (second phase) under Grant No. U1501501, and the Canada Excellence Research Chairs program and the Canadian Institute for Advanced Research (O.P.E.). O.P.E. holds the Anne and Max Tanenbaum Chair in Neuroscience. We also thank the computer centre of East China Normal University for computational resources. The synchrotron radiation experiments were performed at the BL41XU of SPring-8 with the approval of the Japan Synchrotron Radiation Research Institute (proposal numbers 2016B2517, 2016B2518, 2017A2505 and 2017A2506). We thank the beamline staff members K. Hasegawa, N. Mizuno, T. Kawamura and H. Murakami of the BL41XU for help with X-ray data collection.	Ahn JM, 2001, J MED CHEM, V44, P1372, DOI 10.1021/jm000453e; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Brenneman DE, 2007, PEPTIDES, V28, P1720, DOI 10.1016/j.peptides.2007.04.002; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Caffrey M, 2009, NAT PROTOC, V4, P706, DOI 10.1038/nprot.2009.31; Cho YM, 2012, PHARMACOL THERAPEUT, V135, P247, DOI 10.1016/j.pharmthera.2012.05.009; Drucker DJ, 2006, CELL METAB, V3, P153, DOI 10.1016/j.cmet.2006.01.004; Egerod KL, 2012, ENDOCRINOLOGY, V153, P5782, DOI 10.1210/en.2012-1595; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Finan B, 2016, CELL, V167, P843, DOI 10.1016/j.cell.2016.09.014; Fleissner MR, 2009, PROTEIN SCI, V18, P893, DOI 10.1002/pro.96; Gilligan PJ, 2004, CURR OPIN DRUG DISC, V7, P487; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hollenstein K, 2014, TRENDS PHARMACOL SCI, V35, P12, DOI 10.1016/j.tips.2013.11.001; Jazayeri A, 2017, NATURE, V546, P254, DOI 10.1038/nature22800; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Liang YL, 2017, NATURE, V546, P118, DOI 10.1038/nature22327; Longuet C, 2008, CELL METAB, V8, P359, DOI 10.1016/j.cmet.2008.09.008; Mann R, 2008, MOL PHARMACOL, V74, P605, DOI 10.1124/mol.108.048017; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Moon MJ, 2015, J BIOL CHEM, V290, P5696, DOI 10.1074/jbc.M114.612606; Mulder JE, 2006, NAT CLIN PRACT ENDOC, V2, P670, DOI 10.1038/ncpendmet0325; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Parthier C, 2009, TRENDS BIOCHEM SCI, V34, P303, DOI 10.1016/j.tibs.2009.02.004; Polyhach Y, 2011, PHYS CHEM CHEM PHYS, V13, P2356, DOI 10.1039/c0cp01865a; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Runge S, 2003, J BIOL CHEM, V278, P28005, DOI 10.1074/jbc.M301085200; Sherwood NM, 2000, ENDOCR REV, V21, P619, DOI 10.1210/er.21.6.619; Siu FY, 2013, NATURE, V499, P444, DOI 10.1038/nature12393; Smart OS, 2012, ACTA CRYSTALLOGR D, V68, P368, DOI 10.1107/S0907444911056058; UNSON CG, 1987, P NATL ACAD SCI USA, V84, P4083, DOI 10.1073/pnas.84.12.4083; Unson CG, 2002, BIOCHEMISTRY-US, V41, P11795, DOI 10.1021/bi025711j; Van Eps N, 2015, PHOTOCH PHOTOBIO SCI, V14, P1586, DOI 10.1039/c5pp00191a; Wootten D, 2013, P NATL ACAD SCI USA, V110, P5211, DOI 10.1073/pnas.1221585110; Yang DH, 2016, J BIOL CHEM, V291, P12991, DOI 10.1074/jbc.M116.721977; Yang LL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8859; Yin YT, 2016, CELL DISCOV, V2, DOI 10.1038/celldisc.2016.42; Zhang HN, 2017, NATURE, V546, P259, DOI 10.1038/nature22363; Zhang Y, 2017, NATURE, V546, P248, DOI 10.1038/nature22394	44	77	78	5	139	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 4	2018	553	7686					106	+		10.1038/nature25153	http://dx.doi.org/10.1038/nature25153			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS4NI	29300013				2022-12-28	WOS:000419769300039
J	Zilberberg, O; Huang, S; Guglielmon, J; Wang, MH; Chen, KP; Kraus, YE; Rechtsman, MC				Zilberberg, Oded; Huang, Sheng; Guglielmon, Jonathan; Wang, Mohan; Chen, Kevin P.; Kraus, Yaacov E.; Rechtsman, Mikael C.			Photonic topological boundary pumping as a probe of 4D quantum Hall physics	NATURE			English	Article							EDGE STATES; ELECTRONS	When a two-dimensional (2D) electron gas is placed in a perpendicular magnetic field, its in-plane transverse conductance becomes quantized; this is known as the quantum Hall effect(1). It arises from the non-trivial topology of the electronic band structure of the system, where an integer topological invariant (the first Chern number) leads to quantized Hall conductance. It has been shown theoretically that the quantum Hall effect can be generalized to four spatial dimensions(2-4), but so far this has not been realized experimentally because experimental systems are limited to three spatial dimensions. Here we use tunable 2D arrays of photonic waveguides to realize a dynamically generated four-dimensional (4D) quantum Hall system experimentally. The inter-waveguide separation in the array is constructed in such a way that the propagation of light through the device samples over momenta in two additional synthetic dimensions, thus realizing a 2D topological pump(5-8). As a result, the band structure has 4D topological invariants (known as second Chern numbers) that support a quantized bulk Hall response with 4D symmetry(7). In a finite-sized system, the 4D topological bulk response is carried by localized edge modes that cross the sample when the synthetic momenta are modulated. We observe this crossing directly through photon pumping of our system from edge to edge and corner to corner. These crossings are equivalent to charge pumping across a 4D system from one three-dimensional hypersurface to the spatially opposite one and from one 2D hyperedge to another. Our results provide a platform for the study of higher-dimensional topological physics.	[Zilberberg, Oded] ETH, Inst Theoret Phys, CH-8093 Zurich, Switzerland; [Huang, Sheng; Wang, Mohan; Chen, Kevin P.] Univ Pittsburgh, Dept Elect & Comp Engn, Pittsburgh, PA 15261 USA; [Guglielmon, Jonathan; Rechtsman, Mikael C.] Penn State Univ, Dept Phys, 104 Davey Lab, University Pk, PA 16802 USA; [Kraus, Yaacov E.] Holon Inst Technol, Dept Phys, IL-5810201 Holon, Israel	Swiss Federal Institutes of Technology Domain; ETH Zurich; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Zilberberg, O (corresponding author), ETH, Inst Theoret Phys, CH-8093 Zurich, Switzerland.; Rechtsman, MC (corresponding author), Penn State Univ, Dept Phys, 104 Davey Lab, University Pk, PA 16802 USA.	zilberberg@itp.phys.ethz.ch; mcrworld@psu.edu	Wang, Mohan/AAA-2906-2020; Chen, Kevin/GYU-8963-2022; Rechtsman, Mikael C./L-8926-2013; Huang, Sheng/U-5815-2019; Zilberberg, Oded/L-6474-2013	Wang, Mohan/0000-0001-6678-4993; Rechtsman, Mikael C./0000-0002-6909-8355; Zilberberg, Oded/0000-0002-1759-4920	Swiss National Science Foundation; National Science Foundation [ECCS-1509546, ECCS-1509199, DMS-1620218]; Charles E. Kaufman Foundation; Pittsburgh Foundation; Alfred P. Sloan Foundation [FG-2016-6418]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Science Foundation(National Science Foundation (NSF)); Charles E. Kaufman Foundation; Pittsburgh Foundation; Alfred P. Sloan Foundation(Alfred P. Sloan Foundation)	We thank H. M. Price, M. Lohse, C.-X. Liu, W. Benalcazar, E. Prodan and T. Ozawa for their comments and feedback on the manuscript. O. Z. thanks the Swiss National Science Foundation for financial support. M.C.R. acknowledges the National Science Foundation under award number ECCS-1509546, the Charles E. Kaufman Foundation, a supporting organization of the Pittsburgh Foundation, and the Alfred P. Sloan Foundation under fellowship number FG-2016-6418. K.P.C. acknowledges the National Science Foundation under award numbers ECCS-1509199 and DMS-1620218.	Aidelsburger M, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.185301; AVRON JE, 1989, COMMUN MATH PHYS, V124, P595, DOI 10.1007/BF01218452; Benalcazar WA, 2017, SCIENCE, V357, P61, DOI 10.1126/science.aah6442; Boada O, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.133001; Cheng XJ, 2016, NAT MATER, V15, P542, DOI [10.1038/NMAT4573, 10.1038/nmat4573]; Fleischer JW, 2003, NATURE, V422, P147, DOI 10.1038/nature01452; Hafezi M, 2013, NAT PHOTONICS, V7, P1001, DOI [10.1038/NPHOTON.2013.274, 10.1038/nphoton.2013.274]; Haldane FDM, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.013904; HARPER PG, 1955, P PHYS SOC LOND A, V68, P874, DOI 10.1088/0370-1298/68/10/304; HATSUGAI Y, 1993, PHYS REV LETT, V71, P3697, DOI 10.1103/PhysRevLett.71.3697; HOFSTADTER DR, 1976, PHYS REV B, V14, P2239, DOI 10.1103/PhysRevB.14.2239; Jotzu G, 2014, NATURE, V515, P237, DOI 10.1038/nature13915; Jukic D, 2013, PHYS REV A, V87, DOI 10.1103/PhysRevA.87.013814; Kraus YE, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.226401; Kraus YE, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.116404; Kraus YE, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.106402; Lohse M, 2016, NAT PHYS, V12, P350, DOI 10.1038/NPHYS3584; Lohse M, 2018, NATURE, V553, P55, DOI 10.1038/nature25000; Lu L., 2016, TOPOLOGICAL ONE WAY; Lu L, 2015, SCIENCE, V349, P622, DOI 10.1126/science.aaa9273; Nakajima S, 2016, NAT PHYS, V12, P296, DOI 10.1038/NPHYS3622; Noh J., 2016, TOPOLOGICAL PROTECTI; Noh J, 2017, NAT PHYS, V13, P611, DOI [10.1038/NPHYS4072, 10.1038/nphys4072]; Ozawa T, 2016, PHYS REV A, V93, DOI 10.1103/PhysRevA.93.043827; Pedrini B., 2000, MATH PHYS 2000; Price HM, 2016, PHYS REV B, V93, DOI 10.1103/PhysRevB.93.245113; Price HM, 2015, PHYS REV LETT, V115, DOI 10.1103/PhysRevLett.115.195303; Prodan E, 2013, J PHYS A-MATH THEOR, V46, DOI 10.1088/1751-8113/46/48/485202; Qi XL, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.195424; Rechtsman MC, 2013, NATURE, V496, P196, DOI 10.1038/nature12066; Slobozhanyuk A, 2017, NAT PHOTONICS, V11, P130, DOI [10.1038/nphoton.2016.253, 10.1038/NPHOTON.2016.253]; STREDA P, 1982, J PHYS C SOLID STATE, V15, pL717, DOI 10.1088/0022-3719/15/22/005; Sugawa S., 2016, OBSERVATION NONABELI; Szameit A, 2007, OPT EXPRESS, V15, P1579, DOI 10.1364/OE.15.001579; Szameit A, 2010, J PHYS B-AT MOL OPT, V43, DOI 10.1088/0953-4075/43/16/163001; THOULESS DJ, 1983, PHYS REV B, V27, P6083, DOI 10.1103/PhysRevB.27.6083; Verbin M, 2015, PHYS REV B, V91, DOI 10.1103/PhysRevB.91.064201; VONKLITZING K, 1980, PHYS REV LETT, V45, P494, DOI 10.1103/PhysRevLett.45.494; Wang Z, 2009, NATURE, V461, P772, DOI 10.1038/nature08293; Zhang SC, 2001, SCIENCE, V294, P823, DOI 10.1126/science.294.5543.823	40	251	255	12	97	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 4	2018	553	7686					59	+		10.1038/nature25011	http://dx.doi.org/10.1038/nature25011			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS4NI	29300011	Green Submitted			2022-12-28	WOS:000419769300029
J	Sykes, DB; Rosovsky, RP; Singhal, AB; Gonzalez, RG; Moy, AP				Sykes, David B.; Rosovsky, Rachel P.; Singhal, Aneesh B.; Gonzalez, R. Gilberto; Moy, Andrea P.			Case 40-2017: A 32-Year-Old Woman with Headache, Abdominal Pain, Anemia, and Thrombocytopenia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PAROXYSMAL-NOCTURNAL HEMOGLOBINURIA; COMPLEMENT INHIBITOR ECULIZUMAB; NATURAL-HISTORY; FLOW-CYTOMETRY; DIAGNOSIS; GUIDELINES		[Sykes, David B.; Rosovsky, Rachel P.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Singhal, Aneesh B.] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Gonzalez, R. Gilberto] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Moy, Andrea P.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Sykes, David B.; Rosovsky, Rachel P.] Harvard Med Sch, Dept Med, Boston, MA 02115 USA; [Singhal, Aneesh B.] Harvard Med Sch, Dept Neurol, Boston, MA USA; [Gonzalez, R. Gilberto] Harvard Med Sch, Dept Radiol, Boston, MA USA; [Moy, Andrea P.] Harvard Med Sch, Dept Pathol, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Sykes, DB (corresponding author), Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA.; Sykes, DB (corresponding author), Harvard Med Sch, Dept Med, Boston, MA 02115 USA.		Rosovsky, Rachel/AAH-1166-2021					Borowitz MJ, 2010, CYTOM PART B-CLIN CY, V78B, P211, DOI 10.1002/cyto.b.20525; Brodsky RA, 2008, BLOOD, V111, P1840, DOI 10.1182/blood-2007-06-094136; Buttarello M, 2004, AM J CLIN PATHOL, V121, P489, DOI 10.1309/W65295DTUWK7U1HH; CROSBY WH, 1951, BLOOD, V6, P270, DOI 10.1182/blood.V6.3.270.270; de Latour RP, 2008, BLOOD, V112, P3099, DOI 10.1182/blood-2008-01-133918; de Latour RP, 2012, HAEMATOL-HEMATOL J, V97, P1666, DOI 10.3324/haematol.2012.062828; Devalet B, 2015, EUR J HAEMATOL, V95, P190, DOI 10.1111/ejh.12543; Hillmen P, 2004, NEW ENGL J MED, V350, P552, DOI 10.1056/NEJMoa031688; HILLMEN P, 1995, NEW ENGL J MED, V333, P1253, DOI 10.1056/NEJM199511093331904; Hillmen P, 2007, BLOOD, V110, P4123, DOI 10.1182/blood-2007-06-095646; Hillmen P, 2013, BRIT J HAEMATOL, V162, P62, DOI 10.1111/bjh.12347; Hillmen P, 2006, NEW ENGL J MED, V355, P1233, DOI 10.1056/NEJMoa061648; Kelly RJ, 2011, BLOOD, V117, P6786, DOI 10.1182/blood-2011-02-333997; Loschi M, 2016, AM J HEMATOL, V91, P366, DOI 10.1002/ajh.24278; Sutherland DR, 2012, CYTOM PART B-CLIN CY, V82B, P195, DOI 10.1002/cyto.b.21023; Taylor FB, 2001, THROMB HAEMOSTASIS, V86, P1327, DOI 10.1055/s-0037-1616068; Zini G, 2012, INT J LAB HEMATOL, V34, P107, DOI 10.1111/j.1751-553X.2011.01380.x	17	0	0	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 28	2017	377	26					2581	2590		10.1056/NEJMcpc1710566	http://dx.doi.org/10.1056/NEJMcpc1710566			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FR0TX	29281575				2022-12-28	WOS:000418777700011
J	Mervis, J				Mervis, Jeffrey			Trump and scientists: an epic estrangement	SCIENCE			English	Editorial Material																			0	0	0	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 22	2017	358	6370					1528	1529		10.1126/science.358.6370.1528	http://dx.doi.org/10.1126/science.358.6370.1528			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FQ6BO	29269458				2022-12-28	WOS:000418448000030
J	Kourkoumpetis, T; Jarbrink-Sehgal, ME				Kourkoumpetis, Themistoklis; Jarbrink-Sehgal, Maria E.			Melanoma Metastatic to the Duodenum	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								An 87-year-old man presented with a 3-week history of nausea, emesis, anorexia, and weight loss. Upper endoscopy identified three pigmented lesions, and melanoma was confirmed on biopsy.	[Kourkoumpetis, Themistoklis; Jarbrink-Sehgal, Maria E.] Baylor Coll Med, Houston, TX 77030 USA	Baylor College of Medicine	Kourkoumpetis, T (corresponding author), Baylor Coll Med, Houston, TX 77030 USA.	kourkoum@bcm.edu							0	0	0	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 21	2017	377	25					E34	E34		10.1056/NEJMicm1702470	http://dx.doi.org/10.1056/NEJMicm1702470			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FQ5RZ	29262285				2022-12-28	WOS:000418420000001
J	Rusiecki, J; Cifu, AS				Rusiecki, Jennifer; Cifu, Adam S.			Colonoscopy Surveillance After Colorectal Cancer Resection	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							SOCIETY TASK-FORCE; FOLLOW-UP; CONSENSUS UPDATE; STRATEGIES; GUIDELINES; RECURRENCE; TRIAL	GUIDELINE TITLE Colonoscopy Surveillance After Colorectal Cancer Resection RELEASE DATE January 2016 (online); March 2016 (print) DEVELOPER US Multi-Society Task Force (USMSTF) on Colorectal Cancer PRIOR VERSION March 2006 FUNDING SOURCE USMSTF TARGET POPULATION Adult patients who have under gone surgical resection for TNM stages I-III (or Dukes A-C) colorectal cancer(CRC) without Lynch syndrome and select patients with stage IV disease MAJOR RECOMMENDATIONS Patients who undergo surgical resection of obstructing CRC should have a high-quality colonoscopy within 3 to 6 months of surgery (strong recommendation; low-quality evidence). Patients with colon or rectal cancer should have a surveillance colonoscopy 1 year after surgery; for patients with obstructive disease, 1 year after perioperative colonoscopy (strong recommendation; low-quality evidence). After the first surveillance colonoscopy, patients should have a second colonoscopy 3 years later. Subsequent colonoscopies should occur at 5-year intervals until the benefit of continued surveillance is outweighed by diminishing life expectancy (strong recommendation; low-quality evidence). If patients with obstructive CRC are unable to undergo colonoscopy, computed tomographic colonography (CTC) is the best alternative. Double-contrast barium enema is appropriate if CTC is not available (strong recommendation; moderate-quality evidence). Patients with localized rectal cancer who have undergone surgical resection should undergo local surveillance with flexible sigmoidoscopy or endoscopic ultrasound (EUS) every 3 to 6 months for the first 2 to 3 years after surgery (weak recommendation; low-quality evidence).	[Rusiecki, Jennifer; Cifu, Adam S.] Univ Chicago, 5841 S Maryland Ave,MC 3051, Chicago, IL 60637 USA	University of Chicago	Cifu, AS (corresponding author), Univ Chicago, 5841 S Maryland Ave,MC 3051, Chicago, IL 60637 USA.	adamcifu@uchicago.edu						Erenay FS, 2016, CANCER-AM CANCER SOC, V122, P2560, DOI 10.1002/cncr.30091; Gleeson FC, 2012, HEPATO-GASTROENTEROL, V59, P1102, DOI 10.5754/hge11898; Green BL, 2013, BRIT J SURG, V100, P75, DOI 10.1002/bjs.8945; Kahi CJ, 2016, GASTROENTEROLOGY, V150, P758, DOI 10.1053/j.gastro.2016.01.001; Lieberman DA, 2012, GASTROENTEROLOGY, V143, P844, DOI 10.1053/j.gastro.2012.06.001; Meyerhardt JA, 2013, J CLIN ONCOL, V31, P4465, DOI 10.1200/JCO.2013.50.7442; Park SH, 2012, GUT, V61, P1716, DOI 10.1136/gutjnl-2011-301135; Pita-Fernandez S, 2015, ANN ONCOL, V26, P644, DOI 10.1093/annonc/mdu543; Primrose JN, 2014, JAMA-J AM MED ASSOC, V311, P263, DOI 10.1001/jama.2013.285718; Rex DK, 2006, CA-CANCER J CLIN, V56, P160, DOI 10.3322/canjclin.56.3.160	10	4	4	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 19	2017	318	23					2346	2347		10.1001/jama.2017.17613	http://dx.doi.org/10.1001/jama.2017.17613			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FQ3RJ	29260211				2022-12-28	WOS:000418274000023
J	Gulick, SPS; Shevenell, AE; Montelli, A; Fernandez, R; Smith, C; Warny, S; Bohaty, SM; Sjunneskog, C; Leventer, A; Frederick, B; Blankenship, DD				Gulick, Sean P. S.; Shevenell, Amelia E.; Montelli, Aleksandr; Fernandez, Rodrigo; Smith, Catherine; Warny, Sophie; Bohaty, Steven M.; Sjunneskog, Charlotte; Leventer, Amy; Frederick, Bruce; Blankenship, Donald D.			Initiation and long-term instability of the East Antarctic Ice Sheet	NATURE			English	Article							TUNNEL VALLEYS; LATE EOCENE; MELTWATER FEATURES; TOTTEN GLACIER; NORTH-SEA; GLACIATION; EVOLUTION; MORPHOLOGY; MIDDLE; OCEAN	Antarctica's continental-scale ice sheets have evolved over the past 50 million years(1-4). However, the dearth of ice-proximal geological records(5-8) limits our understanding of past East Antarctic Ice Sheet (EAIS) behaviour and thus our ability to evaluate its response to ongoing environmental change. The EAIS is marine-terminating and grounded below sea level within the Aurora subglacial basin, indicating that this catchment, which drains ice to the Sabrina Coast, may be sensitive to climate perturbations(9-11). Here we show, using marine geological and geophysical data from the continental shelf seaward of the Aurora subglacial basin, that marine-terminating glaciers existed at the Sabrina Coast by the early to middle Eocene epoch. This finding implies the existence of substantial ice volume in the Aurora subglacial basin before continental-scale ice sheets were established about 34 million years ago(1-4). Subsequently, ice advanced across and retreated from the Sabrina Coast continental shelf at least 11 times during the Oligocene and Miocene epochs. Tunnel valleys(12) associated with half of these glaciations indicate that a surface-meltwater-rich sub-polar glacial system existed under climate conditions similar to those anticipated with continued anthropogenic warming(10,11). Cooling since the late Miocene(13) resulted in an expanded polar EAIS and a limited glacial response to Pliocene warmth in the Aurora subglacial basin catchment(14-16). Geological records from the Sabrina Coast shelf indicate that, in addition to ocean temperature, atmospheric temperature and surface-derived meltwater influenced East Antarctic ice mass balance under warmer-than-present climate conditions. Our results imply a dynamic EAIS response with continued anthropogenic warming and suggest that the EAIS contribution to future global sea-level projections(10,11,15,17) may be under-estimated.	[Gulick, Sean P. S.; Montelli, Aleksandr; Fernandez, Rodrigo; Frederick, Bruce; Blankenship, Donald D.] Univ Texas Austin, Inst Geophys, Jackson Sch Geosci, Austin, TX 78758 USA; [Shevenell, Amelia E.; Smith, Catherine] Univ S Florida, Coll Marine Sci, St Petersburg, FL 33701 USA; [Warny, Sophie] Louisiana State Univ, Dept Geol & Geophys, Baton Rouge, LA 70803 USA; [Warny, Sophie] Louisiana State Univ, Museum Nat Sci, Baton Rouge, LA 70803 USA; [Bohaty, Steven M.] Univ Southampton, Sch Ocean & Earth Sci, Southampton SO14 3ZH, Hants, England; [Sjunneskog, Charlotte] Florida State Univ, Antarctic Marine Geol Res Facil, Tallahassee, FL 32306 USA; [Leventer, Amy] Colgate Univ, Geol Dept, Hamilton, NY 13346 USA; [Montelli, Aleksandr] Univ Cambridge, Scott Polar Res Inst, Cambridge CB2 1ER, England; [Sjunneskog, Charlotte] Texas A&M Univ, Int Ocean Discovery Program, 1000 Discovery Dr, College Stn, TX 77845 USA; [Frederick, Bruce] Univ Kansas, Dept Geol, Lawrence, KS 66045 USA	University of Texas System; University of Texas Austin; State University System of Florida; University of South Florida; Louisiana State University System; Louisiana State University; Louisiana State University System; Louisiana State University; NERC National Oceanography Centre; University of Southampton; State University System of Florida; Florida State University; Colgate University; University of Cambridge; Texas A&M University System; Texas A&M University College Station; University of Kansas	Gulick, SPS (corresponding author), Univ Texas Austin, Inst Geophys, Jackson Sch Geosci, Austin, TX 78758 USA.	sean@ig.utexas.edu	Frederick, Bruce/N-3916-2019; Gulick, Sean/GNH-2042-2022; Fernandez, Rodrigo/GRF-1350-2022; Fernandez, Rodrigo/ABC-8361-2020	Frederick, Bruce/0000-0002-7381-8693; Gulick, Sean/0000-0003-4740-9068; Leventer, Amy/0000-0001-9401-0987; Warny, Sophie/0000-0002-3451-040X; Fernandez, Rodrigo/0000-0003-4226-6010	National Science Foundation [NSF PLR-1143836, PLR-1143837, PLR-1143843, PLR-1430550, PLR-1048343]; GSA graduate student research grant; UTIG [3137]; NERC [NE/L007452/1] Funding Source: UKRI; Directorate For Geosciences [1048343] Funding Source: National Science Foundation; Natural Environment Research Council [NE/L007452/1] Funding Source: researchfish	National Science Foundation(National Science Foundation (NSF)); GSA graduate student research grant; UTIG; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank the NBP14-02 science party, the ECO captain and crew, and the ASC technical staff aboard the RV/IB N. B. Palmer. NBP14-02 was supported by the National Science Foundation (grants NSF PLR-1143836, PLR-1143837, PLR-1143843, PLR-1430550 and PLR-1048343) and a GSA graduate student research grant (to C.S.). We thank the Antarctic Marine Geology Research Facility staff at Florida State University for sampling assistance and E. Thomas, M. Katz, F. Sangiorni, P. Bijl and S. Manchester for discussions. This is UTIG Contribution #3137.	Aitken ARA, 2016, NATURE, V533, P385, DOI 10.1038/nature17447; Anagnostou E, 2016, NATURE, V533, P380, DOI 10.1038/nature17423; Anderson J., 1992, ANTARCT RES SER, V56, P213; Bart PJ, 2003, EARTH PLANET SC LETT, V216, P93, DOI 10.1016/S0012-821X(03)00509-0; Bjarnadottir LR, 2017, GEOLOGY, V45, P159, DOI 10.1130/G38195.1; Brotzen F., 1948, Sveriges Geologiska Undersokning Arsbok, V42, P1; Carter A, 2017, EARTH PLANET SC LETT, V458, P49, DOI 10.1016/j.epsl.2016.10.045; Close DI, 2007, MAR GEOL, V239, P33, DOI 10.1016/j.margeo.2006.12.010; Cofaigh CO, 1996, PROG PHYS GEOG, V20, P1, DOI 10.1177/030913339602000101; Contreras L., 2014, CLIM PAST DISCUSS, V10, P291; Cook CP, 2013, NAT GEOSCI, V6, P765, DOI [10.1038/ngeo1889, 10.1038/NGEO1889]; Cooper AK, 2009, DEV EARTH ENV SCI, V8, P115, DOI 10.1016/S1571-9197(08)00005-0; Couper RA., 1960, NZ GEOLOGICAL SURVEY, V32, P1; Coxall HK, 2005, NATURE, V433, P53, DOI 10.1038/nature03135; Crampton JS, 2016, P NATL ACAD SCI USA, V113, P6868, DOI 10.1073/pnas.1600318113; DeConto RM, 2003, NATURE, V421, P245, DOI 10.1038/nature01290; DeConto RM, 2016, NATURE, V531, P591, DOI 10.1038/nature17145; Denton GH, 2005, GEOGR ANN A, V87A, P67, DOI 10.1111/j.0435-3676.2005.00245.x; Dettmann M. E., 1990, NZ GEOL SURV PALEONT, V60, P1; Elmore CR, 2013, GEOCHEM GEOPHY GEOSY, V14, P1294, DOI 10.1002/ggge.20097; Escutia Carlota Henk, 2011, P INT OC DRILL PROGR; Fretwell P, 2013, CRYOSPHERE, V7, P375, DOI 10.5194/tc-7-375-2013; Golledge NR, 2017, GEOPHYS RES LETT, V44, P2343, DOI 10.1002/2016GL072422; Golledge NR, 2015, NATURE, V526, P421, DOI 10.1038/nature15706; Greenwood D. R., 2003, CAUSES CONSEQUENCES, P365, DOI [10.1130/0-8137-2369-8.365, DOI 10.1130/0-8137-2369-8.365]; Harris WK, 1965, PALAEONTOGR ABT B, V115, P75; Herbert TD, 2016, NAT GEOSCI, V9, P843, DOI [10.1038/ngeo2813, 10.1038/NGEO2813]; Hill RS, 1994, HIST AUSTR VEGETATIO; Holbourn A., 2013, ATLAS BENTHIC FORAMI; Huuse M, 2000, QUATERNARY SCI REV, V19, P1233, DOI 10.1016/S0277-3791(99)00103-1; Kehew AE, 2012, EARTH-SCI REV, V113, P33, DOI 10.1016/j.earscirev.2012.02.002; KENNETT JP, 1977, J GEOPHYS RES-OC ATM, V82, P3843, DOI 10.1029/JC082i027p03843; Kominz MA, 2008, BASIN RES, V20, P211, DOI 10.1111/j.1365-2117.2008.00354.x; Li Q, 2003, AUST J EARTH SCI, V50, P113, DOI 10.1046/j.1440-0952.2003.00978.x; Li X, 2016, GEOPHYS RES LETT, V43, P6366, DOI 10.1002/2016GL069173; Liebrand D, 2017, P NATL ACAD SCI USA, V114, P3867, DOI 10.1073/pnas.1615440114; Lonergan L, 2006, J QUATERNARY SCI, V21, P891, DOI 10.1002/jqs.1015; Macphail M.K., 2004, Proceedings of the Ocean Drilling Program Scientific Results, V188, P1; Masson-Delmotte V, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P383; McGowran B., 1965, P ROYAL SOC VICTORIA, V79, P9; Mudelsee M, 2014, REV GEOPHYS, V52, P333, DOI 10.1002/2013RG000440; Naish T, 2009, NATURE, V458, P322, DOI 10.1038/nature07867; Naish TR, 2001, NATURE, V413, P719, DOI 10.1038/35099534; Palike H, 2006, SCIENCE, V314, P1894, DOI 10.1126/science.1133822; Partridge A.D., 2006, AUSTR MESOZOIC CENOZ; Passchier S, 2017, GEOL SOC AM BULL, V129, P318, DOI 10.1130/B31482.1; Piotrowski JA, 1997, QUATERNARY SCI REV, V16, P169, DOI 10.1016/S0277-3791(96)00046-7; POCKNALL DT, 1989, J ROY SOC NEW ZEAL, V19, P1; Raine J. I., 2011, GNSCI MISCELLANEOU, V4; Raine JI., 1984, NZ GEOLOGICAL SURVEY; Rintoul SR, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1601610; Rovere A, 2014, EARTH PLANET SC LETT, V387, P27, DOI 10.1016/j.epsl.2013.10.030; Scher HD, 2014, PALEOCEANOGRAPHY, V29, P628, DOI 10.1002/2014PA002648; Scherer Reed P., 1994, Journal of Paleolimnology, V12, P171, DOI 10.1007/BF00678093; STOVER L E, 1973, Proceedings of the Royal Society of Victoria, V85, P237; STOVER L E, 1982, Palynology, V6, P69; Stover L.E., 1973, GEOLOGICAL SOC AUSTR, V4, P55; Tauxe L, 2012, PALEOCEANOGRAPHY, V27, DOI 10.1029/2012PA002308; Thomas E., 1990, Proceedings of the Ocean Drilling Program Scientific Results, V113, P571, DOI 10.2973/odp.proc.sr.113.123.1990; Truswell EM, 2009, AUST SYST BOT, V22, P57, DOI 10.1071/SB08046; TRUSWELL E M, 1983, Palaeontographica Abteilung B Palaeophytologie, V186, P121; van der Vegt P, 2012, GEOL SOC SPEC PUBL, V368, P75, DOI 10.1144/SP368.13; Wright AP, 2012, J GEOPHYS RES-EARTH, V117, DOI 10.1029/2011JF002066; Young DA, 2011, NATURE, V474, P72, DOI 10.1038/nature10114	64	65	66	5	111	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	DEC 14	2017	552	7684					225	+		10.1038/nature25026	http://dx.doi.org/10.1038/nature25026			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ0FK	29239353	Green Accepted, Green Submitted			2022-12-28	WOS:000418029500041
J	Chittori, S; Hong, JJ; Saunders, H; Feng, HQ; Ghirlando, R; Kelly, AE; Bai, YW; Subramaniam, S				Chittori, Sagar; Hong, Jingjun; Saunders, Hayden; Feng, Hanqiao; Ghirlando, Rodolfo; Kelly, Alexander E.; Bai, Yawen; Subramaniam, Sriram			Structural mechanisms of centromeric nucleosome recognition by the kinetochore protein CENP-N	SCIENCE			English	Article							A NUCLEOSOMES; CHROMATIN; HISTONE; ORGANIZATION; ARCHITECTURE; HETERODIMER; COMPLEX	Accurate chromosome segregation requires the proper assembly of kinetochore proteins. A key step in this process is the recognition of the histone H3 variant CENP-A in the centromeric nucleosome by the kinetochore protein CENP-N. We report cryo-electron microscopy (cryo-EM), biophysical, biochemical, and cell biological studies of the interaction between the CENP-A nucleosome and CENP-N. We show that human CENP-N confers binding specificity through interactions with the L1 loop of CENP-A, stabilized by electrostatic interactions with the nucleosomal DNA. Mutational analyses demonstrate analogous interactions in Xenopus, which are further supported by residue-swapping experiments involving the L1 loop of CENP-A. Our results are consistent with the coevolution of CENP-N and CENP-A and establish the structural basis for recognition of the CENP-A nucleosome to enable kinetochore assembly and centromeric chromatin organization.	[Chittori, Sagar; Subramaniam, Sriram] NCI, Lab Cell Biol, CCR, NIH, Bethesda, MD 20892 USA; [Hong, Jingjun; Saunders, Hayden; Feng, Hanqiao; Kelly, Alexander E.; Bai, Yawen] NCI, Lab Biochem & Mol Biol, CCR, NIH, Bethesda, MD 20892 USA; [Ghirlando, Rodolfo] NIDDK, Lab Mol Biol, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Subramaniam, S (corresponding author), NCI, Lab Cell Biol, CCR, NIH, Bethesda, MD 20892 USA.; Kelly, AE; Bai, YW (corresponding author), NCI, Lab Biochem & Mol Biol, CCR, NIH, Bethesda, MD 20892 USA.	alexander.kelly@nih.gov; baiyaw@mail.nih.gov; ss1@nih.gov	Hong, Jingjun/V-7281-2019; Chittori, Sagar/B-9412-2009; Kelly, Alexander/AAZ-8425-2021	Chittori, Sagar/0000-0003-1417-6552; KELLY, ALEXANDER/0000-0002-3395-6012; Hong, Jingjun/0000-0002-1080-6994; Saunders, Hayden/0000-0002-7582-3031; Subramaniam, Sriram/0000-0003-4231-4115	NCI of the NIH; NIDDK of the NIH; NATIONAL CANCER INSTITUTE [ZIABC011491, ZIABC010808] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK033007] Funding Source: NIH RePORTER	NCI of the NIH; NIDDK of the NIH; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by the intramural programs of the NCI and NIDDK of the NIH. We thank T. Fox and U. Baxa at the Center for Molecular Microscopy for help with cryo-EM data collection, A. Bartesaghi for advice with cryo-EM analysis, L. Jenkins for mass spectrometry, S. Li for DNA plasmid purifications, and V. Falconieri for assistance with figure preparation. This study utilized the computational resources of the High- Performance Computing Biowulf cluster at the NIH (http://hpc.nih.gov). The cryo-EM density map and atomic coordinates for the hCENP-N<INF>1-286</INF>/CENP-A nucleosome complex have been deposited in the Electron Microscopy Data Bank and the PDB under accession codes EMD-7293 and 6BUZ, respectively. S.C., J.H., A.E.K., Y.B., and S. S. were involved in all stages of experiment design and interpretation of results; J.H. prepared nucleosome complex samples and performed biochemical analysis; H.F. and J.H. performed nuclear magnetic resonance experiments; R.G. and J.H. performed analytical ultracentrifugation experiments; H.S. and A.E.K. performed in vivo experiments; S.C. carried out cryo-EM grid preparation, data collection, and image processing; S.C. built the structural model, with input from J.H.; S.C., Y.B., A.E.K., and J.H. carried out structural analysis; and S.C., J.H., A.E.K., Y.B., and S. S. integrated all of the data and wrote the manuscript, with help from all authors. We declare no competing financial interests.	Black BE, 2004, NATURE, V430, P578, DOI 10.1038/nature02766; Blower MD, 2002, DEV CELL, V2, P319, DOI 10.1016/S1534-5807(02)00135-1; Bodor DL, 2014, ELIFE, V3, DOI 10.7554/eLife.02137; Carroll CW, 2010, J CELL BIOL, V189, P1143, DOI 10.1083/jcb.201001013; Carroll CW, 2009, NAT CELL BIOL, V11, P896, DOI 10.1038/ncb1899; Cho US, 2011, P NATL ACAD SCI USA, V108, P9367, DOI 10.1073/pnas.1106389108; Fachinetti D, 2013, NAT CELL BIOL, V15, P1056, DOI 10.1038/ncb2805; Fang JN, 2015, GENE DEV, V29, P1058, DOI 10.1101/gad.259432.115; Guo LY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15775; Guse A, 2011, NATURE, V477, P354, DOI 10.1038/nature10379; Henikoff Steven, 2001, Trends in Genetics, V17, P689, DOI 10.1016/S0168-9525(01)02527-6; Hinshaw SM, 2013, CELL REP, V5, P29, DOI 10.1016/j.celrep.2013.08.036; Hu H, 2011, GENE DEV, V25, P901, DOI 10.1101/gad.2045111; Kato H, 2013, SCIENCE, V340, P1110, DOI 10.1126/science.1235532; Klare K, 2015, J CELL BIOL, V210, P11, DOI 10.1083/jcb.201412028; Kops GJPL, 2005, NAT REV CANCER, V5, P773, DOI 10.1038/nrc1714; Malik HS, 2001, GENETICS, V157, P1293; McKinley KL, 2015, MOL CELL, V60, P886, DOI 10.1016/j.molcel.2015.10.027; McKinley KL, 2016, NAT REV MOL CELL BIO, V17, DOI 10.1038/nrm.2015.5; Nagpal H, 2015, MOL BIOL CELL, V26, P3768, DOI 10.1091/mbc.E15-07-0531; Ribeiro SA, 2010, P NATL ACAD SCI USA, V107, P10484, DOI 10.1073/pnas.1002325107; Sukits SF, 2001, J MOL BIOL, V310, P895, DOI 10.1006/jmbi.2001.4790; Suzuki A, 2014, DEV CELL, V30, P717, DOI 10.1016/j.devcel.2014.08.003; Tachiwana H, 2011, NATURE, V476, P232, DOI 10.1038/nature10258; Vargiu G, 2017, P NATL ACAD SCI USA, V114, P3133, DOI 10.1073/pnas.1614145114; Vasudevan D, 2010, J MOL BIOL, V403, P1, DOI 10.1016/j.jmb.2010.08.039; Verdaasdonk JS, 2011, NAT REV MOL CELL BIO, V12, P320, DOI 10.1038/nrm3107; Weir JR, 2016, NATURE, V537, P249, DOI 10.1038/nature19333; Wu Y, 2017, P NATL ACAD SCI USA, V114, P4394, DOI 10.1073/pnas.1616605114; Zhou Z, 2011, NATURE, V472, P234, DOI 10.1038/nature09854	30	61	63	0	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 19	2018	359	6373					339	+		10.1126/science.aar2781	http://dx.doi.org/10.1126/science.aar2781			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT6BB	29269420	Green Accepted			2022-12-28	WOS:000423236700041
J	Su, R; Dong, L; Li, CY; Nachtergaele, S; Wunderlich, M; Qing, Y; Deng, XL; Wang, YG; Weng, XC; Hu, C; Yu, MX; Skibbe, J; Dai, Q; Zou, DL; Wu, T; Yu, KK; Weng, HY; Huang, HL; Ferchen, K; Qin, X; Zhang, B; Qi, J; Sasaki, AT; Plas, DR; Bradner, JE; Wei, MJ; Marcucci, G; Jiang, X; Mulloy, JC; Jin, J; He, C; Chen, JJ				Su, Rui; Dong, Lei; Li, Chenying; Nachtergaele, Sigrid; Wunderlich, Mark; Qing, Ying; Deng, Xiaolan; Wang, Yungui; Weng, Xiaocheng; Hu, Chao; Yu, Mengxia; Skibbe, Jennifer; Dai, Qing; Zou, Dongling; Wu, Tong; Yu, Kangkang; Weng, Hengyou; Huang, Huilin; Ferchen, Kyle; Qin, Xi; Zhang, Bin; Qi, Jun; Sasaki, Atsuo T.; Plas, David R.; Bradner, James E.; Wei, Minjie; Marcucci, Guido; Jiang, Xi; Mulloy, James C.; Jin, Jie; He, Chuan; Chen, Jianjun			R-2HG Exhibits Anti-tumor Activity by Targeting FTO/m(6)A/MYC/CEBPA Signaling	CELL			English	Article							ACUTE MYELOID-LEUKEMIA; ONCOMETABOLITE 2-HYDROXYGLUTARATE; HEMATOPOIETIC DIFFERENTIATION; RNA METHYLATION; GLIOMA-CELLS; IDH MUTATION; NUCLEAR-RNA; C-MYC; INHIBITION; INITIATION	R-2-hydroxyglutarate (R-2HG), produced at high levels by mutant isocitrate dehydrogenase 1/2 (IDH1/2) enzymes, was reported as an oncometabolite. We show here that R-2HG also exerts a broad anti-leukemic activity in vitro and in vivo by inhibiting leukemia cell proliferation/viability and by promoting cell-cycle arrest and apoptosis. Mechanistically, R-2HG inhibits fat mass and obesity-associated protein (FTO) activity, thereby increasing global N-6-methyladenosine (m(6)A) RNA modification in R-2HG-sensitive leukemia cells, which in turn decreases the stability of MYC/CEBPA transcripts, leading to the suppression of relevant pathways. Ectopically expressed mutant IDH1 and S-2HG recapitulate the effects of R-2HG. High levels of FTO sensitize leukemic cells to R-2HG, whereas hyperactivation of MYC signaling confers resistance that can be reversed by the inhibition of MYC signaling. R-2HG also displays anti-tumor activity in glioma. Collectively, while R-2HG accumulated in IDH1/2 mutant cancers contributes to cancer initiation, our work demonstrates anti-tumor effects of 2HG in inhibiting proliferation/survival of FTO-high cancer cells via targeting FTO/m(6)A/MYC/CEBPA signaling.	[Su, Rui; Dong, Lei; Li, Chenying; Qing, Ying; Deng, Xiaolan; Wang, Yungui; Hu, Chao; Skibbe, Jennifer; Zou, Dongling; Weng, Hengyou; Huang, Huilin; Ferchen, Kyle; Qin, Xi; Plas, David R.; Jiang, Xi; Chen, Jianjun] Univ Cincinnati, Dept Canc Biol, Cincinnati, OH 45219 USA; [Nachtergaele, Sigrid; Weng, Xiaocheng; Dai, Qing; Wu, Tong; Yu, Kangkang; He, Chuan] Univ Chicago, Howard Hughes Med Inst, Inst Biophys Dynam, Dept Chem,Dept Biochem & Mol Biol, Chicago, IL 60637 USA; [Li, Chenying; Wang, Yungui; Hu, Chao; Yu, Mengxia; Jin, Jie] Zhejiang Univ, Affiliated Hosp 1, Key Lab Hematopoiet Malignancies, Hangzhou 310003, Zhejiang, Peoples R China; [Wunderlich, Mark; Mulloy, James C.] Cincinnati Childrens Hosp Med Ctr, Div Expt Hematol & Canc Biol, Cincinnati, OH 45229 USA; [Weng, Xiaocheng] Wuhan Univ, Minist Educ, Coll Chem & Mol Sci, Key Lab Biomed Polymers, Wuhan 430072, Hubei, Peoples R China; [Zhang, Bin; Marcucci, Guido; Chen, Jianjun] City Of Hope, Gehr Family Ctr Leukemia Res, 1500 E Duarte Rd, Duarte, CA 91010 USA; [Qi, Jun; Bradner, James E.] Harvard Med Sch, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA; [Sasaki, Atsuo T.] Univ Cincinnati, Dept Internal Med, Div Hematol & Oncol, Cincinnati, OH 45267 USA; [Deng, Xiaolan; Wei, Minjie] China Med Univ, Sch Pharm, Shenyang 110001, Liaoning, Peoples R China; [Zou, Dongling] Chongqing Canc Inst & Hosp & Canc Ctr, Dept Gynecol Oncol, Chongqing 400030, Peoples R China; [Su, Rui; Dong, Lei; Li, Chenying; Qing, Ying; Deng, Xiaolan; Zou, Dongling; Weng, Hengyou; Huang, Huilin; Qin, Xi; Jiang, Xi; Chen, Jianjun] City Of Hope, Beckman Res Inst, Dept Syst Biol, Monrovia, CA 91016 USA	University System of Ohio; University of Cincinnati; Howard Hughes Medical Institute; University of Chicago; Zhejiang University; Cincinnati Children's Hospital Medical Center; Wuhan University; City of Hope; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; University System of Ohio; University of Cincinnati; China Medical University	Chen, JJ (corresponding author), Univ Cincinnati, Dept Canc Biol, Cincinnati, OH 45219 USA.; He, C (corresponding author), Univ Chicago, Howard Hughes Med Inst, Inst Biophys Dynam, Dept Chem,Dept Biochem & Mol Biol, Chicago, IL 60637 USA.; Jin, J (corresponding author), Zhejiang Univ, Affiliated Hosp 1, Key Lab Hematopoiet Malignancies, Hangzhou 310003, Zhejiang, Peoples R China.; Chen, JJ (corresponding author), City Of Hope, Gehr Family Ctr Leukemia Res, 1500 E Duarte Rd, Duarte, CA 91010 USA.; Chen, JJ (corresponding author), City Of Hope, Beckman Res Inst, Dept Syst Biol, Monrovia, CA 91016 USA.	jiej0503@163.com; chuanhe@uchicago.edu; jianchen@coh.org	Huang, Huilin/AAA-8376-2019; Dai, Qing/ABD-8444-2021; Dong, Lei/AAA-9495-2020; Su, Rui/Y-8157-2018	Dong, Lei/0000-0001-9574-0148; Wei, Min-Jie/0000-0002-7907-4189; Su, Rui/0000-0002-4807-6229; Jin, Jie/0000-0002-8166-9915; minjie, wei/0000-0002-0404-7098; Yu, Kangkang/0000-0001-5352-1959; Sasaki, Atsuo/0000-0003-2963-4501; Qin, Xi/0000-0002-1154-5634; Qing, Ying/0000-0001-6763-6204	NIH [CA214965, CA211614, CA178454, CA182528, RM1 HG008935, GM071440, R50 CA211404, R01NS089815, R21NS100077]; Foundation of Innovation Team for Basic and Clinical Research of Zhejiang Province [2011R50015]; Academic and Research Committee of Cincinnati Children's Hospital Medical Center; Damon Runyon Cancer Research Foundation [DRG-2215-15]; NATIONAL CANCER INSTITUTE [R01CA214965, R01CA178454, R01CA211614, R50CA211404, R01CA182528] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [RM1HG008935] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071440] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS089815, R21NS100077] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation of Innovation Team for Basic and Clinical Research of Zhejiang Province; Academic and Research Committee of Cincinnati Children's Hospital Medical Center; Damon Runyon Cancer Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by NIH R01 grants CA214965 (J.C.), CA211614 (J.C.), CA178454 (J.C.), CA182528 (J.C.), RM1 HG008935 (C. He), GM071440 (C. He), R50 CA211404 (M. Wunderlich), the Foundation of Innovation Team for Basic and Clinical Research of Zhejiang Province (2011R50015) (J.J.), and the Academic and Research Committee of Cincinnati Children's Hospital Medical Center (J.C.M.). J.C. is a Leukemia & Lymphoma Society (LLS) Scholar. C. He is an investigator of the Howard Hughes Medical Institute (HHMI). S.N. is an HHMI Fellow of the Damon Runyon Cancer Research Foundation (DRG-2215-15). A.T.S. is supported by two NIH grants (R01NS089815 and R21NS100077).	Boutzen H, 2016, J EXP MED, V213, P483, DOI 10.1084/jem.20150736; Brat DJ, 2015, NEW ENGL J MED, V372, P2481, DOI 10.1056/NEJMoa1402121; Chowdhury R, 2011, EMBO REP, V12, P463, DOI 10.1038/embor.2011.43; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; Eckel-Passow JE, 2015, NEW ENGL J MED, V372, P2499, DOI 10.1056/NEJMoa1407279; Elkashef SM, 2017, CANCER CELL, V31, P619, DOI 10.1016/j.ccell.2017.04.001; Emadi A, 2015, AM J HEMATOL, V90, pE77, DOI 10.1002/ajh.23965; Figueroa ME, 2010, CANCER CELL, V18, P553, DOI 10.1016/j.ccr.2010.11.015; Fu XD, 2015, CELL METAB, V22, P508, DOI 10.1016/j.cmet.2015.06.009; Hodge R, 1998, METH MOL B, V86, P73; Jan M, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004315; Jia GF, 2011, NAT CHEM BIOL, V7, P885, DOI [10.1038/NCHEMBIO.687, 10.1038/nchembio.687]; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; Li ZJ, 2017, CANCER CELL, V31, P127, DOI 10.1016/j.ccell.2016.11.017; Li ZJ, 2013, J CLIN ONCOL, V31, P1172, DOI 10.1200/JCO.2012.44.3184; Lin CY, 2012, CELL, V151, P56, DOI 10.1016/j.cell.2012.08.026; Liu JZ, 2014, NAT CHEM BIOL, V10, P93, DOI 10.1038/nchembio.1432; Losman JA, 2013, SCIENCE, V339, P1621, DOI 10.1126/science.1231677; Lu C, 2012, NATURE, V483, P474, DOI 10.1038/nature10860; Marcucci G, 2010, J CLIN ONCOL, V28, P2348, DOI 10.1200/JCO.2009.27.3730; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; Mauer J, 2017, NATURE, V541, P371, DOI 10.1038/nature21022; Meng J, 2014, METHODS, V69, P274, DOI 10.1016/j.ymeth.2014.06.008; Moran-Crusio K, 2011, CANCER CELL, V20, P11, DOI 10.1016/j.ccr.2011.06.001; Ohlsson E, 2014, J EXP MED, V211, P5, DOI 10.1084/jem.20130932; Papaemmanuil E, 2016, NEW ENGL J MED, V374, P2209, DOI 10.1056/NEJMoa1516192; Patel JP, 2012, NEW ENGL J MED, V366, P1079, DOI 10.1056/NEJMoa1112304; Rohle D, 2013, SCIENCE, V340, P626, DOI 10.1126/science.1236062; Sasaki M, 2012, NATURE, V488, P656, DOI 10.1038/nature11323; Wang F, 2013, SCIENCE, V340, P622, DOI 10.1126/science.1234769; Wang JB, 2014, ASIAN PAC J CANCER P, V15, P427, DOI 10.7314/APJCP.2014.15.1.427; Wang X, 2014, NATURE, V505, P117, DOI 10.1038/nature12730; Ward PS, 2010, CANCER CELL, V17, P225, DOI 10.1016/j.ccr.2010.01.020; Wunderlich M, 2010, LEUKEMIA, V24, P1785, DOI 10.1038/leu.2010.158; Wunderlich M, 2014, BLOOD, V123, pE134, DOI 10.1182/blood-2014-02-556340; Wunderlich M, 2013, BLOOD, V121, pE90, DOI 10.1182/blood-2012-10-464677; Xu W, 2011, CANCER CELL, V19, P17, DOI 10.1016/j.ccr.2010.12.014; Ye M, 2015, CELL STEM CELL, V17, P611, DOI 10.1016/j.stem.2015.08.011; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	40	530	559	11	212	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 11	2018	172	1-2					90	+		10.1016/j.cell.2017.11.031	http://dx.doi.org/10.1016/j.cell.2017.11.031			39	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FS5MI	29249359	Green Accepted, Bronze			2022-12-28	WOS:000419840100012
J	Saldivar, JC; Cimprich, KA				Saldivar, Joshua C.; Cimprich, Karlene A.			A new mitotic activity comes into focus	SCIENCE			English	Editorial Material							R-LOOPS; GENOME; ACTIVATION; CHECKPOINT; KINASE		[Saldivar, Joshua C.; Cimprich, Karlene A.] Stanford Univ, Dept Chem & Syst Biol, Sch Med, 318 Campus Dr, Stanford, CA 94305 USA	Stanford University	Cimprich, KA (corresponding author), Stanford Univ, Dept Chem & Syst Biol, Sch Med, 318 Campus Dr, Stanford, CA 94305 USA.	cimprich@stanford.edu		Saldivar, Joshua/0000-0001-7821-1615	NIH [ES016486, GM119334]; American Cancer Society [PF-15-165-01-DMC]; Postdoctoral Enrichment Program Award from the Burroughs Wellcome Fund; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES016486] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM119334] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Postdoctoral Enrichment Program Award from the Burroughs Wellcome Fund; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	K.A.C. is supported by grants from the NIH (ES016486 and GM119334). J.C.S. is supported by a Postdoctoral Fellowship (PF-15-165-01-DMC) from the American Cancer Society and holds a Postdoctoral Enrichment Program Award from the Burroughs Wellcome Fund.	Aze A, 2016, NAT CELL BIOL, V18, P684, DOI 10.1038/ncb3344; Blower MD, 2016, CELL REP, V15, P1624, DOI 10.1016/j.celrep.2016.04.054; Cimini D, 2005, TRENDS CELL BIOL, V15, P442, DOI 10.1016/j.tcb.2005.06.008; Eykelenboom JK, 2013, CELL REP, V5, P1095, DOI 10.1016/j.celrep.2013.10.027; Ferri F, 2009, NUCLEIC ACIDS RES, V37, P5071, DOI 10.1093/nar/gkp529; Kabeche L, 2018, SCIENCE, V359, P108, DOI 10.1126/science.aan6490; Lampson MA, 2011, TRENDS CELL BIOL, V21, P133, DOI 10.1016/j.tcb.2010.10.007; Nigg EA, 2001, NAT REV MOL CELL BIO, V2, P21, DOI 10.1038/35048096; Petsalaki E, 2011, J CELL BIOL, V195, P449, DOI 10.1083/jcb.201104023; Saldivar JC, 2017, NAT REV MOL CELL BIO, V18, P622, DOI 10.1038/nrm.2017.67; Santos-Pereira JM, 2015, NAT REV GENET, V16, P583, DOI 10.1038/nrg3961; Sollier J, 2015, TRENDS CELL BIOL, V25, P514, DOI 10.1016/j.tcb.2015.05.003	12	2	2	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 5	2018	359	6371					30	31		10.1126/science.aar4799	http://dx.doi.org/10.1126/science.aar4799			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FR8KW	29302000				2022-12-28	WOS:000419324700054
J	Stokstad, E				Stokstad, Erik			Deadly virus threatens European pigs and boar	SCIENCE			English	News Item																			0	8	8	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 22	2017	358	6370					1516	1517		10.1126/science.358.6370.1516	http://dx.doi.org/10.1126/science.358.6370.1516			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ6BO	29269453				2022-12-28	WOS:000418448000017
J	Akhmanova, A; Maiato, H				Akhmanova, Anna; Maiato, Helder			Closing the tubulin detyrosination cycle	SCIENCE			English	Editorial Material							TYROSINE-LIGASE; ANGIOGENESIS; VASOHIBINS		[Akhmanova, Anna] Univ Utrecht, Fac Sci, Dept Biol, Cell Biol, Padualaan 8, NL-3584 CH Utrecht, Netherlands; [Maiato, Helder] Univ Porto, Inst Biol Mol & Celular, Oporto, Portugal; [Maiato, Helder] Univ Porto, Inst Invest & Inovacao Saude i3S, Oporto, Portugal; [Maiato, Helder] Univ Porto, Fac Med, Dept Biomed, Oporto, Portugal	Utrecht University; Universidade do Porto; Universidade do Porto; i3S - Instituto de Investigacao e Inovacao em Saude, Universidade do Porto; Universidade do Porto	Akhmanova, A (corresponding author), Univ Utrecht, Fac Sci, Dept Biol, Cell Biol, Padualaan 8, NL-3584 CH Utrecht, Netherlands.	a.akhmanova@uu.nl; maiato@i3s.up.pt	Maiato, Helder/J-9466-2013	Maiato, Helder/0000-0002-6200-9997	European Research Council [681443] Funding Source: Medline	European Research Council(European Research Council (ERC)European Commission)		Aillaud C, 2017, SCIENCE, V358, P1448, DOI 10.1126/science.aao4165; ARCE CA, 1975, EUR J BIOCHEM, V59, P145, DOI 10.1111/j.1432-1033.1975.tb02435.x; Barisic M, 2015, SCIENCE, V348, P799, DOI 10.1126/science.aaa5175; Erck C, 2005, P NATL ACAD SCI USA, V102, P7853, DOI 10.1073/pnas.0409626102; ERSFELD K, 1993, J CELL BIOL, V120, P725, DOI 10.1083/jcb.120.3.725; Gadadhar S, 2017, J CELL SCI, V130, P1347, DOI 10.1242/jcs.199471; GUNDERSEN GG, 1986, EUR J CELL BIOL, V42, P288; HALLAK ME, 1977, FEBS LETT, V73, P147, DOI 10.1016/0014-5793(77)80968-X; Kimura H, 2009, BLOOD, V113, P4810, DOI 10.1182/blood-2008-07-170316; Nieuwenhuis J, 2017, SCIENCE, V358, P1453, DOI 10.1126/science.aao5676; RAYBIN D, 1975, BIOCHEM BIOPH RES CO, V65, P1088, DOI 10.1016/S0006-291X(75)80497-9; Robison P, 2016, SCIENCE, V352, DOI 10.1126/science.aaf0659; Sanchez-Pulido L, 2016, BIOINFORMATICS, V32, P1441, DOI 10.1093/bioinformatics/btv761; Sato Y, 2013, J BIOCHEM, V153, P5, DOI 10.1093/jb/mvs128; Suzuki Y, 2010, J CELL SCI, V123, P3094, DOI 10.1242/jcs.067538	15	4	4	1	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 15	2017	358	6369					1381	1382		10.1126/science.aar3895	http://dx.doi.org/10.1126/science.aar3895			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FP8TH	29242330	Green Accepted			2022-12-28	WOS:000417918500018
J	Hutson, M				Hutson, Matthew			A MATTER OF TRUST	SCIENCE			English	Editorial Material																			0	5	5	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 15	2017	358	6369					1375	1377		10.1126/science.358.6369.1375	http://dx.doi.org/10.1126/science.358.6369.1375			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FP8TH	29242328				2022-12-28	WOS:000417918500016
J	Iuliano, AD; Roguski, KM; Chang, HH; Muscatello, DJ; Palekar, R; Tempia, S; Cohen, C; Gran, JM; Schanzer, D; Cowling, BJ; Wu, P; Kyncl, J; Ang, LW; Park, M; Redlberger-Fritz, M; Yu, HJ; Espenhain, L; Krishnan, A; Emukule, G; van Asten, L; da Silva, SP; Aungkulanon, S; Buchholz, U; Widdowson, MA; Bresee, JS; Azziz-Baumgartner, E; Cheng, PY; Dawood, F; Foppa, I; Olsen, S; Haber, M; Jeffers, C; MacIntyre, CR; Newall, AT; Wood, JG; Kundi, M; PopowKraupp, T; Ahmed, M; Rahman, M; Marinho, F; Proschle, CV; Mallegas, N; Feng, LZ; Sa, L; Barbosa-Ramirez, J; Sanchez, DM; Gomez, LA; Vargas, XB; Herrera, BA; Llanes, MJ; Fischer, TK; Krause, TG; Molbak, K; Nielsen, J; Trebbien, R; Bruno, A; Ojeda, J; Ramos, H; an der Heiden, M; Signor, LDC; Serrano, CE; Bhardwaj, R; Chadha, M; Narayan, V; Kosen, S; Bromberg, M; Glatman-Freedman, A; Kaufman, Z; Arima, Y; Oishi, K; Chaves, S; Nyawanda, B; Al-Jarallah, RA; Kuri-Morales, PA; Matus, CR; Corona, MEJ; Burmaa, A; Darmaa, O; Obtel, M; Cherkaoui, I; van den Wijngaard, CC; van der Hoek, W; Baker, M; Bandaranayake, D; Bissielo, A; Huang, S; Lopez, L; Newbern, C; Flem, E; Groneng, GM; Hauge, S; de Cosio, FG; de Molto, Y; Castillo, LM; Cabello, MA; von Horoch, M; Osis, JM; Machado, A; Nunes, B; Rodrigues, AP; Rodrigues, E; Calomfirescu, C; Lupulescu, E; Popescu, R; Popovici, O; Bogdanovic, D; Kostic, M; Lazarevic, K; Milosevic, Z; Tiodorovic, B; Chen, M; Cutter, J; Lee, V; Lin, R; Ma, S; Cohen, AL; Treurnicht, F; Kim, WJ; Sanz, CD; Ontanon, SD; Larrauri, A; Leon, I; Vallejo, F; Born, R; Junker, C; Koch, D; Chuang, JH; Huang, WT; Kuo, HW; Tsai, YC; Bundhamcharoen, K; Chittaganpitch, M; Green, HK; Pebody, R; Goni, N; Chiparelli, H; Brammer, L; Mustaquim, D				Iuliano, A. Danielle; Roguski, Katherine M.; Chang, Howard H.; Muscatello, David J.; Palekar, Rakhee; Tempia, Stefano; Cohen, Cheryl; Gran, Jon Michael; Schanzer, Dena; Cowling, Benjamin J.; Wu, Peng; Kyncl, Jan; Ang, Li Wei; Park, Minah; Redlberger-Fritz, Monika; Yu, Hongjie; Espenhain, Laura; Krishnan, Anand; Emukule, Gideon; van Asten, Liselotte; da Silva, Susana Pereira; Aungkulanon, Suchunya; Buchholz, Udo; Widdowson, Marc-Alain; Bresee, Joseph S.; Azziz-Baumgartner, Eduardo; Cheng, Po-Yung; Dawood, Fatimah; Foppa, Ivo; Olsen, Sonja; Haber, Michael; Jeffers, Caprichia; MacIntyre, C. Raina; Newall, Anthony T.; Wood, James G.; Kundi, Michael; PopowKraupp, Therese; Ahmed, Makhdum; Rahman, Mahmudur; Marinho, Fatima; Sotomayor Proschle, C. Viviana; Vergara Mallegas, Natalia; Feng, Luzhao; Sa, Li; Barbosa-Ramirez, Juliana; Malo Sanchez, Diana; Abarca Gomez, Leandra; Badilla Vargas, Xiomara; Acosta Herrera, Betsy; Josefa Llanes, Maria; Fischer, Thea Kolsen; Krause, Tyra Grove; Molbak, Kare; Nielsen, Jens; Trebbien, Ramona; Bruno, Alfredo; Ojeda, Jenny; Ramos, Hector; an der Heiden, Matthias; Castillo Signor, Leticia del Carmen; Enrique Serrano, Carlos; Bhardwaj, Rohit; Chadha, Mandeep; Narayan, Venkatesh; Kosen, Soewarta; Bromberg, Michal; Glatman-Freedman, Aharona; Kaufman, Zalman; Arima, Yuzo; Oishi, Kazunori; Chaves, Sandra; Nyawanda, Bryan; Al-Jarallah, Reem Abdullah; Kuri-Morales, Pablo A.; Ruiz Matus, Cuitlahuac; Jimenez Corona, Maria Eugenia; Burmaa, Alexander; Darmaa, Oyungerel; Obtel, Majdouline; Cherkaoui, Imad; van den Wijngaard, Cees C.; van der Hoek, Wim; Baker, Michael; Bandaranayake, Don; Bissielo, Ange; Huang, Sue; Lopez, Liza; Newbern, Claire; Flem, Elmira; Groneng, Gry M.; Hauge, Siri; de Cosio, Federico G.; de Molto, Yadira; Moreno Castillo, Lourdes; Agueda Cabello, Maria; von Horoch, Marta; Medina Osis, Jose; Machado, Ausenda; Nunes, Baltazar; Rodrigues, Ana Paula; Rodrigues, Emanuel; Calomfirescu, Cristian; Lupulescu, Emilia; Popescu, Rodica; Popovici, Odette; Bogdanovic, Dragan; Kostic, Marina; Lazarevic, Konstansa; Milosevic, Zoran; Tiodorovic, Branislav; Chen, Mark; Cutter, Jeffery; Lee, Vernon; Lin, Raymond; Ma, Stefan; Cohen, Adam L.; Treurnicht, Florette; Kim, Woo Joo; Delgado Sanz, Concha; de mateo Ontanon, Salvador; Larrauri, Amparo; Leon, Inmaculada; Vallejo, Fernando; Born, Rita; Junker, Christoph; Koch, Daniel; Chuang, Jen-Hsiang; Huang, Wan-Ting; Kuo, Hung-Wei; Tsai, Yi-Chen; Bundhamcharoen, Kanitta; Chittaganpitch, Malinee; Green, Helen K.; Pebody, Richard; Goni, Natalia; Chiparelli, Hector; Brammer, Lynnette; Mustaquim, Desiree		Global Seasonal Influenza-Associat	Estimates of global seasonal influenza-associated respiratory mortality: a modelling study	LANCET			English	Article							EXCESS MORTALITY; UNITED-STATES; PANDEMIC INFLUENZA; DEATHS; VIRUS; BURDEN; EPIDEMIOLOGY; CAPACITY; NUMBERS; AFRICA	Background Estimates of influenza-associated mortality are important for national and international decision making on public health priorities. Previous estimates of 250 000-500 000 annual influenza deaths are outdated. We updated the estimated number of global annual influenza-associated respiratory deaths using country-specific influenza-associated excess respiratory mortality estimates from 1999-2015. Methods We estimated country-specific influenza-associated respiratory excess mortality rates (EMR) for 33 countries using time series log-linear regression models with vital death records and influenza surveillance data. To extrapolate estimates to countries without data, we divided countries into three analytic divisions for three age groups (< 65 years, 65-74 years, and >= 75 years) using WHO Global Health Estimate (GHE) respiratory infection mortality rates. We calculated mortality rate ratios (MRR) to account for differences in risk of influenza death across countries by comparing GHE respiratory infection mortality rates from countries without EMR estimates with those with estimates. To calculate death estimates for individual countries within each age-specific analytic division, we multiplied randomly selected mean annual EMRs by the country's MRR and population. Global 95% credible interval (CrI) estimates were obtained from the posterior distribution of the sum of country-specific estimates to represent the range of possible influenza-associated deaths in a season or year. We calculated influenza-associated deaths for children younger than 5 years for 92 countries with high rates of mortality due to respiratory infection using the same methods. Findings EMR-contributing countries represented 57% of the global population. The estimated mean annual influenza-associated respiratory EMR ranged from 0.1 to 6.4 per 100 000 individuals for people younger than 65 years, 2.9 to 44.0 per 100 000 individuals for people aged between 65 and 74 years, and 17 .9 to 223.5 per 100 000 for people older than 75 years. We estimated that 291 243-645 832 seasonal influenza-associated respiratory deaths (4.0-8.8 per 100 000 individuals) occur annually. The highest mortality rates were estimated in sub-Saharan Africa (2.8-16.5 per 100 000 individuals), southeast Asia (3.5-9.2 per 100 000 individuals), and among people aged 75 years or older (51. 3-99.4 per 100 000 individuals). For 92 countries, we estimated that among children younger than 5 years, 9243-105 690 influenza-associated respiratory deaths occur annually. Interpretation These global influenza-associated respiratory mortality estimates are higher than previously reported, suggesting that previous estimates might have underestimated disease burden. The contribution of non-respiratory causes of death to global influenza-associated mortality should be investigated.	[Iuliano, A. Danielle; Roguski, Katherine M.; Tempia, Stefano; Bresee, Joseph S.; Azziz-Baumgartner, Eduardo; Cheng, Po-Yung; Dawood, Fatimah; Foppa, Ivo; Olsen, Sonja; Cohen, Adam L.; Brammer, Lynnette; Mustaquim, Desiree] Ctr Dis Control & Prevent, Influenza Div, Atlanta, GA 30329 USA; [Chang, Howard H.; Haber, Michael; Jeffers, Caprichia] Emory Univ, Dept Biostat & Bioinformat, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA; [Muscatello, David J.] Univ New South Wales, Dept Biostat & Bioinformat, Sydney, NSW, Australia; [Palekar, Rakhee] Pan Amer Hlth Org, Washington, DC USA; [Cohen, Cheryl] Natl Hlth Lab Serv, Natl Inst Communicable Dis, Ctr Resp Dis & Meningitis, Johannesburg, South Africa; [Gran, Jon Michael] Oslo Univ Hosp, Oslo Ctr Biostat & Epidemiol, Oslo, Norway; [Gran, Jon Michael] Univ Oslo, Oslo, Norway; [Gran, Jon Michael] Norwegian Inst Publ Hlth, Domain Infect Control & Environm Hlth, Oslo, Norway; [Schanzer, Dena] Publ Hlth Agcy Canada, Infect Dis Prevent & Control Branch, Ottawa, ON, Canada; [Cowling, Benjamin J.; Wu, Peng; Park, Minah] Univ Hong Kong, Sch Publ Hlth, Li Ka Shing Fac Med, WHO Collaborating Ctr Infect Dis Epidemiol & Cont, Hong Kong, Hong Kong, Peoples R China; [Kyncl, Jan] Natl Inst Publ Hlth, Dept Infect Dis Epidemiol, Prague, Czech Republic; [Ang, Li Wei] Minist Hlth, Dept Infect Dis Epidemiol, Singapore, Singapore; [Redlberger-Fritz, Monika; PopowKraupp, Therese] Med Univ Vienna, Dept Virol, Vienna, Austria; [Yu, Hongjie] Chinese Ctr Dis Control & Prevent, Key Lab Surveillance & Early Warning Infect Dis, Div Infect Dis, Beijing, Peoples R China; [Espenhain, Laura] Statens Serum Inst, Dept Infect Dis Epidemiol, Copenhagen, Denmark; [Krishnan, Anand; Narayan, Venkatesh] All India Inst Med Sci, New Delhi, India; [Emukule, Gideon; Widdowson, Marc-Alain] Ctr Dis Control & Prevent Kenya, Nairobi, Kenya; [van Asten, Liselotte] Natl Inst Publ Hlth & Environm, Bilthoven, Netherlands; [da Silva, Susana Pereira] Natl Hlth Inst Doutor Ricardo Jorge, Dept Epidemiol, Lisbon, Portugal; [Aungkulanon, Suchunya] Minist Publ Hlth, Int Hlth Policy Program, Nonthaburi, Thailand; [Buchholz, Udo] Robert Koch Inst, Dept Infect Dis Epidemiol, Berlin, Germany; [MacIntyre, C. Raina; Newall, Anthony T.] Univ New South Wales, Sch Publ Hlth & Community Med, Sydney, NSW, Australia; [Wood, James G.] Univ New South Wales, Sydney, NSW, Australia; [Kundi, Michael] Med Univ Vienna, Inst Environm Hlth, Ctr Publ Hlth, Vienna, Austria; [Ahmed, Makhdum] Int Ctr Diarrheal Dis Res, Dhaka, Bangladesh; [Rahman, Mahmudur] Inst Epidemiol Dis Control & Res, Dhaka, Bangladesh; [Marinho, Fatima] Minist Hlth Brazil, Brasilia, DF, Brazil; [Sotomayor Proschle, C. Viviana; Vergara Mallegas, Natalia] Minist Hlth Santiago, Dept Epidemiol, Santiago, Chile; [Feng, Luzhao; Sa, Li] Chinese Ctr Dis Control & Prevent, Div Infect Dis, Key Lab Surveillance & EarlyWarning Infect Dis, Beijing, Peoples R China; [Barbosa-Ramirez, Juliana] Natl Influenza Ctr, Div Influenza & Other Resp Viruses, Bogota, Colombia; [Malo Sanchez, Diana] Natl Inst Hlth Colombia, Bogota, Colombia; [Abarca Gomez, Leandra; Badilla Vargas, Xiomara] Caja Costarricense Seguro Social, San Jose, Costa Rica; [Acosta Herrera, Betsy] Natl Influenza Ctr, Inst Pedro Kouri, Dept Virol, Havana, Cuba; [Josefa Llanes, Maria] Minist Salud Publ, Direcc Nacl Epidemiol, Viceminist Higiend Epidemiol & Microbiol, Havana, Cuba; [Fischer, Thea Kolsen; Trebbien, Ramona] Statens Serum Inst, Dept Microbiol Diagnost & Virol, Copenhagen S, Denmark; [Fischer, Thea Kolsen] Univ Southern Denmark, Dept Infect Dis, Copenhagen S, Denmark; [Fischer, Thea Kolsen] Univ Southern Denmark, Ctr Global Hlth, Copenhagen S, Denmark; [Molbak, Kare; Nielsen, Jens] Statens Serum Inst, Dept Infect Dis Epidemiol, Copenhagen S, Denmark; [Bruno, Alfredo] Ctr Referencia Nacl Influenza & Otros Virus Resp, Inst Nacl Invest Salud Publ Dr Leopoldo Izquieta, Guayaquil, Ecuador; [Bruno, Alfredo] Univ Agr Ecuador, Guayaquil, Ecuador; [Ojeda, Jenny] Minestro Salud Publ, Direcc Nacl Vigilancia Epidemiol, Quito, Ecuador; [Ramos, Hector] Minist Hlth, Sanit Surveillance Div, San Salvador, El Salvador; [an der Heiden, Matthias] Robert Koch Inst, Dept Infect Dis Epidemiol, Berlin, Germany; [Castillo Signor, Leticia del Carmen; Enrique Serrano, Carlos] Natl Hlth Lab, Barcenas, Guatemala; [Bhardwaj, Rohit] Off Registrar Gen India, SRS Div, New Delhi, India; [Chadha, Mandeep] 133 Natl Inst Virol, Pune, Maharashtra, India; [Kosen, Soewarta] NIHRD, Jakarta, Indonesia; [Bromberg, Michal; Glatman-Freedman, Aharona; Kaufman, Zalman] Minist Hlth, Israel Ctr Dis Control, Tel Hashomer, Israel; [Glatman-Freedman, Aharona] Tel Aviv Univ, Sackler Fac Med, Dept Epidemiol & Prevent Med, Tel Aviv, Israel; [Arima, Yuzo] Natl Inst Infect Dis, Infect Dis Surveillance Ctr, Tokyo, Japan; [Chaves, Sandra] Ctr Dis Control & Prevent, Kenya Country Off, Nairobi, Kenya; [Nyawanda, Bryan] KEMRI, CGHR, Kisumu, Kenya; [Al-Jarallah, Reem Abdullah] Kuwait Univ, Stat & Operat Res Dept, Coll Sci, Safat, Kuwait; [Kuri-Morales, Pablo A.] UNAM Mexico, Undersecretary Prevent & Hlth Promot, Minist Hlth Sch Med, Mexico City, DF, Mexico; [Ruiz Matus, Cuitlahuac; Jimenez Corona, Maria Eugenia] Direcc Gen Epiemiol, Secretaria Salud, Mexico City, DF, Mexico; [Burmaa, Alexander; Darmaa, Oyungerel] Minist Hlth, Natl Influenza Ctr, Natl Influenza Surveillance Div, Ulaanbata, Mongolia; [Obtel, Majdouline] Univ Mohammed 5, Dept Publ Hlth, Fac Med & Pharm, Rabat, Morocco; [Cherkaoui, Imad] Minist Hlth, Directorate Epidemiol & Dis Control, Rabat, Morocco; [van den Wijngaard, Cees C.; van der Hoek, Wim] RIVM Natl Inst Publ Hlth & Environm, Bilthoven, Netherlands; [Baker, Michael] Univ Otago, Dept Publ Hlth, Wellington, New Zealand; [Bandaranayake, Don; Bissielo, Ange; Huang, Sue; Lopez, Liza; Newbern, Claire] Inst Environm Sci & Res, Upper Hutt, New Zealand; [Flem, Elmira] Norwegian Inst Publ Hlth, Infect Control & Environm Hlth, Oslo, Norway; [Groneng, Gry M.] Norwegian Inst Publ Hlth, Dept Infect Dis Epidemiol, Oslo, Norway; [Hauge, Siri] Norwegian Inst Publ Hlth, Oslo, Norway; [de Cosio, Federico G.] Pan Amer Hlth Org, Hlth Informat & Anal, Washington, DC USA; [de Molto, Yadira; Moreno Castillo, Lourdes] Minist Hlth, Dept Epidemiol, Panama City, Panama; [Agueda Cabello, Maria; von Horoch, Marta] Minist Hlth, Monitoring & Evaluat Unit, Asuncion, Paraguay; [Medina Osis, Jose] Minist Hlth, Gen Directorate Epidemiol, Lima, Peru; [Machado, Ausenda; Nunes, Baltazar; Rodrigues, Ana Paula; Rodrigues, Emanuel] Natl Hlth Inst Doutor Ricardo Jorge INSA, Dept Epidemiol, Lisbon, Portugal; [Calomfirescu, Cristian] Romania Natl Ctr Stat & Informat Publ Hlth, Natl Inst Publ Hlth, Bucharest, Romania; [Lupulescu, Emilia] Natl Res Inst Dr Ioan Cantacuzino, Bucharest, Romania; [Popescu, Rodica; Popovici, Odette] Romania Natl Ctr Communicable Dis Surveillance &, Natl Inst Publ Hlth, Bucharest, Romania; [Bogdanovic, Dragan; Lazarevic, Konstansa] State Univ Novi Pazar, Nish, Serbia; [Kostic, Marina] Publ Hlth Inst Nis, Nish, Serbia; [Milosevic, Zoran; Tiodorovic, Branislav] Univ Nis Med Sch, Nish, Serbia; [Chen, Mark] Natl Univ Singapore, Singapore, Singapore; [Cutter, Jeffery; Lee, Vernon; Lin, Raymond; Ma, Stefan] Minist Hlth, Singapore, Singapore; [Cohen, Adam L.] WHO, Dept Immunizat Vaccines & Biol, Strateg Informat Grp, Expanded Programme Immunizat, Geneva, Switzerland; [Treurnicht, Florette] Ctr Resp Dis & Meningitis, Natl Inst Communicable Dis, Natl Hlth Lab Serv, Johannesburg, South Africa; [Kim, Woo Joo] Korea Univ Coll Med, Div Infect Dis, Dept Internal Med, Seoul, South Korea; [Delgado Sanz, Concha; de mateo Ontanon, Salvador; Larrauri, Amparo; Leon, Inmaculada; Vallejo, Fernando] CIBERESP, Natl Ctr Epidemiol, Carlos III Hlth Inst, Madrid, Spain; [Born, Rita] Fed Off Publ Hlth, Bern, Switzerland; [Junker, Christoph] Fed Stat Off, Neuchatel, Switzerland; [Koch, Daniel] Fed Off Publ Hlth, Div Communicable Dis, Bern, Switzerland; [Chuang, Jen-Hsiang; Huang, Wan-Ting; Kuo, Hung-Wei; Tsai, Yi-Chen] Taiwanese Ctr Dis Control, Taipei, Taiwan; [Bundhamcharoen, Kanitta] Int Hlth Policy Program, Nonthaburi, Thailand; [Chittaganpitch, Malinee] Thai Natl Inst Hlth, Nonthaburi, Thailand; [Green, Helen K.; Pebody, Richard] Publ Hlth England, London, England; [Goni, Natalia; Chiparelli, Hector] Minist Hlth, Natl Influenza Reference Ctr, Dept Publ Hlth Lab, Montevideo, Uruguay	Centers for Disease Control & Prevention - USA; Emory University; Rollins School Public Health; University of New South Wales Sydney; Pan American Health Organization; National Health Laboratory Service; National Institute for Communicable Diseases (NICD); University of Oslo; University of Oslo; Norwegian Institute of Public Health (NIPH); Public Health Agency of Canada; University of Hong Kong; World Health Organization; National Institute of Public Health (SZU) - Czech Republic; Ministry of Health-Singapore; Medical University of Vienna; Chinese Center for Disease Control & Prevention; Statens Serum Institut; All India Institute of Medical Sciences (AIIMS) New Delhi; Netherlands National Institute for Public Health & the Environment; Instituto Nacional de Saude Dr. Ricardo Jorge; Ministry of Public Health - Thailand; Robert Koch Institute; University of New South Wales Sydney; University of New South Wales Sydney; Medical University of Vienna; International Centre for Diarrhoeal Disease Research (ICDDR); Chinese Center for Disease Control & Prevention; Statens Serum Institut; University of Southern Denmark; University of Southern Denmark; Statens Serum Institut; Robert Koch Institute; Indian Council of Medical Research (ICMR); ICMR - National Institute of Virology (NIV); National Institute of Health Research & Development (NIHRD); Tel Aviv University; Sackler Faculty of Medicine; National Institute of Infectious Diseases (NIID); Kuwait University; Universidad Nacional Autonoma de Mexico; Ministry of Health Mongolia; Mohammed First University of Oujda; Mohammed V University in Rabat; Ibn sina University Hospital Center of Rabat; Netherlands National Institute for Public Health & the Environment; University of Otago; Institute of Environmental Science & Research (ESR) - New Zealand; Norwegian Institute of Public Health (NIPH); Norwegian Institute of Public Health (NIPH); Norwegian Institute of Public Health (NIPH); Pan American Health Organization; Ministerio de Salud de la Republica de Panama; Instituto Nacional de Saude Dr. Ricardo Jorge; National University of Singapore; Ministry of Health-Singapore; World Health Organization; National Health Laboratory Service; National Institute for Communicable Diseases (NICD); Korea University; Korea University Medicine (KU Medicine); CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Ministry of Public Health - Thailand; Public Health England	Iuliano, AD (corresponding author), Ctr Dis Control & Prevent, Influenza Div, Atlanta, GA 30329 USA.	aiuliano@cdc.gov	Muscatello, David/HDO-2537-2022; Chen, Mark/CAG-2949-2022; Marinho, Fatima/AFJ-2948-2022; Flem, Elmira/GOG-9451-2022; Fischer, Thea K/AAH-9892-2019; JIMENEZ-CORONA, MARIA-EUGENIA/AAC-1892-2021; Krishnan, Anand/D-8537-2012; Larrauri, Amparo/Q-9613-2017; BRUNO, ALFREDO/AAW-8354-2020; Machado, Ausenda/ABP-0781-2022; Kyncl, Jan/O-7766-2015; Flem, Elmira/AFS-7695-2022; Chen, Mark/AGC-5338-2022; Marinho, Fatima/AAF-4556-2022; Chuang, Jen-Hsiang/G-4356-2010; Silva, Susana P/A-6684-2018; Schanzer, Dena/G-1593-2011; Machado, Ausenda/AAE-9913-2022; Muscatello, David/AAD-9134-2019; Marinho, Fatima/ABC-8725-2021; Yu, Hongjie/GZK-5351-2022; Cowling, Benjamin/C-4263-2009	Chen, Mark/0000-0001-9369-5830; Marinho, Fatima/0000-0003-3287-9163; Flem, Elmira/0000-0002-5099-1960; Fischer, Thea K/0000-0003-4812-980X; Krishnan, Anand/0000-0002-9173-7811; Larrauri, Amparo/0000-0002-1704-2245; BRUNO, ALFREDO/0000-0002-9678-4203; Kyncl, Jan/0000-0002-0804-2729; Flem, Elmira/0000-0002-5099-1960; Chen, Mark/0000-0001-9369-5830; Marinho, Fatima/0000-0003-3287-9163; Chuang, Jen-Hsiang/0000-0002-7114-3418; Silva, Susana P/0000-0003-2524-0548; Schanzer, Dena/0000-0001-7093-4309; Trebbien, Ramona/0000-0003-2352-5726; Wu, Peng/0000-0003-1157-9401; Medina Osis, Jose Lionel/0000-0002-6929-6714; Cowling, Benjamin/0000-0002-6297-7154; MacIntyre, C Raina/0000-0002-3060-0555; Huang, Q. Sue/0000-0002-3923-5195; Newbern, Elizabeth Claire/0000-0002-8486-6471; Pebody, Richard/0000-0002-9069-2885; Ang, Li Wei/0000-0002-0036-255X; Nunes, Baltazar/0000-0001-6230-7209; VALLEJO, FERNANDO/0000-0002-5753-5482; Cohen, Cheryl/0000-0003-0376-2302; Huang, Wan-Ting/0000-0002-4344-9567; Bogdanovic, Dragan/0000-0001-6300-7427; Newall, Anthony/0000-0003-0836-1065; Lazarevic, Konstansa/0000-0002-9993-115X; Redlberger-Fritz, Monika/0000-0001-6265-557X; an der Heiden, Matthias/0000-0001-5863-4549; Rahman, Mohammad Mahmudur/0000-0002-1211-8642; Inmaculada, Leon-Gomez/0000-0002-8565-8332; Molbak, Kare/0000-0002-3100-4990	NIGMS NIH HHS [U54 GM088558] Funding Source: Medline; Intramural CDC HHS [CC999999] Funding Source: Medline; NCIRD CDC HHS [U01 IP001048] Funding Source: Medline; National Center for Immunization and Respiratory Diseases (NCIRD) [U01IP001048] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM088558] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Intramural CDC HHS; NCIRD CDC HHS; National Center for Immunization and Respiratory Diseases (NCIRD)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		[Anonymous], 2012, Wkly Epidemiol Rec, V87, P461; [Anonymous], WORLD POP PROSP 2017; Aungkulanon S, 2015, INFLUENZA OTHER RESP, V9, P298, DOI 10.1111/irv.12344; Centers for Disease Control and Prevention, CLASS DIS INJ; Cheng PY, 2015, INFLUENZA OTHER RESP, V9, P13, DOI 10.1111/irv.12317; Chow A, 2006, EMERG INFECT DIS, V12, P114, DOI 10.3201/eid1201.050826; Cohen C, 2018, CLIN INFECT DIS, V66, P95, DOI 10.1093/cid/cix740; COLLINS S. D., 1932, Public Health Reports, V47, P2159, DOI 10.2307/4580606; Dawood FS, 2012, LANCET INFECT DIS, V12, P687, DOI 10.1016/S1473-3099(12)70121-4; Douglas R G Jr, 1976, Hosp Pract, V11, P43; Feng LZ, 2012, B WORLD HEALTH ORGAN, V90, P279, DOI 10.2471/BLT.11.096958; Fleming D M, 2000, Commun Dis Public Health, V3, P32; Fleming DM, 2005, EPIDEMIOL INFECT, V133, P255, DOI 10.1017/S0950268804003231; Foppa IM, 2008, EMERG THEMES EPIDEMI, V5, DOI 10.1186/1742-7622-5-26; Freitas FTM, 2013, EPIDEMIOL INFECT, V141, P1731, DOI 10.1017/S0950268812002221; Goldstein E, 2012, EPIDEMIOLOGY, V23, P829, DOI 10.1097/EDE.0b013e31826c2dda; Gran JM, 2013, INFLUENZA OTHER RESP, V7, P1370, DOI 10.1111/irv.12125; Green HK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079360; Johnson LEA, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1232-1; Katz MA, 2012, J INFECT DIS, V206, pS1, DOI 10.1093/infdis/jis548; Kostova D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066312; Kuo HW, 2011, WIEN KLIN WOCHENSCHR, V123, P593, DOI 10.1007/s00508-011-0019-7; Kyncl J, 2005, EUR J EPIDEMIOL, V20, P365, DOI 10.1007/s10654-005-1067-y; Lee VJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008096; Lemaitre M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045051; Linhart Y, 2011, INFECTION, V39, P399, DOI 10.1007/s15010-011-0153-1; Lopez-Cuadrado T, 2012, GAC SANIT, V26, P325, DOI 10.1016/j.gaceta.2011.09.033; Mathers CD, 2005, B WORLD HEALTH ORGAN, V83, P171; Muscatello DJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098446; Nair H, 2011, LANCET, V378, P1917, DOI 10.1016/S0140-6736(11)61051-9; Nicholson KG, 2003, LANCET, V362, P1733, DOI 10.1016/S0140-6736(03)14854-4; Nicoll A, 2012, EUROSURVEILLANCE, V17, P18; Nielsen J, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-350; Nunes B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020661; Park Minah, 2016, Am J Prev Med, V50, pe111, DOI 10.1016/j.amepre.2015.09.028; Polansky LS, 2016, EMERG INFECT DIS, V22, P993, DOI [10.3201/eid.2206.151521, 10.3201/eid2206.151521]; Redlberger-Fritz M, 2012, EUR J EPIDEMIOL, V27, P567, DOI 10.1007/s10654-012-9701-y; Reichert TA, 2004, AM J EPIDEMIOL, V160, P492, DOI 10.1093/aje/kwh227; Rizzo C, 2007, EMERG INFECT DIS, V13, P694, DOI 10.3201/eid1305.061309; Schanzer DL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080481; SERFLING RE, 1963, PUBLIC HEALTH REP, V78, P494, DOI 10.2307/4591848; Simonsen L, 1997, EPIDEMIOLOGY, V8, P390, DOI 10.1097/00001648-199707000-00007; Simonsen L, 1997, AM J PUBLIC HEALTH, V87, P1944, DOI 10.2105/AJPH.87.12.1944; Simonsen L, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001558; Stevens GA, 2016, LANCET, V388, pE19, DOI 10.1016/S0140-6736(16)30388-9; Tempia S, 2015, EMERG INFECT DIS, V21, P600, DOI 10.3201/eid2104.141033; The GATHER Working Group, 2016, GUID ACC TRANSP HLTH; Thompson M. G., 2010, Morbidity and Mortality Weekly Report, V59, P1057; Thompson WW, 2006, J INFECT DIS, V194, pS82, DOI 10.1086/507558; Thompson WW, 2009, INFLUENZA OTHER RESP, V3, P37, DOI 10.1111/j.1750-2659.2009.00073.x; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; U.S. Census Bureau, INT PROGR INT DAT BA; UN Statistics Division, 2014, MILL DEV IND WORLD R; UNICEF, WE WORK; van den Wijngaard CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031197; Wang HD, 2016, LANCET, V388, P1459, DOI 10.1016/S0140-6736(16)31012-1; Warren-Gash C, 2011, J INFECT DIS, V203, P1710, DOI 10.1093/infdis/jir171; WHO, 2011, INT STAT CLASS DIS R; WHO, 2017, EST 2000 2015 CAUS S; WHO, 2017, GLOB HLTH EST TECHN; WHO, 2011, INFL TRANSM ZON; Wong KK, 2013, PEDIATRICS, V132, P796, DOI 10.1542/peds.2013-1493; World Bank, 2015, WORLD BANK COUNTR LE; World Health Organization, 2016, FACT SHEET SOL STAR; Wu P, 2012, J INFECT DIS, V206, P1862, DOI 10.1093/infdis/jis628; Zucs P, 2005, EMERG THEMES EPIDEMI, V2, DOI 10.1186/1742-7622-2-6	66	1095	1195	33	260	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 31	2018	391	10127					1285	1300		10.1016/S0140-6736(17)33293-2	http://dx.doi.org/10.1016/S0140-6736(17)33293-2			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GB1DR	29248255	Green Accepted			2022-12-28	WOS:000428791600027
J	Holland, TL; Fowler, VG				Holland, Thomas L.; Fowler, Vance G., Jr.			Rifampicin for Staphylococcus aureus bacteraemia: give it ARREST	LANCET			English	Editorial Material							STANDARD THERAPY; INFECTIONS; GUIDELINES		[Holland, Thomas L.; Fowler, Vance G., Jr.] Duke Univ, Dept Med, Sch Med, Div Infect Dis & Int Hlth, Durham, NC 27710 USA; [Holland, Thomas L.; Fowler, Vance G., Jr.] Duke Clin Res Inst, Durham, NC 27705 USA	Duke University; Duke University	Fowler, VG (corresponding author), Duke Univ, Dept Med, Sch Med, Div Infect Dis & Int Hlth, Durham, NC 27710 USA.; Fowler, VG (corresponding author), Duke Clin Res Inst, Durham, NC 27705 USA.	vance.fowler@duke.edu	Fowler, Vance/AAW-2017-2021; Holland, Thomas/AAA-6096-2022	Holland, Thomas/0000-0001-7745-9010	US National Institutes of Health (NIH); The Medicines Company; Genentech; Theravance; Basilea; Motif Bio; Allergan; Cerexa; Actavis; Pfizer; Advanced Liquid Logics; NIH; MedImmune; Cubist/Merck; Karius; Contrafect; Achaogen; Astellas; Arsanis; Affinergy; Bayer; Cubist; Debiopharm; Durata; Grifols; Merck; Medicines Co; Novadigm; Theravanc; xBiotech; Green Cross; Novartis	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); The Medicines Company; Genentech(Roche HoldingGenentech); Theravance; Basilea; Motif Bio; Allergan(AbbVieAllergan); Cerexa; Actavis; Pfizer(Pfizer); Advanced Liquid Logics; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MedImmune(AstraZenecaMedimmune); Cubist/Merck; Karius; Contrafect; Achaogen; Astellas(Astellas Pharmaceuticals); Arsanis; Affinergy; Bayer(Bayer AG); Cubist; Debiopharm; Durata; Grifols; Merck(Merck & Company); Medicines Co; Novadigm; Theravanc; xBiotech; Green Cross; Novartis(Novartis)	TLH has received grant support from the US National Institutes of Health (NIH), and has been a paid consultant for The Medicines Company, Genentech, Theravance, and Basilea, and all are related to S aureus therapies; and he receives consulting fees as a member of the scientific advisory board for Motif Bio. VGF served as Chair of the Scientific Advisory Committee for the V710 S aureus vaccine for Merck; has received grant support from Allergan and its predecessors (Cerexa and Actavis), and Pfizer, Advanced Liquid Logics, NIH, MedImmune, Cubist/Merck, Karius, Contrafect, and Genentech, and all are related to S aureus therapies. VGF has also been a paid consultant for Achaogen, Astellas, Arsanis, Affinergy, Basilea, Bayer, Cerexa, Contrafect, Cubist, Debiopharm, Durata, Grifols, Genentech, MedImmune, Merck, Medicines Co, Pfizer, Novartis, Novadigm, Theravanc, xBiotech; has received speakers' fees from Theravance, Green Cross, and Debiopharm; and has a patent pending in sepsis diagnostics, and all are related to S aureus therapies.	Fowler VG, 2006, NEW ENGL J MED, V355, P653, DOI 10.1056/NEJMoa053783; Gould FK, 2009, J ANTIMICROB CHEMOTH, V63, P849, DOI 10.1093/jac/dkp065; Holland TL, 2014, JAMA-J AM MED ASSOC, V312, P1330, DOI 10.1001/jama.2014.9743; Kaasch AJ, 2014, J INFECTION, V68, P242, DOI 10.1016/j.jinf.2013.10.015; LEVINE DP, 1991, ANN INTERN MED, V115, P674, DOI 10.7326/0003-4819-115-9-674; Liu C, 2011, CLIN INFECT DIS, V53, P319, DOI [10.1093/cid/cir353, 10.1093/cid/ciq146]; Riedel DJ, 2008, ANTIMICROB AGENTS CH, V52, P2463, DOI 10.1128/AAC.00300-08; Rieg S, 2017, CLIN MICROBIOL INFEC, V23, DOI 10.1016/j.cmi.2016.08.026; Russell CD, 2014, J MED MICROBIOL, V63, P841, DOI 10.1099/jmm.0.072280-0; Thwaites GE, 2017, LANCET	10	4	4	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 17	2018	391	10121					634	636		10.1016/S0140-6736(17)33294-4	http://dx.doi.org/10.1016/S0140-6736(17)33294-4			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FW4MN	29249277	hybrid			2022-12-28	WOS:000425287800005
J	Sinha, NK; Iwasa, J; Shen, PS; Bass, BL				Sinha, Niladri K.; Iwasa, Janet; Shen, Peter S.; Bass, Brenda L.			Dicer uses distinct modules for recognizing dsRNA termini	SCIENCE			English	Article							PHOSPHATE-BINDING POCKET; RIG-I; RNA INTERFERENCE; STRUCTURAL BASIS; HELICASE DOMAIN; RECOGNITION; IMMUNITY; VIRUS; SUPPRESSION; ACTIVATION	Invertebrates rely on Dicer to cleave viral double-stranded RNA (dsRNA), and Drosophila Dicer-2 distinguishes dsRNA substrates by their termini. Blunt termini promote processive cleavage, while 3' overhanging termini are cleaved distributively. To understand this discrimination, we used cryo-electron microscopy to solve structures of Drosophila Dicer-2 alone and in complex with blunt dsRNA. Whereas the Platform-PAZ domains have been considered the only Dicer domains that bind dsRNA termini, unexpectedly, we found that the helicase domain is required for binding blunt, but not 3' overhanging, termini. We further showed that blunt dsRNA is locally unwound and threaded through the helicase domain in an adenosine triphosphate-dependent manner. Our studies reveal a previously unrecognized mechanism for optimizing antiviral defense and set the stage for the discovery of helicase-dependent functions in other Dicers.	[Sinha, Niladri K.; Iwasa, Janet; Shen, Peter S.; Bass, Brenda L.] Univ Utah, Dept Biochem, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah	Shen, PS; Bass, BL (corresponding author), Univ Utah, Dept Biochem, Salt Lake City, UT 84112 USA.	peter.shen@biochem.utah.edu; bbass@biochem.utah.edu		Sinha, Niladri/0000-0002-9143-495X	National Institute of General Medical Sciences [R01GM121706]; H. A. and Edna Benning Presidential Endowed Chair; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM121706] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); H. A. and Edna Benning Presidential Endowed Chair; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. Cazalla and E. Cao for critique of the manuscript and P. J. Aruscavage for technical assistance. EM was performed at University of Utah EM Core Laboratory, with computational support from Utah Center for High Performance Computing. RNA was synthesized by the DNA/Peptide facility (Health Sciences Center Cores at University of Utah). This work was supported by funding from the National Institute of General Medical Sciences (R01GM121706) and the H. A. and Edna Benning Presidential Endowed Chair (to B.L.B.). The authors declare no competing financial interests. The models and cryo-EM maps are available via the following accession numbers: Protein Data Bank (PDB) 6BUA, Electron Microscopy Data Bank (EMDB) EMD-7291, EMD-7292 (apo-dmDcr-2<SUP>RIII</SUP>); PDB 6BU9, EMD-7290 (dmDcr-2<SUP>RIII</SUP>center dot 52 BLT dsRNA center dot ATP-gamma S complex).	Ahmad S, 2015, TRENDS BIOCHEM SCI, V40, P576, DOI 10.1016/j.tibs.2015.08.001; Aliyari R, 2008, CELL HOST MICROBE, V4, P387, DOI 10.1016/j.chom.2008.09.001; Cenik ES, 2011, MOL CELL, V42, P172, DOI 10.1016/j.molcel.2011.03.002; Colmenares SU, 2007, MOL CELL, V27, P449, DOI 10.1016/j.molcel.2007.07.007; Fairman-Williams ME, 2010, CURR OPIN STRUC BIOL, V20, P313, DOI 10.1016/j.sbi.2010.03.011; Flynt A, 2009, P NATL ACAD SCI USA, V106, P5270, DOI 10.1073/pnas.0813412106; Galiana-Arnoux D, 2006, NAT IMMUNOL, V7, P590, DOI 10.1038/ni1335; Ha M, 2014, NAT REV MOL CELL BIO, V15, P509, DOI 10.1038/nrm3838; Kandasamy SK, 2016, P NATL ACAD SCI USA, V113, P14031, DOI 10.1073/pnas.1612393113; Kowalinski E, 2011, CELL, V147, P423, DOI 10.1016/j.cell.2011.09.039; Lau PW, 2012, NAT STRUCT MOL BIOL, V19, P436, DOI 10.1038/nsmb.2268; Lau PW, 2009, STRUCTURE, V17, P1326, DOI 10.1016/j.str.2009.08.013; Lee YS, 2004, CELL, V117, P69, DOI 10.1016/S0092-8674(04)00261-2; Li Y, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2016.250; Linder P, 2011, NAT REV MOL CELL BIO, V12, P505, DOI 10.1038/nrm3154; Liu QH, 2003, SCIENCE, V301, P1921, DOI 10.1126/science.1088710; Luo DH, 2011, CELL, V147, P409, DOI 10.1016/j.cell.2011.09.023; Ma E, 2008, J MOL BIOL, V380, P237, DOI 10.1016/j.jmb.2008.05.005; MacRae IJ, 2006, SCIENCE, V311, P195, DOI 10.1126/science.1121638; Marques JT, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003579; Myong S, 2009, SCIENCE, V323, P1070, DOI 10.1126/science.1168352; Okamura K, 2008, NAT REV MOL CELL BIO, V9, P673, DOI 10.1038/nrm2479; Park JE, 2011, NATURE, V475, P201, DOI 10.1038/nature10198; Qiu Y, 2017, IMMUNITY, V46, P992, DOI 10.1016/j.immuni.2017.05.006; Sabin LR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055458; Sinha NK, 2015, MOL CELL, V58, P406, DOI 10.1016/j.molcel.2015.03.012; Takahasi K, 2008, MOL CELL, V29, P428, DOI 10.1016/j.molcel.2007.11.028; Taylor DW, 2013, NAT STRUCT MOL BIOL, V20, P662, DOI 10.1038/nsmb.2564; Tian Y, 2014, MOL CELL, V53, P606, DOI 10.1016/j.molcel.2014.01.003; Trettin KD, 2017, P NATL ACAD SCI USA, V114, pE7939, DOI 10.1073/pnas.1707063114; Tsutsumi A, 2011, NAT STRUCT MOL BIOL, V18, P1153, DOI 10.1038/nsmb.2125; Wang XH, 2006, SCIENCE, V312, P452, DOI 10.1126/science.1125694; Welker NC, 2011, MOL CELL, V41, P589, DOI 10.1016/j.molcel.2011.02.005; Wilson RC, 2013, ANNU REV BIOPHYS, V42, P217, DOI 10.1146/annurev-biophys-083012-130404; Wu QF, 2010, P NATL ACAD SCI USA, V107, P1606, DOI 10.1073/pnas.0911353107; Zhang HD, 2004, CELL, V118, P57, DOI 10.1016/j.cell.2004.06.017; Zhang HD, 2002, EMBO J, V21, P5875, DOI 10.1093/emboj/cdf582; Zhou R, 2009, RNA, V15, P1886, DOI 10.1261/rna.1611309	38	44	46	0	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 19	2018	359	6373					329	+		10.1126/science.aaq0921	http://dx.doi.org/10.1126/science.aaq0921			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT6BB	29269422	Green Accepted			2022-12-28	WOS:000423236700039
J	Zivin, JG; Neidell, M				Zivin, Joshua Graff; Neidell, Matthew			Air pollution's hidden impacts	SCIENCE			English	Editorial Material							PRODUCTIVITY; EXPOSURE		[Zivin, Joshua Graff] Univ Calif San Diego, Dept Econ, La Jolla, CA 92093 USA; [Zivin, Joshua Graff] Univ Calif San Diego, Sch Global Policy & Strategy, La Jolla, CA 92093 USA; [Neidell, Matthew] Columbia Univ, Mailman Sch Publ Hlth, Dept Hlth Policy & Management, New York, NY 10032 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Columbia University	Zivin, JG (corresponding author), Univ Calif San Diego, Dept Econ, La Jolla, CA 92093 USA.; Zivin, JG (corresponding author), Univ Calif San Diego, Sch Global Policy & Strategy, La Jolla, CA 92093 USA.	jgraffzivin@ucsd.edu	Zivin, Joshua Graff/ABF-1697-2020					ADHVARYU A, 2016, WORKING PAPER; Almond D, 2011, J ECON PERSPECT, V25, P153, DOI 10.1257/jep.25.3.153; Bharadwaj P, 2017, J ASSOC ENVIRON RESO, V4, P505, DOI 10.1086/691591; Chang T., 2016, 22328 WP NAT BUR EC; Chang T, 2016, AM ECON J-ECON POLIC, V8, P141, DOI 10.1257/pol.20150085; Hanna R, 2015, J PUBLIC ECON, V122, P68, DOI 10.1016/j.jpubeco.2014.10.004; Heyes A, 2016, EFFECT AIR POLLUTION; Isen A, 2017, J POLIT ECON, V125, P848, DOI 10.1086/691465; McGartland A, 2017, SCIENCE, V357, P457, DOI 10.1126/science.aam8204; Nelesen R, 2008, ARCH INTERN MED, V168, P943, DOI 10.1001/archinte.168.9.943; Petronis A, 2010, NATURE, V465, P721, DOI 10.1038/nature09230; Sanders NJ, 2012, J HUM RESOUR, V47, P826, DOI 10.3368/jhr.47.3.826; US EPA, 2011, BEN COSTS CLEAN AIR; Zivin JG, 2012, AM ECON REV, V102, P3652, DOI 10.1257/aer.102.7.3652	14	50	52	3	77	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 5	2018	359	6371					39	40		10.1126/science.aap7711	http://dx.doi.org/10.1126/science.aap7711			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FR8KW	29302005				2022-12-28	WOS:000419324700059
J	Caulley, L; Balch, CM; Ross, MI; Robert, C				Caulley, Lisa; Balch, Charles M.; Ross, Merrick I.; Robert, Caroline			Management of Sentinel-Node Metastasis in Melanoma	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							AMERICAN JOINT COMMITTEE; LYMPH-NODES; STAGE-III; PHASE-3 TRIAL; DISSECTION; MULTICENTER; IPILIMUMAB; MORBIDITY		[Caulley, Lisa; Balch, Charles M.; Ross, Merrick I.; Robert, Caroline] Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Caulley, L (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA.		Robert, Caroline/G-6157-2018	Robert, Caroline/0000-0002-9493-0238; Caulley, Lisa/0000-0002-9661-4634				Balch CM, 2009, J CLIN ONCOL, V27, P6199, DOI 10.1200/JCO.2009.23.4799; Eggermont AMM, 2015, LANCET ONCOL, V16, P522, DOI 10.1016/S1470-2045(15)70122-1; Faries MB, 2017, NEW ENGL J MED, V376, P2211, DOI 10.1056/NEJMoa1613210; Faries MB, 2010, ANN SURG ONCOL, V17, P3324, DOI 10.1245/s10434-010-1203-0; Feldmann R, 2014, EJSO-EUR J SURG ONC, V40, P73, DOI 10.1016/j.ejso.2013.08.022; Gershenwald JE, 2008, J CLIN ONCOL, V26, P4296, DOI 10.1200/JCO.2007.15.4179; Gershenwald JE, 2017, CA-CANCER J CLIN, V67, P472, DOI 10.3322/caac.21409; Leiter U, 2016, LANCET ONCOL, V17, P757, DOI 10.1016/S1470-2045(16)00141-8; Leung AM, 2013, JAMA SURG, V148, P879, DOI 10.1001/jamasurg.2013.3044; Long GV, 2017, NEW ENGL J MED, V377, P1813, DOI 10.1056/NEJMoa1708539; Theodore JE, 2017, ANZ J SURG, V87, P44, DOI 10.1111/ans.13526; van Akkooi ACJ, 2010, NAT REV CLIN ONCOL, V7, P446, DOI 10.1038/nrclinonc.2010.100; Weber J, 2017, NEW ENGL J MED, V377, P1824, DOI 10.1056/NEJMoa1709030	13	5	5	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 4	2018	378	1					85	88		10.1056/NEJMclde1712449	http://dx.doi.org/10.1056/NEJMclde1712449			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FR7BE	29298143				2022-12-28	WOS:000419220500022
J	Naylor, CD				Naylor, C. David			Canada as Single-Payer Exemplar for Universal Health Care in the United States A Borderline Option	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Naylor, C. David] Univ Toronto, Dept Med, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Naylor, C. David] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada	University of Toronto; University of Toronto	Naylor, CD (corresponding author), 4 Shorncliffe Ave, Toronto, ON M4V 1T1, Canada.	david.naylor@utoronto.ca						Advisory Panel on Healthcare Innovation, UNL INN EXC HEALTHC; Lazar H, 2013, PARADIGM FREEZE; Morgan SG, PHARMACARE 2020; Naylor C. David, 1986, PRIVATE PRACTICE PUB; Office of the Parliamentary Budget Officer, FED COST NAT PHARM P; Reinhardt Greenwald J., FISCAL TIMES; TAYLOR MG, 1978, HLTH INSURANCE CANAD; World Focus, US MEAS CAN HLTH CAR	8	4	4	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 2	2018	319	1					17	18		10.1001/jama.2017.19668	http://dx.doi.org/10.1001/jama.2017.19668			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FR5ON	29255893				2022-12-28	WOS:000419116000008
J	Wilson, CJN; Morgan, DJ; Charlier, BLA; Barker, SJ				Wilson, Colin J. N.; Morgan, Daniel J.; Charlier, Bruce L. A.; Barker, Simon J.			Comment on "Rapid cooling and cold storage in a silicic magma reservoir recorded in individual crystals"	SCIENCE			English	Editorial Material							LI DIFFUSION; NEW-ZEALAND; ZIRCON	Rubin et al. (Reports, 16 June 2017, p. 1154) proposed that gradients in lithium abundance in zircons from a rhyolitic eruption in New Zealand reflected short-lived residence at magmatic temperatures interleaved with long-term "cold" (< 650 degrees C) storage. Important issues arise with the interpretation of these lithium gradients and consequent crystal thermal histories that raise concerns about the validity of this conclusion.	[Wilson, Colin J. N.; Charlier, Bruce L. A.] Victoria Univ, Sch Geog Environm & Earth Sci, Wellington 6140, New Zealand; [Morgan, Daniel J.] Univ Leeds, Sch Earth & Environm, Leeds LS2 9JT, W Yorkshire, England; [Barker, Simon J.] Univ Auckland, Sch Environm, PB 92019, Auckland 1142, New Zealand	Victoria University Wellington; University of Leeds; University of Auckland	Wilson, CJN (corresponding author), Victoria Univ, Sch Geog Environm & Earth Sci, Wellington 6140, New Zealand.	colin.wilson@vuw.ac.nz	Wilson, Colin J. N./E-9457-2011; Charlier, Bruce L.A./A-7548-2012; Morgan, Daniel J/E-3881-2010	Wilson, Colin J. N./0000-0001-7565-0743; Charlier, Bruce L.A./0000-0003-0285-8978; Morgan, Daniel J/0000-0002-7292-2536; Barker, Simon/0000-0002-3090-1403				Charlier BLA, 2012, EARTH PLANET SC LETT, V319, P218, DOI 10.1016/j.epsl.2011.12.016; Cherniak DJ, 2010, CONTRIB MINERAL PETR, V160, P383, DOI 10.1007/s00410-009-0483-5; Cherniak DJ, 1997, CHEM GEOL, V134, P289, DOI 10.1016/S0009-2541(96)00098-8; Cooper KM, 2014, NATURE, V506, P480, DOI 10.1038/nature12991; De Hoog JCM, 2014, GEOCHIM COSMOCHIM AC, V141, P472, DOI 10.1016/j.gca.2014.06.033; Hoskin PWO, 2000, GEOLOGY, V28, P627, DOI 10.1130/0091-7613(2000)28<627:REECOZ>2.0.CO;2; Klemetti EW, 2011, EARTH PLANET SC LETT, V305, P185, DOI 10.1016/j.epsl.2011.02.054; Nairn IA, 2004, J VOLCANOL GEOTH RES, V131, P265, DOI 10.1016/S0377-0273(03)00381-0; Rubin A, 2016, CONTRIB MINERAL PETR, V171, DOI 10.1007/s00410-015-1216-6; Rubin AE, 2017, SCIENCE, V356, P1154, DOI 10.1126/science.aam8720; Storm S, 2012, CONTRIB MINERAL PETR, V163, P505, DOI 10.1007/s00410-011-0682-8; Tang M., 2016, GOLDSCHMIDT 2016; Tang M, 2017, EARTH PLANET SC LETT, V474, P110, DOI 10.1016/j.epsl.2017.06.034; Tomascak PB, 2016, ADV ISOTOP GEOCHEM, P47, DOI 10.1007/978-3-319-01430-2_4; Trail D, 2016, CONTRIB MINERAL PETR, V171, DOI 10.1007/s00410-016-1238-8	15	10	11	1	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 22	2017	358	6370							eaap8429	10.1126/science.aap8429	http://dx.doi.org/10.1126/science.aap8429			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FQ6BO	29269446	Green Accepted			2022-12-28	WOS:000418448000001
J	Lillicrap, D				Lillicrap, David			FIX It in One Go: Enhanced Factor IX Gene Therapy for Hemophilia B	CELL			English	Editorial Material							AAV	A phase 1/2 clinical trial of AAV-mediated gene therapy in patients with hemophilia B using an enhanced specific activity factor IX (FIX) transgene reports sustained levels of FIX levels, leading to the near elimination of bleeding for more than a year and without serious adverse side effects. These results are the best outcome to date for hemophilia gene therapy.	[Lillicrap, David] Queens Univ, Dept Pathol & Mol Med, Richardson Lab, Kingston, ON K7L 3N6, Canada	McMaster University; Queens University - Canada	Lillicrap, D (corresponding author), Queens Univ, Dept Pathol & Mol Med, Richardson Lab, Kingston, ON K7L 3N6, Canada.	dpl@queensu.ca						George LA, 2017, NEW ENGL J MED, V377, P2215, DOI 10.1056/NEJMoa1708538; Gil-Farina I, 2016, MOL THER, V24, P1100, DOI 10.1038/mt.2016.52; Jeune VL, 2013, HUM GENE THER METHOD, V24, P59, DOI 10.1089/hgtb.2012.243; Mingozzi F, 2011, CURR GENE THER, V11, P321, DOI 10.2174/156652311796150354; Nathwani AC, 2014, NEW ENGL J MED, V371, P1994, DOI 10.1056/NEJMoa1407309; Nathwani AC, 2011, NEW ENGL J MED, V365, P2357, DOI 10.1056/NEJMoa1108046; Pasi J, 2016, HAEMOPHILIA, V22, P151; Simioni P, 2009, NEW ENGL J MED, V361, P1671, DOI 10.1056/NEJMoa0904377	8	6	6	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 14	2017	171	7					1478	1480		10.1016/j.cell.2017.11.049	http://dx.doi.org/10.1016/j.cell.2017.11.049			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FQ0KF	29245009	Bronze			2022-12-28	WOS:000418044000006
J	Brown, N; Sandholm, T				Brown, Noam; Sandholm, Tuomas			Superhuman AI for heads-up no-limit poker: Libratus beats top professionals	SCIENCE			English	Article								No-limit Texas hold'em is the most popular form of poker. Despite artificial intelligence (AI) successes in perfect-information games, the private information and massive game tree have made no-limit poker difficult to tackle. We present Libratus, an AI that, in a 120,000-hand competition, defeated four top human specialist professionals in heads-up no-limit Texas hold'em, the leading benchmark and long-standing challenge problem in imperfect-information game solving. Our game-theoretic approach features application-independent techniques: an algorithm for computing a blueprint for the overall strategy, an algorithm that fleshes out the details of the strategy for subgames that are reached during play, and a self-improver algorithm that fixes potential weaknesses that opponents have identified in the blueprint strategy.	[Brown, Noam; Sandholm, Tuomas] Carnegie Mellon Univ, Comp Sci Dept, 5000 Forbes Ave, Pittsburgh, PA 15213 USA	Carnegie Mellon University	Sandholm, T (corresponding author), Carnegie Mellon Univ, Comp Sci Dept, 5000 Forbes Ave, Pittsburgh, PA 15213 USA.	sandholm@cs.cmu.edu		Sandholm, Tuomas/0000-0001-8861-9366	NSF [IIS-1718457, IIS-1617590, CCF-1733556]; U.S. Army Research Office [W911NF-17-1-0082]; Carnegie Mellon University; Rivers Casino; GreatPoint Ventures; Avenue4Analytics; TNG Technology Consulting; Artificial Intelligence; Intel; Optimized Markets, Inc.; Direct For Computer & Info Scie & Enginr [1445606] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); U.S. Army Research Office; Carnegie Mellon University; Rivers Casino; GreatPoint Ventures; Avenue4Analytics; TNG Technology Consulting; Artificial Intelligence; Intel(Intel Corporation); Optimized Markets, Inc.; Direct For Computer & Info Scie & Enginr(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	This material is based on research supported by the NSF under grants IIS-1718457, IIS-1617590, and CCF-1733556, and by the U.S. Army Research Office under award W911NF-17-1-0082, as well as the Extreme Science and Engineering Discovery Environment (XSEDE) computing resources and advanced user support services provided by the Pittsburgh Supercomputing Center. The Brains vs. Artificial Intelligence: Upping the Ante competition was sponsored by Carnegie Mellon University, Rivers Casino, GreatPoint Ventures, Avenue4Analytics, TNG Technology Consulting, Artificial Intelligence, Intel, and Optimized Markets, Inc. We thank B. Clayman for computing statistics of the play of our AIs against humans. The data presented in this paper are shown in the main text and supplementary materials. Additional data can be obtained from the corresponding author upon request. Because HUNL poker is played commercially, the risk associated with releasing the code outweighs the benefits. To aid reproducibility, we have included the pseudocode for the major components of our program in the supplementary materials. The technology has been exclusively licensed to Strategic Machine, Inc., and the authors have ownership interest in the company.	[Anonymous], 2012, P 26 C ART INT AAAI; [Anonymous], 2011, IJCAI, DOI DOI 10.5591/978-1-57735-516-8/IJCAI11-054; Billings D, 1998, FIFTEENTH NATIONAL CONFERENCE ON ARTIFICIAL INTELLIGENCE (AAAI-98) AND TENTH CONFERENCE ON INNOVATIVE APPLICATIONS OF ARTIFICAL INTELLIGENCE (IAAI-98) - PROCEEDINGS, P493; Billings D., 2003, IJCAI, P661; Brown N., 2017, ADV NEURAL INF PROCE, V30, P689; Brown N., 2015, AAAI C ART INT AAAI, P4270; Brown N., 2016, P 25 INT JOINT C ART, P4238; Brown N, 2015, PROCEEDINGS OF THE 2015 INTERNATIONAL CONFERENCE ON AUTONOMOUS AGENTS & MULTIAGENT SYSTEMS (AAMAS'15), P7; Brown N, 2014, AAAI CONF ARTIF INTE, P594; Burch N, 2014, AAAI CONF ARTIF INTE, P602; Campbell M, 2002, ARTIF INTELL, V134, P57, DOI 10.1016/S0004-3702(01)00129-1; Freund Y, 1997, J COMPUT SYST SCI, V55, P119, DOI 10.1006/jcss.1997.1504; Ganzfried S., 2011, 10 INT C AUT AG MULT, V2, P533; Ganzfried S., 2015, ACM T EC COMPUTATION, V3, P1; Ganzfried S, 2015, PROCEEDINGS OF THE 2015 INTERNATIONAL CONFERENCE ON AUTONOMOUS AGENTS & MULTIAGENT SYSTEMS (AAMAS'15), P37; Ganzfried Sam, 2013, P 23 INT JOINT C ART, P120; Gibson R., 2014, THESIS; Gilpin A., 2005, P NAT C ART INT AAAI, P1684; Gilpin A., 2008, P 7 INT JOINT C AUT, V2, P911; Gilpin A, 2012, MATH PROGRAM, V133, P279, DOI 10.1007/s10107-010-0430-2; Hoda S, 2010, MATH OPER RES, V35, P494, DOI 10.1287/moor.1100.0452; Jackson Eric Griffin, 2014, AAAI WORKSH COMP POK; Johanson M., 2012, P 26 C ART INT AAAI, P1371; Johanson M., 2013, CORR; Johanson M., 2012, P 11 INT C AUT AG MU, V2, P837; Johanson M, 2013, P 2013 INT C AUTONOM, P271; Kroer Christian, 2017, P ACM C EC COMP EC; Lanctot M., 2009, P ADV NEUR INF PROC, P1078; Moravcik M, 2017, SCIENCE, V356, P508, DOI 10.1126/science.aam6960; Moravcik Matej, 2016, AAAI C ART INT AAAI; Nash J, 1950, THESIS; Nash J. F., 1950, CONTRIBUTIONS THEORY, VI, P105; Nesterov Y, 2005, SIAM J OPTIMIZ, V16, P235, DOI 10.1137/S1052623403422285; Schaeffer J., 1997, ONE JUMP AHEAD CHALL; Schnizlein D., 2009, P 21 INT JOINT C ART, P278; Shi J., 2002, CG 00, P333; Silver D, 2016, NATURE, V529, P484, DOI 10.1038/nature16961; Tammelin O, 2015, PROCEEDINGS OF THE TWENTY-FOURTH INTERNATIONAL JOINT CONFERENCE ON ARTIFICIAL INTELLIGENCE (IJCAI), P645; WATERMAN DA, 1970, ARTIF INTELL, V1, P121, DOI 10.1016/0004-3702(70)90004-4; Waugh Kevin, 2009, S ABSTR REF APPR SAR; Zinkevich M., 2007, P ADV NEUR INF PROC, P1729	44	139	150	5	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 26	2018	359	6374					418	+		10.1126/science.aao1733	http://dx.doi.org/10.1126/science.aao1733			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT6SD	29249696				2022-12-28	WOS:000423283200038
J	Pagan, JD; Kitaoka, M; Anthony, RM				Pagan, Jose D.; Kitaoka, Maya; Anthony, Robert M.			Engineered Sialylation of Pathogenic Antibodies In Vivo Attenuates Autoimmune Disease	CELL			English	Article							FC-GAMMA-RIII; ANTIINFLAMMATORY ACTIVITY; INTRAVENOUS IMMUNOGLOBULIN; HUMAN IGG1; THROMBOCYTOPENIC PURPURA; SIALIC-ACID; GLYCOSYLATION; IVIG; RECEPTOR; PROTECTION	Self-reactive IgGs contribute to the pathology of autoimmune diseases, including systemic lupus erythematosus and rheumatoid arthritis. Paradoxically, IgGs are used to treat inflammatory diseases in the form of high-dose intravenous immunoglobulin (IVIG). Distinct glycoforms on the IgG crystallizable fragment (Fc) dictate these divergent functions. IgG anti-inflammatory activity is attributed to sialylation of the Fc glycan. We therefore sought to convert endogenous IgG to anti-inflammatory mediators in vivo by engineering solubilized glycosyltransferases that attach galactose or sialic acid. When both enzymes were administered in a prophylactic or therapeutic fashion, autoimmune inflammation was markedly attenuated in vivo. The enzymes worked through a similar pathway to IVIG, requiring DC-SIGN, STAT6 signaling, and Fc gamma RIIB. Importantly, sialylation was highly specific to pathogenic IgG at the site of inflammation, driven by local platelet release of nucleotide-sugar donors. These results underscore the therapeutic potential of glycoengineering in vivo.	[Pagan, Jose D.; Kitaoka, Maya; Anthony, Robert M.] Massachusetts Gen Hosp, Div Rheumatol Allergy & Immunol, Dept Med, Ctr Immunol & Inflammatory Dis, Boston, MA 02129 USA; [Pagan, Jose D.; Kitaoka, Maya; Anthony, Robert M.] Harvard Med Sch, Boston, MA 02129 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Anthony, RM (corresponding author), Massachusetts Gen Hosp, Div Rheumatol Allergy & Immunol, Dept Med, Ctr Immunol & Inflammatory Dis, Boston, MA 02129 USA.; Anthony, RM (corresponding author), Harvard Med Sch, Boston, MA 02129 USA.	robert.anthony@mgh.harvard.edu			NIAMS/NIH [DP2AR068272]; Lupus Research Alliance; MGH H.M. Goodman Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K22AI091684] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [DP2AR068272] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351] Funding Source: NIH RePORTER	NIAMS/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Lupus Research Alliance; MGH H.M. Goodman Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from NIAMS/NIH (DP2AR068272), the Lupus Research Alliance, and the MGH H.M. Goodman Fellowship to R.M.A. The authors are grateful to J. Paulson for providing anti-ST6GAL1 anti-sera; J. Ravetch for providing K/BxN sera; H. Meade for providing ST6GAL1; M.E. Conroy; J.W. Griffith; R. Rahimi; C. Sokol for clinical expertise; and K. Jeffrey, F. Wermeling, T. Mayadas, M. Pittet, K.T. Shade, E.E. Martinez, M.E. Conroy, T. Means, and A. Luster for constructive comments and careful reading of this manuscript.	Ackerman ME, 2013, J CLIN INVEST, V123, P2183, DOI 10.1172/JCI65708; Aigouy B, 2013, NAT METHODS, V10, P1048, DOI 10.1038/nmeth.2692; Albert H, 2008, P NATL ACAD SCI USA, V105, P15005, DOI 10.1073/pnas.0808248105; Allhorn M, 2010, BLOOD, V115, P5080, DOI 10.1182/blood-2009-08-239020; [Anonymous], EXP IMMUNOL S1, V178, P97; Anthony RM, 2008, SCIENCE, V320, P373, DOI 10.1126/science.1154315; Anthony RM, 2011, NATURE, V475, P110, DOI 10.1038/nature10134; Anthony RM, 2008, P NATL ACAD SCI USA, V105, P19571, DOI 10.1073/pnas.0810163105; Arnold JN, 2007, ANNU REV IMMUNOL, V25, P21, DOI 10.1146/annurev.immunol.25.022106.141702; Bayry J, 2009, P NATL ACAD SCI USA, V106, pE24, DOI 10.1073/pnas.0900016106; Benkhoucha M, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-209; Boilard E, 2010, SCIENCE, V327, P580, DOI 10.1126/science.1181928; Brown DG, 2015, J AM ACAD DERMATOL, V72, P524, DOI 10.1016/j.jaad.2014.10.027; Bruhns P, 2003, IMMUNITY, V18, P573, DOI 10.1016/S1074-7613(03)00080-3; Campbell IK, 2014, J IMMUNOL, V192, P5031, DOI 10.4049/jimmunol.1301611; Chung AW, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007736; Clynes R, 2007, CURR OPIN IMMUNOL, V19, P646, DOI 10.1016/j.coi.2007.09.004; Collin M, 2001, EMBO J, V20, P3046, DOI 10.1093/emboj/20.12.3046; Davies J, 2001, BIOTECHNOL BIOENG, V74, P288, DOI 10.1002/bit.1119.abs; DEBRE M, 1993, LANCET, V342, P945, DOI 10.1016/0140-6736(93)92000-J; Devi S, 2010, AM J PATHOL, V177, P1131, DOI 10.2353/ajpath.2010.091143; Ferrara C, 2011, P NATL ACAD SCI USA, V108, P12669, DOI 10.1073/pnas.1108455108; Fiebiger BM, 2015, P NATL ACAD SCI USA, V112, pE2385, DOI 10.1073/pnas.1505292112; Hansen RJ, 2002, THROMB HAEMOSTASIS, V88, P898, DOI 10.1055/s-0037-1613331; HUBER R, 1976, NATURE, V264, P415, DOI 10.1038/264415a0; IMBACH P, 1981, LANCET, V1, P1228; Ishitsuka Y, 2009, J PHARMACOL SCI, V111, P211, DOI 10.1254/jphs.09128SC; Jefferis R, 2005, BIOTECHNOL PROGR, V21, P11, DOI 10.1021/bp040016j; Jefferis R, 2009, NAT REV DRUG DISCOV, V8, P226, DOI 10.1038/nrd2804; Jefferis Roy, 2009, V483, P223, DOI 10.1007/978-1-59745-407-0_13; Jones MB, 2016, P NATL ACAD SCI USA, V113, P7207, DOI 10.1073/pnas.1523968113; Jones MB, 2012, J BIOL CHEM, V287, P15365, DOI 10.1074/jbc.M112.345710; Kalcheva I, 1997, MAMM GENOME, V8, P619, DOI 10.1007/s003359900518; Kaneko Y, 2006, J EXP MED, V203, P789, DOI 10.1084/jem.20051900; Kaneko Y, 2006, SCIENCE, V313, P670, DOI 10.1126/science.1129594; Korganow AS, 1999, IMMUNITY, V10, P451, DOI 10.1016/S1074-7613(00)80045-X; Kouskoff V, 1996, CELL, V87, P811, DOI 10.1016/S0092-8674(00)81989-3; Lanoue A, 2004, J EXP MED, V200, P1383, DOI 10.1084/jem.20040795; Lee MM, 2014, J BIOL CHEM, V289, P8742, DOI 10.1074/jbc.C113.546713; LERNER RA, 1967, J EXP MED, V126, P989, DOI 10.1084/jem.126.6.989; Li N, 2005, J CLIN INVEST, V115, P3440, DOI 10.1172/JCI24394; Li TZ, 2017, P NATL ACAD SCI USA, V114, P3485, DOI 10.1073/pnas.1702173114; LOO MH, 1987, J UROLOGY, V137, P571, DOI 10.1016/S0022-5347(17)44108-5; Lu LL, 2016, CELL, V167, P433, DOI 10.1016/j.cell.2016.08.072; Meng L, 2013, J BIOL CHEM, V288, P34680, DOI 10.1074/jbc.M113.519041; Natsume A, 2005, J IMMUNOL METHODS, V306, P93, DOI 10.1016/j.jim.2005.07.025; Nimmerjahn F, 2008, ANNU REV IMMUNOL, V26, P513, DOI 10.1146/annurev.immunol.26.021607.090232; Nimmerjahn F, 2008, NAT REV IMMUNOL, V8, P34, DOI 10.1038/nri2206; Nimmerjahn F, 2015, TRENDS IMMUNOL, V36, P325, DOI 10.1016/j.it.2015.04.005; Ohmi Y, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11205; Okazaki A, 2004, J MOL BIOL, V336, P1239, DOI 10.1016/j.jmb.2004.01.007; Pfeifle R, 2017, NAT IMMUNOL, V18, P104, DOI 10.1038/ni.3579; Pincetic A, 2014, NAT IMMUNOL, V15, P707, DOI 10.1038/ni.2939; Pucci F, 2016, CELL REP, V17, P1764, DOI 10.1016/j.celrep.2016.10.031; RAEDER EA, 1982, AM J CARDIOL, V50, P271, DOI 10.1016/0002-9149(82)90176-X; Samuelsson A, 2001, SCIENCE, V291, P484, DOI 10.1126/science.291.5503.484; Scallon BJ, 2007, MOL IMMUNOL, V44, P1524, DOI 10.1016/j.molimm.2006.09.005; Schlothauer T, 2016, PROTEIN ENG DES SEL, V29, P457, DOI 10.1093/protein/gzw040; SCHRIJVER G, 1990, KIDNEY INT, V38, P86, DOI 10.1038/ki.1990.171; Schwab I, 2014, EUR J IMMUNOL, V44, P1444, DOI 10.1002/eji.201344230; Schwab I, 2013, NAT REV IMMUNOL, V13, P176, DOI 10.1038/nri3401; Schwab I, 2012, EUR J IMMUNOL, V42, P826, DOI 10.1002/eji.201142260; Schwarzenberger C, 2015, AM J PHYSIOL-RENAL, V308, pF1238, DOI 10.1152/ajprenal.00535.2014; Shields RL, 2002, J BIOL CHEM, V277, P26733, DOI 10.1074/jbc.M202069200; Stadlmann J, 2009, PROTEOMICS, V9, P4143, DOI 10.1002/pmic.200800931; Sugimoto I, 2007, J BIOL CHEM, V282, P34896, DOI 10.1074/jbc.M704766200; Tackenberg B, 2010, J CLIN IMMUNOL, V30, pS65, DOI 10.1007/s10875-010-9398-1; Tackenberg B, 2009, P NATL ACAD SCI USA, V106, P4788, DOI 10.1073/pnas.0807319106; Tan M, 2016, CELL PHYSIOL BIOCHEM, V38, P2348, DOI 10.1159/000445588; Tuominen VJ, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2615; Underwood M, 2006, BMJ-BRIT MED J, V332, P1315, DOI 10.1136/bmj.332.7553.1315; Wang TT, 2017, SCIENCE, V355, P395, DOI 10.1126/science.aai8128; Wang TT, 2015, CELL, V162, P160, DOI 10.1016/j.cell.2015.06.026; WANG XC, 1993, J BIOL CHEM, V268, P4355; Washburn N, 2015, P NATL ACAD SCI USA, V112, pE1297, DOI 10.1073/pnas.1422481112; Woodard-Grice AV, 2008, J BIOL CHEM, V283, P26364, DOI 10.1074/jbc.M800836200; Yang R, 2010, NEPHROL DIAL TRANSPL, V25, P2479, DOI 10.1093/ndt/gfq115; Youings A, 1996, BIOCHEM J, V314, P621, DOI 10.1042/bj3140621; Zhang G, 2016, EXP NEUROL, V282, P49, DOI 10.1016/j.expneurol.2016.05.020	79	107	113	3	56	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 25	2018	172	3					564	+		10.1016/j.cell.2017.11.041	http://dx.doi.org/10.1016/j.cell.2017.11.041			27	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FT9BS	29275858	Green Accepted, Bronze			2022-12-28	WOS:000423447600015
J	Yordanova, MM; Loughran, G; Zhdanov, AV; Mariotti, M; Kiniry, SJ; O'Connor, PBF; Andreev, DE; Tzani, I; Saffert, P; Michel, AM; Gladyshev, VN; Papkovsky, DB; Atkins, JF; Baranov, PV				Yordanova, Martina M.; Loughran, Gary; Zhdanov, Alexander V.; Mariotti, Marco; Kiniry, Stephen J.; O'Connor, Patrick B. F.; Andreev, Dmitry E.; Tzani, Ioanna; Saffert, Paul; Michel, Audrey M.; Gladyshev, Vadim N.; Papkovsky, Dmitry B.; Atkins, John F.; Baranov, Pavel V.			AMD1 mRNA employs ribosome stalling as a mechanism for molecular memory formation	NATURE			English	Article							S-ADENOSYLMETHIONINE DECARBOXYLASE; OPEN READING FRAME; TRANSLATION INITIATION; HUMAN CYTOMEGALOVIRUS; GENOME BROWSER; READTHROUGH; CODON; M(7)G-CAP; DISEASE; PROTEIN	In addition to acting as template for protein synthesis, messenger RNA (mRNA) often contains sensory sequence elements that regulate this process(1,2). Here we report a new mechanism that limits the number of complete protein molecules that can be synthesized from a single mRNA molecule of the human AMD1 gene encoding adenosylmethionine decarboxylase 1 (AdoMetDC). A small proportion of ribosomes translating AMD1 mRNA stochastically read through the stop codon of the main coding region. These readthrough ribosomes then stall close to the next in-frame stop codon, eventually forming a ribosome queue, the length of which is proportional to the number of AdoMetDC molecules that were synthesized from the same AMD1 mRNA. Once the entire spacer region between the two stop codons is filled with queueing ribosomes, the queue impinges upon the main AMD1 coding region halting its translation. Phylogenetic analysis suggests that this mechanism is highly conserved in vertebrates and existed in their common ancestor. We propose that this mechanism is used to count and limit the number of protein molecules that can be synthesized from a single mRNA template. It could serve to safeguard from dysregulated translation that may occur owing to errors in transcription or mRNA damage.	[Yordanova, Martina M.; Loughran, Gary; Zhdanov, Alexander V.; Mariotti, Marco; Kiniry, Stephen J.; O'Connor, Patrick B. F.; Andreev, Dmitry E.; Tzani, Ioanna; Saffert, Paul; Michel, Audrey M.; Papkovsky, Dmitry B.; Atkins, John F.; Baranov, Pavel V.] Univ Coll Cork, Sch Biochem & Cell Biol, Cork T12 YN60, Ireland; [Mariotti, Marco; Gladyshev, Vadim N.] Brigham & Womens Hosp, Dept Med, Div Genet, Boston, MA 02215 USA; [Mariotti, Marco; Gladyshev, Vadim N.] Harvard Med Sch, Boston, MA 02215 USA; [Andreev, Dmitry E.] Lomonosov Moscow State Univ, Belozersky Inst Physicochem Biol, Moscow 119234, Russia; [Atkins, John F.] Univ Utah, Dept Human Genet, Salt Lake City, UT 84112 USA	University College Cork; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Lomonosov Moscow State University; Utah System of Higher Education; University of Utah	Baranov, PV (corresponding author), Univ Coll Cork, Sch Biochem & Cell Biol, Cork T12 YN60, Ireland.	p.baranov@ucc.ie	Baranov, Pavel/A-2782-2011; Loughran, Gary/AAQ-8791-2020; Andreev, Dmitry/I-6346-2012; Mariotti, Marco/AAB-7136-2019	Baranov, Pavel/0000-0001-9017-0270; Loughran, Gary/0000-0002-2683-5597; Andreev, Dmitry/0000-0001-5320-3045; Mariotti, Marco/0000-0002-7411-4161; Yordanova, Martina/0000-0001-9693-3857; Mannion Michel, Audrey/0000-0002-6421-7036; Zhdanov, Alexander/0000-0001-5787-2035; Gladyshev, Vadim/0000-0002-0372-7016; Kiniry, Stephen/0000-0001-5913-7093	Science Foundation Ireland [12/IA/1335, 13/IA/1853, 12/RC/2276]; National Institute of Health [CA080946, GM065204]; Health Research Board [PhD/2007/04]; Russian Science Foundation [16-14-10065]	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Health Research Board; Russian Science Foundation(Russian Science Foundation (RSF))	We are grateful to I. Jungreis and M. Kellis for allowing us to use CodAlignView and to P.R. Bhatt for technical advice on stable peptidyl-tRNA complex formation. We acknowledge financial support from Science Foundation Ireland ((12/IA/1335) to P.V.B., (13/IA/1853) to J.F.A. and (12/RC/2276) to D.B.P.); National Institute of Health (CA080946) and (GM065204) to V.N.G.; Health Research Board (PhD/2007/04) to I.T.; and Russian Science Foundation (16-14-10065) to D.E.A.	Andreev DE, 2009, NUCLEIC ACIDS RES, V37, P6135, DOI 10.1093/nar/gkp665; Arribere JA, 2016, NATURE, V534, P719, DOI 10.1038/nature18308; Bhushan S, 2010, MOL CELL, V40, P138, DOI 10.1016/j.molcel.2010.09.009; Chiang PK, 1996, FASEB J, V10, P471, DOI 10.1096/fasebj.10.4.8647346; DEGNIN CR, 1993, J VIROL, V67, P5514, DOI 10.1128/JVI.67.9.5514-5521.1993; Doronina VA, 2008, MOL CELL BIOL, V28, P4227, DOI 10.1128/MCB.00421-08; Dyer BW, 2000, ANAL BIOCHEM, V282, P158, DOI 10.1006/abio.2000.4605; Fixsen SM, 2010, J MOL BIOL, V399, P385, DOI 10.1016/j.jmb.2010.04.033; Gao XW, 2015, NAT METHODS, V12, P147, DOI 10.1038/nmeth.3208; Gebauer F, 2004, NAT REV MOL CELL BIO, V5, P827, DOI 10.1038/nrm1488; Grentzmann G, 1998, RNA, V4, P479; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Huerta-Cepas J, 2016, MOL BIOL EVOL, V33, P1635, DOI 10.1093/molbev/msw046; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Ji Z, 2016, NAT BIOTECHNOL, V34, P410, DOI 10.1038/nbt.3441; Kurian L, 2011, NATURE, V477, P490, DOI 10.1038/nature10393; Law GL, 2001, J BIOL CHEM, V276, P38036; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loughran G, 2017, RNA, V23, P1285, DOI 10.1261/rna.061051.117; Loughran G, 2014, NUCLEIC ACIDS RES, V42, P8928, DOI 10.1093/nar/gku608; Lu SC, 2012, PHYSIOL REV, V92, P1515, DOI 10.1152/physrev.00047.2011; Mariotti M, 2010, BIOINFORMATICS, V26, P2656, DOI 10.1093/bioinformatics/btq516; Michel AM, 2014, NUCLEIC ACIDS RES, V42, pD859, DOI 10.1093/nar/gkt1035; Miller-Fleming L, 2015, J MOL BIOL, V427, P3389, DOI 10.1016/j.jmb.2015.06.020; Namy O, 2002, MOL MICROBIOL, V43, P641, DOI 10.1046/j.1365-2958.2002.02770.x; Paasinen-Sohns A, 2011, INT J BIOCHEM CELL B, V43, P441, DOI 10.1016/j.biocel.2010.11.018; Pegg AE, 2009, ESSAYS BIOCHEM, V46, P25, DOI [10.1042/BSE0460003, 10.1042/bse0460003]; Roje S, 2006, PHYTOCHEMISTRY, V67, P1686, DOI 10.1016/j.phytochem.2006.04.019; Rosenbloom KR, 2015, NUCLEIC ACIDS RES, V43, pD670, DOI 10.1093/nar/gku1177; RYAN MD, 1994, EMBO J, V13, P928, DOI 10.1002/j.1460-2075.1994.tb06337.x; Sayers EW, 2009, NUCLEIC ACIDS RES, V37, pD5, DOI 10.1093/nar/gkp967; Schueren F, 2014, ELIFE, V3, DOI 10.7554/eLife.03640; Scuoppo C, 2012, NATURE, V487, P244, DOI 10.1038/nature11126; Sonenberg N, 2007, MOL CELL, V28, P721, DOI 10.1016/j.molcel.2007.11.018; Stiebler AC, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004685; Terenin IM, 2013, NUCLEIC ACIDS RES, V41, P1807, DOI 10.1093/nar/gks1282; Yanagitani K, 2011, SCIENCE, V331, P586, DOI 10.1126/science.1197142; Yanagitani K, 2009, MOL CELL, V34, P191, DOI 10.1016/j.molcel.2009.02.033; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zhang DW, 2012, GENE DEV, V26, P461, DOI 10.1101/gad.182998.111	40	35	37	2	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 18	2018	553	7688					356	+		10.1038/nature25174	http://dx.doi.org/10.1038/nature25174			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT9MB	29310120				2022-12-28	WOS:000423475100055
J	Boetius, A; Haeckel, M				Boetius, Antje; Haeckel, Matthias			Mind the seafloor	SCIENCE			English	Editorial Material							DEEP		[Boetius, Antje] Alfred Wegener Inst, Helmholtz Ctr Polar & Marine Res, Bremerhaven, Germany; [Boetius, Antje] Max Planck Inst Marine Microbiol, Bremen, Germany; [Boetius, Antje] Univ Bremen, MARUM Ctr Marine Environm Sci, Bremerhaven, Germany; [Haeckel, Matthias] GEOMAR Helmholtz Ctr Ocean Res Kiel, Kiel, Germany	Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; Max Planck Society; University of Bremen; Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel	Boetius, A (corresponding author), Alfred Wegener Inst, Helmholtz Ctr Polar & Marine Res, Bremerhaven, Germany.; Boetius, A (corresponding author), Max Planck Inst Marine Microbiol, Bremen, Germany.; Boetius, A (corresponding author), Univ Bremen, MARUM Ctr Marine Environm Sci, Bremerhaven, Germany.	antje.boetius@awi.de; mhaeckel@geomar.de	Boetius, Antje/D-5459-2013	Boetius, Antje/0000-0003-2117-4176	Joint Programming Initiative Healthy and Productive Seas and Oceans (JPI Oceans) "MiningImpact" of the Federal Ministry of Education and Research (BMBF) [Fkz 03F0707A]; EU project Managing Impacts of Deep Sea Resource Exploitation (MIDAS) [GA 603418]; German Research Foundation (DFG) Excellence Cluster "Future Ocean"; German Research Foundation (DFG) Excellence Cluster "MARUM-The Ocean in the Earth System"	Joint Programming Initiative Healthy and Productive Seas and Oceans (JPI Oceans) "MiningImpact" of the Federal Ministry of Education and Research (BMBF); EU project Managing Impacts of Deep Sea Resource Exploitation (MIDAS); German Research Foundation (DFG) Excellence Cluster "Future Ocean"; German Research Foundation (DFG) Excellence Cluster "MARUM-The Ocean in the Earth System"	We acknowledge funding by Joint Programming Initiative Healthy and Productive Seas and Oceans (JPI Oceans) "MiningImpact" (Fkz 03F0707A) of the Federal Ministry of Education and Research (BMBF), the EU project Managing Impacts of Deep Sea Resource Exploitation (MIDAS) (GA 603418), and by the German Research Foundation (DFG) Excellence Clusters "Future Ocean" and "MARUM-The Ocean in the Earth System."	[Anonymous], ANNOUNCED STAKEHOLDE; Durden JM, 2017, MAR POLICY, V84, P193, DOI 10.1016/j.marpol.2017.07.002; Gollner S, 2017, MAR ENVIRON RES, V129, P76, DOI 10.1016/j.marenvres.2017.04.010; Hein J.R., 2014, TREATISE GEOCHEMISTR, V13, P273, DOI [DOI 10.1016/B978-0-08-095975-7.01111-6, 10.1016/B978-0-08-095975-7.01111-6]; Hiddink JG, 2017, P NATL ACAD SCI USA, V114, P8301, DOI 10.1073/pnas.1618858114; Huvenne VAI, 2016, BIOL CONSERV, V200, P60, DOI 10.1016/j.biocon.2016.05.030; Petersen S, 2016, MAR POLICY, V70, P175, DOI 10.1016/j.marpol.2016.03.012; Ramirez-Llodra E, 2010, BIOGEOSCIENCES, V7, P2851, DOI 10.5194/bg-7-2851-2010; Royal Society, 2017, FUT OC RES MET RICH; Smith K. L., 2015, EOS, DOI [10.1029/2015EO038095, DOI 10.1029/2015EO038095]; van Dover CL, 2017, NAT GEOSCI, V10, P464, DOI 10.1038/ngeo2983; Vanreusel A, 2016, SCI REP-UK, V6, DOI 10.1038/srep26808; Wakefield JR, 2018, MAR POLICY, V95, P346, DOI 10.1016/j.marpol.2016.06.018; Wedding LM, 2015, SCIENCE, V349, P144, DOI 10.1126/science.aac6647	14	38	40	0	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 5	2018	359	6371					34	36		10.1126/science.aap7301	http://dx.doi.org/10.1126/science.aap7301			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FR8KW	29302002				2022-12-28	WOS:000419324700056
J	Slomski, A				Slomski, Anita			Gamification Shows Promise in Motivating Physical Activity	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 26	2017	318	24					2419	2419		10.1001/jama.2017.19987	http://dx.doi.org/10.1001/jama.2017.19987			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FQ9ZO	29279929				2022-12-28	WOS:000418720700009
J	Young-Wolff, KC; Tucker, LY; Alexeeff, S; Armstrong, MA; Conway, A; Weisner, C; Goler, N				Young-Wolff, Kelly C.; Tucker, Lue-Yen; Alexeeff, Stacey; Armstrong, Mary Anne; Conway, Amy; Weisner, Constance; Goler, Nancy			Trends in Self-reported and Biochemically Tested Marijuana Use Among Pregnant Females in California From 2009-2016	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							UNITED-STATES		[Young-Wolff, Kelly C.; Tucker, Lue-Yen; Alexeeff, Stacey; Armstrong, Mary Anne] Kaiser Permanente Northern Calif, Div Res, 2000 Broadway, Oakland, CA 94612 USA; [Conway, Amy] Kaiser Permanente Northern Calif, Early Start Program, Oakland, CA USA; [Weisner, Constance] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA; [Goler, Nancy] Kaiser Permanente Northern Calif, Reg Off, Oakland, CA USA	Kaiser Permanente; Kaiser Permanente; University of California System; University of California San Francisco; Kaiser Permanente	Young-Wolff, KC (corresponding author), Kaiser Permanente Northern Calif, Div Res, 2000 Broadway, Oakland, CA 94612 USA.	kelly.c.young-wolff@kp.org			Kaiser Permanente Community; NIDA from the National Institutes of Health [DA043604]; NATIONAL INSTITUTE ON DRUG ABUSE [K01DA043604] Funding Source: NIH RePORTER	Kaiser Permanente Community; NIDA from the National Institutes of Health; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was supported by a grant from the Kaiser Permanente Community Benefits Program and a NIDA K01 award (DA043604) from the National Institutes of Health.	Brown QL, 2017, JAMA-J AM MED ASSOC, V317, P207, DOI 10.1001/jama.2016.17383; ElSohly MA, 2016, BIOL PSYCHIAT, V79, P613, DOI 10.1016/j.biopsych.2016.01.004; Ko JY, 2015, AM J OBSTET GYNECOL, V213, DOI 10.1016/j.ajog.2015.03.021; Salas-Wright CP, 2015, ADDICT BEHAV, V45, P218, DOI 10.1016/j.addbeh.2015.01.039; Volkow ND, 2017, JAMA-J AM MED ASSOC, V317, P129, DOI 10.1001/jama.2016.18612	5	154	155	1	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 26	2017	318	24					2490	2491		10.1001/jama.2017.17225	http://dx.doi.org/10.1001/jama.2017.17225			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FQ9ZO	29279917	Bronze, Green Accepted			2022-12-28	WOS:000418720700028
J	Yaqub, F				Yaqub, Farhat			2017: a year in review	LANCET			English	Editorial Material													Rozsansky, Yosef/N-9171-2018; Kamenarov, Ivan/B-7664-2018	Rozsansky, Yosef/0000-0001-8008-0298; Kamenarov, Ivan/0000-0002-9022-7668					0	0	0	1	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 23	2017	390	10114					2753	2754		10.1016/S0140-6736(17)33358-5	http://dx.doi.org/10.1016/S0140-6736(17)33358-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FQ9GF	29303717				2022-12-28	WOS:000418669800014
J	Ge, ZX; Bergonci, T; Zhao, YL; Zou, YJ; Du, S; Liu, MC; Luo, XJ; Ruan, H; Garcia-Valencia, LE; Zhong, S; Hou, SY; Huang, QP; Lai, LH; Moura, DS; Gu, HY; Dong, J; Wu, HM; Dresselhaus, T; Xiao, JY; Cheung, AY; Qu, LJ				Ge, Zengxiang; Bergonci, Tabata; Zhao, Yuling; Zou, Yanjiao; Du, Shuo; Liu, Ming-Che; Luo, Xingju; Ruan, Hao; Garcia-Valencia, Liliana E.; Zhong, Sheng; Hou, Saiying; Huang, Qingpei; Lai, Luhua; Moura, Daniel S.; Gu, Hongya; Dong, Juan; Wu, Hen-Ming; Dresselhaus, Thomas; Xiao, Junyu; Cheung, Alice Y.; Qu, Li-Jia			Arabidopsis pollen tube integrity and sperm release are regulated by RALF-mediated signaling	SCIENCE			English	Article							RECEPTOR-LIKE KINASES; FERONIA; GROWTH; PROTEIN; FERTILIZATION; REPRODUCTION; PERCEPTION; MECHANISMS; PEPTIDES; LEPRK2	In flowering plants, fertilization requires complex cell-to-cell communication events between the pollen tube and the female reproductive tissues, which are controlled by extracellular signaling molecules interacting with receptors at the pollen tube surface. We found that two such receptors in Arabidopsis, BUPS1 and BUPS2, and their peptide ligands, RALF4 and RALF19, are pollen tube-expressed and are required to maintain pollen tube integrity. BUPS1 and BUPS2 interact with receptors ANXUR1 and ANXUR2 via their ectodomains, and both sets of receptors bind RALF4 and RALF19. These receptor-ligand interactions are in competition with the female-derived ligand RALF34, which induces pollen tube bursting at nanomolar concentrations. We propose that RALF34 replaces RALF4 and RALF19 at the interface of pollen tube-female gametophyte contact, thereby deregulating BUPS-ANXUR signaling and in turn leading to pollen tube rupture and sperm release.	[Ge, Zengxiang; Zhao, Yuling; Du, Shuo; Luo, Xingju; Zhong, Sheng; Hou, Saiying; Huang, Qingpei; Gu, Hongya; Xiao, Junyu; Qu, Li-Jia] Peking Univ, Coll Life Sci, Peking Tsinghua Ctr Life Sci, State Key Lab Prot & Plant Gene Res, Beijing 100871, Peoples R China; [Bergonci, Tabata; Zou, Yanjiao; Liu, Ming-Che; Garcia-Valencia, Liliana E.; Wu, Hen-Ming; Cheung, Alice Y.] Univ Massachusetts, Dept Biochem & Mol Biol, Mol & Cell Biol Program, Plant Biol Program, Amherst, MA 01003 USA; [Bergonci, Tabata; Moura, Daniel S.] Univ Sao Paulo, Escola Super Agr Luiz de Queiroz, Dept Ciencias Biol, BR-13418900 Piracicaba, SP, Brazil; [Ruan, Hao; Lai, Luhua] Peking Univ, Coll Chem & Mol Engn, Beijing 100871, Peoples R China; [Garcia-Valencia, Liliana E.] Univ Nacl Autonoma Mexico, Fac Quim, Dept Bioquim, Mexico City 04510, DF, Mexico; [Gu, Hongya; Qu, Li-Jia] Natl Plant Gene Res Ctr Beijing, Beijing 100101, Peoples R China; [Dong, Juan] Rutgers State Univ, Waksman Inst Microbiol, Piscataway, NJ 08854 USA; [Dresselhaus, Thomas] Univ Regensburg, Biochem Zentrum Regensburg, Cell Biol & Plant Biochem, D-93053 Regensburg, Germany	Peking University; University of Massachusetts System; University of Massachusetts Amherst; Universidade de Sao Paulo; Peking University; Universidad Nacional Autonoma de Mexico; Rutgers State University New Brunswick; University of Regensburg	Qu, LJ (corresponding author), Peking Univ, Coll Life Sci, Peking Tsinghua Ctr Life Sci, State Key Lab Prot & Plant Gene Res, Beijing 100871, Peoples R China.; Cheung, AY (corresponding author), Univ Massachusetts, Dept Biochem & Mol Biol, Mol & Cell Biol Program, Plant Biol Program, Amherst, MA 01003 USA.; Qu, LJ (corresponding author), Natl Plant Gene Res Ctr Beijing, Beijing 100101, Peoples R China.	acheung@biochem.umass.edu; qulj@pku.edu.cn	Bergonci, Tábata/E-3759-2014; Moura, Daniel S/D-6673-2012; Xiao, Junyu/ABE-2192-2020; Liu, Ming-Che/AAJ-3378-2020	Bergonci, Tábata/0000-0001-9100-6974; Moura, Daniel S/0000-0003-2042-1403; Garcia-Valencia, Liliana E./0000-0002-7528-7697; Zengxiang, Ge/0000-0001-9381-3577; Xiao, Junyu/0000-0003-1822-1701	National Natural Science Foundation of China [31620103903, 31621001, 31370344]; China Ministry of Education; NSF [IOS1147165, 1146941, 1645854]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2014/14487-1]; Consejo Nacional de Ciencia y Tecnologia (Mexico) [329718/234690]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [CNPq-201213/2014-1]; Deutsche Forschungsgemeinschaft Collaborative Research Center [SFB924]; National Institute of General Medical Sciences [R01GM109080]; Research Coordination Network on Integrative Pollen Biology (NSF) [MCB0955910]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM109080] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Ministry of Education(Ministry of Education, China); NSF(National Science Foundation (NSF)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Consejo Nacional de Ciencia y Tecnologia (Mexico)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Deutsche Forschungsgemeinschaft Collaborative Research Center(German Research Foundation (DFG)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Research Coordination Network on Integrative Pollen Biology (NSF); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Sodmergen and H. Ren for technical help in pollen germination assay. Supported by National Natural Science Foundation of China grants 31620103903, 31621001, and 31370344; the 111 Project of the China Ministry of Education; NSF grants IOS1147165, 1146941, and 1645854; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo grant 2014/14487-1; Consejo Nacional de Ciencia y Tecnologia (Mexico) grant 329718/234690; and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico fellowship CNPq-201213/2014-1 (T.B.). The Qu laboratory is supported by the Peking-Tsinghua Joint Center for Life Sciences, the Dresselhaus lab by the Deutsche Forschungsgemeinschaft Collaborative Research Center SFB924 consortium, and the Dong lab by National Institute of General Medical Sciences grant R01GM109080. We also thank the Research Coordination Network on Integrative Pollen Biology (NSF grant MCB0955910) for activities that forged this collaboration. Supplement contains additional data.	Bai L, 2014, PLANT CELL, V26, P1497, DOI 10.1105/tpc.114.124586; Bircheneder S, 2016, J EXP BOT, V67, P4849, DOI 10.1093/jxb/erw271; Boisson-Dernier A, 2009, DEVELOPMENT, V136, P3279, DOI 10.1242/dev.040071; do Canto AM, 2014, PLANT PHYSIOL BIOCH, V75, P45, DOI 10.1016/j.plaphy.2013.12.005; Dresselhaus T, 2016, CURR BIOL, V26, pR125, DOI 10.1016/j.cub.2015.12.032; Duan QH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4129; Duan QH, 2010, P NATL ACAD SCI USA, V107, P17821, DOI 10.1073/pnas.1005366107; Escobar-Restrepo JM, 2007, SCIENCE, V317, P656, DOI 10.1126/science.1143562; Guo HQ, 2009, P NATL ACAD SCI USA, V106, P7648, DOI 10.1073/pnas.0812346106; Haruta M, 2014, SCIENCE, V343, P408, DOI 10.1126/science.1244454; Hematy K, 2007, CURR BIOL, V17, P922, DOI 10.1016/j.cub.2007.05.018; Huang QP, 2015, J INTEGR PLANT BIOL, V57, P518, DOI 10.1111/jipb.12356; Li C, 2016, PLANT PHYSIOL, V171, P2379, DOI 10.1104/pp.16.00667; Lin GZ, 2017, GENE DEV, V31, P927, DOI 10.1101/gad.297580.117; Liu JJ, 2013, CURR BIOL, V23, P993, DOI 10.1016/j.cub.2013.04.043; Liu LT, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006085; Miyazaki S, 2009, CURR BIOL, V19, P1327, DOI 10.1016/j.cub.2009.06.064; Murphy E, 2014, TRENDS PLANT SCI, V19, P664, DOI 10.1016/j.tplants.2014.06.005; Nissen KS, 2016, TRENDS PLANT SCI, V21, P516, DOI 10.1016/j.tplants.2015.12.004; Pu CX, 2017, PLANT CELL, V29, P70, DOI 10.1105/tpc.16.00218; Qu LJ, 2015, J EXP BOT, V66, P5139, DOI 10.1093/jxb/erv275; Stegmann M, 2017, SCIENCE, V355, P287, DOI 10.1126/science.aal2541; Takeuchi H, 2016, NATURE, V531, P245, DOI 10.1038/nature17413; Tang WH, 2004, PLANT J, V39, P343, DOI 10.1111/j.1365-313X.2004.02139.x; Tang WH, 2002, PLANT CELL, V14, P2277, DOI 10.1105/tpc.003103; Wang T, 2016, NATURE, V531, P241, DOI 10.1038/nature16975; Wang ZP, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0715-0; Zhang J, 2017, NAT PLANTS, V3, DOI 10.1038/nplants.2017.79	28	190	202	17	207	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 22	2017	358	6370					1596	1599		10.1126/science.aao3642	http://dx.doi.org/10.1126/science.aao3642			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ6BO	29242234	Green Accepted			2022-12-28	WOS:000418448000060
J	Lawler, A				Lawler, Andrew			Were nomads the world's first traders?	SCIENCE			English	News Item																			0	0	0	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 22	2017	358	6370					1518	1519		10.1126/science.358.6370.1518	http://dx.doi.org/10.1126/science.358.6370.1518			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ6BO	29269454				2022-12-28	WOS:000418448000018
J	Salcedo, A; Rutter, W; Wang, SC; Akhunova, A; Bolus, S; Chao, SM; Anderson, N; De Soto, MF; Rouse, M; Szabo, L; Bowden, RL; Dubcovsky, J; Akhunov, E				Salcedo, Andres; Rutter, William; Wang, Shichen; Akhunova, Alina; Bolus, Stephen; Chao, Shiaoman; Anderson, Nickolas; De Soto, Monica Fernandez; Rouse, Matthew; Szabo, Les; Bowden, Robert L.; Dubcovsky, Jorge; Akhunov, Eduard			Variation in the AvrSr35 gene determines Sr35 resistance against wheat stem rust race Ug99	SCIENCE			English	Article								Puccinia graminis f. sp. tritici (Pgt) causes wheat stem rust, a devastating fungal disease. The Sr35 resistance gene confers immunity against this pathogen's most virulent races, including Ug99. We used comparative whole-genome sequencing of chemically mutagenized and natural Pgt isolates to identify a fungal gene named AvrSr35 that is required for Sr35 avirulence. The AvrSr35 gene encodes a secreted protein capable of interacting with Sr35 and triggering the immune response. We show that the origin of Pgt isolates virulent on Sr35 is associated with the nonfunctionalization of the AvrSr35 gene by the insertion of a mobile element. The discovery of AvrSr35 provides a new tool for Pgt surveillance, identification of host susceptibility targets, and characterization of the molecular determinants of immunity in wheat.	[Salcedo, Andres; Rutter, William; Wang, Shichen; Anderson, Nickolas; Akhunov, Eduard] Kansas State Univ, Dept Plant Pathol, Throckmorton Hall, Manhattan, KS 66506 USA; [Akhunova, Alina; De Soto, Monica Fernandez] Kansas State Univ, Integrated Genom Facil, Manhattan, KS 66506 USA; [Bolus, Stephen; Dubcovsky, Jorge] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA; [Chao, Shiaoman] USDA ARS, Cereal Crops Res Unit, Fargo, ND 58102 USA; [Rouse, Matthew; Szabo, Les] USDA ARS, Cereal Dis Lab, St Paul, MN 55108 USA; [Rouse, Matthew; Szabo, Les] Univ Minnesota, Dept Plant Pathol, St Paul, MN 55108 USA; [Bowden, Robert L.] USDA ARS, Hard Winter Wheat Genet Res Unit, Manhattan, KS 66506 USA; [Dubcovsky, Jorge] HHMI, Chevy Chase, MD 20815 USA; [Rutter, William] USDA ARS, US Vegetable Lab, Charleston, SC 29414 USA; [Wang, Shichen] Texas A&M Univ, Texas A&M Engn Expt Stn, AgriLife Ctr Bioinformat & Genom Syst Engn, College Stn, TX 77845 USA	Kansas State University; Kansas State University; University of California System; University of California Davis; United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); University of Minnesota System; University of Minnesota Twin Cities; United States Department of Agriculture (USDA); Howard Hughes Medical Institute; United States Department of Agriculture (USDA); Texas A&M University System; Texas A&M University College Station; Texas A&M Engineering Experimental Station	Akhunov, E (corresponding author), Kansas State Univ, Dept Plant Pathol, Throckmorton Hall, Manhattan, KS 66506 USA.	eakhunov@ksu.edu	Rouse, Matthew N/G-5474-2011; Bowden, Robert/AAL-8948-2020; Dubcovsky, Jorge/T-5214-2019; Dubcovsky, Jorge/A-4969-2008; Wang, Shichen/E-6213-2012	Dubcovsky, Jorge/0000-0002-7571-4345; Rutter, William/0000-0003-1748-2256; Szabo, Les J./0000-0002-0477-7808; Akhunova, Alina/0000-0002-2714-3525; Akhunov, Eduard/0000-0002-0416-5211; Wang, Shichen/0000-0003-1441-2252; Rouse, Matthew/0000-0001-7763-8203; Bolus, Stephen/0000-0001-5472-095X	U.S. Department of Agriculture (USDA) National Institute of Food and Agriculture [2012-67013-19401]; Bill and Melinda Gates Foundation [BMGF:01511000146]; USDA Agricultural Research Service [3020-21000-010-00-D]; Howard Hughes Medical Institute	U.S. Department of Agriculture (USDA) National Institute of Food and Agriculture(United States Department of Agriculture (USDA)); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); USDA Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service); Howard Hughes Medical Institute(Howard Hughes Medical Institute)	Data are available from the National Center for Biotechnology Information database: MF474174, MF596174, PRJNA415853, PRJNA313186, SRX1619622-SRX1619626, and GEO GSE106397. The project is funded by U.S. Department of Agriculture (USDA) National Institute of Food and Agriculture grant 2012-67013-19401 and Bill and Melinda Gates Foundation grant BMGF:01511000146 to E.A., and USDA Agricultural Research Service funding 3020-21000-010-00-D to B.B. J.D. acknowledges support from the Howard Hughes Medical Institute. We thank Y. Jin for providing stem rust cultures, H. Liang and Y. Lun for technical assistance, R. Todd for valuable suggestions, and D. Cantu for initial contribution to the sequencing of Pgt races. The supplementary materials contain additional data. This work is licensed under a Creative Commons Attribution 4.0 International (CC BY 4.0) license, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. This license does not apply to figures/photos/artwork or other content included in the article that is credited to a third party; obtain authorization from the rights holder before using such material.	Cantu D, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-270; Chen JP, 2017, SCIENCE, V358, P1607, DOI 10.1126/science.aao4810; Duplessis S, 2011, P NATL ACAD SCI USA, V108, P9166, DOI 10.1073/pnas.1019315108; Ellis JG, 2009, CURR OPIN PLANT BIOL, V12, P399, DOI 10.1016/j.pbi.2009.05.004; Elmore JM, 2011, CURR OPIN PLANT BIOL, V14, P365, DOI 10.1016/j.pbi.2011.03.011; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Pretorius Z. A., 2000, Plant Disease, V84, P203, DOI 10.1094/PDIS.2000.84.2.203B; Rutter WB, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3678-6; Saintenac C, 2013, SCIENCE, V341, P783, DOI 10.1126/science.1239022; Singh RP, 2015, PHYTOPATHOLOGY, V105, P872, DOI 10.1094/PHYTO-01-15-0030-FI	10	100	110	6	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 22	2017	358	6370					1604	1606		10.1126/science.aao7294	http://dx.doi.org/10.1126/science.aao7294			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ6BO	29269474	Green Submitted, Green Published			2022-12-28	WOS:000418448000062
J	Kulkarni, AV; Schiff, SJ; Mbabazi-Kabachelor, E; Mugamba, J; Ssenyonga, P; Donnelly, R; Levenbach, J; Monga, V; Peterson, M; MacDonald, M; Cherukuri, V; Warf, BC				Kulkarni, Abhaya V.; Schiff, Steven J.; Mbabazi-Kabachelor, Edith; Mugamba, John; Ssenyonga, Peter; Donnelly, Ruth; Levenbach, Jody; Monga, Vishal; Peterson, Mallory; MacDonald, Michael; Cherukuri, Venkateswararao; Warf, Benjamin C.			Endoscopic Treatment versus Shunting for Infant Hydrocephalus in Uganda	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							EUROPEAN CONSENSUS GUIDELINES; EMERGENCY CARDIOVASCULAR CARE; NEONATAL RESUSCITATION 2015; RANDOMIZED CONTROLLED-TRIAL; PRETERM INFANTS; CLINICAL-TRIALS; UMBILICAL-CORD; CARDIOPULMONARY-RESUSCITATION; PLACENTAL TRANSFUSION; UPDATE	BACKGROUND Postinfectious hydrocephalus in infants is a major health problem in sub-Saharan Africa. The conventional treatment is ventriculoperitoneal shunting, but surgeons are usually not immediately available to revise shunts when they fail. Endoscopic third ventriculostomy with choroid plexus cauterization (ETV-CPC) is an alternative treatment that is less subject to late failure but is also less likely than shunting to result in a reduction in ventricular size that might facilitate better brain growth and cognitive outcomes. METHODS We conducted a randomized trial to evaluate cognitive outcomes after ETV-CPC versus ventriculoperitoneal shunting in Ugandan infants with postinfectious hydrocephalus. The primary outcome was the Bayley Scales of Infant Development, Third Edition (BSID-3), cognitive scaled score 12 months after surgery (scores range from 1 to 19, with higher scores indicating better performance). The secondary outcomes were BSID-3 motor and language scores, treatment failure (defined as treatment-related death or the need for repeat surgery), and brain volume measured on computed tomography. RESULTS A total of 100 infants were enrolled; 51 were randomly assigned to undergo ETV-CPC, and 49 were assigned to undergo ventriculoperitoneal shunting. The median BSID-3 cognitive scores at 12 months did not differ significantly between the treatment groups (a score of 4 for ETV-CPC and 2 for ventriculoperitoneal shunting; Hodges-Lehmann estimated difference, 0; 95% confidence interval [CI], -2 to 0; P = 0.35). There was no significant difference between the ETV-CPC group and the ventriculoperitoneal-shunt group in BSID-3 motor or language scores, rates of treatment failure (35% and 24%, respectively; hazard ratio, 0.7; 95% CI, 0.3 to 1.5; P = 0.24), or brain volume (z score, -2.4 and -2.1, respectively; estimated difference, 0.3; 95% CI, -0.3 to 1.0; P = 0.12). CONCLUSIONS This single-center study involving Ugandan infants with postinfectious hydrocephalus showed no significant difference between endoscopic ETV-CPC and ventriculoperitoneal shunting with regard to cognitive outcomes at 12 months. (Funded by the National Institutes of Health; ClinicalTrials.gov number, NCT01936272.)	[Kulkarni, Abhaya V.] Univ Toronto, Toronto, ON, Canada; [Kulkarni, Abhaya V.; Donnelly, Ruth; Levenbach, Jody] Hosp Sick Children, Toronto, ON, Canada; [Schiff, Steven J.; Monga, Vishal; Peterson, Mallory; MacDonald, Michael; Cherukuri, Venkateswararao] Penn State Univ, University Pk, PA 16802 USA; [Mbabazi-Kabachelor, Edith; Mugamba, John; Ssenyonga, Peter; Warf, Benjamin C.] CURE Childrens Hosp Uganda, Mbale, Uganda; [Warf, Benjamin C.] Harvard Med Sch, Boston, MA USA; [Warf, Benjamin C.] Boston Childrens Hosp, Boston, MA USA	University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital	Warf, BC (corresponding author), Boston Childrens Hosp, Dept Neurosurg, 300 Longwood Ave, Boston, MA 02115 USA.	benjamin.warf@childrens.harvard.edu	Cherukuri, Venkateswarararao/U-6206-2019	Peterson, Mallory/0000-0001-5734-9260	National Institutes of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD085853] Funding Source: NIH RePORTER; FOGARTY INTERNATIONAL CENTER [R21TW009612] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	Funded by the National Institutes of Health; ClinicalTrials.gov number, NCT01936272.	[Anonymous], 2002, STAT METHODS ANAL RE; Australian and New Zealand Neonatal Network, 2008, ANZNN 2009 DAT DICT; Australian and New Zealand Neonatal Network, 2013, ANZNN 2009 2010 FOLL; Backes CH, 2014, OBSTET GYNECOL, V124, P47, DOI 10.1097/AOG.0000000000000324; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Clarke M, 2007, J ROY SOC MED, V100, P187, DOI 10.1258/jrsm.100.4.187; Committee on Obstetric Practice American College of Obstetricians and Gynecologists, 2012, Obstet Gynecol, V120, P1522, DOI 10.1097/01.AOG.0000423817.47165.48; Doyle LW, 2017, NEW ENGL J MED, V377, P329, DOI 10.1056/NEJMoa1700827; Eisenstein EL, 2008, CLIN TRIALS, V5, P75, DOI 10.1177/1740774507087551; Farrar D, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-23; Gagliardi L, 2011, ARCH DIS CHILD-FETAL, V96, pF30, DOI 10.1136/adc.2010.183905; Ghavam S, 2014, TRANSFUSION, V54, P1192, DOI 10.1111/trf.12469; Grant AM, 2005, LANCET, V365, P711; HAYBITTLE JL, 1971, BRIT J RADIOL, V44, P793, DOI 10.1259/0007-1285-44-526-793; Jelin AC, 2016, J MATERN-FETAL NEO M, V29, P1705, DOI 10.3109/14767058.2015.1061496; Jelin AC, 2014, J MATERN-FETAL NEO M, V27, P1457, DOI 10.3109/14767058.2013.864275; Jobe Alan H., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1723; Li F, 2013, PLOS ONE, V8; Manley BJ, 2017, LANCET, V389, P1639, DOI 10.1016/S0140-6736(17)30547-0; Manley BJ, 2013, NEW ENGL J MED, V369, P1425, DOI 10.1056/NEJMoa1300071; Medlock S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023441; National Institute for Health and Care Excellence, 2015, PRET LAB BIRTH NIC G; PETO R, 1976, BRIT J CANCER, V34, P585, DOI 10.1038/bjc.1976.220; Peto R, 1998, BMJ-BRIT MED J, V317, P1170, DOI 10.1136/bmj.317.7167.1170; Pocock SJ, 2016, NEW ENGL J MED, V375, P861, DOI 10.1056/NEJMra1510064; Popat H, 2016, J PEDIATR-US, V178, P81, DOI 10.1016/j.jpeds.2016.08.004; Rabe H, 2008, NEONATOLOGY, V93, P138, DOI 10.1159/000108764; Rabe H, 2012, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD003248.pub4, 10.1002/14651858.CD003248.pub3]; Strauss RG, 2008, TRANSFUSION, V48, P658, DOI 10.1111/j.1537-2995.2007.01589.x; Sweet DG, 2017, NEONATOLOGY, V111, P107, DOI 10.1159/000448985; Sweet DG, 2013, NEONATOLOGY, V103, P353, DOI 10.1159/000349928; Tarnow-Mordi W, 2017, BJOG-INT J OBSTET GY, V124, P613, DOI 10.1111/1471-0528.14468; Tarnow-Mordi W, 2015, SEMIN FETAL NEONAT M, V20, P389, DOI 10.1016/j.siny.2015.10.001; Tarnow-Mordi WO, 2014, AM J OBSTET GYNECOL, V211, P118, DOI 10.1016/j.ajog.2014.03.055; Wyckoff MH, 2015, PEDIATRICS, V136, pS196, DOI 10.1542/peds.2015-3373G	36	75	75	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 21	2017	377	25					2456	2464		10.1056/NEJMoa1707568	http://dx.doi.org/10.1056/NEJMoa1707568			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FQ5RZ	29262276	Green Accepted, Bronze			2022-12-28	WOS:000418420000009
J	Tsiaras, SV; Safi, LM; Ghoshhajra, BB; Lindsay, ME; Wood, MJ				Tsiaras, Sarah V.; Safi, Lucy M.; Ghoshhajra, Brian B.; Lindsay, Mark E.; Wood, Malissa J.			Case 39-2017: A 41-Year-Old Woman with Recurrent Chest Pain	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CORONARY-ARTERY DISSECTION; EHLERS-DANLOS-SYNDROME; SYNDROME TYPE-IV; CONNECTIVE-TISSUE DISORDERS; ACUTE PULMONARY-EMBOLISM; FIBROMUSCULAR DYSPLASIA; MYOCARDIAL-INFARCTION; ASSOCIATION; FEATURES		[Tsiaras, Sarah V.; Safi, Lucy M.; Lindsay, Mark E.; Wood, Malissa J.] Massachusetts Gen Hosp, Dept Cardiol, Boston, MA 02114 USA; [Ghoshhajra, Brian B.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA USA; [Tsiaras, Sarah V.; Safi, Lucy M.; Lindsay, Mark E.; Wood, Malissa J.] Harvard Med Sch, Dept Cardiol, Boston, MA 02115 USA; [Ghoshhajra, Brian B.] Harvard Med Sch, Dept Radiol, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Tsiaras, SV (corresponding author), Massachusetts Gen Hosp, Dept Cardiol, Boston, MA 02114 USA.; Tsiaras, SV (corresponding author), Harvard Med Sch, Dept Cardiol, Boston, MA 02115 USA.		Wood, Malissa/T-3201-2019; Ghoshhajra, Brian/J-2114-2016	Ghoshhajra, Brian/0000-0002-3865-3432	Medtronic; Siemens Healthcare	Medtronic(Medtronic); Siemens Healthcare(Siemens AG)	Dr. Ghoshhajra reports receiving consulting fees from Medtronic and Siemens Healthcare. No other potential conflict of interest relevant to this article was reported.	ADES LC, 1995, BRIT HEART J, V74, P112; BEIGHTON P, 1973, ANN RHEUM DIS, V32, P413, DOI 10.1136/ard.32.5.413; Bowen JM, 2017, AM J MED GENET C, V175, P27, DOI 10.1002/ajmg.c.31548; DEC GW, 1992, J AM COLL CARDIOL, V20, P85, DOI 10.1016/0735-1097(92)90141-9; Fattori R, 2012, AM J MED GENET A, V158A, P1216, DOI 10.1002/ajmg.a.35277; Ganesh SK, 2014, FASEB J, V28, P3313, DOI 10.1096/fj.14-251207; Grover Peeyush, 2016, J Med Case Rep, V10, P62, DOI 10.1186/s13256-016-0832-8; Hariharan P, 2015, CLIN CARDIOL, V38, P236, DOI 10.1002/clc.22383; Hendriksen JMT, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4438; Henkin S, 2016, HEART, V102, P876, DOI 10.1136/heartjnl-2015-308645; Malfait F, 2017, AM J MED GENET C, V175, P8, DOI 10.1002/ajmg.c.31552; McConnell MV, 1996, AM J CARDIOL, V78, P469, DOI 10.1016/S0002-9149(96)00339-6; Monney PA, 2011, HEART, V97, P1312, DOI 10.1136/hrt.2010.204818; Pepin M, 2000, NEW ENGL J MED, V342, P673, DOI 10.1056/NEJM200003093421001; Poloskey SL, 2012, VASC MED, V17, P371, DOI 10.1177/1358863X12459650; Saw J, 2014, CIRC-CARDIOVASC INTE, V7, P645, DOI 10.1161/CIRCINTERVENTIONS.114.001760; SUPERTIFURGA A, 1988, J BIOL CHEM, V263, P6226; Tinkle B, 2017, AM J MED GENET C, V175, P48, DOI 10.1002/ajmg.c.31538; Tweet MS, 2016, CURR CARDIOL REP, V18, DOI 10.1007/s11886-016-0737-6; Tweet MS, 2015, MAYO CLIN PROC, V90, P1125, DOI 10.1016/j.mayocp.2015.05.010; Tweet MS, 2012, CIRCULATION, V126, P579, DOI 10.1161/CIRCULATIONAHA.112.105718; van der Linde D, 2012, J AM COLL CARDIOL, V60, P397, DOI 10.1016/j.jacc.2011.12.052	22	0	0	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 21	2017	377	25					2475	2484		10.1056/NEJMcpc1707558	http://dx.doi.org/10.1056/NEJMcpc1707558			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FQ5RZ	29262281				2022-12-28	WOS:000418420000012
J	Stupp, R; Taillibert, S; Kanner, A; Read, W; Steinberg, DM; Lhermitte, B; Toms, S; Idbaih, A; Ahluwalia, MS; Fink, K; Di Meco, F; Lieberman, F; Zhu, JJ; Stragliotto, G; Tran, DD; Brem, S; Hottinger, AF; Kirson, ED; Lavy-Shahaf, G; Weinberg, U; Kim, CY; Paek, SH; Nicholas, G; Burna, J; Hirte, H; Weller, M; Palti, Y; Hegi, M; Ram, Z				Stupp, Roger; Taillibert, Sophie; Kanner, Andrew; Read, William; Steinberg, David M.; Lhermitte, Benoit; Toms, Steven; Idbaih, Ahmed; Ahluwalia, Manmeet S.; Fink, Karen; Di Meco, Francesco; Lieberman, Frank; Zhu, Jay-Jiguang; Stragliotto, Giuseppe; Tran, David D.; Brem, Steven; Hottinger, Andreas F.; Kirson, Eilon D.; Lavy-Shahaf, Gitit; Weinberg, Uri; Kim, Chae-Yong; Paek, Sun-Ha; Nicholas, Garth; Burna, Jordi; Hirte, Hal; Weller, Michael; Palti, Yoram; Hegi, Monika; Ram, Zvi			Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NEWLY-DIAGNOSED GLIOBLASTOMA; CENTRAL-NERVOUS-SYSTEM; QUALITY-OF-LIFE; PHASE-III TRIAL; ADJUVANT TEMOZOLOMIDE; MALIGNANT GLIOMA; OPEN-LABEL; BRAIN; RADIOTHERAPY; BEVACIZUMAB	IMPORTANCE Tumor-treating fields (TTFields) is an antimitotic treatment modality that interferes with glioblastoma cell division and organelle assembly by delivering low-intensity alternating electric fields to the tumor. OBJECTIVE To investigate whether TTFields improves progression-free and overall survival of patients with glioblastoma, a fatal disease that commonly recurs at the initial tumor site or in the central nervous system. DESIGN, SETTING, AND PARTICIPANTS In this randomized, open-label trial, 695 patients with glioblastoma whose tumor was resected or biopsied and had completed concomitant radiochemotherapy (median time from diagnosis to randomization, 3.8 months) were enrolled at 83 centers (July 2009-2014) and followed up through December 2016. A preliminary report from this trial was published in 2015; this report describes the final analysis. INTERVENTIONS Patients were randomized 2: 1 to TTFields plus maintenance temozolomide chemotherapy (n = 466) or temozolomide alone (n = 229). The TTFields, consisting of low-intensity, 200 kHz frequency, alternating electric fields, was delivered (>= 18 hours/d) via 4 transducer arrays on the shaved scalp and connected to a portable device. Temozolomide was administered to both groups (150-200mg/m(2)) for 5 days per 28-day cycle (6-12 cycles). MAIN OUTCOMES AND MEASURES Progression-free survival (tested at a = .046). The secondary end point was overall survival (tested hierarchically at a = .048). Analyses were performed for the intent-to-treat population. Adverse events were compared by group. RESULTS Of the 695 randomized patients (median age, 56 years; IQR, 48-63; 473 men [68%]), 637 (92%) completed the trial. Median progression-free survival from randomization was 6.7 months in the TTFields-temozolomide group and 4.0 months in the temozolomide-alone group (HR, 0.63; 95% CI, 0.52-0.76; P < .001). Median overall survival was 20.9 months in the TTFields-temozolomide group vs 16.0 months in the temozolomide-alone group (HR, 0.63; 95% CI, 0.53-0.76; P < .001). Systemic adverse event frequency was 48% in the TTFields-temozolomide group and 44% in the temozolomide-alone group. Mild to moderate skin toxicity underneath the transducer arrays occurred in 52% of patients who received TTFields-temozolomide vs no patients who received temozolomide alone. CONCLUSIONS AND RELEVANCE In the final analysis of this randomized clinical trial of patients with glioblastoma who had received standard radiochemotherapy, the addition of TTFields to maintenance temozolomide chemotherapy vs maintenance temozolomide alone, resulted in statistically significant improvement in progression-free survival and overall survival. These results are consistent with the previous interim analysis.	[Stupp, Roger] Northwestern Univ, Feinberg Sch Med, Robert H Lurie Comprehens Canc Ctr, Lou & Jean Malnati Brain Tumor Inst, Chicago, IL 60611 USA; [Stupp, Roger; Lhermitte, Benoit; Hottinger, Andreas F.; Hegi, Monika] CHU Vaudois, Lausanne, Switzerland; [Stupp, Roger; Lhermitte, Benoit; Hottinger, Andreas F.; Hegi, Monika] Univ Lausanne, Lausanne, Switzerland; [Stupp, Roger; Weller, Michael] Univ Zurich Hosp, Zurich, Switzerland; [Stupp, Roger; Weller, Michael] Univ Zurich, Zurich, Switzerland; [Taillibert, Sophie; Idbaih, Ahmed] Univ Paris 06, Sorbonne Univ, Inst Cerveau & Moelle Epiniere, CNRS,INSERM,UMR S 1127,U1127,UMR7225,UPMC,ICM, F-75013 Paris, France; [Kanner, Andrew; Ram, Zvi] Tel Aviv Med Ctr & Sch Med, Tel Aviv, Israel; [Read, William] Univ Calif San Diego, San Diego, CA 92103 USA; [Read, William] Emory Univ, Atlanta, GA 30322 USA; [Steinberg, David M.] Tel Aviv Univ, Tel Aviv, Israel; [Toms, Steven] Geisinger Hlth Syst, Danville, PA USA; [Ahluwalia, Manmeet S.] Cleveland Clin Fdn, 9500 Euclid Ave, Cleveland, OH 44195 USA; [Fink, Karen] Baylor Univ, Med Ctr, Houston, TX 77030 USA; [Di Meco, Francesco] Ist Nazl Neurol Carlo Besta, Milan, Italy; [Lieberman, Frank] Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA; [Zhu, Jay-Jiguang] Univ Texas Hlth Sci Ctr Houston, Houston, TX 77030 USA; [Zhu, Jay-Jiguang] Tufts Med Ctr, Boston, MA USA; [Stragliotto, Giuseppe] Karolinska Hosp, Stockholm, Sweden; [Tran, David D.] Washington Univ, Barnes Jewish Hosp, St Louis, MO USA; [Brem, Steven] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA; [Brem, Steven] Univ Penn, Philadelphia, PA 19104 USA; [Kirson, Eilon D.; Lavy-Shahaf, Gitit; Weinberg, Uri; Palti, Yoram] Novocure Ltd, Haifa, Israel; [Kim, Chae-Yong] Seoul Natl Univ, Bundang Hosp, Coll Med, Bundang, South Korea; [Paek, Sun-Ha] Seoul Natl Univ, Seoul, South Korea; [Nicholas, Garth] Ottawa Hosp Res Inst, Ottawa, ON, Canada; [Burna, Jordi] Hosp Univ Bellvitge, Barcelona, Spain; [Hirte, Hal] Juravinski Canc Ctr, Hamilton, ON, Canada	Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; University of Zurich; University Zurich Hospital; University of Zurich; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Tel Aviv University; Sackler Faculty of Medicine; University of California System; University of California San Diego; Emory University; Tel Aviv University; Geisinger Health System; Cleveland Clinic Foundation; Baylor University; IRCCS Istituto Neurologico Besta; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Texas System; University of Texas Health Science Center Houston; Tufts Medical Center; Karolinska Institutet; Karolinska University Hospital; Barnes-Jewish Hospital; Washington University (WUSTL); H Lee Moffitt Cancer Center & Research Institute; University of Pennsylvania; Novocure Limited; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); University of Ottawa; Ottawa Hospital Research Institute; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; McMaster University	Stupp, R (corresponding author), Northwestern Univ, Lou & Jean Malnati Brain Tumor Inst, Robert H Lurie Comprehens Canc Ctr, 676 N St Clair St,Ste 2210, Chicago, IL 60611 USA.	roger.stupp@northwestern.edu	Stupp, Roger/L-3303-2019; Hegi, Monika/O-4796-2015; Brem, Steven/HIK-3353-2022; DiMeco, Francesco/Z-5431-2019; Idbaih, Ahmed/N-8746-2017; DiMeco, Francesco/Q-3785-2016	Hegi, Monika/0000-0003-0855-6495; Weller, Michael/0000-0002-1748-174X; KIM, CHAE-YONG/0000-0001-9773-5553; Kanner, Andrew Ariye/0000-0002-0812-8573; Idbaih, Ahmed/0000-0001-5290-1204; Le Rhun, Emilie/0000-0002-9408-3278; DiMeco, Francesco/0000-0001-6213-5793	Novocure Ltd.	Novocure Ltd.	The study was funded by Novocure Ltd.	AARONSON NK, 1993, J NATL CANCER I, V85, P365, DOI 10.1093/jnci/85.5.365; Chinot OL, 2014, NEW ENGL J MED, V370, P709, DOI 10.1056/NEJMoa1308345; Coulibaly B, 2010, HUM PATHOL, V41, P815, DOI 10.1016/j.humpath.2009.09.020; DeMets D L, 1995, Cancer Treat Res, V75, P1; DEMETS DL, 1994, STAT MED, V13, P1341, DOI 10.1002/sim.4780131308; Ganiere V, 2006, NAT CLIN PRACT ONCOL, V3, P339, DOI 10.1038/ncponc0514; Giladi M, 2015, SCI REP-UK, V5, DOI 10.1038/srep18046; Gilbert MR, 2014, NEW ENGL J MED, V370, P699, DOI 10.1056/NEJMoa1308573; Gilbert MR, 2013, J CLIN ONCOL, V31, P4085, DOI 10.1200/JCO.2013.49.6968; Hegi ME, 2005, NEW ENGL J MED, V352, P997, DOI 10.1056/NEJMoa043331; Hegi ME, 2012, ACTA NEUROPATHOL, V123, P841, DOI 10.1007/s00401-011-0938-4; Kirson ED, 2007, P NATL ACAD SCI USA, V104, P10152, DOI 10.1073/pnas.0702916104; Kirson Eilon D, 2009, BMC Med Phys, V9, P1, DOI 10.1186/1756-6649-9-1; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; MACDONALD DR, 1990, J CLIN ONCOL, V8, P1277, DOI 10.1200/JCO.1990.8.7.1277; Ostrom QT, 2016, NEURO-ONCOLOGY, V18, pv1, DOI 10.1093/neuonc/now207; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Stupp R, 2007, J CLIN ONCOL, V25, P4127, DOI 10.1200/JCO.2007.11.8554; Stupp R, 2015, JAMA-J AM MED ASSOC, V314, P2535, DOI 10.1001/jama.2015.16669; Stupp R, 2014, LANCET ONCOL, V15, P1100, DOI 10.1016/S1470-2045(14)70379-1; Stupp R, 2012, EUR J CANCER, V48, P2192, DOI 10.1016/j.ejca.2012.04.011; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Taphoorn MJB, 2010, EUR J CANCER, V46, P1033, DOI 10.1016/j.ejca.2010.01.012; Vlassenbroeck I, 2008, J MOL DIAGN, V10, P332, DOI 10.2353/jmoldx.2008.070169; Weller M, 2017, LANCET ONCOL, V18, P1373, DOI 10.1016/S1470-2045(17)30517-X; Westphal M, 2015, EUR J CANCER, V51, P522, DOI 10.1016/j.ejca.2014.12.019	26	959	982	10	104	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 19	2017	318	23					2306	2316		10.1001/jama.2017.18718	http://dx.doi.org/10.1001/jama.2017.18718			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FQ3RJ	29260225	Green Published, Bronze, Green Accepted			2022-12-28	WOS:000418274000018
J	Pan, D; Kobayashi, A; Jiang, P; de Andrade, LF; Tay, RE; Luoma, AM; Tsoucas, D; Qiu, XT; Lim, K; Rao, P; Long, HW; Yuan, GC; Doench, J; Brown, M; Liu, XS; Wucherpfennig, KW				Pan, Deng; Kobayashi, Aya; Jiang, Peng; de Andrade, Lucas Ferrari; Tay, Rong En; Luoma, Adrienne M.; Tsoucas, Daphne; Qiu, Xintao; Lim, Klothilda; Rao, Prakash; Long, Henry W.; Yuan, Guo-Cheng; Doench, John; Brown, Myles; Liu, X. Shirley; Wucherpfennig, Kai W.			A major chromatin regulator determines resistance of tumor cells to T cell-mediated killing	SCIENCE			English	Article							CANCER-IMMUNOTHERAPY; ACQUIRED-RESISTANCE; ANTITUMOR-ACTIVITY; IMMUNE-SYSTEM; B7 FAMILY; MELANOMA; COMBINATION; MUTATIONS; BLOCKADE; GENES	Many human cancers are resistant to immunotherapy, for reasons that are poorly understood. We used a genome-scale CRISPR-Cas9 screen to identify mechanisms of tumor cell resistance to killing by cytotoxic T cells, the central effectors of antitumor immunity. Inactivation of >100 genes-including Pbrm1, Arid2, and Brd7, which encode components of the PBAF form of the SWI/SNF chromatin remodeling complex-sensitized mouse B16F10 melanoma cells to killing by T cells. Loss of PBAF function increased tumor cell sensitivity to interferon-g, resulting in enhanced secretion of chemokines that recruit effector T cells. Treatment-resistant tumors became responsive to immunotherapy when Pbrm1 was inactivated. In many human cancers, expression of PBRM1 and ARID2 inversely correlated with expression of T cell cytotoxicity genes, and Pbrm1-deficient murine melanomas were more strongly infiltrated by cytotoxic T cells.	[Pan, Deng; Kobayashi, Aya; de Andrade, Lucas Ferrari; Tay, Rong En; Luoma, Adrienne M.; Wucherpfennig, Kai W.] Dana Farber Canc Inst, Dept Canc Immunol & Virol, Boston, MA 02215 USA; [Kobayashi, Aya] Astellas Pharma, Tokyo 1038411, Japan; [Jiang, Peng; Tsoucas, Daphne; Yuan, Guo-Cheng; Liu, X. Shirley] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02215 USA; [Qiu, Xintao; Lim, Klothilda; Rao, Prakash; Long, Henry W.; Brown, Myles] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA; [Doench, John] Broad Inst MIT & Harvard, Genet Perturbat Platform, Cambridge, MA 02142 USA; [Wucherpfennig, Kai W.] Harvard Med Sch, Dept Microbiol & Immunobiol, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Astellas Pharmaceuticals; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School	Wucherpfennig, KW (corresponding author), Dana Farber Canc Inst, Dept Canc Immunol & Virol, Boston, MA 02215 USA.; Liu, XS (corresponding author), Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02215 USA.; Wucherpfennig, KW (corresponding author), Harvard Med Sch, Dept Microbiol & Immunobiol, Boston, MA 02115 USA.	xsliu@jimmy.harvard.edu; kai_wucherpfennig@dfci.harvard.edu	Kobayashi, Aya/AAA-2530-2020; Tay, Rong En/GYD-6230-2022; Doench, John G/HCI-9570-2022; Doench, John/ABE-6251-2020; Brown, Myles/AAX-5332-2021; Brown, Myles/B-6906-2008; Tay, Rong En/AAP-2860-2021; Miura, Hirotaka/AAB-6840-2020	Doench, John G/0000-0002-3707-9889; Doench, John/0000-0002-3707-9889; Brown, Myles/0000-0002-8213-1658; Tay, Rong En/0000-0003-3647-9271; Liu, Xiaole/0000-0003-4736-7339; Pan, Deng/0000-0003-3305-4884; Pan, Deng/0000-0002-6475-0463; Jiang, Peng/0000-0002-7828-5486; Qiu, Xintao/0000-0002-8560-7017	Friends for Life Neuroblastoma Fellowship; A*STAR Graduate Fellowship; NIH [1T32CA207021-01, U24CA224316]; National Cancer Institute, NIH [R01CA173750]; Astellas Pharma; Genentech; Tango Therapeutics; NATIONAL CANCER INSTITUTE [T32CA207021, U24CA224316, R01CA173750] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG008927] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM074897] Funding Source: NIH RePORTER	Friends for Life Neuroblastoma Fellowship; A*STAR Graduate Fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Astellas Pharma(Astellas Pharmaceuticals); Genentech(Roche HoldingGenentech); Tango Therapeutics; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the staff of the Center for Cancer Genome Discovery and the Molecular Biology Core Facility at Dana-Farber Cancer Institute (DFCI) for DNA sequencing. D.P. is a Cancer Research Institute-Robertson Foundation Fellow; L.F.d.A. was funded by a Friends for Life Neuroblastoma Fellowship, and R.E.T. was supported by an A*STAR Graduate Fellowship. A.M.L. is a Research Fellow of the Training Program in Cancer Immunology at DFCI (NIH grant 1T32CA207021-01). This work was supported by a Transformative R01 grant from the National Cancer Institute, NIH (R01CA173750) (K.W.W.) and NIH (U24CA224316) (X.S.L.), and by a sponsored research agreement with Astellas Pharma. X.S.L. is a cofounder of and is on the scientific advisory board of GV20 Oncotherapy, a precision cancer medicine company. X.S.L. is also on the scientific advisory board of 3DMedCare and is a paid consultant for Genentech. J.D. is a paid consultant for Tango Therapeutics. K.W.W. and D.P. are inventors on patent application DFS-190.6 submitted by DFCI, which covers new targets for cancer immunotherapy. RNA-seq data have been deposited at the Gene Expression Omnibus under accession number GSE107670.	Arafeh R, 2015, NAT GENET, V47, P1408, DOI 10.1038/ng.3427; Blum JS, 2013, ANNU REV IMMUNOL, V31, P443, DOI 10.1146/annurev-immunol-032712-095910; Chen SH, 2015, CANCER IMMUNOL RES, V3, P149, DOI 10.1158/2326-6066.CIR-14-0118; Doench JG, 2016, NAT BIOTECHNOL, V34, P184, DOI 10.1038/nbt.3437; Dong HD, 1999, NAT MED, V5, P1365; Ebert PJR, 2016, IMMUNITY, V44, P609, DOI 10.1016/j.immuni.2016.01.024; Frederick DT, 2013, CLIN CANCER RES, V19, P1225, DOI 10.1158/1078-0432.CCR-12-1630; Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027; Gao JJ, 2016, CELL, V167, P397, DOI 10.1016/j.cell.2016.08.069; Groom JR, 2011, IMMUNOL CELL BIOL, V89, P207, DOI 10.1038/icb.2010.158; Hodis E, 2012, CELL, V150, P251, DOI 10.1016/j.cell.2012.06.024; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Iwai Y, 2002, P NATL ACAD SCI USA, V99, P12293, DOI 10.1073/pnas.192461099; Kadoch C, 2017, NAT GENET, V49, P213, DOI 10.1038/ng.3734; Kadoch C, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500447; Kaiserman D, 2010, CELL DEATH DIFFER, V17, P586, DOI 10.1038/cdd.2009.169; Kleppe M, 2011, BLOOD, V117, P7090, DOI 10.1182/blood-2010-10-314286; Kobayashi KS, 2012, NAT REV IMMUNOL, V12, P813, DOI 10.1038/nri3339; Koya RC, 2012, CANCER RES, V72, P3928, DOI 10.1158/0008-5472.CAN-11-2837; Lemon B, 2001, NATURE, V414, P924, DOI 10.1038/414924a; Li B, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1028-7; Li GQ, 2014, CANCER CELL, V25, P455, DOI 10.1016/j.ccr.2014.02.007; Manguso RT, 2017, NATURE, V547, P413, DOI 10.1038/nature23270; Messina S, 2011, ONCOGENE, V30, P3813, DOI 10.1038/onc.2011.99; Miao D, 2018, SCIENCE, V359, P801, DOI 10.1126/science.aan5951; Overwijk WW, 2003, J EXP MED, V198, P569, DOI 10.1084/jem.20030590; Parker BS, 2016, NAT REV CANCER, V16, P131, DOI 10.1038/nrc.2016.14; Patel SJ, 2017, NATURE, V548, P537, DOI 10.1038/nature23477; Phoenix TN, 2010, GENE DEV, V24, P45, DOI 10.1101/gad.1839510; Ratner N, 2015, NAT REV CANCER, V15, P290, DOI 10.1038/nrc3911; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Sharma P, 2017, CELL, V168, P707, DOI 10.1016/j.cell.2017.01.017; van Elsas A, 1999, J EXP MED, V190, P355, DOI 10.1084/jem.190.3.355; Varela I, 2011, NATURE, V469, P539, DOI 10.1038/nature09639; Yan ZJ, 2005, GENE DEV, V19, P1662, DOI 10.1101/gad.1323805; Zaretsky JM, 2016, NEW ENGL J MED, V375, P819, DOI 10.1056/NEJMoa1604958; Zhang N, 2011, IMMUNITY, V35, P161, DOI 10.1016/j.immuni.2011.07.010; Zhang Q, 2017, CELL, V168, P37, DOI 10.1016/j.cell.2016.12.012	38	417	432	9	174	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 16	2018	359	6377					770	+	aao1710	10.1126/science.aao1710	http://dx.doi.org/10.1126/science.aao1710			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW2ET	29301958	Green Accepted			2022-12-28	WOS:000425116200039
J	Greenland, P				Greenland, Philip			Cardiovascular Guideline Skepticism vs Lifestyle Realism?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							RISK; HEALTH		[Greenland, Philip] Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, 680 N Lake Shore Dr,14th Floor, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Greenland, P (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, 680 N Lake Shore Dr,14th Floor, Chicago, IL 60611 USA.	p-greenland@northwestern.edu	Greenland, Philip/ABD-5528-2021					Goff DC, 2014, J AM COLL CARDIOL, V63, P2935, DOI [10.1016/j.jacc.2013.11.005, 10.1161/01.cir.0000437741.48606.98]; Greenland P, 2003, JAMA-J AM MED ASSOC, V290, P891, DOI 10.1001/jama.290.7.891; Ioannidis JPA, 2014, JAMA-J AM MED ASSOC, V311, P463, DOI 10.1001/jama.2013.284657; Khera AV, 2016, NEW ENGL J MED, V375, P2349, DOI 10.1056/NEJMoa1605086; Lloyd-Jones DM, 2004, AM J CARDIOL, V94, P20, DOI 10.1016/j.amjcard.2004.03.023; Lloyd-Jones DM, 2010, CIRCULATION, V121, P586, DOI 10.1161/CIRCULATIONAHA.109.192703; Stone NJ, 2014, CIRCULATION, V129, pS1, DOI 10.1161/01.cir.0000437738.63853.7a; Whelton PK, 2018, J AM COLL CARDIOL, V71, pE127, DOI 10.1016/j.jacc.2017.11.006; Whelton PK, 2017, JAMA-J AM MED ASSOC, V318, P2073, DOI 10.1001/jama.2017.18209; Younus A, 2016, MAYO CLIN PROC, V91, P649, DOI 10.1016/j.mayocp.2016.01.019	10	15	15	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 9	2018	319	2					117	118		10.1001/jama.2017.19675	http://dx.doi.org/10.1001/jama.2017.19675			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FS4PR	29242938				2022-12-28	WOS:000419775500007
J	Erb, KH; Kastner, T; Plutzar, C; Bais, ALS; Carvalhais, N; Fetzel, T; Gingrich, S; Haberl, H; Lauk, C; Niedertscheider, M; Pongratz, J; Thurner, M; Luyssaert, S				Erb, Karl-Heinz; Kastner, Thomas; Plutzar, Christoph; Bais, Anna Liza S.; Carvalhais, Nuno; Fetzel, Tamara; Gingrich, Simone; Haberl, Helmut; Lauk, Christian; Niedertscheider, Maria; Pongratz, Julia; Thurner, Martin; Luyssaert, Sebastiaan			Unexpectedly large impact of forest management and grazing on global vegetation biomass	NATURE			English	Article							NET PRIMARY PRODUCTION; CARBON-DIOXIDE EMISSIONS; LAND-USE CHANGES; HUMAN APPROPRIATION; TERRESTRIAL; CYCLE; WORLDS; COVER; DENSITY; BOREAL	Carbon stocks in vegetation have a key role in the climate system(1-4). However, the magnitude, patterns and uncertainties of carbon stocks and the effect of land use on the stocks remain poorly quantified. Here we show, using state-of-the-art datasets, that vegetation currently stores around 450 petagrams of carbon. In the hypothetical absence of land use, potential vegetation would store around 916 petagrams of carbon, under current climate conditions. This difference highlights the massive effect of land use on biomass stocks. Deforestation and other land-cover changes are responsible for 53-58% of the difference between current and potential biomass stocks. Land management effects (the biomass stock changes induced by land use within the same land cover) contribute 42-47%, but have been underestimated in the literature. Therefore, avoiding deforestation is necessary but not sufficient for mitigation of climate change. Our results imply that trade-offs exist between conserving carbon stocks on managed land and raising the contribution of biomass to raw material and energy supply for the mitigation of climate change. Efforts to raise biomass stocks are currently verifiable only in temperate forests, where their potential is limited. By contrast, large uncertainties hinder verification in the tropical forest, where the largest potential is located, pointing to challenges for the upcoming stocktaking exercises under the Paris agreement.	[Erb, Karl-Heinz; Kastner, Thomas; Plutzar, Christoph; Bais, Anna Liza S.; Fetzel, Tamara; Gingrich, Simone; Haberl, Helmut; Lauk, Christian; Niedertscheider, Maria] Alpen Adria Univ Klagenfurt Vienna Graz, Inst Social Ecol Vienna, Schottenfeldgasse 29, A-1070 Vienna, Austria; [Kastner, Thomas] Senckenberg Biodivers & Climate Res Ctr SBiK F, Senckenberganlage 25, D-60325 Frankfurt, Germany; [Plutzar, Christoph] Univ Vienna, Div Conservat Biol Vegetat Ecol & Landscape Ecol, Rennweg 14, A-1030 Vienna, Austria; [Carvalhais, Nuno] Max Planck Inst Biogeochem, Hans Knoll Str 10, D-07745 Jena, Germany; [Carvalhais, Nuno] Univ Nova Lisboa, Fac Ciencias & Tecnol, Dept Ciencias & Engn Ambiente, CENSE, P-2829516 Caparica, Portugal; [Pongratz, Julia] Max Planck Inst Meteorol, Bundesstr 53, D-20146 Hamburg, Germany; [Thurner, Martin] Stockholm Univ, Dept Environm Sci & Analyt Chem ACES, Svante Arrhenius Vag 8, S-10691 Stockholm, Sweden; [Thurner, Martin] Stockholm Univ, Bolin Ctr Climate Res, S-10691 Stockholm, Sweden; [Luyssaert, Sebastiaan] Vrije Univ Amsterdam, Dept Ecol Sci, NL-1081 HV Amsterdam, Netherlands	Senckenberg Biodiversitat & Klima- Forschungszentrum (BiK-F); Senckenberg Gesellschaft fur Naturforschung (SGN); University of Vienna; Max Planck Society; Universidade Nova de Lisboa; Max Planck Society; Stockholm University; Stockholm University; Vrije Universiteit Amsterdam	Erb, KH (corresponding author), Alpen Adria Univ Klagenfurt Vienna Graz, Inst Social Ecol Vienna, Schottenfeldgasse 29, A-1070 Vienna, Austria.	karlheinz.erb@aau.at	Lauk, Christian/S-3969-2019; Thurner, Martin/K-4854-2017; Kastner, Thomas/C-6346-2012; Haberl, Helmut/G-3679-2013; Erb, Karlheinz/F-1282-2016; Luyssaert, Sebastiaan/F-6684-2011; Pongratz, Julia/AAG-3274-2019; Gingrich, Simone/L-4862-2016	Thurner, Martin/0000-0003-2362-5161; Kastner, Thomas/0000-0002-8155-136X; Haberl, Helmut/0000-0003-2104-5446; Erb, Karlheinz/0000-0002-8335-4159; Luyssaert, Sebastiaan/0000-0003-1121-1869; Carvalhais, Nuno/0000-0003-0465-1436; Pongratz, Julia/0000-0003-0372-3960; Gingrich, Simone/0000-0001-7891-8688; Lauk, Christian/0000-0002-4173-1753	European Research Council [ERC-2010-stg-263522]; European Commission [H2020-EO-2014-640176]; German Research Foundation's Emmy Noether Program [PO 1751/1-1]; GlobBiomass project of the European Space Agency [4000113100/14/I-NB]; NOVA [UID/AMB/04085/2013]; Amsterdam Academic Alliance (AAA); Vetenskapsradet of the Swedish Research Council [621-2014-4266]	European Research Council(European Research Council (ERC)European Commission); European Commission(European CommissionEuropean Commission Joint Research Centre); German Research Foundation's Emmy Noether Program(German Research Foundation (DFG)); GlobBiomass project of the European Space Agency; NOVA; Amsterdam Academic Alliance (AAA); Vetenskapsradet of the Swedish Research Council	Funding from the European Research Council (ERC-2010-stg-263522 'LUISE'), the European Commission (H2020-EO-2014-640176 'BACI'), the German Research Foundation's Emmy Noether Program (PO 1751/1-1), GlobBiomass project of the European Space Agency (4000113100/14/I-NB), the NOVA grant UID/AMB/04085/2013, the Amsterdam Academic Alliance (AAA) and the Vetenskapsradet grant 621-2014-4266 of the Swedish Research Council are acknowledged. We thank A. Baccini, A. S. Ruesch, S. Saatchi and P. C. West for making their data layers publicly available. K.H.-E. is grateful for the support by K. Kowalski. This research contributes to the Global Land Programme (https://glp.earth/).	Ajtay G. L., 1979, SCOPE Report, P129; Allen CD, 2010, FOREST ECOL MANAG, V259, P660, DOI 10.1016/j.foreco.2009.09.001; Amthor JS, 2001, J GEOPHYS RES-ATMOS, V106, P33623, DOI 10.1029/2000JD900850; Amthor JS, 1998, TERRESTRIAL ECOSYSTE; [Anonymous], IPCC GUIDELINES NATL; Arneth A, 2017, NAT GEOSCI, V10, P79, DOI [10.1038/NGEO2882, 10.1038/ngeo2882]; Avitabile V, 2016, GLOBAL CHANGE BIOL, V22, P1406, DOI 10.1111/gcb.13139; Baccini A, 2012, NAT CLIM CHANGE, V2, P182, DOI [10.1038/NCLIMATE1354, 10.1038/nclimate1354]; Bartholome E, 2005, INT J REMOTE SENS, V26, P1959, DOI 10.1080/01431160412331291297; BAZILEVICH NI, 1971, SOV GEOGR, V12, P293, DOI 10.1080/00385417.1971.10770248; Bloom AA, 2016, P NATL ACAD SCI USA, V113, P1285, DOI 10.1073/pnas.1515160113; Bondeau A, 2007, GLOBAL CHANGE BIOL, V13, P679, DOI 10.1111/j.1365-2486.2006.01305.x; Cai XM, 2011, ENVIRON SCI TECHNOL, V45, P334, DOI 10.1021/es103338e; Cannell MGR, 1982, WORLD FOREST BIOMASS; Carcaillet C, 2002, CHEMOSPHERE, V49, P845, DOI 10.1016/S0045-6535(02)00385-5; DeFries RS, 1999, GLOBAL BIOGEOCHEM CY, V13, P803, DOI 10.1029/1999GB900037; DiMiceli C. M., 2000, ANN GLOBAL AUTOMATED, V65; Erb KH, 2016, NAT GEOSCI, V9, P674, DOI [10.1038/NGEO2782, 10.1038/ngeo2782]; Erb KH, 2007, J LAND USE SCI, V2, P191, DOI 10.1080/17474230701622981; ESSER G, 1987, Tellus Series B Chemical and Physical Meteorology, V39, P245, DOI 10.1111/j.1600-0889.1987.tb00097.x; Fang JY, 2006, CLIMATIC CHANGE, V74, P355, DOI 10.1007/s10584-005-9028-8; FAO, 2010, GLOBAL FOREST RESOUR; FAO (Food and Agriculture Organization), 2001, GLOB EC ZON GLOB FOR; FAOstat, 2015, STAT DAT; GTOS, 2009, BIOMASS; Haberl H, 2007, P NATL ACAD SCI USA, V104, P12942, DOI 10.1073/pnas.0704243104; Haberl H, 2014, ANNU REV ENV RESOUR, V39, P363, DOI 10.1146/annurev-environ-121912-094620; Hall D. O., 1993, PHOTOSYNTHESIS PRODU, P464; Hansis E, 2015, GLOBAL BIOGEOCHEM CY, V29, P1230, DOI 10.1002/2014GB004997; Holtsmark B, 2012, CLIMATIC CHANGE, V112, P415, DOI 10.1007/s10584-011-0222-6; Houghton RA, 2007, ANNU REV EARTH PL SC, V35, P313, DOI 10.1146/annurev.earth.35.031306.140057; Houghton RA, 2000, GLOBAL ECOL BIOGEOGR, V9, P145, DOI 10.1046/j.1365-2699.2000.00164.x; Hurteau MD, 2008, FRONT ECOL ENVIRON, V6, P493, DOI 10.1890/070187; Hurtt GC, 2011, CLIMATIC CHANGE, V109, P117, DOI 10.1007/s10584-011-0153-2; Jarvis P., 2001, TERRESTRIAL GLOBAL P, P211, DOI 10.1016/B978-012505290-0/50011-9; Kaplan JO, 2011, HOLOCENE, V21, P775, DOI 10.1177/0959683610386983; Kleinen T, 2012, BIOGEOSCIENCES, V9, P235, DOI 10.5194/bg-9-235-2012; Le Toan T, 2011, REMOTE SENS ENVIRON, V115, P2850, DOI 10.1016/j.rse.2011.03.020; Lieth H, 1975, PRIMARY PRODUCTIVITY; Malhi Y, 2012, J ECOL, V100, P65, DOI 10.1111/j.1365-2745.2011.01916.x; Mitchard ETA, 2014, GLOBAL ECOL BIOGEOGR, V23, P935, DOI 10.1111/geb.12168; Mitchard Edward Ta, 2013, Carbon Balance Manag, V8, P10, DOI 10.1186/1750-0680-8-10; Monfreda C, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB002947; Neeck SP, 2015, PROC SPIE, V9639, DOI 10.1117/12.2199919; Olofsson J, 2008, VEG HIST ARCHAEOBOT, V17, P605, DOI 10.1007/s00334-007-0126-6; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Olson J.S., 1983, CARBON LIVE VEGETATI; Pan YD, 2013, ANNU REV ECOL EVOL S, V44, P593, DOI 10.1146/annurev-ecolsys-110512-135914; Pan YD, 2011, SCIENCE, V333, P988, DOI 10.1126/science.1201609; Pongratz J, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2009GB003488; Post WM, 1997, GLOBAL BIOGEOCHEM CY, V11, P99, DOI 10.1029/96GB03942; Potapov P, 2008, ECOL SOC, V13, DOI 10.5751/es-02670-130251; Potter CS, 1999, BIOSCIENCE, V49, P769, DOI 10.2307/1313568; Prentice IC, 2011, NEW PHYTOL, V189, P988, DOI 10.1111/j.1469-8137.2010.03620.x; Ramankutty N, 1999, GLOBAL BIOGEOCHEM CY, V13, P997, DOI 10.1029/1999GB900046; Ruesch A., 2008, NEW IPCC TIER 1 GLOB; Saatchi S, 2015, GLOBAL ECOL BIOGEOGR, V24, P606, DOI 10.1111/geb.12256; Saatchi SS, 2011, P NATL ACAD SCI USA, V108, P9899, DOI 10.1073/pnas.1019576108; Sabine CL, 2004, SCIENCE, V305, P367, DOI 10.1126/science.1097403; Sanderson EW, 2002, BIOSCIENCE, V52, P891, DOI 10.1641/0006-3568(2002)052[0891:THFATL]2.0.CO;2; Santoro M, 2015, REMOTE SENS ENVIRON, V168, P316, DOI 10.1016/j.rse.2015.07.005; Saugier B., 2001, TERRESTRIAL GLOBAL P, P543, DOI [10.1016/B978-0-12-505290-0.X5000-5, DOI 10.1016/B978-012505290-0/50024-7]; Scholes RJ, 2009, TRENDS ECOL EVOL, V24, P427, DOI 10.1016/j.tree.2009.03.006; Schulze ED, 2012, GCB BIOENERGY, V4, P611, DOI 10.1111/j.1757-1707.2012.01169.x; Searchinger TD, 2015, NAT CLIM CHANGE, V5, P481, DOI [10.1038/nclimate2584, 10.1038/NCLIMATE2584]; Shevliakova E, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2007GB003176; Simard M, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2011JG001708; Stocker BD, 2014, TELLUS B, V66, DOI 10.3402/tellusb.v66.23188; Stocker T F, 2013, CLIM CHANG 2013 PHYS; Strassmann KM, 2008, TELLUS B, V60, P583, DOI 10.1111/j.1600-0889.2008.00340.x; Thurner M, 2014, GLOBAL ECOL BIOGEOGR, V23, P297, DOI 10.1111/geb.12125; Tian HQ, 2015, GLOBAL BIOGEOCHEM CY, V29, P775, DOI 10.1002/2014GB005021; Tuxen R., 1956, ANGEW PFLANZENSOZIOL, V13, P5; Watson RT, 2000, LAND USE LAND USE CH; West PC, 2010, P NATL ACAD SCI USA, V107, P19645, DOI 10.1073/pnas.1011078107; WHITTAKER RH, 1973, HUM ECOL, V1, P357, DOI 10.1007/BF01536732; Yu ZC, 2011, HOLOCENE, V21, P761, DOI 10.1177/0959683610386982; Zhao MS, 2005, REMOTE SENS ENVIRON, V95, P164, DOI 10.1016/j.rse.2004.12.011; Zika M, 2009, ECOL ECON, V69, P310, DOI 10.1016/j.ecolecon.2009.06.014; Zomer RJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep29987	80	284	291	53	430	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 4	2018	553	7686					73	+		10.1038/nature25138	http://dx.doi.org/10.1038/nature25138			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS4NI	29258288	Green Accepted, Green Submitted, Green Published			2022-12-28	WOS:000419769300032
J	Zheng, MX; Hua, XY; Feng, JT; Li, T; Lu, YC; Shen, YD; Cao, XH; Zhao, NQ; Lyu, JY; Xu, JG; Gu, YD; Xu, WD				Zheng, Mou-Xiong; Hua, Xu-Yun; Feng, Jun-Tao; Li, Tie; Lu, Ye-Chen; Shen, Yun-Dong; Cao, Xiao-Hua; Zhao, Nai-Qing; Lyu, Jia-Ying; Xu, Jian-Guang; Gu, Yu-Dong; Xu, Wen-Dong			Trial of Contralateral Seventh Cervical Nerve Transfer for Spastic Arm Paralysis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BRACHIAL-PLEXUS INJURIES; C7 TRANSFER; ROOT TRANSFER; CEREBRAL-PALSY; UPPER EXTREMITY; HAND MOVEMENTS; MEDIAN NERVE; STROKE; AVULSION; NEUROTIZATION	BACKGROUND Spastic limb paralysis due to injury to a cerebral hemisphere can cause long-term disability. We investigated the effect of grafting the contralateral C7 nerve from the nonparalyzed side to the paralyzed side in patients with spastic arm paralysis due to chronic cerebral injury. METHODS We randomly assigned 36 patients who had had unilateral arm paralysis for more than 5 years to undergo C7 nerve transfer plus rehabilitation (18 patients) or to undergo rehabilitation alone (18 patients). The primary outcome was the change from baseline to month 12 in the total score on the Fugl-Meyer upper-extremity scale (scores range from 0 to 66, with higher scores indicating better function). RESULTS The mean increase in Fugl-Meyer score in the paralyzed arm was 17.7 in the surgery group and 2.6 in the control group (difference, 15.1; 95% confidence interval, 12.2 to 17.9; P<0.001). With regard to improvements in spasticity as measured on the Modified Ashworth Scale (an assessment of five joints, each scored from 0 to 5, with higher scores indicating more spasticity), the smallest between-group difference was in the thumb, with 6, 9, and 3 patients in the surgery group having a 2-unit improvement, a 1-unit improvement, or no change, respectively, as compared with 1, 6, and 7 patients in the control group (P = 0.02). Transcranial magnetic stimulation and functional imaging showed connectivity between the ipsilateral hemisphere and the paralyzed arm. There were no significant differences from baseline to month 12 in power, tactile threshold, or two-point discrimination in the hand on the side of the donor graft. CONCLUSIONS In this single-center trial involving patients who had had unilateral arm paralysis due to chronic cerebral injury for more than 5 years, transfer of the C7 nerve from the nonparalyzed side to the side of the arm that was paralyzed was associated with a greater improvement in function and reduction of spasticity than rehabilitation alone over a period of 12 months. Physiological connectivity developed between the ipsilateral cerebral hemisphere and the paralyzed hand. (Funded by the National Natural Science Foundation of China and others; Chinese Clinical Trial Registry number, 13004466.)	[Zheng, Mou-Xiong; Hua, Xu-Yun; Feng, Jun-Tao; Li, Tie; Lu, Ye-Chen; Shen, Yun-Dong; Xu, Jian-Guang; Gu, Yu-Dong; Xu, Wen-Dong] Huashan Hosp, Dept Hand Surg, Shanghai, Peoples R China; [Zheng, Mou-Xiong; Hua, Xu-Yun; Feng, Jun-Tao; Li, Tie; Lu, Ye-Chen; Shen, Yun-Dong; Xu, Jian-Guang; Gu, Yu-Dong; Xu, Wen-Dong] Natl Clin Res Ctr Aging & Med, Shanghai, Peoples R China; [Zhao, Nai-Qing; Lyu, Jia-Ying] Sch Publ Hlth, Dept Biostat, Shanghai, Peoples R China; [Xu, Wen-Dong] State Key Lab Med Neurobiol, Shanghai, Peoples R China; [Zheng, Mou-Xiong; Hua, Xu-Yun; Feng, Jun-Tao; Li, Tie; Lu, Ye-Chen; Shen, Yun-Dong; Xu, Jian-Guang; Gu, Yu-Dong; Xu, Wen-Dong] Fudan Univ, Minist Hlth, Key Lab Hand Reconstruct, Shanghai, Peoples R China; [Zheng, Mou-Xiong; Hua, Xu-Yun; Feng, Jun-Tao; Li, Tie; Lu, Ye-Chen; Shen, Yun-Dong; Xu, Jian-Guang; Gu, Yu-Dong; Xu, Wen-Dong] Shanghai Key Lab Peripheral Nerve & Microsurg, Shanghai, Peoples R China; [Zheng, Mou-Xiong; Hua, Xu-Yun; Feng, Jun-Tao; Li, Tie; Lu, Ye-Chen; Shen, Yun-Dong; Xu, Wen-Dong] Jingan Dist Cent Hosp, Dept Hand & Upper Extrem Surg, Shanghai, Peoples R China; [Cao, Xiao-Hua] Minist Educ, Key Lab Brain Funct Genom, Shanghai, Peoples R China; [Cao, Xiao-Hua] East China Normal Univ, Shanghai Key Lab Brain Funct Genom, Shanghai, Peoples R China	Fudan University; Fudan University; East China Normal University	Xu, WD (corresponding author), Fudan Univ, Huashan Hosp, Dept Hand Surg, 12 Middle Wulumuqi Rd, Shanghai 200040, Peoples R China.	wendongxu@fudan.edu.cn	gu, yu/GSD-4507-2022	Hua, Xu-Yun/0000-0002-2935-7551; Xu, Jian-Guang/0000-0002-9091-8151; lu, ye-chen/0000-0001-9727-753X	National Natural Science Foundation of China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Funded by the National Natural Science Foundation of China and others; Chinese Clinical Trial Registry number, 13004466.	Beaulieu JY, 2006, MICROSURG, V26, P303, DOI 10.1002/micr.20243; BOHANNON RW, 1987, PHYS THER, V67, P206, DOI 10.1093/ptj/67.2.206; Buetefisch CM, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00214; Chen L, 2007, J HAND SURG-AM, V32A, P96, DOI 10.1016/j.jhsa.2006.05.013; Chorna O, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-010212; Chuang D C, 1999, Tech Hand Up Extrem Surg, V3, P185, DOI 10.1097/00130911-199909000-00007; Dobkin BH, 2005, NEW ENGL J MED, V352, P1677, DOI 10.1056/NEJMcp043511; Friston K, 2007, STATISTICAL PARAMETRIC MAPPING: THE ANALYSIS OF FUNCTIONAL BRAIN IMAGES, P1; FUGLMEYER AR, 1975, SCAND J REHABIL MED, V7, P13; GU YD, 1992, J HAND SURG-BRIT EUR, V17B, P518, DOI 10.1016/S0266-7681(05)80235-9; Hua XY, 2015, NEUROSURGERY, V76, P187, DOI 10.1227/NEU.0000000000000590; Jankowska E, 2006, NEUROSCIENTIST, V12, P67, DOI 10.1177/1073858405283392; Kwakkel G., 1999, PHYSIOTHERAPY, V85, P377, DOI DOI 10.1016/S0031-9406(05)67198-2; Leafblad ND, 2015, J HAND SURG-AM, V40, P1035, DOI 10.1016/j.jhsa.2014.11.025; Leblebicioglu G, 2016, J HAND SURG-EUR VOL, V41, P863, DOI 10.1177/1753193416638999; Legg L, 2004, LANCET, V363, P352; Lo AC, 2010, NEW ENGL J MED, V362, P1772, DOI 10.1056/NEJMoa0911341; Lotze M, 2006, J NEUROSCI, V26, P6096, DOI 10.1523/JNEUROSCI.4564-05.2006; Makki D, 2014, J CHILD ORTHOP, V8, P215, DOI 10.1007/s11832-014-0593-0; McGuiness CN, 2002, J HAND SURG-BRIT EUR, V27B, P159, DOI 10.1054/jhsb.2001.0665; NARAKAS AO, 1988, CLIN ORTHOP RELAT R, P43; Olawale O, 2015, PHYSIOTHERAPY S1, V101, pe1135; Sauser K, 2014, ANN EMERG MED, V64, P235, DOI 10.1016/j.annemergmed.2014.01.034; Seidler RD, 2004, NEUROIMAGE, V22, P1775, DOI 10.1016/j.neuroimage.2004.05.003; Songcharoen P, 2001, J HAND SURG-AM, V26A, P1058, DOI 10.1053/jhsu.2001.27764; Terzis JK, 2008, HAND CLIN, V24, P389, DOI 10.1016/j.hcl.2008.04.003; Terzis JK, 2009, PLAST RECONSTR SURG, V123, P927, DOI 10.1097/PRS.0b013e31819ba48a; Tu YK, 2014, MICROSURG, V34, P91, DOI 10.1002/micr.22148; Verstynen T, 2005, J NEUROPHYSIOL, V93, P1209, DOI 10.1152/jn.00720.2004; Waikakul S, 1999, J HAND SURG-BRIT EUR, V24B, P556, DOI 10.1054/jhsb.1999.0264; Xu WD, 2011, MICROSURG, V31, P404, DOI 10.1002/micr.20877; Ziemann U, 1999, J PHYSIOL-LONDON, V518, P895, DOI 10.1111/j.1469-7793.1999.0895p.x	32	86	104	9	79	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 4	2018	378	1					22	34		10.1056/NEJMoa1615208	http://dx.doi.org/10.1056/NEJMoa1615208			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FR7BE	29262271	Bronze			2022-12-28	WOS:000419220500014
J	Bancks, MP; Kershaw, K; Carson, AP; Gordon-Larsen, P; Schreiner, PJ; Carnethon, MR				Bancks, Michael P.; Kershaw, Kiarri; Carson, April P.; Gordon-Larsen, Penny; Schreiner, Pamela J.; Carnethon, Mercedes R.			Association of Modifiable Risk Factors in Young Adulthood With Racial Disparity in Incident Type 2 Diabetes During Middle Adulthood	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ATHEROSCLEROSIS RISK; CARDIOVASCULAR-DISEASE; INCIDENCE TRENDS; WHITE ADULTS; COMMUNITIES; MELLITUS; HEALTH; CARDIA; BLACK; DETERMINANTS	IMPORTANCE In the United States, black individuals are twice as likely to develop type 2 diabetes compared with white individuals, and these disparities are particularly pronounced in young and middle age. Prior studies have identified differences in traditional risk factors that may be associated with racial disparities in diabetes incidence but have not simultaneously adjusted for risk factors measured across multiple domains (eg, the individual and the environment) and updated over time. OBJECTIVE To determine the relative associations of modifiable biological, neighborhood, psychosocial, socioeconomic, and behavioral factors in young adulthood with the observed racial disparity in diabetes incidence between middle-aged black and white individuals. DESIGN, SETTING, AND PARTICIPANTS Black and white men and women from the observational Coronary Artery Risk Development in Young Adults study, aged 18 to 30 years, without diabetes at baseline (1985-1986; N = 4251) were observed through 2015-2016. Sex-stratified multivariable-adjusted Cox proportional hazards modeling, with adjustment for time-updated covariates, was used to estimate risk for incident diabetes. Percent reduction in the beta coefficient (the logarithm used to calculate the hazard ratio [HR]) was calculated to compare black to white participants. EXPOSURES Self-identified race and factors including biological (eg, fasting glucose, body mass index), neighborhood (racial segregation and tract-level poverty), psychosocial (depressive symptoms), socioeconomic (eg, personal and parental educational attainment, current employment), and behavioral (eg, regular alcohol consumption, smoking) domains. MAIN OUTCOMES AND MEASURES Incident type 2 diabetes mellitus. RESULTS The mean (SD) age at baselinewas 25 (3.6) years, 49%(n = 2066) of the sample was black, and 54%(n = 2304) were women. Over a mean follow-up of 24.5 years, 504 cases of incident diabetes were identified. Using sex-stratified multivariable-adjusted Cox proportional hazards models, black women and men were more likely to develop diabetes than white men and women (blackwomen: HR, 2.86 [95% CI, 2.19-3.72] and risk difference [RD], 89 cases/1000 people [95% CI, 61-117]; black men: HR, 1.67 [95% CI, 1.28-2.17] and RD, 47 cases/1000 people [95% CI, 15-78]) after adjustment for age and center. Biological factors were most strongly associated with the disparity in diabetes risk between black and white individuals for women (percent reduction in beta, 112%) and men (percent reduction in beta, 86%). There was no longer disparity in diabetes risk between black and white middle-aged adults after adjustment for biological, neighborhood, psychosocial, socioeconomic, and behavioral factors measured over time (HR for women, 0.79 [95% CI, 0.55-1.14]; HR for men, 0.92 [95% CI, 0.62-1.38]). CONCLUSIONS AND RELEVANCE In this cohort study comparing black and white participants, there was a statistically significant increased risk of incident type 2 diabetes among black women and men. However, after adjustment for modifiable risk factors during young adulthood, the disparity was no longer statistically significant.	[Bancks, Michael P.; Kershaw, Kiarri; Carnethon, Mercedes R.] Northwestern Univ, Chicago, IL 60611 USA; [Carson, April P.] Univ Alabama Birmingham, Birmingham, AL USA; [Gordon-Larsen, Penny] Univ North Carolina Chapel Hill, Chapel Hill, NC USA; [Schreiner, Pamela J.] Univ Minnesota, Minneapolis, MN USA	Northwestern University; University of Alabama System; University of Alabama Birmingham; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of Minnesota System; University of Minnesota Twin Cities	Bancks, MP (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, 680 N Lake Shore Dr,Ste 1400, Chicago, IL 60611 USA.	michael.bancks@northwestern.edu		Carson, April/0000-0002-7970-6756; Carnethon, Mercedes/0000-0001-7035-0848; Schreiner, Pamela/0000-0002-9920-6257	National Heart, Lung, and Blood Institute (NHLBI); University of Alabama at Birmingham [HHSN268201300025C, HHSN268201300026C]; Northwestern University [HHSN268201300027C]; University of Minnesota [HHSN268201300028C]; Kaiser Foundation Research Institute [HHSN268201300029C]; Johns Hopkins University School of Medicine [HHSN268200900041C]; National Institute on Aging (NIA); NIA [AG0005]; NHLBI [AG0005, R01HL114091, T32HL069771]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P2CHD050924] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL069771, R01HL114091] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK092949] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); University of Alabama at Birmingham; Northwestern University; University of Minnesota(University of Minnesota System); Kaiser Foundation Research Institute; Johns Hopkins University School of Medicine(Johns Hopkins University); National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The Coronary Artery Risk Development in Young Adults Study (CARDIA) is conducted and supported by the National Heart, Lung, and Blood Institute (NHLBI) in collaboration with the University of Alabama at Birmingham (HHSN268201300025C and HHSN268201300026C), Northwestern University (HHSN268201300027C), University of Minnesota (HHSN268201300028C), Kaiser Foundation Research Institute (HHSN268201300029C), and Johns Hopkins University School of Medicine (HHSN268200900041C). CARDIA is also partially supported by the Intramural Research Program of the National Institute on Aging (NIA) and an intra-agency agreement between NIA and NHLBI (AG0005). The neighborhood data were collected with support from NHLBI (R01HL114091). Dr Bancks reports support from the NHLBI award T32HL069771 to conduct the current work.	American Diabetes Association, 2017, Diabetes Care, V40, pS6; [Anonymous], 1993, Schweiz Z Sportmed, V41, P127; [Anonymous], 1979, AM REV RESPIR DIS, V119, P831; [Anonymous], 1995, AM J RESP CRIT CARE, V152, P1107, DOI 10.1164/ajrccm.152.3.7663792; Bancks MP, 2017, NEUROLOGY, V89, P680, DOI 10.1212/WNL.0000000000004222; Brancati FL, 2000, JAMA-J AM MED ASSOC, V283, P2253, DOI 10.1001/jama.283.17.2253; Carnethon MR, 2002, DIABETES CARE, V25, P1358, DOI 10.2337/diacare.25.8.1358; Chatterjee R, 2014, J GEN INTERN MED, V29, P290, DOI 10.1007/s11606-013-2569-z; FRIEDMAN GD, 1988, J CLIN EPIDEMIOL, V41, P1105, DOI 10.1016/0895-4356(88)90080-7; Geiss LS, 2014, JAMA-J AM MED ASSOC, V312, P1218, DOI 10.1001/jama.2014.11494; GETIS A, 1992, GEOGR ANAL, V24, P189, DOI 10.1111/j.1538-4632.1992.tb00261.x; Golden SH, 2012, J CLIN ENDOCR METAB, V97, pE1579, DOI 10.1210/jc.2012-2043; Jacobs David R Jr, 1989, J Cardiopulm Rehabil, V9, P448, DOI 10.1097/00008483-198911000-00003; Kershaw KN, 2015, CIRCULATION, V131, P141, DOI 10.1161/CIRCULATIONAHA.114.011345; Kulick ER, 2016, PREV MED, V83, P31, DOI 10.1016/j.ypmed.2015.11.023; Kurian AK, 2007, ETHNIC DIS, V17, P143; LIPTON RB, 1993, AM J EPIDEMIOL, V138, P826, DOI 10.1093/oxfordjournals.aje.a116786; Liu Kiang, 1994, Ethnicity and Disease, V4, P15; Matthews KA, 2002, HYPERTENSION, V39, P772, DOI 10.1161/hy0302.105682; Mayer-Davis EJ, 2017, NEW ENGL J MED, V376, P1419, DOI 10.1056/NEJMoa1610187; McBean AM, 2004, DIABETES CARE, V27, P2317, DOI 10.2337/diacare.27.10.2317; MCDONALD A, 1991, J AM DIET ASSOC, V91, P1104; Menke A, 2015, JAMA-J AM MED ASSOC, V314, P1021, DOI 10.1001/jama.2015.10029; Piccolo RS, 2016, DIABETES CARE, V39, P1208, DOI 10.2337/dc15-2255; Quinones AR, 2013, ETHNIC DIS, V23, P310; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Resnick HE, 1998, DIABETES CARE, V21, P1828, DOI 10.2337/diacare.21.11.1828; Spanakis EK, 2013, CURR DIABETES REP, V13, P814, DOI 10.1007/s11892-013-0421-9; US Department of Health Human Services, 2017, DIET GUID AM 2015 20; Walker RJ, 2014, ENDOCRINE, V47, P29, DOI 10.1007/s12020-014-0195-0; Warnick G R, 1986, Methods Enzymol, V129, P101; WARNICK GR, 1982, CLIN CHEM, V28, P1379; WEISSMAN MM, 1977, AM J EPIDEMIOL, V106, P203, DOI 10.1093/oxfordjournals.aje.a112455	33	61	61	1	20	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 26	2017	318	24					2457	2465		10.1001/jama.2017.19546	http://dx.doi.org/10.1001/jama.2017.19546			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FQ9ZO	29279935	Bronze, Green Published			2022-12-28	WOS:000418720700023
J	Brynjolfsson, E; Mitchell, T				Brynjolfsson, Erik; Mitchell, Tom			Profound change is coming, but roles for humans remain	SCIENCE			English	Editorial Material									[Brynjolfsson, Erik] MIT, Sloan Sch Management, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Brynjolfsson, Erik] Natl Bur Econ Res, Cambridge, MA 02138 USA; [Mitchell, Tom] Carnegie Mellon Univ, Pittsburgh, PA 15213 USA	Massachusetts Institute of Technology (MIT); National Bureau of Economic Research; Carnegie Mellon University	Brynjolfsson, E (corresponding author), MIT, Sloan Sch Management, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Brynjolfsson, E (corresponding author), Natl Bur Econ Res, Cambridge, MA 02138 USA.	erikb@mit.edu	Brynjolfsson, Erik/H-2412-2012		MIT Initiative on the Digital Economy; U.S. Air Force Office of Scientific Research	MIT Initiative on the Digital Economy; U.S. Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR))	The authors acknowledge helpful discussions and comments from D. Acemoglu, D. Autor, S. Benzell, Y. LeCun, F. Levy, A. Ng, T. Poggio, D. Rus, G. Saint-Jacques, Y. Shavit, C. Syverson, S. Thrun, and especially D. Rock. E.B. acknowledges funding from the MIT Initiative on the Digital Economy for this research. T.M. acknowledges support from the U.S. Air Force Office of Scientific Research.	Acemoglu D., 2016, 22252 NBER; Autor D., 2014, RED RES BANK KANS CI; Autor DH, 2013, AM ECON REV, V103, P1553, DOI 10.1257/aer.103.5.1553; Autor DH, 2003, Q J ECON, V118, P1279, DOI 10.1162/003355303322552801; Brynjolfsson E., 2013, HDB ORG EC, P11, DOI DOI 10.1515/9781400845354-003; Brynjolfsson E., 2017, ARTIF INTELL; Brynjolfsson E., 2017, HARVARD BUS REV, V7, P3; Coates A., 2013, INT C MACHINE LEARNI, P1337; Cybenko G., 1989, Mathematics of Control, Signals, and Systems, V2, P303, DOI 10.1007/BF02551274; Deming DJ, 2017, Q J ECON, V132, P1593, DOI 10.1093/qje/qjx022; Deng J., 2009, P CVPR; Esteva A, 2017, NATURE, V542, P115, DOI 10.1038/nature21056; Gunning D., 2017, EXPLAINABLE ARTIFICI; Legg Shane, 2007, FRONTIERS ARTIFICIAL, P17, DOI DOI 10.1007/978-3-642-44958-1_; Litjens G., 2017, ARXIV170205747CSCV; Manyika J., 2017, FUTURE WORKS AUTOMAT; Milgrom P, 1996, AM ECON REV, V86, P173; Mitchell T., 1990, ML ARTIFICIAL INTELL, VIII; Mnih V, 2015, NATURE, V518, P529, DOI 10.1038/nature14236; National Academies of Sciences Engineering and Medicine, 2017, INF TECHN US WORKF A; Ng A., 2016, HARVARD BUS REV; Polanyi M., 1966, TACIT DIMENSION; Remus D., 2017, GEORGETOWN J LEG SUM, P501	23	222	227	14	86	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 22	2017	358	6370					1530	1534		10.1126/science.aap8062	http://dx.doi.org/10.1126/science.aap8062			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FQ6BO	29269459				2022-12-28	WOS:000418448000033
J	Takeuchi, N; Kawakatsu, H; Shiobara, H; Isse, T; Sugioka, H; Ito, A; Utada, H				Takeuchi, Nozomu; Kawakatsu, Hitoshi; Shiobara, Hajime; Isse, Takehi; Sugioka, Hiroko; Ito, Aki; Utada, Hisashi			Determination of intrinsic attenuation in the oceanic lithosphere-asthenosphere system	SCIENCE			English	Article							SURFACE-WAVE ANALYSIS; TIME WINDOW ANALYSIS; POLYCRYSTAL ANELASTICITY; SEISMIC ATTENUATION; STRUCTURE BENEATH; WESTERN PACIFIC; GUIDED-WAVES; SEA-FLOOR; S-WAVES; SCATTERING	We recorded P and S waves traveling through the oceanic lithosphere-asthenosphere system (LAS) using broadband ocean-bottom seismometers in the northwest Pacific, and we quantitatively separated the intrinsic (anelastic) and extrinsic (scattering) attenuation effects on seismic wave propagation to directly infer the thermomechanical properties of the oceanic LAS. The strong intrinsic attenuation in the asthenosphere obtained at higher frequency (similar to 3 hertz) is comparable to that constrained at lower frequency (similar to 100 seconds) by surface waves and suggests frequency-independent anelasticity, whereas the intrinsic attenuation in the lithosphere is frequency dependent. This difference in frequency dependence indicates that the strong and broad peak dissipation recently observed in the laboratory exists only in the asthenosphere and provides new insight into what distinguishes the asthenosphere from the lithosphere.	[Takeuchi, Nozomu; Kawakatsu, Hitoshi; Shiobara, Hajime; Isse, Takehi; Utada, Hisashi] Univ Tokyo, Earthquake Res Inst, Bunkyo Ku, Yayoi 1-1-1, Tokyo 1130032, Japan; [Sugioka, Hiroko] Kobe Univ, Grad Sch Sci, Nada Ku, 1-1 Rokkodai Cho, Kobe, Hyogo 6578501, Japan; [Ito, Aki] Japan Agcy Marine Earth Sci & Technol, Natsushima Cho 2-15, Yokosuka, Kanagawa 2370061, Japan	University of Tokyo; Kobe University; Japan Agency for Marine-Earth Science & Technology (JAMSTEC)	Takeuchi, N (corresponding author), Univ Tokyo, Earthquake Res Inst, Bunkyo Ku, Yayoi 1-1-1, Tokyo 1130032, Japan.	takeuchi@eri.u-tokyo.ac.jp	Utada, Hisashi/S-8093-2016; Takeuchi, Nozomu/AAJ-3031-2020; Sugioka, Hiroko/N-5368-2015	Utada, Hisashi/0000-0001-5885-5675; Takeuchi, Nozomu/0000-0003-3636-7800; Sugioka, Hiroko/0000-0003-1883-4049; Isse, Takehi/0000-0001-9087-8711	KAKENHI from the Japan Society for the Promotion of Science [JP22000003, JP25400439, JP15H05832]; Grants-in-Aid for Scientific Research [15H03720, 15K13558] Funding Source: KAKEN	KAKENHI from the Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was partially supported by KAKENHI grants JP22000003, JP25400439, and JP15H05832 from the Japan Society for the Promotion of Science. We thank Y. Takei for useful discussions. All of the waveform data used in this study are available at http://ohpdmc.eri.u-tokyo.ac.jp/.	Anderson D.L., 1970, PHYS EARTH PLANET IN, V3, P41, DOI DOI 10.1016/0031-9201(70)90042-7; Booth CM, 2014, J GEOPHYS RES-SOL EA, V119, P3448, DOI 10.1002/2013JB010589; BUTLER R, 1987, J GEOPHYS RES-SOLID, V92, P1383, DOI 10.1029/JB092iB02p01383; Carcole E, 2010, GEOPHYS J INT, V180, P268, DOI 10.1111/j.1365-246X.2009.04394.x; Dalton CA, 2008, J GEOPHYS RES-SOL EA, V113, DOI 10.1029/2007JB005429; DZIEWONSKI AM, 1981, PHYS EARTH PLANET IN, V25, P297, DOI 10.1016/0031-9201(81)90046-7; Faul U, 2015, ANNU REV EARTH PL SC, V43, P541, DOI 10.1146/annurev-earth-060313-054732; FEHLER M, 1992, GEOPHYS J INT, V108, P787, DOI 10.1111/j.1365-246X.1992.tb03470.x; Hawley WB, 2016, SCIENCE, V353, P1406, DOI 10.1126/science.aad8104; Hirth G, 1996, EARTH PLANET SC LETT, V144, P93, DOI 10.1016/0012-821X(96)00154-9; HOSHIBA M, 1993, J GEOPHYS RES-SOL EA, V98, P15809, DOI 10.1029/93JB00347; Jackson I, 2004, J GEOPHYS RES-SOL EA, V109, DOI 10.1029/2003JB002406; Jackson I., 2015, TREATISE GEOPHYS, V2nd, P539, DOI [10.1016/B978-0-444-53802-4.00045-2, DOI 10.1016/B978-0-444-53802-4.00045-2]; Jackson I, 2010, PHYS EARTH PLANET IN, V183, P151, DOI 10.1016/j.pepi.2010.09.005; Kawakatsu H, 2017, ANNU REV EARTH PL SC, V45, P139, DOI 10.1146/annurev-earth-063016-020319; Kawakatsu H, 2009, SCIENCE, V324, P499, DOI 10.1126/science.1169499; Kennett BLN, 2014, GEOPHYS J INT, V199, P614, DOI 10.1093/gji/ggu286; Kennett BLN, 2013, GEOPHYS J INT, V195, P1862, DOI 10.1093/gji/ggt344; KENNETT BLN, 1991, GEOPHYS J INT, V105, P429, DOI 10.1111/j.1365-246X.1991.tb06724.x; Lin PYP, 2016, NATURE, V535, P538, DOI 10.1038/nature18012; MALLICK S, 1990, GEOPHYS J INT, V100, P235, DOI 10.1111/j.1365-246X.1990.tb02483.x; Naif S, 2013, NATURE, V495, P356, DOI 10.1038/nature11939; Romanowicz B., 2015, TREATISE GEOPHYS, V1, P789, DOI [10.1016/B978-0-444-53802-4.00021-X, DOI 10.1016/B978-0-444-53802-4.00021-X]; Schmerr N, 2012, SCIENCE, V335, P1480, DOI 10.1126/science.1215433; SERENO TJ, 1987, J GEOPHYS RES-SOLID, V92, P3541, DOI 10.1029/JB092iB05p03541; Shearer PM, 2004, GEOPHYS J INT, V158, P1103, DOI 10.1111/j.1365-246X.2004.02378.x; Shito A, 2015, J GEOPHYS RES-SOL EA, V120, P5238, DOI 10.1002/2014JB011814; Shito A, 2013, GEOPHYS RES LETT, V40, P1708, DOI 10.1002/grl.50330; Stern TA, 2015, NATURE, V518, P85, DOI 10.1038/nature14146; Takei Y, 2017, ANNU REV EARTH PL SC, V45, P447, DOI 10.1146/annurev-earth-063016-015820; Takei Y, 2014, J GEOPHYS RES-SOL EA, V119, P5414, DOI 10.1002/2014JB011146; Takeo A, 2016, J GEOPHYS RES-SOL EA, V121, P1927, DOI 10.1002/2015JB012429; Takeo A, 2013, J GEOPHYS RES-SOL EA, V118, P2878, DOI 10.1002/jgrb.50219; Takeuchi N, 2016, J GEOPHYS RES-SOL EA, V121, P3428, DOI 10.1002/2015JB012661; Yamauchi H, 2016, J GEOPHYS RES-SOL EA, V121, P7790, DOI 10.1002/2016JB013316; Yang YJ, 2007, EARTH PLANET SC LETT, V258, P260, DOI 10.1016/j.epsl.2007.03.040	36	16	16	0	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 22	2017	358	6370					1593	+		10.1126/science.aao3508	http://dx.doi.org/10.1126/science.aao3508			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ6BO	29269473				2022-12-28	WOS:000418448000059
J	Gallus, A				Gallus, Alexander			Review: In patients with a first VTE, extended testing for undiagnosed cancer does not reduce mortality	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Gallus, Alexander] Flinders Univ South Australia, Adelaide, SA, Australia	Flinders University South Australia	Gallus, A (corresponding author), Flinders Univ South Australia, Adelaide, SA, Australia.			Gallus, Alexander/0000-0001-7347-9989				Carrier M, 2008, ANN INTERN MED, V149, P323, DOI 10.7326/0003-4819-149-5-200809020-00007; Merli GJ, 2017, ANN INTERN MED, V167, P440, DOI 10.7326/M17-2030; van Es N, 2017, ANN INTERN MED, V167, P410, DOI 10.7326/M17-0868	3	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 19	2017	167	12					JC64	JC64		10.7326/ACPJC-2017-167-12-064	http://dx.doi.org/10.7326/ACPJC-2017-167-12-064			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FQ3SD	29255854				2022-12-28	WOS:000418276000004
J	Raco, DL				Raco, Dominic L.			After PCI in AF, dual antithrombotic therapy with dabigatran reduced bleeding compared with triple therapy	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							ATRIAL-FIBRILLATION		[Raco, Dominic L.] McMaster Univ, Hamilton, ON, Canada	McMaster University	Raco, DL (corresponding author), McMaster Univ, Hamilton, ON, Canada.							Gibson CM, 2016, NEW ENGL J MED, V375, P2423, DOI 10.1056/NEJMoa1611594; Ibanez B, 2018, KARDIOL POL, V76, P229, DOI 10.5603/KP.2018.0041; January CT, 2014, J AM COLL CARDIOL, V64, P2304, DOI 10.1016/j.jacc.2014.04.004; Sutton NR, 2016, J AM COLL CARDIOL, V68, P895, DOI 10.1016/j.jacc.2016.05.085	4	0	0	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 19	2017	167	12					JC70	JC70		10.7326/ACPJC-2017-167-12-070	http://dx.doi.org/10.7326/ACPJC-2017-167-12-070			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FQ3SD	29255860				2022-12-28	WOS:000418276000010
J	Hoffmann, D; Palumbo, F; Ravel, J; Roghmann, MC; Rowthorn, V; von Rosenvinge, E				Hoffmann, Diane; Palumbo, Francis; Ravel, Jacques; Roghmann, Mary-Claire; Rowthorn, Virginia; von Rosenvinge, Erik			Improving regulation of microbiota transplants	SCIENCE			English	Editorial Material									[Hoffmann, Diane; Palumbo, Francis; Ravel, Jacques; Roghmann, Mary-Claire; Rowthorn, Virginia; von Rosenvinge, Erik] Univ Maryland, Baltimore, MD 21201 USA; [Roghmann, Mary-Claire; von Rosenvinge, Erik] Vet Affairs Maryland Hlth Care Syst, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore	Hoffmann, D (corresponding author), Univ Maryland, Baltimore, MD 21201 USA.	dhoffmann@law.umaryland.edu	Ravel, Jacques/D-2530-2009	von Rosenvinge, Erik C./0000-0002-1862-7288	National Institute of Allergy and Infectious Diseases [R21AI119633]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI119633] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institute of Allergy and Infectious Diseases (R21AI119633). The opinions expressed are solely those of the aut hors. The authors acknowledge the valuable contributions of the members of the working group (4).	American College of Obstetricians and Gynecologists, PRACT ADV VAG SEED; Barbut F., CLOSTRIDIUM DIFFICIL; Cammarota G, 2015, ALIMENT PHARM THER, V41, P835, DOI 10.1111/apt.13144; Food U.S., 2016, ENF POL REG IN PRESS; Kelly CR, 2016, ANN INTERN MED, V165, P609, DOI 10.7326/M16-0271; Khonits A., 2016, FDA2013D0811; Laakmann Anna B., 2015, CARDOZO L REV, V36, P913; Lessa FC, 2015, NEW ENGL J MED, V372, P825, DOI [10.1056/NEJMoa1408913, 10.1056/NEJMc1505190]; Petrof EO, 2014, GASTROENTEROLOGY, V146, P1573, DOI 10.1053/j.gastro.2014.01.004; Przychodzki Anna, 2016, COMMENT DOCKET NO FD; Riley MF, 2015, J LAW BIOSCI, V2, P742, DOI 10.1093/jlb/lsv046; Sachs RE, 2015, J LAW BIOSCI, V2, P396, DOI 10.1093/jlb/lsv032; Shin H, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0075729, 10.1371/journal.pone.0081330]; Smith MB, 2014, NATURE, V506, P290, DOI 10.1038/506290a; U.S. Food and Drug Administration, 2012, TISS REF GROUP FY201; van Nood E, 2013, NEW ENGL J MED, V368, P407, DOI 10.1056/NEJMoa1205037	16	38	39	2	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 15	2017	358	6369					1390	1391		10.1126/science.aaq0034	http://dx.doi.org/10.1126/science.aaq0034			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FP8TH	29242336	Green Accepted			2022-12-28	WOS:000417918500024
J	Hosseinzadeh, P; Bhardwaj, G; Mulligan, VK; Shortridge, MD; Craven, TW; Pardo-Avila, F; Retti, SA; Kim, DE; Silva, DA; Ibrahim, YM; Webb, IK; Cort, JR; Adkins, JN; Varani, G; Baker, D				Hosseinzadeh, Parisa; Bhardwaj, Gaurav; Mulligan, Vikram Khipple; Shortridge, Matthew D.; Craven, Timothy W.; Pardo-Avila, Fatima; Retti, Stephen A.; Kim, David E.; Silva, Daniel-Adriano; Ibrahim, Yehia M.; Webb, Ian K.; Cort, John R.; Adkins, Joshua N.; Varani, Gabriele; Baker, David			Comprehensive computational design of ordered peptide macrocycles	SCIENCE			English	Article							MOLECULAR-STRUCTURE DETERMINATION; DE-NOVO DESIGN; CONSTRAINED PEPTIDES; CYCLIC-PEPTIDES; XPLOR-NIH; FUTURE; LIBRARIES; PROTEINS; DRUGS	Mixed-chirality peptide macrocycles such as cyclosporine are among the most potent therapeutics identified to date, but there is currently no way to systematically search the structural space spanned by such compounds. Natural proteins do not provide a useful guide: Peptide macrocycles lack regular secondary structures and hydrophobic cores, and can contain local structures not accessible with L-amino acids. Here, we enumerate the stable structures that can be adopted by macrocyclic peptides composed of L- and c-amino acids by near-exhaustive backbone sampling followed by sequence design and energy landscape calculations. We identify more than 200 designs predicted to fold into single stable structures, many times more than the number of currently available unbound peptide macrocycle structures. Nuclear magnetic resonance structures of 9 of 12 designed 7- to 10-residue macrocycles, and three 11- to 14-residue bicyclic designs, are close to the computational models. Our results provide a nearly complete coverage of the rich space of structures possible for short peptide macrocycles and vastly increase the available starting scaffolds for both rational drug design and library selection methods.	[Hosseinzadeh, Parisa; Bhardwaj, Gaurav; Mulligan, Vikram Khipple; Craven, Timothy W.; Retti, Stephen A.; Kim, David E.; Silva, Daniel-Adriano; Baker, David] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Hosseinzadeh, Parisa; Bhardwaj, Gaurav; Mulligan, Vikram Khipple; Craven, Timothy W.; Retti, Stephen A.; Kim, David E.; Silva, Daniel-Adriano; Baker, David] Univ Washington, Inst Prot Design, Seattle, WA 98195 USA; [Shortridge, Matthew D.; Varani, Gabriele] Univ Washington, Dept Chem, Seattle, WA 98195 USA; [Pardo-Avila, Fatima] Stanford Univ, Dept Struct Biol, Sch Med, Stanford, CA 94305 USA; [Ibrahim, Yehia M.; Webb, Ian K.; Cort, John R.; Adkins, Joshua N.] Pacific Northwest Natl Lab, Biol Sci Div, Richland, WA 99352 USA; [Baker, David] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Stanford University; United States Department of Energy (DOE); Pacific Northwest National Laboratory; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Baker, D (corresponding author), Univ Washington, Dept Biochem, Seattle, WA 98195 USA.; Baker, D (corresponding author), Univ Washington, Inst Prot Design, Seattle, WA 98195 USA.; Baker, D (corresponding author), Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA.	dabaker@u.washington.edu	Baker, David/K-8941-2012; Webb, Ian/AAX-7705-2021	Baker, David/0000-0001-7896-6217; Webb, Ian/0000-0001-7223-8729; Hosseinzadeh, Parisa/0000-0002-3128-7433; Mulligan, Vikram/0000-0001-6038-8922; Rettie, Stephen/0000-0001-9797-6939; Ibrahim, Yehia/0000-0001-6085-193X; Kim, David E/0000-0002-0023-956X; Bhardwaj, Gaurav/0000-0001-6554-2335	NIH Ruth Kirschstein F32 award [F32GM120791-02]; Washington Research Foundation; NIH [GM1157490]; American Cancer Society [PF-13-056-01-RMC]; Pew Latin-American fellowship in biomedical sciences; CONACYT postdoctoral fellowship; NIH-National Institute of General Medical Sciences [5R01GM103834]; Howard Hughes Medical Instatute; Laboratory-Directed Research and Development (LDRD); Environmental Molecular Sciences Laboratory (EMSL), a U.S. Department of Energy (DOE Biological and Environmental Research national scientific use facility at Pacific Northwest National Laboratory; National Science Foundation Major Research Instrumentation program [ACI-1429830]; Amazon Web Services (AWS); Innovative and Novel Computational Impact on Theory and Experiment (INCITE) program; DOE Office of Science User Facility [DE-AC02-06CH11357]; Direct For Computer & Info Scie & Enginr [1429830] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM122543, F32GM120791, R01GM115749, R01GM103834] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG005136] Funding Source: NIH RePORTER	NIH Ruth Kirschstein F32 award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Washington Research Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Pew Latin-American fellowship in biomedical sciences; CONACYT postdoctoral fellowship; NIH-National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Instatute; Laboratory-Directed Research and Development (LDRD); Environmental Molecular Sciences Laboratory (EMSL), a U.S. Department of Energy (DOE Biological and Environmental Research national scientific use facility at Pacific Northwest National Laboratory; National Science Foundation Major Research Instrumentation program(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); Amazon Web Services (AWS); Innovative and Novel Computational Impact on Theory and Experiment (INCITE) program; DOE Office of Science User Facility(United States Department of Energy (DOE)); Direct For Computer & Info Scie & Enginr(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by NIH Ruth Kirschstein F32 award no. F32GM120791-02 (P.H.), Washington Research Foundation (P.H. and T.W.C.), NIH award GM1157490 (F.P.-A.), American Cancer Society postdoctoral feHowship PF-13-056-01-RMC (M.D.S.), Pew Latin-American fellowship in biomedical sciences (D.-A.S.), CONACYT postdoctoral fellowship (D.-A.S.), NIH-National Institute of General Medical Sciences 5R01GM103834 (G.V.), and Howard Hughes Medical Instatute (D.B.). The SLIM experiment was supported by Laboratory-Directed Research and Development (LDRD) and was performed in the Environmental Molecular Sciences Laboratory (EMSL), a U.S. Department of Energy (DOE Biological and Environmental Research national scientific use facility at Pacific Northwest National Laboratory. Computing resources were provided by the many volunteers who have donated the spare CPU (central processing unit) cycles of their cellular telephones and computers to the Rosetta@Home project; the Hyak supercomputer at the University of Washington; the XStrearn computational resource, supported by the National Science Foundation Major Research Instrumentation program (ACI-1429830): and Amazon Web Services (AWS) Credits for Research Grant (G.B). In addition, an award of computer time was provided by the Innovative and Novel Computational Impact on Theory and Experiment (INCITE) program. This research used resources of the Argonne Leadership Computing Facility, which is a DOE Office of Science User Facility supported and Contract DE-AC02-06CH11357. We thank A. Roy, H. Park, and many other members of the Baker lab for discussions; R. Flatland, S. Hari, W. J. Lloyd, L. Clitherd and A. Bucher for AWS resources and support; and B. Weitzner A. Nayyeri, S. Oychinnikoy, TJ. Brunette, D. Alonso, L Goldschmidt. and P. Vecchia.to for help with coding and computing resources. Conformational sampling was done with the Rosetta simple_cycpep_prediction application and peptide design was carried out with the rosetta scripts application, both of which are included in the Rosetta software suite. The Rosetta software suite is available free of charge to academic users and can be downloaded from hittp://www.rosettacommons.org. Instructions and inputs for running these applications, and all other data and coding necessary to support the results and conclusions, are in the supplementary materials. All the structures presented here are deposited in PDB and Biological Magnetic Resonance Band (BMRB) (design 71 PDB ID 6BE9, BMRB ID 30356: design 7.2: PDB ID 6BEW, BMRB ID 30364; design 7.3a: PDB ID 6BF3, BMRB ID 30365; design 7.3b: PDB ID 6BF5, BMRB ID 30366; design 8.1: PDB ID 6BE7, BMRB ID 30355; design 8.2: PDB ID 6BEN, BMRB ID 30357; design 9.1. PDB ID 6BEO, BMRB ID 30358; design 10.1: PDB ID 6BEQ, BMRB ID 30359; design 10.2: PDB ID 6BER, BMRB ID 30360; design 11 SS: PDB ID 6BES, BMRB ID 3,0361; design 12 SS: PDB ID 6BET, BMRB ID 30362; design 14_SS: PDB ID 6BEU, BMRB ID 30363) and THE original designs are provided in, database S3. D.B., G.B., P.H., and V.M. are inventors on a U.S. provisional patent application submitted by the University of Washington that covers computational design of small structured macrocycles. P.H., G.B, V.K.M., and D.B. developed research idea, the experimental approach and generated the designed macrocycles. D.B., P.H., G.B, V.K.M., M.D.S., F.P-A, I.W.C., S.A.R D.-A.S., I.K.W., and Y.M.I. performed experiments. All authors aikalyzed data. P.H. and V.K.M. generated neky computational tools with help from D.E.K. P.N., G.B., V.K.M, and D.B.; wrote 'Sc iramiscript, and all authors contributed suggestions. G.V. and D.B. supervised research.	Bhardwaj G, 2016, NATURE, V538, P329, DOI 10.1038/nature19791; Boyken SE, 2016, SCIENCE, V352, P680, DOI 10.1126/science.aad8865; Coutsias EA, 2004, J COMPUT CHEM, V25, P510, DOI 10.1002/jcc.10416; Craik DJ, 2013, CHEM BIOL DRUG DES, V81, P136, DOI 10.1111/cbdd.12055; Driggers EM, 2008, NAT REV DRUG DISCOV, V7, P608, DOI 10.1038/nrd2590; Fosgerau K, 2015, DRUG DISCOV TODAY, V20, P122, DOI 10.1016/j.drudis.2014.10.003; Gavenonis J, 2014, NAT CHEM BIOL, V10, P716, DOI [10.1038/NCHEMBIO.1580, 10.1038/nchembio.1580]; Gray BP, 2014, CHEM REV, V114, P1020, DOI 10.1021/cr400166n; Huang PS, 2016, NATURE, V537, P320, DOI 10.1038/nature19946; Huang PS, 2016, NAT CHEM BIOL, V12, P29, DOI [10.1038/NCHEMBIO.1966, 10.1038/nchembio.1966]; Huang PS, 2014, SCIENCE, V346, P481, DOI 10.1126/science.1257481; HUTCHINSON EG, 1994, PROTEIN SCI, V3, P2207, DOI 10.1002/pro.5560031206; Ibrahim YM, 2017, ANALYST, V142, P1010, DOI 10.1039/c7an00031f; Liu RW, 2017, ADV DRUG DELIVER REV, V110, P13, DOI 10.1016/j.addr.2016.05.009; Mandell DJ, 2009, NAT METHODS, V6, P551, DOI 10.1038/nmeth0809-551; Marasco D, 2008, CURR PROTEIN PEPT SC, V9, P447, DOI 10.2174/138920308785915209; Marcos E, 2017, SCIENCE, V355, P201, DOI 10.1126/science.aah7389; Nielsen DS, 2017, CHEM REV, V117, P8094, DOI 10.1021/acs.chemrev.6b00838; Obexer R, 2017, CURR OPIN CHEM BIOL, V38, P52, DOI 10.1016/j.cbpa.2017.02.020; Passioura T, 2017, CHEM COMMUN, V53, P1931, DOI 10.1039/c6cc06951g; RIZO J, 1992, ANNU REV BIOCHEM, V61, P387, DOI 10.1146/annurev.bi.61.070192.002131; Schwieters CD, 2006, PROG NUCL MAG RES SP, V48, P47, DOI 10.1016/j.pnmrs.2005.10.001; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Thapa P, 2014, INT J PEPT RES THER, V20, P545, DOI 10.1007/s10989-014-9421-0	24	102	103	8	88	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 15	2017	358	6369					1461	1466		10.1126/science.aap7577	http://dx.doi.org/10.1126/science.aap7577			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP8TH	29242347	Green Accepted			2022-12-28	WOS:000417918500048
J	Batty, GD; Zaninotto, P; Watt, RG; Bell, S				Batty, G. David; Zaninotto, Paola; Watt, Richard G.; Bell, Steven			Associations of pet ownership with biomarkers of ageing: population based cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							NORD-TRONDELAG HEALTH; OLDER-PEOPLE; DEPRESSIVE SYMPTOMS; DOG OWNERS; FOLLOW-UP; MORTALITY; RISK; LONELINESS; CAT	OBJECTIVE To examine the prospective relation between animal companionship and biomarkers of ageing in older people. DESIGN Analyses of data from the English Longitudinal Study of Ageing, an ongoing, open, prospective cohort study initiated in 2002-03. SETTING Nationally representative study from England. PARTICIPANTS 8785 adults (55% women) with a mean age of 67 years (SD 9) at pet ownership assessment in 2010-11 (wave 5). MAIN OUTCOME MEASURE Established biomarkers of ageing in the domains of physical, immunological, and psychological function, as assessed in 2012-13 (wave 6). RESULTS One third of study members reported pet ownership: 1619 (18%) owned a dog, 1077 (12%) a cat, and 274 (3%) another animal. After adjustment for a range of covariates, there was no evidence of a clear association of any type of pet ownership with walking speed, lung function, chair rise time, grip strength, leg raises, balance, three markers of systemic inflammation, memory, or depressive symptoms. CONCLUSION In this population of older adults, the companionship of creatures great and small seems to essentially confer no relation with standard ageing phenotypes.	[Batty, G. David; Zaninotto, Paola; Watt, Richard G.] UCL, Dept Epidemiol & Publ Hlth, London, England; [Bell, Steven] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge, England	University of London; University College London; University of Cambridge	Batty, GD (corresponding author), UCL, Dept Epidemiol & Publ Hlth, London, England.	david.batty@ucl.ac.uk	Batty, GD/Y-4401-2018	Batty, GD/0000-0003-1822-5753; Watt, Richard/0000-0001-6229-8584; Bell, Steven/0000-0001-6774-3149	US National Institute on Ageing [1R56AG052519-01, 1R01AG052519-01A1]; UK Medical Research Council (MRC) [MR/P023444/1]; consortium of UK government; MRC [MR/L003120/1] Funding Source: UKRI; British Heart Foundation [RG/08/014/24067] Funding Source: researchfish; Medical Research Council [MR/L003120/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10165, NF-SI-0515-10032] Funding Source: researchfish; NATIONAL INSTITUTE ON AGING [R01AG017644, R01AG052519] Funding Source: NIH RePORTER	US National Institute on Ageing(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); UK Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); consortium of UK government; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was funded by the US National Institute on Ageing, and a consortium of UK government departments coordinated by the Economic and Social Research Council. GDB is supported by the UK Medical Research Council (MRC; MR/P023444/1) and the US National Institute on Ageing (1R56AG052519-01; 1R01AG052519-01A1). The views expressed herein by the authors are independent of all funding agencies.	Adams CL, 2000, J AM VET MED ASSOC, V217, P1303, DOI 10.2460/javma.2000.217.1303; Batty GD, 2018, EPIDEMIOLOGY, V29, pE11, DOI 10.1097/EDE.0000000000000784; Batty GD, 2016, AM J EPIDEMIOL, V183, P183, DOI 10.1093/aje/kwv139; Batty GD, 2017, EPIDEMIOLOG IN PRESS; Bell JA, 2014, PREV MED, V62, P35, DOI 10.1016/j.ypmed.2014.01.028; Britton A, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0273-z; Cherniack EP, 2014, CURR GERONTOL GERIAT, V2014; Christian H, 2016, AM J LIFESTYLE MED; Clarke R, 1999, AM J EPIDEMIOL, V150, P341; COLE TJ, 2017, BMJ-BRIT MED J, V358, DOI DOI 10.1136/BMJ.J3683; Craig R, 2006, HLTH SURVEY ENGLAND, V2; Cutt HE, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-17; Ding D, 2017, AM J PREV M IN PRESS; Enmarker I, 2015, AGING MENT HEALTH, V19, P347, DOI 10.1080/13607863.2014.933310; Enmarker I, 2012, SCAND J PUBLIC HEALT, V40, P718, DOI 10.1177/1403494812465031; Fjeldstad Cecilie, 2017, Int J MS Care, V19, P40, DOI 10.7224/1537-2073.2015-089; FRIEDMANN E, 1980, PUBLIC HEALTH REP, V95, P307; Gale CR, 2015, J EPIDEMIOL COMMUN H, V69, P530, DOI 10.1136/jech-2014-204888; Gale CR, 2014, AGE, V36, DOI 10.1007/s11357-014-9682-8; GURALNIK JM, 1994, J GERONTOL, V49, pM85, DOI 10.1093/geronj/49.2.M85; Hamer M, 2009, AGE, V31, P171, DOI 10.1007/s11357-009-9097-0; Hughes ME, 2004, RES AGING, V26, P655, DOI 10.1177/0164027504268574; Lara J, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0470-9; Levine GN, 2013, CIRCULATION, V127, P2353, DOI 10.1161/CIR.0b013e31829201e1; Mayon-White R, 2005, BRIT MED J, V331, P1254, DOI 10.1136/bmj.331.7527.1254; McNicholas J, 2005, BMJ-BRIT MED J, V331, P1252, DOI 10.1136/bmj.331.7527.1252; Mubanga M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16118-6; Murray JK, 2015, VET REC, V177, DOI 10.1136/vr.103223; Parslow RA, 2005, GERONTOLOGY, V51, P40, DOI 10.1159/000081433; Pikhartova J, 2014, BMC GERIATR, V14, DOI 10.1186/1471-2318-14-106; Raina P, 1999, J AM GERIATR SOC, V47, P323, DOI 10.1111/j.1532-5415.1999.tb02996.x; Rock M, 2009, SOC SCI MED, V68, P991, DOI 10.1016/j.socscimed.2008.12.047; Rubin DB, 1987, MULTIPLE IMPUTATION; Sedgwick P, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e6727; Steptoe A, 2013, INT J EPIDEMIOL, V42, P1640, DOI 10.1093/ije/dys168; Steptoe A, 2013, P NATL ACAD SCI USA, V110, P5797, DOI 10.1073/pnas.1219686110; Stevens KN, 2008, AGE AGEING, V37, P300, DOI 10.1093/ageing/afn019; Stringhini S, 2018, INT J EPIDEMIOL, V47, P36, DOI 10.1093/ije/dyx106; Stringhini S, 2016, SCI REP-UK, V6, DOI 10.1038/srep24780; Stull JW, 2015, CAN MED ASSOC J, V187, P736, DOI 10.1503/cmaj.141020; Thorpe RJ, 2006, J AM GERIATR SOC, V54, P1419, DOI 10.1111/j.1532-5415.2006.00856.x; Turvey C L, 1999, Int Psychogeriatr, V11, P139, DOI 10.1017/S1041610299005694; White J, 2015, PSYCHOL MED, V45, P2771, DOI 10.1017/S0033291715000732; White J, 2017, BRAIN BEHAV IMMUN, V61, P27, DOI 10.1016/j.bbi.2016.08.012; White J, 2016, BRIT J PSYCHIAT, V208, P337, DOI 10.1192/bjp.bp.114.155333; Yohannes AM, 2014, EXPERT REV RESP MED, V8, P515, DOI 10.1586/17476348.2014.919226; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	47	14	14	1	15	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 13	2017	359								j5558	10.1136/bmj.j5558	http://dx.doi.org/10.1136/bmj.j5558			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FQ4KY	29237607	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000418327500005
J	Sullivan, S				Sullivan, Sheena			Challenges in reducing influenza-associated mortality	LANCET			English	Editorial Material							VACCINE; VIRUSES		[Sullivan, Sheena] Peter Doherty Inst Infect & Immun, WHO Collaborating Ctr Reference & Res Influenza, Melbourne, Vic 3000, Australia	World Health Organization	Sullivan, S (corresponding author), Peter Doherty Inst Infect & Immun, WHO Collaborating Ctr Reference & Res Influenza, Melbourne, Vic 3000, Australia.	sheena.sullivan@influenzacentre.org		Sullivan, Sheena G./0000-0002-0856-0294	Australian Government Department of Health	Australian Government Department of Health(Australian GovernmentDepartment of Health & Ageing)	The WHO Collaborating Centre for Reference and Research on Influenza is funded by the Australian Government Department of Health. I declare no competing interests.	[Anonymous], 2012, Wkly Epidemiol Rec, V87, P461; Bedford T, 2015, NATURE, V523, P217, DOI 10.1038/nature14460; Belongia Edward A, 2017, Expert Rev Vaccines, V16, P1, DOI 10.1080/14760584.2017.1334554; Darvishian M, 2014, LANCET INFECT DIS, V14, P1228, DOI 10.1016/S1473-3099(14)70960-0; Hirve S, 2016, INFLUENZA OTHER RESP, V10, P254, DOI 10.1111/irv.12374; Hopping AM, 2016, VACCINE, V34, P540, DOI 10.1016/j.vaccine.2015.11.058; Iuliano A. D., 2017, LANCET; Li L, 2018, AM J EPIDEMIOL, V187, P378, DOI 10.1093/aje/kwx270; Pebody R, 2017, EUROSURVEILLANCE, V22, P10, DOI 10.2807/1560-7917.ES.2017.22.44.17-00306; Ramsay LC, 2017, BMC MED, V15, DOI 10.1186/s12916-017-0919-0; Sullivan SG, 2017, EUROSURVEILLANCE, V22, P2, DOI 10.2807/1560-7917.ES.2017.22.43.17-00707; Vestergaard LS, 2017, EUROSURVEILLANCE, V22, P2, DOI [10.2807/1560-7917.ES.2017.22.14.30506, 10.2807/1560-7917.es.2017.22.14.30506]; Zost SJ, 2017, P NATL ACAD SCI USA, V114, P12578, DOI 10.1073/pnas.1712377114	13	13	14	1	11	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 31	2018	391	10127					1242	1244		10.1016/S0140-6736(17)33292-0	http://dx.doi.org/10.1016/S0140-6736(17)33292-0			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GB1DR	29248256				2022-12-28	WOS:000428791600006
J	Trombetti, A; Hars, M; Hsu, FC; Reid, KF; Church, TS; Gill, TM; King, AC; Liu, CK; Manini, TM; McDermott, MM; Newman, AB; Rejeski, WJ; Guralnik, JM; Pahor, M; Fielding, RA				Trombetti, Andrea; Hars, Melany; Hsu, Fang-Chi; Reid, Kieran F.; Church, Timothy S.; Gill, Thomas M.; King, Abby C.; Liu, Christine K.; Manini, Todd M.; McDermott, Mary M.; Newman, Anne B.; Rejeski, W. Jack; Guralnik, Jack M.; Pahor, Marco; Fielding, Roger A.		LIFE Study Investigators	Effect of Physical Activity on Frailty Secondary Analysis of a Randomized Controlled Trial	ANNALS OF INTERNAL MEDICINE			English	Article							LIFE-STYLE INTERVENTIONS; OLDER-ADULTS; PROSPECTIVE COHORT; PROPENSITY SCORE; WOMENS HEALTH; DISABILITY; PHENOTYPE; TREAT; INDEPENDENCE; METAANALYSIS	Background: Limited evidence suggests that physical activity may prevent frailty and associated negative outcomes in older adults. Definitive data from large long-term randomized trials are lacking. Objective: To determine whether a long-term, structured, moderate-intensity physical activity program is associated with a lower risk for frailty and whether frailty status alters the effect of physical activity on the reduction in major mobility disability (MMD) risk. Design: Multicenter, single-blind, randomized trial. Setting: 8 centers in the United States. Participants: 1635 community-dwelling adults, aged 70 to 89 years, with functional limitations. Intervention: A structured, moderate-intensity physical activity program incorporating aerobic, resistance, and flexibility activities or a health education program consisting of workshops and stretching exercises. Measurements: Frailty, as defined by the SOF (Study of Osteoporotic Fractures) index, at baseline and 6, 12, and 24 months, and MMD, defined as the inability to walk 400 m, for up to 3.5 years. Results: Over 24 months of follow-up, the risk for frailty (n = 1623) was not statistically significantly different in the physical activity versus the health education group (adjusted prevalence difference, -0.021 [95% CI, -0.049 to 0.007]). Among the 3 criteria of the SOF index, the physical activity intervention was associated with improvement in the inability to rise from a chair (adjusted prevalence difference, -0.050 [CI, -0.081 to -0.020]). Baseline frailty status did not modify the effect of physical activity on reducing incident MMD (P for interaction = 0.91). Limitation: Frailty status was neither an entry criterion nor a randomization stratum. Conclusion: A structured, moderate-intensity physical activity program was not associated with a reduced risk for frailty over 2 years among sedentary, community-dwelling older adults. The beneficial effect of physical activity on the incidence of MMD did not differ between frail and nonfrail participants.	Geneva Univ Hosp & Fac Med, Geneva, Switzerland; Tufts Univ, Boston, MA 02111 USA; Wake Forest Sch Med, Winston Salem, NC USA; Pennington Biomed Res Ctr, 6400 Perkins Rd, Baton Rouge, LA 70808 USA; Yale Sch Med, New Haven, CT USA; [King, Abby C.] Stanford Univ, Sch Med, 259 Campus Dr,HRP Redwood Bldg,Room T221, Stanford, CA 94305 USA; [Liu, Christine K.] Boston Univ, Sch Med, 88 East Newton St,Robinson 2, Boston, MA 02118 USA; Univ Florida, Gainesville, FL USA; Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; Univ Pittsburgh, Pittsburgh, PA USA; Wake Forest Univ & Sch Med, Winston Salem, NC 27109 USA; Univ Maryland, Sch Med, Baltimore, MD 21201 USA; [Trombetti, Andrea; Hars, Melany] Geneva Univ Hosp & Fac Med, Div Bone Dis, Dept Internal Med Specialties, Rue Gabrielle Perret Gentil 4, CH-1211 Geneva 14, Switzerland; [Hsu, Fang-Chi] Wake Forest Sch Med, Dept Biostat Sci, Med Ctr Blvd, Winston Salem, NC 27157 USA; [Reid, Kieran F.; Fielding, Roger A.] Tufts Univ, Jean Mayer USDA Human Nutr Res Ctr Aging, Nutr Exercise Physiol & Sarcopenia Lab, 711 Washington St, Boston, MA 02111 USA; [Church, Timothy S.] 6400 Perkins Rd, Baton Rouge, LA USA; [Gill, Thomas M.] Yale Sch Med, Adler Geriatr Ctr, 874 Howard Ave, New Haven, CT 06510 USA; [Manini, Todd M.] Inst Aging, Dept Aging & Geriatr Res, POB 112610, Gainesville, FL 32611 USA; [McDermott, Mary M.] Northwestern Univ, Feinberg Sch Med, Dept Med & Prevent Med, Galter Room 18-200,675 North St Clair, Chicago, IL 60611 USA; [Newman, Anne B.] Univ Pittsburgh, Grad Sch Publ Hlth, A527 Crabtree Hall,130 DeSoto St, Pittsburgh, PA 15261 USA; [Rejeski, W. Jack] Wake Forest Univ, Dept Hlth & Exercise Sci, Box 7868, Winston Salem, NC 27109 USA; [Guralnik, Jack M.] Univ Maryland, Sch Med, Dept Epidemiol & Publ Hlth, Div Gerontol, 660 West Redwood St,Room 204, Baltimore, MD 21201 USA; [Pahor, Marco] Univ Florida, Coll Med, Dept Aging & Geriatr Res, 2004 Mowry Rd, Gainesville, FL 32611 USA	University of Geneva; Tufts University; Wake Forest University; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Yale University; Stanford University; Boston University; State University System of Florida; University of Florida; Northwestern University; Feinberg School of Medicine; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Wake Forest University; University System of Maryland; University of Maryland Baltimore; Wake Forest University; Tufts University; United States Department of Agriculture (USDA); Yale University; Northwestern University; Feinberg School of Medicine; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Wake Forest University; University System of Maryland; University of Maryland Baltimore; State University System of Florida; University of Florida	Trombetti, A (corresponding author), Geneva Univ Hosp & Fac Med, Div Bone Dis, Dept Internal Med Specialties, Rue Gabrielle Perret Gentil 4, CH-1211 Geneva 14, Switzerland.	Andrea.Trombetti@hcuge.ch; Roger.Fielding@tufts.edu	King, Abby/AAD-5257-2021; Trombetti, Andrea/F-4575-2011; Hars, Mélany/AAI-1125-2021; Gill, Thomas M./H-7043-2019; Buford, Thomas W/B-1111-2011; Katula, Jeffrey/K-5905-2013; Stafford, Randall/F-3974-2017	Trombetti, Andrea/0000-0002-0540-7024; Gill, Thomas M./0000-0002-6450-0368; Buford, Thomas W/0000-0002-9541-4358; Leeuwenburgh, Christiaan/0000-0003-0826-4257; King, Abby/0000-0002-7949-8811; Kaplan, Robert/0000-0003-4837-5330; Katula, Jeffrey/0000-0003-2009-2443; Manini, Todd/0000-0002-5970-4462; Stafford, Randall/0000-0003-1805-1271; Castro Sweet, Cynthia/0000-0001-6860-4095; Vaz Fragoso, Carlos/0000-0002-7045-3334; HARS, MELANY/0000-0002-5108-0528; Pepine, Carl/0000-0002-6011-681X	National Institute on Aging (NIA) [UO1AG22376, K07AG3587]; National Institutes of Health [UO1AG22376]; National Heart, Lung, and Blood Institute (NHLBI) [3U01AG022376-05A2S]; Intramural Research Program; Claude D. Pepper Older Americans Independence Centers at the University of Florida [1 P30 AG028740]; Wake Forest University [1 P30 AG21332]; Tufts University [1P30AG031679]; University of Pittsburgh [P30 AG024827]; Yale University [P30AG021342, UL1 TR000142]; NIH/National Center for Research Resources Clinical and Translational Science Award program at Stanford University [UL1 RR025744]; University of Florida [U54RR025208]; Boston Rehabilitation Outcomes Center [1R24HD065688-01A1]; U.S. Department of Agriculture [58-1950-4-003]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD065688] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000142, UL1TR001863] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025744] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [U01AG022376, P30AG021332, P30AG024827, P30AG031679, P30AG028740, P30AG021342] Funding Source: NIH RePORTER	National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Intramural Research Program; Claude D. Pepper Older Americans Independence Centers at the University of Florida; Wake Forest University; Tufts University; University of Pittsburgh(University of Pittsburgh); Yale University; NIH/National Center for Research Resources Clinical and Translational Science Award program at Stanford University; University of Florida(University of Florida); Boston Rehabilitation Outcomes Center; U.S. Department of Agriculture(United States Department of Agriculture (USDA)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The LIFE study was funded by cooperative agreement UO1AG22376 from the NIH and National Institute on Aging (NIA) and supplement 3U01AG022376-05A2S from the National Heart, Lung, and Blood Institute (NHLBI), and was sponsored in part by the Intramural Research Program. The research is partially supported by the Claude D. Pepper Older Americans Independence Centers at the University of Florida (1 P30 AG028740), Wake Forest University (1 P30 AG21332), Tufts University (1P30AG031679), University of Pittsburgh (P30 AG024827), and Yale University (P30AG021342), and is supported by the NIH/National Center for Research Resources Clinical and Translational Science Award program at Stanford University (UL1 RR025744), University of Florida (U54RR025208), and Yale University (UL1 TR000142). Tufts University is also supported by the Boston Rehabilitation Outcomes Center (1R24HD065688-01A1). The following LIFE investigators also are partially supported: Dr. Gill (Yale University) is the recipient of an Academic Leadership Award (K07AG3587) from the NIA. Dr. Fielding (Tufts University) is partially supported by the U.S. Department of Agriculture under agreement 58-1950-4-003.	Austin PC, 2011, MULTIVAR BEHAV RES, V46, P119, DOI 10.1080/00273171.2011.540480; Bandeen-Roche K, 2006, J GERONTOL A-BIOL, V61, P262, DOI 10.1093/gerona/61.3.262; Bilotta C, 2012, ARCH GERONTOL GERIAT, V54, pE23, DOI 10.1016/j.archger.2011.06.037; Boyd CM, 2005, AM J MED, V118, P1225, DOI 10.1016/j.amjmed.2005.01.062; Cameron ID, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-65; Cesari M, 2015, J GERONTOL A-BIOL, V70, P216, DOI 10.1093/gerona/glu099; Chang SF, 2015, INT J NURS STUD, V52, P1362, DOI 10.1016/j.ijnurstu.2015.04.005; Clegg A, 2013, LANCET, V381, P752, DOI 10.1016/S0140-6736(12)62167-9; Daniels R, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-278; de Labra Carmen, 2015, BMC Geriatr, V15, P154, DOI 10.1186/s12877-015-0155-4; Diggle P., 2002, ANAL LONGITUDINAL DA, DOI DOI 10.2307/2983303; Ensrud KE, 2008, ARCH INTERN MED, V168, P382, DOI 10.1001/archinternmed.2007.113; Ferrucci L, 2004, J AM GERIATR SOC, V52, P625, DOI 10.1111/j.1532-5415.2004.52174.x; Fielding RA, 2011, J GERONTOL A-BIOL, V66, P1226, DOI 10.1093/gerona/glr123; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Gine-Garriga M, 2014, ARCH PHYS MED REHAB, V95, P753, DOI 10.1016/j.apmr.2013.11.007; GURALNIK JM, 1995, NEW ENGL J MED, V332, P556, DOI 10.1056/NEJM199503023320902; Hernan MA, 2013, ANN INTERN MED, V159, P560, DOI 10.7326/0003-4819-159-8-201310150-00709; Marsh AP, 2013, J GERONTOL A-BIOL, V68, P1549, DOI 10.1093/gerona/glt064; Morley JE, 2013, J AM MED DIR ASSOC, V14, P392, DOI 10.1016/j.jamda.2013.03.022; Muller CJ, 2014, INT J EPIDEMIOL, V43, P962, DOI 10.1093/ije/dyu029; Pahor M, 2014, JAMA-J AM MED ASSOC, V311, P2387, DOI 10.1001/jama.2014.5616; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Shrier I, 2014, CLIN TRIALS, V11, P28, DOI 10.1177/1740774513504151; Ten Have TR, 2008, PSYCHIAT ANN, V38, P772, DOI 10.3928/00485713-20081201-10; Woods NF, 2005, J AM GERIATR SOC, V53, P1321, DOI 10.1111/j.1532-5415.2005.53405.x; Xue QL, 2011, CLIN GERIATR MED, V27, P1, DOI 10.1016/j.cger.2010.08.009	27	58	61	1	31	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 6	2018	168	5					309	+		10.7326/M16-2011	http://dx.doi.org/10.7326/M16-2011			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FY2GD	29310138	Green Published, Green Accepted			2022-12-28	WOS:000426632600003
J	Weiss, NS; Nahuis, MJ; Bordewijk, E; Oosterhuis, JE; Smeenk, JMJ; Hoek, A; Broekmans, FJM; Fleischer, K; de Bruin, JP; Kaaijk, EM; Laven, JSE; Hendriks, DJ; Gerards, MH; van Rooij, IAJ; Bourdrez, P; Gianotten, J; Koks, C; Lambalk, CB; Hompes, PG; van der Veen, F; Mol, BJ; van Wely, M				Weiss, Nienke S.; Nahuis, Marleen J.; Bordewijk, Esmee; Oosterhuis, Jurjen E.; Smeenk, Jesper M. J.; Hoek, Annemieke; Broekmans, Frank J. M.; Fleischer, Kathrin; de Bruin, Jan Peter; Kaaijk, Eugenie M.; Laven, Joop S. E.; Hendriks, Dave J.; Gerards, Marie H.; van Rooij, Ilse A. J.; Bourdrez, Petra; Gianotten, Judith; Koks, Carolien; Lambalk, Cornelis B.; Hompes, Peter G.; van der Veen, Fulco; Mol, Ben Willem J.; van Wely, Madelon			Gonadotrophins versus clomifene citrate with or without intrauterine insemination in women with normogonadotropic anovulation and clomifene failure (M-OVIN): a randomised, two-by-two factorial trial	LANCET			English	Article							POLYCYSTIC-OVARY-SYNDROME; CLOMIPHENE CITRATE; ENDOMETRIAL THICKNESS; OVULATION INDUCTION; II ANOVULATION; PREGNANCY RATE; INFERTILITY; CYCLES; METAANALYSIS; COHORT	Background In many countries, clomifene citrate is the treatment of first choice in women with normogonadotropic anovulation (ie, absent or irregular ovulation). If these women ovulate but do not conceive after several cycles with clomifene citrate, medication is usually switched to gonadotrophins, with or without intrauterine insemination. We aimed to assess whether switching to gonadotrophins is more effective than continuing clomifene citrate, and whether intrauterine insemination is more effective than intercourse. Methods In this two-by-two factorial multicentre randomised clinical trial, we recruited women aged 18 years and older with normogonadotropic anovulation not pregnant after six ovulatory cycles of clomifene citrate (maximum of 150 mg daily for 5 days) from 48 Dutch hospitals. Women were randomly assigned using a central password-protected internet-based randomisation programme to receive six cycles with gonadotrophins plus intrauterine insemination, six cycles with gonadotrophins plus intercourse, six cycles with clomifene citrate plus intrauterine insemination, or six cycles with clomifene citrate plus intercourse. Clomifene citrate dosages varied from 50 to 150 mg daily orally and gonadotrophin starting dose was 50 or 75 IU daily subcutaneously. The primary outcome was conception leading to livebirth within 8 months after randomisation defined as any baby born alive after a gestational age beyond 24 weeks. Primary analysis was by intention to treat. We made two comparisons, one in which gonadotrophins were compared with clomifene citrate and one in which intrauterine insemination was compared with intercourse. This completed study is registered with the Netherlands Trial Register, number NTR1449. Findings Between Dec 8, 2008, and Dec 16, 2015, we randomly assigned 666 women to gonadotrophins and intrauterine insemination (n=166), gonadotrophins and intercourse (n=165), clomifene citrate and intrauterine insemination (n=163), or clomifene citrate and intercourse (n=172). Women allocated to gonadotrophins had more livebirths than those allocated to clomifene citrate (167 [52%] of 327 women vs 138 [41%] of 334 women, relative risk [RR] 1.24 [95% CI 1.05-1.46]; p=0.0124). Addition of intrauterine insemination did not increase livebirths compared with intercourse (161 [49%] vs 144 [43%], RR 1.14 [95% CI 0.97-1.35]; p=0.1152). Multiple pregnancy rates for the two comparisons were low and not different. There were three adverse events: one child with congenital abnormalities and one stillbirth in two women treated with clomifene citrate, and one immature delivery due to cervical insufficiency in a woman treated with gonadotrophins. Interpretation In women with normogonadotropic anovulation and clomifene citrate failure, a switch of treatment to gonadotrophins increased the chance of livebirth over treatment with clomifene citrate; there was no evidence that addition of intrauterine insemination does so.	[Weiss, Nienke S.; van der Veen, Fulco; van Wely, Madelon] Acad Med Ctr, Ctr Reprod Med, Amsterdam, Netherlands; [Weiss, Nienke S.; Nahuis, Marleen J.; Bordewijk, Esmee; Lambalk, Cornelis B.] Vrije Univ Amsterdam Med Ctr, Ctr Reprod Med, Amsterdam, Netherlands; [Oosterhuis, Jurjen E.] St Antonius Hosp, Dept Obstet & Gynecol, Utrecht, Netherlands; [Smeenk, Jesper M. J.] Elisabeth Ziekenhuis, Dept Obstet & Gynecol, Tilburg, Netherlands; [Hoek, Annemieke] Univ Groningen, Univ Med Ctr Groningen, Dept Obstet & Gynecol, Groningen, Netherlands; [Broekmans, Frank J. M.] Univ Utrecht, Univ Med Ctr Utrecht, Dept Reprod Med & Gynaecol, Utrecht, Netherlands; [Fleischer, Kathrin] Radboud Univ Nijmegen, Dept Obstet & Gynaecol, Nijmegen, Netherlands; [de Bruin, Jan Peter] Jeroen Bosch Hosp, Dept Obstet & Gynecol, sHertogenbosch, Netherlands; [Kaaijk, Eugenie M.] OLVG Amsterdam Oost, Dept Obstet & Gynecol, Amsterdam, Netherlands; [Laven, Joop S. E.] Erasmus MC, Dept Obstet & Gynecol, Rotterdam, Netherlands; [Hendriks, Dave J.] Amphia Ziekenhuis Breda, Dept Obstet & Gynecol, Breda, Netherlands; [Gerards, Marie H.] Martini Hosp Groningen, Dept Obstet & Gynecol, Groningen, Netherlands; [van Rooij, Ilse A. J.] Elisabeth Tweesteden Hosp, Dept Obstet & Gynecol, Tweesteden, Netherlands; [Bourdrez, Petra] VieCuri Med Ctr, Dept Obstet & Gynecol, Venlo, Netherlands; [Gianotten, Judith] Spaarne Gasthuis, Dept Obstet & Gynecol, Haarlem, Netherlands; [Koks, Carolien] Maxima Med Ctr, Dept Obstet & Gynecol, Veldhoven, Netherlands; [Mol, Ben Willem J.] Monash Univ, Dept Obstet & Gynaecol, Melbourne, Vic, Australia; [Mol, Ben Willem J.] Acad Med Ctr, Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; St. Antonius Hospital Utrecht; Elisabeth-TweeSteden Ziekenhuis (ETZ); University of Groningen; Utrecht University; Utrecht University Medical Center; Radboud University Nijmegen; Jeroen Bosch Ziekenhuis; Erasmus University Rotterdam; Erasmus MC; Amphia Hospital; Martini Hospital; VieCuri Medical Center; Spaarne Hospital; Maxima Medical Center; Monash University; University of Amsterdam; Academic Medical Center Amsterdam	van Wely, M (corresponding author), Acad Med Ctr, Dept Obstet & Gynaecol, Ctr Reprod Med, NL-1105 AZ Amsterdam, Netherlands.	m.vanwely@amc.uva.nl	van Wely, Madelon/GXV-1757-2022; Fleischer, Kathrin/ABG-2648-2020	Fleischer, Kathrin/0000-0002-2785-5573; Smeenk, Jesper/0000-0002-3053-0358; van Wely, Madelon/0000-0001-8263-213X; Lambalk, Cornelis/0000-0003-3947-5129	Netherlands Organization for Health Research and Development	Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and Development)	The Netherlands Organization for Health Research and Development.	Baird DT, 2012, HUM REPROD UPDATE, V18, P586, DOI 10.1093/humupd/dms019; Balen AH, 2016, HUM REPROD UPDATE, V22, P687, DOI 10.1093/humupd/dmw025; Brown J, 2016, COCHRANE DB SYST REV, V12, DOI DOI 10.1002/14651858.CD002249.PUB5; Chen ZJ, 2016, NEW ENGL J MED, V375, P523, DOI 10.1056/NEJMoa1513873; De Geyter C, 2000, FERTIL STERIL, V73, P106, DOI 10.1016/S0015-0282(99)00484-7; GELETY TJ, 1993, FERTIL STERIL, V60, P471; HAMMOND MG, 1983, OBSTET GYNECOL, V62, P196; Hessel M, 2014, ACTA OBSTET GYN SCAN, V93, P913, DOI 10.1111/aogs.12442; Homburg R, 2005, HUM REPROD, V20, P2043, DOI 10.1093/humrep/dei042; Kolibianakis EM, 2004, REPROD BIOMED ONLINE, V8, P115, DOI 10.1016/S1472-6483(10)60505-6; Kousta E, 1997, HUM REPROD UPDATE, V3, P359, DOI 10.1093/humupd/3.4.359; Legro RS, 2016, BEST PRACT RES CL OB, V37, P152, DOI 10.1016/j.bpobgyn.2016.08.001; Legro RS, 2014, NEW ENGL J MED, V371, P119, DOI 10.1056/NEJMoa1313517; Nahuis MJ, 2016, EUR J OBSTET GYN R B, V199, P127, DOI 10.1016/j.ejogrb.2016.01.005; Nahuis MJ, 2013, BMC WOMENS HEALTH, V13, DOI 10.1186/1472-6874-13-42; National Institute for Health and Care Excellence (NICE), 2017, FERT ASS TREATM PEOP; Norman RJ, 2007, LANCET, V370, P685, DOI 10.1016/S0140-6736(07)61345-2; Tang T, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003053.pub5; Tarlatzis BC, 2008, HUM REPROD, V23, P462, DOI 10.1093/humrep/dem426; Veltman-Verhulst SM, 2012, FERTIL STERIL, V98, P761, DOI 10.1016/j.fertnstert.2012.04.027; Wang R, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.j138; Weiss NS, 2017, HUM REPROD, V32, P1009, DOI 10.1093/humrep/dex035; Weiss NS, 2014, HUM REPROD, V29, P2482, DOI 10.1093/humrep/deu215; Weiss NS, 2017, HUM REPROD OPEN	24	8	9	0	10	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 24	2018	391	10122					758	765		10.1016/S0140-6736(17)33308-1	http://dx.doi.org/10.1016/S0140-6736(17)33308-1			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FX4ND	29273245	Bronze			2022-12-28	WOS:000426054000027
J	Giammichele, N; Charpinet, S; Fontaine, G; Brassard, P; Green, EM; Van Grootel, V; Bergeron, P; Zong, W; Dupret, MA				Giammichele, N.; Charpinet, S.; Fontaine, G.; Brassard, P.; Green, E. M.; Van Grootel, V.; Bergeron, P.; Zong, W.; Dupret, M. -A.			A large oxygen-dominated core from the seismic cartography of a pulsating white dwarf	NATURE			English	Article							FINITE-ELEMENT CODE; INSTABILITY STRIP; ANGULAR-MOMENTUM; ASTEROSEISMOLOGY; EVOLUTION; PARAMETERS; CONDUCTION; EQUATION; STARS; V777	White-dwarf stars are the end product of stellar evolution for most stars in the Universe(1). Their interiors bear the imprint of fundamental mechanisms that occur during stellar evolution(2,3). Moreover, they are important chronometers for dating galactic stellar populations, and their mergers with other white dwarfs now appear to be responsible for producing the type Ia supernovae that are used as standard cosmological candles(4). However, the internal structure of white-dwarf stars-in particular their oxygen content and the stratification of their cores-is still poorly known, because of remaining uncertainties in the physics involved in stellar modelling codes(5,6). Here we report a measurement of the radial chemical stratification (of oxygen, carbon and helium) in the hydrogendeficient white-dwarf star KIC08626021 (J192904.6+444708), independently of stellar-evolution calculations. We use archival data(7,8) coupled with asteroseismic sounding techniques(9,10) to determine the internal constitution of this star. We find that the oxygen content and extent of its core exceed the predictions of existing models of stellar evolution. The central homogeneous core has a mass of 0.45 solar masses, and is composed of about 86 per cent oxygen by mass. These values are respectively 40 per cent and 15 per cent greater than those expected from typical white-dwarf models. These findings challenge present theories of stellar evolution and their constitutive physics, and open up an avenue for calibrating white-dwarf cosmochronology(11).				noemi.giammichele@irap.omp.eu		Charpinet, Stephane/0000-0002-6018-6180; Giammichele, Noemi/0000-0003-4014-719X; Zong, Weikai/0000-0002-7660-9803	Programme National de Physique Stellaire (PNPS) of CNRS/INSU, France; Centre National d'Etudes Spatiales (CNES, France); Agence Nationale de la Recherche (ANR, France) [ANR-17-CE31-0018]; INSIDE project; CALMIP computing centre [2017-p0205]; Fonds Quebecois de la Recherche sur la Nature et les Technologies (FQRNT, Canada); NASA's Science Mission Directorate	Programme National de Physique Stellaire (PNPS) of CNRS/INSU, France; Centre National d'Etudes Spatiales (CNES, France)(Centre National D'etudes Spatiales); Agence Nationale de la Recherche (ANR, France)(French National Research Agency (ANR)); INSIDE project; CALMIP computing centre; Fonds Quebecois de la Recherche sur la Nature et les Technologies (FQRNT, Canada); NASA's Science Mission Directorate	S.C., N.G. and W.Z. acknowledge financial support from Programme National de Physique Stellaire (PNPS) of CNRS/INSU, France, and from the Centre National d'Etudes Spatiales (CNES, France). We also acknowledge support from the Agence Nationale de la Recherche (ANR, France) under grant ANR-17-CE31-0018, funding the INSIDE project. This work was granted access to the high-performance-computing resources of the CALMIP computing centre under allocation number 2017-p0205. This work was supported by the Fonds Quebecois de la Recherche sur la Nature et les Technologies (FQRNT, Canada) through a postdoctoral fellowship awarded to N.G. G.F. also acknowledges the contribution of the Canada Research Chair Program, and W.Z. the LAMOST fellowship as a young researcher, supported by the Special Funding for Advanced Users, budgeted and administrated by the Center for Astronomical Mega-Science, Chinese Academy of Sciences. V.V.G. is an F.R.S.-FNRS Research Associate. The authors acknowledge the Kepler team and everyone who has contributed to making this mission possible. Funding for the Kepler mission is provided by NASA's Science Mission Directorate.	Althaus LG, 2005, ASTRON ASTROPHYS, V435, P631, DOI 10.1051/0004-6361:20041965; Beauchamp A, 1999, ASTROPHYS J, V516, P887, DOI 10.1086/307148; BERGERON P, 1992, ASTROPHYS J, V394, P228, DOI 10.1086/171575; Bergeron P, 2011, ASTROPHYS J, V737, DOI 10.1088/0004-637X/737/1/28; Bertolami MMM, 2006, ASTRON ASTROPHYS, V449, P313, DOI 10.1051/0004-6361:20053804; Bischoff-Kim A, 2014, ASTROPHYS J, V794, DOI 10.1088/0004-637X/794/1/39; Bischoff-Kim A, 2011, ASTROPHYS J LETT, V742, DOI 10.1088/2041-8205/742/1/L16; Brassard P, 2001, ASTROPHYS J, V563, P1013, DOI 10.1086/323959; Brassard P, 2013, EPJ WEB CONF, V43, DOI 10.1051/epjconf/20134305010; BRASSARD P, 1992, ASTROPHYS J SUPPL S, V80, P725, DOI 10.1086/191679; Brassard P, 2008, ASTROPHYS SPACE SCI, V316, P107, DOI 10.1007/s10509-007-9733-z; Cassisi S, 2007, ASTROPHYS J, V661, P1094, DOI 10.1086/516819; Charpinet S, 2008, ASTRON ASTROPHYS, V489, P377, DOI 10.1051/0004-6361:200809907; Charpinet S, 2005, ASTRON ASTROPHYS, V437, P575, DOI 10.1051/0004-6361:20052709; Charpinet S, 2015, ASTR SOC P, V493, P151; Charpinet S, 2011, ASTRON ASTROPHYS, V530, DOI 10.1051/0004-6361/201016412; Charpinet S, 2009, NATURE, V461, P501, DOI 10.1038/nature08307; Corsico AH, 2012, ASTRON ASTROPHYS, V541, DOI 10.1051/0004-6361/201118736; De Geronimo FC, 2017, ASTRON ASTROPHYS, V599, DOI 10.1051/0004-6361/201629806; Dominguez I, 2001, ASTROPHYS J, V557, P279, DOI 10.1086/321661; Dupret MA, 2001, ASTRON ASTROPHYS, V366, P166, DOI 10.1051/0004-6361:20000219; Fields CE, 2016, ASTROPHYS J, V823, DOI 10.3847/0004-637X/823/1/46; Fontaine G, 2008, PUBL ASTRON SOC PAC, V120, P1043, DOI 10.1086/592788; Fontaine G, 2013, ASTR SOC P, V469, P115; Fontaine G, 2001, PUBL ASTRON SOC PAC, V113, P409, DOI 10.1086/319535; Fontaine G., 2000, WHITE DWARFS, DOI [10.1888/0333750888/1894, DOI 10.1888/0333750888/1894]; Giammichele N, 2017, ASTRON ASTROPHYS, V598, DOI 10.1051/0004-6361/201629935; Giammichele N, 2017, ASTROPHYS J, V834, DOI 10.3847/1538-4357/834/2/136; Giammichele N, 2016, ASTROPHYS J SUPPL S, V223, DOI 10.3847/0067-0049/223/1/10; Gilliland RL, 2010, PUBL ASTRON SOC PAC, V122, P131, DOI 10.1086/650399; Hermes JJ, 2017, ASTROPHYS J, V835, DOI 10.3847/1538-4357/835/2/277; Herwig F, 1999, ASTRON ASTROPHYS, V349, pL5; HUBBARD WB, 1969, ASTROPHYS J SUPPL S, V18, P297, DOI 10.1086/190192; IBEN I, 1983, ASTROPHYS J, V264, P605, DOI 10.1086/160631; Kitsikis A, 2005, ASTR SOC P, V334, P65; Koester D, 2014, ASTRON ASTROPHYS, V568, DOI 10.1051/0004-6361/201424231; Koester D., 2010, MEM SOC ASTRON ITAL, V81, P921; Ostensen RH, 2011, ASTROPHYS J LETT, V736, DOI 10.1088/2041-8205/736/2/L39; Ostensen RH, 2013, ASTR SOC P, V469, P3; Romero AD, 2012, MON NOT R ASTRON SOC, V420, P1462, DOI 10.1111/j.1365-2966.2011.20134.x; Salaris M, 2010, ASTROPHYS J, V716, P1241, DOI 10.1088/0004-637X/716/2/1241; Salaris M, 1997, ASTROPHYS J, V486, P413, DOI 10.1086/304483; Straniero O, 2003, ASTROPHYS J, V583, P878, DOI 10.1086/345427; Sullivan DJ, 2017, ASTR SOC P, V509, P315; Tremblay PE, 2015, ASTROPHYS J, V799, DOI 10.1088/0004-637X/799/2/142; Tremblay PE, 2014, ASTROPHYS J, V791, DOI 10.1088/0004-637X/791/2/92; Van Grootel V, 2017, ASTR SOC P, V509, P321; Van Grootel V, 2013, ASTRON ASTROPHYS, V553, DOI 10.1051/0004-6361/201220896; Van Grootel V, 2013, ASTROPHYS J, V762, DOI 10.1088/0004-637X/762/1/57; Van Grootel V, 2012, ASTRON ASTROPHYS, V539, DOI 10.1051/0004-6361/201118371; Van Grootel V, 2010, ASTRON ASTROPHYS, V524, DOI 10.1051/0004-6361/201015437; Van Grootel V, 2010, ASTROPHYS J LETT, V718, pL97, DOI 10.1088/2041-8205/718/2/L97; Zong W, 2016, ASTRON ASTROPHYS, V585, DOI 10.1051/0004-6361/201526300	55	56	56	2	19	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 1	2018	554	7690					73	+		10.1038/nature25136	http://dx.doi.org/10.1038/nature25136			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU7QX	29310123	Green Published			2022-12-28	WOS:000424048900033
J	Margalef, P; Kotsantis, P; Borel, V; Bellelli, R; Panier, S; Boulton, SJ				Margalef, Pol; Kotsantis, Panagiotis; Borel, Valerie; Bellelli, Roberto; Panier, Stephanie; Boulton, Simon J.			Stabilization of Reversed Replication Forks by Telomerase Drives Telomere Catastrophe	CELL			English	Article							HOYERAAL-HREIDARSSON SYNDROME; GENOME STABILITY; DNA-REPLICATION; HUMAN RTEL1; LENGTH; PROTECTION; SHELTERIN; HELICASE; REVEALS; ZRANB3	Telomere maintenance critically depends on the distinct activities of telomerase, which adds telomeric repeats to solve the end replication problem, and RTEL1, which dismantles DNA secondary structures at telomeres to facilitate replisome progression. Here, we establish that reversed replication forks are a pathological substrate for telomerase and the source of telomere catastrophe in Rtel1(-/-) cells. Inhibiting telomerase recruitment to telomeres, but not its activity, or blocking replication fork reversal through PARP1 inhibition or depleting UBC13 or ZRANB3 prevents the rapid accumulation of dysfunctional telomeres in RTEL1-deficient cells. In this context, we establish that telomerase binding to reversed replication forks inhibits telomere replication, which can be mimicked by preventing replication fork restart through depletion of RECQ1 or PARG. Our results lead us to propose that telomerase inappropriately binds to and inhibits restart of reversed replication forks within telomeres, which compromises replication and leads to critically short telomeres.	[Margalef, Pol; Kotsantis, Panagiotis; Borel, Valerie; Bellelli, Roberto; Panier, Stephanie; Boulton, Simon J.] Francis Crick Inst, 1 Midland Rd, London NW1 1AT, England	Francis Crick Institute	Boulton, SJ (corresponding author), Francis Crick Inst, 1 Midland Rd, London NW1 1AT, England.	simon.boulton@crick.ac.uk	Panier, Stephanie/GVT-6365-2022; Kotsantis, Panagiotis/AGZ-3258-2022; Kotsantis, Panagiotis/AGU-7131-2022	Kotsantis, Panagiotis/0000-0002-6131-4009; Kotsantis, Panagiotis/0000-0002-6131-4009; Bellelli, Roberto/0000-0002-2062-7113	EMBO long-term fellowship [ALTF 439-2015, ALTF 156-2013]; European Union's Horizon research and innovation program under the Marie Sklodowska-Curie [702430]; Francis Crick Institute - Cancer Research UK [FC0010048]; UK Medical Research Council [FC0010048]; Wellcome Trust [FC0010048]; European Research Council (ERC) Advanced Investigator Grant (TelMetab) [742437]; Wellcome Trust Senior Investigator Grant; Cancer Research UK [11581] Funding Source: researchfish; The Francis Crick Institute [742437-TelMetab, 10627, 703228 - RTEL1, 10048] Funding Source: researchfish	EMBO long-term fellowship(European Molecular Biology Organization (EMBO)); European Union's Horizon research and innovation program under the Marie Sklodowska-Curie; Francis Crick Institute - Cancer Research UK; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); European Research Council (ERC) Advanced Investigator Grant (TelMetab)(European Research Council (ERC)); Wellcome Trust Senior Investigator Grant(Wellcome Trust); Cancer Research UK(Cancer Research UK); The Francis Crick Institute	We wish to thank Jerry Shay for providing telomerase inhibitors and Svend Kjaar and Roger George for producing recombinant RTEL1. We also thank Massimo Lopes, Ylli Doksani, Agnel Sfeir, Steve West, Jan Karlseder, Steve Artandi, Titia de Lange, and members of the Boulton laboratory for helpful discussion. P.M. is supported by an EMBO long-term fellowship (ALTF 439-2015) and funding from the European Union's Horizon 2020 research and innovation program under the Marie Sklodowska-Curie grant agreement no. 702430. S.P. is supported by an EMBO long-term fellowship (ALTF 156-2013). The Boulton lab is supported by the Francis Crick Institute, which receives its core funding from Cancer Research UK (FC0010048), the UK Medical Research Council (FC0010048), and the Wellcome Trust (FC0010048). S.J.B. is also funded by European Research Council (ERC) Advanced Investigator Grant (TelMetab; Project ID: 742437) and a Wellcome Trust Senior Investigator Grant.	Asai A, 2003, CANCER RES, V63, P3931; Ballew BJ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003695; Ballew BJ, 2013, HUM GENET, V132, P473, DOI 10.1007/s00439-013-1265-8; Betous R, 2013, EMBO J, V32, P2172, DOI 10.1038/emboj.2013.148; Betous R, 2012, GENE DEV, V26, P151, DOI 10.1101/gad.178459.111; Celli GB, 2005, NAT CELL BIOL, V7, P712, DOI 10.1038/ncb1275; Chaudhuri AR, 2012, NAT STRUCT MOL BIOL, V19, P417, DOI 10.1038/nsmb.2258; Ciccia A, 2012, MOL CELL, V47, P396, DOI 10.1016/j.molcel.2012.05.024; Couch FB, 2013, GENE DEV, V27, P1610, DOI 10.1101/gad.214080.113; Damle RN, 2004, BLOOD, V103, P375, DOI 10.1182/blood-2003-04-1345; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; Denchi EL, 2007, NATURE, V448, P1068, DOI 10.1038/nature06065; Doksani Y, 2013, CELL, V155, P345, DOI 10.1016/j.cell.2013.09.048; Drosopoulos WC, 2015, J CELL BIOL, V210, P191, DOI 10.1083/jcb.201410061; Dungrawala H, 2017, MOL CELL, V67, P374, DOI 10.1016/j.molcel.2017.06.023; Faure G, 2014, PROTEINS, V82, P897, DOI 10.1002/prot.24438; Gelot C, 2015, GENES-BASEL, V6, P267, DOI 10.3390/genes6020267; Gramatges MM, 2013, BLOOD, V121, P3586, DOI 10.1182/blood-2012-08-447755; GREIDER CW, 1985, CELL, V43, P405, DOI 10.1016/0092-8674(85)90170-9; Griffith JD, 1999, CELL, V97, P503, DOI 10.1016/S0092-8674(00)80760-6; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; Herbert BS, 2005, ONCOGENE, V24, P5262, DOI 10.1038/sj.onc.1208760; Hultdin M, 2003, BRIT J CANCER, V88, P593, DOI 10.1038/sj.bjc.6600763; Karlseder J, 1999, SCIENCE, V283, P1321, DOI 10.1126/science.283.5406.1321; Lansdorp PM, 1996, HUM MOL GENET, V5, P685, DOI 10.1093/hmg/5.5.685; Le Guen T, 2013, HUM MOL GENET, V22, P3239, DOI 10.1093/hmg/ddt178; Lee KH, 2001, P NATL ACAD SCI USA, V98, P3381, DOI 10.1073/pnas.051629198; Lemacon D, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01180-5; Mijic S, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01164-5; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; Moye AL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8643; Neelsen KJ, 2015, NAT REV MOL CELL BIO, V16, P207, DOI 10.1038/nrm3935; Neelsen KJ, 2013, J CELL BIOL, V200, P699, DOI 10.1083/jcb.201212058; Norio P, 2001, SCIENCE, V294, P2361, DOI 10.1126/science.1064603; O'Sullivan RJ, 2010, NAT REV MOL CELL BIO, V11, P171, DOI 10.1038/nrm2848; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; Pascolo E, 2002, J BIOL CHEM, V277, P15566, DOI 10.1074/jbc.M201266200; Ray Chaudhuri A., 2015, MOL CELL BIOL, V35, P856; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Sarek G, 2015, MOL CELL, V57, P622, DOI 10.1016/j.molcel.2014.12.024; Schlacher K, 2011, CELL, V145, P529, DOI 10.1016/j.cell.2011.03.041; Schmidt JC, 2016, CELL, V166, P1188, DOI 10.1016/j.cell.2016.07.033; Schmidt JC, 2014, ELIFE, V3, DOI 10.7554/eLife.03563; Sfeir A, 2012, SCIENCE, V336, P593, DOI 10.1126/science.1218498; Sfeir A, 2009, CELL, V138, P90, DOI 10.1016/j.cell.2009.06.021; SHIPPENLENTZ D, 1990, SCIENCE, V247, P546, DOI 10.1126/science.1689074; Sogo JM, 2002, SCIENCE, V297, P599, DOI 10.1126/science.1074023; Taglialatela A, 2017, MOL CELL, V68, P414, DOI 10.1016/j.molcel.2017.09.036; Takai KK, 2011, MOL CELL, V44, P647, DOI 10.1016/j.molcel.2011.08.043; Thangavel S, 2015, J CELL BIOL, V208, P545, DOI 10.1083/jcb.201406100; Uringa EJ, 2012, MOL BIOL CELL, V23, P2782, DOI 10.1091/mbc.E12-03-0179; Vannier JB, 2013, SCIENCE, V342, P239, DOI 10.1126/science.1241779; Vannier JB, 2012, CELL, V149, P795, DOI 10.1016/j.cell.2012.03.030; Vogiatzi P, 2013, PEDIATR BLOOD CANCER, V60, pE4, DOI 10.1002/pbc.24389; Vujanovic M, 2017, MOL CELL, V67, P882, DOI 10.1016/j.molcel.2017.08.010; Walne AJ, 2013, AM J HUM GENET, V92, P448, DOI 10.1016/j.ajhg.2013.02.001; Weston R, 2012, GENE DEV, V26, P1558, DOI 10.1101/gad.193516.112; Wu XL, 2007, GENESIS, V45, P788, DOI 10.1002/dvg.20359; Wyatt HDM, 2017, MOL CELL, V65, P848, DOI 10.1016/j.molcel.2017.01.031; Wyatt HDM, 2013, MOL CELL, V52, P234, DOI 10.1016/j.molcel.2013.08.035; Yeeles JTP, 2013, MOL CELL, V52, P855, DOI 10.1016/j.molcel.2013.10.020; Zellweger R, 2015, J CELL BIOL, V208, P563, DOI 10.1083/jcb.201406099; Zhong FL, 2012, CELL, V150, P481, DOI 10.1016/j.cell.2012.07.012	63	56	57	1	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 25	2018	172	3					439	+		10.1016/j.cell.2017.11.047	http://dx.doi.org/10.1016/j.cell.2017.11.047			29	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FT9BS	29290468	Green Published, hybrid			2022-12-28	WOS:000423447600006
J	de la Torre-Ubieta, L; Stein, JL; Won, HJ; Opland, CK; Liang, D; Lu, DN; Geschwind, DH				de la Torre-Ubieta, Luis; Stein, Jason L.; Won, Hyejung; Opland, Carli K.; Liang, Dan; Lu, Daning; Geschwind, Daniel H.			The Dynamic Landscape of Open Chromatin during Human Cortical Neurogenesis	CELL			English	Article							GENOME-WIDE ASSOCIATION; R/BIOCONDUCTOR PACKAGE; NEURAL DEVELOPMENT; CEREBRAL-CORTEX; RADIAL GLIA; CELL-CYCLE; TRANSCRIPTION; BINDING; ANNOTATION; MECHANISMS	Non-coding regions comprise most of the human genome and harbor a significant fraction of risk alleles for neuropsychiatric diseases, yet their functions remain poorly defined. We created a high-resolution map of non-coding elements involved in human cortical neurogenesis by contrasting chromatin accessibility and gene expression in the germinal zone and cortical plate of the developing cerebral cortex. We link distal regulatory elements (DREs) to their cognate gene(s) together with chromatin interaction data and show that target genes of human-gained enhancers (HGEs) regulate cortical neurogenesis and are enriched in outer radial glia, a cell type linked to human cortical evolution. We experimentally validate the regulatory effects of predicted enhancers for FGFR2 and EOMES. We observe that common genetic variants associated with educational attainment, risk for neuropsychiatric disease, and intracranial volume are enriched within regulatory elements involved in cortical neurogenesis, demonstrating the importance of this early developmental process for adult human cognitive function.	[de la Torre-Ubieta, Luis; Stein, Jason L.; Won, Hyejung; Opland, Carli K.; Lu, Daning; Geschwind, Daniel H.] Univ Calif Los Angeles, Dept Neurol, Neurogenet Program, Los Angeles, CA 90095 USA; [Geschwind, Daniel H.] Univ Calif Los Angeles, Semel Inst, Ctr Autism Res & Treatment, Los Angeles, CA 90095 USA; [Geschwind, Daniel H.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; [Stein, Jason L.; Liang, Dan] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; [Stein, Jason L.; Liang, Dan] Univ N Carolina, UNC Neurosci Ctr, Chapel Hill, NC 27599 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Geschwind, DH (corresponding author), Univ Calif Los Angeles, Dept Neurol, Neurogenet Program, Los Angeles, CA 90095 USA.; Geschwind, DH (corresponding author), Univ Calif Los Angeles, Semel Inst, Ctr Autism Res & Treatment, Los Angeles, CA 90095 USA.; Geschwind, DH (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA.	dhg@mednet.ucla.edu		de la Torre-Ubieta, Luis/0000-0001-8059-6243	NIH [5R37MH060233, 5R01MH100027, 3U01MH103339, 1R01MH110927, 1R01MH094714, R00MH102357, K99MH113823]; California Institute for Regenerative Medicine (CIRM)-BSCRC Training Grant [TG2-01169];  [U01MH103339];  [U01MH103365];  [U01MH103392];  [U01MH103340];  [U01MH103346];  [R01MH105472];  [R01MH094714];  [R01MH105898];  [R21MH102791];  [R21MH105881];  [R21MH103877];  [P50MH106934]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD087101] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI028697] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM067553] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH102791, U01MH103392, R01MH110927, R00MH102357, U01MH103365, R01MH094714, K99MH113823, U01MH103346, R21MH103877, R01MH105898, R01MH100027, R01MH105472, U01MH103340, R01MH060233, R21MH105881, U01MH103339, P50MH106934] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Institute for Regenerative Medicine (CIRM)-BSCRC Training Grant; ; ; ; ; ; ; ; ; ; ; ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank M. Gandal, E. Ruzzo, and members of the Geschwind lab for helpful discussions and critical reading of the manuscript. pL-CRISPR.EFS.GFP and pL-CRISPR.EFS.tRFP plasmids were a gift from Benjamin Ebert. Finger whorl GWAS data were kindly provided by Sarah Medland. ATAC-seq libraries were sequenced by the UCLA BSCRC, RNA-seq libraries were prepared and sequenced by the UCLA Neuroscience Genomics Core, and fetal tissue was collected from the UCLA CFAR (5P30 AI028697). Adult ATAC-seq data were generated as part of the PsychENCODE Consortium, supported by U01MH103339, U01MH103365, U01MH103392, U01MH103340, U01MH103346, R01MH105472, R01MH094714, R01MH105898, R21MH102791, R21MH105881, R21MH103877, and P50MH106934 awarded to S. Akbarian (ISMMS), G. Crawford (Duke), S. Dracheva (ISMMS), P. Farnham (USC), M. Gerstein (Yale), D. Geschwind (UCLA), T. M. Hyde (LIBD), A. Jaffe (LIBD), J.A. Knowles (USC), C. Liu (UIC), D. Pinto (ISMMS), N. Sestan (Yale), P. Sklar (ISMMS), M. State (UCSF), P. Sullivan (UNC), F. Vaccarino (Yale), S. Weissman (Yale), K. White (UChicago), and P. Zandi (JHU). This work was supported by the NIH (5R37MH060233, 5R01MH100027, 3U01MH103339, 1R01MH110927, and 1R01MH094714 to D.H.G., R00MH102357 to J.L.S., and K99MH113823 to H.W.) and the California Institute for Regenerative Medicine (CIRM)-BSCRC Training Grant (TG2-01169 to L.T.-U.).	Aarts E, 2014, NAT NEUROSCI, V17, P491, DOI 10.1038/nn.3648; Adams HHH, 2016, NAT NEUROSCI, V19, P1569, DOI 10.1038/nn.4398; Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Baala L, 2007, NAT GENET, V39, P454, DOI 10.1038/ng1993; Bae BI, 2015, DEV CELL, V32, P423, DOI 10.1016/j.devcel.2015.01.035; Bakken TE, 2016, NATURE, V535, P367, DOI 10.1038/nature18637; Ballas N, 2005, CELL, V121, P645, DOI 10.1016/j.cell.2005.03.013; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Briggs JA, 2015, NEURON, V88, P861, DOI 10.1016/j.neuron.2015.09.045; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Buganim Y, 2013, NAT REV GENET, V14, P427, DOI 10.1038/nrg3473; Bystron I, 2008, NAT REV NEUROSCI, V9, P110, DOI 10.1038/nrn2252; de la Torre-Ubieta L, 2016, NAT MED, V22, P345, DOI 10.1038/nm.4071; De Rubeis S, 2014, NATURE, V515, P209, DOI 10.1038/nature13772; Demontis D., 2017, BIORXIV; Dimidschstein J, 2016, NAT NEUROSCI, V19, P1743, DOI 10.1038/nn.4430; Doan RN, 2016, CELL, V167, P341, DOI 10.1016/j.cell.2016.08.071; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Doench JG, 2014, NAT BIOTECHNOL, V32, P1262, DOI 10.1038/nbt.3026; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Durinck S, 2009, NAT PROTOC, V4, P1184, DOI 10.1038/nprot.2009.97; Ernst J, 2015, NAT BIOTECHNOL, V33, P364, DOI 10.1038/nbt.3157; Estivill-Torrus G, 2002, DEVELOPMENT, V129, P455; Finucane HK, 2015, NAT GENET, V47, P1228, DOI 10.1038/ng.3404; Frank CL, 2015, NAT NEUROSCI, V18, P647, DOI 10.1038/nn.3995; Geschwind DH, 2013, NEURON, V80, P633, DOI 10.1016/j.neuron.2013.10.045; Graham V, 2003, NEURON, V39, P749, DOI 10.1016/S0896-6273(03)00497-5; Gray LT, 2017, ELIFE, V6, DOI 10.7554/eLife.21883; Guillemot F, 2007, DEVELOPMENT, V134, P3771, DOI 10.1242/dev.006379; Hahne F, 2016, METHODS MOL BIOL, V1418, P335, DOI 10.1007/978-1-4939-3578-9_16; Hansen KD, 2012, BIOSTATISTICS, V13, P204, DOI 10.1093/biostatistics/kxr054; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Heck D, 2014, NAT BIOTECHNOL, V32, P941, DOI 10.1038/nbt.2951; Heintzman ND, 2007, CELL MOL LIFE SCI, V64, P386, DOI 10.1007/s00018-006-6295-0; Ho YYW, 2016, J INVEST DERMATOL, V136, P859, DOI 10.1016/j.jid.2015.10.062; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Iossifov I, 2014, NATURE, V515, P216, DOI 10.1038/nature13908; Jamsheer A, 2012, J APPL GENET, V53, P415, DOI 10.1007/s13353-012-0109-x; Jerison H.J., 1997, DEV PREFRONTAL CORTE, P9; Jin FL, 2013, NATURE, V503, P290, DOI 10.1038/nature12644; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kang HJ, 2011, NATURE, V478, P483, DOI 10.1038/nature10523; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Lawrence M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003118; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liang HX, 2013, DEVELOPMENT, V140, P552, DOI 10.1242/dev.085621; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Mathelier A, 2016, NUCLEIC ACIDS RES, V44, pD110, DOI 10.1093/nar/gkv1176; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Miller JA, 2014, NATURE, V508, P199, DOI 10.1038/nature13185; Natarajan A, 2012, GENOME RES, V22, P1711, DOI 10.1101/gr.135129.111; Nord AS, 2015, NEURON, V85, P27, DOI 10.1016/j.neuron.2014.11.011; Okbay A, 2016, NAT GENET, V48, P624, DOI 10.1038/ng.3552; Okbay A, 2016, NATURE, V533, P539, DOI 10.1038/nature17671; Parikshak NN, 2015, NAT REV GENET, V16, P441, DOI 10.1038/nrg3934; Parikshak NN, 2013, CELL, V155, P1008, DOI 10.1016/j.cell.2013.10.031; Pollard KS, 2010, GENOME RES, V20, P110, DOI 10.1101/gr.097857.109; Pollen AA, 2015, CELL, V163, P55, DOI 10.1016/j.cell.2015.09.004; Qin S, 2012, MOL CELL BIOL, V32, P4297, DOI 10.1128/MCB.00838-12; Raballo R, 2000, J NEUROSCI, V20, P5012; Rackham OJL, 2016, NAT GENET, V48, P331, DOI 10.1038/ng.3487; Rakic P, 2009, NAT REV NEUROSCI, V10, P724, DOI 10.1038/nrn2719; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Reilly SK, 2015, SCIENCE, V347, P1155, DOI 10.1126/science.1260943; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Robinson EB, 2016, NAT GENET, V48, P552, DOI 10.1038/ng.3529; Ronan JL, 2013, NAT REV GENET, V14, P347, DOI 10.1038/nrg3413; Ross-Innes CS, 2012, NATURE, V481, P389, DOI 10.1038/nature10730; Rubenstein J.L.R., 2013, PATTERNING CELL TYPE, pxiii; Sessa A, 2008, NEURON, V60, P56, DOI 10.1016/j.neuron.2008.09.028; Stein JL, 2014, NEURON, V83, P69, DOI 10.1016/j.neuron.2014.05.035; Stevens HE, 2010, J NEUROSCI, V30, P5590, DOI 10.1523/JNEUROSCI.5837-09.2010; Sun T, 2014, NAT REV NEUROSCI, V15, P217, DOI 10.1038/nrn3707; Tan G, 2016, BIOINFORMATICS, V32, P1555, DOI 10.1093/bioinformatics/btw024; Taverna E, 2014, ANNU REV CELL DEV BI, V30, P465, DOI 10.1146/annurev-cellbio-101011-155801; Varki A, 2008, NAT REV GENET, V9, P749, DOI 10.1038/nrg2428; Visel A, 2007, NUCLEIC ACIDS RES, V35, pD88, DOI 10.1093/nar/gkl822; Visel A, 2013, CELL, V152, P895, DOI 10.1016/j.cell.2012.12.041; Ward LD, 2012, NAT BIOTECHNOL, V30, P1095, DOI 10.1038/nbt.2422; Won HJ, 2016, NATURE, V538, P523, DOI 10.1038/nature19847; Zambon AC, 2012, BIOINFORMATICS, V28, P2209, DOI 10.1093/bioinformatics/bts366; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	84	153	153	1	34	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 11	2018	172	1-2					289	+		10.1016/j.cell.2017.12.014	http://dx.doi.org/10.1016/j.cell.2017.12.014			34	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FS5MI	29307494	Green Submitted, Green Accepted, Bronze			2022-12-28	WOS:000419840100026
J	Breitburg, D; Levin, LA; Oschlies, A; Gregoire, M; Chavez, FP; Conley, DJ; Garcon, V; Gilbert, D; Gutierrez, D; Isensee, K; Jacinto, GS; Limburg, KE; Montes, I; Naqvi, SWA; Pitcher, GC; Rabalais, NN; Roman, MR; Rose, KA; Seibel, BA; Telszewski, M; Yasuhara, M; Zhang, J				Breitburg, Denise; Levin, Lisa A.; Oschlies, Andreas; Gregoire, Marilaure; Chavez, Francisco P.; Conley, Daniel J.; Garcon, Veronique; Gilbert, Denis; Gutierrez, Dimitri; Isensee, Kirsten; Jacinto, Gil S.; Limburg, Karin E.; Montes, Ivonne; Naqvi, S. W. A.; Pitcher, Grant C.; Rabalais, Nancy N.; Roman, Michael R.; Rose, Kenneth A.; Seibel, Brad A.; Telszewski, Maciej; Yasuhara, Moriaki; Zhang, Jing			Declining oxygen in the global ocean and coastal waters	SCIENCE			English	Review							DIEL-CYCLING HYPOXIA; CLIMATE-CHANGE; MINIMUM ZONES; DEAD ZONES; HABITAT COMPRESSION; MOLECULAR RESPONSES; TROPICAL PACIFIC; NITROGEN; DYNAMICS; FISH	Oxygen is fundamental to life. Not only is it essential for the survival of individual animals, but it regulates global cycles of major nutrients and carbon. The oxygen content of the open ocean and coastal waters has been declining for at least the past half-century, largely because of human activities that have increased global temperatures and nutrients discharged to coastal waters. These changes have accelerated consumption of oxygen by microbial respiration, reduced solubility of oxygen in water, and reduced the rate of oxygen resupply from the atmosphere to the ocean interior, with a wide range of biological and ecological consequences. Further research is needed to understand and predict long-term, global-and regional-scale oxygen changes and their effects on marine and estuarine fisheries and ecosystems.	[Breitburg, Denise] Smithsonian Environm Res Ctr, Edgewater, MD 21037 USA; [Levin, Lisa A.] Univ Calif San Diego, Ctr Marine Biodivers & Conservat, Scripps Inst Oceanog, San Diego, CA 92093 USA; [Levin, Lisa A.] Univ Calif San Diego, Integrat Oceanog Div, Scripps Inst Oceanog, San Diego, CA 92093 USA; [Oschlies, Andreas] GEOMAR Helmholtz Ctr Ocean Res Kiel, D-24105 Kiel, Germany; [Gregoire, Marilaure] Univ Liege, Dept Astrophys Geophys & Oceanog, MAST FOCUS Res Grp, B-4000 Liege, Belgium; [Chavez, Francisco P.] Monterey Bay Aquarium Res Inst, Moss Landing, CA 95039 USA; [Conley, Daniel J.] Lund Univ, Dept Geol, Solvegatan 12, SE-22362 Lund, Sweden; [Garcon, Veronique] CNRS, Lab Etudes Geophys & Oceanog Spatiales, F-31401 Toulouse 9, France; [Gilbert, Denis] Fisheries & Oceans Canada, Maurice Lamontagne Inst, Mont Joli, PQ G5H 3Z4, Canada; [Gutierrez, Dimitri] Inst Mar Peru IMARPE, Esquina Gamarra Gen Valle S-N, Callao, Peru; [Gutierrez, Dimitri] Univ Peruana Cayetano Heredia, Fac Ciencias & Filosofia, Programa Maestria Ciencias Mar, Lima 31, Peru; [Isensee, Kirsten] Intergovt Oceanog Commiss UNESCO, F-75732 Paris 7, France; [Jacinto, Gil S.] Univ Philippines, Inst Marine Sci, Quezon City, Philippines; [Limburg, Karin E.] SUNY Coll Environm Sci & Forestry, Syracuse, NY 13210 USA; [Montes, Ivonne] Inst Geofis Peru, Lima, Peru; [Naqvi, S. W. A.] Kuwait Inst Sci Res, Environm & Life Sci Res Ctr, Salmiya 22017, Kuwait; [Pitcher, Grant C.] Dept Agr Forestry & Fisheries, Fisheries Res & Dev, Cape Town, South Africa; [Rabalais, Nancy N.] Univ Cape Town, Dept Biol Sci, Cape Town, South Africa; [Roman, Michael R.] Louisiana State Univ, Dept Oceanog & Coastal Sci, Baton Rouge, LA 70803 USA; [Rose, Kenneth A.] Univ Maryland, Ctr Environm Sci, Horn Point Lab, Cambridge, MD 21613 USA; [Seibel, Brad A.] Univ S Florida, Coll Marine Sci, St Petersburg, FL 33701 USA; [Telszewski, Maciej] Polish Acad Sci, Int Ocean Carbon Coordinat Project, Inst Oceanol, Ul Powstancow Warszawy 55, PL-81712 Sopot, Poland; [Yasuhara, Moriaki] Univ Hong Kong, Sch Biol Sci, Hong Kong, Hong Kong, Peoples R China; [Yasuhara, Moriaki] Univ Hong Kong, Swire Inst Marine Sci, Hong Kong, Hong Kong, Peoples R China; [Zhang, Jing] East China Normal Univ, State Key Lab Estuarine & Coastal Res, Shanghai 200062, Peoples R China; [Naqvi, S. W. A.] CSIR, Rafi Marg, New Delhi, India	Smithsonian Institution; Smithsonian Environmental Research Center; University of California System; University of California San Diego; Scripps Institution of Oceanography; University of California System; University of California San Diego; Scripps Institution of Oceanography; Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel; University of Liege; Monterey Bay Aquarium Research Institute; Lund University; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Laboratoire d'Etudes en Geophysique et oceanographie spatiales; Fisheries & Oceans Canada; Instituto del Mar del Peru; Universidad Peruana Cayetano Heredia; University of the Philippines System; University of the Philippines Diliman; State University of New York (SUNY) System; State University of New York (SUNY) College of Environmental Science & Forestry; Kuwait Institute for Scientific Research; University of Cape Town; Louisiana State University System; Louisiana State University; University System of Maryland; University of Maryland Center for Environmental Science; State University System of Florida; University of South Florida; Polish Academy of Sciences; Institute of Oceanology of the Polish Academy of Sciences; University of Hong Kong; University of Hong Kong; East China Normal University; Council of Scientific & Industrial Research (CSIR) - India	Breitburg, D (corresponding author), Smithsonian Environm Res Ctr, Edgewater, MD 21037 USA.	breitburgd@si.edu	Montes, Ivonne/J-2638-2014; Gilbert, Denis/A-3067-2010; Rabalais, Nancy N./AAD-2119-2021; Rose, Kenneth/AAA-3534-2022; Montes, Ivonne/AAM-6316-2020; Roman, Michael/F-9390-2013; Oschlies, Andreas/F-9749-2012	Montes, Ivonne/0000-0002-4262-1804; Gilbert, Denis/0000-0002-9554-9594; Rose, Kenneth/0000-0002-9310-8410; Oschlies, Andreas/0000-0002-8295-4013; Telszewski, Maciej/0000-0002-9139-226X; Rabalais, Nancy N./0000-0002-1514-837X; Conley, Daniel Joseph/0000-0001-9668-9284; Limburg, Karin/0000-0003-3716-8555; Levin, Lisa/0000-0002-2858-8622	IOC-UNESCO; National Oceanic and Atmospheric Administration (NOAA)-Center for Sponsored Coastal Ocean Research [NA10NOS4780138]; National Oceanic and Atmospheric Administration (NOAA)-Center for Sponsored Coastal Ocean Research Maryland Sea Grant [SA75281450-P]; NSF-EAR grant [1324095]; Deutsche Forschungsgemeinschaft [SFB754]; Fonds National de la Recherche Scientifique; BENTHOX program grant [T.1009.15]; BONUS COCOA project [2112932-1]; European Union; Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning; Division Of Ocean Sciences [1459243, 1433759] Funding Source: National Science Foundation	IOC-UNESCO; National Oceanic and Atmospheric Administration (NOAA)-Center for Sponsored Coastal Ocean Research(National Oceanic Atmospheric Admin (NOAA) - USA); National Oceanic and Atmospheric Administration (NOAA)-Center for Sponsored Coastal Ocean Research Maryland Sea Grant; NSF-EAR grant; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Fonds National de la Recherche Scientifique(Fonds de la Recherche Scientifique - FNRS); BENTHOX program grant; BONUS COCOA project; European Union(European Commission); Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning(Swedish Research Council Formas); Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	We thank IOC-UNESCO for financial support and for initiating and supporting the Global Ocean Oxygen Network. We also thank R. Diaz for help with updating the list of coastal sites that have reported hypoxia (Fig. 1A); B. Michael and M. Trice of the Maryland Department of Natural Resources for help with the Maryland water quality database; and our many current and past collaborators on deoxygenation research in coastal systems, OMZs, the Black Sea, and elsewhere. Funding was provided by National Oceanic and Atmospheric Administration (NOAA)-Center for Sponsored Coastal Ocean Research grant NA10NOS4780138 and Maryland Sea Grant SA75281450-P (to D.B.), NSF-EAR grant 1324095 (to L.A.L.), the Deutsche Forschungsgemeinschaft via grant SFB754 (to A.O.), and the Fonds National de la Recherche Scientifique and the BENTHOX program grant T.1009.15 (to M.G.). This study was partly supported by the BONUS COCOA project (grant 2112932-1), funded jointly by the European Union and the Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning.	Altieri AH, 2017, P NATL ACAD SCI USA, V114, P3660, DOI 10.1073/pnas.1621517114; Altieri AH, 2015, GLOBAL CHANGE BIOL, V21, P1395, DOI 10.1111/gcb.12754; [Anonymous], 2013, QUANTITATIVE FISHERI; [Anonymous], 2010, NITROUS OXIDE AND CL, DOI [10.4319/lom.2009.7.371, DOI 10.4319/LOM.2009.7.371]; [Anonymous], 2017, CHESAPEAKE BAY PROGR; Arevalo-Martinez DL, 2015, NAT GEOSCI, V8, P530, DOI [10.1038/NGEO2469, 10.1038/ngeo2469]; Bertrand A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029558; Bettencourt JH, 2015, NAT GEOSCI, V8, P937, DOI [10.1038/NGEO2570, 10.1038/ngeo2570]; Bohlen L, 2012, GLOBAL BIOGEOCHEM CY, V26, DOI 10.1029/2011GB004198; Bopp L, 2013, BIOGEOSCIENCES, V10, P6225, DOI 10.5194/bg-10-6225-2013; Bouwman AF, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002314; Breitburg D, 2002, ESTUARIES, V25, P767, DOI 10.1007/BF02804904; Breitburg DL, 2015, OCEANOGRAPHY, V28, P48, DOI 10.5670/oceanog.2015.31; Breitburg DL, 2009, ANNU REV MAR SCI, V1, P329, DOI 10.1146/annurev.marine.010908.163754; Brewer PG, 2017, PHILOS T R SOC A, V375, DOI 10.1098/rsta.2016.0319; Bristow LA, 2017, NAT GEOSCI, V10, P24, DOI [10.1038/ngeo2847, 10.1038/NGEO2847]; Bushinsky SM, 2016, LIMNOL OCEANOGR-METH, V14, P491, DOI 10.1002/lom3.10107; Cabre A, 2015, BIOGEOSCIENCES, V12, P5429, DOI 10.5194/bg-12-5429-2015; Capet A, 2013, BIOGEOSCIENCES, V10, P3943, DOI 10.5194/bg-10-3943-2013; Carstensen J, 2014, P NATL ACAD SCI USA, V111, P5628, DOI 10.1073/pnas.1323156111; Casini M, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.160416; Cayabyab R. R., 2002, REGIONAL EPIDEMIOLOG, DOI [10.1088/1748-9326/9/10/105012, DOI 10.1088/1748-9326/9/10/105012]; Chan F, 2008, SCIENCE, V319, P920, DOI 10.1126/science.1149016; Chavez FP, 2008, PROG OCEANOGR, V79, P95, DOI 10.1016/j.pocean.2008.10.012; Cheung WWL, 2011, ICES J MAR SCI, V68, P1008, DOI 10.1093/icesjms/fsr012; Conley DJ, 2007, ECOL APPL, V17, pS165, DOI 10.1890/05-0766.1; Conley DJ, 2009, HYDROBIOLOGIA, V629, P21, DOI 10.1007/s10750-009-9764-2; Craig JK, 2013, ESTUAR COAST, V36, P268, DOI 10.1007/s12237-012-9577-9; Dalsgaard T, 2013, GEOCHIM COSMOCHIM AC, V106, P247, DOI 10.1016/j.gca.2012.12.038; Davidson EA, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/10/105012; de Mutsert K, 2016, ECOL MODEL, V331, P142, DOI 10.1016/j.ecolmodel.2015.10.013; Deutsch C, 2015, SCIENCE, V348, P1132, DOI 10.1126/science.aaa1605; Deutsch C, 2014, SCIENCE, V345, P665, DOI 10.1126/science.1252332; Diaz RJ, 2008, SCIENCE, V321, P926, DOI 10.1126/science.1156401; Doney SC, 2010, SCIENCE, V328, P1512, DOI 10.1126/science.1185198; Duarte CM, 2009, ESTUAR COAST, V32, P29, DOI 10.1007/s12237-008-9111-2; Duteil O, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL046877; Eby LA, 2002, CAN J FISH AQUAT SCI, V59, P952, DOI 10.1139/F02-067; Eilola K, 2014, TELLUS A, V66, DOI 10.3402/tellusa.v66.23985; Ekau W, 2010, BIOGEOSCIENCES, V7, P1669, DOI 10.5194/bg-7-1669-2010; Eshleman KN, 2016, ATMOS ENVIRON, V146, P280, DOI 10.1016/j.atmosenv.2016.07.004; Farrell AP, 2016, J FISH BIOL, V88, P322, DOI 10.1111/jfb.12789; Feely RA, 2008, SCIENCE, V320, P1490, DOI 10.1126/science.1155676; Gallo ND, 2016, ADV MAR BIOL, V74, P117, DOI 10.1016/bs.amb.2016.04.001; Galton D., 1884, J SOC ART, V33, P290; Gilbert D, 2005, LIMNOL OCEANOGR, V50, P1654, DOI 10.4319/lo.2005.50.5.1654; Gilbert D, 2010, BIOGEOSCIENCES, V7, P2283, DOI 10.5194/bg-7-2283-2010; Gilly WF, 2013, ANNU REV MAR SCI, V5, P393, DOI 10.1146/annurev-marine-120710-100849; Gobler CJ, 2016, BIOL LETTERS, V12, DOI 10.1098/rsbl.2015.0976; Gooday AJ, 2010, MAR ECOL-EVOL PERSP, V31, P125, DOI 10.1111/j.1439-0485.2009.00348.x; Gruber N, 2016, P NATL ACAD SCI USA, V113, P4246, DOI 10.1073/pnas.1603646113; Gutierrez D, 2009, BIOGEOSCIENCES, V6, P835, DOI 10.5194/bg-6-835-2009; Hancock JR, 2016, CONSERV PHYSIOL, V4, DOI 10.1093/conphys/cow040; HASLER AD, 1969, BIOSCIENCE, V19, P425, DOI 10.2307/1294478; Helm KP, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL049513; Hughes BB, 2015, P NATL ACAD SCI USA, V112, P8025, DOI 10.1073/pnas.1505815112; INGALL E, 1994, GEOCHIM COSMOCHIM AC, V58, P2571, DOI 10.1016/0016-7037(94)90033-7; International Fertilizer Association IFADATA, 2016, GLOBAL BIOGEOCHEM CY, V24, DOI [10.1029/2009GB003587, DOI 10.1029/2009GB003587]; Isensee K, 2016, OCEAN CLIMATE SCI NO, P20; Ito T, 2017, GEOPHYS RES LETT, V44, P4214, DOI 10.1002/2017GL073613; Janssen DJ, 2014, P NATL ACAD SCI USA, V111, P6888, DOI 10.1073/pnas.1402388111; Karstensen J, 2015, BIOGEOSCIENCES, V12, P2597, DOI 10.5194/bg-12-2597-2015; Keeling RF, 2010, ANNU REV MAR SCI, V2, P199, DOI 10.1146/annurev.marine.010908.163855; Kemp WM, 2009, BIOGEOSCIENCES, V6, P2985, DOI 10.5194/bg-6-2985-2009; Keppel AG, 2015, MAR ECOL PROG SER, V538, P169, DOI 10.3354/meps11479; Koslow JA, 2011, MAR ECOL PROG SER, V436, P207, DOI 10.3354/meps09270; Larsen M, 2016, LIMNOL OCEANOGR-METH, V14, P784, DOI 10.1002/lom3.10126; Levin LA, 2003, OCEANOGR MAR BIOL, V41, P1; Levin LA, 2015, NAT CLIM CHANGE, V5, P401, DOI 10.1038/nclimate2595; Levin LA, 2015, J MARINE SYST, V141, P3, DOI 10.1016/j.jmarsys.2014.04.016; Li L, 2018, SCI TOTAL ENVIRON, V613, P557, DOI 10.1016/j.scitotenv.2017.09.029; Li M, 2016, GEOPHYS RES LETT, V43, P2127, DOI 10.1002/2015GL067334; Limburg KE, 2011, P NATL ACAD SCI USA, V108, pE177, DOI 10.1073/pnas.1100684108; Martinez-Rey J, 2015, BIOGEOSCIENCES, V12, P4133, DOI 10.5194/bg-12-4133-2015; McCarthy MJ, 2015, ESTUAR COAST, V38, P2279, DOI 10.1007/s12237-015-9964-0; McCormick LR, 2017, PHILOS T R SOC A, V375, DOI 10.1098/rsta.2016.0322; Meier HEM, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL049929; Miller SH, 2016, MAR ECOL PROG SER, V549, P1, DOI 10.3354/meps11695; Nam S, 2015, J GEOPHYS RES-OCEANS, V120, P5387, DOI 10.1002/2015JC010859; Naqvi SWA, 2010, BIOGEOSCIENCES, V7, P2159, DOI 10.5194/bg-7-2159-2010; Neilan RM, 2014, J THEOR BIOL, V343, P54, DOI 10.1016/j.jtbi.2013.11.004; Nixon SW, 2002, ESTUARIES, V25, P782, DOI 10.1007/BF02804905; Norris RD, 2013, SCIENCE, V341, P492, DOI 10.1126/science.1240543; Oschlies A, 2017, PHILOS T R SOC A, V375, DOI 10.1098/rsta.2016.0325; Oschlies A, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB003147; Pauly D, 2018, GLOBAL CHANGE BIOL, V24, pE15, DOI 10.1111/gcb.13831; Portner HO, 2012, MAR ECOL PROG SER, V470, P273, DOI 10.3354/meps10123; Rabalais NN, 2010, BIOGEOSCIENCES, V7, P585, DOI 10.5194/bg-7-585-2010; Rabalais NN, 2014, OCEANOGRAPHY, V27, P172, DOI 10.5670/oceanog.2014.21; Rabotyagov SS, 2014, P NATL ACAD SCI USA, V111, P18530, DOI 10.1073/pnas.1405837111; Reed DC, 2016, GLOBAL BIOGEOCHEM CY, V30, P447, DOI 10.1002/2015GB005303; Revsbech NP, 2009, LIMNOL OCEANOGR-METH, V7, P371, DOI 10.4319/lom.2009.7.371; Rice MA., 2014, AQUACULT, V15, P26; Richards JG, 2009, FISH PHYSIOL, V27, P443, DOI 10.1016/S1546-5098(08)00010-1; Riemann B, 2016, ESTUAR COAST, V39, P82, DOI 10.1007/s12237-015-9980-0; Roman MR, 2012, ESTUAR COAST, V35, P1261, DOI 10.1007/s12237-012-9531-x; Rose K. A., 2017, MODELING COASTAL HYP, P401; Rose KA, 2009, J EXP MAR BIOL ECOL, V381, pS188, DOI 10.1016/j.jembe.2009.07.022; Sato KN, 2017, DEEP-SEA RES PT II, V137, P377, DOI 10.1016/j.dsr2.2016.08.012; Schmidtko S, 2017, NATURE, V542, P335, DOI 10.1038/nature21399; Scholz F, 2014, NAT GEOSCI, V7, P433, DOI [10.1038/NGEO2162, 10.1038/ngeo2162]; Scully ME, 2010, J PHYS OCEANOGR, V40, P1435, DOI 10.1175/2010JPO4321.1; Seibel BA, 2013, DEEP-SEA RES PT II, V95, P139, DOI 10.1016/j.dsr2.2012.10.003; Seibel BA, 2011, J EXP BIOL, V214, P326, DOI 10.1242/jeb.049171; Seitzinger SP, 2017, SCIENCE, V357, P350, DOI 10.1126/science.aao0812; Sokolova IM, 2013, INTEGR COMP BIOL, V53, P597, DOI 10.1093/icb/ict028; Somes CJ, 2013, BIOGEOSCIENCES, V10, P5889, DOI 10.5194/bg-10-5889-2013; Sotto LPA, 2014, MAR POLLUT BULL, V85, P446, DOI 10.1016/j.marpolbul.2014.02.028; Sperling EA, 2013, P NATL ACAD SCI USA, V110, P13446, DOI 10.1073/pnas.1312778110; Steckbauer A, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/2/025003; Stendardo I, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2012JC007909; Stierhoff KL, 2009, CAN J FISH AQUAT SCI, V66, P1033, DOI 10.1139/F09-066; Stortini CH, 2017, GLOBAL CHANGE BIOL, V23, P2284, DOI 10.1111/gcb.13534; Stramma L, 2012, BIOGEOSCIENCES, V9, P4045, DOI 10.5194/bg-9-4045-2012; Stramma L, 2008, SCIENCE, V320, P655, DOI 10.1126/science.1153847; Stramma L, 2012, NAT CLIM CHANGE, V2, P33, DOI 10.1038/NCLIMATE1304; Stramma L, 2010, DEEP-SEA RES PT I, V57, P587, DOI 10.1016/j.dsr.2010.01.005; Sydeman WJ, 2014, SCIENCE, V345, P77, DOI [10.1126/science.1251635, 10.1126/science.1250830]; Thomas P, 2015, MAR POLLUT BULL, V101, P182, DOI 10.1016/j.marpolbul.2015.11.001; Tiano L, 2014, DEEP-SEA RES PT I, V94, P173, DOI 10.1016/j.dsr.2014.10.001; Tyler RM, 2009, ESTUAR COAST, V32, P123, DOI 10.1007/s12237-008-9108-x; United Nations Department of Economic and Social Affairs/Population Division, 2015, WORLD POPULATION PRO; Utne-Palm AC, 2010, SCIENCE, V329, P333, DOI 10.1126/science.1190708; Van Meter KJ, 2017, GLOBAL BIOGEOCHEM CY, V31, P2, DOI 10.1002/2016GB005498; Vaquer-Sunyer R, 2008, P NATL ACAD SCI USA, V105, P15452, DOI 10.1073/pnas.0803833105; Wang DW, 2015, NATURE, V518, P390, DOI 10.1038/nature14235; Wang SY, 2016, INT J DISTRIB SENS N, DOI 10.1155/2016/3159805; Watson AJ, 2016, SCIENCE, V354, P1529, DOI 10.1126/science.aaj2321; Whitney FA, 2007, PROG OCEANOGR, V75, P179, DOI 10.1016/j.pocean.2007.08.007; Wishner KF, 2008, PROG OCEANOGR, V78, P163, DOI 10.1016/j.pocean.2008.03.001; Wright JJ, 2012, NAT REV MICROBIOL, V10, P381, DOI 10.1038/nrmicro2778; Wu RSS, 2002, MAR POLLUT BULL, V45, P35, DOI 10.1016/S0025-326X(02)00061-9; Yasuhara M, 2012, ECOL EVOL, V2, P3242, DOI 10.1002/ece3.425; Zhang J, 2010, BIOGEOSCIENCES, V7, P1443, DOI 10.5194/bg-7-1443-2010	134	1036	1071	161	1159	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 5	2018	359	6371					46	+	eaam7240	10.1126/science.aam7240	http://dx.doi.org/10.1126/science.aam7240			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FR8KW	29301986				2022-12-28	WOS:000419324700062
J	Mack, SC; Pajtler, KW; Chavez, L; Okonechnikov, K; Bertrand, KC; Wang, XX; Erkek, S; Federation, A; Song, A; Lee, C; Wang, X; McDonald, L; Morrow, JJ; Saiakhova, A; Sin-Chan, P; Wu, QL; Michaelraj, KA; Miller, TE; Hubert, CG; Ryzhova, M; Garzia, L; Donovan, L; Dombrowski, S; Factor, DC; Luu, B; Valentim, CLL; Gimple, RC; Morton, A; Kim, L; Prager, BC; Lee, JJY; Wu, XC; Zuccaro, J; Thompson, Y; Holgado, BL; Reimand, J; Ke, SQ; Tropper, A; Lai, SS; Vijayarajah, S; Doan, S; Mahadev, V; Minan, AF; Grobner, SN; Lienhard, M; Zapatka, M; Huang, ZQ; Aldape, KD; Carcaboso, AM; Houghton, PJ; Keir, ST; Milde, T; Witt, H; Li, Y; Li, CJ; Bian, XW; Jones, DTW; Scott, I; Singh, SK; Huang, A; Dirks, PB; Bouffet, E; Bradner, JE; Amaswamy, VR; Jabado, N; Rutka, JT; Northcott, PA; Lupien, M; Lichter, P; Korshunov, A; Scacheri, PC; Pfister, SM; Kool, M; Taylor, MD; Rich, JN				Mack, Stephen C.; Pajtler, Kristian W.; Chavez, Lukas; Okonechnikov, Konstantin; Bertrand, Kelsey C.; Wang, Xiuxing; Erkek, Serap; Federation, Alexander; Song, Anne; Lee, Christine; Wang, Xin; McDonald, Laura; Morrow, James J.; Saiakhova, Alina; Sin-Chan, Patrick; Wu, Qiulian; Michaelraj, Kulandaimanuvel Antony; Miller, Tyler E.; Hubert, Christopher G.; Ryzhova, Marina; Garzia, Livia; Donovan, Laura; Dombrowski, Stephen; Factor, Daniel C.; Luu, Betty; Valentim, Claudia L. L.; Gimple, Ryan C.; Morton, Andrew; Kim, Leo; Prager, Briana C.; Lee, John J. Y.; Wu, Xiaochong; Zuccaro, Jennifer; Thompson, Yuan; Holgado, Borja L.; Reimand, Juri; Ke, Susan Q.; Tropper, Adam; Lai, Sisi; Vijayarajah, Senthuran; Doan, Sylvia; Mahadev, Vaidehi; Fernandez Minan, Ana; Groebner, Susanne N.; Lienhard, Matthias; Zapatka, Marc; Huang, Zhiqin; Aldape, Kenneth D.; Carcaboso, Angel M.; Houghton, Peter J.; Keir, Stephen T.; Milde, Till; Witt, Hendrik; Li, Yan; Li, Chao-Jun; Bian, Xiu-Wu; Jones, David T. W.; Scott, Ian; Singh, Sheila K.; Huang, Annie; Dirks, Peter B.; Bouffet, Eric; Bradner, James E.; Amaswamy, Vijay R.; Jabado, Nada; Rutka, James T.; Northcott, Paul A.; Lupien, Mathieu; Lichter, Peter; Korshunov, Andrey; Scacheri, Peter C.; Pfister, Stefan M.; Kool, Marcel; Taylor, Michael D.; Rich, Jeremy N.			Therapeutic targeting of ependymoma as informed by oncogenic enhancer profiling	NATURE			English	Article							SUPER-ENHANCERS; COMPARTMENTS; EXPRESSION; SUBGROUPS; TUMORS	Genomic sequencing has driven precision-based oncology therapy; however, the genetic drivers of many malignancies remain unknown or non-targetable, so alternative approaches to the identification of therapeutic leads are necessary. Ependymomas are chemotherapy-resistant brain tumours, which, despite genomic sequencing, lack effective molecular targets. Intracranial ependymomas are segregated on the basis of anatomical location (supratentorial region or posterior fossa) and further divided into distinct molecular subgroups that reflect differences in the age of onset, gender predominance and response to therapy(1-3). The most common and aggressive subgroup, posterior fossa ependymoma group A (PF-EPN-A), occurs in young children and appears to lack recurrent somatic mutations(2). Conversely, posterior fossa ependymoma group B (PF-EPN-B) tumours display frequent large-scale copy number gains and losses but have favourable clinical outcomes(1,3). More than 70% of supratentorial ependymomas are defined by highly recurrent gene fusions in the NF-kappa B subunit gene RELA (ST-EPN-RELA), and a smaller number involve fusion of the gene encoding the transcriptional activator YAP1 (ST-EPN-YAP1)(1,3,4). Subependymomas, a distinct histologic variant, can also be found within the supratetorial and posterior fossa compartments, and account for the majority of tumours in the molecular subgroups ST-EPN-SE and PF-EPN-SE. Here we describe mapping of active chromatin landscapes in 42 primary ependymomas in two non-overlapping primary ependymoma cohorts, with the goal of identifying essential super-enhancer-associated genes on which tumour cells depend. Enhancer regions revealed putative oncogenes, molecular targets and pathways; inhibition of these targets with small molecule inhibitors or short hairpin RNA diminished the proliferation of patient-derived neurospheres and increased survival in mouse models of ependymomas. Through profiling of transcriptional enhancers, our study provides a framework for target and drug discovery in other cancers that lack known genetic drivers and are therefore difficult to treat.	[Mack, Stephen C.; Bertrand, Kelsey C.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Mack, Stephen C.; Bertrand, Kelsey C.] Texas Childrens Canc Ctr, Dept Pediat Hematolgy & Oncol, Houston, TX USA; [Mack, Stephen C.; Wang, Xiuxing; Song, Anne; Lee, Christine; Wu, Qiulian; Miller, Tyler E.; Hubert, Christopher G.; Dombrowski, Stephen; Valentim, Claudia L. L.; Gimple, Ryan C.; Morton, Andrew; Kim, Leo; Prager, Briana C.; Ke, Susan Q.; Tropper, Adam; Lai, Sisi; Mahadev, Vaidehi; Rich, Jeremy N.] Cleveland Clin, Lerner Res Inst, Dept Stem Cell Biol & Regenerat Med, Cleveland, OH 44195 USA; [Mack, Stephen C.; Wang, Xiuxing; Song, Anne; Lee, Christine; Wu, Qiulian; Miller, Tyler E.; Hubert, Christopher G.; Dombrowski, Stephen; Valentim, Claudia L. L.; Gimple, Ryan C.; Morton, Andrew; Kim, Leo; Prager, Briana C.; Ke, Susan Q.; Tropper, Adam; Lai, Sisi; Mahadev, Vaidehi; Rich, Jeremy N.] Case Western Reserve Univ, Lerner Coll Med, Cleveland Clin, Dept Mol Med, Cleveland, OH 44195 USA; [Pajtler, Kristian W.; Chavez, Lukas; Okonechnikov, Konstantin; Erkek, Serap; Groebner, Susanne N.; Witt, Hendrik; Jones, David T. W.; Pfister, Stefan M.; Kool, Marcel] NCT Heidelberg KiTZ, Hopp Childrens Canc Ctr, D-69120 Heidelberg, Germany; [Pajtler, Kristian W.; Chavez, Lukas; Okonechnikov, Konstantin; Erkek, Serap; Groebner, Susanne N.; Witt, Hendrik; Jones, David T. W.; Pfister, Stefan M.; Kool, Marcel] German Canc Res Ctr, Div Pediat Neurooncol, D-69120 Heidelberg, Germany; [Pajtler, Kristian W.; Chavez, Lukas; Okonechnikov, Konstantin; Erkek, Serap; Groebner, Susanne N.; Witt, Hendrik; Jones, David T. W.; Pfister, Stefan M.; Kool, Marcel] German Canc Consortium DKTK, D-69120 Heidelberg, Germany; [Pajtler, Kristian W.; Milde, Till; Witt, Hendrik; Pfister, Stefan M.] Heidelberg Univ Hosp, Dept Pediat Oncol Hematol & Immunol, D-69120 Heidelberg, Germany; [Chavez, Lukas] Univ Calif San Diego, Sch Med, Dept Med, Div Med Genet, La Jolla, CA 92093 USA; [Bertrand, Kelsey C.; Vijayarajah, Senthuran] Cleveland Clin, Dept Pediat, Cleveland, OH 44195 USA; [Wang, Xiuxing; Wu, Qiulian; Gimple, Ryan C.; Kim, Leo; Prager, Briana C.; Rich, Jeremy N.] Univ Calif San Diego, Sch Med, Dept Med, Div Regenerat Med, La Jolla, CA 92093 USA; [Erkek, Serap] European Mol Biol Lab, Genome Biol Unit, Heidelberg, Germany; [Federation, Alexander] Univ Washington, Dept Genom Sci, Seattle, WA 98195 USA; [Wang, Xin; McDonald, Laura; Sin-Chan, Patrick; Michaelraj, Kulandaimanuvel Antony; Garzia, Livia; Donovan, Laura; Luu, Betty; Lee, John J. Y.; Wu, Xiaochong; Zuccaro, Jennifer; Thompson, Yuan; Holgado, Borja L.; Scott, Ian; Huang, Annie; Dirks, Peter B.; Bouffet, Eric; Amaswamy, Vijay R.; Rutka, James T.; Taylor, Michael D.] Hosp Sick Children, Arthur & Sonia Labatt Brain Tumour Res Ctr, Program Dev & Stem Cell Biol, Div Neurosurg, Toronto, ON M5G 1X8, Canada; [Morrow, James J.; Saiakhova, Alina; Factor, Daniel C.; Morton, Andrew; Li, Yan; Scacheri, Peter C.] Case Western Reserve Univ, Dept Genet & Genome Sci, Cleveland, OH 44106 USA; [Miller, Tyler E.; Gimple, Ryan C.] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA; [Ryzhova, Marina] NN Burdenko Inst Neurosurg, Dept Neuropathol, 4th Tverskaya Yamskaya 16, Moscow 125047, Russia; [Dombrowski, Stephen; Rich, Jeremy N.] Rose Ella Burkhardt Brain Tumor & Neurooncol Ctr, Neurol Inst, Dept Neurosurg, Cleveland Clin, Cleveland, OH 44195 USA; [Reimand, Juri] Ontario Inst Canc Res, Computat Biol Program, Toronto, ON M5G 0A3, Canada; [Reimand, Juri; Lupien, Mathieu] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 1L7, Canada; [Vijayarajah, Senthuran] Univ Utah, Sch Med, Dept Pediat, Div Crit Care, Salt Lake City, UT USA; [Doan, Sylvia] Univ Utah, Sch Med, Dept Pediat, Salt Lake City, UT USA; [Fernandez Minan, Ana] Ctr Andaluz Biol Desarrollo, Consejo Super Invest Cient, Seville, Spain; [Fernandez Minan, Ana] Univ Pablo Olavide, Seville, Spain; [Lienhard, Matthias] Max Planck Inst Mol Genet, Dept Computat Mol Biol, D-14195 Berlin, Germany; [Zapatka, Marc; Huang, Zhiqin; Lichter, Peter] German Canc Res Ctr, Div Mol Genet, D-69121 Heidelberg, Germany; [Aldape, Kenneth D.] Univ Hlth Network, Dept Pathol, Toronto, ON M5G 1L7, Canada; [Carcaboso, Angel M.] Fundacio Sant Joan Deu, Preclin Therapeut & Drug Delivery Res Program, Barcelona 08950, Spain; [Houghton, Peter J.] Nationwide Childrens Hosp, Ctr Childhood Canc & Blood Dis, Columbus, OH USA; [Keir, Stephen T.] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA; [Milde, Till] German Canc Res Ctr, Clin Cooperat Unit Pediat Oncol, INF 280, D-69120 Heidelberg, Germany; [Li, Chao-Jun] Nanjing Univ, Natl Resource Ctr Mutant Mice, Model Anim Res Ctr, MOE Key Lab Model Anim Dis Study, Nanjing, Jiangsu, Peoples R China; [Bian, Xiu-Wu] Third Mil Med Univ, Southwest Hosp, Inst Pathol, Chongqing, Peoples R China; [Bian, Xiu-Wu] Third Mil Med Univ, Southwest Hosp, Southwest Canc Ctr, Chongqing, Peoples R China; [Bian, Xiu-Wu] Minist Educ China, Key Lab Tumor Immunopathol, Chongqing, Peoples R China; [Singh, Sheila K.] McMaster Univ, Dept Surg, Fac Hlth Sci, Div Neurosurg, Hamilton, ON, Canada; [Huang, Annie; Bouffet, Eric; Bradner, James E.] Novartis Inst Biomed Res, Cambridge, MA 02139 USA; [Amaswamy, Vijay R.] Hosp Sick Children, Div Hematol & Oncol, Toronto, ON M5G 1X8, Canada; [Jabado, Nada] McGill Univ, Dept Pediat, Montreal, PQ H3Z 2Z3, Canada; [Jabado, Nada] McGill Univ, Dept Human Genet, Montreal, PQ H3Z 2Z3, Canada; [Jabado, Nada] McGill Univ Hlth Ctr, Res Inst, Montreal, PQ H3Z 2Z3, Canada; [Northcott, Paul A.] St Jude Childrens Res Hosp, Dev Neurobiol, 332 N Lauderdale St, Memphis, TN 38105 USA; [Korshunov, Andrey] Heidelberg Univ, Dept Neuropathol, D-69120 Heidelberg, Germany; [Korshunov, Andrey] German Canc Res Ctr, Clin Cooperat Unit Neuropathol, D-69121 Heidelberg, Germany	Baylor College of Medicine; Texas Children's Cancer Center; Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; University of California System; University of California San Diego; Cleveland Clinic Foundation; University of California System; University of California San Diego; European Molecular Biology Laboratory (EMBL); University of Washington; University of Washington Seattle; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Case Western Reserve University; Case Western Reserve University; Russian Academy of Medical Sciences; N.N.Burdenko National Medical Research Center of Neurosurgery; Cleveland Clinic Foundation; Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates; University of Toronto; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; CSIC - Andalusian Center for Developmental Biology (CABD); Universidad Pablo de Olavide; Max Planck Society; Helmholtz Association; German Cancer Research Center (DKFZ); University of Toronto; University Toronto Affiliates; University Health Network Toronto; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Duke University; Helmholtz Association; German Cancer Research Center (DKFZ); Nanjing University; Army Medical University; Army Medical University; Ministry of Education, China; McMaster University; Novartis; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); McGill University; McGill University; McGill University; St Jude Children's Research Hospital; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ)	Rich, JN (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Stem Cell Biol & Regenerat Med, Cleveland, OH 44195 USA.; Rich, JN (corresponding author), Case Western Reserve Univ, Lerner Coll Med, Cleveland Clin, Dept Mol Med, Cleveland, OH 44195 USA.; Kool, M (corresponding author), NCT Heidelberg KiTZ, Hopp Childrens Canc Ctr, D-69120 Heidelberg, Germany.; Kool, M (corresponding author), German Canc Res Ctr, Div Pediat Neurooncol, D-69120 Heidelberg, Germany.; Rich, JN (corresponding author), Univ Calif San Diego, Sch Med, Dept Med, Div Regenerat Med, La Jolla, CA 92093 USA.; Taylor, MD (corresponding author), Hosp Sick Children, Arthur & Sonia Labatt Brain Tumour Res Ctr, Program Dev & Stem Cell Biol, Div Neurosurg, Toronto, ON M5G 1X8, Canada.; Rich, JN (corresponding author), Rose Ella Burkhardt Brain Tumor & Neurooncol Ctr, Neurol Inst, Dept Neurosurg, Cleveland Clin, Cleveland, OH 44195 USA.	m.kool@dkfz-heidelberg.de; mdtaylor@sickkids.ca; drjeremyrich@gmail.com	Northcott, Paul A/N-4022-2018; Zapatka, Marc/G-9896-2013; Bouffet, Eric/AAB-8999-2020; Pfister, Stefan M/F-6860-2013; Okonechnikov, Konstantin/AAD-4239-2019; Wang, Xiuxing/HGU-0583-2022; Ryzhova, Marina/G-4178-2014; Gimple, Ryan/AAU-8944-2020; wang, xiuxing/AAY-4068-2021; Reimand, Jüri/U-9264-2019; Singh, Sheila K/W-2799-2018; Jones, David T. W./Z-1963-2019; Jabado, Nada/AAN-4026-2020; Li, Chao-Jun/G-3522-2019; Milde, Till/AAR-4528-2021; Bian, Xiu-Wu/D-4736-2017; Rich, Jeremy/AAM-1445-2021; Wang, Xiuxing/N-6759-2019; Li, Chao/GSM-8117-2022; Erkek, Serap/AAV-5549-2020; Wang, Xiuxing/ABF-8681-2020; Michealraj, Antony/AAJ-7925-2020; Jones, David TW/G-9588-2013; Pajtler, Kristian/AAN-9029-2020	Northcott, Paul A/0000-0002-1220-5252; Zapatka, Marc/0000-0001-8287-5967; Pfister, Stefan M/0000-0002-5447-5322; Wang, Xiuxing/0000-0001-7115-729X; Ryzhova, Marina/0000-0001-7206-6365; Reimand, Jüri/0000-0002-2299-2309; Singh, Sheila K/0000-0003-1272-5300; Li, Chao-Jun/0000-0002-3859-8824; Milde, Till/0000-0002-7267-1052; Bian, Xiu-Wu/0000-0003-4383-0197; Wang, Xiuxing/0000-0002-5993-9368; Li, Chao/0000-0001-6110-6210; Michealraj, Antony/0000-0002-3967-0816; Jones, David TW/0000-0002-2036-5141; Taylor, Michael/0000-0001-7009-3466; Lee, Lee-Poturalski, Christine/0000-0002-3383-6360; Erkek, Serap/0000-0003-4439-5203; Li, Chaojun/0000-0001-9474-7321; Chavez, Lukas/0000-0002-8718-8848; Morton, Andrew/0000-0002-1234-1676; Song, Anne/0000-0003-4717-3374; Carcaboso, Angel/0000-0002-8485-426X; Korshunov, Andrey/0000-0002-5257-3623; Ramaswamy, Vijay/0000-0002-6557-895X; Miller, Tyler E/0000-0002-1269-1895; Donovan, Laura/0000-0001-5557-5539; Pajtler, Kristian W./0000-0002-3562-6121	Alex's Lemonade Stand Young Investigator Award; CIHR Banting Fellowship; Cancer Prevention Research Institute of Texas [RR170023]; Sibylle Assmus Award for Neurooncology; DKFZ-MOST (Ministry of Science, Technology & Space, Israel) program in cancer research; James S. McDonnell Foundation; NIH [CA154130, R01 CA169117, R01 CA171652, R01 NS087913, R01 NS089272, T32GM00725, F30CA217065]; Garron Family Chair in Childhood Cancer Research; Pediatric Brain Tumour Foundation; Grand Challenge Award from CureSearch for Children's Cancer; National Institutes of Health [R01CA148699, R01CA159859]; Terry Fox Research Institute; Brainchild; Stand Up To Cancer St. Baldrick's Pediatric Dream Team Translational Research Grant [SU2C-AACR-DT1113]; ICGC DE-Mining grant [01KU1505]; NATIONAL CANCER INSTITUTE [R01CA204279, R01CA171652, R01CA193677, R01CA159859, F30CA217065, R35CA197718, R01CA169117, R01CA154130, R01CA160356, F30CA203101, R01CA148699] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [TL1TR000441] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK113185] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007250] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS089272, R01NS087913] Funding Source: NIH RePORTER	Alex's Lemonade Stand Young Investigator Award; CIHR Banting Fellowship; Cancer Prevention Research Institute of Texas; Sibylle Assmus Award for Neurooncology; DKFZ-MOST (Ministry of Science, Technology & Space, Israel) program in cancer research; James S. McDonnell Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Garron Family Chair in Childhood Cancer Research; Pediatric Brain Tumour Foundation; Grand Challenge Award from CureSearch for Children's Cancer; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Terry Fox Research Institute; Brainchild; Stand Up To Cancer St. Baldrick's Pediatric Dream Team Translational Research Grant; ICGC DE-Mining grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by an Alex's Lemonade Stand Young Investigator Award (S. C. M.), The CIHR Banting Fellowship (S. C. M.), The Cancer Prevention Research Institute of Texas (S. C. M., RR170023), Sibylle Assmus Award for Neurooncology (K. W. P.), the DKFZ-MOST (Ministry of Science, Technology & Space, Israel) program in cancer research (H. W.), James S. McDonnell Foundation (J. N. R.) and NIH grants: CA154130 (J. N. R.), R01 CA169117 (J. N. R.), R01 CA171652 (J. N. R.), R01 NS087913 (J. N. R.) and R01 NS089272 (J. N. R.). R. C. G. is supported by NIH grants T32GM00725 and F30CA217065. M. D. T. is supported by The Garron Family Chair in Childhood Cancer Research, and grants from the Pediatric Brain Tumour Foundation, Grand Challenge Award from CureSearch for Children's Cancer, the National Institutes of Health (R01CA148699, R01CA159859), The Terry Fox Research Institute and Brainchild. M. D. T. is also supported by a Stand Up To Cancer St. Baldrick's Pediatric Dream Team Translational Research Grant (SU2C-AACR-DT1113). Stand Up To Cancer is a program of the Entertainment Industry Foundation administered by the American Association for Cancer Research. We thank S. Archer for technical writing and editing expertise. In addition, we thank the High-Throughput Sequencing Unit of the DKFZ Genomics and Proteomics Core Facility for technical support and acknowledge technical assistance by M. Mauermann, T. Wedig, A. Wittmann and L. Siebert. Additional support came from the ICGC DE-Mining grant (#01KU1505). We thank The Children's Hospital at Westmead (CHW) Tumour Bank for support of tumour samples (H. W.). We thank D. Schumick (Cleveland Clinic Art Department) and G. Hsu (https://www.hsubiomedicalvisual.com) for their assistance with creative artwork.	Abedalthagafi MS, 2016, J PATHOL, V238, P584, DOI 10.1002/path.4682; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Forbes SA, 2017, NUCLEIC ACIDS RES, V45, pD777, DOI 10.1093/nar/gkw1121; Griffith M, 2013, NAT METHODS, V10, P1209, DOI [10.1038/NMETH.2689, 10.1038/nmeth.2689]; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hnisz D, 2015, MOL CELL, V58, P362, DOI 10.1016/j.molcel.2015.02.014; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Hovestadt V, 2014, NATURE, V510, P537, DOI 10.1038/nature13268; Johann PD, 2016, CANCER CELL, V29, P379, DOI 10.1016/j.ccell.2016.02.001; Johnson RA, 2010, NATURE, V466, P632, DOI 10.1038/nature09173; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Lienhard M, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkw1193; Lin CY, 2016, NATURE, V530, P57, DOI 10.1038/nature16546; Loven J, 2013, CELL, V153, P320, DOI 10.1016/j.cell.2013.03.036; Mack SC, 2014, NATURE, V506, P445, DOI 10.1038/nature13108; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Mohankumar KM, 2015, NAT GENET, V47, P878, DOI 10.1038/ng.3323; Okonechnikov K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167417; Pajtler KW, 2015, CANCER CELL, V27, P728, DOI 10.1016/j.ccell.2015.04.002; Parker M, 2014, NATURE, V506, P451, DOI 10.1038/nature13109; Pope BD, 2014, NATURE, V515, P402, DOI 10.1038/nature13986; Ramsey SA, 2010, BIOINFORMATICS, V26, P2071, DOI 10.1093/bioinformatics/btq405; Reimand J, 2007, NUCLEIC ACIDS RES, V35, pW193, DOI 10.1093/nar/gkm226; Saint-Andre V, 2016, GENOME RES, V26, P385, DOI 10.1101/gr.197590.115; Stein LD, 2015, NATURE, V523, P149, DOI 10.1038/523149a; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Taylor MD, 2005, CANCER CELL, V8, P323, DOI 10.1016/j.ccr.2005.09.001; Witt H, 2011, CANCER CELL, V20, P143, DOI 10.1016/j.ccr.2011.07.007; Zhang XY, 2016, NAT GENET, V48, P176, DOI 10.1038/ng.3470	30	123	123	3	59	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 4	2018	553	7686					101	+		10.1038/nature25169	http://dx.doi.org/10.1038/nature25169			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS4NI	29258295	Green Accepted			2022-12-28	WOS:000419769300038
J	Nimmo, S				Nimmo, Stephanie			Letting my daughter go	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material														Nimmo, Stephanie/0000-0003-2041-2443					0	2	2	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 3	2018	360								j5771	10.1136/bmj.j5771	http://dx.doi.org/10.1136/bmj.j5771			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FS3UP	29298767	Bronze, Green Published			2022-12-28	WOS:000419709400006
J	Biggs, D; Holden, MH; Braczkowski, A; Cook, CN; Milner-Gulland, EJ; Phelps, J; Scholes, RJ; Smith, RJ; Underwood, FM; Adams, VM; Allan, J; Brink, H; Cooney, R; Gao, YF; Hutton, J; Macdonald-Madden, E; Maron, M; Redford, KH; Sutherland, WJ; Possingham, HP				Biggs, Duan; Holden, Matthew H.; Braczkowski, Alex; Cook, Carly N.; Milner-Gulland, E. J.; Phelps, Jacob; Scholes, Robert J.; Smith, Robert J.; Underwood, Fiona M.; Adams, Vanessa M.; Allan, James; Brink, Henry; Cooney, Rosie; Gao, Yufang; Hutton, Jon; Macdonald-Madden, Eve; Maron, Martine; Redford, Kent H.; Sutherland, William J.; Possingham, Hugh P.			Breaking the deadlock on ivory	SCIENCE			English	Editorial Material									[Biggs, Duan] Griffith Univ, Nathan, Qld 4111, Australia; [Holden, Matthew H.; Braczkowski, Alex; Allan, James; Macdonald-Madden, Eve; Maron, Martine] Univ Queensland, St Lucia, Qld, Australia; [Cook, Carly N.] Monash Univ, Clayton, Vic 3800, Australia; [Milner-Gulland, E. J.] Univ Oxford, Oxford, England; [Phelps, Jacob] Univ Lancaster, Lancaster, England; [Scholes, Robert J.] Univ Witwatersrand, Johannesburg, South Africa; [Smith, Robert J.; Brink, Henry] Univ Kent, Canterbury, Kent, England; [Adams, Vanessa M.] Macquarie Univ, Sydney, NSW 2109, Australia; [Cooney, Rosie] IUCN SULi, Gland, Switzerland; [Gao, Yufang] Yale Univ, New Haven, CT USA; [Hutton, Jon] Luc Hoffmann Inst, Gland, Switzerland; [Redford, Kent H.] Archipelago Consulting, Portland, ME USA; [Sutherland, William J.] Univ Cambridge, Cambridge, England; [Possingham, Hugh P.] Nature Conservancy, 1815 N Lynn St, Arlington, VA USA	Griffith University; University of Queensland; Monash University; University of Oxford; Lancaster University; University of Witwatersrand; University of Kent; Macquarie University; Yale University; University of Cambridge; Nature Conservancy	Biggs, D (corresponding author), Griffith Univ, Nathan, Qld 4111, Australia.	ancientantwren@gmail.com	POSSINGHAM, HUGH/R-8310-2019; Adams, Vanessa M./A-3834-2012; Smith, Robert J/D-9660-2011; Holden, Matthew/C-4592-2016; Possingham, Hugh/B-1337-2008; Biggs, Duan/F-9445-2011; Underwood, Fiona/O-6072-2016; mcdonald-madden, eve/A-5186-2012; Allan, James/C-6680-2017	POSSINGHAM, HUGH/0000-0001-7755-996X; Adams, Vanessa M./0000-0002-3509-7901; Smith, Robert J/0000-0003-1599-9171; Holden, Matthew/0000-0001-5135-9433; Possingham, Hugh/0000-0001-7755-996X; Underwood, Fiona/0000-0001-8701-7136; mcdonald-madden, eve/0000-0001-7755-2338; Cooney, Rosie/0000-0001-8384-8469; Biggs, Duan/0000-0003-3177-4677; Allan, James/0000-0001-6322-0172; Maron, Martine/0000-0002-5563-5789; Braczkowski, Alexander/0000-0002-0099-7803				Bennett EL, 2015, CONSERV BIOL, V29, P54, DOI 10.1111/cobi.12377; Biggs D, 2011, CONSERV LETT, V4, P169, DOI 10.1111/j.1755-263X.2011.00170.x; Challender DWS, 2015, GLOB ECOL CONSERV, V3, P129, DOI 10.1016/j.gecco.2014.11.010; CITES, 2002, AFR RANG STAT AGR RE; Cole DH, 2015, NAT CLIM CHANGE, V5, P114, DOI 10.1038/NCLIMATE2490; Daw TM, 2015, P NATL ACAD SCI USA, V112, P6949, DOI 10.1073/pnas.1414900112; Duffy R, 2013, ENVIRON PLANN C, V31, P222, DOI 10.1068/c1105; Gregory R., 2012, STRUCTURED DECISION, DOI [DOI 10.1002/9781444398557, 10.1002/9781444398557]; Kahan D, 2010, NATURE, V463, P296, DOI 10.1038/463296a; Kahane A., 2012, TRANSFORMATIVE SCENA; Martin R. B., 2012, SC62 CITES; Scholes R. J., 2008, ELEPHANT MANAGEMENT; Tetlock PE, 2003, TRENDS COGN SCI, V7, P320, DOI 10.1016/S1364-6613(03)00135-9; Thouless C.R., 2016, AFRICAN ELEPHANT STA; Wittemyer G, 2014, P NATL ACAD SCI USA, V111, P13117, DOI 10.1073/pnas.1403984111	15	44	45	0	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 15	2017	358	6369					1378	1381		10.1126/science.aan5215	http://dx.doi.org/10.1126/science.aan5215			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FP8TH	29242329	Green Accepted			2022-12-28	WOS:000417918500017
J	Enserink, M				Enserink, Martin			Swedish plastics study fabricated, panel finds	SCIENCE			English	News Item																			0	6	6	1	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 15	2017	358	6369					1367	1367		10.1126/science.358.6369.1367	http://dx.doi.org/10.1126/science.358.6369.1367			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FP8TH	29242324				2022-12-28	WOS:000417918500012
J	Odegaard, JI; Lee, MW; Sogawa, Y; Bertholet, AM; Locksley, RM; Weinberg, DE; Kirichok, Y; Deo, RC; Chawla, A				Odegaard, Justin I.; Lee, Min-Woo; Sogawa, Yoshitaka; Bertholet, Ambre M.; Locksley, Richard M.; Weinberg, David E.; Kirichok, Yuriy; Deo, Rahul C.; Chawla, Ajay			Perinatal Licensing of Thermogenesis by IL-33 and ST2 (vol 166, pg 841, 2016)	CELL			English	Correction												ajay.chawla@ucsf.edu			NIAID NIH HHS [R37 AI026918] Funding Source: Medline; NIDDK NIH HHS [R01 DK101064, R01 DK094641, P30 DK098722] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI026918] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK094641, R01DK101064] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Odegaard JI, 2016, CELL, V166, P841, DOI 10.1016/j.cell.2016.06.040	1	4	5	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 14	2017	171	7					1707	1707		10.1016/j.cell.2017.12.003	http://dx.doi.org/10.1016/j.cell.2017.12.003			1	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FQ0KF	29245014	Green Accepted, Bronze			2022-12-28	WOS:000418044000024
J	Castro, KG; Evans, DP; Del Rio, C; Curran, JW				Castro, Kenneth G.; Evans, Dabney P.; Del Rio, Carlos; Curran, James W.			Seven Deadly Sins Resulting From the Centers for Disease Control and Prevention's Seven Forbidden Words	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							WOMEN; CARE; HIV		[Castro, Kenneth G.; Evans, Dabney P.; Del Rio, Carlos; Curran, James W.] Emory Univ, Atlanta, GA 30322 USA; [Castro, Kenneth G.] Emory Univ, Sch Med, Hubert Dept Global Hlth, 1518 Clifton Rd NE,CNR Room 6013, Atlanta, GA 30322 USA; [Castro, Kenneth G.] Emory Univ, Sch Med, Rollins Sch Publ Hlth, Dept Epidemiol,Div Infect Dis,Dept Med, 1518 Clifton Rd NE,CNR Room 6013, Atlanta, GA 30322 USA; [Evans, Dabney P.] Emory Univ, Hubert Dept Global Hlth, 1518 Clifton Rd NE,Mailstop 1518-002-7BB, Atlanta, GA 30322 USA; [Evans, Dabney P.] Emory Univ, Rollins Sch Publ Hlth, Dept Behav Sci & Hlth Educ, 1518 Clifton Rd NE,Mailstop 1518-002-7BB, Atlanta, GA 30322 USA; [Del Rio, Carlos] Emory Univ, Sch Publ Hlth, Dept Global Hlth, Div Infect Dis, 1518 Clifton Rd NE,Room 7011, Atlanta, GA 30322 USA; [Del Rio, Carlos] Emory Univ, Sch Publ Hlth, Dept Med, Div Infect Dis, 1518 Clifton Rd NE,Room 7011, Atlanta, GA 30322 USA; [Del Rio, Carlos] Emory Univ, Sch Med, Dept Global Hlth, Div Infect Dis, 1518 Clifton Rd NE,Room 7011, Atlanta, GA 30322 USA; [Del Rio, Carlos] Emory Univ, Sch Med, Dept Med, Div Infect Dis, 1518 Clifton Rd NE,Room 7011, Atlanta, GA 30322 USA; [Curran, James W.] Emory Univ, Rollins Sch Publ Hlth, 1518 Clifton Rd NE,CNR 8020, Atlanta, GA 30322 USA	Emory University; Emory University; Emory University; Rollins School Public Health; Emory University; Emory University; Rollins School Public Health; Emory University; Emory University; Emory University; Emory University; Emory University; Rollins School Public Health	Castro, KG (corresponding author), Emory Univ, Sch Med, Hubert Dept Global Hlth, 1518 Clifton Rd NE,CNR Room 6013, Atlanta, GA 30322 USA.; Castro, KG (corresponding author), Emory Univ, Sch Med, Rollins Sch Publ Hlth, Dept Epidemiol,Div Infect Dis,Dept Med, 1518 Clifton Rd NE,CNR Room 6013, Atlanta, GA 30322 USA.		Castro, Kenneth G/P-1882-2018; Evans, Dabney/X-6132-2019; del Rio, Carlos/B-3763-2012	Castro, Kenneth G/0000-0001-7964-6354; Evans, Dabney/0000-0002-2201-5655; del Rio, Carlos/0000-0002-0153-3517				Abara WE, 2017, ANN INTERN MED, V167, P794, DOI 10.7326/M17-1106; Baral SD, 2013, LANCET INFECT DIS, V13, P214, DOI 10.1016/S1473-3099(12)70315-8; Centers for Disease Control and Prevention, MISS ROL PLEDG; Institute of Medicine (US) Roundtable on Evidence-Based Medicine, 2009, LEAD COMM IMPR VAL H; Oduyebo T, 2017, MMWR-MORBID MORTAL W, V66, P781, DOI 10.15585/mmwr.mm6629e1; Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338; Santelli JS, 2013, GLOB PUBLIC HEALTH, V8, P1, DOI 10.1080/17441692.2012.759609; Sun L, 2017, WASHINGTON POST; U.S. Department of Health and Human Services, FY 2018 BUDG PERF	9	2	2	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 3	2018	168	7					513	+		10.7326/M17-3410	http://dx.doi.org/10.7326/M17-3410			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GB4AB	29310140				2022-12-28	WOS:000429000900012
J	Kapoor, P; Ansell, SM				Kapoor, Prashant; Ansell, Stephen M.			Acalabrutinib in mantle cell lymphoma	LANCET			English	Editorial Material							PHASE-II; BORTEZOMIB		[Kapoor, Prashant; Ansell, Stephen M.] Mayo Clin, Div Hematol, Rochester, MN 55905 USA	Mayo Clinic	Kapoor, P (corresponding author), Mayo Clin, Div Hematol, Rochester, MN 55905 USA.	kapoor.prashant@mayo.edu			Takeda; Sanofi; Amgen; Bristol-Squibbs Myers; Affimed; Seattle Genetics; Regeneron; Trillium	Takeda(Takeda Pharmaceutical Company Ltd); Sanofi; Amgen(Amgen); Bristol-Squibbs Myers; Affimed; Seattle Genetics; Regeneron(Regeneron); Trillium(University of Toronto)	PK reports grants from Takeda, Sanofi, and Amgen. SMA reports grants from Takeda, Bristol-Squibbs Myers, Affimed, Seattle Genetics, Regeneron, and Trillium.	Byrd JC, 2017, BLOOD, V130; Chanan-Khan A, 2016, LANCET ONCOL, V17, P200, DOI 10.1016/S1470-2045(15)00465-9; Cheson BD, 2007, J CLIN ONCOL, V25, P579, DOI 10.1200/JCO.2006.09.2403; Cheson BD, 2014, J CLIN ONCOL, V32, P3059, DOI 10.1200/JCO.2013.54.8800; Covey T, 2017, BLOOD, V130; Fisher RI, 2006, J CLIN ONCOL, V24, P4867, DOI 10.1200/JCO.2006.07.9665; Goy A, 2013, J CLIN ONCOL, V31, P3688, DOI 10.1200/JCO.2013.49.2835; Hess G, 2009, J CLIN ONCOL, V27, P3822, DOI 10.1200/JCO.2008.20.7977; Honigberg LA, 2010, P NATL ACAD SCI USA, V107, P13075, DOI 10.1073/pnas.1004594107; Markman M, 2011, ONCOLOGY-BASEL, V80, P151, DOI 10.1159/000324707; Wang M, 2017, LANCET; Wang ML, 2013, NEW ENGL J MED, V369, P507, DOI 10.1056/NEJMoa1306220	12	5	6	1	12	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 17	2018	391	10121					633	634		10.1016/S0140-6736(17)33256-7	http://dx.doi.org/10.1016/S0140-6736(17)33256-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FW4MN	29241978				2022-12-28	WOS:000425287800004
J	Ingold, I; Berndt, C; Schmitt, S; Doll, S; Poschmann, G; Buday, K; Roveri, A; Peng, XX; Freitas, FP; Seibt, T; Mehr, L; Aichler, M; Walch, A; Lamp, D; Jastroch, M; Miyamoto, S; Wurst, W; Ursini, F; Amer, ESJ; Fradejas-Villar, N; Schweizer, U; Zischka, H; Angeli, JPF; Conrad, M				Ingold, Irina; Berndt, Carsten; Schmitt, Sabine; Doll, Sebastian; Poschmann, Gereon; Buday, Katalin; Roveri, Antonella; Peng, Xiaoxiao; Freitas, Florencio Porto; Seibt, Tobias; Mehr, Lisa; Aichler, Michaela; Walch, Axel; Lamp, Daniel; Jastroch, Martin; Miyamoto, Sayuri; Wurst, Wolfgang; Ursini, Fulvio; Amer, Elias S. J.; Fradejas-Villar, Noelia; Schweizer, Ulrich; Zischka, Hans; Angeli, Jose Pedro Friedmann; Conrad, Marcus			Selenium Utilization by GPX4 Is Required to Prevent Hydroperoxide-Induced Ferroptosis	CELL			English	Article							GLUTATHIONE-PEROXIDASE 4; THIOREDOXIN REDUCTASE; CELL-DEATH; SELENOPROTEIN EXPRESSION; EMBRYONIC LETHALITY; TRANSFER-RNA; SELENOCYSTEINE; DEFICIENCY; SEIZURES; PROTEIN	Selenoproteins are rare proteins among all kingdoms of life containing the 21st amino acid, selenocysteine. Selenocysteine resembles cysteine, differing only by the substitution of selenium for sulfur. Yet the actual advantage of selenolate-versus thiolate-based catalysis has remained enigmatic, as most of the known selenoproteins also exist as cysteine-containing homologs. Here, we demonstrate that selenolate-based catalysis of the essential mammalian selenoprotein GPX4 is unexpectedly dispensable for normal embryogenesis. Yet the survival of a specific type of interneurons emerges to exclusively depend on selenocysteine-containing GPX4, thereby preventing fatal epileptic seizures. Mechanistically, selenocysteine utilization by GPX4 confers exquisite resistance to irreversible overoxidation as cells expressing a cysteine variant are highly sensitive toward peroxide-induced ferroptosis. Remarkably, concomitant deletion of all selenoproteins in Gpx4(cys/cys) cells revealed that selenoproteins are dispensable for cell viability provided partial GPX4 activity is retained. Conclusively, 200 years after its discovery, a specific and indispensable role for selenium is provided.	[Ingold, Irina; Doll, Sebastian; Buday, Katalin; Freitas, Florencio Porto; Mehr, Lisa; Wurst, Wolfgang; Angeli, Jose Pedro Friedmann; Conrad, Marcus] Helmholtz Zentrum Munchen, Inst Dev Genet, D-85764 Neuherberg, Germany; [Berndt, Carsten] Heinrich Heine Univ, Med Fac, Dept Neurol, D-40255 Dusseldorf, Germany; [Schmitt, Sabine; Zischka, Hans] Tech Univ Munich, Inst Toxicol & Environm Hyg, D-80802 Munich, Germany; [Poschmann, Gereon] Univ Dusseldorf, Mol Prote Lab, Biomed Res Ctr BMFZ, D-40225 Dusseldorf, Germany; [Roveri, Antonella] Univ Padua, Dept Mol Med, Padua, Italy; [Peng, Xiaoxiao] AstraZeneca, CVMD Translat Med Unit, IMED Biotech Unit, Early Clin Dev, Gothenburg, Sweden; [Seibt, Tobias] Klinikum Univ Munchen, Med Klin & Poliklin 4, Dept Nephrol, D-80336 Munich, Germany; [Aichler, Michaela; Walch, Axel] Helmholtz Zentrum Munchen, Res Unit Analyt Pathol, D-85764 Neuherberg, Germany; [Lamp, Daniel; Jastroch, Martin] Helmholtz Zentrum Munchen, Helmholtz Diabet Ctr, D-85764 Neuherberg, Germany; [Lamp, Daniel; Jastroch, Martin] Helmholtz Zentrum Munchen, German Diabet Ctr DZD, D-85764 Neuherberg, Germany; [Lamp, Daniel; Jastroch, Martin] Helmholtz Zentrum Munchen, Inst Diabet & Obes, D-85748 Garching, Germany; [Miyamoto, Sayuri] Univ Sao Paulo, Inst Quim, Dept Bioquim, Sao Paulo, Brazil; [Wurst, Wolfgang] German Ctr Neurodegenerat Dis DZNE, D-81377 Munich, Germany; [Wurst, Wolfgang] Tech Univ Munchen Weihenstephan, Chair Dev Genet, Helmholtz Zentrum Munchen, D-85764 Neuherberg, Germany; [Amer, Elias S. J.] Karolinska Inst, Dept Med Biochem & Biophys, Div Biochem, S-17177 Stockholm, Sweden; [Fradejas-Villar, Noelia; Schweizer, Ulrich] Rhein Friedrich Wilhelms Univ Bonn, Inst Biochem & Mol Biol, D-53115 Bonn, Germany; [Zischka, Hans] Helmholtz Zentrum Munchen, Inst Mol Toxicol & Pharmacol, D-85764 Neuherberg, Germany; [Angeli, Jose Pedro Friedmann] Univ Wurzburg, Rudolf Virchow Ctr Expt Biomed, D-97080 Wurzburg, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Heinrich Heine University Dusseldorf; Technical University of Munich; Heinrich Heine University Dusseldorf; University of Padua; AstraZeneca; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Universidade de Sao Paulo; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Karolinska Institutet; University of Bonn; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Wurzburg	Conrad, M (corresponding author), Helmholtz Zentrum Munchen, Inst Dev Genet, D-85764 Neuherberg, Germany.	marcus.conrad@helmholtz-muenchen.de	Arnér, Elias/K-6737-2019; Berndt, Carsten/X-6260-2018; Jastroch, Martin/I-7494-2017; Roveri, Antonella/AAF-3669-2019; Miyamoto, Sayuri/A-2144-2008; Angeli, J Pedro Friedmann/ABG-6270-2020; Walch, Axel/B-4554-2012; Conrad, Marcus/E-8792-2015; Arnér, Elias S.J./J-5832-2012; Aichler, Michaela/B-5356-2014; Zischka, Hans/M-1490-2017	Arnér, Elias/0000-0002-4807-6114; Berndt, Carsten/0000-0001-8583-7966; Roveri, Antonella/0000-0002-3252-0559; Miyamoto, Sayuri/0000-0002-5714-8984; Angeli, J Pedro Friedmann/0000-0001-7706-1379; Walch, Axel/0000-0001-5578-4023; Conrad, Marcus/0000-0003-1140-5612; Arnér, Elias S.J./0000-0002-4807-6114; Zischka, Hans/0000-0002-4047-1566; Doll, Sebastian/0000-0002-8933-5362; Fradejas-Villar, Noelia/0000-0003-3418-0743; Schweizer, Ulrich/0000-0003-1380-4780; Wurst, Wolfgang/0000-0003-4422-7410	Deutsche Forschungsgemeinschaft (DFG) [CO 291/2-3, CO 291/5-1, BE3259/5-1]; Human Frontier Science Program (HFSP) [RGP0013]; Humboldt Postdoctoral scholarship; FAPESP [13/07937-8, 10/50891-0]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Human Frontier Science Program (HFSP)(Human Frontier Science Program); Humboldt Postdoctoral scholarship; FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	We would like to thank Elena Yefremova and Jonas Wanninger for excellent technical assistance. We would also like to thank Dr. Anton Berns, the Netherlands Cancer Institute, Amsterdam, for providing the Rosa26_CreERT2 mouse line. This work was in part supported by grants from the Deutsche Forschungsgemeinschaft (DFG) (CO 291/2-3 and CO 291/5-1 to M.C., BE3259/5-1 to C.B., and FAPESP 13/07937-8, 10/50891-0 to S.M.), and the Human Frontier Science Program (HFSP) (RGP0013 to M.C. and F.U.), as well as a Humboldt Postdoctoral scholarship to J.P.F.A.	Anestal K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001846; Angeli JPF, 2017, TRENDS PHARMACOL SCI, V38, P489, DOI 10.1016/j.tips.2017.02.005; Angeli JPF, 2014, NAT CELL BIOL, V16, P1180, DOI 10.1038/ncb3064; Barelli H, 2016, CURR OPIN CELL BIOL, V41, P25, DOI 10.1016/j.ceb.2016.03.012; Berzelius J.J., 1818, AFH FYS KEMI MINERAL, V6, P42; Bornkamm GW, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni137; Bosl MR, 1997, P NATL ACAD SCI USA, V94, P5531, DOI 10.1073/pnas.94.11.5531; Brinkman EK, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku936; Brutsch SH, 2015, ANTIOXID REDOX SIGN, V22, P281, DOI 10.1089/ars.2014.5967; Che RC, 2014, AM J PHYSIOL-RENAL, V306, pF367, DOI 10.1152/ajprenal.00571.2013; Chouchani ET, 2014, NATURE, V515, P431, DOI 10.1038/nature13909; Conrad M, 2004, MOL CELL BIOL, V24, P9414, DOI 10.1128/MCB.24.21.9414-9423.2004; Conrad M, 2016, NAT REV DRUG DISCOV, V15, P348, DOI 10.1038/nrd.2015.6; Conrad M, 2010, P NATL ACAD SCI USA, V107, P15774, DOI 10.1073/pnas.1007909107; COSSINS AR, 1978, P NATL ACAD SCI USA, V75, P2040, DOI 10.1073/pnas.75.4.2040; DALTON AJ, 1955, ANAT REC, V121, P281; Dickinson BC, 2011, NAT CHEM BIOL, V7, P106, DOI 10.1038/NCHEMBIO.497; Dixon SJ, 2015, ACS CHEM BIOL, V10, P1604, DOI 10.1021/acschembio.5b00245; Doll S, 2017, NAT CHEM BIOL, V13, P91, DOI [10.1038/NCHEMBIO.2239, 10.1038/nchembio.2239]; Fischer M, 2013, MOL BIOL CELL, V24, P2160, DOI 10.1091/mbc.E12-12-0862; Godoy JR, 2011, BBA-GEN SUBJECTS, V1810, P2, DOI 10.1016/j.bbagen.2010.05.006; Haddad LS, 2007, EXP GERONTOL, V42, P601, DOI 10.1016/j.exger.2007.02.008; Hambright WS, 2017, REDOX BIOL, V12, P8, DOI 10.1016/j.redox.2017.01.021; Hatfield DL, 2014, TRENDS BIOCHEM SCI, V39, P112, DOI 10.1016/j.tibs.2013.12.007; Hitz C, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm475; Holmstrom KM, 2014, NAT REV MOL CELL BIO, V15, P411, DOI 10.1038/nrm3801; Hulbert AJ, 2002, COMP BIOCHEM PHYS B, V132, P515, DOI 10.1016/S1096-4959(02)00066-0; Ingold I, 2015, J BIOL CHEM, V290, P14668, DOI 10.1074/jbc.M115.656363; Kagan VE, 2017, NAT CHEM BIOL, V13, P81, DOI [10.1038/NCHEMBIO.2238, 10.1038/nchembio.2238]; Kann O, 2016, NEUROBIOL DIS, V90, P75, DOI 10.1016/j.nbd.2015.08.005; Klomsiri C, 2010, METHOD ENZYMOL, V473, P77, DOI 10.1016/S0076-6879(10)73003-2; Lobanov AV, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r198; Mandal PK, 2010, J BIOL CHEM, V285, P22244, DOI 10.1074/jbc.M110.121327; Mannes AM, 2011, FASEB J, V25, P2135, DOI 10.1096/fj.10-177147; Mihaly A, 1997, BRAIN RES, V761, P135, DOI 10.1016/S0006-8993(97)00317-X; Moreno-Mateos MA, 2015, NAT METHODS, V12, P982, DOI [10.1038/NMETH.3543, 10.1038/nmeth.3543]; Muller FL, 2008, BIOCHEM J, V409, P491, DOI 10.1042/BJ20071162; Orian L, 2015, FREE RADICAL BIO MED, V87, P1, DOI 10.1016/j.freeradbiomed.2015.06.011; Peng X, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.209; Poschmann G, 2014, J PROTEOME RES, V13, P2339, DOI 10.1021/pr401157k; RAMAEKERS VT, 1994, NEUROPEDIATRICS, V25, P217, DOI 10.1055/s-2008-1073025; Reich HJ, 2016, ACS CHEM BIOL, V11, P821, DOI 10.1021/acschembio.6b00031; Reis RJS, 2011, AGING-US, V3, P125, DOI 10.18632/aging.100275; Renko K, 2008, BIOCHEM J, V409, P741, DOI 10.1042/BJ20071172; Rhee SG, 1999, EXP MOL MED, V31, P53, DOI 10.1038/emm.1999.9; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; ROVERI A, 1994, METHOD ENZYMOL, V233, P202; Savaskan NE, 2002, FASEB J, V16, P112, DOI 10.1096/fj.02-0067fje; Schmitt S, 2014, MITOCHONDRION, V19, P113, DOI 10.1016/j.mito.2014.06.005; Schmitt S, 2013, ANAL BIOCHEM, V443, P66, DOI 10.1016/j.ab.2013.08.007; Schulz S, 2013, BBA-BIOMEMBRANES, V1828, P2121, DOI 10.1016/j.bbamem.2013.05.007; Schwaller B, 2004, MOL CELL NEUROSCI, V25, P650, DOI 10.1016/j.mcn.2003.12.006; Seeher S, 2014, ANTIOXID REDOX SIGN, V21, P835, DOI 10.1089/ars.2013.5358; Seiler A, 2008, CELL METAB, V8, P237, DOI 10.1016/j.cmet.2008.07.005; Sengupta A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012249; Smith AC, 2014, J MED GENET, V51, P470, DOI 10.1136/jmedgenet-2013-102218; Snider GW, 2013, BIOCHEMISTRY-US, V52, P5472, DOI 10.1021/bi400462j; Telorack M, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005800; TIETZE F, 1969, ANAL BIOCHEM, V27, P502, DOI 10.1016/0003-2697(69)90064-5; Wallis JG, 2002, TRENDS BIOCHEM SCI, V27, P467, DOI 10.1016/S0968-0004(02)02168-0; WEBER GF, 1991, LANCET, V337, P1443, DOI 10.1016/0140-6736(91)93130-2; Wirth EK, 2014, BIOL TRACE ELEM RES, V158, P203, DOI 10.1007/s12011-014-9920-z; Wirth EK, 2010, FASEB J, V24, P844, DOI 10.1096/fj.09-143974; Xu XM, 2007, PLOS BIOL, V5, P96, DOI 10.1371/journal.pbio.0050004; Yang WS, 2016, P NATL ACAD SCI USA, V113, pE4966, DOI 10.1073/pnas.1603244113; Yant LJ, 2003, FREE RADICAL BIO MED, V34, P496, DOI 10.1016/S0891-5849(02)01360-6	66	545	572	29	298	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 25	2018	172	3					409	+		10.1016/j.cell.2017.11.048	http://dx.doi.org/10.1016/j.cell.2017.11.048			35	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FT9BS	29290465	Bronze, Green Submitted			2022-12-28	WOS:000423447600004
J	Socias, ME; Wood, E				Socias, M. Eugenia; Wood, Evan			Evaluating Slow-Release Oral Morphine to Narrow the Treatment Gap for Opioid Use Disorders	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							MEDICATION-ASSISTED TREATMENT; EPIDEMIC		[Socias, M. Eugenia; Wood, Evan] British Columbia Ctr Subst Use, 608-1081 Burrard St, Vancouver, BC V6Z 1Y6, Canada		Wood, E (corresponding author), British Columbia Ctr Subst Use, 608-1081 Burrard St, Vancouver, BC V6Z 1Y6, Canada.	bccsu-ew@cfenet.ubc.ca			Michael Smith Foundation for Health Research; Canadian Institute for Health Research; NATIONAL INSTITUTE ON DRUG ABUSE [R25DA037756] Funding Source: NIH RePORTER	Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Dr. Wood is a Tier 1 Canada Research Chairholder. Dr. Socias is supported by postdoctoral fellowship awards from the Michael Smith Foundation for Health Research and the Canadian Institute for Health Research.	British Columbia Centre on Substance Use, 2017, GUID CLIN MAN OP US; Canadian Agency for Drugs and Technologies in Health, 2017, SUST REL OR MORPH IN; Connery HS, 2015, HARVARD REV PSYCHIAT, V23, P63, DOI 10.1097/HRP.0000000000000075; Gates B, 2015, NEW ENGL J MED, V372, P1381, DOI 10.1056/NEJMp1502918; O'Donnell JK, 2017, MMWR-MORBID MORTAL W, V66, P897, DOI 10.15585/mmwr.mm6634a2; Sharma A, 2017, CURR PSYCHIAT REP, V19, DOI 10.1007/s11920-017-0783-9; Timko C, 2016, J ADDICT DIS, V35, P22, DOI 10.1080/10550887.2016.1100960; Volkow ND, 2017, NEW ENGL J MED, V377, P391, DOI 10.1056/NEJMsr1706626; Williams AR, 2016, NEW ENGL J MED, V375, P813, DOI 10.1056/NEJMp1604223	9	9	9	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 16	2018	168	2					141	+		10.7326/M17-2373	http://dx.doi.org/10.7326/M17-2373			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FU8IN	29277849	Green Accepted			2022-12-28	WOS:000424096600018
J	Piazza, I; Kochanowski, K; Cappelletti, V; Fuhrer, T; Noor, E; Sauer, U; Picotti, P				Piazza, Ilaria; Kochanowski, Karl; Cappelletti, Valentina; Fuhrer, Tobias; Noor, Elad; Sauer, Uwe; Picotti, Paola			A Map of Protein-Metabolite Interactions Reveals Principles of Chemical Communication	CELL			English	Article							ESCHERICHIA-COLI; BINDING PROTEINS; SYSTEMS BIOLOGY; CARBOXYLASE; DISCOVERY; LIGAND; CELLS; PYROPHOSPHORYLASE; IDENTIFICATION; PROTEOMICS	Metabolite-protein interactions control a variety of cellular processes, thereby playing a major role in maintaining cellular homeostasis. Metabolites comprise the largest fraction of molecules in cells, but our knowledge of the metabolite-protein interactome lags behind our understanding of protein-protein or protein-DNA interactomes. Here, we present a chemoproteomic workflow for the systematic identification of metabolite-protein interactions directly in their native environment. The approach identified a network of known and novel interactions and binding sites in Escherichia coli, and we demonstrated the functional relevance of a number of newly identified interactions. Our data enabled identification of new enzyme-substrate relationships and cases of metabolite-induced remodeling of protein complexes. Our metabolite-protein interactome consists of 1,678 interactions and 7,345 putative binding sites. Our data reveal functional and structural principles of chemical communication, shed light on the prevalence and mechanisms of enzyme promiscuity, and enable extraction of quantitative parameters of metabolite binding on a proteome-wide scale.	[Piazza, Ilaria; Cappelletti, Valentina; Picotti, Paola] Swiss Fed Inst Technol, Dept Biol, Inst Biochem, Zurich, Switzerland; [Piazza, Ilaria; Kochanowski, Karl; Cappelletti, Valentina; Fuhrer, Tobias; Noor, Elad; Sauer, Uwe; Picotti, Paola] Swiss Fed Inst Technol, Dept Biol, Inst Mol Syst Biol, Zurich, Switzerland; [Kochanowski, Karl] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA USA	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of California System; University of California San Francisco	Picotti, P (corresponding author), Swiss Fed Inst Technol, Dept Biol, Inst Biochem, Zurich, Switzerland.; Picotti, P (corresponding author), Swiss Fed Inst Technol, Dept Biol, Inst Mol Syst Biol, Zurich, Switzerland.	picotti@imsb.biol.ethz.ch	Sauer, Uwe/Y-3556-2019; Noor, Elad/AAN-9042-2020; Kochanowski, Karl/ABE-7236-2021	Noor, Elad/0000-0001-8776-4799; Piazza, Ilaria/0000-0001-5895-6134; Fuhrer, Tobias/0000-0001-5006-6874	long-term EMBO postdoctoral fellowship; European Union Seventh Framework Program (FP7)-European Research Council (ERC) Starting Grant [FP7-ERC-StG-337965]; "Foerderungsprofessur'' grant from the Swiss National Science Foundation [PP00P3_159266/1]; BASF SE (Ludwigshafen, Germany)	long-term EMBO postdoctoral fellowship; European Union Seventh Framework Program (FP7)-European Research Council (ERC) Starting Grant; "Foerderungsprofessur'' grant from the Swiss National Science Foundation; BASF SE (Ludwigshafen, Germany)	We are grateful to Paul Boersema and the Wollscheid and Picotti groups (ETHZ) for assistance with MS instrumentation and advice. We thank Nicola Zamboni, Rudolf Glockshuber, Yaroslav Nikolaev (ETHZ), Abdullah Kahraman (UZH), and Lukas Reiter (Biognosys AG, Switzerland) for insightful discussions. We also acknowledge Marvin Schulz, Tobias Mentzel, and Sebastian Rohrer (BASF SE, Ludwigshafen, Germany) for sharing reagents and for inspiring discussions. Part of the project was funded by BASF SE (Ludwigshafen, Germany). I.P. was supported by a long-term EMBO postdoctoral fellowship. P.P. is supported by a European Union Seventh Framework Program (FP7)-European Research Council (ERC) Starting Grant (FP7-ERC-StG-337965) and a "Foerderungsprofessur'' grant from the Swiss National Science Foundation grant (PP00P3_159266/1).	Aughey GN, 2016, CRIT REV BIOCHEM MOL, V51, P282, DOI 10.3109/10409238.2016.1172555; Backus KM, 2016, NATURE, V534, P570, DOI 10.1038/nature18002; Barthelme D, 2011, P NATL ACAD SCI USA, V108, P3228, DOI 10.1073/pnas.1015953108; Bennett BD, 2009, NAT CHEM BIOL, V5, P593, DOI 10.1038/nchembio.186; Boehr DD, 2009, NAT CHEM BIOL, V5, P789, DOI 10.1038/nchembio.232; Burnell JN, 2010, BMC BIOCHEM, V11, DOI 10.1186/1471-2091-11-1; Castello A, 2012, CELL, V149, P1393, DOI 10.1016/j.cell.2012.04.031; Changeux JP, 2016, CELL, V166, P1084, DOI 10.1016/j.cell.2016.08.015; Chubukov V, 2014, NAT REV MICROBIOL, V12, P327, DOI 10.1038/nrmicro3238; Diether M, 2017, CURR OPIN MICROBIOL, V39, P16, DOI 10.1016/j.mib.2017.07.006; Feng YH, 2014, NAT BIOTECHNOL, V32, P1036, DOI 10.1038/nbt.2999; Fischer ES, 2016, CURR OPIN STRUC BIOL, V37, P115, DOI 10.1016/j.sbi.2016.01.004; Fuhrer T, 2017, MOL SYST BIOL, V13, DOI 10.15252/msb.20167150; Gallego O, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.87; Gerosa L, 2015, CELL SYST, V1, P270, DOI 10.1016/j.cels.2015.09.008; Gerosa L, 2011, CURR OPIN BIOTECH, V22, P566, DOI 10.1016/j.copbio.2011.04.016; Gillet LC, 2016, ANNU REV ANAL CHEM, V9, P449, DOI 10.1146/annurev-anchem-071015-041535; Gillet LC, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.O111.016717; Hein MY, 2015, CELL, V163, P712, DOI 10.1016/j.cell.2015.09.053; Jarosz DF, 2014, CELL, V158, P1083, DOI 10.1016/j.cell.2014.07.025; Keseler IM, 2013, NUCLEIC ACIDS RES, V41, pD605, DOI 10.1093/nar/gks1027; Kirkwood KJ, 2013, MOL CELL PROTEOMICS, V12, P3851, DOI 10.1074/mcp.M113.032367; Kitagawa M, 2005, DNA RES, V12, P291, DOI 10.1093/dnares/dsi012; Li XY, 2010, CELL, V143, P639, DOI 10.1016/j.cell.2010.09.048; Lindsley JE, 2006, P NATL ACAD SCI USA, V103, P10533, DOI 10.1073/pnas.0604452103; Lomenick B, 2009, P NATL ACAD SCI USA, V106, P21984, DOI 10.1073/pnas.0910040106; Marolda CL, 1996, MOL MICROBIOL, V22, P827, DOI 10.1046/j.1365-2958.1996.01531.x; Milo R, 2013, BIOESSAYS, V35, P1050, DOI 10.1002/bies.201300066; Milroy LG, 2014, CHEM REV, V114, P4695, DOI 10.1021/cr400698c; MORIKAWA M, 1980, J BIOCHEM-TOKYO, V87, P441, DOI 10.1093/oxfordjournals.jbchem.a132764; Motlagh HN, 2014, NATURE, V508, P331, DOI 10.1038/nature13001; Mukherjee A, 1998, EMBO J, V17, P462, DOI 10.1093/emboj/17.2.462; Nam H, 2012, SCIENCE, V337, P1101, DOI 10.1126/science.1216861; Niphakis MJ, 2015, CELL, V161, P1668, DOI 10.1016/j.cell.2015.05.045; Nussinov R, 2013, CELL, V153, P293, DOI 10.1016/j.cell.2013.03.034; O'Connell JD, 2012, ANNU REV CELL DEV BI, V28, P89, DOI 10.1146/annurev-cellbio-101011-155841; Orth JD, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.65; Parker CG, 2017, CELL, V168, P527, DOI 10.1016/j.cell.2016.12.029; Pontes MH, 2016, MOL CELL, V64, P480, DOI 10.1016/j.molcel.2016.05.008; Reznik E, 2017, CELL REP, V20, P2666, DOI 10.1016/j.celrep.2017.08.066; SANWAL BD, 1966, BIOCHEM BIOPH RES CO, V22, P194, DOI 10.1016/0006-291X(66)90431-1; Savitski MM, 2014, SCIENCE, V346, P55, DOI 10.1126/science.1255784; Schmidt A, 2016, NAT BIOTECHNOL, V34, P104, DOI 10.1038/nbt.3418; Sevin DC, 2017, NAT METHODS, V14, P187, DOI [10.1038/NMETH.4103, 10.1038/nmeth.4103]; Suefuji K, 2002, P NATL ACAD SCI USA, V99, P16776, DOI 10.1073/pnas.262671699; Vyazmensky M, 1996, BIOCHEMISTRY-US, V35, P10339, DOI 10.1021/bi9605604; Wallace EWJ, 2015, CELL, V162, P1286, DOI 10.1016/j.cell.2015.08.041; Wu H, 2013, CELL, V153, P287, DOI 10.1016/j.cell.2013.03.013; Xu YF, 2012, NAT CHEM BIOL, V8, P562, DOI [10.1038/NCHEMBIO.941, 10.1038/nchembio.941]; Yang L, 2015, P NATL ACAD SCI USA, V112, P10810, DOI 10.1073/pnas.1501384112	50	189	196	18	198	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 11	2018	172	1-2					358	+		10.1016/j.cell.2017.12.006	http://dx.doi.org/10.1016/j.cell.2017.12.006			38	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FS5MI	29307493	Bronze			2022-12-28	WOS:000419840100031
J	Ioannidis, JPA				Ioannidis, John P. A.			Diagnosis and Treatment of Hypertension in the 2017 ACC/AHA Guidelines and in the Real World	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PRESSURE		[Ioannidis, John P. A.] Stanford Univ, Stanford Prevent Res Ctr, Metares Innovat Ctr, Stanford METRICS, Stanford, CA 94305 USA; [Ioannidis, John P. A.] Stanford Univ, Dept Med, Stanford, CA 94305 USA; [Ioannidis, John P. A.] Stanford Univ, Dept Hlth Res & Policy, Stanford, CA 94305 USA; [Ioannidis, John P. A.] Stanford Univ, Dept Biomed Data Sci, Stanford, CA 94305 USA; [Ioannidis, John P. A.] Stanford Univ, Dept Stat, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University; Stanford University	Ioannidis, JPA (corresponding author), Stanford Prevent Res Ctr, 1265 Welch Rd,Med Sch Off Bldg,Room X306, Stanford, CA 94305 USA.	jioannid@stanford.edu	Ioannidis, John P. A./G-9836-2011	Ioannidis, John P./0000-0003-3118-6859	John and Laura Arnold Foundation	John and Laura Arnold Foundation	The work of Dr Ioannidis is supported by an unrestricted gift from Sue and Bob O'Donnell. METRICS is supported with funding from the John and Laura Arnold Foundation.	Bassler D, 2010, JAMA-J AM MED ASSOC, V303, P1180, DOI 10.1001/jama.2010.310; Basu S, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002410; Carter BL, 2009, ARCH INTERN MED, V169, P1748, DOI 10.1001/archinternmed.2009.316; Eckel R. H., 2014, Journal of the American College of Cardiology, V63, P2960, DOI [10.1161/01.cir.0000437740.48606.d1, 10.1016/j.jacc.2013.11.003]; Greenland P, 2017, JAMA-J AM MED ASSOC, V318, P2083, DOI 10.1001/jama.2017.18605; Ioannidis JPA, 2016, J CLIN EPIDEMIOL, V73, P82, DOI 10.1016/j.jclinepi.2016.02.012; Muntner P, 2018, CIRCULATION, V137, P109, DOI 10.1161/CIRCULATIONAHA.117.032582; SPRINT Research Group, 2015, N Engl J Med, V373, P2103, DOI 10.1056/NEJMoa1511939; Whelton PK, ACC AHA AAPA ABC ACP, DOI [10.1161/HYP.0000000000000065, DOI 10.1161/HYP.0000000000000065]	9	52	53	0	14	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 9	2018	319	2					115	116		10.1001/jama.2017.19672	http://dx.doi.org/10.1001/jama.2017.19672			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FS4PR	29242891				2022-12-28	WOS:000419775500006
J	Yanagisawa, Y; Nan, YL; Okuro, K; Aida, T				Yanagisawa, Yu; Nan, Yiling; Okuro, Kou; Aida, Takuzo			Mechanically robust, readily repairable polymers via tailored noncovalent cross-linking	SCIENCE			English	Article							SELF-HEALING MATERIALS; MOLECULAR GLUES; NETWORKS; SOLIDS	Expanding the range of healable materials is an important challenge for sustainable societies. Noncrystalline, high-molecular-weight polymers generally form mechanically robust materials, which, however, are difficult to repair once they are fractured. This is because their polymer chains are heavily entangled and diffuse too sluggishly to unite fractured surfaces within reasonable time scales. Here we report that low-molecular-weight polymers, when cross-linked by dense hydrogen bonds, yield mechanically robust yet readily repairable materials, despite their extremely slow diffusion dynamics. A key was to use thiourea, which anomalously forms a zigzag hydrogen-bonded array that does not induce unfavorable crystallization. Another key was to incorporate a structural element for activating the exchange of hydrogen-bonded pairs, which enables the fractured portions to rejoin readily upon compression.	[Yanagisawa, Yu; Nan, Yiling; Okuro, Kou; Aida, Takuzo] Univ Tokyo, Sch Engn, Dept Chem & Biotechnol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan; [Yanagisawa, Yu; Aida, Takuzo] RIKEN Ctr Emergent Matter Sci, 2-1 Hirosawa, Wako, Saitama 3510198, Japan	University of Tokyo; RIKEN	Aida, T (corresponding author), Univ Tokyo, Sch Engn, Dept Chem & Biotechnol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.; Aida, T (corresponding author), RIKEN Ctr Emergent Matter Sci, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	aida@macro.t.u-tokyo.ac.jp	Aida, Takuzo/I-9117-2012; NAN, YILING/AEP-3982-2022	NAN, YILING/0000-0001-8654-6423; Okuro, Kou/0000-0003-0445-6358	Japan Society for the Promotion of Science's Research Fellowship for Young Scientists; Program for Leading Graduate Schools (MERIT);  [25000005]	Japan Society for the Promotion of Science's Research Fellowship for Young Scientists; Program for Leading Graduate Schools (MERIT); 	We appreciate valuable discussions with Z. Guan (University of California, Irvine), K. Mayumi and K. Ito (The University of Tokyo), H. Sasaki (Toagosei), and E. Silver and K. Morishita (The University of Tokyo). We also thank H. Ejima and N. Yoshie (The University of Tokyo) and Y. Kamei, H. Ochiai, and A. Masumoto (Shimadzu Corporation) for performing the mechanical tests, and we thank M. Ishikawa (Tokyo Institute of Technology) and M. Nakamura, K. Kurono, and T. Tokai (Shoko Science) for the multiangle light-scattering analysis. This work was financially supported by a Grant-in-Aid for Specially Promoted Research (25000005, "Physically perturbed assembly for tailoring high-performance soft materials with controlled macroscopic structural anisotropy.") We also acknowledge assistance from the ImPACT Program of the Council for Science, Technology and Innovation (Cabinet Office, Government of Japan). Y. Y. acknowledges support from the Japan Society for the Promotion of Science's Research Fellowship for Young Scientists and the Program for Leading Graduate Schools (MERIT).	Boils D, 2004, MACROMOLECULES, V37, P7351, DOI 10.1021/ma035977d; Brandrup J., 2003, POLYM HDB, V4th ed.; Brutman JP, 2014, ACS MACRO LETT, V3, P607, DOI 10.1021/mz500269w; Capelot M, 2012, J AM CHEM SOC, V134, P7664, DOI 10.1021/ja302894k; Chen XX, 2002, SCIENCE, V295, P1698, DOI 10.1126/science.1065879; Chen YL, 2012, NAT CHEM, V4, P467, DOI [10.1038/NCHEM.1314, 10.1038/nchem.1314]; Colby R.H., 2003, POLYM PHYS; Cordier P, 2008, NATURE, V451, P977, DOI 10.1038/nature06669; Custelcean R, 2005, CHEM-EUR J, V11, P1459, DOI 10.1002/chem.200400973; Custelcean R, 2008, CHEM COMMUN, P295, DOI 10.1039/b708921j; Diesendruck CE, 2015, ANGEW CHEM INT EDIT, V54, P10428, DOI 10.1002/anie.201500484; FEDORS RF, 1974, POLYM ENG SCI, V14, P147, DOI 10.1002/pen.760140211; Fox J, 2012, J AM CHEM SOC, V134, P5362, DOI 10.1021/ja300050x; Hashim PK, 2015, J AM CHEM SOC, V137, P15608, DOI 10.1021/jacs.5b08948; Kushner AM, 2009, J AM CHEM SOC, V131, P8766, DOI 10.1021/ja9009666; Lebel O, 2006, J AM CHEM SOC, V128, P10372, DOI 10.1021/ja063353s; Maes F, 2012, SOFT MATTER, V8, P1681, DOI 10.1039/c2sm06715c; Mogaki R, 2017, CHEM SOC REV, V46, P6480, DOI 10.1039/c7cs00647k; Mogaki R, 2015, CHEM SCI, V6, P2802, DOI 10.1039/c5sc00524h; Montarnal D, 2011, SCIENCE, V334, P965, DOI 10.1126/science.1212648; Obrzud M, 2012, J MOL STRUCT, V1018, P54, DOI 10.1016/j.molstruc.2012.01.042; Seiffert S, 2012, CHEM SOC REV, V41, P909, DOI 10.1039/c1cs15191f; Stefaniu C, 2015, LANGMUIR, V31, P1296, DOI 10.1021/la5039987; STPOURCAIN CB, 1995, MACROMOLECULES, V28, P4116, DOI 10.1021/ma00116a010; Sun TL, 2013, NAT MATER, V12, P932, DOI [10.1038/NMAT3713, 10.1038/nmat3713]; Toohey KS, 2007, NAT MATER, V6, P581, DOI 10.1038/nmat1934; White SR, 2001, NATURE, V409, P794, DOI 10.1038/35057232; Wool RP, 2008, SOFT MATTER, V4, P400, DOI 10.1039/b711716g; Yang Y, 2014, CHEM SCI, V5, P3486, DOI 10.1039/c4sc00543k; Yang Y, 2013, CHEM SOC REV, V42, P7446, DOI 10.1039/c3cs60109a	30	513	523	87	1074	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 5	2018	359	6371					72	+		10.1126/science.aam7588	http://dx.doi.org/10.1126/science.aam7588			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FR8KW	29242235				2022-12-28	WOS:000419324700069
J	Bonfrer, I; Figueroa, JF; Zheng, J; Orav, EJ; Jha, AK				Bonfrer, Igna; Figueroa, Jose F.; Zheng, Jie; Orav, E. John; Jha, Ashish K.			Impact of Financial Incentives on Early and Late Adopters among US Hospitals: observational study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PAY-FOR-PERFORMANCE; QUALITY; CARE; OUTCOMES	OBJECTIVE To examine how hospitals that volunteered to be under financial incentives for more than a decade as part of the Premier Hospital Quality Incentive Demonstration (early adopters) compared with similar hospitals where these incentives were implemented later under the Hospital Value-Based Purchasing program (late adopters). DESIGN Observational study. SETTING 1189 hospitals in the USA (214 early adopters and 975 matched late adopters), using Hospital Compare data from 2003 through 2013. PARTICIPANTS 1 371 364 patients aged 65 years and older, using 100% Medicare claims. MAIN OUTCOME MEASURES Clinical process scores and 30 day mortality. RESULTS Early adopters started from a slightly higher baseline of clinical process scores (92) than late adopters (90). Both groups reached a ceiling (98) a decade later. Starting from a similar baseline, just below 13%, early and late adopters did not have significantly (P=0.25) different mortality trends for conditions targeted by the program (0.05% point difference quarterly) or for conditions not targeted by the program (-0.02% point difference quarterly). CONCLUSIONS No evidence that hospitals that have been operating under pay for performance programs for more than a decade had better process scores or lower mortality than other hospitals was found. These findings suggest that even among hospitals that volunteered to participate in pay for performance programs, having additional time is not likely to turn pay for performance programs into a success in the future.	[Bonfrer, Igna; Figueroa, Jose F.; Zheng, Jie; Jha, Ashish K.] Harvard TH Chan Sch Publ Hlth, Dept Hlth Policy & Management, 42 Church St, Cambridge, MA 02138 USA; [Bonfrer, Igna] Erasmus Univ, Erasmus Sch Hlth Policy & Management, Rotterdam, Netherlands; [Figueroa, Jose F.; Orav, E. John; Jha, Ashish K.] Harvard Med Sch, Dept Med, Cambridge, MA 02115 USA; [Figueroa, Jose F.; Orav, E. John] Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA; [Orav, E. John] Harvard TH Chan Sch Publ Hlth, Dept Biostat, Cambridge, MA 02138 USA; [Jha, Ashish K.] VA Boston Healthcare Syst, Dept Gen Internal Med, Boston, MA 02130 USA	Harvard University; Harvard T.H. Chan School of Public Health; Erasmus University Rotterdam; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard T.H. Chan School of Public Health; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System	Jha, AK (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Hlth Policy & Management, 42 Church St, Cambridge, MA 02138 USA.; Jha, AK (corresponding author), Harvard Med Sch, Dept Med, Cambridge, MA 02115 USA.; Jha, AK (corresponding author), VA Boston Healthcare Syst, Dept Gen Internal Med, Boston, MA 02130 USA.	ajha@hsph.harvard.edu			Netherlands Organization for Scientific Research; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR001100] Funding Source: NIH RePORTER	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	IB received funding from a Rubicon Fellowship provided by the Netherlands Organization for Scientific Research. The funders had no role in the study design; collection, analysis, and interpretation of data; writing of the report; or decision to submit the article for publication.	[Anonymous], 2015, HOSP VAL BAS PURCH; [Anonymous], 2017, HOSP DAT; [Anonymous], 2015, FACTS MED SPEND FIN; [Anonymous], 2016, HOSP COMP DAT ARCH; [Anonymous], 2012, FREQ ASK QUEST HOSP; [Anonymous], 2015, PREM HOSP QUAL INC D; [Anonymous], 2017, HOSP READM RED PROGR; [Anonymous], 2016, LAW; [Anonymous], 2017, INP MEAS; [Anonymous], 2016, HOSP COMP DAT; [Anonymous], 2016, HOSP VAL BAS PURCH H; [Anonymous], 2016, ROADM IMPL VAL DRIV; Care B, 2015, IMPROVING OUR HLTH C; Cashin C., 2014, PAYING PERFORMANCE H, P287; Cutler DM, 2015, JAMA-J AM MED ASSOC, V313, P1606, DOI 10.1001/jama.2015.1926; Damberg CL, 2009, HEALTH AFFAIR, V28, P517, DOI 10.1377/hlthaff.28.2.517; Damberg CL, 2014, MEASURING SUCCESS HL; DONABEDIAN A, 1966, MILBANK FUND Q, V44, P166, DOI 10.2307/3348969; Eijkenaar F, 2013, HEALTH POLICY, V110, P115, DOI 10.1016/j.healthpol.2013.01.008; Eijkenaar F, 2013, EUR J HEALTH ECON, V14, P117, DOI 10.1007/s10198-011-0347-6; Figueroa JF, 2016, BMJ QUAL SAF, V25, P898, DOI 10.1136/bmjqs-2015-005040; Figueroa JF, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i2214; Glickman SW, 2007, JAMA-J AM MED ASSOC, V297, P2373, DOI 10.1001/jama.297.21.2373; Iacus SM, 2012, POLIT ANAL, V20, P1, DOI 10.1093/pan/mpr013; Jha AK, 2012, NEW ENGL J MED, V366, P1606, DOI 10.1056/NEJMsa1112351; Lindenauer PK, 2007, NEW ENGL J MED, V356, P486, DOI 10.1056/NEJMsa064964; Roland M, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i4060; Rosenthal MB, 2004, HEALTH AFFAIR, V23, P127, DOI 10.1377/hlthaff.23.2.127; Rosenthal MB, 2007, HEALTH AFFAIR, V26, P1674, DOI 10.1377/hlthaff.26.6.1674; Rosenthal MB, 2007, JAMA-J AM MED ASSOC, V297, P740, DOI 10.1001/jama.297.7.740; Ryan AM, 2017, NEW ENGL J MED, V376, P2358, DOI 10.1056/NEJMsa1613412; Ryan AM, 2015, HEALTH SERV RES, V50, P81, DOI 10.1111/1475-6773.12206; Ryan AM, 2012, HEALTH AFFAIR, V31, P797, DOI 10.1377/hlthaff.2011.0626; Ryan AM, 2009, INQUIRY-J HEALTH CAR, V46, P274, DOI 10.5034/inquiryjrnl_46.03.274; Ryan AM, 2009, HEALTH SERV RES, V44, P821, DOI 10.1111/j.1475-6773.2009.00956.x; United States Government Accountability Office, 2015, GAO169 US GOV ACC OF; Van de Poel E, 2016, HEALTH ECON, V25, P688, DOI 10.1002/hec.3219; Werner RM, 2011, HEALTH AFFAIR, V30, P690, DOI 10.1377/hlthaff.2010.1277; Witter S, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007899.pub2	39	11	11	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 4	2018	360								j5622	10.1136/bmj.j5622	http://dx.doi.org/10.1136/bmj.j5622			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FS3UX	29298765	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000419710400007
J	Kuehn, B				Kuehn, Bridget			CMS Vows to Overhaul Medicaid	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 26	2017	318	24					2418	2418		10.1001/jama.2017.19928	http://dx.doi.org/10.1001/jama.2017.19928			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FQ9ZO	29279914				2022-12-28	WOS:000418720700006
J	Zhao, JG; Zeng, XT; Wang, J; Liu, L				Zhao, Jia-Guo; Zeng, Xian-Tie; Wang, Jia; Liu, Lin			Association Between Calcium or Vitamin D Supplementation and Fracture Incidence in Community-Dwelling Older Adults A Systematic Review and Meta-analysis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RANDOMIZED CONTROLLED-TRIAL; HIP FRACTURE; DOUBLE-BLIND; BONE LOSS; OSTEOPOROTIC FRACTURES; UPDATED METAANALYSIS; CLINICAL-TRIALS; ELDERLY-WOMEN; RISK; PREVENTION	IMPORTANCE The increased social and economic burdens for osteoporosis-related fractures worldwide make the prevention of such injuries a major public health goal. Previous studies have reached mixed conclusions regarding the association between calcium, vitamin D, or combined calcium and vitamin D supplements and fracture incidence in older adults. OBJECTIVE To investigate whether calcium, vitamin D, or combined calcium and vitamin D supplements are associated with a lower fracture incidence in community-dwelling older adults. DATA SOURCES The PubMed, Cochrane library, and EMBASE databases were systematically searched from the inception dates to December 24, 2016, using the keywords calcium, vitamin D, and fracture to identify systematic reviews or meta-analyses. The primary randomized clinical trials included in systematic reviews or meta-analyses were identified, and an additional search for recently published randomized trials was performed from July 16, 2012, to July 16, 2017. STUDY SELECTION Randomized clinical trials comparing calcium, vitamin D, or combined calcium and vitamin D supplements with a placebo or no treatment for fracture incidence in community-dwelling adults older than 50 years. DATA EXTRACTION AND SYNTHESIS Two independent reviewers performed the data extraction and assessed study quality. Ameta-analysis was performed to calculate risk ratios (RRs), absolute risk differences (ARDs), and 95% CIs using random-effects models. MAIN OUTCOMES AND MEASURES Hip fracture was defined as the primary outcome. Secondary outcomes were nonvertebral fracture, vertebral fracture, and total fracture. RESULTS A total of 33 randomized trials involving 51 145 participants fulfilled the inclusion criteria. There was no significant association of calcium or vitamin D with risk of hip fracture compared with placebo or no treatment (calcium: RR, 1.53 [95% CI, 0.97 to 2.42]; ARD, 0.01 [95% CI, 0.00 to 0.01]; vitamin D: RR, 1.21 [95% CI, 0.99 to 1.47]; ARD, 0.00 [95% CI, -0.00 to 0.01]. There was no significant association of combined calcium and vitamin D with hip fracture compared with placebo or no treatment (RR, 1.09 [95% CI, 0.85 to 1.39]; ARD, 0.00 [95% CI, -0.00 to 0.00]). No significant associations were found between calcium, vitamin D, or combined calcium and vitamin D supplements and the incidence of nonvertebral, vertebral, or total fractures. Subgroup analyses showed that these results were generally consistent regardless of the calcium or vitamin D dose, sex, fracture history, dietary calcium intake, and baseline serum 25-hydroxyvitamin D concentration. CONCLUSIONS AND RELEVANCE In this meta-analysis of randomized clinical trials, the use of supplements that included calcium, vitamin D, or both compared with placebo or no treatment was not associated with a lower risk of fractures among community-dwelling older adults. These findings do not support the routine use of these supplements in community-dwelling older people.	[Zhao, Jia-Guo; Zeng, Xian-Tie; Wang, Jia] Tianjin Hosp, Dept Orthopaed Surg, 406 Jiefang South Rd, Tianjin 300211, Peoples R China; [Liu, Lin] Hebei Prov Cangzhou Hosp Integrated Tradit & West, Dept Orthopaed Surg, Cangzhou, Peoples R China		Zhao, JG (corresponding author), Tianjin Hosp, Dept Orthopaed Surg, 406 Jiefang South Rd, Tianjin 300211, Peoples R China.	orthopaedic@163.com			Tianjin Science and Technology Research Project [16ZLZXZF00220]	Tianjin Science and Technology Research Project	This study was supported by the Tianjin Science and Technology Research Project (16ZLZXZF00220).	Abrahamsen B, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.b5463; Aloia JF, 2013, J CLIN ENDOCR METAB, V98, pE1702, DOI 10.1210/jc.2013-2121; Avenell Alison, 2004, Clin Trials, V1, P490, DOI 10.1191/1740774504cn053oa; Avenell A, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000227.pub4; Avenell A, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000227.pub3; Baron JA, 1999, NEW ENGL J MED, V340, P101, DOI 10.1056/NEJM199901143400204; Bergman GJD, 2010, CURR MED RES OPIN, V26, P1193, DOI 10.1185/03007991003659814; Bischoff-Ferrari HA, 2007, AM J CLIN NUTR, V86, P1780; Bischoff-Ferrari HA, 2012, NEW ENGL J MED, V367, P40, DOI 10.1056/NEJMoa1109617; Bischoff-Ferrari HA, 2009, ARCH INTERN MED, V169, P551, DOI 10.1001/archinternmed.2008.600; Bolland MJ, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4580; Bolland MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115934; Bolland MJ, 2014, LANCET DIABETES ENDO, V2, P307, DOI 10.1016/S2213-8587(13)70212-2; Bolton-Smith C, 2007, J BONE MINER RES, V22, P509, DOI [10.1359/jbmr.070116, 10.1359/JBMR.070116]; Boonen S, 2007, J CLIN ENDOCR METAB, V92, P1415, DOI 10.1210/jc.2006-1404; CHAPUY MC, 1992, NEW ENGL J MED, V327, P1637, DOI 10.1056/NEJM199212033272305; Chung M, 2011, ANN INTERN MED, V155, P827, DOI 10.7326/0003-4819-155-12-201112200-00005; Cranney A, 2008, AM J CLIN NUTR, V88, p513S, DOI 10.1093/ajcn/88.2.513S; Cranney Ann, 2007, Evid Rep Technol Assess (Full Rep), P1; DawsonHughes B, 1997, NEW ENGL J MED, V337, P670, DOI 10.1056/NEJM199709043371003; Deeks JJ, 2002, STAT MED, V21, P1575, DOI 10.1002/sim.1188; Duque G, 2016, J AM MED DIR ASSOC, V17, P852, DOI 10.1016/j.jamda.2016.05.011; Dyer SM, 2016, BMC GERIATR, V16, DOI 10.1186/s12877-016-0332-0; Geddes JAA, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/463589; Glendenning P, 2012, J BONE MINER RES, V27, P170, DOI 10.1002/jbmr.524; Grant AM, 2005, LANCET, V365, P1621, DOI 10.1016/S0140-6736(05)63013-9; HANSSON T, 1987, CALCIFIED TISSUE INT, V40, P315, DOI 10.1007/BF02556692; Harwood RH, 2004, AGE AGEING, V33, P45, DOI 10.1093/ageing/afh002; Hin H, 2017, OSTEOPOROSIS INT, V28, P841, DOI 10.1007/s00198-016-3833-y; INKOVAARA J, 1983, AGE AGEING, V12, P124, DOI 10.1093/ageing/12.2.124; Izaks GJ, 2007, BMC MUSCULOSKEL DIS, V8, DOI 10.1186/1471-2474-8-26; Jackson C, 2007, QJM-INT J MED, V100, P185, DOI 10.1093/qjmed/hcm005; Jackson RD, 2006, NEW ENGL J MED, V354, P669, DOI 10.1056/NEJMoa055218; Khaw KT, 2017, LANCET DIABETES ENDO, V5, P438, DOI 10.1016/S2213-8587(17)30103-1; Lai JKC, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-331; Larsen ER, 2004, J BONE MINER RES, V19, P370, DOI 10.1359/JBMR.0301240; LeBlanc E, 2014, SCREENING FOR VITAMI; LeBlanc ES, 2015, ANN INTERN MED, V162, P109, DOI 10.7326/M14-1659; Liberati A, 2009, BMJ-BRIT MED J, V339, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Lips P, 1996, ANN INTERN MED, V124, P400, DOI 10.7326/0003-4819-124-4-199602150-00003; Liu BX, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000991; Lo JC, 2015, AM J MANAG CARE, V21, pE206; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; Massart A, 2014, AM J KIDNEY DIS, V64, P696, DOI 10.1053/j.ajkd.2014.04.020; Mitri J, 2011, AM J CLIN NUTR, V94, P486, DOI 10.3945/ajcn.111.011684; Peacock M, 2000, J CLIN ENDOCR METAB, V85, P3011, DOI 10.1210/jc.85.9.3011; Porthouse J, 2005, BMJ-BRIT MED J, V330, P1003; Prince RL, 2006, ARCH INTERN MED, V166, P869, DOI 10.1001/archinte.166.8.869; Punthakee Z, 2012, DIABETOLOGIA, V55, P36, DOI 10.1007/s00125-011-2357-4; Rabenda V, 2011, OSTEOPOROSIS INT, V22, P893, DOI 10.1007/s00198-010-1469-x; Recker RR, 1996, J BONE MINER RES, V11, P1961; Reid IR, 2006, AM J MED, V119, P777, DOI 10.1016/j.amjmed.2006.02.038; REID IR, 1993, NEW ENGL J MED, V328, P460, DOI 10.1056/NEJM199302183280702; Riggs BL, 1998, J BONE MINER RES, V13, P168, DOI 10.1359/jbmr.1998.13.2.168; Robbins JA, 2014, MENOPAUSE, V21, P116, DOI 10.1097/GME.0b013e3182963901; Ruml L A, 1999, Am J Ther, V6, P303, DOI 10.1097/00045391-199911000-00004; Salovaara K, 2010, J BONE MINER RES, V25, P1487, DOI 10.1002/jbmr.48; Sanders KM, 2010, JAMA-J AM MED ASSOC, V303, P1815, DOI 10.1001/jama.2010.594; Si L, 2015, CURR MED RES OPIN, V31, P1149, DOI 10.1185/03007995.2015.1037729; Smith H, 2007, RHEUMATOLOGY, V46, P1852, DOI 10.1093/rheumatology/kem240; Tang BMP, 2007, LANCET, V370, P657, DOI 10.1016/S0140-6736(07)61342-7; Trivedi DP, 2003, BMJ-BRIT MED J, V326, P469; Uusi-Rasi K, 2015, JAMA INTERN MED, V175, P703, DOI 10.1001/jamainternmed.2015.0225; Weaver CM, 2016, OSTEOPOROSIS INT, V27, P367, DOI 10.1007/s00198-015-3386-5; Witham MD, 2013, JAMA INTERN MED, V173, P1672, DOI 10.1001/jamainternmed.2013.9043; Xue Yu, 2017, Zhongguo Yi Xue Ke Xue Yuan Xue Bao, V39, P345, DOI 10.3881/j.issn.1000-503X.2017.03.008; Zheng YT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115850	67	284	321	5	170	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 26	2017	318	24					2466	2482		10.1001/jama.2017.19344	http://dx.doi.org/10.1001/jama.2017.19344			17	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FQ9ZO	29279934	Bronze, Green Published			2022-12-28	WOS:000418720700024
J	Voosen, P				Voosen, Paul			Saturn's rings are solar system newcomers	SCIENCE			English	News Item																			0	1	1	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 22	2017	358	6370					1513	1514		10.1126/science.358.6370.1513	http://dx.doi.org/10.1126/science.358.6370.1513			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ6BO	29269450				2022-12-28	WOS:000418448000014
J	Schroeder, TBH; Guha, A; Lamoureux, A; VanRenterghem, G; Sept, D; Shtein, M; Yang, J; Mayer, M				Schroeder, Thomas B. H.; Guha, Anirvan; Lamoureux, Aaron; VanRenterghem, Gloria; Sept, David; Shtein, Max; Yang, Jerry; Mayer, Michael			An electric-eel-inspired soft power source from stacked hydrogels	NATURE			English	Article							ELECTROPHORUS-ELECTRICUS; ELECTRONICS	Progress towards the integration of technology into living organisms requires electrical power sources that are biocompatible, mechanically flexible, and able to harness the chemical energy available inside biological systems. Conventional batteries were not designed with these criteria in mind. The electric organ of the knifefish Electrophorus electricus (commonly known as the electric eel) is, however, an example of an electrical power source that operates within biological constraints while featuring power characteristics that include peak potential differences of 600 volts and currents of 1 ampere(1,2). Here we introduce an electric-eel-inspired power concept that uses gradients of ions between miniature polyacrylamide hydrogel compartments bounded by a repeating sequence of cation-and anion-selective hydrogel membranes. The system uses a scalable stacking or folding geometry that generates 110 volts at open circuit or 27 milliwatts per square metre per gel cell upon simultaneous, self-registered mechanical contact activation of thousands of gel compartments in series while circumventing power dissipation before contact. Unlike typical batteries, these systems are soft, flexible, transparent, and potentially biocompatible. These characteristics suggest that artificial electric organs could be used to power next-generation implant materials such as pacemakers, implantable sensors, or prosthetic devices in hybrids of living and non-living systems(3-6).	[Schroeder, Thomas B. H.] Univ Michigan, Dept Chem Engn, Ann Arbor, MI 48109 USA; [Schroeder, Thomas B. H.; Guha, Anirvan; Mayer, Michael] Univ Fribourg, Adolphe Merkle Inst, Fribourg, Switzerland; [Lamoureux, Aaron; VanRenterghem, Gloria; Shtein, Max] Univ Michigan, Dept Mat Sci & Engn, Ann Arbor, MI 48109 USA; [Sept, David; Mayer, Michael] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA; [Sept, David] Univ Michigan, Ctr Computat Med & Biol, Ann Arbor, MI 48109 USA; [Yang, Jerry] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA	University of Michigan System; University of Michigan; University of Fribourg; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of California System; University of California San Diego	Mayer, M (corresponding author), Univ Fribourg, Adolphe Merkle Inst, Fribourg, Switzerland.; Mayer, M (corresponding author), Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA.	michael.mayer@unifr.ch	Shtein, Max/K-2238-2013; Mayer, Michael/AAS-1777-2020; Mayer, Michael/C-1299-2010	Shtein, Max/0000-0003-4844-5108; Guha, Anirvan/0000-0001-6018-1438; Mayer, Michael/0000-0002-6148-5756; Sept, David/0000-0003-3719-2483; Schroeder, Thomas/0000-0003-2795-1730	Air Force Office of Scientific Research [FA9550-12-1-0435]; National Institute of General Medical Sciences of the National Institutes of Health [National Institute of General Medical Sciences of the National Institutes of Health under award T32GM008353]; Cellular Biotechnology Training Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008353] Funding Source: NIH RePORTER	Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Cellular Biotechnology Training Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to B. Rothen-Rutishauser and A. Petri-Fink at the Adolphe Merkle Institute for the use of their 3D-Discovery printer. F. Bircher's iPrint institute at the Haute Ecole d'Ingenierie et d'Architecture Fribourg, particularly F. Bourguet and M. Soutrenon, donated time towards adapting a printer for our use and helped us to understand the intricacies of microvalve printing systems. Laser cutting was performed at Fablab Fribourg. U. Steiner's group, in particular P. Sutton and M. Fischer, provided instrumentation and advice related to impedance measurements. Research reported in this publication was supported by the Air Force Office of Scientific Research (grant FA9550-12-1-0435 to M.M., J.Y., D.S. and M.S.) and the National Institute of General Medical Sciences of the National Institutes of Health under award T32GM008353, which funds the Cellular Biotechnology Training Program (T.B.H.S.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ALTAMIRANO M, 1957, J CELL COMPAR PHYSL, V49, P69, DOI 10.1002/jcp.1030490105; Bardin D, 2011, LAB CHIP, V11, P3990, DOI 10.1039/c1lc20615j; Bennett MVL., 1971, FISH PHYSIOL, P347, DOI DOI 10.1016/S1546-5098(08)60051-5; Brown M. V., 1950, ELECTR ENG, V69, P145, DOI DOI 10.1109/EE.1950.6434151; Catania KC, 2016, P NATL ACAD SCI USA, V113, P6979, DOI 10.1073/pnas.1604009113; Chandrakasan AP, 2008, ANNU REV BIOMED ENG, V10, P247, DOI 10.1146/annurev.bioeng.10.061807.160547; Chin SY, 2017, SCI ROBOT, V2, DOI 10.1126/scirobotics.aah6451; COX R. T., 1940, ZOO LOGICA [NEW YORK], V25, P553; COX RT, 1946, ANN NY ACAD SCI, V47, P487, DOI 10.1111/j.1749-6632.1946.tb49548.x; ENGER CC, 1968, NATURE, V218, P180, DOI 10.1038/218180a0; Feng JD, 2016, NATURE, V536, P197, DOI 10.1038/nature18593; Gallant JR, 2014, SCIENCE, V344, P1522, DOI 10.1126/science.1254432; Gotter AL, 1998, COMP BIOCHEM PHYS A, V119, P225, DOI 10.1016/S1095-6433(97)00414-5; Gumuscu B, 2016, ADV FUNCT MATER, V26, P8685, DOI 10.1002/adfm.201603242; Ide T, 2002, SINGLE MOL, V3, P33, DOI 10.1002/1438-5171(200204)3:1<33::AID-SIMO33>3.0.CO;2-U; Ilievski F, 2011, ANGEW CHEM INT EDIT, V50, P1890, DOI 10.1002/anie.201006464; KEYNES RD, 1953, J PHYSIOL-LONDON, V119, P315, DOI 10.1113/jphysiol.1953.sp004849; Kim DH, 2011, SCIENCE, V333, P838, DOI 10.1126/science.1206157; Lai YC, 2016, ADV MATER, V28, P10024, DOI 10.1002/adma.201603527; Lingley AR, 2011, J MICROMECH MICROENG, V21, DOI 10.1088/0960-1317/21/12/125014; Mansouri K, 2012, ARCH OPHTHALMOL-CHIC, V130, P1534, DOI [10.1001/archophthalmol.2012.2280, 10.1001/jamaophthalmol.2013.1350]; Miura K, 1985, 618 I SPAC ASTR SCI; Nachmansohn D, 1942, J NEUROPHYSIOL, V5, P499, DOI 10.1152/jn.1942.5.6.499; NAKAMURA Y, 1965, J GEN PHYSIOL, V49, P321, DOI 10.1085/jgp.49.2.321; PATTLE RE, 1954, NATURE, V174, P660, DOI 10.1038/174660a0; SCHOFFENIELS E, 1959, ANN NY ACAD SCI, V81, P285, DOI 10.1111/j.1749-6632.1959.tb49314.x; SHENKEL S, 1991, J GEN PHYSIOL, V97, P1013, DOI 10.1085/jgp.97.5.1013; Sun H, 2016, ADV MATER, V28, P2070, DOI 10.1002/adma.201505742; Whitesides GM, 2004, ANGEW CHEM INT EDIT, V43, P3632, DOI 10.1002/anie.200330076; Xu J, 2010, ADV MATER, V22, P120, DOI 10.1002/adma.200901945; Xu J, 2008, NAT NANOTECHNOL, V3, P666, DOI 10.1038/nnano.2008.274; Young C, 2013, BIOMICROFLUIDICS, V7, DOI 10.1063/1.4816714; Zeng SJ, 2009, LAB CHIP, V9, P1340, DOI 10.1039/b821803j	33	251	256	74	730	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 14	2017	552	7684					214	+		10.1038/nature24670	http://dx.doi.org/10.1038/nature24670			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ0FK	29239354	Green Accepted, Green Published			2022-12-28	WOS:000418029500039
J	Thwaites, GE; Scarborough, M; Szubert, A; Nsutebu, E; Tilley, R; Greig, J; Wyllie, SA; Wilson, P; Auckland, C; Cairns, J; Ward, D; Lal, P; Guleri, A; Jenkins, N; Sutton, J; Wiselka, M; Armando, GR; Graham, C; Chadwick, PR; Barlow, G; Gordon, NC; Young, B; Meisner, S; McWhinney, P; Price, DA; Harvey, D; Nayar, D; Jeyaratnam, D; Planche, T; Minton, J; Hudson, F; Hopkins, S; Williams, J; Torok, ME; Llewelyn, MJ; Edgeworth, JD; Walker, AS				Thwaites, Guy E.; Scarborough, Matthew; Szubert, Alexander; Nsutebu, Emmanuel; Tilley, Robert; Greig, Julia; Wyllie, Sarah A.; Wilson, Peter; Auckland, Cressida; Cairns, Janet; Ward, Denise; Lal, Pankaj; Guleri, Achyut; Jenkins, Neil; Sutton, Julian; Wiselka, Martin; Armando, Gonzalez-Ruiz; Graham, Clive; Chadwick, Paul R.; Barlow, Gavin; Gordon, N. Claire; Young, Bernadette; Meisner, Sarah; McWhinney, Paul; Price, David A.; Harvey, David; Nayar, Deepa; Jeyaratnam, Dakshika; Planche, Tim; Minton, Jane; Hudson, Fleur; Hopkins, Susan; Williams, John; Torok, M. Estee; Llewelyn, Martin J.; Edgeworth, Jonathan D.; Walker, A. Sarah		UKCIRG	Adjunctive rifampicin for Staphylococcus aureus bacteraemia (ARREST): a multicentre, randomised, double-blind, placebo-controlled trial	LANCET			English	Article							CLINICAL MANAGEMENT; INFECTIONS; THERAPY	Background Staphylococcus aureus bacteraemia is a common cause of severe community-acquired and hospital-acquired infection worldwide. We tested the hypothesis that adjunctive rifampicin would reduce bacteriologically confirmed treatment failure or disease recurrence, or death, by enhancing early S aureus killing, sterilising infected foci and blood faster, and reducing risks of dissemination and metastatic infection. Methods In this multicentre, randomised, double-blind, placebo-controlled trial, adults (>= 18 years) with S aureus bacteraemia who had received <= 96 h of active antibiotic therapy were recruited from 29 UK hospitals. Patients were randomly assigned (1:1) via a computer-generated sequential randomisation list to receive 2 weeks of adjunctive rifampicin (600 mg or 900 mg per day according to weight, oral or intravenous) versus identical placebo, together with standard antibiotic therapy. Randomisation was stratified by centre. Patients, investigators, and those caring for the patients were masked to group allocation. The primary outcome was time to bacteriologically confirmed treatment failure or disease recurrence, or death (all-cause), from randomisation to 12 weeks, adjudicated by an independent review committee masked to the treatment. Analysis was intention to treat. This trial was registered, number ISRCTN37666216, and is closed to new participants. Findings Between Dec 10, 2012, and Oct 25, 2016, 758 eligible participants were randomly assigned: 370 to rifampicin and 388 to placebo. 485 (64%) participants had community-acquired S aureus infections, and 132 (17%) had nosocomial S aureus infections. 47 (6%) had meticillin-resistant infections. 301 (40%) participants had an initial deep infection focus. Standard antibiotics were given for 29 (IQR 18-45) days; 619 (82%) participants received flucloxacillin. By week 12, 62 (17%) of participants who received rifampicin versus 71 (18%) who received placebo experienced treatment failure or disease recurrence, or died (absolute risk difference -1.4%, 95% CI -7.0 to 4.3; hazard ratio 0.96, 0.68-1.35, p=0.81). From randomisation to 12 weeks, no evidence of differences in serious (p=0.17) or grade 3-4 (p=0.36) adverse events were observed; however, 63 (17%) participants in the rifampicin group versus 39 (10%) in the placebo group had antibiotic or trial drug-modifying adverse events (p=0.004), and 24 (6%) versus six (2%) had drug interactions (p=0.0005). Interpretation Adjunctive rifampicin provided no overall benefit over standard antibiotic therapy in adults with S aureus bacteraemia. Copyright (c) The Author(s). Published by Elsevier Ltd.	[Thwaites, Guy E.; Scarborough, Matthew; Gordon, N. Claire; Young, Bernadette; Walker, A. Sarah] Univ Oxford, Nuffield Dept Med, Oxford, England; [Thwaites, Guy E.] Univ Oxford, Clin Res Unit, Ho Chi Minh City, Vietnam; [Szubert, Alexander; Cairns, Janet; Ward, Denise; Hudson, Fleur; Walker, A. Sarah] UCL, MRC, Clin Trials Unit, London, England; [Nsutebu, Emmanuel] Royal Liverpool Univ Hosp, Liverpool, Merseyside, England; [Tilley, Robert] Plymouth Hosp Natl Hlth Serv NHS Trust, Plymouth, Devon, England; [Greig, Julia] Sheffield Teaching Hosp NHS Fdn Trust, Sheffield, S Yorkshire, England; [Wyllie, Sarah A.] Portsmouth Hosp NHS Trust, Portsmouth, Hants, England; [Wilson, Peter] Univ Coll London Hosp Natl Hlth Serv Fdn Trust, London, England; [Auckland, Cressida] Royal Devon & Exeter NHS Fdn Trust, Exeter, Devon, England; [Lal, Pankaj] Aintree Univ Hosp NHS Fdn Trust, Aintree, England; [Guleri, Achyut] Blackpool Teaching Hosp NHS Fdn Trust, Blackpool, England; [Jenkins, Neil] Heart England NHS Fdn Trust, Birmingham, W Midlands, England; [Sutton, Julian] Univ Hosp Southampton NHS Fdn Trust, Southampton, Hants, England; [Wiselka, Martin] Univ Hosp Leicester NHS Trust, Dept Infect & Trop Med, Leicester, Leics, England; [Armando, Gonzalez-Ruiz] Darent Valley Hosp, Dept Microbiol, Dartford, England; [Graham, Clive] North Cumbria Univ Hosp NHS Trust, Carlisle, England; [Chadwick, Paul R.] Salford Royal NHS Fdn Trust, Salford, Lancs, England; [Barlow, Gavin] Hull & East Yorkshire Hosp NHS Trust, Kingston Upon Hull, N Humberside, England; [Meisner, Sarah] Royal United Hosp Bath NHS Fdn Trust, Bath, Avon, England; [McWhinney, Paul] Bradford Teaching Hosp NHS Fdn Trust, Bradford, W Yorkshire, England; [Price, David A.] Newcastle Upon Tyne Hosp NHS Fdn Trust, Newcastle Upon Tyne, Tyne & Wear, England; [Harvey, David] Wirral Univ Teaching Hosp NHS Fdn Trust, Birkenhead, Merseyside, England; [Nayar, Deepa] Cty Durham & Darlington NHS Fdn Trust, Durham, England; [Jeyaratnam, Dakshika] Kings Coll Hosp NHS Fdn Trust, London, England; [Planche, Tim] St Georges Univ Hosp NHS Fdn Trust, London, England; [Minton, Jane] Leeds Teaching Hosp NHS Trust, Leeds, W Yorkshire, England; [Hopkins, Susan] Royal Free London NHS Fdn Trust, London, England; [Williams, John] South Tees Hosp NHS Fdn Trust, Middlesbrough, Cleveland, England; [Torok, M. Estee] Univ Cambridge, Dept Med, Cambridge, England; [Llewelyn, Martin J.] Brighton & Sussex Med Sch, Brighton, E Sussex, England; [Edgeworth, Jonathan D.] Kings Coll London, London, England	University of Oxford; University of Oxford; Medical Research Council Clinical Trials Unit; University of London; University College London; Royal Liverpool & Broadgreen University Hospitals NHS Trust; Royal Liverpool University Hospital; University of Liverpool; University of Sheffield; Portsmouth Hospitals NHS Trust; University of London; University College London; University of Exeter; Aintree University Hospitals NHS Foundation Trust; Heart of England NHS Foundation Trust; University of Southampton; University Hospital Southampton NHS Foundation Trust; University Hospitals of Leicester NHS Trust; University of Leicester; Salford Royal NHS Foundation Trust; Newcastle Upon Tyne Hospitals NHS Foundation Trust; King's College Hospital NHS Foundation Trust; University of Leeds; University of London; University College London; Royal Free London NHS Foundation Trust; University of Cambridge; University of Brighton; University of Sussex; University of London; King's College London	Thwaites, GE (corresponding author), Univ Oxford, Nuffield Dept Med, Ctr Trop Med & Global Hlth, Oxford OX3 7BN, England.	gthwaites@oucru.org	Millard, James Daniel/AAM-5347-2020; Cevik, Muge/N-6588-2019; Young, Bernadette Carmel/AAB-4157-2019; Llewelyn, Martin/Y-1472-2019; Llewelyn, Martin/A-7194-2011; Reynolds, Helen/H-1697-2014; Thwaites, Guy E/R-4993-2019; Walker, Sarah/HDM-8717-2022	Millard, James Daniel/0000-0001-6427-552X; Cevik, Muge/0000-0003-1133-3874; Young, Bernadette Carmel/0000-0001-6071-6770; Llewelyn, Martin/0000-0002-6811-1124; Reynolds, Helen/0000-0001-7443-4520; Thwaites, Guy E/0000-0002-2858-2087; Goodman, Anna/0000-0003-0643-9017; SKOTNICKA, AGNIESZKA/0000-0003-3452-8754; Munoz-Villaverde, Sergio/0000-0002-8374-1589; Ong, Edmund/0000-0002-6594-0509; Price, David/0000-0002-0562-7326; Saunderson, Rebecca/0000-0001-9670-0041; Hopkins, Susan/0000-0001-5179-5702; Biswas, Jason/0000-0002-9260-9512; Torok, Mili Estee/0000-0001-9098-8590; Gouliouris, Theodore/0000-0002-2011-1205; Brown, Colin/0000-0003-4776-3403; Cole, Joby/0000-0002-5258-5835; Lewis, Joseph/0000-0002-3837-5188; Chrdle, Ales/0000-0003-4572-745X; Planche, Timothy/0000-0002-0263-0888; Pareek, Manish/0000-0003-1521-9964; Price, James/0000-0003-2541-8545; Lewszuk, Adam/0000-0002-6549-3411; Smith (nee Oliver), Melody/0000-0002-0987-2564	UK National Institute for Health Research Health Technology Assessment; MRC [MC_UU_12023/22, MR/K023985/1] Funding Source: UKRI; Academy of Medical Sciences (AMS) [AMS-CSF4-Torok] Funding Source: researchfish; Medical Research Council [MC_UU_12023/22, MR/K023985/1] Funding Source: researchfish; National Institute for Health Research [10/104/25, CL-2013-27-001, ACF-2015-14-013] Funding Source: researchfish	UK National Institute for Health Research Health Technology Assessment(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Academy of Medical Sciences (AMS)(Academy of Medical Sciences (AMS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	UK National Institute for Health Research Health Technology Assessment.	Duerden B, 2015, OPEN FORUM INFECT DI, V2, DOI 10.1093/ofid/ofv035; Forrest GN, 2010, CLIN MICROBIOL REV, V23, P14, DOI 10.1128/CMR.00034-09; Fowler VG, 2006, NEW ENGL J MED, V355, P653, DOI 10.1056/NEJMoa053783; Harris PNA, 2017, CLIN MICROBIOL INFEC, V23, P533, DOI 10.1016/j.cmi.2016.10.023; Holland TL, 2014, JAMA-J AM MED ASSOC, V312, P1330, DOI 10.1001/jama.2014.9743; Kaasch AJ, 2014, J INFECTION, V68, P242, DOI 10.1016/j.jinf.2013.10.015; Liu C, 2011, CLIN INFECT DIS, V53, P319, DOI [10.1093/cid/cir353, 10.1093/cid/ciq146]; Loubet P, 2018, CLIN MICROBIOL INFEC, V24, P125, DOI 10.1016/j.cmi.2017.07.003; Naber CK, 2009, CLIN INFECT DIS, V48, pS260, DOI 10.1086/598185; NORDEN CW, 1983, J INFECT DIS, V147, P352, DOI 10.1093/infdis/147.2.352; Rieg S, 2017, CLIN MICROBIOL INFEC, V23, DOI 10.1016/j.cmi.2016.08.026; Ruotsalainen E, 2006, J INTERN MED, V259, P179, DOI 10.1111/j.1365-2796.2005.01598.x; Russell CD, 2014, J MED MICROBIOL, V63, P841, DOI 10.1099/jmm.0.072280-0; Sendi P, 2012, CLIN MICROBIOL INFEC, V18, P1176, DOI 10.1111/1469-0691.12003; Thwaites G, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-241; Thwaites GE, 2011, LANCET INFECT DIS, V11, P208, DOI 10.1016/S1473-3099(10)70285-1; Thwaites GE, 2011, NAT REV MICROBIOL, V9, P215, DOI 10.1038/nrmicro2508; Thwaites GE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014170; Tong SYC, 2015, CLIN MICROBIOL REV, V28, P603, DOI 10.1128/CMR.00134-14; US Department of Health and Human Services, 2010, COMMON TERMINOLOGY C; Vogel M, 2016, J INFECTION, V72, P19, DOI 10.1016/j.jinf.2015.09.037; Wang R, 2007, NEW ENGL J MED, V357, P2189, DOI 10.1056/NEJMsr077003; WATANAKUNAKORN C, 1983, SCAND J INFECT DIS, P151	23	94	94	0	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 17	2018	391	10121					668	678		10.1016/S0140-6736(17)32456-X	http://dx.doi.org/10.1016/S0140-6736(17)32456-X			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FW4MN	29249276	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000425287800026
J	Franzmann, TM; Jahnel, M; Pozniakovsky, A; Mahamid, J; Holehouse, AS; Nuske, E; Richter, D; Baumeister, W; Grill, SW; Pappu, RV; Hyman, AA; Alberti, S				Franzmann, Titus M.; Jahnel, Marcus; Pozniakovsky, Andrei; Mahamid, Julia; Holehouse, Alex S.; Nuske, Elisabeth; Richter, Doris; Baumeister, Wolfgang; Grill, Stephan W.; Pappu, Rohit V.; Hyman, Anthony A.; Alberti, Simon			Phase separation of a yeast prion protein promotes cellular fitness	SCIENCE			English	Article							STRESS; SUP35; PSI+; URE3; GRANULES; DOMAINS; DETERMINANT; PREDICTION; FEATURES; REGIONS	Despite the important role of prion domains in neurodegenerative disease, their physiological function has remained enigmatic. Previous work with yeast prions has defined prion domains as sequences that form self-propagating aggregates. Here, we uncovered an unexpected function of the canonical yeast prion protein Sup35. In stressed conditions, Sup35 formed protective gels via pH-regulated liquid-like phase separation followed by gelation. Phase separation was mediated by the N-terminal prion domain and regulated by the adjacent pH sensor domain. Phase separation promoted yeast cell survival by rescuing the essential Sup35 translation factor from stress-induced damage. Thus, prion-like domains represent conserved environmental stress sensors that facilitate rapid adaptation in unstable environments by modifying protein phase behavior.	[Franzmann, Titus M.; Jahnel, Marcus; Pozniakovsky, Andrei; Nuske, Elisabeth; Richter, Doris; Grill, Stephan W.; Hyman, Anthony A.; Alberti, Simon] Max Planck Inst Mol Cell Biol & Genet, Pfotenhauerstr 108, D-01307 Dresden, Germany; [Jahnel, Marcus; Grill, Stephan W.] Tech Univ Dresden, Biotec, Tatzberg 47-48, D-01307 Dresden, Germany; [Mahamid, Julia] European Mol Biol Lab, Meyerhofstr 1, D-69117 Heidelberg, Germany; [Holehouse, Alex S.; Pappu, Rohit V.] Washington Univ St Louis, Dept Biomed Engn, St Louis, MO USA; [Holehouse, Alex S.; Pappu, Rohit V.] Washington Univ St Louis, Ctr Biol Syst Engn, St Louis, MO USA; [Baumeister, Wolfgang] Max Planck Inst Biochem, Dept Mol Struct Biol, Klopferspitz 18, D-82152 Martinsried, Germany	Max Planck Society; Technische Universitat Dresden; European Molecular Biology Laboratory (EMBL); Washington University (WUSTL); Washington University (WUSTL); Max Planck Society	Hyman, AA; Alberti, S (corresponding author), Max Planck Inst Mol Cell Biol & Genet, Pfotenhauerstr 108, D-01307 Dresden, Germany.	hyman@mpi-cbg.de; alberti@mpi-cbg.de	Hyman, Tony/F-1923-2011; Alberti, Simon/ABB-8277-2021; Franzmann, Titus M/D-1962-2011; Holehouse, Alex/ABE-8308-2020; Alberti, Simon/B-2822-2017	Holehouse, Alex/0000-0002-4155-5729; Franzmann, Titus/0000-0002-4281-7209; Alberti, Simon/0000-0003-4017-6505; Jahnel, Marcus/0000-0002-8355-277X	Services and Facilities of the Max Planck Institute of Molecular Cell Biology and Genetics (MPI-CBG); German Federal Ministry of Research and Education [BMBF 031A359A]; MaxSynBio consortium; Federal Ministry of Education and Research of Germany; Max Planck Society; U.S. National Institutes of Health [5RO1NS056114]; Human Frontiers Program [RGP0034/2017]; Volkswagen "Life?" initiative; German Research Foundation (DFG); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS056114] Funding Source: NIH RePORTER	Services and Facilities of the Max Planck Institute of Molecular Cell Biology and Genetics (MPI-CBG); German Federal Ministry of Research and Education; MaxSynBio consortium; Federal Ministry of Education and Research of Germany(Federal Ministry of Education & Research (BMBF)); Max Planck Society(Max Planck Society); U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontiers Program; Volkswagen "Life?" initiative; German Research Foundation (DFG)(German Research Foundation (DFG)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the following Services and Facilities of the Max Planck Institute of Molecular Cell Biology and Genetics (MPI-CBG) for their support: We thank B. Borgonovo and R. Lemaitre (Protein Expression Purification and Characterization) for help with protein expression and purification; B. Nitzsche and B. Schroth-Diez (Light Microscopy Facility) for help with light microscopy; F. Friedrich for support with visualization (Media Technologies and Outreach); and C. Iserman for a yeast strain BY4742 coexpressing Sup35-GFP and Pab1-mCherry. We thank members of the MPI-CBG and C. Weber from the Max Planck Institute for the Physics of Complex systems for discussion and comments on the manuscript. R. Halfmann is acknowledged for providing the antibody against Sup35C domain. We gratefully acknowledge funding from the German Federal Ministry of Research and Education (BMBF 031A359A to T.M.F and A.A.H.). This work is supported by the MaxSynBio consortium, jointly funded by the Federal Ministry of Education and Research of Germany and the Max Planck Society. We further acknowledge the U.S. National Institutes of Health for grant 5RO1NS056114 to R.V.P., The Human Frontiers Program for grant RGP0034/2017 to S.A. and R.V.P, the Volkswagen "Life?" initiative for a grant to S.A., and the German Research Foundation (DFG) for a grant to S.A. All the data relevant to this study are included in the main paper or the supplementary materials.	Alberti S, 2007, YEAST, V24, P913, DOI 10.1002/yea.1502; Alberti S, 2009, CELL, V137, P146, DOI 10.1016/j.cell.2009.02.044; Anderson P, 2009, CURR BIOL, V19, pR397, DOI 10.1016/j.cub.2009.03.013; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Banani SF, 2017, NAT REV MOL CELL BIO, V18, P285, DOI 10.1038/nrm.2017.7; Brangwynne CP, 2009, SCIENCE, V324, P1729, DOI 10.1126/science.1172046; Brett CL, 2005, MOL BIOL CELL, V16, P1396, DOI 10.1091/mbc.E04-11-0999; Buchan JR, 2009, MOL CELL, V36, P932, DOI 10.1016/j.molcel.2009.11.020; Chernoff YO, 2000, MOL MICROBIOL, V35, P865, DOI 10.1046/j.1365-2958.2000.01761.x; Chernoff YO, 2007, FEBS LETT, V581, P3695, DOI 10.1016/j.febslet.2007.04.075; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Edskes HK, 2014, GENETICS, V198, P605, DOI 10.1534/genetics.114.166538; Forsburg SL, 2006, YEAST, V23, P173, DOI 10.1002/yea.1347; Garcia DM, 2014, FEMS YEAST RES, V14, P136, DOI 10.1111/1567-1364.12116; Glover JR, 1997, CELL, V89, P811, DOI 10.1016/S0092-8674(00)80264-0; Gough J, 2001, J MOL BIOL, V313, P903, DOI 10.1006/jmbi.2001.5080; Halfmann R, 2010, SCIENCE, V330, P629, DOI 10.1126/science.1191081; Halfmann Randal, 2008, J Vis Exp, DOI 10.3791/838; Halfmann R, 2010, TRENDS CELL BIOL, V20, P125, DOI 10.1016/j.tcb.2009.12.003; Harmon TS, 2017, ELIFE, V6, DOI 10.7554/eLife.30294; Harris TK, 2002, IUBMB LIFE, V53, P85, DOI 10.1080/15216540211468; Harrison AF, 2017, BIOCHEM J, V474, P1417, DOI 10.1042/BCJ20160499; Holehouse AS, 2017, BIOPHYS J, V112, P16, DOI 10.1016/j.bpj.2016.11.3200; Jahnel M, 2011, OPT LETT, V36, P1260, DOI 10.1364/OL.36.001260; Kato M, 2012, CELL, V149, P753, DOI 10.1016/j.cell.2012.04.017; Li XM, 2013, NAT METHODS, V10, P584, DOI 10.1038/nmeth.2472; Mahon Matthew J, 2011, Adv Biosci Biotechnol, V2, P132; Malinovska L, 2015, PRION, V9, P339, DOI 10.1080/19336896.2015.1099799; Malinovska L, 2015, P NATL ACAD SCI USA, V112, pE2620, DOI 10.1073/pnas.1504459112; Masek T, 2011, METHODS MOL BIOL, V703, P293, DOI 10.1007/978-1-59745-248-9_20; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; McGlinchey RP, 2011, P NATL ACAD SCI USA, V108, P5337, DOI 10.1073/pnas.1102762108; Molliex A, 2015, CELL, V163, P123, DOI 10.1016/j.cell.2015.09.015; Munder MC, 2016, ELIFE, V5, DOI 10.7554/eLife.09347; Nakayashiki T, 2005, P NATL ACAD SCI USA, V102, P10575, DOI 10.1073/pnas.0504882102; Osherovich LZ, 2001, CELL, V106, P183, DOI 10.1016/S0092-8674(01)00440-8; Parry BR, 2014, CELL, V156, P183, DOI 10.1016/j.cell.2013.11.028; Patel A, 2015, CELL, V162, P1066, DOI 10.1016/j.cell.2015.07.047; Paushkin SV, 1996, EMBO J, V15, P3127, DOI 10.1002/j.1460-2075.1996.tb00675.x; Petrovska I, 2014, ELIFE, V3, DOI 10.7554/eLife.02409; Riback JA, 2017, CELL, V168, P1028, DOI 10.1016/j.cell.2017.02.027; Rubinstein M, 1998, MACROMOLECULES, V31, P1386, DOI 10.1021/ma970617+; Ruggeri F, 2017, NAT NANOTECHNOL, V12, P488, DOI [10.1038/nnano.2017.26, 10.1038/NNANO.2017.26]; Saha S, 2016, CELL, V166, P1572, DOI 10.1016/j.cell.2016.08.006; Serio TR, 2000, SCIENCE, V289, P1317, DOI 10.1126/science.289.5483.1317; SERRANO R, 1977, EUR J BIOCHEM, V80, P97, DOI 10.1111/j.1432-1033.1977.tb11861.x; Shin Y, 2017, SCIENCE, V357, DOI 10.1126/science.aaf4382; Shorter J, 2004, SCIENCE, V304, P1793, DOI 10.1126/science.1098007; STANSFIELD I, 1995, EMBO J, V14, P4365, DOI 10.1002/j.1460-2075.1995.tb00111.x; TERAVANESYAN MD, 1993, MOL MICROBIOL, V7, P683, DOI 10.1111/j.1365-2958.1993.tb01159.x; Wei MT, 2017, NAT CHEM, V9, P1118, DOI [10.1038/NCHEM.2803, 10.1038/nchem.2803]; WICKNER RB, 1994, SCIENCE, V264, P566, DOI 10.1126/science.7909170; Wickner RB, 1995, YEAST, V11, P1671, DOI 10.1002/yea.320111609; Wickner RB, 2011, PRION, V5, P258, DOI [10.4161/pri.5.4.17748, 10.4161/pri.17748]	54	341	346	21	191	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 5	2018	359	6371					47	+	eaao5654	10.1126/science.aao5654	http://dx.doi.org/10.1126/science.aao5654			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FR8KW	29301985				2022-12-28	WOS:000419324700063
J	Lohse, M; Schweizer, C; Price, HM; Zilberberg, O; Bloch, I				Lohse, Michael; Schweizer, Christian; Price, Hannah M.; Zilberberg, Oded; Bloch, Immanuel			Exploring 4D quantum Hall physics with a 2D topological charge pump	NATURE			English	Article							ENERGY-SPECTRUM; MAGNETIC FIELD; EDGE STATES; INSULATORS; TRANSPORT; ELECTRONS; FERMIONS; PHASE; SPIN	The discovery of topological states of matter has greatly improved our understanding of phase transitions in physical systems. Instead of being described by local order parameters, topological phases are described by global topological invariants and are therefore robust against perturbations. A prominent example is the two-dimensional (2D) integer quantum Hall effect(1): it is characterized by the first Chern number, which manifests in the quantized Hall response that is induced by an external electric field(2). Generalizing the quantum Hall effect to four-dimensional (4D) systems leads to the appearance of an additional quantized Hall response, but one that is nonlinear and described by a 4D topological invariant-the second Chern number(3,4). Here we report the observation of a bulk response with intrinsic 4D topology and demonstrate its quantization by measuring the associated second Chern number. By implementing a 2D topological charge pump using ultracold bosonic atoms in an angled optical superlattice, we realize a dynamical version of the 4D integer quantum Hall effect(5,6). Using a small cloud of atoms as a local probe, we fully characterize the nonlinear response of the system via in situ imaging and site-resolved band mapping. Our findings pave the way to experimentally probing higher-dimensional quantum Hall systems, in which additional strongly correlated topological phases, exotic collective excitations and boundary phenomena such as isolated Weyl fermions are predicted(4).	[Lohse, Michael; Schweizer, Christian; Bloch, Immanuel] Ludwig Maximilians Univ Munchen, Fak Phys, Schellingstr 4, D-80799 Munich, Germany; [Lohse, Michael; Schweizer, Christian; Bloch, Immanuel] Max Planck Inst Quantum Opt, Hans Kopfermann Str 1, D-85748 Garching, Germany; [Price, Hannah M.] Univ Trento, INO CNR BEC Ctr, Via Sommarive 14, I-38123 Povo, Italy; [Price, Hannah M.] Univ Trento, Dipartimento Fis, Via Sommarive 14, I-38123 Povo, Italy; [Price, Hannah M.] Univ Birmingham, Sch Phys & Astron, Birmingham B15 2TT, W Midlands, England; [Zilberberg, Oded] ETH, Inst Theoret Phys, Wolfgang Pauli Str 27, CH-8093 Zurich, Switzerland	University of Munich; Max Planck Society; Consiglio Nazionale delle Ricerche (CNR); Istituto Nazionale di Ottica (INO-CNR); University of Trento; University of Trento; University of Birmingham; Swiss Federal Institutes of Technology Domain; ETH Zurich	Bloch, I (corresponding author), Ludwig Maximilians Univ Munchen, Fak Phys, Schellingstr 4, D-80799 Munich, Germany.; Bloch, I (corresponding author), Max Planck Inst Quantum Opt, Hans Kopfermann Str 1, D-85748 Garching, Germany.	immanuel.bloch@physik.uni-muenchen.de	Zilberberg, Oded/L-6474-2013; Bloch, Immanuel/N-9169-2019; Schweizer, Christian/B-1401-2019; Bloch, Immanuel/G-3174-2010	Zilberberg, Oded/0000-0002-1759-4920; Schweizer, Christian/0000-0002-4565-947X; Bloch, Immanuel/0000-0002-0679-4759; Price, Hannah/0000-0002-1377-596X	European Commission (UQUAM, SIQS); Deutsche Forschungsgemeinschaft (DIP) [FOR2414]; Nanosystems Initiative Munich; Elitenetzwerk Bayern (ExQM); European Commission (FET Proactive) [640800, 656093]; Autonomous Province of Trento (SiQuro); Swiss National Science Foundation	European Commission (UQUAM, SIQS); Deutsche Forschungsgemeinschaft (DIP)(German Research Foundation (DFG)); Nanosystems Initiative Munich; Elitenetzwerk Bayern (ExQM); European Commission (FET Proactive)(European Commission); Autonomous Province of Trento (SiQuro); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	We acknowledge discussions with M. Aidelsburger and I. Carusotto. This work was funded by the European Commission (UQUAM, SIQS), the Deutsche Forschungsgemeinschaft (DIP, FOR2414) and the Nanosystems Initiative Munich. M.L. was additionally supported by the Elitenetzwerk Bayern (ExQM), H.M.P. by the European Commission (FET Proactive, grant no. 640800 'AQuS', and Marie Sklodowska-Curie Action, grant no. 656093 'SynOptic') and the Autonomous Province of Trento (SiQuro), and O.Z. by the Swiss National Science Foundation.	Azbel M. Y., 1964, ZH EKSP TEOR FIZ, V46, P929; AZBEL MY, 1964, SOV PHYS JETP-USSR, V19, P634; Benalcazar WA, 2017, SCIENCE, V357, P61, DOI 10.1126/science.aah6442; Frohlich J., 2000, MATH PHYS 2000, P9; Gerbier F, 2006, PHYS REV A, V73, DOI 10.1103/PhysRevA.73.041602; Goldman N, 2016, NAT PHYS, V12, P639, DOI [10.1038/NPHYS3803, 10.1038/nphys3803]; HARPER PG, 1955, P PHYS SOC LOND A, V68, P879, DOI 10.1088/0370-1298/68/10/305; HATSUGAI Y, 1990, PHYS REV B, V42, P8282, DOI 10.1103/PhysRevB.42.8282; HOFSTADTER DR, 1976, PHYS REV B, V14, P2239, DOI 10.1103/PhysRevB.14.2239; Hosur P, 2013, CR PHYS, V14, P857, DOI 10.1016/j.crhy.2013.10.010; Hsieh D, 2008, NATURE, V452, P970, DOI 10.1038/nature06843; Kraus YE, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.226401; Kraus YE, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.116404; Kraus YE, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.106402; LAUGHLIN RB, 1981, PHYS REV B, V23, P5632, DOI 10.1103/PhysRevB.23.5632; Lohse M, 2016, NAT PHYS, V12, P350, DOI 10.1038/NPHYS3584; Lu L, 2015, SCIENCE, V349, P622, DOI 10.1126/science.aaa9273; Lu L, 2014, NAT PHOTONICS, V8, P821, DOI [10.1038/nphoton.2014.248, 10.1038/NPHOTON.2014.248]; Mancini M, 2015, SCIENCE, V349, P1510, DOI 10.1126/science.aaa8736; Marra P, 2015, PHYS REV B, V91, DOI 10.1103/PhysRevB.91.125411; Nakajima S, 2016, NAT PHYS, V12, P296, DOI 10.1038/NPHYS3622; Nayak C, 2008, REV MOD PHYS, V80, P1083, DOI 10.1103/RevModPhys.80.1083; Price HM, 2016, PHYS REV B, V93, DOI 10.1103/PhysRevB.93.245113; Price HM, 2015, PHYS REV LETT, V115, DOI 10.1103/PhysRevLett.115.195303; Qi XL, 2011, REV MOD PHYS, V83, DOI 10.1103/RevModPhys.83.1057; Qi XL, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.195424; RICE MJ, 1982, PHYS REV LETT, V49, P1455, DOI 10.1103/PhysRevLett.49.1455; Roux G, 2008, PHYS REV A, V78, DOI 10.1103/PhysRevA.78.023628; Stuhl BK, 2015, SCIENCE, V349, P1514, DOI 10.1126/science.aaa8515; Sugawa S., 2016, OBSERVATION NONABELI; Switkes M, 1999, SCIENCE, V283, P1905, DOI 10.1126/science.283.5409.1905; THOULESS DJ, 1982, PHYS REV LETT, V49, P405, DOI 10.1103/PhysRevLett.49.405; THOULESS DJ, 1983, PHYS REV B, V27, P6083, DOI 10.1103/PhysRevB.27.6083; VONKLITZING K, 1980, PHYS REV LETT, V45, P494, DOI 10.1103/PhysRevLett.45.494; Widera A, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.190405; Xiao D, 2010, REV MOD PHYS, V82, P1959, DOI 10.1103/RevModPhys.82.1959; Xu SY, 2015, SCIENCE, V349, P613, DOI 10.1126/science.aaa9297; YANG CN, 1954, PHYS REV, V96, P191, DOI 10.1103/PhysRev.96.191; Zhang SC, 2001, SCIENCE, V294, P823, DOI 10.1126/science.294.5543.823; Zhu SL, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.075303; Zilberberg O, 2018, NATURE, V553, P59, DOI 10.1038/nature25011	41	223	224	6	102	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 4	2018	553	7686					55	+		10.1038/nature25000	http://dx.doi.org/10.1038/nature25000			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS4NI	29300006	Green Submitted			2022-12-28	WOS:000419769300028
J	Palesch, D; Bosinger, SE; Tharp, GK; Vanderford, TH; Paiardini, M; Chahroudi, A; Johnson, ZP; Kirchhoff, F; Hahn, BH; Norgren, RB; Patel, NB; Sodora, DL; Dawoud, RA; Stewart, CB; Seepo, SM; Harris, RA; Liu, Y; Aveendran, MR; Han, Y; English, A; Thomas, GWC; Hahn, MW; Pipes, L; Mason, CE; Muzny, DM; Gibbs, RA; Sauter, D; Worley, K; Rogers, J; Silvestri, G				Palesch, David; Bosinger, Steven E.; Tharp, Gregory K.; Vanderford, Thomas H.; Paiardini, Mirko; Chahroudi, Ann; Johnson, Zachary P.; Kirchhoff, Frank; Hahn, Beatrice H.; Norgren, Robert B., Jr.; Patel, Nirav B.; Sodora, Donald L.; Dawoud, Reem A. .; Stewart, Caro-Beth; Seepo, Sara M.; Harris, R. Alan; Liu, Yue; Aveendran, Muthuswamy R.; Han, Yi; English, Adam; Thomas, Gregg W. C.; Hahn, Matthew W.; Pipes, Lenore; Mason, Christopher E.; Muzny, Donna M.; Gibbs, Richard A. .; Sauter, Daniel; Worley, Kim; Rogers, Jeffrey; Silvestri, Guido			Sooty mangabey genome sequence provides insight into AIDS resistance in a natural SIV host	NATURE			English	Article							SIMIAN-IMMUNODEFICIENCY-VIRUS; CD4(+) T-CELLS; PHYLOGENETIC ANALYSIS; GENE-EXPRESSION; INFECTION; ANNOTATION; GENERATION; DATABASE; ICAM-2	In contrast to infections with human immunodeficiency virus (HIV) in humans and simian immunodeficiency virus (SIV) in macaques, SIV infection of a natural host, sooty mangabeys (Cercocebus atys), is non-pathogenic despite high viraemia(1). Here we sequenced and assembled the genome of a captive sooty mangabey. We conducted genome-wide comparative analyses of transcript assemblies from C. atys and AIDS-susceptible species, such as humans and macaques, to identify candidates for host genetic factors that influence susceptibility. We identified several immune-related genes in the genome of C. atys that show substantial sequence divergence from macaques or humans. One of these sequence divergences, a C-terminal frameshift in the toll-like receptor-4 (TLR4) gene of C. atys, is associated with a blunted in vitro response to TLR-4 ligands. In addition, we found a major structural change in exons 3-4 of the immune-regulatory protein intercellular adhesion molecule 2 (ICAM-2); expression of this variant leads to reduced cell surface expression of ICAM-2. These data provide a resource for comparative genomic studies of HIV and/or SIV pathogenesis and may help to elucidate the mechanisms by which SIV-infected sooty mangabeys avoid AIDS.	[Palesch, David; Bosinger, Steven E.; Tharp, Gregory K.; Vanderford, Thomas H.; Paiardini, Mirko; Chahroudi, Ann; Johnson, Zachary P.; Patel, Nirav B.; Dawoud, Reem A. .; Silvestri, Guido] Emory Univ, Emory Vaccine Ctr, Atlanta, GA 30329 USA; [Palesch, David; Bosinger, Steven E.; Tharp, Gregory K.; Vanderford, Thomas H.; Paiardini, Mirko; Chahroudi, Ann; Johnson, Zachary P.; Patel, Nirav B.; Dawoud, Reem A. .; Silvestri, Guido] Emory Univ, Yerkes Natl Primate Res Ctr, Atlanta, GA 30329 USA; [Bosinger, Steven E.; Paiardini, Mirko; Silvestri, Guido] Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30329 USA; [Chahroudi, Ann] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA 30329 USA; [Kirchhoff, Frank; Sauter, Daniel] Univ Ulm, Med Ctr, Inst Mol Virol, D-89081 Ulm, Germany; [Hahn, Beatrice H.] Univ Penn, Perelman Sch Med, Dept Med, Philadelphia, PA 19104 USA; [Hahn, Beatrice H.] Univ Penn, Perelman Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA; [Norgren, Robert B., Jr.] Univ Nebraska Med Ctr, Dept Genet Cell Biol & Anat, Omaha, NE 68198 USA; [Sodora, Donald L.] Seattle Biomed Res Inst, Ctr Infect Dis Res, Seattle, WA 98109 USA; [Stewart, Caro-Beth; Seepo, Sara M.] SUNY Albany, Dept Biol Sci, Albany, NY 12222 USA; [Harris, R. Alan; Liu, Yue; Aveendran, Muthuswamy R.; Han, Yi; English, Adam; Muzny, Donna M.; Gibbs, Richard A. .; Worley, Kim; Rogers, Jeffrey] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Harris, R. Alan; Aveendran, Muthuswamy R.; Muzny, Donna M.; Gibbs, Richard A. .; Worley, Kim; Rogers, Jeffrey] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Thomas, Gregg W. C.; Hahn, Matthew W.] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA; [Thomas, Gregg W. C.; Hahn, Matthew W.] Indiana Univ, Sch Informat & Comp, Bloomington, IN 47405 USA; [Pipes, Lenore; Mason, Christopher E.; Silvestri, Guido] Weill Cornell Med Coll, Dept Physiol & Biophys, New York, NY 10065 USA	Emory University; Emory University; Emory University; Emory University; Ulm University; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Nebraska System; University of Nebraska Medical Center; Center for Infectious Disease Research; Walter Reed Army Institute of Research (WRAIR); State University of New York (SUNY) System; State University of New York (SUNY) Albany; Baylor College of Medicine; Baylor College of Medicine; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Cornell University	Silvestri, G (corresponding author), Emory Univ, Emory Vaccine Ctr, Atlanta, GA 30329 USA.; Silvestri, G (corresponding author), Emory Univ, Yerkes Natl Primate Res Ctr, Atlanta, GA 30329 USA.	gsilves@emory.edu	Mason, Christopher/HCH-3977-2022; Kirchhoff, Frank/O-8367-2018; Harris, R. Alan/AAI-2784-2020	Kirchhoff, Frank/0000-0002-7052-2360; Harris, R. Alan/0000-0002-7333-4752; Norgren, Robert/0000-0002-0021-5875; Hahn, Matthew/0000-0002-5731-8808; Worley, Kim/0000-0002-0282-1000; Hahn, Beatrice/0000-0002-9400-9887	HHS/National Institutes of Health (NIH) [R37 AI66998]; National Institute of Allergy and Infectious Diseases of the National Institutes of Health [P51 OD011132]; NIH [U54-HG006484-01, R37 AI050529, R24 OD010445]; Priority Program 'Innate Sensing and Restriction of Retroviruses' of the German Research Foundation (DFG) [SPP 1923]; Advanced ERC grant 'Anti-Virome'; DFG [SFB 1279]; Precision Health Initiative of Indiana University; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003273] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI066998, R37AI050529, P30AI050409, R37AI066998] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R24OD010445, P51OD011132, R24OD011173] Funding Source: NIH RePORTER	HHS/National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Priority Program 'Innate Sensing and Restriction of Retroviruses' of the German Research Foundation (DFG)(German Research Foundation (DFG)); Advanced ERC grant 'Anti-Virome'; DFG(German Research Foundation (DFG)); Precision Health Initiative of Indiana University; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank S. Ehnert and all animal care and veterinary staff at the Yerkes National Primate Research Center (YNPRC); B. Cervasi and K. Gill at the Emory University Flow Cytometry Core; M. T. Nega at the Emory CFAR Virology & Drug Discovery Core; R. Linsenmeyer for excellent technical assistance; and O. Laur and the Emory Custom Cloning Core Division. We are grateful for the sequence production and related activities at the Human Genome Sequencing Center at Baylor College of Medicine. The production teams involved were: sample tracking (S. Jhangiani, C. Kovar), library production (H. Doddapaneni, H. Chao, S. L. Lee, G. Weissenberger and M. Wang), Illumina sequencing (H. Dinh, G. Okwuonu and J. Santibanez), PacBio sequencing (V. Vee) and production informatics (M. Dahdouli, Z. Khan, J. G. Reid and D. Sexton). D. Rio Derios and S. C. Murali also contributed to the assembly of the genome sequence. This work was funded by HHS/National Institutes of Health (NIH) (R37 AI66998). Research reported in this publication was also supported by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health under award number P51 OD011132 (to the YNPRC). D. M. M., R. A. G., K. W. and J. R. were supported by NIH grant U54-HG006484-01. D. S. was supported by the Priority Program 'Innate Sensing and Restriction of Retroviruses' (SPP 1923) of the German Research Foundation (DFG). F.K. was funded by the Advanced ERC grant 'Anti-Virome' and the DFG-funded SFB 1279. G. W. C. T. and M. W. H. were supported by the Precision Health Initiative of Indiana University. B. H. H. was funded by NIH grant R37 AI050529. Comparative transcriptomics research was funded by NIH grant R24 OD010445.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Beaumier CM, 2009, NAT MED, V15, P879, DOI 10.1038/nm.1970; Bosinger SE, 2004, J IMMUNOL, V173, P6858, DOI 10.4049/jimmunol.173.11.6858; Bosinger SE, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003597; Bosinger SE, 2009, J CLIN INVEST, V119, P3556, DOI 10.1172/JCI40115; Brenchley JM, 2008, MUCOSAL IMMUNOL, V1, P23, DOI 10.1038/mi.2007.1; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Carbone L, 2014, NATURE, V513, P195, DOI 10.1038/nature13679; Cartwright EK, 2014, J IMMUNOL, V192, P4666, DOI 10.4049/jimmunol.1303193; Casasnovas JM, 1999, P NATL ACAD SCI USA, V96, P3017, DOI 10.1073/pnas.96.6.3017; Chahroudi A, 2012, SCIENCE, V335, P1188, DOI 10.1126/science.1217550; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; English AK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041444; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Finstermeier K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069504; Flicek P, 2014, NUCLEIC ACIDS RES, V42, pD749, DOI 10.1093/nar/gkt1196; Geer LY, 2010, NUCLEIC ACIDS RES, V38, pD492, DOI 10.1093/nar/gkp858; Gnerre S, 2011, P NATL ACAD SCI USA, V108, P1513, DOI 10.1073/pnas.1017351108; Gordon SN, 2007, J IMMUNOL, V179, P3026, DOI 10.4049/jimmunol.179.5.3026; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Halai K, 2014, J CELL SCI, V127, P620, DOI 10.1242/jcs.137463; Han MV, 2013, MOL BIOL EVOL, V30, P1987, DOI 10.1093/molbev/mst100; Hedges SB, 2006, BIOINFORMATICS, V22, P2971, DOI 10.1093/bioinformatics/btl505; Jacquelin B, 2009, J CLIN INVEST, V119, P3544, DOI 10.1172/JCI40093; Klatt NR, 2008, J CLIN INVEST, V118, P2039, DOI 10.1172/JCI33814; Koressaar T, 2007, BIOINFORMATICS, V23, P1289, DOI 10.1093/bioinformatics/btm091; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Medvedev AE, 2003, J ENDOTOXIN RES, V9, P60, DOI 10.1179/096805103125001360; Mendes FK, 2016, SYST BIOL, V65, P711, DOI 10.1093/sysbio/syw018; Mir KD, 2015, J VIROL, V89, P10136, DOI 10.1128/JVI.00710-15; Mirarab S, 2015, J COMPUT BIOL, V22, P377, DOI 10.1089/cmb.2014.0156; Morgan E, 2004, CLIN IMMUNOL, V110, P252, DOI 10.1016/j.clim.2003.11.017; O'Leary NA, 2016, NUCLEIC ACIDS RES, V44, pD733, DOI 10.1093/nar/gkv1189; Paiardini M, 2011, NAT MED, V17, P830, DOI 10.1038/nm.2395; Pandrea I, 2008, J VIROL, V82, P5501, DOI 10.1128/JVI.02555-07; Peng XX, 2015, NUCLEIC ACIDS RES, V43, pD737, DOI 10.1093/nar/gku1110; Perelman P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001342; Pipes L, 2013, NUCLEIC ACIDS RES, V41, pD906, DOI 10.1093/nar/gks1268; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Rogers J, 2014, NAT REV GENET, V15, P347, DOI 10.1038/nrg3707; Sauter D, 2015, CELL REP, V10, P586, DOI 10.1016/j.celrep.2014.12.047; Simao FA, 2015, BIOINFORMATICS, V31, P3210, DOI 10.1093/bioinformatics/btv351; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; STAUNTON DE, 1989, NATURE, V339, P61, DOI 10.1038/339061a0; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Subramanian A, 2007, BIOINFORMATICS, V23, P3251, DOI 10.1093/bioinformatics/btm369; Sumpter B, 2007, J IMMUNOL, V178, P1680, DOI 10.4049/jimmunol.178.3.1680; Tapping RI, 2000, J IMMUNOL, V165, P5780, DOI 10.4049/jimmunol.165.10.5780; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Warren WC, 2015, GENOME RES, V25, P1921, DOI 10.1101/gr.192922.115; Xue C, 2016, GENOME RES, V26, P1651, DOI 10.1101/gr.204255.116; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zimin AV, 2014, BIOL DIRECT, V9, DOI 10.1186/1745-6150-9-20	54	36	38	2	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 4	2018	553	7686					77	+		10.1038/nature25140	http://dx.doi.org/10.1038/nature25140			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS4NI	29300007	hybrid, Green Accepted, Green Submitted			2022-12-28	WOS:000419769300033
J	Tan, TSE; Cheah, FK				Tan, Timothy Shao Ern; Cheah, Foong Koon			SPOT DIAGNOSIS An uncommon cause of abdominal pain in a young man	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							EPIPLOIC APPENDAGITIS		[Tan, Timothy Shao Ern; Cheah, Foong Koon] Singapore Gen Hosp, Dept Diagnost Radiol, Singapore, Singapore	Singapore General Hospital	Tan, TSE (corresponding author), Singapore Gen Hosp, Dept Diagnost Radiol, Singapore, Singapore.	timothy.tan.shao.ern@doctors.org.uk		Tan, Timothy Shao Ern/0000-0001-9297-4598				RIOUX M, 1994, RADIOLOGY, V191, P523, DOI 10.1148/radiology.191.2.8153333; Sand Michael, 2007, BMC Surg, V7, P11, DOI 10.1186/1471-2482-7-11; Schnedl WJ, 2011, NAT REV GASTRO HEPAT, V8, P45, DOI 10.1038/nrgastro.2010.189; Singh AK, 2005, RADIOGRAPHICS, V25, P1521, DOI 10.1148/rg.256055030	4	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 4	2018	360								j5182	10.1136/bmj.j5182	http://dx.doi.org/10.1136/bmj.j5182			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FS3UX	29301739				2022-12-28	WOS:000419710400003
J	New, JP; Leather, D; Bakerly, ND; McCrae, J; Gibson, JM				New, John P.; Leather, David; Bakerly, Nawar Diar; McCrae, John; Gibson, J. Martin			Putting patients in control of data from electronic health records	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							WORLD EFFECTIVENESS TRIAL; SALFORD LUNG; REAL; PROTOCOL		[New, John P.; Bakerly, Nawar Diar; McCrae, John; Gibson, J. Martin] Salford Royal NHS Fdn Trust, Salford, Lancs, England; [New, John P.; Bakerly, Nawar Diar; Gibson, J. Martin] Univ Manchester, Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England; [Leather, David] GlaxoSmithKline UK, GSK Resp Ctr Excellence, Uxbridge, Middx, England	Salford Royal NHS Foundation Trust; University of Manchester; GlaxoSmithKline	New, JP (corresponding author), Salford Royal NHS Fdn Trust, Salford, Lancs, England.; New, JP (corresponding author), Univ Manchester, Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England.	john.new@manchester.ac.uk		New, John/0000-0003-4146-025X; Diar Bakerly, Nawar/0000-0003-2102-1997	GSK	GSK(GlaxoSmithKline)	We have read and understood BMJ policy on declaration of interests and declare the following interests: JPN has received consulting and speaker's fees, an educational grant from GSK, and is employed by NorthWest EHealth on a grant from GSK for the Salford Lung Study; JMcC is employed by NorthWest EHealth on a grant from GSK for the Salford Lung Study; DL is an employee of, and holds shares/stock options in, GSK; JMG's institution has received funding from GSK as the Salford Lung Study sponsor; NDB is employed by Salford Royal NHS Foundation Trust and NWEH, and has received travel support and an honorarium to speak for GSK and Novartis.	Bakerly ND, 2015, RESP RES, V16, DOI 10.1186/s12931-015-0267-6; Bounthavong M, 2015, PHARMACOTHERAPY, V35, P380, DOI 10.1002/phar.1569; Carter P, 2015, J MED ETHICS, V41, P404, DOI 10.1136/medethics-2014-102374; Curtiss Frederic R, 2004, J Manag Care Pharm, V10, P60; Eichler HG, 2012, CLIN PHARMACOL THER, V91, P426, DOI 10.1038/clpt.2011.345; Elkhenini HF, 2015, BMC MED INFORM DECIS, V15, DOI 10.1186/s12911-015-0132-z; Fiore LD, 2016, NEW ENGL J MED, V374, P2152, DOI 10.1056/NEJMra1510057; Garrison LP, 2007, VALUE HEALTH, V10, P326, DOI 10.1111/j.1524-4733.2007.00186.x; Heitmueller A, 2014, HEALTH AFFAIR, V33, P1523, DOI 10.1377/hlthaff.2014.0771; New JP, 2014, THORAX, V69, P1152, DOI 10.1136/thoraxjnl-2014-205259; New JP, 2011, EUR RESP J S55, V38, p732S; O'Dowd A, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h419; Parkinson J, 2014, NAT REV DRUG DISCOV, V13, P639, DOI 10.1038/nrd4415; Swedish Ministry of Health and Social Affairs, 2010, NAT EHEALTH STRAT AC; Todd R, 2012, DIGITAL HLTH; Todd R, 2013, DIGITAL HLTH; VANSTAA TP, 2016, BMJ-BRIT MED J, V354, DOI DOI 10.1136/BMJ.I3636; Woodcock A, 2015, BMC PULM MED, V15, DOI 10.1186/s12890-015-0150-8	18	19	19	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 2	2018	360								j5554	10.1136/bmj.j5554	http://dx.doi.org/10.1136/bmj.j5554			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FS3UL	29295813				2022-12-28	WOS:000419708800003
J	Murff, HJ				Murff, Harvey J.			Review: Weak evidence of benefits of cannabis for chronic neuropathic pain; moderate to weak evidence of adverse effects	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Murff, Harvey J.] Vanderbilt Univ, Med Ctr, Nashville, TN 37235 USA	Vanderbilt University	Murff, HJ (corresponding author), Vanderbilt Univ, Med Ctr, Nashville, TN 37235 USA.							Dzau VJ, 2014, JAMA-J AM MED ASSOC, V312, P1507, DOI 10.1001/jama.2014.12986; Park JY, 2017, DRUG ALCOHOL DEPEN, V177, P1, DOI 10.1016/j.drugalcdep.2017.03.009; Treede RD, 2015, PAIN, V156, P1003, DOI 10.1097/j.pain.0000000000000160; Volkow ND, 2014, NEW ENGL J MED, V370, P2219, DOI 10.1056/NEJMra1402309	4	0	0	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 19	2017	167	12					JC62	JC62		10.7326/ACPJC-2017-167-12-062	http://dx.doi.org/10.7326/ACPJC-2017-167-12-062			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FQ3SD	29255852				2022-12-28	WOS:000418276000002
J	Lucey, M; Clark, J; Glasziou, P				Lucey, Morgan; Clark, Jocalyn; Glasziou, Paul			Public availability of trial protocols	LANCET			English	Editorial Material									[Lucey, Morgan] Princeton Univ, Princeton, NJ 08544 USA; [Clark, Jocalyn] The Lancet, London EC2Y 5AS, England; [Glasziou, Paul] Bond Univ, Ctr Res Evidence Based Practice, Robina, Qld, Australia	Princeton University; Bond University	Clark, J (corresponding author), The Lancet, London EC2Y 5AS, England.	jocalyn.clark@lancet.com	Glasziou, Paul/A-7832-2008	Glasziou, Paul/0000-0001-7564-073X; Clark, Jocalyn/0000-0002-8014-3989				[Anonymous], 2010, LANCET, V375, P1225, DOI 10.1016/S0140-6736(10)60523-5; Chan A-W, 2013, BMJ-BRIT MED J, V2013, P346, DOI DOI 10.1136/BMJ.E7586; Chan AW, 2013, ANN INTERN MED, V158, P200, DOI 10.7326/0003-4819-158-3-201302050-00583	3	11	11	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 16	2017	390	10113					E54	E55		10.1016/S0140-6736(17)33255-5	http://dx.doi.org/10.1016/S0140-6736(17)33255-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FQ1FF	29256405				2022-12-28	WOS:000418101000002
J	Kater, L; Thoms, M; Barrio-Garcia, C; Cheng, JD; Ismail, S; Ahmed, YL; Bange, G; Kressler, D; Berninghausen, O; Sinning, I; Hurt, E; Beckmann, R				Kater, Lukas; Thoms, Matthias; Barrio-Garcia, Clara; Cheng, Jingdong; Ismail, Sherif; Ahmed, Yasar Luqman; Bange, Gert; Kressler, Dieter; Berninghausen, Otto; Sinning, Irmgard; Hurt, Ed; Beckmann, Roland			Visualizing the Assembly Pathway of Nucleolar Pre-60S Ribosomes	CELL			English	Article							NUCLEAR-EXPORT FACTOR; BEAM-INDUCED MOTION; SACCHAROMYCES-CEREVISIAE; EUKARYOTIC RIBOSOME; MACROMOLECULAR CRYSTALLOGRAPHY; BIOGENESIS FACTORS; PRE-RIBOSOME; CRYO-EM; SUBUNIT; YEAST	Eukaryotic 60S ribosomal subunits are comprised of three rRNAs and similar to 50 ribosomal proteins. The initial steps of their formation take place in the nucleolus, but, owing to a lack of structural information, this process is poorly understood. Using cryo-EM, we solved structures of early 60S biogenesis intermediates at 3.3 angstrom to 4.5 angstrom resolution, thereby providing insights into their sequential folding and assembly pathway. Besides revealing distinct immature rRNA conformations, we map 25 assembly factors in six different assembly states. Notably, the Nsa1-Rrp1-Rpf1-Mak16 module stabilizes the solvent side of the 60S subunit, and the Erb1-Ytm1-Nop7 complex organizes and connects through Erb1's meandering N-terminal extension, eight assembly factors, three ribosomal proteins, and three 25S rRNA domains. Our structural snapshots reveal the order of integration and compaction of the six major 60S domains within early nucleolar 60S particles developing step-wise from the solvent side around the exit tunnel to the central protuberance.	[Kater, Lukas; Barrio-Garcia, Clara; Cheng, Jingdong; Berninghausen, Otto; Beckmann, Roland] Univ Munich, Gene Ctr Munich, Dept Biochem, Feodor Lynen Str 25, D-81377 Munich, Germany; [Kater, Lukas; Barrio-Garcia, Clara; Cheng, Jingdong; Berninghausen, Otto; Beckmann, Roland] Univ Munich, Ctr Integrated Prot Sci Munich, Dept Biochem, Feodor Lynen Str 25, D-81377 Munich, Germany; [Thoms, Matthias; Ismail, Sherif; Ahmed, Yasar Luqman; Bange, Gert; Kressler, Dieter; Sinning, Irmgard; Hurt, Ed] Heidelberg Univ, Biochem Zentrum, D-69120 Heidelberg, Germany; [Bange, Gert] LOEWE Ctr Synthet Microbiol SYNMIKRO, D-35043 Marburg, Germany; [Bange, Gert] Philipps Univ Marburg, Dept Chem, Hans Meerwein Str, D-35043 Marburg, Germany; [Kressler, Dieter] Univ Fribourg, Dept Biol, Unit Biochem, CH-1700 Fribourg, Switzerland	University of Munich; University of Munich; Ruprecht Karls University Heidelberg; Philipps University Marburg; University of Fribourg	Beckmann, R (corresponding author), Univ Munich, Gene Ctr Munich, Dept Biochem, Feodor Lynen Str 25, D-81377 Munich, Germany.; Beckmann, R (corresponding author), Univ Munich, Ctr Integrated Prot Sci Munich, Dept Biochem, Feodor Lynen Str 25, D-81377 Munich, Germany.	beckmann@lmb.uni-muenchen.de	Bange, Gert/AAB-3734-2021; Kressler, Dieter/C-2218-2012; Ed Hurt, Dr./AAE-8874-2019	Ed Hurt, Dr./0000-0002-4535-8255; Thoms, Matthias/0000-0001-8084-6097; Bange, Gert/0000-0002-7826-0932; Ismail, Sherif/0000-0002-6063-1475; Kressler, Dieter/0000-0003-4855-3563	German Research Council (QBM) [GRK 1721, FOR 1805, SFB646, HU363/10-5, HU363/12-1, GRK1188]; German Research Council (Leibniz Programme) [SFB638]; German Research Council (Cluster of Excellence/CellNetworks Ectop1); CellNetworks Ectop1; Leibnitz Programme; Center for Integrated Protein Science (CiPS-M); European Research Council (advanced grant CRYOTRANSLATION); DFG fellowship through Graduate School of Quantitative Biosciences Munich (QBM)	German Research Council (QBM); German Research Council (Leibniz Programme); German Research Council (Cluster of Excellence/CellNetworks Ectop1); CellNetworks Ectop1; Leibnitz Programme; Center for Integrated Protein Science (CiPS-M); European Research Council (advanced grant CRYOTRANSLATION); DFG fellowship through Graduate School of Quantitative Biosciences Munich (QBM)	We thank S. Rieder for preparation of Cryo-EM grids; T. Becker for critical input on the manuscript; A. Heuer and the Leibniz Rechenzentrum for support with HPC infrastructure; and J. Kopp and C. Siegmann from the BZH/CellNetworks crystallization platform. This work was supported by grants from the German Research Council (QBM, GRK 1721, FOR 1805, and SFB646 to R.B.; HU363/10-5 and HU363/12-1 to E.H.; SFB638, the Leibniz Programme and the Cluster of Excellence/CellNetworks Ectop1 to I.S.; and GRK1188 to M.T.). This work was also supported by CellNetworks Ectop1 and the LeibnitzProgramme (to I.S.). I.S. and E.H. are investigators of the Cluster of Excellence/CellNetworks. R.B. acknowledges support from the Center for Integrated Protein Science (CiPS-M) and the European Research Council (advanced grant CRYOTRANSLATION). L.K. was supported by a DFG fellowship through the Graduate School of Quantitative Biosciences Munich (QBM).	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Amunts A, 2014, SCIENCE, V343, P1485, DOI 10.1126/science.1249410; Bai XC, 2013, ELIFE, V2, DOI 10.7554/eLife.00461; Barrio-Garcia C, 2016, NAT STRUCT MOL BIOL, V23, P37, DOI 10.1038/nsmb.3132; Bassler J, 2017, PROTEIN SCI, V26, P327, DOI 10.1002/pro.3085; Bassler J, 2010, MOL CELL, V38, P712, DOI 10.1016/j.molcel.2010.05.024; Ben-Shem A, 2011, SCIENCE, V334, P1524, DOI 10.1126/science.1212642; Bradatsch B, 2012, NAT STRUCT MOL BIOL, V19, P1234, DOI 10.1038/nsmb.2438; Brown A, 2015, ACTA CRYSTALLOGR D, V71, P136, DOI 10.1107/S1399004714021683; Chaker-Margot M, 2017, SCIENCE, V355, DOI 10.1126/science.aal1880; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chen W, 2017, NUCLEIC ACIDS RES, V45, P6837, DOI 10.1093/nar/gkx254; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; de Sanctis D, 2012, J SYNCHROTRON RADIAT, V19, P455, DOI 10.1107/S0909049512009715; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Gamalinda M, 2014, GENE DEV, V28, P198, DOI 10.1101/gad.228825.113; Grandi P, 2002, MOL CELL, V10, P105, DOI 10.1016/S1097-2765(02)00579-8; Granneman S, 2011, EMBO J, V30, P4006, DOI 10.1038/emboj.2011.256; Greber BJ, 2012, NAT STRUCT MOL BIOL, V19, P1228, DOI 10.1038/nsmb.2425; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Kabsch W, 2014, ACTA CRYSTALLOGR D, V70, P2204, DOI 10.1107/S1399004714013534; Kappel L, 2012, J CELL BIOL, V199, P771, DOI 10.1083/jcb.201205021; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kimanius D, 2016, ELIFE, V5, DOI 10.7554/eLife.18722; Konikkat S, 2017, NUCLEIC ACIDS RES, V45, P4853, DOI 10.1093/nar/gkw1361; Kornprobst M, 2016, CELL, V166, P380, DOI 10.1016/j.cell.2016.06.014; Kressler D, 1999, NUCLEIC ACIDS RES, V27, P4598, DOI 10.1093/nar/27.23.4598; Kressler D, 2008, J CELL BIOL, V181, P935, DOI 10.1083/jcb.200801181; Lapeyre B, 2004, MOL CELL, V16, P663, DOI 10.1016/j.molcel.2004.10.022; Leidig C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4491; Li XM, 2013, NAT METHODS, V10, P584, DOI 10.1038/nmeth.2472; Lo KY, 2010, MOL CELL, V39, P196, DOI 10.1016/j.molcel.2010.06.018; Lo YH, 2017, STRUCTURE, V25, P762, DOI 10.1016/j.str.2017.03.008; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Ma CY, 2017, NAT STRUCT MOL BIOL, V24, P214, DOI 10.1038/nsmb.3364; Malyutin AG, 2017, EMBO J, V36, P854, DOI 10.15252/embj.201696012; Matsuo Y, 2014, NATURE, V505, P112, DOI 10.1038/nature12731; McCann KL, 2015, GENE DEV, V29, P862, DOI 10.1101/gad.256370.114; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meier A, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004343; Menne TF, 2007, NAT GENET, V39, P486, DOI 10.1038/ng1994; Miles TD, 2005, MOL CELL BIOL, V25, P10419, DOI 10.1128/MCB.25.23.10419-10432.2005; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nissan TA, 2002, EMBO J, V21, P5539, DOI 10.1093/emboj/cdf547; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Pertschy B, 2007, MOL CELL BIOL, V27, P6581, DOI 10.1128/MCB.00668-07; Pestov DG, 2001, NUCLEIC ACIDS RES, V29, P3621, DOI 10.1093/nar/29.17.3621; Ramesh M, 2016, RNA, V22, P1153, DOI 10.1261/rna.056705.116; Sarkar A, 2016, NAT STRUCT MOL BIOL, V23, P1074, DOI 10.1038/nsmb.3312; Scheres SHW, 2014, ELIFE, V3, DOI 10.7554/eLife.03665; Sharma S, 2013, NUCLEIC ACIDS RES, V41, P9062, DOI 10.1093/nar/gkt679; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Sun Q, 2017, ELIFE, V6, DOI 10.7554/eLife.22086; Talkish J, 2012, NUCLEIC ACIDS RES, V40, P8646, DOI 10.1093/nar/gks609; THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9; Thoms M, 2016, NUCLEIC ACIDS RES, V44, P926, DOI 10.1093/nar/gkv1365; Thoms M, 2015, CELL, V162, P1029, DOI 10.1016/j.cell.2015.07.060; Turowski TW, 2015, WIRES RNA, V6, P129, DOI 10.1002/wrna.1263; Ulbrich C, 2009, CELL, V138, P911, DOI 10.1016/j.cell.2009.06.045; Wegrecki Marcin, 2015, Nucleic Acids Res, V43, P11017, DOI 10.1093/nar/gkv1043; Wehner KA, 2002, MOL CELL, V9, P329, DOI 10.1016/S1097-2765(02)00438-0; Weis F, 2015, NAT STRUCT MOL BIOL, V22, P914, DOI 10.1038/nsmb.3112; Winn MD, 2002, ACTA CRYSTALLOGR D, V58, P1929, DOI 10.1107/S0907444902016116; Woolford JL, 2013, GENETICS, V195, P643, DOI 10.1534/genetics.113.153197; Wu S, 2016, NATURE, V534, P133, DOI 10.1038/nature17942; Zhang K, 2016, J STRUCT BIOL, V193, P1, DOI 10.1016/j.jsb.2015.11.003; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193	68	91	92	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 14	2017	171	7					1599	+		10.1016/j.cell.2017.11.039	http://dx.doi.org/10.1016/j.cell.2017.11.039			25	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FQ0KF	29245012	Green Published, hybrid			2022-12-28	WOS:000418044000016
J	Hawkes, N				Hawkes, Nigel			Big tobacco's new year's resolution to quit smoking	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												nigel.hawkes1@btinternet.com						[Anonymous], 2017, PHILIP MORRIS INT SU; CHAPMAN S, 2017, BMJ-BRIT MED J, V358, DOI DOI 10.1136/BMJ.J4443; Gillette F, 2017, BLOOMBERG       0308; Hoggan K., 2018, BBC             0102	4	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 5	2018	360								k79	10.1136/bmj.k79	http://dx.doi.org/10.1136/bmj.k79			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FS3VJ	29305417				2022-12-28	WOS:000419711800004
J	Zhang, Z; Schwanz, D; Narayanan, B; Kotiuga, M; Dura, JA; Cherukara, M; Zhou, H; Freeland, JW; Li, JR; Sutarto, R; He, FZ; Wu, CZ; Zhu, JX; Sun, YF; Ramadoss, K; Nonnenmann, SS; Yu, NF; Comin, R; Rabe, KM; Sankaranarayanan, SKRS; Ramanathan, S				Zhang, Zhen; Schwanz, Derek; Narayanan, Badri; Kotiuga, Michele; Dura, Joseph A.; Cherukara, Mathew; Zhou, Hua; Freeland, John W.; Li, Jiarui; Sutarto, Ronny; He, Feizhou; Wu, Chongzhao; Zhu, Jiaxin; Sun, Yifei; Ramadoss, Koushik; Nonnenmann, Stephen S.; Yu, Nanfang; Comin, Riccardo; Rabe, Karin M.; Sankaranarayanan, Subramanian K. R. S.; Ramanathan, Shriram			Perovskite nickelates as electric-field sensors in salt water	NATURE			English	Article							TEMPERATURE; SHARKS; ORGANS; PHASE; FILMS	Designing materials to function in harsh environments, such as conductive aqueous media, is a problem of broad interest to a range of technologies, including energy, ocean monitoring and biological applications(1-4). The main challenge is to retain the stability and morphology of the material as it interacts dynamically with the surrounding environment. Materials that respond to mild stimuli through collective phase transitions and amplify signals could open up new avenues for sensing. Here we present the discovery of an electric-field-driven, water-mediated reversible phase change in a perovskite-structured nickelate, SmNiO35-7. This prototypical strongly correlated quantum material is stable in salt water, does not corrode, and allows exchange of protons with the surrounding water at ambient temperature, with the concurrent modification in electrical resistance and optical properties being capable of multi-modal readout. Besides operating both as thermistors and pH sensors, devices made of this material can detect sub-volt electric potentials in salt water. We postulate that such devices could be used in oceanic environments for monitoring electrical signals from various maritime vessels and sea creatures.	[Zhang, Zhen; Schwanz, Derek; Sun, Yifei; Ramadoss, Koushik; Ramanathan, Shriram] Purdue Univ, Sch Mat Engn, W Lafayette, IN 47907 USA; [Narayanan, Badri; Cherukara, Mathew; Sankaranarayanan, Subramanian K. R. S.] Argonne Natl Lab, Ctr Nanoscale Mat, Argonne, IL 60439 USA; [Kotiuga, Michele; Rabe, Karin M.] Rutgers State Univ, Dept Phys & Astron, Piscataway, NJ 08854 USA; [Dura, Joseph A.] NIST, NIST Ctr Neutron Res, Gaithersburg, MD 20899 USA; [Zhou, Hua; Freeland, John W.] Argonne Natl Lab, Adv Photon Source, Xray Sci Div, Argonne, IL 60439 USA; [Li, Jiarui; Comin, Riccardo] MIT, Dept Phys, Cambridge, MA 02139 USA; [Sutarto, Ronny; He, Feizhou] Univ Saskatchewan, Canadian Light Source, Saskatoon, SK S7N 2V3, Canada; [Wu, Chongzhao] Columbia Univ, Dept Appl Phys & Appl Math, New York, NY 10027 USA; [Zhu, Jiaxin; Nonnenmann, Stephen S.] Univ Massachusetts, Dept Mech & Ind Engn, Amherst, MA 01003 USA; [Narayanan, Badri] Argonne Natl Lab, Div Mat Sci, Lemont, IL 60439 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; United States Department of Energy (DOE); Argonne National Laboratory; Rutgers State University New Brunswick; National Institute of Standards & Technology (NIST) - USA; United States Department of Energy (DOE); Argonne National Laboratory; Massachusetts Institute of Technology (MIT); University of Saskatchewan; Columbia University; University of Massachusetts System; University of Massachusetts Amherst; United States Department of Energy (DOE); Argonne National Laboratory	Ramanathan, S (corresponding author), Purdue Univ, Sch Mat Engn, W Lafayette, IN 47907 USA.	shriram@purdue.edu	Dura, Joseph A/B-8452-2008; Comin, Riccardo/H-7731-2016; sun, yifei/Q-1171-2018; Yu, Nanfang/AAA-2634-2020; Zhou, Hua/V-1827-2017; He, Feizhou/G-8493-2015; Li, Jiarui/AHA-0911-2022; zhen, zhang/B-8007-2009	Dura, Joseph A/0000-0001-6877-959X; Comin, Riccardo/0000-0002-1069-9973; sun, yifei/0000-0002-2346-8402; Zhou, Hua/0000-0001-9642-8674; He, Feizhou/0000-0002-3125-1406; Li, Jiarui/0000-0003-1692-4833; Nonnenmann, Stephen/0000-0002-5369-9279; Kotiuga, Michele/0000-0002-2592-7342; Zhang, Zhen/0000-0001-7154-8573; Narayanan, Badri/0000-0001-8147-1047; Ramadoss, Koushik/0000-0002-3974-7561	Army Research Office [W911NF-16-1-0289, W911NF-16-1-0042]; National Science Foundation [DMR-1609898, DMR-1610215]; Defense Advanced Research Projects Agency [D15AP00111]; Office of Naval Research [N00014-16-1-2442, N00014-12-1040]; Air Force Office of Scientific Research [FA9550-16-1-0159, FA9550-14-10389]; US Department of Energy (DOE), the Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]; US DOE Office of Science User Facility [DE-AC02-06CH11357]; Office of Science of the US DOE [DE-AC02-06CH11357, DE-AC02-05CH11231]; University of Massachusetts-Amherst; Canada Foundation for Innovation; Natural Sciences and Engineering Research Council of Canada; University of Saskatchewan; Government of Saskatchewan; Western Economic Diversification Canada; National Research Council Canada; Canadian Institutes of Health Research; Direct For Mathematical & Physical Scien [1609898] Funding Source: National Science Foundation	Army Research Office; National Science Foundation(National Science Foundation (NSF)); Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Office of Naval Research(Office of Naval Research); Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); US Department of Energy (DOE), the Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); US DOE Office of Science User Facility(United States Department of Energy (DOE)); Office of Science of the US DOE(United States Department of Energy (DOE)); University of Massachusetts-Amherst; Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); University of Saskatchewan; Government of Saskatchewan; Western Economic Diversification Canada; National Research Council Canada; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	S.R. thanks K. Catania (Vanderbilt University) for discussions on bioelectric fields in marine organisms and B. Robinson and K. Benoit-Bird of the Monterey Bay Aquarium Research Institute for technical discussions on electroreception in sharks. We acknowledge financial support from the Army Research Office (W911NF-16-1-0289, W911NF-16-1-0042), National Science Foundation (DMR-1609898, DMR-1610215), Defense Advanced Research Projects Agency (grant D15AP00111), Office of Naval Research (grants N00014-16-1-2442 and N00014-12-1040) and Air Force Office of Scientific Research (grants FA9550-16-1-0159 and FA9550-14-10389). Use of the Center for Nanoscale Materials, an Office of Science user facility, was supported by the US Department of Energy (DOE), the Office of Science, Office of Basic Energy Sciences under contract number DE-AC02-06CH11357. This research used resources of the Advanced Photon Source, a US DOE Office of Science User Facility operated by Argonne National Laboratory under contract number DE-AC02-06CH11357. This research used resources of the National Energy Research Scientific Computing Center, which is supported by the Office of Science of the US DOE under contract number DE-AC02-05CH11231. An award of computer time was provided by the Innovative and Novel Computational Impact on Theory and Experiment (INCITE) programme. This research used resources of the Argonne Leadership Computing Facility at Argonne National Laboratory, which is supported by the Office of Science of the US DOE under contract DE-AC02-06CH11357. S.S.N. acknowledges support from the University of Massachusetts-Amherst through start-up funding. Part of the research described in this paper was performed at the Canadian Light Source, which is supported by the Canada Foundation for Innovation, Natural Sciences and Engineering Research Council of Canada, the University of Saskatchewan, the Government of Saskatchewan, Western Economic Diversification Canada, the National Research Council Canada and the Canadian Institutes of Health Research.	Allen M. P., 1989, COMPUTER SIMULATION, DOI DOI 10.1093/OSO/9780198803195.001.0001; Bard A.J., 1980, ELECTROCHEMICAL METH, V2; Baron V. D., 2009, J ICHTHYOL, V49, P1065, DOI DOI 10.1134/S0032945209110058; Bedore CN, 2013, PHYSIOL BIOCHEM ZOOL, V86, P298, DOI 10.1086/669973; Bellono NW, 2017, NATURE, V543, P391, DOI 10.1038/nature21401; BENNETT MV, 1961, J GEN PHYSIOL, V44, P757, DOI 10.1085/jgp.44.4.757; BLOCHL PE, 1994, PHYS REV B, V49, P16223, DOI 10.1103/PhysRevB.49.16223; BLOCHL PE, 1994, PHYS REV B, V50, P17953, DOI 10.1103/PhysRevB.50.17953; Brown BR, 2003, NATURE, V421, P495, DOI 10.1038/421495a; Catalan G, 2008, PHASE TRANSIT, V81, P729, DOI 10.1080/01411590801992463; Chen YW, 2011, NAT MATER, V10, P539, DOI [10.1038/nmat3047, 10.1038/NMAT3047]; DeCaluwe SC, 2014, SOFT MATTER, V10, P5763, DOI 10.1039/c4sm00850b; Dura JA, 2006, REV SCI INSTRUM, V77, DOI 10.1063/1.2219744; Fields RD, 2007, SCI AM, V297, P74, DOI 10.1038/scientificamerican0807-74; Gibaud A., 2008, XRAY NEUTRON REFLECT, V770; Henkelman G, 2000, J CHEM PHYS, V113, P9901, DOI 10.1063/1.1329672; Hirota M., 2000, Proceedings of the 2000 International Symposium on Underwater Technology (Cat. No.00EX418), P224, DOI 10.1109/UT.2000.852547; Josberger EE, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600112; KALMIJN AJ, 1971, J EXP BIOL, V55, P371; KALMIJN AJ, 1982, SCIENCE, V218, P916, DOI 10.1126/science.7134985; Kim JG, 2000, J MATER SCI LETT, V19, P477, DOI 10.1023/A:1006789217304; Kresse G, 1996, PHYS REV B, V54, P11169, DOI 10.1103/PhysRevB.54.11169; Kresse G, 1999, PHYS REV B, V59, P1758, DOI 10.1103/PhysRevB.59.1758; Kreuer KD, 2003, ANNU REV MATER RES, V33, P333, DOI 10.1146/annurev.matsci.33.022802.091825; Kritzer P, 2004, J SUPERCRIT FLUID, V29, P1, DOI 10.1016/S0896-8446(03)00031-7; Li ZY, 2016, ADV MATER, V28, P9117, DOI 10.1002/adma.201601204; LIECHTENSTEIN AI, 1995, PHYS REV B, V52, pR5467, DOI 10.1103/PhysRevB.52.R5467; Mamayev O. I., 1975, TEMPERATURE SALINITY, V11, P305; MATHEWSON R, 1958, BIOL BULL, V115, P126, DOI 10.2307/1539099; MEDARDE M, 1992, PHYS REV B, V46, P14975, DOI 10.1103/PhysRevB.46.14975; Medarde ML, 1997, J PHYS-CONDENS MAT, V9, P1679, DOI 10.1088/0953-8984/9/8/003; Middey S, 2016, ANNU REV MATER RES, V46, P305, DOI 10.1146/annurev-matsci-070115-032057; MIZOKAWA T, 1995, PHYS REV B, V52, P13865, DOI 10.1103/PhysRevB.52.13865; Pelloquin D, 2005, SOLID STATE SCI, V7, P853, DOI 10.1016/j.solidstatesciences.2005.01.023; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; Perez-Cacho J, 1999, J PHYS-CONDENS MAT, V11, P405, DOI 10.1088/0953-8984/11/2/007; Persson K., 2016, MAT DATA H4CSN2 SG62; Robison BH, 2004, J EXP MAR BIOL ECOL, V300, P253, DOI 10.1016/j.jembe.2004.01.012; Shi J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3676; Uhlig H.H, 2011, UHLIGS CORROSION HDB, V3rd; Wootton JT, 2008, P NATL ACAD SCI USA, V105, P18848, DOI 10.1073/pnas.0810079105; Yuh J, 2000, AUTON ROBOT, V8, P7, DOI 10.1023/A:1008984701078; Zhou Y, 2016, NATURE, V534, P231, DOI 10.1038/nature17653	43	100	104	16	396	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 4	2018	553	7686					68	+		10.1038/nature25008	http://dx.doi.org/10.1038/nature25008			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS4NI	29258293	Green Submitted			2022-12-28	WOS:000419769300031
J	Lenarcic, T; Albert, I; Bohm, H; Hodnik, V; Pirc, K; Zavec, AB; Podobnik, M; Pahovnik, D; Zagar, E; Pruitt, R; Greimel, P; Yamaji-Hasegawa, A; Kobayashi, T; Zienkiewicz, A; Gomann, J; Mortimer, JC; Fang, L; Mamode-Cassim, A; Deleu, M; Lins, L; Oecking, C; Feussner, I; Mongrand, S; Anderluh, G; Nurnberger, T				Lenarcic, Tea; Albert, Isabell; Boehm, Hannah; Hodnik, Vesna; Pirc, Katja; Zavec, Apolonija B.; Podobnik, Marjetka; Pahovnik, David; Zagar, Ema; Pruitt, Rory; Greimel, Peter; Yamaji-Hasegawa, Akiko; Kobayashi, Toshihide; Zienkiewicz, Agnieszka; Goemann, Jasmin; Mortimer, Jenny C.; Fang, Lin; Mamode-Cassim, Adiilah; Deleu, Magali; Lins, Laurence; Oecking, Claudia; Feussner, Ivo; Mongrand, Sebastien; Anderluh, Gregor; Nuernberger, Thorsten			Eudicot plant-specific sphingolipids determine host selectivity of microbial NLP cytolysins	SCIENCE			English	Article							IMMUNE-RESPONSES; PROTEINS	Necrosis and ethylene-inducing peptide 1-like (NLP) proteins constitute a superfamily of proteins produced by plant pathogenic bacteria, fungi, and oomycetes. Many NLPs are cytotoxins that facilitate microbial infection of eudicot, but not of monocot plants. Here, we report glycosylinositol phosphorylceramide (GIPC) sphingolipids as NLP toxin receptors. Plant mutants with altered GIPC composition were more resistant to NLP toxins. Binding studies and x-ray crystallography showed that NLPs form complexes with terminal monomeric hexose moieties of GIPCs that result in conformational changes within the toxin. Insensitivity to NLP cytolysins of monocot plants may be explained by the length of the GIPC head group and the architecture of the NLP sugar-binding site. We unveil early steps in NLP cytolysin action that determine plant clade-specific toxin selectivity.	[Lenarcic, Tea; Hodnik, Vesna; Pirc, Katja; Zavec, Apolonija B.; Podobnik, Marjetka; Anderluh, Gregor] Natl Inst Chem, Dept Mol Biol & Nanobictechnol, Hajdrihova 19, Ljubljana TEA LENAREI, Slovenia; [Albert, Isabell; Boehm, Hannah; Pruitt, Rory; Oecking, Claudia; Nuernberger, Thorsten] Eberhard Karls Univ Tubingen, Ctr Plant Mol Biol, Morgenstelle 32, D-72076 Tubingen, Germany; [Hodnik, Vesna] Univ Ljubljana, Dept Biol, Bictech Fac, Jamnikarjeva 101, Ljubljana 1000, Slovenia; [Pahovnik, David; Zagar, Ema] Natl Inst Chem, Dept Polymer Chem & Technol, Hajdrihova 19, Ljubljana 1000, Slovenia; [Greimel, Peter; Yamaji-Hasegawa, Akiko; Kobayashi, Toshihide] RIKEN, Lipid Biol Lab, Wako, Saitama 3510198, Japan; [Greimel, Peter] Riken Inst Phys & Chem Res, Lab Cell Funct Dynam, Brain Sci Inst, Wako, Saitama 3510198, Japan; [Yamaji-Hasegawa, Akiko] Riken Inst Phys & Chem Res, Mol Membrane Neurosci, Brain Sci Inst, Wako, Saitama 3510198, Japan; [Kobayashi, Toshihide] Univ Strasbourg, CNRS, UMR 7213, F-67401 Illkirch Graffenstaden, France; [Zienkiewicz, Agnieszka; Goemann, Jasmin; Feussner, Ivo] Univ Gottingen, Dept Plant Biochem, Albrecht von Haller Inst Plant Sci, Gottingen, Germany; [Zienkiewicz, Agnieszka; Goemann, Jasmin; Feussner, Ivo] Univ Gottingen, Gottingen Ctr Mol Biosci, Gottingen, Germany; [Mortimer, Jenny C.; Fang, Lin] Joint Bioenergy Inst, Emeryville, CA 94608 USA; [Mortimer, Jenny C.; Fang, Lin] Lawrence Berkeley Natl Lab, Biosci Div, Berkeley, CA 94720 USA; [Mamode-Cassim, Adiilah; Mongrand, Sebastien] Univ Bordeaux, CNRS, UMR 5200, Lab Biogenese Membranaire, 71 Ave Edouard Bourlaux, F-33883 Villenave Dornon, France; [Deleu, Magali; Lins, Laurence] Univ Liege, Lab Mol Biophys Interfaces, Gembloux, Belgium	Eberhard Karls University of Tubingen; University of Ljubljana; National Institute of Chemistry - Slovenia; RIKEN; RIKEN; RIKEN; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Gottingen; University of Gottingen; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; University of Liege	Anderluh, G (corresponding author), Natl Inst Chem, Dept Mol Biol & Nanobictechnol, Hajdrihova 19, Ljubljana TEA LENAREI, Slovenia.; Nurnberger, T (corresponding author), Eberhard Karls Univ Tubingen, Ctr Plant Mol Biol, Morgenstelle 32, D-72076 Tubingen, Germany.	gregor.anderluh@ki.si; nuernberger@uni-tuebingen.de	Albert, Isabell/GQB-3655-2022; KOBAYASHI, TOSHIHIDE/S-8313-2019; Mortimer, Jenny C/AAY-6648-2021; Mortimer, Jenny/A-8043-2008; Pahovnik, David/K-7029-2019; Anderluh, Gregor/C-6905-2014; LINS, LAURENCE/Y-1661-2019; Zienkiewicz, Agnieszka/AAA-1496-2020; Feussner, Ivo/H-9320-2013; ZIENKIEWICZ, AGNIESZKA/I-2757-2015	Albert, Isabell/0000-0003-2223-496X; KOBAYASHI, TOSHIHIDE/0000-0002-4811-7270; Mortimer, Jenny C/0000-0001-6624-636X; Mortimer, Jenny/0000-0001-6624-636X; Anderluh, Gregor/0000-0002-9916-8465; LINS, LAURENCE/0000-0001-7772-6748; Feussner, Ivo/0000-0002-9888-7003; Greimel, Peter/0000-0002-4931-6183; Mamode Cassim, Adiilah/0000-0002-7950-0504; ZIENKIEWICZ, AGNIESZKA/0000-0003-0799-0521; Podobnik, Marjetka/0000-0001-6786-9737; Lenarcic, Tea/0000-0003-2590-0323; Deleu, Magali/0000-0001-8255-2965	Deutsche Forschungsgemeinschaft [Nu70/1-9, SFB1101, INST 186/1167-1]; Slovenian Research Agency [P1-0391, J1-7515]; Seventh Framework Program BioStinictX [283570]; Japan Ministry for Science and Technology [JP16K08259]; L'Agence Nationale de la Recherche [11-INBS-0010]; U.S. Department of Energy Joint BioEnergy Institute [DE-AC02-05CH11231]; Fonds de la Recherche Scientifique [T.1003.14, IAN P7/44 iPros]; Belgian Program on Interuniversity Attraction Poles [IAPP7/44iPros]; University of Liege (HELD); RISEN Integrated Lipidology Program; RISEN Center for Sustainable Resource Science Wako; Platform Metabolome-Fluxonse-Lipidorne Bordeaux; Gottingen Metabolornics and Lipidomics Platform	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Slovenian Research Agency(Slovenian Research Agency - Slovenia); Seventh Framework Program BioStinictX; Japan Ministry for Science and Technology; L'Agence Nationale de la Recherche(French National Research Agency (ANR)); U.S. Department of Energy Joint BioEnergy Institute(United States Department of Energy (DOE)); Fonds de la Recherche Scientifique(Fonds de la Recherche Scientifique - FNRS); Belgian Program on Interuniversity Attraction Poles(Belgian Federal Science Policy Office); University of Liege (HELD); RISEN Integrated Lipidology Program; RISEN Center for Sustainable Resource Science Wako; Platform Metabolome-Fluxonse-Lipidorne Bordeaux; Gottingen Metabolornics and Lipidomics Platform	Work was supported by Deutsche Forschungsgemeinschaft (Nu70/1-9, SFB1101, INST 186/1167-1), Slovenian Research Agency (P1-0391, J1-7515), Seventh Framework Program BioStinictX No 283570, Japan Ministry for Science and Technology JP16K08259, L'Agence Nationale de la Recherche (11-INBS-0010), U.S. Department of Energy Joint BioEnergy Institute (DE-AC02-05CH11231), Fonds de la Recherche Scientifique (Projet de Recherche grant T.1003.14, IAN P7/44 iPros), Belgian Program on Interuniversity Attraction Poles (IAPP7/44iPros), University of Liege (HELD), RISEN Integrated Lipidology Program, RISEN Center for Sustainable Resource Science Wako, Platform Metabolome-Fluxonse-Lipidorne Bordeaux and Gottingen Metabolornics and Lipidomics Platform. We thank S. P. Novak, C. Thurow, N. Li, B. Thornrna, G. Felix, M. Gijzen, A. Gust, J. Parker, T. Romeis, synchrotron Elletra, and the Graduate School of Biomedicine, University of Ljubljana (T.L) for support. This work is dedicated to late Prof. Harms Ulrich Seitz. All authors agreed on the manuscript. Structures are deposited (PDB: 5NNW, 5NO9). Supplementary materials contain additional data..	Anderluh G, 2008, TRENDS BIOCHEM SCI, V33, P482, DOI 10.1016/j.tibs.2008.07.004; Bailey Bryan A., 1995, Phytopathology, V85, P1250, DOI 10.1094/Phyto-85-1250; Bakrac B, 2008, J BIOL CHEM, V283, P18665, DOI 10.1074/jbc.M708747200; Bure C, 2014, ANAL BIOANAL CHEM, V406, P995, DOI 10.1007/s00216-013-7130-8; Cacas JL, 2016, PLANT PHYSIOL, V170, P367, DOI 10.1104/pp.15.00564; Cacas JL, 2013, PHYTOCHEMISTRY, V96, P191, DOI 10.1016/j.phytochem.2013.08.002; Fang L, 2016, PLANT CELL, V28, P2991, DOI 10.1105/tpc.16.00186; Gijzen M, 2006, PHYTOCHEMISTRY, V67, P1800, DOI 10.1016/j.phytochem.2005.12.008; Griffitts JS, 2005, SCIENCE, V307, P922, DOI 10.1126/science.1104444; Konig S, 2012, NEW PHYTOL, V196, P1086, DOI 10.1111/j.1469-8137.2012.04351.x; Markham JE, 2013, CURR OPIN PLANT BIOL, V16, P350, DOI 10.1016/j.pbi.2013.02.009; Mortimer JC, 2013, PLANT CELL, V25, P1881, DOI 10.1105/tpc.113.111500; Nagano M, 2016, PLANT CELL, V28, P1966, DOI 10.1105/tpc.16.00201; Oome S, 2014, MOL PLANT MICROBE IN, V27, P1081, DOI 10.1094/MPMI-04-14-0118-R; Ottmann C, 2009, P NATL ACAD SCI USA, V106, P10359, DOI 10.1073/pnas.0902362106; Pina DG, 2005, TOXICON, V45, P389, DOI 10.1016/j.toxicon.2004.12.014; Qutob D, 2006, PLANT CELL, V18, P3721, DOI 10.1105/tpc.106.044180; Rojko N, 2016, BBA-BIOMEMBRANES, V1858, P446, DOI 10.1016/j.bbamem.2015.09.007; Ternes P, 2011, NEW PHYTOL, V192, P841, DOI 10.1111/j.1469-8137.2011.03852.x; VANDAMME EJM, 1991, EUR J BIOCHEM, V202, P23, DOI 10.1111/j.1432-1033.1991.tb16339.x	20	104	105	4	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 15	2017	358	6369					1431	+		10.1126/science.aan6874	http://dx.doi.org/10.1126/science.aan6874			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP8TH	29242345				2022-12-28	WOS:000417918500041
J	Zhan, XC; Yan, CY; Zhang, XF; Lei, JL; Shi, YG				Zhan, Xiechao; Yan, Chuangye; Zhang, Xiaofeng; Lei, Jianlin; Shi, Yigong			Structure of a human catalytic step I spliceosome	SCIENCE			English	Article							PRE-MESSENGER-RNA; CRYO-EM STRUCTURE; ACTIVATED SPLICEOSOME; SACCHAROMYCES-CEREVISIAE; ANGSTROM RESOLUTION; CYCLOPHILINS; MECHANISM; INSIGHTS; COMPLEX; PRP16	Splicing by the spliceosome involves branching and exon ligation. The branching reaction leads to the formation of the catalytic step I spliceosome (C complex). Here we report the cryo-electron microscopy structure of the human C complex at an average resolution of 4.1 angstroms. Compared with the Saccharomyces cerevisiae C complex, the human complex contains 11 additional proteins. The step I splicing factors CCDC49 and CCDC94 (Cwc25 and Yju2 in S. cerevisiae, respectively) closely interact with the DEAH-family adenosine triphosphatase/helicase Prp16 and bridge the gap between Prp16 and the active-site RNA elements. These features, together with structural comparison of the human C and C* complexes, provide mechanistic insights into ribonucleoprotein remodeling and allow the proposition of a working mechanism for the C-to-C* transition.	[Zhan, Xiechao; Yan, Chuangye; Zhang, Xiaofeng; Lei, Jianlin; Shi, Yigong] Tsinghua Univ, Beijing Adv Innovat Ctr Struct Biol, Sch Life Sci, Tsinghua Peking Joint Ctr Life Sci, Beijing 100084, Peoples R China; [Lei, Jianlin] Tsinghua Univ, Sch Life Sci, Technol Ctr Prot Sci, Minist Educ,Key Lab Prot Sci, Beijing 100084, Peoples R China; [Shi, Yigong] Westlake Univ, Inst Biol, Westlake Inst Adv Study, Shilongshan Rd 18, Hangzhou 310064, Zhejiang, Peoples R China	Tsinghua University; Tsinghua University; Westlake University	Yan, CY; Shi, YG (corresponding author), Tsinghua Univ, Beijing Adv Innovat Ctr Struct Biol, Sch Life Sci, Tsinghua Peking Joint Ctr Life Sci, Beijing 100084, Peoples R China.; Shi, YG (corresponding author), Westlake Univ, Inst Biol, Westlake Inst Adv Study, Shilongshan Rd 18, Hangzhou 310064, Zhejiang, Peoples R China.	yancy05@mails.tsinghua.edu.cn; shi-lab@tsinghua.edu.cn	Yan, Chuangye/AAJ-5832-2021; Zhan, Xiechao/GLQ-9287-2022	Shi, Yigong/0000-0003-2030-168X; Zhan, Xiechao/0000-0001-5198-6461; Yan, Chuangye/0000-0001-9338-8048; Zhang, Xiaofeng/0000-0002-9658-5917; Zhang, Xiaofeng/0000-0002-8690-8823	National Natural Science Foundation of China [31621092, 31430020]; Ministry of Science and Technology [2016YFA0501100]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea)	We thank L. Zu for synthesizing the compound BN82685, the Tsinghua University Branch of the China National Center for Protein Sciences (Beijing) for the cryo-EM facility, and the Bio Computing Platform for computational support. This work was supported by funds from the National Natural Science Foundation of China (31621092 and 31430020) and the Ministry of Science and Technology (2016YFA0501100 to J.L.). The atomic coordinates have been deposited in the Protein Data Bank with the accession code 5YZG, and the EM maps have been deposited in the Electron Microscopy Data Bank with the accession code EMD-6864.	Adams BM, 2015, BIOCHEM J, V469, P223, DOI 10.1042/BJ20150396; Bai R, 2017, CELL, V171, P1589, DOI 10.1016/j.cell.2017.10.038; Berg MG, 2012, MOL CELL BIOL, V32, P1271, DOI 10.1128/MCB.05788-11; Bertram K, 2017, CELL, V170, P701, DOI 10.1016/j.cell.2017.07.011; Bertram K, 2017, NATURE, V542, P318, DOI 10.1038/nature21079; CHENG SC, 1994, NUCLEIC ACIDS RES, V22, P1548, DOI 10.1093/nar/22.9.1548; Chiu YF, 2009, MOL CELL BIOL, V29, P5671, DOI 10.1128/MCB.00773-09; Davis TL, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000439; DeLano W.L, PYMOL MOL GRAPHICS S; Fica SM, 2017, NATURE, V542, P377, DOI 10.1038/nature21078; Galej WP, 2016, NATURE, V537, P197, DOI 10.1038/nature19316; Hang J, 2015, SCIENCE, V349, P1191, DOI 10.1126/science.aac8159; HARRISON RK, 1990, BIOCHEMISTRY-US, V29, P3813, DOI 10.1021/bi00468a001; Horowitz DS, 2002, EMBO J, V21, P470, DOI 10.1093/emboj/21.3.470; Keating KS, 2010, RNA, V16, P1, DOI 10.1261/rna.1791310; Liu SH, 2017, SCIENCE, V358, P1278, DOI 10.1126/science.aar3462; Liu YC, 2007, MOL CELL BIOL, V27, P5403, DOI 10.1128/MCB.00346-07; Ohrt T, 2013, RNA, V19, P902, DOI 10.1261/rna.039024.113; Plaschka C, 2017, NATURE, V546, P617, DOI 10.1038/nature22799; Rasche N, 2012, EMBO J, V31, P1591, DOI 10.1038/emboj.2011.502; Rauhut R, 2016, SCIENCE, V353, P1399, DOI 10.1126/science.aag1906; SCHWER B, 1992, EMBO J, V11, P5033, DOI 10.1002/j.1460-2075.1992.tb05610.x; Semlow DR, 2016, CELL, V164, P985, DOI 10.1016/j.cell.2016.01.025; Shi YG, 2017, NAT REV MOL CELL BIO, V18, P655, DOI 10.1038/nrm.2017.86; Stegmann CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010013; STEITZ TA, 1993, P NATL ACAD SCI USA, V90, P6498, DOI 10.1073/pnas.90.14.6498; Tauchert MJ, 2017, ELIFE, V6, DOI 10.7554/eLife.21510; Nguyen THD, 2013, STRUCTURE, V21, P910, DOI 10.1016/j.str.2013.04.017; Tseng CK, 2017, RNA, V23, P546, DOI 10.1261/rna.059204.116; Tseng CK, 2011, RNA, V17, P145, DOI 10.1261/rna.2459611; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; Wan RX, 2017, CELL, V171, P120, DOI 10.1016/j.cell.2017.08.029; Wan RX, 2016, SCIENCE, V353, P895, DOI 10.1126/science.aag2235; Wang P, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-7-226; Wilkinson ME, 2017, SCIENCE, V358, P1283, DOI 10.1126/science.aar3729; Xu C, 2006, J BIOL CHEM, V281, P15900, DOI 10.1074/jbc.M511155200; Yan CY, 2017, SCIENCE, V355, P149, DOI 10.1126/science.aak9979; Yan CY, 2016, SCIENCE, V353, P904, DOI 10.1126/science.aag0291; Yan CY, 2015, SCIENCE, V349, P1182, DOI 10.1126/science.aac7629; Zhang XF, 2017, CELL, V169, P918, DOI 10.1016/j.cell.2017.04.033	40	76	77	8	138	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 2	2018	359	6375					537	544		10.1126/science.aar6401	http://dx.doi.org/10.1126/science.aar6401			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU4AS	29301961				2022-12-28	WOS:000423795800034
J	Mortensen, MB; Nordestgaard, BG				Mortensen, Martin Bodtker; Nordestgaard, Borge Gronne			Comparison of Five Major Guidelines for Statin Use in Primary Prevention in a Contemporary General Population	ANNALS OF INTERNAL MEDICINE			English	Article							CARDIOVASCULAR SOCIETY GUIDELINES; 2013 ACC/AHA GUIDELINE; LDL CHOLESTEROL; TASK-FORCE; RISK; DISEASE; THERAPY; DYSLIPIDEMIA; BRITISH; EUROPE	Background: Five major organizations recently published guidelines for using statins to prevent atherosclerotic cardiovascular disease (ASCVD): in 2013, the American College of Cardiology/American Heart Association (ACC/AHA); in 2014, the United Kingdom's National Institute for Health and Care Excellence (NICE); and in 2016, the Canadian Cardiovascular Society (CCS), the U.S. Preventive Services Task Force (USPSTF), and the European Society of Cardiology/European Atherosclerosis Society (ESC/EAS). Objective: To compare the utility of these guidelines for primary prevention of ASCVD. Design: Observational study of actual ASCVD events during 10 years, followed by a modeling study to estimate the effectiveness of different guidelines. Setting: The Copenhagen General Population Study. Participants: 45 750 Danish persons aged 40 to 75 years who did not use statins and did not have ASCVD at baseline. Measurements: The number of participants eligible to use statins according to each guideline and the estimated number of ASCVD events that statins could have prevented. Results: The percentage of participants eligible for statins was 44% by the CCS guideline, 42% by ACC/AHA, 40% by NICE, 31% by USPSTF, and 15% by ESC/EAS. The estimated percentage of ASCVD events that could have been prevented by using statins for 10 years was 34% for CCS, 34% for ACC/AHA, 32% for NICE, 27% for USPSTF, and 13% for ESC/EAS. Limitation: This study was limited to primary prevention in white Europeans. Conclusion: Guidelines recommending that more persons use statins for primary prevention of ASCVD should prevent more events than guidelines recommending use by fewer persons.	[Mortensen, Martin Bodtker] Aarhus Univ Hosp, Dept Cardiol, Palle Juul Jensens Blvd 99, DK-8200 Aarhus N, Denmark; [Nordestgaard, Borge Gronne] Copenhagen Univ Hosp, Herlev & Gentofte Hosp, Dept Clin Biochem, Herlev Ringvej 75, DK-2730 Herlev, Denmark	Aarhus University; University of Copenhagen	Nordestgaard, BG (corresponding author), Copenhagen Univ Hosp, Herlev & Gentofte Hosp, Dept Clin Biochem, Herlev Ringvej 75, DK-2730 Herlev, Denmark.	Martin.bodtker.mortensen@clin.au.dk; boerge.nordestgaard@regionh.dk	Nordestgaard, Borge Gronne/ABF-1310-2020	Mortensen, Martin Bodtker/0000-0003-2693-4154; Nordestgaard, Borge/0000-0002-1954-7220	Copenhagen University Hospital; Herlev and Gentofte Hospital; Aarhus University; Copenhagen County Foundation	Copenhagen University Hospital; Herlev and Gentofte Hospital; Aarhus University; Copenhagen County Foundation	By Herlev and Gentofte Hospital, Copenhagen University Hospital, Aarhus University, and the Copenhagen County Foundation.	Anderson TJ, 2016, CAN J CARDIOL, V32, P1263, DOI 10.1016/j.cjca.2016.07.510; Anderson TJ, 2013, CAN J CARDIOL, V29, P151, DOI 10.1016/j.cjca.2012.11.032; Bibbins-Domingo K, 2016, JAMA-J AM MED ASSOC, V316, P1997, DOI 10.1001/jama.2016.15450; Brondum-Jacobsen P, 2013, ANN NEUROL, V73, P38, DOI 10.1002/ana.23738; Cannon CP, 2015, NEW ENGL J MED, V372, P2387, DOI 10.1056/NEJMoa1410489; Conroy RM, 2003, EUR HEART J, V24, P987, DOI 10.1016/S0195-668X(03)00114-3; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; Deanfield J, 2014, HEART, V100, P1, DOI 10.1136/heartjnl-2014-305693; Goff DC, 2014, J AM COLL CARDIOL, V63, P2935, DOI [10.1016/j.jacc.2013.11.005, 10.1161/01.cir.0000437741.48606.98]; Greenland P, 2016, JAMA-J AM MED ASSOC, V316, P1977, DOI 10.1001/jama.2016.15087; Greenland P, 2014, HEART, V100, P678, DOI 10.1136/heartjnl-2014-305651; Hippisley-Cox J, 2008, BMJ-BRIT MED J, V336, P1475, DOI 10.1136/bmj.39609.449676.25; Jorgensen AB, 2014, NEW ENGL J MED, V371, P32, DOI 10.1056/NEJMoa1308027; Kavousi M, 2014, JAMA-J AM MED ASSOC, V311, P1416, DOI 10.1001/jama.2014.2632; Law MR, 2003, BRIT MED J, V326, P1423, DOI 10.1136/bmj.326.7404.1423; Lee JC, 2016, JAMA CARDIOL, V1, P700, DOI 10.1001/jamacardio.2016.1585; Mancini GBJ, 2014, CAN J CARDIOL, V30, P661, DOI 10.1016/j.cjca.2014.04.001; Mihaylova B, 2012, LANCET, V380, P581, DOI 10.1016/S0140-6736(12)60367-5; Mortensen MB, 2015, J AM COLL CARDIOL, V66, P2699, DOI 10.1016/j.jacc.2015.09.089; Mortensen MB, 2015, EUR HEART J, V36, P2446, DOI 10.1093/eurheartj/ehv251; Mortensen MB, 2017, EUR HEART J, V38, P2259, DOI 10.1093/eurheartj/ehw568; Mortensen MB, 2017, EUR HEART J, V38, P586, DOI 10.1093/eurheartj/ehw426; National Clinical Guideline Center, 2014, LIP MOD CARD RISK AS; Pencina MJ, 2014, NEW ENGL J MED, V370, P1422, DOI 10.1056/NEJMoa1315665; Piepoli MF, 2016, EUR HEART J, V37, P2315, DOI 10.1093/eurheartj/ehw106; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Ridker PM, 2016, EUR HEART J, V37, P1373, DOI 10.1093/eurheartj/ehw046; Robinson JG, 2015, EUR HEART J, V36, P2110, DOI 10.1093/eurheartj/ehv182; Sabatine MS, 2017, NEW ENGL J MED, V376, P1713, DOI [10.1056/NEJMoa1615664, 10.4997/JRCPE.2017.212]; Soran H, 2015, EUR HEART J, V36, P2975, DOI 10.1093/eurheartj/ehv340; Soran H, 2014, CURR OPIN LIPIDOL, V25, P239, DOI 10.1097/MOL.0000000000000097; Stone NJ, 2014, J AM COLL CARDIOL, V63, P2889, DOI 10.1016/j.jacc.2013.11.002	32	50	52	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 16	2018	168	2					85	+		10.7326/M17-0681	http://dx.doi.org/10.7326/M17-0681			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FU8IN	29297004				2022-12-28	WOS:000424096600012
J	Brumbaugh, J; Di Stefano, B; Wang, XY; Borkent, M; Forouzmand, E; Clowers, KJ; Ji, F; Schwarz, BA; Kalocsay, M; Elledge, SJ; Chen, Y; Sadreyev, RI; Gygi, SP; Hu, G; Shi, YS; Hochedlinger, K				Brumbaugh, Justin; Di Stefano, Bruno; Wang, Xiuye; Borkent, Marti; Forouzmand, Elmira; Clowers, Katie J.; Ji, Fei; Schwarz, Benjamin A.; Kalocsay, Marian; Elledge, Stephen J.; Chen, Yue; Sadreyev, Ruslan I.; Gygi, Steven P.; Hu, Guang; Shi, Yongsheng; Hochedlinger, Konrad			Nudt21 Controls Cell Fate by Connecting Alternative Polyadenylation to Chromatin Signaling	CELL			English	Article							CLEAVAGE FACTOR-I; 3' UNTRANSLATED REGIONS; ACUTE MYELOID-LEUKEMIA; EMBRYONIC STEM-CELLS; SELF-RENEWAL; MESSENGER-RNAS; DIFFERENTIAL EXPRESSION; BINDING PROTEINS; MOUSE; PLURIPOTENCY	Cell fate transitions involve rapid gene expression changes and global chromatin remodeling, yet the underlying regulatory pathways remain incompletely understood. Here, we identified the RNA-processing factor Nudt21 as a novel regulator of cell fate change using transcription-factor-induced reprogramming as a screening assay. Suppression of Nudt21 enhanced the generation of induced pluripotent stem cells, facilitated transdifferentiation into trophoblast stem cells, and impaired differentiation of myeloid precursors and embryonic stem cells, suggesting a broader role for Nudt21 in cell fate change. We show that Nudt21 directs differential polyadenylation of over 1,500 transcripts in cells acquiring pluripotency, although only a fraction changed protein levels. Remarkably, these proteins were strongly enriched for chromatin regulators, and their suppression neutralized the effect of Nudt21 during reprogramming. Collectively, our data uncover Nudt21 as a novel post-transcriptional regulator of cell fate and establish a direct, previously unappreciated link between alternative polyadenylation and chromatin signaling.	[Brumbaugh, Justin; Di Stefano, Bruno; Borkent, Marti; Ji, Fei; Schwarz, Benjamin A.; Sadreyev, Ruslan I.; Hochedlinger, Konrad] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Brumbaugh, Justin; Di Stefano, Bruno; Borkent, Marti; Schwarz, Benjamin A.; Hochedlinger, Konrad] Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA; [Brumbaugh, Justin; Di Stefano, Bruno; Borkent, Marti; Schwarz, Benjamin A.; Sadreyev, Ruslan I.; Hochedlinger, Konrad] Massachusetts Gen Hosp, Canc Ctr, Boston, MA 02114 USA; [Brumbaugh, Justin; Di Stefano, Bruno; Borkent, Marti; Schwarz, Benjamin A.; Hochedlinger, Konrad] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Brumbaugh, Justin; Di Stefano, Bruno; Borkent, Marti; Schwarz, Benjamin A.; Hochedlinger, Konrad] Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Wang, Xiuye; Forouzmand, Elmira; Shi, Yongsheng] Univ Calif Irvine, Sch Med, Dept Microbiol & Mol Genet, Irvine, CA 92697 USA; [Clowers, Katie J.; Kalocsay, Marian; Gygi, Steven P.] Harvard Med Sch, Dept Cell Biol, Boston, MA 02115 USA; [Elledge, Stephen J.] Harvard Med Sch, Howard Hughes Med Inst, Brigham & Womens Hosp, Boston, MA 02115 USA; [Elledge, Stephen J.] Harvard Med Sch, Dept Genet, Boston, MA 02115 USA; [Chen, Yue] Univ Minnesota, Coll Biol Sci, Dept Biochem Mol Biol & Biophys, St Paul, MN 55018 USA; [Hu, Guang] NIEHS, Epigenet & Stem Cell Biol Lab, POB 12233, Res Triangle Pk, NC 27709 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; University of California System; University of California Irvine; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; University of Minnesota System; University of Minnesota Twin Cities; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Hochedlinger, K (corresponding author), Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA.; Hochedlinger, K (corresponding author), Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA.; Hochedlinger, K (corresponding author), Massachusetts Gen Hosp, Canc Ctr, Boston, MA 02114 USA.; Hochedlinger, K (corresponding author), Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA.; Hochedlinger, K (corresponding author), Harvard Stem Cell Inst, Cambridge, MA 02138 USA.; Shi, YS (corresponding author), Univ Calif Irvine, Sch Med, Dept Microbiol & Mol Genet, Irvine, CA 92697 USA.	yongshes@uci.edu; khochedlinger@mgh.harvard.edu	Di Stefano, Bruno/K-5020-2017; Kalocsay, Marian/ABH-5959-2020; Hu, Guang/E-7474-2016	Di Stefano, Bruno/0000-0003-2532-3087; Kalocsay, Marian/0000-0002-4187-5829; Hu, Guang/0000-0003-0437-4723; Clowers, Katie/0000-0001-8484-7118; Brumbaugh, Justin/0000-0002-9605-2010	MGH; NIH [R01 HD058013-06, P01GM099134-06, 1F32HD078029-01A1, GM090056, CA17488, Z01ES102745, AG11085]; Gerald and Darlene Jordan Chair in Regenerative Medicine; EMBO long-term fellowship [ALTF 1143-2015]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [F32HD078029, R01HD058013] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA177651] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES102745] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM099134, R01GM067945, R01GM090056] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG011085] Funding Source: NIH RePORTER	MGH; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gerald and Darlene Jordan Chair in Regenerative Medicine; EMBO long-term fellowship(European Molecular Biology Organization (EMBO)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Maris Handley, Amy Galvin, Marianne Gesner, and Eric Surette of the Harvard Stem Cell Institute flow cytometry core. We are grateful to David Sykes for sharing HOXB8-ER/LYZ-GFP cells. We thank Aaron Goldstrohm and members of the Hochedlinger lab for discussions. K.H. was supported by funds from the MGH, NIH (R01 HD058013-06, P01GM099134-06), and the Gerald and Darlene Jordan Chair in Regenerative Medicine. J.B. is grateful for support from the NIH (1F32HD078029-01A1). B.D.S. was supported by an EMBO long-term fellowship (ALTF 1143-2015). Y.S. was supported by NIH grants GM090056 and CA17488. G.H. was supported by the NIH Intramural Research Program (Z01ES102745). S.J.E. was supported by the NIH (AG11085).	Ang YS, 2011, CELL, V145, P183, DOI 10.1016/j.cell.2011.03.003; Apostolou E, 2013, NATURE, V502, P462, DOI 10.1038/nature12749; Arnold K, 2011, CELL STEM CELL, V9, P317, DOI 10.1016/j.stem.2011.09.001; Bar-Nur O, 2014, NAT METHODS, V11, P1170, DOI [10.1038/nmeth.3142, 10.1038/NMETH.3142]; Beausoleil SA, 2006, NAT BIOTECHNOL, V24, P1285, DOI 10.1038/nbt1240; Benchetrit H, 2015, CELL STEM CELL, V17, P543, DOI 10.1016/j.stem.2015.08.006; Borkent M, 2016, STEM CELL REP, V6, P704, DOI 10.1016/j.stemcr.2016.02.004; Boutet SC, 2012, CELL STEM CELL, V10, P327, DOI 10.1016/j.stem.2012.01.017; Brown KM, 2003, MOL CELL, V12, P1467, DOI 10.1016/S1097-2765(03)00453-2; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Bussmann LH, 2009, CELL STEM CELL, V5, P554, DOI 10.1016/j.stem.2009.10.004; Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128; Choi YJ, 2011, NAT CELL BIOL, V13, P1353, DOI 10.1038/ncb2366; Elias JE, 2010, METHODS MOL BIOL, V604, P55, DOI 10.1007/978-1-60761-444-9_5; Fraguas MS, 2017, STEM CELL RES, V19, P21, DOI 10.1016/j.scr.2016.12.020; Gaspar-Maia A, 2009, NATURE, V460, P863, DOI 10.1038/nature08212; Grebien F, 2015, NAT CHEM BIOL, V11, P571, DOI [10.1038/nchembio.1859, 10.1038/NCHEMBIO.1859]; Gruber AR, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6465; Gupta I, 2014, MOL SYST BIOL, V10, DOI 10.1002/msb.135068; Ji Z, 2009, P NATL ACAD SCI USA, V106, P7028, DOI 10.1073/pnas.0900028106; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kubaczka C, 2015, CELL STEM CELL, V17, P557, DOI 10.1016/j.stem.2015.08.005; Kundu S, 2017, MOL CELL, V65, P432, DOI 10.1016/j.molcel.2017.01.009; Lackford B, 2014, EMBO J, V33, P878, DOI 10.1002/embj.201386537; Lengner CJ, 2007, CELL STEM CELL, V1, P403, DOI 10.1016/j.stem.2007.07.020; Leung AKL, 2011, NAT STRUCT MOL BIOL, V18, P237, DOI 10.1038/nsmb.1991; Li H, 2012, BIOINFORMATICS, V28, P1838, DOI 10.1093/bioinformatics/bts280; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li HH, 2017, CELL STEM CELL, V20, P462, DOI 10.1016/j.stem.2016.12.002; Li HH, 2017, CELL STEM CELL, V20, P571, DOI 10.1016/j.stem.2017.03.014; Li WC, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005166; Martin G, 2012, CELL REP, V1, P753, DOI 10.1016/j.celrep.2012.05.003; Masamha CP, 2014, NATURE, V510, P412, DOI 10.1038/nature13261; Mayr C., 2017, ANN REV GENET; Mayr C, 2009, CELL, V138, P673, DOI 10.1016/j.cell.2009.06.016; McAlister GC, 2014, ANAL CHEM, V86, P7150, DOI 10.1021/ac502040v; Neve J, 2016, GENOME RES, V26, P24, DOI 10.1101/gr.193995.115; Paulo JA, 2016, J PROTEOMICS, V148, P85, DOI 10.1016/j.jprot.2016.07.005; Pirity MK, 2005, MOL CELL BIOL, V25, P7193, DOI 10.1128/MCB.25.16.7193-7202.2005; Polo JM, 2012, CELL, V151, P1617, DOI 10.1016/j.cell.2012.11.039; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ramirez F, 2016, NUCLEIC ACIDS RES, V44, pW160, DOI 10.1093/nar/gkw257; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Ruegsegger U, 1998, MOL CELL, V1, P243, DOI 10.1016/S1097-2765(00)80025-8; Sandberg R, 2008, SCIENCE, V320, P1643, DOI 10.1126/science.1155390; Shakya A, 2015, MOL CELL BIOL, V35, P1014, DOI 10.1128/MCB.01105-14; Shen Y, 2012, NATURE, V488, P116, DOI 10.1038/nature11243; Shepard PJ, 2011, RNA, V17, P761, DOI 10.1261/rna.2581711; Shi YS, 2012, RNA, V18, P2105, DOI 10.1261/rna.035899.112; Spies N, 2013, GENOME RES, V23, P2078, DOI 10.1101/gr.156919.113; Stadtfeld M, 2008, CELL STEM CELL, V2, P230, DOI 10.1016/j.stem.2008.02.001; Stadtfeld M, 2010, NAT METHODS, V7, P53, DOI [10.1038/NMETH.1409, 10.1038/nmeth.1409]; Sykes DB, 2016, CELL, V167, P171, DOI 10.1016/j.cell.2016.08.057; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tian B, 2017, NAT REV MOL CELL BIO, V18, P18, DOI 10.1038/nrm.2016.116; Tucker KL, 2001, NAT NEUROSCI, V4, P29, DOI 10.1038/82868; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Wang GG, 2006, NAT METHODS, V3, P287, DOI 10.1038/NMETH865; Ye J, 2014, CELL STEM CELL, V15, P271, DOI 10.1016/j.stem.2014.08.010; Zhou L, 2012, J BIOL CHEM, V287, P25255, DOI 10.1074/jbc.M112.357053; Zhu N, 2016, J CLIN INVEST, V126, P997, DOI 10.1172/JCI82978	61	57	61	2	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 11	2018	172	1-2					106	+		10.1016/j.cell.2017.11.023	http://dx.doi.org/10.1016/j.cell.2017.11.023			36	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FS5MI	29249356	Green Submitted, Bronze, Green Accepted			2022-12-28	WOS:000419840100013
J	Butler, M; McCreedy, E; Nelson, VA; Desai, P; Ratner, E; Fink, HA; Hemmy, LS; McCarten, JR; Barclay, TR; Brasure, M; Davila, H; Kane, RL				Butler, Mary; McCreedy, Ellen; Nelson, Victoria A.; Desai, Priyanka; Ratner, Edward; Fink, Howard A.; Hemmy, Laura S.; McCarten, J. Riley; Barclay, Terry R.; Brasure, Michelle; Davila, Heather; Kane, Robert L.			Does Cognitive Training Prevent Cognitive Decline? A Systematic Review	ANNALS OF INTERNAL MEDICINE			English	Review							RANDOMIZED CONTROLLED-TRIAL; OLDER-ADULTS; ALZHEIMERS-DISEASE; IMPAIRMENT; PERFORMANCE; PEOPLE	Background: Structured activities to stimulate brain functionthat is, cognitive training exercises-are promoted to slow or prevent cognitive decline, including dementia, but their effectiveness is highly debated. Purpose: To summarize evidence on the effects of cognitive training on cognitive performance and incident dementia outcomes for adults with normal cognition or mild cognitive impairment (MCI). Data Sources: Ovid MEDLINE, EMBASE, the Cochrane Central Register of Controlled Trials, and PsycINFO through July 2017, supplemented by hand-searches. Study Selection: Trials (published in English) lasting at least 6 months that compared cognitive training with usual care, waitlist, information, or attention controls in adults without dementia. Data Extraction: Single-reviewer extraction of study characteristics confirmed by a second reviewer; dual-reviewer risk-of-bias assessment; consensus determination of strength of evidence. Only studies with low or medium risk of bias were analyzed. Data Synthesis: Of 11 trials with low or medium risk of bias, 6 enrolled healthy adults with normal cognition and 5 enrolled adults with MCI. Trainings for healthy older adults were mostly computer based; those for adults with MCI were mostly held in group sessions. The MCI trials used attention controls more often than trials with healthy populations. For healthy older adults, training improved cognitive performance in the domain trained but not in other domains (moderate-strength evidence). Results for populations with MCI suggested no effect of training on performance (low-strength and insufficient evidence). Evidence for prevention of cognitive decline or dementia was insufficient. Adverse events were not reported. Limitation: Heterogeneous interventions and outcome measures; outcomes that mostly assessed test performance rather than global function or dementia diagnosis; potential publication bias. Conclusion: In older adults with normal cognition, training improves cognitive performance in the domain trained. Evidence regarding prevention or delay of cognitive decline or dementia is insufficient.	[Butler, Mary; Nelson, Victoria A.; Desai, Priyanka; Brasure, Michelle; Davila, Heather] Univ Minnesota, Div Hlth Policy & Management, 420 Delaware St Southeast,Mayo Mem Bldg D351, Minneapolis, MN 55455 USA; [McCreedy, Ellen] Brown Univ, Ctr Gerontol & Healthcare Res, Sch Publ Hlth, 121 South Main St,Suite 6, Providence, RI 02912 USA; Minneapolis VA Hlth Care Syst, Minneapolis, MN USA; HealthPartners, Minneapolis, MN USA; [Ratner, Edward; Fink, Howard A.; Hemmy, Laura S.; McCarten, J. Riley] VA Hlth Care Syst, Geriatr Res Educ & Clin Ctr, One Vet Dr,11-G, Minneapolis, MN 55417 USA; [Barclay, Terry R.] Univ Minnesota, Dept Neurol, 295 Phalen Blvd,Mailstop 41203C, St Paul, MN 55130 USA	University of Minnesota System; University of Minnesota Twin Cities; Brown University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System; Geriatric Research Education & Clinical Center; University of Minnesota System; University of Minnesota Twin Cities	Butler, M (corresponding author), Univ Minnesota, Div Hlth Policy & Management, 420 Delaware St Southeast,Mayo Mem Bldg D351, Minneapolis, MN 55455 USA.	butl0092@umn.edu		Davila, Heather/0000-0003-1832-7901	Agency for Healthcare Research and Quality [290-2015-00008-I]	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	This manuscript is based on research conducted by the Minnesota Evidence-based Practice Center under AHRQ contract 290-2015-00008-I.	Bahar-Fuchs A, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003260.pub2; Ball K, 2002, JAMA-J AM MED ASSOC, V288, P2271, DOI 10.1001/jama.288.18.2271; Buschert Verena C, 2012, J Clin Psychiatry, V73, pe1492, DOI 10.4088/JCP.11m07270; Carretti B, 2013, INT J GERIATR PSYCH, V28, P539, DOI 10.1002/gps.3859; Clare L., 2003, COCHRANE DB SYST REV, V4, P1, DOI [https://doi.org/10.1002/14651858.CD003260, DOI 10.1002/14651858.CD003260]; Forster S, 2011, J ALZHEIMERS DIS, V26, P337, DOI 10.3233/JAD-2011-0025; Herrera C, 2012, NEUROPSYCHOLOGIA, V50, P1871, DOI 10.1016/j.neuropsychologia.2012.04.012; Kane RL, 2017, 17EHC008EF AHRQ; Klusmann V, 2010, J GERONTOL A-BIOL, V65, P680, DOI 10.1093/gerona/glq053; Kwok TCY, 2013, INT J GERIATR PSYCH, V28, P208, DOI 10.1002/gps.3812; Martin M, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006220.pub2; Miller KJ, 2013, AM J GERIAT PSYCHIAT, V21, P655, DOI 10.1016/j.jagp.2013.01.077; PATRICK DL, 1994, MED DECIS MAKING, V14, P9, DOI 10.1177/0272989X9401400102; Rapp S, 2002, AGING MENT HEALTH, V6, P5, DOI 10.1080/13607860120101077; Rebok GW, 2014, J AM GERIATR SOC, V62, P16, DOI 10.1111/jgs.12607; Stine-Morrow EAL, 2014, PSYCHOL AGING, V29, P891, DOI 10.1037/a0038244; Vidovich MR, 2015, AM J GERIAT PSYCHIAT, V23, P360, DOI 10.1016/j.jagp.2014.04.002; Viswanathan M, 2012, 12EHC047 AHRQ; Williams John W, 2010, Evid Rep Technol Assess (Full Rep), P1; Willis SL, 2006, JAMA-J AM MED ASSOC, V296, P2805, DOI 10.1001/jama.296.23.2805; Wolinsky FD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061624	21	98	108	8	51	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 2	2018	168	1					63	+		10.7326/M17-1531	http://dx.doi.org/10.7326/M17-1531			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FR5SO	29255842				2022-12-28	WOS:000419126700008
J	Prescott, HC; Angus, DC				Prescott, Hallie C.; Angus, Derek C.			Enhancing Recovery From Sepsis A Review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							QUALITY-OF-LIFE; INTENSIVE-CARE-UNIT; POSTTRAUMATIC-STRESS-DISORDER; CRITICALLY-ILL PATIENTS; RANDOMIZED CONTROLLED-TRIAL; CRITICAL ILLNESS; PHYSICAL REHABILITATION; HOSPITAL READMISSIONS; FUNCTIONAL DISABILITY; CARDIOVASCULAR EVENTS	IMPORTANCE Survival from sepsis has improved in recent years, resulting in an increasing number of patients who have survived sepsis treatment. Current sepsis guidelines do not provide guidance on posthospital care or recovery. OBSERVATIONS Each year, more than 19 million individuals develop sepsis, defined as a life-threatening acute organ dysfunction secondary to infection. Approximately 14 million survive to hospital discharge and their prognosis varies. Half of patients recover, one-third die during the following year, and one-sixth have severe persistent impairments. Impairments include development of an average of 1 to 2 new functional limitations (eg, inability to bathe or dress independently), a 3-fold increase in prevalence of moderate to severe cognitive impairment (from 6.1% before hospitalization to 16.7% after hospitalization), and a high prevalence of mental health problems, including anxiety (32% of patients who survive), depression (29%), or posttraumatic stress disorder (44%). About 40% of patients are rehospitalized within 90 days of discharge, often for conditions that are potentially treatable in the outpatient setting, such as infection (11.9%) and exacerbation of heart failure (5.5%). Compared with patients hospitalized for other diagnoses, those who survive sepsis (11.9%) are at increased risk of recurrent infection than matched patients (8.0%) matched patients (P < .001), acute renal failure (3.3% vs 1.2%, P < .001), and new cardiovascular events (adjusted hazard ratio [HR] range, 1.1-1.4). Reasons for deterioration of health after sepsis are multifactorial and include accelerated progression of preexisting chronic conditions, residual organ damage, and impaired immune function. Characteristics associated with complications after hospital discharge for sepsis treatment are not fully understood but include both poorer presepsis health status, characteristics of the acute septic episode (eg, severity of infection, host response to infection), and quality of hospital treatment (eg, timeliness of initial sepsis care, avoidance of treatment-related harms). Although there is a paucity of clinical trial evidence to support specific postdischarge rehabilitation treatment, experts recommend referral to physical therapy to improve exercise capacity, strength, and independent completion of activities of daily living. This recommendation is supported by an observational study involving 30 000 sepsis survivors that found that referral to rehabilitation within 90 days was associated with lower risk of 10-year mortality compared with propensity-matched controls (adjusted HR, 0.94; 95% CI, 0.92-0.97, P < .001). CONCLUSIONS AND RELEVANCE In the months after hospital discharge for sepsis, management should focus on (1) identifying new physical, mental, and cognitive problems and referring for appropriate treatment, (2) reviewing and adjusting long-term medications, and (3) evaluating for treatable conditions that commonly result in hospitalization, such as infection, heart failure, renal failure, and aspiration. For patients with poor or declining health prior to sepsis who experience further deterioration after sepsis, it may be appropriate to focus on palliation of symptoms.	[Prescott, Hallie C.] Univ Michigan, Dept Internal Med, 2800 Plymouth Rd,North Campus Res Ctr,Bldg 16, Ann Arbor, MI 48109 USA; [Prescott, Hallie C.] Univ Michigan, Inst Healthcare Policy & Innovat, 2800 Plymouth Rd,North Campus Res Ctr,Bldg 16, Ann Arbor, MI 48109 USA; [Prescott, Hallie C.] VA Ctr Clin Management Res, Hlth Serv Res & Dev Ctr Innovat, Ann Arbor, MI USA; [Angus, Derek C.] Univ Pittsburgh, Sch Med, Dept Crit Care Med, Clin Res Invest & Syst Modeling Acute Illness CRI, Pittsburgh, PA USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Prescott, HC (corresponding author), Univ Michigan, Dept Internal Med, 2800 Plymouth Rd,North Campus Res Ctr,Bldg 16, Ann Arbor, MI 48109 USA.; Prescott, HC (corresponding author), Univ Michigan, Inst Healthcare Policy & Innovat, 2800 Plymouth Rd,North Campus Res Ctr,Bldg 16, Ann Arbor, MI 48109 USA.	hprescot@med.umich.edu	Angus, Derek C/E-9671-2012	Prescott, Hallie/0000-0002-8442-6724	National Institute of General Medical Sciences of the National Institutes of Health [K08 GM115859, R01 GM097471]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097471, K08GM115859] Funding Source: NIH RePORTER	National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants K08 GM115859 (Dr Prescott) and R01 GM097471 (Dr Angus) from the National Institute of General Medical Sciences of the National Institutes of Health.	Andersson U, 2012, ANNU REV IMMUNOL, V30, P313, DOI 10.1146/annurev-immunol-020711-075015; Angus DC, 2013, NEW ENGL J MED, V369, P840, DOI [10.1056/NEJMc1312359, 10.1056/NEJMra1208623]; Annane D, 2015, LANCET RESP MED, V3, P61, DOI 10.1016/S2213-2600(14)70246-2; [Anonymous], CRIT CARE MED, DOI [10.1097/01.ccm.0000510071.45969.89, DOI 10.1097/01.CCM.0000510071.45969.89]; [Anonymous], CRIT CARE MED; Barr J, 2013, CRIT CARE MED, V41, P263, DOI 10.1097/CCM.0b013e3182783b72; Batterham AM, 2014, BRIT J ANAESTH, V113, P130, DOI 10.1093/bja/aeu051; Bell CM, 2011, JAMA-J AM MED ASSOC, V306, P840, DOI 10.1001/jama.2011.1206; Bienvenu OJ, 2013, PSYCHOL MED, V43, P2657, DOI 10.1017/S0033291713000214; Borges RC, 2015, INTENS CARE MED, V41, P1433, DOI 10.1007/s00134-015-3914-y; Brummel NE, 2017, AM J RESP CRIT CARE, V196, P64, DOI 10.1164/rccm.201605-0939OC; Brummel NE, 2014, CRIT CARE MED, V42, P369, DOI 10.1097/CCM.0b013e3182a645bd; Carson WF, 2011, EPIGENETICS-US, V6, P273, DOI 10.4161/epi.6.3.14017; Chao PW, 2014, AM J RESP CRIT CARE, V190, P1003, DOI 10.1164/rccm.201406-1170OC; Connolly B, 2016, THORAX, V71, P881, DOI 10.1136/thoraxjnl-2015-208273; Connolly B, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008632.pub2; CREDITOR MC, 1993, ANN INTERN MED, V118, P219, DOI 10.7326/0003-4819-118-3-199302010-00011; Cuthbertson BH, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3723; CUTHBERTSON BH, 2013, CRIT CARE, V0017; Daly BJ, 2005, CHEST, V128, P507, DOI 10.1378/chest.128.2.507; Davydow DS, 2012, CRIT CARE MED, V40, P2335, DOI 10.1097/CCM.0b013e3182536a81; DiMatteo MR, 2000, ARCH INTERN MED, V160, P2101, DOI 10.1001/archinte.160.14.2101; Douglas SL, 2007, AM J CRIT CARE, V16, P447; Elliott D, 2011, CRIT CARE, V15, DOI 10.1186/cc10265; Ferrante LE, 2016, AM J RESP CRIT CARE, V194, P299, DOI 10.1164/rccm.201506-1256OC; Ferrante LE, 2015, JAMA INTERN MED, V175, P523, DOI 10.1001/jamainternmed.2014.7889; Fleischmann C, 2016, AM J RESP CRIT CARE, V193, P259, DOI 10.1164/rccm.201504-0781OC; Forster A, 2000, COCHRANE DB SYST REV; Gallop KH, 2015, CRIT CARE MED, V43, P296, DOI 10.1097/CCM.0000000000000613; Girard TD, 2008, LANCET, V371, P126, DOI 10.1016/S0140-6736(08)60105-1; Govindan Sushant, 2014, Ann Am Thorac Soc, V11, P587, DOI 10.1513/AnnalsATS.201401-007BC; Heyland DK, 2016, CRIT CARE MED, V44, P1718, DOI 10.1097/CCM.0000000000001762; Hopkins RO, 2017, ANN AM THORAC SOC, V14, P1332, DOI 10.1513/AnnalsATS.201701-059SR; Hotchkiss RS, 2013, NAT REV IMMUNOL, V13, P862, DOI 10.1038/nri3552; Huang C, 2016, CRIT CARE MED, V44, P429; Huggins EL, 2016, AACN ADV CRIT CARE, V27, P204, DOI 10.4037/aacnacc2016611; Iwashyna TJ, 2014, JAMA-J AM MED ASSOC, V311, P1295, DOI 10.1001/jama.2014.2639; Iwashyna TJ, 2012, J AM GERIATR SOC, V60, P1070, DOI 10.1111/j.1532-5415.2012.03989.x; Iwashyna TJ, 2010, JAMA-J AM MED ASSOC, V304, P1787, DOI 10.1001/jama.2010.1553; Jackson JC, 2014, LANCET RESP MED, V2, P369, DOI 10.1016/S2213-2600(14)70051-7; Jackson JC, 2012, CRIT CARE MED, V40, P1088, DOI 10.1097/CCM.0b013e3182373115; Jackson JC, 2009, SOUTH MED J, V102, P1150, DOI 10.1097/SMJ.0b013e3181b6a592; Jensen JF, 2016, INTENS CARE MED, V42, P1733, DOI 10.1007/s00134-016-4522-1; JOHANSEN K, 1993, AM J SURG, V165, P642, DOI 10.1016/S0002-9610(05)80452-0; Jones C, 2003, CRIT CARE MED, V31, P2456, DOI 10.1097/01.CCM.0000089938.56725.33; Jones C, 2012, AM J CRIT CARE, V21, P172, DOI 10.4037/ajcc2012569; Jones C, 2010, CRIT CARE, V14, DOI 10.1186/cc9260; Kansagara D, 2011, JAMA-J AM MED ASSOC, V306, P1688, DOI 10.1001/jama.2011.1515; Kaukonen KM, 2014, JAMA-J AM MED ASSOC, V311, P1308, DOI 10.1001/jama.2014.2637; Kress JP, 2014, NEW ENGL J MED, V370, P1626, DOI 10.1056/NEJMra1209390; Kress JP, 2003, AM J RESP CRIT CARE, V168, P1457, DOI 10.1164/rccm.200303-455OC; Krumholz HM, 2013, NEW ENGL J MED, V368, P100, DOI 10.1056/NEJMp1212324; Leligdowicz A, 2014, AM J RESP CRIT CARE, V189, P1204, DOI 10.1164/rccm.201310-1875OC; Leppin AL, 2014, JAMA INTERN MED, V174, P1095, DOI 10.1001/jamainternmed.2014.1608; Lewis M, 2017, J PHYSIOTHER, V63, P23, DOI 10.1016/j.jphys.2016.11.005; Major ME, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1508-x; Marra A, 2017, CRIT CARE CLIN, V33, P225, DOI 10.1016/j.ccc.2016.12.005; Mayr FB, 2017, JAMA-J AM MED ASSOC, V317, P530, DOI 10.1001/jama.2016.20468; Mehlhorn J, 2014, CRIT CARE MED, V42, P1263, DOI 10.1097/CCM.0000000000000148; Mikkelsen ME, 2016, AACN ADV CRIT CARE, V27, P221, DOI 10.4037/aacnacc2016667; Mikkelsen ME, AM J; Mikkelsen ME, THRIVE ACCOMPLISHMEN; Morandi A, 2013, J AM GERIATR SOC, V61, P1128, DOI 10.1111/jgs.12329; Nikayin S, 2016, GEN HOSP PSYCHIAT, V43, P23, DOI 10.1016/j.genhosppsych.2016.08.005; Ou SM, 2016, AM J RESP CRIT CARE, V194, P209, DOI 10.1164/rccm.201510-2023OC; Page DB, 2015, CRIT CARE MED, V43, P1945, DOI 10.1097/CCM.0000000000001164; Parker AM, 2015, CRIT CARE MED, V43, P1121, DOI 10.1097/CCM.0000000000000882; Pollock A, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001920.pub3; Poulsen JB, 2000, ACTA ANAESTH SCAND, V53, P724; Prescott HC, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i2375; Prescott HC, 2015, JAMA-J AM MED ASSOC, V313, P1055, DOI 10.1001/jama.2015.1410; Prescott HC, 2014, AM J RESP CRIT CARE, V190, P62, DOI 10.1164/rccm.201403-0471OC; Rabiee A, 2016, CRIT CARE MED, V44, P1744, DOI 10.1097/CCM.0000000000001811; Reade MC, 2014, NEW ENGL J MED, V370, P444, DOI 10.1056/NEJMra1208705; Rhodes A, 2017, CRIT CARE MED, V45, P486, DOI 10.1097/CCM.0000000000002255; Scales DC, 2016, J GEN INTERN MED, V31, P196, DOI 10.1007/s11606-015-3501-5; Schaller SJ, 2016, LANCET, V388, P1377, DOI 10.1016/S0140-6736(16)31637-3; Schmidt K, 2016, JAMA-J AM MED ASSOC, V315, P2703, DOI 10.1001/jama.2016.7207; Schweickert WD, 2009, LANCET, V373, P1874, DOI 10.1016/S0140-6736(09)60658-9; Seymour CW, 2017, NEW ENGL J MED, V376, P2235, DOI 10.1056/NEJMoa1703058; Shah FA, 2013, AM J RESP CRIT CARE, V188, P586, DOI 10.1164/rccm.201212-2154OC; Shen HN, 2016, CRIT CARE MED, V44, P1833, DOI 10.1097/CCM.0000000000001824; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Vanderbeken I, 2017, NEUROREHABILITATION, V40, P33, DOI 10.3233/NRE-161388; WILSON IB, 1995, JAMA-J AM MED ASSOC, V273, P59, DOI 10.1001/jama.273.1.59; Wintermann GB, 2015, CRIT CARE MED, V43, P1213, DOI 10.1097/CCM.0000000000000936; Winters BD, 2010, CRIT CARE MED, V38, P1276, DOI 10.1097/CCM.0b013e3181d8cc1d; Woon FL, 2012, AM J RESP CRIT CARE, V186, P333, DOI 10.1164/rccm.201112-2261OC; Wunsch H, 2014, JAMA-J AM MED ASSOC, V311, P1133, DOI 10.1001/jama.2014.2137; Yang LC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5436; Yende S, 2016, CRIT CARE MED, V44, P1461, DOI 10.1097/CCM.0000000000001658; Yende S, 2014, AM J RESP CRIT CARE, V189, P1065, DOI 10.1164/rccm.201307-1321OC; Zaborin A, 2014, MBIO, V5, DOI 10.1128/mBio.01361-14; Zielske J, 2014, EUR ARCH OTO-RHINO-L, V271, P3085, DOI 10.1007/s00405-014-3148-6	94	355	371	5	120	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 2	2018	319	1					62	75		10.1001/jama.2017.17687	http://dx.doi.org/10.1001/jama.2017.17687			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FR5ON	29297082	Green Accepted			2022-12-28	WOS:000419116000016
J	AbdelRazek, MA; Venna, N				AbdelRazek, Mahmoud A.; Venna, Nagagopal			Ventriculoperitoneal-Shunt Placement for Normal-Pressure Hydrocephalus	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[AbdelRazek, Mahmoud A.; Venna, Nagagopal] Harvard Univ, Cambridge, MA 02138 USA	Harvard University	AbdelRazek, MA (corresponding author), Harvard Univ, Cambridge, MA 02138 USA.	razek2@hotmail.com	AbdelRazek, Mahmoud/AAL-3887-2021	AbdelRazek, Mahmoud/0000-0002-2391-3502					0	0	1	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 28	2017	377	26					E35	E35		10.1056/NEJMicm1701226	http://dx.doi.org/10.1056/NEJMicm1701226			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FR0TX	29281574				2022-12-28	WOS:000418777700010
J	Smith, KT				Smith, Keith T.			AN ILLUMINATING COSMIC COLLISION	SCIENCE			English	Editorial Material																			0	0	0	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 22	2017	358	6370					1554	1555		10.1126/science.aar6069	http://dx.doi.org/10.1126/science.aar6069			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FQ6BO	29269471				2022-12-28	WOS:000418448000049
J	Nguyen, TT; Koh, MJ; Mann, TJ; Schrock, RR; Hoveyda, AH				Nguyen, Thach T.; Koh, Ming Joo; Mann, Tyler J.; Schrock, Richard R.; Hoveyda, Amir H.			Synthesis of E- and Z-trisubstituted alkenes by catalytic cross-metathesis	NATURE			English	Article							OLEFIN-METATHESIS; STEREOSELECTIVE-SYNTHESIS; ALKYLIDENE COMPLEXES; COUPLING REACTION; ALLYLIC ALCOHOLS; WITTIG REACTION; MOLYBDENUM; EFFICIENT; ALKYNES; CARBOMETALATION	Catalytic cross-metathesis is a central transformation in chemistry, yet corresponding methods for the stereoselective generation of acyclic trisubstituted alkenes in either the E or the Z isomeric forms are not known. The key problems are a lack of chemoselectivity-namely, the preponderance of side reactions involving only the less hindered starting alkene, resulting in homo-metathesis by-products-and the formation of short-lived methylidene complexes. By contrast, in catalytic cross-coupling, substrates are more distinct and homocoupling is less of a problem. Here we show that through cross-metathesis reactions involving E-or Z-trisubstituted alkenes, which are easily prepared from commercially available starting materials by cross-coupling reactions, many desirable and otherwise difficult-to-access linear E-or Z-trisubstituted alkenes can be synthesized efficiently and in exceptional stereoisomeric purity (up to 98 per cent E or 95 per cent Z). The utility of the strategy is demonstrated by the concise stereoselective syntheses of biologically active compounds, such as the antifungal indiacen B and the anti-inflammatory coibacin D.	[Nguyen, Thach T.; Koh, Ming Joo; Mann, Tyler J.; Hoveyda, Amir H.] Boston Coll, Dept Chem, Merkert Chem Ctr, Chestnut Hill, MA 02467 USA; [Schrock, Richard R.] MIT, Dept Chem, Cambridge, MA 02139 USA	Boston College; Massachusetts Institute of Technology (MIT)	Hoveyda, AH (corresponding author), Boston Coll, Dept Chem, Merkert Chem Ctr, Chestnut Hill, MA 02467 USA.	amir.hoveyda@bc.edu	Koh, Ming Joo/O-8549-2019; Koh, Ming Joo/GOV-7124-2022	Koh, Ming Joo/0000-0002-2534-4921; Koh, Ming Joo/0000-0002-2534-4921	United States National Institutes of Health, Institute of General Medical Sciences [GM-59426, CHE-1362763]; Bristol Myers-Squibb Fellowship in Organic Chemistry; John LaMattina Graduate Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059426] Funding Source: NIH RePORTER	United States National Institutes of Health, Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Bristol Myers-Squibb Fellowship in Organic Chemistry; John LaMattina Graduate Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by the United States National Institutes of Health, Institute of General Medical Sciences (GM-59426 and, in part, CHE-1362763). M.J.K. and T.J.M. are grateful for support in the form of a Bristol Myers-Squibb Fellowship in Organic Chemistry and a John LaMattina Graduate Fellowship, respectively.	Alexakis A, 2014, COPPER-CATALYZED ASYMMETRIC SYNTHESIS, P33; Anantoju KK, 2017, TETRAHEDRON LETT, V58, P1499, DOI 10.1016/j.tetlet.2017.03.002; Balunas MJ, 2012, ORG LETT, V14, P3878, DOI 10.1021/ol301607q; Basle O, 2014, COPPER-CATALYZED ASYMMETRIC SYNTHESIS, P85; BROWN HC, 1986, SYNTHESIS-STUTTGART, P480; Chatterjee AK, 2002, ORG LETT, V4, P1939, DOI 10.1021/ol0259793; Chatterjee AK, 1999, ORG LETT, V1, P1751, DOI 10.1021/ol991023p; Chemler SR, 2001, ANGEW CHEM INT EDIT, V40, P4544, DOI 10.1002/1521-3773(20011217)40:24<4544::AID-ANIE4544>3.0.CO;2-N; Coombs JR, 2015, ORG LETT, V17, P1708, DOI 10.1021/acs.orglett.5b00480; CUVIGNY T, 1980, TETRAHEDRON LETT, V21, P1331, DOI 10.1016/S0040-4039(00)74568-0; Edwards JT, 2017, NATURE, V545, P213, DOI 10.1038/nature22307; Ely RJ, 2011, ORG SYNTH, V88, P342, DOI 10.15227/orgsyn.088.0342; FLEMING I, 1981, J CHEM SOC PERK T 1, P2527, DOI 10.1039/p19810002527; Gribble GW, 2015, MAR DRUGS, V13, P4044, DOI 10.3390/md13074044; Hoveyda A. H., 2014, HDB METATHESIS, P503; Hoveyda AH, 2007, NATURE, V450, P243, DOI 10.1038/nature06351; Hoveyda AH, 2014, J ORG CHEM, V79, P4763, DOI 10.1021/jo500467z; Kirchhoff JH, 2002, J AM CHEM SOC, V124, P13662, DOI 10.1021/ja0283899; Koh MJ, 2017, NATURE, V542, P80, DOI 10.1038/nature21043; Koh MJ, 2016, NATURE, V531, P459, DOI 10.1038/nature17396; Koh MJ, 2015, NATURE, V517, P181, DOI 10.1038/nature14061; Kolska K, 2016, ASIAN J ORG CHEM, V5, P646, DOI 10.1002/ajoc.201600022; Lam JK, 2016, J AM CHEM SOC, V138, P15774, DOI 10.1021/jacs.6b10499; Lu Z, 2006, J ORG CHEM, V71, P2655, DOI 10.1021/jo0524021; Ma SM, 1997, J ORG CHEM, V62, P784, DOI 10.1021/jo9622688; Marsch N, 2015, BEILSTEIN J ORG CHEM, V11, P1700, DOI 10.3762/bjoc.11.184; MARYANOFF BE, 1989, CHEM REV, V89, P863, DOI 10.1021/cr00094a007; MINATO A, 1987, J AM CHEM SOC, V109, P1257, DOI 10.1021/ja00238a052; Miyazawa M, 1997, TETRAHEDRON LETT, V38, P3419, DOI 10.1016/S0040-4039(97)00635-7; MORI A, 1985, J ORGANOMET CHEM, V285, P83, DOI 10.1016/0022-328X(85)87359-9; Morrill C, 2004, TETRAHEDRON LETT, V45, P7733, DOI 10.1016/j.tetlet.2004.08.069; Mun B, 2017, J ORG CHEM, V82, P6349, DOI 10.1021/acs.joc.7b00920; NEGISHI E, 1985, J AM CHEM SOC, V107, P6639, DOI 10.1021/ja00309a036; Negishi EI, 2008, ACCOUNTS CHEM RES, V41, P1474, DOI 10.1021/ar800038e; Nguyen TT, 2016, SCIENCE, V352, P569, DOI 10.1126/science.aaf4622; NORTHCOTE PT, 1991, TETRAHEDRON LETT, V32, P6411, DOI 10.1016/0040-4039(91)80182-6; Nunnery JK, 2012, J ORG CHEM, V77, P4198, DOI 10.1021/jo300160e; Ondi L, 2016, ORG PROCESS RES DEV, V20, P1709, DOI 10.1021/acs.oprd.6b00161; Schrock RR, 2003, ANGEW CHEM INT EDIT, V42, P4592, DOI 10.1002/anie.200300576; Shang G., 2010, CATALYTIC ASYMMETRIC, P344; Siau WY, 2012, TOP CURR CHEM, V327, P33, DOI 10.1007/128_2012_315; SREEKUMAR C, 1980, J ORG CHEM, V45, P4260, DOI 10.1021/jo01309a051; Steinmetz H, 2012, J NAT PROD, V75, P1803, DOI 10.1021/np300288b; Taber DF, 1996, J ORG CHEM, V61, P5723, DOI 10.1021/jo960973a; Trost BM, 2005, SYNTHESIS-STUTTGART, P853, DOI 10.1055/s-2005-861874; Tsukamoto H, 2008, ORG BIOMOL CHEM, V6, P3005, DOI 10.1039/b804991b; Wang C, 2009, ORG LETT, V11, P4092, DOI 10.1021/ol901566e; Wang ZJ, 2013, ORG LETT, V15, P3006, DOI 10.1021/ol401194h; Xu CF, 2017, J AM CHEM SOC, V139, P10919, DOI 10.1021/jacs.7b06552; Zhang HM, 2014, J AM CHEM SOC, V136, P16493, DOI 10.1021/ja510768c	51	47	48	5	107	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 21	2017	552	7685					347	+		10.1038/nature25002	http://dx.doi.org/10.1038/nature25002			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ7RI	29293209	Green Accepted, Green Submitted			2022-12-28	WOS:000418559800048
J	Nowotny, H				Nowotny, Helga			Fotis Kafatos (1940-2017)	SCIENCE			English	Biographical-Item									[Nowotny, Helga] European Res Council, Brussels, Belgium		Nowotny, H (corresponding author), European Res Council, Brussels, Belgium.	heiga.nowotny@wwtf.at						KAFATOS F, PUBLICATION LIST	1	0	0	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 15	2017	358	6369					1387	1387		10.1126/science.aar6095	http://dx.doi.org/10.1126/science.aar6095			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP8TH	29242334				2022-12-28	WOS:000417918500022
J	Srinivas, N; Parkin, J; Seelig, G; Winfree, E; Soloveiehile, D				Srinivas, Niranjan; Parkin, James; Seelig, Georg; Winfree, Erik; Soloveiehile, David			Enzyme-free nucleic acid dynamical systems	SCIENCE			English	Article							DNA STRAND DISPLACEMENT; ESCHERICHIA-COLI; CHEMICAL IMPLEMENTATION; SELF-ORGANIZATION; SEQUENCE DESIGN; TOGGLE SWITCH; KINETICS; CELL; COMPUTATION; CONSTRUCTION	Chemistries exhibiting complex dynamics-from inorganic oscillators to gene regulatory networks-have been long known but either cannot be reprogrammed at will or rely on the sophisticated enzyme chemistry underlying the central dogma. Can simpler molecular mechanisms, designed from scratch, exhibit the same range of behaviors? Abstract chemical reaction networks have been proposed as a programming language for complex dynamics, along with their systematic implementation using short synthetic DNA molecules. We developed this technology for dynamical systems by identifying critical design principles and codifying them into a compiler automating the design process. Using this approach, we built an oscillator containing only DNA components, establishing that Watson-Crick base-pairing interactions alone suffice for complex chemical dynamics and that autonomous molecular systems can be designed via molecular programming languages.	[Srinivas, Niranjan; Winfree, Erik] CALTECH, Computat & Neural Syst, Pasadena, CA 91125 USA; [Parkin, James; Winfree, Erik] CALTECH, Bioengn, Pasadena, CA 91125 USA; [Seelig, Georg] Univ Washington, Dept Elect Engn, Seattle, WA 98195 USA; [Seelig, Georg] Univ Washington, Paul G Allen Sch Comp Sci & Engn, Seattle, WA 98195 USA; [Winfree, Erik] CALTECH, Comp Sci, Pasadena, CA 91125 USA; [Soloveiehile, David] Univ Texas Austin, Dept Elect & Comp Engn, Austin, TX 78701 USA	California Institute of Technology; California Institute of Technology; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; California Institute of Technology; University of Texas System; University of Texas Austin	Srinivas, N (corresponding author), CALTECH, Computat & Neural Syst, Pasadena, CA 91125 USA.; Soloveiehile, D (corresponding author), Univ Texas Austin, Dept Elect & Comp Engn, Austin, TX 78701 USA.	niranjan@dna.caltech.edu; david.soloveichik@utexas.edu	Winfree, Erik/L-4002-2013	Winfree, Erik/0000-0002-5899-7523; Soloveichik, David/0000-0002-2585-4120	NSF [0728703, 0829805, 0832824, 1317694, 1117143, 1618895]; Office of Naval Research award [N00014-16-1-2139]; Gordon and Betty Moore Foundation's Programmable Molecular Technology Initiative; National Institute of General Medical Sciences Systems Biology Center [P50 GM081879]	NSF(National Science Foundation (NSF)); Office of Naval Research award(Office of Naval Research); Gordon and Betty Moore Foundation's Programmable Molecular Technology Initiative; National Institute of General Medical Sciences Systems Biology Center	We thank L. Qian for help with initial experiments and technical training; C. G. Evans for supporting the development of Piperine; A. Phillips for assistance with Visual DSD; and L. Cardelli, C. Geary, C. T. Martin N. A. Pierce, P. W. K. Rothemund, S. L. Sparvath a wore, F. Dannenberg, and D. Y. Zhang for helpful discussions. This work was supported by the NSF grants 0728703, 0829805, 0832824, 1317694, 1117143, and 1618895; Office of Naval Research award N00014-16-1-2139; the Gordon and Betty Moore Foundation's Programmable Molecular Technology Initiative; and National Institute of General Medical Sciences Systems Biology Center grant P50 GM081879. Data presented in the paper are archived in the Supplementary Materials.	ASPNES J, 2009, MIDDLEWARE NETWORK E, P97, DOI DOI 10.1007/978-3-540-89707-1_5; Atkinson MR, 2003, CELL, V113, P597, DOI 10.1016/S0092-8674(03)00346-5; Baccouche A, 2014, METHODS, V67, P234, DOI 10.1016/j.ymeth.2014.01.015; Belousov B.P., 1959, COLLECTION SHORT PAP, V147, P1; BRAY D, 1995, NATURE, V376, P307, DOI 10.1038/376307a0; Bray WC, 1921, J AM CHEM SOC, V43, P1262, DOI 10.1021/ja01439a007; Cardelli L, 2013, MATH STRUCT COMP SCI, V23, P247, DOI 10.1017/S0960129512000102; Cardelli L, 2011, NAT COMPUT, V10, P407, DOI 10.1007/s11047-010-9236-7; Cardelli L, 2009, NAT COMPUT SER, P429, DOI 10.1007/978-3-540-88869-7_22; Chen YJ, 2013, NAT NANOTECHNOL, V8, P755, DOI 10.1038/nnano.2013.189; Cho EJ, 2009, ANNU REV ANAL CHEM, V2, P241, DOI 10.1146/annurev.anchem.1.031207.112851; Cu H., 2010, NATURE, V465, P202, DOI [10.1038/nature09, DOI 10.1038/NATURE09]; Dirks RM, 2004, NUCLEIC ACIDS RES, V32, P1392, DOI 10.1093/nar/gkh291; Dobrinevski A, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.051903; Douglas SM, 2012, SCIENCE, V335, P831, DOI 10.1126/science.1214081; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Epstein I.R., 1998, INTRO NONLINEAR CHEM; EPSTEIN IR, 1984, J PHYS CHEM-US, V88, P187, DOI 10.1021/j150646a007; ERDI P., 1989, MATH MODELS CHEM REA; Evans CG, 2013, LECT NOTES COMPUT SC, V8141, P61, DOI 10.1007/978-3-319-01928-4_5; Fu JL, 2012, J AM CHEM SOC, V134, P5516, DOI 10.1021/ja300897h; Fujii T, 2013, ACS NANO, V7, P27, DOI 10.1021/nn3043572; Garamella J, 2016, ACS SYNTH BIOL, V5, P344, DOI 10.1021/acssynbio.5b00296; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Genot AJ, 2011, J AM CHEM SOC, V133, P2177, DOI 10.1021/ja1073239; Gianneschi NC, 2007, ANGEW CHEM INT EDIT, V46, P3955, DOI 10.1002/anie.200700047; He Y, 2010, NAT NANOTECHNOL, V5, P778, DOI [10.1038/nnano.2010.190, 10.1038/NNANO.2010.190]; HJELMFELT A, 1995, PHYSICA D, V84, P180, DOI 10.1016/0167-2789(95)00014-U; HJELMFELT A, 1991, P NATL ACAD SCI USA, V88, P10983, DOI 10.1073/pnas.88.24.10983; HJELMFELT A, 1992, P NATL ACAD SCI USA, V89, P383, DOI 10.1073/pnas.89.1.383; HORN F, 1972, ARCH RATION MECH AN, V47, P81; Kim J., 2005, ADV NEURAL INFORM PR, V17, P681; Kim J, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100099; Kim J, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2010.119; KLONOWSKI W, 1983, BIOPHYS CHEM, V18, P73, DOI 10.1016/0301-4622(83)85001-7; KORZUKHIN MD, 1967, OSCILLATORY PROCESSE, P231; LACHMANN M, 1995, ADV ART LIF LECT, V929, P784; Lakin MR, 2012, J R SOC INTERFACE, V9, P470, DOI 10.1098/rsif.2011.0343; Liao SP, 2004, SCIENCE, V306, P2072, DOI 10.1126/science.1104299; Liu MH, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3127; Meng WJ, 2016, NAT CHEM, V8, P542, DOI [10.1038/NCHEM.2495, 10.1038/nchem.2495]; Montagne K, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2010.120; Niederholtmeyer H, 2015, ELIFE, V4, DOI 10.7554/eLife.09771; Noireaux V, 2011, P NATL ACAD SCI USA, V108, P3473, DOI 10.1073/pnas.1017075108; Oishi K, 2011, IET SYST BIOL, V5, P252, DOI 10.1049/iet-syb.2010.0056; Ouldridge TE, 2013, NUCLEIC ACIDS RES, V41, P8886, DOI 10.1093/nar/gkt687; Padirac A, 2012, P NATL ACAD SCI USA, V109, pE3212, DOI 10.1073/pnas.1212069109; Qian L, 2011, LECT NOTES COMPUT SC, V6518, P123, DOI 10.1007/978-3-642-18305-8_12; Qian L, 2011, SCIENCE, V332, P1196, DOI 10.1126/science.1200520; Reichenbach T, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.051907; Reynaldo LP, 2000, J MOL BIOL, V297, P511, DOI 10.1006/jmbi.2000.3573; Sadowski JP, 2014, ACS NANO, V8, P3251, DOI 10.1021/nn4038223; SantaLucia J, 2004, ANNU REV BIOPH BIOM, V33, P415, DOI 10.1146/annurev.biophys.32.110601.141800; Schaeffer Joseph Malcolm, 2015, DNA Computing and Molecular Programming. 21st International Conference, DNA 21. Proceedings 9211, P194, DOI 10.1007/978-3-319-21999-8_13; Schreiber R, 2014, NAT NANOTECHNOL, V9, P74, DOI [10.1038/nnano.2013.253, 10.1038/NNANO.2013.253]; Seelig G, 2006, SCIENCE, V314, P1585, DOI 10.1126/science.1132493; Seeman N. C., 2016, STRUCTURAL DNA NANOT; SEEMAN NC, 1990, J BIOMOL STRUCT DYN, V8, P573, DOI 10.1080/07391102.1990.10507829; Semenov SN, 2015, NAT CHEM, V7, P160, DOI [10.1038/NCHEM.2142, 10.1038/nchem.2142]; Shimizu Y, 2001, NAT BIOTECHNOL, V19, P751, DOI 10.1038/90802; Soloveichik D, 2010, P NATL ACAD SCI USA, V107, P5393, DOI 10.1073/pnas.0909380107; Srinivas N, 2013, NUCLEIC ACIDS RES, V41, P10641, DOI 10.1093/nar/gkt801; Stojanovic MN, 2004, J AM CHEM SOC, V126, P9266, DOI 10.1021/ja032013t; Stricker J, 2008, NATURE, V456, P516, DOI 10.1038/nature07389; Thachuk Chris, 2015, DNA Computing and Molecular Programming. 21st International Conference, DNA 21. Proceedings 9211, P133, DOI 10.1007/978-3-319-21999-8_9; Tyson JJ, 2003, CURR OPIN CELL BIOL, V15, P221, DOI 10.1016/S0955-0674(03)00017-6; Wlotzka B, 1997, CHEM BIOL, V4, P25, DOI 10.1016/S1074-5521(97)90234-9; Wolfe BR, 2017, J AM CHEM SOC, V139, P3134, DOI 10.1021/jacs.6b12693; Wolfe BR, 2015, ACS SYNTH BIOL, V4, P1086, DOI 10.1021/sb5002196; Wollman AJM, 2014, NAT NANOTECHNOL, V9, P44, DOI [10.1038/NNANO.2013.230, 10.1038/nnano.2013.230]; Yin P, 2008, NATURE, V451, P318, DOI 10.1038/nature06451; Yurke B, 2000, NATURE, V406, P605, DOI 10.1038/35020524; Yurke B., 2003, Genetic Programming and Evolvable Machines, V4, P111, DOI 10.1023/A:1023928811651; Zadeh JN, 2011, J COMPUT CHEM, V32, P439, DOI 10.1002/jcc.21633; Zadeh JN, 2011, J COMPUT CHEM, V32, P170, DOI 10.1002/jcc.21596; Zhang DY, 2007, SCIENCE, V318, P1121, DOI 10.1126/science.1148532; Zhang DY, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2965; Zhang DY, 2011, NAT CHEM, V3, P103, DOI 10.1038/NCHEM.957; Zhang DY, 2010, NUCLEIC ACIDS RES, V38, P4182, DOI 10.1093/nar/gkq088; Zhang DY, 2009, J AM CHEM SOC, V131, P17303, DOI 10.1021/ja906987s; Zhou C, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9102	81	163	163	19	140	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 15	2017	358	6369							eaal2052	10.1126/science.aal2052	http://dx.doi.org/10.1126/science.aal2052			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP8TH	29242317	Green Submitted			2022-12-28	WOS:000417918500032
